<SEC-DOCUMENT>0000859737-20-000039.txt : 20201117
<SEC-HEADER>0000859737-20-000039.hdr.sgml : 20201117
<ACCEPTANCE-DATETIME>20201117082030
ACCESSION NUMBER:		0000859737-20-000039
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		140
CONFORMED PERIOD OF REPORT:	20200926
FILED AS OF DATE:		20201117
DATE AS OF CHANGE:		20201117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0928

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		201319294

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>holx-20200926.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:f4bb5493-eda8-449d-a170-7314862f7798,g:08da96e9-86db-4711-b125-e777b2cffbcd,d:8ddb964a7a024d63b8e4009970e71997--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:holx="http://www.hologic.com/20200926" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>holx-20200926</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF8yLTEtMS0xLTA_60d90d53-915f-494b-ae95-47b84f171267">0000859737</ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF8zLTEtMS0xLTA_9df90387-efa4-48be-b753-6237e3007892">false</ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF80LTEtMS0xLTA_d6dffb4d-56c9-4cdf-ab34-384bcc3dadc3">2020</ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF81LTEtMS0xLTA_e9bc2480-8ddc-4fc5-92bb-8599f29d3fec">FY</ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF82LTEtMS0xLTA_69661694-c7f1-41c6-af38-e7d86d151f46">September 26</ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:WarrantyTermForProducts" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM5NjU4_08c7a977-3e74-4ea4-ab24-1584cb253ab9">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ie9ec2f408f84441f8be19c8da6fe2ecd_I20200926" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzItMi0xLTEtMA_dbc9583d-1d41-47b6-aada-7cab33c5f74f">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="id732b75e70474fdd99cfef04a578daac_I20200926" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzMtMi0xLTEtMA_23db73e8-5082-4111-86d3-c46174f867d5">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="id940ceae94cd453190bd3a93d6db3048_I20200926" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzQtMi0xLTEtMA_ad91072a-4255-4ad6-aae2-f57ea6b9b2e9">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i6f509287fa7d48aba904c4bc91d15c97_I20200926" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzUtMi0xLTEtMA_4ddc10a3-9a09-4d05-b567-135c73003dd4">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i60dfb47aa97248bd8efcffeb6e4c16e7_I20200926" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzYtMi0xLTEtMA_241a53f0-5beb-4a91-b348-f1a1ccd5833a"></ix:nonNumeric><ix:nonNumeric contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929" name="us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c">us-gaap:LiabilitiesAbstract</ix:nonNumeric><ix:nonNumeric contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4">us-gaap:LiabilitiesAbstract</ix:nonNumeric><ix:nonNumeric contextRef="id3c092381c12421482497e088d638a81_I20200926" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af">us-gaap:OtherAssets</ix:nonNumeric><ix:nonNumeric contextRef="id3c092381c12421482497e088d638a81_I20200926" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="id3c092381c12421482497e088d638a81_I20200926" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf">us-gaap:OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ib5d1f26c41db4389981295f374b306d4_D20190929-20200926" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM1OTU_52c76a56-1dfb-4edb-afc4-0cd46b21920e">P4Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ife111ee530c544909f65a587ba76bf81_D20131201-20131231" decimals="4" name="holx:PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzgvZnJhZzphNjUwNjM2NTc5NmY0M2NkOTJlOTg3ZGZkMTMyZDE1Ni90YWJsZToyOTg3YTBjNDVkNWI0YTM3OTc4YjMzNDJmNzZmMDFhMS90YWJsZXJhbmdlOjI5ODdhMGM0NWQ1YjRhMzc5NzhiMzM0MmY3NmYwMWExXzAtMS0xLTEtMA_6694f192-c0d8-4ed3-90b7-495579ca19f2">33.33</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926" decimals="4" name="holx:EmployerContributionsPercentVestedAnnually" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODcvZnJhZzpkZThhNzFhNjUxNWY0NzdhYTk5MzVkNzdlNjk0MTdmMC90ZXh0cmVnaW9uOmRlOGE3MWE2NTE1ZjQ3N2FhOTkzNWQ3N2U2OTQxN2YwXzU4_e65b27c9-a236-421d-9881-84dff81ca375">33.33</ix:nonFraction><ix:nonNumeric contextRef="ic0a23c124e8840a1a8dcbc946578856b_D20200628-20200926" name="holx:TransitionServicesAgreementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczODg_f503a2d8-b974-4218-b6e9-25fc199ad879">P3M</ix:nonNumeric><ix:nonNumeric contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMC0xLTEtMTkyODM_140646f7-9eab-40d5-8cc6-927f67371b99">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzQtMC0xLTEtMTkzODg_736c4b8f-a57e-416d-9e6e-a6211fed51d8">us-gaap:OtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="holx-20200926.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i618d0cdeac854d4092ca21e44cfcda3b_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ic2880c96e3234c25bfd593a102de3acd_I20201112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d41300e13ae45ef8bfefa0d42f63c4c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c26ccbfa54e4fe0839a4a6c78466347_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia549e6971a604015a25803b16c10a03b_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i794e99945f544149a4dfb0dc4430defe_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76b85f8e0cc641d6811b0f647a80c0b4_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i688ec76adf1140acaab8d25b511667aa_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3117997fe434239b20f6cf308ee6614_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6199234c2a9d4588aa6dd0e453b067ee_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d2a775a080b412fa3dafce51e6d15ba_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cc3451a488c432f89410a83c10d5d44_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3c092381c12421482497e088d638a81_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08aaa1dc14eb440ab123d505e79e47ec_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i009d515470734764a45e17ec26571fe8_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319b89b955fe451e88544cf9b525eb59_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7928b977a78c48f7a935d7a39083e59e_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03175a6288164c5db9844f6e6247dd76_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb9f527854bf4eb285447a902fcd7098_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84c88a850d71453097932f0bcbe84825_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3680c6a61084f738e0282f1f1563837_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50a8cec88f63482ca86e8907428a7f7a_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic930cb3d51304cadbaffbad6e4174a9f_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95ca35177efc4ae98f89b9162289d0f8_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6afd02343ba40d68f7f7d2d38b8d6bb_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fdee7361ebc4584bbc3a5cfe6444f08_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03e40fe371564654b09f93a1ae599923_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0174c6f539e747949d68830c151f307c_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie46091349b474da791e8169a5e898ab5_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57069c8fd22f43268f97f2c41b7f2a8d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d8bd96d523f45339390f0f694678659_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdbdc18a2bcb43a3bdf8e6c1cf19d396_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1a27903b45f460e8b58b329d59f97d8_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21125621c43043b5a43f09df6f874b52_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71115cc05c394a8a980ec543ca44bc53_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id804545a264447f98e68c02862888397_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c166eb8bb6741edb7c59919ec94dfc7_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4d7c88b3174a34837a1c0045f15e4d_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadd2a9a1773e4a9b84d417b384632c4a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id050245a51244dfdad49743f31133eb8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i032815f3d67a43c29b8c166834679ea4_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36030839f7884303bb258fae716235dd_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1957ccc6b7a54f27a19bf968742bbf75_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94e21961902342f58ae493fd44252348_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49a3d6edcda84d5e8d51e6886159c6f0_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc54b6fd6f2747fb9422322da3ef9079_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa08cbf6d272455e8f8d4fc150075d1e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75f2f7acec1c4c4aa787e72d606b369e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31584edc599f43b4b1edbb086c4349e5_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibce62cc16e0d420ab20aa0dd17c08716_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f2b3be1822c481ea0d7d8b6f100c51b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>holx:Segment</xbrli:measure></xbrli:unit><xbrli:context id="i3f897a5c14ce46fcb14ced01b6827380_D20170322-20170322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-22</xbrli:startDate><xbrli:endDate>2017-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>holx:Customer</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i8f6314cda1fe40489c80c8c7c917a7b8_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcc5fcf2f538489bae3a4254ce198ccf_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a4fb96be7934eb29629fbdb7e72fd0f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff73c4f9e92e403e8fd1003738851496_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i552f7643b15a4fdd94f4b733fd38a0ef_D20180701-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d5133bbb5b643cfb4039e7683d511b2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01e39e16ad0d4d43bded461c3c400be6_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentAndSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i284a1c2b8fc740deac2cf49770588de2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentUnderCustomerUsageAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifba3583f30724dd495ffe080e345c8e2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentUnderCustomerUsageAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64ce780d2bc74dc48f001fe80ae1ff75_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ab13270771d45d3b753d44c0a05c023_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia576d0947dd14fb899e60c78615447af_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8383367e78c40ac903ab338ea02c2d8_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26ac442ab8104d62a507939b10fa969a_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c09129ca98843beadfd374cfab77639_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i957c4bc90df349dc9fad1b82c2de15a1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12c940cf715b419190f1afe48785d4c8_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d996d37cd674a338e18e859a3513b71_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c8b5f4261041a985e22dbcc3ec25a6_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d0f493e80c8407b9a276a3459c6e266_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i860ddac9336c4aa397d8f6b67401b31c_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68050ea428a94c1688589a99714f38cc_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2a5caec8822438c887854c7fefc3007_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie69340311e9a4b308c4862870d12638e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17f074670baa4f1d934cf4b17758e8d5_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6a066f4761243508c40140e40ef6af9_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i302abd2449094a9093740c9423c08c05_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04d58cdf3b9742bab6c632b1c6bde482_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58479218662d4362a06891b6d76a89ee_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0db0cb781464d528ec7ee04920ecb28_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8f4cbe1c0914b04bceeebc3cbe0bb61_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea670c4c01544dafa2cba9693bceb1e2_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f5a289dcef4642b1a31621e515e16e_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16c34f677a2d4f08b3c7c62af376754c_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic47589113cf749b8b8b586c11fd7976e_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61c55e342da24eee9282df815b492d78_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51211784b29941399cb1944d9f011a2a_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89813ed8f2ea44b085d80d8ab6c4fc94_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41cbe32e1f1041339f89ddea6ec9c266_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i744c7283185f454f92fabd0f80a0ef92_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie578122249b043b0bdb831bf79737e98_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dd76668352442978fe04a0c59a5c795_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6223b3508b8c463aa3289a1a509edccc_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bfbe4fe947c43a4a22bb3f6c17cb1cd_D20171231-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-31</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae131a61f51b418f8d16b147c4f2e986_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6724b08a2857420f938843bdf83228a2_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52f401bcab374c9da21ba458593af4a7_I20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58ab6ed21a0e49acb17f46bb533a208d_I20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72959050a334423eb15ca612ed289237_I20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4eb2eab1b56414c8fbb0c756bf25fdd_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5548619644d4005832478fe4f7a75d0_D20171231-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-31</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i169afb67581f4042a9907e319c8aaee1_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b9b859e952c4dc086ae9de8f3020603_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i294e83c0d77f4a76b4cb43739eaeaf9f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5bea17c720745bbbe2f47855b322570_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dc3eeb5d8a7429f994641e93253a6bd_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69dbc69319c941ca9448d21361773988_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e140addb4a24ea78dd4c7f462c399ba_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96ce5d4500f64edfa02758b406d21f90_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7876712181a4f0394252851c3247e89_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i988d23f94723457db513c5aa1234acc7_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8b49a0c00624209ae298e13d31a8705_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib231ff2385b64b9ca2bb871bcfec1dc3_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf0c977d98c5446ca36e0ca5d209a7e5_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d5aea5a6dce4ff3a0ea7a9f0a6e7e04_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34dc1d8ed3e448048896ea6acd36bec6_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a8e80b3d02048368499f2fc987b666c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8c69c195a394e1abb1f0343c9c25508_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66e0c7ded43e4ffc9af56c596610e242_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i339a5d0289c34c65ac5ba8480d1803a2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437292e8142d4d96839af5869cecaab3_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i305c6e69d9584df69b07d0c58b68dc88_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if85520f01ace43129ad7669c2083f920_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bbb9f4ee2a14c8a8ff8db71fcca17b1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e1f1b09ac83442a8c991f025f87c36c_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafc353efac2f474997f4ab38d4cd03dd_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9b833795a14c34b98fd573a5bb02aa_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2febf310c33479bb7213e376d43d131_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">holx:PensioninAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice34049f21724d2a89b07c75c6bfe1a0_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96d2d76048144084a688883b4c23ca74_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49fd9cd9c1a44756877deaf8449c4ce5_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">holx:PensioninAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8acf153e8175463d854199e3d5b100f5_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd3354045a94ad6bc4f7dec67555173_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2018-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa82070dc0674b2b93dfb59c5365695c_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3eb72f6ddde4172af624dbe36bc89d5_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4a7fbf31ef34d35a542b3139d2d97b4_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61680decf3094210970e74b87feb098a_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21e0c51c686947c9a4167c8b13e37d11_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a6303307844b9ebc5be9434c2819ad_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie21e889f681c47ca83ea648b1fe24ff2_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i059452d2deb54b2cb9873ef23f27c960_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7aa80690b724dda81b234de06742f9c_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id438b62a9541447d91c50df6ab64b0c1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dfd4338227d46fc8dfbceb1cff06631_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d44b346ba2949ff849a666fdf96eb13_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib23d81f77fd54000b2214c1d2555f31c_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0150d6d7caa4efe85607759c805b3e2_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic52f7f7067a847028ef4c89e9a861db1_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica6b881644254b8fae9fbb03c69fdc79_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb6934bac52449f8aa6c53b295caf5db_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if04f766e5e7f41629fd5954a52f9482d_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6599845afc5441e58d23ed545c1c2d90_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4ca89e21b3c4afa91bf0c9de4dead2b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i304856dff4354c09a218d0c4abcec6b1_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i826045fe76ba4dfba8d2b77577790871_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51127895ec4446f88b062df8c3424fed_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc65f9a1944847ea81ab96621f47b0ce_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8333f1fcd3424edeb40667341d0ef184_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e78594f4bdd44c39236b9e9233d4e5d_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93d07ccd1813413cb535430965ca43e1_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife0a4b80cdd24c8182c3da3c0ac3badd_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1dc4960757847fa975cbc5ef31a88f8_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibce772764f914f9883988915d86d6810_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d1559cdd9cb44c1af1d7faf1f2cef88_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if521ee7691434488a8c4a940762af9c0_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if06ae85100604f48a0354fb2181504ee_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d08665ff5e7428b92f2f87f995f6523_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8a91b66ec814b6bb11ea904156f4239_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95cf893d7ec14704bea7fa6c16427a5b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83bb398da9034ac4a5154a80046899ad_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7ee31ee47384d66a52b606454a9d4ab_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibddc782db0444af8bb871d7496ee5746_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i590c2022b4324ab994b2164138508d88_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf8dc695c92a4feca4702aef44167616_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bb5a21e92604faebf807887f9102015_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8a58cf3c461492482d5dcd9b88379ed_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4781b8d56e34db4ac93197bd725223a_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i104ac377ebbd4e05bcb47bf521f5ce4d_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1facf79e2182457ba4133a1ec0ba491c_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28a65a25ce95429a82c5b19cf486e81d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e1e43e160f844f3be9e65aaa9ae3159_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50934cec2c9c407b8ea520ce4db8e3b7_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42a30e107b544ef4b4edea002da71960_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ca63f8d157f42aba21c14ee7c153d70_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i592f0856c5084a32af46ff3a1e046ee9_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd3b478fa0f24dc3aa889f9a058d9d98_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4da82173bd744edb84691e936f7ccda0_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5464405dc015456e9897532307f11895_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ddddff86b3044d7b0fc9b7b2b963bf1_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19d3c5f4df704cddbdd7827a6451b621_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc133df909ca464f9c8e3787dcfe2475_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc84af9eb3104cfdb19db77db92ed7b4_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00e65a49339a4f9bb26bf6c415e08e18_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c33876277774ccea23ac78561fc07e0_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fc5ccd5fc274beeb5b3be51f76cd623_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4cf0729ec2044dcae9c2f4801fd2420_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c664f83a3cb4954bc77a1877cfdc72c_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e2f531aee5246619095d14dc0f8b6bf_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i309e38f390b74c389c1f84c1b4db88ec_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieec8d0273727499c80a7201ea239a090_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if95130eeb1d844f0a7c10fea2f52bf39_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f3886c217574265bcf1ad1049b1aa4c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a29accf22242549a492fab1782cb94_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a1ccd58830248da8f29187c9cdd3079_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff15a89761f34f66a3761888623b4f23_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0833ea6babff4e13aa4c24c6994f576a_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65e9eb24efa944359e8a021229406acd_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic60ae0c151b445a292490043ea13881d_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fba52a0614b49c585ea7cb3df44be14_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8471b299d850453f8bfca6a20cd0512b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i828ebe5b8d494e04936a9b538c0e1948_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia999e530e95c420abe9226d29b3d86e0_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ee90fa905a04d32957b8acbaa2c1bfc_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaafb7ab1c0441ec87d9abecb35da291_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i006de4dd9201414fb767930e647b4405_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadefe10680934f5580492d9dea95bf7d_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60a5014f96a34cdab508fb56b98ac1d4_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadcf8aa033b9410c824f6c8d1cf3ad39_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b04cfb9cc74ed9bb9c61e376dc2794_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i962c11ce0c514729be1b050aa28ff2e0_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e9161faf1934aa3accab7a9fad64784_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i512a078a5a374931bada540cfa1a291e_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83a4bfcac8ba430ba82768a85a67c700_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47df0fbe43fe4e708bd87bf78a6c73aa_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aeae7e636114e169ab5ca6cd732bffd_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i939dcccc02d247098b6f0021c007686c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbc8d674b6954826ab5d78856d5fc97d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i667ad16a082a4c12a8188f400249f907_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96c41424e4c4429f833f974caca3e9d0_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i640618ae1089409aa397c0b1d6630ba7_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67b306ed18214b529569e273c6cbc1b2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24e8f75e7420456aa25cbce56e1e8320_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5d4c49bd355481485ca7470fc27601a_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60c82065c41f4b4c993bb38268ef4b55_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i790335fe6b504d0694a773e693b48987_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1410a37395f9458e8fa278adf018a579_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie06d07afd66d4433896cd49ac429b433_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb8cafb83e0443fd9f04b2a54be10659_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98a1be5bf1eb40548cf881d45cfa3212_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1af779ff4d349c0bb004322df29066a_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c3b64e5f16145bab3d37ee0bbc5df6e_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i374d2bf4a31b4fada151536edc6446b7_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d7773a142f248d98fc047e667923b9a_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0b1fbf643bf4d87a0f62662f56e72a9_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eb202acec0f4f65bc34389e2af40e3c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22ccaf1b86dd4ce1975c67773f6132e3_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68690342c39340df929646cbbb4d0fb5_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a86961b941f4c698ca817317ebb55f1_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia95060407ff54c468b06a661c8fabc25_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65a03228708e48bd91808873ac0aef49_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9775b97e92684b93a13c7004b3787bb9_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52f05bd0d07b41cc91cc734c6e8aabd4_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f2349edc55c45de9425f98b0200d5a7_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic693f14699ba4968bcb36cc7b8b023a7_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6acedc8e09c84b2e89c7f0cc800be0dd_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb0fdba95bf14963b575eed35c0be6b7_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia889c74fa094451886ddf4da8cfb8b39_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i404bb6871a4c4ab480a92c1a5f85724a_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42c9ec0a387465384f173e101feaa39_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37a58071a6be4fa68958f54a1146729c_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i105ba05d0c354f20b5883424ecfbbfeb_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia619a463826c4b1aaca754c1bbd0a455_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad9d09e7d14346609c65daa29e0cc27a_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe6d7468b24745749de9948726eabd87_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb6352a521944f2fb02cc1dcea86de83_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb8e030e4bcb4d11b83c486a8c3deb7f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ca6c2bd19e94add871a8ae7f87f8147_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9ec2f408f84441f8be19c8da6fe2ecd_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id732b75e70474fdd99cfef04a578daac_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id940ceae94cd453190bd3a93d6db3048_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f509287fa7d48aba904c4bc91d15c97_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60dfb47aa97248bd8efcffeb6e4c16e7_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id022bc111cb949abb3f669ff592a75c9_I20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22479589b7d74fc680fef5abcd3d9de8_I20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i570d6e2471dd4d25a99fe27c526db531_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32158b5e90814831821e7b0a2eb47b70_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63fa7301a7954f429d5733f26da0769e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica831abf5b804562b479ecb7d6da8ff9_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ba215b8102842d7a0db14145f80c875_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic439fbf0ea984bcba40c13f6cae3a03b_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60c64e349e7248b4926861f03af3baf7_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6628d4bd404a4b39ae1f8755ac19e156_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64e80cf41696467c9ffc4409327aade0_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf4c2cfcfc8644a2ac89ad085cbdce46_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6e062bb74fb4a87a11ce9920ba3bf95_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d09efae7507467987336d04e3509634_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i862a3c45416648d297e125475abce254_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie33a898c5926488b9bf6ad622a0bd9a1_D20191230-20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2019-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13b5b561b723452ba061ef7677378758_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c2998316cac4e238f728957efe3c4b1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic533d50defe448fdb707c6f87a49077f_I20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22886537724e44318a4d4b7a40157a84_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90fc1953e74547ef8567e85c0335320d_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id37fc47d83b14b95b70cbb4ef25f42b3_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie68d86ac2e6a4c928f6d1a734e19ab2a_D20190728-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-28</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib35735436ab04420aac409cb3a577c1d_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6add9e14054057a65ac31b811fae48_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06df67bcc2a94911a7069e16ec48fb7a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36b884f4d126493b8f8989d941004da4_I20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13dcce25b11542068d5ad5a656336c29_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2090212e7314cac8f3f33afb4394112_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2576885bfe07425f9e425c469ebe8367_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02f15446f52343a9adfc4e8ef6c280fb_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia43db9b88a3d4ca894ba73187fb33e22_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i781dbf5ddcb549d383a457e18753ded3_I20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c2a49b788f14bf48455c95dcf507a9e_I20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9c201c0913b44d98e588a279d1fe985_D20191001-20191001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica9f97800f804e4a9d1eae5069d40e02_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eb9aadeebec4587b35023639ede565a_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieefe5f2ec3a649449b7f480aa2fad0c5_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie12b0a99842a4517ba08e440afbc7c60_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i847787c89a874c6892ea179463d444ff_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17ca3ee0e1d24409acd2b837d6b9f512_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22cb2f3e35b1476184e3b5ea02888210_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib017ae2e40794fb6b06de53aea426df5_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6140a77a89524e3f94a9becd6d726c2d_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf55a89911c2418c862ba56b871a233c_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iece20c91b1524a47b452db31a8c50766_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e553e7d9bfc4efaafc3811a17018296_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3a1dcaf42754d9c9a3ff74faf8f61fd_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c4512920904aa3814e9c7a9fd62545_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibec87245e37445459f0a3ed8735ffec3_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9b201cf75b8459db2ad76cb990ec129_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8f378dddadb4b4fac57b2fbc214b4c9_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i045b09a2ab1943b59f87d6eb5f4942ef_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d6a98785a404f99847c50b43c96a34d_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78dfbab8f2fc4de39f7b4e445e2589f2_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9916a6d68484e70bff8c6d8f2a2e4ad_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i266eecec31bc4b7d8dcaf10d0b94db47_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4079f996b6274dfb9512d61934ca5bd0_D20171211-20171211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:EmsorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-11</xbrli:startDate><xbrli:endDate>2017-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:EmsorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb2ff4168e384034bbf5532623a74329_D20171211-20171211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:EmsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-11</xbrli:startDate><xbrli:endDate>2017-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if04a98f140e34852950c49c8a2573bae_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7847ac8d91804cd389031be4f03425da_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44573f3f88454bfc98195170bba8514d_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40fdaceff578441ea2d62d53dd29115e_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2966db0031f44886b68900666c4010d4_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eba256d6a1542db8c06d5ffa4b20a07_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6630fc5f65496eaec9acaa3d5c7aba_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i585bf0cfe60944f78c6482f3beb7d14b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia99af639d7f84346aca75ba9ef329ad7_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ad1871e11b04ce3a9b3d2d7995b3439_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia488122214b14db38171d7681cd5d254_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cef01ab57d64322aacba4e684ef1326_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84c64923b6e84649978c4e2b356e67ae_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i245b71f07dc5421b90a64dfe2ca519cf_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7917afc51a284eb389f470fc51464390_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c335097c1214c7b8b5089dfca5b78e6_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id214db94d871423c97d744696fba6ee9_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i383968572a2740c4b1b1c3a6102235ad_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd8fe4ad3af14cb080a973256cf16e71_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a33f36d28a4ad59b7fcbc84448ad87_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1545ced1b6bf4384a44fd70aaf8d5dc0_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ided55a75f2a34ea9b423f3093d7e3bf2_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82fe25951b1d47608e534a368540c8f7_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4caceec0ff464ef58e11ca526344ce87_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41126a20c7047088eb9a490e7b9aaaf_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdfa048e3caf49b6b54a8569a1e075b7_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f7c0803ecd34f7192e3525b7d33f970_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e85e552551046dd94bb25760309804f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i092a31ade66f4c8eba80fb2ee0565ae7_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i405e231a699e41a6b9f765aee4c70e34_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i107f31108f574bb2985391d4a79fc410_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13214cc3feb64fcf927862343c34707b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i644ee2acfbde47e4a5410d9be6acf9cd_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bf13b4f96464ec4bab32a562712a405_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a3bbfc15f424fce8faf36fa3102c868_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ff6affa1f43454fb0e3a3b5001fa866_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7868b801a844b96ba9f57ab9d96e829_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a76896977394657b24f892dabfb2d28_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b403fb32e214730a66931c9f20f7ee5_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">holx:TepnelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9ffe8cc379041dc95ec1a2845bdef3c_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">holx:CynosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18bb9b460f2948c6b33b79494de5a775_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d2600bf769f47179667bb435345373d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75761de28d1343d2a77be06b0d507b3d_D20171001-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:LybertyWayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i762786f0664c4c22b2ae67f6b01c9bd8_D20180930-20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:LybertyWayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2018-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b4bd78551ab435bb3059282b0371b60_D20171001-20171230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0932a399229f47ac83074c5e06bbc0c6_D20170402-20170701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-04-02</xbrli:startDate><xbrli:endDate>2017-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i520af16098c04865986cb5e430b160c5_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2da745af2d74be6a6328bb22fc1c348_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb22b22b518245c5af080bc07bace384_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fd7ad15f5e24a678e288eb53e978668_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60d56d6d8a714585ac83977c31d4ab60_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id80a9b5c1e0a48b8a0ad99dbff5d9c5b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e1b2436330a4b7a9a2624f5cd7ca5cf_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id57204513f2e4047bb34a203195e5e4a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9495f528a35e4d6db0680ff16dda56e4_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c014abf52b48b3b4f228ca2997399b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfc9503585304f80b0bda5108dc6141d_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i855bab3266d4415c8e89b6d9be79edb6_I20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i643139a0070945419368a19ab57e080d_I20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if777467cbe914235ad2b43c07ebb9e28_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebc8390a06a94a30a7711d90782cbfff_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i890f64beadb143b09f67fea3c0b0f562_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i832ef0aa8ca34dfab05f2e95257c6146_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f1547ab54254a239a247c8a112272c3_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25098fcc693a4912b794f37a396afce9_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib968be61a4094d0eb0f1daf52ff7d843_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditFacility2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i594b4573152b448cb7a66c5d84a63dbb_D20220625-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditFacility2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-25</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb75a80924734ad9834561c374f802e1_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="debt_instrument"><xbrli:measure>holx:debt_instrument</xbrli:measure></xbrli:unit><xbrli:context id="i5e8f4af13fc243f99fc0c25b9dbb20b3_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idde9cb65eaea4006b4a3a0e5a2272ddd_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25f90cd313c948d2a108a87d9a94999a_I20171003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:TermLoan2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b9bbbdde31f436aa1a5765b37448a8b_I20171003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:Revolver2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4663f101db0a4ba091c45be3b47b7c37_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:Revolver2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c5d81b35a2241da877d3e4a3da33071_I20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bbf0b9e21774990be085b97a15bbd5a_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee1d3923c6ba4dc4829757b7a7580a3e_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i974288f6285044128c2b4e1690e36c23_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfd0405aae91417aae27ed964af861e1_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ecb1b74ff6b4d1b9db466141397e214_I20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7afb5a8c40684333859218062faaf200_D20180930-20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2018-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa285bba80d14c0cba66dd5448fb5440_I20171010"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic272797ead73491a9d8ada44c35c9e1c_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad5df08e269f4792a90def353802fc8b_I20180119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06ed0e83b77e4dac8ff73405d8588a14_I20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e0434291a6f4c76aa8fb300ab8d179c_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd7482e7e024b1d8623378c63515cb0_D20180119-20180119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-19</xbrli:startDate><xbrli:endDate>2018-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0594ade531b74789862cd43513f6fea7_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a0afc09611c426282e6aac4be10661a_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3d6e02785004a0d8d101ecf6ec84b38_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c177c25617f48bdac09172a3df4017c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic678ac46fcb54d49b964689428ff6dc3_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee80a400131f496b9f303169165255f9_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i208ccf38964e488ba11badb451812ff1_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i625f89ab8266425986dabfe1ea7cce94_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i949893e5021e4b72b6e04ed4c620d53a_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53165e60abab42ee834675a6c4488642_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i181188c2b11e4f169032adefb6546ee2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04f56e3fa2a540c0b6ff0e3af30ebd18_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic79a7b8640a04f25812f29fbf9199284_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91a5f72252c948bd9ae64687e324075a_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i053c6045e0324fa0adf4cc3c967de7c3_I20180215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6263cf3be0e74b85ba827b9b7dd3bcc5_D20181230-20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-30</xbrli:startDate><xbrli:endDate>2019-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4300b435e3a4c91a4ec915b5cdebce4_I20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c7d1f23582b432c91b2a801b77b2fff_I20071210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandSevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2007-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56b1e7b3625d4668b6803a4af269897d_I20101118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandSevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-11-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ddc0c2de1e45d59da01228f7057b59_I20101118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:NovemberEighteenTwoThousandTenOriginalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-11-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c1f5e115c2b4f279149b8ef1e703af0_I20120229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandSevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie58aa7f211694a7f95581b9c6ccdee6c_I20120229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9671b6718f6540d09891ee6161cbe7e2_I20130214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandSevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7243cd452dc4ea3a000e9653cbfe838_I20130214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11258e03918544b983db64585b8a57d3_D20160925-20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-25</xbrli:startDate><xbrli:endDate>2017-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b2cfabcfcd5475e8db2636fdfd71b6a_D20160925-20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2013NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-25</xbrli:startDate><xbrli:endDate>2017-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dec2acad41c49ebadf65a9fe79a16cf_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82d36f9b38d44e27b3125f3ed8fc2179_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2f74c33a2674954819e52e2acf2aaac_I20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic93b7c0c776447f09fd2252ab71327a8_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i024d7046a83a4ae88bd3445fe4d74f1e_D20181230-20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-30</xbrli:startDate><xbrli:endDate>2019-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ec620e29d184821ba41fb6c0d5e4744_I20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafbd2a1d68ff4c35b4234cfba95c6ccf_I20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2013NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c7d3a787bc64690aad62c65bab997c8_D20180930-20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2013NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2018-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i821e7870d37a477694bc08b8bbc795c9_D20180930-20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2018-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2bbe4541be240b88496af586754a36c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2da5b318239428794fe8166e45245a4_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9d2a93700d14286b21749a928e012e8_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eb2ee0310c54acaa58b9b3c9ff34788_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba4c5eec04f245b89eebd5d83438a62c_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6ba005a39094d34834366256211a18d_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c5c02cb6674ecaa58ca75f0fce481a_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4a62771e5894787a4fdaf44eca8d691_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d1dbd5a9ccd498d8398ec990203070a_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41746832831b4728af50d9772e03b7d7_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b6105964ce549019e14f33028ca3323_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c15de09124143ea8a8d715fc0b85a09_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f7f09624f1434eb681cb9758d19eb0_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida7278d273404326ba040e840b670dbf_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c634ae6117f4462bbe028987d490806_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90fd61a9da9e4ce2a983dd400f24501b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ea11973d1af4316b1f3c636f82b9cf5_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0666efcb300b4877b0616c64336ca6bb_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id307307c5904493785fe09305537074f_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e49a76f02bc4a9a9d1333c24ffbf535_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7c95670b0ba433f9c62a89eb2e10a1b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ef55f270ba4439e93dee1c6e0b97d71_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf733f9b57054072ba3f09920206c6a8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if62353ddace04e659ec61002adae44d8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0649c66c33ae4abdab88cfc48ee8e0d4_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i494b1a50020e4595a4944efc9524702e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68139d7bb5fe4486ae433c49b7b0574b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2397882191544728c3e25abcecedd2d_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5f94ddfbab141ca9fd6143ef82e2729_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd832222fbea4e8a87ad22cac73a787b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ff8a401caf348ccba10912b17de5ff3_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3500b3aa228e41f5a89f346d0296c04b_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d97a6111f044441be4473a086df1d40_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i173b234856a64d389d94ce9755869ba6_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0172a062a11d4a9b9ff8ce7f340127e5_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8cc4295af424a959b5d571941ae558b_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e5807a53cf54cc88b9b54d32079f6fe_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52321d5b7f4c43e0a78b02f5e2f66d46_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ed21b822c534ff5bac482a2f45adb03_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a6bc74d82454a129b9c287e500fb859_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a09695c32df4cd28cb1bcb683a730eb_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aaaf1ae6a5547bc9c542f11e36741ed_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72dae67f6ad547c18f4306ab436421f8_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9cf7097d00744cb8193ee46040dab6f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c79ca9a01124b35bef6eba993c991c6_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a00d43da17d4cf2a160f87d1575594f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id123129c423e45f0bbc343073fa91e2a_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe5b12d49cf249b58198f0ed8726f8b1_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e18b40497764e718b638209aca9eb1e_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icba5dbf998314e0387202bf4eb404a3f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17ba19a80b3e451d950ab549195d0151_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7975507c75e442eca0e695649ed6acd8_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d9bb748a0d64e65b6a66c49ad23d0a5_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9bcf8515f054405a36ddfe578351f4c_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4434900ec76643218f461bb16c843300_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5082098bb8404831baa99e0bb0a4ab26_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-30</xbrli:startDate><xbrli:endDate>2019-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73c475cf26a140439e4b7915e83f35fb_D20181230-20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-30</xbrli:startDate><xbrli:endDate>2019-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i216e053a60db43869c143b5ae19d8870_D20181230-20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-30</xbrli:startDate><xbrli:endDate>2019-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6475457bf9c44539a19af401366b4fa_D20171231-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-31</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84d0c5013ed249be85fc1ea500342cb0_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5afd9d954b4489889417286bf08a16e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2070f7d8bb34bab958a30daea1bbd42_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfd0cb53981e490ea162a76a039de64a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99e5be2075214d609076dc73419bf0c8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f5ae045d54044febe4e33ec32c959c3_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d5ec4cbaba458ca1b77246243d3989_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">holx:NetOperatingLossCarryforwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd756bca5be3431186e7d993f7bc13be_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">holx:TaxCreditCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic48110a0e8a642a6b8ca649bef79b27e_D20180701-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4df61e30f2e54979bf7daad2c81da1e8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47e07aff515740c893c4234255dbd894_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5fc614f9e5f468fa0553b7f4576669e_D20171231-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-31</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87614e59ad424355a0cfa527678f7644_I20160621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Jun212016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i567472971b68464e8f2541822940d766_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Jun212016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ffa5f4f0fd34c458b8ea83bfee55899_I20160613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2016-06-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87938771f4f4dbea1c6111f383adb40_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:June132019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i344d60e17e06466e9922242e3ef82b89_I20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70de3cec1a1146a9ab433c3d475cc634_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i236a8bf2139a42498b9343877c328ea5_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f4f0e51b7443bd94ce48cf225a28d3_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:TwoThousandEightEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied1237c55f6c496982f5cf0a7ad5371b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b8a865cdda34642b4c153cb74f8c7c8_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65ece6ed881340c0983a4d9a30e84a4f_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8fb000016144a92804e2ae8b96faa97_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i760d62d34b6c4e3d9fd83595b9544c75_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec0c47dbd6d148fd815d60b69a3d1af1_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec342e530b5b4e5cbbfb80a971db360b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9277765060a44848fd3c1bf6489f2f8_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63c9f52dca544401a06085cc4efa3e15_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if09747d2102e4179be4850c578ac2e26_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58a4ba4198cf4304a5d2849a8cd03384_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27273d926f654c129c15a62dc39b61d9_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae964ccd43014ae6a1f6c43ed006fd89_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95e9ea3fbbd84b0ca265d809ab74762a_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0f1f9a60e324df19c668bddb5052108_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d1f26c41db4389981295f374b306d4_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c2c9561d23a4512999038eae996412d_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09b6196b4174420b8327b0919e55fd26_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice730bb0ac124aad881fa4077c12c6df_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e8fd89d9b9f477a8ed2176e6f8d2ed8_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b926d761276461084bf3fb001bd3488_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i104ee4ba76c74aed9b201714d5f8ce04_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43643c78c5974a028da555a478aa52e7_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec34ce09c17f4512b3a712e8d193c4ce_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d45047c3cf742559c39657d33045548_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia847fce0b90344668cafc984721d53fe_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29db4dc36329440196aa20118733f489_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i938586f669074d699e349df7bfd5a870_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26da8197478a4c5594b3a0e032588eea_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2faaf0252c0e495f89cf1661f67bfe89_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fce35bd4c5b47ffb3ff0ea7000a3d6b_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bfbce83a3f04755b0b598f232407953_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28b5094554845ab80d0c3c9b07c0ebd_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15f3d181c2484886bc4ceaa42ec74fc4_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cdd3310d03c410ca044b216790a4efd_D20120301-20120331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-03-01</xbrli:startDate><xbrli:endDate>2012-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03f873eba04440daa1996d87fcc393ff_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8a80c13b2f643e4ba3bad6e12f15dce_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie56ea29037024f99b13b9416f137590f_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if304b540b69e455f95347a24194deea2_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife111ee530c544909f65a587ba76bf81_D20131201-20131231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-01</xbrli:startDate><xbrli:endDate>2013-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89dc067ea55a42809194d94e740c9bee_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">holx:OneThirdAnnuallyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f373267ff8f45d1911298976ebff835_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c7afed9db584308a9e0b366c0c10595_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6c043d4da794f2fa73ea7b9a2d37948_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e43de73b36940809bd154646af2ad6b_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e92294f2cda48528702362448bfea27_D20180727-20180727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">holx:CompanyVs.MinervaSurgicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-27</xbrli:startDate><xbrli:endDate>2018-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0114d332bb424de8ad15f9a123dde503_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic44cf4cf70a04fdb8f94550d3bfe376d_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic289be57c33044b29af60557d0832bb1_D20191120-20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-20</xbrli:startDate><xbrli:endDate>2019-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb517eaea5304290a5928b03c9057b33_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0a23c124e8840a1a8dcbc946578856b_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb5e44232158447d887e2d49f5bc7e16_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9dabb1d61574d2cab21bd7863b8df8b_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67c6559862da4a42b4a96b86727df860_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1250d182bbb64e628b8bb4c093917a38_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ee604a08d9432db6b6ba59a610c36f_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7514ebbfb861409a9489e0c250534728_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dcaf3ae16134f4ca7481e8ef0375fed_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7906857f1349431c8b718e5f5bc62d21_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fb0d5ec5a3d40e791cd77fed8adb08f_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79dbfa348b4b4250b64c8e02c8ba3ef5_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b57161c436e4f6eb5e739380ff16c77_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfe6d8929f8f4eb6b145835c10a13bfc_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11802e38f47f4fc3810df7e5a6f3b7f2_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if32c7c1cad54473c92473002d9ec70e2_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ff4e72158d04b05abd672b5cdb231cd_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia04cebdd8bba46d7a211ca6aa1dca44f_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a1f0fc50e2e42c4bf2f36b322f42bb2_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia19f8ef5fe114be8ae437ed2b272af87_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37cc679d8c4e4a0585fbc179881a744b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c4387e1e2e64a7ea880cc5c3543acd3_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbeba5af33fd49de80e3ad69f10870d4_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6be6be2339044138fe1152c23d299af_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8efe51ef6dc4ed2a908a1cb2c698d12_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id99c49be9fbe42c6bb3e8f1497f9525a_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2d7bf9f967242eaba9ddd491ab703ed_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d1106e7081e4cabb0de079d952b614f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie488bc746f864b9cabc2df04f892e4ae_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26440a4dc78a4e2f9d24bd4827a7712e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic343686a6d7c4439b1715ce8372cb1b6_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i931d24edcf44412ebaf8ac5e6dc89022_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6455cb9268744d129ad43c18c13a0b49_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafd22066f01e475cb0434fb76714ac0f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127aa7477232423cb1285753b3416534_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dbb50a9fc7a4683852d6c1668547edc_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77fd19f2aabe44c188795c7adbdd651f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9562418944fb4261a833f679ae6db905_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cc490c87029449399e9fbd9f9732f85_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i129bb08ac6114158bac9490c19681bde_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f382276eec44239bdc0d3cebf1f2d75_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8ddb964a7a024d63b8e4009970e71997_1"></div><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTY5_349b1ed8-2ae6-4f1b-9317-7291459090eb">10-K</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6N2MyOGUyMjYwNDJkNDNiNTkzMDc5OTY0NzczYjEwOTYvdGFibGVyYW5nZTo3YzI4ZTIyNjA0MmQ0M2I1OTMwNzk5NjQ3NzNiMTA5Nl8wLTAtMS0xLTA_1066b7b7-ef09-48ea-9cd8-caf7bb44480d">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the fiscal year ended: <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18xOTU_3c1ddd27-ef8a-4d5b-bbe9-33ad39e50f55">September&#160;26, 2020</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6NjQ0YWNiYWE1MTc1NDUxOGJmYzM5NzE2ODgzZWRjZDEvdGFibGVyYW5nZTo2NDRhY2JhYTUxNzU0NTE4YmZjMzk3MTY4ODNlZGNkMV8wLTAtMS0xLTA_2533d79f-c164-40e2-aa07-1f02b4dfead7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc1_fb5432f8-098f-45d1-b733-5f46526375b8">1-36214</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc2_23a9113a-b345-4a89-b4b8-1051b2744b68">HOLOGIC, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:252.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:241.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGNkMDFmMTdjZGMyNDZmYmJhMzBjNWZmYWM3MjNkMzQvdGFibGVyYW5nZTowY2QwMWYxN2NkYzI0NmZiYmEzMGM1ZmZhYzcyM2QzNF8wLTAtMS0xLTA_df770045-f111-462a-ad7b-d2641d87befa">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGNkMDFmMTdjZGMyNDZmYmJhMzBjNWZmYWM3MjNkMzQvdGFibGVyYW5nZTowY2QwMWYxN2NkYzI0NmZiYmEzMGM1ZmZhYzcyM2QzNF8wLTItMS0xLTA_57e098cb-079f-4926-8d07-89db3263db16">04-2902449</ix:nonNumeric></span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc3_31c7f062-5d61-4ea8-8639-0d38cf97fade">250 Campus Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc4_26e21203-261d-4c1b-a231-a74a35241f2d">Marlborough</ix:nonNumeric>, <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc5_b95ce53c-5a4d-4255-ac58-e40e8ae32ecf">Massachusetts</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTcw_1bd0c279-7727-4d08-a917-2bfca7d01352">01752</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code (<ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTgw_136e062c-2a24-49bc-b474-09cf41da35cf">508</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTY3_accc0371-d43c-4ce2-811e-030cbeccbd02">263-2900</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:184.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:139.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:184.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Each Exchange on which Registered</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MTMyMTU4YjkyZWQ5NDdjNTg2M2FjMzNkMzgyYjJmMWQvdGFibGVyYW5nZToxMzIxNThiOTJlZDk0N2M1ODYzYWMzM2QzODJiMmYxZF8yLTAtMS0xLTA_b97eb6b5-ff91-4d07-8665-c15de471a97b">Common Stock, $.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MTMyMTU4YjkyZWQ5NDdjNTg2M2FjMzNkMzgyYjJmMWQvdGFibGVyYW5nZToxMzIxNThiOTJlZDk0N2M1ODYzYWMzM2QzODJiMmYxZF8yLTEtMS0xLTA_098aa1f0-3cf3-4fa2-94f5-735ffe6c8b8c">HOLX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MTMyMTU4YjkyZWQ5NDdjNTg2M2FjMzNkMzgyYjJmMWQvdGFibGVyYW5nZToxMzIxNThiOTJlZDk0N2M1ODYzYWMzM2QzODJiMmYxZF8yLTItMS0xLTA_5ab42dc3-c1f5-43d9-a086-8f09fb0dcf9d">The NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:&#160;None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTY4_5adda3e7-bede-49a9-913a-0036a4181601">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d)&#160;of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTY2_347941d6-1be0-4d45-ad31-0cdc486f0048">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTcx_191c1fda-d20e-40a2-81bc-60d66ecb335e">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTcy_2c4a64d8-2c86-4a83-b198-972017c569fb">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act (Check one).</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.715%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.572%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGI3MTE0NmMzZDczNDBmOTg5MDU4NzZmZWI4NzNhNzgvdGFibGVyYW5nZTowYjcxMTQ2YzNkNzM0MGY5ODkwNTg3NmZlYjg3M2E3OF8wLTAtMS0xLTA_36865c6f-4783-4b6c-8c05-a9cc56bf0ad6">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGI3MTE0NmMzZDczNDBmOTg5MDU4NzZmZWI4NzNhNzgvdGFibGVyYW5nZTowYjcxMTQ2YzNkNzM0MGY5ODkwNTg3NmZlYjg3M2E3OF8xLTctMS0xLTA_ba3bd213-78e0-4909-85d8-4d6904492d5d">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGI3MTE0NmMzZDczNDBmOTg5MDU4NzZmZWI4NzNhNzgvdGFibGVyYW5nZTowYjcxMTQ2YzNkNzM0MGY5ODkwNTg3NmZlYjg3M2E3OF8yLTctMS0xLTA_80e64589-0940-49d1-b15e-b95fd06c71cb">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. &#167;7262(b)) by the registered public accounting firm that prepared or issued its audit report. &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18xOTI0MTQ1MzQ5MDM1NA_8a3929a1-e5d5-4d85-aee2-84737e974f7c">&#9746;</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTcz_0a651a05-6755-4df0-914a-2c3e8aef0a5a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant's Common Stock held by non-affiliates of the registrant as of March 28, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i618d0cdeac854d4092ca21e44cfcda3b_I20200328" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18yNTkz_9b8a36f1-d87d-42ec-8fdf-b5672445dacf">8,530,248,376</ix:nonFraction> based on the price of the last reported sale on NASDAQ Global Select Market on that date.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;12, 2020, <ix:nonFraction unitRef="shares" contextRef="ic2880c96e3234c25bfd593a102de3acd_I20201112" decimals="0" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18yNjk2_91ddad5e-1d36-414e-97f0-ad2cfa745aea">257,009,683</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $0.01 par value, were outstanding.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc0_16f97dd1-3bae-4fb8-ad6c-f54b0cb30487" escape="true">Portions of the registrant&#8217;s Proxy Statement for the registrant&#8217;s annual meeting of stockholders to be filed within 120 days of the end of its fiscal year ended September&#160;26, 2020 are incorporated into Part III (Items 10, 11, 12, 13 and 14) of this Annual Report on Form&#160;10-K where indicated.</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT ON FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Fiscal Year Ended September&#160;26, 2020 </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_10">PART I</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_13">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_16">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_19">29</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_22">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_25">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_28">30</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_31">PART&#160;II</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_34">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_34">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_40">Selected Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_40">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_43">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_43">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_58">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_58">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_61">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_61">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_64">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_64">57</a></span></div></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_67">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_67">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_70">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_70">60</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_73">PART&#160;III</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_76">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_76">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_79">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_79">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_82">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_82">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_85">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_85">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_88">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_88">61</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_91">PART&#160;IV</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_94">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_94">62</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_97">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_97">67</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Some of the statements contained in this report, and documents incorporated by reference herein,  are forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements involve known and unknown risks, uncertainties and other factors which may cause our or our industry&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements regarding:</span></div><div style="padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:7.75pt">the ongoing and possible future effects of the global COVID-19 pandemic and associated economic disruptions on our business, financial condition, results of operations and cash flows and our ability to further draw down our revolver;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ongoing and possible future effects of the global COVID-19 pandemic on our customers and suppliers;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">continued demand for our COVID-19 assays; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to manufacture, on a scale necessary to meet demand, our COVID-19 assays as well as the systems on which the assays run; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to predict accurately the demand for our products, and products under development and to develop strategies to address markets successfully;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of the continuing worldwide macroeconomic uncertainty, including the UK&#8217;s decision to leave the European Union (known as Brexit), on our business and results of operations; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of the current trade war between the U.S. and other nations, most notably China, and the impending impact of tariffs on the sale of our products in those countries and potential increased costs we may incur to purchase materials from our suppliers to manufacture our products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the development of new competitive technologies and products, and the impact and anticipated benefits of completed acquisitions;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to consolidate certain of our manufacturing and other operations on a timely basis and within budget, without disrupting our business and to achieve anticipated cost synergies related to such actions; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to successfully manage ongoing organizational and strategic changes, including our ability to attract, motivate and retain key employees and maintain engagement and efficiency in remote work environments; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to obtain regulatory approvals and clearances for our products, including the implementation of the new European Union Medical Device Regulations, and maintain compliance with complex and evolving regulations; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">potential cybersecurity threats and targeted computer crime;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the coverage and reimbursement decisions of third-party payors; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the guidelines, recommendations, and studies published by various organizations relating to the use of our products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of consolidation in the healthcare industry;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the possibility of interruptions or delays at our manufacturing facilities, or the failure to secure alternative suppliers if any of our sole source third-party manufacturers fail to supply us;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to meet production and delivery schedules for our products; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to protect our intellectual property rights; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the possibility that products may contain undetected errors or defects or otherwise not perform as anticipated;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">strategic alliances and the ability of the Company to realize anticipated benefits of those alliances;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the anticipated development of markets we sell our products into and the success of our products in these markets; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the anticipated performance and benefits of our products; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">business strategies; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">estimated asset and liability values; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">conducting business internationally;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the impact and costs and expenses of any litigation we may be subject to now or in the future; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our compliance with covenants contained in our debt agreements; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">anticipated trends relating to our financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations, including the potential impact of the phase out of LIBOR by the end of 2021; and </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our liquidity, capital resources and the adequacy thereof. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:31.5pt"><span><br/></span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; "intends," &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; "likely," "future," "strategy," &#8220;potential,&#8221; "seeks," "goal" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events, conditions or circumstances on which any of our forward-looking statements are based. Factors that could cause or contribute to differences in our future financial results include the cautionary statements set forth herein and in our other filings with the U.S. Securities and Exchange Commission (the "SEC") including those set forth under &#8220;Risk Factors&#8221; set forth in Part I, Item&#160;1A of this annual report on Form 10-K. We qualify all of our forward-looking statements by these cautionary statements.</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRADEMARK NOTICE</span></div><div style="margin-top:12pt;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic is a trademark of Hologic, Inc. Other trademarks, logos, and slogans registered or used by Hologic and its divisions and subsidiaries in the United States and other countries include, but are not limited to, the following: 3Dimensions, 3D Mammography, 3D Performance, 3DQuorum, Acessa, Acessa Health, Acessa Pro Vu, AccuProbe, Aixplorer, Affirm, Affirm Prone, Alpha Imaging, Aptima, ATEC, BioZorb, Brevera, Celero, Cervista, Clarity HD, C-View, Definity, DirectRay, Emsor, Eviva, Faxitron, Faxitron Bioptics, Fluent, Fluoroscan, Focal, Focal Therapeutics, Genius 3D, Genius 3D Mammography, Genius AI, Health Beacons, Hitec-Imaging, Hologic, Horizon DXA, Insight, Intelligent 2D, LOCalizer, Medicor, MyoSure, NovaSure, Panther, Panther Fusion, Progensa, Rapid Ffn, SecurViewDX, Selenia, Selenia Dimensions, Sertera, SmartCurve, Smart-Depth, SmartSlices, SuperSonic Imagine, ThinPrep, Tigris, Tomcat, UltraFast, and Unify Workspace. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other brand names or trademarks appearing in this Annual Report on Form 10-K are the property of their respective owners. Hologic&#8217;s use or display of other parties&#8217; trademarks, trade dress or products in this offering circular does not imply that Hologic has a relationship with, or endorsement or sponsorship of, the trademark or trade dress owners. </span></div><div style="margin-bottom:18pt;margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Business</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives. We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Until December 30, 2019, our product portfolio included light-based aesthetic and medical treatment systems sold by our former Medical Aesthetic business. We completed the sale of our Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020).</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Through our Diagnostics segment, we offer a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther, Panther Fusion and Tigris), our ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Our Aptima family of molecular diagnostic assays is used to detect, among other things, the infectious microorganisms that cause common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, certain high-risk strains of human papillomavirus, or HPV, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, the parasite that causes trichomoniasis. In addition, in 2017 and 2018 we introduced the Aptima quantitative viral load tests for HIV, Hepatitis C and Hepatitis B. Our assay portfolio also includes diagnostic tests for a range of acute respiratory infections, including SARS-CoV-2, as well as a test for the detection of Group B Streptococcus, or GBS, that are run on the Panther Fusion system, a field upgradeable instrument addition to the base Panther system. In 2020, in response to the COVID-19 global pandemic, we developed and launched the Aptima SARS-CoV-2 assay (which runs on our standard Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system). The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. In January 2017, we sold our blood screening business to Grifols. We have continued to provide Grifols with instrumentation and certain raw materials, manufacture assays, and perform research and development services to support the blood screening business Grifols acquired from us.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Breast Health segment offers a broad portfolio of solutions for breast cancer care for radiology, pathology and surgery. These solutions include breast imaging and analytics, such as our 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, ultrasound and connectivity solutions and breast conserving surgery products. Our most advanced breast imaging platforms, Selenia Dimensions and 3Dimensions, utilize a technology called tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam, as well as conventional 2D full field digital mammography images. Our clinical results for FDA approval demonstrated that conventional 2D digital mammography with the addition of 3D tomosynthesis is superior to 2D digital mammography alone for both screening and diagnostics for women of all ages and breast densities. With the acquisition of SuperSonic Imagine in the first quarter of fiscal 2020, we now offer premium ultrasound imaging, further connecting Hologic capabilities across the continuum of breast care from screening to diagnosis and treatment. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our GYN Surgical products include our NovaSure Endometrial Ablation System, or NovaSure, and our MyoSure Hysteroscopic Tissue Removal System, or Myosure, as well as our Fluent Fluid Management system, or Fluent. The NovaSure portfolio is comprised of the NovaSure CLASSIC and NovaSure ADVANCED devices and involves a trans-cervical procedure for the treatment of abnormal uterine bleeding. The MyoSure suite of devices offers multiple options to provide incision-less removal of fibroids, polyps, and other pathology within the uterus. The Fluent system is a fluid management system that provides liquid distention during diagnostic and operative hysteroscopic procedures.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Skeletal Health segment's products includes the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm, which assists in performing minimally invasive orthopedic surgical procedures on a patient's extremities, such as the hand, wrist, knee, foot, and ankle.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical Aesthetics segment consisted of a portfolio of aesthetic treatment systems and procedures. We completed the sale of our Medical Aesthetic business on December 30, 2019.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Internet website address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.hologic.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Through our website, we make available, free of charge, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports, as well as proxy statements, and, from time to time, other documents as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. These SEC reports can be accessed through the investor relations section of our website. The information found on our website is not part of this or any other report we file with or furnish to the SEC. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors and others should note that we announce material financial information to our investors using our investor relations website (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">investors.hologic.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), SEC filings, press releases, public conference calls and webcasts. We use these channels as well as social media to communicate with our members and the public about our Company, our services and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, we encourage investors, the media, and others interested in our Company to review the information we post on the social media channels listed on our investor relations website. Hologic has used, and intends to continue to use, our investor relations website, as well as our Twitter account (@Hologic), as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Additional corporate governance information, including our certificate of incorporation, bylaws, governance guidelines, board committee charters, and code of business conduct and ethics, is also available on our investor relations website under the heading &#8220;Corporate Governance.&#8221; The contents of our websites are not intended to be incorporated by reference into this Annual Report on Form 10-K or in any other report or document we file with the SEC, and any references to our websites are intended to be inactive textual references only.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC maintains an Internet website that contains reports, proxy and information statements, and other information regarding Hologic and other issuers that file electronically with the SEC. The SEC&#8217;s Internet website address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We view our operations and manage our current business in four principal reporting segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Financial information concerning these segments is provided in Note 16 to our audited consolidated financial statements contained in Item 15 of this Annual Report. The following describes our principal products in each of our segments.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostics Products</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Molecular Diagnostic Assay Portfolio</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aptima Family of Molecular Diagnostic Assays.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Aptima molecular diagnostic assays are used to detect, among other things, the infectious microorganisms that cause common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, certain high-risk strains of human papillomavirus, or HPV, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parasite that causes trichomoniasis. In addition, we also offer viral load assays for the quantitation of hepatitis B virus, or HBV, hepatitis C virus, or HCV, and human immunodeficiency virus, or HIV-1 for use on our Panther instrument system. All three of these viral load assays are both CE-marked and FDA approved. We also offer our Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis, a common and complex ailment affecting millions of women a year. In 2020, in response to the COVID-19 global pandemic, we developed and launched our Aptima SARS-CoV-2 assays for the detection of SARS-CoV-2, the virus that causes COVID-19 disease, which runs on our standard Panther and Panther Fusion systems. The Aptima SARS-CoV-2 assay for our standard Panther system was granted Emergency Use Authorization by the FDA in May 2020 and is also CE-marked. Our Aptima products integrate a number of proprietary core technologies, including our target capture technology, our Transcription Mediated Amplification, or TMA, technology, and our hybridization protection assay, or HPA, and dual kinetic assay, or DKA, technologies, to produce highly sensitive amplification assays that increase assay performance, improve laboratory efficiency and reduce laboratory costs. Each of these technologies is described in greater detail below.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Target Capture/Nucleic Acid Extraction Technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The detection of target organisms that are present in small numbers in a large-volume clinical sample requires that target organisms be concentrated to a detectable level. One way to accomplish this is to isolate the particular nucleic acid of interest by binding it to a solid support. This support, with the target bound to it, can then be separated from the original sample. We refer to such techniques as &#8220;target capture.&#8221; We have developed target capture techniques to immobilize nucleic acids on magnetic beads by using a &#8220;capture probe&#8221; that binds to the bead and to the target nucleic acid. We use magnetic separation to concentrate the target by drawing the magnetic beads to the sides of a sample tube, while the remainder of the sample is removed from the tube. When used in conjunction with our amplification procedures, target capture techniques concentrate the nucleic acid target(s) and also remove materials in the sample that might otherwise interfere with amplification.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transcription-Mediated Amplification (TMA) Technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The goal of amplification technologies is to increase the copy </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of a target nucleic acid sequences that may be present in samples in small numbers. These copies can then be detected using nucleic acid probes. Amplification technologies can yield results in only a few hours versus the several days or weeks required for traditional culture methods. TMA is a transcription-based amplification system that uses two different enzymes to drive the process. The first enzyme is a reverse transcriptase that creates a double-stranded DNA copy from an RNA or DNA template. The second enzyme, an RNA polymerase, makes thousands of copies of the complementary RNA sequence, known as the &#8220;RNA amplicon,&#8221; from the double-stranded DNA template. Each RNA amplicon serves as a new target for the reverse transcriptase and the process repeats automatically, resulting in an exponential amplification of the original target that can produce over a billion copies of amplicon in less than thirty minutes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hybridization Protection Assay (HPA) and Dual Kinetic Assay (DKA) Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With our HPA technology, we have simplified testing, further increased test sensitivity and specificity, and increased convenience. In the HPA process, the acridinium ester, or AE, molecule is protected within the double-stranded helix that is formed when the probe binds to its specific target. Prior to activating the AE molecule, known as &#8220;lighting off,&#8221; a chemical is added that destroys the AE molecule on any unhybridized probes, leaving the label on the hybridized probes largely unaffected. When the &#8220;light off&#8221; or detection reagent is added to the specimen, only the label attached to the hybridized probe is left to produce a signal indicating that the target organism&#8217;s DNA or RNA is present. All of these steps occur in a single tube and without any wash steps, which were required as part of conventional probe tests. Our DKA technology uses two types of AE molecules that can be differentiated from each other-one that &#8220;flashes&#8221; and another one that &#8220;glows.&#8221; By using DKA technology, we have created nucleic acid test, or NAT, assays that can detect two separate targets simultaneously.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Panther Fusion Family of Molecular Diagnostic Assays</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Panther Fusion molecular diagnostic assays are performed on the Panther Fusion system and utilize polymerase chain reaction, or PCR, technology to amplify target nucleic acid sequences for easier detection. Our Panther Fusion assay portfolio includes diagnostic tests for a range of acute respiratory infections (influenza A virus, influenza B virus, respiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus and parainfluenza), as well as a test for the detection of Group B Streptococcus, or GBS. In addition, in response to the COVID-19 global pandemic, in 2020 we developed and launched the Panther Fusion SARS-CoV-2 assay for the detection of SARS-CoV-2. The Panther Fusion SARS-CoV-2 assay was granted Emergency Use Authorization by the FDA in March 2020.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Molecular Diagnostic Instrumentation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed and continue to develop instrumentation and software designed specifically for use with certain of our molecular diagnostic assays. We also provide technical support and service to maintain these instrument systems in the field. By placing our proprietary instrumentation in laboratories and hospitals, we can establish a platform for future sales of our assays.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our instrumentation includes the Tigris system, an integrated, fully-automated testing instrument for high-volume laboratories which is approved for use with a number of our Aptima assays, the Panther instrument system, an integrated, fully-automated testing instrument capable of serving both high-, medium- and low-volume laboratories, and our semi-automated direct tube sampling, or DTS, instruments which are used to run a number of infectious disease assays. Our instrumentation includes the Tomcat instrument, a fully automated general-purpose instrument designed to improve pre-analytical sample processing by eliminating the inefficient and error-prone activities associated with manually transferring samples from one tube to another. In fiscal 2017, we released our new Panther Fusion system and related Fusion assays for flu and respiratory testing, which extends the capabilities of the existing Panther system by adding the flexibility of PCR, functionality to our existing TMA-based technology, all as a modular in-lab upgrade to the existing Panther system. We received CE-mark approval for the Panther Fusion system in the third quarter of fiscal 2017 and FDA clearance in October 2017.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ThinPrep System</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The ThinPrep System is the most widely used method for cervical cancer screening in the U.S. The ThinPrep System has multiple configurations, including one or more of the following: the ThinPrep 2000 Processor, ThinPrep 5000 Processor, ThinPrep5000 Processor with Autoloader, ThinPrep Imaging System, and related reagents, filters and other supplies, such as the ThinPrep Pap Test and our ThinPrep PreservCyt Solution.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The ThinPrep Process.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ThinPrep process begins with the patient&#8217;s cervical sample being obtained by the physician using a cervical sampling device that, rather than being smeared on a microscope slide as in a conventional Pap smear, is inserted into a vial filled with our proprietary ThinPrep PreservCyt Solution. This enables most of the patient&#8217;s cell samples to be preserved before the cells can be damaged by air drying. The ThinPrep specimen vial is then labeled and sent to a laboratory equipped with a ThinPrep Processor for slide preparation. At the laboratory, the ThinPrep specimen vial is inserted into a ThinPrep Processor, a proprietary sample preparation device, which automates the process of preparing cervical slides for staining and microscopic examination.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of manual screening, the cytotechnologist screens each Pap test slide with a microscope to first determine the adequacy of the slide and then to examine the entire slide to differentiate diseased or abnormal cells from normal cells. With the ThinPrep Imaging System, the screening process has been automated to combine the power of computer imaging technology and human interpretive skills. Prior to human review, the ThinPrep Imaging System rapidly scans, locates and highlights areas of interest for review. By directing the cytotechnologist to areas of interest on a slide, the system may increase a cytology laboratory&#8217;s screening productivity and diagnostic accuracy. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Applications.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;In addition to serving as a replacement for the conventional Pap smear, the ThinPrep System can also be used for non-gynecological cytology screening applications including fine-needle aspiration specimens (e.g., breast, thyroid, lung or liver), body fluids (e.g., urine, pleural fluid, ascitic fluid or pericardial fluid), respiratory specimens (e.g., sputum or brushing of respiratory tracts) and ancillary testing (e.g., cell blocks, immunocytochemistry or special stains).</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Rapid Fetal Fibronectin Test</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rapid Fetal Fibronectin Test is a single-use disposable test used to determine a woman&#8217;s risk of pre-term birth by detecting the presence of a specific protein, fetal fibronectin, in vaginal secretions during pregnancy. The test utilizes a single-use, disposable cassette and is analyzed on our instrument, the TLI IQ System.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Breast Health Products</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mammography Solutions</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our Dimensions platform includes the Selenia Dimensions and 3Dimensions gantries capable of performing both 2D and tomosynthesis image acquisition and display, which is referred to as 3D. When operating in tomosynthesis mode, each system acquires a series of low dose x-ray images taken in a scanning motion at various angles. The images are mathematically processed into a series of small slices, allowing for visualization of the breast in multiple contiguous slices. Our clinical results for FDA approval demonstrated that conventional 2D digital mammography with the addition of our Genius 3D Mammography is superior to 2D digital mammography alone for both screening and diagnostics. Our Synthesized 2D product has two offerings: C-View and Intelligent 2D. These software products provide a 2D image that is mathematically synthesized from the data within a tomosynthesis exam. Our current recommended clinical practice involves what we refer to as a &#8220;combo&#8221; exam involving a tomosynthesis exam and a conventional digital 2D exam, but performed under the same breast compression. The C-View product allows for the mathematical construction of a 2D image in standard resolution format from the tomosynthesis data, without the need for an actual 2D exposure. Elimination of the 2D exposure reduces the breast compression time and patient dose compared to the current combo exam. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our new Intelligent 2D product, allows for the mathematical construction of a 2D image in high resolution format. Intelligent 2D is constructed from Clarity HD 3D images. Clarity HD high-resolution imaging is designed to clearly reveal subtle lesions and fine calcifications to help pinpoint cancers early. Our recently released 3DQuorum technology, powered by Genius AI, is an artificial intelligence, or AI, powered algorithm that expedites mammography exam reading time without compromising image quality, sensitivity or accuracy. The 3DQuorum technology uses Genius AI-powered analytics to uniquely reconstruct high-resolution 3D data to produce 6 mm &#8220;SmartSlices.&#8221; By utilizing 3DQuorum technology the number of 3D images to review is reduced by two-thirds, saving an estimated average of one hour per eight hours of daily image interpretation time. The 3DQuorum technology also reduces the typical Clarity HD and Intelligent 2D study size by an estimated over 50%, bringing the storage space and network impact back down to that of standard resolution 3D imaging. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The images captured by digital mammography systems are typically transmitted electronically for review by a radiologist at a reading workstation. To address this process, we offer the SecurViewDX workstation and Unifi Workspace, approved for interpretation of digital mammograms from most vendors as well as images from other diagnostic breast modalities. We also offer computer-aided detection, or CAD, software tools for our mammography products. Mammography CAD is used by radiologists as &#8220;a second pair of eyes&#8221; when reading a woman&#8217;s mammogram. Use of this technology provides reviewers with the potential to detect findings that might otherwise be overlooked during the review process, thus potentially increasing cancer detection.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stereotactic Breast Biopsy Systems</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We provide clinicians with the flexibility of choosing upright or prone systems for breast biopsy by offering two minimally invasive stereotactic breast biopsy guidance systems: Affirm Prone breast biopsy table and the Affirm upright attachment. The Affirm upright attachment is employed with our Dimensions systems. These breast biopsy systems provide an alternative to open surgical biopsy and can be performed as an outpatient procedure under local anesthesia, allowing shorter recovery times. The Affirm tomosynthesis option provides faster lesion targeting and reduced patient procedure time compared </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to traditional stereotactic biopsy procedures. The Affirm system is pre-programmed for use with our Brevera, Eviva and ATEC vacuum-assisted breast biopsy devices.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Ultrasound Solutions</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultrasound is used extensively by clinicians across the breast health continuum including screening, diagnosis, interventions, and surgical treatments. Ultrasound is commonly used as a complement to 3D mammography screening for women with dense breast tissue, as a diagnostic tool to further characterize lesions prior to biopsy, and for interventional and surgical guidance. To address this need, we acquired SuperSonic Imagine in the first quarter of fiscal 2020 following our equity method investment in fiscal 2019. Our UltraFast technology enables innovative imaging modes and frame rates of up to 20,000 images per second resulting in high performance and image quality. Our portfolio consists of premium ultrasound carts including the Aixplorer, Mach 20, Mach 30, and Mach 40 ultrasound systems. The Supersonic Mach 40 ultrasound systems offers integration benefits with our existing breast health portfolio. We also offer a full line of ultraportable wireless solutions for breast and general imaging applications via a partnership with Clarius Mobile Health.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Breast Biopsy and Surgery Products</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer a wide range of minimally invasive products for breast biopsy and breast surgery. Our breast biopsy portfolio includes three types of tethered vacuum-assisted breast biopsy products, the Brevera, ATEC, and Eviva devices. Each tethered device is powered by a console and utilizes our fluid management system. The ATEC device can be used under all standard imaging guidance modalities (stereotactic x-ray, ultrasound, MRI and molecular breast imaging) whereas our Brevera and Eviva devices are used exclusively under stereotactic x-ray guidance. We also offer the Celero and Sertera biopsy devices, both of which are non-tethered (no separate console), spring-loaded, disposable core biopsy devices, which are used exclusively under ultrasound-guidance. We also have products for marking, localizing and filling the void after surgery in addition to specimen imaging products for radiology, surgery and pathology.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GYN Surgical Products</span></div><div style="margin-top:5pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NovaSure</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NovaSure CLASSIC endometrial ablation system allows physicians to treat women suffering from abnormal uterine bleeding. The system features Smart-Depth technology that continuously monitors and measures tissue impedance to provide a more customized, reliable and reproducible depth of ablation for every patient. The NovaSure system consists of a disposable device and a controller that delivers RF energy to ablate the endometrial lining of the uterus in order to eliminate or reduce the patient&#8217;s abnormal bleeding. The NovaSure disposable device is a hand-held, single-use device that incorporates a flexible gold-plated mesh electrode used to deliver the RF energy to the endometrial tissue. The NovaSure RF Controller generates and delivers RF energy customized for each patient, monitors several critical treatment and safety parameters, and automatically controls the endpoint of the procedure. We also offer the NovaSure ADVANCED device which has a slimmer diameter. This device is designed to improve patient comfort and physician ease-of-use while maintaining the clinical efficacy of the NovaSure system.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">MyoSure</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The MyoSure system is designed to provide efficient and effective hysteroscopic removal of tissue within the uterus, including fibroids and polyps. Removal of fibroids can provide effective relief from heavy menstrual bleeding commonly attributed to such pathology. Unlike other methods of tissue removal, the excavated tissue samples remain intact, which allows them to be tested for abnormalities. The MyoSure system consists of a tissue removal device, control unit, and hysteroscope. The MyoSure tissue removal device is single-use and features simultaneous tissue cutting and removal. The device incorporates a rapidly rotating cutting blade. During the procedure, the tissue removal device is inserted through the MyoSure hysteroscope. This tissue removal device is powered by a control unit, which features a simple user interface and is foot pedal activated. We offer multiple handpiece devices that differ in size and are focused on addressing different pathology types.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fluent Fluid Management System</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Fluent Fluid Management System is utilized for diagnostic and operative hysteroscopic procedures. Fluent is designed for simplified setup and operation, and streamlined workflow for the operating room team.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skeletal Health Products</span></div><div style="margin-top:5pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Horizon DXA Systems</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bone densitometry is the measurement of bone density to assist in the diagnosis and monitoring of osteoporosis and other metabolic bone diseases that can lead to frailty and debilitating bone fractures. Osteoporosis is a disease that is most prevalent </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in post-menopausal women. Our Horizon line of x-ray bone densitometers incorporates advanced features designed for bone health screening and body composition assessment. Body composition assessment is the precise measurement of bone, lean mass, and fat mass within the body. These measurements are valued within the health and wellness and human performance categories, informing nutrition and exercise programming decisions. </span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fluoroscan Insight FD</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Fluoroscan Insight FD is a mini C-arm imaging system that provides low intensity, real-time x-ray imaging, with high-resolution images at radiation levels and at a cost below those of conventional x-ray and standard sized fluoroscopic equipment. Mini C-arm systems are used primarily by orthopedic surgeons to assist in performing minimally invasive surgical procedures on a patient&#8217;s extremities, such as the hand, wrist, knee, foot and ankle.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing, Sales and Service</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell and service our products through a combination of direct sales and service forces and a network of independent distributors and sales representatives. In fiscal 2020, 2019, and 2018, no customer accounted for more than 10% of our consolidated revenues. In fiscal 2020 revenues from two customers accounted for 12.5% and 10.9% of our Diagnostics segment revenue. Comparatively, in fiscal 2019 and 2018 revenues from only one customer accounted for more than 10% of our Diagnostics segment revenue, at 14.5% and 14.2%, respectively. These 10% customers were all large clinical laboratories reflecting the consolidation in that industry. No other customer accounted for more than 10% of our revenues in any other business segment in fiscal 2020, 2019, or 2018. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. sales force is structured to specifically target the customers in each of our business segments. We maintain distinct teams focused on the Diagnostics, Breast Health, GYN Surgical, and Skeletal Health markets. Our end customers include clinical laboratories, hospitals, healthcare providers and surgeons in both hospital and office settings, and we target various specialists at healthcare entities who use our products, such as ob-gyns, radiologists and breast surgeons. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A critical element of our strategy in the U.S. for our Diagnostics, Breast and Skeletal Health and GYN Surgical divisions has been to utilize the results of our clinical trials and expanded FDA labeling to demonstrate safety, efficacy and productivity improvements to our target customers. Our U.S. sales efforts for these divisions also include the use of national account managers focused on obtaining purchasing contracts from large purchasing entities, such as managed care organizations, integrated delivery networks and government healthcare facilities. In addition, in certain regions of the U.S., we use a limited number of independent dealers or distributors to sell and service certain of our products. Internationally, our products in all divisions are marketed and sold through a combination of a direct sales force and a network of distributors.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our service organization is responsible for installing our products and providing warranty and repair services, applications training and biomedical training. Products sold by our direct sales force typically carry limited warranties covering parts and labor for twelve months. Products sold through dealers also carry limited warranties that are typically for twelve months and cover only parts and components. We also offer service contracts that generally cover one to three years after the original warranty period. We provide both repair services and routine maintenance services under these arrangements, and also offer repair and maintenance services on a time and materials basis to customers that do not have service contracts. Our Breast Health business generates a majority of our service revenue, primarily relating to service contracts for our digital mammography and related products. Internationally, we primarily use distributors, sales representatives and third parties to provide maintenance service for our products, however, we do provide direct service in countries where we have a subsidiary (Germany, UK, France, Spain, Japan, China, and Australia).</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is highly competitive and characterized by continual change and improvements in technology. This is particularly the case in the market segments in which we operate. A number of companies have developed or are expected to develop products that compete or will compete with our products. Many of these competitors offer a broader product portfolio and have greater brand recognition than we do, which may make these competitors more attractive to hospitals, radiology clients, group purchasing organizations, laboratories, physicians and other potential customers. Competitors may develop superior products or products of similar quality for sale at the same or lower prices. Moreover, our products could be rendered obsolete by changes to industry standards or guidelines or advances in technology. We can give no assurance that we will be able to compete successfully with existing or new competitors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current environment of managed care, economically motivated buyers, consolidation among healthcare providers, increased competition and declining reimbursement rates, we have been increasingly required to compete on the basis of price, value, reliability and efficiency. We believe the current global economic conditions and healthcare reform measures are putting additional competitive pressure on us, including on our average selling prices, overall procedure rates and market sizes.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the success of our products depends on our ability to differentiate ourselves and to demonstrate that our products deliver the clinical and operational attributes that are most important and cost-effective to customers. These attributes include, but are not limited to, superiority in efficacy, ease of use, reliability, accuracy, quality and cost. We believe our continued success depends in large part upon our ability to invest in product enhancements and technologies that will help us distinguish ourselves from our competitors.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diagnostics.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ThinPrep liquid-based cytology product faces direct competition in the U.S. primarily from Becton, Dickinson and Company, or BD, which manufactures a competitive offering. We also compete with the conventional Pap smear and other alternative methods for detecting cervical cancer and/or its precursors. Internationally, our ThinPrep product competes with a variety of companies and other non-FDA approved tests, since fewer regulatory barriers exist in most international markets as compared to the U.S. Additionally, testing volume in this category is also under pressure due to clinical guideline changes, which lengthen the interval between screenings and increasingly afford the option of HPV testing as the primary means of detection.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our Rapid Fetal Fibronectin Test is currently the only available in vitro diagnostic test for predicting the risk of pre-term birth in the U.S. Internationally, our Rapid Fetal Fibronectin Test competes with Actim Partus manufactured by Medix Biochemical and PartoSure manufactured by Qiagen. However, this product could experience competition from companies that manufacture and market pregnancy-related diagnostic products and services. In addition, healthcare providers use diagnostic techniques such as clinical examination and transvaginal ultrasound to help diagnose the likelihood of pre-term birth and may use these techniques together with the Rapid Fetal Fibronectin Test or instead of using the Rapid Fetal Fibronectin Test.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the molecular diagnostics market, our products compete with many companies in the U.S. and abroad engaged in the development, commercialization and distribution of similar products intended for clinical molecular diagnostic applications. Clinical laboratories also may offer testing services that are competitive with our products and may use reagents purchased from us or others to develop their own laboratory-developed tests, or LDTs.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the global clinical diagnostics market, we compete with several companies offering alternative technologies to our diagnostic products. For example, in the U.S., our Aptima Combo 2 test competes against BD and Roche Diagnostics Corporation, or Roche, and our Aptima HPV and Cervista HPV tests compete with tests marketed by BD, Qiagen and Roche.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breast Health.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mammography and related products and subsystems compete on a worldwide basis with products offered by a number of competitors, including General Electric Company, or GE, Siemens, Koninklijke Philips NV, or Philips, Planmed Oy, or Planmed, Carestream Health, Inc., FUJIFILM Holdings Corporation, or Fuji, I.M.S., and Toshiba Corporation. In the U.S., our digital mammography systems compete with digital mammography systems from GE, Siemens, Fuji, I.M.S., Philips and Planmed. Our digital mammography systems also compete with Fuji&#8217;s and Carestream Health&#8217;s Computed Radiography, or CR mammography systems, and other lower-priced alternatives to 2D digital mammography and analog mammography systems. In the U.S., GE, Siemens and Fuji have received FDA approval for their breast tomosynthesis systems, and we believe that other competitors are developing tomosynthesis systems for commercial use in the U.S. Our Dimensions tomosynthesis systems also compete in certain countries outside of the U.S. with tomosynthesis systems developed by GE, Siemens, Fuji, and I.M.S.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary competitor for our breast biopsy product line is Devicor Medical Products, Inc., part of Danaher Corporation's Leica Biosystems division. In addition, other competitors include CareFusion, a BD Company, Sanarus Technologies, LLC and Intact Medical Corporation.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GYN Surgical.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NovaSure system currently faces direct competition from Boston Scientific Corporation, or Boston Scientific, The Cooper Companies, Inc., or CooperSurgical, and Minerva Surgical, Inc., or Minerva, each of which currently markets an FDA-approved endometrial ablation device for the treatment of abnormal uterine bleeding. In addition to these devices, we also compete with alternative treatments to our NovaSure system, such as drug therapy, intrauterine devices, hysterectomy, dilation and curettage and rollerball ablation. Because drug therapy is an alternative to our NovaSure procedure, NovaSure&#8217;s competitors also include many major pharmaceutical companies that manufacture hormonal drugs for women.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MyoSure product competes directly with hysteroscopic loop resection, as well as hysteroscopic tissue removal systems such as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic&#8217;s TruClear device and Boston Scientific's Symphion device. The MyoSure product also competes </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with alternative therapeutic techniques such as hysteroscopic resection with a monopolar or bipolar loop, which is currently the most common technique for removing intrauterine fibroids and polyps.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skeletal Health.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GE is our primary competitor in the bone densitometry market, and we also compete with Orthoscan in the mini-C arm market.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase many of the components, subassemblies, and raw materials used in our products from numerous suppliers worldwide. For reasons of quality assurance, scarcity and/or cost effectiveness, certain components, subassemblies, and raw materials used in our products are available only from one or a limited number of suppliers. We work closely with our suppliers to develop contingency plans to ensure continuity of quality and reliable supply. We established long-term supply contracts with many of our suppliers, and in other instances, we developed in-house capability to offset potential shortages caused by sole source suppliers. Due to the high standards and FDA requirements applicable to manufacturing our products, such as the FDA's Quality System Regulation and Good Manufacturing Practices, we may not be able to quickly establish additional or replacement sources for certain components or materials. In the event that we are unable to obtain sufficient quantities of raw materials or components or subassemblies on commercially reasonable terms or in a timely manner, our ability to manufacture our products on a timely and cost-competitive basis may be compromised, which may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current supplier of certain key raw materials for certain of our amplified NAT diagnostic assays is Roche Diagnostics Corporation, a direct competitor of our Diagnostics business. Our Diagnostic business has two supply agreements with GE Healthcare Bio-Sciences Corp., an affiliate of GE, for membranes used in connection with our ThinPrep product line and for primers used in the manufacture of Aptima, Fusion, Cervista, Progensa and AccuProbe product lines. GE is a direct competitor with our Breast Health and Skeletal Health businesses. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have sole source third-party contract manufacturers for each of our molecular diagnostics instrument product lines and for our Skeletal Health products. KMC Systems, Inc., or KMC Systems, is the only manufacturer of the Tigris instrument spare parts, Stratec Biomedical AG, or Stratec, is the only manufacturer of the Panther instrument, and Flextronics Medical Sales and Marketing, LTD, or Flextronics, is the only manufacturer of our Skeletal Health finished goods products. We are dependent on these sole source third-party manufacturers, and this dependence exposes us to increased risks associated with production delays, delivery schedules, manufacturing capability, quality control, quality assurance and costs. We have no firm long-term volume commitments with either KMC Systems, Stratec or Flextronics. If KMC Systems, Stratec, Flextronics or any of our other third-party manufacturers experiences delays, disruptions, capacity constraints or quality control problems in its development or manufacturing operations, curtails operations or otherwise fails to supply us with products in sufficient quantities, instrument and equipment shipments to our customers could be delayed or cancelled, which would decrease our revenues and may harm our competitive position and reputation. Further, because we place orders with our manufacturers based on forecasts of expected demand for our instruments and Skeletal Health products, if we inaccurately forecast demand, we may be unable to obtain adequate manufacturing capacity or adequate quantities of components to meet our customers' delivery requirements.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, and our contract manufacturers, manufacture our products at a limited number of different facilities located in the U.S. and throughout the world. In most cases, the manufacturing of each of our products is concentrated in one or a few locations. An interruption in manufacturing capabilities at any of these facilities, as a result of equipment failure or other reasons, could reduce, delay or prevent the production of our products. Some of our manufacturing operations are located outside of the U.S., including in Costa Rica and the United Kingdom. Those manufacturing operations are also subject to additional challenges and risks associated with international operations described under the caption &#8220;Risk Factors&#8221; set forth in Part I, Item 1A of this annual report on Form 10-K.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time new regulations are enacted that can affect the content and manufacturing of our products. We evaluate the necessary steps for compliance with regulations as they are enacted. In August 2012, the SEC adopted a rule requiring disclosures of specified minerals, known as conflict minerals, that are necessary to the functionality or production of products manufactured or contracted to be manufactured by public companies. The conflict minerals rule requires companies annually to disclose and report whether or not such minerals originate from the Democratic Republic of Congo or an adjoining country. The conflict minerals rule could affect sourcing at competitive prices and availability in sufficient quantities of certain minerals used in the manufacture of our products, including tantalum, tin, gold and tungsten. The number of suppliers who provide conflict-free minerals may be limited. In addition, there may be material costs associated with complying with the disclosure requirements, such as costs related to determining the source of certain minerals used in our products, as well as costs of possible changes to products, processes, or sources of supply as a consequence of such verification activities. Since our supply chain is complex, we may not be able to sufficiently verify the origins of the relevant minerals used in our products through the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due diligence procedures that we implement, which may harm our reputation. In addition, we may encounter challenges to satisfy those customers who require that all of the components of our products be certified as conflict-free, which could place us at a competitive disadvantage if we are unable to do so.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other regulations which affect the content and manufacturing of our products include, for example, the Registration, Evaluation, Authorization and Restriction of Chemical substances, or REACH, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, or RoHS, and the Waste Electrical and Electronic Equipment Directive, or WEEE, enacted in the European Union which require the registration of and regulate the use of certain hazardous substances and chemicals in, and require the collection, reuse and recycling of waste from, certain products we manufacture. Similar legislation that has been or is in the process of being enacted in Japan and China and various states of the U.S. may require us to re-design our products to ensure compliance with the applicable standards, for example by requiring the use of different types of materials. These redesigns or alternative materials may detrimentally impact the performance of our products, add greater testing lead-times for product introductions, result in additional costs or have other similar effects.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets in which we participate are characterized by rapid technological change, frequent product introductions and evolving customer requirements. Investment in research and development is critical to driving our future growth. Our research and development efforts are focused on the further development and improvement of our existing products, the design and development of new innovative medical technologies and regulatory compliance across all our business segments. In fiscal 2020, in response to the COVID-19 global pandemic, we developed and launched the Aptima SARS-CoV-2 assay (which runs on our Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to product development, our research and development personnel play an active role in the review of product specifications, clinical protocols and FDA submissions, as well as ensuring that certain of our products conform to European health, safety and environmental requirements, or CE-marking. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents and Proprietary Rights</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely primarily on a combination of trade secrets, patents, copyrights, trademarks and confidentiality procedures to protect our products and technology. Due to the rapid technological changes that characterize the markets we operate in, we believe that trade secrets and other unpatented know-how relied upon in connection with the development of new products and the enhancement of existing products are generally as important as patent protection in establishing and maintaining a competitive advantage. Nevertheless, we have obtained patents and will continue to make efforts to obtain patents, when available, in connection with our product development programs. We do not consider our business to be materially dependent upon any individual patent.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own numerous U.S. patents and have applied for numerous additional U.S. patents relating to our technologies. We also own or have applied for corresponding patents in selected foreign countries. These patents relate to various aspects of most of our products. We do not know if current or future patent applications will be issued with the full scope of the claims sought, if at all, or whether any patents issued will be challenged or invalidated. There is a risk that our patent applications will not result in granted patents or that granted patents will not provide significant protection for our products and technology. Third parties may infringe, misappropriate or otherwise violate our intellectual property rights, or copy or reverse engineer portions of our technology. Our competitors may independently develop similar or superior technology that our patents do not cover. In addition, because patent applications in the U.S. are not generally publicly disclosed until eighteen months after the application is filed, unpublished applications may have been filed by third parties that relate to our technology. Moreover, there is a risk that foreign intellectual property laws will not protect our intellectual property rights to the same extent as intellectual property laws in the U.S. The rights provided by a patent are finite in time. Over the coming years, certain patents relating to current products will expire in the U.S. and abroad which may allow third parties to exploit those technologies. In the absence of significant patent protection, we may be vulnerable to competitors who attempt to copy our products, processes or technology.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the patents we have been issued or we have acquired, we license patents from others on a variety of terms and conditions.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged in intellectual property litigation as described in Note 14 to our consolidated financial statements entitled "Litigation and Related Matters," and as may also be described herein, and we may be notified in the future of claims that we may be infringing, misappropriating or otherwise violating the intellectual property rights of third parties. In connection with any such claims, we may seek to enter into settlement and/or licensing arrangements. There is a risk in these situations that no license will be available or that a license will not be available on reasonable terms. Alternatively, we may decide or be required to litigate such claims. A successful claim against us may require us to remove the alleged infringing product from the market or to design around the third party's patent, potentially resulting in less market demand for the product.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture, sale, lease and service of medical diagnostic and surgical devices intended for commercial use are subject to extensive governmental regulation by the FDA in the U.S. and by a variety of regulatory agencies in other countries. Under the Federal Food, Drug and Cosmetic Act, known as the FD&amp;C Act, manufacturers of medical products and devices must comply with certain regulations governing the design, testing, manufacturing, packaging, servicing and marketing of medical products. Some of our products are also subject to the Radiation Control for Health and Safety Act, administered by the FDA, which imposes performance standards and record keeping, reporting, product testing and product labeling requirements for devices that emit radiation, such as x-rays. FDA product approvals may be withdrawn or suspended if compliance with regulatory standards is not maintained or if problems occur following initial marketing. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA classifies medical devices into three classes based on risk. Regulatory control increases from Class I (lowest risk) to Class III (highest risk). The FDA generally must clear or approve the commercial sale of new medical devices in Classes II and III. Commercial sales of our Class II (except for Class II exempt devices) and Class III medical devices within the U.S. must be preceded by either a pre-market notification filing pursuant to Section&#160;510(k) of the FD&amp;C Act (Class II) or the granting of a pre-market approval, or PMA (Class III). Our Class I and Class II exempt medical devices must follow Hologic&#8217;s internal Quality System processes prior to commercialization and throughout their product lifecycle. All classes of devices must meet FDA's quality system (QS), establishment registration, medical device listing, labeling and medical device reporting (MDR) regulations. The FDA can authorize the emergency use of an unapproved medical product or an unapproved use of an approved medical product, referred to as Emergency Use Authorization, or EUA, for certain emergency circumstances after the Health and Human Services Secretary has made a declaration of emergency justifying authorization of emergency use. An EUA allows use in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by emerging infectious disease threats when there are no adequate, approved, and available alternatives.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA may also waive otherwise-applicable current good manufacturing practice (CGMP) requirements to accommodate emergency response needs. In March 2020, the FDA granted EUA for our Panther Fusion SARS-CoV-2 assay for testing for the COVID-19 virus. In May 2020, the FDA granted EUA for our Aptima SARS-CoV-2 assay for use on our standard Panther instrument.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A 510(k) pre-market notification filing must contain information establishing that the device to be sold is substantially equivalent to a device commercially distributed prior to May&#160;28, 1976 or to a device that has been determined by the FDA to be substantially equivalent. The PMA procedure involves a complex and lengthy testing process that is subject to review by the FDA and may require several years to obtain. We may need to first obtain an investigational device exemption (for significant risk devices), known as an IDE, in order to conduct extensive clinical testing of the device to obtain the necessary clinical data for submission to the FDA. The FDA will approve a PMA only if after evaluating the supporting technical data it finds that the PMA contains sufficient, valid scientific evidence to assure that the device is safe and effective for its intended use(s). This approval may be granted with post-approval requirements including inspection of manufacturing facilities and/or additional patient follow-up for an indefinite period of time.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laboratories that purchase certain of our products, including the ThinPrep System, ThinPrep Imaging System, Rapid Fetal Fibronectin Test, Aptima Combo 2, Aptima HPV tests and Aptima HIV-1 Quant, HCV Quant Dx, HBV Quant, Aptima Trichomonas Vaginalis (Trich), Aptima Mycoplasma Genitalium (MGen), Aptima HSV 1 &amp; 2, Aptima BV, Aptima CV/TV, and Panther Fusion Assays are subject to extensive regulation under the Clinical Laboratory Improvement Amendments of 1988, or CLIA, which requires laboratories to meet specified standards in the areas of personnel qualifications, administration, participation in proficiency testing, patient test management, quality control, quality assurance and inspections. Adverse interpretations of current CLIA regulations or future changes in CLIA regulations could have an adverse effect on sales of any affected products.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain analyte specific reagents, referred to as ASR products, as with other Class I products, may be sold without 510(k) clearance or PMA approval. However, ASR products are subject to significant restrictions. The manufacturer may not make clinical or analytical performance claims for the ASR product, may not promote their use with specific laboratory equipment and may only sell the ASR product to clinical laboratories that are qualified to run high complexity tests under CLIA. Each laboratory must validate the ASR product for use in diagnostic procedures as a laboratory developed test. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to a variety of federal, state and foreign laws which broadly relate to our interactions with healthcare practitioners and other participants in the healthcare system, including, among others, the following:</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anti-kickback and anti-bribery laws, such as the Foreign Corrupt Practices Act, or the FCPA, the UK&#8217;s Bribery Act 2010, or the UK Anti-Bribery Act;</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws regulating the confidentiality of sensitive personal information and the circumstances under which such information may be released and/or collected, such as the Health Insurance Portability and Accountability Act of 1996, or HIPAA, the Health Information Technology for Economic and Clinical Health Act, or HITECH Act, and the European Union General Data Protection Regulation, or GDPR; and</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">healthcare reform laws, such as the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act of 2010, which we refer to together as PPACA, which include new regulatory mandates and other measures designed to constrain medical costs, as well as stringent new reporting requirements of financial relationships between device manufacturers and physicians and teaching hospitals.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are subject to numerous federal, state, foreign and local laws relating to safe working conditions, manufacturing practices, environmental protection, fire hazard control and disposal of hazardous or potentially hazardous substances, data privacy and protection among others. We may be required to incur significant costs to comply with these laws and regulations in the future and complying with these laws may result in a material adverse effect upon our business, financial condition and results of operations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of medical devices outside of the U.S. are subject to foreign requirements that vary widely from country to country. For example, our ability to market our products outside of the U.S. is contingent upon maintaining our International Standards Organization, or ISO, Quality System certification, complying with European directives and in some cases receiving specific marketing authorization from the appropriate foreign regulatory authorities. Foreign registration is an ongoing process as we register additional products and/or product modifications.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The time required to obtain approval from a foreign country to market and sell our products may be longer or shorter than that required for FDA approval and the requirements may differ. In addition, we may be required to meet the FDA&#8217;s export requirements or receive FDA export approval for the export of our products to foreign countries.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are also subject to approval and regulation by foreign regulatory and safety agencies. For example, the EU has adopted the EU Medical Device Regulation (the "EU MDR") and the In Vitro Diagnostic Regulation (the "EU IVDR"), each of which impose stricter requirements for the marketing and sale of medical devices, including in the area of clinical evaluation requirements, quality systems and post-market surveillance. Manufacturers of currently approved medical devices will have until May 2021 to meet the requirements of the EU MDR and until May 2022 to meet the EU IVDR. Complying with the requirements of these regulations may require us to incur significant expenditures. Failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to the EU requirements. The recently rebranded National Medical Products Administration (formerly CFDA), or the NMPA, has historically been conservative leading to extended review times. However, more recently, the NMPA has been more interactive, which we attribute to its response to the long delays in getting lifesaving medical devices into China. If this continues, this could favorably affect our ability to introduce new products in the Chinese market. For example, the NMPA recently approved the Selenia 3Dimensions imaging product.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory environment in China is evolving, and officials in the Chinese government exercise broad discretion in deciding how to interpret and apply regulations. It is possible that the Chinese government's current or future interpretation and application of existing or new regulations will negatively impact our China operations, result in regulatory investigations or lead to fines or penalties.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that governmental authorities will continue to scrutinize the healthcare industry closely and that changes in laws, regulations or policies by governmental authorities may cause increases in uncertainties and compliance costs, exposure to litigation and other adverse effects to our business and operations. Delays in receipt of, or failure to obtain, clearances or approvals for future products could delay or preclude realization of product revenues from new products or result in substantial additional costs which could decrease our profitability.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information about the regulations to which our business is subject and the impact such regulations may have on our business, see the disclosures under the captions &#8220;Manufacturing&#8221; and &#8220;Reimbursement&#8221; in this Item 1, and &#8220;Risk Factors&#8221; in Item 1A below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reimbursement</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market acceptance of our medical products in the U.S. and other countries is dependent upon the purchasing and procurement practices of our customers, patient need for our products and procedures, and, other than for our Medical Aesthetics products, the coverage and reimbursement of patients&#8217; medical expenses by government healthcare programs, private insurers or other healthcare payors. In the U.S., the Centers for Medicare&#160;&amp; Medicaid Services, known as CMS, establishes coverage policies and payment rates for Medicare beneficiaries. CMS publishes payment rates for physician, hospital, laboratory and ambulatory surgical center services on an annual basis. Under current CMS policies and regulations, varying payment levels have been established for tests and procedures performed using our products. Coverage policies for Medicare patients may vary by regional Medicare contractor in the absence of a national coverage determination and payment rates for procedures will vary based on the geographic price index. Coverage policies and reimbursement rates for Medicaid patients are dependent on each state Medicaid plan and will vary. Coverage policies and reimbursement rates for patients with private insurance is dependent on the individual private payor&#8217;s decisions. Moreover, private insurance carriers may choose not to follow the CMS coverage policies or payment rates. The use of our products outside of the U.S. is similarly affected by reimbursement policies adopted by foreign regulatory authorities and insurance carriers.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare policy and payment reform proposals and medical cost containment measures are being adopted in the U.S. and in many foreign countries. The ability of our customers to obtain adequate reimbursement for our products and services from private and governmental third-party payors is critical to the success of medical technology companies because it may affect which products customers purchase and the prices they are willing to pay. Reimbursement and coverage vary by country and can significantly impact acceptance of new products and technologies. Even if we develop a promising new product, we may find limited demand for the product unless reimbursement approval and coverage is obtained from private and governmental third-party payors. Further, ongoing legislative or administrative reform to the reimbursement system in the U.S. and other countries may impact reimbursement for procedures using our medical products and/or limit coverage for those procedures facilitated by our products. This includes price regulation, competitive bidding and tendering, coverage and payment policies, comparative effectiveness of therapies, technology assessments and managed-care arrangements. These trends could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Resources</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;26, 2020, we had 5,814 full-time employees, including 1,655 in manufacturing operations, 706 in research and development, 2,827 in marketing, sales and support services, and 626 in general administration. As of that date, the 54 employees (53 non-management and one management) of our Hitec-Imaging subsidiary located in Germany are represented by a union and are subject to collective bargaining agreements. In addition, Hitec-Imaging&#8217;s German employees are represented by a works council, a Betriebsrat, with respect to various shop agreements for social matters and working conditions. We believe that our relationship with our employees is good. Except as described herein, none of our other employees are represented by a union.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Worldwide sales, including U.S. sales, do not reflect any significant degree of seasonality; however, customer purchases of our GYN Surgical products have been historically lower in our second fiscal quarter as compared to our other fiscal quarters. Our respiratory infectious disease product line within our Diagnostics segment is also subject to significant seasonal and year-over-year fluctuations. In addition, the summer months, which occur during our fourth fiscal quarter, typically have had lower order rates internationally for most of our products.</span></div><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_16"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors </span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In evaluating our business, the risks described below, as well as other information contained in this Annual Report on Form 10-K and in our other filings with the SEC should be considered carefully. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business. The occurrence of any of these events or circumstances could individually or in the aggregate have a material adverse effect on our business, financial condition, cash flow or results of operations. This report contains forward-looking statements; please refer to the cautionary statements made under the heading "Special Note Regarding Forward-Looking Statements" for more information on the qualifications and limitations on forward-looking statements.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">THE COVID-19 GLOBAL PANDEMIC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize anticipated revenue from our COVID-19 diagnostic assays</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed assays to detect the novel strain of coronavirus, which causes the infectious disease known as COVID-19 ("COVID-19"). While we have seen significant demand for our COVID-19 assays, other companies are working to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">produce or have produced tests for COVID-19 which may lead to the diversion of customers, including governmental and quasi-governmental entities, away from us and toward other companies. Moreover, the dangers posed by COVID-19 may subside over time. We expect that, if and when the current COVID-19 pandemic subsides, there may be a significantly reduced demand for ongoing testing, and thus, for our COVID-19 assays. There is no guarantee that current or anticipated demand will continue, or if demand does continue, that we will be able to produce in quantities to meet the demand. A significant decline in demand for our COVID-19 assays without a corresponding uptick in our other businesses could have a material, adverse effect on our results of operations, cash flow and financial position.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional resources allocated to our Diagnostics business may negatively impact our other development programs or production capacities.</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the significant current demand for our COVID-19 assays as well as for our Panther systems on which the assays run, we have devoted significant financial resources and personnel to scaling up production of the assay and our Panther systems. This resource allocation may cause delays in or otherwise negatively impact our other development programs or production capacities. Our business could be negatively impacted by our allocation of significant resources to a global health threat that is unpredictable and that could dissipate.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The COVID-19 pandemic and associated economic disruptions have adversely affected and could in the future continue to have a material adverse impact on the demand for many of our products.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has created significant volatility, uncertainty and economic disruption in the markets we sell our products into and operate in, primarily the U.S, Europe and Asia-Pacific and negatively impacted business and healthcare activity globally. As healthcare systems respond to the increasing demands of managing COVID-19 and the resulting economic uncertainties, governments around the world have imposed measures designed to reduce the transmission of COVID-19 and individuals are responding to the fears of contracting COVID-19. In particular, elective procedures and exams were delayed or cancelled, there has been a significant reduction in physician office visits, and hospitals postponed or canceled capital purchases as well as limited or eliminated services. While elective procedures and exams and capital purchases are increasing from initially depressed levels, anticipated unemployment increases will result in more uninsured patients in the U.S. which will likely lead to fewer elective procedures, including screenings. The reduction in elective procedures, exams and capital purchases has had, and we believe will continue to have, a significant negative impact on the sales of most of our products (other than our COVID-19 assays and related systems) which has adversely affected our operating results, cash flows and financial condition. Additionally, governments and other third-party payors around the world facing tightening budgets could move to further reduce the reimbursement rates or the scope of coverage offered, which could further adversely affect sales of our products. We believe that COVID-19&#8217;s adverse impact on our operating results, cash flows and financial condition will be primarily driven by the severity and duration of the COVID-19 pandemic; the COVID-19 pandemic&#8217;s impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental responses to the COVID-19 pandemic and associated economic disruptions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The COVID-19 pandemic and associated economic disruptions could have a material adverse effect on manufacturing, distribution and supply chain.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and associated economic disruptions could have an adverse impact on our manufacturing capacity, supply chains and distribution systems, including as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments are taking. Although we have not experienced significant manufacturing or supply chain difficulties as a result of COVID-19, we may in the future. A reduction or interruption in any of our manufacturing processes could have a material adverse effect on our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GLOBAL CHALLENGES</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continuing worldwide political and social uncertainty, as well as existing tariffs and trade wars and social tensions, may adversely affect our business and prospects, both domestically and internationally.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Political and social uncertainty and divisions are rife in the U.S. and throughout the world, impairing political, trade and economic relations worldwide. This impacts how we are able to do business and expand our global footprint. Changes in policy in the U.S. and other countries regarding international trade, including import and export regulation and international trade agreements, could negatively impact our business. In 2018, 2019 and 2020, the U.S. imposed tariffs on goods imported from China and certain other countries, which has resulted in retaliatory tariffs by China and other countries. Additional tariffs or further retaliatory trade measures taken by China or other countries in response, could affect the demand for our products and services, impact the competitive position of our products, prevent us from being able to sell products in certain countries or otherwise adversely impact our results of operations. The implementation of more restrictive trade policies, such as more detailed inspections, higher tariffs or new barriers to entry, could negatively impact our business, results of operations and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial condition. There is also uncertainty surrounding the impact of U.S. presidential and congressional elections in 2020 on existing and future healthcare legislation; changes in such legislation could have a material adverse impact on our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our international operations and foreign acquisitions expose us to additional operational challenges that we might not otherwise face.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International expansion is a key component of our growth strategy. In fiscal 2020, 24.2% of our revenue came from outside of the U.S. As we grow internationally, our future and existing international operations may subject us to a number of additional risks and expenses, any of which could harm our operating results. These risks and expenses include:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political and economic changes and disruptions, export/import controls and tariff regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in developing staffing and simultaneously managing operations in multiple locations as a result of, among other things, distance, language and cultural differences; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">governmental currency controls;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">multiple, conflicting and changing government laws and regulations (including, among other things, antitrust and tax requirements);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">protectionist laws and business practices that favor local companies; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in the collection of trade accounts receivable; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties and expenses related to implementing internal controls over financial reporting and disclosure controls and procedures; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses associated with customizing products for clients in foreign countries; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">possible adverse tax consequences; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to obtain and maintain required regulatory approvals or favorable third-party reimbursement;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operation in parts of the world where strict compliance with anti-bribery laws may conflict with local customs and practices; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to effectively obtain, maintain, protect or enforce intellectual property rights, reduced protection for intellectual property rights in some countries, and the inability to otherwise protect against clone or &#8220;knock off&#8221; products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the lack of ability to enforce non-compete agreements with former owners of acquired businesses competing with us in China and other foreign countries; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower margins on a number of our products sold outside of the U.S.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS CONTINUITY AND RELIANCE ON THIRD PARTIES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Supply Chain and Manufacturing</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reliance on one third-party manufacturer for certain of our product lines and a limited number of suppliers for some key raw materials, components and subassemblies for our products exposes us to increased risks associated with production delays, delivery schedules, manufacturing capability, quality control, quality assurance and costs.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have sole source third-party manufacturers for each of our Panther and Tigris molecular diagnostics instruments and for our Skeletal Health products. Similarly, we rely on one or a limited number of suppliers for some key components or subassemblies for our products due to cost, quality, expertise or other considerations. We have no firm long-term volume commitments with certain of our sole source suppliers, including the manufacturers of our Panther or Tigris instruments. Similarly, we rely on one or a limited number of suppliers for some key raw materials for our products due to cost, quality, expertise or other considerations, and some of these suppliers are competitors. For example, F. Hoffmann-LaRoche Ltd, a direct competitor of our Diagnostics business, is the parent company of Roche Diagnostics Corporation, our current supplier of certain key raw materials for certain of our amplified NAT diagnostic assays. GE Healthcare Bio-Sciences Corp., an affiliate of GE, supplies us with the membranes used in connection with our ThinPrep product line. GE is a direct competitor with our Breast Health and Skeletal Health businesses. If any of our sole source manufacturers or suppliers, or other third-party manufacturers or suppliers, experiences delays, disruptions, capacity constraints or quality control problems in its development or manufacturing operations or becomes insolvent or otherwise fails to supply us with goods in sufficient quantities, including as a result of disruptions caused by the COVID-19 pandemic (as described above), then shipments to our customers could be delayed, which would decrease our revenues and harm our competitive position and reputation. Moreover, the failure of a supplier to provide sufficient quantities, acceptable quality and timely delivery of goods at an acceptable price, or an interruption in the delivery of goods from such a supplier could adversely affect our business and results of operations. Obtaining alternative sources of supply of products, components, subassemblies or raw materials could involve significant delays and other costs and regulatory challenges and may not be available to us on reasonable terms, if at all.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future need to find new contract manufacturers or suppliers to replace existing manufacturers or suppliers, increase our volumes or reduce our costs. We may not be able to find contract manufacturers or suppliers that meet our needs, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including regulatory requirements, and even if we do, the process of qualifying such alternative manufacturers and suppliers is often expensive and time consuming. As a result, we may lose revenues and our customer relationships may suffer.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interruptions, delays, shutdowns or damage at our manufacturing facilities could harm our business.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In most cases, the manufacturing of each of our products is concentrated in one or a few locations. An interruption in manufacturing capabilities at any of these facilities, as a result of equipment failure, disruptions caused by the COVID-19 pandemic, or other reasons, could reduce, delay or prevent the production of our products. Our manufacturing facilities and those of our contract manufacturers or suppliers are subject to the risk of catastrophic loss due to unanticipated events, such as fires, earthquakes, explosions, floods or weather conditions. Manufacturing facilities may experience plant shutdowns, strikes or other labor disruptions, or periods of reduced production as a result of equipment failures, loss of power, gray outs, delays in deliveries or extensive damage, which could harm our business and prospects. Some of our manufacturing operations are located outside the U.S., including in Costa Rica and the United Kingdom. Those manufacturing operations are also subject to additional challenges and risks associated with international operations described herein.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Customer Concentration and Distributors</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Diagnostics segment depends on a small number of customers for a significant portion of its product sales, the loss of any of these customers or any cancellation or delay of a large purchase by any of these customers could significantly reduce revenues in our Diagnostics segment.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Although we do not currently have any customers that represent more than 10% of our consolidated revenues, a material portion of product sales in our Diagnostics segment comes from (and we anticipate will continue to come from) a limited number of customers, two of which accounted for 12.5% and 10.9% of our Diagnostics segment revenue in fiscal 2020. The loss of any of these key customers, or a significant reduction in sales volume or pricing to these customers, could significantly reduce our Diagnostics segment revenues or profitability.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We utilize distributors for a portion of our sales, the loss of which could harm our revenues in the territory serviced by these distributors.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on strategic relationships with a number of key distributors for sales and service of our products. If any of our strategic relationships terminate without replacement or if our strategic partners fail to perform their contractual obligations, our revenues and/or ability to service our products in the territories serviced by these distributors could be adversely affected. We do not control our distributors, and these parties may not be successful in marketing our products. These parties may fail to commit the necessary resources to market and sell our products to the level of our expectations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we elect to distribute new products directly, we will have to invest in additional sales and marketing resources, including additional field sales personnel, which would significantly increase future selling, general and administrative expenses. If we fail to successfully market our products, our product sales will decrease. We may also be exposed to risks as a result of transitioning a territory from a distributor sales model to a direct sales model, such as difficulties maintaining relationships with specific customers, hiring appropriately trained personnel or ensuring compliance with local product registration requirements, any of which could result in lower revenues than previously received from the distributor in that territory.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS DEVELOPMENT AND COMPETITION</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our long-term success will depend upon our ability to execute on business development activities and integrate acquired businesses.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our long-term strategy, we are engaged in business development activities including evaluating acquisitions, joint development opportunities, technology licensing arrangements and other opportunities to further expand our presence in or diversify into priority growth areas by accessing new products and technologies. We may not be able to identify appropriate business development activities or acquisition candidates, consummate transactions or obtain agreements with favorable terms, if at all. Further, once we develop a product or acquire a business, any inability to successfully integrate the new product or business, decreases in customer loyalty or product orders, failure to retain or develop the acquired workforce, failure to establish and maintain appropriate controls or unknown or contingent liabilities could adversely affect our ability to realize the anticipated benefits of any new product or acquisition. The integration of new products or an acquired business, whether or not successful, requires significant efforts which may result in additional expenses and divert the attention of our management and technical personnel from other projects. Acquisitions, in particular, are inherently risky, and we cannot guarantee that any past or future transaction will be successful. If we are successful in pursuing future acquisitions, we may be required to expend significant funds, incur additional debt or other obligations, or issue additional securities, which may negatively affect our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating results and financial condition. If we spend significant funds or incur additional debt or other obligations, our ability to obtain financing for working capital or other purposes could be adversely affected, and we may be more vulnerable to economic downturns and competitive pressures. If we fail to identify, acquire and integrate complementary businesses and products, our business, results of operations and/or financial condition could be adversely affected.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face intense competition from other companies and may not be able to compete successfully.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets in which we sell our products are intensely competitive, subject to rapid technological change and may be significantly affected by new product introductions and other market activities of industry participants, and these competitive pressures may reduce the demand and prices for our products. Other companies may develop products that are superior to and/or less expensive than our products. Improvements in existing competitive products or the introduction of new competitive products may reduce our ability to compete for sales, particularly if those competitive products demonstrate better safety or effectiveness, clinical results, ease of use or lower costs.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some companies may have significant competitive advantages over us, which may make them more attractive to hospitals, clinics, radiology clients, group purchasing organizations, laboratories, and physicians, including:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater brand recognition; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger or more established distribution networks and customer bases; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a broader product portfolio, resulting in the ability to offer rebates or bundle products to offer discounts or incentives to gain a competitive advantage; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher levels of automation and greater installed bases of such equipment; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">more extensive research, development, sales, marketing, and manufacturing capabilities and greater financial resources; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater technical resources positioning them to continue to improve their technology in order to compete in an evolving industry. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Challenges in the development of our products could materially impact our long-term success.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth depends in large part on our ability to identify and develop new products or new indications for or enhancements of existing products. The development of new products and enhancement of existing products requires significant investment in research and development, clinical trials and regulatory approvals. The results of our product development efforts may be affected by a number of factors, including our ability to anticipate customer needs, innovate and develop new products, complete clinical trials, obtain regulatory clearances and approvals and reimbursement in the U.S. and abroad, manufacture products in a cost-effective manner, obtain, maintain, protect and enforce appropriate intellectual property protection for our products, gain and maintain market approval of our products and access capital. If we are not able to successfully enhance existing products or develop new products, our products may be rendered obsolete or uncompetitive by changing technology or new industry standards. We cannot assure that any products now in development or that we may seek to develop in the future will achieve technological feasibility, obtain regulatory approval or gain market acceptance, and we may be unable to recover all or a meaningful part of our investment in such products and technologies.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The markets for our newly developed products and newly introduced enhancements to our existing products may not develop as expected.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The successful commercialization of our newly developed products and newly introduced enhancements to our existing products are subject to numerous risks, both known and unknown, including:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty of the development of a market for such product; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trends relating to, or the introduction or existence of, competing products or technologies that may be more effective, safer or easier to use than our products or technologies; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the perception of our products as compared to other products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recommendation and support for the use of our products by influential customers, such as highly regarded hospitals, physicians and treatment centers; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability and extent of data demonstrating the clinical efficacy of our products or treatments; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition, including the presence of competing products sold by companies with longer operating histories, more recognizable names and more established distribution networks; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other technological developments. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Often, the development of a significant market for a product will depend upon the establishment of a reimbursement code or an advantageous reimbursement level for use of the product. Moreover, even if addressed, such reimbursement codes or levels frequently are not established until after a product is developed and commercially introduced, which can delay the successful commercialization of a product. If we are unable to successfully commercialize and create a significant market for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our newly developed products and newly introduced enhancements to our existing products our business and prospects could be harmed.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot maintain our current corporate collaborations and enter into new corporate collaborations, our product development could be delayed and our revenue could be adversely impacted.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relied and/or expect to rely on corporate collaborators for funding development, marketing, distribution, and the commercialization of certain products. If any of our corporate collaborators were to breach, terminate, fail to renew our agreements or otherwise fail to properly conduct its obligations in a timely manner, the development or commercialization and subsequent marketing of the products contemplated by the collaboration could be delayed or terminated. Further, we would be required to devote additional resources to product development or marketing, to terminate some development programs or to seek alternative corporate collaborations. Any corporate collaboration may divert management time and resources. In some instances, we have entered into corporate collaborations with certain partners or companies that could make it more difficult for us to enter into advantageous business transactions or relationships with others. Any of the foregoing risks could harm our business and prospects.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THIRD-PARTY REIMBURSEMENT AND GUIDELINES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare cost containment legislation and the failure of third-party payors to provide appropriate levels of coverage and reimbursement for the use of products and treatments facilitated by our products could harm our business and prospects.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and market acceptance of our diagnostics, breast and skeletal health and surgical products and the treatments facilitated by these products are dependent upon the coverage decisions and reimbursement policies established by government healthcare programs and private health insurers. These policies affect which products customers purchase and the prices they are willing to pay. Reimbursement varies by country and can significantly impact the acceptance of new products and technologies. Even if we develop a promising new product, we may find limited demand for the product unless appropriate reimbursement approval is obtained from private and governmental third-party payors. Further legislative or administrative reforms to the reimbursement systems in the U.S. and other countries in a manner that significantly reduces reimbursement for procedures using our diagnostics, breast and skeletal health and surgical products or denies coverage for those procedures facilitated by our products, including price regulation, competitive bidding and tendering, coverage and payment policies, comparative effectiveness of therapies, technology assessments and managed-care arrangements, could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guidelines, recommendations and studies published by various organizations may reduce the use of our products.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional societies, government agencies, practice management groups, private health/science foundations, and organizations involved in healthcare issues may publish guidelines, recommendations or studies to the healthcare and patient communities. Organizations like these have in the past made recommendations about our products and those of our competitors. If followed by healthcare providers and insurers, such publications could result in decreased use of our products. For example, in November 2012, the American Congress of Obstetrics and Gynecologists, known as the ACOG, released updates in which they have recommended less frequent cervical cancer screening similar to guidelines released in March 2012 by the U.S. Preventative Services Task Force, or the USPSTF, and the American Cancer Society. We believe that these recommendations and guidelines may have contributed to increased screening intervals for cervical cancer, which we believe has and may continue to adversely affect our ThinPrep revenues. Our ThinPrep revenues may also be adversely affected by the July 2020 American Cancer Society cervical cancer screening recommendation for a primary human papillomavirus (HPV) test rather than a Pap test. In addition, on October 20, 2015, the American Cancer Society issued new guidelines recommending that women start annual mammograms at age 45 instead of 40 and have a mammogram every two years instead of annually. This recommendation could result in a decrease in purchases of our mammography systems.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CYBERSECURITY AND DATA PRIVACY</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increased cybersecurity requirements, vulnerabilities, threats and more sophisticated and targeted computer crime could pose a risk to our systems, networks, products, solutions, services and data.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased global cybersecurity vulnerabilities, threats, computer viruses and more sophisticated and targeted cyber-related attacks, as well as cybersecurity failures resulting from human error and technological errors, pose a risk to the security of Hologic and its customers, business partners' and suppliers' products, systems and networks and the confidentiality, availability and integrity of data on these products, systems and networks. As the perpetrators of such attacks become more capable, and as critical infrastructure is increasingly becoming digitized, the risks in this area continue to grow. While we attempt to mitigate these risks by employing a number of measures, including employee training, monitoring and testing, and maintenance of protective systems and contingency plans, we remain potentially vulnerable to additional known or unknown threats, and we </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cannot assure that the impact from such threats will not be material. In addition to existing risks, the adoption of new technologies may also increase our exposure to cybersecurity breaches and failures. Additionally, we have access to sensitive, confidential or personal data or information that is subject to privacy and security laws, regulations or customer-imposed controls. Despite our implementation of controls to protect our systems and sensitive, confidential or personal data or information, we may be vulnerable to material security breaches, theft, misplaced, lost or corrupted data, employee errors and/or malfeasance (including misappropriation by departing employees) that could potentially lead to the compromising of sensitive, confidential or personal data or information, improper use of our systems, software solutions or networks, unauthorized access, use, disclosure, modification or destruction of information, defective products, production downtimes and operational disruptions. In addition, a cyber-related attack could result in other negative consequences, including damage to our reputation or competitiveness, remediation or increased protection costs, litigation or regulatory action. Although we have experienced occasional actual or attempted breaches of our computer systems, to date we do not believe any of these breaches has had a material effect on our business, operations or reputation.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with laws relating to the confidentiality of sensitive personal information or standards related to the transmission of electronic health data, may require us to make significant changes to our products, or incur penalties or other liabilities.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State, federal and foreign laws, such as the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, regulate the confidentiality of sensitive personal information and the circumstances under which such information may be released. These measures may govern the disclosure and use of personal and patient medical record information and may require users of such information to implement specified security measures, and to notify individuals in the event of privacy and security breaches. Evolving laws and regulations in this area could restrict the ability of our customers to obtain, use or disseminate patient information, or could require us to incur significant additional costs to re-design our products in a timely manner, either of which could have an adverse impact on our results of operations. Other health information standards, such as regulations under HIPAA, establish standards regarding electronic health data transmissions and transaction code set rules for specified electronic transactions, for example transactions involving submission of claims to third-party payors. These standards also continue to evolve and are often unclear and difficult to apply. Outside the U.S., we are impacted by privacy and data security requirements at the international, national and regional level, and on an industry specific basis. More privacy and security laws and regulations are being adopted, and more are being enforced, with potential for significant financial penalties. In the EU, increasingly stringent data protection and privacy rules have been enacted. The EU General Data Protection Regulation (GDPR) applies uniformly across the EU and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances. The GDPR also requires companies processing personal data of individuals residing in the EU to comply with EU privacy and data protection rules. Failure to maintain the confidentiality of sensitive personal information in accordance with the applicable regulatory requirements, or to abide by electronic health data transmission standards, could expose us to breach of contract claims, fines and penalties, costs for remediation and harm to our reputation.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGULATORY AND LEGAL</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly regulated industry, and changes in healthcare laws and regulations or our inability to obtain in a timely manner or at all U.S. or foreign regulatory clearances or approvals for our current and newly developed products or product enhancements, could adversely affect our business and prospects.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a highly regulated industry. As a result, governmental actions may adversely affect our business, operations or financial condition, including</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new laws, regulations or judicial decisions, or new interpretations of existing laws, regulations or decisions, related to healthcare availability, method of delivery and payment for healthcare products and services; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the FDA and foreign regulatory approval processes that may delay or prevent the approval of new products and result in lost market opportunity; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in FDA and foreign regulations that may require additional safety monitoring, labeling changes, restrictions on product distribution or use, or other measures after the introduction of our products to market, which could increase our costs of doing business, adversely affect the future permitted uses of approved products, or otherwise adversely affect the market for our products; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new laws, regulations and judicial decisions affecting pricing or marketing practices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the high level of regulatory oversight to which our products are subject, the process of obtaining clearances and approvals can be costly and time consuming. In addition, there is a risk that any approvals or clearances, once obtained, may be withdrawn. Most medical devices cannot be marketed in the U.S. without 510(k) clearance or pre-market approval by the FDA. Any modifications to a device that has received a pre-market approval that affect the safety or effectiveness of the device require a pre-market approval supplement or possibly a separate pre-market approval, either of which is likely to be time </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consuming, expensive and uncertain to obtain. If the FDA requires us to seek one or more pre-market approval supplements or new pre-market approvals for any modification to a previously approved device, we may be required to cease marketing or to recall the modified device until we obtain approval, and we may be subject to significant criminal and/or civil sanctions, including, but not limited to, regulatory fines or penalties. States may also regulate the manufacture, sale and use of medical devices, particularly those that employ x-ray technology. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are also subject to approval and regulation by foreign regulatory and safety agencies. For example, the EU has adopted the EU Medical Device Regulation (the &#8220;EU MDR&#8221;) and the In Vitro Diagnostic Regulation (the &#8220;EU IVDR&#8221;), each of which impose stricter requirements for the marketing and sale of medical devices, including in the area of clinical evaluation requirements, quality systems and post-market surveillance. Manufacturers of currently approved medical devices will have until May 2021 to meet the requirements of the EU MDR and until May 2022 to meet the EU IVDR. Complying with the requirements of these regulations may require us to incur significant expenditures. Failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to the EU requirements. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that governmental authorities will continue to scrutinize the healthcare industry closely and that changes in laws, regulations or policies by governmental authorities may cause increased uncertainties and compliance costs, exposure to litigation and other adverse effects to our business and operations. Delays in receipt of, or failure to obtain or maintain, clearances or approvals for future products could delay or preclude realization of product revenues from new or existing products or result in substantial additional costs which could decrease our profitability.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, maintaining compliance with multiple regulators, and multiple centers within the FDA, adds complexity and cost to our manufacturing processes. Our manufacturing facilities and those of our contract manufacturers are subject to periodic regulatory inspections by the FDA and other regulatory agencies, and these facilities are subject to the FDA's Quality System Regulation and Good Manufacturing Practices. We or our contractors may fail to satisfy these regulatory requirements in the future, and any failure to do so may prevent us from selling our products.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our activities may subject us to risks under federal and state laws prohibiting &#8220;kickbacks&#8221; and false or fraudulent claims.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the provisions of a federal law commonly known as the anti-kickback statute, and several similar state laws, which prohibit payments intended to induce physicians or others either to refer patients or to acquire or arrange for or recommend the acquisition of healthcare products or services. While the federal law applies only to products or services for which payment may be made by a federal healthcare program, state laws often apply regardless of whether federal funds may be involved. These laws constrain the sales, marketing and other promotional activities of manufacturers of medical devices by limiting the kinds of financial arrangements, including sales programs that may be used with hospitals, physicians, laboratories and other potential purchasers of medical devices. Other federal and state laws generally prohibit individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other third-party payors that are false or fraudulent, or are for items or services that were not provided as claimed. Similarly, the Patient Protection and Affordable Care Act also includes stringent reporting requirements of financial relationships between device manufacturers and physicians and teaching hospitals. Specifically, under one provision of the law, which is commonly referred to as the Physician Payment Sunshine Act, we are required to collect data on and annually report to CMS certain payments or other transfers of value to physicians and teaching hospitals and annually report certain ownership and investment interests held by physicians or their immediate family members. Anti-kickback and false claims laws and the Physician Payment Sunshine Act prescribe civil and criminal penalties (including fines) for noncompliance that can be substantial.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, our international operations are subject to the provisions of the U.S. Foreign Corrupt Practices Act of 1977, as amended ("FCPA"), which prohibits U.S. companies and their representatives from offering or making improper payments to foreign officials for the purpose of obtaining or retaining business. In many countries, the healthcare professionals we regularly interact with may meet the definition of a foreign official for purposes of the FCPA. Our international operations are also subject to various other international anti-bribery laws such as the UK Anti-Bribery Act. Despite meaningful measures that we undertake to facilitate lawful conduct, which include training and compliance programs and internal policies and procedures, we may not always prevent unauthorized, reckless or criminal acts by our employees or agents, or employees or agents of businesses or operations we may acquire. Violations of these laws, or allegations of such violations, could disrupt our operations, involve significant management distraction and have a material adverse effect on our business, financial condition and results of operations. We also could be subject to adverse publicity, severe penalties, including criminal and civil penalties, disgorgement, further changes or enhancements to our procedures, policies and controls, personnel changes and other remedial actions. Moreover, our failure to comply with domestic or foreign laws could result in various adverse consequences, including possible delay in approval or refusal to approve a product, recalls, seizures, and withdrawal of an approved product from the market.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to the risk of product liability claims relating to our products for which we may not have adequate insurance.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business involves the risk of product liability and other claims inherent to the medical device business. If even one of our products is found to have caused or contributed to injuries or deaths, we could be held liable for substantial damages. We maintain product liability insurance subject to deductibles and exclusions. There is a risk that the insurance coverage will not be sufficient to protect us from product and other liability claims, or that product liability insurance will not be available to us at a reasonable cost, if at all. An under-insured or uninsured claim could harm our business and prospects. In addition, claims could adversely affect the reputation of the related product, which could damage that product&#8217;s competitive position in the market.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sale and use of our diagnostic products could also lead to product liability claims if someone were to allege that one of our products contained a design or manufacturing defect that resulted in inaccurate test results or the failure to detect a disorder for which it was being used to screen, or caused injuries to a patient. Any product liability claim brought against us, with or without merit, could result in an increase in our product liability insurance rates or the inability to secure additional coverage in the future. Also, even a meritless or unsuccessful product liability claim could be time consuming and expensive to defend. This could result in a diversion of management&#8217;s attention from our business and adversely affect the perceived safety and efficacy of our products, which could harm our business and prospects.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to environmental, health and safety laws and regulations, including related to our use and recycling of hazardous materials and the composition of our products.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development and manufacturing processes involve the controlled use of hazardous materials, such as toxic and carcinogenic chemicals and various radioactive compounds, and the risk of contamination or injury from these materials cannot be eliminated. In such event, we could be held liable for any resulting damages, and any such liability could be extensive. From time to time new regulations are enacted, and it is difficult to anticipate how such regulations will be implemented and enforced. We continue to evaluate the necessary steps for compliance with regulations as they are enacted. These regulations include, for example, regulations enacted in the EU such as the Registration, Evaluation, Authorization and Restriction of Chemical Substances, or REACH, which requires the registration of and regulates use of certain chemicals, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, or RoHS, which regulates the use of certain hazardous substances in certain products we manufacture, and the Waste Electrical and Electronic Equipment Directive, or WEEE, which requires the collection, reuse and recycling of waste from certain products we manufacture. These and similar legislation that has been or is in the process of being enacted in Japan, China and various states of the U.S. may require us to re-design our products to ensure compliance with the applicable standards, for example by requiring the use of different types of materials. These redesigns or the use of alternative materials may detrimentally impact the performance of our products, add greater testing lead times for product introductions, result in additional costs or have other similar effects. We are also subject to other substantial regulation relating to environmental, health and safety matters, including occupational health and safety, environmental protection, hazardous substance control, and waste management and disposal. The failure to comply with such regulations could subject us to, among other things, fines and criminal liability. We may also be required to incur significant costs to comply with these and future regulations, which may result in a material adverse effect upon our business, financial condition and results of operation.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or exposures to additional tax liabilities could negatively impact the Company&#8217;s operating results.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes, as well as taxes that are not income-based, in both the U.S. and various foreign jurisdictions. We are also subject to ongoing tax audits in various jurisdictions, and tax authorities may disagree with certain positions we have taken and assess additional taxes. Our future effective tax rate could be unfavorably affected by numerous factors including a change in, or the interpretation of, tax rules and regulations in the jurisdictions in which we operate, a change in our geographic earnings mix, or a change in the measurement of our deferred taxes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is dependent on technologies we license, and if we fail to maintain these licenses or license new technologies and rights to particular nucleic acid sequences for targeted diseases in the future, we may be limited in our ability to develop new products.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is dependent on licenses from third parties for some of our key technologies. For example, our patented TMA technology is based on technology we licensed from Stanford University. We anticipate that we will enter into new licensing arrangements in the ordinary course of business to expand our product portfolio and access new technologies to enhance our products and develop new products. Many of these licenses will provide us with exclusive rights to the subject technology or disease marker. If our license with respect to any of these technologies or markers is terminated for any reason, we may not be able to sell products that incorporate that technology. Similarly, we may lose competitive advantages if we fail to maintain exclusivity under an exclusive license.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to develop additional diagnostic tests for diseases may depend on the ability of third parties to discover particular sequences or markers and correlate them with disease, as well as the rate at which such discoveries are made. Our ability to design products that target these diseases may depend on our ability to obtain the necessary rights from the third parties that make any of these discoveries. In addition, there are a finite number of diseases and conditions for which our NAT diagnostic assays may be economically viable. If we are unable to access new technologies or the rights to particular sequences or markers necessary for additional diagnostic products on commercially reasonable terms, we may be limited in our ability to develop new diagnostic products.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and manufacturing processes may require access to technologies and materials that may be subject to patents or other intellectual property rights held by third parties. Our business could be adversely affected if we are unable to obtain the additional intellectual property rights necessary to commercialize our products.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be harmed if we are unable to protect our proprietary technology.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relied primarily on a combination of trade secrets, patents, copyrights, trademarks and confidentiality procedures to protect our products and technology. Despite these precautions, unauthorized third parties may infringe, misappropriate or otherwise violate our intellectual property, or copy or reverse engineer portions of our technology. The pursuit and assertion of a patent right, particularly in areas like nucleic acid diagnostics and biotechnology, involve complex determinations and, therefore, are characterized by substantial uncertainty. We do not know if current or future patent applications will be issued with the full scope of the claims sought, if at all, or whether any patents that do issue will be challenged or invalidated. The patents that we own or license could also be subjected to invalidation proceedings or similar disputes, and an unfavorable outcome could require us to cease using the related technology or to attempt to license rights to the technology from the prevailing party. There is also a risk that intellectual property laws outside of the U.S. will not protect our intellectual property rights to the same extent as intellectual property laws in the U.S. Even if our proprietary information is protected by patents or otherwise, the initiation of actions to protect our proprietary information could be costly and divert the efforts and attention of our management and technical personnel, and the outcome of such litigation is often uncertain. As a result of these uncertainties, we could also elect to forego such litigation or settle such litigation without fully enforcing our proprietary rights. In the absence of significant patent protection, we may be vulnerable to competitors who attempt to copy our products, processes or technology. Additionally, rights provided by a patent are finite in time. Over the coming years, certain patents relating to current products will expire in the U.S. and abroad thus allowing third parties to utilize certain of our technologies.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be harmed if we infringe upon the intellectual property rights of others.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been substantial litigation regarding patent and other intellectual property rights in the medical device, diagnostic products and related industries. We are and have been involved in patent litigation and may in the future be subject to further claims of infringement of intellectual property rights possessed by third parties. In connection with claims of patent infringement, we may seek to enter into settlement and/or licensing arrangements. There is a risk in these situations that no license will be available or that a license will not be available on reasonable terms. Alternatively, we may decide to litigate such claims or to design around the COVID-19 assays technology. These actions could be costly and would divert the efforts and attention of our management and technical personnel. As a result, any infringement claims by third parties or claims for indemnification by customers resulting from infringement claims, whether or not proven to be true, may harm our business and prospects.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEBTEDNESS</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a significant amount of indebtedness outstanding, which limits our operating flexibility, and could adversely affect our operations and financial results and prevent us from fulfilling our obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 26, 2020, we had approximately $3.0 billion aggregate principal of indebtedness outstanding (exclusive of an additional $1.25 billion that would be available to draw under our revolver and any funds that we may draw under our temporarily suspended accounts receivable securitization program). We also have other contractual obligations and deferred tax liabilities, which as of September 26, 2020, are described under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operation&#8212;Contractual Obligations.&#8221; This significant level of indebtedness and our other obligations may:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make it more difficult for us to satisfy our obligations with respect to our outstanding indebtedness; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to general adverse economic and industry conditions, including increases in interest rates; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to dedicate a substantial portion of our cash flow from operations to interest and principal payments on our indebtedness, which would reduce the availability of our cash flow to fund working capital, capital expenditures, expansion efforts, strategic transactions and other general corporate purposes; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we participate; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our competitors that have less debt; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to borrow additional funds for working capital, capital expenditures, expansion efforts, strategic transactions or other general corporate purposes. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the terms of our financing obligations contain certain covenants that restrict our ability, and that of our subsidiaries, to engage in certain transactions and may impair our ability to respond to changing business and economic conditions, including, among other things, limitations on our ability to:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur indebtedness or issue certain preferred equity; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay dividends, repurchase our common stock, or make other distributions or restricted payments; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make certain investments; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">agree to payment restrictions affecting the restricted subsidiaries; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell or otherwise transfer or dispose of assets, including equity interests of our subsidiaries; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enter into transactions with our affiliates; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create liens; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">designate our subsidiaries as unrestricted subsidiaries; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consolidate, merge or sell substantially all of our assets; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">use the proceeds of permitted sales of our assets. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated credit facilities also require us to satisfy certain financial covenants. Our ability to comply with these provisions may be affected by general economic conditions, political decisions, industry conditions and other events beyond our control. Our failure to comply with the covenants contained in our amended and restated credit facilities, including financial covenants, could result in an event of default, which could materially and adversely affect our results of operations and financial condition.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there were an event of default under one of our debt instruments or a change of control, the holders of the defaulted debt could cause all amounts outstanding with respect to that debt to be due and payable immediately and may be cross-defaulted to other debt, including our outstanding notes. Our assets or cash flow may not be sufficient to fully repay borrowings under our outstanding debt instruments if accelerated upon an event of default or a change of control, and there is no guarantee that we would be able to repay, refinance or restructure the payments on such debt. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations-Liquidity and Capital Resources.&#8221;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to generate sufficient cash flow to service all of our indebtedness and other obligations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make payments on and to refinance our indebtedness and to fund planned capital expenditures, strategic transactions and expansion efforts will depend on our ability to generate cash in the future. This, to a certain extent, is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. Our business may not be able to generate sufficient cash flow from operations, and we cannot assure that future borrowings will be available to us in amounts sufficient to enable us to pay our indebtedness as such indebtedness matures and to fund our other liquidity needs. If this occurs, we will need to refinance all or a portion of our indebtedness on or before maturity, and there can be no assurance that we will be able to refinance any of our indebtedness on commercially reasonable terms, or at all. We may need to adopt one or more alternatives, such as reducing or delaying planned expenses and capital expenditures, selling assets, restructuring debt, or obtaining additional equity or debt financing. These alternative strategies may not be affected on satisfactory terms, if at all. Our ability to refinance our indebtedness or obtain additional financing, or to do so on commercially reasonable terms, will depend on, among other things, our financial condition at the time, restrictions in agreements governing our indebtedness, and other factors, including the condition of the financial markets and the markets in which we compete. If we do not generate sufficient cash flow from operations, and additional borrowings, refinancings or proceeds from asset sales are not available to us, we may not have sufficient cash to enable us to meet all of our obligations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A significant portion of our indebtedness is subject to floating interest rates, which may expose us to higher interest payments.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our indebtedness is subject to floating interest rates, which makes us more vulnerable in the event of adverse economic conditions, increases in prevailing interest rates, or a downturn in our business. As of September 26, 2020, approximately $1.7 billion aggregate principal of our indebtedness, which represented the outstanding principal under our Amended and Restated Credit Facilities, was subject to floating interest rates. We currently have limited hedging arrangements in place to mitigate the impact of higher interest rates, including interest rate cap agreements and an interest rate swap agreement. These interest rate cap agreements expire through December 23, 2020, and the interest rate swap contract expires on December 17, 2023. We may not be able to extend these at an attractive economic price.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The proposed discontinuation or replacement of LIBOR would require us to amend certain agreements and may otherwise adversely affect our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intends to phase out LIBOR by the end of 2021. Changes in the method of calculating LIBOR, or the replacement of LIBOR with an alternative rate or benchmark, may adversely affect interest rates and result in higher borrowing costs. This could materially and adversely affect our results of operations, cash flows and liquidity. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, including our Credit Agreement and related interest rate swap agreements, and we cannot predict what alternative rate or benchmark would be negotiated. This may result in an increase to our interest expense.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL RISK FACTORS</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends on our ability to attract, motivate and retain key personnel and plan for future executive transitions.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess the key personnel that we believe are essential to our long-term success. Following the recent retirement of the President of our Breast and Skeletal Health division, we established the role of Group President, Breast and Skeletal Health and Surgical and appointed a new President for each of the Breast and Skeletal Health and Surgical divisions. All of these roles were filled with internal candidates. As we promote from within, we must fill the roles that are left vacant due to the promotions. If we fail to effectively manage our ongoing organizational and strategic changes, our financial condition, results of operations, and reputation, as well as our ability to successfully attract, motivate and retain key employees, could be harmed. Additionally, facilitating seamless leadership transitions for key positions is a critical factor in sustaining the success of our organization. If our succession planning efforts are not effective, it could adversely impact our business. Also, in our industry, there is substantial competition for key personnel in the regions in which we operate. We face intense competition for employees, particularly as employees are increasingly able to work remotely. We also continue to face the challenges of maintaining employee well-being, recognizing that the additional financial, family and health burdens that many employees may be experiencing during the current health and economic uncertainties may adversely impact job performance and employee retention. The loss of any of our key personnel, particularly management or key research and development personnel, could harm our business and prospects and could impede the achievement of our research and development, operational or strategic objectives. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in our charter, bylaws, and indebtedness may have the effect of discouraging advantageous offers for our business or common stock and limit the price that investors might be willing to pay in the future for shares of our common stock.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our charter, bylaws, and the provisions of the Delaware General Corporation Law include provisions that may have the effect of discouraging or preventing a change of control. Our indebtedness also contains provisions which either accelerate or require us to offer to repurchase the indebtedness at a premium upon a change of control. These provisions could limit the price that our stockholders might receive in the future for shares of our common stock.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is volatile.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock has been, and may continue to be, highly volatile. We believe that a variety of factors could cause the price of our common stock to fluctuate, perhaps substantially, including:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new, or changes in, recommendations, guidelines or studies that could affect the use of our products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements and rumors of developments related to our business, including changes in reimbursement rates or regulatory requirements, proposed and completed acquisitions, or the industry in which we compete; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">published studies and reports relating to the comparative efficacy of products and markets in which we participate; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quarterly fluctuations in our actual or anticipated operating results and order levels; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general conditions in the U.S. or worldwide economy; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our stock repurchase program; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements of technological innovations; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new products or product enhancements by us or our competitors; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments in patents or other intellectual property rights and litigation; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments in relationships with our customers and suppliers; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of healthcare reform legislation and the adoption of additional reform legislation in the future; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success or lack of success of integrating our acquisitions. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the stock market in general and the markets for shares of &#8220;high-tech&#8221; and life sciences companies, have historically experienced extreme price fluctuations which have often been unrelated to the operating performance of affected companies. Any such fluctuations in the future could adversely affect the market price of our common stock, and the market price of our common stock may decline.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_22"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own and lease real property to support our business, including manufacturing, marketing, research and development, logistical support and administration. The following lists those properties that we own or lease that we believe are material to our business. We believe that we have adequate space for our anticipated needs and that suitable additional space will be available at commercially reasonable prices as needed.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.847%"><tr><td style="width:1.0%"></td><td style="width:24.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.422%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Material Properties&#160;Owned:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Primary Use</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newark, DE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DirectRay digital detector research and development and plate manufacturing operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warstein, Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations, research and development and administrative functions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Livingston, UK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations and research and development</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manchester, UK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative and supply chain operations</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Londonderry, NH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego, CA </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics headquarters, including administrative and manufacturing operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego, CA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics research and development, administrative and manufacturing operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.502%"><tr><td style="width:1.0%"></td><td style="width:19.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Material&#160;Properties Leased:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Primary Use</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease<br/>Expiration<br/>(fiscal&#160;year)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Renewals</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danbury, CT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing facility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,&#160;five-yr.&#160;periods</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danbury, CT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations and research and development</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,&#160;five-yr. period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marlborough, MA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Headquarters, including research and development, manufacturing and distribution operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,&#160;five-yr.&#160;periods</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marlborough, MA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,&#160;five-yr.&#160;period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alajuela, Costa Rica</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing facility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,&#160;five-yr.&#160;periods</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manchester, England</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations and research and development</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><div style="margin-top:9pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also leases various administrative and customer support centers throughout the world including in Brussels, Belgium, Kerpen, Germany, Madrid, Spain, Suzhou, China, Wiesbaden, Germany, and also maintains specialized research and development and manufacturing operations at various additional locations.</span></div><div style="text-indent:31.5pt"><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_25"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of legal matters as of September&#160;26, 2020, please see Note 14 to our consolidated financial statements entitled &#8220;Litigation and Related Matters,&#8221; which is incorporated by reference into this item.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_31"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;HOLX.&#8221; </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Number of Holders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of November&#160;12, 2020, there were approximately 930 holders of record of our common stock, including multiple beneficial holders at depositories, banks and brokers listed as a single holder in the street name of each respective depository, bank or broker.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Policy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have never declared or paid cash dividends on our capital stock, and we currently have no plans to do so. Our current policy is to retain all of our earnings to finance future growth, pay down our existing indebtedness and repurchase our common stock. The existing covenants under certain of our credit facilities also place limits on our ability to issue dividends and repurchase stock.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Sales of Unregistered Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We did not sell unregistered securities during the fourth quarter of fiscal 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer's Purchases of Equity Securities</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of Repurchase</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>(#)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share<br/>($)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased As Part of Publicly<br/>Announced Plans or<br/>Programs&#160;<br/>(#)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per<br/>Share As Part of Publicly<br/>Announced Plans or<br/>Programs&#160;<br/>($)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under Our<br/>Programs <br/>(in millions) <br/>($) (2)&#160;(3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2020 &#8211; July 25, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 26, 2020 &#8211; August 22, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 23, 2020 &#8211; September 26, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,360&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668,422&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;___________________________________</span></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the majority of restricted stock units granted, the number of shares issued on the date that the restricted stock units vest is net of the minimum statutory tax withholding requirements that we pay in cash to the appropriate tax authorities on behalf of our employees. These deemed repurchases of our common stock were to cover employee income tax withholding obligations in connection with the vesting of restricted stock units under our equity incentive plans.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On June 13, 2018, the Company's Board of Directors authorized a share repurchase plan to repurchase up to $500.0 million of our outstanding common stock. This share repurchase plan, which replaced the prior plan, was effective August 1, 2018 and expired on March 27, 2020. On December 11, 2019, the Board of Directors authorized a new share repurchase plan to repurchase up to $500.0 million of our outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020, the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On November 22, 2019, the Company's Board of Directors authorized the further repurchase of up to $205 million of our outstanding shares pursuant to an accelerated share repurchase ("ASR") agreement with Goldman Sachs. Under the ASR, Hologic agreed to purchase $205 million of Hologic&#8217;s common stock. The initial delivery was 3.3 million shares for which the Company has initially allocated $164.0 million of the $205 million paid to Goldman Sachs, based on the then current market price of $50.02 per share. The ASR was completed in the second quarter of fiscal 2020. At settlement, Goldman Sachs delivered an additional 0.6 million shares of the Company&#8217;s common stock.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_37"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information shall not be deemed to be "filed" with the SEC nor shall the information be incorporated by reference into any future filings under the Securities Act, except to the extent that we specifically incorporate it by reference into a document filed under the Securities Act or the Exchange Act.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares cumulative total shareholder return on our common stock since September&#160;26, 2015 with the cumulative total return of the Standard&#160;&amp; Poor&#8217;s Health Care Supplies Index. This graph assumes the investment of $100 on September&#160;26, 2015 in our common stock, and the S&amp;P Health Care Supplies Index. Measurement points are the last trading day of each respective fiscal year.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><img src="holx-20200926_g1.jpg" alt="holx-20200926_g1.jpg" style="height:568px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Selected Financial Data</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following selected financial data should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Annual Report on Form 10-K, beginning on page F-1. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of fiscal 2017, we divested our blood screening business and acquired the Medical Aesthetics business, which consisted of Cynosure, Inc., and in the third quarter of fiscal 2017 we acquired Medicor. In the first and fourth quarters of fiscal 2018, we acquired Emsor and Faxitron, respectively. In the first quarter of fiscal 2019, we acquired Focal Therapeutics. In the first quarter of fiscal 2020, we divested Cynosure. In the first and fourth quarters of fiscal 2020, we acquired SuperSonic Imagine and Acessa Health, respectively. Results of operations for these businesses are included in our consolidated financial statements from the date of acquisition.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:34.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.210%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.210%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.214%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;26,<br/>2020 (5)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;28,<br/>2019 (4)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;30,<br/>2018 (3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;24,<br/>2017 (2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;26,<br/>2016 (1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Consolidated Statement of Operations Data</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,058.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,455.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,284.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Hologic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) per common share attributable to Hologic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per common share attributable to Hologic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.40)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Consolidated Balance Sheet Data</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,442.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,979.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,317.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, less current portion (6)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,812.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,058.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Hologic's stockholders&#8217; equity</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,428.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Fiscal 2016 total operating costs and expenses include restructuring and divestiture charges of $10.5 million. Included in net income was a gain on the sale of a marketable security of $25.1 million partially offset by a debt extinguishment loss of $5.3 million.</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Fiscal 2017 total operating costs and expenses include a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gain on sale of the blood screening business of $899.7 million (reduces operating costs and expenses), inventory step-up costs of $39.7 million, transaction expenses for acquisitions of $23.2 million, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restructuring charges of $13.3 million. </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Fiscal 2018 total operating costs and expenses include a goodwill impairment charge of $685.7 million, an intangible asset impairment charge of $46.0 million, a legal settlement charge of $34.8 million and restructuring charges of $14.2 million. Included in net loss was a debt extinguishment loss of $45.9 million and related transaction costs of $4.3 million.</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Fiscal 2019 total operating costs and expenses include an intangible assets and equipment impairment charge of $685.4 million,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inventory step-up costs of $7.1 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a net legal settlement charge of $4.5 million and restructuring charges of $6.6 million. Included in net loss was a $3.3 million loss for the Company's proportionate share of its equity method investment in SuperSonic Imagine.</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Fiscal 2020 total operating costs and expenses include an intangible assets and equipment impairment charge of $30.2 million, restructuring charges of $15.3 million, and inventory step-up costs of $6.8 million.</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Long-term obligations are net of unamortized debt discounts and deferred issuance costs aggregating $23.6 million, $29.0 million, $32.9 million, $27.9 million and $62.9 million for fiscal years 2020, 2019, 2018, 2017, and 2016, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with the Consolidated Financial Statements, the information described under the caption &#8220;Risk Factors&#8221; in Part I, Item&#160;1A of this report and our Special Note Regarding Forward-Looking Statements at the outset of this report.</span></div><div id="i8ddb964a7a024d63b8e4009970e71997_46"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on women's health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives. We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Until December 30, 2019, our product portfolio included aesthetic and medical treatments systems sold by our former Medical Aesthetic business. We completed the sale of our Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Diagnostics segment, we offer a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther, Panther Fusion and Tigris), our ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Our Aptima family of molecular diagnostic assays is used to detect, among other things, the infectious microorganisms that cause common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, certain high-risk strains of human papillomavirus, or HPV, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parasite that causes trichomoniasis. In addition, in 2017 and 2018 we introduced the Aptima quantitative viral load tests for HIV, Hepatitis C and Hepatitis B. Our assay portfolio also includes diagnostic tests for a range of acute respiratory infections, including SARS-CoV-2, as well as a test for the detection of Group B Streptococcus, or GBS, that are run on the Panther Fusion system, a field upgradeable instrument addition to the base Panther system. In 2020, in response to the COVID-19 global pandemic, we developed and launched the Aptima SARS-CoV-2 assay (which runs on our standard Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system). The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. In January 2017, we sold our blood screening business to Grifols. We have continued to provide Grifols with instrumentation and certain raw materials, manufacture assays, and perform research and development services to support the blood screening business Grifols acquired from us.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Breast Health segment offers a broad portfolio of solutions for breast cancer care for radiology, pathology and surgery. These solutions include breast imaging and analytics, such as our 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, ultrasound and connectivity solutions and breast conserving surgery products. Our most advanced breast imaging platforms, Selenia Dimensions and 3Dimensions, utilize a technology called tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam, as well as conventional 2D full field digital mammography images. Our clinical results for FDA approval demonstrated that conventional 2D digital mammography with the addition of 3D tomosynthesis is superior to 2D digital mammography alone for both screening and diagnostics for women of all ages and breast densities. With the acquisition of SuperSonic Imagine in the first quarter of fiscal 2020, we now offer premium ultrasound imaging, further connecting Hologic capabilities across the continuum of breast care from screening to diagnosis and treatment. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GYN Surgical products include our NovaSure Endometrial Ablation System, or NovaSure, and our MyoSure Hysteroscopic Tissue Removal System, or MyoSure, as well as our Fluent Fluid Management system, or Fluent. The NovaSure portfolio is comprised of the NovaSure CLASSIC and NovaSure ADVANCED devices and involves a trans-cervical procedure for the treatment of abnormal uterine bleeding. The MyoSure suite of devices offers four options to provide incision-less removal of fibroids, polyps, and other pathology within the uterus. The Fluent system is a fluid management system that provides liquid distention during diagnostic and operative hysteroscopic procedures.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Skeletal Health segment's products includes the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm, which assists in performing minimally invasive orthopedic surgical procedures on a patient's extremities, such as the hand, wrist, knee, foot, and ankle.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical Aesthetics segment consisted of a portfolio of aesthetic treatment systems. We completed the sale of our Medical Aesthetics business on December 30, 2019.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to we, us, Hologic or our company refer to Hologic, Inc. and its consolidated subsidiaries.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Considerations</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic caused by the spread of the novel strain of coronavirus disease 2019 ("COVID-19") has created significant volatility, uncertainty and economic disruption in the markets we sell our products into, primarily the U.S., Europe and Asia-Pacific. In the second, third and fourth quarters of fiscal 2020, the spread of COVID-19 has negatively impacted business and healthcare activity globally. As healthcare systems respond to the increasing demands of managing COVID-19 and the resulting economic uncertainties, governments around the world have imposed measures designed to reduce the transmission of COVID-19, and individuals are responding to the fears of contracting COVID-19. In particular, elective procedures and exams have been and continue to be delayed or cancelled, there has been a significant reduction in physician office visits, and hospitals have postponed or canceled capital purchases as well as limited or eliminated services, however in the second half of the third quarter of fiscal 2020, we started to see a recovery of elective procedures and exams, which continued into the fourth quarter. The reductions in testing and procedures have had, and we believe will continue to have, a negative impact on our operating results and cash flows. However, the impact of the commercial release of our COVID-19 assays more than offset these negative impacts as we generated significant revenue from the sales of these assays in the third and fourth quarters of fiscal 2020.The negative effects of COVID-19 and the associated economic disruptions were felt primarily beginning in the second half of March in many of our end-markets and earlier in Asia, primarily China, and the impact to our legacy products in the third fiscal quarter was significant. The impact to our legacy products was less severe in the fourth quarter.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our results of operations and cash flows in the third and fourth quarters of fiscal 2020 were positively impacted by the sale of our COVID-19 assays, the COVID-19 pandemic could have an adverse impact on our operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: the severity and duration of the COVID-19 pandemic; continued demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products; the COVID-19 pandemic&#8217;s impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental responses to the COVID-19 pandemic and associated economic disruptions.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to adversely affecting demand for our products, other than our COVID-19 assays, COVID-19 and associated economic disruptions could continue to have an adverse impact on our supply chains and distribution systems, including as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments have taken and will take. A reduction or interruption in any of our manufacturing processes could have a material adverse effect on our business.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the uncertainty surrounding global financial markets and deteriorating worldwide macroeconomic conditions resulting from the pandemic have caused and may continue to cause the purchasers of medical equipment to decrease their medical equipment purchasing and procurement activities. Additionally, the pandemic has caused and may further cause constrictions in world credit markets that have caused and could cause our customers to experience increased difficulty in paying their existing obligations to us or in securing the financing necessary to purchase our products. Economic uncertainty has resulted and may continue to result in cost-conscious consumers focusing on acute care rather than wellness, which may also continue to adversely affect demand for our products (other than our COVID-19 assays).</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we assessed the potential longer term economic and capital market uncertainties resulting from the COVID-19 pandemic, at the end of March 2020 we suspended our accounts receivable securitization program and borrowed $750.0 million under our revolver. We used $250.0 million of these proceeds to pay off all amounts then owed under our accounts receivable securitization agreement, and retained the balance as cash reserve. As of the end of fiscal 2020, the Company repaid $500.0&#160;million of the $750.0&#160;million borrowed under its revolver. As of September 26, 2020 the Company had an additional $1.25&#160;billion available under its revolver and $701.0&#160;million of cash on hand.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the negative impact of COVID-19 on our business, in April 2020 we initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but we also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances, employee terminations. Further, in April 2020, we shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of our products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased, and the majority of the impacted manufacturing facilities were back to pre-COVID-19 pandemic levels.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also taken measures to ensure the safety of our employees and to comply with governmental orders. These measures could require that our employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in our commercial and marketing activities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions and Disposition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth a description of certain of our acquisitions and dispositions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our last three fiscal years:</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acessa Health</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, we completed the acquisition of Acessa Health, Inc., or Acessa for a purchase price of $161.3&#160;million, which included a hold-back of $3.0 million payable up to 5 months from the date of acquisition, and contingent consideration, which we estimated at $81.8 million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its Acessa ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. The contingent consideration is based on annual incremental revenue growth over a three-year period ending annually in December. The contingent consideration is payable after each annual measurement period. Based on our preliminary purchase price allocation, we have allocated $128.2 million of the purchase price to the preliminary value of intangible assets and $48.4 million to goodwill. The allocation of the purchase price is preliminary as we continue to gather information supporting the acquired assets and liabilities. Acessa's results of operations are reported in our Surgical segment from the date of acquisition.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, we completed the acquisition of Health Beacons, Inc., or Health Beacons, for a purchase price of $19.7 million, which included hold-backs of $2.3 million that are payable up to 18 months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on our preliminary valuation, we have allocated $10.7 million of the purchase price to the preliminary value of developed technology and $6.2 million to goodwill. The remaining $2.8 million of the purchase price has been allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as we continue to gather information supporting the acquired assets and liabilities. Health Beacon's results of operations are reported in our Breast Health reportable segment from the date of acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the acquisition of assets from Alpha Imaging, LLC, or Alpha Imaging, for a purchase price of $18.0 million, which included a hold-back of $1.0 million and contingent consideration estimated at $0.9 million. The contingent consideration was payable upon shipment of certain backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of our Breast and Skeletal products in the U.S. Based on our preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset. The allocation of the purchase price is preliminary as we continue to gather information supporting the acquired assets and liabilities.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, we acquired approximately 46% of the outstanding shares of SuperSonic Imagine S. A., or SSI. SSI, headquartered in France, specializes in ultrasound imaging and designs, develops and markets an ultrasound platform used in the non-invasive care path for the characterization of breast, liver or prostate diseases. We initially accounted for this investment as an equity method investment.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, we acquired an additional 7.6 million common shares of SSI for $12.6 million. As a result, we owned approximately 78% of the outstanding common shares of SSI at November 21, 2019 and controlled SSI's voting interest and operations. We performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within our consolidated financial statements, specifically within our Breast Health segment. We remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million in the first quarter of fiscal 2020. The total purchase price was $69.3 million, which consisted of $17.9 million for the equity method investment in SSI, $12.6 million for shares acquired on November 21, 2019, $30.2 million for loans we provided to SSI prior to the acquisition that are considered forgiven, and $8.6 million representing the fair value of the noncontrolling interests as of November 21, 2019. Based on our preliminary purchase price allocation, we have allocated $45.3 million of the purchase price to the preliminary value of intangible assets and $34.3 million to goodwill. The allocation of the purchase price is preliminary as we continue to gather information supporting the acquired assets and liabilities, primarily income taxes and recognition of uncertain tax positions, to finalize the purchase price allocation. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 26, 2020, we owned approximately 81% of SSI, and accordingly we have recorded an adjustment to our net income for the non-controlling interest we do not own of $4.7 million in the current year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Focal Therapeutics</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, we completed the acquisition of Focal Therapeutics, Inc., or Focal, for a purchase price of $120.1 million, which included hold-backs of $14.0 million payable up to one year from the date of acquisition. In the second quarter of fiscal 2019, $1.5 million of the hold-back was paid, and the remaining $12.5 million was paid on October 1, 2019. Focal, headquartered in California, manufactures and markets its BioZorb marker, which is an implantable three-dimensional marker that helps clinicians overcome certain challenges in breast conserving surgery. Based on our valuation, we allocated $97.2 million of the purchase price to the value of intangible assets and $31.1 million to goodwill. Focal's results of operations are reported in our Breast Health reportable segment from the date of acquisition. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Faxitron</span></div><div style="margin-top:4pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2018, we completed the acquisition of Faxitron Bioptics, LLC, or Faxitron, for a purchase price of $89.5 million, which included hold-backs of $11.7 million that were payable up to one year from the date of acquisition, and contingent consideration, which we estimated at $2.9 million as of the measurement date. The contingent consideration was payable upon meeting certain revenue growth metrics. In fiscal 2019, the continent consideration liability was increased, and we paid $5.0 million in the second quarter of fiscal 2020. In fiscal 2019, we paid $6.5 million of the hold-back and withheld the remaining $5.2 million under the indemnification provisions of the purchase agreement, which the former shareholders had disputed. We resolved this dispute in the first quarter of fiscal 2020 and made a $4.1 million payment to the former shareholders. Based on our valuation, we allocated $53.2 million of the purchase price to the value of intangible assets and $45.6 million to goodwill. Faxitron, headquartered in Tucson, Arizona, develops, manufactures, and markets digital radiography systems. Faxitron's results of operations are reported in our Breast Health reportable segment from the date of acquisition.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emsor, S.A.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2017, we completed the acquisition of Emsor S.A., or Emsor, a distributor of our Breast and Skeletal Health products in Spain and Portugal, for a purchase price of $16.3 million, which included contingent consideration estimated at $4.9 million as of the measurement date. The contingent consideration was payable upon Emsor achieving predefined amounts of cumulative revenue over a two-year period from the date of acquisition. The contingent consideration was paid in the second quarter of fiscal 2020.</span></div><div style="margin-top:4pt;text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Disposition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the sale of our Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R"). At the closing, the Company received cash proceeds of $153.4 million. The sales price was finalized in the fourth quarter of fiscal 2020, and the Company paid $3.4 million, resulting in a final sales price of $150.0 million. As a result of the sale, we recorded a $30.2 million impairment charge in the first quarter of fiscal 2020 to record the asset group at fair value less costs to dispose as it met the assets held-for-sale criteria. For additional information, see Note 15 to our consolidated financial statements included herein. Following the sale of our Medical Aesthetics business, we have not received any further product revenue related to this business, although additional expenses will be incurred primarily in connection with the indemnification of legal and tax matters that existed as of the date of disposition. In addition, we agreed to provide transition services for a period of up to 15 months.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, the percentage of total revenues represented by items as shown in our Consolidated Statements of Operations. All dollar amounts in tables are presented in millions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.277%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year Ended September&#160;26, 2020 Compared to Fiscal Year Ended September&#160;28, 2019 </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.078%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.047%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Product Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,227.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,771.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated a 16.4% increase in product revenues in fiscal 2020 compared to fiscal 2019 primarily due to the increase in the Diagnostics business from sales of our newly introduced COVID-19 assays that were partially offset by reduced sales of our legacy products. We had decreases in our Breast Health, GYN Surgical and Skeletal Health segments which we attribute primarily to the impact of the COVID-19 pandemic across our businesses. We disposed of the Medical Aesthetics business segment on December 30, 2019, the beginning of our second quarter of fiscal 2020, and generated no Medical Aesthetics revenue after that sale.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics product revenues increased 75.8% in fiscal 2020 compared to fiscal 2019 primarily due to increases in Molecular Diagnostics (excluding blood screening) of $965.6 million, partially offset by decreases in Cytology &amp; Perinatal of $62.7 million and a decrease of $9.0 million in blood screening. While we divested our blood screening business in the second quarter of fiscal 2017, we continue to provide long-term access to Panther instrumentation and certain supplies to the purchaser of that business. Molecular Diagnostics product revenue (excluding blood screening) was $1.6 billion in fiscal 2020 compared to $665.4 million in fiscal 2019. The increase was primarily attributable to revenues of $929.3 million from our two SARS-CoV-2 assays (primarily the Aptima SARS-CoV-2 assay and to a lesser extent the Panther Fusion SARS-CoV-2 assay) and an increase in Panther and Panther Fusion instrument sales due to demand for increased testing capacity for COVID-19. We are actively working to increase capacity production to meet worldwide demand of these assays. These increases were partially offset by decreases in our Aptima women's health assays of $10.7 million on a worldwide basis in the current fiscal year primarily due to lower volumes, which we attribute primarily to the impact of the COVID-19 pandemic resulting in a reduction in physician office visits and hospitals limiting services. In addition, we had an increase of $8.1 million in worldwide sales of our virology products in the current fiscal year. Cytology &amp; Perinatal product revenue decreased $62.7 million in the current fiscal year primarily due to lower ThinPrep test volumes, which we attribute primarily to the reduction in wellness office visits in response to the COVID-19 pandemic, and to a lesser extent lower Perinatal product volumes. Testing volume in this category is also under pressure due to clinical guideline changes, which lengthen the interval between screenings and increasingly afford the option of HPV testing as the primary means of detection. Most recently, in July 2020, the American Cancer Society recommended using a primary human papillomavirus (HPV) test, rather than a Pap test, for cervical cancer screening. While the impact of the COVID-19 pandemic has negatively impacted our legacy product lines, we have experienced an increase in revenues sequentially from the third quarter of fiscal 2020 to the fourth quarter indicating strength in a recovery of these end markets. We expect the market for our legacy diagnostics products to continue to be challenging in the first quarter of 2021 and beyond as the COVID-19 pandemic continues and wellness visits continue to be delayed or cancelled. In the first two months of fiscal 2021, there has been an increase in the volume of reported positive COVID-19 cases.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health product revenues decreased 19.7% in fiscal 2020 compared to fiscal 2019 primarily due to a decrease in sales volume of our 3D and 2D digital mammography systems and related workflow products (primarily Intelligent 2D, Clarity HD and SmartCurve), Affirm Prone breast biopsy tables and our interventional breast solutions Eviva, ATEC and Celero handpieces. We primarily attribute the decline in revenues to the COVID-19 pandemic. In particular, in the U.S. as hospitals and imaging centers either slowed down purchases or delayed orders and installations of capital equipment units in order to focus their efforts towards COVID-19 patients and concerns on maintaining their cash and liquidity, as well as from the impact of delayed or cancelled elective imaging exams and procedures in response to the pandemic. While the impact of the COVID-19 pandemic has negatively impacted these product lines, we have experienced an increase in revenues sequentially from the third quarter of fiscal 2020 to the fourth quarter indicating strength in a recovery of these end markets. These decreases were partially offset by the inclusion of revenues from SSI which contributed $18.8 million of product revenue in fiscal 2020. We obtained control of SSI and began consolidating their results for the last fiscal month of the first quarter of fiscal 2020. We expect the market for our Breast Health products to continue to be challenging in the first quarter of fiscal 2021 and beyond to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the extent the COVID-19 pandemic continues and hospitals and healthcare centers continue to restrict access and wellness visits and elective medical procedures, and hospital and healthcare center capital expenditures continue to be delayed or cancelled. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical product revenues decreased 14.1% in fiscal 2020 compared to fiscal 2019, which we primarily attribute to reduced sales volumes resulting from the impact of the COVID-19 pandemic. MyoSure system sales decreased $21.5 million, and NovaSure system sales decreased $44.5 million. While the impact of the COVID-19 pandemic has negatively impacted these product lines, we have experienced an increase in revenues sequentially from the third quarter of fiscal 2020 to the fourth quarter indicating strength in a recovery of these end markets. Partially offsetting the decreases in fiscal 2020 compared to fiscal 2019 was an increase in Fluent system and disposable sales of $9.2 million. We expect the market for our GYN Surgical products to continue to be challenging in the first quarter of fiscal 2021 and beyond to the extent the COVID-19 pandemic continues and hospitals and healthcare centers continue to restrict access and elective medical procedures continue to be delayed or cancelled. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Skeletal Health product revenues decreased 13.7% in fiscal 2020 compared to fiscal 2019 which we attribute primarily to the impact of the COVID-19 pandemic resulting in a decrease in sales volume of our Horizon DXA systems and Insight FD mini C-arm system. While the impact of the COVID-19 pandemic has negatively impacted these product lines, we have experienced an increase in revenues sequentially from the third quarter of fiscal 2020 to the fourth quarter indicating strength in a recovery of these end markets. We expect a continued reduced demand for our Skeletal products in the first quarter of fiscal 2021 and beyond to the extent the COVID-19 pandemic continues and hospitals and healthcare centers continue to restrict access, wellness and elective medical procedures continue to be delayed or cancelled and hospital and healthcare center capital expenditures continue to be delayed or cancelled.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020. We have generated no revenue from the segment since that date.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues by geography as a percentage of total revenues were as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:22.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.327%"><tr><td style="width:1.0%"></td><td style="width:69.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The slight increase in the percentage of U.S. revenues in fiscal 2020 was primarily driven by sales of our SARS-CoV-2 assays, the majority of which were sold domestically. The increase in the percentage of product revenue derived from Europe was primarily due to sales of our SARS-CoV-2 assays in fiscal 2020, and also included growth in Molecular Diagnostics as we expanded our customer base and increased sales from the adoption of co-testing for cervical cancer screening in Germany, as well as, the inclusion of SSI revenues, which are predominantly in Europe. Asia-Pacific product revenue as a percentage of total product revenue decreased primarily due to lower sales in China in fiscal 2020, which we primarily attribute to the effect of the COVID-19 pandemic disrupting wellness visits and the disposition of Medical Aesthetics.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Other Revenues</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Service and Other Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues are primarily comprised of revenue generated from our field service organization to provide ongoing service, installation and repair of our products. The majority of these revenues are generated within our Breast Health segment, and to a lesser extent, our Medical Aesthetics business prior to its disposition in the beginning of the second quarter of fiscal 2020.&#160;Service and other revenues decreased 7.8% in fiscal 2020 compared to fiscal 2019 primarily due to the disposition of Medical Aesthetics, resulting in a decrease in revenue of $47.0 million in fiscal 2020. The Breast Health business continues to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period, and Breast Health service contract revenue increased by $19.6 million in the current fiscal year. This increase </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was partially offset by the decline in installation, spare parts and training revenue as hospitals and healthcare centers restricted access and capital expenditures continue to be delayed or cancelled due to the COVID-19 pandemic. In the current year, we generated additional royalty revenue from Grifols related to licensing intellectual property related to our COVID-19 assays for their sale in Spain. Additionally, we generated less service revenue in blood screening from Grifols in the current year and the prior year period included additional one-time license revenue in Breast Health.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:25.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.506%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Product<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Product<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cost of Product Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amortization of Intangible Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment of Intangible Assets and Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(613.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross margin was 61.8% in fiscal 2020 compared to 33.4% in fiscal 2019. Excluding the impairment of intangible assets and equipment included in cost of product revenues in both fiscal 2020 and 2019, product gross margin increased by 8.3% in fiscal 2020 compared to fiscal 2019.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cost of product revenues as a percentage of product revenues was 29.6% in the current year compared to 34.2% in the prior year. Cost of product revenues as a percentage of revenue decreased in fiscal 2020 primarily due to sales of our SARS-CoV-2 assays, which have higher gross margins compared to our other diagnostic products, and comprised 28.8% of total product revenue in fiscal 2020. Also benefiting gross margin was the disposition of Medical Aesthetics, which had lower gross margins compared to our remaining businesses. Partially offsetting these decreases was an increase in inventory reserves, higher freight costs and the step-up in fair value of inventory acquired in the SSI and Health Beacons acquisitions resulting in additional costs of $6.8 million.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics' product costs as a percentage of revenue decreased in fiscal 2020 compared to fiscal 2019 primarily due to sales of our SARS-CoV-2 assays and higher overall production reducing fixed overhead on a unit basis, partially offset by lower volumes of ThinPrep, an increase in inventory reserves, higher field service costs for the instrument installed base and an increase in freight charges internationally.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health&#8217;s product costs as a percentage of revenue increased in fiscal 2020 compared to fiscal 2019 primarily due to decreased sales volume across the majority of its product lines, period costs for temporary facility shut-downs and reduced manufacturing utilization, an increase in inventory reserves and the step-up in fair value of inventory acquired in the SSI and Health Beacons acquisitions resulting in additional costs of $6.8 million. We attribute these decreases primarily to the COVID-19 global pandemic as hospitals and imaging centers either slowed down purchases or delayed orders and installations of capital equipment units in order to focus their efforts towards COVID-19 patients and concerns on maintaining their cash and liquidity, as well as from the impact of delayed or cancelled elective imaging exams, screenings and procedures as described above. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical&#8217;s product costs as a percentage of revenue increased in fiscal 2020 compared to fiscal 2019 primarily due to the significant decrease in sales volume of our NovaSure and MyoSure devices, period costs for the temporary shutdown of our manufacturing facility and reduced manufacturing utilization, higher Fluent disposable sales at lower margins, as well as the continued product mix shift to a higher percentage of sales of MyoSure devices, which have lower margins than NovaSure devices. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health&#8217;s product costs as a percentage of revenue increased in fiscal 2020 compared to fiscal 2019 due to lower sales volume and an increase in inventory reserves. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets included in cost of product revenues relates to acquired developed technology, which is generally amortized over its estimated useful life of between 5 and 15 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed. Amortization expense decreased in fiscal 2020 compared to fiscal 2019 primarily due to lower amortization of $63.5 million from intangible assets acquired in the Cynosure acquisition as a result of impairment charges (partially offset by shortening lives of certain assets) in fiscal 2019, the classification of the Medical Aesthetics business as assets held-for-sale in November 2019 and its subsequent disposition on December 30, 2019, and lower amortization of intangible assets acquired in the Cytyc acquisition which reduce over time. These decreases were partially offset by amortization expense in the current fiscal year related to intangible assets primarily acquired in the SSI acquisition of $3.6 million.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets and Equipment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As discussed in Note 2 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets, of which $25.8 million was allocated to developed technology assets and written off to cost of revenues. During fiscal 2019, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we identified indicators of impairment for our Medical Aesthetics reporting unit as a result of reductions in forecasts during the year, and in connection with our efforts to sell the business that began prior to the end of fiscal 2019. As a result of these indicators of impairment, we recorded total impairment charges of $685.4 million in fiscal 2019, which was allocated to developed technology for $576.9 million and equipment assets for $1.8 million, which is included in cost of revenues.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:26.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Service<br/>and Other<br/>Revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Service<br/>and Other<br/>Revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cost of Service and Other Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues gross margin was 42.4% in fiscal 2020 compared to 41.2% in fiscal 2019. The increase in gross margin was primarily due to the disposition of Medical Aesthetics as service margins for Medical Aesthetics were lower compared to the Breast Health business, which generated the majority of our service revenues. In addition, in the current year, the Breast Health business had lower warranty and repair costs, including personnel costs, as hospitals and healthcare centers restricted access. The decrease in revenue from installation, spare parts and training also benefited gross margin as these services have lower margins compared to service contract revenue. In addition, the Diagnostics business had higher royalty revenue in fiscal 2020, which has higher margins. Partially offsetting these increases was lower license revenue in Breast Health in the current year, as the prior year period included additional one-time license revenue.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:27.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses decreased 4.2% in fiscal 2020 compared to fiscal 2019 primarily due to the disposition of the Medical Aesthetics business in the beginning of the second quarter of fiscal 2020. As a result, we had a $19.8 million decrease in research and development expenses for that segment in fiscal 2020. Partially offsetting this decrease was higher compensation and benefits driven by higher bonus and expense from our deferred </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation plan as the expense is primarily driven by the mark-to-market of the value of the underlying investments, the addition of SSI expenses, increased spending to implement the European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) requirements, and higher software development costs. These increases were partially offset by a decrease in R&amp;D consulting and project spend across the divisions as cuts or deferred spending actions were implemented in response to the effects of the COVID-19 pandemic and resources in Diagnostics were focused on the development and approval of our SARS-CoV-2 assays. In addition, during the current fiscal year, we recorded a reduction to research and development expenses of $7.1 million attributable to our grant from the Biomedical Advanced Research and Development Authority (BARDA) to expand manufacturing capacity, obtain FDA approval of our SARS-CoV-2 assays and develop sampling pooling capability and other enhancements to our SARS-CoV-2 assays. The prior fiscal year included a $4.5 million charge related to the purchase of intellectual property in the third quarter of fiscal 2019. At any point in time, we have a number of different research projects and clinical trials being conducted and the timing of these projects and related costs can vary from period to period.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and Marketing Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling and marketing expenses decreased 14.2% in fiscal 2020 compared to fiscal 2019 primarily due to the disposition of the Medical Aesthetics business. As a result, we had a $86.9 million decrease in sales and marketing expenses for that segment in fiscal 2020. In addition, in fiscal 2020, there were decreases in travel, commissions, third party commissions, trade shows and consulting, partially offset by an increase in marketing initiatives spending primarily for the Diagnostics segment and to a lesser extent corporate initiatives, an increase in bonus expense and the inclusion of SSI expenses in the current fiscal year of $15.3 million. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General and administrative expenses increased 7.1% in fiscal 2020 compared to fiscal 2019 primarily due to higher compensation and benefits driven by higher bonus, stock compensation and expense from our deferred compensation plan, charitable donations of $15.0 million, an increase in bad debt expense, higher facilities and infrastructure costs, and the addition of $6.9 million of SSI expenses. Partially offsetting these increases were lower expenses of $10.6 million in fiscal 2020 from the disposition of the Medical Aesthetics business, credits related to services provided under the transition services agreement with Cynosure, lower travel, and lower legal expenses as the prior year period included higher litigation and settlement costs related to the Fuji, Enzo and Minerva lawsuits. In addition, in fiscal 2020 expenses were higher due to project expenses related to the Medical Aesthetics disposition including accelerated stock compensation, partially offset by acquisition-related hold-back and accrual reversals.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets results from customer relationships, trade names, distributor relationships and business licenses related to our acquisitions. These intangible assets are generally amortized over their estimated useful lives of between 5 and 30 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed utilizing expected undiscounted future cash flows. Amortization expense decreased 23.7% in fiscal 2020 compared to fiscal 2019 primarily due to lower amortization from intangible assets acquired in the Cynosure acquisition as a result of impairment charges (partially offset by shortening lives of certain assets) in fiscal 2019 and the classification of the Medical Aesthetics business as assets held-for-sale in November 2019 and its subsequent disposition on December 30, 2019.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets of which $4.4 million was written off to operating expenses. As discussed above, we recorded aggregate impairment charges of $685.4 million during fiscal 2019. The impairment charges were allocated to the long-lived assets and written off to operating expenses in the amounts of $22.4 million to customer relationships, $48.6 million to trade names, $27.7 million to distribution agreements and $8.0 million to equipment.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring Charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have implemented various cost reduction initiatives to align our cost structure with our operations and related to integration activities. In addition, we have recorded divestiture charges. These actions have primarily resulted in the termination of employees. As a result, we recorded charges of $15.3 million in fiscal 2020 and $6.6 million in fiscal 2019, primarily related to severance benefits. For additional information, please refer to Note 6 to our consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.591%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense in fiscal 2020 and 2019 consists primarily of the cash interest costs and the related amortization of the debt discount and deferred issuance costs on our outstanding debt. Interest expense in fiscal 2020 decreased compared to fiscal 2019 primarily due to a decrease in LIBOR year over year, the basis for determining interest expense under our 2018 Credit Agreement and lower interest expense from the Securitization Program which was paid-off in full in the second quarter of fiscal 2020, partially offset by interest expense on net borrowings on our revolver and lower proceeds received under our interest rate cap agreements that hedge the variable interest rate under our credit facilities in fiscal 2020 compared to fiscal 2019.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Extinguishment Losses</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt Extinguishment Losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2019, we entered into the 2018 Credit Agreement with Bank of America, N.A. The proceeds under the 2018 Agreement were used to pay off the term loan and revolver outstanding under the 2017 Credit Agreement. In connection with this transaction, we recorded a debt extinguishment loss of $0.8 million in the first quarter of fiscal 2019. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, net</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2020, this account primarily consisted of net foreign currency exchange gains of $3.2 million primarily due to hedging activities, a net gain of $3.2 million to reflect an adjustment to remeasure our initial investment in SSI in connection with purchase accounting and a gain of $2.3 million on the cash surrender value of life insurance contracts related to our deferred compensation plans.</span></div><div style="margin-top:12pt;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, this account primarily consisted of net foreign currency exchange gains of $5.1 million primarily due to hedging activities, a gain of $0.9 million on the sale of an investment and a gain of $0.4 million on the cash surrender value of life insurance contracts related to our deferred compensation plans, partially offset by a $3.3 million loss related to our proportionate share of investment in SSI, which is being accounted for an equity method investment.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefit for Income Taxes.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Benefit for Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for fiscal 2020 was a benefit of 10.8%. The effective tax rate differed from the U.S. statutory tax rate primarily due to a $313.4 million discrete net tax benefit related to the sale of the Medical Aesthetics business, the impact of the U.S. deduction for foreign derived intangible income, federal and state tax credits, and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes, reserves for uncertain tax positions net of releases resulting from statute of limitations expirations and favorable audit settlements, the global intangible low-taxed income inclusion, and unbenefited foreign losses. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for fiscal 2019 was 21.0%. The effective tax rate, applied to an overall pre-tax loss resulting in a benefit, was equal to the statutory tax rate primarily due to the offsetting impacts of a discrete benefit related to an internal restructuring, earnings in jurisdictions subject to lower tax rates, reserves for uncertain tax positions and releases resulting from statute of limitations expirations and favorable audit settlements, a valuation allowance resulting from the Medical Aesthetics impairment charge, and finalizing the impact of the enactment of the Tax Cuts and Jobs Act (the "Act") in the first quarter of fiscal 2019. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 29, 2018, we completed our accounting for the tax effects of enactment of the Act, recording a benefit reduction of $5.0 million in the three months ended December 29, 2018. We recognized a final net benefit amount of $341.2 million related to the Act, which was included as a component of income tax expense.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Results of Operations</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the divestiture of our Medical Aesthetics segment, we reported our business in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. We completed the disposition of the Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). The accounting policies of the segments are the same as those described in the footnotes to the accompanying consolidated financial statements contained in Item&#160;15 of this Annual Report. We measure segment performance based on total revenues and operating income. Revenues from product sales of each of these segments are described in further detail above. The discussion that follows is a summary analysis of total revenues and the primary changes in operating income or loss by segment.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diagnostics</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:36.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.805%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.894%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929.7&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics revenues increased in fiscal 2020 compared to fiscal 2019 primarily due to the increase in product revenues associated with the commercial launch of our SARS-CoV-2 assays discussed above. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in fiscal 2020 compared to fiscal 2019 primarily due to an increase in gross profit from higher revenues partially offset by an increase in operating expenses. Gross margin was 65.2% in the current year compared to 47.3% in the prior year. The increase in gross margin was primarily due to sales of our SARS-CoV-2 assays, higher overall production reducing fixed overhead on a unit basis and royalty revenue from Grifols, partially offset by lower volumes of ThinPrep, an increase in inventory reserves, higher field service costs for the instrument installed base and an increase in freight charges internationally. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in fiscal 2020 compared to fiscal 2019 primarily due to an increase in research and development expenses from higher compensation and benefits driven by higher bonus expense, increased project spend and software development costs partially offset by the BARDA $7.1 million credit, higher compensation across other functions due to focus on the development and approval of our SARS-CoV-2 assays, an increase in marketing initiatives, an increase in bad debt expense and an allocated portion of charitable donations. These increases were partially offset by a reduction in travel, consulting and trade shows. The increase in the current year period was also partially offset as a result of the prior year period including a $10.5 million settlement charge related to the Enzo litigation.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breast Health</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:37.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.907%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.907%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.907%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.8&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.3&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206.5)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health revenues decreased in fiscal 2020 compared to fiscal 2019 primarily due to a decrease of $164.7 million in product revenue as discussed above, partially offset by an increase of $2.4 million in service and other revenue. The increase in service revenue is primarily due to continued conversion of a high percentage of the installed base of digital mammography systems to service contracts upon expiration of the warranty period, partially offset by lower installation, spare parts and training revenue as hospitals and healthcare centers continue to restrict access and capital expenditures continue to be delayed or cancelled due to the COVID-19 pandemic, and the prior year period including additional one-time license revenue.</span></div><div style="margin-top:12pt;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment decreased in fiscal 2020 compared to fiscal 2019 primarily due to a decrease in gross profit from lower revenues with lower gross margin and an increase in operating expenses. Gross margin was 52.8% in the current fiscal year, compared to 57.8% in the prior fiscal year. The decrease in gross margin was primarily due to decreased sales volume of our products, period costs related to temporary facility shut-downs and reduced manufacturing utilization, an increase in inventory reserves, the step-up in fair value of inventory acquired in the SSI and Health Beacons acquisitions resulting in additional costs of $6.8 million and higher intangible asset amortization expense.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in fiscal 2020 compared to fiscal 2019 due to higher compensation and benefits driven by higher bonus expense and increased stock compensation expenses, an increase in bad debt expense, restructuring charges, an allocated portion of charitable donations and the inclusion in the current period of SSI expenses of $26.1 million. These increases were partially offset by a decrease in travel expenses, trade shows, R&amp;D project spend, commissions and third party commissions. The increase is also driven as a result of the prior year period included a benefit from settling the Fuji litigation, partially offset by the reversal of acquisition related accruals and a hold-back in fiscal 2020. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GYN Surgical</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.2)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical revenues decreased in fiscal 2020 compared to fiscal 2019 due to the decrease in product revenues discussed above. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment decreased in fiscal 2020 compared to fiscal 2019 primarily due to a decrease in gross profit from lower revenues with lower gross margins, partially offset by a decrease in operating expenses. Gross margin was 59.1% in the current fiscal year, compared to 64.3% in the prior year. The decrease in gross margin was primarily due to a decrease in sales volume of our products and period costs from the temporary facility shut-down and reduced manufacturing utilization. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses decreased in fiscal 2020 compared to fiscal 2019 primarily due to lower commissions from the decrease in sales, lower marketing initiative spend, decreased spending on research and development projects and a decrease in travel, partially offset by higher bonus, increased stock compensation expenses, transaction expenses, and an allocated portion of charitable donations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skeletal Health</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:36.042%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.539%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Loss as a % of Segment Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health revenues decreased in fiscal 2020 compared to fiscal 2019 primarily due to the decrease in product revenues discussed above. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss decreased in fiscal 2020 compared to the prior year primarily due to a decrease in operating expenses, partially offset by a decrease in gross profit from lower revenues with lower gross margins. Gross margin decreased to 33.2% in the current year compared to 37.4% in the prior year primarily due to lower sales volume of our products and an increase in inventory reserves.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses decreased in fiscal 2020 compared to fiscal 2019 primarily due to a decrease in travel expenses, a decrease in trade show expenses, and lower commissions, partially offset by higher compensation and benefits driven by higher bonus and stock compensation expense.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Aesthetics</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:36.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(781.2)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Loss as a % of Segment Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Aesthetics revenue and operating loss decreased in fiscal 2020 compared to fiscal 2019 primarily due to the divestiture of the Medical Aesthetics segment on December 30, 2019, the first day of our second quarter of fiscal 2020. We will continue to incur expenses related to legal and tax matters that we have agreed to retain. The operating loss in the current fiscal year and the corresponding period in the prior year included intangible assets and equipment impairment charges of $30.2 million recorded in the first quarter of fiscal 2020 and $443.8 million and $241.6 million recorded in the second and fourth quarter of fiscal 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year Ended September&#160;28, 2019 Compared to Fiscal Year Ended September&#160;29, 2018</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Discussions of year-to-year comparisons between fiscal 2019 and 2018 that are not included in this Form 10-K can be found in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended September 28, 2019.</span></div><div id="i8ddb964a7a024d63b8e4009970e71997_52"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;26, 2020, we had working capital of $983.0 million, and our cash and cash equivalents totaled $701.0 million. Our cash and cash equivalents balance increased by $99.2 million during fiscal 2020 principally due to cash generated from operating activities partially offset by cash used in financing and investing activities related to net repayments of debt, repurchases of common stock and capital expenditures.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we assessed the potential longer term economic and capital market uncertainties resulting from the COVID-19 pandemic, in March 2020 we suspended our accounts receivable securitization program and borrowed $750.0 million under our revolver. We used $250.0 million of these proceeds to pay off all amounts then owed under our accounts receivable securitization agreement, and retained the balance as cash reserves. In the third and fourth quarters of fiscal 2020, we repaid a total of $500.0 million on amounts borrowed under our revolver. As of September 26, 2020, we had $1.25 billion available under our revolver.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2020, our operating activities provided us with $896.6 million of cash, primarily due to net income of $1,110.5 million, non-cash charges for depreciation and amortization aggregating $376.0 million, stock-based compensation expense of $83.3 million, and non-cash intangible asset and equipment impairment charges aggregating $30.2 million. These adjustments to net income were partially offset by a decrease in net deferred tax liabilities of $94.4 million primarily due to the amortization </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of intangible assets and the intangible assets impairment charge. Cash provided by operations included a net cash outflow of $636.3 million from changes in our operating assets and liabilities. Changes in our operating assets and liabilities were driven primarily by an increase in accounts receivable of $427.1 million primarily due to increased sales of our SARS-CoV-2 assays, an increase in prepaid expenses and other assets of $286.2 million, primarily due to recording a $313.4 million tax refund receivable in connection with carrying back the Medical Aesthetics' loss, and an increase in inventory of $25.3 million primarily due to lower Breast Health sales than anticipated due to the COVID-19 pandemic and increased raw materials and inventory to support SARS-CoV-2 assay demand. Partially offsetting these cash outflows was an increase in accrued expenses of $96.0 million primarily due to an increase in accrued bonus, federal income taxes and other taxes, and an increase in deferred revenue of $15.0 million primarily due to an increase in service contracts as the Breast Health business continues to convert a high percentage of its installed base of digital mammography systems to service contracts upon expiration of the warranty period.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2020, our investing activities used cash of $141.6 million primarily related to acquisition payments of $119.4 million primarily for the Acessa Health, Alpha Imaging and Health Beacons acquisitions and $156.4 million for capital expenditures, which consisted of the placement of equipment under customer usage agreements and purchases of manufacturing equipment primarily to expand the capacity of our molecular diagnostics manufacturing facilities. These uses of cash were primarily offset by net proceeds received from the sale of the Medical Aesthetics business of $139.3 million.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2020, our financing activities used cash of $659.9 million, primarily for payments of $653.6 million for repurchases of our common stock on the open market, $234.0 million for the net repayment of amounts borrowed under our accounts receivable securitization agreement, $37.5 million for scheduled principal payments under our 2018 Credit Agreement, payment of $24.3 million for hold-back and contingent consideration payments related to the Focal, Faxitron and Emsor acquisitions, and payments of $14.3 million for employee-related taxes withheld for the net share settlement of vested restricted stock units. Partially offsetting these uses of cash were $250.0 million of net proceeds on amounts borrowed under our revolving credit line and $65.6 million from our equity plans, primarily the exercise of stock options.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total recorded debt outstanding of $3.0 billion at September&#160;26, 2020, which was comprised of our term loan under our 2018 Credit Agreement of $1.45 billion (principal of $1.46 billion), our revolver under our 2018 Credit Agreement of $250.0 million (principal of $250.0 million), 2025 Senior Notes of $939.4 million (principal of $950.0 million), and 2028 Senior Notes of $394.6 million (principal of $400.0 million)</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Credit Agreement</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, we refinanced our term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement, dated as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated our prior credit and guaranty agreement, dated as of October 3, 2017 ("2017 Credit Agreement"). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2018 Credit Agreement consist of:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $1.5 billion secured term loan ("2018 Term Loan") with a maturity date of December 17, 2023; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility ("2018 Revolver"; together with the 2018 Term Loan, the "Amended Credit Facilities") under which the Company may borrow up to $1.5 billion, subject to certain sublimits, with a maturity date of December 17, 2023.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings on the 2018 Term Loan bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was equal to 1.25% as of September 26, 2020. The borrowings of the 2018 Amended Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to 1.25% as of September 26, 2020. At September 26, 2020, borrowings under the 2018 Term Loan were subject to an interest rate of 1.40%.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings made under the 2018 Credit Agreement, bear interest, at a variable rate plus an applicable margin. The applicable margin is based upon our total net leverage ratio as defined in the 2018 Credit Agreement.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to make scheduled principal payments under the 2018 Term Loan in increasing amounts ranging from $9.375 million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $28.125 million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Term Loan after the scheduled principal payments, which is $1.2 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">billion as of September 26, 2020, and any amounts outstanding under the 2018 Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, we may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by us,&#160;first, to the 2018 Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2018 Credit Facilities without premium or penalty.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company and its U.S. subsidiaries, with certain exceptions. For example, borrowings under the 2018 Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under our Accounts Receivable Securitization program. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting our ability, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement requires us to maintain certain financial ratios. The 2018 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the company.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants (a total net leverage ratio and an interest coverage ratio) measured as of the last day of each fiscal quarter. As of September 26, 2020, we were in compliance with these covenants.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 26, 2020, we had 2025 Senior Notes outstanding in the total aggregate principal of $950.0 million. On September 28, 2020 (in the first quarter of fiscal 2021), we completed a private placement of $950 million aggregate principal amount of our 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The proceeds from this offering and cash on hand were used to redeem the 2025 Senior Notes in full on October 15, 2020, a redemption price of approximately $970.8 million (equal to 102.2% of the aggregate principal amount of the 2025 Senior Notes). See "Subsequent Event - 2029 Senior Notes" for further discussion.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 26, 2020, the total aggregate principal balance of the 2028 Senior Notes was $400.0 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries. The 2028 Senior Notes were issued pursuant to an indenture, dated as of January 19, 2018, among the Company, the guarantors and Wells Fargo Bank, National Association, as trustee. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. We may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. We may also redeem up to&#160;35%&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;104.625%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We also have the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2016, we entered into a one-year $200.0 million accounts receivable securitization program (the "Securitization Program") with several of our wholly owned subsidiaries and certain financial institutions, which provides for annual renewals.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Securitization Program, we and certain of our wholly-owned subsidiaries sell our customer receivables to a bankruptcy remote special purpose entity, which is wholly-owned by us. The special purpose entity, as borrower, and we, as servicer, have entered into a Credit and Security Agreement with several lenders pursuant to which the special purpose entity may borrow from the lenders up to the maximum borrowing amount allowed, with the loans secured by the receivables. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay our other debts or liabilities.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Effective April 18, 2019, we entered into an amendment to extend the Securitization Program an additional year to April 17, 2020. Under the amendment, the maximum borrowing amount increased from $225.0 million to $250.0 million. In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, we paid-off the total amount outstanding of $250.0 million previously borrowed under the Securitization Program. On April 13, 2020, we amended the Credit and Security agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. As of September&#160;26, 2020, we did not have any borrowings under this program.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings outstanding under the Securitization Program bear interest at LIBOR plus the applicable margin of 0.7% and are included as a component of current liabilities in our consolidated balance sheet, while the accounts receivable securing these obligations remain as a component of net receivables in our consolidated balance sheet. We and the special purpose entity are operated and maintained as separate legal entities. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay our other debts or liabilities.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit and Security Agreement contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, and an event of default upon a change of control. In addition, it contains financial covenants consistent with that of the Credit Agreement. As of September&#160;26, 2020, the Company had amended the Credit and Security Agreement, temporarily suspending the need to comply with the financial covenants for up to one year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, we completed a private placement of our 2029 Senior Notes. The total aggregate principal balance of the 2029 Senior Notes is $950.0 million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries. The 2029 Senior Notes were issued pursuant to an indenture, dated as of September 28, 2020, among the Company, the guarantors and Wells Fargo Bank, National Association, as trustee. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021. We may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. We may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We also have the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration Earn-Out Payments</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain of our acquisitions, we have incurred the obligation to make contingent earn-out payments tied to performance criteria, principally revenue growth of the acquired business over a specified period. In addition, contractual provisions relating to these contingent earn-out obligations may result in the risk of litigation relating to the calculation of the amount due or our operation of the acquired business. Such litigation could be expensive and divert management attention and resources. Our obligation to make contingent payments may also result in significant operating expenses.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contingent consideration arrangements are recorded as either additional purchase price or compensation expense if continuing employment is required to receive such payments. Pursuant to ASC 805, contingent consideration that is deemed to be part of the purchase price is recorded as a liability based on the estimated fair value of the consideration we expect to pay to the former shareholders of the acquired business as of the acquisition date. This liability is re-measured each reporting period with the change in fair value recorded through a separate line item within our Consolidated Statements of Operations. Increases or decreases in the fair value of contingent consideration liabilities can result from changes in discount rates, changes in the timing, probabilities and amount of revenue estimates, and accretion of the liability for the passage of time. </span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary contingent consideration liability is from our acquisition of Acessa Health. We have an obligation to the former Acessa Health shareholders to make contingent payments based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, the contingent consideration was deemed to be part of the purchase price and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of the business, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. At September 26, 2020 this liability was recorded at $81.8 million and no contingent payments have earned or been made.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, the Board of Directors authorized a new share repurchase plan to repurchase up to $500.0 million of our outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020, the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020. As of September 26, 2020, $262.4 million remained available under this authorization. Subsequent to September 26, 2020, we have repurchased 1.1 million shares of our common stock for $74.8 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contractual obligations and commitments as of September&#160;26, 2020:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:30.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments Due by Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1-3 years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3-5 years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt Obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on Long-Term Debt Obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Obligations (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Obligations (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Contractual Obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,890.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:31.5pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Purchase obligations primarily represent minimum purchase commitments for inventory and instruments and, to a lesser extent, other operating expense commitments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Pension obligations do not include our obligation under our deferred compensation plans of $57.7 million at September 26, 2020, which is recorded as a current liability. Deferred compensation plan benefits are generally paid out at retirement or termination of employment.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above table does not reflect our long-term liabilities associated with reserves for uncertain tax positions recorded under ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> totaling $103.7 million. Due to the complexity associated with tax uncertainties, we cannot reasonably make a reliable estimate of the period in which we expect to settle these non-current liabilities. See Note 9 to our consolidated financial statements contained in Item&#160;15 of this Annual Report for more information on our unrecognized tax benefits. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Liquidity Considerations</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to review and evaluate potential strategic transactions (both acquisitions and dispositions) and alliances that we believe will complement or enhance our business and stockholder value. Subject to the Risk Factors set forth in Part I, Item&#160;1A of this Annual Report and the general disclaimers set forth in our Special Note Regarding Forward-Looking Statements at the outset of this Annual Report, we believe that our cash and cash equivalents, cash flows from operations, the cash available under our 2018 Revolver and our Securitization Program will provide us with sufficient funds in order to fund our expected normal operations and debt payments over the next twelve months. Our longer-term liquidity is contingent upon future operating performance. We may also require additional capital in the future to fund capital expenditures, repayment of debt, acquisitions including contingent consideration payments, strategic transactions or other investments. As described above, we have significant indebtedness outstanding under our 2018 Credit Agreement, 2028 Senior Notes, and 2029 Senior Notes. These capital requirements could be substantial. Our operating performance may also be affected by matters discussed under the above-referenced Risk Factors set forth elsewhere in this report. These risks, trends and uncertainties may also adversely affect our long-term liquidity.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently involved in certain legal proceedings and claims. In connection with these legal proceedings and claims, management periodically reviews estimates of potential costs to be incurred by us in connection with the adjudication or settlement, if any, of these proceedings. These estimates are based on an analysis of potential litigation outcomes and settlement strategies. In accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, loss contingencies are accrued if, in the opinion of management, an adverse outcome is probable and such outcome can be reasonably estimated. It is possible that future results for any particular quarter or annual period may be materially affected by changes in our assumptions or the effectiveness of our strategies relating to these proceedings.</span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Off-Balance Sheet Arrangements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, of a magnitude that we believe could have a material impact on our financial condition or liquidity.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition for multiple element arrangements, allowance for doubtful accounts, reserves for excess and obsolete inventories, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, stock-based compensation, contingent liabilities, tax reserves and recoverability of our net deferred tax assets and related valuation allowances. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates if past experience or other assumptions do not turn out to be substantially accurate. Any differences may have a material impact on our financial condition and results of operations.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of what we believe to be the more significant critical accounting policies and estimates used in the preparation of our consolidated financial statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inventories include material, labor and overhead, and are stated at the lower of cost (first-in, first-out) or market. As a developer and manufacturer of high technology medical equipment and diagnostic test kits, we may be exposed to a number of economic and industry factors that could result in portions of our inventory becoming either obsolete or in excess of anticipated usage. Our policy is to establish inventory reserves when conditions exist that suggest that our inventory may be in excess of anticipated demand or is obsolete based upon our assumptions about future demand for our products and market conditions. Although considerable effort is made to ensure the accuracy of our forecasts of future product demand, any significant unanticipated changes in demand or expected usage could have a significant negative impact on the value of our inventory and our operating results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record tangible and intangible assets acquired and liabilities assumed in business combinations under the purchase method of accounting. Amounts paid for each acquisition are allocated to the assets acquired and liabilities assumed based on their fair values at the dates of acquisition. Contingent consideration, which is not deemed to be linked to continuing employment, is recorded at fair value as measured on the date of acquisition using an appropriate valuation model, such as the Monte Carlo simulation model. The value recorded is based on estimates of future financial projections under various potential scenarios, in which the model runs many simulations based on comparable companies' growth rates and their implied volatility. These cash flow projections are discounted with a risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and given the inherent uncertainties in making these estimates, actual results are likely to differ from the amounts originally recorded and could be materially different.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of identifiable intangible assets is based on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimate of inputs and assumptions that a market participant would use. We allocate any excess purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed to goodwill. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally use the income approach in which cash flow projections on an after-tax basis are discounted using a risk adjusted rate to determine the estimated fair value of certain identifiable intangible assets including developed technology, in-process research and development projects, customer relationships, and trade names.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to property, plant and equipment, we estimate the fair value of these assets using a combination of the cost and market approaches, depending on the component. Generally, we apply the cost or income approach as the primary methods in estimating the fair value of land and buildings as the market approach is less reliable based on potential significant differences between the property being valued and the potentially comparable sales of similar properties.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test goodwill at the reporting unit level for impairment on an annual basis and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying value. Events that </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could indicate impairment and trigger an interim impairment assessment include, but are not limited to current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate, operational performance of the business or key personnel, and an adverse action or assessment by a regulator. Our annual impairment test date is the first day of our fiscal fourth quarter.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the test, we either use the qualitative assessment permitted by ASC 350 or the single step quantitative approach prescribed under ASC 350 including amendments under ASU 2017-04. Under the qualitative approach we consider a number of factors, including the amount by which the previous quantitative test's fair value exceeded the carrying value of the reporting units, the forecasts in our then-current 5 year strategic plan compared to the forecasts in the previous quantitative test, an evaluation of discount rates, long-term growth rates including the terminal year rate, if tax rates would have significantly changed, an evaluation of current economic factors for both the worldwide economy and specifically the medical device industry, and any significant changes in customer and supplier relationships. We weigh these factors to determine if it is more likely than not that the fair value of the reporting unit exceeds its carrying value. If after performing a qualitative assessment, indicators are present, or we identify factors that cause us to believe it is appropriate to perform a more precise calculation of fair value, we would move beyond the qualitative assessment and perform a quantitative impairment test.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the quantitative impairment test, we perform a comparison of the reporting unit&#8217;s carrying value to its fair value. We consider a number of factors to determine the fair value of a reporting unit, including an independent valuation to conduct this test. The valuation is based upon expected future discounted operating cash flows of the reporting unit as well as analysis of recent sales and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ratio comparisons of similar companies. We base the discount rate on the weighted average cost of capital, or WACC, of market participants. If the carrying value of a reporting unit exceeds its estimated fair value, we apply the single step approach under ASU 2017-04. As a result of this simplified approach the goodwill impairment is calculated as the amount by which the carrying value of the reporting unit exceeds its fair value to the extent of the goodwill balance.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our fiscal 2020 annual impairment test on the first day of the fourth quarter and utilized the quantitative approach. We utilized discounted cash flows, or DCF, and market approaches to estimate the fair value of our reporting units as of June 28, 2020 and ultimately used the fair value determined by the DCF in making our impairment test conclusions. We believe we used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of our reporting units had fair values exceeding their carrying values. For illustrative purposes, had the fair value of each of our reporting units been lower by 10%, all of our reporting units would still have passed the goodwill impairment test.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;26, 2020, we believe that our reporting units, with goodwill aggregating $2.6 billion, were not at risk of failing the goodwill impairment test based on its current forecasts and qualitative assessment.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the fair value of our reporting units was determined by use of the DCF, and the key assumptions that drive the fair value in this model are the WACC, terminal values, growth rates, and the amount and timing of expected future cash flows, significant judgment is applied in determining fair value. If the current economic environment were to deteriorate, this would likely result in a higher WACC because market participants would require a higher rate of return. In the DCF as the WACC increases, the fair value decreases. The other significant factor in the DCF is our projected financial information (i.e., amount and timing of expected future cash flows and growth rates) and if these assumptions were to be adversely impacted, this could result in a reduction of the fair value of a reporting unit.</span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are initially recorded at fair value and stated net of accumulated amortization and impairments. We amortize intangible assets that have finite lives using either the straight-line method, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be utilized. We evaluate the recoverability of our definite lived intangible assets whenever events or changes in circumstances or business conditions indicate that the carrying value of these assets may not be recoverable based on expectations of future undiscounted cash flows for each asset group. If the carrying value of an asset or asset group exceeds its undiscounted cash flows, the Company estimates the fair value of the assets, generally utilizing a discounted cash flow analysis based on the present value of estimated future cash flows to be generated by the assets using a risk-adjusted discount rate. To estimate the fair value of the assets, the Company uses market participant assumptions pursuant to ASC 820.</span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue from the sale of our products, primarily medical imaging systems and diagnostic and surgical disposable products, and related services, which are primarily support and maintenance services on our medical imaging systems. See Note 3 for further discussion of revenue recognition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider revenue to be earned when all of the following criteria are met: we have a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount that we expect to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and we have transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration we expect to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for our products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefit of the product. As such, the performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts and extended warranties are recognized over time based on the contract term, which represents a faithful depiction of the transfer of goods and services given the stand-ready nature of the performance obligations. Service revenue related to professional services for installation, training and repairs is recognized as the services are performed based on the specific nature of the service.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize receivables when we have an unconditional right to payment, which represents the amount we expect to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we are required to allocate the transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. We determine the best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, we rely on prices set by our pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also place instruments (or equipment) at customer sites but retain title to the instrument (for example, the ThinPrep Processor, ThinPrep Imaging System, and the Panther system). The customer has the right to use the instrument for a period of time, and then we recover the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded operating lease for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. We recognize a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the asset and liability method for accounting for income taxes in accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under this method, we recognize deferred income tax assets and liabilities for the future tax consequences of differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases, and also for operating loss and tax credit carry-forwards at each reporting period. We measure deferred tax assets and liabilities using enacted tax rates and laws applicable to the period and jurisdiction in which we expect the differences to affect taxable income. We evaluate both the positive and negative evidence that affects the realizability of net deferred tax assets and assess the need for a valuation allowance. The future benefit to be derived from our deferred tax assets is dependent upon our ability to generate sufficient future taxable income in each jurisdiction of the right type to realize the assets. We establish a valuation allowance when necessary to reduce deferred tax assets to the amounts expected to be realized. To the extent we establish or release a valuation allowance, a tax charge or benefit will be recorded as a component of the income tax provision on the statement of operations in the reporting period that such determination is made.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recognized $186.3 million in net deferred tax liabilities at September&#160;26, 2020 and $258.1 million at September&#160;28, 2019. The reduction was primarily due to intangible asset amortization recorded in fiscal 2020. The liabilities primarily relate to deferred taxes associated with our acquisitions. The tax assets relate primarily to net operating loss carryforwards, accruals and reserves, stock-based compensation, and research credits. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for income taxes requires a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if, based on the technical merits, it is more likely than not that the position will be sustained upon audit, including resolutions of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. We evaluate these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes in facts or circumstances, changes in tax law, effectively settled issues under audit and new audit activity. Any change in these factors could result in the recognition of a tax benefit or an additional charge to the tax provision.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;26, 2020, we had $197.1 million in gross unrecognized tax benefits excluding interest, of which $184.9 million, if recognized, would reduce our effective tax rate. As of September&#160;28, 2019, we had $101.6 million in gross unrecognized tax benefits excluding interest, of which $87.3 million, if recognized, would have reduced our effective tax rate. The Tax Cuts and Jobs Act subjects a U.S. shareholder to tax on global intangible low-taxed income (&#8220;GILTI&#8221;) earned by certain foreign subsidiaries. The FASB Staff Q&amp;A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed Income, states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. The Company accounts for GILTI in the year the tax is incurred as a period cost.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, there are many transactions and calculations where the ultimate tax outcome is uncertain. Judgment is required in determining our worldwide income tax provision. In our opinion, we have made adequate provisions for income taxes for all years subject to audit. While we consider our estimates reasonable, no assurance can be given that the final tax outcome will not be different than amounts reflected in our historical income tax provisions and accruals. If our assumptions are incorrect, the differences could have a material impact on our income tax provision and operating results in the period in which such determination is made.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2 to our consolidated financial statements contained in Item&#160;15 of this Annual Report.</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments, Other Financial Instruments, and Derivative Commodity Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments consist of cash and cash equivalents, accounts receivable, equity cost-method investments, foreign currency contracts, interest rate cap and interest rate swap agreements, insurance contracts, accounts payable and debt obligations. Except for our outstanding 2025 and 2028 Senior Notes, the fair value of these financial instruments approximate their carrying amount. The fair value of our 2025 and 2028 Senior Notes was approximately $971.5 million and $419.1 million, respectively, as of September 26, 2020. Amounts outstanding under our 2018 Credit Agreement of $1.71 billion aggregate principal as of September&#160;26, 2020 are subject to variable rates of interest based on current market rates, and as such, we believe the carrying amount of these obligations approximates fair value.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Primary Market Risk Exposures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our primary market risk exposure is in the areas of interest rate risk and foreign currency exchange rate risk. We incur interest expense on borrowings outstanding under our 2025 and 2028 Senior Notes and 2018 Credit Agreement. The 2025 and 2028 Senior Notes have fixed interest rates. Borrowings under our 2018 Credit Agreement currently bear interest at the Eurocurrency Rate (i.e., Libor) plus the applicable margin of 1.25% per annum. Borrowings under our accounts receivable securitization program currently bear interest at Libor plus the applicable margin of 0.7%.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;26, 2020, there was $1.71 billion of aggregate principal outstanding under the 2018 Credit Agreement aggregate principal outstanding. Since these debt obligations are variable rate instruments, our interest expense associated with these instruments is subject to change. A 10% adverse movement (increase in LIBOR rate) would increase annual interest expense by approximately $0.3 million. We entered into multiple interest rate cap agreements and an interest rate swap agreement to help mitigate the interest rate volatility associated with the variable rate interest on the amounts outstanding. The critical terms of the interest rate caps and interest rate swap were designed to mirror the terms of our LIBOR-based borrowings under the 2018 Credit Agreement, and therefore the interest rate caps and interest rate swap are highly effective at offsetting the cash flows being hedged. We designated these derivatives as cash flow hedges of the variability of the Libor-based interest payments on $1.0 billion of principal. The interest rate cap contract expires on December 23, 2020, and the interest rate swap contract expires on December 17, 2023.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intends to phase out LIBOR by the end of 2021. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, including our 2018 Credit Agreement and related interest rate cap and swap agreements, and we cannot predict what alternative rate or benchmark would be negotiated or the extent to which this would adversely affect our interest rate and the effectiveness of our interest rate hedging activity.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The return from cash and cash equivalents will vary as short-term interest rates change. A hypothetical 10% increase or decrease in interest rates, however, would not have a material adverse effect on our financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our international business is subject to risks, including, but not limited to: unique economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility. Accordingly, our future results could be materially adversely impacted by changes in these or other factors.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business worldwide and maintain sales and service offices outside the United States as well as manufacturing facilities in Costa Rica and the United Kingdom. Our international sales are denominated in a number of currencies, primarily the Euro, U.S. dollar, UK Pound and Renminbi. The majority of our foreign subsidiaries functional currency is the local currency, although certain foreign subsidiaries functional currency is the U.S. dollar based on the nature of their operations or functions. Fluctuations in the foreign currency rates could affect our sales, cost of goods and operating margins and could result in exchange losses. In addition, currency devaluations can result in a loss if we hold deposits of that currency. We have executed forward foreign currency contracts and foreign currency option contracts to hedge a portion of results denominated in the Euro, UK Pound, Australian dollar, Japanese Yen, Canadian dollar and Chinese Renminbi. These contracts do not qualify for hedge accounting. As a result, we may experience volatility in our Consolidated Statements of Operations due to (i) the impact of unrealized gains and losses reported in other income, net on the mark-to-market of outstanding contracts and (ii) realized gains and losses recognized in other income, net, whereas the offsetting economic gains and losses are reported in the line item of the underlying cash flow, for example, revenue. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the operating expenses of our international subsidiaries that are incurred in local currencies will not have a material adverse effect on our business, results of operations or financial condition. Our operating results and certain assets and liabilities that are denominated in foreign currencies are affected by changes in the relative strength of the U.S. dollar against those currencies. Our expenses, denominated in foreign currencies, are positively affected when the U.S. dollar strengthens against those currencies and adversely affected when the U.S. dollar weakens. However, we believe that the foreign currency exchange risk is not significant. We believe a hypothetical 10% increase or decrease in foreign currencies that we transact in would not have a material adverse impact on our financial condition or results of operations. During fiscal 2020, 2019 and 2018, we incurred net foreign exchange gains (losses) of $3.4 million, $5.1 million and $5.9 million, respectively.</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Financial Statements and Supplementary Data</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Consolidated Financial Statements and Supplementary Data are set forth under Part IV, Item&#160;15, which is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9A. Controls and Procedures</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;26, 2020, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Management on Internal Control over Financial Reporting</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act, as amended, as a process designed by, or under the supervision of our principal executive and principal financial officers and effected by our board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles and includes those policies and procedures that:</span></div><div style="margin-top:5pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and disposition of our assets;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorization of our management and directors; and</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our internal control system was designed to provide reasonable assurance to our management and board of directors regarding the preparation and fair presentation of published financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has assessed the effectiveness of our internal control over financial reporting as of September&#160;26, 2020. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (COSO) in Internal Control-Integrated Framework.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has excluded from our assessment of and conclusion on the effectiveness of internal control over financial reporting the internal controls of Acessa Health, Inc. acquired on August 23, 2020, which is included in the consolidated financial statements of Hologic, Inc. as of and for the year ended September 26, 2020 and constituted less than 1% of our total assets and net assets as of September 26, 2020 and less than 1% of revenues and pre-tax income for the year then ended.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the foregoing, based on management&#8217;s assessment, we believe that, as of September&#160;26, 2020, our internal control over financial reporting is effective at a reasonable assurance level based on these criteria.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst&#160;&amp; Young LLP, an independent registered public accounting firm, has issued an attestation report on the effectiveness of our internal control over financial reporting. This report in which they expressed an unqualified opinion is included below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of Hologic, Inc.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have audited Hologic, Inc.&#8217;s internal control over financial reporting as of September 26, 2020, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Hologic, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of September 26, 2020, based on the COSO criteria.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As indicated in the accompanying Report of Management on Internal Control over Financial Reporting, management&#8217;s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Acessa Health, Inc., which is included in the 2020 consolidated financial statements of the Company and constituted less than 1% of total and net assets, respectively, as of September 26, 2020 and less than 1% of revenues and pre-tax income, respectively, for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Acessa Health, Inc.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2020 consolidated financial statements of the Company and our report dated November 17, 2020 expressed an unqualified opinion thereon.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Report of Management on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ernst&#160;&amp; Young LLP</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston, Massachusetts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended September&#160;26, 2020, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i8ddb964a7a024d63b8e4009970e71997_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9B. Other Information</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_73"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section&#160;406 of the Sarbanes-Oxley Act of 2002, we have adopted a Code of Ethics for Senior Financial Officers that applies to our principal executive officer, principal financial officer, and principal accounting officer and controller, and other persons performing similar functions. Our Code of Ethics for Senior Financial Officers is publicly available on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">investors.hologic.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as Appendix A to our Code of Conduct. We intend to satisfy the disclosure requirement under Item&#160;5.05 of Current Report on Form 8-K regarding an amendment to, or waiver from, a provision of this code by posting such information on our website, at the address specified above.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;11. Executive Compensation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a number of equity compensation plans for employees, officers, directors and others whose efforts contribute to our success. The table below sets forth certain information as of the end of our fiscal year ended September&#160;26, 2020 regarding the shares of our common stock available for grant or granted under stock option plans and equity incentives that (i)&#160;were approved by our stockholders, and (ii)&#160;were not approved by our stockholders.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:44.061%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>securities&#160;to&#160;be<br/>issued upon<br/>exercise&#160; of<br/>outstanding<br/>options,&#160;warrants<br/>and rights<br/>(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average<br/>exercise&#160; price&#160; of<br/>outstanding<br/>options,<br/>warrants&#160;and&#160; rights<br/>(b) (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160; securities<br/>remaining&#160;available&#160;for<br/>future&#160;issuance&#160;under<br/>equity&#160;compensation<br/>plans&#160;(excluding<br/>securities&#160;reflected&#160;in<br/>column (a))<br/>(c)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by security holders&#160;(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,231,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,673,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by security holders</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,231,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,673,843&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________</span></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 3,664,256 shares that are issuable upon restricted stock units (RSUs), performance stock units (PSUs) and market stock units (MSUs) vesting. The remaining balance consists of outstanding stock option grants.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The weighted average exercise price does not take into account the shares issuable upon vesting of outstanding RSUs, PSUs and MSUs, which have no exercise price.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i8ddb964a7a024d63b8e4009970e71997_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;13. Certain Relationships and Related Transactions and Director Independence</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;14. Principal Accounting Fees and Services</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_94"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15. Exhibits and Financial Statement Schedules</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The following documents are filed as part of this report:</span></div><div style="margin-top:9pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Financial Statements</span></div><div style="margin-top:5pt;padding-left:81pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firm on Consolidated Financial Statements</span></div><div style="margin-top:5pt;padding-left:81pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Operations for the years ended September&#160;26, 2020, September&#160;28, 2019 and September&#160;29, 2018 </span></div><div style="margin-top:5pt;padding-left:81pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Comprehensive Income (Loss) for the years ended September&#160;26, 2020,&#160;September&#160;28, 2019 and September&#160;29, 2018 </span></div><div style="margin-top:5pt;padding-left:81pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets as of September&#160;26, 2020 and September&#160;28, 2019 </span></div><div style="margin-top:5pt;padding-left:81pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity for the years ended September&#160;26, 2020, September&#160;28, 2019 and September&#160;29, 2018 </span></div><div style="margin-top:5pt;padding-left:81pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows for the years ended September&#160;26, 2020, September&#160;28, 2019 and September&#160;29, 2018 </span></div><div style="margin-top:5pt;text-indent:81pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:9pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Financial Statement Schedules</span></div><div style="margin-top:5pt;padding-left:81pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All schedules have been omitted because they are not required or because the required information is given in the Consolidated Financial Statements or Notes thereto.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Listing of Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312516793341/d299707dex21.htm">Asset Purchase Agreement, dated December 14, 2016, by and among Hologic, Inc., Grifols Diagnostic Solutions Inc. and Grifols, S.A.</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/15/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/859737/000119312519296652/d820369d8k.htm">Securities Purchase Agreement, dated as of November 20, 2019, by and among Hologic, Inc., Hologic Holdings Limited and Lotus Buyer, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/20/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973717000023/holx_q4-2017xex31.htm">Certificate of Incorporation of Hologic, with </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973717000023/holx_q4-2017xex31.htm">amendments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/30/2017</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000019/exhibit31-hologicseventham.htm">Seventh Amended and Restated Bylaws of Hologic, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">06/25/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specimen Certificate for Shares of Hologic&#8217;s Common Stock (filed in paper format)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-A</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/31/1990</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520256460/d942100dex41.htm">Indenture, dated September 28, 2020, by and among Hologic, Inc., the guarantors party thereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520256460/d942100dex41.htm">Form of 3.250% Senior Note due 2029 (included in Exhibit 4.2)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2020</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex44.htm">Indenture dated January 19, 2018, by and among Hologic, the Guarantors party thereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/19/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex43.htm">First Supplemental Indenture dated January, 19, 2018, by and among Hologic, the Guarantors party thereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/19/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex44.htm">Form of 4.625% Senior Note due 2028 (included in Exhibit 4.5)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/19/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex47.htm">Description of Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312506100450/dex103.htm">Second Amended and Restated 1999 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/25/2006</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312507223967/dex102.htm">Amendment No. 1 to Second Amended and Restated 1999 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/23/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312507222834/dex1017.htm">Amendment No. 2 to Second Amended and Restated 1999 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/22/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312508252760/dex103.htm">Amendment No. 3 to Second Amended and Restated 1999 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/12/2008</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312512331837/d385376dex101.htm">The 2003 Incentive Award Plan of Gen-Probe Incorporated as amended and restated.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">08/02/2012</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513101083/d499702dex102.htm">Hologic Amended and Restated 2008 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/15/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000027/exhibit101-formofrestricte.htm">Form of Stock Option Award Agreement Under 2008 Equity Incentive Plan (adopted fiscal 2016).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/14/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000064/exhibit101-fy17psuawardagr.htm">Form of Stock Option Award Agreement Under 2008 Equity Incentive Plan (adopted fiscal 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/09/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000064/exhibit101-fy17psuawardagr.htm">Form of Restricted Stock Unit Award Agreement Under 2008 Equity Incentive Plan (adopted fiscal 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/09/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973718000018/a102-fy19psuagxtsr.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (relative TSR) (adopted fiscal 2019).</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/07/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973718000018/a101-fy19psuagxroic.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (ROIC) (adopted fiscal 2019).</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/07/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312519288355/d830662dex102.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (relative TSR) (adopted fiscal 2020).</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/08/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312519288355/d830662dex101.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (ROIC) (adopted fiscal 2020).</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/08/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312519288355/d830662dex103.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (Free Cash Flow) (adopted fiscal 2020).</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/08/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex102.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (relative TSR) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex101.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (ROIC) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex103.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (Free </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex103.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (Free Cash Flow) (adopted fiscal 2021).</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex103.htm"> Flow) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex104.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (ROIC &#8211; Outside US) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex105.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (relative TSR &#8211; Outside US) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex106.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (Free Cash Flow &#8211; Outside US) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513453681/d592931dex1018.htm">Form of Independent Director Restricted Stock Unit Award Agreement Under 2008 Equity Incentive Plan (annual grant).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2013</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000049/exhibit101-esppasamended.htm">Hologic, Inc. 2012 Employee Stock Purchase Plan, as amended</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/04/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000029/exhibit102short-termincent.htm">Hologic Short-Term Incentive Plan, as amended and restated</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/07/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000036/exhibit101-deferredequityp.htm">Hologic Amended and Restated Deferred Equity Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/16/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513453681/d592931dex1031.htm">Rabbi Trust Agreement.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312509047232/dex101.htm">Form of Indemnification Agreement (as executed with each director of Hologic).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/06/2009</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513466750/d640972dex101.htm">Employment Agreement dated December 6, 2013 by and between Stephen P. MacMillan and Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/09/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000023/exhibit103-amendedandresta.htm">Amended and Restated Employment Agreement by and between the Company and Stephen P. MacMillan, dated September 18, 2015.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/21/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1033.htm">Amendment No. 1 to Amended and Restated Employment Agreement by and between the Company and Stephen P. MacMillan, dated September&#160;24, 2016.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/17/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520264729/d25481dex101.htm">Amendment No. 2 to Amended and Restated Employment Agreement by and between the Company and Stephen P. MacMillan, dated October 5, 2020.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/06/2020</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513466750/d640972dex103.htm">Form of Matching Restricted Stock Unit Award Agreement</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/09/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513466750/d640972dex104.htm">Change of Control Agreement dated December 6, 2013 by and between Stephen P. MacMillan and Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/09/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518233148/d585850dex101.htm">Severance and Change of Control Agreement dated July 31, 2018 by and between Karleen M. Oberton and Hologic, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">07/31/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973717000023/holx_q4-2017xex1045.htm">Severance and Change of Control Agreement dated September 13, 2017 by and between Allison Bebo and Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/30/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000010/holx_q2-2015xex101.htm">Offer Letter dated January 6, 2015 by and between John M. Griffin and Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/28/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000010/holx_q2-2015xex102.htm">Severance and Change of Control Agreement dated February 2, 2015 by and between John M. Griffin and Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/28/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973720000032/a8-kxthornalex101xcica.htm">Severance and Change of Control Agreement dated September 15, 2020 by and between Kevin R. Thornal and Hologic, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/15/2020</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520229875/d901581dex101.htm">Retirement and Separation Agreement by and between Hologic, Inc. and Peter J. Valenti, III, dated August 25, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">08/25/2020</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2020ex1039.htm">Severance and Change of Control Agreement by and between Hologic, Inc. and Sean S. Daugherty, dated August 31, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed Herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility Lease (Danbury) dated December&#160;20, 1995 by and among Melvin J. Powers and Mary P. Powers D/B/A M&amp;N Realty and Lorad (filed in paper format).</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trex&#160;Medical<br/>Corporation<br/>S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/29/1996</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1046.htm">First Addendum to Lease Agreement by and between Melvyn J. Powers and Mary P. Powers d/b/a M&amp;M Realty and Lorad, a Division of Trex-Medical Corporation dated as of March 1, 1996.</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1047.htm">Second Addendum to Lease Agreement by and between Melvyn J. Powers and Mary P. Powers d/b/a M&amp;M Realty and Lorad, a Division of Trex-Medical Corporation dated as of April 1, 1996.</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1048.htm">Third Addendum to Lease Agreement by and between Melvyn J. Powers and Mary P. Powers d/b/a M&amp;M Realty and Lorad, a Division of Trex-Medical Corporation dated as of May 1, 1996. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1048.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1048.htm">)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1049.htm">Notice of Lease by Commerce Park Realty, LLC, successor-in-interest to Melvyn J. Powers and Mary P. Powers d/b/a M&amp;M Realty and Hologic, Inc. dated as of October 7, 2005 and Fourth Addendum to Lease. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1049.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1049.htm">)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1050.htm">Fifth Addendum to Agreement of Lease by and between Commerce Park Realty, LLC and Hologic, Inc. dated as of March 2012. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1050.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1050.htm">)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1051.htm">Sixth Addendum to Agreement of Lease by and between Commerce Park Realty, LLC and Hologic, Inc. dated as of July 2016. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1051.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1051.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000102140802015499/dex1027.txt">Lease Agreement (Danbury and Bedford) by and between BONE (DE) QRS 15-12, INC., and Hologic dated August 28, 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312507253993/dex1041.htm">First Amendment to Lease Agreement (Danbury and Bedford) by and between BONE (DE) QRS 15-12, INC., and Hologic dated October 29, 2007.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/29/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/849778/000104746904002696/a2127335zex-10_17.txt">Office Lease dated December&#160;31, 2003 between Cytyc and Marlborough Campus Limited Partnership.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytyc<br/>Corporation<br/>10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2003</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973717000023/holx_q4-2017xex1052.htm">First Amendment to that Office Lease dated December&#160;31, 2003 between Cytyc and Marlborough Campus Limited Partnership, entered into August 23, 2017, by and between Hines Global REIT Marlborough Campus LLC and Hologic, Inc. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973717000023/holx_q4-2017xex1052.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973717000023/holx_q4-2017xex1052.htm">)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/30/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312507253993/dex1045.htm">Lease Agreement by and between Zona Franca Coyol S.A. and Cytyc Surgical Products Costa Rica S.A. dated April 23, 2007.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/29/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1057.htm">Addendum 1 to Lease Agreement by and between Zona Franca Coyol S.A. and Cytyc Surgical Products Costa Rica S.A. dated July 22, 2007. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1057.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1057.htm">) (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1057.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1057.htm">)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1058.htm">Addendum 2 to Lease Agreement by and between Zona Franca Coyol S.A. and Cytyc Surgical Products Costa Rica S.A. dated September 22, 2008. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1058.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1058.htm">) (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1058.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1058.htm">)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973718000002/holx_q1-2018xex105.htm">Addendum No. 3 to Current Lease by and Between BCR Fondo de Inversion Inmobiliario and Hologic Surgical Products Costa Rica S.R.L. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973718000002/holx_q1-2018xex105.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973718000002/holx_q1-2018xex105.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/30/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312507253993/dex1046.htm">Lease Agreement by and between 445 Simarano Drive, Marlborough LLC and Cytyc dated July 11, 2006.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/29/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1061.htm">First Amendment to Lease by and between 445 Simarano Drive Marlborough LLC and Hologic, Inc. dated July 14, 2016. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1061.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1061.htm">)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517302740/d417723dex101.htm">Amended and Restated Credit and Guaranty Agreement, originally dated May 29, 2015, and amended and restated as of October 3, 2017 among Hologic, Hologic GGO 4 Ltd, each Designated Borrower from time to time party thereto, the Guarantors from time to time party thereto, each Lender from time to time party thereto and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/04/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518351385/d677404dex101.htm">Refinancing Amendment No. 1 dated as of December 17, 2018 to the Amended and Restated Credit and Guaranty Agreement dated as of October 3, 2017.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/18/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/820237/000093639207000824/a35067exv10w101.htm">Supply Agreement for Panther Instrument System effective November&#160;22, 2006 between Gen-Probe Incorporated and STRATEC Biomedical Systems AG. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/820237/000093639207000824/a35067exv10w101.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/820237/000093639207000824/a35067exv10w101.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gen-Probe<br/>10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/30/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1062.htm">Amendment No. 1 dated June 1, 2011 to Supply Agreement for Panther Instrument System. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1062.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1062.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/24/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1063.htm">Amendment No. 2 dated February 28, 2013 to Supply Agreement for Panther Instrument System. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1063.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1063.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/24/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517028258/d339131dex101.htm">Intellectual Property License, dated as of January 31, 2017, by and among Hologic, Inc., Gen-Probe Incorporated and Grifols Diagnostics Solutions Inc.</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/02/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000013/holx_q2-2019xex101.htm">First Amendment, dated as of April 9, 2019, to Intellectual Property License, dated as of January 31, 2017, by and among Hologic, Inc., Gen-Probe Incorporated and Grifols Diagnostic Solutions.</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">05/01/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2020ex211.htm">Subsidiaries of Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2020ex231.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2020ex311.htm">Certification of Hologic&#8217;s CEO pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2020ex312.htm">Certification of Hologic&#8217;s CFO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2020ex321.htm">Certification of Hologic&#8217;s CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2020ex322.htm">Certification of Hologic&#8217;s CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indicates management contract or compensatory plan, contract or arrangement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Confidential treatment has been granted with respect to certain portions of this exhibit. A complete version of this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;exhibit has been filed separately with the SEC.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain portions of this exhibit are considered confidential and have been omitted as permitted under SEC rules and regulations.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;16. Form 10-K Summary</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_100"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:14pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:243.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:213.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HOLOGIC, INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;STEPHEN P. MACMILLAN&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November&#160;17, 2020 </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-bottom:5pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:213.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:166.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:16.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:91.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;         STEPHEN P. MACMILLAN</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer (Principal Executive Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STEPHEN P. MACMILLAN&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;           KARLEEN M. OBERTON</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">KARLEEN M. OBERTON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;                BENJAMIN J. COHN</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Corporate Controller (Principal Accounting Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BENJAMIN J. COHN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;            SALLY W. CRAWFORD</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lead Independent Director<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SALLY W. CRAWFORD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;         CHARLES DOCKENDORFF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CHARLES DOCKENDORFF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;              SCOTT T. GARRETT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SCOTT T. GARRETT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;             LUDWIG N. HANTSON</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LUDWIG N. HANTSON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;                 NAMAL NAWANA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NAMAL NAWANA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;         CHRISTIANA STAMOULIS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CHRISTIANA STAMOULIS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;                AMY M. WENDELL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AMY M. WENDELL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_106"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Financial Statements</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Years ended September&#160;26, 2020,&#160;September&#160;28, 2019 and September&#160;29, 2018 </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_109">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_109">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_112">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_112">6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_115">Consolidated Statements of Comprehensive Income (Loss</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_115">7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_121">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_121">8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_127">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_127">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_130">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_130">11</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_133">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_133">13</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_109"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of Hologic, Inc.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Hologic, Inc. (the Company) as of September 26, 2020 and September 28, 2019, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity and cash flows for each of the three years in the period ended September 26, 2020, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at September 26, 2020 and September 28, 2019, and the results of its operations and its cash flows for each of the three years in the period ended September 26, 2020, in conformity with U.S. generally accepted accounting principles. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of September 26, 2020, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated November 17, 2020 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Adoption of ASU No. 2016-02</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2 to the consolidated financial statements, the Company changed its method of accounting for leases in the year ended September 26, 2020 due to the adoption of Accounting Standards Update (ASU) No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (Topic 842), and the related amendments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income Taxes - Uncertain Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 9 to the consolidated financial statements, at September 26, 2020 the Company had $197.1 million in gross unrecognized tax benefits excluding interest. The Company is a party to many transactions in the ordinary course of business where the ultimate tax outcome is uncertain. To account for this uncertainty, the Company must determine whether each tax position&#8217;s technical merits are more-likely-than-not to be sustained in an audit by a taxing authority and then measure the amount of tax benefit that qualifies for recognition.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing the recognition and measurement of uncertain tax positions requires significant auditor judgment because the determination of whether a tax position&#8217;s technical merits are more likely than not to be sustained in an audit is judgmental and is based on interpretations of tax laws and legal rulings. In addition, measuring the amount of tax benefit that qualifies for recognition for each uncertain tax position requires judgment in assessing the potential outcomes that could occur when a tax position undergoes an audit by a taxing authority.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s processes to assess and measure both the determination of the tax basis of certain assets and liabilities underlying uncertain tax positions as well as the positions taken.  Our procedures included management&#8217;s controls to determine if a tax position&#8217;s technical merits are more likely than not to be sustained in an audit and, if so, measure the amount of tax benefit that qualifies for recognition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the Company&#8217;s assessment and measurement of uncertain tax positions, we involved our tax professionals to assess whether the uncertain tax positions identified by the Company are more-likely-than-not to be sustained upon audit and if so, to assist in testing the assumptions made by the Company in measuring the amount of tax benefit that qualifies for recognition. Our procedures included, among others, assessing the Company&#8217;s correspondence with the relevant tax authorities and evaluating income tax opinions or other third-party advice obtained by the Company. We also used our knowledge of, and experience with, the application of domestic and international income tax laws by the relevant income tax authorities to evaluate the Company&#8217;s assessments of whether the uncertain tax position is more-likely-than-not to be sustained and if so, the potential outcomes that could occur upon an audit by a taxing authority. We tested the completeness and accuracy of the data and calculations used to determine the amount of tax benefit to recognize. We also compared the Company&#8217;s income tax disclosures included in Note 9 to the consolidated financial statements to disclosures required by the relevant accounting guidance. </span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Product Revenue Recognition</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 3 to the consolidated financial statements, the Company generates product revenue from the sale of medical imaging systems, diagnostic and surgical disposable products. The Company&#8217;s contracts for capital equipment sales generally have multiple performance obligations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing the timing and amount of revenue recognized for product sales required significant auditor judgment because it involves several subjective management assumptions and estimates including the identification of performance obligations within the contracts, the estimation of the standalone selling price of each performance obligation, the determination of transaction price (including collectability) and the allocation of transaction price to each performance obligation, and a determination of the point in time at which those performance obligations were satisfied.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s processes to account for product revenue recognition, including management&#8217;s controls over determining the transaction price and assessing collectability, the identification of performance obligations in revenue contracts, the estimation of the standalone selling price for each performance obligation, the allocation of the transaction price to each performance obligation, and the determination of the point in time at which the Company transferred control of the promised items to the customer.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test product revenue, we evaluated whether management&#8217;s revenue recognition policies are appropriate and in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. We tested management&#8217;s determination of the transaction price and assessments of collectability by comparing the price to the contract and performing an independent assessment of collectability using available evidence of the customer&#8217;s financial condition and payment history. We also tested management&#8217;s identification of the performance obligations and the allocation of transaction price to each performance obligation by performing an independent assessment, in comparison to the standard, on a sample of customer contracts. We tested management&#8217;s estimated standalone selling prices for its identified performance obligations based on actual prices charged for similar products and services sold on a standalone basis.   We also tested management&#8217;s assertion that control was transferred to the customer by inspecting documentation supporting the transfer of control on a sample of contracts. In addition, we performed other analytical procedures over product revenue and tested a higher volume of revenue transactions that occurred near the end of the fiscal year to evaluate accounting cut-off.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Business Combinations</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 5 to the consolidated financial statements, during 2020, the Company completed the acquisition of all outstanding equity of Acessa Health, Inc. (&#8220;Acessa&#8221;) for consideration of approximately $161.3 million, net of cash acquired. In connection with the acquisition of Acessa, the Company recognized a contingent consideration liability for acquisition consideration that is payable based on a multiple of annual incremental revenue growth over a three-year period for which there is no maximum earnout. The Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation both as part of the initial purchase price allocation, and as of September 26, 2020. As of September 26, 2020, the amount accrued for future estimated contingent consideration is $81.8 million. The Company also recognized the fair value of intangible technology assets of $127.0 million using an income approach.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing the Company&#8217;s accounting for the Acessa business combination was complex due to the significant estimation required by management to determine the fair value of the intangible technology assets and to determine the fair value of the Acessa contingent consideration arrangement. The significant assumptions used to determine the fair value of contingent consideration included forecasted revenue projections, revenue volatility based on the comparable peer companies, and a risk adjusted discount rate. The significant assumptions used to estimate the value of the developed technology assets included a discount rate and forecasted revenue assumptions. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design and tested the operating effectiveness of the controls over the Company&#8217;s calculation of the estimated fair values of the intangible technology assets and the contingent consideration. For example, we tested controls over the valuation models and underlying assumptions used to develop such estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the estimated fair value of the developed technology assets and the contingent consideration liability, we performed audit procedures that included, among others, evaluating the Company's use of the different valuation methods and testing the significant assumptions described above that were used in the models. In testing the valuation of contingent consideration, we assessed, among other things, the terms of the arrangement and the conditions that must be met for the amounts to become payable. We evaluated the completeness and accuracy of the underlying data used in the analyses. We compared the significant assumptions to current industry, market and economic trends, to the assumptions used to value similar assets in other acquisitions, to the historical results of the acquired business and to other comparable companies within the same industry. We involved our valuation professionals to test the Monte Carlo simulation used to fair value the contingent consideration liability and to test the certain significant assumptions, including the discount rate and volatility of future revenue. We also involved our valuation professionals to test the income approach used to fair value the intangible technology assets and to test the discount rate used in the valuation.</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ernst&#160;&amp; Young LLP</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2002.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston, Massachusetts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.134%"><tr><td style="width:1.0%"></td><td style="width:52.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.497%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.497%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d41300e13ae45ef8bfefa0d42f63c4c_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMtMi0xLTEtMA_840a39f8-cbab-43e0-a11a-0ef12019911c">3,227.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c26ccbfa54e4fe0839a4a6c78466347_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMtNC0xLTEtMA_37225f1d-7402-4fbc-8437-0146b6bff8d8">2,771.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia549e6971a604015a25803b16c10a03b_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMtNi0xLTEtMA_76574913-feb1-454d-85c3-c89d4593645f">2,643.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i794e99945f544149a4dfb0dc4430defe_D20190929-20200926" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzQtMi0xLTEtMA_eae6021d-ea60-4823-8585-817f64b5726c">549.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b85f8e0cc641d6811b0f647a80c0b4_D20180930-20190928" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzQtNC0xLTEtMA_c7b7cfb6-bcab-4f4e-830a-fc438160e3d8">596.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i688ec76adf1140acaab8d25b511667aa_D20171001-20180929" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzQtNi0xLTEtMA_779c63b1-c08d-4a8e-8e13-86164518557b">574.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzUtMi0xLTEtMA_dd722cb6-b0e0-431c-a382-195bc9ecb2b7">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzUtNC0xLTEtMA_6bf38b9a-9dfb-4b15-8db9-584b413c0a22">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzUtNi0xLTEtMA_8035c724-91dd-4ce1-8643-91630e1e22de">3,217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d41300e13ae45ef8bfefa0d42f63c4c_D20190929-20200926" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzctMi0xLTEtMA_3eb919f9-580c-45b4-b2c9-da775cef80bb">953.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c26ccbfa54e4fe0839a4a6c78466347_D20180930-20190928" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzctNC0xLTEtMA_b4e2ecdb-0db4-4c06-94f7-bc6da5455d09">948.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia549e6971a604015a25803b16c10a03b_D20171001-20180929" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzctNi0xLTEtMA_6f83ce7b-cfaa-4fc8-a496-090838cb03f0">886.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzgtMi0xLTEtMA_c0f01fc6-c83d-4074-bf8f-4bcb24e043d8">253.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzgtNC0xLTEtMA_ed4f4255-ca5d-494c-b256-91ca7f5f5b15">318.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzgtNi0xLTEtMA_42ef50d7-5f5a-4e8a-a6f4-0d37303f9083">319.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzktMi0xLTEtMA_63462447-ea95-4f2c-8e50-f9349c275517">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzktNC0xLTEtMA_609c377d-3732-44b3-aba6-003881fe890f">578.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzktNi0xLTEtMA_2bb53ee9-01e7-40d0-bd15-d4cc3d40d553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i794e99945f544149a4dfb0dc4430defe_D20190929-20200926" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEwLTItMS0xLTA_e6f0ddec-a58d-409b-9a5a-b8ee775a01bc">316.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b85f8e0cc641d6811b0f647a80c0b4_D20180930-20190928" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEwLTQtMS0xLTA_f917f57e-1997-444c-9a06-de4fd7115424">350.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i688ec76adf1140acaab8d25b511667aa_D20171001-20180929" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEwLTYtMS0xLTA_997cb8a2-e7d1-4966-a130-93579c5a2143">315.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzExLTItMS0xLTA_4b25cab8-1df6-4559-8924-44cec6795e8f">2,227.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzExLTQtMS0xLTA_fb6c93f4-04c8-4573-a1b5-5da0eabed9d3">1,170.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzExLTYtMS0xLTA_23b1b563-c71b-4e89-8f62-df6181e2cd43">1,696.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEzLTItMS0xLTA_23b6718a-9421-486f-940e-0151f892922a">222.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEzLTQtMS0xLTA_9f6fdfc9-b444-4791-86a0-7b071dfb530e">232.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEzLTYtMS0xLTA_5d5f9f34-b506-43c7-9498-929e3171e8d6">218.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE0LTItMS0xLTA_da90f9a1-7551-4c3a-80ea-924394d30e92">484.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE0LTQtMS0xLTA_797ac249-c22a-4936-8dde-3ad35774814b">564.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE0LTYtMS0xLTA_783ac4bf-6375-49b6-bc25-a0574275c523">544.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE1LTItMS0xLTA_d1023d27-a372-4352-a468-8557909f6bc1">356.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE1LTQtMS0xLTA_e2d16b2d-a921-40bd-b77b-fa63dd09cc84">332.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE1LTYtMS0xLTA_6eacdf2a-81dc-48e3-8433-7868b499fe1b">366.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE2LTItMS0xLTA_46760c28-53d5-4343-85ed-0d97be157455">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE2LTQtMS0xLTA_1e3947a0-417b-43f5-b6f0-ba14dc8f018f">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE2LTYtMS0xLTA_33122baf-0179-4a68-8ab3-ef98c97be958">59.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE3LTItMS0xLTA_22fd9678-7994-40b4-ad68-62a5de7bfe61">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE3LTQtMS0xLTA_7f1c5ba9-c6a8-4660-8cd9-a41ab2749780">106.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE3LTYtMS0xLTA_e36bffa5-e323-4a61-b813-2b7988f51a4a">46.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzIwLTItMS0xLTA_1cf84bcc-8494-492d-a727-4aa5864312c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzIwLTQtMS0xLTA_7d308e19-c7be-4405-8461-0f17e1ff50d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzIwLTYtMS0xLTA_1843205d-ef88-4888-ab57-536fb8bcbd80">685.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and divestiture charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI0LTItMS0xLTA_cda715ef-1f39-41e2-adec-89854c7e2361">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI0LTQtMS0xLTA_2bb5149e-0327-4169-830a-d5a1755c0afb">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI0LTYtMS0xLTA_24f9ac76-52f0-42b6-a5a0-7bbc5315f7cd">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI1LTItMS0xLTA_03494229-100c-43b4-9152-51d066f2f4c6">1,122.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI1LTQtMS0xLTA_b7d55a6a-f7c6-4a7b-b821-050c41199a42">1,294.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI1LTYtMS0xLTA_5f6d15bc-12bb-41fc-b4bc-c732fd5ffd99">1,934.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI2LTItMS0xLTA_04db1e73-22e7-4216-9281-826fbfb41a7b">1,105.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI2LTQtMS0xLTA_8f87dfaa-58af-4819-bd2b-73cb805551f9">123.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI2LTYtMS0xLTA_5c011724-52b0-4dfb-92ef-618eafd956eb">237.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI3LTItMS0xLTA_71e43554-0a83-47a3-b656-13a91d348a08">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI3LTQtMS0xLTA_fb69591d-e398-4466-8696-603c5ccbf0e1">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI3LTYtMS0xLTA_bcfb5463-5d3c-4832-8efb-d9b3ea53115d">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI4LTItMS0xLTA_8cf407c7-87a3-4574-a6da-82c0e6a91146">116.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI4LTQtMS0xLTA_6e9c381e-0972-4602-9c5d-530e1946352b">140.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI4LTYtMS0xLTA_72be97ad-ff32-4946-a3d7-a15657fd0e00">148.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI5LTItMS0xLTA_85c50eef-fd93-459f-ab76-bc402b29bfcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI5LTQtMS0xLTA_bccb311b-d92c-4939-90dd-7d8c733b0116">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI5LTYtMS0xLTA_af6d9cb3-34c3-493e-8f4d-09305078e857">45.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMwLTItMS0xLTA_529427f3-cb43-4ee8-a181-007f827d2bc3">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMwLTQtMS0xLTA_4fd6c526-adf1-4eeb-ace1-8b15c366390d">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMwLTYtMS0xLTA_f70ac073-61ec-4f88-96e5-4632ba082d9d">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMxLTItMS0xLTA_a5691244-5edd-4dad-a0c4-511126b4b946">1,001.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMxLTQtMS0xLTA_1f1e513e-62d5-4e99-9649-e18c2f50fc93">257.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMxLTYtMS0xLTA_b7739538-812d-4881-9862-e14cfac32009">418.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMyLTItMS0xLTA_91785c3d-aeaa-4a82-a9bc-743378c808cc">108.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMyLTQtMS0xLTA_7d046dd3-08cd-4a87-a692-6a57e7600577">54.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMyLTYtMS0xLTA_31701d3a-62c4-4dce-b3f4-366fb8d9ddee">307.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMzLTItMS0xLTA_1b74c0ee-fed2-431d-9316-e02281d1d8d1">1,110.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMzLTQtMS0xLTA_1acbdfbd-34c7-45d2-bc37-a565af0fc741">203.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMzLTYtMS0xLTA_81210d42-8042-4ade-a2f3-8bcd3b35c2c5">111.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM0LTItMS0xLTEyMjA_c729818b-03fd-44a7-a572-62ab189b1db1">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM0LTQtMS0xLTEyMjA_4ebf056e-2bd2-4bdb-8bd6-af2f92dd00bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM0LTYtMS0xLTEyMjA_e333796f-7110-4b02-b7d5-b1ce0f48f174">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Hologic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTItMS0xLTEwNzMw_054bc051-af3a-4cc5-aef3-d3f1e051d2f7">1,115.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTQtMS0xLTEwNzMz_80466197-076e-4863-af69-0e4546c11dff">203.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTYtMS0xLTEwNzM2_e45571cc-0076-4e13-9f9c-34b054ac57b5">111.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share attributable to Hologic:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTItMS0xLTA_56e1738f-cf25-4110-ab63-21753767332a">4.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTQtMS0xLTA_ae9d8669-1b58-4620-b26c-70a121380255">0.76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTYtMS0xLTA_adf48c95-cef0-495b-9d10-dfbdf1d89261">0.40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM2LTItMS0xLTA_014efd4e-0797-47b7-92b3-20c854902083">4.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM2LTQtMS0xLTA_a90f8f0b-db92-4ab2-88a7-ffb4d401b5cc">0.76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM2LTYtMS0xLTA_843f59d2-c254-49ec-a395-02794d579000">0.40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM4LTItMS0xLTA_de0dd35f-4f1f-453d-923a-4ab0462ba9c2">262,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM4LTQtMS0xLTA_e427ae2f-4849-4476-b4e3-0db50435b065">269,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM4LTYtMS0xLTA_a7fe682c-ce44-4536-8abc-edad5910c810">275,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM5LTItMS0xLTA_0db0c280-14bb-48b0-8511-7cb6b7e69df7">264,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM5LTQtMS0xLTA_feb35c31-e764-4dc2-a08e-b6a9889910e7">269,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM5LTYtMS0xLTA_76c8863b-5c76-4d3a-894a-2c195c0a109a">275,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.426%"><tr><td style="width:1.0%"></td><td style="width:53.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.448%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzItMi0xLTEtMA_9138be34-cbee-470f-ae5c-593c47d5d93c">1,110.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzItNC0xLTEtMA_cd44113d-e4ba-41cb-b38b-1e607f3d62a2">203.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzItNi0xLTEtMA_e4acc75c-17c3-4cb8-b716-dfdf2c315937">111.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzMtMi0xLTEtMA_7099bc3a-0b52-4306-bd6f-ed82eba1ff4a">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzMtNC0xLTEtMA_20d4d5d5-08c1-4a0a-848e-1aaabf1d1eae">14.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzMtNi0xLTEtMA_b3cb2a59-08a4-4082-87a6-8918238d6254">8.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in unrealized holding gains and losses on available-for-sale securities, net of tax of $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjc4NjVlNjhkY2JjZjQwMWQ4NDBmMjk0MGZmNWJjOTY0XzkzNDU4NDg4MzYyMTI_56783bfc-9a77-43de-94e8-cceda1478812">0.2</ix:nonFraction> in 2018:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Loss (gain) reclassified from accumulated other       <br/>       comprehensive income (loss) to the statement of                 <br/>       operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzYtMi0xLTEtMA_79a8933b-3b3b-4002-b867-54d818b17324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzYtNC0xLTEtMA_006e1f2e-0b36-40ee-a630-59e8231e7216">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzYtNi0xLTEtMA_f5c89626-cfb0-47c9-94ce-11bba24b91f3">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in pension plans, net of taxes of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctMC0xLTEtMC90ZXh0cmVnaW9uOmVjYzc1ZjcxMzQzYTQyMzE5MTQ4ZmJjY2JkOWNmMzBkXzkzNDU4NDg4MzYxOTI_58f333e8-8fa8-4837-b799-dbd5c07482ff">0.1</ix:nonFraction> in 2020, $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctMC0xLTEtMC90ZXh0cmVnaW9uOmVjYzc1ZjcxMzQzYTQyMzE5MTQ4ZmJjY2JkOWNmMzBkXzkzNDU4NDg4MzYxOTk_05faca64-1f5c-4729-9071-2fc477e54e91">0.3</ix:nonFraction> in 2019, and $(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctMC0xLTEtMC90ZXh0cmVnaW9uOmVjYzc1ZjcxMzQzYTQyMzE5MTQ4ZmJjY2JkOWNmMzBkXzkzNDU4NDg4MzYyMDg_bc1a9c4c-d186-4565-83ad-81f2a562179f">0.6</ix:nonFraction>) in 2018</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctMi0xLTEtMA_a7e1c2d6-056d-4a93-b97e-a3148c246524">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctNC0xLTEtMA_c646e732-de41-45a6-8cb6-480a7ac1e898">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctNi0xLTEtMA_4529f66b-a57a-49f5-bf29-0204754d7dd0">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain recognized, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="holx:Taxpaidoninterestrateswaps" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjIxYjE4OTk5ZmM1NTQ5MTE4ZDM1N2FiZTJjOWI2ZmI4XzkzNDU4NDg4MzYyMTU_bab11ac0-2b36-41d7-bead-a3671f1213af">8.3</ix:nonFraction>) million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:Taxpaidoninterestrateswaps" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjIxYjE4OTk5ZmM1NTQ5MTE4ZDM1N2FiZTJjOWI2ZmI4XzkzNDU4NDg4MzYyMjI_740196dd-405a-4aca-96b0-edcb63f33c17">1.2</ix:nonFraction> million in 2019 for interest rate swaps</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtMi0xLTEtMA_981c08d8-fa78-47c1-bc17-3e70b6352632">27.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtNC0xLTEtMA_6e1e0b95-2b93-4e04-8464-6d9ab36c6016">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3117997fe434239b20f6cf308ee6614_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtNi0xLTEtMA_423b3049-1add-440e-8919-9b1300ef2c60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in value of hedged interest rate caps, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzktMC0xLTEtMC90ZXh0cmVnaW9uOjVhYjFjNGM4NThkZTRjMWZiZTYwYmU3MDcyZGYwMzdkXzkzNDU4NDg4MzYyMTE_aba31b79-6eb3-465f-8760-f408f11d3cc4">0.5</ix:nonFraction> in 2020, $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzktMC0xLTEtMC90ZXh0cmVnaW9uOjVhYjFjNGM4NThkZTRjMWZiZTYwYmU3MDcyZGYwMzdkXzkzNDU4NDg4MzYyMTg_8ea1f4eb-16ce-4d2b-a698-82cd58419454">1.1</ix:nonFraction> in 2019, and $(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzktMC0xLTEtMC90ZXh0cmVnaW9uOjVhYjFjNGM4NThkZTRjMWZiZTYwYmU3MDcyZGYwMzdkXzkzNDU4NDg4MzYyMjc_7f0dc62c-3b69-41dc-9b2c-7ff92c4a9ff6">5.0</ix:nonFraction>) in 2018</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Loss recognized in other comprehensive income    <br/>       (loss), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6199234c2a9d4588aa6dd0e453b067ee_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEwLTItMS0xLTA_de4b533c-43d9-429a-bcc5-990a13ce40ad">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d2a775a080b412fa3dafce51e6d15ba_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEwLTQtMS0xLTA_9ae1cd63-b6bf-41c9-9c9d-efe1e04e23e8">8.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cc3451a488c432f89410a83c10d5d44_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEwLTYtMS0xLTA_07d01c90-8473-43a1-a395-fbbdc7331bdc">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Loss reclassified from accumulated other    <br/>      comprehensive loss to the statement of operations, <br/>      net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzExLTItMS0xLTA_b7bde9f1-14a1-4d85-8155-83df7e8183b9">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzExLTQtMS0xLTA_aac9bf63-c1bd-4f6b-b9c2-d89a6e5cf813">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzExLTYtMS0xLTA_617b9623-2958-4b50-be8e-8e8c7e0b5f9d">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEyLTItMS0xLTA_a2b22fbb-db73-41c0-9d1d-be6ef015ba57">7.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEyLTQtMS0xLTA_6b6e4781-ebef-41c3-a7e1-3f8ef128e9cd">16.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEyLTYtMS0xLTA_cc6e2d66-ff2b-46dc-90e6-eef6b1978c19">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEzLTItMS0xLTA_e5d0b35f-aa63-42b3-a951-c66ec6b586cd">1,103.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEzLTQtMS0xLTA_54300396-1aa8-4587-bb81-cc7dfb136045">220.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEzLTYtMS0xLTA_a050d314-505a-4de5-94f1-6b86b3ef5088">120.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of comprehensive income (loss) attributable to noncontrolling interest:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE1LTItMS0xLTEyMjc_b0e24f1f-5eab-40d6-bf1e-5e74f9eee9f7">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE1LTQtMS0xLTEyMjc_4ebf056e-2bd2-4bdb-8bd6-af2f92dd00bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE1LTYtMS0xLTEyMjc_e333796f-7110-4b02-b7d5-b1ce0f48f174">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE2LTItMS0xLTExNTY0_3811ad07-7771-45e8-9216-f5d47781a2b5">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE2LTQtMS0xLTExNTc0_ec17f563-d271-4c6b-86fb-6e748214e557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE2LTYtMS0xLTExNTc2_175a8309-62eb-495f-8972-aa778371d778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to Hologic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE3LTItMS0xLTExNTY3_5211c5ff-f319-4f97-92ba-21f97528965b">1,107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE3LTQtMS0xLTExNTcw_6275bc92-a2ce-4289-9f3a-088f1d952232">220.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE3LTYtMS0xLTExNTcy_978f5c19-69aa-4355-a1c2-70580d9e2075">120.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and par value)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMtMS0xLTEtMA_70f7bbaf-07ad-4179-97cb-81188ad5979c">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMtMy0xLTEtMA_bafc8f25-b28b-4781-9078-dfcc55ea92be">601.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less reserves of $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjUyYjVhZjc3NzQ4YjQ5ZDA5YWU5ODVmNGUzY2E0MzNmXzkzNDU4NDg4MzYxNzI_66ae13f8-47cb-4bd3-8c08-2839c1f68f37">31.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjUyYjVhZjc3NzQ4YjQ5ZDA5YWU5ODVmNGUzY2E0MzNmXzkzNDU4NDg4MzYxODA_80d16cc2-a99f-4146-b084-419dfb003f7b">17.8</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzUtMS0xLTEtMA_b900f62a-7feb-4598-ab39-cabe1aad3d76">1,028.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzUtMy0xLTEtMA_99e63c4d-834b-4eea-a796-b2c0430ec565">648.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzYtMS0xLTEtMA_fde63635-1b91-48d1-939d-4e2a3ddd755a">395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzYtMy0xLTEtMA_d99f5fa6-e6ff-4c75-ba32-5e2d93c9292e">444.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzgtMS0xLTEtMA_9bfab2ec-76db-433e-b68c-280314f81fd7">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzgtMy0xLTEtMA_ffc7e54f-64e5-4718-a96e-485f6e3de9a5">34.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzktMS0xLTEtMA_cb5e102d-6005-4844-908f-2a8bab4ec1f4">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzktMy0xLTEtMA_10f7c4d7-828c-4b4d-af7a-d32669f696b4">62.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzExLTEtMS0xLTA_b8b487e9-6ba2-49de-8060-a29a1909ab21">2,222.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzExLTMtMS0xLTA_ee44b276-4d1e-4c5f-a0f6-9412219aa832">1,793.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzEyLTEtMS0xLTA_caaf6f38-9715-4ba3-85f2-b93a69002398">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzEyLTMtMS0xLTA_9677eb0c-5542-438e-a20d-71956051aeff">470.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzEzLTEtMS0xLTA_85cd86e8-4c06-4d42-91b7-f3a7e3b3c89f">1,307.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzEzLTMtMS0xLTA_c4192231-4dba-473c-89d7-12bf2824657b">1,459.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE0LTEtMS0xLTA_8ad86443-3199-44e3-99f7-032f289db733">2,657.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE0LTMtMS0xLTA_10cfd652-02dc-4d97-b167-9c33616593d0">2,563.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE1LTEtMS0xLTA_0b22dfa2-18f6-43a8-908d-d58fbb2d09dc">516.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE1LTMtMS0xLTA_10b7b324-c3d5-4435-8a52-fc4dcd4808dc">154.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE2LTEtMS0xLTA_5ebc497a-7531-4ec3-ad99-0c4f0c35e066">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE2LTMtMS0xLTA_c240baa5-2fdc-444c-9abc-f61aba151bc5">6,442.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE5LTEtMS0xLTA_3f872025-efb7-4172-9a1d-87f52c0ef593">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE5LTMtMS0xLTA_037febfa-ed7f-46c0-bfc6-199fd200dc1c">271.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIwLTEtMS0xLTA_22faac34-9044-4808-9f4f-b0c4c71caa4b">178.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIwLTMtMS0xLTA_c4c53b7f-f0e1-472b-8e08-a2f712cd14ce">186.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIxLTEtMS0xLTA_cdcc2302-1c6c-4dab-b572-621f9dbf6f42">547.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIxLTMtMS0xLTA_2a85c234-c19e-4d62-8c78-bac1915e653d">430.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIyLTEtMS0xLTA_6cf6ab1f-f505-4703-9be7-d3840cf302a2">186.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIyLTMtMS0xLTA_eb89a036-c346-40c6-a198-c649272e98ab">179.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation (capital lease obligation in 2019)<br/></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:CapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI0LTEtMS0xLTA_ff8e097a-d514-4ad5-b1e4-8c7f57c8ca8d">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:CapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI0LTMtMS0xLTA_df3b62e4-7d94-4f69-8365-335d305cc977">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI1LTEtMS0xLTA_40b5f33e-3579-40ee-a9fc-b2920c80996e">1,239.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI1LTMtMS0xLTA_36ee6ad5-77b3-4ebd-9664-73cf5ae89de4">1,070.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI2LTEtMS0xLTA_359e59e6-c0e7-4121-ad14-010ce4a02558">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI2LTMtMS0xLTA_cd45fe8d-9e9f-44dd-bd40-6c896e6323cd">2,783.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation - long term (capital lease obligation in 2019)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:CapitalLeaseObligationsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI3LTEtMS0xLTA_8688186e-aa5c-483f-a720-57adaa1365e6">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:CapitalLeaseObligationsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI3LTMtMS0xLTA_0b6235fe-9179-4cf5-8ecf-9d90c351126e">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI4LTEtMS0xLTA_74c543df-f1b5-49d3-8b7b-00097e336c59">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI4LTMtMS0xLTA_2b9c7f7f-0759-477d-833e-2afe017d4448">275.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI5LTEtMS0xLTA_81bf8b5f-fd2f-43fc-befb-133ecc45cdcb">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI5LTMtMS0xLTA_ba053b15-097a-4d11-9882-5e33be27ec01">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMwLTEtMS0xLTA_c0a3640d-9c6a-4c99-8a6d-9bcc292c60dd">303.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMwLTMtMS0xLTA_0d3b9519-9f00-41cc-8c8e-caa44bf3c125">162.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 13 and 14)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMxLTEtMS0xLTA_af75e81d-e235-4be5-ac45-38d79736fc58"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMxLTMtMS0xLTA_2ee86000-37e6-49a8-83d9-08d1d2fbb9e6"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTgx_38b42173-48d7-4b75-9fa8-69dd9771576b"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTgx_604837e6-bfec-47c3-8b8e-95fc58e673b6">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTk0_074d78a0-919d-439d-aaef-0bcffbd54c44"><ix:nonFraction unitRef="shares" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTk0_25dca06c-f05f-4958-9e72-9d7c6f0ab5e7">1,623</ix:nonFraction></ix:nonFraction> shares autho</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">rized; <ix:nonFraction unitRef="shares" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTk4_0f1d4bed-b7c6-49e6-a06a-c69061ce7f0a"><ix:nonFraction unitRef="shares" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTk4_9087c10b-5c68-4eaf-a930-735ee0df01ed">0</ix:nonFraction></ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shares issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTEtMS0xLTA_b5d293a4-ef48-4cf3-b341-7c5f853834bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTMtMS0xLTA_5d5a98b2-44ee-4ba7-9776-d1a3a9e31b7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjEx_acc3b1ae-f39c-4291-8bdb-e30bfb01a240"><ix:nonFraction unitRef="usdPerShare" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjEx_d4d05fef-a661-471c-9a25-cac1bcaf5bed">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjIy_595d05ef-3c17-437a-ab22-a73e0222d8e8"><ix:nonFraction unitRef="shares" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjIy_be17f234-660c-4011-ae22-d273e0f7410c">750,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjMy_70e48138-e321-4d53-aade-1225af0bda14">295,107</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjQy_b9a02728-8ce9-42dc-abf7-809be86745bb">292,323</ix:nonFraction> shares issued, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTEtMS0xLTA_a12a5b08-3d29-4835-bd51-ee191c8412ad">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTMtMS0xLTA_5baac526-5290-4de5-b54b-2cd638e0bd80">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM1LTEtMS0xLTA_4d17ff58-50c4-410e-ac8d-d4ebc8a137a9">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM1LTMtMS0xLTA_b243c4dd-4136-4346-bdb9-f430636c0d69">5,769.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM2LTEtMS0xLTA_75cc01bb-3bf1-495e-bf15-cb4aebd816b1">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM2LTMtMS0xLTA_15b50a34-132a-49ba-b416-c41b897da105">2,688.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost &#8211; <ix:nonFraction unitRef="shares" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo3NzY0ZDViM2U3MWQ0ZjVjYTRhNzY5MGMwZDM1ZWMyZl85MzQ1ODQ4ODM2MTcw_953df5b1-60bd-4c5c-9d1d-79c83f7880b3">37,609</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo3NzY0ZDViM2U3MWQ0ZjVjYTRhNzY5MGMwZDM1ZWMyZl85MzQ1ODQ4ODM2MTc5_50870157-0cd3-4374-8bde-ebd0018e96b6">24,639</ix:nonFraction> shares, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM3LTEtMS0xLTA_055b34a6-a74c-4c06-b1d6-4198325821dd">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM3LTMtMS0xLTA_48002483-818a-4644-9338-08195b0a1c3b">926.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM4LTEtMS0xLTA_04fbb2fc-5ee4-4e6e-912f-23fef79c56cc">49.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM4LTMtMS0xLTA_c5a122d8-4c0b-4670-9f4e-c482c0189f91">42.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Hologic's stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM5LTEtMS0xLTA_abb27cbb-ea0f-4590-b3db-d72517817ceb">2,705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM5LTMtMS0xLTA_92518861-ae47-4d98-9633-cb9b8e7f2c9b">2,115.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQwLTEtMS0xLTExNDY_14098bc6-cdd6-4453-94cd-311c8e065882">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQwLTMtMS0xLTExNDY_84a59682-8514-4af6-b489-52709a1d5846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQxLTEtMS0xLTEwODcx_b0c64bf5-d055-4dd2-b071-6b8435978510">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQxLTMtMS0xLTEwODc1_253af585-b50a-4d1d-9720-151910509943">2,115.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQwLTEtMS0xLTA_08c91d67-7fe0-4145-8331-447d4ea17bd4">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQwLTMtMS0xLTA_74b0d0e9-4620-4d1c-b3eb-8ceb7d0f6f5d">6,442.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.833%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.908%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in-<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par&#160;<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i08aaa1dc14eb440ab123d505e79e47ec_I20170930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTItMS0xLTA_39a80dda-ea27-4c1a-81f5-c7f513ec33c5">287,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08aaa1dc14eb440ab123d505e79e47ec_I20170930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTQtMS0xLTA_4dd72e82-bc57-4325-a5ad-690eb83941c4">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009d515470734764a45e17ec26571fe8_I20170930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTYtMS0xLTA_4ebe1de5-45d4-47db-970b-2670a3735162">5,630.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i319b89b955fe451e88544cf9b525eb59_I20170930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTgtMS0xLTA_5c2160b1-f53e-4e3a-b62e-dd5ebb32b257">2,382.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7928b977a78c48f7a935d7a39083e59e_I20170930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTEwLTEtMS0w_bd127aad-f901-4427-894a-b7e3c078f3ad">16.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03175a6288164c5db9844f6e6247dd76_I20170930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTEyLTEtMS0w_9b292bf7-21f3-4230-8e01-5f373d556024">12,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03175a6288164c5db9844f6e6247dd76_I20170930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTE0LTEtMS0w_64700916-f93e-4d88-8c93-9c0cdb63f787">450.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb9f527854bf4eb285447a902fcd7098_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzItMTgtMS0xLTE1NTQ1_c5d36e98-eac1-4bb3-9d3a-f704ea7c5687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84c88a850d71453097932f0bcbe84825_I20170930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTE4LTEtMS0w_0a1f355d-2fd9-4b9e-85d8-af04f1709cb3">2,784.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3680c6a61084f738e0282f1f1563837_D20171001-20180929" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE4LTItMS0xLTA_95f9bc47-189e-4a1e-a878-26443248e3a9">795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE4LTYtMS0xLTA_56a20c4d-d980-4b1a-8fe3-ed0cec19d106">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE4LTE4LTEtMS0w_65d5ff4b-156b-4570-9b5f-c5e9cecc8f25">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3680c6a61084f738e0282f1f1563837_D20171001-20180929" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE5LTItMS0xLTA_60a588ec-2204-4113-8bac-eb99a13f2f41">804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE5LTYtMS0xLTA_7c786faa-c53f-429e-b3d9-308d106cdb44">16.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE5LTE4LTEtMS0w_df1596db-1607-444c-9e9b-d997ac62636e">16.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3680c6a61084f738e0282f1f1563837_D20171001-20180929" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIwLTItMS0xLTA_9b6d73d2-602a-43cb-85bd-bff4a5ba449e">448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIwLTYtMS0xLTA_f9e95056-4d41-4920-be6a-bffa98719465">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIwLTE4LTEtMS0w_75351266-37d3-4e7d-b683-582e988bec29">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIxLTYtMS0xLTA_05ccb6a2-9bab-4607-b1d9-c5e8656ea23b">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIxLTE4LTEtMS0w_322ffbb6-38c7-4649-907a-0f78afe5c0b5">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity component from convertible notes repurchase, net of taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIzLTYtMS0xLTA_8a37a621-47e6-4762-b92b-a545561582f9">40.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIzLTE4LTEtMS0w_c2f1f37d-734e-4de9-becb-e7aa085dabd8">40.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50a8cec88f63482ca86e8907428a7f7a_D20171001-20180929" decimals="5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI0LTgtMS0xLTA_40aba8ad-4482-42ed-8b9e-8dfd7e7842c9">111.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI0LTE4LTEtMS0w_b0fc4011-9227-4d54-9909-606c4a58573d">111.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI1LTEwLTEtMS0w_53ade7db-c731-43d2-95ba-769e569a68de">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI1LTE4LTEtMS0w_daf5758f-c02e-4f6b-afdd-aab303b0c766">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to minimum pension liability, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI2LTEwLTEtMS0w_49ccff99-543e-45b2-8d6b-487241c20344">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI2LTE4LTEtMS0w_41b1b96b-e9a2-41f7-a1a0-16a111c51d26">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic930cb3d51304cadbaffbad6e4174a9f_D20171001-20180929" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI3LTEyLTEtMS0w_8af2b44e-0df8-4912-bc68-15562d029e3b">7,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic930cb3d51304cadbaffbad6e4174a9f_D20171001-20180929" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI3LTE0LTEtMS0w_d73c6ca2-0ef7-42a9-8054-287f50804cba">275.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI3LTE4LTEtMS0w_7ddff5f8-4b3d-400a-90b5-cf9f87fb09d2">275.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized losses on derivatives, net of taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI4LTEwLTEtMS0w_590e7e58-f805-4e46-9887-20cd81728f00">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI4LTE4LTEtMS0w_89b411d4-9e5f-4808-bd09-8c2c34a9d863">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest cost of interest rate cap reclassified to statement of operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMwLTEwLTEtMS0w_d19c31f5-6e43-459d-a730-398acd6e9734">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMwLTE4LTEtMS0w_4ae7eeda-bfe4-4b4c-a368-aa21a3d42821">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized loss on marketable securities reclassified out of accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMxLTEwLTEtMS0w_1224448b-5578-4065-b572-54c0698b33e9">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMxLTE4LTEtMS0w_10baf807-418b-447d-9c4c-c35ad8b9f6c6">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 29, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95ca35177efc4ae98f89b9162289d0f8_I20180929" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTItMS0xLTA_2c904651-89ff-40ec-85a5-496f402008ea">289,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ca35177efc4ae98f89b9162289d0f8_I20180929" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTQtMS0xLTA_65a1e30f-8321-4cf4-9337-44ded8c015e0">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6afd02343ba40d68f7f7d2d38b8d6bb_I20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTYtMS0xLTA_59bde5cf-36b5-479e-9ee2-af84f1d41121">5,671.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fdee7361ebc4584bbc3a5cfe6444f08_I20180929" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTgtMS0xLTA_66243ff0-2328-4778-86d9-c6e7aaef1065">2,494.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03e40fe371564654b09f93a1ae599923_I20180929" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTEwLTEtMS0w_7724350d-8c85-4730-bce6-bd43a5866cb8">25.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0174c6f539e747949d68830c151f307c_I20180929" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTEyLTEtMS0w_5a993a46-5170-490a-b82e-c07976cd5be5">19,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0174c6f539e747949d68830c151f307c_I20180929" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTE0LTEtMS0w_733cb484-97d0-4131-9e1a-2dbc8f8096df">725.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie46091349b474da791e8169a5e898ab5_I20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTE4LTEtMS0xNTU0Mg_35a5dd16-226b-4cfe-a979-ff5082ca8269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTE4LTEtMS0w_d1a2e662-dbff-4072-938b-2423975edf1d">2,428.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting standard transition adjustment - ASC 606</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57069c8fd22f43268f97f2c41b7f2a8d_D20180930-20190928" decimals="-5" sign="-" name="holx:AccountingstandardtransitionadjustmentASC606" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMzLTgtMS0xLTA_f6377091-bae1-4c3d-b142-e8247b3d30f3">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="holx:AccountingstandardtransitionadjustmentASC606" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMzLTE4LTEtMS0w_ed8b1405-ea73-4cc6-bc76-69faaae2b6e2">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting standard transition adjustment - ASU 2016-16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57069c8fd22f43268f97f2c41b7f2a8d_D20180930-20190928" decimals="-5" sign="-" name="holx:AccountingstandardtransitionadjustmentASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM0LTgtMS0xLTA_95fbb42a-2eef-4b1b-8318-87c0b8ca4711">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="holx:AccountingstandardtransitionadjustmentASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM0LTE4LTEtMS0w_da841f99-c939-4e16-9b99-8a8ff6ac7ba8">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d8bd96d523f45339390f0f694678659_D20180930-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTItMS0xLTA_418de46c-2020-499b-b12e-cb746e25ee11">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTYtMS0xLTA_a960aeaa-3997-47a9-bc02-2ae5cf1ac552">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTE4LTEtMS0w_1e630bee-7bca-47e8-b500-7325536090ee">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d8bd96d523f45339390f0f694678659_D20180930-20190928" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTItMS0xLTA_7a9073c9-0cec-4d32-bb0a-8366562a2a1a">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTYtMS0xLTA_03744327-b22a-480b-9cc1-25b492390159">12.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTE4LTEtMS0w_f0965677-4405-4923-b055-8e9c5c9c7d45">12.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d8bd96d523f45339390f0f694678659_D20180930-20190928" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTItMS0xLTA_e2263fb0-103c-4ca1-a7fd-89c5e21d6457">474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTYtMS0xLTA_edd0a326-b88b-44e7-b57b-2b2254a2f725">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTE4LTEtMS0w_84b16423-6eb3-4ecd-b012-cc73a7e52b1b">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM4LTYtMS0xLTA_81030829-94eb-4984-a134-eacfec6cf93a">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM4LTE4LTEtMS0w_a2f9ca56-4681-45e7-a2ba-c541f337deb6">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57069c8fd22f43268f97f2c41b7f2a8d_D20180930-20190928" decimals="5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTgtMS0xLTA_996681da-256a-4ac6-9891-d956c8ed521f">203.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTE4LTEtMS0w_dfb1a62b-380b-4f69-b23c-2ac985192572">203.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQwLTEwLTEtMS0w_1f33b281-3d2d-4709-a475-0e88e45bc5e6">14.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQwLTE4LTEtMS0w_8b39fc05-1122-470e-afdc-449396ecd971">14.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to minimum pension liability, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQxLTEwLTEtMS0w_aa9c85ca-aa00-4445-8c48-0c112d03d2ff">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQxLTE4LTEtMS0w_9c4fb1bb-6c1c-490e-b9b8-e9db7571dee6">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibdbdc18a2bcb43a3bdf8e6c1cf19d396_D20180930-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTEyLTEtMS0w_55593979-e9e8-4534-b603-79f33e1b4cbd">4,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdbdc18a2bcb43a3bdf8e6c1cf19d396_D20180930-20190928" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTE0LTEtMS0w_63fa5047-4bb1-40e6-b7c2-bd7be406a16d">200.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTE4LTEtMS0w_5193a441-1b4b-40d0-89a3-f60c0358e77d">200.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on derivatives, net of taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTEwLTEtMS0w_1e23e596-7859-4b68-a718-cf9d24b1457d">8.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTE4LTEtMS0w_82621c82-b6f4-42b7-af63-ca0cd28084ff">8.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928" decimals="-5" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ0LTEwLTEtMS0w_c58e167e-a9a8-45d0-9fce-8c359aab6f37">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ0LTE4LTEtMS0w_6bc013f6-3310-4c65-8506-ddacf95bdb32">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest cost of interest rate cap reclassified to statement of operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ1LTEwLTEtMS0w_6561924c-b3ff-44c2-9b58-d50e1d167453">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ1LTE4LTEtMS0w_25902720-210f-4fb3-a021-09e49cb9e399">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1a27903b45f460e8b58b329d59f97d8_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTItMS0xLTA_b3973d4e-aaee-4f8b-920e-be9dc6eaa5a3">292,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a27903b45f460e8b58b329d59f97d8_I20190928" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTQtMS0xLTA_31033f78-ab7a-4f08-90e5-c4ee19d1b914">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21125621c43043b5a43f09df6f874b52_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTYtMS0xLTA_d0758f08-c825-44bd-b3d8-3fe55da35769">5,769.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71115cc05c394a8a980ec543ca44bc53_I20190928" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTgtMS0xLTA_25ce1667-1f7a-4201-acfb-63913f3ff0dc">2,688.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id804545a264447f98e68c02862888397_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTEwLTEtMS0w_bd5a2d15-3be8-4b72-a00a-b9fd4badb014">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c166eb8bb6741edb7c59919ec94dfc7_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTEyLTEtMS0w_ae7b2e77-97d1-4431-a40a-28e6e7d3f980">24,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c166eb8bb6741edb7c59919ec94dfc7_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTE0LTEtMS0w_4e2e440b-9d13-4be7-999d-9660b436a6ca">926.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb9f527854bf4eb285447a902fcd7098_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTE4LTEtMS0xNTUzNg_5d581f61-ce71-4706-b484-b30d0330cf03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTE4LTEtMS0w_04588bad-9336-4a49-bb10-563e9ac5499e">2,115.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interest created in acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4d7c88b3174a34837a1c0045f15e4d_D20190929-20200926" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMzLTE4LTEtMS0xNTUyOQ_7819b19c-ba66-414c-a14b-d7a0d7da09b6">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMzLTIwLTEtMS0xNDg2MA_98fed2c5-39e7-475b-a2ab-41133c9be1f6">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting standard transition adjustment - ASC 842</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd2a9a1773e4a9b84d417b384632c4a_I20200926" decimals="-5" sign="-" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM0LTgtMS0xLTE0ODEw_05bcab10-c6a7-49e8-b6fe-94eb0d138a48">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id050245a51244dfdad49743f31133eb8_I20200926" decimals="-5" sign="-" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM0LTIwLTEtMS0xNDg2MQ_55e2ec03-d5c6-4891-ab02-373c02c8e962">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i032815f3d67a43c29b8c166834679ea4_D20190929-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTItMS0xLTE0Nzc0_0697040b-8586-4f6a-afa8-e55ed4b4d7b5">1,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTYtMS0xLTE0Nzk4_8a7e99d1-331c-4465-ae07-7dccb034b979">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTIwLTEtMS0xNDg2NA_0f5beaed-8660-4018-b50a-10c949f6f49b">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i032815f3d67a43c29b8c166834679ea4_D20190929-20200926" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTItMS0xLTE0Nzc2_094b0472-5499-43bc-89ef-dca84f6d5cf2">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTYtMS0xLTkxNDE_d007ccee-79f6-4fb9-a5c5-6570b909711b">14.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTIwLTEtMS0xNDg2Ng_fb2b4fd9-1f66-476d-a05b-d4de034e6921">14.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i032815f3d67a43c29b8c166834679ea4_D20190929-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTItMS0xLTE0Nzc4_780c28c3-0134-44b8-958d-da7a9b001042">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTYtMS0xLTE0ODAy_a4cd3c86-3dfc-4436-9124-d3073f92050e">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTIwLTEtMS0xNDg2Nw_4fc0ca3f-8710-4c9c-a690-eb45c415da1f">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM4LTYtMS0xLTkxMzk_311bc01a-165c-4486-a674-357068823da2">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM4LTIwLTEtMS0xNDg3MA_6c55eb31-ead8-460d-8b03-bc05a0b69032">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36030839f7884303bb258fae716235dd_D20190929-20200926" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTgtMS0xLTkxODI_3e614886-aef0-4414-b603-dbadfb21ce18">1,115.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a4d7c88b3174a34837a1c0045f15e4d_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTE4LTEtMS0xNDg5MA_f5b5c92f-44f3-4410-80cb-12959ab37914">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTIwLTEtMS0xNDg3Mg_2282fdc2-2965-409c-98ee-69236b29aaf4">1,110.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQwLTEwLTEtMS0xNDgxNA_49dec108-9892-4a1f-a726-d303539701e0">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQwLTIwLTEtMS0xNDg3NA_3bda1a54-7559-4f9e-b8ea-15fd2c3102a2">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to minimum pension liability, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQxLTEwLTEtMS0xNDgxNQ_eb3179e8-cbc0-405c-8580-f3de3b9d04df">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQxLTIwLTEtMS0xNDg3Ng_7ae94b43-03bd-473d-81f1-378667995bb0">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1957ccc6b7a54f27a19bf968742bbf75_D20190929-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTEyLTEtMS0xNDg5Mg_ca1144f9-f50e-41d7-98da-b1db7b9363a2">9,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1957ccc6b7a54f27a19bf968742bbf75_D20190929-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTE0LTEtMS0xNDg5OA_7821a85b-2403-4ab3-ac06-d423a03235b3">448.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTIwLTEtMS0xNDg3OA_676877ff-7e09-4bd9-a6c2-08a2e0e7895d">448.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated share repurchase agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94e21961902342f58ae493fd44252348_D20190929-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTEyLTEtMS0xNDg5Mw_163c27aa-d984-4818-875e-b3aa8aa25367">3,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e21961902342f58ae493fd44252348_D20190929-20200926" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTE0LTEtMS0xNDkwMA_41bd63fd-1b04-4281-9c85-2599343369a7">205.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49a3d6edcda84d5e8d51e6886159c6f0_D20190929-20200926" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTIwLTEtMS0xNDg4MA_3bcb2c1f-e06a-43e5-af77-e26981f4742e">205.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on derivatives, net of taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ0LTEwLTEtMS0xNDgxOA_9831111f-6a02-46dc-b6d2-2acd807255ea">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ0LTIwLTEtMS0xNDg4MQ_b3ae05fc-975b-4fb5-9713-717c20b222b5">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ1LTEwLTEtMS0xNDgxOQ_364f8b5a-3fa1-4dea-b978-2ecfeecbdc19">27.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ1LTIwLTEtMS0xNDg4NA_0b868a54-82c4-4a0f-b6f1-7887030074cc">27.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest cost of interest rate cap reclassified to statement of operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ2LTEwLTEtMS0xNDgyMg_112ac7d0-53c6-4f3e-90c7-d22886ed99f2">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ2LTIwLTEtMS0xNDg4Ng_bfcc462e-867a-4752-8689-1ff4b7ff30bb">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a4d7c88b3174a34837a1c0045f15e4d_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTE4LTEtMS0xNTUyMA_dd9be4b3-b13d-4b20-864d-e6e138b919d3">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTIwLTEtMS0xNDg4OA_9fedfbdf-99f3-49cc-8314-6147a760bb2a">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibc54b6fd6f2747fb9422322da3ef9079_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTItMS0xLTE0ODMy_518ddf9b-4373-468a-800d-2b9bcf83c034">295,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc54b6fd6f2747fb9422322da3ef9079_I20200926" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTQtMS0xLTE0ODM0_3863a33b-b2fd-492c-b059-fad7ca8344f7">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa08cbf6d272455e8f8d4fc150075d1e_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTYtMS0xLTkyMjA_769ed2b9-b24b-49bf-abb9-791e3dbb95ef">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f2f7acec1c4c4aa787e72d606b369e_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTgtMS0xLTkyMTg_68866479-aed8-4aca-ae0f-519cf8c76224">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31584edc599f43b4b1edbb086c4349e5_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTEwLTEtMS0xNDg0MA_d3714676-49e6-4340-acfd-64e5dd815a01">49.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibce62cc16e0d420ab20aa0dd17c08716_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTEyLTEtMS0xNDg0Mg_2d145713-8fc2-4eba-8330-8d5b21c85648">37,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce62cc16e0d420ab20aa0dd17c08716_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTE0LTEtMS0xNDg0NA_8d9a654f-d300-4f8c-be2c-237180450697">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f2b3be1822c481ea0d7d8b6f100c51b_I20200926" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTE4LTEtMS0xNDg0Ng_d113a965-dcc2-4e75-b790-6c7ac4340ed6">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTIwLTEtMS0xNDg0OQ_c70a7649-1f7a-4093-960e-3789be8f58a0">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:60.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMtMS0xLTEtMA_9a1ae78a-cfca-4e60-bff4-3e70d417eb22">1,110.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMtMy0xLTEtMA_6305f581-fb29-45e6-9288-a68a3092b8dc">203.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMtNS0xLTEtMA_8365dc9d-9d8b-4b35-854f-628012451fed">111.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUtMS0xLTEtMA_2cadc93f-613c-4699-b257-50e045dff997">83.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUtMy0xLTEtMA_532e2667-93b8-49e1-b7fb-c0c39b7789b9">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUtNS0xLTEtMA_73ac0db1-2a6c-464e-b97d-995511fe9d1e">101.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYtMS0xLTEtMA_b368e7ab-8639-40a2-8155-06a7907c5b52">292.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYtMy0xLTEtMA_da88d4b4-a855-4310-af94-a917e1c816d7">370.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYtNS0xLTEtMA_53f0d298-0a92-461c-8afd-ffb9a806a1f4">378.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzgtMS0xLTEtMA_2c6370ab-2d5a-451b-baa7-33e4d1651e71">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzgtMy0xLTEtMA_7672225f-2d3e-4c2d-881c-b57d26b95bd7">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzgtNS0xLTEtMA_98110298-f7d4-48e2-8ad4-750133b45185">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes and other non-cash taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEwLTEtMS0xLTA_3cf0d27c-773c-49c0-97bc-9debbd1aa9a6">94.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEwLTMtMS0xLTA_93ec2167-b1bf-4a88-aa1b-cc3434b61d59">235.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEwLTUtMS0xLTA_6d65204d-43f8-4275-88a5-557d5a2fda20">477.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill impairment charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEyLTEtMS0xLTA_cee0e58f-af22-4fea-8eff-4093dce501f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEyLTMtMS0xLTA_c656eb36-de75-41c4-8dba-ad9791f3e8e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEyLTUtMS0xLTA_e4cc570a-b4aa-43cf-bb46-7957929c7a84">685.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset and equipment impairment charges<br/></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="holx:Impairmentofintangibleassetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEzLTEtMS0xLTA_79e7ebdc-a2d7-4947-9234-b877e5d34b6d">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:Impairmentofintangibleassetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEzLTMtMS0xLTA_29564bad-a6ac-4e59-9a3f-6772e5130a05">685.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="holx:Impairmentofintangibleassetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEzLTUtMS0xLTA_f12e488e-9163-4c95-bd1a-527a0532e5f4">46.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt extinguishment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzE4LTEtMS0xLTA_4766aa31-371c-403f-9ede-1121b0f5937a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzE4LTMtMS0xLTA_050800c4-d7f2-455b-8260-f4c286064fc3">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzE4LTUtMS0xLTA_88fbdd57-0acd-4e64-b1eb-23bc12d32e56">45.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments and non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzIzLTEtMS0xLTA_190b13ba-93c0-45c9-b3b9-6576379369c2">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzIzLTMtMS0xLTA_fad301ed-b2c7-4ed8-ada4-ca66220abc3a">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzIzLTUtMS0xLTA_65fa871e-8cd8-4d8e-9d5f-829d1ce613a9">24.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI1LTEtMS0xLTA_73b03104-6e0d-4449-b3ec-a7c081617e31">427.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI1LTMtMS0xLTA_2c2563e3-52fa-4697-8133-e99b1f575cc4">76.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI1LTUtMS0xLTA_7adfb452-1274-41b2-b231-264c4a091256">38.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI2LTEtMS0xLTA_28e35eb1-6c17-41fd-b09c-718e666f6fd7">25.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI2LTMtMS0xLTA_eb827d77-4941-485d-99d4-7fd321ba0409">63.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI2LTUtMS0xLTA_7ecc0762-6c5d-4734-930f-381361e6d4d4">50.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI3LTEtMS0xLTA_fcb1b42f-57d3-485d-891f-011670e05a7d">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI3LTMtMS0xLTA_4e20eabe-0be3-46ba-a40b-b5babb08e8de">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI3LTUtMS0xLTA_a88ad0d6-5771-4d12-82fa-e1b295698e36">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI4LTEtMS0xLTA_52d41896-bea0-4aa0-a16d-d758bc74ca4c">286.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI4LTMtMS0xLTA_ea5e89c5-5f91-4d6f-9d06-ea1068d32731">6.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI4LTUtMS0xLTA_ca21c0ec-71f8-41ae-9ed6-93d93b9dda47">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI5LTEtMS0xLTA_10327168-4d70-4b0c-aa00-6ae4ebc4f2cb">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI5LTMtMS0xLTA_710c996d-fc19-4f2d-8fee-19eea83c6734">5.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI5LTUtMS0xLTA_e16fd2a4-df88-4fd1-a11a-e6dd616ba294">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMwLTEtMS0xLTA_252f1c6f-9a6d-48c3-9341-785d2cadb666">96.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMwLTMtMS0xLTA_083eaa8b-51af-4463-b93e-f7e762483cd4">16.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMwLTUtMS0xLTA_39e8c94a-4adf-41a3-9a6f-e6e810bfbd2d">53.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMxLTEtMS0xLTA_333eb06f-e0d5-400b-89ad-fc56431cd655">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMxLTMtMS0xLTA_1eb4a84d-1176-4d68-abc3-893e68647136">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMxLTUtMS0xLTA_dae0b018-3f8e-4159-8a5d-c9e2fd73e87d">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMyLTEtMS0xLTA_c8ab4086-3fb5-4eb1-abd5-cc236fe9981c">896.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMyLTMtMS0xLTA_70258c6e-f64f-4242-90ea-f1f190200172">649.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMyLTUtMS0xLTA_1abc8986-92e2-4d33-80eb-e8103f17875c">732.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM0LTEtMS0xLTA_41ff7fc0-22af-442e-a52a-eab5e9abcee0">119.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM0LTMtMS0xLTA_9f6ce184-295e-464d-b474-9c08d454b81c">110.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM0LTUtMS0xLTA_08cf25f3-df30-4a5f-b9a7-56fef4f4e7ec">76.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM2LTEtMS0xLTA_a6e158a9-a1bc-4306-99fb-11c6ab81a182">139.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM2LTMtMS0xLTA_565739fc-f1d2-4fec-a1ec-f07510ed5cfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM2LTUtMS0xLTA_47266239-f05b-4d23-87cf-17b32e996897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equity method investment in SSI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM3LTEtMS0xLTA_2638f4e6-3918-4b1b-8d7d-cf227d4587e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM3LTMtMS0xLTA_2d301796-8658-4a15-9d72-67ea92f19752">18.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM3LTUtMS0xLTA_273e0503-b290-45c6-bcf0-49146a50caa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loans to SSI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:FundingOfLoansToSSI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM4LTEtMS0xLTA_f05ce790-7a40-4db0-b8c7-bcfcdabb1c6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:FundingOfLoansToSSI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM4LTMtMS0xLTA_97fba08d-f40c-4352-8d92-8bbb876cd011">28.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:FundingOfLoansToSSI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM4LTUtMS0xLTA_a142923f-28dc-4104-ac12-7145e389f144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM5LTEtMS0xLTA_ae812832-62e4-492f-9948-8a5fc22f74b2">98.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM5LTMtMS0xLTA_63d4be9a-53f8-42ab-b95f-64a2d635025c">57.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM5LTUtMS0xLTA_7a4e8b59-3126-4f80-aaf0-0b8d4cfc0866">58.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase in equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQwLTEtMS0xLTA_1774b917-7c1f-498c-b847-8882e75502a4">58.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQwLTMtMS0xLTA_681560ee-07ec-4778-a071-068673f65a20">52.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQwLTUtMS0xLTA_96e583b4-02da-4298-b758-c67a9331715d">47.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of cost-method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:Purchaseofcostmethodinvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQyLTEtMS0xLTA_094a514f-c0d4-434d-aff4-ac4053cef6e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:Purchaseofcostmethodinvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQyLTMtMS0xLTA_825fadeb-e7d8-4183-855f-ae3d6c35bcc5">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="holx:Purchaseofcostmethodinvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQyLTUtMS0xLTA_c5bde7ee-9663-4bf0-8b77-fb3e48ec8bff">6.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="holx:Purchaseofinsurancecontracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ0LTEtMS0xLTA_5e21226a-ab7c-4cba-9e36-3ec1c1484cb6">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:Purchaseofinsurancecontracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ0LTMtMS0xLTA_19a59080-a037-4f20-8ca0-a92d419a4cf8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:Purchaseofinsurancecontracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ0LTUtMS0xLTA_108a91b8-c582-4465-a422-82880ca15468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ3LTEtMS0xLTA_5fb70eae-0c7a-4649-b630-31cba88a0298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ3LTMtMS0xLTA_5fbb5fb9-bddc-4ef6-9d6e-40ab92eb1a7f">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ3LTUtMS0xLTA_b60fcc38-0470-4eea-b3b4-0b2c7cd05b92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ5LTEtMS0xLTA_a845d002-3de0-4015-b1af-1f08fd74defb">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ5LTMtMS0xLTA_086e7982-53a1-4d29-8b64-36b9a71a022e">6.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ5LTUtMS0xLTA_29495fa2-6cba-4347-9473-df162101947c">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUwLTEtMS0xLTA_d1716793-484a-438c-89c6-2697c0edcb32">141.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUwLTMtMS0xLTA_d628142c-f15d-447b-98f8-583c5ee3c048">280.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUwLTUtMS0xLTA_992c4f21-3244-4a52-8273-f2af27c70c07">195.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUyLTEtMS0xLTA_ca89f64c-0438-4c14-a35a-f9c8f0bf8447">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUyLTMtMS0xLTA_d36aab47-70a3-465f-9e48-089ebac934c9">1,500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUyLTUtMS0xLTA_857f53c3-dd4f-445e-8862-733431649f73">1,500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUzLTEtMS0xLTA_2c204cd7-7437-44d5-ae5f-d8ec71e533f3">37.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUzLTMtMS0xLTA_d9c88502-1f01-448a-ba18-c37259bc52ba">1,462.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUzLTUtMS0xLTA_607f3c31-e56b-4617-88c0-fcecadd20ea8">1,359.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:ProceedsfromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU0LTEtMS0xLTA_13f5d057-bfec-47da-8b04-9939a066f1f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:ProceedsfromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU0LTMtMS0xLTA_d353be08-798c-46a9-8991-d72c29ab6785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="holx:ProceedsfromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU0LTUtMS0xLTA_e99bd259-bc38-4f27-9a7e-38b861951688">1,350.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:RepaymentofSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU1LTEtMS0xLTA_c5170796-5ced-4778-8d79-09019d324b3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:RepaymentofSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU1LTMtMS0xLTA_7cd0cdbe-150f-4618-8259-da4b696ab468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="holx:RepaymentofSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU1LTUtMS0xLTA_4c2df064-ccd1-4024-bca4-9d8d39244c79">1,037.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to extinguish convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU2LTEtMS0xLTA_f52514c4-364d-4830-a54e-ead2ffb1ca7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU2LTMtMS0xLTA_5690c009-cc7f-4ea1-b099-d7c677c49774">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU2LTUtMS0xLTA_e3db023f-234c-4984-9305-63e85698307f">546.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payoff of acquired long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="holx:Repaymentofacquireddebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU3LTEtMS0xLTA_f115b033-b151-47cf-8be3-aa1eee2ac26a">8.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:Repaymentofacquireddebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU3LTMtMS0xLTA_96415177-d02d-4b24-bb77-3a2c87333a97">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="holx:Repaymentofacquireddebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU3LTUtMS0xLTA_6df23ed6-19aa-4e85-b312-5bbcf1a87adf">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from revolving credit line</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU4LTEtMS0xLTA_66d374f9-adfa-491e-acf0-6ec634db20f2">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU4LTMtMS0xLTA_47da30f4-a4f9-4e9f-ad2f-972eddf4a163">480.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU4LTUtMS0xLTA_e6064e86-bcbd-42e6-9bf3-cc8076db8609">1,150.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments under revolving credit line</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU5LTEtMS0xLTA_07ffd9d3-83a3-4b0e-8b42-09e0be065ad4">500.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU5LTMtMS0xLTA_4655fe4b-ed04-4d85-b47c-c48bc61955c5">780.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU5LTUtMS0xLTA_1ec818f8-38f3-4e28-ab75-7f2950902669">1,195.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from accounts receivable securitization agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYwLTEtMS0xLTA_bc997bed-ec4d-4479-b0b1-116b6cf05413">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYwLTMtMS0xLTA_7cfb96ab-0c9b-44e1-a9f5-bafa0c3a0c83">43.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYwLTUtMS0xLTA_3636c901-f1eb-44b8-a465-eb0334c39666">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments under accounts receivable securitization agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYxLTEtMS0xLTA_edd0e0e3-d139-4814-86fc-15c984d84710">250.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYxLTMtMS0xLTA_3dbe79c1-3d93-45e2-a22b-47cc144e48c6">34.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYxLTUtMS0xLTA_7aaee804-0850-44b4-9fd3-7244da9351bd">9.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTEtMS0xLTEyODk_d8865e07-0800-4482-a8d0-ef8e9347d3ff">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTMtMS0xLTEyODk_6d55b55e-bb99-4638-a3ae-3320e84cc2c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTUtMS0xLTEyODk_beb537b0-1416-4425-a403-81df43dbfccb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTEtMS0xLTA_8bc30aab-9d7b-49b4-9697-d3d9531aee45">653.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTMtMS0xLTA_54f37c26-afc3-4cc6-8218-1ac4b7a76316">200.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTUtMS0xLTA_394b0bdf-202f-4903-9ce0-f785cfbc3455">275.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYzLTEtMS0xLTA_453dfd3f-fc56-4010-9ab2-96080bc6cbe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYzLTMtMS0xLTA_e214be40-2ab1-4131-b27a-28ff139b421a">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYzLTUtMS0xLTA_c5e51092-5e95-469f-b5af-78308a5234b4">23.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of deferred acquisition consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY0LTEtMS0xLTA_4674a34a-2a30-49a4-ad85-530b98295066">24.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY0LTMtMS0xLTA_0332a668-0ac4-4ca5-be20-3fb42e04958b">6.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY0LTUtMS0xLTA_f347ffc8-9ac2-4b61-aca2-91b8a77fea29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of interest rate caps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY1LTEtMS0xLTA_5e485293-3771-484d-855d-ae737c098a9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY1LTMtMS0xLTA_bf628c75-929c-4b92-9ddb-f58bff847e9a">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY1LTUtMS0xLTA_45e0e756-897a-4dfa-8595-a266c15f59ee">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY3LTEtMS0xLTA_921e5a39-88fb-4870-9c04-00513f48d67e">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY3LTMtMS0xLTA_f880d7bc-393e-4a6b-89b2-5e3a0bfa7ae2">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY3LTUtMS0xLTA_30d48553-dc69-4502-aea5-198289e71a69">33.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of minimum tax withholdings on net share settlements of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTEtMS0xLTEwMTg2_57649b4d-c400-461e-8a6f-b8d56dde7f06">14.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTMtMS0xLTEwMTg2_5c80ef9d-a1bd-47dc-af51-0ab8eb51e559">12.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTUtMS0xLTEwMTg2_1776da33-5cd1-445f-a290-52a5acbfeeb0">16.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments under finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY5LTEtMS0xLTA_ed9f6bb5-19eb-478a-a297-29b235c6a608">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY5LTMtMS0xLTA_822152c3-b604-4ea4-a970-3d7ea88d2825">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY5LTUtMS0xLTA_a1204ec8-2cc5-4a41-8683-6eef5ce85289">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTEtMS0xLTA_d99d1679-21c8-4c43-aec5-ce5dc0102488">659.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTMtMS0xLTA_162db0da-d07a-43fe-8d74-1252460c62a3">431.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTUtMS0xLTA_eae1e711-4500-4a9b-bfe0-af27fbf3cbe1">404.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcyLTEtMS0xLTA_e0b5f82e-98ea-4f02-aced-c720c08310c7">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcyLTMtMS0xLTA_19a0b28e-a64d-4cf7-8afe-1657b8c2c487">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcyLTUtMS0xLTA_e6c3d604-9492-4b7f-839a-019ad47255f1">6.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzczLTEtMS0xLTA_82463c1f-e055-4fd2-99b6-89f2eecb5761">99.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzczLTMtMS0xLTA_28a7f470-6838-41cf-bfba-da52ca95e235">64.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzczLTUtMS0xLTA_46b4ef2e-a88d-49cb-bf15-e7b61fefeee4">126.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc0LTEtMS0xLTA_2ae05d67-8f52-4395-b584-0e84183d0853">601.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc0LTMtMS0xLTA_34b1f24e-6370-4b09-8820-b255106102b3">666.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84c88a850d71453097932f0bcbe84825_I20170930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc0LTUtMS0xLTA_12b1fb29-143a-4428-a484-49cbd6c1af63">540.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc1LTEtMS0xLTA_aa333845-333f-4c78-b6b6-ba7efef96201">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc1LTMtMS0xLTA_d249ce74-1a4a-4f8b-ba75-d347ae14f087">601.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc1LTUtMS0xLTA_576f73c9-1813-4a79-8d4a-80c8745eea01">666.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(all tabular amounts in millions, except number of shares which are reflected in thousands)</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_136"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzM4Mw_1c7f145e-b286-46e5-8b28-155c7d9986e2" continuedAt="i181b277183384bc0a20526df92ce006e" escape="true">Operations</ix:nonNumeric></span></div><ix:continuation id="i181b277183384bc0a20526df92ce006e" continuedAt="i4ccb1b488682429bb9f8d79187f1918e"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic, Inc. (the &#8220;Company&#8221; or &#8220;Hologic&#8221;) develops, manufactures and supplies premium diagnostics products, medical imaging systems, and surgical products with an emphasis on women's health and well-being through early detection and treatment. Until December 30, 2019, the Company's product portfolio included light-based aesthetic and medical treatment systems sold by its former Medical Aesthetics business. The Company completed the sale of its Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). During the second, third and fourth quarters of fiscal 2020, the Company operated in <ix:nonFraction unitRef="segment" contextRef="i3f897a5c14ce46fcb14ced01b6827380_D20170322-20170322" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzI4Nw_70f4a5f6-eaa5-47fa-b09d-6ec5b1990b75">four</ix:nonFraction> segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Considerations</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic caused by the spread of the novel strain of coronavirus disease 2019 ("COVID-19") has created significant volatility, uncertainty and economic disruption in the markets the Company sells its products into, primarily the U.S., Europe and Asia-Pacific. In the second, third and fourth quarters of fiscal 2020, the spread of COVID-19 has negatively impacted business and healthcare activity globally. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As healthcare systems respond to the increasing demands of managing COVID-19 and the resulting economic uncertainties, governments around the world have imposed measures designed to reduce the transmission of COVID-19, and individuals are responding to the fears of contracting COVID-19. In particular, elective procedures and exams have been and continue to be delayed or cancelled, there has been a significant reduction in physician office visits, and hospitals have postponed or cancelled capital purchases as well as limited or eliminated services, however in the second half of the third quarter of fiscal 2020, the Company started to see a recovery of elective procedures and exams, which continued into the fourth quarter. The reductions in testing and procedures have had, and the Company believes will continue to have, a negative impact on the Company's operating results and cash flows. However, the impact of the Company's commercial release of its COVID-19 assays more than offset these negative impacts, as the Company generated significant revenue from the sales of these assays in the third and fourth quarters of fiscal 2020. The negative effects of COVID-19 and the associated economic disruptions were felt primarily beginning in the second half of March in many of the Company's end-markets and earlier in Asia, primarily China, and the impact to the Company's legacy products in the third fiscal quarter was significant. The impact to its legacy products was less severe in the fourth quarter.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company's results of operations and cash flows in the third and fourth quarter of fiscal 2020 were positively impacted by the sale of its COVID-19 assays, the COVID-19 pandemic could have an adverse impact on its operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: the severity and duration of the COVID-19 pandemic; continued demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products; the COVID-19 pandemic&#8217;s impact on the U.S. and international healthcare system, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental responses to the COVID-19 pandemic and associated economic disruptions.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to adversely affecting demand for the Company's products, other than its COVID-19 assays, COVID-19 and associated economic disruptions could continue to have an adverse impact on the Company's supply chains and distribution systems, including as a result of impacts associated with preventive and precautionary measures that it, other businesses and governments have taken and will take. A reduction or interruption in any of the Company's manufacturing processes could have a material adverse effect on its business.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the uncertainty surrounding global financial markets and deteriorating worldwide macroeconomic conditions resulting from the pandemic have caused and may continue to cause the purchasers of medical equipment to decrease their medical equipment purchasing and procurement activities. Additionally, the pandemic has caused and may further cause constrictions in world credit markets that have caused and could cause its customers to experience increased difficulty in paying their existing obligations to the Company or in securing the financing necessary to purchase the Company's products. Economic uncertainty has resulted and may continue to result in cost-conscious consumers focusing on acute care rather than wellness, which may also continue to adversely affect demand for the Company's products (other than the Company's COVID-19 assays).</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company assessed the potential longer term economic and capital market uncertainties resulting from the COVID-19 pandemic, at the end of March 2020 the Company suspended its accounts receivable securitization program and borrowed $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1NDIxMjI_f9761d96-ae46-4f26-983b-bf58f9fa034a">750.0</ix:nonFraction>&#160;million under its revolver. The Company used $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1NDIxMzg_c4fb28d1-3125-4c27-a857-c520c3c72776">250.0</ix:nonFraction>&#160;million of these proceeds to pay off all amounts then </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i4ccb1b488682429bb9f8d79187f1918e"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">owed under its accounts receivable securitization agreement and retained the balance as cash reserve. As of the end of fiscal 2020, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1MzM5Nzk_1b6a964a-34df-453e-a11d-cb5b68f7d9f7">500.0</ix:nonFraction>&#160;million of the $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1MzM5OTU_5dbd987e-64b4-4f6c-af80-09f920242104">750.0</ix:nonFraction>&#160;million borrowed under its revolver. As of September 26, 2020 the Company had an additional $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-6" format="ixt:numdotdecimal" name="holx:UnusedCreditFacility" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1MzQwNTE_b82c0782-2a24-4559-8333-cb93b1c2d6d1">1.25</ix:nonFraction>&#160;billion available under its revolver and $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1MzQwMzU_c0d4c221-f735-47b3-98d0-c44bd7b7680f">701.0</ix:nonFraction>&#160;million of cash on hand.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the negative impact of COVID-19 on the Company's business, in April 2020 the Company initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but the Company also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances employee terminations. Further, in April 2020, the Company had shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of its products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased, and the majority of the impacted manufacturing facilities are back to pre-COVID levels.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also taken measures to ensure the safety of its employees and to comply with governmental orders. These measures could require that the Company's employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in its commercial and marketing activities.</span></div></ix:continuation><div id="i8ddb964a7a024d63b8e4009970e71997_139"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE5MjQxNDUzNzE2NDA0_83bb14c4-3419-48dc-b9da-a2d2ff8c0d7b" continuedAt="iaddcfb61bb9a4463ae498986ee03a222" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="iaddcfb61bb9a4463ae498986ee03a222" continuedAt="i6b4f443a17594490b7305dd0b469aa65"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTY5_32557a1a-4a9b-48a0-973e-1b927197fb0a" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned and majority owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#8217;s fiscal year ends on the last Saturday in September. Fiscal 2020, 2019 and 2018 ended on September&#160;26, 2020, September&#160;28, 2019 and September&#160;29, 2018, respectively. Fiscal 2020, 2019 and 2018 were 52-week years.</span></div></ix:nonNumeric><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events Consideration</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events recorded in the consolidated financial statements as of and for the year ended September&#160;26, 2020. Subsequent to September 26, 2020, the Company's issued its 2029 Notes on September 28, 2020 and used the proceeds and cash on hand to pay off its 2025 Notes. For additional information, refer to Note 7.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzE4_35a7ac7c-2c9e-4410-828d-021d1b85c8bc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Estimates and Uncertainties</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#8217;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#8217;s net deferred tax assets and related valuation allowances.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#8217;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i6b4f443a17594490b7305dd0b469aa65" continuedAt="i0d8fc7f492544a7e921603734e791d3c"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzI4_750ad777-010e-41ed-8f93-bbe0316b4532" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:CashEquivalentsMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzQw_9a439204-ba78-4288-9749-c327193b2975">three months or less</ix:nonNumeric> at the time of acquisition.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzAy_b362919e-d815-488b-ba5c-735bb5e67e46" continuedAt="i977de9d86cf540c2b68e1ffef70a1b84" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers are principally located in the United States, Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;26, 2020. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i977de9d86cf540c2b68e1ffef70a1b84">There was <ix:nonFraction unitRef="customer" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="INF" format="ixt-sec:numwordsen" name="holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU0MzM_891b8b5b-add1-4afb-98f5-a51ffc0fddd6">one</ix:nonFraction> customer with a balance greater than <ix:nonFraction unitRef="number" contextRef="i8f6314cda1fe40489c80c8c7c917a7b8_D20190929-20200926" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU0NzM_10301916-c785-4bad-ae58-c0e6416c25db">10</ix:nonFraction>% of accounts receivable as of September&#160;26, 2020, at 11.9%. There were <ix:nonFraction unitRef="customer" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="INF" format="ixt-sec:numwordsen" name="holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzkzNDU4NDkwNDcyMTI_c890be53-9622-4d87-a327-389642d53ffb">no</ix:nonFraction> customers with a balance greater than <ix:nonFraction unitRef="number" contextRef="ifcc5fcf2f538489bae3a4254ce198ccf_D20180930-20190928" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzkzNDU4NDkwNDcyMDg_c948c54e-41a2-4f18-9a2e-98fc22c2c18d">10</ix:nonFraction>% of accounts receivable as of September&#160;28, 2019. There were no customers that represented greater than <ix:nonFraction unitRef="number" contextRef="i5a4fb96be7934eb29629fbdb7e72fd0f_D20180930-20190928" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU1NjM_65cc4ee7-6a17-4b70-9437-f024068e3ae6"><ix:nonFraction unitRef="number" contextRef="iff73c4f9e92e403e8fd1003738851496_D20190929-20200926" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU1NjM_be9fef20-2651-42a0-b837-c686984b3ef3"><ix:nonFraction unitRef="number" contextRef="i552f7643b15a4fdd94f4b733fd38a0ef_D20180701-20180929" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU1NjM_f7fa4910-453f-4ca2-a38d-085484e73adc">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of consolidated revenues for fiscal years 2020, 2019 and 2018</ix:continuation>.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Suppliers</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases certain components of its products from a single or small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which could adversely affect results of operations; however, management believes that suitable replacement suppliers could be obtained in such an event.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjQ0_4bb24251-aa3c-4e1c-a3a5-98d8da51fb19" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flow Statement Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.911%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzItMi0xLTEtMA_d6429850-059d-47cb-9c6b-c7bce1dbf41f">265.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzItNC0xLTEtMA_6994b5ac-9764-4b56-956c-db8f0983cd7f">180.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzItNi0xLTEtMA_e36097f4-0c24-4b08-a7a1-81b877904674">178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzMtMi0xLTEtMA_ae580ad9-0ba5-4713-8a5f-083cab48a8f6">109.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzMtNC0xLTEtMA_9c555c36-ede6-423a-adf4-f9cb54df0395">132.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzMtNi0xLTEtMA_c4138992-8261-4c45-b5dc-cdf6131e1cd6">122.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration at acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5ODEz_824d8c89-9051-416b-9303-14a73ab7cff0" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#8217;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#8217;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njgz_239aa1fe-4745-4632-86e7-965edd4c43ca" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:52.471%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzEtMi0xLTEtMA_231fd047-fbb9-4dbe-a1a6-b27fb1282d7d">152.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzEtNC0xLTEtMA_a8376169-9743-446b-8e9f-c43ecd65e4a0">166.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzItMi0xLTEtMA_079c5f92-69f5-44ae-85e5-3fa3f0365be8">46.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzItNC0xLTEtMA_8c64ab41-64a8-4b3b-8441-0afe1dd624d7">54.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzMtMi0xLTEtMA_1122c817-edeb-4a8d-af80-deabc3582cfc">196.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzMtNC0xLTEtMA_3ba59133-19bb-4652-a0e2-ce3b47fcc77a">224.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzQtMi0xLTEtMA_63277f7f-9ba9-4b30-81de-6905dd7f4f76">395.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzQtNC0xLTEtMA_93716bfd-13f8-4caa-ba8a-57863566913b">444.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i0d8fc7f492544a7e921603734e791d3c" continuedAt="i66b5b135c3584a538ef35ad5cdddc64a"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjIz_dddc960d-1728-419a-a4e1-3396defbcd43" continuedAt="i2faa02952fee48cdb095673fe7be1d25" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. </span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTc3_67b0d745-00a8-4a8f-aa3f-4d933a79fb84" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:36.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.308%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d5133bbb5b643cfb4039e7683d511b2_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzEtMS0xLTEtMTY4MjUvdGV4dHJlZ2lvbjo1ZjQ1NWFlYmFhODE0ZjNiOTA3ZTFkMDVlYjgwYTM3OF85MzQ1ODQ4ODM2MTEz_21647d19-166e-4070-953a-449fabd5386b">3</ix:nonNumeric>&#8211;<ix:nonNumeric contextRef="i01e39e16ad0d4d43bded461c3c400be6_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzEtMS0xLTEtMTY4MjUvdGV4dHJlZ2lvbjo1ZjQ1NWFlYmFhODE0ZjNiOTA3ZTFkMDVlYjgwYTM3OF85MzQ1ODQ4ODM2MTE5_a31dc260-0fe1-41c6-b0c9-d07892fbe6e4">10</ix:nonNumeric> years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzEtMy0xLTEtMA_b9a49365-d5f5-4fff-955b-7c8efa929c01">460.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzEtNS0xLTEtMA_5cbb6908-55ab-4234-8fb9-e5e0373c1f7e">379.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i284a1c2b8fc740deac2cf49770588de2_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzItMS0xLTEtMTY4MzEvdGV4dHJlZ2lvbjo0NGY2YjAzNjMxZjg0NTdjOWMzNzE2ODE3YmM0YTNlYl85MzQ1ODQ4ODM2MTI3_a3b3595d-7ca1-4bb7-ac5c-721330d59f05">3</ix:nonNumeric>&#8211;<ix:nonNumeric contextRef="ifba3583f30724dd495ffe080e345c8e2_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzItMS0xLTEtMTY4MzEvdGV4dHJlZ2lvbjo0NGY2YjAzNjMxZjg0NTdjOWMzNzE2ODE3YmM0YTNlYl85MzQ1ODQ4ODM2MTMy_acea8581-1446-4e50-9625-f5bb722f3f7f">8</ix:nonNumeric> years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzItMy0xLTEtMA_808f021b-0f86-46e0-9c59-bf82cff78fc4">456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzItNS0xLTEtMA_d4368125-98e6-43a9-a542-4a994823e207">427.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64ce780d2bc74dc48f001fe80ae1ff75_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzMtMS0xLTEtMTY4MzgvdGV4dHJlZ2lvbjowNDgzMzRjNjM4NDQ0NTc1ODJhNWMyNmYxZjRhNGIzZV85MzQ1ODQ4ODM2MTIx_91f140ce-636a-44d4-89cc-b9819e67f8d3">20</ix:nonNumeric>&#8211;<ix:nonNumeric contextRef="i5ab13270771d45d3b753d44c0a05c023_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzMtMS0xLTEtMTY4MzgvdGV4dHJlZ2lvbjowNDgzMzRjNjM4NDQ0NTc1ODJhNWMyNmYxZjRhNGIzZV85MzQ1ODQ4ODM2MTI3_79968881-f2e7-4b5d-af32-af3fcd9dd6cb">35</ix:nonNumeric> years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzMtMy0xLTEtMA_cbada85e-a43d-4924-8549-b8ef7fe33c74">167.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzMtNS0xLTEtMA_91ce90e4-520e-47f6-bf2f-224c1ac9162b">196.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the Original Term of Lease</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or Estimated Useful Life</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzQtMy0xLTEtMA_70ed1e22-76c6-4761-851a-b4d943cc8d78">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzQtNS0xLTEtMA_1945c7ab-ba78-4cf2-a426-a25cb3ee1ad6">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzUtMy0xLTEtMA_8b0a9eee-3609-4a96-8e64-08b5b6799754">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzUtNS0xLTEtMA_0ccf0e89-2735-413c-ba5e-c341a4080410">46.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia576d0947dd14fb899e60c78615447af_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzYtMS0xLTEtMTY4NTUvdGV4dHJlZ2lvbjpjNmMyYzM5NTQ5MjM0OGMzOWFjYjNhNmUzMGE3NDYxNF85MzQ1ODQ4ODM2MTEy_deacd995-4b2f-4d07-9c33-e12cab9be3dc">5</ix:nonNumeric>&#8211;<ix:nonNumeric contextRef="if8383367e78c40ac903ab338ea02c2d8_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzYtMS0xLTEtMTY4NTUvdGV4dHJlZ2lvbjpjNmMyYzM5NTQ5MjM0OGMzOWFjYjNhNmUzMGE3NDYxNF85MzQ1ODQ4ODM2MTE3_63821d8a-c56d-4273-ac92-9568152b9e5f">7</ix:nonNumeric> years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzYtMy0xLTEtMA_dad76e17-595c-4c3d-8775-eaddf5cc3d6c">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzYtNS0xLTEtMA_78304c63-b686-4710-b48d-40710682f1ab">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzctMy0xLTEtMA_37513641-7e8c-4b58-a5af-304c89d7b9c5">1,185.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzctNS0xLTEtMA_77f86058-0894-4ef6-a55d-f627d1199443">1,128.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzgtMy0xLTEtMA_a44ae655-72e1-4430-b5e6-c238d8658516">694.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzgtNS0xLTEtMA_8507830d-6414-47a8-8cea-fd4ba2d6cee9">658.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzktMy0xLTEtMA_d6d40c73-604d-4948-8ad0-bce3032848fe">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzktNS0xLTEtMA_e5310fd2-04ac-4a58-838e-8179428e22a8">470.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2faa02952fee48cdb095673fe7be1d25">Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred.</ix:continuation> </span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:LongLivedAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzAx_fc1e02a8-2745-4d23-b115-aeef1df80bbb" continuedAt="i25214cfbd7a6440e830661de5630fe2c" escape="true">Long-Lived Assets</ix:nonNumeric></span></div><div style="margin-top:5pt;text-indent:24.75pt"><ix:continuation id="i25214cfbd7a6440e830661de5630fe2c" continuedAt="i49d9e4c4d2014c5e986e2f06f3202f3e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment&#8212;Impairment or Disposal of Long-Lived Assets</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i49d9e4c4d2014c5e986e2f06f3202f3e"> (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique.</ix:continuation> </span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzMx_a5454a4b-604e-4eb7-b86e-e2124fafe85d" continuedAt="i62784101d2684ecf815fc573f9b6be94" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations and Acquisition of Intangible Assets</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company accounts for the acquisition of a business in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i66b5b135c3584a538ef35ad5cdddc64a" continuedAt="i8a01c5b944594298a2d73201290fb06d"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i62784101d2684ecf815fc573f9b6be94" continuedAt="i87d571a759e94bc69a96d9b2db4e6ecc">the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets.</ix:continuation></span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i87d571a759e94bc69a96d9b2db4e6ecc">The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names</ix:continuation>.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets and Goodwill</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are initially recorded at fair value and stated net of accumulated amortization and impairments. The Company amortizes its intangible assets that have finite lives using either the straight-line method, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be utilized. Amortization is recorded over the estimated useful lives ranging from <ix:nonNumeric contextRef="i26ac442ab8104d62a507939b10fa969a_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzExNDMw_4c6a647f-4455-47b7-9da7-642cb6bbd108">2</ix:nonNumeric> to <ix:nonNumeric contextRef="i8c09129ca98843beadfd374cfab77639_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzExNDM2_04a5590d-c475-4929-8a35-4f20ca7842d0">30</ix:nonNumeric> years. The Company evaluates the recoverability of its definite lived intangible assets whenever events or changes in circumstances or business conditions indicate that the carrying value of these assets may not be recoverable based on expectations of future undiscounted cash flows for each asset group. If the carrying value of an asset or asset group exceeds its undiscounted cash flows, the Company estimates the fair value of the assets, generally utilizing a discounted cash flow analysis based on the present value of estimated future cash flows to be generated by the assets using a risk-adjusted discount rate. To estimate the fair value of the assets, the Company uses market participant assumptions pursuant to ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite lived intangible assets, such as IPR&amp;D assets, are required to be tested for impairment annually, or more frequently if indicators of impairment are present. The Company&#8217;s annual impairment test date is as of the first day of its fourth quarter. </span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njc3_a9f2c71d-c0d2-4076-81b7-9ccae05a6c0d" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:36.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.757%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957c4bc90df349dc9fad1b82c2de15a1_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzMtMi0xLTEtMA_9d307a62-4a4f-463e-9210-29c2e2255511">4,054.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957c4bc90df349dc9fad1b82c2de15a1_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzMtNC0xLTEtMA_f9d8d4e0-de49-47c3-83c5-5a38b7fa6b61">2,907.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12c940cf715b419190f1afe48785d4c8_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzMtNi0xLTEtMA_9e650723-54bb-4ac5-8601-e7d0ba596b77">3,927.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12c940cf715b419190f1afe48785d4c8_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzMtOC0xLTEtMA_ddd31ad5-5441-421a-afca-58d19fa520d3">2,654.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d996d37cd674a338e18e859a3513b71_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzUtMi0xLTEtMA_ce7d9e61-2a24-4036-a25f-6b58d9fd4874">549.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d996d37cd674a338e18e859a3513b71_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzUtNC0xLTEtMA_f1608dd8-ab97-40e4-a8b5-1ae170ab2d9d">477.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07c8b5f4261041a985e22dbcc3ec25a6_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzUtNi0xLTEtMA_90457e4b-b25c-4763-b759-d6fae7f0739b">525.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07c8b5f4261041a985e22dbcc3ec25a6_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzUtOC0xLTEtMA_6ef9a7fd-7f75-46fc-917a-5dc382c63eb1">447.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0f493e80c8407b9a276a3459c6e266_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzYtMi0xLTEtMA_1a2b0447-b5d8-406c-8416-940e446dbacf">245.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0f493e80c8407b9a276a3459c6e266_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzYtNC0xLTEtMA_e1f41fc7-6b4c-4b70-b1c3-431f47ac4e29">181.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i860ddac9336c4aa397d8f6b67401b31c_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzYtNi0xLTEtMA_ba3114fb-9cdd-4bd6-8aa8-4fda84043f31">245.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i860ddac9336c4aa397d8f6b67401b31c_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzYtOC0xLTEtMA_ecb1190f-c430-49e1-8a85-fc1b2060eaed">171.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68050ea428a94c1688589a99714f38cc_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzctMi0xLTEtMA_b8147519-349f-4cb4-86fb-bc67c226cd25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68050ea428a94c1688589a99714f38cc_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzctNC0xLTEtMA_b09ce222-f63b-40ed-be77-ca9b6904a4a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2a5caec8822438c887854c7fefc3007_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzctNi0xLTEtMA_16f68d57-80dd-4aad-b04e-6f887eb47d95">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2a5caec8822438c887854c7fefc3007_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzctOC0xLTEtMA_3bcee761-7dbb-4103-bd14-0b7d7dd0f0cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie69340311e9a4b308c4862870d12638e_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzgtMi0xLTEtMA_913c7673-2001-406e-bedb-c7e3bb52c7f0">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie69340311e9a4b308c4862870d12638e_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzgtNC0xLTEtMA_a245bdd0-c1a3-4337-b73f-bf5906feb514">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f074670baa4f1d934cf4b17758e8d5_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzgtNi0xLTEtMA_67773541-d8ab-41a1-8757-b86902f26f98">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f074670baa4f1d934cf4b17758e8d5_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzgtOC0xLTEtMA_f0926627-b1ae-40f5-bd38-587138292f62">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6a066f4761243508c40140e40ef6af9_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzktMi0xLTEtMA_168b3559-013e-4685-8d7d-755935c4019f">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6a066f4761243508c40140e40ef6af9_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzktNC0xLTEtMA_99749144-08f7-47d6-a736-3c1d6f8eee3e">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302abd2449094a9093740c9423c08c05_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzktNi0xLTEtMA_f574dcdd-a505-4862-bf32-63332c8f5c7e">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302abd2449094a9093740c9423c08c05_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzktOC0xLTEtMA_5770bc06-908b-498b-bcfb-1492f4635e3e">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04d58cdf3b9742bab6c632b1c6bde482_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEwLTItMS0xLTA_39a03372-8441-4102-bf5b-cc2f432fcc21">4,852.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04d58cdf3b9742bab6c632b1c6bde482_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEwLTQtMS0xLTA_074cc1f4-21d8-4cb3-ab6f-6f4621e9ed17">3,569.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58479218662d4362a06891b6d76a89ee_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEwLTYtMS0xLTA_d42c61c0-427d-4847-b7c9-447e44f520f2">4,704.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58479218662d4362a06891b6d76a89ee_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEwLTgtMS0xLTA_d6d914cd-61a9-425b-8664-647962b61ff9">3,276.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0db0cb781464d528ec7ee04920ecb28_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEyLTItMS0xLTA_99c2a05c-4288-4fb0-bd3a-1c0fe3aacdec">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0db0cb781464d528ec7ee04920ecb28_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEyLTQtMS0xLTA_672eedcb-1cf1-4c27-adda-c95b212200c3">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f4cbe1c0914b04bceeebc3cbe0bb61_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEyLTYtMS0xLTA_7f0c8d3f-1f32-46fb-8fe1-cc37e5d4814e">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f4cbe1c0914b04bceeebc3cbe0bb61_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEyLTgtMS0xLTA_e839812b-1b0f-415b-914f-6772137d4d5e">43.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea670c4c01544dafa2cba9693bceb1e2_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEzLTItMS0xLTA_3dcbfec3-6a25-459c-9d70-b4c06feb49a4">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea670c4c01544dafa2cba9693bceb1e2_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEzLTQtMS0xLTA_f634697d-46d0-46d1-aca1-1abcfedbd16f">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f5a289dcef4642b1a31621e515e16e_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEzLTYtMS0xLTA_995ffce8-f76b-427f-b4c7-256c7ede4aa7">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f5a289dcef4642b1a31621e515e16e_I20190928" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEzLTgtMS0xLTA_f9869d0c-72cc-4807-a290-c4101f22685b">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzE0LTItMS0xLTA_26ab215d-a63a-4289-8c66-f60875a7ed37">4,931.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzE0LTQtMS0xLTA_cb026e46-c3d0-46d0-a5c0-e4c329e7b548">3,623.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzE0LTYtMS0xLTA_3c821e25-108a-4f45-847f-bc2f428441e3">4,786.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzE0LTgtMS0xLTA_4bfa9096-e245-4323-b710-a4cca92b04f1">3,326.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Aesthetics Impairment</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, the Company's Medical Aesthetics business met the criteria to be designated as assets held-for-sale. As a result, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i16c34f677a2d4f08b3c7c62af376754c_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4ODc_35ea27e4-a0d3-4fa2-8be5-090fa6d5286f">30.2</ix:nonFraction>&#160;million charge to record the asset group at fair value less costs to sell. In addition, developed technology, customer lists, trade names, and distribution agreement related to Medical Aesthetics of $<ix:nonFraction unitRef="usd" contextRef="ic47589113cf749b8b8b586c11fd7976e_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4NzI_3376bfce-d3c8-4933-94bf-a5bd402cb51b">24.1</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i61c55e342da24eee9282df815b492d78_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4MzA_33ebc8db-ac02-48bc-a5e1-eafc619eef6d">0.9</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i51211784b29941399cb1944d9f011a2a_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4NDQ_d0b6662f-961c-4f37-ac9c-e6b4f42c0011">2.0</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i89813ed8f2ea44b085d80d8ab6c4fc94_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4NTg_98ebec6f-118f-4e19-bad4-494be0f78e46">1.2</ix:nonFraction>&#160;million, respectively, were reclassified accordingly in the Company's Consolidated Balance Sheet to assets held-for-sale as of December 28, 2019 and subsequently disposed of in the second quarter of fiscal 2020. See Note 15 for additional information.</span></div></ix:continuation><div style="text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i8a01c5b944594298a2d73201290fb06d" continuedAt="i1ee84c3c1cef45d8a66cc0560c3af06f"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company identified indicators of impairment for its Medical Aesthetics reporting unit as a result of reductions in forecasts during the year, and in connection with the Company&#8217;s efforts to sell the business that began prior to the end of fiscal 2019. In performing the undiscounted cash flow analysis pursuant to ASC 360, the expected undiscounted cash flows of the asset group were determined using a probability-weighted approach taking into consideration the planned disposition, which was deemed to be highly probable as of the balance sheet date. Based on this analysis, the undiscounted cash flows were not sufficient to recover the carrying value of the asset group. As a result, the Company was required to perform Step 3 of the impairment test and determine the fair value of the asset group. The Company executed a definitive agreement on November 20, 2019 to sell the business. Although this agreement was signed subsequent to the balance sheet date, the Company concluded that it provided evidence regarding the estimate of fair value of the asset group at September 28, 2019 and that there were no events that occurred between September 28, 2019 and the date the Company entered into the definitive agreement that would significantly affect the fair value of the asset group. As a result, the Company recorded total impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="5" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTAyNDU_97856844-08bd-4cc8-98f1-a25bdff0ac4b">685.4</ix:nonFraction>&#160;million in fiscal 2019. The impairment charge was allocated to the long-lived assets as follows: $<ix:nonFraction unitRef="usd" contextRef="i41cbe32e1f1041339f89ddea6ec9c266_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MDE2_3542bdb3-ca4d-4cf4-ab00-376cd2a8a196">576.9</ix:nonFraction> million to developed technology, $<ix:nonFraction unitRef="usd" contextRef="i744c7283185f454f92fabd0f80a0ef92_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MDQ0_b1909a98-3253-4a02-b056-38e014a544bd">22.4</ix:nonFraction> million to customer relationships, $<ix:nonFraction unitRef="usd" contextRef="ie578122249b043b0bdb831bf79737e98_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MDc0_21d7043b-cc42-41f9-a9fd-49c344f6b5c6">48.6</ix:nonFraction> million to trade names, $<ix:nonFraction unitRef="usd" contextRef="i5dd76668352442978fe04a0c59a5c795_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MDkz_b124e784-0a7f-4349-b12e-3b6c3569c297">27.7</ix:nonFraction> million to distribution agreements and $<ix:nonFraction unitRef="usd" contextRef="i6223b3508b8c463aa3289a1a509edccc_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MTI3_4d05e922-648c-4d5f-a41d-b96d58d3c50c">9.8</ix:nonFraction> million to equipment. On November 20, 2019, this asset group met the assets held-for-sale criteria and was recorded at fair value less the costs to sell as noted above. See Note 15. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2018, the Company abandoned an in-process research and development project acquired in the Cynosure acquisition and recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i1bfbe4fe947c43a4a22bb3f6c17cb1cd_D20171231-20180331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTAyNjI_2f748af3-de56-4777-95e8-dea3e1a764f6">46.0</ix:nonFraction>&#160;million. The Company abandoned the project as a result of unsuccessful clinical results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Activity</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2020, the Company acquired Acessa Health, Inc. and recorded $<ix:nonFraction unitRef="usd" contextRef="iae131a61f51b418f8d16b147c4f2e986_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTAzMzE_1f70f375-723a-4229-920e-2abf7cf5b26d">127.0</ix:nonFraction>&#160;million of developed technology and $<ix:nonFraction unitRef="usd" contextRef="i6724b08a2857420f938843bdf83228a2_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTAzNDc_c941cdb1-e42a-4f28-986a-801532d590e2">1.2</ix:nonFraction>&#160;million of trade names based on its preliminary purchase accounting. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2019, the Company acquired Focal Therapeutics, Inc. and recorded $<ix:nonFraction unitRef="usd" contextRef="i52f401bcab374c9da21ba458593af4a7_I20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE1MzMx_f9b014a5-e833-4d23-9c73-0e0993043d2a">83.1</ix:nonFraction> million of developed technology, $<ix:nonFraction unitRef="usd" contextRef="i58ab6ed21a0e49acb17f46bb533a208d_I20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE1MzU5_9f3e75ad-c64a-4875-bb82-677c4daf1992">11.4</ix:nonFraction> million of in-process research and development and $<ix:nonFraction unitRef="usd" contextRef="i72959050a334423eb15ca612ed289237_I20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE1NDA1_76248fee-238f-441c-a1bf-c6b67b464831">2.7</ix:nonFraction> million of trade names. In the fourth quarter of fiscal 2019, the Company obtained FDA approval for the in-process research and development project and reclassified this value to developed technology. During fiscal 2019, the two in-process research and development projects acquired in the Faxitron acquisition aggregating $<ix:nonFraction unitRef="usd" contextRef="ie4eb2eab1b56414c8fbb0c756bf25fdd_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="holx:Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE1NzIz_dd1fe849-0d3c-4ff7-8ef7-ae4dd68abfba">5.5</ix:nonFraction> million were completed and reclassified to developed technology.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to developed technology is classified as cost of product revenues&#8212;amortization of intangible assets. Amortization expense related to customer relationships, contracts, trade names, distribution agreements, and business licenses is classified as a component of amortization of intangible assets within operating expenses.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjYx_1746a93c-ff02-4503-9395-08be6948e129" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amortization expense at September&#160;26, 2020 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzAtMS0xLTEtMA_9dcb013e-e3c5-4137-bb16-ab1437a0c8ba">283.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzEtMS0xLTEtMA_695ffb92-eac6-4654-9039-a1fa5eb852eb">273.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzItMS0xLTEtMA_37c3bade-7cfc-4742-8f1d-610a2372eb9b">176.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzMtMS0xLTEtMA_837a0ed5-c8d2-4afb-bab3-63077fc19463">164.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzQtMS0xLTEtMA_1c1636a2-0ac4-4e68-b773-67359dcc6f85">151.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 350), the Company tests goodwill for impairment annually at the reporting unit level and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying value. Events that could indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate, operational performance of the business or key personnel, and an adverse action or assessment by a regulator. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the impairment test, the Company utilizes the single-step approach prescribed under Accounting Standards Update No. 2017-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2017-04) . This approach requires a comparison of the carrying value of each reporting unit to its estimated fair value and to the extent the carrying value exceeds the fair value a charge is recorded up to the amount of goodwill in the reporting unit. To estimate the fair value of its reporting units, the Company primarily utilizes the income approach. The income approach is based on a DCF analysis and calculates the fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting the after-tax cash flows to present value using a risk-adjusted discount rate. Assumptions used in the DCF require significant judgment, including judgment about appropriate discount rates and terminal values, growth rates, and the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i1ee84c3c1cef45d8a66cc0560c3af06f" continuedAt="i5a1196feb6f843dd9ac333685c92c6ec"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount and timing of expected future cash flows. The forecasted cash flows are based on the Company&#8217;s most recent budget and strategic plan and for years beyond this period, the Company&#8217;s estimates are based on assumed growth rates expected as of the measurement date. The Company believes its assumptions are consistent with the plans and estimates used to manage the underlying businesses. The discount rates used are intended to reflect the risks inherent in future cash flow projections and are based on estimates of the weighted-average cost of capital (&#8220;WACC&#8221;) of market participants relative to each respective reporting unit. The market approach considers comparable market data based on multiples of revenue or earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) and is primarily used as a corroborative analysis to the results of the DCF analysis. The Company believes its assumptions used to determine the fair value of its reporting units are reasonable. If different assumptions were used, particularly with respect to forecasted cash flows, terminal values, WACCs, or market multiples, different estimates of fair value may result and there could be the potential that an impairment charge could result. Actual operating results and the related cash flows of the reporting units could differ from the estimated operating results and related cash flows.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducted its fiscal 2020 impairment test for its reporting units on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of June 28, 2020, and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of the Company's reporting units had fair values exceeding their carrying values. For illustrative purposes, had the fair value of each of the reporting units been lower by 10%, all of the reporting units would still have passed the goodwill impairment test.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;26, 2020, the Company believes that its reporting units, with goodwill aggregating $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-6" format="ixt:numdotdecimal" name="holx:GoodwillNotAtRiskOfFailingImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY2OTM2NDk_70d2ba8e-931c-4462-ac4d-20521bd18380">2.6</ix:nonFraction>&#160;billion, were not at risk of failing the goodwill impairment test based on its current forecasts and qualitative assessment.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, the Company used the qualitative approach as of June 29, 2019 to assess its goodwill for impairment. Under this approach the Company considered a number of factors, including the amount by which the previous quantitative test's fair value exceeded the carrying value of the reporting units, the forecasts in the Company's strategic plan compared to the forecast used in the previous quantitative test, an evaluation of discount rates, long-term growth rates including the terminal year rate, if tax rates would have significantly changed, an evaluation of current economic factors for both the worldwide economy and specifically the medical device industry, and any significant changes in customer and supplier relationships. The Company weighed these factors to determine if it was more likely than not that the fair value of the reporting unit exceeded its carrying value. If after performing a qualitative assessment, indicators are present, or the Company identified factors that cause it to believe it is appropriate to perform a more precise calculation of fair value, the Company would have moved beyond the qualitative assessment and perform a quantitative impairment test. As a result of completing the qualitative assessment for each of its reporting units for fiscal 2019, the Company concluded that it was more likely than not that the fair value of each reporting exceeded its carrying value by a significant amount and a quantitative test was unnecessary.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2018, in connection with commencing its company-wide annual budgeting and strategic planning process, evaluating its current operating performance of its Medical Aesthetics reporting unit, and abandoning an in-process research and development project, the Company reduced its short term and long term revenue and operating income forecasts and determined that indicators of impairment existed in its Medical Aesthetics reporting unit. The Medical Aesthetics reporting unit was solely comprised of the Cynosure business, which the Company acquired on March 22, 2017. The updated forecast reflected significantly reduced volume and market penetration projections resulting in lower short-term and long-term profitability than expected at the time of the Cynosure acquisition. As a result of those events and circumstances at that time, the Company determined that it was more likely than not that this change would reduce the fair value of the reporting unit below its carrying amount. To estimate the fair value of the reporting unit, the Company utilized the DCF analysis. The forecasted cash flows were based on the Company's most recent budget and strategic plan and for period beyond the strategic plan, the Company's estimates were based on assumed growth rates expected as of the measurement date. The Company believed its assumptions were consistent with the plans and estimates used to manage the underlying business. The discount rate used is intended to reflect the risks inherent in future cash flow projections and was based on an estimate of the weighted average cost of capital (WACC) of market participants relative to the reporting unit. The basis of fair value for Medical Aesthetics assumed the reporting unit would be purchased or sold in a non-taxable transaction, and the discount rate of 12.0% applied to the after-tax cash flows was consistent with that used in the purchase accounting performed in fiscal 2017. As a result of this analysis, the fair value of the Medical Aesthetic reporting unit was significantly below its carrying value, and the Company recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ic5548619644d4005832478fe4f7a75d0_D20171231-20180331" decimals="5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzExNTQ0ODcyMjExNTIx_778c0ef2-0340-4ff6-a969-55f811e56a5c">685.7</ix:nonFraction> million during the second quarter of fiscal 2018.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the goodwill impairment test in the second quarter of fiscal 2018, the Company also performed an impairment test of this reporting unit&#8217;s long-lived assets. This impairment evaluation was based on expectations of future undiscounted cash flows compared to the carrying value of the long-lived assets. The Company&#8217;s cash flow estimates were consistent with those used in the goodwill impairment test discussed above. Based on this analysis, the undiscounted cash flows </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i5a1196feb6f843dd9ac333685c92c6ec" continuedAt="i10168ad93444420488e630842a31d634"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Medical Aesthetics long-lived assets were in excess of their carrying value and thus deemed to not be impaired. The Company believed its procedures for estimating future cash flows were reasonable and consistent with market conditions at the time of estimation.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducted its 2018 impairment test on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of July 1, 2018 and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. As a result of completing Step 1, all of the Company's reporting units had fair values exceeding their carrying values, and as such, Step 2 of the impairment test was not required. </span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:ScheduleOfGoodwillBySegmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzMy_dd9e2d07-8f20-4ced-8fbf-8214cd1db5e0" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of goodwill activity by reportable segment from September&#160;28, 2019 to September&#160;26, 2020 is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"><tr><td style="width:1.0pt"></td><td style="width:130.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:57.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:57.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Breast&#160;Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GYN&#160;Surgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skeletal&#160;Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 28, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169afb67581f4042a9907e319c8aaee1_I20190928" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtMS0xLTEtMA_94ef120c-3016-476d-8834-4fb7b18fe28e">819.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b9b859e952c4dc086ae9de8f3020603_I20190928" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtMy0xLTEtMA_a0bdb88c-a20b-40b7-a545-eed06380c886">722.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i294e83c0d77f4a76b4cb43739eaeaf9f_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtNy0xLTEtMA_d6127b05-8b88-4eb7-9968-25d22c72659c">1,014.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bea17c720745bbbe2f47855b322570_I20190928" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtOS0xLTEtMA_6ebec40f-84b2-475c-9714-aa5be206f22d">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtMTEtMS0xLTA_d9a355a0-ac7e-47b0-9b0a-d440e307ff5f">2,563.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc3eeb5d8a7429f994641e93253a6bd_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtMS0xLTEtMA_efa66b41-e56d-4f06-8853-6c2a94063c2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69dbc69319c941ca9448d21361773988_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtMy0xLTEtMA_9f2fcd29-c428-4f20-b73f-ef81cd269bcc">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e140addb4a24ea78dd4c7f462c399ba_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtNy0xLTEtMA_ca99672e-79e0-482b-884e-2f48e01b21ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ce5d4500f64edfa02758b406d21f90_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtOS0xLTEtMA_677b8d6f-6171-456b-b4d3-97c966c5f0ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7876712181a4f0394252851c3247e89_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtMTEtMS0xLTA_9fc1d1ce-045a-4ae0-b459-7bb3a6c6e2e8">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Beacons acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988d23f94723457db513c5aa1234acc7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtMS0xLTEtMA_c963b01c-76d0-4705-b00d-71517b881f34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b49a0c00624209ae298e13d31a8705_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtMy0xLTEtMA_b344fdb1-d81d-4614-ba6b-6f2a361483b4">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib231ff2385b64b9ca2bb871bcfec1dc3_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtNy0xLTEtMA_3a858b86-974d-4653-93af-98f10067eb3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0c977d98c5446ca36e0ca5d209a7e5_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtOS0xLTEtMA_1884fac6-7ab7-4d94-ae2e-09a6f2cd0600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5aea5a6dce4ff3a0ea7a9f0a6e7e04_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtMTEtMS0xLTA_f646a7fa-f9e7-466a-baf0-6fa48cee5b16">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acessa Health acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34dc1d8ed3e448048896ea6acd36bec6_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMS0xLTEtMTQ3MTg_20de3eef-1b86-4bd8-8aca-c370aba7481e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8e80b3d02048368499f2fc987b666c_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMy0xLTEtMTQ3NTM_06bb252e-20c2-4d24-85a3-18c8c9c711d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8c69c195a394e1abb1f0343c9c25508_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctNS0xLTEtMzc4Mg_f9033519-1466-4d0e-84a0-386f156a80ac">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e0c7ded43e4ffc9af56c596610e242_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctNy0xLTEtMTQ3NzA_9e8ac672-cb24-4894-9608-e946934a6b59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339a5d0289c34c65ac5ba8480d1803a2_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctOS0xLTEtMTQ3MTY_4153d2bc-f30a-4f92-a2a0-386174a87e85">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMS0xLTEtMA_d4e664f9-f6e2-4a82-a4a4-5f0e89266a5d">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMy0xLTEtMA_58e03e6a-ff24-4418-9bde-e7ff0a3f90a6">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctNy0xLTEtMA_c919531f-fa88-474a-b026-83dfebda0826">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctOS0xLTEtMA_15ac2ab2-dd63-4dd2-ba2e-55bbedf2a0a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMTEtMS0xLTA_914a26c5-151c-4800-ae5b-2f4e32f5dbb6">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437292e8142d4d96839af5869cecaab3_I20200926" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtMS0xLTEtMA_9263b1a5-24ce-4e6e-b139-ffe5bf2e2237">821.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305c6e69d9584df69b07d0c58b68dc88_I20200926" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtMy0xLTEtMA_222e8a0e-9e7d-43d0-bcd2-617e5a554fa5">764.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if85520f01ace43129ad7669c2083f920_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtNy0xLTEtMA_4d6ce615-7993-4fe8-b434-58e474b864ca">1,063.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbb9f4ee2a14c8a8ff8db71fcca17b1_I20200926" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtOS0xLTEtMA_7abd1a57-f3f7-48f5-bf01-9d7b5372bb5d">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtMTEtMS0xLTA_c7b0bfc4-64f2-46e0-8b70-f83463d043f8">2,657.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:OtherAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjA1_698f571e-f2fe-4ff9-bc14-b48c71cc288c" continuedAt="i47b475d3b2c345148498ab8430956602" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5ODAz_efba5c93-66cb-420b-864e-27ea70d8390f" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"><tr><td style="width:1.0%"></td><td style="width:40.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.866%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" name="us-gaap:IncomeTaxReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzMtMi0xLTEtNjM3OQ_c5cb73c8-a7f6-449d-ade7-928d9161c3a4">325.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeTaxReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzMtNC0xLTEtNjM3OQ_81429a0b-5be3-4040-be1e-154521527599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzQtMi0xLTEtMTA2NzA_3eed18a0-06c0-4c76-b2fd-797ceaad6306">80.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-6" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzQtNC0xLTEtMTA2NzA_7b2a90b1-9888-4db2-85da-319241bc32a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzMtMi0xLTEtMA_a4ef45de-76a3-4d98-957e-5a9de1753ff9">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzMtNC0xLTEtMA_ac018c63-87f9-48f6-bb17-40ec39c89555">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzQtMi0xLTEtMA_8008d5b7-6699-4a49-8d73-e0726f4ede77">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzQtNC0xLTEtMA_d0ce4f92-f3f0-41fd-b227-7b0368d4a575">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-method equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="holx:CostMethodEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzgtMi0xLTEtMA_438a250f-0d63-40fb-9d72-1cc07215428d">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="holx:CostMethodEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzgtNC0xLTEtMA_1ff315d7-8126-4c8e-9722-4cb4190b87eb">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-method investment and loans to SSI (Note 5)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:zerodash" name="holx:EquityMethodInvestmentAndLoansToAcquiree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzEwLTItMS0xLTA_edff48cb-a163-4d28-b86a-8bd8241b4de6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="holx:EquityMethodInvestmentAndLoansToAcquiree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzEwLTQtMS0xLTA_6be54ee8-95d7-4d4c-8cf6-17d00db80666">42.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OtherAssetsMiscellaneous" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzExLTItMS0xLTA_8898d472-2b3c-4b36-bc96-dc6a94b26945">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:OtherAssetsMiscellaneous" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzExLTQtMS0xLTA_5b592866-97f2-4f10-9073-ddc6bfabe24a">38.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzEyLTItMS0xLTA_5c0c8ef2-a1d6-420f-96d0-28151913df3e">516.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzEyLTQtMS0xLTA_be0fcc8f-98e7-498c-9a83-e993696c1f9c">154.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt;text-indent:24.75pt"><ix:continuation id="i47b475d3b2c345148498ab8430956602" continuedAt="i2a1ae0d587c147bbbdc5d563651a0c2a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax receivable primarily relates to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. The right of use assets were recorded in connection with the adoption of ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2a1ae0d587c147bbbdc5d563651a0c2a">, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#8217;s Nonqualified Deferred Compensation Plan (&#8220;DCP&#8221;) and are recorded at their cash surrender value (see Note 12 for further discussion).</ix:continuation> </span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTk4_766e3fce-af38-4c2c-a354-503d9a23aa7a" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Software Development Costs</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred for the research and development of the Company&#8217;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the development costs of software embedded in the Company&#8217;s products in accordance with ASC 985, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#8217;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimate useful life and recorded within cost of revenues - product.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i10168ad93444420488e630842a31d634" continuedAt="i5edbd9657c5442d8bfef04327d040199"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njgw_4c733847-747d-4e01-9bf8-b5e700e072f7" continuedAt="i2d621510854e4c60a1c1d1281d14db78" escape="true">Foreign Currency Translation</ix:nonNumeric></span></div><div style="margin-top:5pt;text-indent:24.75pt"><ix:continuation id="i2d621510854e4c60a1c1d1281d14db78" continuedAt="i487ffdbe01b14e4b89f06f0dc6ea0f35"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries are translated in accordance with ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i487ffdbe01b14e4b89f06f0dc6ea0f35"> The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#8217;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income, net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss) as a separate component of stockholders&#8217; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income, net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented.</ix:continuation> </span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njg0_f66c535c-89cc-4d28-a409-2b088ca3e6d9" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (loss)</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#8217; equity. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njcy_e11642a4-1206-4348-bf8f-1c3e02b20414" continuedAt="i181d508c43504264822ec3aba7a7b88a" escape="true">The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:11pt"><ix:continuation id="i181d508c43504264822ec3aba7a7b88a"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMS0xLTEtMA_00fd5d78-bb29-404e-a15a-4cc8a12abc19">41.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMy0xLTEtMA_76aade2f-7881-4d59-bc74-23874ba9ca3f">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItNS0xLTEtMA_3f738773-518d-4f12-a0f2-4dd316124dfc">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1f1b09ac83442a8c991f025f87c36c_I20190928" decimals="-5" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItNy0xLTEtMA_3b50972a-d54b-413e-b46d-7968da5e8be5">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItOS0xLTEtMA_48a7effa-b3a6-4aa5-aa23-301d7f22e611">42.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTEtMS0xLTA_f27c2cf4-e1e6-48d2-99b7-cd973cbfc966">26.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTUtMS0xLTA_a7894b13-e1db-4d24-8c3d-ed836572e860">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTctMS0xLTA_cb5328c5-c01f-4006-b971-3f31680fe7c7">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc353efac2f474997f4ab38d4cd03dd_I20180929" decimals="-5" format="ixt:zerodash" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTctMS0xLTE2MzM_1bd3369e-48bc-4227-9118-32f43dd62ba2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTktMS0xLTA_d4b22199-b1f0-45e0-9bda-beffa5d9ea97">25.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMS0xLTEtMA_8c1f1f14-6398-4d73-9417-eef1204ff837">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMy0xLTEtMA_a7e1c2d6-056d-4a93-b97e-a3148c246524">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtNS0xLTEtMA_656db8bb-7d36-4434-86a3-45b4701d7383">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtNy0xLTEtMA_3c9b33a2-c588-4874-b9b6-384c4c09e44f">27.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtOS0xLTEtMA_fcdc0599-22dc-4651-948e-ab64d96f4e1f">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTEtMS0xLTA_52ea2e19-782b-48cd-995a-bba378ec0912">14.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTUtMS0xLTA_c646e732-de41-45a6-8cb6-480a7ac1e898">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTctMS0xLTA_2d5bac23-21ad-4247-9d98-3f72294f9650">8.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTctMS0xLTE2MzM_8c19d91d-013f-46b3-884b-9c4ba62000b5">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTktMS0xLTA_229a529c-82f9-42fe-b46e-bddc801704f6">19.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charges (gains) reclassified to statement of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9b833795a14c34b98fd573a5bb02aa_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMS0xLTEtMA_459d2ea0-f630-4ae9-bae3-4f8d91f73ef8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2febf310c33479bb7213e376d43d131_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMy0xLTEtMA_abedd080-aaa7-4735-8d22-337c9f47015d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice34049f21724d2a89b07c75c6bfe1a0_D20190929-20200926" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtNS0xLTEtMA_2700e7b2-942a-4996-a398-c2762c26880e">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtNy0xLTEtMA_b3e3f32d-d81c-4c8d-8a0d-5d423d50fc08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtOS0xLTEtMA_a5bed582-675a-4003-83da-001e41fed4ab">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d2d76048144084a688883b4c23ca74_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTEtMS0xLTA_0224c034-3984-4dd5-80a6-21835ece4f08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fd9cd9c1a44756877deaf8449c4ce5_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTUtMS0xLTA_bd32e007-dcde-454b-ac51-ed8d1325c208">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8acf153e8175463d854199e3d5b100f5_D20180930-20190928" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTctMS0xLTA_746d9814-15c3-4a1b-afa0-4341db9dace8">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTctMS0xLTE2MzM_8e6fecd8-32c3-4e35-ad59-035525b30c13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTktMS0xLTA_056053d3-1492-4b1e-8a75-5ae44c6f6daa">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMS0xLTEtMA_6e861a66-d2a9-4506-af5a-c3c0716d4972">22.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMy0xLTEtMA_1ebe4a7e-e861-4d3c-bb05-914f164be6ff">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtNS0xLTEtMA_20bdb955-88c5-4378-aeca-edf2a9a1d94d">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd3354045a94ad6bc4f7dec67555173_I20200926" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtNy0xLTEtMA_207120d4-6c7f-4aeb-abb5-3801df75d712">24.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtOS0xLTEtMA_3ae5fbfe-b543-464d-b7d8-768272ed5b3a">49.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTEtMS0xLTA_00fd5d78-bb29-404e-a15a-4cc8a12abc19">41.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTUtMS0xLTA_76aade2f-7881-4d59-bc74-23874ba9ca3f">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTctMS0xLTA_3f738773-518d-4f12-a0f2-4dd316124dfc">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1f1b09ac83442a8c991f025f87c36c_I20190928" decimals="-5" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTctMS0xLTE1NjAx_70bf248e-1a89-429b-bf59-ef052660dc7c">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTktMS0xLTA_c08ae597-e91b-4f24-a69c-0aa36da78526">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzMz_95d1b4bf-fbac-4d57-9351-b148c04547b2" continuedAt="ieb453329e58544f6b2327e8c3fe3b768" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income, net in the Consolidated Statements of Operations.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $<ix:nonFraction unitRef="usd" contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MzAxMzc_e4a7383b-f280-47e4-9f85-1a839371065c">3.7</ix:nonFraction>&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5 million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i5edbd9657c5442d8bfef04327d040199" continuedAt="i83c7afdc4424446584b69637ac459815"><ix:continuation id="ieb453329e58544f6b2327e8c3fe3b768" continuedAt="ie046e2bb6f754f8eab94f4d6ecdc203d"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments on $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-8" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMwNjQ2_439569f4-7159-49bb-beef-a29080a48d81">1.0</ix:nonFraction> billion of principal, which ended on December 27, 2019 for the contracts entered into in fiscal 2018, and which will end on December 23, 2020 for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;26, 2020, the Company determined that the existence of hedge ineffectiveness, if any, was immaterial and all changes in the fair value of the interest rate caps were recorded within AOCI.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, 2019 and 2018, interest expense of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxMDkx_b7bde9f1-14a1-4d85-8155-83df7e8183b9">2.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxMDk1_cd8f3055-3e21-493f-8873-4fa841194ed4">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxMTAy_3abf9564-b313-4ed0-a26a-7ab57f6149d4">3.6</ix:nonFraction> million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The Company expects to similarly reclassify approximately $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxMzA1_949303cb-6a4a-4143-aea3-386a050871a8">0.5</ix:nonFraction> million from AOCI to the Consolidated Statements of Operations in the next twelve months.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of these interest rate caps was $<ix:nonFraction unitRef="usd" contextRef="iaa82070dc0674b2b93dfb59c5365695c_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxNDQ3_108d54e5-4642-40bc-b96c-ceeb77cc79fb">0.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic3eb72f6ddde4172af624dbe36bc89d5_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxNDU0_f46bad8a-fd01-40ec-9576-d8a44ff748b8">0.1</ix:nonFraction> million at September&#160;26, 2020 and September&#160;28, 2019, respectively, and is included in both Prepaid expenses and other current assets and Other assets on the Company&#8217;s Consolidated Balance Sheet. Refer to Note 8 &#8220;Fair Value Measurements&#8221; for related fair value disclosures.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxOTk1_c5c2356e-41cb-4029-95b3-e257bb4d7b43">1.0</ix:nonFraction> billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMyMDcw_414dcd87-dcd1-425f-8728-22a2b521c617">1.0</ix:nonFraction> billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-8" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMyNDg0_439569f4-7159-49bb-beef-a29080a48d81">1.0</ix:nonFraction> billion of principal. Therefore, changes in the fair value of the swap are recorded in accumulated other comprehensive income (loss) and were a loss, net of taxes, of $<ix:nonFraction unitRef="usd" contextRef="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTA0NTM_45daf7e9-0d29-4335-8ac6-64733f42c7d4">27.6</ix:nonFraction>&#160;million and a gain, net of taxes, of $<ix:nonFraction unitRef="usd" contextRef="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTA0Njg_a6a7aa74-ddbe-4529-83a8-fc8a512c2401">3.5</ix:nonFraction>&#160;million for the years ended September 26, 2020 and September 28, 2019, respectively. The fair value of this derivative was in a liability position of $<ix:nonFraction unitRef="usd" contextRef="i2dd3354045a94ad6bc4f7dec67555173_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMyNjUw_49dac984-1ed6-4e47-b337-8c273bc152ce">31.2</ix:nonFraction> million as of September 26, 2020.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of <ix:nonNumeric contextRef="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926" format="ixt-sec:durwordsen" name="us-gaap:DerivativeTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzkzNDU4NDkwNTc3Mzg_d37581b2-a456-496d-a9b1-5278d9187a18">one year</ix:nonNumeric> or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzkzNDU4NDkwNTc3MjY_9043de89-e227-43c2-bd2d-2f51027435c4" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28. 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29. 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzMtMS0xLTEtNjQ0MA_26050f93-5a97-43fb-bcbe-3a78f76fc015">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4a7fbf31ef34d35a542b3139d2d97b4_D20180930-20190928" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzMtMy0xLTEtMTg5MTY_81d494ad-218d-492f-b117-db4bad64e7a5">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61680decf3094210970e74b87feb098a_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzMtNS0xLTEtMTg5MTY_91cfc2d8-7cd0-4277-9232-7456812c1076">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21e0c51c686947c9a4167c8b13e37d11_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzQtMS0xLTEtMTg5MTY_7118a653-687b-47f6-90b4-5b6ac2d31a72">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a6303307844b9ebc5be9434c2819ad_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzQtMy0xLTEtMTg5MTY_fe570e1a-e4a6-443a-b309-395c72877c02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21e889f681c47ca83ea648b1fe24ff2_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzQtNS0xLTEtMTg5MTY_9a75e565-471f-4742-af61-54dac9e99386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzUtMS0xLTEtMTg5MTY_b5fd1cab-d7a6-4785-8ed5-44b1663eeb82">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzUtMy0xLTEtMTg5MTY_2ee4a371-d418-4fe3-abc3-d37f8269f461">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzUtNS0xLTEtMTg5MTY_b810ac8a-a165-4b05-b8d1-dbacedc233a6">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzgtMS0xLTEtMzU5Mw_abdbc4df-7032-4ac1-9d05-0aa1c58e8865">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4a7fbf31ef34d35a542b3139d2d97b4_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzgtMy0xLTEtMTg5MTY_9493f2fd-3d42-4373-b5b5-8964ebc56afd">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61680decf3094210970e74b87feb098a_D20171001-20180929" decimals="-5" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzgtNS0xLTEtMTg5MTY_c771084b-78ab-4c7c-ad89-48a7f5ca001b">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21e0c51c686947c9a4167c8b13e37d11_D20190929-20200926" decimals="-5" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzktMS0xLTEtMTg5MTY_90a5a184-1c13-4a5d-9a3f-c6f08c4c0d13">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a6303307844b9ebc5be9434c2819ad_D20180930-20190928" decimals="-5" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzktMy0xLTEtMTg5MTY_6710d6e1-04e1-4080-ac67-cf584ad6fc65">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21e889f681c47ca83ea648b1fe24ff2_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzktNS0xLTEtMTg5MTY_66fed802-2e19-425d-adeb-9bd37ebb4942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzEwLTEtMS0xLTE4OTE2_ebe50698-4f8d-4764-946f-82852a4e2843">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzEwLTMtMS0xLTE4OTE2_308f50b6-7cb5-405d-a7a8-9935d2bd400a">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzEwLTUtMS0xLTE4OTE2_064e6846-2feb-4343-a5ea-722d1e210238">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 26, 2020, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM0NjQ0_b47b2b9f-f2d0-4a0a-b4e3-13008ef874e2">172.6</ix:nonFraction> million. As of September 26, 2020, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i2dd3354045a94ad6bc4f7dec67555173_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM0OTI1_93c2cafa-13b1-4c69-b4cb-d75dbabe79b9">380.2</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i83c7afdc4424446584b69637ac459815" continuedAt="i343cd8ad87734c68a5c74fa4cef06649"><ix:continuation id="ie046e2bb6f754f8eab94f4d6ecdc203d"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzQ5_e08b01ab-59ff-4c67-86a6-0cdd0a9f4d10" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:23pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:47.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059452d2deb54b2cb9873ef23f27c960_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzMtMy0xLTEtMA_72bda84f-fcd8-4208-8b1d-37e44c141bcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7aa80690b724dda81b234de06742f9c_I20190928" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzMtNS0xLTEtMA_079f8620-fffe-44b6-a229-e4ccbf2aefc6">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id438b62a9541447d91c50df6ab64b0c1_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzUtMy0xLTEtMA_4a9d55be-e2b4-435c-8141-cbb2c29bc8d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfd4338227d46fc8dfbceb1cff06631_I20190928" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzUtNS0xLTEtMA_491789fa-8d8f-49d8-8d4f-767e8d86d6e5">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzYtMy0xLTEtMA_d0925ab2-bdc5-4f6a-8cc9-f1e2586eaafa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzYtNS0xLTEtMA_e77856b7-0a06-421b-ab49-55f59914d8e2">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d44b346ba2949ff849a666fdf96eb13_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzktMy0xLTEtMA_d92b8996-4941-49fd-ac7d-90c99bf99bcd">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib23d81f77fd54000b2214c1d2555f31c_I20190928" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzktNS0xLTEtMA_38947686-26ed-4e8b-9d79-6d9445b13a89">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0150d6d7caa4efe85607759c805b3e2_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzEwLTMtMS0xLTA_c20a066c-5136-46e6-8176-1bda78ec2784">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic52f7f7067a847028ef4c89e9a861db1_I20190928" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzEwLTUtMS0xLTA_e487f41d-d958-4e50-b55f-1531fe5bfdf4">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica6b881644254b8fae9fbb03c69fdc79_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzExLTMtMS0xLTA_4843438a-84a9-480e-8a82-4634995709b1">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb6934bac52449f8aa6c53b295caf5db_I20190928" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzExLTUtMS0xLTA_b8082365-4d86-4d19-a634-a05361059309">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04f766e5e7f41629fd5954a52f9482d_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE1LTMtMS0xLTExODcx_6869fa84-53fe-48c8-b6d2-33ee96b33f7d">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6599845afc5441e58d23ed545c1c2d90_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE1LTUtMS0xLTExODcz_f2f745d1-2953-4413-ad80-e4fb3df29863">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ca89e21b3c4afa91bf0c9de4dead2b_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE2LTMtMS0xLTExODYy_09fabe9c-a38d-45a5-844b-d0fc50b5a88f">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i304856dff4354c09a218d0c4abcec6b1_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE2LTUtMS0xLTExODY2_f8fae6b7-1bf4-48f5-8548-9fb63438e05b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE3LTMtMS0xLTExODc1_38d0a082-be1c-489a-abb9-69082f127721">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE3LTUtMS0xLTExODc3_549dc3c3-2df5-47e6-90ba-abc7834ee622">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i826045fe76ba4dfba8d2b77577790871_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE1LTMtMS0xLTA_6f7e6b4a-c32e-49b5-88fe-2766d2891b76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51127895ec4446f88b062df8c3424fed_I20190928" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE1LTUtMS0xLTA_d6c31e7f-0cf3-44ba-89cf-490ca1395dbb">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjEz_efc91c40-d0d4-471d-bb11-0eb5c864a4ed" escape="true"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.842%"><tr><td style="width:1.0%"></td><td style="width:49.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.896%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc65f9a1944847ea81ab96621f47b0ce_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzItMS0xLTEtMA_d2e8f053-b7cb-467c-9509-7bf6e003e69c">27.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8333f1fcd3424edeb40667341d0ef184_D20180930-20190928" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzItMy0xLTEtMA_b70e9854-d2d8-49fc-9625-f7103dcee959">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e78594f4bdd44c39236b9e9233d4e5d_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzItNS0xLTEtMA_409f1beb-2a6f-41bf-b928-d2a94551ced1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6199234c2a9d4588aa6dd0e453b067ee_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzMtMS0xLTEtMA_5150da19-6843-4f41-a17d-19e2ff3f8c6d">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d2a775a080b412fa3dafce51e6d15ba_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzMtMy0xLTEtMA_9ae1cd63-b6bf-41c9-9c9d-efe1e04e23e8">8.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cc3451a488c432f89410a83c10d5d44_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzMtNS0xLTEtMA_07d01c90-8473-43a1-a395-fbbdc7331bdc">5.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzQtMS0xLTEtMA_e274658e-895f-4461-b57b-f4e6a194a455">28.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzQtMy0xLTEtMA_20df2fe3-4893-49f2-bbbb-02b6d5d5bc98">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzQtNS0xLTEtMA_c2253f3a-1dda-4cb5-8d25-ed3d6b6ce75c">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5ODA0_4828f0f7-bff5-474f-9d6d-347fdc29ab12" escape="true"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Operations for derivative instruments for which the Company did not elect hedge accounting:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:32.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not classified as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain Recognized in Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzItMi0xLTEtMA_176665b8-4bd9-42cc-90c1-518fa141f720">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4a7fbf31ef34d35a542b3139d2d97b4_D20180930-20190928" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzItNC0xLTEtMA_baa83b8f-56c2-42f8-b1b6-faba9bb9c2cf">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61680decf3094210970e74b87feb098a_D20171001-20180929" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzItNi0xLTEtMA_f381df5c-411e-4c33-a03a-10998b4bec78">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21e0c51c686947c9a4167c8b13e37d11_D20190929-20200926" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzMtMi0xLTEtMA_3ea97c39-5455-437b-afb3-1a1b3e8127a9">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a6303307844b9ebc5be9434c2819ad_D20180930-20190928" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzMtNC0xLTEtMA_9848804d-7d2e-4c4e-a1f9-cec5d7ba1d63">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21e889f681c47ca83ea648b1fe24ff2_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzMtNi0xLTEtMA_b463ea65-d45d-4d0c-91d4-b7093a53a61a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzQtMi0xLTEtMA_b6813dde-d616-4fee-8c46-5fc2f80371b3">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzQtNC0xLTEtMA_2a26e135-7b96-433f-aebc-d2c64d46b096">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzQtNi0xLTEtMA_51e42e31-0393-4cc7-8f88-5875681c97f0">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:AccountsReceivableAndReservesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTU2_c2fb49e8-0634-41b0-8cd0-80627d70a782" continuedAt="iba10f9f854b04a75a5a56526abc66489" escape="true">Accounts Receivable and Reserves</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i343cd8ad87734c68a5c74fa4cef06649" continuedAt="i052eb2355b00460a85d6a190d5a9cf0f"><ix:continuation id="iba10f9f854b04a75a5a56526abc66489"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves for doubtful accounts based upon a specific review of all outstanding invoices, known collection issues and historical experience. The Company regularly evaluates the collectability of its trade accounts receivables and performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and its assessment of the customer&#8217;s current credit worthiness.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzAw_a79fe837-4edb-41e5-b1ff-ff51a486df95" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable reserve activity for fiscal 2020, 2019 and 2018 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.812%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItMi0xLTEtMA_4fc77273-7143-4e9e-ba67-664636788baf">17.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItNC0xLTEtMA_c903328a-5dd0-4efa-8eb0-f006910be673">26.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="5" sign="-" name="holx:AccountsReceivableReserveDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItNi0xLTEtNjE0NQ_e97c055b-1b50-4aee-9460-0fa9cbccc6f7">5.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="holx:AccountsReceivableAllowanceReduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItNi0xLTEtMA_581de41e-390d-4de4-839c-f01ed8f63946">7.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItOC0xLTEtMA_ea6fb65e-7b5c-4516-a890-2615fd12a014">31.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtMi0xLTEtMA_0bd52b03-5e5e-49d2-85f9-ac150aa4bb33">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtNC0xLTEtMA_c080d4b3-7b87-413c-b238-918acd729bae">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="5" format="ixt:zerodash" name="holx:AccountsReceivableReserveDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtNi0xLTEtNjE0OQ_eefdfdcc-53fd-40f4-afe8-898dfaa04207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:AccountsReceivableAllowanceReduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtNi0xLTEtMA_7463d013-4973-4f5f-92f5-4a32b1d1f38d">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtOC0xLTEtMA_fd06cff8-1c79-4a32-85e4-0dbe9f51ce88">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 29, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84c88a850d71453097932f0bcbe84825_I20170930" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtMi0xLTEtMA_9af4d461-7130-4dc4-833c-932de594e7fb">9.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtNC0xLTEtMA_59353272-e324-42b5-85e8-84e73bab935c">7.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="5" format="ixt:zerodash" name="holx:AccountsReceivableReserveDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtNi0xLTEtNjE1Mw_7a17db6e-b5cf-45b9-a72b-84fa137ff93f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="holx:AccountsReceivableAllowanceReduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtNi0xLTEtMA_1a865b80-cd24-4750-8b80-c3887c23850e">0.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtOC0xLTEtMA_001d50fb-dd34-4f32-b8c9-bbdafe14779d">16.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjI3_d5dd59de-256a-476b-89db-d6c20ccd98bb" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#8217;s professional services&#8217; employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.</span></div></ix:nonNumeric><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjY2_2a58d860-e342-4561-bba0-752c67a52e99" continuedAt="i61b0063b66124e698a41028917137744" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div style="margin-top:5pt;text-indent:24.75pt"><ix:continuation id="i61b0063b66124e698a41028917137744" continuedAt="i43c95e2c0c604a1c9b024bbdc31e3ad5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based payments in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 718)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i43c95e2c0c604a1c9b024bbdc31e3ad5"> As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#8217;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, as a result of the adoption of ASU 2016-09 in fiscal 2017, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled.</ix:continuation> </span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Nzg0_6a499764-9edf-4970-9b09-860e2f9ff3ea" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options, restricted stock units and convertible debt for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzA5_ef060e2d-9428-49af-97b1-416254842f82" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts for fiscal 2020, 2019, and 2018 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzEtMi0xLTEtMA_de0dd35f-4f1f-453d-923a-4ab0462ba9c2">262,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzEtNC0xLTEtMA_e427ae2f-4849-4476-b4e3-0db50435b065">269,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzEtNi0xLTEtMA_a7fe682c-ce44-4536-8abc-edad5910c810">275,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-3" format="ixt:numdotdecimal" name="holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzItMi0xLTEtMA_39c70f75-4745-481e-a854-4083a5848f8a">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-3" format="ixt:zerodash" name="holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzItNC0xLTEtMA_31c1542b-5a57-4bf1-af3c-cc1cb7d15a09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-3" format="ixt:zerodash" name="holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzItNi0xLTEtMA_5504272c-6a4b-4b81-9354-d2f338927c42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzQtMi0xLTEtMA_ea80fc1e-01d3-4700-a5ce-b09de2a47620">264,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzQtNC0xLTEtMA_3c7139be-1654-4a0e-aa8d-cbbdf330dd60">269,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzQtNi0xLTEtMA_ae149438-26a2-4dbf-91ae-dde45dcb9d00">275,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93d07ccd1813413cb535430965ca43e1_D20190929-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzYtMi0xLTEtMA_8a90efd8-e0d3-4364-b611-0464511608e1">1,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife0a4b80cdd24c8182c3da3c0ac3badd_D20180930-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzYtNC0xLTEtMA_9d95fdef-d790-409c-b030-d9fc698b7caa">4,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1dc4960757847fa975cbc5ef31a88f8_D20171001-20180929" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzYtNi0xLTEtMA_9f3f1fe5-28d7-4a52-ba22-dced30dcefbc">5,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibce772764f914f9883988915d86d6810_D20190929-20200926" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzctMi0xLTEtMA_5709f6fc-945a-49fd-8d74-5727de91718a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d1559cdd9cb44c1af1d7faf1f2cef88_D20180930-20190928" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzctNC0xLTEtMA_9251a7a5-4013-44b9-8f01-d7b35970df5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if521ee7691434488a8c4a940762af9c0_D20171001-20180929" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzctNi0xLTEtMA_c6555b65-2b53-41b6-ae5b-0fc9718218c8">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In those reporting periods in which the Company has reported net income, anti-dilutive shares generally are comprised of those stock options that either have an exercise price above the average stock price for the period or the stock options&#8217; combined exercise price and average unrecognized stock compensation expense upon exercise is greater than the average stock price. In those reporting periods in which the Company has a net loss, anti-dilutive shares are comprised of the impact of those number of shares that would have been dilutive had the Company had net income plus the number of common stock equivalents that would be anti-dilutive had the company had net income.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i052eb2355b00460a85d6a190d5a9cf0f" continuedAt="i061da307302448b4b5f85f58dc4bf49e"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:StandardProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzU3_2679f5d1-d01d-433c-9861-b53062e871f9" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally offers a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM5NjU4_08c7a977-3e74-4ea4-ab24-1584cb253ab9">one</span>-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#8217;s warranty reserves include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTg1_411bfd64-b890-402d-bb92-82d42ddd8d40" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity for fiscal 2020 and 2019 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.489%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at&#160;End<br/>of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItMi0xLTEtMA_359dab85-bdbc-40c1-9c9c-5f7179e54e4b">13.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItNi0xLTEtMA_9c577f87-281d-4557-983b-f9678c71e6e9">11.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItOC0xLTEtMTcxMw_da16981f-f323-45dc-be25-e624fd639dca">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItMTAtMS0xLTE3MDA_c681ce48-1b63-4289-b05e-895d34bec12a">6.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItOC0xLTEtMA_5280f015-0771-4e41-8cde-86921da68420">10.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItMTAtMS0xLTA_2a497561-3320-41b9-b33d-df2160b0dccd">9.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtMi0xLTEtMA_b6e7d176-6da6-4425-a16c-e0daeb38203e">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtNi0xLTEtMA_f9d41508-f257-424b-aef2-83afbef319f2">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtOC0xLTEtMTcxMw_ad971a5f-4be6-414f-af48-82e432338364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtMTAtMS0xLTE3MDQ_842b0866-bc5d-473e-8b26-e16285a03ad7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtOC0xLTEtMA_3423a615-36e5-4705-9d7e-3af48405d3b6">16.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtMTAtMS0xLTA_69b88154-3fac-44dc-9ee9-811d85b82b15">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjIy_0c6eb182-83ee-42bf-9da1-248e905eb73c" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQwMzU2_e54b101b-5430-4f11-9326-f4aa5110acbe">15.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQwMzYw_5ea2cbd3-9eab-41bd-97f8-03d2daca258b">29.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQwMzY3_50165826-2f1d-42a7-bb52-1b7a972c27e5">26.9</ix:nonFraction> million for fiscal 2020, 2019 and 2018, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.</span></div></ix:nonNumeric><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, the FASB issued ASU No. 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 815): Targeted Improvements to Accounting for Hedging Activities.&#160;The guidance requires certain changes to the presentation of hedge accounting in the financial statements and also simplifies the application of hedge accounting and expands the strategies that qualify for hedge accounting.&#160;The Company adopted the standard in the first quarter of fiscal 2020. The adoption of ASU 2017-12 did not have a material effect on the Company's consolidated financial statements.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently a number of improvements. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-13, as well as all codification improvements in ASU 2019-04, ASU 2019-10, ASU 2019-11 and ASU 2020-03, on its consolidated financial position and results of operations. The Company expects the adoption to primarily be applicable to its accounts receivable and does not believe the impact will be material to its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in that Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. For entities that have adopted the amendments in Update 2018-07, the updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2019-08 on its consolidated financial position and results of operations but does not expect the adoption to have a material impact to its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board is issuing this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i061da307302448b4b5f85f58dc4bf49e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">those fiscal years, beginning after December 15, 2020. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board is issuing this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-03,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board is issuing this Update to clarify or improve the Codification, as well as, make the Codification easier to understand and apply by eliminating inconsistencies. This update is to improve various financial instruments Topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process. For entities that have adopted the amendments in Update 2020-03, the updated guidance is effective for all entities beginning in fiscal 2021. The Company is currently evaluating the impact of the adoption of ASU 2020-03 on its consolidated financial position and results of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board is issuing this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzE3NDY0_ba39cb1b-43d9-4f09-a4f0-9bc96f780ee0" continuedAt="i982d0c4eeac94f718b1cb7c06ca7fb32" escape="true">Revenue</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i982d0c4eeac94f718b1cb7c06ca7fb32" continuedAt="i3074d543095449a5988346cbbaafe0ea"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2014, the FASB issued ASC 606. The Company adopted the standard, which superseded ASC Topic 605, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 605), as of September 30, 2018 using the modified retrospective method for contracts that were not complete as of September 30, 2018. Under this method, the Company recognized the cumulative effect of initially applying the standard to its open contracts and recorded an adjustment to decrease the opening balance of accumulated deficit within stockholders' equity by $<ix:nonFraction unitRef="usd" contextRef="if06ae85100604f48a0354fb2181504ee_I20180930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzUxNQ_00f534c0-28e9-4987-9bd3-f704390a0e2e">6.4</ix:nonFraction> million, which is net of taxes of $<ix:nonFraction unitRef="usd" contextRef="if06ae85100604f48a0354fb2181504ee_I20180930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="holx:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzU0NA_1c104636-f408-4c4d-b509-3965be50caa0">2.4</ix:nonFraction> million, as of September 30, 2018 (the first day of fiscal 2019). The cumulative effect adjustment was primarily due to the Company applying the principles of ASC 606 to contracts for which the Company had deferred revenue as of September 29, 2018 for collectability uncertainty and providing extended payment terms resulting in the fee not being fixed or determinable under ASC 605. Under ASC 606, revenue from certain arrangements may be recognized earlier than under ASC 605 as a result of the ability to apply additional judgment in evaluating collectability and the elimination of the requirement to assess whether a fee is fixed or determinable, specifically as it relates to providing customers with extended payment terms. Results for reporting periods beginning September 30, 2018 and after are presented in accordance with ASC 606. Prior period results were not adjusted and will continue to be reported in accordance with the legacy GAAP requirements of ASC 605. As the adoption of this standard did not have a material impact on the Company&#8217;s revenue recorded for the years ended September 28, 2019 and September 29, 2018, transitional disclosures have not been presented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. Prior to the Cynosure divestiture, the Company also generated revenue from the sale and service of medical aesthetic treatment systems. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzE3NDYz_de0c221e-83f6-45a1-ae78-019f89cccd9e" continuedAt="i36359fab9de140668d8fd8fda96b2f34" escape="true">The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i3074d543095449a5988346cbbaafe0ea" continuedAt="i6c9c8e1ddb0a4440938db64494f94d74"><ix:continuation id="i36359fab9de140668d8fd8fda96b2f34"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:2.984%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d08665ff5e7428b92f2f87f995f6523_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMi0xLTEtMA_21788013-c6f3-4f35-b577-efe318651e78">266.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a91b66ec814b6bb11ea904156f4239_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMy0xLTEtMA_65a7f740-8582-492c-ba79-ade57aba31bd">143.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95cf893d7ec14704bea7fa6c16427a5b_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtNC0xLTEtMA_2c440bd8-a748-4272-ac81-01d49f2a0577">410.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bb398da9034ac4a5154a80046899ad_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtNi0xLTEtMA_a92ce41e-f069-4b17-bb0b-475709e08d26">312.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7ee31ee47384d66a52b606454a9d4ab_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtNy0xLTEtMA_2dc744cb-fce2-4522-bcda-2a0b56f911c1">159.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddc782db0444af8bb871d7496ee5746_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtOC0xLTEtMA_27ddedc9-2c2e-4c57-8a06-bb74a8fcdbcf">472.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590c2022b4324ab994b2164138508d88_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMTAtMS0xLTA_93bf13de-9a0d-477d-a7ba-498b745571d5">322.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf8dc695c92a4feca4702aef44167616_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMTEtMS0xLTA_b558ebf0-044d-4466-9bb6-50d2757f4f54">157.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bb5a21e92604faebf807887f9102015_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMTItMS0xLTA_511d49ce-1d50-4e6a-a1a5-fa9ec63e6323">480.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8a58cf3c461492482d5dcd9b88379ed_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMi0xLTEtMA_42566017-517f-431e-a381-e1a0cdac66fa">1,272.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4781b8d56e34db4ac93197bd725223a_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMy0xLTEtMA_4f689718-b502-411c-b846-18318f8cc6b5">375.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i104ac377ebbd4e05bcb47bf521f5ce4d_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtNC0xLTEtMA_ff0103a3-23cc-4d95-a4db-e9b05548b4fe">1,648.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1facf79e2182457ba4133a1ec0ba491c_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtNi0xLTEtMA_36db9085-0357-430b-a343-cce59a0f0d97">549.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a65a25ce95429a82c5b19cf486e81d_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtNy0xLTEtMA_ae441298-1148-4f7e-91db-9be35cc0085f">125.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e1e43e160f844f3be9e65aaa9ae3159_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtOC0xLTEtMA_3e33965a-456b-4ab2-b333-9c738169b231">675.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50934cec2c9c407b8ea520ce4db8e3b7_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMTAtMS0xLTA_3f7d70b9-0635-442e-80b9-e00996de58c4">503.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a30e107b544ef4b4edea002da71960_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMTEtMS0xLTA_4a9a5d78-8a1a-456f-9306-401ae31f8ee7">108.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca63f8d157f42aba21c14ee7c153d70_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMTItMS0xLTA_8a31676b-f92b-41a9-845e-fc395fbfe207">611.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i592f0856c5084a32af46ff3a1e046ee9_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMi0xLTEtMA_446c8c6d-90f9-4f50-bd0d-f78e4b439ab6">43.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd3b478fa0f24dc3aa889f9a058d9d98_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMy0xLTEtMA_bb4ccc18-1e9a-4600-b28b-d595b05874bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da82173bd744edb84691e936f7ccda0_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtNC0xLTEtMA_d49146f0-b944-436e-80e5-8215f790fbf2">43.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5464405dc015456e9897532307f11895_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtNi0xLTEtMA_fe54933d-6a71-4f97-b249-0dba44e96280">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ddddff86b3044d7b0fc9b7b2b963bf1_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtNy0xLTEtMA_41f1bee7-d09e-47ac-9820-48aa73039905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d3c5f4df704cddbdd7827a6451b621_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtOC0xLTEtMA_1941e684-3af7-464d-aa40-57539335f53b">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc133df909ca464f9c8e3787dcfe2475_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMTAtMS0xLTA_71e14193-f060-4c0c-98a9-1053de240ec0">55.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc84af9eb3104cfdb19db77db92ed7b4_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMTEtMS0xLTA_1cd45ca1-a322-4aab-81c2-ec6d1a7bb52d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e65a49339a4f9bb26bf6c415e08e18_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMTItMS0xLTA_c2a0478d-0c4e-4714-952b-a2c39dfbe0b8">55.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c33876277774ccea23ac78561fc07e0_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMi0xLTEtMA_2b33bad2-42b8-428d-b32c-06e3fefdc1b2">1,582.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fc5ccd5fc274beeb5b3be51f76cd623_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMy0xLTEtMA_afd12943-ff7b-4de2-9b5b-02a6e0139bdd">519.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtNC0xLTEtMA_791ddfba-543c-4a8b-b0b5-52db06b6bf8d">2,102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4cf0729ec2044dcae9c2f4801fd2420_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtNi0xLTEtMA_ec39e660-e096-463b-836d-f8893d3f865c">921.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c664f83a3cb4954bc77a1877cfdc72c_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtNy0xLTEtMA_c74837c5-4f44-41ac-bce6-3bf603912660">284.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtOC0xLTEtMA_eb98a262-0063-46c8-a2f4-8f789185d25a">1,205.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2f531aee5246619095d14dc0f8b6bf_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMTAtMS0xLTA_4313d817-b70a-4a6c-b65e-e1f80a2bdf28">881.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309e38f390b74c389c1f84c1b4db88ec_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMTEtMS0xLTA_f5433fcc-861b-4979-b0e5-d2b828341671">265.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMTItMS0xLTA_050bd97a-68f7-4e61-a17d-7dce5dd7abc4">1,147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec8d0273727499c80a7201ea239a090_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMi0xLTEtMA_ba2346d0-cd2d-40f4-ae1f-c8fa76a51796">722.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if95130eeb1d844f0a7c10fea2f52bf39_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMy0xLTEtMA_23a5ebc5-2ab8-472c-8c64-695ee674e019">231.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3886c217574265bcf1ad1049b1aa4c_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktNC0xLTEtMA_03a8395b-df4e-48b6-8312-17b5888b583a">953.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a29accf22242549a492fab1782cb94_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktNi0xLTEtMA_d4a4d9b4-3613-4fa5-ab07-9b945cdb3639">853.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a1ccd58830248da8f29187c9cdd3079_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktNy0xLTEtMA_267b6a64-81ee-4014-918c-dbe23d716332">241.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff15a89761f34f66a3761888623b4f23_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktOC0xLTEtMA_126e3841-f7cf-4d34-aa4b-750f7c109014">1,094.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833ea6babff4e13aa4c24c6994f576a_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMTAtMS0xLTA_6d3dedc1-de9b-4d87-8d29-3af6d00f6c71">782.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e9eb24efa944359e8a021229406acd_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMTEtMS0xLTA_44606412-f62f-4237-9baf-3709f4f52aa9">234.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic60ae0c151b445a292490043ea13881d_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMTItMS0xLTA_ba53ea9f-3ec3-4c81-a2f2-ded5d33dd170">1,016.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fba52a0614b49c585ea7cb3df44be14_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTItMS0xLTA_10a705e5-1d7f-4836-9274-dec8cfefe7bc">166.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8471b299d850453f8bfca6a20cd0512b_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTMtMS0xLTA_df473946-b205-4921-8c8e-12bb6ea03f08">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828ebe5b8d494e04936a9b538c0e1948_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTQtMS0xLTA_60130dde-dceb-4d94-8940-81042a4dfe5e">198.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia999e530e95c420abe9226d29b3d86e0_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTYtMS0xLTA_f92ca9dc-d9b2-4f3f-9ffb-fb6eecc059e4">184.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ee90fa905a04d32957b8acbaa2c1bfc_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTctMS0xLTA_db859f6d-7e0c-4a18-a2f4-0b1975d05cf7">34.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaafb7ab1c0441ec87d9abecb35da291_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTgtMS0xLTA_1939aa0e-90ff-4238-b44f-97fd0bcb1a20">219.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006de4dd9201414fb767930e647b4405_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTEwLTEtMS0w_89e4558d-7fa6-44f4-9a14-c840e73edd30">169.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadefe10680934f5580492d9dea95bf7d_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTExLTEtMS0w_5d43a8c0-0f7b-4580-ae31-67e35e8459d3">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60a5014f96a34cdab508fb56b98ac1d4_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTEyLTEtMS0w_0254cbd2-3086-4abe-bced-c19bde72d82c">201.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadcf8aa033b9410c824f6c8d1cf3ad39_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTItMS0xLTA_94d71759-714e-4412-882d-5d686caba53a">888.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b04cfb9cc74ed9bb9c61e376dc2794_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTMtMS0xLTA_d24423af-33c0-46f3-8d2a-b637b64b72c5">263.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTQtMS0xLTA_40f592a6-ee30-4741-a174-8800e4808b06">1,151.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i962c11ce0c514729be1b050aa28ff2e0_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTYtMS0xLTA_02de7f67-2b2a-4e09-a7aa-6b56c80d0bed">1,037.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9161faf1934aa3accab7a9fad64784_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTctMS0xLTA_04ece261-0320-49bf-bd68-2cf9f3e1fa22">276.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTgtMS0xLTA_c07346bc-d6b3-4a5c-baad-b872a1cc2596">1,314.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83a4bfcac8ba430ba82768a85a67c700_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTEwLTEtMS0w_d76e504e-b533-4254-8f0a-bad37e048fa5">951.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47df0fbe43fe4e708bd87bf78a6c73aa_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTExLTEtMS0w_3c80c3a0-0f5f-4f10-a438-74a5a6bf529f">266.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTEyLTEtMS0w_6e02ed70-044b-41a7-9bcc-81e8bdcea0b5">1,218.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aeae7e636114e169ab5ca6cd732bffd_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTItMS0xLTA_cbeda397-7e29-4634-beaf-ef11c5a2f445">310.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i939dcccc02d247098b6f0021c007686c_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTMtMS0xLTA_ebc30fe2-f0db-4769-afd5-3aa6b4bb0645">66.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTQtMS0xLTA_feb172cb-5689-4f74-97c7-5be359adf231">376.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc8d674b6954826ab5d78856d5fc97d_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTYtMS0xLTA_42635825-aae0-4184-8fb4-4f018cd2446d">362.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i667ad16a082a4c12a8188f400249f907_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTctMS0xLTA_5bd9b69b-f706-42fc-8554-360854d85a7b">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTgtMS0xLTA_22046f05-fb94-4962-89ff-1d6dda3e8e28">437.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96c41424e4c4429f833f974caca3e9d0_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTEwLTEtMS0w_293b7ecb-2425-43e0-bcbe-13f6c6d0e6fd">352.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640618ae1089409aa397c0b1d6630ba7_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTExLTEtMS0w_16143d34-8cf8-4083-9726-061e0bf60436">69.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTEyLTEtMS0w_549d8143-073c-4aed-9887-33359b5211e0">422.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67b306ed18214b529569e273c6cbc1b2_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTItMS0xLTEwNTc2_2bc334ba-77b0-442c-894b-535af0de76bd">51.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24e8f75e7420456aa25cbce56e1e8320_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTMtMS0xLTEwNTc2_15984e98-ae29-413a-8606-95f8825a66cb">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTQtMS0xLTEwNTc2_0873bc80-9e29-42a5-b0b5-51343dc1b7ae">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5d4c49bd355481485ca7470fc27601a_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTYtMS0xLTEwNTc2_4a9fb7b0-76c4-476d-ad88-12c2f37b475b">58.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c82065c41f4b4c993bb38268ef4b55_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTctMS0xLTEwNTc2_4aab930f-cb89-4730-ae64-f0e2825f45bc">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTgtMS0xLTEwNTc2_bb26e886-1e79-4587-abc3-bd8eff370549">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1410a37395f9458e8fa278adf018a579_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTEwLTEtMS0xMDU3Ng_d8656f96-7c90-477f-8462-bdaab1cfce34">59.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie06d07afd66d4433896cd49ac429b433_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTExLTEtMS0xMDU3Ng_f1b5a7d1-6ae1-4fd3-9490-d9cd3d964597">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTEyLTEtMS0xMDU3Ng_03a50a41-7c34-43f8-bd70-c133d0e493ed">91.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8cafb83e0443fd9f04b2a54be10659_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTItMS0xLTg3MjU_317ad225-2f39-40c3-b4ba-666e525c13b8">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a1be5bf1eb40548cf881d45cfa3212_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTMtMS0xLTg3MjU_0a4e010b-79a0-4e7f-a742-7c035846fc08">34.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTQtMS0xLTg3MjU_01515dcc-e861-4b8d-a9fc-a517c609af58">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1af779ff4d349c0bb004322df29066a_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTYtMS0xLTg3MjU_92edf2fb-660d-46ff-b2fb-5e483f442e3e">155.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c3b64e5f16145bab3d37ee0bbc5df6e_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTctMS0xLTg3MjU_1e892a9f-7cd5-4c89-b07f-85b028f59fb9">160.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTgtMS0xLTg3MjU_5d209ca9-0330-4c31-ac08-eaa9d2f92e32">315.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374d2bf4a31b4fada151536edc6446b7_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTEwLTEtMS04NzI1_4de33db1-f5db-4b72-9404-53b4526a54f9">172.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7773a142f248d98fc047e667923b9a_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTExLTEtMS04NzI1_0840c7a2-1ccd-48fc-80c2-2acc4492172a">166.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTEyLTEtMS04NzI1_dafb9961-e6cd-4ac7-81c5-acd203f7860d">339.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b1fbf643bf4d87a0f62662f56e72a9_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTItMS0xLTA_05f10964-09ca-4bcb-ab66-18a16e1f3012">2,863.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eb202acec0f4f65bc34389e2af40e3c_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTMtMS0xLTA_0c60c53d-2bbe-4dce-88e9-1de618a48da7">913.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTQtMS0xLTA_bd668945-52b5-4143-b5f7-94b3c35e6c81">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ccaf1b86dd4ce1975c67773f6132e3_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTYtMS0xLTA_23f5e34d-41e9-4ac6-b2f8-0453bb50ceac">2,536.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68690342c39340df929646cbbb4d0fb5_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTctMS0xLTA_6937e301-4edc-4bd5-ace1-8e79ccf0d841">831.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTgtMS0xLTA_a8dcc05c-46f7-4ebb-8813-0e123b1ae63d">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a86961b941f4c698ca817317ebb55f1_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTEwLTEtMS0w_93409cc6-a309-4c70-b5d6-628a7d85f720">2,417.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95060407ff54c468b06a661c8fabc25_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTExLTEtMS0w_896b1b61-f7f8-483c-a6fb-6c28f0794d4e">800.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTEyLTEtMS0w_ad7df712-6c69-48d1-9add-cb2ce04e61b4">3,217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"><tr><td style="width:1.0%"></td><td style="width:37.510%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.765%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b1fbf643bf4d87a0f62662f56e72a9_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzItNS0xLTEtMA_0e33c26a-abd4-41e7-804e-5a87752efa81">2,863.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ccaf1b86dd4ce1975c67773f6132e3_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzItNi0xLTEtMA_61a668b7-1041-4b32-9e0f-473a6739d0a6">2,536.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a86961b941f4c698ca817317ebb55f1_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzItNy0xLTEtMA_0da14541-6a07-4811-97ce-bd07e703abcd">2,417.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a03228708e48bd91808873ac0aef49_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzMtNS0xLTEtMA_70306c9f-e0ba-40e9-90b5-fc6dc5cc3123">569.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9775b97e92684b93a13c7004b3787bb9_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzMtNi0xLTEtMA_638a3b10-ace2-44ef-bef2-72c3b9497d0c">396.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f05bd0d07b41cc91cc734c6e8aabd4_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzMtNy0xLTEtMA_b4fccb12-53d9-44ad-93ca-d77f9b23853d">377.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2349edc55c45de9425f98b0200d5a7_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzQtNS0xLTEtMA_098b716b-22ae-468d-a29c-63e094165da9">226.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic693f14699ba4968bcb36cc7b8b023a7_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzQtNi0xLTEtMA_35f30578-f497-4e4a-91cc-6509e87a3cea">286.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6acedc8e09c84b2e89c7f0cc800be0dd_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzQtNy0xLTEtMA_ddb21cde-51ef-40b4-abc9-da18bbf2760a">275.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0fdba95bf14963b575eed35c0be6b7_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzUtNS0xLTEtMA_a2b42ee2-f591-4696-bea3-86b87e3ea4f6">116.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia889c74fa094451886ddf4da8cfb8b39_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzUtNi0xLTEtMA_1de46df0-b8c1-48ea-bb07-b3f7e669066c">149.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i404bb6871a4c4ab480a92c1a5f85724a_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzUtNy0xLTEtMA_4d8e0c55-8dd5-4c9b-9566-9cafac7ba8a1">147.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzYtNS0xLTEtMA_1c4af9f1-e2cb-44ee-b9f2-11b777d01b3c">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzYtNi0xLTEtMA_6a4c40fa-b11d-4e8e-b210-7912688a9d90">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzYtNy0xLTEtMA_cacebd3e-6fd5-40ee-ae5b-2799441353dc">3,217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:32.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:20.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic42c9ec0a387465384f173e101feaa39_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNS0xLTEtMTAxNTY_2082e120-bf2d-4045-897c-89bfc44b956f">2,561.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37a58071a6be4fa68958f54a1146729c_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNi0xLTEtMTAxNTY_9abf34a1-0ab1-41ea-af65-e3460e16f9d5">1,786.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i105ba05d0c354f20b5883424ecfbbfeb_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNy0xLTEtMTAxNTY_29aaafab-330d-4b6d-a8ef-da34d89d9e93">1,666.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia619a463826c4b1aaca754c1bbd0a455_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNS0xLTEtMA_c61135c4-45db-4274-90a7-4f543c018173">665.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad9d09e7d14346609c65daa29e0cc27a_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNi0xLTEtMA_6c88802b-1017-43c2-8eb3-3a73ba3e8ce1">984.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6d7468b24745749de9948726eabd87_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNy0xLTEtMA_ff0bbe0c-3572-4f4d-a317-5ea85add18cc">977.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i794e99945f544149a4dfb0dc4430defe_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzQtNS0xLTEtMA_55b1e0cb-a7c8-4bd0-8fa0-ef55bc5ab842">516.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b85f8e0cc641d6811b0f647a80c0b4_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzQtNi0xLTEtMA_758c4d99-78f5-416a-b989-57e5361c2cb2">568.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i688ec76adf1140acaab8d25b511667aa_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzQtNy0xLTEtMA_6cf923b6-4daa-4d70-b424-74412c199635">551.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6352a521944f2fb02cc1dcea86de83_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzUtNS0xLTEtMA_6d027f87-82dc-491c-a2f4-d95632a7cad9">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8e030e4bcb4d11b83c486a8c3deb7f_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzUtNi0xLTEtMA_93975560-8b99-4936-aa6d-576e4f2d0eb7">27.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ca6c2bd19e94add871a8ae7f87f8147_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzUtNy0xLTEtMA_396443db-3c0e-46b4-bcb5-855c0ff239cb">22.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzYtNS0xLTEtMA_fde7e7be-9ac0-44bd-a3f0-70ff9f78a94c">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzYtNi0xLTEtMA_2d4db676-b12d-4966-93c1-35e124c3ceed">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzYtNy0xLTEtMA_2ed26656-0834-408d-abaa-ce04c3060145">3,217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i6c9c8e1ddb0a4440938db64494f94d74" continuedAt="i4423f355e3634443acae33b8f92dcbfa"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefit of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's contracts typically do not provide the right to return product. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September 26, 2020, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzc4Mzc_da6e28cb-5cca-4c2b-8b5a-1cd1e861cb78">635.6</ix:nonFraction> million. These remaining performance obligations primarily relate to extended warranty and support and maintenance obligations in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="ie9ec2f408f84441f8be19c8da6fe2ecd_I20200926" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgwOTg_9201e6a2-4e81-49dd-b28f-f0951ffb4b88">39</ix:nonFraction>% of this amount as revenue in 2021, <ix:nonFraction unitRef="number" contextRef="id732b75e70474fdd99cfef04a578daac_I20200926" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgxMzY_6fbaa33e-aa1f-4e0e-8ad0-ca6fbc6357ed">28</ix:nonFraction>% in 2022, <ix:nonFraction unitRef="number" contextRef="id940ceae94cd453190bd3a93d6db3048_I20200926" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgxNDg_36a71a44-ee49-4407-8658-fc6d8a6d9a79">19</ix:nonFraction>% in 2023, <ix:nonFraction unitRef="number" contextRef="i6f509287fa7d48aba904c4bc91d15c97_I20200926" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgxNjA_2f0e3d40-e25c-4786-8046-f4879bd2255d">10</ix:nonFraction>% in 2024, and <ix:nonFraction unitRef="number" contextRef="i60dfb47aa97248bd8efcffeb6e4c16e7_I20200926" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgxNzY_1ac13848-fb61-4ed4-a0e1-3f22f36e3230">4</ix:nonFraction>% thereafter. The Company has applied the practical expedient to not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i4423f355e3634443acae33b8f92dcbfa" continuedAt="i56f0f257e2134d29afc4f1cef633c86b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments and, until December 30, 2019, the divested Medical Aesthetics segment. Contract liabilities are classified as other current liabilities and other long-term liabilities on the Consolidated Balance Sheets. The Company recognized revenue of $106.2&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzk1MDQ_04cb0265-5939-47bb-ab10-dad2362ed8cc">158.9</ix:nonFraction> million in the years ended September 26, 2020 and September 28, 2019, respectively, that was included in the contract liability balance at September 28, 2019 and September 29, 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical Expedients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;With the adoption of ASC 606, the Company elected to apply certain permitted practical expedients. In evaluating the cumulative-effect adjustment to retained earnings, the Company adopted the standard only for contracts that were not complete as of the date of adoption. For contracts that were modified prior to the adoption date, the Company elected to present the aggregate effect of all contract modifications in determining the transaction price and for the allocation to the satisfied and unsatisfied performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition under ASC 605 (prior to the adoption of ASC 606, which applies to fiscal 2018)</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 605, the Company recognized product revenue upon shipment provided that there was persuasive evidence of an arrangement, there were no uncertainties regarding acceptance, the sales price was fixed or determinable, and collection of the resulting receivable was reasonably assured. Generally, the Company&#8217;s product arrangements for capital equipment sales, primarily in its Breast Health, Medical Aesthetics and Skeletal Health reporting segments, were multiple-element arrangements, including services, such as installation, training and support and maintenance, and multiple products. Based on the terms and conditions of the product arrangements, the Company believed that these services and undelivered products could be accounted for separately from the delivered product element as the Company&#8217;s delivered products have value to its customers on a stand-alone basis. Accordingly, revenue for services not yet performed at the time of product delivery were deferred and recognized as such services were performed. The relative selling price of any undelivered products was also deferred at the time of shipment and recognized as revenue when these products were delivered. There was no customer right of return in the Company&#8217;s sales agreements for its capital equipment.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Service revenues primarily consist of amounts recorded under service and maintenance contracts and repairs not covered under warranty, installation and training, and shipping and handling costs billed to customers. Service and maintenance contract revenues were recognized ratably over the term of the contract. Other service revenues were recognized as the services were completed using the specific performance method. Service and other revenue also included royalties which were recognized in the period the payments were due to the Company.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For revenue arrangements with multiple deliverables, the Company recorded revenue as separate units of accounting if the delivered items had value to the customer on a stand-alone basis and the delivery or performance of the undelivered items was considered probable and substantially within the Company&#8217;s control. Some of the Company&#8217;s products have both software and non-software components that function together to deliver the product&#8217;s essential functionality. The Company determined that except for its computer-aided detection (&#8220;CAD&#8221;) products and C-View and Intelligent 2D products, the software element in its other products was not within the scope of the software revenue recognition rules, ASC 985-605, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software&#8212;Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company determined that given the significance of the software component&#8217;s functionality to its CAD, C-View and Intelligent 2D components, which are sold by its Breast Health segment, these products were within the scope of the software revenue recognition rules. The Company evaluated the appropriate revenue recognition treatment of it hardware products, including its Dimensions digital mammography systems, which had both software and non-software components that function together to deliver the products&#8217; essential functionality (i.e., it is a tangible product), and determined they were not within the scope of ASC&#160;985-605.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i56f0f257e2134d29afc4f1cef633c86b"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company was required to allocate revenue to its multiple element arrangements based on the relative fair value of each element&#8217;s selling price. The Company typically determined the selling price of its products based on its best estimate of selling prices (&#8220;ESP&#8221;) and services based on vendor-specific objective evidence of selling price (&#8220;VSOE&#8221;). The Company determined VSOE based on its normal pricing and discounting practices for the specific product or service when sold on a stand-alone basis. In determining VSOE, the Company&#8217;s policy was to require a substantial majority of selling prices for a product or service to be within a reasonably narrow range. The Company also considered the class of customer, method of distribution, and the geographies into which its products and services were sold when determining VSOE. If VSOE could not be established, which could occur in instances when a product or service had not been sold separately, stand-alone sales were too infrequent, or product pricing was not within a relatively narrow range, the Company would generally establish the selling price using ESP to allocate arrangement consideration. The objective of ESP was to determine the price at which the Company would typically transact a stand-alone sale of the product or service. ESP was determined by considering a number of factors including Company pricing policies, internal costs and gross margin objectives, method of distribution, information gathered from experience in customer negotiations, market research and information, recent technological trends, competitive landscape and geographies.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For those arrangements accounted for under the software revenue recognition rules, ASC 985-605 generally required revenue earned on software arrangements involving multiple elements to be allocated to each element based on their relative VSOE of fair value. If VSOE did not exist for a delivered element, the residual method was applied in which the arrangement consideration was allocated to the undelivered elements based on their VSOE with the remaining consideration recognized as revenue for the delivered elements. For multiple-element software arrangements where VSOE of fair value of Post-Contract Customer Support (&#8220;PCS&#8221;) had been established, the Company recognized revenue using the residual method at the time all other revenue recognition criteria were met.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;While the majority of its instruments are placed at customer sites, in certain instances the Company sold instruments to its clinical diagnostics customers and recorded sales of these instruments upon shipment or delivery, depending on the terms of the arrangement.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Within its Diagnostics business, and to a lesser extent, its GYN Surgical business, the Company provided its instrumentation (for example, the ThinPrep Processor, ThinPrep Imaging System, and the Panther and Tigris systems) and certain other hardware to customers without requiring them to purchase the equipment or enter into a lease. The Company installed the instrumentation or equipment at the customer&#8217;s site and recovered the cost of providing the instrumentation or equipment in the amount it charged for its diagnostic tests, assays and other disposables. Customers entered into a customer usage agreement and typically committed to purchasing minimum quantities of disposable products at a stated price over a defined contract term, which was typically between three and five years. Revenue was recognized over the term of the customer usage agreement as tests, assays and other disposable products are shipped or delivered, depending on the customer's arrangement.</span></div></ix:continuation><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_1816"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjMy_29092f43-4134-48f8-812c-8b01d099f2ae" continuedAt="i5159eaf5a62a4e8a9986957f3d0616f3" escape="true"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjMy_38888da8-0228-4520-986f-e711ca972e6f" continuedAt="i2bb629a200064212a05b646cf7545b6f" escape="true"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:LessorSalesTypeLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjMy_9e4a9fdb-3733-4ef6-b1b3-0857e0464161" continuedAt="if2b993fa2eb743c9959267054d872071" escape="true"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:OperatingLeasesOfLessorDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjMy_f870a16d-7b72-42a1-8775-0b11d504c358" continuedAt="i936132b413d9454393baa7f89f3843cf" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i5159eaf5a62a4e8a9986957f3d0616f3" continuedAt="i22b0104c61124b73b428ffa395b54762"><ix:continuation id="i2bb629a200064212a05b646cf7545b6f" continuedAt="icf651e3d5f4d4aa6b300b9590533b963"><ix:continuation id="if2b993fa2eb743c9959267054d872071" continuedAt="i87daa705a19443bb808410073c164fc3"><ix:continuation id="i936132b413d9454393baa7f89f3843cf" continuedAt="i24465ed816ce477a8932553087482c4c"><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to as ASC 842. The purpose of ASU 2016-02 is to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, is effective for public entities for annual periods beginning after December 15, 2018, including interim periods within those annual periods and was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, Leases (Topic 842): Targeted Improvements. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements. Prior periods are presented in accordance with the lease guidance under ASC Topic 840, Leases (ASC 840). </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not </span></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i22b0104c61124b73b428ffa395b54762" continuedAt="iac1cada72c7c4351b20cfb1ce6d30009"><ix:continuation id="icf651e3d5f4d4aa6b300b9590533b963" continuedAt="i3266575501a44854802417d2ae1036b4"><ix:continuation id="i87daa705a19443bb808410073c164fc3" continuedAt="i55487614c70f4c3692dd1a39d799feae"><ix:continuation id="i24465ed816ce477a8932553087482c4c" continuedAt="ib1168ee753064e609128b8eb32a103e7"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have a significant amount of sales-type leases. Under ASC 840, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $<ix:nonFraction unitRef="usd" contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NDgy_9413628f-2539-4ad3-87bc-6b0c5b228056">91.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTEw_2a432609-91cc-4e5b-8080-46c56df39e8a">10.2</ix:nonFraction>&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c"><ix:nonFraction unitRef="usd" contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_66c21da7-ee6c-486f-95e7-40eca7018660">96.6</ix:nonFraction>&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4"><ix:nonFraction unitRef="usd" contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_0ba1b9fd-5309-4f7b-9fca-85ce8213fbf0">21.0</ix:nonFraction>&#160;million</span>, respectively. This includes recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $<ix:nonFraction unitRef="usd" contextRef="i22479589b7d74fc680fef5abcd3d9de8_I20190929" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTk2_1ac8a9c5-35e8-49fb-96eb-74f644a42239">32.6</ix:nonFraction>&#160;million of property, plant and equipment and $<ix:nonFraction unitRef="usd" contextRef="i22479589b7d74fc680fef5abcd3d9de8_I20190929" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NjI1_b0fcd9c5-1639-44a9-a4af-4c263a742047">35.2</ix:nonFraction>&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements are included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:durwordsen" name="holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNTYz_9f4f06fb-d68d-48cb-9a36-4c722c117e93">one year</ix:nonNumeric>. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of <ix:nonNumeric contextRef="i26ac442ab8104d62a507939b10fa969a_D20190929-20200926" format="ixt-sec:durwordsen" name="holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNTc0_97c68474-3490-43b8-8479-4f6ba8083e2a">one year</ix:nonNumeric> to approximately <ix:nonNumeric contextRef="i8c09129ca98843beadfd374cfab77639_D20190929-20200926" format="ixt-sec:duryear" name="holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNTg1_e1d7a42f-87f6-4c13-94f7-27ab1725ac14">15</ix:nonNumeric> years, some of which may include options to extend the leases for up to <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:duryear" name="holx:LesseeOperatingAndFinanceLeasesExtensionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjQ2_25912838-a71f-4dcd-8fd8-6c3129a06ff5">20</ix:nonNumeric> years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;26, 2020. The Company's lease classified as a capital lease in fiscal 2019 is now classified as a finance lease on the balance sheet as of September&#160;26, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;26, 2020 was <ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="4" name="holx:LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2MTEw_0ea8c27c-728f-49d8-aa3c-74f4382eb760">2.62</ix:nonFraction>%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjUy_b7693120-1331-4223-93cc-536f94b286c1" continuedAt="ide03b37ef049493d90696ab29f9fb77c" escape="true">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><ix:continuation id="ide03b37ef049493d90696ab29f9fb77c" continuedAt="if74328d6895245e7b901a5f070b52217"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i570d6e2471dd4d25a99fe27c526db531_I20200926" decimals="-2" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTMtMS0xLTM4Nzk_3ad76ed7-729d-4761-9486-007e46f6d2ff">80.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71">Accrued expenses</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32158b5e90814831821e7b0a2eb47b70_I20200926" decimals="-2" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTMtMS0xLTM4Nzk_ebccae36-211c-45d2-8eea-142e84c4a987">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63fa7301a7954f429d5733f26da0769e_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF83LTQtMS0xLTM4Nzk_a36a973d-5e09-4f06-ba78-e1a3bfd33bb8">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica831abf5b804562b479ecb7d6da8ff9_I20200926" decimals="-2" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTMtMS0xLTM4Nzk_7ef09ba5-03cb-4fef-b23e-e8b338285285">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ba215b8102842d7a0db14145f80c875_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF85LTQtMS0xLTM4Nzk_502ac779-7e3a-4e04-abb1-f48511cae720">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The finance lease was previously recorded as a capital lease in the consolidated balance at September 28, 2019, and the short-term and long-term liabilities were $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2MTYz_45aaede5-eb6c-473d-9b5c-43a5fc02d29d">1.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2MTc3_01076c36-c7c0-4832-b9e9-6dca5c5ac32b">19.2</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="iac1cada72c7c4351b20cfb1ce6d30009" continuedAt="i0ac3a7a72b934c32b6392e297abac60d"><ix:continuation id="i3266575501a44854802417d2ae1036b4" continuedAt="ie14f3ee6afa8436d8896585965fc48e9"><ix:continuation id="i55487614c70f4c3692dd1a39d799feae" continuedAt="ibe97496431484f7c8e9beee2d0417087"><ix:continuation id="ib1168ee753064e609128b8eb32a103e7" continuedAt="i4041cc93e9184c1bb368996ee02334c8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:continuation id="if74328d6895245e7b901a5f070b52217" continuedAt="i5638a78503d7489d981540a4b4aa1f4d">The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</ix:continuation></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i5638a78503d7489d981540a4b4aa1f4d"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"><tr><td style="width:1.0%"></td><td style="width:52.168%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.010%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.420%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id3c092381c12421482497e088d638a81_I20200926" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6M2Q4NDhhYzhmZDZkNDM3NWEwNjcxYTIzZTM1Y2E4MmEvdGFibGVyYW5nZTozZDg0OGFjOGZkNmQ0Mzc1YTA2NzFhMjNlMzVjYTgyYV8yLTItMS0xLTIxMg_681cd066-6753-4e00-bb68-39e2c48fe9c5">5.58</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id3c092381c12421482497e088d638a81_I20200926" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6M2Q4NDhhYzhmZDZkNDM3NWEwNjcxYTIzZTM1Y2E4MmEvdGFibGVyYW5nZTozZDg0OGFjOGZkNmQ0Mzc1YTA2NzFhMjNlMzVjYTgyYV8yLTMtMS0xLTIxMg_c8b19f07-6af2-4f97-9d2c-78428e9b700b">7.64</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6M2Q4NDhhYzhmZDZkNDM3NWEwNjcxYTIzZTM1Y2E4MmEvdGFibGVyYW5nZTozZDg0OGFjOGZkNmQ0Mzc1YTA2NzFhMjNlMzVjYTgyYV8zLTItMS0xLTM5Mjc_750a4d96-0625-455c-b6b0-468b525310f1">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6M2Q4NDhhYzhmZDZkNDM3NWEwNjcxYTIzZTM1Y2E4MmEvdGFibGVyYW5nZTozZDg0OGFjOGZkNmQ0Mzc1YTA2NzFhMjNlMzVjYTgyYV8zLTMtMS0xLTM5Mjc_e6efb3bc-d631-4dab-8443-d2dcdc074a84">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjU4_f58be50d-d645-4e1f-b2e1-e19fd3b2c6d4" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"><tr><td style="width:1.0%"></td><td style="width:2.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.572%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-2" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF8xLTItMS0xLTM5NjU_575d8753-11d9-476c-8fa7-042a1f397fab">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-2" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF8yLTItMS0xLTM5NjU_8d611193-6cf5-463e-a872-ae8b0ddbd533">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-2" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF8zLTItMS0xLTM5NjU_f00f6b9b-f2e7-404a-95dc-ccf589122471">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-2" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF81LTItMS0xLTM5Njk_de33031d-6c78-436e-a8b4-6162151ef960">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-2" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF82LTItMS0xLTM5Njk_880092b2-a157-408c-bb60-9ae5eeb8041d">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-2" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF83LTItMS0xLTM5Njk_497d24b6-37d7-4022-9ae8-74f0e5fb5754">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-2" name="holx:OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF84LTItMS0xLTM5Njk_24fea4bb-0adc-4e41-85a0-acdc88aa7596">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-2" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF8xMC0yLTEtMS0zOTcx_6d48684e-eaa7-4dbf-919b-d4d35848996c">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQzODc3_46096385-ce02-492f-8289-4e822c62795c"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQzODc3_4609d514-e4dc-4dcf-8575-b10f5eaf2138">23.1</ix:nonFraction></ix:nonFraction>&#160;million for fiscal 2019 and 2018.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjU5_1204091e-a389-4aa9-be7f-4e039b2df865" continuedAt="ifa53a03ae49a46d59f7bcee255190788" escape="true"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjU5_df80c994-6866-489a-85c9-373fd79422ba" continuedAt="i85ae075745d9401fa639facbea081260" escape="true">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="ifa53a03ae49a46d59f7bcee255190788"><ix:continuation id="i85ae075745d9401fa639facbea081260"><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:64.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8xLTItMS0xLTM5OTI_71b35ecd-0461-43c8-8221-28e2aa54902d">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8xLTMtMS0xLTM5OTI_37dd8cb6-a334-40e7-91ce-cfff579bbe34">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8yLTItMS0xLTM5OTI_475ebb36-e37b-4643-a629-57e8b03f7e19">20.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8yLTMtMS0xLTM5OTI_01fb368e-5930-469c-812e-b813bb366a7b">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8zLTItMS0xLTM5OTI_592f8c81-91e4-4674-96aa-72b45e2942b8">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8zLTMtMS0xLTM5OTI_8b65c49e-00e9-4ea5-8d18-dcbf797a155c">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV80LTItMS0xLTM5OTI_f5e95691-e1c6-4347-9900-3ca9cad693e4">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV80LTMtMS0xLTM5OTI_342c3ca3-8380-40d9-bdde-a7f458a6e090">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV81LTItMS0xLTE1Nzc4_819db018-150d-4594-8546-cfc00e0b8d47">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV81LTMtMS0xLTE1Nzc4_b718323a-86e6-4101-8890-23e82629bfe6">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV81LTItMS0xLTM5OTI_4b743dc9-e4a6-43f4-8314-cae5f8bd55bd">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV81LTMtMS0xLTM5OTI_e3fa41f4-c33d-4d36-a33a-6dce194567cb">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV82LTItMS0xLTM5OTI_7dac1bbf-95d6-4847-b4b2-cb3f5f6939d0">94.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV82LTMtMS0xLTM5OTI_5c1b90ee-7d2f-4114-bda4-fcf2668f2d0a">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV83LTItMS0xLTM5OTI_b2ee3f0f-5836-430d-8d97-a8ec99951852">5.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV83LTMtMS0xLTM5OTI_a53e7562-6748-4699-ad5b-3d8362df17aa">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV84LTItMS0xLTM5OTI_8195c162-c7ba-47d0-abf4-bae08202310c">89.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV84LTMtMS0xLTM5OTI_4c1dc469-fdde-4ac2-bfdf-a9ca1db97d7b">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:64.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8xLTItMS0xLTE1Nzg5_4ea2def6-6d32-4344-92ab-c895ca9e337e">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8xLTMtMS0xLTE1Nzkx_ae11c2d0-d1b2-407a-b866-4caa0e30d0da">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8yLTItMS0xLTE1Nzg5_480675c9-4f3c-4b61-b6f8-9500e2f70f1e">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8yLTMtMS0xLTE1Nzkx_390420b8-292e-4838-9fa5-3f65e330125d">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8zLTItMS0xLTE1Nzg5_56485283-5da0-4dba-bb23-1d2737d0c942">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8zLTMtMS0xLTE1Nzkx_ca6ba648-f3c8-41fe-93f9-968170bb398f">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml80LTItMS0xLTE1Nzg5_ccb74a0b-af03-45e9-a135-2e2a151cc2a7">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml80LTMtMS0xLTE1Nzkx_1562bc72-9afd-47a8-8e53-3dc914442257">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml81LTItMS0xLTE1Nzg5_7d429b77-e096-4742-9133-1f2511b93f64">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml81LTMtMS0xLTE1Nzkx_56b8ac55-fd74-4449-b975-7980f964d586">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml82LTItMS0xLTE1Nzg5_f32fe4fd-6233-485a-add0-35fc5965d0f0">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:CapitalLeasesFutureMinimumPaymentsDueThereafter" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml82LTMtMS0xLTE1Nzkx_aaf58276-453a-46e4-8aa0-8ccdd2365a58">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml83LTItMS0xLTE1Nzg5_552fd04f-e353-4576-8285-9534e1cea5f6">78.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-2" name="us-gaap:CapitalLeasesFutureMinimumPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml83LTMtMS0xLTE1Nzkx_7c271a7b-8aaa-4e67-a475-e3bb1a932604">48.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i0ac3a7a72b934c32b6392e297abac60d"><ix:continuation id="ie14f3ee6afa8436d8896585965fc48e9"><ix:continuation id="ibe97496431484f7c8e9beee2d0417087"><ix:continuation id="i4041cc93e9184c1bb368996ee02334c8"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately <ix:nonFraction unitRef="number" contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926" decimals="2" name="holx:LeaseRevenuePercentageOfTotalRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjU0_dd61c659-dc01-4f5a-8af6-1c1215d51e01">4</ix:nonFraction>% of the Company&#8217;s consolidated revenue for the twelve months ended September&#160;26, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the disposition of the Medical Aesthetics business, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="5" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2NDg1_b59266ec-4c9f-4230-a0bd-c652bb661593">10.2</ix:nonFraction>&#160;million for the right-of-use asset for the finance lease, included in property, plant and equipment, and recorded a lease receivable, which was $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" format="ixt:numdotdecimal" name="holx:LeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2NTAw_3061fd3f-ad6e-4bf8-9cfe-b087abab8aa5">19.3</ix:nonFraction>&#160;million as of September&#160;26, 2020.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company subleases a portion of a building it owns and some of its rented facilities and has received aggregate rental income of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseSubleaseRentals1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV84MjQ2MzM3MjE0MTUw_39b541d3-e036-449f-917a-c6333bbfd93f">2.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseSubleaseRentals1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV84MjQ2MzM3MjE0MTU1_bb9f7f35-caad-4e5c-8b2b-6bb5c675c18a">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseSubleaseRentals1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV84MjQ2MzM3MjE0MTYz_88a1559a-3d97-4abc-939f-0199eb40205a">2.6</ix:nonFraction> million in fiscal 2020, 2019 and 2018, respectively, which has been recorded as an offset to operating lease costs. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQzODc1_75373696-17ba-4fd6-8b34-85afa37b3b95" continuedAt="id4f1a5e02c304d3facb7ff755841b23c" escape="true">The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:</ix:nonNumeric></span></div><ix:continuation id="id4f1a5e02c304d3facb7ff755841b23c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"><tr><td style="width:1.0%"></td><td style="width:76.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.004%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl8wLTEtMS0xLTY5NTE_d1b6ef99-db7b-4435-b101-65a6f4839c7a">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl8xLTEtMS0xLTY5NTE_3c1aeb87-62a8-48ce-9e42-a48bf788826a">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl8yLTEtMS0xLTY5NTE_794dd5aa-7bb0-4e26-aae0-5b35390f13f9">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl8zLTEtMS0xLTY5NTE_5abe8d6e-d6eb-4e32-83a3-29a543258905">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl80LTEtMS0xLTY5NTE_b359b8b2-a362-4b9c-8098-b7f23a55da09">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl81LTEtMS0xLTY5NTE_26857ea3-50d6-46d8-aa0e-fcf8aa035f83">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl82LTItMS0xLTE1Nzk1_4dea9c7c-91d2-4a67-ae63-eb89f412abf5">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_151"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzE0MjA3_f961f383-6f08-4877-9911-f7fe7aade290" continuedAt="i4d38496c7f4d4842ae0aab1b8005dd07" escape="true">Business Combinations</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4d38496c7f4d4842ae0aab1b8005dd07" continuedAt="i22d7fc1807204957a95059c8889ba978"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ic439fbf0ea984bcba40c13f6cae3a03b_D20200823-20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA4NzU_7d311dce-9187-421f-96d9-dcf2402dc09b">161.3</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="i60c64e349e7248b4926861f03af3baf7_I20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2MDk_1f32fac8-520f-48f3-9e02-6d496401f9ce">3.0</ix:nonFraction>&#160;million payable <ix:nonNumeric contextRef="i6628d4bd404a4b39ae1f8755ac19e156_D20200823-20200823" format="ixt-sec:durwordsen" name="holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2NjY_d5c0ce3c-d997-4276-9f81-e2b113f6f921">five months</ix:nonNumeric> from the date of acquisition, and contingent consideration, which the Company estimated the fair value to be $<ix:nonFraction unitRef="usd" contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2MjM_98a8b3c7-cd33-4c33-b42f-41637a729495">81.8</ix:nonFraction>&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i64e80cf41696467c9ffc4409327aade0_D20190929-20200926" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk4OTU2MDQ3MDUwNDc_92caf90d-67ed-4cff-a927-1d15a0c4f2f0" continuedAt="ib3014d63177e476290810fad552e5581" escape="true">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i22d7fc1807204957a95059c8889ba978" continuedAt="i766ffebb6e8947339d74a13f473637aa"><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="ib3014d63177e476290810fad552e5581"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"><tr><td style="width:1.0%"></td><td style="width:5.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823" decimals="1" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzAtMi0xLTEtNDMyMg_5634bf54-f4ca-450b-ab28-6c0b8f6d72f8">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823" decimals="1" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzEtMi0xLTEtMTU4NzY_8335034d-43b4-42fe-aabb-cc57b2a8eb26">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823" decimals="1" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzItMi0xLTEtMTU4NzY_367f167a-53dc-4c3e-b96f-cf024fe79d5a">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf4c2cfcfc8644a2ac89ad085cbdce46_I20200823" decimals="1" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzItMi0xLTEtNDMyMg_5238e5b7-3e78-48a8-8dcc-85ff91dca182">127.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6e062bb74fb4a87a11ce9920ba3bf95_I20200823" decimals="1" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzQtMi0xLTEtNDMyMg_1326fdbd-5842-445a-ab2e-b0f932d5ce3d">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823" decimals="1" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzgtMi0xLTEtMTE2ODQ_712acbe7-19a2-4697-b193-86d15466ec2b">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823" decimals="1" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzEwLTItMS0xLTk5ODg_b9fcd332-14ba-47a0-a203-d67586bd161b">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823" decimals="1" name="us-gaap:Goodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzUtMi0xLTEtNDMyMg_33b1772b-4350-4904-a19b-b2162d4eee31">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823" decimals="1" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzYtMi0xLTEtNDMyMg_01a18155-5ee5-4d76-8247-6d157e33607d">161.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company has determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets has been estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="ic439fbf0ea984bcba40c13f6cae3a03b_D20200823-20200823" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2Mzg_f8032829-ddc6-4476-a1dc-12e18a02cf05">18.0</ix:nonFraction>% rate. The cash flows are based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is <ix:nonNumeric contextRef="ic439fbf0ea984bcba40c13f6cae3a03b_D20200823-20200823" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2ODU_585256c9-4c46-4967-a7f5-5c3b4e4b559b">10</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill are based on synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical's sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i1d09efae7507467987336d04e3509634_D20200329-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1ODM_986f2b50-34ca-4d7c-ac0e-80bc026124d4">19.7</ix:nonFraction>&#160;million, which included hold-backs of $<ix:nonFraction unitRef="usd" contextRef="i862a3c45416648d297e125475abce254_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1Nzk_2d891b82-0857-4d02-b68e-8af1eaa25ad7">2.3</ix:nonFraction>&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's preliminary valuation, it has allocated $<ix:nonFraction unitRef="usd" contextRef="i862a3c45416648d297e125475abce254_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1OTE_81171914-42cd-44c7-b913-0c64d0e4e114">10.7</ix:nonFraction>&#160;million of the purchase price to the preliminary value of developed technology and $<ix:nonFraction unitRef="usd" contextRef="i862a3c45416648d297e125475abce254_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1OTU_06d08936-b9c4-4229-9235-435718c62bd1">6.2</ix:nonFraction>&#160;million to goodwill. The remaining $<ix:nonFraction unitRef="usd" contextRef="i862a3c45416648d297e125475abce254_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1ODc_c632c2f2-b457-44cc-92a1-1e7f18006d46">2.8</ix:nonFraction>&#160;million of the purchase price has been allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="ie33a898c5926488b9bf6ad622a0bd9a1_D20191230-20191230" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1OTk_294db286-d3a2-4fbd-b657-16d128a78f6d">18.0</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="i13b5b561b723452ba061ef7677378758_I20190928" decimals="-5" format="ixt:numdotdecimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MDc_22686315-ce4c-43d3-8514-45635eafe1ab">1.0</ix:nonFraction>&#160;million and contingent consideration which the Company has estimated at $<ix:nonFraction unitRef="usd" contextRef="i4c2998316cac4e238f728957efe3c4b1_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MDM_19aac112-8906-4074-be0a-8844eea5162f">0.9</ix:nonFraction>&#160;million. The contingent consideration is payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. Goodwill was immaterial. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased <ix:nonFraction unitRef="number" contextRef="ic533d50defe448fdb707c6f87a49077f_I20190801" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MTk_72fbcdda-dc9c-428c-a288-88a7a38d9579">46</ix:nonFraction>% of the outstanding shares of SuperSonic Imagine ("SSI") for $<ix:nonFraction unitRef="usd" contextRef="i22886537724e44318a4d4b7a40157a84_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MTU_1b9032cb-ff4a-4deb-a8ee-7a7beee76195">18.2</ix:nonFraction>&#160;million. SSI is a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;<ix:nonFraction unitRef="usdPerShare" contextRef="i90fc1953e74547ef8567e85c0335320d_D20190901-20190930" decimals="INF" name="holx:BusinessAcquisitionCashTenderOfferPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MjM_0b632d24-f7fc-4b6b-acc1-17f877845ff2">1.50</ix:nonFraction> per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i766ffebb6e8947339d74a13f473637aa" continuedAt="iae3ff50528234859833a882dc832daba"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 21, 2019 when the Company's ownership of SSI's voting stock exceeded <ix:nonFraction unitRef="number" contextRef="id37fc47d83b14b95b70cbb4ef25f42b3_I20191120" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MzE_bd40b9cd-67ea-41b6-9770-f34451ec65bd">50</ix:nonFraction>%. Accordingly, the Company initially accounted for this investment under the equity method of accounting and included its proportionate share of SSI's net loss of $<ix:nonFraction unitRef="usd" contextRef="ie68d86ac2e6a4c928f6d1a734e19ab2a_D20190728-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2Mjc_d4590ea0-326d-443d-b438-a78e8629b441">3.3</ix:nonFraction>&#160;million for the two months ended September 28, 2019 within Other income, net. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional <ix:nonFraction unitRef="shares" contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MzU_a040bb47-e71d-43fd-85a3-905b4e791520">7.6</ix:nonFraction>&#160;million common shares of SSI for $<ix:nonFraction unitRef="usd" contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:AdditionalPurchaseConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2Mzk_85a0a0a8-9176-4c05-be4b-3a7ac5b4a7cb">12.6</ix:nonFraction>&#160;million. As a result, the Company's ownership interest increased to approximately <ix:nonFraction unitRef="number" contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121" decimals="2" name="holx:BusinessCombinationOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NDM_b8f2ec55-bddb-43ef-b82b-e58899d583b7">78</ix:nonFraction>% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of <ix:nonFraction unitRef="number" contextRef="ic533d50defe448fdb707c6f87a49077f_I20190801" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NDc_4ad93797-d027-43bf-97b2-a1adc2712e65">46</ix:nonFraction>% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $<ix:nonFraction unitRef="usd" contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NTE_62b3468b-2059-41e3-86fe-a8d7510aa0c7">3.2</ix:nonFraction>&#160;million recorded in the first quarter of fiscal 2020. The total accounting purchase price was $<ix:nonFraction unitRef="usd" contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NTk_8a4f0658-663d-47c2-b2f5-e7209c7027b1">69.3</ix:nonFraction>&#160;million, which consisted of $<ix:nonFraction unitRef="usd" contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NTU_8b4350f8-e496-40d6-9790-9f34256ffe38">17.9</ix:nonFraction>&#160;million for the equity method investment in SSI, $<ix:nonFraction unitRef="usd" contextRef="ib35735436ab04420aac409cb3a577c1d_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NjM_cd1cce3f-83f3-4b20-b070-2e99e26fe2f4">12.6</ix:nonFraction>&#160;million for shares acquired on November 21, 2019, $<ix:nonFraction unitRef="usd" contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2Njc_de486272-1e18-4302-b071-072d1117b72b">30.2</ix:nonFraction>&#160;million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $<ix:nonFraction unitRef="usd" contextRef="icb6add9e14054057a65ac31b811fae48_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NzE_db796751-91b8-4a9c-a1bd-d2f538d1e3ac">8.6</ix:nonFraction>&#160;million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional <ix:nonFraction unitRef="shares" contextRef="if7876712181a4f0394252851c3247e89_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2Nzk_21e1e705-ded9-4920-8400-088521b1e03b">1.1</ix:nonFraction>&#160;million outstanding shares in fiscal 2020 for $<ix:nonFraction unitRef="usd" contextRef="if7876712181a4f0394252851c3247e89_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NzU_72ddf80d-2b01-4808-8427-5087acfa0f96">1.8</ix:nonFraction>&#160;million, and as of September 26, 2020, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i06df67bcc2a94911a7069e16ec48fb7a_I20200926" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2ODM_ede0024a-b027-473d-9b88-1c05b995c3c4">81</ix:nonFraction>% of the outstanding shares of SSI.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="if7876712181a4f0394252851c3247e89_D20190929-20200926" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2OTc_b466942e-e166-4982-bce7-4975735b2654" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"></td><td style="width:73.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzAtMS0xLTEtMTU5NzU_fae62a81-3383-4d94-9bab-7895b1a25d4a">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzEtMS0xLTEtMTU5NzU_be9e7571-c9a8-4157-b3c8-626285b8277c">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzItMS0xLTEtMTU5NzU_b6d0cc75-3b65-4637-a779-51a23bbfb0ed">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzMtMS0xLTEtMTU5NzU_b846b817-069a-40da-9e9b-857358342d64">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzQtMS0xLTEtMTU5NzU_976a4dec-a23d-49d6-85e6-fe45b4c4302c">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzUtMS0xLTEtMTU5NzU_50f96b88-2953-471a-a5c1-e050813f3d34">24.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzYtMS0xLTEtMTU5NzU_44d12628-bf37-4dcc-b72d-2be7180f03ba">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzctMS0xLTEtMTU5NzU_eb1757ba-3e47-4040-9956-df703d093dab">8.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzgtMS0xLTEtMTU5NzU_d1f40c4e-9fdb-419a-9368-db654110619f">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzEwLTEtMS0xLTE1OTc1_af29cfb9-d267-47c0-a66e-9f2e6a7dd258">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzExLTEtMS0xLTE1OTc1_1cc3be26-b29d-49bb-b368-a317acf2b3fd">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzEyLTEtMS0xLTE1OTc1_91b5e295-ec5f-45a8-a8c9-e98201db386d">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzEzLTEtMS0xLTE1OTc1_a2e53bf4-acae-4e8d-9743-f57acf477a75">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzE0LTEtMS0xLTE1OTc1_b2dbdc6a-ca54-4186-8b01-2f515ff944a5">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b884f4d126493b8f8989d941004da4_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzE1LTEtMS0xLTE1OTc1_4fa275e8-677e-4e1b-a009-485c93077ea8">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. The Company has not yet obtained all of the information related to the fair value of the acquired assets and liabilities, primarily income taxes and recognition of uncertain tax positions, to finalize the purchase price allocation.&#160;</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology, customer relationships, and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="i13dcce25b11542068d5ad5a656336c29_D20180930-20190928" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2OTk_f404f454-b1bc-49d8-9a63-4afcf245d8ce">12.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is <ix:nonNumeric contextRef="if2090212e7314cac8f3f33afb4394112_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NjA2NjQ_18531c64-4f56-4e28-b049-4f95bf5063aa">9</ix:nonNumeric> years, customer relationships is <ix:nonNumeric contextRef="i2576885bfe07425f9e425c469ebe8367_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NjA2MjE_e1e6c8bd-0768-4c7b-b371-1dad591d4fc3">9</ix:nonNumeric> years and trade names is <ix:nonNumeric contextRef="i02f15446f52343a9adfc4e8ef6c280fb_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NjA2MzY_0b7142e5-09cc-49da-9611-ff8173e91ac3">8.6</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill are based on synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="iae3ff50528234859833a882dc832daba" continuedAt="i686b31db6a2e47d6a4360bedb7dd5937"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Focal Therapeutics</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Company completed the acquisition of Focal Therapeutics, Inc. ("Focal") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="ia43db9b88a3d4ca894ba73187fb33e22_D20181001-20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzQzOTgwNDY1Mjk5MDY_c3cfbed1-87cc-4967-a491-56954f324910">120.1</ix:nonFraction>&#160;million, which included hold-backs of $<ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzQzOTgwNDY1Mjk5Mzk_0ab7501b-0cea-463f-9ff2-e85065c172db">14.0</ix:nonFraction>&#160;million payable up to <ix:nonNumeric contextRef="ia43db9b88a3d4ca894ba73187fb33e22_D20181001-20181001" format="ixt-sec:durwordsen" name="holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTExMzk_bae5e39a-19c1-48b0-9127-a389bd0fb989">one year</ix:nonNumeric> from the date of acquisition. In the second quarter of fiscal 2019, $<ix:nonFraction unitRef="usd" contextRef="i9c2a49b788f14bf48455c95dcf507a9e_I20190330" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzQzOTgwNDY1NjQ4MTU_5721c9f7-ac54-4e4d-a871-5740effeaea6">1.5</ix:nonFraction>&#160;million of the hold-back was paid, and the remaining $<ix:nonFraction unitRef="usd" contextRef="ie9c201c0913b44d98e588a279d1fe985_D20191001-20191001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzQzOTgwNDY1Mjk5MjM_9a44a3fd-31c0-48ae-b7f3-c6dd147e4f0f">12.5</ix:nonFraction>&#160;million was paid in the first quarter of fiscal 2020. Focal, headquartered in California, manufactures and markets its BioZorb marker, which is an implantable three-dimensional marker that helps clinicians overcome certain challenges in breast conserving surgery. Focal's results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="ica9f97800f804e4a9d1eae5069d40e02_D20190929-20200926" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA4ODk_3ed12157-d814-4fd9-84cf-337e9bb59802" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"></td><td style="width:73.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzAtMS0xLTEtNDI1MQ_91b05f2f-099a-4d0c-bc30-9bd3ab746d60">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzEtMS0xLTEtNDI1MQ_5fca6bfa-04ea-44bf-9a7c-90978417ad37">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzItMS0xLTEtNDI1MQ_9327b8ff-9769-4a0b-aed9-4f0fdbbc80ee">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzMtMS0xLTEtNDI1MQ_fb6ca4a5-090f-4c11-8b1e-b390183d8126">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzQtMS0xLTEtNDI1MQ_eff4de50-90b6-4330-8290-1b7a50c40a09">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzUtMS0xLTEtNDI1MQ_378a1879-d388-4af2-896f-bce050eae1f7">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f401bcab374c9da21ba458593af4a7_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzctMS0xLTEtNDI1Mw_cfef7dba-d1f9-4f8c-bfb1-7522bbaeff4a">83.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ab6ed21a0e49acb17f46bb533a208d_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzgtMS0xLTEtNDI1Mw_1333792c-1e35-4c44-8c86-14160f7ab26b">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72959050a334423eb15ca612ed289237_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzktMS0xLTEtNDI1Mw_d6a44fb9-c57b-4776-9ff0-9d3c4f17742d">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzEwLTEtMS0xLTQyNTM_e9db5036-242e-48a5-b620-b94642545dc5">12.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzExLTEtMS0xLTQyNTM_8b619103-face-403f-897a-78fde0dde7c2">31.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzEyLTEtMS0xLTQyNTM_ac1499e8-3eb7-4fda-a73b-a5189041d44a">120.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Focal's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, in-process research and development ("IPR&amp;D"), and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from&#160;<ix:nonFraction unitRef="number" contextRef="i6eb9aadeebec4587b35023639ede565a_D20181001-20181001" decimals="INF" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA4OTE_228037be-ed06-411f-b428-9d4a1ca19030">15.5</ix:nonFraction>%&#160;to <ix:nonFraction unitRef="number" contextRef="ieefe5f2ec3a649449b7f480aa2fad0c5_D20181001-20181001" decimals="INF" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA4OTg_ca198e4b-5fb0-4417-9d80-2779fde485db">16.5</ix:nonFraction>%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names was <ix:nonNumeric contextRef="ie12b0a99842a4517ba08e440afbc7c60_D20181001-20181001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA5MjE_17515ed1-4d68-4946-8a4d-15cbb43e0caa">11</ix:nonNumeric> years and <ix:nonNumeric contextRef="i847787c89a874c6892ea179463d444ff_D20181001-20181001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA5NDA_8b810dcc-6507-4929-b1c9-67d1681f3d98">13</ix:nonNumeric> years, respectively. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the amount of goodwill were based on synergistic benefits that are expected to be realized from this acquisition. Benefits include the expectation of broadening the Company's Breast Health portfolio of products and technology. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Faxitron</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2018, the Company completed the acquisition of Faxitron Bioptics, LLC ("Faxitron") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i17ca3ee0e1d24409acd2b837d6b9f512_D20180731-20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk0NTE_70ece8ef-76c9-4934-b165-29c7fb2b30ce">89.5</ix:nonFraction> million, which included hold-backs of $<ix:nonFraction unitRef="usd" contextRef="i22cb2f3e35b1476184e3b5ea02888210_I20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk0ODQ_47bee4b8-7f0b-4c56-bd5e-7e71c3480674">11.7</ix:nonFraction> million payable up to <ix:nonNumeric contextRef="ib017ae2e40794fb6b06de53aea426df5_D20180731-20180731" format="ixt-sec:durwordsen" name="holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk1MDE_04b07055-2bdc-4922-8b43-0c67cac3e469">one year</ix:nonNumeric> from the date of acquisition, and contingent consideration, which the Company estimated at $<ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk1OTQ_6453e67c-18cc-4e59-8c25-59a3e73690f7">2.9</ix:nonFraction> million as of the measurement date. Faxitron, headquartered in Tucson, Arizona, develops, manufactures, and markets digital radiography systems. The contingent consideration is payable upon meeting certain revenue growth metrics. In the fourth quarter of fiscal 2019, the Company increased the contingent consideration liability by $<ix:nonFraction unitRef="usd" contextRef="idf55a89911c2418c862ba56b871a233c_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzEwMDQ3_d063b984-5f7d-4fc9-852f-004138450926">1.7</ix:nonFraction> million based on updated projections, and the Company paid $<ix:nonFraction unitRef="usd" contextRef="iece20c91b1524a47b452db31a8c50766_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg3MjE_e27a46a6-e07a-43f7-b842-4db61e0dc56d">5.0</ix:nonFraction>&#160;million in the second quarter of fiscal 2020. During fiscal 2019, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i8e553e7d9bfc4efaafc3811a17018296_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzEwMTE3_bf050aa0-f9da-4720-a574-8f63b831bb57">6.5</ix:nonFraction> million of the hold-backs and withheld the remainder of $<ix:nonFraction unitRef="usd" contextRef="i8e553e7d9bfc4efaafc3811a17018296_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzEwMTY3_f8e2c4e9-e0cf-45a6-a180-8ae441108026">5.2</ix:nonFraction> million under the indemnification provisions of the purchase agreement, which the former shareholders had disputed. In the first quarter of fiscal 2020, the Company resolved this dispute and paid $<ix:nonFraction unitRef="usd" contextRef="id3a1dcaf42754d9c9a3ff74faf8f61fd_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="holx:PaymentOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg3MDc_9e2dceab-8bab-44e9-a967-fcd02663eae0">4.1</ix:nonFraction>&#160;million to the former shareholders. Faxitron's results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie9c4512920904aa3814e9c7a9fd62545_D20190929-20200926" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzE0MjAy_4328379e-fb2a-40b8-8cd6-71a4b0185d4a" continuedAt="i7bbc8cea86fc436697000dd9a3faf873" escape="true">The total purchase price was allocated to Faxitron's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of July 31, 2018, as set forth below:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i686b31db6a2e47d6a4360bedb7dd5937" continuedAt="i08d58225264f4c1096a1653e010558cd"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i7bbc8cea86fc436697000dd9a3faf873"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"></td><td style="width:73.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzAtMS0xLTEtMA_492a0b53-d91b-448c-b0bb-9390dc6a1cad">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzEtMS0xLTEtMA_8990054b-f71f-40cb-9bef-b60b8c53a2b3">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzItMS0xLTEtMA_b7aa5670-8069-4b69-92c1-c87924acb4fb">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzMtMS0xLTEtMA_7573af69-62b7-465e-b2a1-8089fb213bf4">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzQtMS0xLTEtMA_910b9d8b-fb4a-414f-9001-6916b1b9637f">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzUtMS0xLTEtMA_bfdb26a0-359e-459c-b541-d9e6dc0b42f3">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzYtMS0xLTEtMA_ad68d6c2-4dd8-4080-853f-decde256cf6a">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec87245e37445459f0a3ed8735ffec3_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzgtMS0xLTEtMA_5fb57a33-9cbe-4691-92a3-20cf058f279f">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b201cf75b8459db2ad76cb990ec129_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzktMS0xLTEtMA_838e6f78-44d1-4d70-a099-537ba3a21f3b">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f378dddadb4b4fac57b2fbc214b4c9_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzEwLTEtMS0xLTA_765af85b-fd00-4504-a8f2-10f2bf46486b">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045b09a2ab1943b59f87d6eb5f4942ef_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzExLTEtMS0xLTA_9b92d04b-b97b-4520-be26-63768e1951aa">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzEyLTEtMS0xLTA_c2d80063-2bd5-4dea-81a4-442bc98df033">10.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzEzLTEtMS0xLTA_2ed3cbe8-3a36-41a0-b17d-4563d1ccf8a7">45.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzE0LTEtMS0xLTA_a6b46fec-2206-49c5-be97-65bcdda1aaf1">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Faxitron's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, in-process research and development ("IPR&amp;D"), customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from&#160;<ix:nonFraction unitRef="number" contextRef="i3d6a98785a404f99847c50b43c96a34d_D20180731-20180731" decimals="2" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzExMDk3_abb61f5a-ae35-4004-bded-0d3f70d97168">17</ix:nonFraction>%&#160;to&#160;<ix:nonFraction unitRef="number" contextRef="i78dfbab8f2fc4de39f7b4e445e2589f2_D20180731-20180731" decimals="2" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzExMTAz_74fe6630-fe5e-43e9-b59f-1078c716375f">19</ix:nonFraction>%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for both developed technology and customer relationships is <ix:nonNumeric contextRef="id9916a6d68484e70bff8c6d8f2a2e4ad_D20180731-20180731" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzExNDI1_685e78cf-bf2e-44ce-ab36-047b2f9a3eb4">9</ix:nonNumeric> years and for trade names it is <ix:nonNumeric contextRef="i266eecec31bc4b7d8dcaf10d0b94db47_D20180731-20180731" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzExNDU0_673ab53d-5c5f-40af-a18b-0e07713543e9">7</ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill were based on synergistic benefits that are expected to be realized from this acquisition. Benefits include the expectation of broadening the Company's Breast Health portfolio of products and technology. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emsor, S.A.</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i08d58225264f4c1096a1653e010558cd">On December 11, 2017, the Company completed the acquisition of Emsor S.A. ("Emsor") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i4079f996b6274dfb9512d61934ca5bd0_D20171211-20171211" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2ODc_79881808-2547-410c-afc4-8dd33f1d59ba">16.3</ix:nonFraction> million, and contingent consideration, which the Company estimated at $<ix:nonFraction unitRef="usd" contextRef="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2OTE_7be1dbf5-5233-400b-ac0c-a772f564dfeb">4.9</ix:nonFraction> million as of the measurement date. The contingent consideration was payable upon Emsor achieving predefined amounts of cumulative revenue over a <ix:nonNumeric contextRef="icb2ff4168e384034bbf5532623a74329_D20171211-20171211" format="ixt-sec:durwordsen" name="holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NjA2ODc_c2a01a65-8aaa-419d-8f5d-29baab2a26ee">two-year</ix:nonNumeric> period from the date of acquisition. The contingent consideration was paid in the second quarter of fiscal 2020. Emsor was a distributor of the Company's Breast and Skeletal Health products in Spain and Portugal. Based on the Company's valuation, it allocated $<ix:nonFraction unitRef="usd" contextRef="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2OTU_1285c6a2-a29d-4d65-9954-f7bb2c7b50c8">4.6</ix:nonFraction> million of the purchase price to the value of customer relationship intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc3MDM_4d14f60d-cf9c-4e31-902d-633b91865c1f">5.7</ix:nonFraction> million to goodwill. The remaining $<ix:nonFraction unitRef="usd" contextRef="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211" decimals="-6" format="ixt:numdotdecimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2OTk_78556f0e-65aa-41f7-8f7b-ff8078dc9074">6.0</ix:nonFraction> million of purchase price was allocated to acquired tangible assets and liabilities.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. Restructuring and Divestiture Charges</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its operations for opportunities to improve operational effectiveness and efficiency, including facility and operations consolidation, and to better align expenses with revenues. As a result of these assessments, the Company has undertaken various restructuring actions which are described below. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzYzMzA_240858fe-5e8d-4717-8ce3-f9b950da733d" continuedAt="i54eab4775d114ebf838391c5daca1c8c" escape="true">The following table displays charges taken related to restructuring actions in fiscal 2020, 2019 and 2018 and a rollforward of the charges to the accrued balances as of September&#160;26, 2020:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i54eab4775d114ebf838391c5daca1c8c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.596%"><tr><td style="width:1.0%"></td><td style="width:34.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.946%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.946%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.946%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2018 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Restructuring Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2018 charges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTEtMS0xLTEzOTUz_f3a7b4ce-f59a-4cf1-a129-63b2daa57ebd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTEtMS0xLTA_8d13a8f7-7427-4d40-a256-2fc35505af01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTMtMS0xLTA_7d711a79-8233-4e93-8b39-7c2719064dcf">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7847ac8d91804cd389031be4f03425da_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTctMS0xLTA_658c40fd-7bd3-4649-94d2-8e9510bb6341">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTExLTEtMS0w_2cc62a7b-e5d4-4eb6-ac89-7ac0e53e5811">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTEtMS0xLTEzOTU4_b0da0485-29fa-4576-991b-4418ae4fca56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTEtMS0xLTA_1859a341-5b7b-45b7-95e5-a21aeb74b3fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929" decimals="-5" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTMtMS0xLTA_f879813d-8bda-4dfb-80ad-b105363b79d9">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7847ac8d91804cd389031be4f03425da_D20171001-20180929" decimals="-5" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTctMS0xLTA_fa54a94c-1c68-4364-9290-c151f2837f1d">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929" decimals="-5" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTExLTEtMS0w_e90f036c-9528-4fbf-a68b-18c94dd38091">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2018 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTEtMS0xLTEzOTYw_18d260f8-e92c-47a4-925e-88ac90d9bceb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTEtMS0xLTA_9c854306-2342-4ff0-9dff-872506f2450e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTMtMS0xLTA_a11bd0f1-f217-40f9-859f-6e5df881a1b1">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7847ac8d91804cd389031be4f03425da_D20171001-20180929" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTctMS0xLTA_80c864c8-0763-4dc6-8a44-370e45e82912">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTExLTEtMS0w_7a5801c8-e43f-4f5c-aedc-36dce031b4f4">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTEtMS0xLTEzOTQ3_9ffa0d34-2e30-42ae-9747-f82cdf2ce3bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTEtMS0xLTA_e7d81f1d-cf41-4a70-8342-323a11929eaa">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTMtMS0xLTA_ca9e3505-fc35-4d9b-bf43-ee12a8274970">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40fdaceff578441ea2d62d53dd29115e_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTctMS0xLTA_1525cdb6-87fa-4b9a-aee2-93adbe3919f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTExLTEtMS0w_7def55db-c339-4957-a118-8d77de46cdf0">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTEtMS0xLTEzOTQ5_de81c287-7129-4303-8d71-dbd45eeb101a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTEtMS0xLTA_cf680f96-34fa-4667-87c5-cc1dbc5e7bdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928" decimals="-5" sign="-" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTMtMS0xLTA_2ce2cde6-a46c-42c3-9d89-80958b70f220">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40fdaceff578441ea2d62d53dd29115e_D20180930-20190928" decimals="-5" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTctMS0xLTA_6eedb836-2079-445d-84b0-70f8f79c824b">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928" decimals="-5" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTExLTEtMS0w_b28b1986-5044-49ea-88ad-56d20d349d07">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTEtMS0xLTEzOTUx_b8aa05f6-e239-4b29-aec2-9b53f3b0ce5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTEtMS0xLTA_1c5c11b5-8e21-4477-b524-2d2ae092898b">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTMtMS0xLTA_55bc9da0-8f15-4089-a1f3-8d61e3d72657">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40fdaceff578441ea2d62d53dd29115e_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTctMS0xLTA_8e32645e-d005-45da-a13e-fcdacd41c36a">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTExLTEtMS0w_ca015fb4-c676-4ae5-9758-6ed86a7d62cd">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eba256d6a1542db8c06d5ffa4b20a07_D20190929-20200926" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTEtMS0xLTEzOTQy_65dcdb30-cb55-48f3-8db4-10b3d9689ea3">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6630fc5f65496eaec9acaa3d5c7aba_D20190929-20200926" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTMtMS0xLTEzOTAx_422a02d5-940b-4d17-98c4-355c31bd4b74">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i585bf0cfe60944f78c6482f3beb7d14b_D20190929-20200926" decimals="-5" sign="-" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTUtMS0xLTEzOTA3_7a401d2f-d430-44ab-9f91-f9bd5468a4d7">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia99af639d7f84346aca75ba9ef329ad7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTctMS0xLTEzOTEz_e8dab73b-fcb0-4697-be8c-68ac9d8a9dae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad1871e11b04ce3a9b3d2d7995b3439_D20190929-20200926" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTExLTEtMS0xMzkxOQ_4815162c-75ae-4770-abfb-99d77bd8decb">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Divestiture charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eba256d6a1542db8c06d5ffa4b20a07_D20190929-20200926" decimals="-5" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTEtMS0xLTEzOTI1_ee11debe-80a2-401a-847d-874aac14fe9e">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6630fc5f65496eaec9acaa3d5c7aba_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTMtMS0xLTEzOTAz_51882956-64a7-4ae4-9382-b81b4d4c7467">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i585bf0cfe60944f78c6482f3beb7d14b_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTUtMS0xLTEzOTA5_133e977b-de27-43f7-a60c-6ad5d52be825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia99af639d7f84346aca75ba9ef329ad7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTctMS0xLTEzOTE1_379c47ff-00cb-4fa7-b0ba-bec3bf16ba69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad1871e11b04ce3a9b3d2d7995b3439_D20190929-20200926" decimals="-5" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTExLTEtMS0xMzkyMQ_377c0c67-63bf-4b67-a0cf-3bce3ffc8257">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eba256d6a1542db8c06d5ffa4b20a07_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTEtMS0xLTEzOTQ0_165753d0-2f6e-4265-9668-37b2eb0391a9">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6630fc5f65496eaec9acaa3d5c7aba_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTMtMS0xLTEzOTA1_d82414df-3313-4f0b-866f-2b7d8014882f">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i585bf0cfe60944f78c6482f3beb7d14b_D20190929-20200926" decimals="-5" sign="-" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTUtMS0xLTEzOTEx_f7a30706-9095-45e1-bbbf-af80ca479e60">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia99af639d7f84346aca75ba9ef329ad7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTctMS0xLTEzOTE3_a574621a-b825-446a-b2d9-8ab1fb1b6475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad1871e11b04ce3a9b3d2d7995b3439_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTExLTEtMS0xMzkyMw_91a0879c-f85d-4d67-a912-afccb3666d18">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzYzMjc_84af7b4a-6d3d-4e5e-8247-24b81e2f4a1c" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.523%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.523%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.523%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.523%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2018 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2017 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Previous Other Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Rollforward of Accrued Restructuring</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2017</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia488122214b14db38171d7681cd5d254_I20170930" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzItMS0xLTEtMTQwNTY_ffb2af82-0251-44a7-a64b-d613301a0e03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cef01ab57d64322aacba4e684ef1326_I20170930" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctMS0xLTEtMA_25cf8a15-44eb-4049-ab47-09a284a4b5c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84c64923b6e84649978c4e2b356e67ae_I20170930" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctMy0xLTEtMA_def7006b-f292-4e76-aee2-f81c3b59ac1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245b71f07dc5421b90a64dfe2ca519cf_I20170930" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctNS0xLTEtMA_9c4b77ee-0c07-4359-a55f-1074de429e8b">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7917afc51a284eb389f470fc51464390_I20170930" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctNy0xLTEtMA_e155c171-86fe-4617-b477-10750b371277">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c335097c1214c7b8b5089dfca5b78e6_I20170930" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctOS0xLTEtMA_6d69bc0d-e4d2-431f-a8b0-6d802b4f5419">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2018 restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzQtMS0xLTEtMTQwNjI_2eecd301-ef31-4c99-a550-c6f81b2335cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktMS0xLTEtMA_eb5b0029-e4da-42ac-84d3-e33b14312e19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktMy0xLTEtMA_12c9b35a-0d77-467b-a11d-c5b030a5f2ed">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktNS0xLTEtMA_45405b1a-dc79-4faf-9877-932ff556c588">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktNy0xLTEtMA_c8fdcf0d-2f68-4733-bdca-7791f8d10420">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktOS0xLTEtMA_8b7c2d8f-0bbd-4d30-8ad7-14a3ad900795">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzUtMS0xLTEtMTQwNjU_4e989647-a66d-4a49-928f-136f3d7a8e6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTEtMS0xLTA_73a3c9bf-d410-4d51-ba3b-626eb1924b94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929" decimals="-5" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTMtMS0xLTA_94dbe48b-eba0-4222-ad6f-6bfba0280ae5">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTUtMS0xLTA_8983ce37-7dd1-49a5-b474-fece4dff4e0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTctMS0xLTA_0a7de33b-e71c-4aed-ab8d-a9caa6fd24c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929" decimals="-5" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTktMS0xLTA_7c07e53e-b4e2-48a5-a847-4788616ad314">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzYtMS0xLTEtMTQwNjc_4aaa798c-1ef9-4091-9310-2867593c503a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTEtMS0xLTA_fa9da56e-120c-4a81-8d86-c1fd30954e30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTMtMS0xLTA_d848aab5-38d7-4062-980e-9f0c113d7a64">6.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTUtMS0xLTA_9a8488c9-f4d3-4b99-8671-28a90e45ec16">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTctMS0xLTA_23bdacd3-cedd-43b5-9f55-b373b0150750">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTktMS0xLTA_7f3ed035-9e62-487f-85fe-0c86ca7689c4">13.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctMS0xLTEtMTQwNjk_1c4897f6-d3a5-4385-9d1a-b9f56198e893">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTEtMS0xLTA_6837d63a-0956-4480-b854-88cdc793d938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTMtMS0xLTA_080989ca-9fad-45c9-afc8-c84f852f77bc">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTUtMS0xLTA_139aea86-8c99-40e4-83a4-1aea5e51d3f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTctMS0xLTA_144dcc7f-43c7-41c8-925d-2f846589ef24">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTktMS0xLTA_b80a48a7-f8ed-490c-b79e-5da326856901">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 29, 2018</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id214db94d871423c97d744696fba6ee9_I20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzgtMS0xLTEtMTQwNzE_ec0d1d3e-a9ef-47cb-b56d-bfd41b6f32ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383968572a2740c4b1b1c3a6102235ad_I20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTEtMS0xLTA_9147b706-72ca-4193-bafb-f1601adb5e01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8fe4ad3af14cb080a973256cf16e71_I20180929" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTMtMS0xLTA_8856d16c-e62a-431b-8ddb-e995b39bc8b2">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a33f36d28a4ad59b7fcbc84448ad87_I20180929" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTUtMS0xLTA_e9a85aa5-5c43-4d9e-acb7-3eef4eef1137">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1545ced1b6bf4384a44fd70aaf8d5dc0_I20180929" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTctMS0xLTA_1a98b851-7489-4771-98c7-37348ff58dd6">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ided55a75f2a34ea9b423f3093d7e3bf2_I20180929" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTktMS0xLTA_6efbbf04-5962-46ee-bcf1-b20a08a21137">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTEtMS0xLTE0MDcz_08b81950-6b73-4e30-ad3a-0f3c3e1fe643">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTEtMS0xLTA_4b2a697b-4665-4a70-be53-69f353a307ec">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTMtMS0xLTA_f4cab64b-8504-4443-9de8-90e6708b15b3">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fe25951b1d47608e534a368540c8f7_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTUtMS0xLTA_9becf455-1add-4400-97a1-30c16302d06c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4caceec0ff464ef58e11ca526344ce87_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTctMS0xLTA_c79558db-3cc1-4261-b703-6143b8e6865b">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTktMS0xLTA_3af11d37-a742-4070-89dd-3ff159d38f22">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTEtMS0xLTE0MDgw_950b2283-6c01-4b51-92d2-0ad47f33768d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTEtMS0xLTA_6c701e8f-2a08-4e4b-ad0a-d4dac1dd77d0">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTMtMS0xLTA_aec2690d-2573-455a-804f-24dbe86c0b57">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82fe25951b1d47608e534a368540c8f7_D20180930-20190928" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTUtMS0xLTA_396facec-3fe9-4b98-a33b-7af11998f845">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4caceec0ff464ef58e11ca526344ce87_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTctMS0xLTA_72bae1bc-9af6-4a12-8ba7-b3208ee092f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTktMS0xLTA_ecb90bd1-b63b-4cea-93b8-d28209ce6e26">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTEtMS0xLTE0MDgy_36285bea-c6f4-4961-b258-027dc412045c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTEtMS0xLTA_6f968750-00ea-4d2a-90b8-bfca57fab983">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTMtMS0xLTA_e91f8f29-10fa-4a6e-b4f2-aa6221d6b853">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fe25951b1d47608e534a368540c8f7_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTUtMS0xLTA_af77984b-5cfc-4fed-9864-9614220e1dc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4caceec0ff464ef58e11ca526344ce87_D20180930-20190928" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTctMS0xLTA_5779b1eb-743c-4f9a-8096-53538c29b4c0">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTktMS0xLTA_206d1b5e-3636-4ccb-8be0-e3fc4286e2d8">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 28, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41126a20c7047088eb9a490e7b9aaaf_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE0LTEtMS0xLTE0MDg0_5c3ea22f-8483-4ec7-b489-af223d08273a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfa048e3caf49b6b54a8569a1e075b7_I20190928" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTEtMS0xLTA_362a5fd4-9a1b-422e-889a-cd74745a9253">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f7c0803ecd34f7192e3525b7d33f970_I20190928" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTMtMS0xLTA_8ccbd9f1-30fd-4988-9120-e8db59e634a9">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e85e552551046dd94bb25760309804f_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTUtMS0xLTA_33d0307b-1b98-4141-9692-66071fcd4634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092a31ade66f4c8eba80fb2ee0565ae7_I20190928" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTctMS0xLTA_f9b09ab9-7401-43e5-8433-9b4ff4b7dda3">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i405e231a699e41a6b9f765aee4c70e34_I20190928" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTktMS0xLTA_0ac08fcc-32d9-42e4-a8ef-59fe0256f92d">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTEtMS0xLTE0MDMw_8330adc8-327d-4cf7-8130-aee7bfdfe78f">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107f31108f574bb2985391d4a79fc410_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTMtMS0xLTEzOTg2_f2ac33c5-953a-480d-91f6-0874997aea25">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926" decimals="-5" sign="-" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTUtMS0xLTEzOTk4_391fc639-a28f-4252-a916-b0adbe34bc78">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTctMS0xLTE0MDA2_a2a1d58d-4836-4bd2-9e65-a63d95950de0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTktMS0xLTE0MDE0_842c623a-0d68-4935-9a9f-79bd57e08871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTExLTEtMS0xNDAyMg_037d6290-8a16-4155-b8c9-cb7dee12f449">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926" decimals="-5" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTEtMS0xLTUyNDc_93015386-5e7b-488e-adc0-309f5517c784">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107f31108f574bb2985391d4a79fc410_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTMtMS0xLTEzOTky_26fd3852-4213-466f-8bf0-5cf41689ad95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTUtMS0xLTE0MDAw_7f65569b-c99a-45fd-8621-0a87ae698fea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTctMS0xLTE0MDA4_07bc4595-d05f-4c94-a433-f28f452cd480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTktMS0xLTE0MDE2_c3f4b2fd-f401-4b59-bd48-e59dbcc0df1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926" decimals="-5" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTExLTEtMS0xNDAyNA_f82baa4f-b7e5-4a64-b9f8-46fc991595eb">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTEtMS0xLTE0MDQ4_20b66bf8-18aa-4bf4-8679-e8d388df6cf9">4.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i107f31108f574bb2985391d4a79fc410_D20190929-20200926" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTMtMS0xLTEzOTk0_a0b150f6-56da-46b5-8a17-dbb4dcf7b86e">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTUtMS0xLTE0MDAy_7dddb3b2-8b63-4b5d-806a-9a9376d6d246">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTctMS0xLTE0MDEw_2e62472c-0ca2-45c4-80d6-17ac99ca0df8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTktMS0xLTE0MDE4_7f6b6b21-511e-47df-9889-b8b787bbcb17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTExLTEtMS0xNDAyNg_ff70dcd0-a64d-4300-b95b-55dd5c44be9e">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments and adjustments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926" decimals="-5" sign="-" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTEtMS0xLTY0OTM_6920a30e-2c9c-4fb9-aae0-6844ba66a472">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107f31108f574bb2985391d4a79fc410_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTMtMS0xLTEzOTk2_ee6276d9-cf9e-4c75-b97d-2cc5cc053dda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTUtMS0xLTE0MDA0_83c3d122-21c7-4d47-affe-d1db38f78871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTctMS0xLTE0MDEy_c10f9451-7845-4926-8ee2-679d6d3785db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTktMS0xLTE0MDIw_c7d0bf9c-46f2-4825-b1c4-91302f9ccdde">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTExLTEtMS0xNDAyOA_00426201-2249-4ccc-a575-160a5ce3dbbe">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 26, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13214cc3feb64fcf927862343c34707b_I20200926" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTEtMS0xLTE0MDU0_edbeb61f-5996-4da5-9099-9bdb670ff1b0">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644ee2acfbde47e4a5410d9be6acf9cd_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTMtMS0xLTEzOTc0_f0538032-0c21-47aa-90d1-bbb2627f12cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bf13b4f96464ec4bab32a562712a405_I20200926" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTUtMS0xLTEzOTc2_9d23ce8c-5dd2-4034-ac01-a2ba05009f30">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a3bbfc15f424fce8faf36fa3102c868_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTctMS0xLTEzOTc4_1a728fcc-9643-478e-ac9d-233db05a026b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff6affa1f43454fb0e3a3b5001fa866_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTktMS0xLTEzOTgw_55410072-6bf3-4f71-802d-0adce5edeeaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7868b801a844b96ba9f57ab9d96e829_I20200926" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTExLTEtMS0xMzk4Mg_7b26a210-2f4b-4d9f-ae0e-aadfb7490235">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) In fiscal 2020, as part of the adoption of ASC 842, the Company reclassified $<ix:nonFraction unitRef="usd" contextRef="i9a76896977394657b24f892dabfb2d28_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:RemainingLeaseBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzM1MTA_e9dda07b-7aff-4267-a343-fb63032550b1">3.8</ix:nonFraction>&#160;million from a lease liability to offset the right of use asset on the Company's consolidated balance sheet.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020 Actions</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, the Company made various decisions to terminate certain personnel across all divisions in multiple departments, transfer production and close certain manufacturing facilities for minor product lines. The Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEyNTg_38b0d351-c698-4458-9f22-1c4580877eba">13.4</ix:nonFraction>&#160;million for severance and benefits related to these actions. The charges were recorded pursuant to ASC 712, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Postemployment Benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 712) or ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 420), depending on the employee. Included within this charge was $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEyODg_19b3d772-9908-45dd-9441-f31288e0d51b">5.0</ix:nonFraction>&#160;million related to the modification of equity awards for a certain executive. The Company expects to record additional charges related to these actions totaling $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" format="ixt:numdotdecimal" name="holx:ExpectedFutureSeveranceCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEyNzM_aaaf7e63-5965-4d33-838b-aba69f6a8ae7">1.7</ix:nonFraction>&#160;million over the next twelve months, primarily related to the closure of its Sunnyvale, CA location as the Perinatal production line is being transferred to San Diego.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, the Company recorded net divestiture charges of $<ix:nonFraction unitRef="usd" contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328" decimals="5" format="ixt:numdotdecimal" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEzMDI_331c4f8f-46ef-49e4-a213-00515508a4d6">1.9</ix:nonFraction>&#160;million. The charge included $<ix:nonFraction unitRef="usd" contextRef="i3b403fb32e214730a66931c9f20f7ee5_D20191229-20200328" decimals="5" format="ixt:numdotdecimal" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEzMTY_e48d0794-dad5-4a93-8126-ac9eabe60875">1.3</ix:nonFraction>&#160;million to dispose of the Company's life sciences testing business located in the UK, which performs research testing for pharmaceutical companies. Separately, in connection with the Cynosure divestiture, the Company accelerated stock compensation expense and other benefits of $<ix:nonFraction unitRef="usd" contextRef="ia9ffe8cc379041dc95ec1a2845bdef3c_D20191229-20200328" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEzMzA_de78455c-6be4-4560-bd35-11894ae20581">2.6</ix:nonFraction>&#160;million, partially offset by other adjustments of $<ix:nonFraction unitRef="usd" contextRef="ia9ffe8cc379041dc95ec1a2845bdef3c_D20191229-20200328" decimals="-6" format="ixt:numdotdecimal" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEzNDQ_4647adf0-9dca-41c9-bc81-1d2f890b6670">2.0</ix:nonFraction>&#160;million.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019 Actions</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company decided to transfer certain shared services positions to its Costa Rica facility from its Marlborough location and announced the termination of 24 personnel and implemented other employee termination actions. The charges for these actions are being recorded pursuant to ASC 420 for one-time termination benefits. The Company recorded severance benefits charges of $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4Xzk4Nw_b776bdb3-0bbb-4767-8a57-22e0d164073a">4.0</ix:nonFraction> million in fiscal 2019 related to these actions and this action was completed in the first quarter of fiscal 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2018 Actions</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first, second and third quarters of fiscal 2018, the Company decided to terminate certain employees across the organization, including a corporate executive and primarily sales and marketing personnel in its Diagnostics and Medical Aesthetics reportable segments. The charges were recorded pursuant to ASC 712 or ASC 420 depending on the employee. As such, the Company recorded severance benefits charges of $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzE3NDE_10c8924c-8352-4623-92de-c4c23b338b96">9.0</ix:nonFraction> million in fiscal 2018. Included within the charge was $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzE3OTA_330aab57-7409-4c67-b120-7b7df41faae8">1.3</ix:nonFraction> million related to the modification of equity awards.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company finalized its decision and plan to consolidate its legacy international accounting and customer service organizations into its Manchester, UK location and eliminated positions in Belgium, France, Italy, Spain and Germany. During fiscal 2018, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i18bb9b460f2948c6b33b79494de5a775_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzIyNTM_de1bcbdc-1655-4f58-9b9d-9eca2080371d">2.2</ix:nonFraction> million for severance benefits pursuant to both ASC 712 and ASC 420 depending on the legal requirements on a country by country basis. The Company recorded an additional $<ix:nonFraction unitRef="usd" contextRef="i7d2600bf769f47179667bb435345373d_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzI0MTg_c04170fd-9cd8-4eb8-8c13-afc8b2ea0107">1.0</ix:nonFraction> million in fiscal 2019 for the remaining pro-rata charges. This transition was completed in the first quarter of fiscal 2019.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of fiscal 2018, the Company determined it would not use warehouse space located on Lyberty Way in Westford, Massachusetts. The Company met the cease use date criteria in the third quarter of fiscal 2018 and estimated the time period to sublet the space and related sublease rates resulting in a lease obligation charge of $<ix:nonFraction unitRef="usd" contextRef="i75761de28d1343d2a77be06b0d507b3d_D20171001-20180630" decimals="-5" format="ixt:numdotdecimal" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzM2MDU_a25aa9b8-a7fa-4cf0-8927-29c8ec885eff">0.9</ix:nonFraction> million. During the first quarter of fiscal 2019, the Company executed a termination agreement with the landlord and agreed to pay a termination payment of $<ix:nonFraction unitRef="usd" contextRef="i762786f0664c4c22b2ae67f6b01c9bd8_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="holx:Propertyclosurecostpayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzM3NTY_c0e510ee-8c47-41bb-be0e-404c6e825889">0.6</ix:nonFraction> million resulting in a benefit of $<ix:nonFraction unitRef="usd" contextRef="i762786f0664c4c22b2ae67f6b01c9bd8_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="holx:Propertyclosurebenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzM3ODU_626c9f5e-3742-4e2a-bf5e-9995d664ef54">0.3</ix:nonFraction> million recorded in the first quarter of fiscal 2019.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the closure of the Bedford location during the first quarter of fiscal 2017, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i4b4bd78551ab435bb3059282b0371b60_D20171001-20171230" decimals="-5" format="ixt:numdotdecimal" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzUwNDg_e5c7966e-7bcf-451e-9ac5-a02969338e6c">3.5</ix:nonFraction> million for lease obligation charges related to the first floor of the facility as the Company determined it had met the cease-use date criteria. The Company made certain assumptions regarding the time period it would take to obtain a subtenant and the sublease rates it could obtain. During the third quarter of fiscal 2017, the Company updated its assumption regarding the time period it would take to obtain a subtenant at the Bedford location and as a result recorded an additional $<ix:nonFraction unitRef="usd" contextRef="i0932a399229f47ac83074c5e06bbc0c6_D20170402-20170701" decimals="-5" format="ixt:numdotdecimal" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzU1Mjk_7919ed34-9dc9-4abb-af5f-a502b3ae740a">1.3</ix:nonFraction> million lease obligation charge. During the third quarter of fiscal 2018, the Company further adjusted its assumptions and lowered the estimate of the sublease income rate and extended the time period to obtain a sub-tenant. As a result, the Company recorded an additional charge of $<ix:nonFraction unitRef="usd" contextRef="i520af16098c04865986cb5e430b160c5_D20180401-20180630" decimals="-5" format="ixt:numdotdecimal" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzU4MDc_71c7676f-0052-4664-8430-adb5b71f0e1f">1.6</ix:nonFraction> million. During the third quarter of fiscal 2019, the Company further updated its assumption regarding its ability to sublet the first floor and recorded an additional lease obligation charge of $<ix:nonFraction unitRef="usd" contextRef="if2da745af2d74be6a6328bb22fc1c348_D20190331-20190629" decimals="-5" format="ixt:numdotdecimal" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzU5OTc_64fe0675-964c-442e-b367-5581c5e1e5fb">1.4</ix:nonFraction> million. These estimates may vary from the actual sublease agreements executed, if any, resulting in an adjustment to the charge. The Company has vacated other portions of the building but not the entire facility, and at this time does not meet the cease-use date criteria to record additional restructuring charges. In connection with the adoption of ASC 842, the Company reclassified the remaining accrued lease balance of $<ix:nonFraction unitRef="usd" contextRef="i9a76896977394657b24f892dabfb2d28_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:RemainingLeaseBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzM1MjQ_bd25b1e2-0d6b-4d34-a0e7-55d5728edf1e">3.8</ix:nonFraction>&#160;million from restructuring to offset the right of use assets on the consolidated balance sheet.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_163"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDg5_b7f29e32-ba2c-492a-84e1-46ff265683bb" continuedAt="i084f293f356c45bc88ee44d6c4364cff" escape="true">Borrowings and Credit Agreements</ix:nonNumeric></span></div><ix:continuation id="i084f293f356c45bc88ee44d6c4364cff" continuedAt="ie74812029b214d8db387a0221d0b1350"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDY5_6687be60-d219-4008-9778-0e4460ff685f" continuedAt="ib9d7fb3ec52e49c7aab27420be66943f" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:82.456%"><tr><td style="width:1.0%"></td><td style="width:67.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzItMS0xLTEtMA_2210d285-2def-462e-9a71-97946feffca0">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb22b22b518245c5af080bc07bace384_I20190928" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzItMy0xLTEtMA_01cc8280-5746-4322-9192-c6afb375708e">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fd7ad15f5e24a678e288eb53e978668_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzMtMS0xLTEtMA_051b13c2-56bb-4fc5-b035-68e57728d782">250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d56d6d8a714585ac83977c31d4ab60_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzMtMy0xLTEtMA_d916ad9c-266a-43ce-a543-e7de27ab6343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80a9b5c1e0a48b8a0ad99dbff5d9c5b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzQtMS0xLTEtMA_6f042e21-bf86-499b-b938-1e12815a50c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1b2436330a4b7a9a2624f5cd7ca5cf_I20190928" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzQtMy0xLTEtMA_a0087821-9108-407e-a25d-3c0675f71719">234.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzYtMS0xLTEtMA_3f872025-efb7-4172-9a1d-87f52c0ef593">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzYtMy0xLTEtMA_037febfa-ed7f-46c0-bfc6-199fd200dc1c">271.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzgtMS0xLTEtMA_948b560d-c160-4428-b1b9-cc826f87a093">1,379.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb22b22b518245c5af080bc07bace384_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzgtMy0xLTEtMA_0b1b75b8-6237-40f2-851b-7626cdbe5971">1,452.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzExLTEtMS0xLTA_196204ed-20eb-4df6-af16-c2f94cb4705f">939.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9495f528a35e4d6db0680ff16dda56e4_I20190928" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzExLTMtMS0xLTA_11e8fd8c-1f3c-4a76-a158-0de251101a3f">937.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzEyLTEtMS0xLTA_e6589b5b-0a80-4d70-8824-fdb2b6c6d0bb">394.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfc9503585304f80b0bda5108dc6141d_I20190928" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzEyLTMtMS0xLTA_1a77d15b-4a3c-404e-9cd1-859f65d2ba19">393.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzE0LTEtMS0xLTA_359e59e6-c0e7-4121-ad14-010ce4a02558">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzE0LTMtMS0xLTA_cd45fe8d-9e9f-44dd-bd40-6c896e6323cd">2,783.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzE1LTEtMS0xLTA_38879db3-a706-419d-8f13-f4be63cae315">3,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzE1LTMtMS0xLTA_2bfb57a2-aaac-43f2-aa32-c5291b4eebab">3,055.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDcw_9fd7695a-6b63-4e1c-ae51-3246598c6bd6" escape="true"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt maturity schedule for the Company&#8217;s obligations as of September&#160;26, 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026 and Thereafter </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtMi0xLTEtMA_b9d48f28-cab1-43b3-a575-2d4dc9257a53">75.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtNC0xLTEtMA_dcf163dc-7e02-4ccb-b0cd-981c207f9937">75.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtNi0xLTEtMA_3e451744-cd08-4aef-83fe-2370d9387843">112.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtOC0xLTEtMA_48d42013-6a7b-43ed-bbc8-f1d6c922fb0f">1,200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtMTAtMS0xLTA_13c9e61c-adc5-45ca-a081-f934017d1bed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtMTItMS0xLTA_ccab034e-8f73-4403-97fa-df4d57ad55c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtMTQtMS0xLTA_95d04f5e-6154-412d-bc66-a23f5e969449">1,462.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtMi0xLTEtMA_73cbf36f-77dc-4df7-bcdb-d3947cb3a7f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtNC0xLTEtMA_76e816a7-d77b-426c-8646-8893c125adfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtNi0xLTEtMA_a64cf92f-2f61-4eed-96e0-4743abd3d5b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtOC0xLTEtMA_5600bc7d-cd40-4926-afab-d72dc0360ed3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtMTAtMS0xLTA_07a3fa25-2ab8-46a1-9d76-06301695a3c4">950.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtMTItMS0xLTA_2fc3e76a-3c24-4bda-a7fe-d918fac7d6f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtMTQtMS0xLTA_112d390d-25ad-4860-8ae1-ca8efc8e9e53">950.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtMi0xLTEtMA_e5874d2c-2a2a-4a61-8d80-e61b42725fec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtNC0xLTEtMA_5256bf3d-9fc6-47c3-8656-a8f2a7c7c3d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtNi0xLTEtMA_240f2fe1-877b-488c-8cc8-e1d128d2bc70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtOC0xLTEtMA_95cb1247-5f80-4bc4-941e-205d2a72bdb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtMTAtMS0xLTA_ad7c251f-f43a-4157-b837-b8025a2eb461">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtMTItMS0xLTA_272351d6-0a02-443b-bb53-329072533303">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtMTQtMS0xLTA_7c62f13d-88bd-4a19-af9b-7746debaa45e">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtMi0xLTEtMA_4cbc8131-8249-4ee8-a7d9-6bfe16a229b3">325.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtNC0xLTEtMA_e3179fa8-9a01-4e7f-805f-7cbad45ca80c">75.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtNi0xLTEtMA_27daba4e-9729-4e72-8f29-9fe8077c54ab">112.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtOC0xLTEtMA_4a8abc33-3cc6-4159-b21b-fc9c8f3e1f2c">1,200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtMTAtMS0xLTA_50423ea0-76d8-4686-a480-d78d24a04db1">950.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtMTItMS0xLTA_064a5b0b-1fce-43c7-8717-681b4802a6cf">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtMTQtMS0xLTA_decccd06-dbfb-4e96-9033-98887fd3a04f">3,062.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement as of October 3, 2017 ("2017 Credit Agreement"). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2018 Credit Agreement consist of:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $<ix:nonFraction unitRef="usd" contextRef="i855bab3266d4415c8e89b6d9be79edb6_I20181217" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzgyMw_eb2a4dd6-a61f-4175-8f40-5b05f1449a94">1.5</ix:nonFraction> billion secured term loan ("2018 Term Loan") with a maturity date of December 17, 2023; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility ("2018 Revolver"; together with the 2018 Term Loan, the "Amended Credit Facilities") under which the Company may borrow up to $<ix:nonFraction unitRef="usd" contextRef="i643139a0070945419368a19ab57e080d_I20181217" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwOTc_37fd6526-3645-4e23-bd6b-0b4c8ed56f5c">1.5</ix:nonFraction> billion, subject to certain sublimits, with a maturity date of December 17, 2023.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company initially borrowed $<ix:nonFraction unitRef="usd" contextRef="if777467cbe914235ad2b43c07ebb9e28_D20181217-20181217" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEyMDY_e08e1845-d2d3-44ff-8dd4-55dfbe6dd8f7">350</ix:nonFraction> million under the 2018 Revolver. This initial borrowing, together with the net proceeds of the 2018 Term Loan, were used to repay the amounts outstanding under the term loan and revolving credit facility under the 2017 Credit Agreement.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2018 Credit Agreement bear interest, at the Company's option and in each case plus an applicable margin as follows: </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">2018 Term Loan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: at the Base Rate, Eurocurrency Rate or LIBOR Daily Floating Rate,&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">2018 Revolver</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: if funded in U.S. dollars, the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate, and, if funded in an alternative currency, the Eurocurrency Rate; and if requested under the swing line sublimit, the Base Rate.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="ie74812029b214d8db387a0221d0b1350" continuedAt="ie49988df4b6243458ac80d8e27b85adb"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 26, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i3fd7ad15f5e24a678e288eb53e978668_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NTgxMDc_98e63daf-70b7-4f8b-bb1a-ba75383a21c7">250.0</ix:nonFraction>&#160;million outstanding under the 2018 Revolver and the interest rate under the Term loan was <ix:nonFraction unitRef="number" contextRef="i3fd7ad15f5e24a678e288eb53e978668_I20200926" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NjQxNzQ_8b3801a3-6650-4a08-a0ea-950aec4ca366">1.40</ix:nonFraction>%.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable margin to the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate is subject to specified changes depending on the total net leverage ratio as defined in the 2018 Credit Agreement. The borrowings of the 2018 Term Loan initially bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate equal to <ix:nonFraction unitRef="number" contextRef="iebc8390a06a94a30a7711d90782cbfff_D20181217-20181217" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI0NjA_4973ca5e-3222-4631-a92a-702d356e59d8">1.25</ix:nonFraction>%. The borrowings of the 2018 Revolver initially bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to <ix:nonFraction unitRef="number" contextRef="i890f64beadb143b09f67fea3c0b0f562_D20181217-20181217" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI2MTQ_60f00f4a-9a3c-4542-a35a-f0be9d14a2d3">1.25</ix:nonFraction>%. The Company is also required to pay a quarterly commitment fee calculated on the undrawn committed amount available under the 2018 Revolver.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to make scheduled principal payments under the 2018 Term Loan in increasing amounts ranging from $<ix:nonFraction unitRef="usd" contextRef="i832ef0aa8ca34dfab05f2e95257c6146_D20181217-20181217" decimals="-3" format="ixt:numdotdecimal" name="holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4OTc_8416fa96-9870-4a75-aabe-4a94bed442be">9.375</ix:nonFraction> million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $<ix:nonFraction unitRef="usd" contextRef="i3f1547ab54254a239a247c8a112272c3_D20181217-20181217" decimals="-3" format="ixt:numdotdecimal" name="holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI5OTM_9394b99e-4c35-4964-b7cd-9aab35c109be">28.125</ix:nonFraction> million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Term Loan after the scheduled principal payments, which is $<ix:nonFraction unitRef="usd" contextRef="i25098fcc693a4912b794f37a396afce9_I20200926" decimals="-8" format="ixt:numdotdecimal" name="holx:DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzMyMjE_29614085-252a-4b04-94c8-5aaa2021ae59">1.2</ix:nonFraction> billion, and any amounts outstanding under the 2018 Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, the Company may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by the Company,&#160;first, to the 2018 Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2018 Credit Facilities without premium or penalty.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement requires the Company to maintain certain financial ratios. The 2018 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company and its U.S. subsidiaries, with certain exceptions. For example, borrowings under the 2018 Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under the Company's Accounts Receivable Securitization program. The 2018 Credit Agreement contains total net leverage ratio and interest coverage ratio financial covenants measured as of the last day of each fiscal quarter. The total net leverage ratio covenant was <ix:nonFraction unitRef="number" contextRef="ib968be61a4094d0eb0f1daf52ff7d843_D20190929-20200926" decimals="INF" name="holx:LeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzU3MjM_526ef6f3-a428-4683-bcb0-fcbadc2c365b">5.00</ix:nonFraction>:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and remains as such until it decreases to <ix:nonFraction unitRef="number" contextRef="i594b4573152b448cb7a66c5d84a63dbb_D20220625-20220625" decimals="INF" name="holx:LeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzU4NDA_857220fc-9d4c-443a-b67f-4b696ae89e39">4.50</ix:nonFraction>:1.00 for the quarter ending June 25, 2022. The interest coverage ratio covenant was <ix:nonFraction unitRef="number" contextRef="ib968be61a4094d0eb0f1daf52ff7d843_D20190929-20200926" decimals="INF" name="holx:InterestCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzU5Mjc_2220672b-5ba3-4ed2-9f7a-df857625609d">3.75</ix:nonFraction>:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and remains as such for each quarter thereafter. The total net leverage ratio is defined as the ratio of the Company's consolidated net debt as of the quarter end to its consolidated adjusted EBITDA (as defined in the 2018 Credit Agreement) for the four-fiscal quarter period ending on the measurement date. The interest coverage ratio is defined as the ratio of the Company's consolidated adjusted EBITDA for the prior four-fiscal quarter period ending on the measurement date to adjusted consolidated cash interest expense (as defined in the 2018 Credit Agreement) for the same measurement period. The Company was in compliance with these covenants as of September 26, 2020.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2018 Credit Agreement for derivatives pursuant to ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and identified embedded derivatives that required bifurcation as the features are not clearly and closely related to the host instrument. The embedded derivatives were a default provision, which could require additional interest payments, and a provision requiring contingent payments to compensate the lenders for changes in tax deductions. The Company determined that the fair value of these embedded derivatives was nominal as of September 26, 2020.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 470), the accounting related to entering into the 2018 Credit Agreement and using the proceeds to pay off the 2017 Credit Agreement was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2017 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $<ix:nonFraction unitRef="usd" contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzc3NjE_08adc5e1-a352-486e-9493-499500b493ad">0.8</ix:nonFraction> million in the first quarter of fiscal 2019. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the <ix:nonFraction unitRef="debt_instrument" contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228" decimals="INF" format="ixt-sec:numwordsen" name="holx:DebtInstrumentNumberOfInstruments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzc5Nzg_ede7538a-7c04-47d8-8ec1-b3d84dc7438a">two</ix:nonFraction> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="ie49988df4b6243458ac80d8e27b85adb" continuedAt="i854c3d85ea1c43a782fd77b2a1f57ac0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt instruments before and after the transaction was less than <ix:nonFraction unitRef="number" contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228" decimals="INF" name="holx:MaximumRangeofPresentValueofCashFlowPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzgwNDU_d0d59917-9235-4b1d-90d2-482bc891aff3">10</ix:nonFraction>%. We accounted for the amendments pursuant to ASC 470, subtopic 50-40, and third-party costs of $<ix:nonFraction unitRef="usd" contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="holx:DirectThirdPartyCostsinterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzgxNDM_7af39730-0f19-4e85-aff7-016ee9018f49">0.8</ix:nonFraction> million related to this transaction were recorded as interest expense and $<ix:nonFraction unitRef="usd" contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzgyMTI_a43121f7-1f42-4e03-bd81-d03a694f6574">1.9</ix:nonFraction> million was recorded as a reduction to debt representing deferred issuance costs and debt discount for fees paid directly to the lenders.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Agreement</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 3, 2017, the Company and certain of its domestic subsidiaries entered into an Amended and Restated Credit and Guaranty Agreement (the "2017 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto. The 2017 Credit Agreement amended and restated the Company's prior credit and guaranty agreement, originally dated as of May 29, 2015 (the "Prior Credit Agreement"). The proceeds under the 2017 Credit Agreement of $<ix:nonFraction unitRef="usd" contextRef="i5e8f4af13fc243f99fc0c25b9dbb20b3_D20190929-20200926" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzg5MTM_e417a33a-bc3f-42f5-b45a-7538aee437e7">1.8</ix:nonFraction> billion were used, among other things, to pay off the Term Loan of $<ix:nonFraction unitRef="usd" contextRef="idde9cb65eaea4006b4a3a0e5a2272ddd_D20190929-20200926" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzg5NzU_0e136176-53e0-4b61-9f34-6e22e85d0961">1.32</ix:nonFraction> billion and the Revolver then outstanding under the Company's Prior Credit Agreement. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2017 Credit Agreement consisted of:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $<ix:nonFraction unitRef="usd" contextRef="i25f90cd313c948d2a108a87d9a94999a_I20171003" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkxMzA_3095ba97-9257-44cb-9e76-77b0f74ffe7f">1.5</ix:nonFraction> billion secured term loan to the Company with a maturity date of October 3, 2022; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility under which the Company could borrow up to $<ix:nonFraction unitRef="usd" contextRef="i1b9bbbdde31f436aa1a5765b37448a8b_I20171003" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkyOTE_3f7c5fd9-7799-4ec1-9267-3b654ccd240e">1.5</ix:nonFraction> billion, subject to certain sublimits, with a maturity date of October 3, 2022.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2018, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i4663f101db0a4ba091c45be3b47b7c37_D20190331-20190629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzk0Mjk_39b1cff3-d60c-4d9b-bbf0-a81c9b8e018b">250.0</ix:nonFraction> million under the revolver to cash settle the conversions of its <ix:nonFraction unitRef="number" contextRef="i8c5d81b35a2241da877d3e4a3da33071_I20190629" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzk0ODk_2196e915-9dba-4543-ba81-9a971f233e62">2.00</ix:nonFraction>% Convertible Senior Notes due 2042.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDgx_80317e03-a8d6-41b1-95cc-4498a46d8beb" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement, the 2017 Credit Agreement and the Prior Credit Agreement was as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"><tr><td style="width:1.0%"></td><td style="width:36.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzItMS0xLTEtMA_afcb3784-d4b3-42ae-8ff5-6094182abb53">46.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bbf0b9e21774990be085b97a15bbd5a_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzItMi0xLTEtMA_ffda1d60-c182-4fbd-8f44-fff750260141">67.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1d3923c6ba4dc4829757b7a7580a3e_D20171001-20180929" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzItMy0xLTEtMA_0c1d80e9-e602-4738-9a20-4a2808001767">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzMtMS0xLTEtMA_e6639935-6588-44f9-9090-4961a2cd694d">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bbf0b9e21774990be085b97a15bbd5a_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzMtMi0xLTEtMA_52af574c-ecd7-4a0c-a59b-06732ffb7be4">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1d3923c6ba4dc4829757b7a7580a3e_D20171001-20180929" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzMtMy0xLTEtMA_6fdd17df-4e8a-4d68-b723-e11929a3f959">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzQtMS0xLTEtMA_9b560f96-7fff-4a9b-8283-f504fad622a5">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8bbf0b9e21774990be085b97a15bbd5a_D20180930-20190928" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzQtMi0xLTEtMA_e2af97c5-75fe-4c3b-83fb-90101ae5e1ab">3.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee1d3923c6ba4dc4829757b7a7580a3e_D20171001-20180929" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzQtMy0xLTEtMA_45feddde-b6b0-4b72-809c-da97ecef2dc8">3.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i974288f6285044128c2b4e1690e36c23_I20200926" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzUtMS0xLTEtMA_1b46fb1a-ea8d-48a6-beb8-b61d58306529">1.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfd0405aae91417aae27ed964af861e1_I20190928" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzUtMi0xLTEtMA_c155bf42-812f-420f-a9bd-94f2c6284a05">3.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ecb1b74ff6b4d1b9db466141397e214_I20170930" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzUtMy0xLTEtMA_d2e0e637-9741-4e52-89e1-d411f741c5dd">3.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, the accounting for entering into the 2017 Credit Agreement and using the proceeds to pay off the Prior Credit Agreement was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the Prior Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $<ix:nonFraction unitRef="usd" contextRef="i7afb5a8c40684333859218062faaf200_D20180930-20181229" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwNDEz_26ffa6f0-390c-4480-9a15-85713043a9bd">1.0</ix:nonFraction> million in the first quarter of fiscal 2018. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two debt instruments before and after the transaction was less than <ix:nonFraction unitRef="number" contextRef="i7afb5a8c40684333859218062faaf200_D20180930-20181229" decimals="INF" name="holx:MaximumRangeofPresentValueofCashFlowPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwNjk4_646b01b1-70bf-4097-9b9b-b6558dbbeb58">10</ix:nonFraction>%. Pursuant to ASC 470, subtopic 50-40, third-party costs of $<ix:nonFraction unitRef="usd" contextRef="i7afb5a8c40684333859218062faaf200_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="holx:DirectThirdPartyCostsinterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwNzYw_f7b7e2a6-6fd5-43fb-b6fa-197da14f8723">1.7</ix:nonFraction> million related to this transaction were recorded as interest expense and $<ix:nonFraction unitRef="usd" contextRef="i7afb5a8c40684333859218062faaf200_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwODI5_237ab852-b6eb-4f3f-8f6a-4243bbbabe36">4.9</ix:nonFraction> million was recorded as a reduction to debt representing deferred issuance costs and debt discount for fees paid directly to the lenders.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i854c3d85ea1c43a782fd77b2a1f57ac0" continuedAt="i59cbefce94c04e938ca4d43080d92612"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;10, 2017, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="ifa285bba80d14c0cba66dd5448fb5440_I20171010" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExMDYx_c1f34583-4560-4a21-ab78-5971c3ce7c10">350</ix:nonFraction> million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="ic272797ead73491a9d8ada44c35c9e1c_I20200926" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExMDk4_7f854334-9393-4924-9507-1e121c8048dd">4.375</ix:nonFraction>% Senior Notes due 2025 (the "2025 Senior Notes") at an offering price of <ix:nonFraction unitRef="number" contextRef="ifa285bba80d14c0cba66dd5448fb5440_I20171010" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExMTcz_96187a2e-31f0-4bab-a26a-93b4b8105790">100</ix:nonFraction>% of the aggregate principal amount of the 2025 Senior Notes. On January 19, 2018, the Company completed a private placement and allocated an additional $<ix:nonFraction unitRef="usd" contextRef="iad5df08e269f4792a90def353802fc8b_I20180119" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExMzI3_6e09a52e-e325-41af-8764-72c6ab8598f2">600</ix:nonFraction> million in aggregate principal amount to its 2025 Senior Notes pursuant to a supplement to the indenture governing the Company's existing 2025 Senior Notes at an offering price of <ix:nonFraction unitRef="number" contextRef="iad5df08e269f4792a90def353802fc8b_I20180119" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExNTAy_e85e19a4-5841-4010-a70a-0c7875eb3927">100</ix:nonFraction>% of the aggregate principal amount. As a result, the total aggregate principal balance of 2025 Senior Notes is $<ix:nonFraction unitRef="usd" contextRef="ic272797ead73491a9d8ada44c35c9e1c_I20200926" decimals="-6" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExNjE1_ff2ee328-76e8-4d19-bc9b-92b876f7fcd5">950</ix:nonFraction> million. The 2025 Senior Notes were general senior unsecured obligations of the Company and were guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2025 Senior Notes were to mature on October&#160;15, 2025 and bore interest at the rate of <ix:nonFraction unitRef="number" contextRef="ic272797ead73491a9d8ada44c35c9e1c_I20200926" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExODYw_00e863f4-7607-494c-a194-bf8e7696789a">4.375</ix:nonFraction>%&#160;per year, payable semi-annually on April&#160;15 and October&#160;15 of each year, commencing on April&#160;15, 2018. On September 28, 2020 (in the first quarter of fiscal 2021), the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2MzM_9c6ef10b-0cab-47de-8c52-be4286528942">950.0</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2NjU_1a02dd5e-6c8a-4aa7-8f7a-71ca4e094e8c">3.250</ix:nonFraction>% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The proceeds from this offering and cash on hand were used to redeem the 2025 Senior Notes in full on October 15, 2020, at a redemption price of approximately $<ix:nonFraction unitRef="usd" contextRef="i1e0434291a6f4c76aa8fb300ab8d179c_D20200928-20200928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2NDk_da90debd-eeb6-48da-872c-36721df89ccb">970.8</ix:nonFraction>&#160;million (equal to <ix:nonFraction unitRef="number" contextRef="i1e0434291a6f4c76aa8fb300ab8d179c_D20200928-20200928" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4MDk_76f780a0-f395-4f63-8c11-48e7b0d0127c">102.2</ix:nonFraction>% of the aggregate principal amount of the 2025 Senior Notes). In the first quarter of fiscal 2021, the Company will complete the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis and record a debt extinguishment loss as applicable.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 19, 2018, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="i1fd7482e7e024b1d8623378c63515cb0_D20180119-20180119" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzNDkw_28c2ef7e-56ad-4c4b-8b22-873551fa47a7">1.0</ix:nonFraction> billion aggregate principal amount of senior notes and allocated $<ix:nonFraction unitRef="usd" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzNTUw_9e773714-246b-47e0-9dea-f6d502116ede">400</ix:nonFraction> million in aggregate principal amount to its <ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzNTkw_fa14150d-5f37-4712-a8b1-eb263cae24e8">4.625</ix:nonFraction>% Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of <ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzNjY1_0b9a3366-8e96-4392-9a8e-9303689fcb5b">100</ix:nonFraction>% of the aggregate principal amount of the 2028 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;<ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzOTY5_ca99dd5b-82c8-428e-8346-f8cc3678a4bc">4.625</ix:nonFraction>%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;<ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0MTgw_446a21ad-8d56-47d5-8dab-aa2bcee6eec1">100</ix:nonFraction>%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to&#160;<ix:nonFraction unitRef="number" contextRef="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0Mzgy_8ba4cd97-a4db-4e7d-9149-93860fb87aa0">35</ix:nonFraction>%&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;<ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" name="holx:DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0NTg5_8c3be637-85b9-4839-a43a-341dcc0b6cf5">104.625</ix:nonFraction>%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;<ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" name="holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0ODI3_cbd01c6b-1921-4a2b-9886-98f57c8d4dc0">102.312</ix:nonFraction>%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;<ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" name="holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0ODgz_9bfd5160-f3dc-4632-8ca0-83f7daa5548f">101.541</ix:nonFraction>%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;<ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="5" name="holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0OTM5_5af1b85f-fc6f-4229-b104-3699f0b9e412">100.770</ix:nonFraction>%&#160;of par; and February 1, 2026 and thereafter at&#160;<ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" name="holx:DebtInstrumentPercentageRedemptionPriceSixthPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0OTg5_1d70fe53-09d8-448f-a54e-c55baa8b5f6f">100</ix:nonFraction>%&#160;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;<ix:nonFraction unitRef="number" contextRef="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926" decimals="INF" name="holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE1MjMz_28d62789-4fca-4545-868c-dbe3ed809576">101</ix:nonFraction>%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2028 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><ix:continuation id="ib9d7fb3ec52e49c7aab27420be66943f"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2028 Senior Notes, 2025 Senior Notes and 2022 Senior Notes is as follows:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:20.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0594ade531b74789862cd43513f6fea7_I20200926" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtMS0xLTEtMA_2fdbcfec-badd-4bed-94ea-a7c29a0fc6aa">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtMy0xLTEtMA_2a4cc697-2aa6-4c01-bb05-8031edd43c44">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtNC0xLTEtMA_d464bc84-a488-4f16-9a9c-14b85ab65528">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0afc09611c426282e6aac4be10661a_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtNi0xLTEtMA_1e015c10-778c-48b9-bb16-a49a4c8bc616">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0afc09611c426282e6aac4be10661a_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtNy0xLTEtMA_1e391af1-b4ba-4d7c-81dc-2ed96f23b6fc">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d6e02785004a0d8d101ecf6ec84b38_D20171001-20180929" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtOS0xLTEtMA_1af75efe-8e92-410f-9005-6f29bcbba2f2">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d6e02785004a0d8d101ecf6ec84b38_D20171001-20180929" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtMTAtMS0xLTA_c62c6c6f-8c98-4aa2-ac66-c203e526300f">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic272797ead73491a9d8ada44c35c9e1c_I20200926" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtMS0xLTEtMA_1135e985-0886-4157-a054-6d89d197250b">4.375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c177c25617f48bdac09172a3df4017c_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtMy0xLTEtMA_14646580-b25f-47a9-8708-8402383493b5">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c177c25617f48bdac09172a3df4017c_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtNC0xLTEtMA_b08c63e4-d782-44af-bf92-b3c4cfbeafff">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic678ac46fcb54d49b964689428ff6dc3_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtNi0xLTEtMA_d9f01a69-8f4f-4c5a-873e-2af264242fcb">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic678ac46fcb54d49b964689428ff6dc3_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtNy0xLTEtMA_3502bc0e-b875-4d89-9c3f-01db29f47686">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee80a400131f496b9f303169165255f9_D20171001-20180929" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtOS0xLTEtMA_61081687-ca5f-46f6-b466-a12d6d556c67">34.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee80a400131f496b9f303169165255f9_D20171001-20180929" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtMTAtMS0xLTA_75635ef7-7ac7-46f5-9922-f52585994184">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i208ccf38964e488ba11badb451812ff1_I20190928" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtMS0xLTEtMA_78da0220-8b32-4fe5-8c14-b185fa9a68de">5.250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625f89ab8266425986dabfe1ea7cce94_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtMy0xLTEtMA_560e36c1-d862-486c-be15-8b84b29b9357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625f89ab8266425986dabfe1ea7cce94_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtNC0xLTEtMA_c1a75edf-004e-49f7-813f-8b41035dbda1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949893e5021e4b72b6e04ed4c620d53a_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtNi0xLTEtMA_9029accc-9c60-4662-ba95-6bc44ffd089d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949893e5021e4b72b6e04ed4c620d53a_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtNy0xLTEtMA_0c686706-4560-4487-9722-816e6546cea7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53165e60abab42ee834675a6c4488642_D20171001-20180929" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtOS0xLTEtMA_577f30b0-9434-4089-8dc7-ccd38ef6ab9d">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53165e60abab42ee834675a6c4488642_D20171001-20180929" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtMTAtMS0xLTA_7e16a574-4fb2-4127-9922-f24bac4ade3c">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181188c2b11e4f169032adefb6546ee2_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtMy0xLTEtMA_0cb93904-fae5-45ee-8973-2beec55605a9">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181188c2b11e4f169032adefb6546ee2_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtNC0xLTEtMA_4b9342c6-e6fe-491e-a546-348c0923302c">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f56e3fa2a540c0b6ff0e3af30ebd18_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtNi0xLTEtMA_48f25f50-ac8f-48ee-bf87-2d30cc7e8dad">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f56e3fa2a540c0b6ff0e3af30ebd18_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtNy0xLTEtMA_9ced70c3-7f66-48fb-b7e2-8b2bda43c525">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic79a7b8640a04f25812f29fbf9199284_D20171001-20180929" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtOS0xLTEtMA_000b3998-e6fc-471b-b208-8b631109e436">69.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic79a7b8640a04f25812f29fbf9199284_D20171001-20180929" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtMTAtMS0xLTA_55f60d43-a4f5-44c9-87dc-b06df613d295">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i59cbefce94c04e938ca4d43080d92612" continuedAt="ifa7efd051a3f4943b861f6e97e3df55f"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Senior Notes</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="number" contextRef="i91a5f72252c948bd9ae64687e324075a_I20190928" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE1ODUz_e1d5c426-fae5-4c6f-99cb-dcf0773e36cb">5.250</ix:nonFraction>% Senior Notes due 2022 (the &#8220;2022 Senior Notes&#8221;) outstanding and bore interest at the rate of <ix:nonFraction unitRef="number" contextRef="i91a5f72252c948bd9ae64687e324075a_I20190928" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE1OTQ5_043e30a2-1edb-424f-aa15-cb03c2d1e7a9">5.250</ix:nonFraction>%&#160;per year, payable semi-annually on January 15 and July 15 of each year. The Company used the net proceeds of the 2025 Senior Notes and the 2028 Senior Notes offering in January 2018 to redeem in full the 2022 Senior Notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i053c6045e0324fa0adf4cc3c967de7c3_I20180215" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE2MjEx_bc73f029-2038-4d1d-8ace-c8b4cecbc715">1.0</ix:nonFraction> billion on February 15, 2018 at an aggregate redemption price of $<ix:nonFraction unitRef="usd" contextRef="i053c6045e0324fa0adf4cc3c967de7c3_I20180215" decimals="-7" format="ixt:numdotdecimal" name="holx:OfferingPriceofPrincipalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE2Mjcx_b1b843a2-67cf-452e-9ec1-29b9c57e0810">1.04</ix:nonFraction> billion, including a make-whole provision payment $<ix:nonFraction unitRef="usd" contextRef="i053c6045e0324fa0adf4cc3c967de7c3_I20180215" decimals="-5" format="ixt:numdotdecimal" name="holx:MakeWholeProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE2MzE2_95460b0f-ceeb-494f-9283-d8ffd92bd0fc">37.7</ix:nonFraction> million. Since the Company planned to use the proceeds from the 2025 Senior Notes and the 2028 Senior Notes offering to redeem the 2022 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2022 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the second quarter of fiscal 2018 of $<ix:nonFraction unitRef="usd" contextRef="i6263cf3be0e74b85ba827b9b7dd3bcc5_D20181230-20190330" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE2OTA2_6e705617-47b4-44d4-8af5-6f424edbac95">44.9</ix:nonFraction> million, which comprised pro-rata amounts of the make-whole provision premium payment, debt discount and debt issuance costs. For the remaining 2022 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than <ix:nonFraction unitRef="number" contextRef="i6263cf3be0e74b85ba827b9b7dd3bcc5_D20181230-20190330" decimals="INF" name="holx:MaximumRangeofPresentValueofCashFlowPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3MzE1_e4d04a59-6755-4236-8917-cdaf2548ae6b">10</ix:nonFraction>%. The Company recorded a portion of the transaction expenses of $<ix:nonFraction unitRef="usd" contextRef="i6263cf3be0e74b85ba827b9b7dd3bcc5_D20181230-20190330" decimals="-5" format="ixt:numdotdecimal" name="holx:DirectThirdPartyCostsinterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3Mzgx_486dcdbb-f083-4b19-bdf8-2a234accb651">2.6</ix:nonFraction> million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ie4300b435e3a4c91a4ec915b5cdebce4_I20190330" decimals="-5" format="ixt:numdotdecimal" name="holx:DebtIssuanceCostsReallocatedUponDebtModification" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3NDc4_eca2f286-e5f0-4cd1-bb81-8f9d6bab2880">1.5</ix:nonFraction> million and debt discount of $<ix:nonFraction unitRef="usd" contextRef="ie4300b435e3a4c91a4ec915b5cdebce4_I20190330" decimals="-5" format="ixt:numdotdecimal" name="holx:DebtDiscountReallocatedUponDebtModification" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3NTAy_7b083550-2d2f-42ab-9f6e-2bd811474ea3">1.5</ix:nonFraction> million related to the modified debt were allocated between the 2025 Senior Notes and 2028 Senior Notes on a pro-rata basis, and are being amortized over the life of the debt using the effective interest method.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 28, 2019 and September 29, 2018, the Company had no Convertible Notes outstanding. The following describes the Convertible Note transactions during fiscal 2018.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;10, 2007, the Company issued and sold $<ix:nonFraction unitRef="usd" contextRef="i7c7d1f23582b432c91b2a801b77b2fff_I20071210" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3OTYx_1da38921-c539-4e99-a4ad-99d4125215cd">1.725</ix:nonFraction> billion, at par, of <ix:nonFraction unitRef="number" contextRef="i7c7d1f23582b432c91b2a801b77b2fff_I20071210" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3OTc2_c9dedf39-85b2-49f3-a6f9-2bd82a273266">2.00</ix:nonFraction>% Convertible Senior Notes due December&#160;15, 2037 (&#8220;2007 Notes&#8221;). On November&#160;18, 2010, the Company entered into separate, privately-negotiated exchange agreements under which it retired $<ix:nonFraction unitRef="usd" contextRef="i56b1e7b3625d4668b6803a4af269897d_I20101118" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4MTYx_6c0e9444-e834-4198-824c-d19f2ca7f58b">450.0</ix:nonFraction> million in aggregate principal of its 2007 Notes for $<ix:nonFraction unitRef="usd" contextRef="i91ddc0c2de1e45d59da01228f7057b59_I20101118" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4MjA5_4ca9010b-d1b4-4215-a7ff-ebc5aad799ab">450.0</ix:nonFraction> million in aggregate principal of new <ix:nonFraction unitRef="number" contextRef="i91ddc0c2de1e45d59da01228f7057b59_I20101118" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4MjQy_c147dcf7-b2d5-4520-99b7-923de978b229">2.00</ix:nonFraction>% Convertible Exchange Senior Notes due December&#160;15, 2037 (&#8220;2010 Notes&#8221;). On February&#160;29, 2012, the Company entered into separate, privately-negotiated exchange agreements under which it retired $<ix:nonFraction unitRef="usd" contextRef="i9c1f5e115c2b4f279149b8ef1e703af0_I20120229" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4NDM2_2bb76518-e301-4306-8c20-7c970eeb4a35">500.0</ix:nonFraction> million in aggregate principal of the 2007 Notes for $<ix:nonFraction unitRef="usd" contextRef="ie58aa7f211694a7f95581b9c6ccdee6c_I20120229" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4NDg0_04a900dd-682b-49ef-afe3-dd34d2a83da4">500.0</ix:nonFraction> million in aggregate principal of new <ix:nonFraction unitRef="number" contextRef="ie58aa7f211694a7f95581b9c6ccdee6c_I20120229" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4NTE3_07f686a9-3cad-4aaf-a52b-124e6bbd5831">2.00</ix:nonFraction>% Convertible Senior Notes due March&#160;1, 2042 (&#8220;2012 Notes&#8221;). On February&#160;14, 2013, the Company entered into separate, privately-negotiated exchange agreements under which it retired $<ix:nonFraction unitRef="usd" contextRef="i9671b6718f6540d09891ee6161cbe7e2_I20130214" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4Njk4_deb37c83-98eb-4fe4-b60a-ff4a6d785680">370.0</ix:nonFraction> million in aggregate principal of the 2007 Notes for $<ix:nonFraction unitRef="usd" contextRef="ib7243cd452dc4ea3a000e9653cbfe838_I20130214" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4NzQ2_6dddccdb-7dd1-4bb4-af15-4b4a4be4d336">370.0</ix:nonFraction> million in aggregate principal of new <ix:nonFraction unitRef="number" contextRef="ib7243cd452dc4ea3a000e9653cbfe838_I20130214" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4Nzc5_2d1d2018-112c-4504-a396-34ba8703e58b">2.00</ix:nonFraction>% Convertible Senior Notes due December 15, 2043 (&#8220;2013 Notes&#8221;). The remaining 2007 Notes were redeemed in fiscal 2014. In fiscal 2017, all remaining 2010 Notes were either converted or surrendered for conversion. On various dates in fiscal 2017, the Company entered into privately negotiated repurchase transactions and extinguished $<ix:nonFraction unitRef="usd" contextRef="i11258e03918544b983db64585b8a57d3_D20160925-20170930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2ODE_c02705cd-4093-443f-b635-42269da7c598">117.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5b2cfabcfcd5475e8db2636fdfd71b6a_D20160925-20170930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2OTc_001ef993-689e-40f1-b16a-2fc79afd51fe">168.0</ix:nonFraction>&#160;million principal amount of the 2012 Notes and 2013 Notes, respectively.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2018, the Company announced that pursuant to the terms of the indenture for the 2012 Notes, holders of the 2012 Notes had the option of requiring the Company to repurchase their 2012 Notes on March 1, 2018 at a repurchase price payable in cash equal to&#160;<ix:nonFraction unitRef="number" contextRef="i2dec2acad41c49ebadf65a9fe79a16cf_D20190929-20200926" decimals="INF" name="holx:RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwMjg5_911d6483-5dea-46ab-8ed2-bd49285f61ce">100</ix:nonFraction>%&#160;of the accreted principal amount of the 2012 Notes, plus accrued and unpaid interest. The Company also announced on January 29, 2018 that, it had elected to redeem, on March 6, 2018, all of the then outstanding 2012 Notes at a redemption price payable in cash equal to&#160;<ix:nonFraction unitRef="number" contextRef="i82d36f9b38d44e27b3125f3ed8fc2179_D20190929-20200926" decimals="INF" name="holx:RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwNTYx_a32b6cf7-10b7-49d4-8404-4e54a6a7ccd3">100</ix:nonFraction>%&#160;of the accreted principal amount of the 2012 Notes, plus accrued and unpaid interest. Holders also had the right to convert their 2012 Notes. During the second quarter of fiscal 2018, 2012 Notes in aggregate original principal amount of&#160;$<ix:nonFraction unitRef="usd" contextRef="if2f74c33a2674954819e52e2acf2aaac_I20190330" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwODAx_83dd4443-10c3-49ac-b70c-d2790bdbc59d">200.5</ix:nonFraction> million&#160;were surrendered for conversion and the Company cash settled these conversions for&#160;$<ix:nonFraction unitRef="usd" contextRef="ic93b7c0c776447f09fd2252ab71327a8_D20190331-20190629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwODg3_ca01cb6b-a195-429a-98e6-30fa856c6d1a">243.3</ix:nonFraction> million&#160;during April 2018. As a result, on a gross basis,&#160;$<ix:nonFraction unitRef="usd" contextRef="i024d7046a83a4ae88bd3445fe4d74f1e_D20181230-20190330" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwOTQw_47567129-5157-41f9-b81e-8574c162dda2">42.8</ix:nonFraction> million&#160;of the consideration paid was allocated to the reacquisition of the equity component of the original instrument, which was recorded net of deferred taxes of&#160;$<ix:nonFraction unitRef="usd" contextRef="i024d7046a83a4ae88bd3445fe4d74f1e_D20181230-20190330" decimals="-5" format="ixt:numdotdecimal" name="holx:DeferredTaxesReacquisitionofEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxMTAw_02c086d2-2947-41ab-909d-a442baab9250">12.0</ix:nonFraction> million&#160;within additional paid-in-capital. The remaining&#160;$<ix:nonFraction unitRef="usd" contextRef="i4ec620e29d184821ba41fb6c0d5e4744_I20181229" decimals="-5" format="ixt:numdotdecimal" name="holx:Debtinstrumentremainingtoberedeemed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxMTUy_6613f065-57ea-44c0-9954-3c3bb20cbbba">5.5</ix:nonFraction> million&#160;in original principal amount of the 2012 Notes was redeemed by the Company on March 6, 2018.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 15, 2017, pursuant to the provisions of the indenture governing the Company's&#160;2013 Notes, the Company redeemed or repurchased an aggregate of&#160;$<ix:nonFraction unitRef="usd" contextRef="iafbd2a1d68ff4c35b4234cfba95c6ccf_I20181229" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxNDAy_e15882d2-da24-4772-ab9f-11da87ff6523">201.7</ix:nonFraction> million&#160;in original principal amount of the 2013 Notes then outstanding for an aggregate repurchase price of&#160;$<ix:nonFraction unitRef="usd" contextRef="i2c7d3a787bc64690aad62c65bab997c8_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxNTA2_875b92e3-bcaf-49b8-9ec7-fe1bc1977054">244.1</ix:nonFraction> million, representing the then accreted principal amount of the 2013 Notes. The remaining&#160;$<ix:nonFraction unitRef="usd" contextRef="iafbd2a1d68ff4c35b4234cfba95c6ccf_I20181229" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxNTkx_d4cef696-9725-4df4-87bb-210dcfbc6a8a">0.3</ix:nonFraction> million&#160;in original principal amount of the 2013 Notes were converted, and the Company settled these conversions in cash in the second quarter of fiscal 2018.&#160;</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On various dates during the first quarter of fiscal 2018, the Company entered into privately negotiated repurchase transactions and extinguished&#160;$<ix:nonFraction unitRef="usd" contextRef="i4ec620e29d184821ba41fb6c0d5e4744_I20181229" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxODkx_736c6f57-ce6d-4076-8f37-2408758a80e3">39.3</ix:nonFraction> million&#160;principal amount of its 2012 Notes for total payments of&#160;$<ix:nonFraction unitRef="usd" contextRef="i821e7870d37a477694bc08b8bbc795c9_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxOTUx_2c2b69f6-0d03-45e4-950e-e63093bd415f">52.8</ix:nonFraction> million. This amount includes the conversion premium resulting from the Company's stock price on the date of the transactions being in excess of the conversion prices of&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i4ec620e29d184821ba41fb6c0d5e4744_I20181229" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIyMTE2_57eec60a-7d61-4238-be7d-3510ff40e12b">31.175</ix:nonFraction>. As a result, on a gross basis,&#160;$<ix:nonFraction unitRef="usd" contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIyMTUx_971fedff-5d13-4e97-9191-1143a4f4b07f">13.4</ix:nonFraction> million&#160;of the consideration paid was allocated </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="ifa7efd051a3f4943b861f6e97e3df55f" continuedAt="i2d0d9a4cfe26417698a095008bf1dd23"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the reacquisition of the equity component of the original instrument, which was recorded net of deferred taxes of&#160;$<ix:nonFraction unitRef="usd" contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="holx:DeferredTaxesReacquisitionofEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIyMzEx_b8b951bc-6753-4dbd-a582-7dcc50ce7954">3.8</ix:nonFraction> million&#160;within additional paid-in-capital.&#160;</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDcy_be79deaa-4dcb-4dbf-a8f4-b42f3533f76b" escape="true"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense under the Convertible Notes was as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:53.362%"><tr><td style="width:1.0%"></td><td style="width:75.612%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:22.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzItNS0xLTEtMA_64590be2-b48a-4353-8fed-dbac75e813b3">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929" decimals="-5" name="holx:AmortizationOfDeferredFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzMtNS0xLTEtMA_23898f43-208e-44e2-8b1e-d0f264b6c9eb">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal accretion</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929" decimals="-5" name="holx:BasePrincipalAmountForAccretionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzQtNS0xLTEtMA_47b555ca-9f5d-44db-af64-6451eabde70a">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzUtNS0xLTEtMA_72c2528c-a472-4dad-a0b1-206aa1d6d9da">5.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00% accrued interest (cash)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzYtNS0xLTEtMA_4eda8a01-df4c-4405-874f-9547cb6cc4d2">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzctNS0xLTEtMA_079d3f86-9944-4837-97f3-d2f2d150e231">7.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i2d0d9a4cfe26417698a095008bf1dd23"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2016, the Company entered into a <ix:nonNumeric contextRef="ie2bbe4541be240b88496af586754a36c_D20190929-20200926" format="ixt-sec:durwordsen" name="holx:TermARSecuritizationProgram" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4OTk_a98d3942-6f85-42e2-826a-2451028352d3">one-year</ix:nonNumeric> $<ix:nonFraction unitRef="usd" contextRef="ia2da5b318239428794fe8166e45245a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableFromSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI1NTU3_aa1351c9-1611-457e-b6c0-1dcf3c58db5b">200.0</ix:nonFraction> million accounts receivable securitization program (the "Securitization Program") with several of its wholly owned subsidiaries and certain financial institutions, which provides for annual renewals.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Securitization Program, the Company and certain of its wholly-owned subsidiaries sell their respective customer receivables to a bankruptcy remote special purpose entity, which is also a wholly-owned subsidiary of the Company. In addition, the Company also contributed a portion of its customer receivables to the special purpose entity in connection with its establishment. The Company retains servicing responsibility. The special purpose entity, as borrower, and the Company, as servicer, entered into a Credit and Security Agreement with several lenders pursuant to which the special purpose entity may borrow up to $<ix:nonFraction unitRef="usd" contextRef="ia2da5b318239428794fe8166e45245a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:MaximumBorrowingUnderSecuritizationProgram" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI2MzU5_6537586f-598b-42ba-ab7c-7ccfb4692dee">200.0</ix:nonFraction> million from the lenders, with the loans secured by the receivables. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. The entire amount available was borrowed in the third quarter of fiscal 2016. Borrowings outstanding under the Securitization Program bear interest at LIBOR plus the applicable margin of <ix:nonFraction unitRef="number" contextRef="ie2bbe4541be240b88496af586754a36c_D20190929-20200926" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI2ODE5_961e0fd0-7468-41f7-bd7b-cb7d9b9e3142">0.7</ix:nonFraction>% and are included as a component of current liabilities in the Company's consolidated balance sheet, while the accounts receivable securing these obligations remain as a component of net receivables in the Company's consolidated balance sheet. The Company and the special purpose entity are operated and maintained as separate legal entities. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay other debts or liabilities of the Company.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In subsequent years, the Company amended the agreement to extend it for one-year periods and increase the borrowing capacity. The maximum borrowing amount increased to $<ix:nonFraction unitRef="usd" contextRef="ia2da5b318239428794fe8166e45245a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI3Njcw_af675e31-bf1c-43db-b2f9-0d8e36e14fb7">250.0</ix:nonFraction> million. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, the Company paid-off the total amount outstanding of $<ix:nonFraction unitRef="usd" contextRef="id9d2a93700d14286b21749a928e012e8_D20200628-20200926" decimals="5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2MTc_17edefd4-48e4-4fcb-96ce-1828c880edb6">250.0</ix:nonFraction>&#160;million previously borrowed. On April 13, 2020, the Company amended the Credit and Security agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. As of September 26, 2020, the Company did not have any borrowings under this program.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense under the Securitization Program was $<ix:nonFraction unitRef="usd" contextRef="ie2bbe4541be240b88496af586754a36c_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI3OTAz_a5d07a28-bc3e-4ae7-bc94-0e0157bf34ca">3.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6eb2ee0310c54acaa58b9b3c9ff34788_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI3OTA3_5fad1043-ccda-4cec-861d-90f5b515d59a">7.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iba4c5eec04f245b89eebd5d83438a62c_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI3OTE0_b10f0eb3-e6ee-4bf1-9ba5-2af39aa55449">5.4</ix:nonFraction> million for fiscal 2020, 2019 and 2018, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit and Security Agreement contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, and an event of default upon a change of control of the Company. In addition, it contains financial covenants consistent with that of the Credit Agreement. As of September&#160;26, 2020, the Company was not required to be in compliance with the Credit and Security Agreement covenants.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2MDM_bbd54c21-d132-4e75-bed5-7745946f7171">950</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2NzM_248f6882-3d54-46b5-b574-33efb346d0eb">3.250</ix:nonFraction>% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of <ix:nonFraction unitRef="number" contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NzA_960d132f-f98b-4bad-bdf3-a6acf68c90e2">100</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NzY_0375673f-7161-4252-8436-9ddbc14afb14">3.250</ix:nonFraction>%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to <ix:nonFraction unitRef="number" contextRef="ic6ba005a39094d34834366256211a18d_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NTg_258547df-5a5f-4eb2-a14e-18735972f775">100</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to <ix:nonFraction unitRef="number" contextRef="ic9c5c02cb6674ecaa58ca75f0fce481a_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4MTc_eb2d9bf5-f4a2-45ec-a1e3-206b52a1e4e9">40</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="if4a62771e5894787a4fdaf44eca8d691_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4MjI_038d0f79-6357-495c-b371-ba896c824973">103.250</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at <ix:nonFraction unitRef="number" contextRef="i3d1dbd5a9ccd498d8398ec990203070a_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4MzI_282ca6b6-9100-449a-bef2-43d160d5d162">101.625</ix:nonFraction>% of par; September 28, 2024 through September 27, 2025 at <ix:nonFraction unitRef="number" contextRef="i41746832831b4728af50d9772e03b7d7_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NDI_7df90e95-d761-4999-aefe-c4cc3b8db292">100.813</ix:nonFraction>% of par; and September 28, 2025 and thereafter at <ix:nonFraction unitRef="number" contextRef="i9b6105964ce549019e14f33028ca3323_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NTI_5ae37796-646b-4ac5-b648-e0234672fbce">100</ix:nonFraction>% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="i2c15de09124143ea8a8d715fc0b85a09_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NjQ_46e8644a-cf08-4b0c-a1b8-2e6fc7d323e5">101</ix:nonFraction>% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. Fair Value Measurements</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the provisions of ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value each reporting period and its nonfinancial assets and liabilities that are re-measured and reported at fair value on a non-recurring basis. Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability.</span></div><div style="margin-top:14pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hierarchy</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. Financial assets and liabilities are categorized within the valuation hierarchy based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:5pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of interest rate caps, an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third-party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 2 for further discussion and information on these derivative contracts. In addition, the Company has contingent consideration liabilities that are recorded at fair value and are based on Level 3 inputs. The contingent consideration liability as of September 26, 2020 was related to the Acessa acquisition (see Note 5). </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQ3MzM_f0ae789c-87d4-47be-bcee-f3be54b44761" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:37.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f7f09624f1434eb681cb9758d19eb0_I20200926" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzctMS0xLTEtMA_ee2b96fa-7249-4dfd-90f4-852085384958">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7278d273404326ba040e840b670dbf_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzctMy0xLTEtMA_ecf178d4-7232-448c-a141-cfd63da5485b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c634ae6117f4462bbe028987d490806_I20200926" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzctNS0xLTEtMA_da96d181-cd2d-4407-a404-9d8eed995a0f">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90fd61a9da9e4ce2a983dd400f24501b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzctNy0xLTEtMA_4aaf9c6a-df06-42da-a503-4439acc5d04f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ea11973d1af4316b1f3c636f82b9cf5_I20200926" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzgtMS0xLTEtMA_0e13cb9b-0b04-4fd8-a8d0-4a82095d9185">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0666efcb300b4877b0616c64336ca6bb_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzgtMy0xLTEtMA_c9b47630-6b02-47b4-bf40-2b0926ffc617">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id307307c5904493785fe09305537074f_I20200926" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzgtNS0xLTEtMA_1430faa6-e8f1-4dc3-95a9-08dea2cad87c">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e49a76f02bc4a9a9d1333c24ffbf535_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzgtNy0xLTEtMA_94299e94-8a2c-417a-be7c-d076341307da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzktMS0xLTEtMA_3b0c395f-91b8-4fee-b7ce-b599ea29d4a9">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7c95670b0ba433f9c62a89eb2e10a1b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzktMy0xLTEtMA_d6e4b762-d1de-48d0-b4ca-63b5f91ecc8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef55f270ba4439e93dee1c6e0b97d71_I20200926" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzktNS0xLTEtMA_fbb9cb08-9b40-4c0c-821d-993837e754ea">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf733f9b57054072ba3f09920206c6a8_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzktNy0xLTEtMA_bb5b9913-399e-44b9-9cf7-0b265d39d22a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62353ddace04e659ec61002adae44d8_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzExLTEtMS0xLTA_a83d0c56-e641-4a2f-9646-4cc1175c5256">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0649c66c33ae4abdab88cfc48ee8e0d4_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzExLTMtMS0xLTA_0c1a8f5c-d568-470b-bbcb-ee89b92eb9ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494b1a50020e4595a4944efc9524702e_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzExLTUtMS0xLTA_67e4a44b-32e1-4a7e-a3a7-3f6665050b70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68139d7bb5fe4486ae433c49b7b0574b_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzExLTctMS0xLTA_a76482a6-5138-48aa-9df6-0839f5c1d595">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - derivative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd3354045a94ad6bc4f7dec67555173_I20200926" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEyLTEtMS0xLTQ3ODE_9ff26662-b188-4ee1-8fdf-48cb04c57650">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2397882191544728c3e25abcecedd2d_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEyLTMtMS0xLTEyNTE0_0bb1c17c-7204-40e8-8bee-a9d160af6993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f94ddfbab141ca9fd6143ef82e2729_I20200926" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEyLTUtMS0xLTEyNTE3_49866683-7f3b-43a9-a1e9-9f30cd03eb9e">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd832222fbea4e8a87ad22cac73a787b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEyLTctMS0xLTEyNTIw_84e623fd-aeb8-4825-a680-f2176f4838f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEzLTEtMS0xLTA_8787683e-4241-43a5-8d91-9fb7da211196">113.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7c95670b0ba433f9c62a89eb2e10a1b_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEzLTMtMS0xLTA_b6a71a52-d392-4ed7-a07f-06c16b2a1a58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef55f270ba4439e93dee1c6e0b97d71_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEzLTUtMS0xLTA_11c02f19-cf64-41bc-a14b-c782f2492bc8">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf733f9b57054072ba3f09920206c6a8_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEzLTctMS0xLTA_48ff63b3-1211-4b15-8b38-8a054a5f21cf">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:484.50pt"><tr><td style="width:1.0pt"></td><td style="width:183.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 28, 2019</span></td></tr><tr style="height:42pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate caps - derivative</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff8a401caf348ccba10912b17de5ff3_I20190928" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzQtMS0xLTEtMA_d1c4f54e-4c05-4e44-b989-7d2204d47418">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3500b3aa228e41f5a89f346d0296c04b_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzQtMy0xLTEtMA_ae99ba9f-10c1-4b78-8f6b-8f38f0451a51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d97a6111f044441be4473a086df1d40_I20190928" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzQtNS0xLTEtMA_9484c5e4-ade5-477a-bc53-86c31792210f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173b234856a64d389d94ce9755869ba6_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzQtNy0xLTEtMA_8709ed32-c172-4ebb-b229-e1308f378d99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - derivative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1f1b09ac83442a8c991f025f87c36c_I20190928" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtMS0xLTEtMjIzMA_c00f6f84-3cf4-40cc-8d19-39674c68a9d7">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0172a062a11d4a9b9ff8ce7f340127e5_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtMy0xLTEtMTI1MjY_f779148e-ebaf-4735-a797-096b2e716195">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8cc4295af424a959b5d571941ae558b_I20190928" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtNS0xLTEtMTI1MzA_eb975990-6cb8-4dd5-99ac-cf68355b1084">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e5807a53cf54cc88b9b54d32079f6fe_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtNy0xLTEtMTI1MzQ_38da6ed5-90d0-415c-8f7b-94ffb40d1b2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52321d5b7f4c43e0a78b02f5e2f66d46_I20190928" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtMS0xLTEtMTI1MjQ_f01a1665-b95b-4344-a68f-029f4f1c470f">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed21b822c534ff5bac482a2f45adb03_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtMy0xLTEtMTI1Mjg_3360562c-9f11-4f2d-9784-d38a1f385429">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a6bc74d82454a129b9c287e500fb859_I20190928" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtNS0xLTEtMTI1MzI_9ee25789-e965-4f4f-b267-aeedb7a2be7c">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a09695c32df4cd28cb1bcb683a730eb_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtNy0xLTEtMTI1MzY_c036c4cf-9aa3-4aed-a6c7-173a5f7a7002">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aaaf1ae6a5547bc9c542f11e36741ed_I20190928" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtMS0xLTEtMA_97fb0839-7678-40f4-a274-fe62e5badc05">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72dae67f6ad547c18f4306ab436421f8_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtMy0xLTEtMA_0861d0c3-1961-4a61-a919-214d7ecc5bd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9cf7097d00744cb8193ee46040dab6f_I20190928" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtNS0xLTEtMA_bb28972b-e358-4e38-8321-a98069a1c1ec">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c79ca9a01124b35bef6eba993c991c6_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtNy0xLTEtMA_80d9ea25-27b3-4251-b3a5-7fe2ba537899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtMS0xLTEtMA_9ec705e9-83c5-4bad-9dbc-94137d31066e">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a00d43da17d4cf2a160f87d1575594f_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtMy0xLTEtMA_37b98c8b-19e8-431b-9b6f-6f95ad5e4051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id123129c423e45f0bbc343073fa91e2a_I20190928" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtNS0xLTEtMA_4171cb5c-24bf-4a4f-b571-ec3abd03ffa3">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5b12d49cf249b58198f0ed8726f8b1_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtNy0xLTEtMA_a3e32269-deae-4a2a-bf1e-b793e46d6041">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e18b40497764e718b638209aca9eb1e_I20190928" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzgtMS0xLTEtMA_a5a73b58-7148-499e-9225-3e602cd5be5e">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba5dbf998314e0387202bf4eb404a3f_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzgtMy0xLTEtMA_ddf0a75f-3147-42de-bd81-89f501d14890">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ba19a80b3e451d950ab549195d0151_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzgtNS0xLTEtMA_b60c49e9-8d5a-463e-b223-8efd2c3c7138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7975507c75e442eca0e695649ed6acd8_I20190928" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzgtNy0xLTEtMA_95f2ed73-1159-4b0f-abae-2c8f8d2acf93">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d9bb748a0d64e65b6a66c49ad23d0a5_I20190928" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzktMS0xLTEtMA_7ef79cf4-d18c-4749-bb4f-59d3ada82e4c">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bcf8515f054405a36ddfe578351f4c_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzktMy0xLTEtMA_cf0d609d-8a87-417f-9d30-da9781a483b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4434900ec76643218f461bb16c843300_I20190928" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzktNS0xLTEtMA_0de66ca0-0fa2-4bcf-b05f-2dcd9e4925cf">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5082098bb8404831baa99e0bb0a4ab26_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzktNy0xLTEtMA_e9bbfe00-d4d7-429a-9050-c4fdc6010408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzEwLTEtMS0xLTA_da682cb7-411c-4903-9bf5-3de2c1a1d3ec">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a00d43da17d4cf2a160f87d1575594f_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzEwLTMtMS0xLTA_cdbb9843-cf9f-4c44-99aa-1bbe0f1e216d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id123129c423e45f0bbc343073fa91e2a_I20190928" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzEwLTUtMS0xLTA_efebd02c-2fec-4109-91e1-a4b1ebd276e5">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5b12d49cf249b58198f0ed8726f8b1_I20190928" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzEwLTctMS0xLTA_1425c02a-c5d2-4a56-815c-12589a78e8b0">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the years ended September 26, 2020, September 28, 2019, and September 29, 2018 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.510%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzEtMi0xLTEtODE0OA_3b8c230b-4be1-4c47-b227-55716a51c936">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzItNC0xLTEtMTg5Mjc_a4fb5306-c152-4ed9-9713-7ede45e2c021">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84c88a850d71453097932f0bcbe84825_I20170930" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzItNi0xLTEtMTg5Mjk_4c851779-2ae9-4eb2-a4f6-b6baeacf4c93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzItMi0xLTEtMTA3NzA_4bd1a4b8-f262-4eeb-89a3-d39c345befef">82.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzMtNC0xLTEtMTg5Mjc_77d87ded-6e72-4d5e-be1c-cc6a8ceaf502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzMtNi0xLTEtMTg5Mjk_9be3e3d2-9c43-49b5-b6d8-d0acf07f4cde">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzQtMi0xLTEtMTg5MjU_c79d6a21-03b5-450f-a422-9e2123a651b3">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzQtNC0xLTEtMTg5Mjc_d30a4cc8-85fc-4a38-991e-21034e6e53bb">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzQtNi0xLTEtMTg5Mjk_47769f1c-7873-4565-bc44-f5221cf0b6e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzUtMi0xLTEtMTg5MjU_6a368554-8976-42c3-a3be-12993cbd2aee">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzUtNC0xLTEtMTg5Mjc_ebe58121-a911-4a0e-afa5-91ba1d2c5c4f">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzUtNi0xLTEtMTg5Mjk_97245c26-35fb-45b4-a99a-4629f5b10980">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzYtMi0xLTEtMTg5MjU_f04b9966-811a-4667-898a-4b05ef1e123c">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzYtNC0xLTEtMTg5Mjc_92a465c9-902e-4118-bc72-db5ecb2f77e9">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzYtNi0xLTEtMTg5Mjk_c042c49c-79a0-4cee-8f68-d27f71a4383e">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in fiscal 2020, 2019 and 2018. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228" decimals="5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzOTgwNDY1MjA2Mzc_9b913464-bfbe-4a81-bf59-7f2f73e36175">30.2</ix:nonFraction>&#160;million loss to record the asset group at its fair value less costs to sell. This is a level 1 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measurement. During the second quarter of fiscal 2019, the Company identified indicators of impairment related to its long-lived assets of its Medical Aesthetics reportable segment and recorded impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330" decimals="5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzkzNDU4NDg4NDczODA_bfabff39-67ca-442c-99d0-c626bacddf1b">685.4</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="i73c475cf26a140439e4b7915e83f35fb_D20181230-20190330" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzOTgwNDY1MjA2MjE_ca531648-fc1a-40d7-a707-f59fd6815b8c">675.6</ix:nonFraction>&#160;million was allocated to intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i216e053a60db43869c143b5ae19d8870_D20181230-20190330" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzOTgwNDY1MjA1OTA_5e361913-aa7c-4e55-8ba1-4040c022df41">9.8</ix:nonFraction>&#160;million was allocated to equipment. This was a level 3 measurement. During the second quarter of fiscal 2018, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="id6475457bf9c44539a19af401366b4fa_D20171231-20180331" decimals="5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzOTgwNDY1MjA2MDQ_a840eb8e-fb4b-49ec-be0c-213d3d321b16">685.7</ix:nonFraction>&#160;million goodwill impairment charge in its Medical Aesthetics reportable segment Refer to Note 6 for disclosure of the nonrecurring fair value measurement related to the debt extinguishment losses recorded in fiscal 2019 and 2018. </span></div><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, cost-method equity investments, interest rate caps, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate caps, interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts outstanding under the Company&#8217;s 2018 Credit Agreement of $<ix:nonFraction unitRef="usd" contextRef="i84d0c5013ed249be85fc1ea500342cb0_I20200926" decimals="-7" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzMDA_9ac5d6da-bc25-406f-b601-d3d7fb4637fc">1.71</ix:nonFraction> billion aggregate principal as of September&#160;26, 2020 are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2025 Senior Notes and 2028 Senior Notes had fair values of approximately $<ix:nonFraction unitRef="usd" contextRef="ib5afd9d954b4489889417286bf08a16e_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQ2MTQ_45f5f96c-2aa2-46fc-9be4-6194eea1a8e7">971.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie2070f7d8bb34bab958a30daea1bbd42_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQ2MjE_3ff05039-1fd6-4ee8-a1a8-6fcffc237e1a">419.1</ix:nonFraction> million, respectively, as of September&#160;26, 2020 based on their trading price, representing a Level 1 measurement.</span></div><div style="text-align:center"><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. Income Taxes</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzE0MDIy_ff3f27a4-711c-424b-9020-a6c0757e725b" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income (loss) before income taxes consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:42.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.500%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzItMi0xLTEtMA_85d11bc9-63f4-4c25-bf26-abe40d8e8c00">921.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzItNC0xLTEtMA_790f1aad-d8ef-4ece-a757-6307e0c7601c">174.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzItNi0xLTEtMA_2834f6c7-8f60-4cf4-8c18-45a4619c666a">581.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzMtMi0xLTEtMA_bdfc5221-691b-4c86-86ee-ad4dd293e081">80.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzMtNC0xLTEtMA_acc8694c-9cc8-423a-8246-7333597b5f34">83.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzMtNi0xLTEtMA_1b55642e-273f-45f5-8cfa-3002a33ac828">163.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzQtMi0xLTEtMA_7c66641c-146c-4b9c-9adf-1b20b998a80c">1,001.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzQtNC0xLTEtMA_c18fbc58-ed3a-4c7b-bef2-de8c7ba590be">257.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzQtNi0xLTEtMA_b77d6958-226c-45ab-92d5-16f081f0502c">418.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzE0MDEw_ff390e60-a32e-48a2-89ca-1f7c0472c4ab" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit for income taxes contained the following components:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:42.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.500%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzMtMi0xLTEtMA_7165388a-5b3b-4f0a-a5eb-6c8d15726105">62.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzMtNC0xLTEtMA_e45c265f-5753-4726-856f-fb52728ae32d">142.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzMtNi0xLTEtMA_eca3025c-9fa4-4101-a21e-4374725384d9">137.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzQtMi0xLTEtMA_d7c97c4e-2eb8-47d5-93b6-1d085cfff0a9">76.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzQtNC0xLTEtMA_5524bc1b-76e6-4cea-b14e-37d1ec8e0924">189.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzQtNi0xLTEtMA_7ed25a64-41ae-4d85-81c2-8e546096890c">461.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzUtMi0xLTEtMA_6a2f9293-6cf4-4445-98a9-f2d96038962b">138.7</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzUtNC0xLTEtMA_0466eb98-cf7e-40aa-908a-00cec7222f69">47.0</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzUtNi0xLTEtMA_ae812f84-1eac-40e7-b901-20ceab2d39d8">324.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzctMi0xLTEtMA_6f8bf1df-521f-462a-b60e-b4d8cb35e118">33.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzctNC0xLTEtMA_195ed324-4a1d-4f0d-bc06-5f4c793441d1">22.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzctNi0xLTEtMA_4ca9a440-cd68-49b2-906e-4800b7c5f2c8">11.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzgtMi0xLTEtMA_f78f98c0-0c74-4712-b770-fe06b3251967">12.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzgtNC0xLTEtMA_10af7d85-1ee5-4f5c-a285-ef3a774470ee">41.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzgtNi0xLTEtMA_7276cfe9-21f4-4e43-bbc0-e5590ed97302">11.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzktMi0xLTEtMA_2d63c131-7235-40f5-9a0b-fd946c08cce0">21.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzktNC0xLTEtMA_7649c53b-2046-4175-aca4-f936271fb332">18.9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzktNi0xLTEtMA_cb7dd6f2-bc78-40a1-8c7b-b1dc346471c2">0.3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzExLTItMS0xLTA_92278782-aa36-4025-818d-66945ddc40e8">14.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzExLTQtMS0xLTA_a53a589d-d7b5-49d2-9ec9-ee83e69647ef">16.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzExLTYtMS0xLTA_4abd0a4a-11f7-4068-99b0-5009b7610c28">21.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEyLTItMS0xLTA_4c20086a-e99c-4e14-9396-921265eef3bc">5.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEyLTQtMS0xLTA_2a88fe23-4fe9-4795-9c97-3098304ab77f">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEyLTYtMS0xLTA_c29c668e-2856-476e-890c-27477cc2037d">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEzLTItMS0xLTA_c60dc639-40b7-4817-89ae-5dc37cb5b9f6">8.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEzLTQtMS0xLTA_1090cc46-3c0e-4905-858a-f7b7f091c815">11.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEzLTYtMS0xLTA_ea2932b4-a4d9-4566-a2e0-418f72bbd835">17.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzE0LTItMS0xLTA_91785c3d-aeaa-4a82-a9bc-743378c808cc">108.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzE0LTQtMS0xLTA_7d046dd3-08cd-4a87-a692-6a57e7600577">54.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzE0LTYtMS0xLTA_31701d3a-62c4-4dce-b3f4-366fb8d9ddee">307.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEzOTky_abd8d50e-b019-444c-a151-692cd4fb9bc8" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit differed from the tax benefit computed at the U.S. federal statutory rate due to the following:</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.187%"><tr><td style="width:1.0%"></td><td style="width:51.448%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) provision at federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzItMi0xLTEtMA_dbc4b957-a88c-497a-b3ea-a096c88ddb16">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzItNC0xLTEtMA_a0bf66de-9264-4e2d-b8e0-79a5449ee104">21.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzItNi0xLTEtMA_c5b76555-8060-4d1b-a568-19f33ada535b">24.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in tax resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale of Cynosure</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzQtMi0xLTEtMA_3d913d54-1441-4cad-bc2b-d51a4bf9f671">31.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" format="ixt:zerodash" name="holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzQtNC0xLTEtMA_842bb276-e75a-4103-b927-1360a3ddf049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" format="ixt:zerodash" name="holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzQtNi0xLTEtMA_c683d7ce-efb6-43ba-acc5-4b5d9d615052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic production activities deduction</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzUtMi0xLTEtMA_1c67122e-05be-4db8-b25f-3bea0b937189">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzUtNC0xLTEtMA_c899da37-eb3e-4dd8-90c2-298dd3a1b453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzUtNi0xLTEtMA_ab47f401-a58c-4f68-90a7-88ad13d39e77">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzYtMi0xLTEtMA_80bd5756-df91-4d6d-aa02-cc6c785b7717">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzYtNC0xLTEtMA_0e6b617a-e380-450b-bbce-6192c6080f15">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzYtNi0xLTEtMA_112da5ff-6c55-4a35-a5ab-c400dbc946b3">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on foreign earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzctMi0xLTEtMA_df2d19c7-f155-4e3a-945f-476fa2709d52">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzctNC0xLTEtMA_2f30b3d8-19b3-4c71-8379-c648536d3da3">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzctNi0xLTEtMA_b834f68a-b6b8-4216-a9d5-c272546b907d">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzgtMi0xLTEtMA_b887e0e6-8e83-46a6-9e35-f198fbfaebfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzgtNC0xLTEtMA_7415af96-4bb7-425a-a711-8c3895b8d1a2">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzgtNi0xLTEtMA_3fa16083-6b6e-4431-a540-e5639336a7e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" format="ixt:zerodash" name="holx:EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzktMi0xLTEtMA_3a22bead-b66b-45a0-8cd8-9ed6da2e2af4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" format="ixt:zerodash" name="holx:EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzktNC0xLTEtMA_340d3d41-9904-47f8-9f27-7b7572fb4956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" sign="-" name="holx:EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzktNi0xLTEtMA_4a62ab13-360f-41f5-9803-499b8132c3a0">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEwLTItMS0xLTA_87ccf28b-1864-48b2-93bf-67a18d3e3f60">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" sign="-" name="holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEwLTQtMS0xLTA_ab846914-8c7b-42a5-a813-ec46d23bbce3">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" sign="-" name="holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEwLTYtMS0xLTA_6677b7a3-d5cf-4e37-95a5-6b0f4faf82fa">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax reform</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzExLTItMS0xLTA_15630bc6-ae0d-4995-a526-3ded39789091">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzExLTQtMS0xLTA_8428d0c4-5b41-4f3f-92c5-750ac757840d">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzExLTYtMS0xLTA_9e64e21e-54f9-4521-801c-8353e5501c6c">82.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" format="ixt:zerodash" name="holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEyLTItMS0xLTA_88f7e540-6509-4295-8c47-242127f3ef1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEyLTQtMS0xLTA_1f43b173-cae3-450f-b35f-cdb27ae6e6bd">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" sign="-" name="holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEyLTYtMS0xLTA_f78ac5a8-c278-427c-acab-b3efa5a924ee">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE2LTItMS0xLTA_a297e31a-021a-4887-931e-7707b8e12d28">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" sign="-" name="holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE2LTQtMS0xLTA_4dc43e2e-55eb-4a3a-bc7e-656a631913af">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" sign="-" name="holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE2LTYtMS0xLTA_cd2f5579-fd6d-412e-b819-3146f891fd4f">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE3LTItMS0xLTA_48d7b613-66c7-40bd-b9de-6b7eeaf49c11">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE3LTQtMS0xLTA_793c6728-64bd-415f-8607-8b5e8a699748">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE3LTYtMS0xLTA_bc5761d9-bf17-4d73-9527-70dcfb10a627">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE4LTItMS0xLTA_c4cfb1ed-0d1b-4358-b971-802fdd650adb">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE4LTQtMS0xLTA_c685125e-f80e-4fe3-99c4-2945d302c289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE4LTYtMS0xLTA_779032ba-534b-4001-b35f-3d3a40e8109a">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE5LTItMS0xLTA_e713c861-4f72-4de3-a5f8-8db3c640457b">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE5LTQtMS0xLTA_67c86cbe-9b55-402e-ab5a-77a858aca0fb">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE5LTYtMS0xLTA_2234f631-4ab5-418f-a8b8-37c8dbcc8c91">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIwLTItMS0xLTA_8a99b53e-a06c-459e-819b-31212d0efb18">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIwLTQtMS0xLTA_c9618047-9528-4684-a936-0843ac158de4">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIwLTYtMS0xLTA_0ec1ea9b-986d-444d-a97f-2df2b2a40f96">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIxLTItMS0xLTA_b09b3178-0ebf-4f24-a4dc-49ac30f56399">10.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIxLTQtMS0xLTA_902f8eee-391a-4eca-b0a5-a8b84f841a1d">21.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIxLTYtMS0xLTA_3f7fa85f-cf38-4dfc-bd0a-b6ddee72a176">73.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for fiscal 2020, which was a net benefit, differed from the U.S. statutory tax rate primarily due to a $<ix:nonFraction unitRef="usd" contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzOTgwNDY1NDMzNTk_74cc7692-3087-4c46-918b-90c0d9ba88b5">313.4</ix:nonFraction>&#160;million net tax benefit related to the sale of the Medical Aesthetics business, which is recorded in other assets net of unrecognized tax benefits noted below, the impact of the U.S. deduction for foreign derived intangible income, federal and state tax credits, and the geographic mix of income earned by our international subsidiaries which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes, reserves for uncertain tax positions net of releases resulting from statute of limitations expirations and favorable audit settlements, the global intangible low-taxed income inclusion, and unbenefited foreign losses. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in fiscal 2019, applied to an overall pre-tax loss resulting in a benefit, was equal to the statutory tax rate primarily due to the offsetting impacts of a discrete benefit related to an internal restructuring, earnings in jurisdictions subject to lower tax rates, reserves for uncertain tax positions and releases resulting from statute of limitations expirations and favorable audit settlements, a valuation allowance resulting from the Medical Aesthetics impairment charge, and finalizing the impact of the enactment of the Tax Cuts and Jobs Act (the "Act") in the first quarter of fiscal 2019. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for fiscal 2018, applied to an overall pre-tax loss resulting in a benefit, differed from the statutory rate primarily due to the favorable impact of the Act, which required the Company to remeasure its U.S. net deferred tax liabilities at a lower rate, partially offset by the unfavorable impact of the Medical Aesthetics goodwill impairment charge, substantially all of which was non-deductible. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Act, which was enacted on December 22, 2017, reduced the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018, required companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred and created new taxes on certain foreign sourced earnings. The Company applied SAB 118 when accounting for the enactment effects of the Act. In accordance with SAB 118, the Company recorded an estimated tax benefit of $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" format="ixt:numdotdecimal" name="holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzE3NjM_4450413b-ebeb-49d3-8821-89d3f2858f9e">346.2</ix:nonFraction>&#160;million related to the enactment of the Act during the fiscal year ended September 29, 2018. During the quarter ended December 29, 2018, the Company completed its accounting for the Act, and recorded a final net benefit amount of $<ix:nonFraction unitRef="usd" contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229" decimals="-5" sign="-" format="ixt:numdotdecimal" name="holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzOTgwNDY1NDMzNDM_ba6ee315-c4ce-4e23-9d2c-0198fd11f042">341.2</ix:nonFraction>&#160;million, based on its understanding and interpretation of the regulatory guidance issued.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the asset and liability method to account for income taxes in accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences of differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and also for operating loss and tax credit carry-forwards at each reporting period. Deferred income taxes are based on enacted tax laws and statutory tax rates applicable to the period and jurisdiction which these differences are expected to affect taxable income. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEzOTkz_e7b7ec2c-ee33-46d4-b69b-111d8e32e42f" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s significant deferred tax assets and liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:61.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzItMi0xLTEtMA_c7883265-6aa6-49cc-89f8-dd7e536c1d82">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzItNC0xLTEtMA_bd852c9b-b82f-4b3d-a339-0c121ea058f6">34.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzMtMi0xLTEtMA_2a5fd986-40a1-4ab5-8c3a-ec8ce53459a8">57.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzMtNC0xLTEtMA_009214f5-49cf-40c6-be30-015889e16729">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible accruals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzQtMi0xLTEtMA_d1334a8f-5eb7-4c2f-99c3-fb58a3032de4">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzQtNC0xLTEtMA_778367c7-31f1-4331-b835-820d19a893bf">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzUtMi0xLTEtMA_2da4373a-af18-45c4-9508-cb814c8d83e5">33.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzUtNC0xLTEtMA_42c028a6-6111-498f-ae8b-2e1358989144">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:zerodash" name="holx:UKIntangibleassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzYtMi0xLTEtMA_b2b1ee0a-86ea-4502-8847-e57b6c55cd8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="holx:UKIntangibleassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzYtNC0xLTEtMA_67fa1e46-62e6-4429-8822-ac55f555f88b">25.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzctMi0xLTEtMA_5d1b6630-d078-42f3-aa9c-c09d1158913d">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzctNC0xLTEtMA_0df7e60f-c688-4010-8b94-c5bcf1bd444a">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzgtMi0xLTEtMA_6ea332ff-5c88-4e6a-97ab-7527838bea5f">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzgtNC0xLTEtMA_e8bfe0b5-1ba6-4e8e-b817-75f69524e30d">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified deferred compensation plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzktMi0xLTEtMA_d5031256-5f2c-4eca-acd2-a79053c8b794">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzktNC0xLTEtMA_187e8e87-ded7-460c-b6e7-b225d27e1fad">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" name="holx:DeferredTaxAssetsLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEwLTItMS0xLTEyMTgy_598f93d6-a39b-4b1d-a9d3-f8056dbad6d4">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="5" format="ixt:zerodash" name="holx:DeferredTaxAssetsLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEwLTQtMS0xLTEyMTg2_6873223d-8790-4cdf-b532-d28a80feb976">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEwLTItMS0xLTA_c984d40b-ddfd-4827-be28-e0e9644991a9">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEwLTQtMS0xLTA_1bfed8b7-7f24-440e-a2a5-dbaab672513d">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzExLTItMS0xLTA_9a00db84-cbbe-4d24-bc58-cc857dfa1780">281.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzExLTQtMS0xLTA_62e19e34-4425-49ad-a228-a03a362b56bc">180.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEyLTItMS0xLTA_15a7dc91-312e-49b9-9a55-958f43199013">118.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEyLTQtMS0xLTA_4af40abf-8fde-4325-a5b4-c803b7769a34">60.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEzLTItMS0xLTA_2ba47f79-d7c7-4d29-885d-94f49a6af3b1">163.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEzLTQtMS0xLTA_ae04548f-2e62-475c-93e1-2809a7f0f473">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation&#160;and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="holx:DeferredTaxLiabilitiesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE1LTItMS0xLTA_c33cac85-df26-46b9-9b7a-8e481bbfd9d8">333.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="holx:DeferredTaxLiabilitiesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE1LTQtMS0xLTA_efa4e247-8b3e-4eba-8289-a8400a36ed67">373.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="holx:DeferredTaxLiabilitiesRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE4LTItMS0xLTEyNTkx_46370428-702c-45bc-a238-ef7a5af00fbe">15.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:zerodash" name="holx:DeferredTaxLiabilitiesRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE4LTQtMS0xLTEyNTk1_636a7c92-56f1-426a-9254-a4e0a1e0af73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discounts and deferrals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:zerodash" name="holx:DeferredTaxLiabilitiesDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE2LTItMS0xLTA_bbcea328-7b83-4da5-8698-8ae211faadd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="holx:DeferredTaxLiabilitiesDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE2LTQtMS0xLTA_4a87e63f-2ec6-4f3f-99c8-8da443a32ed6">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE5LTItMS0xLTA_b395eb3d-ffb5-4659-94d0-220c5524df05">349.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE5LTQtMS0xLTA_ca3a4ea9-5cdd-470b-b0dc-6420716d050c">377.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzIwLTItMS0xLTA_8332e2a7-9008-4f52-9d4b-cef00c9c4187">186.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzIwLTQtMS0xLTA_03232685-6025-4ceb-8007-0625786eef2a">258.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under ASC 740, the Company can only recognize the future benefit of deferred tax assets to the extent that it is &#8220;more likely than not&#8221; that these assets will be realized. After considering all available positive and negative evidence, the Company established a valuation allowance against specifically identified deferred tax assets because it is more-likely-than-not that these assets will not be realized. In making this determination, the Company considered numerous factors including historical profitability, estimated future taxable income and the character of such income. The valuation allowance increased $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQwMjI_29424c86-99e3-429a-bbc7-3d05504fd28f">57.8</ix:nonFraction> million in fiscal 2020 from fiscal 2019 primarily due to acquired foreign loss carryforwards and state loss carryforwards resulting from the sale of the Medical Aesthetics business, partially offset by attribute expiration and valuation allowance releases.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September&#160;26, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="icfd0cb53981e490ea162a76a039de64a_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQyMzg_60b73e45-39dd-449e-b6c6-69b416160a9c">40.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i99e5be2075214d609076dc73419bf0c8_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQyNDI_97e86dea-1d23-4873-8f0c-27229a9ca8b5">44.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i9f5ae045d54044febe4e33ec32c959c3_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQyNTA_153f23c0-05f7-4dbd-97c9-3ac85ba28e3e">207.1</ix:nonFraction> million in gross federal, state, and foreign net operating losses, respectively, $<ix:nonFraction unitRef="usd" contextRef="icfd0cb53981e490ea162a76a039de64a_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzMzA_475c3434-cbd3-49bd-a7b7-4c4018d1a628">5.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i99e5be2075214d609076dc73419bf0c8_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzMzQ_9e67e2f9-8c15-4e4a-b9a8-b96fd9bf010d">4.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i9f5ae045d54044febe4e33ec32c959c3_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzNDI_fb52c13c-14ee-4ef6-8065-afa5f5b902e6">1.2</ix:nonFraction> million in federal, state, and foreign credit carryforwards, respectively, and $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" format="ixt:numdotdecimal" name="holx:GrossStateLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTM3MjY_a81cc6dd-1796-49f4-a480-cf91f9dbb258">0.0</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" format="ixt:numdotdecimal" name="holx:GrossForeignLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTM3MTE_e6d944dc-78c6-4bab-b455-810ce99d11e9">32.2</ix:nonFraction>&#160;million in gross state and foreign capital loss carryforwards </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-49</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">respectively. These losses, credits, and capital loss carryforwards expire between 2021 and 2040, except for $<ix:nonFraction unitRef="usd" contextRef="ie7d5ec4cbaba458ca1b77246243d3989_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ0NzQ_c8380931-7cff-45b8-954a-1d22d60dacef">22.5</ix:nonFraction> million in losses, $<ix:nonFraction unitRef="usd" contextRef="ibd756bca5be3431186e7d993f7bc13be_D20190929-20200926" decimals="4" format="ixt:numdotdecimal" name="holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ0OTI_437556b0-98cb-4486-a725-2f5f75156760">3.4</ix:nonFraction> million in credits, and $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTM4Mzc_f58fb841-be0b-4cb2-86a5-e1e20241e1fc">32.2</ix:nonFraction>&#160;million in capital loss carryforwards that have unlimited carryforward periods. The federal, state, and foreign net operating losses exclude $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ2MDk_4a88c12a-8199-4cdc-b094-966a164b07ed">4.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ2MTM_5125522c-b141-4d0f-8ac1-00b8d5a17e4a">74.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ2MjE_69053e88-0998-4d2d-8368-2a1986301358">47.2</ix:nonFraction> million, respectively, and the state capital loss carryforwards exclude $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" format="ixt:numdotdecimal" name="holx:StateLossCarryforwardExpectedToUnutilize" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTM5Mzg_9fa31259-f67b-420a-b18c-47e4b5b21e9b">26.1</ix:nonFraction>&#160;million, that the Company expects will expire unutilized.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 29, 2018, the Company recorded a final net reduction of its deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229" decimals="-5" sign="-" format="ixt:numdotdecimal" name="holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzOTgwNDY1NDMzNzY_af6d7b60-611e-4f9a-bd2f-0463e2a1e881">341.2</ix:nonFraction>&#160;million related to the Act, as compared to the Company&#8217;s provisional net reduction of $<ix:nonFraction unitRef="usd" contextRef="ic48110a0e8a642a6b8ca649bef79b27e_D20180701-20180929" decimals="-5" sign="-" format="ixt:numdotdecimal" name="holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzOTgwNDY1NjEwNDQ_660a4ee9-014b-4b92-af7a-dc78119c6e67">346.4</ix:nonFraction>&#160;million as of September 29, 2018. The Act resulted in a tax benefit relating to the re-measurement of certain U.S. deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21%, partially offset by additional tax expense pertaining to credit utilization limitations and executive compensation deduction disallowances.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;26, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:GrossUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ3Mzk_27450021-49eb-4563-b2cb-86e557ccc234">197.1</ix:nonFraction> million in gross unrecognized tax benefits excluding interest, of which $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ4MDY_ecee2fd6-068d-4292-8493-ee5690527847">184.9</ix:nonFraction> million, if recognized, would reduce the Company's effective tax rate. As of September&#160;28, 2019, the Company had $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="holx:GrossUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ4OTg_0ece6e64-f533-4ff8-987f-988d9cc3152c">101.6</ix:nonFraction> million in gross unrecognized tax benefits excluding interest, of which $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ5NjU_50a9aa6c-2d36-4671-9530-2fdb0987fd91">87.3</ix:nonFraction> million, if recognized, would have reduced the Company's effective tax rate. The $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzUwNDE_f880ad8f-ca03-4388-a052-0ceec16f0a30">95.5</ix:nonFraction> million increase in gross unrecognized tax benefits from fiscal 2019 was primarily related to the divestiture of the Medical Aesthetics business, and to a lesser extent intercompany transfer pricing related to ordinary business operations and other current year positions, partially offset by reserve releases resulting from statute of limitations expirations and audit settlements. In the next twelve months it is reasonably possible that the Company will reduce its gross unrecognized tax benefits by up to $<ix:nonFraction unitRef="usd" contextRef="i4df61e30f2e54979bf7daad2c81da1e8_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzU0MjY_8efcbae3-e491-4403-a4e1-b22893ddc119">1.3</ix:nonFraction> million due to expiring statutes of limitations.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEzOTk1_9d7e5358-35dc-4c7c-ad72-4fb7df11d8b5" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unrecognized income tax benefits activity for fiscal 2020 and 2019 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:61.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzEtMi0xLTEtMA_f2861051-b375-4f20-8574-65b1968da346">101.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzEtNC0xLTEtMA_acee4737-88d4-415d-abde-453cf0e445dd">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax positions related to current year:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzMtMi0xLTEtMA_58c77286-fb9e-4f62-b6ec-24e16cfd42a9">109.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzMtNC0xLTEtMA_acbb2a8e-5915-46be-8bbc-c2c5ca163975">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzQtMi0xLTEtMA_f4cc0588-4e3a-4373-b6cc-0b25e594c39c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzQtNC0xLTEtMA_dfafe1a3-1b74-4b39-bce1-eb6ecd5bac51">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax positions related to prior years:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions related to change in estimate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzYtMi0xLTEtMA_57a57744-4ec1-4d1a-b813-ebc6681eb1fd">1.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzYtNC0xLTEtMA_25b18e54-d060-4926-9bcb-add128ba8484">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzctMi0xLTEtMA_e357c3cb-4ec3-4414-a5f6-5d5349290844">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzctNC0xLTEtMA_fd9a3c8e-9841-428b-8827-fdd3cf2b51e7">4.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzgtMi0xLTEtMA_b0f674df-8f09-4f65-9b86-6c17f1ceee5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzgtNC0xLTEtMA_4a2d582f-09b1-48ef-abef-d480d9847403">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapses in statutes of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzktMi0xLTEtMA_6e37e2f6-fc70-4571-a5d9-6d54a835bc0d">15.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzktNC0xLTEtMA_00b6057e-511c-4b85-9678-f62159d42adc">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired tax positions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions related to reserves acquired from acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzExLTItMS0xLTA_430f91f1-7839-4974-9624-24add6d43662">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzExLTQtMS0xLTA_e9115501-baa7-4a50-aa69-6980cbdf95ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of the end of the fiscal year</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzEyLTItMS0xLTA_50af8c39-90a5-49ef-9017-2c4d21bc288c">197.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzEyLTQtMS0xLTA_bc955309-1f38-41d1-baf4-18e89c119aec">101.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy is to include accrued interest and penalties related to unrecognized tax benefits and income tax liabilities, when applicable, as a component of income tax expense. As of September&#160;26, 2020, and September&#160;28, 2019, gross accrued interest was $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzU3ODI_155a45a7-3152-4863-aff8-a67d6de7da69">11.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzU3OTE_ea0030f9-2ceb-4901-b0a8-732e088cdfdc">11.1</ix:nonFraction> million, respectively. As of September&#160;26, 2020, <ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzU4MTk_bb278b8e-2920-457d-966a-516e34101e2a">no</ix:nonFraction> penalties have been accrued.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are subject to examination by U.S. federal, state, and foreign tax authorities. The Company&#8217;s U.S. Federal income tax returns are generally no longer subject to examination prior to fiscal year 2017. State income tax returns are generally no longer subject to examination prior to fiscal year 2016. The Company is undergoing a tax examination in California (fiscal years 2017-2018). The Massachusetts income tax examination for fiscal years 2014-2015 was settled and the amount assessed was not material. The Company is undergoing a tax examination in the United Kingdom (fiscal years 2016-2018). </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2020, the Company determined that unremitted foreign earnings are no longer considered indefinitely reinvested to the extent foreign earnings can be distributed without a significant tax cost.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As such, the Company records foreign withholding tax liabilities related to the future repatriation of such earnings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to indefinitely reinvest all other outside basis differences to the extent reversal would incur a significant tax liability. It is not practicable for the Company to calculate the unrecognized deferred tax liability related to such incremental tax costs on those outside basis differences.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-50</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Tax Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2016, the FASB issued ASU 2016-16, which removes the prohibition in ASC 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. Under ASU 2016-16, the selling (transferring) entity is required to recognize a current tax expense&#160;or benefit upon transfer of the asset. Similarly, the purchasing (receiving) entity is required&#160;to recognize a deferred tax asset or deferred tax liability, as well as the related&#160;deferred tax benefit or expense, upon receipt of the asset.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU is effective for annual periods beginning after December&#160;15, 2017, and interim periods within those annual periods. The Company adopted ASU 2016-16 in the first quarter of fiscal 2019 on a modified retrospective basis through a cumulative-effect adjustment to decrease the opening balance of accumulated deficit within stockholders' equity as of September 30, 2018, the first day of fiscal 2019. This change in accounting principle resulted in an increase in deferred tax assets of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzExNzY5_7f639f71-03e3-410f-9c7d-b62ee444ce5c">2.9</ix:nonFraction> million, a decrease in accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzExODEw_5a8edd77-3944-43a1-b6c2-64de6a16af77">2.5</ix:nonFraction> million, and a decrease in prepaid taxes of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:DeceasetoprepaidtaxesresultingfromadoptionofASCU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzExODQ5_140e77a7-8078-446a-8f9c-cfdb0fcb9473">0.4</ix:nonFraction> million as of the beginning of the Company&#8217;s fiscal year beginning September 30, 2018.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was required to account for the internal restructuring discussed above under ASU 2016-16 and recorded a $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:IncreasetoincometaxexpenseadoptionofASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEyMDQ3_4d5957a7-39b1-41e6-bf62-ec8dabb91d55">27.8</ix:nonFraction> million increase to income tax expense and income tax liabilities and a decrease of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:DecreaseindeferredtaxliabilitiesduetoASC201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEyMTI2_23528adb-f38c-4020-86b4-fc41f578fe02">37.7</ix:nonFraction> million to deferred tax expense and net deferred tax liabilities for the fiscal year ended September 28, 2019. The net result was a reduction to net loss of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:IncreasetoNetIncomeresultedfromadoptionofASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEyMjc4_194ce866-cf82-4492-8154-1869c13ed532">9.9</ix:nonFraction> million, or $<ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="holx:IncreasetoEarningsperShareresultedfromadoptionofASC201616" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEyMjg1_21fcf2f2-2274-4708-8c39-a31bd08faf7e">0.04</ix:nonFraction> to diluted net loss per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to tax examinations for value added, sales-based, payroll and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates and records loss contingencies pursuant to ASC 450. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company settled an ongoing state non-income tax audit during the fourth quarter of fiscal 2020, which was fully reserved. The settlement resulted in a net benefit of $<ix:nonFraction unitRef="usd" contextRef="i47e07aff515740c893c4234255dbd894_D20200628-20200926" decimals="4" sign="-" format="ixt:numdotdecimal" name="holx:NonIncomeTaxLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEzNTk3_46c20c59-2532-4b10-8929-6dcf6b55ff98">2.9</ix:nonFraction> million recorded to general and administrative expenses from the reserve release. The Company settled an ongoing state non-income tax audit during the second quarter of fiscal 2018. This settlement resulted in a net $<ix:nonFraction unitRef="usd" contextRef="ic5fc614f9e5f468fa0553b7f4576669e_D20171231-20180331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="holx:NonIncomeTaxLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTI3MDc_9b4eb213-2b59-406a-87eb-1562294419e6">4.0</ix:nonFraction>&#160;million benefit recorded to general and administrative expenses from the reserve release.</span></div><div id="i8ddb964a7a024d63b8e4009970e71997_175"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4OTE_dc582b2c-2c1f-4edb-a8cd-985cc5ffaed8" continuedAt="ibcdeee13aa3e47648d2fb60f3aa2b4b4" escape="true">Stockholders' Equity and Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="ibcdeee13aa3e47648d2fb60f3aa2b4b4" continuedAt="i67885bbd3bf44b4f80f44a00f77a616f"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2016, the Company's Board of Directors authorized the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i87614e59ad424355a0cfa527678f7644_I20160621" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzE4NQ_31f5f2e6-8ef7-4aa0-a229-eea5618b5e7a">500.0</ix:nonFraction> million of the Company's outstanding common stock over the next <ix:nonNumeric contextRef="i567472971b68464e8f2541822940d766_D20190929-20200926" format="ixt-sec:durwordsen" name="us-gaap:StockRepurchaseProgramPeriodInForce1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzI0NA_b9ec47bc-e243-4889-b21e-625f18ef931a">five years</ix:nonNumeric>. During fiscal 2018, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQxMQ_de337e20-8207-48e0-acb9-8936f82e5895">5.0</ix:nonFraction> million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ3MA_a875e8af-b11b-46f6-8815-c37e20f3ff18">187.3</ix:nonFraction> million under this authorization. </span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 13, 2018, the Board of Directors authorized another share repurchase plan to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i2ffa5f4f0fd34c458b8ea83bfee55899_I20160613" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYwMg_0276defc-e29f-43f1-bd87-c9e3c28678d9">500.0</ix:nonFraction> million of the Company's outstanding common stock. This share repurchase plan, which replaced the prior plan, was effective August 1, 2018 and expired March 27, 2020. Under this authorization, during the fourth quarter of 2018, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg1MQ_71fa5d61-9ad0-444a-bb72-dd2a8e5ad399">2.3</ix:nonFraction> million shares of its common stock for total consideration of $<ix:nonFraction unitRef="usd" contextRef="ic48110a0e8a642a6b8ca649bef79b27e_D20180701-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkxMA_eebf8e28-707d-4f32-9473-7d1c10c0fb11">88.5</ix:nonFraction> million. During fiscal 2019, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzk1OA_68c49f85-ec94-44b3-96f1-c786443b7a0b">4.8</ix:nonFraction> million shares of its common stock for total consideration of $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzEwMTU_549ade0a-df06-4613-8aa7-4dc81a72ad47">200.1</ix:nonFraction> million. During the first and second quarters of fiscal 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="id87938771f4f4dbea1c6111f383adb40_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MjkxNDk_77c26292-4316-44f8-a9a0-0a6a0915924a">3.9</ix:nonFraction>&#160;million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="id87938771f4f4dbea1c6111f383adb40_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MjkxNjI_dc328007-3939-41b7-8876-5936667f9b33">210.9</ix:nonFraction>&#160;million. As of March 28, 2020, the Company had completed this authorization. </span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, the Board of Directors authorized a new share repurchase plan to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i344d60e17e06466e9922242e3ef82b89_I20191211" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MjkxNzg_fefa74ff-356d-4347-bf3d-ae23efff197e">500.0</ix:nonFraction>&#160;million of the Company's outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020 the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020. Under this revised authorization during fiscal 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i70de3cec1a1146a9ab433c3d475cc634_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg3NTY_0d12e238-0fa7-4c8b-ae8d-bdd38582a1ee">5.1</ix:nonFraction>&#160;million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="i70de3cec1a1146a9ab433c3d475cc634_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg4NTY_59b2ac1c-e8a2-4692-b557-f4b00d386949">237.7</ix:nonFraction>&#160;million. As of September 26, 2020, $<ix:nonFraction unitRef="usd" contextRef="i236a8bf2139a42498b9343877c328ea5_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg4Mjc_3915ac6b-2fdc-4507-8310-3eca195ec23f">262.4</ix:nonFraction>&#160;million was available under this authorization. Subsequent to September 26, 2020, the Company repurchased 1.1 million shares of its common stock for $74.8 million.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2019, the Board of Directors authorized the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926" decimals="5" format="ixt:numdotdecimal" name="holx:ASRAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg3Njg_e8e4afcb-4b7d-4438-9e58-61dd6400c537">205</ix:nonFraction> million of its outstanding shares pursuant to an accelerated share repurchase ("ASR") agreement. On November 22, 2019, the Company executed the ASR agreement with Goldman Sachs &amp; Co. ("Goldman Sachs") pursuant to which the Company repurchased $<ix:nonFraction unitRef="usd" contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328" decimals="-6" format="ixt:numdotdecimal" name="holx:ASRAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg4MTM_56c109ea-519b-419f-8a10-5af17fd5261e">205</ix:nonFraction>&#160;million of the Company's common stock. The initial delivery of approximately 80% of the shares under the ASR was 3.3&#160;million shares for which the Company initially allocated $<ix:nonFraction unitRef="usd" contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="holx:AmountpaidduringtheperiodunderASRAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg3NzA_05131825-3625-4963-a54d-3610afa95002">164.0</ix:nonFraction>&#160;million of the $<ix:nonFraction unitRef="usd" contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328" decimals="-6" format="ixt:numdotdecimal" name="holx:ASRAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg3ODY_987b486d-6568-4954-ad8b-18af712004a7">205</ix:nonFraction>&#160;million paid to Goldman Sachs during the first quarter of fiscal 2020. The Company evaluated the nature of the forward contract aspect of the ASR under ASC 815 </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-51</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i67885bbd3bf44b4f80f44a00f77a616f" continuedAt="i41c94edd2d564e5aa4e93aad2f373424"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and concluded equity classification was appropriate. Final settlement of the transaction under the ASR occurred in the second quarter of fiscal 2020. At settlement, Goldman Sachs delivered an additional <ix:nonFraction unitRef="usd" contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627" decimals="-5" format="ixt:numdotdecimal" name="holx:ASRSharesRepurchasedduringtheperiod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg4NDM_6ce01564-93fb-45ea-80ff-a2cad39c2e7c">0.6</ix:nonFraction>&#160;million shares of the Company's common stock.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Compensation Plans</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has one share-based compensation plan pursuant to which awards are currently being issued&#8212;the 2008 amended and restated Equity Incentive Plan (&#8220;2008 Equity Plan&#8221;). The purpose of the 2008 Equity Plan is to provide stock options, restricted stock units and other equity interests in the Company to employees, officers, directors, consultants and advisors of the Company and any other person who is determined by the Board of Directors to have made (or is expected to make) contributions to the Company. The 2008 Equity Plan is administered by the Board of Directors of the Company, and a total of <ix:nonFraction unitRef="shares" contextRef="ie6f4f0e51b7443bd94ce48cf225a28d3_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzIyMzc_b57ac03e-b7df-49bb-9089-96442b773857">31.5</ix:nonFraction> million shares were reserved for issuance under this plan. As of September&#160;26, 2020, the Company had <ix:nonFraction unitRef="shares" contextRef="ie6f4f0e51b7443bd94ce48cf225a28d3_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzIzMTc_376b57d5-3843-4ef6-9cbd-3c55511e88a4">5.7</ix:nonFraction> million shares available for future grant under the 2008 Equity Plan.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg2OTQ_bd268358-0e83-4fcd-9d31-db11b2704158" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Operations in fiscal 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied1237c55f6c496982f5cf0a7ad5371b_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzEtMi0xLTEtMA_b0828cf2-5ab5-423b-a40d-0d617c4810aa">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b8a865cdda34642b4c153cb74f8c7c8_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzEtNC0xLTEtMA_9a53fe2a-220e-4b0e-a9fa-5ecdef17c85a">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65ece6ed881340c0983a4d9a30e84a4f_D20171001-20180929" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzEtNi0xLTEtMA_92073ede-04bf-4b54-a3f8-659a5e6489a9">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8fb000016144a92804e2ae8b96faa97_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzItMi0xLTEtMA_cd280f8d-9b97-45a8-b16a-51b0b578c400">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i760d62d34b6c4e3d9fd83595b9544c75_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzItNC0xLTEtMA_1496b812-1c68-476f-b4ec-64f6409549b4">9.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec0c47dbd6d148fd815d60b69a3d1af1_D20171001-20180929" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzItNi0xLTEtMA_5919453b-c014-4086-a799-ae7815a8fd7f">9.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec342e530b5b4e5cbbfb80a971db360b_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzMtMi0xLTEtMA_2fac1492-6c79-4f25-b122-0fedacd2263e">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9277765060a44848fd3c1bf6489f2f8_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzMtNC0xLTEtMA_9c6b100c-f620-4525-aa29-5e4a7f72f3b7">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c9f52dca544401a06085cc4efa3e15_D20171001-20180929" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzMtNi0xLTEtMA_e64d5ed1-1a16-49b6-9d99-2cdaa4cb7140">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09747d2102e4179be4850c578ac2e26_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzQtMi0xLTEtMA_081c2e6f-0110-494c-a020-d9f4028278ad">50.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58a4ba4198cf4304a5d2849a8cd03384_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzQtNC0xLTEtMA_c1b3610b-04ad-441a-9e84-fe87891a8923">35.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27273d926f654c129c15a62dc39b61d9_D20171001-20180929" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzQtNi0xLTEtMA_a467a0d8-5d12-422f-b267-75175f21f87f">35.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae964ccd43014ae6a1f6c43ed006fd89_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzUtMi0xLTEtMA_b2e943bd-72ae-47ce-8360-05759905dc3c">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e9ea3fbbd84b0ca265d809ab74762a_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzUtNC0xLTEtMA_5229df41-41e5-4800-a05e-837943d6c220">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0f1f9a60e324df19c668bddb5052108_D20171001-20180929" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzUtNi0xLTEtMA_f87f24c5-c21f-46d1-9407-c440506c3024">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzYtMi0xLTEtMA_a9ab3909-7620-40fc-8657-8fde909385f1">83.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzYtNC0xLTEtMA_4444271d-4a6a-4ca7-aa0f-870c25c735a3">62.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzYtNi0xLTEtMA_6d8b3c5e-f072-4be1-bebd-e198f155ee2c">65.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Grant-Date Fair Value</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The Company considers a number of factors to determine the fair value of options including the assistance of an outside valuation adviser. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg2NzY_964f60d0-ceb7-4736-88db-e045464fdf16" continuedAt="i12081611c9894d4cb0b91361411d7f3b" escape="true">Information pertaining to stock options granted during fiscal 2020, 2019 and 2018 and related assumptions are noted in the following table:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i12081611c9894d4cb0b91361411d7f3b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted (in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzItMi0xLTEtMA_5864bed1-3ea7-4eb7-a604-0b1b76fe2210">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzItNC0xLTEtMA_627a9d9b-0223-4fc6-bb3e-102de3ce28c7">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzItNi0xLTEtMA_295425ce-1072-49ef-8aa7-8f6cbeb3f459">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzMtMi0xLTEtMA_07dcd311-2ac2-4a7f-ae4b-5d7b009eea2b">45.96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzMtNC0xLTEtMA_9c01bc3d-3a39-427e-9d8d-863c1dcfd5f8">41.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzMtNi0xLTEtMA_6e61672c-213c-4715-9915-8a2702916478">40.76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzQtMi0xLTEtMA_87186ae0-cb29-43c4-a99e-46544ad6ed0e">13.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzQtNC0xLTEtMA_8d9332d9-44b7-4ac9-884d-0a75d0a81317">13.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzQtNi0xLTEtMA_6d681397-ad23-4027-8d43-99b6519ed6d9">12.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzYtMi0xLTEtMA_d3bf5707-b7be-41fb-8508-f64e0d988a4d">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzYtNC0xLTEtMA_826e7f8f-9b1c-4bd6-84fd-827c3cf82749">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzYtNi0xLTEtMA_b5934830-3c9a-463c-b064-43cfa3d286ae">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzctMi0xLTEtMA_2833b285-e0c5-40b5-a538-40fe31cc2174">4.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzctNC0xLTEtMA_eceb8c06-55db-4634-bac1-3513f49e5335">4.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzctNi0xLTEtMA_83a1a5b4-7a44-4050-a429-37258cf37c4d">4.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzgtMi0xLTEtMA_eec9c569-d33a-4f35-a808-5b06cf03e6e6">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzgtNC0xLTEtMA_0893bf09-13d5-4b6b-9148-d1587694d33b">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzgtNi0xLTEtMA_40bec5b3-43c7-46c1-ae51-f961f3ae0f27">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzktMi0xLTEtMA_a266b9c4-6b65-4f44-8e01-991e36b6e527">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzktNC0xLTEtMA_fea216bd-a27b-4396-858d-9c527d86c246">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzktNi0xLTEtMA_018be374-982c-4e1a-ac4c-8df8caa4c859">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. In projecting expected stock price volatility, the Company uses a combination of historical stock price volatility and implied volatility from observable market prices of similar equity instruments. The Company estimated the expected life of stock options based on historical experience using employee exercise and option expiration data.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation Expense Attribution</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the straight-line attribution method to recognize stock-based compensation expense for stock options and restricted stock units ("RSUs"). The vesting term of stock options is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM1OTU_52c76a56-1dfb-4edb-afc4-0cd46b21920e">four</span> or <ix:nonNumeric contextRef="i1c2c9561d23a4512999038eae996412d_D20190929-20200926" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4ODc_6ccc50a7-ad08-4d2a-b149-0d66b802c76b">five years</ix:nonNumeric> with annual vesting of <ix:nonFraction unitRef="number" contextRef="ib5d1f26c41db4389981295f374b306d4_D20190929-20200926" decimals="2" name="holx:PercentageOfVestingForStockOptionsGrantedToEmployees" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM2MzM_c60893d9-e6a6-4771-860a-b9610f6fe79f">25</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1c2c9561d23a4512999038eae996412d_D20190929-20200926" decimals="2" name="holx:PercentageOfVestingForStockOptionsGrantedToEmployees" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM2NDA_4d98d913-82cd-4180-afc4-4855058a5c48">20</ix:nonFraction>%&#160;per year, respectively, on the anniversary of the grant date, and RSUs generally vest over <ix:nonNumeric contextRef="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4ODg_5bec3966-965b-4082-a35f-7e8677681ee0">three years</ix:nonNumeric> with annual vesting at <ix:nonFraction unitRef="number" contextRef="i09b6196b4174420b8327b0919e55fd26_D20190929-20200926" decimals="2" name="holx:PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM3NzI_dd83f58d-5cdc-4c12-b026-5e5e01452519">33</ix:nonFraction>% per year on the anniversary of the grant date. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company's accounting policy is to estimate forfeitures at the time awards are granted and revise, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based on an analysis of historical forfeitures, the Company has determined a specific forfeiture rate for certain employee groups and has </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-52</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i41c94edd2d564e5aa4e93aad2f373424" continuedAt="i4bfaa712a459423483fcf0f1535d8240"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applied forfeiture rates ranging from <ix:nonFraction unitRef="number" contextRef="i26ac442ab8104d62a507939b10fa969a_D20190929-20200926" decimals="INF" name="holx:ShareBasedCompensationPercentageOfForfeitureRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzODg_092f9489-b4ad-4a6b-8a91-2aa25f593037">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i8c09129ca98843beadfd374cfab77639_D20190929-20200926" decimals="3" name="holx:ShareBasedCompensationPercentageOfForfeitureRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTQ_5b94967b-4bb6-43ea-b32a-4ab1b3531884">6.0</ix:nonFraction>% as of September&#160;26, 2020 depending on the specific employee group. This analysis is re-evaluated annually and the forfeiture rate adjusted as necessary. Ultimately, the actual stock-based compensation expense recognized will only be for those stock options and RSUs that vest.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to stock options was $<ix:nonFraction unitRef="usd" contextRef="ice730bb0ac124aad881fa4077c12c6df_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ3Mjg_751adfe5-000c-4e33-a4ef-23c924a27b88">15.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2e8fd89d9b9f477a8ed2176e6f8d2ed8_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ3MzI_e299cc6c-f471-4970-a6af-5ff8c372d3c7">14.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4b926d761276461084bf3fb001bd3488_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ3NDA_aa45ed9d-fa50-4797-8a49-af46034be291">14.3</ix:nonFraction> million in fiscal 2020, 2019 and 2018, respectively. Stock compensation expense related to stock units, including RSUs, performance stock units ("PSUs"), free cash flow performance stock units ("FCFs") and market stock units ("MSUs") was $<ix:nonFraction unitRef="usd" contextRef="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ5MTg_b9e46652-a9d6-4965-9b61-cf7823ba0f27">63.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i104ee4ba76c74aed9b201714d5f8ce04_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ5MjI_e2a88151-e07d-47d9-ad4b-78ba0af31069">43.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i43643c78c5974a028da555a478aa52e7_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ5MzA_9c5e7497-6d59-4761-90dd-93b22e92a0e5">46.5</ix:nonFraction> million in fiscal 2020, 2019 and 2018, respectively. The related tax benefit recorded in the Consolidated Statements of Operations was $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUwNTQ_298158f1-1766-4910-ac3a-253109aa1b94">9.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUwNTg_6ec17272-6b09-4a87-b390-01060229cffa">8.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUwNjU_028b0517-913b-470e-8f91-19621fbed876">11.7</ix:nonFraction> million in fiscal 2020, 2019 and 2018, respectively. At September&#160;26, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="iec34ce09c17f4512b3a712e8d193c4ce_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUxMjg_bb24d834-c11c-4c36-bb68-6df7daa664ef">19.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9d45047c3cf742559c39657d33045548_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUxMzU_66e238f3-7e52-46d1-ab4e-e745784b390b">50.0</ix:nonFraction> million of unrecognized compensation expense related to stock options and RSUs, respectively, to be recognized over a weighted average period of <ix:nonNumeric contextRef="ice730bb0ac124aad881fa4077c12c6df_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUyNzU_9add0e32-90a7-47fe-b756-a2b3f072a463">2.3</ix:nonNumeric> years and <ix:nonNumeric contextRef="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUyODg_8f0f3184-7b70-4779-a002-f2343966b233">1.7</ix:nonNumeric> years, respectively.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment Activity</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg3MDE_5f961a9c-b0c1-4721-91bd-4ced38838b56" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all stock option activity under the Company&#8217;s stock option plans for the year ended September&#160;26, 2020:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.181%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.181%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.181%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares<br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzEtMi0xLTEtMA_f8109d1e-f2cd-40fc-8981-b1ca01b84179">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzEtNC0xLTEtMA_ae492b8d-8dee-44bb-9f8e-80395181b036">35.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" format="ixt-sec:duryear" name="holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzEtNi0xLTEtMA_50d32b90-eb34-4850-a56c-306b995657eb">6.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzEtOC0xLTEtMA_a4fbd03b-97cf-4b8d-8879-cd14b4aa57db">78.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzItMi0xLTEtMA_a40bdaa4-47f2-4016-b84e-8455001e3f2a">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzItNC0xLTEtMA_e8d10029-bf22-4c16-87f8-043723ba8eb3">45.96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/ forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzMtMi0xLTEtMA_b39ebf87-4087-44aa-9560-28e30dfec2c3">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzMtNC0xLTEtMA_1ad8756d-0849-426f-8199-4db1f2d7471b">42.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzQtMi0xLTEtMA_51633511-64b6-4fb0-975c-7bbde7ea154e">1.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzQtNC0xLTEtMA_0a422bf3-8f92-4ef4-a74b-2c5725c9af6d">27.51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzQtOC0xLTEtMA_0a3a8f06-ad4b-4b99-836b-5c75b2ff3294">44.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzUtMi0xLTEtMA_977fec56-69e0-4c2d-86ec-88fe5850e254">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzUtNC0xLTEtMA_761d5c71-13ef-44dd-b09e-c58abbc04bed">40.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:duryear" name="holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzUtNi0xLTEtMA_3e26c9e6-6f58-4130-baae-d25589980422">7.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzUtOC0xLTEtMA_8a5a869f-5617-4f3f-b0d3-b56a4523d22d">109.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzYtMi0xLTEtMA_39885875-e6e5-44fb-9152-51c27d4840a9">2.2</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzYtNC0xLTEtMA_ab423d0e-a6bf-4e26-ab25-5b30e918dcb5">37.81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzYtNi0xLTEtMA_b734c70c-a7c1-4b8b-bb70-3851f08e9553">6.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzYtOC0xLTEtMA_fa35d8b3-07e6-445b-9981-780f100dcbcb">57.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest at September 26, 2020 (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzctMi0xLTEtMA_24c42ba5-fdf6-4102-a7dd-48341cadf5fe">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzctNC0xLTEtMA_99b23fee-1d51-458b-a853-0319510c1722">40.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzctNi0xLTEtMA_d6bc9fe7-a779-4b1b-ab8c-255d53a3f0da">7.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzctOC0xLTEtMA_52fd646a-317e-40d3-90d2-25e95378c8c6">108.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This represents the number of vested stock options as of September&#160;26, 2020 plus the unvested outstanding options at September&#160;26, 2020 expected to vest in the future, adjusted for estimated forfeitures.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019 and 2018, the total intrinsic value of options exercised (i.e., the difference between the market price on the date of exercise and the price paid by the employee to exercise the options) was $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzU4NDY_f7f965cc-e7e3-4c25-9b06-02f13ecfe22b">26.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzU4NTM_20005131-7ed2-498e-9ccc-c734b3fb21ee">15.2</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg2OTA_a5585e35-6ce8-49fa-83a7-183443ef23ef" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s RSU, PSU, FCF and MSU activity during the year ended September&#160;26, 2020 is presented below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"><tr><td style="width:1.0%"></td><td style="width:50.978%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-vested Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-Date&#160;Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzEtMi0xLTEtMA_287f646e-b50a-494a-979a-57bdfb2ccbff">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzEtNC0xLTEtMA_a291c830-f923-4880-a818-d7c745287cc1">42.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzItMi0xLTEtMA_04a70ede-9ba3-464e-9675-e9168bf5f8e0">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzItNC0xLTEtMA_7b9fef6b-eebc-46c1-869b-2f4f2064b6f2">45.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzMtMi0xLTEtMA_af883ff1-e40f-465f-9472-7d333caf8c8d">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzMtNC0xLTEtMA_4361269b-9879-4a00-8f12-8095e0403aa0">38.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzQtMi0xLTEtMA_7c3ea5af-49c3-4b73-a951-a2c9ef276dc5">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzQtNC0xLTEtMA_ec1b4e0a-3eb4-45fe-bf2f-c2bf4c4e660b">42.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzUtMi0xLTEtMA_47bada09-799c-4e22-8c96-cc527aca5bdc">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzUtNC0xLTEtMA_822c264c-7d1e-4400-9af3-56c7cc1a9322">44.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of RSUs vested includes shares withheld on behalf of employees to satisfy minimum statutory tax withholding requirements. The Company pays the minimum statutory tax withholding requirement on behalf of its employees. During fiscal 2020, 2019 and 2018 the total fair value of RSUs and PSUs vested was $<ix:nonFraction unitRef="usd" contextRef="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYyNzg_142222a6-fe76-476e-bc1c-541688369592">34.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i104ee4ba76c74aed9b201714d5f8ce04_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYyODI_86f55e12-12e6-4bec-b130-40c5f344f8ce">34.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i43643c78c5974a028da555a478aa52e7_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYyODk_72c2f5ea-d5ad-44f7-95fe-f86ec752f9f1">38.9</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted <ix:nonFraction unitRef="shares" contextRef="ia847fce0b90344668cafc984721d53fe_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2MzI_5256e4d2-418b-4c9d-8311-c607d613a0d2">0.6</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="shares" contextRef="i29db4dc36329440196aa20118733f489_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2NDU_59c2c6bb-4fa6-47a1-ab2c-b7f496eee8ff">0.9</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i938586f669074d699e349df7bfd5a870_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2NTg_9e3230a8-1720-4a2a-8fa4-3ee7569e0b52">0.8</ix:nonFraction>&#160;million RSUs during fiscal 2020, 2019 and 2018, respectively. In addition, included in the above chart, the Company also granted <ix:nonFraction unitRef="shares" contextRef="i26da8197478a4c5594b3a0e032588eea_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYzNTY_962feb72-c153-4a7b-90cc-f314ab15e73f">0.1</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="i2faaf0252c0e495f89cf1661f67bfe89_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYzNjM_7ae2c64f-812f-412f-b083-9e156e96c4e7">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i8fce35bd4c5b47ffb3ff0ea7000a3d6b_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYzNzA_40b8ee1d-5572-4a13-869e-e6052040c193">0.6</ix:nonFraction> million PSUs during fiscal </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-53</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i4bfaa712a459423483fcf0f1535d8240"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, 2019, and 2018 respectively, to members of the Company's senior management team, which includes additional shares issued upon achieving metrics within the performance criteria. The PSUs were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i26da8197478a4c5594b3a0e032588eea_D20190929-20200926" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2NzE_c0a6cd72-9a71-421a-b980-6ee0d83c4855">45.38</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2faaf0252c0e495f89cf1661f67bfe89_D20180930-20190928" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2ODE_5dfecd53-5af2-45da-bf33-5d65472250b3">40.97</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i8fce35bd4c5b47ffb3ff0ea7000a3d6b_D20171001-20180929" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2ODk_b9d9bf46-f7c5-4c17-bbb8-283119000645">40.86</ix:nonFraction> per share based on the ending stock price on the date of grant in fiscal 2020, 2019 and 2018, respectively. Each recipient of the PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="INF" format="ixt-sec:numwordsen" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzY2MzA_ac535bd4-97f7-44a0-b4d2-c58a1291c63b">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzY2Mzc_85f19a30-0a8e-42ec-97f0-92ca71b0d155">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4ODk_40c68acf-0a57-48ce-8ad8-d533c97620e8">three year</ix:nonNumeric> performance period provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted <ix:nonFraction unitRef="shares" contextRef="i4bfbce83a3f04755b0b598f232407953_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MjQ3MDQ_29412ed7-4d78-4087-a24b-eab40fc7587d">0.1</ix:nonFraction>&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" format="ixt-sec:durwordsen" name="holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTgwMTY_ddcde8fb-ac00-457b-89d7-8ed2f40488fc">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted <ix:nonFraction unitRef="shares" contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzcyOTA_4083cfca-928e-4328-ab0c-bafef7533f57">0.1</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="if28b5094554845ab80d0c3c9b07c0ebd_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzcyOTQ_86091c64-ae1c-4ca4-9122-f030bf760073">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i15f3d181c2484886bc4ceaa42ec74fc4_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzczMDE_4f21e616-c071-4742-9fd2-a17b14fd77c6">0.3</ix:nonFraction> million MSUs during fiscal 2020, 2019 and 2018, respectively, to its senior management team. Each recipient of MSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926" decimals="INF" format="ixt-sec:numwordsen" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc0NDM_7e3daa5e-bdd3-4ea8-86b0-52aa84316875">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc0NTA_47c57859-da1e-4a99-9b10-78edfe300db4">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of three year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc2Njk_43f13941-c8da-4d42-b5f6-972ec41ed190">43.54</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="if28b5094554845ab80d0c3c9b07c0ebd_D20180930-20190928" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc2NzM_6f2f3e10-f235-4cdb-b266-db1f5f9c6880">55.13</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i15f3d181c2484886bc4ceaa42ec74fc4_D20171001-20180929" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc2ODA_33dda1e6-de4f-4e6a-a538-59fb54a1ba03">49.44</ix:nonFraction> per share using the Monte Carlo simulation model in fiscal 2020, 2019 and 2018, respectively. These awards cliff-vest <ix:nonNumeric contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926" format="ixt-sec:durwordsen" name="holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4OTA_9ac3a47f-a01e-4290-a477-5abab1f0f5ab">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hologic, Inc. 2012 Employee Stock Purchase Plan (&#8220;2012 ESPP&#8221;) provides for the granting of up to <ix:nonFraction unitRef="shares" contextRef="i9cdd3310d03c410ca044b216790a4efd_D20120301-20120331" decimals="-5" format="ixt:numdotdecimal" name="holx:NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzgwNTg_fb877be8-3bc2-429d-90f9-6ffb93c73799">2.5</ix:nonFraction> million shares of the Company&#8217;s common stock to eligible employees. The 2012 ESPP plan period is semi-annual and allows participants to purchase the Company&#8217;s common stock at <ix:nonFraction unitRef="number" contextRef="i9cdd3310d03c410ca044b216790a4efd_D20120301-20120331" decimals="2" name="holx:PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzgyMjg_3b7c8e77-a8e2-4882-983a-d326ead1b2f6">85</ix:nonFraction>% of the lower of (i)&#160;the market value per share of the common stock on the first day of the offering period or (ii)&#160;the market value per share of the common stock on the purchase date. Stock-based compensation expense in fiscal 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i03f873eba04440daa1996d87fcc393ff_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg0NzY_c496bf55-a089-4e99-9abd-20326d74d5dc">4.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia8a80c13b2f643e4ba3bad6e12f15dce_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg0ODA_43088191-8ea8-4a57-999e-10562773cba0">4.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie56ea29037024f99b13b9416f137590f_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg0ODc_6ea52e84-0687-4be8-8ff2-482f70133210">4.0</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg2OTI_62c539bf-a08a-4ea3-9fb2-5ff4e1fccba5" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:42.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzItMi0xLTEtMA_721299bf-89d7-426d-9639-ae9e564d21e8">1.32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzItNC0xLTEtMA_7c4e987d-89fd-4c4d-9be8-de6b7a8d4f3e">2.27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if304b540b69e455f95347a24194deea2_D20171001-20180929" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzItNi0xLTEtMA_bff854e1-a077-44f8-a55b-e57d195631ef">1.62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzMtMi0xLTEtMA_8af27cb9-7e7c-43a8-a23f-1db52bbc946a">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzMtNC0xLTEtMA_ef08d1d9-2c2b-418c-8284-6c0eb59adb89">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if304b540b69e455f95347a24194deea2_D20171001-20180929" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzMtNi0xLTEtMA_eea6d823-7fd4-4b8a-8b72-219fe52d30ab">0.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzQtMi0xLTEtMA_d6b63db2-5a75-43d2-8b4a-8f7b525e4825">26.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzQtNC0xLTEtMA_26769ece-f2df-4900-8a5f-d34e65b68af3">27.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if304b540b69e455f95347a24194deea2_D20171001-20180929" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzQtNi0xLTEtMA_eecd5ac9-776e-4c73-baba-2334d72fb5f5">25.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzUtMi0xLTEtMA_9bcb9791-992b-4ad0-a75c-3652a04ea0c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzUtNC0xLTEtMA_8fa5a627-d606-4469-a321-4d8533e2ed5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if304b540b69e455f95347a24194deea2_D20171001-20180929" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzUtNi0xLTEtMA_ebfe2324-cb3f-4f07-966d-522fab07698f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_181"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:ProfitSharingFourZeroOneKPlanTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODEvZnJhZzozODg3NzVhNGVhMzk0ZWRkYjY1YTE5NjhhNzQ0N2RiYy90ZXh0cmVnaW9uOjM4ODc3NWE0ZWEzOTRlZGRiNjVhMTk2OGE3NDQ3ZGJjXzE5Nw_42755769-aea2-40ad-9d17-a0e34a7ebb22" continuedAt="i71e9f3d3f1b24f578a1f77346377d207" escape="true">401(k) Plan</ix:nonNumeric></span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i71e9f3d3f1b24f578a1f77346377d207">The Company's U.S. employees have access to a qualified 401(k) defined contribution plan. The Company made contributions of $<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODEvZnJhZzozODg3NzVhNGVhMzk0ZWRkYjY1YTE5NjhhNzQ0N2RiYy90ZXh0cmVnaW9uOjM4ODc3NWE0ZWEzOTRlZGRiNjVhMTk2OGE3NDQ3ZGJjXzE0NQ_240ebd3d-2e84-4a5b-9acc-c71512ce45a6">19.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODEvZnJhZzozODg3NzVhNGVhMzk0ZWRkYjY1YTE5NjhhNzQ0N2RiYy90ZXh0cmVnaW9uOjM4ODc3NWE0ZWEzOTRlZGRiNjVhMTk2OGE3NDQ3ZGJjXzE0OQ_a396126a-90f1-4394-823b-8262a7c2d5a5">19.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODEvZnJhZzozODg3NzVhNGVhMzk0ZWRkYjY1YTE5NjhhNzQ0N2RiYy90ZXh0cmVnaW9uOjM4ODc3NWE0ZWEzOTRlZGRiNjVhMTk2OGE3NDQ3ZGJjXzE1Ng_ad81c348-848b-4d13-9241-bdc407826b19">18.6</ix:nonFraction> million for fiscal 2020, 2019 and 2018, respectively.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-54</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. Deferred Compensation Plans</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nonqualified Deferred Compensation Plan</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March&#160;15, 2006, the Company adopted its Nonqualified Deferred Compensation Plan ("DCP") to provide non-qualified retirement benefits to a select group of executive officers, senior management and highly compensated employees of the Company. Eligible employees may elect to contribute up to <ix:nonFraction unitRef="number" contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926" decimals="INF" name="holx:MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzM3Nw_f5b87b1a-b682-4540-9260-e57bd32c0377">75</ix:nonFraction>% of their annual base salary and <ix:nonFraction unitRef="number" contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926" decimals="INF" name="holx:MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzQxMg_d7fcbbbb-5cc8-43df-b94e-6b67a946d75a">100</ix:nonFraction>% of their annual bonus to the DCP and such employee contributions are <ix:nonFraction unitRef="number" contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926" decimals="INF" name="holx:EmployeeContributionsVestedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzQ4NA_5e9016df-b400-4a25-aefa-c93edb619d68">100</ix:nonFraction>% vested. In addition, the Company may elect to make annual discretionary contributions on behalf of participants in the DCP. Each Company contribution is subject to a <ix:nonNumeric contextRef="i89dc067ea55a42809194d94e740c9bee_D20190929-20200926" format="ixt-sec:durwordsen" name="holx:EmployerContributionsVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzkzNDU4NDg4Mzk4NDI_91d98935-5fa6-4c84-8964-16f14c55f06d">three-year</ix:nonNumeric> vesting schedule, such that each contribution vests one third annually. Employee contributions are recorded within accrued expenses.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon enrollment into the DCP, employees make investment elections for both their voluntary contributions and discretionary contributions, if any, made by the Company. Earnings and losses on contributions based on these investment elections are recorded as a component of compensation expense in the period earned.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annually, the Compensation Committee of the Board of Directors has approved a discretionary cash contribution to the DCP for each year. Discretionary contributions by the Company to the DCP are held in a Rabbi Trust. The Company records compensation expense for the DCP discretionary contributions ratably over the <ix:nonNumeric contextRef="i89dc067ea55a42809194d94e740c9bee_D20190929-20200926" format="ixt-sec:durwordsen" name="holx:EmployerContributionsVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzkzNDU4NDg4Mzk4NDE_cc47945a-8959-4dbe-81ed-4a438e1ad573">three-year</ix:nonNumeric> vesting period of each annual contribution, unless the participant meets the plan retirement provision of reaching a certain age and years of service criteria in which case the expense is accelerated to match the required service period to receive such benefit. Under the DCP, the Company recorded compensation expense related to Company contributions of $<ix:nonFraction unitRef="usd" contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:NonqualifiedDeferredCompensationPlanAnnualContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE3ODY_2c343d70-f946-4ad8-8967-f30ba92b76ce">3.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4f373267ff8f45d1911298976ebff835_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="holx:NonqualifiedDeferredCompensationPlanAnnualContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE3OTA_eb38c64a-7e0e-4caa-988d-243191aca039">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7c7afed9db584308a9e0b366c0c10595_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="holx:NonqualifiedDeferredCompensationPlanAnnualContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE3OTc_44f353b2-e74d-4344-a3e6-82b5cd221e1e">2.9</ix:nonFraction> million in fiscal 2020, 2019 and 2018, respectively. The full amount of the discretionary contribution, net of forfeitures, along with employee deferrals is recorded within accrued expenses and totaled $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE5ODg_90b7310c-b676-40bf-9b19-77918d34f17e">57.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="5" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE5OTU_036e389d-5ea3-44f5-b13f-6af9b8ebe0ec">51.9</ix:nonFraction> million at September&#160;26, 2020 and September&#160;28, 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has purchased Company-owned group life insurance contracts, in which both voluntary and discretionary Company DCP contributions are invested, to partially fund payment of the Company&#8217;s obligation to the DCP participants. The total amount invested at September&#160;26, 2020 and September&#160;28, 2019 was $<ix:nonFraction unitRef="usd" contextRef="ib6c043d4da794f2fa73ea7b9a2d37948_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:InvestmentInGroupLifeInsuranceContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzIzMDI_2eddb08f-bcf5-40a9-a4a7-132955344f04">49.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8e43de73b36940809bd154646af2ad6b_I20190928" decimals="-5" format="ixt:numdotdecimal" name="holx:InvestmentInGroupLifeInsuranceContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzIzMDk_00dcdac8-d16c-463a-9541-0031f146fe6b">44.6</ix:nonFraction> million, respectively. The values of these life insurance contracts are recorded in other long-term assets. Changes in the cash surrender value of life insurance contracts, which were not significant in fiscal 2020, 2019 and 2018, are recorded within other income, net.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Equity Plan</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 17, 2015, the Company adopted the Hologic, Inc. Deferred Equity Plan (the &#8220;DEP&#8221;). The DEP is designed to allow executives and non-employee Directors to accumulate Company stock in a tax-efficient manner to meet their long-term equity accumulation goals and shareholder ownership guidelines. Under the DEP, eligible participants may elect to defer the settlement of RSUs and PSUs granted under the 2008 Equity Plan until separation from service or separation from service plus a fixed number of years. Participants may defer settlement by vesting tranche. Although the equity will vest on schedule, if deferral of settlement is elected, no shares are issued until the settlement date. The settlement date is the earlier of death, disability, change in control of the Company or separation from service plus the number of years of deferral elected by the participant. While these shares upon vesting are not distributed to the individuals and are not outstanding, these shares are included in basic weighted average shares outstanding used to calculate earnings per share.</span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_190"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. Non-cancelable Purchase Commitments</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90ZXh0cmVnaW9uOjc0OTZmYWEzYzE0MzQyMmFhZjU4OTIyMTk5NTQ5YWZmXzQ4Nzg_59fc9029-ce74-438c-a219-52a1a4f5dab1" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain non-cancelable purchase obligations primarily related to inventory purchases and diagnostics instruments, primarily Panther systems, and to a lesser extent other operating expense commitments. These obligations are not recorded in the Consolidated Balance Sheets. For reasons of quality assurance, sole source availability or cost effectiveness, certain key components and raw materials and instruments are available only from a sole supplier and the Company has certain long-term supply contracts to assure continuity of supply. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90ZXh0cmVnaW9uOjc0OTZmYWEzYzE0MzQyMmFhZjU4OTIyMTk5NTQ5YWZmXzQ4NTU_8a07ba4f-8b37-4145-8d9d-f154c4457d94" continuedAt="ie89b3646ffbd45769160bff4e33c8ab5" escape="true">At September&#160;26, 2020, non-cancelable purchase commitments are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ie89b3646ffbd45769160bff4e33c8ab5"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"></td><td style="width:70.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzAtMS0xLTEtMA_aff81fee-83ee-4557-a39d-d53ea01ff7f4">267.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PurchaseObligationDueInSecondYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzEtMS0xLTEtMA_21a3d422-2096-4398-864d-10f7cad0cb96">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PurchaseObligationDueInThirdYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzItMS0xLTEtMA_9663128b-a9e7-4165-b5c6-6caaa58d9842">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PurchaseObligationDueInFourthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzMtMS0xLTEtMA_8a5ce909-0f3f-4e06-a743-124ca5e0d26c">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PurchaseObligationDueInFifthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzQtMS0xLTEtMA_fb423eb0-5b9a-4981-b397-6f4d364277f4">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="holx:Purchaseobligationthereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzUtMS0xLTEtMA_4e1279ec-6afc-4565-ad87-4a0ac5854f3a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PurchaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzYtMS0xLTEtMA_fa9afa51-25fa-40df-b180-36824cd93c33">279.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-55</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="margin-top:14pt"><span><br/></span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_193"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:LitigationAndOtherMattersTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTMvZnJhZzoxODE4ZTc0ZTQxMjI0MjhjOTIyMTc2NDc0MzI2MDU1Zi90ZXh0cmVnaW9uOjE4MThlNzRlNDEyMjQyOGM5MjIxNzY0NzQzMjYwNTVmXzEzMzQw_8073d1de-6428-415c-9ac0-c271a2b09175" continuedAt="ibfe132b78d6343468022a75e2020831f" escape="true">Litigation and Related Matters</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibfe132b78d6343468022a75e2020831f" continuedAt="i9dd8fae776694efe86989e258f72bf35"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $<ix:nonFraction unitRef="usd" contextRef="i2e92294f2cda48528702362448bfea27_D20180727-20180727" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTMvZnJhZzoxODE4ZTc0ZTQxMjI0MjhjOTIyMTc2NDc0MzI2MDU1Zi90ZXh0cmVnaW9uOjE4MThlNzRlNDEyMjQyOGM5MjIxNzY0NzQzMjYwNTVmXzE5NTE_a0622c2a-2fbe-45b6-b09c-d0f1ab1dcc63">4.8</ix:nonFraction> million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the &#8216;348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review, which was filed on September 30, 2020. On November 5, 2020, the Company opposed Minerva&#8217;s petition and filed a counter petition for Supreme Court review.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. On March 9, 2020, Minerva elected to withdraw its claim for lost profits damages</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The original trial date of July 20, 2020 was vacated due to circumstances surrounding the COVID-19 pandemic. On October 21, 2020, the Court entered an amended case schedule and set a new trial date of August 9, 2021. The parties submitted a joint status report on September 25, 2020. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 8, 2020, the Company filed suit against Minerva in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s redesigned endometrial ablation device infringes U.S. Patent 9,095,348 (the '348 patent). A trial is set to begin on August 23, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 3, 2017, bioM&#233;rieux, S.A. and bioM&#233;rieux, Inc. (collectively &#8220;bioM&#233;rieux&#8221;) filed suit against the Company in the United States District Court for the Middle District of North Carolina ("MDNC"), alleging that the Company&#8217;s HIV products, including blood screening products previously manufactured by the Company for its former blood screening </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-56</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="i9dd8fae776694efe86989e258f72bf35"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partner Grifols Diagnostic Solutions Inc. ("Grifols USA"), infringe U.S. Patent Nos. 8,697,352 and 9,074,262. On January 3, 2018, the MDNC Court granted the parties&#8217; consent motion to transfer the case to Delaware. On June 11, 2019, the Court issued a claim construction ruling regarding the disputed terms in the patents. Motions for summary judgment were filed by the parties on September 30, 2019, and a hearing on these motions was held on December 18, 2019. A six-day trial concluded on February 25, 2020, with the jury finding that all claims of U.S. Patent No. 8,697,352 are invalid (U.S. Patent No. 9,074,262 was dropped from the case by bioM&#233;rieux prior to trial). On March 18, 2020, the parties agreed to a settlement under which bioM&#233;rieux agreed to dismiss all claims with prejudice and to waive the filing of post-trial motions and pursuing an appeal in exchange for a de minimis payment from the Company and Grifols USA.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 15, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $<ix:nonFraction unitRef="usd" contextRef="i0114d332bb424de8ad15f9a123dde503_I20200926" decimals="5" format="ixt:numdotdecimal" name="holx:LegalAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTMvZnJhZzoxODE4ZTc0ZTQxMjI0MjhjOTIyMTc2NDc0MzI2MDU1Zi90ZXh0cmVnaW9uOjE4MThlNzRlNDEyMjQyOGM5MjIxNzY0NzQzMjYwNTVmXzQzOTgwNDY1NTk3NTQ_6e8954d3-9f42-4146-86f4-f00f6cfeabe9">8.5</ix:nonFraction>&#160;million accrued as of September 26, 2020, but this amount could become greater if some or all of the cases which it is indemnifying have an adverse result.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-57</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i8ddb964a7a024d63b8e4009970e71997_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzUwNTQ_707c5ec6-2160-43c6-957d-86bbde94a6e9" continuedAt="i6026968139bd4b2ab73111d4b37ddbbe" escape="true">Disposition</ix:nonNumeric></span></div><ix:continuation id="i6026968139bd4b2ab73111d4b37ddbbe" continuedAt="i25b8db8f62264c4a9da108181d5edd7c"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Medical Aesthetics</span></div><div><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$<ix:nonFraction unitRef="usd" contextRef="ic44cf4cf70a04fdb8f94550d3bfe376d_I20191120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwMzM_82a12680-b7a2-4f4e-8dc0-156c7151bc09">205.0</ix:nonFraction>&#160;million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic289be57c33044b29af60557d0832bb1_D20191120-20191120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTI1MTI_c41e5d65-6d0f-47bf-94f0-12cc7514c74b">153.4</ix:nonFraction>&#160;million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $<ix:nonFraction unitRef="usd" contextRef="idb517eaea5304290a5928b03c9057b33_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczMzg_ee6ec03e-8449-4c83-81ff-4a811dbe2553">150.0</ix:nonFraction>&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczODg_f503a2d8-b974-4218-b6e9-25fc199ad879">three</span> to <ix:nonNumeric contextRef="icb5e44232158447d887e2d49f5bc7e16_D20200628-20200926" format="ixt-sec:durwordsen" name="holx:TransitionServicesAgreementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczNzM_bdb92fe3-7468-4b78-b05c-744a17526fa5">fifteen months</ix:nonNumeric>, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $<ix:nonFraction unitRef="usd" contextRef="idb517eaea5304290a5928b03c9057b33_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:IndemnificationLiabily" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwNTA_85f02185-6116-44d7-9f72-742efb64ad29">10.9</ix:nonFraction>&#160;million within accrued expenses associated with its obligations under the sale agreement. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or that will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwOTQ_95ddfba5-5cfa-482d-acf3-a9fcf17cf1ae">30.2</ix:nonFraction>&#160;million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $<ix:nonFraction unitRef="usd" contextRef="ie9dabb1d61574d2cab21bd7863b8df8b_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwNzk_c30f184d-7013-4ee4-aebe-fbe7e0f74c3c">25.8</ix:nonFraction>&#160;million was allocated to cost of product revenues and $<ix:nonFraction unitRef="usd" contextRef="i67c6559862da4a42b4a96b86727df860_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwNjU_f461913a-ca87-4d01-bfa7-8d1eeebeb69f">4.4</ix:nonFraction>&#160;million to operating expenses.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTI0ODE_7955c357-d73e-42a9-a6b0-13c3b51104b0" escape="true"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of the disposed business at the date of disposition were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.169%"><tr><td style="width:1.0%"></td><td style="width:73.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzEtMi0xLTEtNDAyOA_81241999-c3c1-42b1-8d02-0e7c8d969ff6">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzItMi0xLTEtNDAyOA_2da97304-a4e4-4ef5-8cb3-ee6c4cab6558">59.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzMtMi0xLTEtNDAyOA_b53f4c55-e2e2-4a67-8710-f41ccc155381">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzQtMi0xLTEtNDAyOA_3721f4fa-5faa-4830-9fce-1b65cbfb9d03">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzUtMi0xLTEtNDAyOA_98e4d9ab-347a-46ac-9e04-ce160902d3ca">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzYtMi0xLTEtNDAyOA_d8adc42c-4f41-4faa-a789-21d8ae5031de">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzctMi0xLTEtNDAyOA_540649d1-04db-4d77-8f61-8a175ab02de0">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets disposed of</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzgtMi0xLTEtNDAyOA_4eac528e-163e-4709-ac7d-d546991e4fee">210.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzExLTItMS0xLTQwMzA_4addfb0f-850a-497a-b3ca-6eb491f6a04a">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzEyLTItMS0xLTQwMzA_12244af4-d73a-4aa1-b735-e10a2fae3314">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzEzLTItMS0xLTQwMzA_33a4da7b-56f7-4e8b-8bef-bf8f9fcd964b">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities disposed of</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328" decimals="-2" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzE3LTItMS0xLTQwMzA_5d880a50-04b3-412e-af6a-fac2c41dcee8">77.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations of the disposed business presented below represents the operating loss of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business. As noted above, the Company is performing a number of transition services and the financial impact from these services are not included in the amounts presented below. In addition, the Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition, which it will continue to report in the Medical Aesthetics reportable segment. Subsequent to the disposition, the Company recorded additional expenses of $<ix:nonFraction unitRef="usd" contextRef="ib7ee604a08d9432db6b6ba59a610c36f_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:Expensesfromdisposition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczMjQ_d1b93677-9808-4a53-9339-3e9969059b07">6.2</ix:nonFraction>&#160;million primarily for accelerated stock compensation, inventory reserves under the manufacturing supply agreement, and legal expenses and settlements, which are not included in the below amounts. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTI0ODA_c3fdcf15-93bf-4f0e-8ae2-54b276fa88be" continuedAt="i5e81e6d5d7b244ea8d9771256e0fd85c" escape="true">Loss from operations of the disposed business for the years ended September&#160;26, 2020 and September&#160;28, 2019 was as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-58</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i25b8db8f62264c4a9da108181d5edd7c"><ix:continuation id="i5e81e6d5d7b244ea8d9771256e0fd85c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"><tr><td style="width:1.0%"></td><td style="width:47.412%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:23.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-2" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTo4ODAwMzE3ZjIzN2U0YzdiYjU2ZGY3NzJkZjAwYjI2MC90YWJsZXJhbmdlOjg4MDAzMTdmMjM3ZTRjN2JiNTZkZjc3MmRmMDBiMjYwXzMtNS0xLTEtNDA0Mw_b4b463be-5253-45aa-9d53-2ede3d920530">46.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-2" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTo4ODAwMzE3ZjIzN2U0YzdiYjU2ZGY3NzJkZjAwYjI2MC90YWJsZXJhbmdlOjg4MDAzMTdmMjM3ZTRjN2JiNTZkZjc3MmRmMDBiMjYwXzMtNi0xLTEtNDA0Mw_bd04499e-f18a-4001-ab60-d8835ddbdd84">781.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div id="i8ddb964a7a024d63b8e4009970e71997_202"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzI1MTg_bff92be6-5135-476e-acab-96d6f201f8ce" continuedAt="i3768e89e0b02468c84f11b870bd0c9c1" escape="true">Business Segments and Geographic Information</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:24.75pt"><ix:continuation id="i3768e89e0b02468c84f11b870bd0c9c1" continuedAt="ie32c5dd2624144518b85d316e4aebf10"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports segment information in accordance with ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions about how to allocate resources and assess performance. The Company&#8217;s chief operating decision maker is its chief executive officer, and the Company&#8217;s reportable segments have been identified based on the types of products manufactured and the end markets to which the products are sold. Each reportable segment generates revenue from either the sale of medical equipment and related services and/or sale of disposable supplies, primarily used for diagnostic testing and surgical procedures. During the first quarter of fiscal 2020, and each of fiscal 2019 and 2018, the Company had five reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. The Company completed the sale of its Medical Aesthetics business on December 30, 2019, but has continued to incur operating expenses primarily related to indemnification provisions and other matters. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.</span></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-59</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="ie32c5dd2624144518b85d316e4aebf10" continuedAt="ia3cc832391b941809a11e890b20ad81d"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the <ix:nonFraction unitRef="segment" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzE0Mzg_eaba9541-35b1-4a9a-8349-85b9b262bbf1">five</ix:nonFraction> reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its five reportable segments. The Company has presented all other identifiable assets as corporate assets. There were <ix:nonFraction unitRef="usd" contextRef="i7514ebbfb861409a9489e0c250534728_D20180930-20190928" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzE3MTk_276babe0-dd8b-4943-8759-465d1fb1f4af"><ix:nonFraction unitRef="usd" contextRef="i6dcaf3ae16134f4ca7481e8ef0375fed_D20171001-20180929" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzE3MTk_785b3333-b1e5-4a50-9b43-7e7f77adc128"><ix:nonFraction unitRef="usd" contextRef="i7906857f1349431c8b718e5f5bc62d21_D20190929-20200926" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzE3MTk_ee843421-0fa7-4e1e-bb07-4ac0e56e6c55">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> intersegment revenues. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzI1MjI_1aa050cf-57c4-4803-8500-5c0374896199" continuedAt="iaaee6eae22814899b3afac4242e4f3fd" escape="true">Segment information for fiscal 2020, 2019, and 2018 was as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="iaaee6eae22814899b3afac4242e4f3fd"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:52.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMtMi0xLTEtMA_cf073c34-9630-4392-b5a7-9b90e1d09a57">2,102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMtNC0xLTEtMA_27cc5306-86a9-4838-a440-01c65fd1a533">1,205.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMtNi0xLTEtMA_57e44c69-b8a5-4494-9517-46d498333406">1,147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzQtMi0xLTEtMA_28b9c348-b3b5-4c4b-8a1f-0728627ebf1a">1,151.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzQtNC0xLTEtMA_bafd83d3-02e3-4a24-a1c1-b61259d23cbb">1,314.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzQtNi0xLTEtMA_909c38a1-5a0e-408a-8852-dbd32b392f7b">1,218.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtMi0xLTEtNjY0Mg_1bbff9b2-0317-4e8e-9229-f1581438a85a">376.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtNC0xLTEtNjY0Mg_2f20cb1e-c511-4d7e-be61-da541eb93d2d">437.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtNi0xLTEtNjY0Mg_d3d12a19-1f56-4b63-9d4f-893788be90cd">422.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzYtMi0xLTEtMTA1ODY_0bbabfaa-5025-4379-a3ce-18571684660b">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzYtNC0xLTEtMTA1ODY_1d4025f7-e83e-4cd7-9933-e5c8da08e446">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzYtNi0xLTEtMTA1ODY_aa38ff9f-821e-4aad-b691-630163d9dca0">91.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtMi0xLTEtMA_469cfb00-8e6c-463f-a822-2a2c5d33a9a5">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtNC0xLTEtMA_ef02b4c1-5429-4ca9-916e-72e49e358fc5">315.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtNi0xLTEtMA_317b608d-3728-4944-a51c-1697af0a7b64">339.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzgtMi0xLTEtMA_e8c88956-55f5-4c60-b92f-78be4a0ce2a3">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzgtNC0xLTEtMA_574bbecc-b7b0-42a3-b317-280fd3dc3bc9">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzgtNi0xLTEtMA_392d1eae-da99-4224-950a-65569789107a">3,217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEwLTItMS0xLTA_d38ce389-6b08-41c9-96b4-f9e7d6286108">929.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEwLTQtMS0xLTA_ffbbb39e-af03-47bc-90c7-e5c905761086">163.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEwLTYtMS0xLTA_2b2f104a-d69c-4288-a427-b52cd2ddb9b2">145.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzExLTItMS0xLTA_14db2787-7acf-4396-84a3-92905aa432c7">192.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzExLTQtMS0xLTA_cd5751f7-def5-4f05-99d4-404070abfaed">399.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzExLTYtMS0xLTA_0261ec6a-2254-4505-9a08-85984ba0718b">399.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTItMS0xLTY2ODU_7919db90-b54c-4595-a30e-abae7d1147f8">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTQtMS0xLTY2ODU_bc3a5e14-abb8-4e76-a4cc-62e786080659">99.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTYtMS0xLTY2ODU_4331ae9a-f5d2-4a95-b8ba-4ab72298fef8">58.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEzLTItMS0xLTEwNTk3_a1fbacf8-f97e-42f3-b504-c21ad146e828">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEzLTQtMS0xLTEwNTk3_4e9e34b7-b819-43e0-a86a-c6af1556e697">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEzLTYtMS0xLTEwNTk3_88f227b7-b1e5-4a51-98f9-c52f67142e80">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTItMS0xLTA_c687384c-0cde-4b05-8ffc-0912a41e1be0">57.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTQtMS0xLTA_cfe6f4fb-9e6c-49fa-a5c3-4e9c2c889f4c">781.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTYtMS0xLTA_385ac197-53b1-4106-8b5f-ef90516a7a33">844.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE1LTItMS0xLTA_aa34c14b-c1fe-45af-a8aa-1c0e60bccff0">1,105.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE1LTQtMS0xLTA_0a503878-6888-4eda-a22c-ea86eb53a61f">123.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE1LTYtMS0xLTA_d3512083-b31b-4d0c-8531-c22439c68641">237.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE3LTItMS0xLTA_9a5e36d9-b2cf-40bb-ac38-b10fe9f72fc7">237.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE3LTQtMS0xLTA_1c6a78a5-fe05-46b3-84ee-fe2c4a732ec5">246.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE3LTYtMS0xLTA_93398262-cb4b-4ca3-870e-90266c49b3f5">257.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE4LTItMS0xLTA_145ad9fd-3980-45dc-914c-20c544366e9c">48.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE4LTQtMS0xLTA_a42ae2d1-997b-4037-8a16-afab6fb4dced">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE4LTYtMS0xLTA_4b6740ea-3706-48bd-83eb-84c51d9819b8">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTItMS0xLTY3MDM_e715eeff-9b0c-4282-97a0-6beb58817cc8">85.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTQtMS0xLTY3MDM_4ec8c53c-f409-4e47-bfd5-4fd2f6f79c0c">87.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTYtMS0xLTY3MDM_27e34031-f04d-41eb-a1d1-6ba0ffc188bd">91.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIwLTItMS0xLTEwNjA3_d2fdd85b-1b48-436f-be45-d774477c35e0">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIwLTQtMS0xLTEwNjA3_05b8521e-3088-4af5-8bd0-171196dc3058">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIwLTYtMS0xLTEwNjA3_a793849a-dcbb-4bde-88f8-69bf2870552d">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTItMS0xLTA_dc346b9c-222d-421c-9449-060a6f703a4a">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTQtMS0xLTA_142e7679-85af-46da-b166-4697400f8ac3">91.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTYtMS0xLTA_65fa8bb6-0d12-4190-918d-7b7ebba71485">108.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIyLTItMS0xLTA_62e0b37d-43b1-4774-8f1b-c7bee64786ca">376.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIyLTQtMS0xLTA_60bdb4e9-20f9-43c9-82a2-23bb44ede681">463.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIyLTYtMS0xLTA_02add1e9-36bf-40cd-8028-c13455e6351b">480.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI0LTItMS0xLTA_788efcfd-8294-4207-b2b1-b8c2645def46">110.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI0LTQtMS0xLTA_512bacf9-7268-48cf-a2bd-e850d7789348">59.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI0LTYtMS0xLTA_2e59286c-0e54-493e-9de8-8d4d28933fc7">57.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI1LTItMS0xLTA_d65af542-416e-406e-93e0-36050174d661">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI1LTQtMS0xLTA_22b7e86f-d6e6-4223-a8a5-24a6faf63741">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI1LTYtMS0xLTA_b99f55bc-312f-415c-af53-1f252d053338">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTItMS0xLTY3MTU_f55dc985-3249-4b05-9506-fc87c2862c93">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTQtMS0xLTY3MTU_67fb9709-a61e-4f29-9884-7db0ee9c351d">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTYtMS0xLTY3MTU_a26f63b7-dde3-4b29-b089-bf941b510d46">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI3LTItMS0xLTEwNjE2_854dd9fd-9c1f-43fd-943d-a3030d4a7a39">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI3LTQtMS0xLTEwNjE2_347ada45-4533-4522-a186-3a8ae9d59664">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI3LTYtMS0xLTEwNjE2_61d233c3-9af3-4e38-8d76-ba5bdccb76da">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTItMS0xLTA_4227af4e-e8fa-45e8-9d61-2e6b146ef384">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTQtMS0xLTA_a55ed84d-9f16-4889-b75c-213acc09a504">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTYtMS0xLTA_56b90051-2eee-4a27-a339-60a3158eea69">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb0d5ec5a3d40e791cd77fed8adb08f_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI5LTItMS0xLTA_3b44d791-0005-4004-aa50-b8bf11210e0a">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79dbfa348b4b4250b64c8e02c8ba3ef5_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI5LTQtMS0xLTA_ab0f749a-89b4-4ba6-a960-a4a1d48559a3">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b57161c436e4f6eb5e739380ff16c77_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI5LTYtMS0xLTA_272cacfd-663a-4d60-8ab5-d456e4ced940">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMwLTItMS0xLTA_8d7744be-a1cd-4812-aef2-4fcc258c31eb">156.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMwLTQtMS0xLTA_3e62feb0-be5e-42e2-a1a8-8e0221e61606">109.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMwLTYtMS0xLTA_ef24eee3-c178-4efc-bdbc-bfcc5c998bea">105.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437292e8142d4d96839af5869cecaab3_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMzLTItMS0xLTE1Mjcy_7f9b1f66-c064-4d93-8155-0016cf9becc2">2,161.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169afb67581f4042a9907e319c8aaee1_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMzLTQtMS0xLTE1Mjcy_487d0274-7394-4fed-be7c-a38c0e903293">2,276.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfe6d8929f8f4eb6b145835c10a13bfc_I20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMzLTYtMS0xLTE1Mjcy_3e974cf1-f5b8-4de5-b644-ab29ae7d600a">2,442.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305c6e69d9584df69b07d0c58b68dc88_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM0LTItMS0xLTE1Mjcy_72e7fbc9-ea52-42cd-a7e5-0eb2083ffb23">1,200.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b9b859e952c4dc086ae9de8f3020603_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM0LTQtMS0xLTE1Mjcy_5c3fc53c-4898-46c5-b064-08822e1c7652">1,127.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11802e38f47f4fc3810df7e5a6f3b7f2_I20180929" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM0LTYtMS0xLTE1Mjcy_9f5da535-013e-4363-88ac-41ce0d66c6ae">972.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if85520f01ace43129ad7669c2083f920_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM1LTItMS0xLTE1Mjcy_f83f4c27-2ad1-49e5-b183-bfced7d206b7">1,438.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i294e83c0d77f4a76b4cb43739eaeaf9f_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM1LTQtMS0xLTE1Mjcy_8a7334aa-705f-4b07-a99c-422d589290b9">1,328.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32c7c1cad54473c92473002d9ec70e2_I20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM1LTYtMS0xLTE1Mjcy_aa926dce-87cd-4e18-b57f-d7b6a00eae99">1,414.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbb9f4ee2a14c8a8ff8db71fcca17b1_I20200926" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM2LTItMS0xLTE1Mjcy_2f2ffad6-398f-4354-81dd-60b9aaa7f8f2">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bea17c720745bbbe2f47855b322570_I20190928" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM2LTQtMS0xLTE1Mjcy_ee27e867-67bb-4a08-bd1a-a71c9f1c346c">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ff4e72158d04b05abd672b5cdb231cd_I20180929" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM2LTYtMS0xLTE1Mjcy_64f830e1-f887-4a2a-94b1-593782769fee">30.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia04cebdd8bba46d7a211ca6aa1dca44f_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM3LTItMS0xLTE1Mjcy_f2789af4-f453-4cbd-aa99-462853e96d1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a1f0fc50e2e42c4bf2f36b322f42bb2_I20190928" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM3LTQtMS0xLTE1Mjcy_73bc5ecd-9afe-460e-9d99-649bd1cb7433">159.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia19f8ef5fe114be8ae437ed2b272af87_I20180929" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM3LTYtMS0xLTE1Mjcy_611be294-c0dd-4f17-bb78-b3f51b91f399">913.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37cc679d8c4e4a0585fbc179881a744b_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM4LTItMS0xLTE1Mjcy_9ac94f75-252f-42a1-a31c-70d2f43ff2cc">2,355.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c4387e1e2e64a7ea880cc5c3543acd3_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM4LTQtMS0xLTE1Mjcy_f6b6a32b-179c-46b4-9f58-9dddbd3972f8">1,522.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbeba5af33fd49de80e3ad69f10870d4_I20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM4LTYtMS0xLTE1Mjcy_bc47c60d-4a08-449e-8551-9040fa4c991e">1,457.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM5LTItMS0xLTE1Mjcy_1a81dfa0-2860-4aa4-801c-cbe5e8195d6f">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM5LTQtMS0xLTE1Mjcy_e26f1553-5734-42e1-b70a-73e39e4c6964">6,442.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM5LTYtMS0xLTE1Mjcy_93fcf312-e973-41ba-b087-7dd4282fbbf7">7,230.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-60</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="ia3cc832391b941809a11e890b20ad81d"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzI1MTY_03f28192-8619-4d99-99e0-6d9d6992ec24" escape="true"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:53.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0b1fbf643bf4d87a0f62662f56e72a9_D20190929-20200926" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzItMi0xLTEtMA_5814a216-f1a2-461f-9e91-ab7b74479435">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i22ccaf1b86dd4ce1975c67773f6132e3_D20180930-20190928" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzItNC0xLTEtMA_84f90523-2681-4abe-bcc5-70fb9727faa9">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a86961b941f4c698ca817317ebb55f1_D20171001-20180929" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzItNi0xLTEtMA_c3f6c7ad-0584-4a65-a3fd-141ebc6e88c3">75.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i65a03228708e48bd91808873ac0aef49_D20190929-20200926" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzMtMi0xLTEtMA_f83b108b-c0dd-4a87-8aa9-5ca73257682c">15.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9775b97e92684b93a13c7004b3787bb9_D20180930-20190928" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzMtNC0xLTEtMA_e7b27470-2092-4c3a-b3b8-1c933e461a60">11.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52f05bd0d07b41cc91cc734c6e8aabd4_D20171001-20180929" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzMtNi0xLTEtMA_2a92b96f-bb8e-4c99-a261-ba39629d44ec">11.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f2349edc55c45de9425f98b0200d5a7_D20190929-20200926" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzQtMi0xLTEtMA_8fecca58-f47a-4145-872b-379892d3be95">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic693f14699ba4968bcb36cc7b8b023a7_D20180930-20190928" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzQtNC0xLTEtMA_51496217-37de-4ea1-a4ca-52e2105bf6f2">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6acedc8e09c84b2e89c7f0cc800be0dd_D20171001-20180929" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzQtNi0xLTEtMA_ffcbaa40-934b-4b3b-88ec-8307b0363c73">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia6be6be2339044138fe1152c23d299af_D20190929-20200926" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzUtMi0xLTEtMA_ddde03a6-9e81-4688-a738-0f98d17fb63d">3.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8efe51ef6dc4ed2a908a1cb2c698d12_D20180930-20190928" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzUtNC0xLTEtMA_e8a559cd-e9a3-49d8-a81e-c143fe76eb26">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id99c49be9fbe42c6bb3e8f1497f9525a_D20171001-20180929" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzUtNi0xLTEtMA_57f9e60e-36c9-431c-87f3-24b39deed9a8">4.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzYtMi0xLTEtMA_928d2e42-51ae-4837-a421-19b9c12dc09c">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzYtNC0xLTEtMA_a6de8e27-92fb-4d44-8921-b51bacdea6e3">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzYtNi0xLTEtMA_626352a9-75f4-4d65-82ee-6e31254491ab">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzI1MDQ_efba6d99-a2d6-400e-917d-066cf6073e20" continuedAt="i3c50fe468aca4e44858778de2048b2c2" escape="true">The Company&#8217;s property, plant and equipment, net were geographically located as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt"><ix:continuation id="i3c50fe468aca4e44858778de2048b2c2"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:53.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d7bf9f967242eaba9ddd491ab703ed_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzEtMi0xLTEtMA_8498647c-909b-4b26-8a87-8554239c4652">383.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d1106e7081e4cabb0de079d952b614f_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzEtNC0xLTEtMA_3b7425d5-edc1-4cbc-ae57-b1e2d43ca0dc">355.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie488bc746f864b9cabc2df04f892e4ae_I20180929" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzEtNi0xLTEtMA_8eab4756-1967-4bd1-a9ab-2fbf2b7086ae">366.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26440a4dc78a4e2f9d24bd4827a7712e_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzMtMi0xLTEtMA_c885660a-30b3-42e8-82f4-15c29fdba326">77.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic343686a6d7c4439b1715ce8372cb1b6_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzMtNC0xLTEtMA_503358b4-cb5e-4dbb-80c3-47e0ffea2d79">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931d24edcf44412ebaf8ac5e6dc89022_I20180929" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzMtNi0xLTEtMA_d7874c07-83bc-4f86-aed7-29fcefbe8576">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6455cb9268744d129ad43c18c13a0b49_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtMi0xLTEtMTE0OTI_8db0fc77-0f3f-436b-949d-ab1acbea2fd9">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd22066f01e475cb0434fb76714ac0f_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtNC0xLTEtMTE0OTI_19bc2acb-13f5-4b23-b952-54a1463b40a3">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127aa7477232423cb1285753b3416534_I20180929" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtNi0xLTEtMTE0OTI_60aae4a6-2d68-4400-a8b8-38d94e5740ae">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dbb50a9fc7a4683852d6c1668547edc_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtMi0xLTEtMA_0694312e-2716-4a34-a476-dbde02861274">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77fd19f2aabe44c188795c7adbdd651f_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtNC0xLTEtMA_56ea1a71-e2fb-4873-87b3-5ac6f6540773">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562418944fb4261a833f679ae6db905_I20180929" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtNi0xLTEtMA_4c383fc2-ce64-41d3-bda7-8917c67b08c9">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzUtMi0xLTEtMA_d7f6bb53-f561-4333-b1c0-18d0a47465f1">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzUtNC0xLTEtMA_7d189742-89d2-43be-8dfd-3812051efba4">470.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzUtNi0xLTEtMA_91fc90a6-1299-462c-9cf1-8e590c9e6743">478.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:18pt"><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_208"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90ZXh0cmVnaW9uOjAwN2NlY2E5NDE3MTQ3NTZiNTg5ZWYwNzNkZTdmZTEyXzE1Mw_e31d88e5-dd38-4e23-bbf9-0d34fbc2a08a" continuedAt="i4287de9e78f640d0b32f2b546c61844e" escape="true">Accrued Expenses and Other Long-Term Liabilities</ix:nonNumeric></span></div><ix:continuation id="i4287de9e78f640d0b32f2b546c61844e"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90ZXh0cmVnaW9uOjAwN2NlY2E5NDE3MTQ3NTZiNTg5ZWYwNzNkZTdmZTEyXzE2MA_2c6d9779-332f-4107-b6ce-6ecf46a02804" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other long-term liabilities consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"></td><td style="width:59.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzItMi0xLTEtMA_968dbd99-fcf7-46c2-a6b2-3a511ae9da76">262.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzItNC0xLTEtMA_7e5e2992-1968-45eb-bf55-5e3a8506acb3">223.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income and other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="holx:AccruedIncomeAndOtherTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzQtMi0xLTEtMA_84246a85-31e3-484a-b14e-a5e5d89b4515">125.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="holx:AccruedIncomeAndOtherTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzQtNC0xLTEtMA_e777e30f-623a-48f6-a486-aab64c88b562">56.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMC0xLTEtMTkyODM_140646f7-9eab-40d5-8cc6-927f67371b99">Operating leases</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMi0xLTEtMzc3MA_42fabbf7-77bb-4e6e-af2c-f75ea231d436">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="5" format="ixt:zerodash" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtNC0xLTEtMzc3Ng_d6887f0c-d444-4554-ae27-43a8ab85ea43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="5" name="holx:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzctMi0xLTEtMTE5NTk_609f28d2-9841-40ec-b16b-16bdbf98b54e">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="5" name="holx:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzctNC0xLTEtMTE5NjE_f8e5d61b-f72a-475e-bd17-54906992f9be">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMi0xLTEtMA_43bf110d-e6da-47a0-ac83-632bc9ee7b4d">114.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtNC0xLTEtMA_ded3f57b-daf7-4064-bf1a-19186c2a7cd0">128.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzctMi0xLTEtMA_cdcc2302-1c6c-4dab-b572-621f9dbf6f42">547.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzctNC0xLTEtMA_2a85c234-c19e-4d62-8c78-bac1915e653d">430.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:OtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90ZXh0cmVnaW9uOjAwN2NlY2E5NDE3MTQ3NTZiNTg5ZWYwNzNkZTdmZTEyXzE2MQ_e23396ad-2a46-4a4e-b7a9-22ce3cc94ca2" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"></td><td style="width:59.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#160;Long-Term Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for income tax uncertainties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzItMi0xLTEtMA_e8d4ecaa-e155-4a68-972e-ff8537c00541">103.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzItNC0xLTEtMA_55aa284b-8e32-4fb4-96e6-aa3e0f3665ed">106.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzMtMi0xLTEtMTE1MDk_521bb944-7ed4-45de-be40-2b8121ebdec9">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzMtNC0xLTEtMTE4NjA_d89ce777-2f88-4f3b-a22c-061657749eab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzQtMC0xLTEtMTkzODg_736c4b8f-a57e-416d-9e6e-a6211fed51d8">Operating leases</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzYtMi0xLTEtNTQwNw_56783088-3b0f-4da0-88a1-c365a7d38f9d">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzQtNC0xLTEtMTE4NTQ_2ea63032-0287-4f82-8b71-617cb5f5df10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzUtMi0xLTEtMTE1NTg_7318dd84-87f0-43e6-982f-0a1e41127f50">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzUtNC0xLTEtMTE1NTg_65e1ece0-7058-478a-8b9f-b97180466089">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzctMi0xLTEtMTE1MTU_352ea4e9-d16d-424a-ac2c-6bb2241e010c">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzctNC0xLTEtMTE1MTU_2254381e-a6e7-4415-998f-67579b70db28">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued lease obligation&#8212;long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:AccruedRentNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzctMi0xLTEtMTE1NDE_738129b2-dd3b-4c65-b0c6-9d3bf4ce92db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:AccruedRentNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzctNC0xLTEtMTE1NDE_0fe4c74a-f2f4-481f-8abe-2c447df5a5bf">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzUtMi0xLTEtMA_fb356665-ff68-4848-8297-e25904581e2a">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzUtNC0xLTEtMA_4218d755-1e41-4ebc-b21e-34ffcf6ea955">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzYtMi0xLTEtMA_c0a3640d-9c6a-4c99-8a6d-9bcc292c60dd">303.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzYtNC0xLTEtMA_0d3b9519-9f00-41cc-8c8e-caa44bf3c125">162.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_211"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-61</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxODQ_fd051e23-41d7-4d32-9282-9e581dfb29a7" continuedAt="i4f1c7a4880eb491fb90ce325b066ddbb" escape="true">Pension and Other Employee Benefits</ix:nonNumeric></span></div><ix:continuation id="i4f1c7a4880eb491fb90ce325b066ddbb" continuedAt="iae2c3a08d55d42d9baa3d4740e0f9346"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain defined benefit pension plans covering the employees of its Hitec Imaging German subsidiary (the &#8220;Pension Benefits&#8221;).&#160;As of September&#160;26, 2020 and September&#160;28, 2019, the Company&#8217;s pension liability was $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzI0MA_959f740f-2f3f-4571-89e9-b45d9b08337d">10.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzI0Nw_a02d9b4f-7937-4e48-be46-96c4e684e2c7">10.0</ix:nonFraction> million, respectively, which is primarily recorded as a component of long-term liabilities in the Consolidated Balance Sheets. Under German law, there are no rules governing investment or statutory supervision of the pension plan. As such, there is no minimum funding requirement imposed on employers. Pension benefits are safeguarded by the Pension Guaranty Fund, a form of compulsory reinsurance that guarantees an employee will receive vested pension benefits in the event of insolvency. The pension plans were closed on December 31, 1997 and only eligible employees at that date could participate in the plans prior to closing to new participants.</span></div><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxNjE_181d6ae9-8d87-4ff8-a2b6-ccdb78eb91a5" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:49.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Benefit Obligation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzItMi0xLTEtMA_409d5f19-e3e5-4cf3-b30d-3fb13c2c3990">10.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzItNC0xLTEtMA_31f178ed-c5ef-4426-ac1a-46f1923b7b9f">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84c88a850d71453097932f0bcbe84825_I20170930" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzItNi0xLTEtMA_022ec6dd-06e4-4c7c-9682-2cc988f8ef1b">9.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzMtMi0xLTEtMA_49a7e825-20cb-40a9-b717-0e3e3d826576">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzMtNC0xLTEtMA_41594d51-fb22-4b7f-8da7-50182021533b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzMtNi0xLTEtMA_fc9bbad7-ccf4-4aaa-989c-3b92cd733835">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzQtMi0xLTEtMA_a7c27030-0ee0-4df5-abd6-96a127a0a255">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzQtNC0xLTEtMA_3645e1fa-56fa-4175-b5a4-8ed2da19fd26">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzQtNi0xLTEtMA_007a0eaf-6612-4288-b9a8-521ab2a588cd">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzUtMi0xLTEtMA_a55abca0-3949-41f8-9435-c4aa61073c6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzUtNC0xLTEtMA_a18835d4-dabd-426d-9643-78e859cd7501">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzUtNi0xLTEtMA_673c52d5-5bd0-48f2-9b55-f70ac1608064">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzYtMi0xLTEtMA_dd118bd2-bf08-48b9-a38e-0954cbdc8ac3">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzYtNC0xLTEtMA_0ae6064f-b55a-4fd6-97ee-201eb2936ae9">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzYtNi0xLTEtMA_ebc5252b-1c43-4582-816e-251e1358b313">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzctMi0xLTEtMA_88933d64-2686-4abb-864b-8e8160fe8d2f">0.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzctNC0xLTEtMA_3c8d9940-4c61-4a75-85eb-8df9a75fa26a">0.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzctNi0xLTEtMA_de167143-37a1-44de-b40d-6effbeb9aa12">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzgtMi0xLTEtMA_c6534fa7-5717-4f7d-9998-da6cc1b8b46d">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzgtNC0xLTEtMA_d8049748-31de-47bf-ad2a-b1275504c901">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzgtNi0xLTEtMA_a32d9765-7bc3-4ec0-ace6-4e7348612326">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzktMi0xLTEtMA_a568b092-9840-4204-a285-c6d7f23e371e">10.9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzktNC0xLTEtMA_6cf0703e-f7a0-428e-b7b6-08a71f62d866">10.0</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzktNi0xLTEtMA_dee25ddd-9cbd-43bc-9197-c2ba863f539d">9.7</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzEwLTItMS0xLTA_b13970e8-53ec-4843-9968-bbb0c24806fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzEwLTQtMS0xLTA_c3190743-1567-42aa-b23e-28ad668741e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzEwLTYtMS0xLTA_d717bfee-26d9-4a08-9671-773e0483b36e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzExLTItMS0xLTA_39c268df-1ee4-4729-a0c5-584eb2dc6e89">10.9</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzExLTQtMS0xLTA_c4818aab-c20c-4dab-b7b7-48bb39e4cf23">10.0</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzExLTYtMS0xLTA_db266f6a-9d42-4aa7-8e12-0c9279b5091e">9.7</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxODc_79ede1aa-146c-4993-bf48-8a0a2966dd5b" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzItMi0xLTEtMA_bc92839d-4ed4-4d1b-9900-f64b590d9676">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzItNC0xLTEtMA_607e6640-d641-4e1e-8c4d-7f3a27394b5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzItNi0xLTEtMA_db526e2c-365d-413f-a46d-bc5f5d6ecc47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="holx:ComponentsofNetPeriodicBenefitCostInterestcost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzMtMi0xLTEtMA_ca02d16f-cbdc-47b1-a3ca-71238241c474">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="holx:ComponentsofNetPeriodicBenefitCostInterestcost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzMtNC0xLTEtMA_02c132a0-776d-489a-9166-b8254957a0ba">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="holx:ComponentsofNetPeriodicBenefitCostInterestcost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzMtNi0xLTEtMA_7fcab8ce-5298-44c5-b005-2cba62cfda8f">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzQtMi0xLTEtMA_a642f8d0-9de7-4824-96cf-b2f20a67582b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzQtNC0xLTEtMA_51962087-618a-4e8d-bdc3-580c9182ff06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzQtNi0xLTEtMA_7d6ad21b-25f3-4bc5-9e41-991973052b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzUtMi0xLTEtMA_06532c82-f05e-45c0-aada-e66853bdf8a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzUtNC0xLTEtMA_3d25b7b8-c530-45b0-b540-dbb933708719">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzUtNi0xLTEtMA_1f8991d3-121f-49ff-b125-cd6d0f5492e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzYtMi0xLTEtMA_d80175d2-1b89-4f71-981d-7f0a64d000d1">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzYtNC0xLTEtMA_2f6d60db-62e4-48ef-9d7d-783113a5e6ed">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzYtNi0xLTEtMA_913289c3-394d-4755-8315-1349b0957ea4">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzctMi0xLTEtMA_6129920f-f2f9-453f-9879-2fd62edd5f47">0.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzctNC0xLTEtMA_21f1e267-97a6-4efa-affc-e0af7e34e562">0.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzctNi0xLTEtMA_be28098f-f2c5-418f-813e-72e6459db6bf">0.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxODE_1b16b590-c911-44d4-8f2d-41e7a1b0ea25" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Net Periodic Benefit Cost Assumptions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzEtMi0xLTEtMA_dc66535b-7c0f-4af0-8282-56daef1915d2">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzEtNC0xLTEtMA_99a363d3-9778-4b63-b645-f84f834fc4d2">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzEtNi0xLTEtMA_450c5072-2b73-4953-a013-2d73b4f1d779">1.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzItMi0xLTEtMA_61d73d7f-28a3-48ed-a46c-b32f621c7160">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="2" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzItNC0xLTEtMA_bc6e6723-47b0-45fa-820a-7d57439496b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="2" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzItNi0xLTEtMA_a074121f-8844-46ea-b12a-e20c5a69be51">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" decimals="2" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzMtMi0xLTEtMA_86e965fb-cf72-45e9-8378-1851d9a44741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928" decimals="2" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzMtNC0xLTEtMA_c768df91-e868-4f97-bf35-6a015584bc10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929" decimals="2" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzMtNi0xLTEtMA_2fe886e8-f680-42bb-b833-c34e8b6170eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected benefit obligation for the German Pension Benefits with projected benefit obligations in excess of plan assets was $<ix:nonFraction unitRef="usd" contextRef="i6cc490c87029449399e9fbd9f9732f85_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzEzNTE_6bcdfe14-8a20-4650-b043-ca1488bb3900">10.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i129bb08ac6114158bac9490c19681bde_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzEzNTg_d573e3cd-d597-4d82-891f-42b14ccfbe84">10.0</ix:nonFraction> million at September&#160;26, 2020 and September&#160;28, 2019, respectively, and the accumulated benefit obligation for the German Pension Benefits was $<ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzE0NjQ_8fb28505-355d-44f8-b803-6d9e214ca8d3">10.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzE0NzE_406444e3-84ce-4ec8-a6c0-f582b7504f69">10.0</ix:nonFraction> million at September&#160;26, 2020 and September&#160;28, 2019, respectively. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also obligated to pay long-term service award benefits under the German Pension Benefits. The projected benefit obligation for long-term service awards was $<ix:nonFraction unitRef="usd" contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928" decimals="-5" format="ixt:numdotdecimal" name="holx:ProjectedBenefitObligationForLongTermServiceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzE2NzQ_50f7d299-7af9-4c34-9691-ddd9206d7183"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:ProjectedBenefitObligationForLongTermServiceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzE2NzQ_f5b10c28-2c4c-48b0-8641-4eeede9b84fb">0.1</ix:nonFraction></ix:nonFraction> million at both September&#160;26, 2020 and September&#160;28, 2019, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-62</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i8ddb964a7a024d63b8e4009970e71997_7">Table of Contents</a></span></div></div><ix:continuation id="iae2c3a08d55d42d9baa3d4740e0f9346"><ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxODI_754d832a-5b49-4685-a2a9-53f5a22bd475" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"></td><td style="width:70.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.424%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzEtMS0xLTEtMA_17d9418f-29a7-47b0-bccb-45e849a02ba5">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzItMS0xLTEtMA_c74725e4-173b-498a-9c21-06ebea6c8dad">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzMtMS0xLTEtMA_81a4a020-fcb3-450f-97da-9fed807b9b14">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzQtMS0xLTEtMA_a49a7a47-619c-4076-9a7c-7fe786421526">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzUtMS0xLTEtMA_953ff06c-635d-4033-8408-9a317a377fa3">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 to 2030</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c092381c12421482497e088d638a81_I20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzYtMS0xLTEtMA_553a772f-c9ae-4c52-8fef-137e1f58132f">2.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains additional contractual pension benefits for its top German executive officers in the form of a defined contribution plan. These contributions were insignificant in fiscal 2020, 2019 and 2018. Additionally, the Company has Swiss pension plans, which were insignificant in fiscal 2020, 2019, and 2018.</span></div></ix:continuation><div><span><br/></span></div><div id="i8ddb964a7a024d63b8e4009970e71997_217"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzg0NQ_d189cf62-508f-4445-a1af-4d96ee5d498a" continuedAt="i09a82b3b435d4178b208439dbf28adda" escape="true">Quarterly Statement of Operations Information (Unaudited)</ix:nonNumeric></span></div><ix:continuation id="i09a82b3b435d4178b208439dbf28adda" continuedAt="i0b23f5348f17409abc8b5620a839b8c5"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of quarterly results of operations for fiscal 2020 and 2019:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.619%"><tr><td style="width:1.0%"></td><td style="width:40.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.770%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzItMi0xLTEtMA_916b5300-33b1-48fc-b159-f4c269ee7e27">850.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzItNC0xLTEtMA_75b65d13-2c90-4040-86ad-ec26258a4def">756.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzItNi0xLTEtMA_ac26424a-4711-4cb5-9bdf-ae5f68fb5f3b">822.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzItOC0xLTEtMA_17cb02e1-e5f5-4b45-a527-0ec0f61d7b40">1,347.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzMtMi0xLTEtMA_132a8f43-fd29-4cb7-b479-b458be833258">433.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzMtNC0xLTEtMA_20bdf753-15dc-4e5f-be81-c3754d5e2be0">395.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzMtNi0xLTEtMA_41a3ce92-be0a-4577-8e33-eae0dc6cc7b0">466.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzMtOC0xLTEtMA_9a3840d8-b049-4937-a695-df26006d509e">931.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Hologic (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzQtMi0xLTEtMA_4870b528-2e15-4f2e-b63b-fc0a8af2fb64">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzQtNC0xLTEtMA_60acb51c-43f6-47d1-8476-01f2e4afcef3">96.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzQtNi0xLTEtMA_7de5b08c-2a38-4d33-9bb5-2d89b687410d">137.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzQtOC0xLTEtMA_aa1bcdae-7ce3-4efe-bd7c-70770b79e93e">495.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per common share</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzUtMi0xLTEtMA_da67ab23-1c8b-4065-9089-99570c58172b">1.43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzUtNC0xLTEtMA_daa8d079-e307-42dd-9481-0f139154320a">0.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzUtNi0xLTEtMA_17946e4b-3a76-46f6-b5f0-76f6069e9d7f">0.53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzUtOC0xLTEtMA_08c591b5-5b26-40c8-87bb-63af5b2462d6">1.88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.619%"><tr><td style="width:1.0%"></td><td style="width:40.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.770%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzItMi0xLTEtMA_ea7b326d-0eee-45a7-8e45-2d175b954b2d">830.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzItNC0xLTEtMA_8a9fe9de-fb30-4b21-bfb6-b02aa6761f32">818.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzItNi0xLTEtMA_bc0002cb-0291-45da-b6cd-90eab93b2bbd">852.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzItOC0xLTEtMA_0795794c-8436-4e47-a889-ff448a69353c">865.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzMtMi0xLTEtMA_56a7eb5f-6806-4e32-a930-a70344b24fe1">434.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzMtNC0xLTEtMA_1d2b09de-a1ee-41be-8cd8-5a215b5d3719">42.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzMtNi0xLTEtMA_0135a47c-b923-4776-a6c7-84299de28723">444.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzMtOC0xLTEtMA_42b6e971-83c0-472b-9201-7d1616e2323c">249.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) (2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzQtMi0xLTEtMA_9a5c1c92-d687-4e0a-904f-f78f9df6090a">98.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzQtNC0xLTEtMA_69f74f8d-d7b4-4c9e-bcce-65c3104cb605">272.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzQtNi0xLTEtMA_6da56101-97e6-4a2b-b15b-20a637b4db58">93.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzQtOC0xLTEtMA_d0aeebdf-5699-4778-99b9-e478b3b7320f">123.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per common share</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzUtMi0xLTEtMA_e3663024-2f97-4cdb-bdb1-4c9f5ad9dba8">0.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzUtNC0xLTEtMA_71b3f17b-a986-4391-bd2b-ac2fbf21a358">1.01</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzUtNi0xLTEtMA_2550850e-b307-4b01-88c9-7b7f19a90423">0.35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzUtOC0xLTEtMA_21ea7be3-89ce-4de4-808c-2583690fb131">0.46</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net income in the first quarter of fiscal 2020 included an intangible assets and equipment charge of $<ix:nonFraction unitRef="usd" contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzQzOTgwNDY1MTI3MDQ_3c97d9fb-6be4-4071-a4e9-63e32c134822">30.2</ix:nonFraction>&#160;million due to classifying the Medical Aesthetics business as assets held-for-sale. Net income also included a discrete tax benefit related to the disposition of this business of $<ix:nonFraction unitRef="usd" contextRef="i7f382276eec44239bdc0d3cebf1f2d75_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzQzOTgwNDY1MTM2Mjk_7bed6fa6-0f51-41ed-b05d-9cf50e4bc066">312.2</ix:nonFraction>&#160;million related to its outside basis difference.</span></div></ix:continuation><div><span><br/></span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0b23f5348f17409abc8b5620a839b8c5" continuedAt="iba924c75dbf444eb9e9c4017be1825a9">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="iba924c75dbf444eb9e9c4017be1825a9">Net loss in the second quarter of fiscal 2019 included intangible asset and equipment impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzI4Mg_1819de04-25df-4b4d-bda9-af7a01b5b61c">443.8</ix:nonFraction> million. Net loss in the fourth quarter of fiscal 2019 included intangible asset and equipment impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzM5NA_c5d155c3-0b54-4fdf-adc1-637a162675fa">241.6</ix:nonFraction> million.</ix:continuation> </span></div><div style="padding-left:31.5pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-63</span></div><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.39
<SEQUENCE>2
<FILENAME>holxq4-2020ex1039.htm
<DESCRIPTION>EX-10.39
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i8df9631c8a424f67a011b56c2cd01e4a_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Ex.10.39</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SEVERANCE AND </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CHANGE OF CONTROL AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;CHANGE OF CONTROL AGREEMENT by and between HOLOGIC, INC., a Delaware corporation (the &#34;Company&#34;), and Sean S. Daugherty (the &#34;Executive&#34;), dated as of August 31, 2020.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the Executive has been appointed to serve as Group President, Breast and Skeletal Health and GYN Surgical, of the Company, effective August 31, 2020&#59; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Board of Directors of the Company (the &#34;Board&#34;), has determined that it is in the best interests of the Company and its shareholders to assure that the Company will have the continued dedication of the Executive, notwithstanding the possibility, threat, or occurrence of a Change of Control (as defined below) of the Company.  The Board believes it is imperative to diminish the inevitable distraction of the Executive by virtue of the personal uncertainties and risks created by a pending or threatened Change of Control and to encourage the Executive's full attention and dedication to the Company currently and in the event of any threatened or pending Change of Control, and to provide the Executive with compensation and benefits arrangements upon a Change of Control which ensure that the compensation and benefits expectations of the Executive will be satisfied and which are competitive with those of other corporations&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, in recognition of the Executive&#8217;s new role, the Company and Executive now desire to enter into this Severance and Change of Control Agreement, which is consistent with the change of control and severance protection provided to the Company&#8217;s most senior officers (the &#8220;Agreement&#8221;)&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, this Agreement shall supersede and replace the Executive&#8217;s existing Change of Control Agreement, dated as of July 17, 2017, and existing Severance Agreement dated as of July 17, 2017. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, the parties hereto, each intending to be legally bound, do hereby agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Certain Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The &#34;Effective Date&#34; shall be the first date during the &#34;Change of Control Period&#34; (as defined in Section 1(b)) on which a Change of Control occurs.  Anything in this Agreement to the contrary notwithstanding, if the Executive's employment with the Company is terminated or the Executive ceases to be an officer of the Company prior to the date on which a Change of Control occurs, and it is reasonably demonstrated that such termination of employment (1) was at the request of a third party who has taken steps reasonably calculated to effect the Change of Control or (2) otherwise arose in connection with or in anticipation of the Change of Control, then for all purposes of this Agreement the &#34;Effective Date&#34; shall mean the date immediately prior to the date of such termination of employment.  If prior to the Effective Date, the Executive&#8217;s employment with the Company terminates, then the Executive shall have </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">no further rights under this Agreement, except with respect to benefits under Section 6(e), if applicable, or unless such termination of Employment was in anticipation of the Change of Control in which case the termination shall be deemed to have occurred after the consummation of the Change of Control.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;The &#34;Change of Control Period&#34; is the period commencing on the date hereof and ending on December 31, 2023&#59; provided, that commencing on December 31, 2023 and each December 31 thereafter (each such date to be referred to as the &#8220;Renewal Date&#8221;), the term of this Agreement shall automatically be extended, without any further action by the Company or the Executive, so as to terminate three years from such Renewal Date&#59; provided, however that if the Company shall give notice in writing to the Executive at least thirty (30) days prior to a Renewal Date (the &#8220;Pending Renewal Date&#8221;), stating that the Change of Control Period shall not be extended, then the Change of Control Period shall expire two years from the Pending Renewal Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For the purpose of this Agreement, a &#34;Change of Control&#34; shall mean&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of the Voting Stock of the Company&#59; provided, however, that any acquisition by the Company or its subsidiaries, or any employee benefit plan (or related trust) of the Company or its subsidiaries of 30% or more of Voting Stock shall not constitute a Change in Control&#59; and provided, further, that any acquisition by a corporation with respect to which, following such acquisition, more than 50% of the Voting Stock of such corporation, is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners of the Voting Stock immediately prior to such acquisition in substantially the same proportion as their ownership, immediately prior to such acquisition, of the Voting Stock, shall not constitute a Change in Control&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any transaction which results in the Continuing Directors (as defined in the Certificate of Incorporation of the Company) constituting less than a majority of the Board of Directors of the Company (the &#8220;Board&#8221;)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The consummation of (i) a Merger  with respect to which all or substantially all of the individuals and entities who were the beneficial owners of the Voting Stock immediately prior to such Merger do not, following such Merger, beneficially own, directly or indirectly, more than 50% of the Voting Stock of the corporation resulting from the Merger (the &#8220;Resulting Corporation&#8221;) as a result of the individuals&#8217; and entities&#8217; shareholdings in the Company immediately prior to the consummation of the Merger, (ii) a complete liquidation or dissolution of the Company or (iii) the sale or other disposition of all or substantially all (as defined under Delaware General Corporation Law) of the assets of the Company excluding a sale or other disposition of assets to a subsidiary of the Company.  For purposes of this Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Merger&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means a reorganization, merger or consolidation involving the Company, including without limitation as a parent of a direct or indirect subsidiary of the Company effecting such transaction</font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Anything in this Agreement to the contrary notwithstanding, if an event that would, but for this paragraph, constitute a Change of Control results from or arises out of a purchase or other acquisition of the Company, directly or indirectly, by a corporation or other entity in which the Executive has a greater than ten percent (10%) direct or indirect equity interest, such event shall not constitute a Change of Control.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Employment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the terms and conditions hereof, the Company hereby agrees to continue the Executive in its employ, and the Executive hereby agrees to remain in the employ of the Company, for the period commencing on the Effective Date and ending on the last day of the thirty-sixth month following the month in which the Effective Date occurs (the &#34;Employment Period&#34;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Position and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;During the Employment Period, (A) the Executive's position (including status, offices, titles and reporting requirements), authority, duties and responsibilities shall be at least commensurate in all material respects with the most significant of those held, exercised and assigned at any time during the 90-day period immediately preceding the Effective Date and (B) the Executive's services shall be performed at the location where the Executive was employed immediately preceding the Effective Date or any office or location less than 35 miles from such location.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;During the Employment Period, and excluding any periods of vacation and sick leave to which the Executive is entitled, the Executive agrees to devote his full business time to the business and affairs of the Company and, to the extent necessary to discharge the responsibilities assigned to the Executive hereunder, to use the Executive's reasonable best efforts to perform faithfully and efficiently such responsibilities. During the Employment Period it shall not be a violation of this Agreement for the Executive to (A) serve on corporate, civic or charitable boards or committees, (B) deliver lectures, fulfill speaking engagements or teach at educational institutions and (C) manage personal investments, so long as such activities do not significantly interfere with the performance of the Executive's responsibilities as an employee of the Company in accordance with this Agreement.  It is expressly understood and agreed that to the extent that any such activities have been conducted by the Executive prior to the Effective Date, the continued conduct of such activities (or the conduct of activities similar in nature and scope thereto) subsequent to the Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Employment Period, the Executive shall receive an annual base salary (&#34;Annual Base Salary&#34;), which shall be paid monthly, having a value at least equal to twelve times the highest monthly base salary paid or payable to the Executive by the Company and its affiliated companies in respect of the twelve-month period immediately preceding the month in which the Effective Date occurs.  During the Employment Period, the Annual Base Salary shall be reviewed at least annually and shall be increased at any time and from time to time as shall be substantially consistent with increases in base salary awarded in the ordinary course of business to other peer executives of the Company and its affiliated companies.  Any increase in Annual Base Salary shall not serve to limit or reduce any other obligation to the Executive under this Agreement.  Annual Base Salary shall not be reduced after any such increase and the term Annual Base Salary as utilized in this Agreement shall refer to Annual Base Salary as so increased.  As used in this Agreement, the term &#34;affiliated companies&#34; includes any company controlled by, controlling or under common control with the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In addition to Annual Base Salary, the Executive shall be awarded, for each fiscal year during the Employment Period, an annual cash  bonus (the &#34;Annual Bonus&#34;&#59; which shall include, without limitation, any other annual cash bonus plan or program provided to Executive such as the Short Term Incentive Plan or any other similar plan, but shall not include any cash sign-on, relocation, retention or other special bonus or payments. ) in cash at least equal to the greater of (a) the average (annualized for any fiscal year consisting of less than twelve full months or with respect to which the Executive has been employed by the Company for less than twelve full months) bonus (the &#34;Average Annual Bonus&#34;) paid or that has been earned and accrued, but unpaid to the Executive by the Company and its affiliated companies in respect of the three fiscal years immediately preceding the fiscal year in which the Effective Date occurs, (b) the Annual Bonus paid for the fiscal year immediately preceding the Effective Date, or (c) the target bonus associated with the Company achieving its 100 percent target payout level as determined in accordance with the terms of the Company&#8217;s bonus plans for senior executives for the fiscal year immediately preceding the Effective Date (the &#8220;Target Bonus&#8221;&#59; the greater of clauses (a), (b) or (c) to be referred to as the &#8220;Highest Annual Bonus&#8221;)&#59; for the avoidance of doubt,  the determination of bonus under clause (c) above  shall not be reduced for the application of the Compensation Committee&#8217;s discretion to reduce such bonus or bonus funding, or increased to reflect additional amounts that may be paid or payable if the Company exceeds target.  Each such Annual Bonus shall be paid no later than the 15th day of the third month of the fiscal year next following the fiscal year for which the Annual Bonus is awarded, unless the Executive shall elect to defer the receipt of such Annual Bonus pursuant to any nonqualified plan of the Company.  Notwithstanding anything herein to the contrary, any portion of  Annual Base Salary or Annual Bonus electively deferred by the Executive pursuant to a qualified or a non-qualified plan including, but not limited to, the Hologic, Inc. Deferred Compensation Plan or any successor thereto (&#8220;DCP&#8221;) shall be included in determining the Annual Base Salary, Annual Bonus and the Average Annual Bonus.  If the fiscal year of any successor to this Agreement, as described by Section 11(c) herein, is different than the Company&#8217;s fiscal year at the time of the Change of Control, then the Executive shall be paid (i) the Annual Bonus that would have been </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">paid upon the end of Company&#8217;s fiscal year ending after the Change of Control, and (ii) a pro-rata  Annual Bonus for any months of service performed following the end of  the Company&#8217;s fiscal year, but prior to the first day of the successor&#8217;s  fiscal year immediately following the Change of Control.  The Annual Bonuses thereafter shall be based on the successor&#8217;s first full fiscal year beginning after the Change of Control and successive fiscal years thereafter.  &#8220;Pro Rata Bonus&#34; shall mean an amount equal to the Bonus Amount (average of the Annual Bonuses paid or that has been earned and accrued, but unpaid during the three full fiscal years ended prior to the Date of Termination) multiplied by a fraction the numerator of which is the number of months worked in the fiscal year through the Date of Termination and the denominator of which is 12.  Any partial months shall be rounded to the nearest whole number using normal mathematical convention.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive, Savings and Retirement Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In addition to Annual Base Salary and Annual Bonus payable as hereinabove provided, the Executive shall be entitled to participate during the Employment Period in all incentive, savings and retirement plans, practices, policies and programs applicable to other peer executives of the Company and its affiliated companies, but in no event shall such plans practices, policies and programs provide the Executive with incentive, savings and retirement benefits opportunities, in each case, less favorable, in the aggregate, than the most favorable of those provided by the Company and its affiliated companies for the Executive under such plans, practices, policies and programs as in effect at any time during the one-year immediately preceding the Effective Date, or, if more favorable to the Executive, those provided generally at any time after the Effective Date to other peer executives of the Company and its affiliated companies.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Welfare Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Employment Period, the Executive and&#47;or the Executive's family, as the case may be, shall be eligible for participation in and shall receive all benefits under welfare benefit plans, practices, policies and programs provided by the Company and its affiliated companies (including, without limitation, medical, prescription, dental, disability, salary continuance, employee life, group life, accidental death and travel accident insurance plans and programs) and applicable to other peer executives of the Company and its affiliated companies, but in no event shall such plans, practices, policies and programs provide benefits which are less favorable, in the aggregate, than the most favorable of such plans, practices, policies and programs in effect at any time during the one-year period immediately preceding the Effective Date, or, if more favorable to the Executive, those provided generally at any time after the Effective Date to other peer executives of the Company and its affiliated companies.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Employment Period, the Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by the Executive upon submission of appropriate accountings in accordance with the most favorable policies, practices and procedures of the Company and its affiliated companies in effect at any time during the one-year period immediately preceding the Effective Date or, if more favorable to the Executive, as in effect at any time thereafter with respect to other peer executives of the Company and its affiliated companies.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Fringe Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Employment Period, the Executive shall be entitled to fringe benefits in accordance with the most favorable plans, practices, programs and policies of the Company and its affiliated companies in effect at any time during the one-year period immediately preceding the Effective Date or, if more favorable to the Executive, as in effect at any time thereafter with respect to other peer executives of the Company and its affiliated companies.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Office and Support Staff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Employment Period, the Executive shall be entitled to an office or offices of a size and with furnishings and other appointments, and to exclusive personal secretarial and other assistance, at least equal to the most favorable of the foregoing provided to the Executive by the Company and its affiliated companies at any time during the one-year period immediately preceding the Effective Date or, if more favorable to the Executive, as provided at any time thereafter with respect to other peer executives of the Company and its affiliated companies.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(viii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vacation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Employment Period, the Executive shall be entitled to paid vacation of at least five (5) weeks and in accordance with the most favorable plans, policies, programs and practices of the Company and its affiliated companies as in effect at any time during the one-year period immediately preceding the Effective Date or, if more favorable to the Executive, as in effect at any time thereafter with respect to other peer incentives of the Company and its affiliated companies.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Executive's employment shall terminate automatically upon the Executive's death during the Employment Period.  If the Company determines in good faith that the Disability of the Executive has occurred during the Employment Period (pursuant to the definition of &#34;Disability&#34; set forth below), it may give to the Executive written notice in accordance with Section 13(b) of this Agreement of its intention to terminate the Executive's employment.  In such event, the Executive's employment with the Company shall terminate effective on the 30th day after receipt of such notice by the Executive (the &#34;Disability Effective Date&#34;), provided that, within the 30 days after such receipt, the Executive shall not have returned to full-time performance of the Executive's duties.  For purposes of this Agreement, &#34;Disability&#34; means the absence of the Executive from the Executive's duties with the Company on a full-time basis for 180 consecutive business days as a result of incapacity due to mental or physical illness which is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to the Executive or the Executive's legal representative (such agreement as to acceptability not to be withheld unreasonably).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company may terminate the Executive's employment during the Employment Period for &#34;Cause&#34;.  For purposes of this Agreement, &#34;Cause&#34; means (i) an act or acts of personal dishonesty taken by the Executive and intended to result in substantial personal enrichment of the Executive at the expense of the Company, (ii) repeated violations by the Executive of the Executive's obligations under Section 4(a) of this Agreement (other than as a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">result of incapacity due to physical or mental illness) which are demonstrably willful and deliberate on the Executive's part, which are committed in bad faith or without reasonable belief that such violations are in the best interests of the Company and which are not remedied in a reasonable period of time after receipt of written notice from the Company or (iii) the conviction of the Executive of a felony involving moral turpitude.  The Company shall provide the Executive with 30 days written notice of any determination of Cause and provide the Executive, for a period of 30 days following such notice, with the opportunity to appear before the Board, with or without legal representation, to present arguments and evidence on his behalf and following such presentation to the Board, the Executive may only be terminated for Cause if the Board (excluding the Executive if he is a member of the Board), by unanimous consent reasonably determines in good faith that his actions did, in fact, constitute for Cause.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Executive's employment may be terminated during the Employment Period by the Executive for Good Reason.  For purposes of this Agreement, &#34;Good Reason&#34; means&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;A material diminution in the Executive&#8217;s base compensation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;A material diminution in the Executive&#8217;s authority, duties and responsibilities as in effect immediately prior to the Change of Control or, if applicable, the Date of Termination&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;A material diminution in the authority, duties and responsibilities of the supervisor to whom the Executive is required to report as in effect immediately prior to the Change of Control or, if applicable, the Date of Termination&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;A material change in the geographic location in which Executive&#8217;s principal office was located immediately prior to the Change of Control or, if applicable, the Date of Termination&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;A material diminution in the budget over which the Executive had authority immediately prior to the of the Change of Control or, if applicable, the Date of Termination&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;Any other action or inaction that constitutes a material breach by the Company of this Agreement or any other agreement under which the Executive provides services&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provided, however, that Good Reason shall not exist unless the Executive has given written notice to the Company within ninety (90) days of the initial existence of the Good Reason event or condition(s) giving specific details regarding the event or condition&#59; and unless the Company has had at least thirty (30) days to cure such Good Reason event or condition after the delivery of such written notice and has failed to cure such event or condition within such thirty (30) day cure period.</font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any termination by the Company for Cause or by the Executive for Good Reason shall be communicated by Notice of Termination to the other party hereto given in accordance with Section 13(b) of this Agreement.  For purposes of this Agreement, a &#34;Notice of Termination&#34; means a written notice which (i) indicates the specific termination provision in this Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive's employment under the provision so indicated and (iii) if the Date of Termination (as defined below) is other than the date of receipt of such notice, specifies the termination date (which date shall be not more than fifteen days after the giving of such notice).  The failure by the Executive or the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company hereunder or preclude the Executive or the Company from asserting such fact or circumstance in enforcing the Executive's or the Company&#8217;s rights hereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#34;Date of Termination&#34; means the date of receipt of the Notice of Termination or any later date (taking into account any applicable notice and cure period) specified therein, as the case may be&#59; provided  however, that (i) if the Executive's employment is terminated by the Company other than for Cause, death or Disability, the Date of Termination shall be the date on which the Company notifies the Executive of such termination, and (ii) if the Executive's employment is terminated by reason of death or Disability, the Date of Termination shall be the date of death of the Executive or the Disability Effective Date, as the case may be. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Obligations of the Company upon Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Executive's employment is terminated by reason of the Executive's death during the Employment Period, this Agreement shall terminate without further obligations to the Executive's legal representatives under this Agreement, other than for (i) payment of the sum of the following amounts&#58;  (A) the Executive's Annual Base Salary through the Date of Termination to the extent not theretofore paid, (B) the product of (I) the Highest Annual Bonus and (II) a fraction, the numerator of which is the number of days in the current fiscal year through the Date of Termination, and the denominator of which is 365, and (C) any accrued and unpaid Annual Bonus amounts, compensation or vacation pay, in each case, to the extent not yet paid by the Company (the amounts described in subparagraphs (A), (B) and (C) are hereafter referred to as &#34;Accrued Obligations&#34; and shall be paid to the Executive&#8217;s estate or beneficiary, as applicable, in a lump sum in cash within 30 days of the Date of Termination), (ii) any other benefits or compensation payable under any employee benefit plan in accordance with the applicable plans&#8217; terms, including, without limitation, any non-qualified plan or DCP&#59; (iii) for the remainder of the Employment Period, or such longer period as any plan, program, practice or policy may provide, the Company shall continue benefits to the Executive and&#47;or the Executive's family at least equal to those which would have been provided in accordance with the applicable plans, programs, practices and policies described in Section 4(b)(v) and (vi) of this Agreement as if the Executive's employment had not been terminated in accordance with the most favorable plans, practices, programs or policies of the Company and its affiliated companies as in effect and applicable generally to other peer executives and their families during the one year period </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-8-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">immediately preceding the Effective Date or, if more favorable to the Executive, as in effect at any time thereafter with respect to other peer executives of the Company and its affiliated companies and their families (such continuation of such benefits for the applicable period herein set forth and such transfer of the Individual Policy shall be hereinafter referred to as &#8220;Welfare Benefit Continuation&#8221;&#59; for purposes of determining eligibility of the Executive for retiree benefits pursuant to such plans, practices, programs and policies, the Executive shall be considered to have remained employed until the end of the Employment Period and to have retired on the last day of such period), and (iv) payment to the Executive&#8217;s estate or beneficiary, as applicable, in a lump sum in cash within 30 days of the Date of Termination of an amount equal to the sum of the Executive&#8217;s Annual Base Salary and the Highest Annual Bonus.  Subject to the provisions of Section 9 hereof, but, otherwise, anything herein to the contrary notwithstanding, the Executive's family shall be entitled to receive benefits at least equal to the most favorable benefits provided by the Company and any of its affiliated companies to surviving families of peer executives of the Company and such affiliated companies under such plans, programs, practices and policies relating to family death benefits, if any, as in effect with respect to other peer executives and their families at any time during the one year period immediately preceding the Effective Date or, if more favorable to the Executive and&#47;or the Executive's family, as in effect on the date of the Executive's death with respect to other peer executives of the Company and its affiliated companies and their families.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Executive's employment is terminated by reason of the Executive's Disability during the Employment Period, this Agreement shall terminate without further obligations to the Executive, other than for (i) payment of the Accrued Obligations (which shall be paid in a lump sum in cash within 30 days of the Date of Termination), (ii) the timely payment and provision of the Welfare Benefit Continuation, and (iii) payment to the Executive in a lump sum in cash within 30 days of the Date of Termination of an amount equal to the sum of the Executive&#8217;s Annual Base Salary and the Highest Annual Bonus.    Subject to the provisions of Section 9 hereof, but, otherwise, anything herein to the contrary notwithstanding, the Executive shall be entitled after the Disability Effective Date to receive disability and other benefits at least equal to the most favorable of those provided by the Company and its affiliated companies to disabled executives and&#47;or their families in accordance with such plans, programs, practices and policies relating to disability, if any, as in effect with respect to other peer executives and their families at any time during the one year period immediately preceding the Effective Date or, if more favorable to the Executive and&#47;or the Executive's family, as in effect at any time thereafter with respect to other peer executives of the Company and its affiliated companies and their families.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause, Other than for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Executive's employment shall be terminated by the Company for Cause or by the Executive other than for Good Reason (and other than by reason of his death or disability) during the Employment Period, this Agreement shall terminate without further obligations to the Executive other than the obligation to pay to the Executive Annual Base Salary through the Date of Termination.  In such case, such amounts shall be paid to the Executive in a lump sum in cash within 30 days of the Date of Termination.  The Executive shall, in such event, also be entitled to any benefits required by law that are not otherwise provided by this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-9-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Following a Change of Control by the Company without Cause or by the Executive for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If during the Employment Period the Executive is terminated by the Company without Cause or he resigns for Good Reason, then the Company shall pay the Executive the following&#58;</font></div><div style="padding-right:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the Company shall pay to the Executive in a lump sum in cash within 30 days after the Date of Termination all Accrued Obligations&#59; and</font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the Company shall pay to the Executive a lump sum amount in cash within 30 days after the Date of Termination equal to the (such amount shall be hereinafter referred to as the &#8220;Change of Control Payment&#8221;) to the product of (X) two point ninety nine (2.99) multiplied by the sum of (i) (Y) the Annual Base Salary for the fiscal year immediately preceding the Date of Termination and (ii) Highest Annual Bonus&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (iii)&#160;&#160;&#160;&#160;notwithstanding any other provisions to the contrary contained herein or in any option agreement, restricted stock agreement, performance stock unit or other equity compensation agreement, between the  Company and the Executive, or any stock option, restricted stock or other equity compensation plans sponsored by the Company, unless such agreement or plan expressly references and supersedes this Agreement, then all such unvested equity awards which Executive holds as of the Effective Date shall be immediately and automatically exercisable and&#47;or vested, and the Executive shall have the right to exercise any such equity awards (to the extent applicable) for the shorter of  one year after the Date of Termination or the remaining term of the applicable equity award.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination by the Company Without Cause or by Executive for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Executive's employment with the Company shall be terminated by the Company without Cause or by the Executive for Good Reason (as defined in Section 5(c) without regard to whether a Change of Control has occurred) at any time prior to the Effective Date, then the Executive shall be entitled to each and all of the following&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">the Company shall pay the Executive all Accrued Obligations&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">the Company shall continue to pay the Executive his Base Salary and an amount equal to the Average Annual Bonus divided by the number of payroll periods during the one year severance period for the period of one (1) year from the Date of Termination in accordance with its normal payroll practices and subject to applicable tax withholding&#59;  and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">provide the Executive and his family with the Welfare Benefit Continuation for a period of one (1) year from the Date of Termination.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Mitigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Executive shall not be required to mitigate the amount of any payment provided for in this Agreement by seeking other employment or otherwise and no such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-10-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">payment shall be offset or reduced by the amount of any compensation or benefits provided to the Executive in any subsequent employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Other Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The severance pay and benefits provided for in Section 6(e) shall be in lieu of any other severance or termination pay to which the Executive may be entitled under any Company severance or termination plan, program, practice or arrangement.  The Executive's entitlement to any other compensation or benefits shall be determined in accordance with the Company's employee benefit plans and other applicable programs, policies and practices then in effect.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Non-exclusivity of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as provided in Section 6, nothing in this Agreement shall prevent or limit the Executive's continuing or future participation in any benefit, bonus, incentive or other plans, programs, policies or practices, provided by the Company or any of its affiliated companies and for which the Executive may qualify, nor shall anything herein limit or otherwise affect such rights as the Executive may have under any other agreements with the Company or any of its affiliated companies.  Amounts which are vested benefits or which the Executive is otherwise entitled to receive under any plan, policy, practice or program of the Company or any of its affiliated companies at or subsequent to the Date of Termination shall be payable in accordance with such plan, policy, practice or program except as explicitly modified by this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Full Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company's obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Executive or others.  In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts shall not be reduced whether or not the Executive obtains other employment.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Prior to the occurrence of a Change of Control, the Company agrees to reimburse the Executive for all legal fees and expenses which the Executive may reasonably incur as a result of any contest by the Company, the Executive or others of the validity or enforceability of, or liability under, any provision of this Agreement or any guarantee of performance thereof, if the Executive prevails in such contest.  Following a Change of Control, the Company agrees to pay promptly as incurred, to the full extent permitted by law, all legal fees and expenses which the Executive may reasonably incur as a result of any contest (regardless of the outcome thereof) by the Company, the Executive or others of the validity or enforceability of, or liability under, any provision of this Agreement or any guarantee of performance thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;If there shall be any dispute between the Company and the Executive (i) in the event of any termination of the Executive&#8217;s employment by the Company, whether such termination was for Cause, or (ii) in the event of any termination of employment by the Executive, whether Good Reason existed, then, unless and until there is a final, nonappealable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-11-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">judgment by a court of competent jurisdiction declaring that such termination was for Cause or that the determination by the Executive of the existence of Good Reason was not made in good faith, the Company shall pay all amounts, and provide all benefits, to the Executive and&#47;or the Executive&#8217;s family or other beneficiaries, as the case may be, that the Company would be required to pay or provide pursuant to Section 6(d) as though such termination were by the Company without Cause, or by the Executive with Good Reason&#59; provided, however, that the Company shall not be required to pay any disputed amount pursuant to this paragraph except upon receipt of an undertaking by or on behalf of the Executive to repay all such amounts to which the Executive is ultimately adjudged by such court not to be entitled.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">280G Protection</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:37.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;In the event that the Executive shall become entitled to payment and&#47;or benefits provided by this Agreement or any other amounts in the &#8220;nature of compensation&#8221; (whether pursuant to the terms of this Agreement or any other plan, arrangement or agreement with the Company, any person whose actions result in a change of ownership or effective control covered by Section 280G(b)(2) of the Internal Revenue Code (the &#8220;Code&#8221;) or any person affiliated with the Company or such person) as a result of such change in ownership or effective control (collectively the &#8220;Company Payments&#8221;), and such Company Payments will be subject to the tax (the &#8220;Excise Tax&#8221;) imposed by Section 4999 of the Code (and any similar tax that may hereafter be imposed by any taxing authority) the Company shall pay to the Executive the greater of the following, whichever gives the Executive the highest net after-tax amount (after taking into account federal, state, local and social security taxes at the maximum marginal rates) (x) the Company Payments or (y) one dollar less than the amount of the Company Payments that would subject the Executive to the Excise Tax.  In the event that the Company Payments are required to be reduced pursuant to the foregoing sentence, then the Company Payments shall be reduced as mutually agreed between the Company and the Executive or, in the event the parties cannot agree, in the following order (1) any lump sum severance based on Base Salary or Annual Bonus, (2) any other cash amounts payable to the Executive, (3) any benefits valued as parachute payments&#59; and (4) acceleration of vesting of any equity.</font></div><div style="text-align:justify;text-indent:40.25pt"><font><br></font></div><div style="text-align:justify;text-indent:28.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For purposes of determining whether any of the Company Payments will be subject to the Excise Tax and the amount of such Excise Tax, (x) the Company Payments shall be treated as &#8220;parachute payments&#8221; within the meaning of Section 280G(b)(2) of the Code, and all &#8220;parachute payments&#8221; in excess of the &#8220;base amount&#8221; (as defined under Code Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax, unless and except to the extent that, in the opinion of the Company&#8217;s independent certified public accountants appointed prior to any change in ownership (as defined under Section 280G(b)(2) of the Code) or tax counsel selected by such accountants or the Company (the &#8220;Accountants&#8221;) such Company Payments (in whole or in part) either expressly do not constitute &#8220;parachute payments,&#8221; represent reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code in excess of the &#8220;base amount&#8221; or are otherwise not subject to the Excise Tax, and (y) the value of any non-cash benefits or any deferred payment or benefit shall be determined by the Accountants. All determinations hereunder shall be made by the Accountants which shall provide detailed supporting calculations both to the Company and the Executive at </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-12-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">such time as it is requested by the Company or the Executive.  If the Accountants determine that payments under this Agreement must be reduced pursuant to this paragraph, they shall furnish the Executive with a written opinion to such effect.  The determination of the Accountants shall be final and binding upon the Company and the Executive.</font></div><div style="text-align:justify;text-indent:40.25pt"><font><br></font></div><div style="text-align:justify;text-indent:37.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In the event of any controversy with the Internal Revenue Service (or other taxing authority) with regard to the Excise Tax, the Executive shall permit the Company to control issues related to the Excise Tax (at its expense), provided that such issues do not potentially materially adversely affect the Executive, but the Executive shall control any other issues.  In the event the issues are interrelated, the Executive and the Company shall in good faith cooperate so as not to jeopardize resolution of either issue, but if the parties cannot agree the Executive shall make the final determination with regard to the issues.  In the event of any conference with any taxing authority regarding the Excise Tax or associated income taxes, the Executive shall permit the representative of the Company to accompany the Executive, and the Executive and the Executive&#8217;s representative shall cooperate with the Company and its representative.</font></div><div style="text-align:justify;text-indent:40.25pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Executive shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its affiliated companies, and their respective businesses, which shall have been obtained by the Executive during the Executive's employment by the Company or any of its affiliated companies and which shall not be or become public knowledge (other than by acts by the Executive or representatives of the Executive in violation of this Agreement).  After termination of the Executive's employment with the Company, the Executive shall not, without the prior written consent of the Company or as may otherwise be required by law or legal process, communicate or divulge any such information, knowledge or data to anyone other than the Company and those designated by it.  In no event shall an asserted violation of the provisions of this Section 10 constitute a basis for deferring or withholding any amounts otherwise payable to the Executive under this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution.  This Agreement shall inure to the benefit of and be enforceable by the Executive's legal representatives.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  The Company shall provide written evidence to the Executive to document compliance with the foregoing sentence within ten (10) business days of the Effective Date.  As </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-13-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">used in this Agreement, &#34;Company&#34; shall mean the Company as hereinbefore defined and any successor to its business and&#47;or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise. In addition, the Executive shall be entitled, upon exercise of any outstanding stock options or stock appreciation rights of the Company, to receive in lieu of shares of the Company&#8217;s stock, shares of such stock or other securities of such successor as the holders of shares of the Company&#8217;s stock received pursuant to the terms of the merger, consolidation or sale.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Compliance With Section 409A of the Internal Revenue Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent applicable, it is intended that this Agreement comply with the provisions of Section 409A of the Code (hereinafter referred to as &#8220;Section 409A&#8221;).  This Agreement shall be administered in a manner consistent with its intent, and any provision that would cause the Agreement to fail to satisfy Section 409A shall have no force and effect until amended to comply with Section 409A.  Notwithstanding any provision of this Agreement to the contrary, in the event any payment or benefit hereunder is determined to constitute non-qualified deferred compensation subject to Section 409A, then to the extent necessary to comply with Section 409A, such payment or benefits shall not be made, provided or commenced until six (6) months after the Executive&#8217;s &#8220;separation from service&#8221; as such phrase is defined for the purposes of Section 409A.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   The Executive agrees that, with the exception of the Accrued Obligations due to him in accordance with the terms hereunder, that the payment of any severance under this Agreement to the Executive by the Company, is subject to and conditioned on Executive executing a general release of the Company in a form and scope determined by the Company in its sole discretion (the &#8220;Release Agreement&#8221;), without Executive revoking such Release Agreement within fifty-two (52) days of the Date of Termination (the &#8220;Consideration Period&#8221;) and provided that (a) if the Date of Termination occurs in one calendar year and the Consideration Period (including the payment date) expires during the following calendar year, then notwithstanding anything herein to the contrary, the payments of severance under Section 6(e) will be paid by the Company to the Executive in the second calendar year&#59; (b) the Executive continues to comply with the provisions of the Non-Competition Agreement&#59; and (c) prior to the expiration of the Consideration Period (i) Executive provides satisfactory evidence to the Company that he has returned all Company property, confidential information and documentation to the Company, and (ii) provides the Company with a signed written resignation of Executive&#8217;s status as an officer of the Company or any of its affiliates, if applicable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, without reference to principles of conflict of laws.  The captions of this Agreement are not part of the provisions hereof and shall have no force or effect.  This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-14-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;All notices and other communications hereunder shall be in writing and shall be given by hand delivery to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If to the Executive&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Sean S. Daugherty </font></div><div style="padding-left:58.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(at the address on record with the company)</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Company&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hologic, Inc.</font></div><div style="padding-left:58.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">250 Campus Drive</font></div><div style="padding-left:58.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Marlborough, Massachusetts 02038</font></div><div style="padding-left:58.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Chief Executive Officer</font></div><div style="padding-left:58.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or to such other address as either party shall have furnished to the other in writing in accordance herewith.  Notices and communications shall be effective when actually received by the addressee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;The Company may withhold from any amounts payable under this Agreement such Federal, state or local taxes as shall be required to be withheld pursuant to any applicable law or regulation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;The Executive's or the Company&#8217;s failure to insist upon strict compliance with any provision hereof shall not be deemed to be a waiver of such provision or any other provision thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;This Agreement contains the entire understanding of the Company and the Executive with respect to the rights and other benefits that the Executive shall be entitled during the Employment Period, and in connection therewith shall supersede all prior oral and written communications with the Executive with respect thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Offer Letter, and Employee Intellectual Property Rights and Non-Competition Agreement, option or other equity agreements or other employment agreement by and between the Company and Executive shall remain in full force and effect and if the Company&#8217;s separation policy would provide greater benefits to the Executive than this Agreement, then the Executive may elect to receive benefits under the Company&#8217;s separation policy in lieu of the benefits provided hereunder.  Nothing herein shall affect the application of the Company&#8217;s separation policy in lieu of the benefits provided hereunder.  Nothing herein shall affect the application of the Company&#8217;s separation policy prior to the Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-15-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(g)&#160;&#160;&#160;&#160;The Executive and the Company acknowledge that, except as may otherwise be provided under this Agreement or any other written agreement between the Executive and the Company, prior to the Effective Date, the employment of the Executive by the Company is &#8220;at will&#8221; and may be terminated by either the Executive or the Company at any time.  Notwithstanding anything contained herein, if during or prior to the Employment Period, the Executive shall terminate employment with the Company other than for Good Reason,  then the Executive shall have no liability to the Company. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Signature page follows&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-16-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;IN WITNESS WHEREOF, the Executive has hereunto set his hand and, pursuant to the authorization from its Board of Directors, the Company has caused these presents to be executed in its name on its behalf, all as of the day and year first above written.</font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">HOLOGIC, INC.</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">   &#47;s&#47; Allison P. Bebo&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58;  Allison P. Bebo&#160;&#160;&#160;&#160;</font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President, Human Resources</font></div><div style="padding-left:216pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Sean S. Daugherty&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Sean S. Daugherty</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-17-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>holxq4-2020ex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i35fe5c7b738548e88e35c92a72f73d19_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:250.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries of Hologic</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation or Organization</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acessa Health Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beijing Hologic Technology Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benassar Diagnostica-Equipamientos Medicos Unipessoal, Lda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioLucent, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bioptics, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytyc Cayman Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cayman Islands</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytyc Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytyc Prenatal Products Corp.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytyc Surgical Products, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct Radiography Corp.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emsor, Sociedad de responsabilidad limitada </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Faxitron Bioptics, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Focal Therapeutics, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gen-Probe Incorporated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gen-Probe Prodesse, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gen-Probe Sales &#38; Service, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Beacons, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic (Australia &#38; New Zealand) Pty Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic (MA), LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic ASE, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Asia, Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Asia Pacific Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Austria GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic BV</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Canada ULC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Caribbean (Barbados) SRL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbados</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Denmark ApS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Deutschland GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Espana S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Europe Middle East and Africa, S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Finance Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic France SARL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic GGO 2, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic GGO 3 LLP</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic GGO 4 LTD</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Global Holding LTD</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Hitec-Imaging GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Holdings Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic HUB LTD</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Iberia, S.L.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic India LLP</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic International Holdings B.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic IP LTD</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Ireland Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:250.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries of Hologic</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation or Organization</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Italia S.r.l.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Japan KK</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hologic Latin America (Servicos Em Marketing E Negocios) Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Malaysia SDN. BHD.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Medical Technologies (Beijing) Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Medicor GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Medicor Suisse GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Netherlands B.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic (Shanghai) Medical Supplies Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Singapore Pte. Ltd</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Suisse SA</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Surgical Products Costa Rica, S.R.L.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Sweden AB</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic UK Finance Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic US Finance Co LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Navigation Three Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sentinelle Medical ULC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine SA</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine Ltd</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine Srl</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine HK Ltd</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine (Shanghai) Medical Devices Co., Ltd</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suros Surgical Systems, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TCT International Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Virgin Islands</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>holxq4-2020ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i7857690b81024d3893c9aa2c61058f0b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:472.50pt"><tr><td style="width:1.0pt"></td><td style="width:16.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:429.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Statement (Form S-3ASR No. 333-235287) pertaining to Hologic, Inc.&#8217;s shelf registration statement for common stock, preferred stock, debt securities, rights, warrants, purchase contracts, units or any combination of the foregoing, and</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:472.50pt"><tr><td style="width:1.0pt"></td><td style="width:16.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:429.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Statements (Form S-8 Nos. 333-79167, 333-60046, 333-112222, 333-121111, 333-130170, 333-139341, 333-150796, 333-181126, 333-183019, 333-188468, 333-224613, 333-210968) pertaining to the equity incentive plans and employee stock purchase plan of Hologic, Inc.&#59;</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated November&#160;17, 2020, with respect to the consolidated financial statements of Hologic, Inc. and the effectiveness of internal control over financial reporting of Hologic, Inc., included in this Annual Report (Form 10-K) of Hologic, Inc. for the year ended September&#160;26, 2020. </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#47;s&#47; Ernst &#38; Young LLP </font></div><div style="margin-bottom:10pt;margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:186.75pt"><tr><td style="width:1.0pt"></td><td style="width:184.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston, Massachusetts</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2020</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>holxq4-2020ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ida045b156fb04124ab43573dda3a1bf9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;17, 2020 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>holxq4-2020ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i4e0e907ba73249eb90113b8ff0f070ae_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;17, 2020 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>holxq4-2020ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="if86695f31a5f4d6e828be5cbd00794c7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, Chief Executive Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Annual Report on Form 10-K for the year ended September&#160;26, 2020 (the &#8220;Form 10-K&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November 17, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>holxq4-2020ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i7a14b8ec4b2648f7ab4eafa9b24f7831_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, Chief Financial Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Annual Report on Form 10-K for the year ended September&#160;26, 2020 (the &#8220;Form 10-K&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November 17, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>holx-20200926.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f4bb5493-eda8-449d-a170-7314862f7798,g:08da96e9-86db-4711-b125-e777b2cffbcd-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:holx="http://www.hologic.com/20200926" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.hologic.com/20200926">
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20200926_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20200926_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20200926_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20200926_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.hologic.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome">
        <link:definition>100010002 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>100020003 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical">
        <link:definition>100030004 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets">
        <link:definition>100040005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100050006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>100060007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100070008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Operations" roleURI="http://www.hologic.com/role/Operations">
        <link:definition>210011001 - Disclosure - Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperationsDetails" roleURI="http://www.hologic.com/role/OperationsDetails">
        <link:definition>240024001 - Disclosure - Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>210031002 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>240064002 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail">
        <link:definition>240074003 - Disclosure - Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail">
        <link:definition>240084004 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail">
        <link:definition>240094005 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail">
        <link:definition>240104006 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails">
        <link:definition>240114007 - Disclosure - Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail">
        <link:definition>240124008 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail">
        <link:definition>240134009 - Disclosure - Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails">
        <link:definition>240144010 - Disclosure - Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail">
        <link:definition>240154011 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails">
        <link:definition>240164012 - Disclosure - Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails">
        <link:definition>240174013 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails">
        <link:definition>240184014 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails">
        <link:definition>240194015 - Disclosure - Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails">
        <link:definition>240204016 - Disclosure - Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails">
        <link:definition>240214017 - Disclosure - Summary of Significant Accounting Policies - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail">
        <link:definition>240224018 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail">
        <link:definition>240234019 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesProductWarrantyDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail">
        <link:definition>240244020 - Disclosure - Summary of Significant Accounting Policies - Product Warranty (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNotes" roleURI="http://www.hologic.com/role/RevenueNotes">
        <link:definition>210251003 - Disclosure - Revenue (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.hologic.com/role/RevenueTables">
        <link:definition>230263002 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.hologic.com/role/RevenueNarrativeDetails">
        <link:definition>240274021 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueBusinessRevenueDetails" roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails">
        <link:definition>240284022 - Disclosure - Revenue - Business Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueGeographicalRevenueDetails" roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails">
        <link:definition>240294023 - Disclosure - Revenue - Geographical Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenuebyTypeDetails" roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails">
        <link:definition>240304024 - Disclosure - Revenue - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationsDetails" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails">
        <link:definition>240314025 - Disclosure - Revenue - Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationsDetails_1" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1">
        <link:definition>240314025 - Disclosure - Revenue - Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.hologic.com/role/Leases">
        <link:definition>210321004 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.hologic.com/role/LeasesTables">
        <link:definition>230333003 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.hologic.com/role/LeasesNarrativeDetails">
        <link:definition>240344026 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>240354027 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalLeaseInformationDetails" roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails">
        <link:definition>240364028 - Disclosure - Leases - Additional Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseLiabilityMaturitySchedule2020Details" roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details">
        <link:definition>240374029 - Disclosure - Leases - Lease Liability Maturity Schedule 2020 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseLiabilityMaturitySchedule2020Details_1" roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1">
        <link:definition>240374029 - Disclosure - Leases - Lease Liability Maturity Schedule 2020 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseLiabilityMaturitySchedule2019Details" roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details">
        <link:definition>240384030 - Disclosure - Leases - Lease Liability Maturity Schedule 2019 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" roleURI="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails">
        <link:definition>240394031 - Disclosure - Leases - Future Minimum Annual Rental Income Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.hologic.com/role/BusinessCombinations">
        <link:definition>210401005 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.hologic.com/role/BusinessCombinationsTables">
        <link:definition>230413004 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsNarrativeDetails">
        <link:definition>240424032 - Disclosure - Business Combinations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsPurchasePriceAllocationAcessaDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails">
        <link:definition>240434033 - Disclosure - Business Combinations - Purchase Price Allocation Acessa (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails">
        <link:definition>240444034 - Disclosure - Business Combinations - Purchase Price Allocation SuperSonic Imagine (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails">
        <link:definition>240454035 - Disclosure - Business Combinations - Purchase Price Allocation Focal Therapeutics (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsPurchasePriceAllocationFaxitronDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails">
        <link:definition>240464036 - Disclosure - Business Combinations - Purchase Price Allocation Faxitron (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentDetails" roleURI="http://www.hologic.com/role/EquityMethodInvestmentDetails">
        <link:definition>240474037 - Disclosure - Equity Method Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesTables" roleURI="http://www.hologic.com/role/RestructuringChargesTables">
        <link:definition>230483005 - Disclosure - Restructuring Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail">
        <link:definition>240494038 - Disclosure - Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail">
        <link:definition>240504039 - Disclosure - Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesAdditionalInformationDetail" roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail">
        <link:definition>240514040 - Disclosure - Restructuring Charges - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangements" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements">
        <link:definition>210521006 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsTables" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables">
        <link:definition>230533006 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsCompanysBorrowingsDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
        <link:definition>240544041 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails">
        <link:definition>240554042 - Disclosure - Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
        <link:definition>240564043 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail">
        <link:definition>240574044 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
        <link:definition>240584045 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail">
        <link:definition>240594046 - Disclosure - Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.hologic.com/role/FairValueMeasurementsTables">
        <link:definition>230603007 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
        <link:definition>240614047 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail">
        <link:definition>240624048 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails">
        <link:definition>240634049 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.hologic.com/role/IncomeTaxesTables">
        <link:definition>230643008 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" roleURI="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail">
        <link:definition>240654050 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesProvisionforIncomeTaxesDetail" roleURI="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail">
        <link:definition>240664051 - Disclosure - Income Taxes - Provision for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" roleURI="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail">
        <link:definition>240674052 - Disclosure - Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" roleURI="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail">
        <link:definition>240684053 - Disclosure - Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetail" roleURI="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail">
        <link:definition>240694054 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" roleURI="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail">
        <link:definition>240704055 - Disclosure - Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensation" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation">
        <link:definition>210711007 - Disclosure - Stockholders' Equity and Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationTables" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables">
        <link:definition>230723009 - Disclosure - Stockholders' Equity and Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail">
        <link:definition>240734056 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail">
        <link:definition>240744057 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail">
        <link:definition>240754058 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail">
        <link:definition>240764059 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail">
        <link:definition>240774060 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail">
        <link:definition>240784061 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="A401kPlan" roleURI="http://www.hologic.com/role/A401kPlan">
        <link:definition>210791008 - Disclosure - 401(k) Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="A401kPlanAdditionalInformationDetail" roleURI="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail">
        <link:definition>240804062 - Disclosure - 401(k) Plan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredCompensationPlanAdditionalInformationDetail" roleURI="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail">
        <link:definition>240814063 - Disclosure - Deferred Compensation Plan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.hologic.com/role/CommitmentsandContingencies">
        <link:definition>210821009 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.hologic.com/role/CommitmentsandContingenciesTables">
        <link:definition>230833010 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" roleURI="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails">
        <link:definition>240844064 - Disclosure - Commitments and Contingencies - Summary of Purchase Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationandRelatedMatters" roleURI="http://www.hologic.com/role/LitigationandRelatedMatters">
        <link:definition>210851010 - Disclosure - Litigation and Related Matters</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationandOtherMattersAdditionalInformationDetail" roleURI="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail">
        <link:definition>240864065 - Disclosure - Litigation and Other Matters - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Disposition" roleURI="http://www.hologic.com/role/Disposition">
        <link:definition>210871011 - Disclosure - Disposition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionTables" roleURI="http://www.hologic.com/role/DispositionTables">
        <link:definition>230883011 - Disclosure - Disposition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionAdditionalInformationDetails" roleURI="http://www.hologic.com/role/DispositionAdditionalInformationDetails">
        <link:definition>240894066 - Disclosure - Disposition - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>240904067 - Disclosure - Disposition - Schedule of Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" roleURI="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails">
        <link:definition>240914068 - Disclosure - Disposition - Schedule of Disposition Related Income Statement Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformation" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation">
        <link:definition>210921012 - Disclosure - Business Segments and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationTables" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables">
        <link:definition>230933012 - Disclosure - Business Segments and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
        <link:definition>240944069 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationSegmentInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail">
        <link:definition>240954070 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
        <link:definition>240964071 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails">
        <link:definition>240974072 - Disclosure - Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherLongTermLiabilities" roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities">
        <link:definition>210981013 - Disclosure - Accrued Expenses and Other Long-Term Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherLongTermLiabilitiesTables" roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables">
        <link:definition>230993013 - Disclosure - Accrued Expenses and Other Long-Term Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail">
        <link:definition>241004073 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail">
        <link:definition>241014074 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefits" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefits">
        <link:definition>211021014 - Disclosure - Pension and Other Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsTables" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables">
        <link:definition>231033014 - Disclosure - Pension and Other Employee Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail">
        <link:definition>241044075 - Disclosure - Pension and Other Employee Benefits - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail">
        <link:definition>241054076 - Disclosure - Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail">
        <link:definition>241064077 - Disclosure - Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail">
        <link:definition>241074078 - Disclosure - Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail">
        <link:definition>241084079 - Disclosure - Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyStatementofOperationsInformationUnaudited" roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited">
        <link:definition>211091015 - Disclosure - Quarterly Statement of Operations Information (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyStatementofOperationsInformationUnauditedDetail" roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail">
        <link:definition>241104080 - Disclosure - Quarterly Statement of Operations Information (Unaudited) - (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail" roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail">
        <link:definition>241114081 - Disclosure - Quarterly Statement of Operations Information (Unaudited) - (Narrative) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessLicensesMember" abstract="true" name="BusinessLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_TwothousandeighteenMember" abstract="true" name="TwothousandeighteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616" abstract="false" name="DeceasetoprepaidtaxesresultingfromadoptionofASCU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SegmentReportingDisclosureTable" abstract="true" name="SegmentReportingDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" abstract="false" name="DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RestructuringChargesUnderExitOrDisposalPlan" abstract="false" name="RestructuringChargesUnderExitOrDisposalPlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" abstract="false" name="CostOfGoodsSoldImpairmentOfIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax" abstract="false" name="CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" abstract="false" name="LesseeOperatingAndFinanceLeasesExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_OtherGeographicRegionsMember" abstract="true" name="OtherGeographicRegionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AdditionalPurchaseConsideration" abstract="false" name="AdditionalPurchaseConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Jun212016Member" abstract="true" name="Jun212016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DivestitureCharges" abstract="false" name="DivestitureCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ShareRepurchseAuthorizationDateAxis" abstract="true" name="ShareRepurchseAuthorizationDateAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_Repaymentofacquireddebt" abstract="false" name="Repaymentofacquireddebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EmsorMember" abstract="true" name="EmsorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2029SeniorNotesMember" abstract="true" name="A2029SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" abstract="false" name="PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CynosureMember" abstract="true" name="CynosureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_HealthBeaconsMember" abstract="true" name="HealthBeaconsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" abstract="false" name="ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_ASRAuthorized" abstract="false" name="ASRAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_GynSurgicalMember" abstract="true" name="GynSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Debtinstrumentremainingtoberedeemed" abstract="false" name="Debtinstrumentremainingtoberedeemed" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DeferredTaxesReacquisitionofEquityComponent" abstract="false" name="DeferredTaxesReacquisitionofEquityComponent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CapitalizedsoftwareMember" abstract="true" name="CapitalizedsoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" abstract="false" name="MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_ProjectedBenefitObligationForLongTermServiceAwards" abstract="false" name="ProjectedBenefitObligationForLongTermServiceAwards" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions" abstract="false" name="BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RevenueMember" abstract="true" name="RevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" abstract="false" name="PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" abstract="true" name="GeographicInformationForPropertyPlantAndEquipmentLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_AccountsReceivableSecuritizationMember" abstract="true" name="AccountsReceivableSecuritizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Expensesfromdisposition" abstract="false" name="Expensesfromdisposition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2025SeniorNotesMember" abstract="true" name="A2025SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616" abstract="false" name="DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ManufacturingEquipmentAndSoftware" abstract="false" name="ManufacturingEquipmentAndSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_June132019PlanMember" abstract="true" name="June132019PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AmendedCreditFacility2018Member" abstract="true" name="AmendedCreditFacility2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" abstract="false" name="DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" abstract="true" name="DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_NonqualifiedDeferredCompensationPlanAnnualContribution" abstract="false" name="NonqualifiedDeferredCompensationPlanAnnualContribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" abstract="false" name="LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_StateLossCarryforwardExpectedToUnutilize" abstract="false" name="StateLossCarryforwardExpectedToUnutilize" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DebtDiscountReallocatedUponDebtModification" abstract="false" name="DebtDiscountReallocatedUponDebtModification" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmountpaidduringtheperiodunderASRAgreement" abstract="false" name="AmountpaidduringtheperiodunderASRAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" abstract="false" name="MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DeferredTaxAssetsLeaseLiability" abstract="false" name="DeferredTaxAssetsLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" abstract="false" name="AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_CytologyPerinatalMember" abstract="true" name="CytologyPerinatalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" abstract="false" name="WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" abstract="false" name="NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="holx_EmployerContributionsPercentVestedAnnually" abstract="false" name="EmployerContributionsPercentVestedAnnually" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_PercentageOfVestingForStockOptionsGrantedToEmployees" abstract="false" name="PercentageOfVestingForStockOptionsGrantedToEmployees" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_InternalusesoftwareMember" abstract="true" name="InternalusesoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LongLivedAssetsPolicyPolicyTextBlock" abstract="false" name="LongLivedAssetsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_ComprehensiveIncome" abstract="false" name="ComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ShareBasedCompensationPercentageOfForfeitureRate" abstract="false" name="ShareBasedCompensationPercentageOfForfeitureRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_BusinessCombinationAdditionalSharesAcquiredValue" abstract="false" name="BusinessCombinationAdditionalSharesAcquiredValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Fiscal2019chargesMember" abstract="true" name="Fiscal2019chargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InvestmentInGroupLifeInsuranceContracts" abstract="false" name="InvestmentInGroupLifeInsuranceContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_IncreasetoincometaxexpenseadoptionofASU201616" abstract="false" name="IncreasetoincometaxexpenseadoptionofASU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_GrossForeignLossCarryforwards" abstract="false" name="GrossForeignLossCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_Fiscal2020ChargesMember" abstract="true" name="Fiscal2020ChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherTypeofRevenueMember" abstract="true" name="OtherTypeofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" abstract="false" name="MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_CashEquivalentsMaturityPeriod" abstract="false" name="CashEquivalentsMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_TermARSecuritizationProgram" abstract="false" name="TermARSecuritizationProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" abstract="false" name="DebtInstrumentPeriodicPaymentPrincipalPerQuarter" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" abstract="false" name="IncreasetoEarningsperShareresultedfromadoptionofASC201616" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="holx_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" abstract="false" name="DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" abstract="false" name="DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_ProfitSharingFourZeroOneKPlanTextBlock" abstract="false" name="ProfitSharingFourZeroOneKPlanTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_A2012NotesMember" abstract="true" name="A2012NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Impairmentofintangibleassetsandequipment" abstract="false" name="Impairmentofintangibleassetsandequipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616" abstract="false" name="IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccountsReceivableReserveDivested" abstract="false" name="AccountsReceivableReserveDivested" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmortizationOfDeferredFinancingCosts" abstract="false" name="AmortizationOfDeferredFinancingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LitigationAndOtherMattersTextBlock" abstract="false" name="LitigationAndOtherMattersTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_EquityMethodInvestmentAndLoansToAcquiree" abstract="false" name="EquityMethodInvestmentAndLoansToAcquiree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" abstract="false" name="EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_FaxitronMember" abstract="true" name="FaxitronMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" abstract="false" name="RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_CreditAgreement2018Member" abstract="true" name="CreditAgreement2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" abstract="false" name="DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_WarrantyTermForProducts" abstract="false" name="WarrantyTermForProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_CashSeverancePayments" abstract="false" name="CashSeverancePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_PSUFreeCashFlowMember" abstract="true" name="PSUFreeCashFlowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" abstract="false" name="AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_BasePrincipalAmountForAccretionValue" abstract="false" name="BasePrincipalAmountForAccretionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OfferingPriceofPrincipalAmount" abstract="false" name="OfferingPriceofPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_RepaymentofSeniorNotes" abstract="false" name="RepaymentofSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_FinanceLeaseObligationsLongTermMember" abstract="true" name="FinanceLeaseObligationsLongTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PensioninAccumulatedOtherComprehensiveIncomeMember" abstract="true" name="PensioninAccumulatedOtherComprehensiveIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DirectThirdPartyCostsinterestExpense" abstract="false" name="DirectThirdPartyCostsinterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" abstract="false" name="DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_TaxPositionsRelatedToPriorYearsAbstract" abstract="true" name="TaxPositionsRelatedToPriorYearsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" abstract="false" name="NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_A2013NotesMember" abstract="true" name="A2013NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" abstract="false" name="DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherOperatingCostReductionsMember" abstract="true" name="OtherOperatingCostReductionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" abstract="false" name="LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_BusinessCombinationSharesAcquired" abstract="false" name="BusinessCombinationSharesAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_TermLoan2017Member" abstract="true" name="TermLoan2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" abstract="false" name="EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" abstract="false" name="NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TepnelMember" abstract="true" name="TepnelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SemiAnnualEmployeeStockPurchasePlanMember" abstract="true" name="SemiAnnualEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" abstract="false" name="MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_ComponentsofNetPeriodicBenefitCostInterestcost" abstract="false" name="ComponentsofNetPeriodicBenefitCostInterestcost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DeferredTaxLiabilitiesDepreciationAndAmortization" abstract="false" name="DeferredTaxLiabilitiesDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_UnusedCreditFacility" abstract="false" name="UnusedCreditFacility" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LeaseRevenuePercentageOfTotalRevenue" abstract="false" name="LeaseRevenuePercentageOfTotalRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_DebtInstrumentOfferingPricePercentOfFaceValue" abstract="false" name="DebtInstrumentOfferingPricePercentOfFaceValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_EmployerContributionsVestingPeriod" abstract="false" name="EmployerContributionsVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_FocalTherapeuticsInc.Member" abstract="true" name="FocalTherapeuticsInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_ExpectedFutureSeveranceCharges" abstract="false" name="ExpectedFutureSeveranceCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BreastHealthMember" abstract="true" name="BreastHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccruedInterest" abstract="false" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmendedRevolver2018Member" abstract="true" name="AmendedRevolver2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsLineItems" abstract="true" name="ScheduleOfGeographicalSegmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_CompanyVs.MinervaSurgicalInc.Member" abstract="true" name="CompanyVs.MinervaSurgicalInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Fiscal2018ActionMember" abstract="true" name="Fiscal2018ActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccruedIncomeAndOtherTaxes" abstract="false" name="AccruedIncomeAndOtherTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" abstract="false" name="IncreasetoNetIncomeresultedfromadoptionofASU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherAssetsPolicyPolicyTextBlock" abstract="false" name="OtherAssetsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" abstract="false" name="AccountsReceivableAndReservesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" abstract="false" name="PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_Dec112019Member" abstract="true" name="Dec112019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ContingentHoldbackMember" abstract="true" name="ContingentHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LeaseReceivable" abstract="false" name="LeaseReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessAcquisitionCashTenderOfferPricePerShare" abstract="false" name="BusinessAcquisitionCashTenderOfferPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology" abstract="false" name="Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2022SeniorNotesMember" abstract="true" name="A2022SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EquipmentUnderCustomerUsageAgreements" abstract="false" name="EquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Propertyclosurecostpayment" abstract="false" name="Propertyclosurecostpayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Holdback" abstract="false" name="Holdback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PrincipalAmountOfBorrowings" abstract="false" name="PrincipalAmountOfBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" abstract="false" name="OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Fiscal2019ActionMember" abstract="true" name="Fiscal2019ActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_FinanceLeaseObligationsShortTermMember" abstract="true" name="FinanceLeaseObligationsShortTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MaximumRangeofPresentValueofCashFlowPercentage" abstract="false" name="MaximumRangeofPresentValueofCashFlowPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_NetOperatingLossCarryforwardsMember" abstract="true" name="NetOperatingLossCarryforwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MarketBasedStockUnitsMember" abstract="true" name="MarketBasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_GrossStateLossCarryforwards" abstract="false" name="GrossStateLossCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_FacilityClosureCosts" abstract="false" name="FacilityClosureCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LeverageRatioMaximum" abstract="false" name="LeverageRatioMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" abstract="false" name="TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" abstract="false" name="DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_AllOtherCountriesMember" abstract="true" name="AllOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_SecuredTermLoanMember" abstract="true" name="SecuredTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AuthorizationDateDomain" abstract="true" name="AuthorizationDateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BloodScreeningMember" abstract="true" name="BloodScreeningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Fiscal2017ActionsMember" abstract="true" name="Fiscal2017ActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsTable" abstract="true" name="ScheduleOfGeographicalSegmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" abstract="true" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_A2022NotesMember" abstract="true" name="A2022NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" abstract="false" name="PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_LegalAccrual" abstract="false" name="LegalAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" abstract="false" name="CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_A2042NotesMember" abstract="true" name="A2042NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_GeographicInformationForPropertyPlantAndEquipmentTable" abstract="true" name="GeographicInformationForPropertyPlantAndEquipmentTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_SuperSonicImagineMember" abstract="true" name="SuperSonicImagineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_GoodwillNotAtRiskOfFailingImpairment" abstract="false" name="GoodwillNotAtRiskOfFailingImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" abstract="true" name="AmountoflossrecognizedinothercomprehensiveincomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_DeferredTaxLiabilitiesDebtDiscount" abstract="false" name="DeferredTaxLiabilitiesDebtDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MaximumBorrowingUnderSecuritizationProgram" abstract="false" name="MaximumBorrowingUnderSecuritizationProgram" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" abstract="false" name="EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_CostMethodEquityInvestments" abstract="false" name="CostMethodEquityInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EmployeeContributionsVestedPercentage" abstract="false" name="EmployeeContributionsVestedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_AcessaHealthMember" abstract="true" name="AcessaHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" abstract="false" name="LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_BedfordMember" abstract="true" name="BedfordMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" abstract="false" name="ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TaxPositionsRelatedToCurrentYearAbstract" abstract="true" name="TaxPositionsRelatedToCurrentYearAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_InternationalMember" abstract="true" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember" abstract="true" name="FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtInstrumentNumberOfInstruments" abstract="false" name="DebtInstrumentNumberOfInstruments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="holx_CapitalEquipmentComponentsandSoftwareMember" abstract="true" name="CapitalEquipmentComponentsandSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MedicalAestheticsBusinessMember" abstract="true" name="MedicalAestheticsBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" abstract="false" name="DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ProceedsfromSeniorNotes" abstract="false" name="ProceedsfromSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CreditAgreementPriorMember" abstract="true" name="CreditAgreementPriorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InterestRateCapAgreementsAggregatePremiumPayable" abstract="false" name="InterestRateCapAgreementsAggregatePremiumPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccumulatedothercomprehensiveIncomelossHedge" abstract="false" name="AccumulatedothercomprehensiveIncomelossHedge" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ReductionOfWorkforceExpenses" abstract="false" name="ReductionOfWorkforceExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DeferredTaxLiabilitiesRightOfUseAsset" abstract="false" name="DeferredTaxLiabilitiesRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherRestructuringPayments" abstract="false" name="OtherRestructuringPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" abstract="false" name="BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_OtheractionMember" abstract="true" name="OtheractionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_FundingOfLoansToSSI" abstract="false" name="FundingOfLoansToSSI" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BreastImagingMember" abstract="true" name="BreastImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_UKIntangibleassets" abstract="false" name="UKIntangibleassets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AlphaImagingMember" abstract="true" name="AlphaImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InterventionalBreastSolutionsMember" abstract="true" name="InterventionalBreastSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Purchaseobligationthereafter" abstract="false" name="Purchaseobligationthereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Taxpaidoninterestrateswaps" abstract="false" name="Taxpaidoninterestrateswaps" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EquipmentAndSoftwareMember" abstract="true" name="EquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccountingstandardtransitionadjustmentASU201616" abstract="false" name="AccountingstandardtransitionadjustmentASU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationOwnershipPercentage" abstract="false" name="BusinessCombinationOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember" abstract="true" name="FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CreditAgreement2017Member" abstract="true" name="CreditAgreement2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_IndemnificationLiabily" abstract="false" name="IndemnificationLiabily" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DebtIssuanceCostsReallocatedUponDebtModification" abstract="false" name="DebtIssuanceCostsReallocatedUponDebtModification" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TwoThousandSevenNotesMember" abstract="true" name="TwoThousandSevenNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AmendedTermLoan2018Member" abstract="true" name="AmendedTermLoan2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Propertyclosurebenefit" abstract="false" name="Propertyclosurebenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" abstract="false" name="DebtInstrumentPercentageRedemptionPriceSixthPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_GrossUnrecognizedTaxBenefits" abstract="false" name="GrossUnrecognizedTaxBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Purchaseofinsurancecontracts" abstract="false" name="Purchaseofinsurancecontracts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RevolverMember" abstract="true" name="RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccountsReceivableAllowanceReduction" abstract="false" name="AccountsReceivableAllowanceReduction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccountingstandardtransitionadjustmentASC606" abstract="false" name="AccountingstandardtransitionadjustmentASC606" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PaymentOfContingentConsideration" abstract="false" name="PaymentOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CustomerRelationshipsContractsMember" abstract="true" name="CustomerRelationshipsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SkeletalHealthMember" abstract="true" name="SkeletalHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NotionalAmount" abstract="false" name="NotionalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ASRSharesRepurchasedduringtheperiod" abstract="false" name="ASRSharesRepurchasedduringtheperiod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfGoodwillBySegmentTableTextBlock" abstract="false" name="ScheduleOfGoodwillBySegmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_BusinessCombinationAdditionalSharesAcquiredShares" abstract="false" name="BusinessCombinationAdditionalSharesAcquiredShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_TwoThousandSeventeenMember" abstract="true" name="TwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InterestCoverageRatio" abstract="false" name="InterestCoverageRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" abstract="false" name="DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SegmentReportingDisclosureLineItems" abstract="true" name="SegmentReportingDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_DistributionagreementMember" abstract="true" name="DistributionagreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" abstract="false" name="DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MolecularDiagnosticsMember" abstract="true" name="MolecularDiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MakeWholeProvision" abstract="false" name="MakeWholeProvision" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ConvertibleNotesMember" abstract="true" name="ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_TaxCreditCarryforwardMember" abstract="true" name="TaxCreditCarryforwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_UnrecognizedTaxBenefitsIncreasesAbstract" abstract="true" name="UnrecognizedTaxBenefitsIncreasesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_DecreaseindeferredtaxliabilitiesduetoASC201616" abstract="false" name="DecreaseindeferredtaxliabilitiesduetoASC201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AcquiredintangibleassetsMember" abstract="true" name="AcquiredintangibleassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_OneThirdAnnuallyMember" abstract="true" name="OneThirdAnnuallyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_TwoThousandEightEquityPlanMember" abstract="true" name="TwoThousandEightEquityPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RemainingLeaseBalance" abstract="false" name="RemainingLeaseBalance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Revolver2017Member" abstract="true" name="Revolver2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Fiscal2020Member" abstract="true" name="Fiscal2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AcessaMember" abstract="true" name="AcessaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_TransitionServicesAgreementTerm" abstract="false" name="TransitionServicesAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" abstract="false" name="PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_LybertyWayMember" abstract="true" name="LybertyWayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NovemberEighteenTwoThousandTenOriginalNotesMember" abstract="true" name="NovemberEighteenTwoThousandTenOriginalNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EquipmentUnderCustomerUsageAgreementMember" abstract="true" name="EquipmentUnderCustomerUsageAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Fiscal2020ActionMember" abstract="true" name="Fiscal2020ActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NonIncomeTaxLoss" abstract="false" name="NonIncomeTaxLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Purchaseofcostmethodinvestment" abstract="false" name="Purchaseofcostmethodinvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MedicalAestheticsMember" abstract="true" name="MedicalAestheticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PercentageOfRevenues" abstract="false" name="PercentageOfRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" abstract="false" name="PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>holx-20200926_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f4bb5493-eda8-449d-a170-7314862f7798,g:08da96e9-86db-4711-b125-e777b2cffbcd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20200926.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_dbaedc51-0ebb-4ae1-aac8-31e45a349ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_ee5405d1-9218-4923-a547-5fca4dc85bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dbaedc51-0ebb-4ae1-aac8-31e45a349ef0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_ee5405d1-9218-4923-a547-5fca4dc85bbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8364be4e-3602-4972-b86e-b919eead96b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dbaedc51-0ebb-4ae1-aac8-31e45a349ef0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8364be4e-3602-4972-b86e-b919eead96b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_1f877b6c-189c-4395-bdff-7e110a550af1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dbaedc51-0ebb-4ae1-aac8-31e45a349ef0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_1f877b6c-189c-4395-bdff-7e110a550af1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_af53b4b6-ce30-4f62-a968-0e23070d1564" xlink:href="holx-20200926.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dbaedc51-0ebb-4ae1-aac8-31e45a349ef0" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_af53b4b6-ce30-4f62-a968-0e23070d1564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d8e94f06-5c6a-49dc-85f8-9d28a2ac7acb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e0f2370b-549c-4611-88f3-1034d8ed2d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d8e94f06-5c6a-49dc-85f8-9d28a2ac7acb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e0f2370b-549c-4611-88f3-1034d8ed2d2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2229cce1-a8db-469e-a1bd-c952b258668b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d8e94f06-5c6a-49dc-85f8-9d28a2ac7acb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2229cce1-a8db-469e-a1bd-c952b258668b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_469c9f4f-0b94-4f18-980a-edefe9adb5c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c2d34d8f-b6d1-4e74-8b3b-b29d7d53de11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_469c9f4f-0b94-4f18-980a-edefe9adb5c5" xlink:to="loc_us-gaap_GrossProfit_c2d34d8f-b6d1-4e74-8b3b-b29d7d53de11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_67fe0089-2700-43aa-b4b4-26817d7ebcc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_469c9f4f-0b94-4f18-980a-edefe9adb5c5" xlink:to="loc_us-gaap_OperatingExpenses_67fe0089-2700-43aa-b4b4-26817d7ebcc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_479f8fc4-f420-430e-acf2-b2f94ff2b896" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_8827c141-fe83-4142-90b4-b804eb8e17af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_479f8fc4-f420-430e-acf2-b2f94ff2b896" xlink:to="loc_us-gaap_SellingAndMarketingExpense_8827c141-fe83-4142-90b4-b804eb8e17af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_41afdb34-78ab-46f3-a0f9-d60599f58218" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_479f8fc4-f420-430e-acf2-b2f94ff2b896" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_41afdb34-78ab-46f3-a0f9-d60599f58218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f0e2cb42-22fa-4f64-b1ca-2f28e2e5f419" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_479f8fc4-f420-430e-acf2-b2f94ff2b896" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f0e2cb42-22fa-4f64-b1ca-2f28e2e5f419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_dd8c3d8f-9af6-46b6-acfd-54813c391e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_479f8fc4-f420-430e-acf2-b2f94ff2b896" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_dd8c3d8f-9af6-46b6-acfd-54813c391e2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8829857b-9ce9-4134-87cd-4b7d7ebc051c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_479f8fc4-f420-430e-acf2-b2f94ff2b896" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8829857b-9ce9-4134-87cd-4b7d7ebc051c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3ba0eb7f-0664-47bc-bd61-36519b62df11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_479f8fc4-f420-430e-acf2-b2f94ff2b896" xlink:to="loc_us-gaap_RestructuringCharges_3ba0eb7f-0664-47bc-bd61-36519b62df11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fc8e5a56-3a0a-4601-8836-3c97955c7e32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_479f8fc4-f420-430e-acf2-b2f94ff2b896" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fc8e5a56-3a0a-4601-8836-3c97955c7e32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0e9cdbc3-e95a-491c-8e7b-192eadd9c419" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_658a9813-d6dd-4eff-b29b-9128531a89c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0e9cdbc3-e95a-491c-8e7b-192eadd9c419" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_658a9813-d6dd-4eff-b29b-9128531a89c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_56383b4e-ab4f-4924-92c2-a83c7a5c4e73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0e9cdbc3-e95a-491c-8e7b-192eadd9c419" xlink:to="loc_us-gaap_ProfitLoss_56383b4e-ab4f-4924-92c2-a83c7a5c4e73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_820449e4-b735-4f09-b11e-3188669a982c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3a17e0d8-ec65-4437-a799-e1e8f3787375" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_820449e4-b735-4f09-b11e-3188669a982c" xlink:to="loc_us-gaap_OperatingIncomeLoss_3a17e0d8-ec65-4437-a799-e1e8f3787375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_716d56a3-998c-4fc5-8518-384faa11ffe7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_820449e4-b735-4f09-b11e-3188669a982c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_716d56a3-998c-4fc5-8518-384faa11ffe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_bc4128ff-05a4-4ae2-8357-e29546c674bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_820449e4-b735-4f09-b11e-3188669a982c" xlink:to="loc_us-gaap_InterestExpense_bc4128ff-05a4-4ae2-8357-e29546c674bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d6e238f3-5f4c-49aa-9ed9-bc06793ed8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_820449e4-b735-4f09-b11e-3188669a982c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d6e238f3-5f4c-49aa-9ed9-bc06793ed8f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_efc619cc-ad8d-4dbf-90bf-8cfbbbfda2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_820449e4-b735-4f09-b11e-3188669a982c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_efc619cc-ad8d-4dbf-90bf-8cfbbbfda2ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60df3a3d-2493-47ff-b1dc-3c8333b74bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_eb3d7ffc-5c7a-4a11-bb97-7104d0d06cf4" xlink:href="holx-20200926.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60df3a3d-2493-47ff-b1dc-3c8333b74bd0" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_eb3d7ffc-5c7a-4a11-bb97-7104d0d06cf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_ce17ca19-6bc0-415b-b45b-59f7a80f08cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60df3a3d-2493-47ff-b1dc-3c8333b74bd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_ce17ca19-6bc0-415b-b45b-59f7a80f08cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3dbc98ef-314d-4ca3-af5d-e88cf049855c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60df3a3d-2493-47ff-b1dc-3c8333b74bd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3dbc98ef-314d-4ca3-af5d-e88cf049855c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_930f2cea-726f-4f4e-8710-195e8080e2ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60df3a3d-2493-47ff-b1dc-3c8333b74bd0" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_930f2cea-726f-4f4e-8710-195e8080e2ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_33be0cee-dfcd-42a6-bc9e-864aa4e432b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60df3a3d-2493-47ff-b1dc-3c8333b74bd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_33be0cee-dfcd-42a6-bc9e-864aa4e432b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_43ba379c-e59d-443a-8183-796702f915fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_60df3a3d-2493-47ff-b1dc-3c8333b74bd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_43ba379c-e59d-443a-8183-796702f915fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8f912aa5-bb27-4977-9bb1-05dec7b76d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7c562894-1bbe-4cc1-9f2c-795fb4f60a0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8f912aa5-bb27-4977-9bb1-05dec7b76d4f" xlink:to="loc_us-gaap_ProfitLoss_7c562894-1bbe-4cc1-9f2c-795fb4f60a0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3dae23ee-dd04-404e-b957-5c068ab108ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8f912aa5-bb27-4977-9bb1-05dec7b76d4f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3dae23ee-dd04-404e-b957-5c068ab108ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6db881c9-8eee-4178-a8c0-4756ad502551" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a2034ac8-a4be-40b0-a0e8-a1ebd1a81b2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6db881c9-8eee-4178-a8c0-4756ad502551" xlink:to="loc_us-gaap_PreferredStockValue_a2034ac8-a4be-40b0-a0e8-a1ebd1a81b2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f2c05b4e-e10a-4288-8ead-da4056e79b23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6db881c9-8eee-4178-a8c0-4756ad502551" xlink:to="loc_us-gaap_CommonStockValue_f2c05b4e-e10a-4288-8ead-da4056e79b23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_98d4a36c-f5a9-4c9e-912b-61b4903bfb4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6db881c9-8eee-4178-a8c0-4756ad502551" xlink:to="loc_us-gaap_AdditionalPaidInCapital_98d4a36c-f5a9-4c9e-912b-61b4903bfb4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2b0b433b-313b-494a-9882-ece252afd770" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6db881c9-8eee-4178-a8c0-4756ad502551" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2b0b433b-313b-494a-9882-ece252afd770" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_37eadc16-4011-486a-8c01-a091c7a71d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6db881c9-8eee-4178-a8c0-4756ad502551" xlink:to="loc_us-gaap_TreasuryStockValue_37eadc16-4011-486a-8c01-a091c7a71d7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_23eaf6cd-cdf9-4116-831e-532b7ab52864" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6db881c9-8eee-4178-a8c0-4756ad502551" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_23eaf6cd-cdf9-4116-831e-532b7ab52864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_90d28709-7601-4638-8910-d97f0daff436" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_22b34cea-ef9d-4086-b2a7-2485cbb3e2d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90d28709-7601-4638-8910-d97f0daff436" xlink:to="loc_us-gaap_LiabilitiesCurrent_22b34cea-ef9d-4086-b2a7-2485cbb3e2d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8bfbe9c2-2ed9-4725-bc95-8214cdd5940d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90d28709-7601-4638-8910-d97f0daff436" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8bfbe9c2-2ed9-4725-bc95-8214cdd5940d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f1cff692-8def-42c1-8d3d-400c2c91f229" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90d28709-7601-4638-8910-d97f0daff436" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f1cff692-8def-42c1-8d3d-400c2c91f229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_6ab20fe3-0ada-48a5-ba97-f072b4f53759" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90d28709-7601-4638-8910-d97f0daff436" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_6ab20fe3-0ada-48a5-ba97-f072b4f53759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7db755c3-089f-4396-99e1-8c2e23b929f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90d28709-7601-4638-8910-d97f0daff436" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7db755c3-089f-4396-99e1-8c2e23b929f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_64f8c147-1f8e-4002-a290-262f6c1be144" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90d28709-7601-4638-8910-d97f0daff436" xlink:to="loc_us-gaap_CommitmentsAndContingencies_64f8c147-1f8e-4002-a290-262f6c1be144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_027eac24-b845-440a-9946-4ae0044ecdcf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90d28709-7601-4638-8910-d97f0daff436" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_027eac24-b845-440a-9946-4ae0044ecdcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5d426605-8679-4c30-85dc-451d705c681e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90d28709-7601-4638-8910-d97f0daff436" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5d426605-8679-4c30-85dc-451d705c681e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_df7879af-01c7-4c32-b1c3-2b3cdd245d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ebad99bd-81c6-4120-bbd2-d3849483e104" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df7879af-01c7-4c32-b1c3-2b3cdd245d7e" xlink:to="loc_us-gaap_LongTermDebtCurrent_ebad99bd-81c6-4120-bbd2-d3849483e104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_370b209d-6481-4af7-84e9-aa93847bb94a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df7879af-01c7-4c32-b1c3-2b3cdd245d7e" xlink:to="loc_us-gaap_AccountsPayableCurrent_370b209d-6481-4af7-84e9-aa93847bb94a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_df387573-f11b-4957-9cdf-108cbd51b30d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df7879af-01c7-4c32-b1c3-2b3cdd245d7e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_df387573-f11b-4957-9cdf-108cbd51b30d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_656e509c-2428-4450-ba70-584eb0631691" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df7879af-01c7-4c32-b1c3-2b3cdd245d7e" xlink:to="loc_us-gaap_DeferredRevenueCurrent_656e509c-2428-4450-ba70-584eb0631691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_9537b5a3-eb9c-4b20-874e-7a2795ec0e81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df7879af-01c7-4c32-b1c3-2b3cdd245d7e" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_9537b5a3-eb9c-4b20-874e-7a2795ec0e81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_10f712c3-31fa-414a-b27b-0a05e5aa714a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c4211db7-bbf4-4307-ba0c-cb915229fc66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_10f712c3-31fa-414a-b27b-0a05e5aa714a" xlink:to="loc_us-gaap_AssetsCurrent_c4211db7-bbf4-4307-ba0c-cb915229fc66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0c95874a-6384-41e1-9359-72bdc78e72c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_10f712c3-31fa-414a-b27b-0a05e5aa714a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0c95874a-6384-41e1-9359-72bdc78e72c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5cb7f985-121c-4f55-8fb6-44feb78993cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_10f712c3-31fa-414a-b27b-0a05e5aa714a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5cb7f985-121c-4f55-8fb6-44feb78993cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_745cdc71-6aab-4672-a18d-6e0c02170f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_10f712c3-31fa-414a-b27b-0a05e5aa714a" xlink:to="loc_us-gaap_Goodwill_745cdc71-6aab-4672-a18d-6e0c02170f7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_31331161-6cfa-46b5-83a5-d7e1263ca67c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_10f712c3-31fa-414a-b27b-0a05e5aa714a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_31331161-6cfa-46b5-83a5-d7e1263ca67c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fe09e24-51ca-4a36-9947-1516a844b941" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7adb8caf-5fb5-4dbd-abd5-7e775cdcf99d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fe09e24-51ca-4a36-9947-1516a844b941" xlink:to="loc_us-gaap_StockholdersEquity_7adb8caf-5fb5-4dbd-abd5-7e775cdcf99d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_68f0113b-b191-4bc5-b90b-618753df957a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fe09e24-51ca-4a36-9947-1516a844b941" xlink:to="loc_us-gaap_MinorityInterest_68f0113b-b191-4bc5-b90b-618753df957a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9ef8f468-7df0-40ae-8f42-9a22cf3b50f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_490c0cd1-0987-4466-8966-525453c74db2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ef8f468-7df0-40ae-8f42-9a22cf3b50f1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_490c0cd1-0987-4466-8966-525453c74db2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_49ae1806-5642-4949-a17e-9c05fd422f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ef8f468-7df0-40ae-8f42-9a22cf3b50f1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_49ae1806-5642-4949-a17e-9c05fd422f3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3ff9c326-a729-4329-8a42-99fbc970538f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ef8f468-7df0-40ae-8f42-9a22cf3b50f1" xlink:to="loc_us-gaap_InventoryNet_3ff9c326-a729-4329-8a42-99fbc970538f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_bd554ca8-77fd-4dde-9043-f956e2f8e2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ef8f468-7df0-40ae-8f42-9a22cf3b50f1" xlink:to="loc_us-gaap_PrepaidTaxes_bd554ca8-77fd-4dde-9043-f956e2f8e2b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1057b419-8b36-475d-9c4c-8488c946e082" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9ef8f468-7df0-40ae-8f42-9a22cf3b50f1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1057b419-8b36-475d-9c4c-8488c946e082" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_bfb76ccc-4672-41df-9d83-2963f033a24d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_bfb76ccc-4672-41df-9d83-2963f033a24d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_37f5e553-ed6d-40a1-9436-0f242405522b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_37f5e553-ed6d-40a1-9436-0f242405522b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsfromSeniorNotes_26008725-7c10-44ab-915d-2359474aa072" xlink:href="holx-20200926.xsd#holx_ProceedsfromSeniorNotes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_holx_ProceedsfromSeniorNotes_26008725-7c10-44ab-915d-2359474aa072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentofSeniorNotes_8512aef9-d88b-4cb5-8f49-8997242d24ce" xlink:href="holx-20200926.xsd#holx_RepaymentofSeniorNotes"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_holx_RepaymentofSeniorNotes_8512aef9-d88b-4cb5-8f49-8997242d24ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_3570bba0-20a1-4845-a563-69161027e6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_3570bba0-20a1-4845-a563-69161027e6e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Repaymentofacquireddebt_caf0bc82-952c-4f20-88fb-003fad1c41d3" xlink:href="holx-20200926.xsd#holx_Repaymentofacquireddebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_holx_Repaymentofacquireddebt_caf0bc82-952c-4f20-88fb-003fad1c41d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_f101a601-1924-494f-b4c1-6cd6c584c5b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_f101a601-1924-494f-b4c1-6cd6c584c5b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_30110d07-8f2d-4b64-986b-611a07e1c73c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_30110d07-8f2d-4b64-986b-611a07e1c73c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_48840f44-8fbb-41d8-aa27-cdd7dd379c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_48840f44-8fbb-41d8-aa27-cdd7dd379c1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_473b9ef9-c54f-4221-b6bd-b0bf1982e57f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_473b9ef9-c54f-4221-b6bd-b0bf1982e57f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_43e02fb3-7ac2-4f2f-956d-6ccfd64afef8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_43e02fb3-7ac2-4f2f-956d-6ccfd64afef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cefddd1f-16eb-4169-9e9f-c5d59077a936" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cefddd1f-16eb-4169-9e9f-c5d59077a936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1ecee4f1-aef2-4dd4-a4c3-18fee5785a49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1ecee4f1-aef2-4dd4-a4c3-18fee5785a49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_8bc3ae1d-90e3-4f08-aff5-7706c47dfac4" xlink:href="holx-20200926.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_8bc3ae1d-90e3-4f08-aff5-7706c47dfac4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_692a4032-0266-47ad-bc4e-815d136aa387" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_692a4032-0266-47ad-bc4e-815d136aa387" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_4bb5befb-04a9-46a7-a407-36e40cf278aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_4bb5befb-04a9-46a7-a407-36e40cf278aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_192b68c4-b9a6-4a80-a3b6-3612597aa562" xlink:href="holx-20200926.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_192b68c4-b9a6-4a80-a3b6-3612597aa562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_dc2ab718-c6cf-4a8a-b48b-e39d14fa222f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df62dfb5-a6b2-4e2f-a97c-636fea892c14" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_dc2ab718-c6cf-4a8a-b48b-e39d14fa222f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_97586e27-e65b-44de-9fad-972cd97be368" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35eb2d38-a8b3-4678-96e6-f393e6d64261" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_97586e27-e65b-44de-9fad-972cd97be368" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35eb2d38-a8b3-4678-96e6-f393e6d64261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c1b7eb68-7dd0-42e0-9479-4a8816ee3942" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_97586e27-e65b-44de-9fad-972cd97be368" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c1b7eb68-7dd0-42e0-9479-4a8816ee3942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01dbd679-e0c6-4bcd-95e8-7e8d22e86ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_97586e27-e65b-44de-9fad-972cd97be368" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01dbd679-e0c6-4bcd-95e8-7e8d22e86ac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f343e32d-21c0-45b7-bc05-e39a23d05fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_97586e27-e65b-44de-9fad-972cd97be368" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f343e32d-21c0-45b7-bc05-e39a23d05fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_cad037ff-ffc0-4cb4-9c58-c5daeada9210" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_Depreciation_cad037ff-ffc0-4cb4-9c58-c5daeada9210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_0fe319aa-e894-475e-853d-2f4aceb250e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_AdjustmentForAmortization_0fe319aa-e894-475e-853d-2f4aceb250e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e4803a2a-8f07-4518-a0cb-6a5feb11bb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e4803a2a-8f07-4518-a0cb-6a5feb11bb2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_38ad8cbb-5b90-4956-8059-97655c6165eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_ShareBasedCompensation_38ad8cbb-5b90-4956-8059-97655c6165eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6a2742d2-aca1-4697-9bb9-da9657754e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6a2742d2-aca1-4697-9bb9-da9657754e7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dbaf1f46-ab53-44b2-ba59-6d3effa05d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dbaf1f46-ab53-44b2-ba59-6d3effa05d3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_5f0057c8-dcfe-4d4b-8f91-f516921cf410" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_5f0057c8-dcfe-4d4b-8f91-f516921cf410" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7b214898-74ec-407e-b936-912358120271" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7b214898-74ec-407e-b936-912358120271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a2e89f42-363b-4437-8315-c5e2917c4a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a2e89f42-363b-4437-8315-c5e2917c4a5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_7064b7ef-44f0-4c98-bb80-6ee9c7777192" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_7064b7ef-44f0-4c98-bb80-6ee9c7777192" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_969967cc-7049-48bb-b0ee-b5004e405785" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_969967cc-7049-48bb-b0ee-b5004e405785" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a12ea26b-943e-4bb1-a35c-f61f9cb39ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a12ea26b-943e-4bb1-a35c-f61f9cb39ed5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1d974cb1-b74f-463c-9922-8eedeae0a16c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1d974cb1-b74f-463c-9922-8eedeae0a16c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_235c099e-c525-4430-ba1f-a52f725d79b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_235c099e-c525-4430-ba1f-a52f725d79b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ebdbd639-512a-46b7-8606-630fb78e55c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_ProfitLoss_ebdbd639-512a-46b7-8606-630fb78e55c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Impairmentofintangibleassetsandequipment_56190c26-11c5-463c-b161-2f5484530fa1" xlink:href="holx-20200926.xsd#holx_Impairmentofintangibleassetsandequipment"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_holx_Impairmentofintangibleassetsandequipment_56190c26-11c5-463c-b161-2f5484530fa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_06c70f68-7f2e-4750-8e07-11c1f5f6e411" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f27c478-84f8-42c5-adea-525a71e7038c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_06c70f68-7f2e-4750-8e07-11c1f5f6e411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ad2f9521-4284-49a5-a463-3703ec258acc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ad2f9521-4284-49a5-a463-3703ec258acc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b435f2b5-0a20-4331-b325-cf61bd5af1ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b435f2b5-0a20-4331-b325-cf61bd5af1ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_dbffd9a6-e46b-4fef-a008-419e49ff1073" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_dbffd9a6-e46b-4fef-a008-419e49ff1073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FundingOfLoansToSSI_a1a8bf69-28f7-4ce5-ab27-f11ba68c939b" xlink:href="holx-20200926.xsd#holx_FundingOfLoansToSSI"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_holx_FundingOfLoansToSSI_a1a8bf69-28f7-4ce5-ab27-f11ba68c939b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb0e2f0f-532b-4bf4-83e0-98a16f7c12ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb0e2f0f-532b-4bf4-83e0-98a16f7c12ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_26c650e9-3bab-4b25-b52e-3802d63bf8b5" xlink:href="holx-20200926.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_26c650e9-3bab-4b25-b52e-3802d63bf8b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofcostmethodinvestment_8b8a29de-a993-4784-bb84-004cba8b0cfb" xlink:href="holx-20200926.xsd#holx_Purchaseofcostmethodinvestment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_holx_Purchaseofcostmethodinvestment_8b8a29de-a993-4784-bb84-004cba8b0cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_43691c8f-56db-4d7a-9b7e-cd11a63547f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_43691c8f-56db-4d7a-9b7e-cd11a63547f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_67deb0fa-e68e-4862-9590-936d654e51ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_67deb0fa-e68e-4862-9590-936d654e51ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts_51e956d1-4c82-4ea9-8b17-42ca3adbfbfa" xlink:href="holx-20200926.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81159ae5-b734-4b30-aa75-73f38a3695f4" xlink:to="loc_holx_Purchaseofinsurancecontracts_51e956d1-4c82-4ea9-8b17-42ca3adbfbfa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Operations" xlink:type="simple" xlink:href="holx-20200926.xsd#Operations"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Operations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OperationsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#OperationsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OperationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9999d046-3155-417d-9da4-fe21f6a262e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_5cdf104a-a368-4cb9-b4e1-96b24a61ad67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9999d046-3155-417d-9da4-fe21f6a262e7" xlink:to="loc_us-gaap_InventoryRawMaterials_5cdf104a-a368-4cb9-b4e1-96b24a61ad67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_0f4bc020-6afd-457f-a76f-e4b5e01ede7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9999d046-3155-417d-9da4-fe21f6a262e7" xlink:to="loc_us-gaap_InventoryWorkInProcess_0f4bc020-6afd-457f-a76f-e4b5e01ede7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_f48d8b05-d83a-4160-b5f3-984693206690" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9999d046-3155-417d-9da4-fe21f6a262e7" xlink:to="loc_us-gaap_InventoryFinishedGoods_f48d8b05-d83a-4160-b5f3-984693206690" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_602ba26d-f0f8-4c0f-8ec0-88eaa15246fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4b9626fb-7c60-4960-b305-6941cba7caa2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_602ba26d-f0f8-4c0f-8ec0-88eaa15246fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4b9626fb-7c60-4960-b305-6941cba7caa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9533781e-70ac-40b1-b4a4-8ae0fcc97441" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_602ba26d-f0f8-4c0f-8ec0-88eaa15246fc" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9533781e-70ac-40b1-b4a4-8ae0fcc97441" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_cc7f6b6e-ce70-41c1-a0a0-4ef73fa8aeb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_db29c6b8-abff-4fad-a00a-b05e6d62854c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_cc7f6b6e-ce70-41c1-a0a0-4ef73fa8aeb0" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_db29c6b8-abff-4fad-a00a-b05e6d62854c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostMethodEquityInvestments_a8316d8d-b109-4869-85d0-8bd03af5278e" xlink:href="holx-20200926.xsd#holx_CostMethodEquityInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_cc7f6b6e-ce70-41c1-a0a0-4ef73fa8aeb0" xlink:to="loc_holx_CostMethodEquityInvestments_a8316d8d-b109-4869-85d0-8bd03af5278e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c52966e1-fbbd-47af-9eb1-05bd720aba4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_cc7f6b6e-ce70-41c1-a0a0-4ef73fa8aeb0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c52966e1-fbbd-47af-9eb1-05bd720aba4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_da064b2e-d3ad-4520-b1d6-0a2bf9b5bcb5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_cc7f6b6e-ce70-41c1-a0a0-4ef73fa8aeb0" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_da064b2e-d3ad-4520-b1d6-0a2bf9b5bcb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquityMethodInvestmentAndLoansToAcquiree_030a0ef9-0974-4fbf-9008-7303761d0ced" xlink:href="holx-20200926.xsd#holx_EquityMethodInvestmentAndLoansToAcquiree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_cc7f6b6e-ce70-41c1-a0a0-4ef73fa8aeb0" xlink:to="loc_holx_EquityMethodInvestmentAndLoansToAcquiree_030a0ef9-0974-4fbf-9008-7303761d0ced" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_1202947b-1b4b-42d6-8bfa-80d509761f09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_cc7f6b6e-ce70-41c1-a0a0-4ef73fa8aeb0" xlink:to="loc_us-gaap_IncomeTaxReceivable_1202947b-1b4b-42d6-8bfa-80d509761f09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_877de339-1d2d-46b3-8641-b669fcf0a33d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_cc7f6b6e-ce70-41c1-a0a0-4ef73fa8aeb0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_877de339-1d2d-46b3-8641-b669fcf0a33d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e21216d4-cdbc-4bba-b788-9c07c9eae655" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f6b688d8-7226-4a5f-aca3-977cf850d99d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e21216d4-cdbc-4bba-b788-9c07c9eae655" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f6b688d8-7226-4a5f-aca3-977cf850d99d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_70666512-6619-4f6b-8bd2-c7184314ff1a" xlink:href="holx-20200926.xsd#holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e21216d4-cdbc-4bba-b788-9c07c9eae655" xlink:to="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_70666512-6619-4f6b-8bd2-c7184314ff1a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesProductWarrantyDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNotes" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueNotes"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueBusinessRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueGeographicalRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueRevenuebyTypeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueRemainingPerformanceObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueRemainingPerformanceObligationsDetails_1"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20200926.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_5a35ab5f-9648-4b6a-962e-d7c6d76957b3" xlink:href="holx-20200926.xsd#holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_c18c4334-eef7-4cd8-bfc4-4a277cbaa3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_5a35ab5f-9648-4b6a-962e-d7c6d76957b3" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_c18c4334-eef7-4cd8-bfc4-4a277cbaa3f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_9f9c3359-9da7-4751-90e4-2c23e6217960" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_5a35ab5f-9648-4b6a-962e-d7c6d76957b3" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_9f9c3359-9da7-4751-90e4-2c23e6217960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_2d8e7890-cb46-4c45-8d77-cfec223d304b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_5a35ab5f-9648-4b6a-962e-d7c6d76957b3" xlink:to="loc_us-gaap_OperatingLeasePayments_2d8e7890-cb46-4c45-8d77-cfec223d304b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesLeaseLiabilityMaturitySchedule2020Details"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_ab6a25a2-4cd9-4768-8481-7b27eed54b49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e9c873db-5cb1-4109-8ea8-ab41b40a0701" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_ab6a25a2-4cd9-4768-8481-7b27eed54b49" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e9c873db-5cb1-4109-8ea8-ab41b40a0701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4601f583-6098-40dd-bf90-dad8efdd2885" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_ab6a25a2-4cd9-4768-8481-7b27eed54b49" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4601f583-6098-40dd-bf90-dad8efdd2885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a1420c66-ae18-44b9-84a1-84888912df1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_ab6a25a2-4cd9-4768-8481-7b27eed54b49" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a1420c66-ae18-44b9-84a1-84888912df1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e7f25f6a-03e6-452a-8598-40c1df59da7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_ab6a25a2-4cd9-4768-8481-7b27eed54b49" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e7f25f6a-03e6-452a-8598-40c1df59da7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_ffa7b8b4-eac4-4219-8335-3820d5a97c67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_ab6a25a2-4cd9-4768-8481-7b27eed54b49" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_ffa7b8b4-eac4-4219-8335-3820d5a97c67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a0438d85-f8b1-4762-bf74-cbdc735ed084" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_ab6a25a2-4cd9-4768-8481-7b27eed54b49" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a0438d85-f8b1-4762-bf74-cbdc735ed084" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_803c6028-2407-481c-824a-a6b22a42e2b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b68570f6-e466-4cfd-8f40-2c4d5601281b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_803c6028-2407-481c-824a-a6b22a42e2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b68570f6-e466-4cfd-8f40-2c4d5601281b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fef91e2a-7771-47ac-969f-999db8eefe28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_803c6028-2407-481c-824a-a6b22a42e2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fef91e2a-7771-47ac-969f-999db8eefe28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a542053a-bb32-4867-9afd-921cea2c5cef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_803c6028-2407-481c-824a-a6b22a42e2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a542053a-bb32-4867-9afd-921cea2c5cef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4b08e18c-c0dc-4343-b681-ca4b7a78af44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_803c6028-2407-481c-824a-a6b22a42e2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4b08e18c-c0dc-4343-b681-ca4b7a78af44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a1284f15-3b64-4453-9975-a7278662258f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_803c6028-2407-481c-824a-a6b22a42e2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a1284f15-3b64-4453-9975-a7278662258f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c6488e3c-3f33-4bbc-90d1-dad89342bf3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_803c6028-2407-481c-824a-a6b22a42e2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c6488e3c-3f33-4bbc-90d1-dad89342bf3d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesLeaseLiabilityMaturitySchedule2020Details_1"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18eaeff6-ce6a-4e3d-b92c-6700d429261b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8e1476fa-76bf-4d8c-8c1f-4b1249e5caf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18eaeff6-ce6a-4e3d-b92c-6700d429261b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8e1476fa-76bf-4d8c-8c1f-4b1249e5caf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d723cdb3-2509-4229-ab4b-d7538c639272" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18eaeff6-ce6a-4e3d-b92c-6700d429261b" xlink:to="loc_us-gaap_OperatingLeaseLiability_d723cdb3-2509-4229-ab4b-d7538c639272" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6ead0bb0-6092-4526-ba24-0037ecc8c485" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3beb4a0a-d5b4-446c-a713-58e4eb448566" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6ead0bb0-6092-4526-ba24-0037ecc8c485" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3beb4a0a-d5b4-446c-a713-58e4eb448566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_faa50ecc-7fed-44dd-a2f0-3099d24851eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6ead0bb0-6092-4526-ba24-0037ecc8c485" xlink:to="loc_us-gaap_FinanceLeaseLiability_faa50ecc-7fed-44dd-a2f0-3099d24851eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesLeaseLiabilityMaturitySchedule2019Details"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_7583d123-a546-49fc-ae8d-9e46082d22b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears_adcda83d-a142-4f11-ab16-a5d0f69445c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_7583d123-a546-49fc-ae8d-9e46082d22b8" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears_adcda83d-a142-4f11-ab16-a5d0f69445c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears_f52572cc-3aad-4512-b5d5-ef6ad0383051" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_7583d123-a546-49fc-ae8d-9e46082d22b8" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears_f52572cc-3aad-4512-b5d5-ef6ad0383051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter_16a1f5c7-3deb-4533-9723-ba945de5865c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_7583d123-a546-49fc-ae8d-9e46082d22b8" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter_16a1f5c7-3deb-4533-9723-ba945de5865c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent_10a6c012-220f-42ee-9b6a-96bfac9aaf2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_7583d123-a546-49fc-ae8d-9e46082d22b8" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent_10a6c012-220f-42ee-9b6a-96bfac9aaf2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears_a5ee4b2e-4517-420a-b03f-a77e5adae742" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_7583d123-a546-49fc-ae8d-9e46082d22b8" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears_a5ee4b2e-4517-420a-b03f-a77e5adae742" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears_2e7916bf-b891-4975-8a33-3484a5b67bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_7583d123-a546-49fc-ae8d-9e46082d22b8" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears_2e7916bf-b891-4975-8a33-3484a5b67bcb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinations"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationAcessaDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationFaxitronDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#EquityMethodInvestmentDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_a0801f80-c58c-4814-9b6d-649be07db3fd" xlink:href="holx-20200926.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_d06369f8-aac6-43e5-a835-88ec16c505e2" xlink:href="holx-20200926.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_a0801f80-c58c-4814-9b6d-649be07db3fd" xlink:to="loc_holx_ReductionOfWorkforceExpenses_d06369f8-aac6-43e5-a835-88ec16c505e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_1bacce23-035c-4ff8-ba3c-1736417217b9" xlink:href="holx-20200926.xsd#holx_FacilityClosureCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_a0801f80-c58c-4814-9b6d-649be07db3fd" xlink:to="loc_holx_FacilityClosureCosts_1bacce23-035c-4ff8-ba3c-1736417217b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_f6e96ffb-7535-4f7b-a48c-b796e8917afb" xlink:href="holx-20200926.xsd#holx_DivestitureCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_a0801f80-c58c-4814-9b6d-649be07db3fd" xlink:to="loc_holx_DivestitureCharges_f6e96ffb-7535-4f7b-a48c-b796e8917afb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangements"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9cfd9176-23bd-4867-b69c-764e1d108905" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9ec3d7b6-152f-41d2-930a-094594961ad5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_9cfd9176-23bd-4867-b69c-764e1d108905" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9ec3d7b6-152f-41d2-930a-094594961ad5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_166e7085-f168-4504-a0af-71ba94f8c853" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_9cfd9176-23bd-4867-b69c-764e1d108905" xlink:to="loc_us-gaap_LongTermDebtCurrent_166e7085-f168-4504-a0af-71ba94f8c853" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51982383-396f-4da0-8752-bcca41c645c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_aab69293-6e39-430a-80f5-b991a8764feb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51982383-396f-4da0-8752-bcca41c645c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_aab69293-6e39-430a-80f5-b991a8764feb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0adecf1d-50e0-4fef-9787-b9b26445751f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51982383-396f-4da0-8752-bcca41c645c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0adecf1d-50e0-4fef-9787-b9b26445751f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0e54fd26-b33b-409f-b91c-e94d4b10c765" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51982383-396f-4da0-8752-bcca41c645c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0e54fd26-b33b-409f-b91c-e94d4b10c765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e473ed48-474a-4262-8dcf-ef4237a6d0cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51982383-396f-4da0-8752-bcca41c645c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e473ed48-474a-4262-8dcf-ef4237a6d0cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ff32181-56a1-4ac8-bf9b-9bfe2c58ef2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51982383-396f-4da0-8752-bcca41c645c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ff32181-56a1-4ac8-bf9b-9bfe2c58ef2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_bb0592d4-93eb-44ce-97fa-a734fbfff1a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51982383-396f-4da0-8752-bcca41c645c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_bb0592d4-93eb-44ce-97fa-a734fbfff1a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_42cbbe31-6095-4048-8714-4af142b1645b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_3b093b50-9408-4d90-8ad2-63860276a5f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_42cbbe31-6095-4048-8714-4af142b1645b" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_3b093b50-9408-4d90-8ad2-63860276a5f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_e0ad03d2-cd1a-4061-b6d4-c82379e99ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_42cbbe31-6095-4048-8714-4af142b1645b" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_e0ad03d2-cd1a-4061-b6d4-c82379e99ae5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3ccbbeb4-e9c5-409b-9b46-3adfac9fc374" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9d553816-24e9-4168-9da9-b9bbc33b6dc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3ccbbeb4-e9c5-409b-9b46-3adfac9fc374" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9d553816-24e9-4168-9da9-b9bbc33b6dc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e84871d2-90bd-4425-9a39-7db7b5b00e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3ccbbeb4-e9c5-409b-9b46-3adfac9fc374" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e84871d2-90bd-4425-9a39-7db7b5b00e1e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesProvisionforIncomeTaxesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_4c45fe98-2eed-47d9-bcb6-66b1801679d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_cbb4396f-2aec-499d-bf10-dc5475672390" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_4c45fe98-2eed-47d9-bcb6-66b1801679d9" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_cbb4396f-2aec-499d-bf10-dc5475672390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d6859b24-f28b-4e5b-a052-b756346734fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_4c45fe98-2eed-47d9-bcb6-66b1801679d9" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d6859b24-f28b-4e5b-a052-b756346734fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2225bd35-7564-4cb6-86bd-c7a8591472f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_adf8d108-e743-44ca-a727-d0c8e4be482d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2225bd35-7564-4cb6-86bd-c7a8591472f9" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_adf8d108-e743-44ca-a727-d0c8e4be482d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_dafcd50f-6b58-4f3a-b64b-4d0558bba36b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2225bd35-7564-4cb6-86bd-c7a8591472f9" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_dafcd50f-6b58-4f3a-b64b-4d0558bba36b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e5bb47b7-05d7-4e8e-9450-607c85743d28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2225bd35-7564-4cb6-86bd-c7a8591472f9" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e5bb47b7-05d7-4e8e-9450-607c85743d28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_03af1a22-eb76-4f6e-8ca7-e8ce5ba02190" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2225bd35-7564-4cb6-86bd-c7a8591472f9" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_03af1a22-eb76-4f6e-8ca7-e8ce5ba02190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_178df62c-90a2-4d10-85aa-496e3ecaf2db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2225bd35-7564-4cb6-86bd-c7a8591472f9" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_178df62c-90a2-4d10-85aa-496e3ecaf2db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a9b0f0dd-35f2-46f5-bba6-9c1c498be30c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2225bd35-7564-4cb6-86bd-c7a8591472f9" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a9b0f0dd-35f2-46f5-bba6-9c1c498be30c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_ee743ee6-c17e-4aba-97b5-1826a56596e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7a2fc518-98d1-43e9-97e2-6d5c749e7cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_ee743ee6-c17e-4aba-97b5-1826a56596e6" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7a2fc518-98d1-43e9-97e2-6d5c749e7cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_efaa9e53-47cc-43f7-8599-f8b484a3d450" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_ee743ee6-c17e-4aba-97b5-1826a56596e6" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_efaa9e53-47cc-43f7-8599-f8b484a3d450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_4cf23e36-1158-442a-ac37-65abdbf89b27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_05457c8b-a31e-40a4-9861-019c83e87860" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_4cf23e36-1158-442a-ac37-65abdbf89b27" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_05457c8b-a31e-40a4-9861-019c83e87860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5d481ce3-5d48-4347-8f01-402ca5ce68d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_4cf23e36-1158-442a-ac37-65abdbf89b27" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5d481ce3-5d48-4347-8f01-402ca5ce68d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9a05cfeb-19d8-4386-8c0e-27e7cbe672eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9a05cfeb-19d8-4386-8c0e-27e7cbe672eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_f9b66d94-0daf-4422-b178-bc6e6dc8635a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_f9b66d94-0daf-4422-b178-bc6e6dc8635a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_99067d7a-66bf-4f87-a637-951eb649f537" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_99067d7a-66bf-4f87-a637-951eb649f537" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_2bf290d7-7518-490c-aa37-3be4b3c12c39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_2bf290d7-7518-490c-aa37-3be4b3c12c39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_232cd9f2-0fd1-4e34-be99-8631423dd033" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_232cd9f2-0fd1-4e34-be99-8631423dd033" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill_5d2d0d4f-4fbf-4e24-a494-e12eae8bee3b" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill_5d2d0d4f-4fbf-4e24-a494-e12eae8bee3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_eb8fa3ca-8e2e-424a-b648-de260582d613" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_eb8fa3ca-8e2e-424a-b648-de260582d613" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_f93d0cd7-5223-44ac-b079-b5ac83d1f863" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_f93d0cd7-5223-44ac-b079-b5ac83d1f863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_45b5391f-648f-4f61-b802-335060c8c62e" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_45b5391f-648f-4f61-b802-335060c8c62e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_a8e18677-e507-41c6-a2ee-f29f3e85ff52" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_a8e18677-e507-41c6-a2ee-f29f3e85ff52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_77f69c97-5169-4715-b561-03bda315c6ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_77f69c97-5169-4715-b561-03bda315c6ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_ed00d6d1-58fc-4e8b-a4b9-baa8a92092db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_ed00d6d1-58fc-4e8b-a4b9-baa8a92092db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8fcee4c-d73d-4daa-9682-081da1cce933" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8fcee4c-d73d-4daa-9682-081da1cce933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_e235e8ed-4bab-45b0-8c35-a1b82e3962ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_e235e8ed-4bab-45b0-8c35-a1b82e3962ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_1c24d455-8951-4b59-b88e-657e9cf461b5" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e2fbb2-0fcf-4b1f-b967-6f800829a4ef" xlink:to="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_1c24d455-8951-4b59-b88e-657e9cf461b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e89753a6-cde7-4539-96cc-fcce3fe65231" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_7c698079-24da-4ddd-b98d-08b2fa1a5c8b" xlink:href="holx-20200926.xsd#holx_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e89753a6-cde7-4539-96cc-fcce3fe65231" xlink:to="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_7c698079-24da-4ddd-b98d-08b2fa1a5c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesDebtDiscount_aa6e7e1a-c9f2-474b-99c0-c725851a5248" xlink:href="holx-20200926.xsd#holx_DeferredTaxLiabilitiesDebtDiscount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e89753a6-cde7-4539-96cc-fcce3fe65231" xlink:to="loc_holx_DeferredTaxLiabilitiesDebtDiscount_aa6e7e1a-c9f2-474b-99c0-c725851a5248" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset_201a0f1b-8be8-40d8-a8a0-637cd301e683" xlink:href="holx-20200926.xsd#holx_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e89753a6-cde7-4539-96cc-fcce3fe65231" xlink:to="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset_201a0f1b-8be8-40d8-a8a0-637cd301e683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_c1bcc80b-0e16-46bf-9842-52454a611aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_a1ee39e1-4a5d-40c1-82bc-c999d96e016c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_c1bcc80b-0e16-46bf-9842-52454a611aa8" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_a1ee39e1-4a5d-40c1-82bc-c999d96e016c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1723fdec-aa92-4316-bdac-d6fd56e7c8df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_c1bcc80b-0e16-46bf-9842-52454a611aa8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1723fdec-aa92-4316-bdac-d6fd56e7c8df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_76484c4c-2d41-46d9-b527-afe8ea403afc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_76484c4c-2d41-46d9-b527-afe8ea403afc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_17a0528e-31d2-4e84-bb51-69d0c60062bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_17a0528e-31d2-4e84-bb51-69d0c60062bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_eb8674d1-61d9-456b-a0dd-6b6ca52954e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_eb8674d1-61d9-456b-a0dd-6b6ca52954e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_53cd595f-0e97-4952-8ba1-96f43b045bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_53cd595f-0e97-4952-8ba1-96f43b045bf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_5144e01b-70f8-4109-bddb-4da21afb4887" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_5144e01b-70f8-4109-bddb-4da21afb4887" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_fe54e1a4-5e1c-44b9-a154-28a98bc659b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_fe54e1a4-5e1c-44b9-a154-28a98bc659b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_2a1dc1ab-d890-4b92-b782-a546e7709116" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_2a1dc1ab-d890-4b92-b782-a546e7709116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_10d7f1e5-acce-4d10-b057-26a1d6f024cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_10d7f1e5-acce-4d10-b057-26a1d6f024cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UKIntangibleassets_0266cdbc-5f81-4097-a17d-4b4b252539ac" xlink:href="holx-20200926.xsd#holx_UKIntangibleassets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_holx_UKIntangibleassets_0266cdbc-5f81-4097-a17d-4b4b252539ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsLeaseLiability_3f008f0d-861c-4cbe-a584-9959fbb7e8d6" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsLeaseLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a52ad28f-c10c-4c80-aa27-e89d841876db" xlink:to="loc_holx_DeferredTaxAssetsLeaseLiability_3f008f0d-861c-4cbe-a584-9959fbb7e8d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_599d54cc-b43a-421c-ab51-09ea500f47ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_07e5bc4f-684c-4383-a563-6cc2d5f869d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_599d54cc-b43a-421c-ab51-09ea500f47ad" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_07e5bc4f-684c-4383-a563-6cc2d5f869d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_deea379a-3bee-4849-9120-607154af7f10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_599d54cc-b43a-421c-ab51-09ea500f47ad" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_deea379a-3bee-4849-9120-607154af7f10" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/A401kPlan" xlink:type="simple" xlink:href="holx-20200926.xsd#A401kPlan"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/A401kPlan" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#A401kPlanAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#DeferredCompensationPlanAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20200926.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#CommitmentsandContingenciesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_79da2a3f-eaa2-409d-b098-5b8c0ea22be9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_59bd5315-b029-4d1e-a01b-c73efa7f5172" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_79da2a3f-eaa2-409d-b098-5b8c0ea22be9" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_59bd5315-b029-4d1e-a01b-c73efa7f5172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_eb72bac6-af5e-4512-965a-134fb2721e53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_79da2a3f-eaa2-409d-b098-5b8c0ea22be9" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_eb72bac6-af5e-4512-965a-134fb2721e53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_f6832fba-6b57-46c0-978c-1896cec45dea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_79da2a3f-eaa2-409d-b098-5b8c0ea22be9" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_f6832fba-6b57-46c0-978c-1896cec45dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_a1b08952-98f5-49f9-9da9-1d9557f3e361" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_79da2a3f-eaa2-409d-b098-5b8c0ea22be9" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_a1b08952-98f5-49f9-9da9-1d9557f3e361" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_1b3aec22-1b2e-4b4b-bd64-d82eeb845c44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_79da2a3f-eaa2-409d-b098-5b8c0ea22be9" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_1b3aec22-1b2e-4b4b-bd64-d82eeb845c44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseobligationthereafter_4f68ecf9-9470-46c1-aab6-fba71ae6373a" xlink:href="holx-20200926.xsd#holx_Purchaseobligationthereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_79da2a3f-eaa2-409d-b098-5b8c0ea22be9" xlink:to="loc_holx_Purchaseobligationthereafter_4f68ecf9-9470-46c1-aab6-fba71ae6373a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LitigationandRelatedMatters" xlink:type="simple" xlink:href="holx-20200926.xsd#LitigationandRelatedMatters"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LitigationandRelatedMatters" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#LitigationandOtherMattersAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20200926.xsd#Disposition"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionTables" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DispositionTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_23eb580a-7053-41d8-9aae-bc03534703b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_b713a904-b6ff-4c4f-a3f9-a1c5b21b6ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_23eb580a-7053-41d8-9aae-bc03534703b8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_b713a904-b6ff-4c4f-a3f9-a1c5b21b6ebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_4b84470d-f5ae-4eff-acd4-a90ba3a883e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_23eb580a-7053-41d8-9aae-bc03534703b8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_4b84470d-f5ae-4eff-acd4-a90ba3a883e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_8493b1e6-179b-4c61-af5d-cc1cf58c7e8b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_23eb580a-7053-41d8-9aae-bc03534703b8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_8493b1e6-179b-4c61-af5d-cc1cf58c7e8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3b5367ea-8657-49ca-a1d3-e8ec878b8d86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_23eb580a-7053-41d8-9aae-bc03534703b8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3b5367ea-8657-49ca-a1d3-e8ec878b8d86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_7bf5b4b7-56d5-4809-8951-5756fdc12691" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_23eb580a-7053-41d8-9aae-bc03534703b8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_7bf5b4b7-56d5-4809-8951-5756fdc12691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6f22c4a1-536c-48df-8598-9519f0c18c9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_23eb580a-7053-41d8-9aae-bc03534703b8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6f22c4a1-536c-48df-8598-9519f0c18c9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4e2f4749-cc3e-4690-8d70-ef0d387b662c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_23eb580a-7053-41d8-9aae-bc03534703b8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4e2f4749-cc3e-4690-8d70-ef0d387b662c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_824c2924-75cb-47d3-be5d-63c90846efba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_7123e1ed-c565-4ca0-96bb-1509641bb29f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_824c2924-75cb-47d3-be5d-63c90846efba" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_7123e1ed-c565-4ca0-96bb-1509641bb29f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_3880eee5-14a9-4e86-9d57-ce4bd86d24f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_824c2924-75cb-47d3-be5d-63c90846efba" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_3880eee5-14a9-4e86-9d57-ce4bd86d24f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_6e7a5b19-ddaf-46ff-aa6c-db666a61bde6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_824c2924-75cb-47d3-be5d-63c90846efba" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_6e7a5b19-ddaf-46ff-aa6c-db666a61bde6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilities"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0b456341-7f3b-4a42-b79a-67d79469f82f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_b0d683e0-0438-41f1-9262-bedb68198a92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0b456341-7f3b-4a42-b79a-67d79469f82f" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_b0d683e0-0438-41f1-9262-bedb68198a92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedIncomeAndOtherTaxes_5e92e9c9-cdcf-46cd-8928-b09fec798cb2" xlink:href="holx-20200926.xsd#holx_AccruedIncomeAndOtherTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0b456341-7f3b-4a42-b79a-67d79469f82f" xlink:to="loc_holx_AccruedIncomeAndOtherTaxes_5e92e9c9-cdcf-46cd-8928-b09fec798cb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_63ad923b-5ae2-4f57-9088-3b8415dcb505" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0b456341-7f3b-4a42-b79a-67d79469f82f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_63ad923b-5ae2-4f57-9088-3b8415dcb505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_946e287e-141f-4102-8948-1b83d0eda031" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0b456341-7f3b-4a42-b79a-67d79469f82f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_946e287e-141f-4102-8948-1b83d0eda031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedInterest_d8ea60a9-c05f-4d2c-b4a0-7aaedc67e5b1" xlink:href="holx-20200926.xsd#holx_AccruedInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0b456341-7f3b-4a42-b79a-67d79469f82f" xlink:to="loc_holx_AccruedInterest_d8ea60a9-c05f-4d2c-b4a0-7aaedc67e5b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6d80a181-b936-469e-871b-c21f46bcede0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_ee819af3-2d0c-4057-bad8-dc1650873695" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6d80a181-b936-469e-871b-c21f46bcede0" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_ee819af3-2d0c-4057-bad8-dc1650873695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_5b714736-c541-4a39-99dd-f257e5c10010" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6d80a181-b936-469e-871b-c21f46bcede0" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_5b714736-c541-4a39-99dd-f257e5c10010" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_8281878c-5cad-4f22-b6df-d2ca05249e25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6d80a181-b936-469e-871b-c21f46bcede0" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_8281878c-5cad-4f22-b6df-d2ca05249e25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentNoncurrent_b0464f28-aa80-4cc7-a2d8-a8cab0b5c298" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedRentNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6d80a181-b936-469e-871b-c21f46bcede0" xlink:to="loc_us-gaap_AccruedRentNoncurrent_b0464f28-aa80-4cc7-a2d8-a8cab0b5c298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_64ee0d52-f86d-45ae-82cf-1d3e2d9f91ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6d80a181-b936-469e-871b-c21f46bcede0" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_64ee0d52-f86d-45ae-82cf-1d3e2d9f91ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_4104d023-af2d-4601-9209-d346a9747d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6d80a181-b936-469e-871b-c21f46bcede0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_4104d023-af2d-4601-9209-d346a9747d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cedb28a0-8f34-4463-8100-4c8c12a08d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6d80a181-b936-469e-871b-c21f46bcede0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cedb28a0-8f34-4463-8100-4c8c12a08d6e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefits" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefits"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefits" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_2d4568e7-46fd-4352-ba40-c48a5e4f96c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e04293ab-f211-41cb-9dd8-22e63147eef6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_2d4568e7-46fd-4352-ba40-c48a5e4f96c8" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e04293ab-f211-41cb-9dd8-22e63147eef6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c0d368d0-0f46-4c02-90ba-43a23017eda1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_2d4568e7-46fd-4352-ba40-c48a5e4f96c8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c0d368d0-0f46-4c02-90ba-43a23017eda1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4880a1a0-25c1-4abe-8324-bd882cef6d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_93cbcc66-ce95-40a3-8281-8379ecfea29b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4880a1a0-25c1-4abe-8324-bd882cef6d2a" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_93cbcc66-ce95-40a3-8281-8379ecfea29b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost_6546b8cf-1503-4151-ab12-181d99b41b18" xlink:href="holx-20200926.xsd#holx_ComponentsofNetPeriodicBenefitCostInterestcost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4880a1a0-25c1-4abe-8324-bd882cef6d2a" xlink:to="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost_6546b8cf-1503-4151-ab12-181d99b41b18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_611a5939-8248-48f8-96dc-df91737a0490" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4880a1a0-25c1-4abe-8324-bd882cef6d2a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_611a5939-8248-48f8-96dc-df91737a0490" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a6f85344-10ad-4947-ab6e-e0c93ea2d36d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4880a1a0-25c1-4abe-8324-bd882cef6d2a" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a6f85344-10ad-4947-ab6e-e0c93ea2d36d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_0b5b2ea8-d010-49c6-a9aa-6a36ea94b98f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4880a1a0-25c1-4abe-8324-bd882cef6d2a" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_0b5b2ea8-d010-49c6-a9aa-6a36ea94b98f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited" xlink:type="simple" xlink:href="holx-20200926.xsd#QuarterlyStatementofOperationsInformationUnaudited"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#QuarterlyStatementofOperationsInformationUnauditedDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>holx-20200926_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f4bb5493-eda8-449d-a170-7314862f7798,g:08da96e9-86db-4711-b125-e777b2cffbcd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20200926.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended" id="i0b7c5ffa1f5144c4a557c741f95073bc_CoverPage"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended" id="if6272546559345e3a7fdbff7723a9b57_ConsolidatedStatementsofIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6eeef100-6930-409a-9945-ef37690d314e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_RevenuesAbstract_6eeef100-6930-409a-9945-ef37690d314e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_52ea6660-d02a-460b-a01e-d26c42298d58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_6eeef100-6930-409a-9945-ef37690d314e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_52ea6660-d02a-460b-a01e-d26c42298d58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_55e7f84f-16fd-45e4-8724-a13c5da7ebda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_55e7f84f-16fd-45e4-8724-a13c5da7ebda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_4edd962d-172a-4fb4-98b2-d6dff65c74bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_4edd962d-172a-4fb4-98b2-d6dff65c74bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_f0f20764-cade-4b2a-92b3-62e5af28f8d0" xlink:href="holx-20200926.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_f0f20764-cade-4b2a-92b3-62e5af28f8d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b0a4d93d-48cb-45da-a8f8-317f536ed57e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_GrossProfit_b0a4d93d-48cb-45da-a8f8-317f536ed57e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_fba1b65a-2669-418e-b6b9-67ab5f3bc0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_fba1b65a-2669-418e-b6b9-67ab5f3bc0ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_ece72044-f5a5-4d61-85b9-d32a45466a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_SellingAndMarketingExpense_ece72044-f5a5-4d61-85b9-d32a45466a0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_448c5bd6-17ac-4477-94bf-ae5009f3da9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_448c5bd6-17ac-4477-94bf-ae5009f3da9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a08f0ba6-bd98-4364-999e-bc7cebab8357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a08f0ba6-bd98-4364-999e-bc7cebab8357" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1223471d-21e1-4558-864e-5fd1e1419e74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1223471d-21e1-4558-864e-5fd1e1419e74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_96e890f4-0a6f-44cf-ac3a-0c4a57ffafac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_96e890f4-0a6f-44cf-ac3a-0c4a57ffafac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_31f57ba0-17f4-4a4d-895a-2286c36496c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_RestructuringCharges_31f57ba0-17f4-4a4d-895a-2286c36496c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4f188a8a-b02f-45b3-8dfa-3d14cacf23ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_OperatingExpenses_4f188a8a-b02f-45b3-8dfa-3d14cacf23ec" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4b204674-8175-4fbf-bca5-0d112d7a0f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_OperatingIncomeLoss_4b204674-8175-4fbf-bca5-0d112d7a0f9c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5fd7c1b5-8306-4874-84aa-9b59ca26d884" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5fd7c1b5-8306-4874-84aa-9b59ca26d884" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_da049c53-33b8-453b-b662-5ab2455bd1d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_InterestExpense_da049c53-33b8-453b-b662-5ab2455bd1d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_45ddcbc7-8ebf-426e-995e-d7e3aeaf306a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_45ddcbc7-8ebf-426e-995e-d7e3aeaf306a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0b099381-9b4d-44e2-854f-c284c275de2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0b099381-9b4d-44e2-854f-c284c275de2c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_268b3964-4362-4dee-8f52-6e22d9612a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_268b3964-4362-4dee-8f52-6e22d9612a5c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_37e8f305-9bf5-4a94-98a6-25d5761f29ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_37e8f305-9bf5-4a94-98a6-25d5761f29ba" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_535e0023-cc4d-4560-bd3a-1dbac2a641cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_ProfitLoss_535e0023-cc4d-4560-bd3a-1dbac2a641cd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_a8597b93-3d18-4827-9006-f4d749ef753d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_a8597b93-3d18-4827-9006-f4d749ef753d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b6323cb-40b2-4842-b494-83f9d04c55fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_NetIncomeLoss_1b6323cb-40b2-4842-b494-83f9d04c55fc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8e92581d-01e4-43f7-9d29-5796185395cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8e92581d-01e4-43f7-9d29-5796185395cf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_42a4ea63-1ab9-43ff-872d-19affb8fde86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8e92581d-01e4-43f7-9d29-5796185395cf" xlink:to="loc_us-gaap_EarningsPerShareBasic_42a4ea63-1ab9-43ff-872d-19affb8fde86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4a237dea-d3b1-49ff-b876-bf956ed909d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8e92581d-01e4-43f7-9d29-5796185395cf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4a237dea-d3b1-49ff-b876-bf956ed909d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7761d3a7-58a4-4960-a3e1-cb89b7c5471f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7761d3a7-58a4-4960-a3e1-cb89b7c5471f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_450dd8a3-f0db-4369-b75c-bac5977485c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7761d3a7-58a4-4960-a3e1-cb89b7c5471f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_450dd8a3-f0db-4369-b75c-bac5977485c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80526d37-6b5d-4ffa-8ab1-ad394eb0ddd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7761d3a7-58a4-4960-a3e1-cb89b7c5471f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80526d37-6b5d-4ffa-8ab1-ad394eb0ddd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_359e321b-9046-4ec5-8611-fbccd0accf1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_StatementTable_359e321b-9046-4ec5-8611-fbccd0accf1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b4f78db2-c635-4843-80d1-3f60bad6b0b6" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_359e321b-9046-4ec5-8611-fbccd0accf1b" xlink:to="loc_srt_ProductOrServiceAxis_b4f78db2-c635-4843-80d1-3f60bad6b0b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b4f78db2-c635-4843-80d1-3f60bad6b0b6_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b4f78db2-c635-4843-80d1-3f60bad6b0b6" xlink:to="loc_srt_ProductsAndServicesDomain_b4f78db2-c635-4843-80d1-3f60bad6b0b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4d76dbad-e50a-44c9-b96c-247c23007488" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b4f78db2-c635-4843-80d1-3f60bad6b0b6" xlink:to="loc_srt_ProductsAndServicesDomain_4d76dbad-e50a-44c9-b96c-247c23007488" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_6c5b99b6-9a67-437a-b8ce-af02cd1bee96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4d76dbad-e50a-44c9-b96c-247c23007488" xlink:to="loc_us-gaap_ProductMember_6c5b99b6-9a67-437a-b8ce-af02cd1bee96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ba1024a2-e1c5-4353-ba87-8bb503b80361" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4d76dbad-e50a-44c9-b96c-247c23007488" xlink:to="loc_us-gaap_ServiceMember_ba1024a2-e1c5-4353-ba87-8bb503b80361" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="id42bedf54cdd4b1b8a36c8aeaa9be54e_ConsolidatedStatementsofComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6224e636-eba3-420f-8e89-c17851ec74f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_ProfitLoss_6224e636-eba3-420f-8e89-c17851ec74f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_ff58e32e-4100-41d9-a667-3b1dce161e3e" xlink:href="holx-20200926.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_ff58e32e-4100-41d9-a667-3b1dce161e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_28e9f3a2-c194-4961-a3ad-8a5ad4b961f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_28e9f3a2-c194-4961-a3ad-8a5ad4b961f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3476e0f9-bdaa-4731-810a-2ea6baa6b71b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3476e0f9-bdaa-4731-810a-2ea6baa6b71b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_d80115d8-551a-4ab2-9eaf-611d3591f94a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_d80115d8-551a-4ab2-9eaf-611d3591f94a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a4f68792-36d6-4321-b11d-1debaeb62d68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a4f68792-36d6-4321-b11d-1debaeb62d68" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_1c691efe-4330-46fb-bf2e-46772b2f0f48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_1c691efe-4330-46fb-bf2e-46772b2f0f48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fb4b1ffa-4dba-4de0-8160-bd03b67d387b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fb4b1ffa-4dba-4de0-8160-bd03b67d387b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_05299af5-9558-4da0-90d0-db5593b2b87f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_05299af5-9558-4da0-90d0-db5593b2b87f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_c4f124aa-2497-47fa-bbf1-473984e5adae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_c4f124aa-2497-47fa-bbf1-473984e5adae" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_7b39890a-a19e-4d05-bd62-e9ecb0d2d691" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_7b39890a-a19e-4d05-bd62-e9ecb0d2d691" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_f8c2c039-7bd1-4f66-8bf6-ccf2f6f29b19" xlink:href="holx-20200926.xsd#holx_ComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_holx_ComprehensiveIncome_f8c2c039-7bd1-4f66-8bf6-ccf2f6f29b19" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2b8c965a-56d8-401f-8191-d6a59b8693a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_StatementTable_2b8c965a-56d8-401f-8191-d6a59b8693a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_df795111-b1f1-414c-9ff3-265d93388c43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2b8c965a-56d8-401f-8191-d6a59b8693a9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_df795111-b1f1-414c-9ff3-265d93388c43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_df795111-b1f1-414c-9ff3-265d93388c43_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_df795111-b1f1-414c-9ff3-265d93388c43" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_df795111-b1f1-414c-9ff3-265d93388c43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4c4c90e6-2857-43d7-8de0-8ccb7d927063" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_df795111-b1f1-414c-9ff3-265d93388c43" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4c4c90e6-2857-43d7-8de0-8ccb7d927063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_1cfd5d08-a608-4e70-9c2c-311152999809" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4c4c90e6-2857-43d7-8de0-8ccb7d927063" xlink:to="loc_us-gaap_InterestRateCapMember_1cfd5d08-a608-4e70-9c2c-311152999809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e4a0a179-7257-4009-86b8-579d1dcda53c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2b8c965a-56d8-401f-8191-d6a59b8693a9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e4a0a179-7257-4009-86b8-579d1dcda53c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4a0a179-7257-4009-86b8-579d1dcda53c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e4a0a179-7257-4009-86b8-579d1dcda53c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4a0a179-7257-4009-86b8-579d1dcda53c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e3450d2f-70ae-4e22-bff0-9865577cbf80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e4a0a179-7257-4009-86b8-579d1dcda53c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e3450d2f-70ae-4e22-bff0-9865577cbf80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_07074539-d4e5-4876-8c43-db68f3147341" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e3450d2f-70ae-4e22-bff0-9865577cbf80" xlink:to="loc_us-gaap_InterestRateSwapMember_07074539-d4e5-4876-8c43-db68f3147341" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended" id="i2f11de95f2f94bbe93b07c534dc85d2b_ConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i8b0f689a34b34029b58515e11c180422_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="ie8d05bbd4d414b628f35422c8a908a4d_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="iad2bcd2628b34cc1885ec33f506acf9c_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1694f307-4053-4798-9ba8-07109c5f3c6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1694f307-4053-4798-9ba8-07109c5f3c6f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_64963bf3-aca5-477f-99c1-0d081262b1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_SharesIssued_64963bf3-aca5-477f-99c1-0d081262b1d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a80e9ed-2d49-4051-9b19-16377dee8974" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a80e9ed-2d49-4051-9b19-16377dee8974" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASC606_26ecfb59-891c-4942-8d89-c91905bd3ca8" xlink:href="holx-20200926.xsd#holx_AccountingstandardtransitionadjustmentASC606"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_holx_AccountingstandardtransitionadjustmentASC606_26ecfb59-891c-4942-8d89-c91905bd3ca8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASU201616_fae1147c-7f58-4dde-a1cd-ba3b805d4926" xlink:href="holx-20200926.xsd#holx_AccountingstandardtransitionadjustmentASU201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_holx_AccountingstandardtransitionadjustmentASU201616_fae1147c-7f58-4dde-a1cd-ba3b805d4926" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_555711be-e055-4c4c-bc39-c8cfbd4e1a76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_555711be-e055-4c4c-bc39-c8cfbd4e1a76" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4a81a424-fba2-47cc-af6e-c23fc3baeacd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4a81a424-fba2-47cc-af6e-c23fc3baeacd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_43fb2476-0bdd-4ef7-9c78-757be2821d80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_43fb2476-0bdd-4ef7-9c78-757be2821d80" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2ba320d3-0d02-4248-8615-7987363bfd96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2ba320d3-0d02-4248-8615-7987363bfd96" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f3cced9e-210a-46e0-b5f5-b06d78e725e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f3cced9e-210a-46e0-b5f5-b06d78e725e4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_36262a40-defc-4ff2-af12-7966d7a5541a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_36262a40-defc-4ff2-af12-7966d7a5541a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcb6a7b1-c123-4042-a9cd-80ba6ee8d2f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcb6a7b1-c123-4042-a9cd-80ba6ee8d2f1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1ca0ea32-b0a1-4f57-9965-50a94d4c4cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1ca0ea32-b0a1-4f57-9965-50a94d4c4cb9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_dde09d53-237f-44f3-823f-f3099e78fe09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_dde09d53-237f-44f3-823f-f3099e78fe09" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_8ccf8292-1da0-41c8-b8a2-43906add05d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_8ccf8292-1da0-41c8-b8a2-43906add05d1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ea290315-ac05-4418-9eb0-a18a413eb4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ea290315-ac05-4418-9eb0-a18a413eb4e9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_fd57e79e-2207-4f7c-aaa0-921b56994889" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_fd57e79e-2207-4f7c-aaa0-921b56994889" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_4889cec6-1d4b-4424-a1d5-b647639e859e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_4889cec6-1d4b-4424-a1d5-b647639e859e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_c2817c80-4170-4699-ba43-29853b068c46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_c2817c80-4170-4699-ba43-29853b068c46" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_56e52540-9d97-4b9b-9012-96976ba77098" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_56e52540-9d97-4b9b-9012-96976ba77098" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5ed9fa2f-c5d8-4f62-a247-849dacab0e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5ed9fa2f-c5d8-4f62-a247-849dacab0e6c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9e2a39fb-965f-41d6-b0af-9a4e3dc5746b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_ProfitLoss_9e2a39fb-965f-41d6-b0af-9a4e3dc5746b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_03975575-142f-4e9f-a2ba-1989564117aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_03975575-142f-4e9f-a2ba-1989564117aa" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_288be744-cb48-4791-be11-973bd2869b53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_288be744-cb48-4791-be11-973bd2869b53" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_efd6bea8-b57b-4a69-b382-5a713f51dd30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_efd6bea8-b57b-4a69-b382-5a713f51dd30" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_425d968d-0c2b-49d0-a7fa-352ba0090f98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5655b700-69ea-4d3b-a940-3871b72c73aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1694f307-4053-4798-9ba8-07109c5f3c6f" xlink:to="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ba9d4596-0913-4f4d-bd2e-94a6307701b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ba9d4596-0913-4f4d-bd2e-94a6307701b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ba9d4596-0913-4f4d-bd2e-94a6307701b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ba9d4596-0913-4f4d-bd2e-94a6307701b7" xlink:to="loc_us-gaap_EquityComponentDomain_ba9d4596-0913-4f4d-bd2e-94a6307701b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ba9d4596-0913-4f4d-bd2e-94a6307701b7" xlink:to="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c7f7e6cd-43c8-4bb2-8f5d-1207a8edc6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_CommonStockMember_c7f7e6cd-43c8-4bb2-8f5d-1207a8edc6b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f5ea7494-2ef2-4604-8a80-d7fdb6f1c750" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f5ea7494-2ef2-4604-8a80-d7fdb6f1c750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b35fd9d0-f1c7-4d33-9a1b-0ad70481cfbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_RetainedEarningsMember_b35fd9d0-f1c7-4d33-9a1b-0ad70481cfbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b31cd8-7b02-4fc4-820f-0100a32403fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b31cd8-7b02-4fc4-820f-0100a32403fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_b3f0cdad-b592-4c60-ac40-545ea6e927f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_TreasuryStockMember_b3f0cdad-b592-4c60-ac40-545ea6e927f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_79d95fd3-d8e5-47de-851f-7c024676e4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_NoncontrollingInterestMember_79d95fd3-d8e5-47de-851f-7c024676e4e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f17bec48-f3a4-4c10-86e3-ecad40568a46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f17bec48-f3a4-4c10-86e3-ecad40568a46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f17bec48-f3a4-4c10-86e3-ecad40568a46_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f17bec48-f3a4-4c10-86e3-ecad40568a46" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f17bec48-f3a4-4c10-86e3-ecad40568a46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f0519db6-9393-4923-9e8d-7575630c8727" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f17bec48-f3a4-4c10-86e3-ecad40568a46" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f0519db6-9393-4923-9e8d-7575630c8727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_f551d10d-0fa8-4815-ad5b-93db010af8fc" xlink:href="holx-20200926.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f0519db6-9393-4923-9e8d-7575630c8727" xlink:to="loc_holx_ShareRepurchaseProgramMember_f551d10d-0fa8-4815-ad5b-93db010af8fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f8138da0-c848-4055-94ac-e178f3f28162" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f8138da0-c848-4055-94ac-e178f3f28162" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f8138da0-c848-4055-94ac-e178f3f28162_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f8138da0-c848-4055-94ac-e178f3f28162" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f8138da0-c848-4055-94ac-e178f3f28162_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f48c0771-a4d9-4778-8192-01df7a55b017" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f8138da0-c848-4055-94ac-e178f3f28162" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f48c0771-a4d9-4778-8192-01df7a55b017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_d84e166a-b701-42a7-8370-4750a7177dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_f48c0771-a4d9-4778-8192-01df7a55b017" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_d84e166a-b701-42a7-8370-4750a7177dd5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i9c6257141fc343baa002b8c790461055_ConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Operations" xlink:type="simple" xlink:href="holx-20200926.xsd#Operations"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Operations" xlink:type="extended" id="iac9fdbda986b4517821936869ad4d13a_Operations"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OperationsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#OperationsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/OperationsDetails" xlink:type="extended" id="id96f0f99c7d5450fb5aa3976c6f70d0e_OperationsDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="ia460a5b87462400a8b2493577a43dfe3_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i803c9f5b9b2c46e38773e8e2f397970f_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="i0911ce07921047279e6159c1c01b893e_SummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended" id="iadd89f1ddcf74c6199c551d159303ead_SummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:href="holx-20200926.xsd#holx_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7120210d-366a-4e10-8bfe-0f205c340a13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7120210d-366a-4e10-8bfe-0f205c340a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_6f1ffaa1-e579-4b05-9300-22f649d60b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_6f1ffaa1-e579-4b05-9300-22f649d60b5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1fa73fce-fed8-43c0-9961-40269891a183" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1fa73fce-fed8-43c0-9961-40269891a183" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_2d7bdf06-ab06-4d6e-b6cb-698b00243b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_AssetImpairmentCharges_2d7bdf06-ab06-4d6e-b6cb-698b00243b2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_33961b64-8e24-4a10-952a-5c222362addc" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_33961b64-8e24-4a10-952a-5c222362addc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3d23a940-9489-46de-881c-5fdfac4b56da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3d23a940-9489-46de-881c-5fdfac4b56da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashEquivalentsMaturityPeriod_991443ca-1369-4d49-91cc-b749e6f6c463" xlink:href="holx-20200926.xsd#holx_CashEquivalentsMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_CashEquivalentsMaturityPeriod_991443ca-1369-4d49-91cc-b749e6f6c463" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c09edb29-6633-4ece-8489-eda31a3b7edd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c09edb29-6633-4ece-8489-eda31a3b7edd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_7ce43f8a-34ff-4d85-9e57-3d86df386f9f" xlink:href="holx-20200926.xsd#holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_7ce43f8a-34ff-4d85-9e57-3d86df386f9f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_da83e291-3e8d-4239-94af-39c1d3b470aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_da83e291-3e8d-4239-94af-39c1d3b470aa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_1cc450f9-34ff-4b39-80f5-590f6b9e038d" xlink:href="holx-20200926.xsd#holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_1cc450f9-34ff-4b39-80f5-590f6b9e038d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8711a739-913d-420c-af9f-e933668f80a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8711a739-913d-420c-af9f-e933668f80a0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0f480ecd-270f-4a00-8c15-9f1aa32d0c2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0f480ecd-270f-4a00-8c15-9f1aa32d0c2b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d9367730-1340-404b-9e7f-0d6ad3abb46f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d9367730-1340-404b-9e7f-0d6ad3abb46f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_361db683-d303-476b-968d-54ce92f6933e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_Goodwill_361db683-d303-476b-968d-54ce92f6933e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_77e3fc44-3c1c-4939-b8b6-c6e64a46d060" xlink:href="holx-20200926.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_77e3fc44-3c1c-4939-b8b6-c6e64a46d060" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_c63c4025-551a-49fa-a94a-cbf49b337206" xlink:href="holx-20200926.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_PrincipalAmountOfBorrowings_c63c4025-551a-49fa-a94a-cbf49b337206" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_5ff46eec-d7d9-49f9-8b3b-3080b6138212" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_5ff46eec-d7d9-49f9-8b3b-3080b6138212" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_cbf2c2a8-4a91-4d0e-82ef-6d38221aaa1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_cbf2c2a8-4a91-4d0e-82ef-6d38221aaa1d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_efcf35ba-31ef-4cdd-9b4b-397f1d980f03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_DerivativeTermOfContract_efcf35ba-31ef-4cdd-9b4b-397f1d980f03" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_bfe86ed2-a0bf-4807-8952-bb2f481d7e26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_bfe86ed2-a0bf-4807-8952-bb2f481d7e26" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_e25055b2-fdca-4361-81ce-6c2afa4d198c" xlink:href="holx-20200926.xsd#holx_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_NotionalAmount_e25055b2-fdca-4361-81ce-6c2afa4d198c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WarrantyTermForProducts_70333b57-d182-4e38-a754-c3a3508ad92f" xlink:href="holx-20200926.xsd#holx_WarrantyTermForProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_WarrantyTermForProducts_70333b57-d182-4e38-a754-c3a3508ad92f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_5506f05b-c37a-43bf-b1c9-a5f9fc5c24f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_AdvertisingExpense_5506f05b-c37a-43bf-b1c9-a5f9fc5c24f1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bd53c98c-6c0a-4fe3-9af6-e30f311ab95b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bd53c98c-6c0a-4fe3-9af6-e30f311ab95b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3685a5ed-a51e-42ca-870f-61d31acd6c3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3685a5ed-a51e-42ca-870f-61d31acd6c3a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TransitionServicesAgreementTerm_b62a58e8-34cf-4ca8-8631-2efb3434d6c9" xlink:href="holx-20200926.xsd#holx_TransitionServicesAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_TransitionServicesAgreementTerm_b62a58e8-34cf-4ca8-8631-2efb3434d6c9" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_e8f59ea8-e1f0-428e-8854-fa7785d10d93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_e8f59ea8-e1f0-428e-8854-fa7785d10d93" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_1f647a75-4f5c-4d18-9983-e4123e4eb1ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_1f647a75-4f5c-4d18-9983-e4123e4eb1ea" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_0740f9f1-9bba-4d0d-bbad-900e20b7f9df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_0740f9f1-9bba-4d0d-bbad-900e20b7f9df" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:href="holx-20200926.xsd#holx_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8808645-60df-4658-851b-1bf318fcb668" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8808645-60df-4658-851b-1bf318fcb668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d8808645-60df-4658-851b-1bf318fcb668_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8808645-60df-4658-851b-1bf318fcb668" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d8808645-60df-4658-851b-1bf318fcb668_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a33b7762-3629-4084-9482-baf4edf04544" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8808645-60df-4658-851b-1bf318fcb668" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a33b7762-3629-4084-9482-baf4edf04544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_80fce343-b69a-4744-bb82-26cc56f7c598" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a33b7762-3629-4084-9482-baf4edf04544" xlink:to="loc_holx_MedicalAestheticsBusinessMember_80fce343-b69a-4744-bb82-26cc56f7c598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_9b219737-f1e6-4012-b00f-ddd2d353af7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_9b219737-f1e6-4012-b00f-ddd2d353af7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_9b219737-f1e6-4012-b00f-ddd2d353af7d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_9b219737-f1e6-4012-b00f-ddd2d353af7d" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_9b219737-f1e6-4012-b00f-ddd2d353af7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_449f714f-474f-49b7-b513-d94488c652e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_9b219737-f1e6-4012-b00f-ddd2d353af7d" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_449f714f-474f-49b7-b513-d94488c652e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b1dc99cd-6475-4c41-a910-d9a5e2a77ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_449f714f-474f-49b7-b513-d94488c652e1" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b1dc99cd-6475-4c41-a910-d9a5e2a77ec4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_75dbe432-fc5d-4381-90ce-5751ea1921e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_75dbe432-fc5d-4381-90ce-5751ea1921e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_75dbe432-fc5d-4381-90ce-5751ea1921e4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_75dbe432-fc5d-4381-90ce-5751ea1921e4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_75dbe432-fc5d-4381-90ce-5751ea1921e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1adfa3c-bb61-4876-826d-4422eab135ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_75dbe432-fc5d-4381-90ce-5751ea1921e4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1adfa3c-bb61-4876-826d-4422eab135ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ac7687ba-a65e-41f3-913f-d41b877dd3a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1adfa3c-bb61-4876-826d-4422eab135ba" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ac7687ba-a65e-41f3-913f-d41b877dd3a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6c9ac22f-61dc-4c9c-9fb8-7dac89a69357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6c9ac22f-61dc-4c9c-9fb8-7dac89a69357" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6c9ac22f-61dc-4c9c-9fb8-7dac89a69357_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6c9ac22f-61dc-4c9c-9fb8-7dac89a69357" xlink:to="loc_us-gaap_SegmentDomain_6c9ac22f-61dc-4c9c-9fb8-7dac89a69357_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_594987ac-d6c0-4f3e-942c-e3d96bf23031" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6c9ac22f-61dc-4c9c-9fb8-7dac89a69357" xlink:to="loc_us-gaap_SegmentDomain_594987ac-d6c0-4f3e-942c-e3d96bf23031" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_afc5c9dc-e15e-4d9f-99a0-7bbc787dece5" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_594987ac-d6c0-4f3e-942c-e3d96bf23031" xlink:to="loc_holx_MedicalAestheticsMember_afc5c9dc-e15e-4d9f-99a0-7bbc787dece5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b664ce9a-7d28-4315-9eaa-b8ca484e9605" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b664ce9a-7d28-4315-9eaa-b8ca484e9605" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b664ce9a-7d28-4315-9eaa-b8ca484e9605_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b664ce9a-7d28-4315-9eaa-b8ca484e9605" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b664ce9a-7d28-4315-9eaa-b8ca484e9605_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b664ce9a-7d28-4315-9eaa-b8ca484e9605" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_389a554a-9c56-463f-9559-ad3454ec678c" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_FocalTherapeuticsInc.Member_389a554a-9c56-463f-9559-ad3454ec678c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_05bf3dfa-e55b-4bac-81e5-a861157417b3" xlink:href="holx-20200926.xsd#holx_CynosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_CynosureMember_05bf3dfa-e55b-4bac-81e5-a861157417b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmsorMember_079cb765-dad5-48e6-9268-4294ec05135d" xlink:href="holx-20200926.xsd#holx_EmsorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_EmsorMember_079cb765-dad5-48e6-9268-4294ec05135d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_4d5d1899-07cf-4fb2-bed0-3092d49a85eb" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_FaxitronMember_4d5d1899-07cf-4fb2-bed0-3092d49a85eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_33f3505c-3ab2-48fb-9c5e-73c58c174312" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_AcessaHealthMember_33f3505c-3ab2-48fb-9c5e-73c58c174312" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_97dabbc3-23a5-4b52-835f-1d23cd906c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_FinancialInstrumentAxis_97dabbc3-23a5-4b52-835f-1d23cd906c2d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97dabbc3-23a5-4b52-835f-1d23cd906c2d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_97dabbc3-23a5-4b52-835f-1d23cd906c2d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97dabbc3-23a5-4b52-835f-1d23cd906c2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d330eceb-0580-4cf2-a64f-2c25bd18baeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_97dabbc3-23a5-4b52-835f-1d23cd906c2d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d330eceb-0580-4cf2-a64f-2c25bd18baeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c360ecc6-5d3b-470e-9623-c139b44cb519" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d330eceb-0580-4cf2-a64f-2c25bd18baeb" xlink:to="loc_us-gaap_InterestRateCapMember_c360ecc6-5d3b-470e-9623-c139b44cb519" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f8da2ce7-b0d3-4637-aab0-bf5ed2a4fb8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d330eceb-0580-4cf2-a64f-2c25bd18baeb" xlink:to="loc_us-gaap_InterestRateSwapMember_f8da2ce7-b0d3-4637-aab0-bf5ed2a4fb8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3c2c60c2-1bfa-461b-b980-d2f042d709d3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_srt_RangeAxis_3c2c60c2-1bfa-461b-b980-d2f042d709d3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3c2c60c2-1bfa-461b-b980-d2f042d709d3_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3c2c60c2-1bfa-461b-b980-d2f042d709d3" xlink:to="loc_srt_RangeMember_3c2c60c2-1bfa-461b-b980-d2f042d709d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ebdcc926-02cb-4a7b-bd70-e5b50bcc12df" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3c2c60c2-1bfa-461b-b980-d2f042d709d3" xlink:to="loc_srt_RangeMember_ebdcc926-02cb-4a7b-bd70-e5b50bcc12df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6ce97583-f261-466b-9913-63f42bddd7d3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ebdcc926-02cb-4a7b-bd70-e5b50bcc12df" xlink:to="loc_srt_MinimumMember_6ce97583-f261-466b-9913-63f42bddd7d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9203f631-ebca-4a55-aed8-70ae15f69cc4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ebdcc926-02cb-4a7b-bd70-e5b50bcc12df" xlink:to="loc_srt_MaximumMember_9203f631-ebca-4a55-aed8-70ae15f69cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b9cdf22e-0933-45ab-a864-c4d22d5a0057" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b9cdf22e-0933-45ab-a864-c4d22d5a0057" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b9cdf22e-0933-45ab-a864-c4d22d5a0057_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b9cdf22e-0933-45ab-a864-c4d22d5a0057" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b9cdf22e-0933-45ab-a864-c4d22d5a0057_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a22e9080-3ba2-4dfd-99d6-2d002de2dce4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b9cdf22e-0933-45ab-a864-c4d22d5a0057" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a22e9080-3ba2-4dfd-99d6-2d002de2dce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_d7493501-b0f9-4639-9f35-254166f595ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a22e9080-3ba2-4dfd-99d6-2d002de2dce4" xlink:to="loc_us-gaap_AccountsReceivableMember_d7493501-b0f9-4639-9f35-254166f595ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevenueMember_d7b7352d-6614-4acc-85ab-420089ce0ed9" xlink:href="holx-20200926.xsd#holx_RevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a22e9080-3ba2-4dfd-99d6-2d002de2dce4" xlink:to="loc_holx_RevenueMember_d7b7352d-6614-4acc-85ab-420089ce0ed9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_70d0bc04-c970-4e23-abbd-23cb0bbe30d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_70d0bc04-c970-4e23-abbd-23cb0bbe30d4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_70d0bc04-c970-4e23-abbd-23cb0bbe30d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_70d0bc04-c970-4e23-abbd-23cb0bbe30d4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_70d0bc04-c970-4e23-abbd-23cb0bbe30d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_70d0bc04-c970-4e23-abbd-23cb0bbe30d4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_97d636c0-00ae-4156-bc17-3f2b39144545" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_97d636c0-00ae-4156-bc17-3f2b39144545" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember_e1e3fb27-80fe-4737-8153-9f51103243a9" xlink:href="holx-20200926.xsd#holx_DistributionagreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_holx_DistributionagreementMember_e1e3fb27-80fe-4737-8153-9f51103243a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4906408f-626f-43cb-b738-5ab8accf3e55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4906408f-626f-43cb-b738-5ab8accf3e55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ea574b51-de57-4af4-b289-7a8d62769a63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_us-gaap_TradeNamesMember_ea574b51-de57-4af4-b289-7a8d62769a63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_2feff5d2-6825-4f7d-95d1-a8c1f636e24d" xlink:href="holx-20200926.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_holx_DevelopedTechnologyMember_2feff5d2-6825-4f7d-95d1-a8c1f636e24d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_4995ec71-03b6-46c0-ab0c-d3136a8fc1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_4995ec71-03b6-46c0-ab0c-d3136a8fc1e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b825c2a2-b9a6-4f95-af18-208159dcc55b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b825c2a2-b9a6-4f95-af18-208159dcc55b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b825c2a2-b9a6-4f95-af18-208159dcc55b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b825c2a2-b9a6-4f95-af18-208159dcc55b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b825c2a2-b9a6-4f95-af18-208159dcc55b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b825c2a2-b9a6-4f95-af18-208159dcc55b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_de5f5775-a1ec-409d-96cb-6bbdde360635" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:to="loc_us-gaap_TradeNamesMember_de5f5775-a1ec-409d-96cb-6bbdde360635" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_fcb68357-0e99-442c-ab03-e41d98944d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_fcb68357-0e99-442c-ab03-e41d98944d6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_5b11aa17-80dc-4c99-afa7-9a2ac2ab6fda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_5b11aa17-80dc-4c99-afa7-9a2ac2ab6fda" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" xlink:type="extended" id="ic5639340f08c4034b3459765284aaae3_SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="extended" id="ifc9e95088c6f4a5a838cba792a80c1f9_SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="extended" id="i9825753aac184c18b8482a58ad935b73_SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_25ffe9dc-9cca-4461-8206-6cb73140241b" xlink:href="holx-20200926.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_25ffe9dc-9cca-4461-8206-6cb73140241b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_ceca5345-d4d9-4caf-8019-0731e74baeab" xlink:href="holx-20200926.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_ceca5345-d4d9-4caf-8019-0731e74baeab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_fbcc4937-0a65-46db-a829-579fc903704d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_fbcc4937-0a65-46db-a829-579fc903704d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_3c312c6c-329f-4f5e-9bb8-703042ad1ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_3c312c6c-329f-4f5e-9bb8-703042ad1ceb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_925611b1-eae0-4f6c-a3b9-717ea26def59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Land"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_Land_925611b1-eae0-4f6c-a3b9-717ea26def59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_03a49d64-c20d-4ca8-a338-6cfce4637907" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_03a49d64-c20d-4ca8-a338-6cfce4637907" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3bec301b-4fd9-40e7-bdb8-68a10a3d65e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3bec301b-4fd9-40e7-bdb8-68a10a3d65e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_214bc797-6718-4b28-89d7-f90301983081" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_214bc797-6718-4b28-89d7-f90301983081" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6ed059e5-ce50-4f0a-9f54-577815f64252" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6ed059e5-ce50-4f0a-9f54-577815f64252" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5d015212-e4df-461e-a208-798cc80c32a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5d015212-e4df-461e-a208-798cc80c32a1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9704803-e160-4884-8b0e-5cba94a08ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9704803-e160-4884-8b0e-5cba94a08ae5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3851495-acca-4943-9b3c-2cbeba6c4d19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9704803-e160-4884-8b0e-5cba94a08ae5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3851495-acca-4943-9b3c-2cbeba6c4d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d3851495-acca-4943-9b3c-2cbeba6c4d19_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3851495-acca-4943-9b3c-2cbeba6c4d19" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d3851495-acca-4943-9b3c-2cbeba6c4d19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3851495-acca-4943-9b3c-2cbeba6c4d19" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentAndSoftwareMember_8640374d-f884-439c-b1bd-f21ef63032d1" xlink:href="holx-20200926.xsd#holx_EquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:to="loc_holx_EquipmentAndSoftwareMember_8640374d-f884-439c-b1bd-f21ef63032d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreementMember_31c8cdf8-339e-425f-aaf9-f5aa93e9578f" xlink:href="holx-20200926.xsd#holx_EquipmentUnderCustomerUsageAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreementMember_31c8cdf8-339e-425f-aaf9-f5aa93e9578f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_4094d198-3e3f-4e42-a191-39f209c8617a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_4094d198-3e3f-4e42-a191-39f209c8617a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c776a399-e57a-4908-97a6-2c494ac06de9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c776a399-e57a-4908-97a6-2c494ac06de9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ca74f93-1389-4964-bbb5-c638e59e1d5c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9704803-e160-4884-8b0e-5cba94a08ae5" xlink:to="loc_srt_RangeAxis_1ca74f93-1389-4964-bbb5-c638e59e1d5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ca74f93-1389-4964-bbb5-c638e59e1d5c_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1ca74f93-1389-4964-bbb5-c638e59e1d5c" xlink:to="loc_srt_RangeMember_1ca74f93-1389-4964-bbb5-c638e59e1d5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84775ab6-dfa3-435b-bb24-eb457eb48b07" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1ca74f93-1389-4964-bbb5-c638e59e1d5c" xlink:to="loc_srt_RangeMember_84775ab6-dfa3-435b-bb24-eb457eb48b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2d8140e1-344b-458a-a8b3-5918d24dadf8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_84775ab6-dfa3-435b-bb24-eb457eb48b07" xlink:to="loc_srt_MinimumMember_2d8140e1-344b-458a-a8b3-5918d24dadf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dcd04ae5-bad0-416c-8837-9edbc301ef87" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_84775ab6-dfa3-435b-bb24-eb457eb48b07" xlink:to="loc_srt_MaximumMember_dcd04ae5-bad0-416c-8837-9edbc301ef87" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="extended" id="i0e070682851e4746922a9705cf0afcfb_SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_78223d6d-97c7-402a-954b-db41ed6aea27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_78223d6d-97c7-402a-954b-db41ed6aea27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_37485c11-16f7-4c90-bca7-c365279677a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_37485c11-16f7-4c90-bca7-c365279677a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_71625baf-e34b-43f5-966b-6ac50e72fef3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_us-gaap_AssetImpairmentCharges_71625baf-e34b-43f5-966b-6ac50e72fef3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b9609e18-9a2b-48fc-a79b-6936ca9fcbb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b9609e18-9a2b-48fc-a79b-6936ca9fcbb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_52cac4ce-7d78-411b-95cc-fd3e81e89425" xlink:href="holx-20200926.xsd#holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_52cac4ce-7d78-411b-95cc-fd3e81e89425" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4f1acd17-e850-4a8d-bc38-5229f3c8f92c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4f1acd17-e850-4a8d-bc38-5229f3c8f92c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f1acd17-e850-4a8d-bc38-5229f3c8f92c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4f1acd17-e850-4a8d-bc38-5229f3c8f92c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f1acd17-e850-4a8d-bc38-5229f3c8f92c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4202e02e-e3e4-4540-892b-ff2f37d999e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4f1acd17-e850-4a8d-bc38-5229f3c8f92c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4202e02e-e3e4-4540-892b-ff2f37d999e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_3d698ae6-e7a7-4150-96e4-167b38b50fbb" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4202e02e-e3e4-4540-892b-ff2f37d999e9" xlink:to="loc_holx_FocalTherapeuticsInc.Member_3d698ae6-e7a7-4150-96e4-167b38b50fbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_e7e14a49-8a03-4e12-81d1-2bb8352ff144" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4202e02e-e3e4-4540-892b-ff2f37d999e9" xlink:to="loc_holx_AcessaHealthMember_e7e14a49-8a03-4e12-81d1-2bb8352ff144" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5ee94043-d5cc-4b85-9f5c-aedec7f384cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5ee94043-d5cc-4b85-9f5c-aedec7f384cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5ee94043-d5cc-4b85-9f5c-aedec7f384cb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5ee94043-d5cc-4b85-9f5c-aedec7f384cb" xlink:to="loc_us-gaap_SegmentDomain_5ee94043-d5cc-4b85-9f5c-aedec7f384cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4543383d-0fc4-4f0e-bc6d-0affb1c28d64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5ee94043-d5cc-4b85-9f5c-aedec7f384cb" xlink:to="loc_us-gaap_SegmentDomain_4543383d-0fc4-4f0e-bc6d-0affb1c28d64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_10ee6da6-c9ff-4c99-bd50-583ccbbb03df" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4543383d-0fc4-4f0e-bc6d-0affb1c28d64" xlink:to="loc_holx_MedicalAestheticsMember_10ee6da6-c9ff-4c99-bd50-583ccbbb03df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_c4aa67a6-c951-4e6b-855e-22a383739bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_c4aa67a6-c951-4e6b-855e-22a383739bd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c4aa67a6-c951-4e6b-855e-22a383739bd8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_c4aa67a6-c951-4e6b-855e-22a383739bd8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c4aa67a6-c951-4e6b-855e-22a383739bd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_c4aa67a6-c951-4e6b-855e-22a383739bd8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_872dfa67-bc67-4c4a-8f1c-c5a623a9a116" xlink:href="holx-20200926.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:to="loc_holx_DevelopedTechnologyMember_872dfa67-bc67-4c4a-8f1c-c5a623a9a116" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d85355fd-d3b2-4ffb-b486-13cbaf80a816" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d85355fd-d3b2-4ffb-b486-13cbaf80a816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_91ca1926-ebdb-4889-aadf-78d523f9ab3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:to="loc_us-gaap_TradeNamesMember_91ca1926-ebdb-4889-aadf-78d523f9ab3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_464e6838-d475-48d6-8df3-ab9f113bf9fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_464e6838-d475-48d6-8df3-ab9f113bf9fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_15543993-9544-43e3-82da-76d0729a61b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_15543993-9544-43e3-82da-76d0729a61b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_15543993-9544-43e3-82da-76d0729a61b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_15543993-9544-43e3-82da-76d0729a61b7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_15543993-9544-43e3-82da-76d0729a61b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_15543993-9544-43e3-82da-76d0729a61b7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_addbbde2-cb17-4d1a-b760-5b456b6bbf14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_addbbde2-cb17-4d1a-b760-5b456b6bbf14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_aaf79380-b9f1-48ec-8aed-0c9526cc59fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_aaf79380-b9f1-48ec-8aed-0c9526cc59fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_2452b80a-b63e-4ac6-a38c-56d9cbf99ac9" xlink:href="holx-20200926.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_CustomerRelationshipsContractsMember_2452b80a-b63e-4ac6-a38c-56d9cbf99ac9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_35ce0e59-e906-4135-b0fc-ef97fb5e31e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_TradeNamesMember_35ce0e59-e906-4135-b0fc-ef97fb5e31e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_5989b2c5-2cf8-4e94-bd85-0d7b14850410" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_DistributionRightsMember_5989b2c5-2cf8-4e94-bd85-0d7b14850410" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d638b076-4123-4f84-a404-d4220729a705" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d638b076-4123-4f84-a404-d4220729a705" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_ff276b89-3ecc-442a-bab6-3bebd0c76ad1" xlink:href="holx-20200926.xsd#holx_BusinessLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_BusinessLicensesMember_ff276b89-3ecc-442a-bab6-3bebd0c76ad1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_f9b2538d-8d2c-4409-9dfd-82d01c12aad8" xlink:href="holx-20200926.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_AcquiredintangibleassetsMember_f9b2538d-8d2c-4409-9dfd-82d01c12aad8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_7b9fba74-cc62-4d11-8769-3adf4accbeaa" xlink:href="holx-20200926.xsd#holx_InternalusesoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_InternalusesoftwareMember_7b9fba74-cc62-4d11-8769-3adf4accbeaa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_17d2b3de-78a2-4947-8b77-e7f4b0318de3" xlink:href="holx-20200926.xsd#holx_CapitalizedsoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_CapitalizedsoftwareMember_17d2b3de-78a2-4947-8b77-e7f4b0318de3" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="extended" id="i3df67d9a34004a17b225426d1edb710d_SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_faa61c43-42e5-4728-9c5a-5281f4137eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:to="loc_us-gaap_AssetImpairmentCharges_faa61c43-42e5-4728-9c5a-5281f4137eeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d084e251-d319-49fb-8cd7-d1e8d700f410" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d084e251-d319-49fb-8cd7-d1e8d700f410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_389d5bfd-9960-48d8-b147-1ecb40ce2c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_389d5bfd-9960-48d8-b147-1ecb40ce2c1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_33956ae6-72a6-4432-b563-e44260643818" xlink:href="holx-20200926.xsd#holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:to="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_33956ae6-72a6-4432-b563-e44260643818" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b6881827-0fe6-45fa-b71e-7ebff4e36573" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b6881827-0fe6-45fa-b71e-7ebff4e36573" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b6881827-0fe6-45fa-b71e-7ebff4e36573_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b6881827-0fe6-45fa-b71e-7ebff4e36573" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b6881827-0fe6-45fa-b71e-7ebff4e36573_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b6881827-0fe6-45fa-b71e-7ebff4e36573" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember_2b03e819-71d2-42a8-9ad2-dde8df105c78" xlink:href="holx-20200926.xsd#holx_DistributionagreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_holx_DistributionagreementMember_2b03e819-71d2-42a8-9ad2-dde8df105c78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e895bac7-4b83-43cb-a136-ca977f6c640c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e895bac7-4b83-43cb-a136-ca977f6c640c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_acb8aa24-ec21-4193-b527-45af87a9314c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_us-gaap_TradeNamesMember_acb8aa24-ec21-4193-b527-45af87a9314c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_258ff8a6-06df-424a-b2a1-bf3b52dc5ad5" xlink:href="holx-20200926.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_holx_DevelopedTechnologyMember_258ff8a6-06df-424a-b2a1-bf3b52dc5ad5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_632ad5cb-80ba-40aa-9fc2-cfb3f897a46c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_632ad5cb-80ba-40aa-9fc2-cfb3f897a46c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_a58df637-6621-4a47-bd23-4cf3e2be4ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_a58df637-6621-4a47-bd23-4cf3e2be4ac8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_aeb59737-5e74-4914-a7a5-e0937c04d0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_aeb59737-5e74-4914-a7a5-e0937c04d0fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aeb59737-5e74-4914-a7a5-e0937c04d0fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_aeb59737-5e74-4914-a7a5-e0937c04d0fa" xlink:to="loc_us-gaap_SegmentDomain_aeb59737-5e74-4914-a7a5-e0937c04d0fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b1baec1a-6122-4019-b675-f5a7f9938d44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_aeb59737-5e74-4914-a7a5-e0937c04d0fa" xlink:to="loc_us-gaap_SegmentDomain_b1baec1a-6122-4019-b675-f5a7f9938d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_ca445ec7-e979-4709-82e2-0ba9b8bfc564" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b1baec1a-6122-4019-b675-f5a7f9938d44" xlink:to="loc_holx_MedicalAestheticsMember_ca445ec7-e979-4709-82e2-0ba9b8bfc564" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d0acf118-3100-4ea7-8540-829bfeef673c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d0acf118-3100-4ea7-8540-829bfeef673c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0acf118-3100-4ea7-8540-829bfeef673c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d0acf118-3100-4ea7-8540-829bfeef673c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0acf118-3100-4ea7-8540-829bfeef673c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4dc94b0-35de-49a8-8ff4-d4b9e3c7bee5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d0acf118-3100-4ea7-8540-829bfeef673c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4dc94b0-35de-49a8-8ff4-d4b9e3c7bee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_3b0d8ab8-0b2a-417e-8147-9e873ad7c95a" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4dc94b0-35de-49a8-8ff4-d4b9e3c7bee5" xlink:to="loc_holx_AcessaHealthMember_3b0d8ab8-0b2a-417e-8147-9e873ad7c95a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_e44225eb-a2d0-40c1-a8af-8f4d1ce0dcd6" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4dc94b0-35de-49a8-8ff4-d4b9e3c7bee5" xlink:to="loc_holx_FocalTherapeuticsInc.Member_e44225eb-a2d0-40c1-a8af-8f4d1ce0dcd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32a3ebf5-136e-4125-a4ac-1077ed072e5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32a3ebf5-136e-4125-a4ac-1077ed072e5f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32a3ebf5-136e-4125-a4ac-1077ed072e5f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32a3ebf5-136e-4125-a4ac-1077ed072e5f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32a3ebf5-136e-4125-a4ac-1077ed072e5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32a3ebf5-136e-4125-a4ac-1077ed072e5f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a0a7c30d-abfd-4fd0-8828-ce1f808d739d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a0a7c30d-abfd-4fd0-8828-ce1f808d739d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_24eb41fd-6c9d-43a5-8eda-450c80622ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:to="loc_us-gaap_TradeNamesMember_24eb41fd-6c9d-43a5-8eda-450c80622ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1c50a8c2-2ccb-4e6d-bd85-3f1e4162b91a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1c50a8c2-2ccb-4e6d-bd85-3f1e4162b91a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended" id="ic16a7b61b2264224a20772ad3de99515_SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="extended" id="i3e9472cad3d4437c99e12faf59c39a84_SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_986c2d69-ae8a-49c2-9844-098a3d625749" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_986c2d69-ae8a-49c2-9844-098a3d625749" xlink:to="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7ed334cb-a3a3-4896-9a82-e9b64111502f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:to="loc_us-gaap_Goodwill_7ed334cb-a3a3-4896-9a82-e9b64111502f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8f655bd3-df8e-409c-869d-e293c3a79b77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8f655bd3-df8e-409c-869d-e293c3a79b77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_55082499-8231-4fae-92aa-eaccb2e646c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_55082499-8231-4fae-92aa-eaccb2e646c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf9d6ef2-bee7-413b-b064-727a5190e648" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_0d337e57-0388-4c02-ab00-745f61c83cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_986c2d69-ae8a-49c2-9844-098a3d625749" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_0d337e57-0388-4c02-ab00-745f61c83cdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_af6729fa-bcd3-4d81-a7d6-3044fcaa0687" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0d337e57-0388-4c02-ab00-745f61c83cdf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_af6729fa-bcd3-4d81-a7d6-3044fcaa0687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af6729fa-bcd3-4d81-a7d6-3044fcaa0687_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_af6729fa-bcd3-4d81-a7d6-3044fcaa0687" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af6729fa-bcd3-4d81-a7d6-3044fcaa0687_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_af6729fa-bcd3-4d81-a7d6-3044fcaa0687" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_0dd87ec7-2ee0-408f-b794-87099bdc314a" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:to="loc_holx_FaxitronMember_0dd87ec7-2ee0-408f-b794-87099bdc314a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_78756646-a490-4d8c-87b8-5c4731ef7385" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:to="loc_holx_SuperSonicImagineMember_78756646-a490-4d8c-87b8-5c4731ef7385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_6cb515fc-51a6-4d94-9f8e-1de99cef2901" xlink:href="holx-20200926.xsd#holx_HealthBeaconsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:to="loc_holx_HealthBeaconsMember_6cb515fc-51a6-4d94-9f8e-1de99cef2901" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_1d929034-74c6-4370-9a96-209d7e18306d" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:to="loc_holx_AcessaHealthMember_1d929034-74c6-4370-9a96-209d7e18306d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ea2eb3d1-69e6-48c4-98c1-036d979a45d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0d337e57-0388-4c02-ab00-745f61c83cdf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ea2eb3d1-69e6-48c4-98c1-036d979a45d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ea2eb3d1-69e6-48c4-98c1-036d979a45d3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ea2eb3d1-69e6-48c4-98c1-036d979a45d3" xlink:to="loc_us-gaap_SegmentDomain_ea2eb3d1-69e6-48c4-98c1-036d979a45d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ea2eb3d1-69e6-48c4-98c1-036d979a45d3" xlink:to="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_214e3e7a-7081-49c5-b0ea-b32832bebf96" xlink:href="holx-20200926.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:to="loc_holx_DiagnosticsMember_214e3e7a-7081-49c5-b0ea-b32832bebf96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_078d02b7-2b8f-443d-8c4a-fb8db1c69f50" xlink:href="holx-20200926.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:to="loc_holx_BreastHealthMember_078d02b7-2b8f-443d-8c4a-fb8db1c69f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_3828578e-bfd2-43d9-a899-2367eb6563a7" xlink:href="holx-20200926.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:to="loc_holx_GynSurgicalMember_3828578e-bfd2-43d9-a899-2367eb6563a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_d77e6439-dd13-4f4b-875c-7988d9eb9856" xlink:href="holx-20200926.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:to="loc_holx_SkeletalHealthMember_d77e6439-dd13-4f4b-875c-7988d9eb9856" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="extended" id="i796a6e6d6d74446380a3fae50e0391e8_SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_db5acd5c-baac-42ad-9445-b3adf873ccb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_db5acd5c-baac-42ad-9445-b3adf873ccb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_32e8700a-87db-4fba-a69f-58e4db3bd3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:to="loc_us-gaap_Goodwill_32e8700a-87db-4fba-a69f-58e4db3bd3b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1625988f-2676-406a-82db-616997e6e0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1625988f-2676-406a-82db-616997e6e0b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GoodwillNotAtRiskOfFailingImpairment_ed6771b9-9c4a-459e-942f-0a87792aa378" xlink:href="holx-20200926.xsd#holx_GoodwillNotAtRiskOfFailingImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:to="loc_holx_GoodwillNotAtRiskOfFailingImpairment_ed6771b9-9c4a-459e-942f-0a87792aa378" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d53f5392-a434-4502-b3e3-82d18f2aded4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d53f5392-a434-4502-b3e3-82d18f2aded4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ed5439ae-9492-40cf-9548-e772b826d70f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d53f5392-a434-4502-b3e3-82d18f2aded4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ed5439ae-9492-40cf-9548-e772b826d70f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed5439ae-9492-40cf-9548-e772b826d70f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ed5439ae-9492-40cf-9548-e772b826d70f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed5439ae-9492-40cf-9548-e772b826d70f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b69fc7fd-c62a-4635-b8ff-97aafca2f9c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ed5439ae-9492-40cf-9548-e772b826d70f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b69fc7fd-c62a-4635-b8ff-97aafca2f9c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_ea162b38-c86b-408e-80cd-be29ac8c502c" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b69fc7fd-c62a-4635-b8ff-97aafca2f9c4" xlink:to="loc_holx_FocalTherapeuticsInc.Member_ea162b38-c86b-408e-80cd-be29ac8c502c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_ac22ae3b-135e-4c49-abfb-87470889a0fa" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b69fc7fd-c62a-4635-b8ff-97aafca2f9c4" xlink:to="loc_holx_AcessaHealthMember_ac22ae3b-135e-4c49-abfb-87470889a0fa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="extended" id="i0ac34f7ad6e34ddd903b8855209322a4_SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="extended" id="ib8fbef95cc5147d887b261aca79830f6_SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a88aab2c-9c6c-4bba-9570-0e153b51cee7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a88aab2c-9c6c-4bba-9570-0e153b51cee7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_d08932d2-b991-4881-bcb7-1048640efc35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_d08932d2-b991-4881-bcb7-1048640efc35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_5487007d-5f7e-4a85-9620-12c7446c2bb3" xlink:href="holx-20200926.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_5487007d-5f7e-4a85-9620-12c7446c2bb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b1fa972c-62d4-481f-98c7-02858c5e048a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b1fa972c-62d4-481f-98c7-02858c5e048a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_996c870c-7c7b-4877-b320-31f3585b7920" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_996c870c-7c7b-4877-b320-31f3585b7920" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_f77b7347-de14-4b4b-84c4-d2b84e4831ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_f77b7347-de14-4b4b-84c4-d2b84e4831ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c5c04f83-4581-4134-9633-c65078b37af7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c5c04f83-4581-4134-9633-c65078b37af7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_430a3a69-2085-4aaf-8473-71207ccfe766" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_430a3a69-2085-4aaf-8473-71207ccfe766" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_691e383e-00a7-4efe-a4ad-361210786ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_691e383e-00a7-4efe-a4ad-361210786ad8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_8f864836-687c-4324-a385-b96b3d9fc621" xlink:href="holx-20200926.xsd#holx_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_holx_NotionalAmount_8f864836-687c-4324-a385-b96b3d9fc621" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_21d34810-d6b0-47f9-b203-035eead9afa3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_21d34810-d6b0-47f9-b203-035eead9afa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_21d34810-d6b0-47f9-b203-035eead9afa3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21d34810-d6b0-47f9-b203-035eead9afa3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_21d34810-d6b0-47f9-b203-035eead9afa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8ef393e6-d310-474a-b5ef-c81ad04bf7a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21d34810-d6b0-47f9-b203-035eead9afa3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8ef393e6-d310-474a-b5ef-c81ad04bf7a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a47f0d75-ee65-44db-84f4-84b30da556a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a47f0d75-ee65-44db-84f4-84b30da556a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a47f0d75-ee65-44db-84f4-84b30da556a8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a47f0d75-ee65-44db-84f4-84b30da556a8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a47f0d75-ee65-44db-84f4-84b30da556a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89dfbd04-15ed-4f85-a2ab-57643425737b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a47f0d75-ee65-44db-84f4-84b30da556a8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89dfbd04-15ed-4f85-a2ab-57643425737b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e111da4c-85ca-4022-9e13-2436bbccf1e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89dfbd04-15ed-4f85-a2ab-57643425737b" xlink:to="loc_us-gaap_InterestRateSwapMember_e111da4c-85ca-4022-9e13-2436bbccf1e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_dc79d82d-cf67-4a56-b124-b8a1bcae772b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89dfbd04-15ed-4f85-a2ab-57643425737b" xlink:to="loc_us-gaap_InterestRateCapMember_dc79d82d-cf67-4a56-b124-b8a1bcae772b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b7ef945f-abd6-46ba-87b9-8d681943a359" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b7ef945f-abd6-46ba-87b9-8d681943a359" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7ef945f-abd6-46ba-87b9-8d681943a359_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b7ef945f-abd6-46ba-87b9-8d681943a359" xlink:to="loc_us-gaap_EquityComponentDomain_b7ef945f-abd6-46ba-87b9-8d681943a359_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4b5d9916-f5dd-4c8b-87ea-c019886bca61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b7ef945f-abd6-46ba-87b9-8d681943a359" xlink:to="loc_us-gaap_EquityComponentDomain_4b5d9916-f5dd-4c8b-87ea-c019886bca61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_94ac311b-e96a-4b38-aa89-7b04abf2ddd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4b5d9916-f5dd-4c8b-87ea-c019886bca61" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_94ac311b-e96a-4b38-aa89-7b04abf2ddd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_7b42c242-f4ec-4678-ad94-d49c8cfca9b6" xlink:href="holx-20200926.xsd#holx_PensioninAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4b5d9916-f5dd-4c8b-87ea-c019886bca61" xlink:to="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_7b42c242-f4ec-4678-ad94-d49c8cfca9b6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="extended" id="ifed5511add1c4245a6d9b7a0067d1139_SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_baff3b08-af71-4241-93d3-316271786bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_963d692a-21f5-4cf0-825b-d79f48843627" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_baff3b08-af71-4241-93d3-316271786bcd" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_963d692a-21f5-4cf0-825b-d79f48843627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_666b4824-02ed-4415-8f0c-b9467fb68cac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_baff3b08-af71-4241-93d3-316271786bcd" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_666b4824-02ed-4415-8f0c-b9467fb68cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ff8a541b-6406-411e-96e8-c0fc33d0d82b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_baff3b08-af71-4241-93d3-316271786bcd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ff8a541b-6406-411e-96e8-c0fc33d0d82b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c6a0663f-d356-4eaa-b2e0-b88f20b33ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ff8a541b-6406-411e-96e8-c0fc33d0d82b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c6a0663f-d356-4eaa-b2e0-b88f20b33ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c6a0663f-d356-4eaa-b2e0-b88f20b33ba1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c6a0663f-d356-4eaa-b2e0-b88f20b33ba1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c6a0663f-d356-4eaa-b2e0-b88f20b33ba1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6a024b31-fb59-41b1-9ca0-e0af2b247720" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c6a0663f-d356-4eaa-b2e0-b88f20b33ba1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6a024b31-fb59-41b1-9ca0-e0af2b247720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d3edcf15-025c-4ec6-b3b8-ae8fb4e2cdea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6a024b31-fb59-41b1-9ca0-e0af2b247720" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d3edcf15-025c-4ec6-b3b8-ae8fb4e2cdea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_381e1686-9a4a-4060-bb97-c5486bfffdae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6a024b31-fb59-41b1-9ca0-e0af2b247720" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_381e1686-9a4a-4060-bb97-c5486bfffdae" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="extended" id="ib1b66572ad01481b8fb4c4de57ae7f6f_SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0b22985d-31a3-4853-ac22-50b6fceade6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_bc80e4c2-c16d-4ca9-9f61-6a4b1c55df52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0b22985d-31a3-4853-ac22-50b6fceade6e" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_bc80e4c2-c16d-4ca9-9f61-6a4b1c55df52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_cbd91459-844a-4c3d-afe3-949b5aa0bb86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0b22985d-31a3-4853-ac22-50b6fceade6e" xlink:to="loc_us-gaap_DerivativeLiabilities_cbd91459-844a-4c3d-afe3-949b5aa0bb86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0b22985d-31a3-4853-ac22-50b6fceade6e" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ad03544b-851e-4816-8e0f-b8470ae5ba59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ad03544b-851e-4816-8e0f-b8470ae5ba59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad03544b-851e-4816-8e0f-b8470ae5ba59_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ad03544b-851e-4816-8e0f-b8470ae5ba59" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad03544b-851e-4816-8e0f-b8470ae5ba59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dc437339-c781-49ad-8025-378c2f4585b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ad03544b-851e-4816-8e0f-b8470ae5ba59" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dc437339-c781-49ad-8025-378c2f4585b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5825e450-886c-4c37-a689-431783f165dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dc437339-c781-49ad-8025-378c2f4585b3" xlink:to="loc_us-gaap_InterestRateSwapMember_5825e450-886c-4c37-a689-431783f165dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f790977f-a774-4a5c-a007-6ce354ea4c93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f790977f-a774-4a5c-a007-6ce354ea4c93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f790977f-a774-4a5c-a007-6ce354ea4c93_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f790977f-a774-4a5c-a007-6ce354ea4c93" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f790977f-a774-4a5c-a007-6ce354ea4c93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f790977f-a774-4a5c-a007-6ce354ea4c93" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_e973e261-493f-43e3-89ae-9b2a5e81d9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:to="loc_us-gaap_InterestRateCapMember_e973e261-493f-43e3-89ae-9b2a5e81d9fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_86ad4686-f35d-440e-8475-2f19ab967f37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_86ad4686-f35d-440e-8475-2f19ab967f37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_90214d72-fb1a-4fa9-a444-9a89464c7efb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_90214d72-fb1a-4fa9-a444-9a89464c7efb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c8b28a0d-a0e1-41c9-b04f-9565273016e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:to="loc_us-gaap_InterestRateSwapMember_c8b28a0d-a0e1-41c9-b04f-9565273016e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9b40cb7e-97c9-4825-a553-12f0c1e0628d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9b40cb7e-97c9-4825-a553-12f0c1e0628d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b40cb7e-97c9-4825-a553-12f0c1e0628d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9b40cb7e-97c9-4825-a553-12f0c1e0628d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b40cb7e-97c9-4825-a553-12f0c1e0628d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9b40cb7e-97c9-4825-a553-12f0c1e0628d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0b9cde31-4c7a-498e-b82b-c2166323c9a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0b9cde31-4c7a-498e-b82b-c2166323c9a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_5d6c0ef3-6693-42fa-b4e9-dd51e3f0e5d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:to="loc_us-gaap_OtherAssetsMember_5d6c0ef3-6693-42fa-b4e9-dd51e3f0e5d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_68f918c0-eef2-4635-8d0f-779faf294b41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_68f918c0-eef2-4635-8d0f-779faf294b41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_afbe0330-3497-446f-8380-5ff02f7627b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_afbe0330-3497-446f-8380-5ff02f7627b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1f88544d-ded6-4e6b-ba47-17b49d27961d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:to="loc_us-gaap_HedgingDesignationAxis_1f88544d-ded6-4e6b-ba47-17b49d27961d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1f88544d-ded6-4e6b-ba47-17b49d27961d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_1f88544d-ded6-4e6b-ba47-17b49d27961d" xlink:to="loc_us-gaap_HedgingDesignationDomain_1f88544d-ded6-4e6b-ba47-17b49d27961d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bf6f8c6e-844c-4387-ad3c-2530b15c04aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_1f88544d-ded6-4e6b-ba47-17b49d27961d" xlink:to="loc_us-gaap_HedgingDesignationDomain_bf6f8c6e-844c-4387-ad3c-2530b15c04aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_53d29c9a-1fc3-44e9-bb0c-d8eb019de70f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_bf6f8c6e-844c-4387-ad3c-2530b15c04aa" xlink:to="loc_us-gaap_NondesignatedMember_53d29c9a-1fc3-44e9-bb0c-d8eb019de70f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="extended" id="id0675bcaa8cc4ceab95916dc3c71c01e_SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_4c05bab8-d37c-4dd4-85f0-33d687580016" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_4c05bab8-d37c-4dd4-85f0-33d687580016" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e46ae4e8-8996-4b6e-9c17-2c3f303713c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e46ae4e8-8996-4b6e-9c17-2c3f303713c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c5147ded-fd85-410c-8401-ae0c590df643" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c5147ded-fd85-410c-8401-ae0c590df643" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_200b5f0e-e374-4132-88a9-302e1b806236" xlink:href="holx-20200926.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_200b5f0e-e374-4132-88a9-302e1b806236" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f17899a6-ddf1-4cc7-ae2a-5d1fc519fe7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f17899a6-ddf1-4cc7-ae2a-5d1fc519fe7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f17899a6-ddf1-4cc7-ae2a-5d1fc519fe7f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f17899a6-ddf1-4cc7-ae2a-5d1fc519fe7f" xlink:to="loc_us-gaap_EquityComponentDomain_f17899a6-ddf1-4cc7-ae2a-5d1fc519fe7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_33d3ecad-b15d-4103-b2ed-44aeeee47e81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f17899a6-ddf1-4cc7-ae2a-5d1fc519fe7f" xlink:to="loc_us-gaap_EquityComponentDomain_33d3ecad-b15d-4103-b2ed-44aeeee47e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_afd18d3a-d8f2-4ba8-bdf5-d47f8341c56c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_33d3ecad-b15d-4103-b2ed-44aeeee47e81" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_afd18d3a-d8f2-4ba8-bdf5-d47f8341c56c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_23258e75-f842-4962-b1e1-ee816e347455" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_23258e75-f842-4962-b1e1-ee816e347455" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23258e75-f842-4962-b1e1-ee816e347455_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_23258e75-f842-4962-b1e1-ee816e347455" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23258e75-f842-4962-b1e1-ee816e347455_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa24be6-96c4-4caa-a397-bdb0b85330aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_23258e75-f842-4962-b1e1-ee816e347455" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa24be6-96c4-4caa-a397-bdb0b85330aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_efc53921-283e-4cd5-b1c2-1f938c94162f" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa24be6-96c4-4caa-a397-bdb0b85330aa" xlink:to="loc_holx_FocalTherapeuticsInc.Member_efc53921-283e-4cd5-b1c2-1f938c94162f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d5ea7fdc-3932-4d53-8edb-7357c0092b72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d5ea7fdc-3932-4d53-8edb-7357c0092b72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5ea7fdc-3932-4d53-8edb-7357c0092b72_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d5ea7fdc-3932-4d53-8edb-7357c0092b72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5ea7fdc-3932-4d53-8edb-7357c0092b72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d1582a2-2a64-4964-8504-e51e15b7257c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d5ea7fdc-3932-4d53-8edb-7357c0092b72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d1582a2-2a64-4964-8504-e51e15b7257c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_08e8bf0f-7116-4cb3-b309-db29aba9b4cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d1582a2-2a64-4964-8504-e51e15b7257c" xlink:to="loc_us-gaap_TradeNamesMember_08e8bf0f-7116-4cb3-b309-db29aba9b4cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a1d1aec6-5368-4047-80f2-fa8fab21e397" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a1d1aec6-5368-4047-80f2-fa8fab21e397" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1d1aec6-5368-4047-80f2-fa8fab21e397_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1d1aec6-5368-4047-80f2-fa8fab21e397" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1d1aec6-5368-4047-80f2-fa8fab21e397_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b213012-b84b-48d9-b8ea-7d0fd6f21fce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1d1aec6-5368-4047-80f2-fa8fab21e397" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b213012-b84b-48d9-b8ea-7d0fd6f21fce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_efa24279-ecf8-45f2-9ed0-0b8271ba71cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b213012-b84b-48d9-b8ea-7d0fd6f21fce" xlink:to="loc_us-gaap_InterestRateSwapMember_efa24279-ecf8-45f2-9ed0-0b8271ba71cc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="extended" id="ifa0307cbd34747e6bf10ad7ede0a162d_SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_75393afc-9b44-447f-9f78-9b9cb4da8a88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_09a13d74-0abb-4063-ad58-dd92a14b871d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75393afc-9b44-447f-9f78-9b9cb4da8a88" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_09a13d74-0abb-4063-ad58-dd92a14b871d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_bc7c3e12-e525-474c-bf32-e35bfe9c6107" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_75393afc-9b44-447f-9f78-9b9cb4da8a88" xlink:to="loc_us-gaap_DerivativeTable_bc7c3e12-e525-474c-bf32-e35bfe9c6107" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b40ed29d-fccf-4560-be03-59e3284508ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_bc7c3e12-e525-474c-bf32-e35bfe9c6107" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b40ed29d-fccf-4560-be03-59e3284508ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b40ed29d-fccf-4560-be03-59e3284508ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b40ed29d-fccf-4560-be03-59e3284508ac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b40ed29d-fccf-4560-be03-59e3284508ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2c4f2a26-efe0-41b0-b85e-407f8ef84303" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b40ed29d-fccf-4560-be03-59e3284508ac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2c4f2a26-efe0-41b0-b85e-407f8ef84303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c6bf1446-06e0-4a72-b2ba-367f29b26546" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2c4f2a26-efe0-41b0-b85e-407f8ef84303" xlink:to="loc_us-gaap_InterestRateCapMember_c6bf1446-06e0-4a72-b2ba-367f29b26546" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ea680788-3697-49a3-a2e4-761adb1b2f77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2c4f2a26-efe0-41b0-b85e-407f8ef84303" xlink:to="loc_us-gaap_InterestRateSwapMember_ea680788-3697-49a3-a2e4-761adb1b2f77" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="extended" id="i87a26e19009643b7b7a6e98081fe33ad_SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e54dd441-5a4c-4797-a4d6-d8439aa3d2ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_d510ad05-f913-4208-bd4a-52da74917d07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e54dd441-5a4c-4797-a4d6-d8439aa3d2ec" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_d510ad05-f913-4208-bd4a-52da74917d07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f8159bd4-dc87-4543-b40f-ac31eed18dde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e54dd441-5a4c-4797-a4d6-d8439aa3d2ec" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f8159bd4-dc87-4543-b40f-ac31eed18dde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0468b1ff-4cff-4768-a700-4cba5e592a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f8159bd4-dc87-4543-b40f-ac31eed18dde" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0468b1ff-4cff-4768-a700-4cba5e592a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0468b1ff-4cff-4768-a700-4cba5e592a7f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0468b1ff-4cff-4768-a700-4cba5e592a7f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0468b1ff-4cff-4768-a700-4cba5e592a7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9e2bcdd1-ada2-4147-812a-da250e122225" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0468b1ff-4cff-4768-a700-4cba5e592a7f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9e2bcdd1-ada2-4147-812a-da250e122225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ffbd04c1-787d-4a25-94c2-625c1d31a33f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9e2bcdd1-ada2-4147-812a-da250e122225" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ffbd04c1-787d-4a25-94c2-625c1d31a33f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_a96667f8-04dd-4d44-be25-d8d6b29ca7ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9e2bcdd1-ada2-4147-812a-da250e122225" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_a96667f8-04dd-4d44-be25-d8d6b29ca7ab" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" xlink:type="extended" id="i16354a0e06ee420994bbb7ce37bfb2df_SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended" id="i8e97258e42fb4b8f94f8548bce8f6281_SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:href="holx-20200926.xsd#holx_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf9a0f0c-0c57-482c-abaf-b31491f124f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf9a0f0c-0c57-482c-abaf-b31491f124f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_32b38473-fc60-4177-8ff3-3c1267361894" xlink:href="holx-20200926.xsd#holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:to="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_32b38473-fc60-4177-8ff3-3c1267361894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ebc472c4-f775-4592-ab88-a18c202c924d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ebc472c4-f775-4592-ab88-a18c202c924d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_fecf4729-1a65-4661-a665-f84cc43c5e96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_fecf4729-1a65-4661-a665-f84cc43c5e96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_47610952-c03c-4808-8f89-e66e72db1b71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_fecf4729-1a65-4661-a665-f84cc43c5e96" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_47610952-c03c-4808-8f89-e66e72db1b71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_0fe89e1f-28b1-4b58-9966-7b5967c65899" xlink:href="holx-20200926.xsd#holx_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:to="loc_holx_EarningsPerShareTable_0fe89e1f-28b1-4b58-9966-7b5967c65899" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6570b2fa-4fb9-4475-a2d2-ea16bcfcc4cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_EarningsPerShareTable_0fe89e1f-28b1-4b58-9966-7b5967c65899" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6570b2fa-4fb9-4475-a2d2-ea16bcfcc4cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6570b2fa-4fb9-4475-a2d2-ea16bcfcc4cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6570b2fa-4fb9-4475-a2d2-ea16bcfcc4cf" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6570b2fa-4fb9-4475-a2d2-ea16bcfcc4cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b340582e-9c4c-426d-93f6-fd35694740bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6570b2fa-4fb9-4475-a2d2-ea16bcfcc4cf" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b340582e-9c4c-426d-93f6-fd35694740bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_5aaecfdf-c8dd-4d06-a199-b30971f624b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b340582e-9c4c-426d-93f6-fd35694740bc" xlink:to="loc_us-gaap_StockCompensationPlanMember_5aaecfdf-c8dd-4d06-a199-b30971f624b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConvertibleNotesMember_8046d265-4b57-469e-a054-7d3890e5f0f4" xlink:href="holx-20200926.xsd#holx_ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b340582e-9c4c-426d-93f6-fd35694740bc" xlink:to="loc_holx_ConvertibleNotesMember_8046d265-4b57-469e-a054-7d3890e5f0f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesProductWarrantyDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail" xlink:type="extended" id="i2d1b95d7d7b246718dfc44e90b697f17_SummaryofSignificantAccountingPoliciesProductWarrantyDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNotes" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueNotes"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueNotes" xlink:type="extended" id="i8a5dc6b7a3f641faa06f080419a8b313_RevenueNotes"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended" id="ifc6b52b4106f4649af1fadee5aaa5bc9_RevenueTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended" id="i0ba639b799ee416e8c0889c0c7aa437b_RevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_904ca97a-2a52-4d87-b463-9103b6cef3e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_904ca97a-2a52-4d87-b463-9103b6cef3e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax_37e303fb-a159-4d3e-808e-f80fd4018078" xlink:href="holx-20200926.xsd#holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:to="loc_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax_37e303fb-a159-4d3e-808e-f80fd4018078" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ca050517-e1ac-466f-a190-0bd3bba52fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ca050517-e1ac-466f-a190-0bd3bba52fc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_9a44d2c7-a721-488f-ae21-1500f1b8d268" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_9a44d2c7-a721-488f-ae21-1500f1b8d268" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac43eed7-b92e-4506-afe6-56304d952a80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac43eed7-b92e-4506-afe6-56304d952a80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4b993eca-bb9c-461b-ad61-64c9e43e754d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac43eed7-b92e-4506-afe6-56304d952a80" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4b993eca-bb9c-461b-ad61-64c9e43e754d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4b993eca-bb9c-461b-ad61-64c9e43e754d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4b993eca-bb9c-461b-ad61-64c9e43e754d" xlink:to="loc_us-gaap_EquityComponentDomain_4b993eca-bb9c-461b-ad61-64c9e43e754d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_493e4722-a98c-4a1f-8b62-1373527c2f43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4b993eca-bb9c-461b-ad61-64c9e43e754d" xlink:to="loc_us-gaap_EquityComponentDomain_493e4722-a98c-4a1f-8b62-1373527c2f43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1c31d25e-1239-43f2-bbee-bd07e0918d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_493e4722-a98c-4a1f-8b62-1373527c2f43" xlink:to="loc_us-gaap_RetainedEarningsMember_1c31d25e-1239-43f2-bbee-bd07e0918d1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_82acd79f-a53d-4630-8c5f-cf9ac306359a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac43eed7-b92e-4506-afe6-56304d952a80" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_82acd79f-a53d-4630-8c5f-cf9ac306359a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_82acd79f-a53d-4630-8c5f-cf9ac306359a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_82acd79f-a53d-4630-8c5f-cf9ac306359a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_82acd79f-a53d-4630-8c5f-cf9ac306359a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8911a794-593b-43a4-9ad9-944e1629d3c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_82acd79f-a53d-4630-8c5f-cf9ac306359a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8911a794-593b-43a4-9ad9-944e1629d3c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_1a88ec58-075a-49cd-ab87-a9f78f3985e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8911a794-593b-43a4-9ad9-944e1629d3c5" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_1a88ec58-075a-49cd-ab87-a9f78f3985e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueBusinessRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended" id="i054748dca41d46cba633a5fba3ee3d5f_RevenueBusinessRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_54ff10eb-8518-405a-bad9-a844bcc2b8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_57bb3221-1ee6-4630-8395-d200c8dba91b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_54ff10eb-8518-405a-bad9-a844bcc2b8d7" xlink:to="loc_us-gaap_Revenues_57bb3221-1ee6-4630-8395-d200c8dba91b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_54ff10eb-8518-405a-bad9-a844bcc2b8d7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3b52da39-c240-45e8-8e39-dacfed241c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3b52da39-c240-45e8-8e39-dacfed241c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3b52da39-c240-45e8-8e39-dacfed241c5a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3b52da39-c240-45e8-8e39-dacfed241c5a" xlink:to="loc_us-gaap_SegmentDomain_3b52da39-c240-45e8-8e39-dacfed241c5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3b52da39-c240-45e8-8e39-dacfed241c5a" xlink:to="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_ff38a5f2-c0bb-40aa-b72b-243ffde77ab2" xlink:href="holx-20200926.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:to="loc_holx_DiagnosticsMember_ff38a5f2-c0bb-40aa-b72b-243ffde77ab2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_266bce31-9c9c-4ceb-b599-c46d5da89d55" xlink:href="holx-20200926.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:to="loc_holx_BreastHealthMember_266bce31-9c9c-4ceb-b599-c46d5da89d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_9e1ab62d-67b7-42b3-9f94-b9d6038b13ad" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:to="loc_holx_MedicalAestheticsMember_9e1ab62d-67b7-42b3-9f94-b9d6038b13ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_681b80ba-4872-42d8-b000-2080daad81d3" xlink:href="holx-20200926.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:to="loc_holx_SkeletalHealthMember_681b80ba-4872-42d8-b000-2080daad81d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d821c49f-ee05-4656-858e-51ec2801b8c3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:to="loc_srt_ProductOrServiceAxis_d821c49f-ee05-4656-858e-51ec2801b8c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d821c49f-ee05-4656-858e-51ec2801b8c3_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d821c49f-ee05-4656-858e-51ec2801b8c3" xlink:to="loc_srt_ProductsAndServicesDomain_d821c49f-ee05-4656-858e-51ec2801b8c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d821c49f-ee05-4656-858e-51ec2801b8c3" xlink:to="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_d978215b-9f95-41ce-ade7-0780a91e682e" xlink:href="holx-20200926.xsd#holx_CytologyPerinatalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_CytologyPerinatalMember_d978215b-9f95-41ce-ade7-0780a91e682e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_60017af4-0050-46ae-9ab6-3b128d1e0518" xlink:href="holx-20200926.xsd#holx_MolecularDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_MolecularDiagnosticsMember_60017af4-0050-46ae-9ab6-3b128d1e0518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_ccb5572e-5835-4034-86f3-68bcb366722b" xlink:href="holx-20200926.xsd#holx_BloodScreeningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_BloodScreeningMember_ccb5572e-5835-4034-86f3-68bcb366722b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_fd295b55-b5e7-4bb2-a087-365627af8053" xlink:href="holx-20200926.xsd#holx_BreastImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_BreastImagingMember_fd295b55-b5e7-4bb2-a087-365627af8053" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_df334e02-6f19-48c9-beed-ad394b84d5f9" xlink:href="holx-20200926.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_InterventionalBreastSolutionsMember_df334e02-6f19-48c9-beed-ad394b84d5f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b22c341e-296b-4d6d-8454-a59861c42fd9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:to="loc_srt_StatementGeographicalAxis_b22c341e-296b-4d6d-8454-a59861c42fd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b22c341e-296b-4d6d-8454-a59861c42fd9_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b22c341e-296b-4d6d-8454-a59861c42fd9" xlink:to="loc_srt_SegmentGeographicalDomain_b22c341e-296b-4d6d-8454-a59861c42fd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8863a0bb-8df7-436e-9429-ad3b131a1da3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b22c341e-296b-4d6d-8454-a59861c42fd9" xlink:to="loc_srt_SegmentGeographicalDomain_8863a0bb-8df7-436e-9429-ad3b131a1da3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_794d426c-7713-4b63-9584-d116b168970e" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8863a0bb-8df7-436e-9429-ad3b131a1da3" xlink:to="loc_country_US_794d426c-7713-4b63-9584-d116b168970e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_c17a2de5-6036-4d55-9400-daa71e4547d4" xlink:href="holx-20200926.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8863a0bb-8df7-436e-9429-ad3b131a1da3" xlink:to="loc_holx_InternationalMember_c17a2de5-6036-4d55-9400-daa71e4547d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueGeographicalRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended" id="i94c756a37fa94a959acb1fd55d29fad4_RevenueGeographicalRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ed97fe5f-01be-41cf-b15a-1176d86c069e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1215d8f7-5fa8-4776-afcd-aa64db53d38b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ed97fe5f-01be-41cf-b15a-1176d86c069e" xlink:to="loc_us-gaap_Revenues_1215d8f7-5fa8-4776-afcd-aa64db53d38b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8b2959b5-a1c7-4b49-816a-16726ee2d2b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ed97fe5f-01be-41cf-b15a-1176d86c069e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8b2959b5-a1c7-4b49-816a-16726ee2d2b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_11565aef-feed-4144-9e44-a42fd5b47cc2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8b2959b5-a1c7-4b49-816a-16726ee2d2b5" xlink:to="loc_srt_ProductOrServiceAxis_11565aef-feed-4144-9e44-a42fd5b47cc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_11565aef-feed-4144-9e44-a42fd5b47cc2_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_11565aef-feed-4144-9e44-a42fd5b47cc2" xlink:to="loc_srt_ProductsAndServicesDomain_11565aef-feed-4144-9e44-a42fd5b47cc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_67663ccf-3f04-4ec9-83b9-652905e61543" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_11565aef-feed-4144-9e44-a42fd5b47cc2" xlink:to="loc_srt_ProductsAndServicesDomain_67663ccf-3f04-4ec9-83b9-652905e61543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f09648bb-2ac1-48a6-82ad-b3317082fb08" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8b2959b5-a1c7-4b49-816a-16726ee2d2b5" xlink:to="loc_srt_StatementGeographicalAxis_f09648bb-2ac1-48a6-82ad-b3317082fb08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f09648bb-2ac1-48a6-82ad-b3317082fb08_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f09648bb-2ac1-48a6-82ad-b3317082fb08" xlink:to="loc_srt_SegmentGeographicalDomain_f09648bb-2ac1-48a6-82ad-b3317082fb08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f09648bb-2ac1-48a6-82ad-b3317082fb08" xlink:to="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_51146e55-a9b6-46ea-8181-6484b0adce17" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:to="loc_country_US_51146e55-a9b6-46ea-8181-6484b0adce17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_db8c4193-e8e5-439c-9ef4-510496c64732" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:to="loc_srt_EuropeMember_db8c4193-e8e5-439c-9ef4-510496c64732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_bc1264e8-14be-49df-80ce-332f2e318321" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:to="loc_srt_AsiaPacificMember_bc1264e8-14be-49df-80ce-332f2e318321" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherGeographicRegionsMember_1a901599-c13a-48e9-bc08-349c2523d282" xlink:href="holx-20200926.xsd#holx_OtherGeographicRegionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:to="loc_holx_OtherGeographicRegionsMember_1a901599-c13a-48e9-bc08-349c2523d282" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueRevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended" id="i5afc9aebd3204d98b0ea06b64d564d5f_RevenueRevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_7aea7960-e582-416d-84b6-e0edb4319065" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4f1e462e-4090-4e7c-b69d-c829e11cf67f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7aea7960-e582-416d-84b6-e0edb4319065" xlink:to="loc_us-gaap_Revenues_4f1e462e-4090-4e7c-b69d-c829e11cf67f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7aea7960-e582-416d-84b6-e0edb4319065" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_adcc1f0d-d664-4c82-b38b-512962097ecf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:to="loc_srt_ProductOrServiceAxis_adcc1f0d-d664-4c82-b38b-512962097ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_adcc1f0d-d664-4c82-b38b-512962097ecf_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_adcc1f0d-d664-4c82-b38b-512962097ecf" xlink:to="loc_srt_ProductsAndServicesDomain_adcc1f0d-d664-4c82-b38b-512962097ecf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_adcc1f0d-d664-4c82-b38b-512962097ecf" xlink:to="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4c83f5e8-93fa-4182-b455-dc19859eee28" xlink:href="holx-20200926.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4c83f5e8-93fa-4182-b455-dc19859eee28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_46d123df-fca7-4da4-b1da-74ca03eb872d" xlink:href="holx-20200926.xsd#holx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:to="loc_holx_ConsumablesMember_46d123df-fca7-4da4-b1da-74ca03eb872d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_46b71f11-db99-4b90-bfa6-0df827bdc6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:to="loc_us-gaap_ServiceMember_46b71f11-db99-4b90-bfa6-0df827bdc6bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_7c3d562c-fcaa-4c62-b05c-edf74155fa2b" xlink:href="holx-20200926.xsd#holx_OtherTypeofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:to="loc_holx_OtherTypeofRevenueMember_7c3d562c-fcaa-4c62-b05c-edf74155fa2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e545e7f1-d90f-4359-b3ba-00d5637356bd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:to="loc_srt_StatementGeographicalAxis_e545e7f1-d90f-4359-b3ba-00d5637356bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e545e7f1-d90f-4359-b3ba-00d5637356bd_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e545e7f1-d90f-4359-b3ba-00d5637356bd" xlink:to="loc_srt_SegmentGeographicalDomain_e545e7f1-d90f-4359-b3ba-00d5637356bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7a38f919-43c4-4829-acb4-4a1387a09237" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e545e7f1-d90f-4359-b3ba-00d5637356bd" xlink:to="loc_srt_SegmentGeographicalDomain_7a38f919-43c4-4829-acb4-4a1387a09237" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9035ea0d-bd51-4d6d-b956-43581638748f" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7a38f919-43c4-4829-acb4-4a1387a09237" xlink:to="loc_country_US_9035ea0d-bd51-4d6d-b956-43581638748f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_aa2395e4-5ab2-453c-be44-71ca2dff339c" xlink:href="holx-20200926.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7a38f919-43c4-4829-acb4-4a1387a09237" xlink:to="loc_holx_InternationalMember_aa2395e4-5ab2-453c-be44-71ca2dff339c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1f7198ef-4e2e-49d8-ad8a-af7d936f3836" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1f7198ef-4e2e-49d8-ad8a-af7d936f3836" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1f7198ef-4e2e-49d8-ad8a-af7d936f3836_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1f7198ef-4e2e-49d8-ad8a-af7d936f3836" xlink:to="loc_us-gaap_SegmentDomain_1f7198ef-4e2e-49d8-ad8a-af7d936f3836_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_31183347-b183-4423-acb1-3e181e7aea8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1f7198ef-4e2e-49d8-ad8a-af7d936f3836" xlink:to="loc_us-gaap_SegmentDomain_31183347-b183-4423-acb1-3e181e7aea8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_98363bd0-3947-4f3d-abaa-7961c24998ec" xlink:href="holx-20200926.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_31183347-b183-4423-acb1-3e181e7aea8e" xlink:to="loc_holx_GynSurgicalMember_98363bd0-3947-4f3d-abaa-7961c24998ec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueRemainingPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="extended" id="i096ea941a6b64817833358b71c53d0cb_RevenueRemainingPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_bfc1f2cf-5e49-47b3-a559-e73199675cac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_bfc1f2cf-5e49-47b3-a559-e73199675cac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c411c2e5-c6e6-4385-9961-b8a4391a2d95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c411c2e5-c6e6-4385-9961-b8a4391a2d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_27a0feae-3900-45a5-9361-4fe93d294cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_27a0feae-3900-45a5-9361-4fe93d294cf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b1543832-91ff-4082-a637-fc1bea46881f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_27a0feae-3900-45a5-9361-4fe93d294cf7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b1543832-91ff-4082-a637-fc1bea46881f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueRemainingPerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="extended" id="i82410b16a1214188804e43e8383c4dee_RevenueRemainingPerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_bfc1f2cf-5e49-47b3-a559-e73199675cac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_bfc1f2cf-5e49-47b3-a559-e73199675cac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c411c2e5-c6e6-4385-9961-b8a4391a2d95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c411c2e5-c6e6-4385-9961-b8a4391a2d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_27a0feae-3900-45a5-9361-4fe93d294cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_27a0feae-3900-45a5-9361-4fe93d294cf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20200926.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended" id="i82cea790e5f8481e82aa225694cc2ae4_Leases"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesTables" xlink:type="extended" id="i4f6d8b2e1a684a6ebd5131ce29de8c07_LeasesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="extended" id="icc8d89c08dbe44f4adfb6edc9768c299_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_72d07812-2f9b-409e-8b06-94a01a0dcc22" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_72d07812-2f9b-409e-8b06-94a01a0dcc22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_cd34326c-cd2c-4511-b109-317e783ea17e" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_cd34326c-cd2c-4511-b109-317e783ea17e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_0c23409c-a2f8-4542-b322-39163d519419" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeasesExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_0c23409c-a2f8-4542-b322-39163d519419" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_5a4a289d-1190-430d-8771-ca6894aabd9e" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_5a4a289d-1190-430d-8771-ca6894aabd9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b29a7da0-5b36-4b2c-82b4-534ba5b30514" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b29a7da0-5b36-4b2c-82b4-534ba5b30514" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_bb50fdda-7a74-401d-9517-0e3885bc7afc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_bb50fdda-7a74-401d-9517-0e3885bc7afc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_d4489d7f-1795-43a9-8486-27409b59e49d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_d4489d7f-1795-43a9-8486-27409b59e49d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue_3693d0e0-0cea-4917-be1c-a551bfffe23e" xlink:href="holx-20200926.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LeaseRevenuePercentageOfTotalRevenue_3693d0e0-0cea-4917-be1c-a551bfffe23e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3038ad96-9918-450f-bbe2-e72b6e41360a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3038ad96-9918-450f-bbe2-e72b6e41360a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseReceivable_c8808cf3-90de-4ca5-9994-375aab7df43d" xlink:href="holx-20200926.xsd#holx_LeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LeaseReceivable_c8808cf3-90de-4ca5-9994-375aab7df43d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_20a8e157-bf31-4d3a-8f63-f4fbc120ca32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_20a8e157-bf31-4d3a-8f63-f4fbc120ca32" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a305c6bc-bd5a-42d4-8fe2-347ac268c565" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a305c6bc-bd5a-42d4-8fe2-347ac268c565" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_e5106199-3bc4-434a-906a-46bd2b7823d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_e5106199-3bc4-434a-906a-46bd2b7823d5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_279905d0-5679-4287-8e0b-4056f5c7db6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeaseLiability_279905d0-5679-4287-8e0b-4056f5c7db6f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4a523670-5667-49b3-b68a-c46b6624d0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseLiability_4a523670-5667-49b3-b68a-c46b6624d0d8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d1296377-4b10-4bfb-95e2-ff8f582c164f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d1296377-4b10-4bfb-95e2-ff8f582c164f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_133473c9-d497-40a3-be2c-f16497167f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_133473c9-d497-40a3-be2c-f16497167f4c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_c29e5a0d-b629-45b6-a310-8de7a7f540d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_c29e5a0d-b629-45b6-a310-8de7a7f540d7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_2d8fc1a4-d096-4462-9d06-299f9bd1e1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_2d8fc1a4-d096-4462-9d06-299f9bd1e1f1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4510c99c-4a50-4101-b79f-2fb923794977" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4510c99c-4a50-4101-b79f-2fb923794977" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_644124cb-9abd-4b26-91a5-abaf5fdbc796" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4510c99c-4a50-4101-b79f-2fb923794977" xlink:to="loc_srt_RangeAxis_644124cb-9abd-4b26-91a5-abaf5fdbc796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_644124cb-9abd-4b26-91a5-abaf5fdbc796_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_644124cb-9abd-4b26-91a5-abaf5fdbc796" xlink:to="loc_srt_RangeMember_644124cb-9abd-4b26-91a5-abaf5fdbc796_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf0d655b-0d5a-420b-900e-8124e27a6c05" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_644124cb-9abd-4b26-91a5-abaf5fdbc796" xlink:to="loc_srt_RangeMember_bf0d655b-0d5a-420b-900e-8124e27a6c05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_da58a14d-f584-4372-8d2e-331f8eff24c7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bf0d655b-0d5a-420b-900e-8124e27a6c05" xlink:to="loc_srt_MinimumMember_da58a14d-f584-4372-8d2e-331f8eff24c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3c46fdfc-f9a7-40b9-97e1-cdde44321fed" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bf0d655b-0d5a-420b-900e-8124e27a6c05" xlink:to="loc_srt_MaximumMember_3c46fdfc-f9a7-40b9-97e1-cdde44321fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4d1cc665-c0a3-4d8c-8ced-04cc2d7754c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4510c99c-4a50-4101-b79f-2fb923794977" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4d1cc665-c0a3-4d8c-8ced-04cc2d7754c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_4d1cc665-c0a3-4d8c-8ced-04cc2d7754c4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4d1cc665-c0a3-4d8c-8ced-04cc2d7754c4" xlink:to="loc_us-gaap_TypeOfAdoptionMember_4d1cc665-c0a3-4d8c-8ced-04cc2d7754c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0e349d16-8eed-4f8e-a131-4e86ccf3774c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4d1cc665-c0a3-4d8c-8ced-04cc2d7754c4" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0e349d16-8eed-4f8e-a131-4e86ccf3774c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_663863ee-8571-4a9c-a93b-6e8f3d761f92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_0e349d16-8eed-4f8e-a131-4e86ccf3774c" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_663863ee-8571-4a9c-a93b-6e8f3d761f92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_bf0388d2-9e9e-4fda-a226-7087613ff24a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_2b603295-65f9-43b8-ba37-2ad1ff41f5b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_2b603295-65f9-43b8-ba37-2ad1ff41f5b9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6a31d2cc-69e3-4378-a640-27f86283d22d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="iab9bf05793f74c12b92a801b1043bc8a_LeasesSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_60725eb3-e6d3-453a-b245-2b231912ae2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_60725eb3-e6d3-453a-b245-2b231912ae2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_16482daf-9699-4f68-8a4a-f40df6a346c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_16482daf-9699-4f68-8a4a-f40df6a346c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_602721f0-cc5c-4ff0-8909-5450017befd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_602721f0-cc5c-4ff0-8909-5450017befd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_b2c45174-9c13-4de8-aa3c-a4d99818ee55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_b2c45174-9c13-4de8-aa3c-a4d99818ee55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d2a4103e-ac67-421f-8667-866c8e07616c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d2a4103e-ac67-421f-8667-866c8e07616c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_376aa2c0-2547-47ee-ada2-8efa7366ffe2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_376aa2c0-2547-47ee-ada2-8efa7366ffe2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8d487b72-da79-4e1e-8e2b-67d5e45f9373" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8d487b72-da79-4e1e-8e2b-67d5e45f9373" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_66d2ace1-2ef4-4a82-9a70-29115a73d839" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_66d2ace1-2ef4-4a82-9a70-29115a73d839" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c26cd2b6-91f6-4549-8c97-0810e605a076" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c26cd2b6-91f6-4549-8c97-0810e605a076" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ac992165-4b1b-4967-99ab-2386860f3196" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ac992165-4b1b-4967-99ab-2386860f3196" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_8583b03b-1acc-47c1-967e-e727a7e3e242" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_8583b03b-1acc-47c1-967e-e727a7e3e242" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_692288f5-1877-49c2-8290-6f454f7e8e67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_692288f5-1877-49c2-8290-6f454f7e8e67" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_3a175356-a0b0-40e8-802a-f7f88a3a52f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_3a175356-a0b0-40e8-802a-f7f88a3a52f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_86f4c596-1db2-4f3f-9b91-0e391a7944e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3a175356-a0b0-40e8-802a-f7f88a3a52f0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_86f4c596-1db2-4f3f-9b91-0e391a7944e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_86f4c596-1db2-4f3f-9b91-0e391a7944e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_86f4c596-1db2-4f3f-9b91-0e391a7944e1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_86f4c596-1db2-4f3f-9b91-0e391a7944e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_86f4c596-1db2-4f3f-9b91-0e391a7944e1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_bf52cdfa-5b28-4f95-971c-1e93a81e0083" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_us-gaap_OtherAssetsMember_bf52cdfa-5b28-4f95-971c-1e93a81e0083" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_a5885cbd-f41d-4323-8ff7-bbd3146298bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_a5885cbd-f41d-4323-8ff7-bbd3146298bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d01779d8-82fb-4591-b5b6-79a14c7b5c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d01779d8-82fb-4591-b5b6-79a14c7b5c7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsShortTermMember_9eea3575-36cf-438a-973f-63c69bd6fd43" xlink:href="holx-20200926.xsd#holx_FinanceLeaseObligationsShortTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_holx_FinanceLeaseObligationsShortTermMember_9eea3575-36cf-438a-973f-63c69bd6fd43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsLongTermMember_6f55ce8a-d058-4b21-97ae-79f67ec8c7e3" xlink:href="holx-20200926.xsd#holx_FinanceLeaseObligationsLongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_holx_FinanceLeaseObligationsLongTermMember_6f55ce8a-d058-4b21-97ae-79f67ec8c7e3" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended" id="i21c2277caef14226a085cc8599085600_LeasesAdditionalLeaseInformationDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesLeaseLiabilityMaturitySchedule2020Details"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="extended" id="i5b0be17f93b94516be67b32cf0bffa55_LeasesLeaseLiabilityMaturitySchedule2020Details"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesLeaseLiabilityMaturitySchedule2019Details"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details" xlink:type="extended" id="ic670b38f88b947389fb248a5e02c7795_LeasesLeaseLiabilityMaturitySchedule2019Details"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" xlink:type="extended" id="ieb769e1e66fc4c4c9924cdac48c3db75_LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinations"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended" id="ia6a168f05b8b4921a4173cc7d18c130a_BusinessCombinations"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended" id="i5a963b6e49bd4fe186d193e0da357755_BusinessCombinationsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1f57fbe2-befc-4788-a68c-b53f76ca3205" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_399d55c5-f166-46f8-ad8f-0e698652fcd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1f57fbe2-befc-4788-a68c-b53f76ca3205" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_399d55c5-f166-46f8-ad8f-0e698652fcd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_07ada461-28f5-4354-b0d9-8278e6c22461" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1f57fbe2-befc-4788-a68c-b53f76ca3205" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_07ada461-28f5-4354-b0d9-8278e6c22461" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fb61bce3-2985-45b4-bb3b-9d0cb25acc41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_07ada461-28f5-4354-b0d9-8278e6c22461" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fb61bce3-2985-45b4-bb3b-9d0cb25acc41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb61bce3-2985-45b4-bb3b-9d0cb25acc41_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fb61bce3-2985-45b4-bb3b-9d0cb25acc41" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb61bce3-2985-45b4-bb3b-9d0cb25acc41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fb61bce3-2985-45b4-bb3b-9d0cb25acc41" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_6aaba386-6e78-441c-bfb0-bd0c81f5b21c" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:to="loc_holx_FocalTherapeuticsInc.Member_6aaba386-6e78-441c-bfb0-bd0c81f5b21c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_181e43c5-90b5-4810-a9ed-31e45844a9fe" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:to="loc_holx_SuperSonicImagineMember_181e43c5-90b5-4810-a9ed-31e45844a9fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_60702871-84e2-4d69-9719-24ab456dc148" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:to="loc_holx_FaxitronMember_60702871-84e2-4d69-9719-24ab456dc148" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaMember_14f878e9-bce0-40b7-89af-cbfa7ada52ee" xlink:href="holx-20200926.xsd#holx_AcessaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:to="loc_holx_AcessaMember_14f878e9-bce0-40b7-89af-cbfa7ada52ee" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended" id="i7aa4e0b63c7c459da642a59dbb585c4e_BusinessCombinationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2f79ae8d-b764-4a5d-86f6-5231ece1377b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2f79ae8d-b764-4a5d-86f6-5231ece1377b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f71b2818-08ff-4b38-b671-71a3dec8b852" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f71b2818-08ff-4b38-b671-71a3dec8b852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_4ae03416-6682-43b8-a3c9-3cd8ad012989" xlink:href="holx-20200926.xsd#holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_4ae03416-6682-43b8-a3c9-3cd8ad012989" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_82fb8fea-3415-48cb-80e3-c3d5ca477657" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_82fb8fea-3415-48cb-80e3-c3d5ca477657" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_86209e4a-53ac-4cf8-9d77-d77e8122b714" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_86209e4a-53ac-4cf8-9d77-d77e8122b714" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_6b6fcd59-71e0-493f-a69c-8990612106a6" xlink:href="holx-20200926.xsd#holx_Holdback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_Holdback_6b6fcd59-71e0-493f-a69c-8990612106a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9ebbf1b-7e75-4bdd-a607-ff1efc97126a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9ebbf1b-7e75-4bdd-a607-ff1efc97126a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_43bf0710-107e-4393-9d9f-462edbe53a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_Goodwill_43bf0710-107e-4393-9d9f-462edbe53a29" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2459896b-211c-49ae-a630-fc310b2fa80d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2459896b-211c-49ae-a630-fc310b2fa80d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_2598db13-8eda-49eb-a82e-b2a7a3c5d677" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_2598db13-8eda-49eb-a82e-b2a7a3c5d677" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b5583b4c-fa07-4a1b-99c3-c41a26835421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b5583b4c-fa07-4a1b-99c3-c41a26835421" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_6bfef7ed-f68c-49fd-92d3-66f5eb089db9" xlink:href="holx-20200926.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_6bfef7ed-f68c-49fd-92d3-66f5eb089db9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_aa06a90b-27c4-4551-ba7f-422146f56b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_aa06a90b-27c4-4551-ba7f-422146f56b0c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired_21966ff0-e9e7-4580-9ec7-f24ecefe8374" xlink:href="holx-20200926.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationSharesAcquired_21966ff0-e9e7-4580-9ec7-f24ecefe8374" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_aa1c4a30-d41d-4c79-b309-2127f81500e8" xlink:href="holx-20200926.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_aa1c4a30-d41d-4c79-b309-2127f81500e8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_c581bebc-e6b5-4925-8443-1fd121db00dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_c581bebc-e6b5-4925-8443-1fd121db00dc" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_0246f3a7-62e6-4541-b1f9-3ce6b2ba95b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_0246f3a7-62e6-4541-b1f9-3ce6b2ba95b4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_43dd15df-4aa0-474f-b9e6-85e5eee05469" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_43dd15df-4aa0-474f-b9e6-85e5eee05469" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_ce8c059f-c6d8-4de2-b5ac-9f47f99a781d" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_ce8c059f-c6d8-4de2-b5ac-9f47f99a781d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_897e4afe-91c8-4397-85d7-f79a87f71638" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_897e4afe-91c8-4397-85d7-f79a87f71638" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_e03ce3fa-8423-44c8-990b-bf83b0a23d3e" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_e03ce3fa-8423-44c8-990b-bf83b0a23d3e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a8d361d0-bb57-4f0f-8033-baac77d48701" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a8d361d0-bb57-4f0f-8033-baac77d48701" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet_07f4ac0a-34ed-47fc-8192-5353548d6ec6" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet_07f4ac0a-34ed-47fc-8192-5353548d6ec6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a8060df7-1a87-4820-8834-1fafa1f26a49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a8060df7-1a87-4820-8834-1fafa1f26a49" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_cfcf5091-6a82-49ff-822c-f14ff00a931b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_cfcf5091-6a82-49ff-822c-f14ff00a931b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions_2ed94eed-ea1f-4083-bd43-01056f36202f" xlink:href="holx-20200926.xsd#holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions_2ed94eed-ea1f-4083-bd43-01056f36202f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentOfContingentConsideration_de22b998-a8dd-4127-944f-82ba1dbacf8b" xlink:href="holx-20200926.xsd#holx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_PaymentOfContingentConsideration_de22b998-a8dd-4127-944f-82ba1dbacf8b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AdditionalPurchaseConsideration_d187ac12-8044-46b5-9d0f-0814738d419c" xlink:href="holx-20200926.xsd#holx_AdditionalPurchaseConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_AdditionalPurchaseConsideration_d187ac12-8044-46b5-9d0f-0814738d419c" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_8b4499ef-6d68-4b59-bb26-55a8e77bfcd8" xlink:href="holx-20200926.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_8b4499ef-6d68-4b59-bb26-55a8e77bfcd8" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_c5dc05a1-3d7d-409c-ad70-eb2cf09cf729" xlink:href="holx-20200926.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_c5dc05a1-3d7d-409c-ad70-eb2cf09cf729" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_dc3b6948-c996-4c1e-987f-2cc766a5fc4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_dc3b6948-c996-4c1e-987f-2cc766a5fc4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc3b6948-c996-4c1e-987f-2cc766a5fc4d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_dc3b6948-c996-4c1e-987f-2cc766a5fc4d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc3b6948-c996-4c1e-987f-2cc766a5fc4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_dc3b6948-c996-4c1e-987f-2cc766a5fc4d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaMember_d6dc7b92-4fc7-4725-b93b-d0321eba3496" xlink:href="holx-20200926.xsd#holx_AcessaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_AcessaMember_d6dc7b92-4fc7-4725-b93b-d0321eba3496" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_3376c1e1-8358-4c9b-9c55-c4184e73bb34" xlink:href="holx-20200926.xsd#holx_HealthBeaconsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_HealthBeaconsMember_3376c1e1-8358-4c9b-9c55-c4184e73bb34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_5c4fd7e6-7572-4bda-a427-c14e0dbbcd80" xlink:href="holx-20200926.xsd#holx_AlphaImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_AlphaImagingMember_5c4fd7e6-7572-4bda-a427-c14e0dbbcd80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_58368008-74de-4784-90cc-0bf752a45441" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_SuperSonicImagineMember_58368008-74de-4784-90cc-0bf752a45441" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_6f3109db-84f1-4fd8-a7a5-f6be6b4420bd" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_FocalTherapeuticsInc.Member_6f3109db-84f1-4fd8-a7a5-f6be6b4420bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_884350ac-f403-4c3c-aa43-242bd49ece56" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_FaxitronMember_884350ac-f403-4c3c-aa43-242bd49ece56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmsorMember_df22a456-468d-41fd-8d6a-f8d4eeef80fe" xlink:href="holx-20200926.xsd#holx_EmsorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_EmsorMember_df22a456-468d-41fd-8d6a-f8d4eeef80fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b2b174a-2836-4d1c-8f8e-94f5288f5d47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b2b174a-2836-4d1c-8f8e-94f5288f5d47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b2b174a-2836-4d1c-8f8e-94f5288f5d47_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b2b174a-2836-4d1c-8f8e-94f5288f5d47" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b2b174a-2836-4d1c-8f8e-94f5288f5d47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b2b174a-2836-4d1c-8f8e-94f5288f5d47" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_50ccfb03-1025-43e9-b2f3-db11d48d900a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_50ccfb03-1025-43e9-b2f3-db11d48d900a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_9bbe4939-de19-41fc-855e-6dacf284285f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_9bbe4939-de19-41fc-855e-6dacf284285f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_67ec83ee-a821-4b32-92c4-a619d9288671" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_67ec83ee-a821-4b32-92c4-a619d9288671" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c15b3f2f-b840-48fa-8b87-e3dca7f46469" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:to="loc_us-gaap_TradeNamesMember_c15b3f2f-b840-48fa-8b87-e3dca7f46469" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a96820ea-20e7-4558-bc8f-f39b750b1850" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a96820ea-20e7-4558-bc8f-f39b750b1850" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_a96820ea-20e7-4558-bc8f-f39b750b1850_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a96820ea-20e7-4558-bc8f-f39b750b1850" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_a96820ea-20e7-4558-bc8f-f39b750b1850_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_0c5876e5-6689-4815-a34e-d149fbfbe61d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a96820ea-20e7-4558-bc8f-f39b750b1850" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_0c5876e5-6689-4815-a34e-d149fbfbe61d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_4a8e5816-2a9e-4678-a4f2-542bc4630f0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_0c5876e5-6689-4815-a34e-d149fbfbe61d" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_4a8e5816-2a9e-4678-a4f2-542bc4630f0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d41d875b-e195-41ac-98ce-2c3f72069b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d41d875b-e195-41ac-98ce-2c3f72069b4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d41d875b-e195-41ac-98ce-2c3f72069b4a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d41d875b-e195-41ac-98ce-2c3f72069b4a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d41d875b-e195-41ac-98ce-2c3f72069b4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_154eb651-9edc-4a80-98c7-ed007345995c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d41d875b-e195-41ac-98ce-2c3f72069b4a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_154eb651-9edc-4a80-98c7-ed007345995c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_a1e8ec51-e7ed-44d0-a8a9-6ba262f5598e" xlink:href="holx-20200926.xsd#holx_ContingentHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_154eb651-9edc-4a80-98c7-ed007345995c" xlink:to="loc_holx_ContingentHoldbackMember_a1e8ec51-e7ed-44d0-a8a9-6ba262f5598e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b4682c8f-fc2a-44d2-9e44-06469814b98d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_srt_RangeAxis_b4682c8f-fc2a-44d2-9e44-06469814b98d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b4682c8f-fc2a-44d2-9e44-06469814b98d_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b4682c8f-fc2a-44d2-9e44-06469814b98d" xlink:to="loc_srt_RangeMember_b4682c8f-fc2a-44d2-9e44-06469814b98d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d4981116-d87a-4746-aaf4-aa1e7d9a8c63" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b4682c8f-fc2a-44d2-9e44-06469814b98d" xlink:to="loc_srt_RangeMember_d4981116-d87a-4746-aaf4-aa1e7d9a8c63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_06a1f183-6b54-4cc8-9bc9-c3ad89a78908" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d4981116-d87a-4746-aaf4-aa1e7d9a8c63" xlink:to="loc_srt_MinimumMember_06a1f183-6b54-4cc8-9bc9-c3ad89a78908" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_24c12df7-24ae-494f-af8b-b880c11d6f3c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d4981116-d87a-4746-aaf4-aa1e7d9a8c63" xlink:to="loc_srt_MaximumMember_24c12df7-24ae-494f-af8b-b880c11d6f3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f958da73-d476-4a63-a1cd-2d4be0c04992" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f958da73-d476-4a63-a1cd-2d4be0c04992" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f958da73-d476-4a63-a1cd-2d4be0c04992_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f958da73-d476-4a63-a1cd-2d4be0c04992" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f958da73-d476-4a63-a1cd-2d4be0c04992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4c737125-12d6-48b9-8eb8-4ecb1aa9d32b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f958da73-d476-4a63-a1cd-2d4be0c04992" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4c737125-12d6-48b9-8eb8-4ecb1aa9d32b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_b35b061f-7e4e-4003-b6d6-1e64ebe19593" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4c737125-12d6-48b9-8eb8-4ecb1aa9d32b" xlink:to="loc_us-gaap_OtherIncomeMember_b35b061f-7e4e-4003-b6d6-1e64ebe19593" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationAcessaDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails" xlink:type="extended" id="i44a9af209e764568b6191149ea1a7d0a_BusinessCombinationsPurchasePriceAllocationAcessaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c2c6255d-d798-4aa1-b014-f7e17094899b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c2c6255d-d798-4aa1-b014-f7e17094899b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_655d940a-640f-414e-bbc3-8cc81b4e5cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_655d940a-640f-414e-bbc3-8cc81b4e5cf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dc197667-a336-41c8-afc4-d9a574d50f58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dc197667-a336-41c8-afc4-d9a574d50f58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_01bf65f5-9532-415b-9734-cc132e5cc1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_01bf65f5-9532-415b-9734-cc132e5cc1b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5d4ea596-f7a8-4130-b294-6262d4ba75e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5d4ea596-f7a8-4130-b294-6262d4ba75e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0eca6595-8a5d-40bf-a860-fdaae39bde84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0eca6595-8a5d-40bf-a860-fdaae39bde84" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dd71ce0b-1fa8-412a-821a-8dc1bd4432e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_Goodwill_dd71ce0b-1fa8-412a-821a-8dc1bd4432e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8045aeb0-760c-4018-88a5-57833b411372" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8045aeb0-760c-4018-88a5-57833b411372" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bdcc675d-f76e-40d3-a2af-784ee2729278" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bdcc675d-f76e-40d3-a2af-784ee2729278" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9ee24c51-84fa-44de-abbb-ad0530d7d205" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bdcc675d-f76e-40d3-a2af-784ee2729278" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9ee24c51-84fa-44de-abbb-ad0530d7d205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ee24c51-84fa-44de-abbb-ad0530d7d205_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ee24c51-84fa-44de-abbb-ad0530d7d205" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ee24c51-84fa-44de-abbb-ad0530d7d205_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22b8b57c-6d32-4d35-90df-40ad6f42e251" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ee24c51-84fa-44de-abbb-ad0530d7d205" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22b8b57c-6d32-4d35-90df-40ad6f42e251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaMember_7efe1b41-c9ce-4e36-ab9b-bdcb26d5fd22" xlink:href="holx-20200926.xsd#holx_AcessaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22b8b57c-6d32-4d35-90df-40ad6f42e251" xlink:to="loc_holx_AcessaMember_7efe1b41-c9ce-4e36-ab9b-bdcb26d5fd22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0737b6d1-3255-44a6-8136-459f746323fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bdcc675d-f76e-40d3-a2af-784ee2729278" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0737b6d1-3255-44a6-8136-459f746323fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0737b6d1-3255-44a6-8136-459f746323fd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0737b6d1-3255-44a6-8136-459f746323fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0737b6d1-3255-44a6-8136-459f746323fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dfdc8181-43b9-4bd8-88da-4c4409930b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0737b6d1-3255-44a6-8136-459f746323fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dfdc8181-43b9-4bd8-88da-4c4409930b0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a56d3e2a-25b5-4ca5-b0c8-90326e38f991" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dfdc8181-43b9-4bd8-88da-4c4409930b0d" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a56d3e2a-25b5-4ca5-b0c8-90326e38f991" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4536c4bb-ac9c-44b8-8180-713f45b9b10b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dfdc8181-43b9-4bd8-88da-4c4409930b0d" xlink:to="loc_us-gaap_TradeNamesMember_4536c4bb-ac9c-44b8-8180-713f45b9b10b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails" xlink:type="extended" id="i79c25b08395b4ed2b8e940d2175a648c_BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6e2e62ec-aca6-4f87-b94c-6a6a98953bca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6e2e62ec-aca6-4f87-b94c-6a6a98953bca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8683f8f8-ce53-40ed-8f87-db84f5ece143" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8683f8f8-ce53-40ed-8f87-db84f5ece143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1aeec56d-b2af-4019-b030-ac66638c0ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1aeec56d-b2af-4019-b030-ac66638c0ab1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f65538b3-c980-47aa-a7f4-6ca2346ac482" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f65538b3-c980-47aa-a7f4-6ca2346ac482" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1d678f39-543b-4b67-8c09-19d6b72bf701" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1d678f39-543b-4b67-8c09-19d6b72bf701" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_9e958fa6-c546-4b97-a1d1-644001a35f09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_9e958fa6-c546-4b97-a1d1-644001a35f09" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_e1fba439-969b-40c4-8b45-f38ab6aef5b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_e1fba439-969b-40c4-8b45-f38ab6aef5b0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_426f5bbc-4f39-4cac-a06d-de7c30459a67" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_426f5bbc-4f39-4cac-a06d-de7c30459a67" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_b2dc22d6-2087-415d-8646-0297222e689c" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_b2dc22d6-2087-415d-8646-0297222e689c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_9be3c49b-5139-4274-b565-a96995e21ff1" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_9be3c49b-5139-4274-b565-a96995e21ff1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_948c5102-cf61-4a90-89ae-9e74e800f818" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_948c5102-cf61-4a90-89ae-9e74e800f818" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_10244f64-38ae-4307-8c27-ac531e684ad9" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_10244f64-38ae-4307-8c27-ac531e684ad9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_99bf94aa-8ce6-4560-85c3-710e3a778a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_99bf94aa-8ce6-4560-85c3-710e3a778a29" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a73a5a55-e9a9-481d-baf8-2d728a8e518b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_Goodwill_a73a5a55-e9a9-481d-baf8-2d728a8e518b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a6e3430a-e050-4231-ab13-c47eec754afc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a6e3430a-e050-4231-ab13-c47eec754afc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f151bc0-67e2-49f9-965e-8b3e601d1365" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f151bc0-67e2-49f9-965e-8b3e601d1365" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_43585a04-7731-49fe-b85f-307e4d074838" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f151bc0-67e2-49f9-965e-8b3e601d1365" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_43585a04-7731-49fe-b85f-307e4d074838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_43585a04-7731-49fe-b85f-307e4d074838_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_43585a04-7731-49fe-b85f-307e4d074838" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_43585a04-7731-49fe-b85f-307e4d074838_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24566ba0-8d56-4ef8-aa9b-5c4e0feeeaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_43585a04-7731-49fe-b85f-307e4d074838" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24566ba0-8d56-4ef8-aa9b-5c4e0feeeaa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_9372a432-9e91-4848-9ec3-2f5202af7c7b" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24566ba0-8d56-4ef8-aa9b-5c4e0feeeaa3" xlink:to="loc_holx_SuperSonicImagineMember_9372a432-9e91-4848-9ec3-2f5202af7c7b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails" xlink:type="extended" id="i7b16ee85b9ce42c1aad3ca5f96f0464e_BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_cda3186e-7175-4207-b0db-c6e10fdeeee4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_cda3186e-7175-4207-b0db-c6e10fdeeee4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b412fedf-7455-45a6-a677-44de539daaac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b412fedf-7455-45a6-a677-44de539daaac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9b7350dc-d75c-4ed4-b7bd-2901d6c00937" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9b7350dc-d75c-4ed4-b7bd-2901d6c00937" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_7c9dfc4a-1370-404a-bf33-e58f3eb7422c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_7c9dfc4a-1370-404a-bf33-e58f3eb7422c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_734b4569-a9db-4f36-a5b3-e75b0d017064" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_734b4569-a9db-4f36-a5b3-e75b0d017064" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_07c1ef5c-5839-4a0d-9405-914101d41e31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_07c1ef5c-5839-4a0d-9405-914101d41e31" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d3268878-628a-4931-93c6-f8faadec802b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d3268878-628a-4931-93c6-f8faadec802b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_169a2347-3ec1-4af7-9523-dd3ac5523503" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_169a2347-3ec1-4af7-9523-dd3ac5523503" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c6befe5c-7dd5-4767-b9ea-80a182df008f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_Goodwill_c6befe5c-7dd5-4767-b9ea-80a182df008f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c77b8e3d-4548-4248-b924-c0cf1f0bbf10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c77b8e3d-4548-4248-b924-c0cf1f0bbf10" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2b44e9a-cec1-4805-979c-e3350a4572e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2b44e9a-cec1-4805-979c-e3350a4572e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_81d5771a-3a4b-41e6-aa2b-02184401c34e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2b44e9a-cec1-4805-979c-e3350a4572e6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_81d5771a-3a4b-41e6-aa2b-02184401c34e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81d5771a-3a4b-41e6-aa2b-02184401c34e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81d5771a-3a4b-41e6-aa2b-02184401c34e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81d5771a-3a4b-41e6-aa2b-02184401c34e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01b28e84-5470-467e-b37c-59e6484445e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81d5771a-3a4b-41e6-aa2b-02184401c34e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01b28e84-5470-467e-b37c-59e6484445e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_4a7d75ee-64bf-4a34-8046-3304b9fbf947" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01b28e84-5470-467e-b37c-59e6484445e6" xlink:to="loc_holx_FocalTherapeuticsInc.Member_4a7d75ee-64bf-4a34-8046-3304b9fbf947" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c5045cd-0937-415d-a834-97289bb7725e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2b44e9a-cec1-4805-979c-e3350a4572e6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c5045cd-0937-415d-a834-97289bb7725e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c5045cd-0937-415d-a834-97289bb7725e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c5045cd-0937-415d-a834-97289bb7725e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c5045cd-0937-415d-a834-97289bb7725e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c5045cd-0937-415d-a834-97289bb7725e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_60bceb52-85f4-47f6-8374-5dc4240530e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_60bceb52-85f4-47f6-8374-5dc4240530e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_928a43a1-c6fa-4328-ac8c-54cb6b6fb1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_928a43a1-c6fa-4328-ac8c-54cb6b6fb1d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_0d2d77a6-106c-4a7b-8e93-4c799b110b1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:to="loc_us-gaap_TradeNamesMember_0d2d77a6-106c-4a7b-8e93-4c799b110b1f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationFaxitronDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails" xlink:type="extended" id="i49160fa6b966446c90d25866df81932a_BusinessCombinationsPurchasePriceAllocationFaxitronDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d53883e0-b065-4170-aa5e-9d911fce8e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d53883e0-b065-4170-aa5e-9d911fce8e8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_367858ab-c096-4a86-8843-cc0ee9201688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_367858ab-c096-4a86-8843-cc0ee9201688" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1af2b40e-d9ad-4521-a154-ebd1351d4120" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1af2b40e-d9ad-4521-a154-ebd1351d4120" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_23dddd8b-191d-42e0-9c2d-fa3fe50f3cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_23dddd8b-191d-42e0-9c2d-fa3fe50f3cbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_68b0207c-3434-4573-b2b8-e7db5b606ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_68b0207c-3434-4573-b2b8-e7db5b606ad6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f8e2d5c9-8e62-4e5e-8c35-9afcae4bf905" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f8e2d5c9-8e62-4e5e-8c35-9afcae4bf905" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_48f0bce4-aed7-4c85-946e-0ee65f9ef197" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_48f0bce4-aed7-4c85-946e-0ee65f9ef197" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_61fb9dfd-bae0-4de5-b100-4801e6eadf1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_61fb9dfd-bae0-4de5-b100-4801e6eadf1e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_50e605fe-7cbb-42c9-8286-132b3948c72a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_50e605fe-7cbb-42c9-8286-132b3948c72a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_083b559a-3c28-47a9-b581-9c7d209dad5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_Goodwill_083b559a-3c28-47a9-b581-9c7d209dad5a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20deafda-40c8-4d49-ac85-f890cdd54cec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20deafda-40c8-4d49-ac85-f890cdd54cec" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e88bd571-bf50-442c-8405-16e99683425c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e88bd571-bf50-442c-8405-16e99683425c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0bf8431f-aa1f-4a01-822d-92b7a2d8fa1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e88bd571-bf50-442c-8405-16e99683425c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0bf8431f-aa1f-4a01-822d-92b7a2d8fa1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0bf8431f-aa1f-4a01-822d-92b7a2d8fa1e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0bf8431f-aa1f-4a01-822d-92b7a2d8fa1e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0bf8431f-aa1f-4a01-822d-92b7a2d8fa1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_364a636f-01a4-4258-a0d5-6297a8a471c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0bf8431f-aa1f-4a01-822d-92b7a2d8fa1e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_364a636f-01a4-4258-a0d5-6297a8a471c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_87b3de2f-7213-41ae-936d-05597018adcb" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_364a636f-01a4-4258-a0d5-6297a8a471c6" xlink:to="loc_holx_FaxitronMember_87b3de2f-7213-41ae-936d-05597018adcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_df6ee9f0-d22b-4898-8766-001e493629e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e88bd571-bf50-442c-8405-16e99683425c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_df6ee9f0-d22b-4898-8766-001e493629e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_df6ee9f0-d22b-4898-8766-001e493629e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_df6ee9f0-d22b-4898-8766-001e493629e2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_df6ee9f0-d22b-4898-8766-001e493629e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_df6ee9f0-d22b-4898-8766-001e493629e2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_35b1abfe-1a23-4a43-83f1-8239b2e609b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_35b1abfe-1a23-4a43-83f1-8239b2e609b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c91b6df4-6e0e-4a4a-b4d3-cfa385500f3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c91b6df4-6e0e-4a4a-b4d3-cfa385500f3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4fa43345-dac0-4c5e-aac6-8428a4094d99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4fa43345-dac0-4c5e-aac6-8428a4094d99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b0411ec7-f970-4ef5-ab8f-923b448accff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:to="loc_us-gaap_TradeNamesMember_b0411ec7-f970-4ef5-ab8f-923b448accff" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#EquityMethodInvestmentDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="extended" id="i28401b1a51e847faaff27b575452a35f_EquityMethodInvestmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5ef8344f-f535-4837-9a54-b15959dd32b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_206e1ab1-a62e-458b-ae1a-f09b8e2d8244" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5ef8344f-f535-4837-9a54-b15959dd32b6" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_206e1ab1-a62e-458b-ae1a-f09b8e2d8244" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ad39bac0-7c1a-4510-bb36-a112156cfcd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5ef8344f-f535-4837-9a54-b15959dd32b6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ad39bac0-7c1a-4510-bb36-a112156cfcd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7e1ffdd9-480c-4213-8283-239ec6b18f31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5ef8344f-f535-4837-9a54-b15959dd32b6" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7e1ffdd9-480c-4213-8283-239ec6b18f31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_35735db9-e57d-4447-a4ba-69173d4638da" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7e1ffdd9-480c-4213-8283-239ec6b18f31" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_35735db9-e57d-4447-a4ba-69173d4638da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_35735db9-e57d-4447-a4ba-69173d4638da_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_35735db9-e57d-4447-a4ba-69173d4638da" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_35735db9-e57d-4447-a4ba-69173d4638da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5c8a021f-5279-4f16-8586-93d3524d1098" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_35735db9-e57d-4447-a4ba-69173d4638da" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5c8a021f-5279-4f16-8586-93d3524d1098" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_49b44e2d-e21a-4b72-a6ff-2f2dda7f01ca" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5c8a021f-5279-4f16-8586-93d3524d1098" xlink:to="loc_holx_SuperSonicImagineMember_49b44e2d-e21a-4b72-a6ff-2f2dda7f01ca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="extended" id="i0255d5da35b349bc88f033507935b666_RestructuringChargesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="extended" id="iaf97e723ae724ca6bdaab5acd4c60451_RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_f51b213e-d926-410a-9361-9d8baa2d2ae8" xlink:href="holx-20200926.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:to="loc_holx_ReductionOfWorkforceExpenses_f51b213e-d926-410a-9361-9d8baa2d2ae8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_32625e23-42fd-4b6a-869d-58873fe9db8e" xlink:href="holx-20200926.xsd#holx_DivestitureCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:to="loc_holx_DivestitureCharges_32625e23-42fd-4b6a-869d-58873fe9db8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_bef91c67-1e09-4e1a-b8cb-25544b8fe3ec" xlink:href="holx-20200926.xsd#holx_FacilityClosureCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:to="loc_holx_FacilityClosureCosts_bef91c67-1e09-4e1a-b8cb-25544b8fe3ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_0703c6ef-d955-4ed4-b62f-5f8fd6581c8d" xlink:href="holx-20200926.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_0703c6ef-d955-4ed4-b62f-5f8fd6581c8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_901419dd-a267-42d6-ba6a-1b1466e95571" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_901419dd-a267-42d6-ba6a-1b1466e95571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_901419dd-a267-42d6-ba6a-1b1466e95571_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_901419dd-a267-42d6-ba6a-1b1466e95571" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_901419dd-a267-42d6-ba6a-1b1466e95571_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_901419dd-a267-42d6-ba6a-1b1466e95571" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember_0ff4c2c1-ba40-47f4-97c1-ab093f1153c8" xlink:href="holx-20200926.xsd#holx_Fiscal2019ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_Fiscal2019ActionMember_0ff4c2c1-ba40-47f4-97c1-ab093f1153c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember_ff1a7407-36e6-424f-b34c-6468312aae71" xlink:href="holx-20200926.xsd#holx_Fiscal2018ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_Fiscal2018ActionMember_ff1a7407-36e6-424f-b34c-6468312aae71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtheractionMember_1998d066-67d3-46e5-979d-d007d0eb1358" xlink:href="holx-20200926.xsd#holx_OtheractionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_OtheractionMember_1998d066-67d3-46e5-979d-d007d0eb1358" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember_fcb42a46-267d-46ca-9687-b017cd1e3949" xlink:href="holx-20200926.xsd#holx_Fiscal2020ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_Fiscal2020ActionMember_fcb42a46-267d-46ca-9687-b017cd1e3949" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020Member_9727b4be-b23b-4302-8eb6-23a1a77d5f64" xlink:href="holx-20200926.xsd#holx_Fiscal2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_Fiscal2020Member_9727b4be-b23b-4302-8eb6-23a1a77d5f64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ebd01cc9-f333-44a1-ab89-129d8ff52643" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:to="loc_us-gaap_RestructuringPlanAxis_ebd01cc9-f333-44a1-ab89-129d8ff52643" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_ebd01cc9-f333-44a1-ab89-129d8ff52643_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_ebd01cc9-f333-44a1-ab89-129d8ff52643" xlink:to="loc_us-gaap_RestructuringPlanDomain_ebd01cc9-f333-44a1-ab89-129d8ff52643_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_ebd01cc9-f333-44a1-ab89-129d8ff52643" xlink:to="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSeventeenMember_2b51418a-c11d-4c15-847d-0b4bff492193" xlink:href="holx-20200926.xsd#holx_TwoThousandSeventeenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_TwoThousandSeventeenMember_2b51418a-c11d-4c15-847d-0b4bff492193" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwothousandeighteenMember_afb58f92-03ea-40bf-8941-44bc5b7cdeca" xlink:href="holx-20200926.xsd#holx_TwothousandeighteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_TwothousandeighteenMember_afb58f92-03ea-40bf-8941-44bc5b7cdeca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_6cb791f6-813b-4395-a861-bbe0a3ad6282" xlink:href="holx-20200926.xsd#holx_Fiscal2019chargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_Fiscal2019chargesMember_6cb791f6-813b-4395-a861-bbe0a3ad6282" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020Member_0e0e564f-a77f-405b-ba33-88c2cddd8a33" xlink:href="holx-20200926.xsd#holx_Fiscal2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_Fiscal2020Member_0e0e564f-a77f-405b-ba33-88c2cddd8a33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember_d2ae8d1e-5457-4938-9fa1-305f4eefef58" xlink:href="holx-20200926.xsd#holx_Fiscal2020ChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_Fiscal2020ChargesMember_d2ae8d1e-5457-4938-9fa1-305f4eefef58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7865baff-60a8-4ac7-a671-75b9953d0e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7865baff-60a8-4ac7-a671-75b9953d0e1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7865baff-60a8-4ac7-a671-75b9953d0e1a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7865baff-60a8-4ac7-a671-75b9953d0e1a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7865baff-60a8-4ac7-a671-75b9953d0e1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c3f6bdd6-d1c1-4f9d-9e33-d41f55e79e47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7865baff-60a8-4ac7-a671-75b9953d0e1a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c3f6bdd6-d1c1-4f9d-9e33-d41f55e79e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_fcd9d95b-f489-4610-90e2-3ab30a1302d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c3f6bdd6-d1c1-4f9d-9e33-d41f55e79e47" xlink:to="loc_us-gaap_RestructuringChargesMember_fcd9d95b-f489-4610-90e2-3ab30a1302d5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="extended" id="i165321b122d84bb590f0f44847a127b8_RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c8599add-9541-4df9-88f5-ed973a17534b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c8599add-9541-4df9-88f5-ed973a17534b" xlink:to="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f0b25c7d-13ef-413f-8f80-6aa119871faa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_us-gaap_RestructuringReserve_f0b25c7d-13ef-413f-8f80-6aa119871faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_d1ccb55e-7bed-4204-b40f-e37d115fe94d" xlink:href="holx-20200926.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_d1ccb55e-7bed-4204-b40f-e37d115fe94d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_481e1da3-065e-49cf-a39d-4c82e1670a70" xlink:href="holx-20200926.xsd#holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_481e1da3-065e-49cf-a39d-4c82e1670a70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashSeverancePayments_088236cd-cc43-43f5-8284-e8eeb700ce3c" xlink:href="holx-20200926.xsd#holx_CashSeverancePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_holx_CashSeverancePayments_088236cd-cc43-43f5-8284-e8eeb700ce3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherRestructuringPayments_fcf31dd3-c175-4166-8c06-867baed71751" xlink:href="holx-20200926.xsd#holx_OtherRestructuringPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_holx_OtherRestructuringPayments_fcf31dd3-c175-4166-8c06-867baed71751" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7cc311a4-7cd5-4090-8a4f-19717f951142" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c8599add-9541-4df9-88f5-ed973a17534b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_483ac3cb-2778-49e4-896d-7b77c7c8bebe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:to="loc_us-gaap_RestructuringPlanAxis_483ac3cb-2778-49e4-896d-7b77c7c8bebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_483ac3cb-2778-49e4-896d-7b77c7c8bebe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_483ac3cb-2778-49e4-896d-7b77c7c8bebe" xlink:to="loc_us-gaap_RestructuringPlanDomain_483ac3cb-2778-49e4-896d-7b77c7c8bebe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_483ac3cb-2778-49e4-896d-7b77c7c8bebe" xlink:to="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember_1363829a-6c40-4e79-89bd-78eff581dae6" xlink:href="holx-20200926.xsd#holx_Fiscal2020ChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:to="loc_holx_Fiscal2020ChargesMember_1363829a-6c40-4e79-89bd-78eff581dae6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_eaf16d76-6e21-4bd6-b363-c3dc6360290a" xlink:href="holx-20200926.xsd#holx_Fiscal2019chargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:to="loc_holx_Fiscal2019chargesMember_eaf16d76-6e21-4bd6-b363-c3dc6360290a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwothousandeighteenMember_4fabb933-89cf-4d3f-abb7-feceed93c044" xlink:href="holx-20200926.xsd#holx_TwothousandeighteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:to="loc_holx_TwothousandeighteenMember_4fabb933-89cf-4d3f-abb7-feceed93c044" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSeventeenMember_a9079f28-1a3b-4647-ac00-d3606fbd85be" xlink:href="holx-20200926.xsd#holx_TwoThousandSeventeenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:to="loc_holx_TwoThousandSeventeenMember_a9079f28-1a3b-4647-ac00-d3606fbd85be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5510617b-72c2-48dd-bdca-e4e94beef70c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5510617b-72c2-48dd-bdca-e4e94beef70c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5510617b-72c2-48dd-bdca-e4e94beef70c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5510617b-72c2-48dd-bdca-e4e94beef70c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5510617b-72c2-48dd-bdca-e4e94beef70c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5510617b-72c2-48dd-bdca-e4e94beef70c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember_8f644711-2014-4c74-afaf-6e6b1a0d729c" xlink:href="holx-20200926.xsd#holx_Fiscal2020ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_Fiscal2020ActionMember_8f644711-2014-4c74-afaf-6e6b1a0d729c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember_696b904f-504c-4d78-b18e-0a7dc4651f28" xlink:href="holx-20200926.xsd#holx_Fiscal2019ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_Fiscal2019ActionMember_696b904f-504c-4d78-b18e-0a7dc4651f28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember_21b593c5-5334-44c7-a010-a279b878dd3b" xlink:href="holx-20200926.xsd#holx_Fiscal2018ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_Fiscal2018ActionMember_21b593c5-5334-44c7-a010-a279b878dd3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherOperatingCostReductionsMember_9c3280ef-fea9-4ccc-ab5e-7cf304d3c4f1" xlink:href="holx-20200926.xsd#holx_OtherOperatingCostReductionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_OtherOperatingCostReductionsMember_9c3280ef-fea9-4ccc-ab5e-7cf304d3c4f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2017ActionsMember_2eb85966-8192-4dd3-a322-5abe4498a9c2" xlink:href="holx-20200926.xsd#holx_Fiscal2017ActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_Fiscal2017ActionsMember_2eb85966-8192-4dd3-a322-5abe4498a9c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bdb922f0-644d-4078-b021-e4b0b8b7f764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bdb922f0-644d-4078-b021-e4b0b8b7f764" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bdb922f0-644d-4078-b021-e4b0b8b7f764_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bdb922f0-644d-4078-b021-e4b0b8b7f764" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bdb922f0-644d-4078-b021-e4b0b8b7f764_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2a1a96da-0bd4-44c7-86b3-3c0f76ea24b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bdb922f0-644d-4078-b021-e4b0b8b7f764" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2a1a96da-0bd4-44c7-86b3-3c0f76ea24b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_40b57bd0-3a7b-4ee2-b844-67aa5cb614fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2a1a96da-0bd4-44c7-86b3-3c0f76ea24b9" xlink:to="loc_us-gaap_RestructuringChargesMember_40b57bd0-3a7b-4ee2-b844-67aa5cb614fd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="extended" id="ief513eb5abec4f499d77afa7ea77579b_RestructuringChargesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_c8f2b6e7-abb9-4a88-8e41-44be6a06f376" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_us-gaap_SeveranceCosts1_c8f2b6e7-abb9-4a88-8e41-44be6a06f376" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_3efcd535-bee3-4c77-82ae-31487b28f2a4" xlink:href="holx-20200926.xsd#holx_FacilityClosureCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_FacilityClosureCosts_3efcd535-bee3-4c77-82ae-31487b28f2a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Propertyclosurecostpayment_44c6af2e-d0d0-4b34-b046-b87f123fb7e7" xlink:href="holx-20200926.xsd#holx_Propertyclosurecostpayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_Propertyclosurecostpayment_44c6af2e-d0d0-4b34-b046-b87f123fb7e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Propertyclosurebenefit_6292d7f9-761e-4e1a-82f9-880a98856099" xlink:href="holx-20200926.xsd#holx_Propertyclosurebenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_Propertyclosurebenefit_6292d7f9-761e-4e1a-82f9-880a98856099" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_1a595dca-3899-4a9e-956c-232cacca5fb8" xlink:href="holx-20200926.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_ReductionOfWorkforceExpenses_1a595dca-3899-4a9e-956c-232cacca5fb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_d532a8f3-856b-4676-8938-7f070035368d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_d532a8f3-856b-4676-8938-7f070035368d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ExpectedFutureSeveranceCharges_b31378b9-ef50-4e38-90a3-0c517a8a263d" xlink:href="holx-20200926.xsd#holx_ExpectedFutureSeveranceCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_ExpectedFutureSeveranceCharges_b31378b9-ef50-4e38-90a3-0c517a8a263d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RemainingLeaseBalance_3a00addb-e080-46a8-ad6c-a9dc0fe54075" xlink:href="holx-20200926.xsd#holx_RemainingLeaseBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_RemainingLeaseBalance_3a00addb-e080-46a8-ad6c-a9dc0fe54075" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_f13e9a5c-37b0-41b0-97f3-52899fb7e5d1" xlink:href="holx-20200926.xsd#holx_DivestitureCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_DivestitureCharges_f13e9a5c-37b0-41b0-97f3-52899fb7e5d1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d7d8fa58-21d8-4958-a892-516574cc68d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d7d8fa58-21d8-4958-a892-516574cc68d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d7d8fa58-21d8-4958-a892-516574cc68d6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d7d8fa58-21d8-4958-a892-516574cc68d6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d7d8fa58-21d8-4958-a892-516574cc68d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d1392684-c933-4a45-8353-489ddc2de652" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d7d8fa58-21d8-4958-a892-516574cc68d6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d1392684-c933-4a45-8353-489ddc2de652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_41c89ef7-c967-4340-b678-294ad3c51b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1392684-c933-4a45-8353-489ddc2de652" xlink:to="loc_us-gaap_RestructuringChargesMember_41c89ef7-c967-4340-b678-294ad3c51b5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_bfdfae82-0de0-46ea-86f3-cc3f160026b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:to="loc_us-gaap_RestructuringPlanAxis_bfdfae82-0de0-46ea-86f3-cc3f160026b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bfdfae82-0de0-46ea-86f3-cc3f160026b1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_bfdfae82-0de0-46ea-86f3-cc3f160026b1" xlink:to="loc_us-gaap_RestructuringPlanDomain_bfdfae82-0de0-46ea-86f3-cc3f160026b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_bfdfae82-0de0-46ea-86f3-cc3f160026b1" xlink:to="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_a4e6f29b-997e-48b1-98fa-5c0f44362472" xlink:href="holx-20200926.xsd#holx_CynosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_holx_CynosureMember_a4e6f29b-997e-48b1-98fa-5c0f44362472" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BedfordMember_4c711785-f4d1-43df-8393-ce1bc746dd52" xlink:href="holx-20200926.xsd#holx_BedfordMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_holx_BedfordMember_4c711785-f4d1-43df-8393-ce1bc746dd52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_298cfda9-779a-4213-b9eb-e045074e7b7d" xlink:href="holx-20200926.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_holx_InternationalMember_298cfda9-779a-4213-b9eb-e045074e7b7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_5118fa6c-3df8-44ba-97d6-92171bc5aa1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_us-gaap_RestructuringChargesMember_5118fa6c-3df8-44ba-97d6-92171bc5aa1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LybertyWayMember_4d3a81d6-e1f3-4e60-9037-e8e5660fb9c3" xlink:href="holx-20200926.xsd#holx_LybertyWayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_holx_LybertyWayMember_4d3a81d6-e1f3-4e60-9037-e8e5660fb9c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityByLocationAxis_4e15fc73-9f91-4db8-9173-2aaa5efeb9f4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityByLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:to="loc_dei_EntityByLocationAxis_4e15fc73-9f91-4db8-9173-2aaa5efeb9f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocationDomain_4e15fc73-9f91-4db8-9173-2aaa5efeb9f4_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityByLocationAxis_4e15fc73-9f91-4db8-9173-2aaa5efeb9f4" xlink:to="loc_dei_LocationDomain_4e15fc73-9f91-4db8-9173-2aaa5efeb9f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocationDomain_236c8f35-f288-4d9e-ab93-f5ac38379d6d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityByLocationAxis_4e15fc73-9f91-4db8-9173-2aaa5efeb9f4" xlink:to="loc_dei_LocationDomain_236c8f35-f288-4d9e-ab93-f5ac38379d6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TepnelMember_75d34bac-6f10-4407-afc7-dbeb1645176e" xlink:href="holx-20200926.xsd#holx_TepnelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_LocationDomain_236c8f35-f288-4d9e-ab93-f5ac38379d6d" xlink:to="loc_holx_TepnelMember_75d34bac-6f10-4407-afc7-dbeb1645176e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_9793b609-506b-4b66-8bd1-41ac4d511b7e" xlink:href="holx-20200926.xsd#holx_CynosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_LocationDomain_236c8f35-f288-4d9e-ab93-f5ac38379d6d" xlink:to="loc_holx_CynosureMember_9793b609-506b-4b66-8bd1-41ac4d511b7e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangements"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended" id="i56cb2842d83341d08c5b36f0d3f433b8_BorrowingsandCreditArrangements"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended" id="i438eb4d431da4511a3316045ba400b13_BorrowingsandCreditArrangementsTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended" id="id37e8258478e4dadb0bd8a9ab64a1abd_BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8dc202ca-cb1c-48e1-a070-730178070ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:to="loc_us-gaap_LongTermDebtCurrent_8dc202ca-cb1c-48e1-a070-730178070ed4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c576d14c-780c-4dbd-b942-b2ee9e0bfa57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c576d14c-780c-4dbd-b942-b2ee9e0bfa57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_42bdf5f9-d7c4-4eb4-9149-ae4296d694f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:to="loc_us-gaap_LongTermDebt_42bdf5f9-d7c4-4eb4-9149-ae4296d694f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_558bc6d8-e9a3-4c40-9896-03a3b9aac31f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:to="loc_us-gaap_DebtInstrumentTable_558bc6d8-e9a3-4c40-9896-03a3b9aac31f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_29856fd9-cfe2-4246-bf98-c29df865eb19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_558bc6d8-e9a3-4c40-9896-03a3b9aac31f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_29856fd9-cfe2-4246-bf98-c29df865eb19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_29856fd9-cfe2-4246-bf98-c29df865eb19_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_29856fd9-cfe2-4246-bf98-c29df865eb19" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_29856fd9-cfe2-4246-bf98-c29df865eb19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_29856fd9-cfe2-4246-bf98-c29df865eb19" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_5c7f4b76-3596-4533-b1fa-646bec42e410" xlink:href="holx-20200926.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_TermLoanMember_5c7f4b76-3596-4533-b1fa-646bec42e410" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_38ad1c5b-1987-4471-81eb-c29177ff2cc3" xlink:href="holx-20200926.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_RevolverMember_38ad1c5b-1987-4471-81eb-c29177ff2cc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_fc1db549-b796-453b-9187-a34012c29b6f" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_fc1db549-b796-453b-9187-a34012c29b6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_598140b0-0f9d-48a7-a0ee-c4d4a2d5eca6" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_A2025SeniorNotesMember_598140b0-0f9d-48a7-a0ee-c4d4a2d5eca6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_cf845588-85b3-4cf7-98a7-211033809b2e" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_A2028SeniorNotesMember_cf845588-85b3-4cf7-98a7-211033809b2e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="extended" id="i4418464ef2f745b290a4857e2126e1ae_BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ebdef8f7-3460-48c9-9420-479a37cae4e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ebdef8f7-3460-48c9-9420-479a37cae4e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c6948ac2-18fe-4000-9083-520ba734e9eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c6948ac2-18fe-4000-9083-520ba734e9eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5013be3d-4ef3-4f75-96e4-84fa160746c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5013be3d-4ef3-4f75-96e4-84fa160746c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_28371d64-00ff-48f4-ac80-d0a85889f9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_28371d64-00ff-48f4-ac80-d0a85889f9cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_422589eb-5346-496b-a964-293bd290a999" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_422589eb-5346-496b-a964-293bd290a999" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_999fd3e6-8e15-4c06-9907-4535d281bfb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_999fd3e6-8e15-4c06-9907-4535d281bfb3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_88304fa9-dcf1-4845-8695-3dd7ca0f1bde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_88304fa9-dcf1-4845-8695-3dd7ca0f1bde" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e50cf100-d8aa-464b-a3cc-a39db3f430b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_DebtInstrumentTable_e50cf100-d8aa-464b-a3cc-a39db3f430b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8ff5c903-bb66-4822-b396-ac8db2965d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e50cf100-d8aa-464b-a3cc-a39db3f430b9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8ff5c903-bb66-4822-b396-ac8db2965d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8ff5c903-bb66-4822-b396-ac8db2965d2d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8ff5c903-bb66-4822-b396-ac8db2965d2d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8ff5c903-bb66-4822-b396-ac8db2965d2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8ff5c903-bb66-4822-b396-ac8db2965d2d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_bc4e783f-d422-464c-a855-227fd6014f72" xlink:href="holx-20200926.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:to="loc_holx_TermLoanMember_bc4e783f-d422-464c-a855-227fd6014f72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_cde88fcc-85a5-4e59-b8c7-d314d08e04c2" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_cde88fcc-85a5-4e59-b8c7-d314d08e04c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_06d528a1-be28-4b80-8dac-92effe23b2e9" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:to="loc_holx_A2025SeniorNotesMember_06d528a1-be28-4b80-8dac-92effe23b2e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_ce651c8b-7463-44c5-87c2-b2cfaf60f4f5" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:to="loc_holx_A2028SeniorNotesMember_ce651c8b-7463-44c5-87c2-b2cfaf60f4f5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended" id="i12a51df44f6f47bab09bf0fb2fbda9e2_BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_5f20bd96-7048-4553-9d2f-aeae0008ff0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:to="loc_us-gaap_InterestExpenseBorrowings_5f20bd96-7048-4553-9d2f-aeae0008ff0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b4b312fd-c7e8-47e8-9c59-1e0c508f3e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b4b312fd-c7e8-47e8-9c59-1e0c508f3e8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_242a9c0f-1142-4a37-bdeb-475656a4b5ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_242a9c0f-1142-4a37-bdeb-475656a4b5ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_fa0fc2ff-785a-4b8a-bae4-75e6b5644694" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_fa0fc2ff-785a-4b8a-bae4-75e6b5644694" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e47a00a2-6035-4eb2-be35-78aa776d04bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e47a00a2-6035-4eb2-be35-78aa776d04bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_af8b0ffc-2205-4918-9726-d9423c013c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e47a00a2-6035-4eb2-be35-78aa776d04bb" xlink:to="loc_us-gaap_DebtInstrumentAxis_af8b0ffc-2205-4918-9726-d9423c013c2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_af8b0ffc-2205-4918-9726-d9423c013c2a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_af8b0ffc-2205-4918-9726-d9423c013c2a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_af8b0ffc-2205-4918-9726-d9423c013c2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_af8b0ffc-2205-4918-9726-d9423c013c2a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2018Member_9dff0c18-20d2-4a28-b1cc-5e0ae9b7cac0" xlink:href="holx-20200926.xsd#holx_CreditAgreement2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:to="loc_holx_CreditAgreement2018Member_9dff0c18-20d2-4a28-b1cc-5e0ae9b7cac0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member_d0d00403-c042-4776-9ce0-c6c08e04c128" xlink:href="holx-20200926.xsd#holx_CreditAgreement2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:to="loc_holx_CreditAgreement2017Member_d0d00403-c042-4776-9ce0-c6c08e04c128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember_97bb78de-76a3-4f55-8690-297d108b7280" xlink:href="holx-20200926.xsd#holx_CreditAgreementPriorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:to="loc_holx_CreditAgreementPriorMember_97bb78de-76a3-4f55-8690-297d108b7280" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended" id="ib5bbaaf1a76d4a5f8451ce4498ef9377_BorrowingsandCreditArrangementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4d996214-4942-4a53-ae1f-ae65d8b685c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4d996214-4942-4a53-ae1f-ae65d8b685c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1eda578b-9592-47e4-8764-2a10b3007334" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1eda578b-9592-47e4-8764-2a10b3007334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_cb1c7acb-9b64-4193-8359-f3b5d01b96da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_cb1c7acb-9b64-4193-8359-f3b5d01b96da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cf474d6c-3d64-4e45-b859-ec2d0c91ccec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cf474d6c-3d64-4e45-b859-ec2d0c91ccec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_843ce2c0-9d30-4ad8-b5cd-ecce8cfa6d81" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_843ce2c0-9d30-4ad8-b5cd-ecce8cfa6d81" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_ac6b2f8a-c5f9-4886-8d3a-260458f98c7e" xlink:href="holx-20200926.xsd#holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_ac6b2f8a-c5f9-4886-8d3a-260458f98c7e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeverageRatioMaximum_8ea372d4-04e4-43cf-9261-2eafbe4ea3c7" xlink:href="holx-20200926.xsd#holx_LeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_LeverageRatioMaximum_8ea372d4-04e4-43cf-9261-2eafbe4ea3c7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestCoverageRatio_eacbee4f-0961-463c-93a7-375237db3e33" xlink:href="holx-20200926.xsd#holx_InterestCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_InterestCoverageRatio_eacbee4f-0961-463c-93a7-375237db3e33" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f228921-8355-4a3c-a0cb-eb7072f15fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f228921-8355-4a3c-a0cb-eb7072f15fe5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentNumberOfInstruments_42205f7b-5122-4f4f-8088-ec46c8b96d11" xlink:href="holx-20200926.xsd#holx_DebtInstrumentNumberOfInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentNumberOfInstruments_42205f7b-5122-4f4f-8088-ec46c8b96d11" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_a7c58f46-513a-4cb6-a681-beb17aa4c0ca" xlink:href="holx-20200926.xsd#holx_MaximumRangeofPresentValueofCashFlowPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_a7c58f46-513a-4cb6-a681-beb17aa4c0ca" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DirectThirdPartyCostsinterestExpense_a4d3f2f6-303a-4168-a78d-08000a1f019b" xlink:href="holx-20200926.xsd#holx_DirectThirdPartyCostsinterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DirectThirdPartyCostsinterestExpense_a4d3f2f6-303a-4168-a78d-08000a1f019b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cde91fb9-4674-4bfb-be8f-4066738abf95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cde91fb9-4674-4bfb-be8f-4066738abf95" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_50707dae-fe27-459b-b99a-bde124672886" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_50707dae-fe27-459b-b99a-bde124672886" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_e18ce4bf-646a-400c-a441-9ed2efc20e04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_e18ce4bf-646a-400c-a441-9ed2efc20e04" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2a30622f-5751-4e81-b8b3-bebc0e6074f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2a30622f-5751-4e81-b8b3-bebc0e6074f7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtIssuanceCostsReallocatedUponDebtModification_f6a930d9-d878-40d7-ab1f-f839f9a2a85b" xlink:href="holx-20200926.xsd#holx_DebtIssuanceCostsReallocatedUponDebtModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtIssuanceCostsReallocatedUponDebtModification_f6a930d9-d878-40d7-ab1f-f839f9a2a85b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtDiscountReallocatedUponDebtModification_0467210a-8e4f-4c4b-a1c3-a44082f10287" xlink:href="holx-20200926.xsd#holx_DebtDiscountReallocatedUponDebtModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtDiscountReallocatedUponDebtModification_0467210a-8e4f-4c4b-a1c3-a44082f10287" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_8f5b848f-20c9-4a96-ae01-27476f332b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_8f5b848f-20c9-4a96-ae01-27476f332b2a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_9af3201d-78a9-411a-bb95-6c4d910d6edb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_SeniorNotes_9af3201d-78a9-411a-bb95-6c4d910d6edb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_a72d3936-daa0-4fe0-92ba-48a464e0c9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_a72d3936-daa0-4fe0-92ba-48a464e0c9a0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_9e9c8aab-5c2f-4127-89cf-d92e23e6f4f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_InterestExpenseDebt_9e9c8aab-5c2f-4127-89cf-d92e23e6f4f2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_5f0f33c4-42b3-43da-bfe3-20a705727c4a" xlink:href="holx-20200926.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_PrincipalAmountOfBorrowings_5f0f33c4-42b3-43da-bfe3-20a705727c4a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_4dc128a2-5945-4134-aa90-25232fd0a563" xlink:href="holx-20200926.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_4dc128a2-5945-4134-aa90-25232fd0a563" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OfferingPriceofPrincipalAmount_77db770d-ae94-45bd-95a2-294f7c7e4b72" xlink:href="holx-20200926.xsd#holx_OfferingPriceofPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_OfferingPriceofPrincipalAmount_77db770d-ae94-45bd-95a2-294f7c7e4b72" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MakeWholeProvision_e69a8b8b-3eb4-46a6-9f68-fc478d2ca110" xlink:href="holx-20200926.xsd#holx_MakeWholeProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_MakeWholeProvision_e69a8b8b-3eb4-46a6-9f68-fc478d2ca110" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_e449e931-cc06-4546-b988-339a7e4e3660" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_e449e931-cc06-4546-b988-339a7e4e3660" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_605c1799-480b-4f32-a09b-7eaa3fb83fae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_605c1799-480b-4f32-a09b-7eaa3fb83fae" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_ebbe9ece-b73c-4c01-a323-e19c1731b0b3" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_ebbe9ece-b73c-4c01-a323-e19c1731b0b3" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_6d8823d1-f235-4f8e-9306-ba9c17d238c0" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_6d8823d1-f235-4f8e-9306-ba9c17d238c0" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_933439d9-8d29-4060-a022-df6f11d16df5" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_933439d9-8d29-4060-a022-df6f11d16df5" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_3a04d8bf-049b-4153-9e8f-7b2047be556c" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_3a04d8bf-049b-4153-9e8f-7b2047be556c" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest_4e2839d2-6968-4229-8c96-d9b2133ad6b2" xlink:href="holx-20200926.xsd#holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest_4e2839d2-6968-4229-8c96-d9b2133ad6b2" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_9420aa6a-e506-4755-b8f1-7c568f23e86c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_9420aa6a-e506-4755-b8f1-7c568f23e86c" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxesReacquisitionofEquityComponent_24f4122a-4c55-4d61-b041-f8f792d47ffc" xlink:href="holx-20200926.xsd#holx_DeferredTaxesReacquisitionofEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DeferredTaxesReacquisitionofEquityComponent_24f4122a-4c55-4d61-b041-f8f792d47ffc" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Debtinstrumentremainingtoberedeemed_42a41c8b-2a05-4f0c-80c1-d79e0bcca741" xlink:href="holx-20200926.xsd#holx_Debtinstrumentremainingtoberedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_Debtinstrumentremainingtoberedeemed_42a41c8b-2a05-4f0c-80c1-d79e0bcca741" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_b094e7e1-bd68-4b85-b1a7-2695584c4774" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_b094e7e1-bd68-4b85-b1a7-2695584c4774" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermARSecuritizationProgram_03b5fb4e-1ca6-4adc-80ea-34bbd293f79e" xlink:href="holx-20200926.xsd#holx_TermARSecuritizationProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_TermARSecuritizationProgram_03b5fb4e-1ca6-4adc-80ea-34bbd293f79e" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization_19a9f5a3-f910-4f16-9fd8-80483e2112e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_AccountsReceivableFromSecuritization_19a9f5a3-f910-4f16-9fd8-80483e2112e2" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumBorrowingUnderSecuritizationProgram_587ee2fe-c7f4-4b74-8f29-8b4f918498b9" xlink:href="holx-20200926.xsd#holx_MaximumBorrowingUnderSecuritizationProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_MaximumBorrowingUnderSecuritizationProgram_587ee2fe-c7f4-4b74-8f29-8b4f918498b9" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ae3caba8-90f7-4e4e-ac85-7003763138ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ae3caba8-90f7-4e4e-ac85-7003763138ab" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_4a861951-8833-4c8f-9694-4c4b6fc9b8fd" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_4a861951-8833-4c8f-9694-4c4b6fc9b8fd" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_689cf195-2401-4c80-86ce-07a4a25dc1ba" xlink:href="holx-20200926.xsd#holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_689cf195-2401-4c80-86ce-07a4a25dc1ba" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_7b8d44d7-8f53-4ee6-bf30-e42bb4229f29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_7b8d44d7-8f53-4ee6-bf30-e42bb4229f29" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_e2d24a47-fe52-41d1-aa60-ce8069189212" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_RepaymentsOfDebt_e2d24a47-fe52-41d1-aa60-ce8069189212" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_45fd6e38-5e6e-4c09-b7a0-c8e735e8a7cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_45fd6e38-5e6e-4c09-b7a0-c8e735e8a7cf" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_fa3e5387-3522-4a31-bd10-2b0b331e53a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_fa3e5387-3522-4a31-bd10-2b0b331e53a6" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e2c31643-f834-4406-864a-76cd63498e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e2c31643-f834-4406-864a-76cd63498e3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e2c31643-f834-4406-864a-76cd63498e3d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e2c31643-f834-4406-864a-76cd63498e3d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e2c31643-f834-4406-864a-76cd63498e3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e2c31643-f834-4406-864a-76cd63498e3d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember_9edda31c-4514-4b49-b7f2-c68d2b19cd25" xlink:href="holx-20200926.xsd#holx_SecuredTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_SecuredTermLoanMember_9edda31c-4514-4b49-b7f2-c68d2b19cd25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_c25d2d96-3b51-41da-8e3a-0278a30152ed" xlink:href="holx-20200926.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_RevolverMember_c25d2d96-3b51-41da-8e3a-0278a30152ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9976bdee-ec92-49f2-90b9-aba3c75dc431" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_us-gaap_LineOfCreditMember_9976bdee-ec92-49f2-90b9-aba3c75dc431" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1265e120-7576-4f45-a514-589bd7d25968" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_us-gaap_SeniorNotesMember_1265e120-7576-4f45-a514-589bd7d25968" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSevenNotesMember_4cbff681-dc18-47d0-96d2-ba916f559d99" xlink:href="holx-20200926.xsd#holx_TwoThousandSevenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_TwoThousandSevenNotesMember_4cbff681-dc18-47d0-96d2-ba916f559d99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NovemberEighteenTwoThousandTenOriginalNotesMember_6f346ef7-62d8-4913-b2a2-06f3afc121f6" xlink:href="holx-20200926.xsd#holx_NovemberEighteenTwoThousandTenOriginalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_NovemberEighteenTwoThousandTenOriginalNotesMember_6f346ef7-62d8-4913-b2a2-06f3afc121f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember_ef6373c8-bbb6-410e-add8-1d0041f0e1d7" xlink:href="holx-20200926.xsd#holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember_ef6373c8-bbb6-410e-add8-1d0041f0e1d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember_46e77333-b6cb-4d27-ac01-cb3d1ea24d0c" xlink:href="holx-20200926.xsd#holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember_46e77333-b6cb-4d27-ac01-cb3d1ea24d0c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_0ed58781-5ee2-47db-9d60-c93138dd449c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_0ed58781-5ee2-47db-9d60-c93138dd449c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_436ea3ee-ca0f-43ec-848f-0b589c15550c" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_436ea3ee-ca0f-43ec-848f-0b589c15550c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_a0a854cb-ba6e-48bb-82a8-f9f89a11c97f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_us-gaap_ConvertibleDebtMember_a0a854cb-ba6e-48bb-82a8-f9f89a11c97f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_54145159-7a69-482b-9d9e-7c0c0fe7b50e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_DebtInstrumentAxis_54145159-7a69-482b-9d9e-7c0c0fe7b50e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_54145159-7a69-482b-9d9e-7c0c0fe7b50e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_54145159-7a69-482b-9d9e-7c0c0fe7b50e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_54145159-7a69-482b-9d9e-7c0c0fe7b50e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_54145159-7a69-482b-9d9e-7c0c0fe7b50e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoan2018Member_8ef6ece0-d949-4e21-aa02-2079589ec738" xlink:href="holx-20200926.xsd#holx_AmendedTermLoan2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_AmendedTermLoan2018Member_8ef6ece0-d949-4e21-aa02-2079589ec738" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedRevolver2018Member_61bb97f6-7830-4223-b0ca-41cb560a26a3" xlink:href="holx-20200926.xsd#holx_AmendedRevolver2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_AmendedRevolver2018Member_61bb97f6-7830-4223-b0ca-41cb560a26a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedCreditFacility2018Member_9af741e7-99af-4002-933b-0c72a1d9162c" xlink:href="holx-20200926.xsd#holx_AmendedCreditFacility2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_AmendedCreditFacility2018Member_9af741e7-99af-4002-933b-0c72a1d9162c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member_b5ac096f-725b-4178-869f-ed3cad460bb3" xlink:href="holx-20200926.xsd#holx_CreditAgreement2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_CreditAgreement2017Member_b5ac096f-725b-4178-869f-ed3cad460bb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoan2017Member_b0b208f0-3e88-4533-b6d6-f8c4f477a6d1" xlink:href="holx-20200926.xsd#holx_TermLoan2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_TermLoan2017Member_b0b208f0-3e88-4533-b6d6-f8c4f477a6d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Revolver2017Member_5c9966ab-8695-4af0-92ed-bc1fa120f163" xlink:href="holx-20200926.xsd#holx_Revolver2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_Revolver2017Member_5c9966ab-8695-4af0-92ed-bc1fa120f163" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember_a6801c78-1337-4ab6-9e47-c2b56db0f0fd" xlink:href="holx-20200926.xsd#holx_CreditAgreementPriorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_CreditAgreementPriorMember_a6801c78-1337-4ab6-9e47-c2b56db0f0fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_60d3ec1c-4b47-46ec-b1a8-eaf29bc4a68b" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2025SeniorNotesMember_60d3ec1c-4b47-46ec-b1a8-eaf29bc4a68b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_19a35472-02e6-49fe-b6b7-c05ce44c907c" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2028SeniorNotesMember_19a35472-02e6-49fe-b6b7-c05ce44c907c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2022NotesMember_a5ac0c4f-36f8-4c2d-9e99-f0ddbe9dcd27" xlink:href="holx-20200926.xsd#holx_A2022NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2022NotesMember_a5ac0c4f-36f8-4c2d-9e99-f0ddbe9dcd27" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConvertibleNotesMember_4aca742c-eb10-4493-8b9a-5647d60e9b29" xlink:href="holx-20200926.xsd#holx_ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_ConvertibleNotesMember_4aca742c-eb10-4493-8b9a-5647d60e9b29" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2012NotesMember_1f748c6a-9314-41f3-87cb-8a141a777474" xlink:href="holx-20200926.xsd#holx_A2012NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2012NotesMember_1f748c6a-9314-41f3-87cb-8a141a777474" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2013NotesMember_f1b8a6f5-1b8f-4480-980d-dbce688e9a66" xlink:href="holx-20200926.xsd#holx_A2013NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2013NotesMember_f1b8a6f5-1b8f-4480-980d-dbce688e9a66" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_66392dda-32bf-4d82-89ab-af704f6b3eea" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_66392dda-32bf-4d82-89ab-af704f6b3eea" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2042NotesMember_982ff5a0-a5be-4888-80d6-026c0d34ef16" xlink:href="holx-20200926.xsd#holx_A2042NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2042NotesMember_982ff5a0-a5be-4888-80d6-026c0d34ef16" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_ee69fd11-b719-4de3-8dc4-be5ec7ca0aa7" xlink:href="holx-20200926.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2029SeniorNotesMember_ee69fd11-b719-4de3-8dc4-be5ec7ca0aa7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_265873af-2ef2-433c-acf5-8db72f948030" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_FinancialInstrumentAxis_265873af-2ef2-433c-acf5-8db72f948030" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_265873af-2ef2-433c-acf5-8db72f948030_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_265873af-2ef2-433c-acf5-8db72f948030" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_265873af-2ef2-433c-acf5-8db72f948030_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_43b5480d-4cb5-48b1-a245-bb4f01db27f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_265873af-2ef2-433c-acf5-8db72f948030" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_43b5480d-4cb5-48b1-a245-bb4f01db27f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSevenNotesMember_e42ad1be-cf0c-4920-9576-1e60c1d68cd1" xlink:href="holx-20200926.xsd#holx_TwoThousandSevenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_43b5480d-4cb5-48b1-a245-bb4f01db27f8" xlink:to="loc_holx_TwoThousandSevenNotesMember_e42ad1be-cf0c-4920-9576-1e60c1d68cd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2712d7ef-c385-4b84-af85-2c2f9a4e980c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_VariableRateAxis_2712d7ef-c385-4b84-af85-2c2f9a4e980c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2712d7ef-c385-4b84-af85-2c2f9a4e980c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_2712d7ef-c385-4b84-af85-2c2f9a4e980c" xlink:to="loc_us-gaap_VariableRateDomain_2712d7ef-c385-4b84-af85-2c2f9a4e980c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_04953f21-674b-4884-9c4a-80e88ebec0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_2712d7ef-c385-4b84-af85-2c2f9a4e980c" xlink:to="loc_us-gaap_VariableRateDomain_04953f21-674b-4884-9c4a-80e88ebec0a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ea78b9e9-cdda-4c7d-bcd3-04c4d92ad473" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_04953f21-674b-4884-9c4a-80e88ebec0a3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ea78b9e9-cdda-4c7d-bcd3-04c4d92ad473" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c7db34fd-ba1f-4b99-ae8d-125e62b76fba" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_srt_StatementScenarioAxis_c7db34fd-ba1f-4b99-ae8d-125e62b76fba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c7db34fd-ba1f-4b99-ae8d-125e62b76fba_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_c7db34fd-ba1f-4b99-ae8d-125e62b76fba" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c7db34fd-ba1f-4b99-ae8d-125e62b76fba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_17d130c3-b5ac-4c57-b57f-8e300f841322" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_c7db34fd-ba1f-4b99-ae8d-125e62b76fba" xlink:to="loc_srt_ScenarioUnspecifiedDomain_17d130c3-b5ac-4c57-b57f-8e300f841322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_f3b1a32d-06fa-4c3d-86e1-382e5c9af1f0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_17d130c3-b5ac-4c57-b57f-8e300f841322" xlink:to="loc_srt_ScenarioForecastMember_f3b1a32d-06fa-4c3d-86e1-382e5c9af1f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3f1752ad-0a9c-4c33-9343-e3dbd6832316" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3f1752ad-0a9c-4c33-9343-e3dbd6832316" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3f1752ad-0a9c-4c33-9343-e3dbd6832316_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3f1752ad-0a9c-4c33-9343-e3dbd6832316" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3f1752ad-0a9c-4c33-9343-e3dbd6832316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3f1752ad-0a9c-4c33-9343-e3dbd6832316" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_535e06d3-2d81-43f2-8c5c-857d5859d765" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_535e06d3-2d81-43f2-8c5c-857d5859d765" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e0d25340-8354-4f2f-afe9-98436420f750" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e0d25340-8354-4f2f-afe9-98436420f750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_666caa31-de22-4f4a-9188-4c405fcb6698" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_666caa31-de22-4f4a-9188-4c405fcb6698" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_fbff6fa5-9691-4a69-86e0-fed876e4d64b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_fbff6fa5-9691-4a69-86e0-fed876e4d64b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_41ab8166-f1f4-48bc-882c-4375355e0838" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_41ab8166-f1f4-48bc-882c-4375355e0838" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7a55bc99-fa4b-47f5-a15d-42756a749a50" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_srt_RangeAxis_7a55bc99-fa4b-47f5-a15d-42756a749a50" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7a55bc99-fa4b-47f5-a15d-42756a749a50_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7a55bc99-fa4b-47f5-a15d-42756a749a50" xlink:to="loc_srt_RangeMember_7a55bc99-fa4b-47f5-a15d-42756a749a50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1c6908bc-3f8f-4003-bc29-cc8e04e87fd7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7a55bc99-fa4b-47f5-a15d-42756a749a50" xlink:to="loc_srt_RangeMember_1c6908bc-3f8f-4003-bc29-cc8e04e87fd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9ae9d74f-9b81-4f0d-b172-0ad5c5a44b3b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1c6908bc-3f8f-4003-bc29-cc8e04e87fd7" xlink:to="loc_srt_MinimumMember_9ae9d74f-9b81-4f0d-b172-0ad5c5a44b3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2edb77ae-79a0-4393-b839-3b81916e6188" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1c6908bc-3f8f-4003-bc29-cc8e04e87fd7" xlink:to="loc_srt_MaximumMember_2edb77ae-79a0-4393-b839-3b81916e6188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e7b4b536-fb87-42be-9290-d673cd2eaf1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e7b4b536-fb87-42be-9290-d673cd2eaf1f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e7b4b536-fb87-42be-9290-d673cd2eaf1f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e7b4b536-fb87-42be-9290-d673cd2eaf1f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e7b4b536-fb87-42be-9290-d673cd2eaf1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fd378900-d4ce-4c95-b0b8-a3cbedb25827" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e7b4b536-fb87-42be-9290-d673cd2eaf1f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fd378900-d4ce-4c95-b0b8-a3cbedb25827" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_349c19e7-ddba-44cf-ad24-57bb341412ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_fd378900-d4ce-4c95-b0b8-a3cbedb25827" xlink:to="loc_us-gaap_SubsequentEventMember_349c19e7-ddba-44cf-ad24-57bb341412ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended" id="i882cde8eb47f44d9b2bc31297d4cc7e8_BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_24de15d1-0fae-41e8-9be2-49563eaa4524" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:to="loc_us-gaap_InterestExpenseBorrowings_24de15d1-0fae-41e8-9be2-49563eaa4524" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_08bebffa-7737-4ce7-b99f-33ec2f3f7829" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_08bebffa-7737-4ce7-b99f-33ec2f3f7829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6d36ab8a-7ba0-4923-8b5c-aa0cad6c6b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6d36ab8a-7ba0-4923-8b5c-aa0cad6c6b9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9bff292e-6c39-4201-a986-0cda0dade32a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:to="loc_us-gaap_DebtInstrumentTable_9bff292e-6c39-4201-a986-0cda0dade32a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_02b587dc-18ba-4733-a8b8-28630effff43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9bff292e-6c39-4201-a986-0cda0dade32a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_02b587dc-18ba-4733-a8b8-28630effff43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_02b587dc-18ba-4733-a8b8-28630effff43_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_02b587dc-18ba-4733-a8b8-28630effff43" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_02b587dc-18ba-4733-a8b8-28630effff43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_03dad57d-0b47-4afc-9cbb-9aafffc293a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_02b587dc-18ba-4733-a8b8-28630effff43" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_03dad57d-0b47-4afc-9cbb-9aafffc293a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_32c086e7-af4c-49c4-b442-39d456eb1b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_03dad57d-0b47-4afc-9cbb-9aafffc293a9" xlink:to="loc_us-gaap_SeniorNotesMember_32c086e7-af4c-49c4-b442-39d456eb1b9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9477ebff-057a-4610-8a7a-d841ea91a18a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9bff292e-6c39-4201-a986-0cda0dade32a" xlink:to="loc_us-gaap_DebtInstrumentAxis_9477ebff-057a-4610-8a7a-d841ea91a18a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9477ebff-057a-4610-8a7a-d841ea91a18a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9477ebff-057a-4610-8a7a-d841ea91a18a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9477ebff-057a-4610-8a7a-d841ea91a18a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9477ebff-057a-4610-8a7a-d841ea91a18a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_2dbbe2ef-caf1-45e9-943e-becd0b164e33" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:to="loc_holx_A2028SeniorNotesMember_2dbbe2ef-caf1-45e9-943e-becd0b164e33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_09339a49-b69e-4dbf-af4b-73f3bba8f47b" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:to="loc_holx_A2025SeniorNotesMember_09339a49-b69e-4dbf-af4b-73f3bba8f47b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2022SeniorNotesMember_74adc951-6c63-4a34-b440-88e1fe110165" xlink:href="holx-20200926.xsd#holx_A2022SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:to="loc_holx_A2022SeniorNotesMember_74adc951-6c63-4a34-b440-88e1fe110165" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail" xlink:type="extended" id="i5f152910063646db87f85b7f9201954c_BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_93e0340f-3e85-49bb-a2bd-52ebb536e1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_93e0340f-3e85-49bb-a2bd-52ebb536e1d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationOfDeferredFinancingCosts_028441b3-ba26-47d1-be88-af315b687b99" xlink:href="holx-20200926.xsd#holx_AmortizationOfDeferredFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_holx_AmortizationOfDeferredFinancingCosts_028441b3-ba26-47d1-be88-af315b687b99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasePrincipalAmountForAccretionValue_40092d2b-9bd6-486c-a153-8dff3b40c53e" xlink:href="holx-20200926.xsd#holx_BasePrincipalAmountForAccretionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_holx_BasePrincipalAmountForAccretionValue_40092d2b-9bd6-486c-a153-8dff3b40c53e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1fb89260-4546-472a-a4db-bdf827427fba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1fb89260-4546-472a-a4db-bdf827427fba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1dd1d7a1-8cbf-4c62-a531-e82edde0d0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1dd1d7a1-8cbf-4c62-a531-e82edde0d0f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_2d4a9cd1-2393-4088-852f-047efce0054e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_InterestExpenseDebt_2d4a9cd1-2393-4088-852f-047efce0054e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cec27676-2c2a-4167-9db9-6144f6eac396" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cec27676-2c2a-4167-9db9-6144f6eac396" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionTable_d195fe01-d521-49b8-9df4-e24fe68094e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_DebtConversionTable_d195fe01-d521-49b8-9df4-e24fe68094e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e4aacaee-3ca2-4c8f-bd59-2b8edaff7e11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtConversionTable_d195fe01-d521-49b8-9df4-e24fe68094e1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e4aacaee-3ca2-4c8f-bd59-2b8edaff7e11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e4aacaee-3ca2-4c8f-bd59-2b8edaff7e11_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4aacaee-3ca2-4c8f-bd59-2b8edaff7e11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e4aacaee-3ca2-4c8f-bd59-2b8edaff7e11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f10fd1e1-4aab-4096-989d-1aac04fc2a46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4aacaee-3ca2-4c8f-bd59-2b8edaff7e11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f10fd1e1-4aab-4096-989d-1aac04fc2a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_caed14aa-72e1-464d-ab7c-d665a3e52352" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f10fd1e1-4aab-4096-989d-1aac04fc2a46" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_caed14aa-72e1-464d-ab7c-d665a3e52352" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i1a54853b7108455e96bf96dd90ac7b92_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended" id="i336e2807c9cc468cb552a5ed47ac2184_FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4660cc2b-2d83-43bb-9db0-774a0a144423" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4660cc2b-2d83-43bb-9db0-774a0a144423" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_635acf82-6989-4590-9d19-41c452f8c0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_635acf82-6989-4590-9d19-41c452f8c0fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_fc034a9e-ad58-4df1-8dfa-5456149a17f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_fc034a9e-ad58-4df1-8dfa-5456149a17f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e1b50080-f12b-4ec1-9498-c24cc1963b07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e1b50080-f12b-4ec1-9498-c24cc1963b07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_07847eac-d375-4311-9740-6ed7a174e438" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4660cc2b-2d83-43bb-9db0-774a0a144423" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_07847eac-d375-4311-9740-6ed7a174e438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_97acf56c-bbfc-4d5c-9ca0-bcc4cabc68e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_07847eac-d375-4311-9740-6ed7a174e438" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_97acf56c-bbfc-4d5c-9ca0-bcc4cabc68e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4660cc2b-2d83-43bb-9db0-774a0a144423" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1637034c-46bc-4f23-8b42-1c1a4bd7457a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1637034c-46bc-4f23-8b42-1c1a4bd7457a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1637034c-46bc-4f23-8b42-1c1a4bd7457a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1637034c-46bc-4f23-8b42-1c1a4bd7457a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1637034c-46bc-4f23-8b42-1c1a4bd7457a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1637034c-46bc-4f23-8b42-1c1a4bd7457a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_0117adec-5b4c-4da1-b794-e8574d24c3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_us-gaap_InterestRateCapMember_0117adec-5b4c-4da1-b794-e8574d24c3dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6f5ef5c1-a74f-4099-8a63-1e5926f51759" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_us-gaap_InterestRateSwapMember_6f5ef5c1-a74f-4099-8a63-1e5926f51759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_0e8d5b03-b345-4b7f-a363-186d9b48207d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_us-gaap_StockOptionMember_0e8d5b03-b345-4b7f-a363-186d9b48207d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_173b34d3-d3be-4fd6-8932-388f7295a28e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_173b34d3-d3be-4fd6-8932-388f7295a28e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_3f1a9354-30c3-4cb7-9b19-22bf31c2b6c1" xlink:href="holx-20200926.xsd#holx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_holx_ContingentConsiderationMember_3f1a9354-30c3-4cb7-9b19-22bf31c2b6c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a32f72a7-40f8-4adb-830f-cc7691397c63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a32f72a7-40f8-4adb-830f-cc7691397c63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a32f72a7-40f8-4adb-830f-cc7691397c63_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a32f72a7-40f8-4adb-830f-cc7691397c63" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a32f72a7-40f8-4adb-830f-cc7691397c63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_be3721bc-48fa-4de0-a40e-0d13075ccb52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a32f72a7-40f8-4adb-830f-cc7691397c63" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_be3721bc-48fa-4de0-a40e-0d13075ccb52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_1f5b53e1-ef37-4961-9dc9-a347b852da2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_be3721bc-48fa-4de0-a40e-0d13075ccb52" xlink:to="loc_us-gaap_AssetsMember_1f5b53e1-ef37-4961-9dc9-a347b852da2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0950f8f5-4ef2-42e8-9634-d53583822231" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0950f8f5-4ef2-42e8-9634-d53583822231" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0950f8f5-4ef2-42e8-9634-d53583822231_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0950f8f5-4ef2-42e8-9634-d53583822231" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0950f8f5-4ef2-42e8-9634-d53583822231_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0950f8f5-4ef2-42e8-9634-d53583822231" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1cf2e71f-d319-496a-80af-9d0c9eeda2e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1cf2e71f-d319-496a-80af-9d0c9eeda2e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2c5606de-0eb2-4ecb-8ac8-5bdde59f2ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2c5606de-0eb2-4ecb-8ac8-5bdde59f2ce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3099e870-8a67-4f10-bf4c-5a01826fe3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3099e870-8a67-4f10-bf4c-5a01826fe3ea" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="idaea94a74f5e4e9abcc6f2b5919c09b7_FairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_aac2849d-8012-483e-bc72-58bb2714ea00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_aac2849d-8012-483e-bc72-58bb2714ea00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_64a5db31-bb90-46e1-9776-849f383ded8f" xlink:href="holx-20200926.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_holx_PrincipalAmountOfBorrowings_64a5db31-bb90-46e1-9776-849f383ded8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1a762584-ec3a-4112-bad7-974d6c4e2cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1a762584-ec3a-4112-bad7-974d6c4e2cb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2c6e5b69-8bf3-40c3-8011-be445b830283" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2c6e5b69-8bf3-40c3-8011-be445b830283" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3f77737e-d7f4-4513-8dda-53e7361a2165" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3f77737e-d7f4-4513-8dda-53e7361a2165" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_0b82450a-5524-475e-a8f8-fc2002acc9ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_AssetImpairmentCharges_0b82450a-5524-475e-a8f8-fc2002acc9ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2d25b9f2-8404-42ad-827e-7656151120e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2d25b9f2-8404-42ad-827e-7656151120e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2d25b9f2-8404-42ad-827e-7656151120e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2d25b9f2-8404-42ad-827e-7656151120e1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2d25b9f2-8404-42ad-827e-7656151120e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d539ac6e-f530-4564-8cf6-399da923c4da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2d25b9f2-8404-42ad-827e-7656151120e1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d539ac6e-f530-4564-8cf6-399da923c4da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_9c3acf83-b2d7-4a1f-8bbb-cb758f383e38" xlink:href="holx-20200926.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d539ac6e-f530-4564-8cf6-399da923c4da" xlink:to="loc_holx_AcquiredintangibleassetsMember_9c3acf83-b2d7-4a1f-8bbb-cb758f383e38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_2057e635-719c-4f89-a172-3fa1446a190c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d539ac6e-f530-4564-8cf6-399da923c4da" xlink:to="loc_us-gaap_EquipmentMember_2057e635-719c-4f89-a172-3fa1446a190c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8cd67c01-75b1-4988-965c-2629092ce19b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8cd67c01-75b1-4988-965c-2629092ce19b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8cd67c01-75b1-4988-965c-2629092ce19b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8cd67c01-75b1-4988-965c-2629092ce19b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8cd67c01-75b1-4988-965c-2629092ce19b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_64e15c1e-e24b-44bf-a3b8-6a1b04f4384e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8cd67c01-75b1-4988-965c-2629092ce19b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_64e15c1e-e24b-44bf-a3b8-6a1b04f4384e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2022SeniorNotesMember_6453c5b3-757e-4f0c-8463-b0f56df98199" xlink:href="holx-20200926.xsd#holx_A2022SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_64e15c1e-e24b-44bf-a3b8-6a1b04f4384e" xlink:to="loc_holx_A2022SeniorNotesMember_6453c5b3-757e-4f0c-8463-b0f56df98199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_6d79a12f-ca87-439a-9e74-b7a362431f30" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_64e15c1e-e24b-44bf-a3b8-6a1b04f4384e" xlink:to="loc_holx_A2028SeniorNotesMember_6d79a12f-ca87-439a-9e74-b7a362431f30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_f5f076dd-9327-46ef-ae0c-7673fb682028" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_A2028SeniorNotesMember_6d79a12f-ca87-439a-9e74-b7a362431f30" xlink:to="loc_holx_A2025SeniorNotesMember_f5f076dd-9327-46ef-ae0c-7673fb682028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1bdfc5a9-b7e4-461d-98c0-9bb75593bf7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1bdfc5a9-b7e4-461d-98c0-9bb75593bf7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1bdfc5a9-b7e4-461d-98c0-9bb75593bf7a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1bdfc5a9-b7e4-461d-98c0-9bb75593bf7a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1bdfc5a9-b7e4-461d-98c0-9bb75593bf7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f32dfd5-5b33-4db3-b429-3720da34d100" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1bdfc5a9-b7e4-461d-98c0-9bb75593bf7a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f32dfd5-5b33-4db3-b429-3720da34d100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b57e1583-0929-4efa-8929-b8ec68ec8ad1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f32dfd5-5b33-4db3-b429-3720da34d100" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b57e1583-0929-4efa-8929-b8ec68ec8ad1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f76d8936-26f2-4d1e-92ff-ca2c655b580b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_DebtInstrumentAxis_f76d8936-26f2-4d1e-92ff-ca2c655b580b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f76d8936-26f2-4d1e-92ff-ca2c655b580b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f76d8936-26f2-4d1e-92ff-ca2c655b580b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f76d8936-26f2-4d1e-92ff-ca2c655b580b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f76d8936-26f2-4d1e-92ff-ca2c655b580b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_f1f85502-d3b6-483a-a511-7bf7a28bcf81" xlink:href="holx-20200926.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:to="loc_holx_CreditAgreementMember_f1f85502-d3b6-483a-a511-7bf7a28bcf81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_55e9763c-2b51-4621-a0d6-77e4e384075f" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_55e9763c-2b51-4621-a0d6-77e4e384075f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_c550b6c5-2b25-4936-acd0-856a57094fa1" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:to="loc_holx_A2028SeniorNotesMember_c550b6c5-2b25-4936-acd0-856a57094fa1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_96a33305-8236-4ad1-b59e-f8fdc1b1bfbf" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4772910c-0180-4e45-a3c3-adf425b77405" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4772910c-0180-4e45-a3c3-adf425b77405" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4772910c-0180-4e45-a3c3-adf425b77405_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4772910c-0180-4e45-a3c3-adf425b77405" xlink:to="loc_us-gaap_SegmentDomain_4772910c-0180-4e45-a3c3-adf425b77405_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e4c9e295-cbcb-4ccb-a28d-75b4b9a5add8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4772910c-0180-4e45-a3c3-adf425b77405" xlink:to="loc_us-gaap_SegmentDomain_e4c9e295-cbcb-4ccb-a28d-75b4b9a5add8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_e81813b6-3e78-41b0-9394-409188162c4d" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e4c9e295-cbcb-4ccb-a28d-75b4b9a5add8" xlink:to="loc_holx_MedicalAestheticsBusinessMember_e81813b6-3e78-41b0-9394-409188162c4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1d8f0b90-07c1-4b81-98b4-b526fed600ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1d8f0b90-07c1-4b81-98b4-b526fed600ca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1d8f0b90-07c1-4b81-98b4-b526fed600ca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1d8f0b90-07c1-4b81-98b4-b526fed600ca" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1d8f0b90-07c1-4b81-98b4-b526fed600ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86d3f6c9-61e4-4029-b7e1-17df219a6ef9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1d8f0b90-07c1-4b81-98b4-b526fed600ca" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86d3f6c9-61e4-4029-b7e1-17df219a6ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_d391f160-87ff-4e6c-a27e-07522d47baf2" xlink:href="holx-20200926.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86d3f6c9-61e4-4029-b7e1-17df219a6ef9" xlink:to="loc_holx_AcquiredintangibleassetsMember_d391f160-87ff-4e6c-a27e-07522d47baf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_97aff2db-3f80-47d1-b1ef-a63b2a0165d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86d3f6c9-61e4-4029-b7e1-17df219a6ef9" xlink:to="loc_us-gaap_EquipmentMember_97aff2db-3f80-47d1-b1ef-a63b2a0165d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" xlink:type="extended" id="i88b17f628fce40eab6def99cdd9c4060_FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesTables" xlink:type="extended" id="if023eca9d9e44bbdb99b6c1d06cb982f_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="extended" id="ifa7e57b83df041cfba3f09a885c3cd8f_IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesProvisionforIncomeTaxesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="extended" id="id7dac284c46344f3a8e046108064e3d0_IncomeTaxesProvisionforIncomeTaxesDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="extended" id="i6108cf893b5c4a519f3898ce31e73c16_IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended" id="i0899ee05302a4192ba03a3e013f1dff7_IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended" id="i454e1af0ea9a4440b2c22e21242ae224_IncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:href="holx-20200926.xsd#holx_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit_fa64574e-6e87-4513-8108-ce3f801773eb" xlink:href="holx-20200926.xsd#holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit_fa64574e-6e87-4513-8108-ce3f801773eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_fce475d4-1afd-48a0-9013-520853fd036e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_fce475d4-1afd-48a0-9013-520853fd036e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_fcdd0bbc-4613-47e0-b295-f751b0d21f55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_OperatingLossCarryforwards_fcdd0bbc-4613-47e0-b295-f751b0d21f55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_8f3f798f-a3a5-4e9d-8658-9dad642f7af5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_8f3f798f-a3a5-4e9d-8658-9dad642f7af5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_933ece14-58dd-40af-b200-76f520b61885" xlink:href="holx-20200926.xsd#holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_933ece14-58dd-40af-b200-76f520b61885" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_8c5c5996-59a1-4e72-a25d-42adec4cf0c4" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_8c5c5996-59a1-4e72-a25d-42adec4cf0c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_77b1e9a3-05e1-4666-8997-e1c94a89270d" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_77b1e9a3-05e1-4666-8997-e1c94a89270d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_118c3c84-3161-4eec-94ed-cba43cdd4b29" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_118c3c84-3161-4eec-94ed-cba43cdd4b29" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossUnrecognizedTaxBenefits_7fc7d179-50d5-49aa-9287-b1fd934b0558" xlink:href="holx-20200926.xsd#holx_GrossUnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_GrossUnrecognizedTaxBenefits_7fc7d179-50d5-49aa-9287-b1fd934b0558" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_30bc2786-f57a-47cb-abf8-1efe68d5b9b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_30bc2786-f57a-47cb-abf8-1efe68d5b9b5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_3c01d38a-dcc1-459d-a27d-f41c48e790dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_3c01d38a-dcc1-459d-a27d-f41c48e790dd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d3f9add3-6bba-40aa-8abe-f6be187b6e28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d3f9add3-6bba-40aa-8abe-f6be187b6e28" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_d2b4cb6b-eb59-40b3-8a34-14b79d9e9f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_d2b4cb6b-eb59-40b3-8a34-14b79d9e9f8e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued_b84e49f1-9574-4292-9419-ed81a94f9e74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued_b84e49f1-9574-4292-9419-ed81a94f9e74" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616_c8605a7f-7894-4af7-9299-72e171d1a148" xlink:href="holx-20200926.xsd#holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616_c8605a7f-7894-4af7-9299-72e171d1a148" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616_3b61cab6-9276-4a2a-8db8-ff1068e2b40c" xlink:href="holx-20200926.xsd#holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616_3b61cab6-9276-4a2a-8db8-ff1068e2b40c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616_0681feb5-322d-4644-a674-e1f863b8c6d5" xlink:href="holx-20200926.xsd#holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616_0681feb5-322d-4644-a674-e1f863b8c6d5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616_3ceb7882-4a13-428f-8a4e-5638a7b3614a" xlink:href="holx-20200926.xsd#holx_IncreasetoincometaxexpenseadoptionofASU201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616_3ceb7882-4a13-428f-8a4e-5638a7b3614a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_2e043692-fe85-49d1-bdf4-2fff170cf4d9" xlink:href="holx-20200926.xsd#holx_DecreaseindeferredtaxliabilitiesduetoASC201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_2e043692-fe85-49d1-bdf4-2fff170cf4d9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_614c1a0a-24b0-468c-aedd-3e33efa61f85" xlink:href="holx-20200926.xsd#holx_IncreasetoNetIncomeresultedfromadoptionofASU201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_614c1a0a-24b0-468c-aedd-3e33efa61f85" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_e44767b8-33c1-40f4-b4fd-99881cdce7b1" xlink:href="holx-20200926.xsd#holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_e44767b8-33c1-40f4-b4fd-99881cdce7b1" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonIncomeTaxLoss_67e386f6-b8c4-4a91-bceb-1b148822495c" xlink:href="holx-20200926.xsd#holx_NonIncomeTaxLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_NonIncomeTaxLoss_67e386f6-b8c4-4a91-bceb-1b148822495c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_a890cde5-0ee9-4f1a-8245-98eba0456083" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_a890cde5-0ee9-4f1a-8245-98eba0456083" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_StateLossCarryforwardExpectedToUnutilize_186c0127-995f-4136-9eab-1eea4fc11143" xlink:href="holx-20200926.xsd#holx_StateLossCarryforwardExpectedToUnutilize"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_StateLossCarryforwardExpectedToUnutilize_186c0127-995f-4136-9eab-1eea4fc11143" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_42a2783b-9853-4384-a928-69f4c4473af6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_42a2783b-9853-4384-a928-69f4c4473af6" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossStateLossCarryforwards_902a3c0f-f0d3-44bc-82f0-cd08807ff8ff" xlink:href="holx-20200926.xsd#holx_GrossStateLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_GrossStateLossCarryforwards_902a3c0f-f0d3-44bc-82f0-cd08807ff8ff" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossForeignLossCarryforwards_749a38b7-d511-4166-b675-9bb3e785fd0d" xlink:href="holx-20200926.xsd#holx_GrossForeignLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_GrossForeignLossCarryforwards_749a38b7-d511-4166-b675-9bb3e785fd0d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:href="holx-20200926.xsd#holx_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_79e8e257-ce46-40da-ac0a-641d56f35bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_79e8e257-ce46-40da-ac0a-641d56f35bb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_79e8e257-ce46-40da-ac0a-641d56f35bb4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_79e8e257-ce46-40da-ac0a-641d56f35bb4" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_79e8e257-ce46-40da-ac0a-641d56f35bb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_79e8e257-ce46-40da-ac0a-641d56f35bb4" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_47af23d9-ca73-41a3-90d4-ce9dcfe8eaea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:to="loc_us-gaap_DomesticCountryMember_47af23d9-ca73-41a3-90d4-ce9dcfe8eaea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_ae57cadc-6679-4181-908a-5c2b335504e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_ae57cadc-6679-4181-908a-5c2b335504e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_14bfbc17-efba-4fac-811c-963d238a5ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:to="loc_us-gaap_ForeignCountryMember_14bfbc17-efba-4fac-811c-963d238a5ad3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7255f269-752c-4f17-83b4-ca12dddbbe1e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_srt_RangeAxis_7255f269-752c-4f17-83b4-ca12dddbbe1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7255f269-752c-4f17-83b4-ca12dddbbe1e_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7255f269-752c-4f17-83b4-ca12dddbbe1e" xlink:to="loc_srt_RangeMember_7255f269-752c-4f17-83b4-ca12dddbbe1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2e5cb34b-ac4f-4750-88c5-00e5db0631fa" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7255f269-752c-4f17-83b4-ca12dddbbe1e" xlink:to="loc_srt_RangeMember_2e5cb34b-ac4f-4750-88c5-00e5db0631fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_732a4916-d7ad-4393-a393-2b6d3de0fd85" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2e5cb34b-ac4f-4750-88c5-00e5db0631fa" xlink:to="loc_srt_MaximumMember_732a4916-d7ad-4393-a393-2b6d3de0fd85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_b8e9562a-1d16-4ff3-9fbc-b239edec1848" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_b8e9562a-1d16-4ff3-9fbc-b239edec1848" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_b8e9562a-1d16-4ff3-9fbc-b239edec1848_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_b8e9562a-1d16-4ff3-9fbc-b239edec1848" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_b8e9562a-1d16-4ff3-9fbc-b239edec1848_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_3089dfc4-d2c4-4a16-92ed-31bd8c1b38d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_b8e9562a-1d16-4ff3-9fbc-b239edec1848" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_3089dfc4-d2c4-4a16-92ed-31bd8c1b38d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossCarryforwardsMember_4f71cd26-5880-4dc9-8614-c0f022b81e37" xlink:href="holx-20200926.xsd#holx_NetOperatingLossCarryforwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_3089dfc4-d2c4-4a16-92ed-31bd8c1b38d7" xlink:to="loc_holx_NetOperatingLossCarryforwardsMember_4f71cd26-5880-4dc9-8614-c0f022b81e37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxCreditCarryforwardMember_f1378cd7-3d45-4643-95ad-ab4159f225db" xlink:href="holx-20200926.xsd#holx_TaxCreditCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_3089dfc4-d2c4-4a16-92ed-31bd8c1b38d7" xlink:to="loc_holx_TaxCreditCarryforwardMember_f1378cd7-3d45-4643-95ad-ab4159f225db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7d6e665f-ee7c-4b18-ac00-4fc7321ceb24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7d6e665f-ee7c-4b18-ac00-4fc7321ceb24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7d6e665f-ee7c-4b18-ac00-4fc7321ceb24_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7d6e665f-ee7c-4b18-ac00-4fc7321ceb24" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7d6e665f-ee7c-4b18-ac00-4fc7321ceb24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bfc29945-91ca-4787-b497-d64d467a52db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7d6e665f-ee7c-4b18-ac00-4fc7321ceb24" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bfc29945-91ca-4787-b497-d64d467a52db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_713f29aa-9e97-4446-b350-746e27535c29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bfc29945-91ca-4787-b497-d64d467a52db" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_713f29aa-9e97-4446-b350-746e27535c29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d0f29a40-97dd-4727-ba27-a153c978cecc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d0f29a40-97dd-4727-ba27-a153c978cecc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d0f29a40-97dd-4727-ba27-a153c978cecc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d0f29a40-97dd-4727-ba27-a153c978cecc" xlink:to="loc_us-gaap_SegmentDomain_d0f29a40-97dd-4727-ba27-a153c978cecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7da8bc37-55d7-4367-8a7f-ff0690b4594d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d0f29a40-97dd-4727-ba27-a153c978cecc" xlink:to="loc_us-gaap_SegmentDomain_7da8bc37-55d7-4367-8a7f-ff0690b4594d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_318e1740-d838-46e3-bf6d-4be9e5de0d99" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7da8bc37-55d7-4367-8a7f-ff0690b4594d" xlink:to="loc_holx_MedicalAestheticsMember_318e1740-d838-46e3-bf6d-4be9e5de0d99" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" xlink:type="extended" id="i8cd0f871801c402d9f4a8d4e5ec088fb_IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation" xlink:type="extended" id="id3a1c1eca61e42b3ba319bdb8e5c391a_StockholdersEquityandStockBasedCompensation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables" xlink:type="extended" id="i083c29879b0845f0b23dd46f1fa2814b_StockholdersEquityandStockBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="extended" id="ibdcc977d4fb54228beefd8114dd66c8a_StockholdersEquityandStockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6005ff3c-f345-402c-84d9-0a22ba683f79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6005ff3c-f345-402c-84d9-0a22ba683f79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8312d884-1aa5-4c41-a66e-4c92ebcd0125" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8312d884-1aa5-4c41-a66e-4c92ebcd0125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_412ff85c-2948-4e18-804d-0bc5475c2f88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_412ff85c-2948-4e18-804d-0bc5475c2f88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_f0dcc479-1a5b-4e77-94ea-5adf538535de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_f0dcc479-1a5b-4e77-94ea-5adf538535de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4b35f59b-487b-4e22-a3b0-ffbf5a78c52d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4b35f59b-487b-4e22-a3b0-ffbf5a78c52d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_0158a216-4a58-41ac-ad7b-969dce7105eb" xlink:href="holx-20200926.xsd#holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_0158a216-4a58-41ac-ad7b-969dce7105eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9e1d2307-b487-4f1c-a8f9-330236615982" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9e1d2307-b487-4f1c-a8f9-330236615982" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_2b4f199a-1c28-4853-b234-ef83d4ef12e7" xlink:href="holx-20200926.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_2b4f199a-1c28-4853-b234-ef83d4ef12e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_a16770de-c41c-46e5-8e44-cd24d7e81b3f" xlink:href="holx-20200926.xsd#holx_PercentageOfVestingForStockOptionsGrantedToEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_a16770de-c41c-46e5-8e44-cd24d7e81b3f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_99a49168-88aa-48af-9948-d0fc0740910a" xlink:href="holx-20200926.xsd#holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_99a49168-88aa-48af-9948-d0fc0740910a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate_f4f021c5-5255-49b4-be30-4c4c7f4ec9e6" xlink:href="holx-20200926.xsd#holx_ShareBasedCompensationPercentageOfForfeitureRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate_f4f021c5-5255-49b4-be30-4c4c7f4ec9e6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_daf2a6d8-a97a-4331-86e9-3509ba9f051b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_daf2a6d8-a97a-4331-86e9-3509ba9f051b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a322a981-f0cf-48ad-998f-55bf68b7a3d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a322a981-f0cf-48ad-998f-55bf68b7a3d8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_54915ef8-c126-41dd-9fdc-5a9d3d4974fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_54915ef8-c126-41dd-9fdc-5a9d3d4974fb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22c36d3e-02c6-4cc2-89a3-1a05ff9798d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22c36d3e-02c6-4cc2-89a3-1a05ff9798d9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_21d77911-f53c-4be5-bea8-26191ccc3308" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_21d77911-f53c-4be5-bea8-26191ccc3308" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8302c16d-7e9c-4e47-8fac-741b488ae2ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8302c16d-7e9c-4e47-8fac-741b488ae2ab" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dee715c2-f0a1-4571-86f8-edfbcb631f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dee715c2-f0a1-4571-86f8-edfbcb631f5e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_d6ae5712-13aa-4473-947c-e0c3b925109f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_d6ae5712-13aa-4473-947c-e0c3b925109f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_d4d2fced-6578-44b2-a5e8-976368026573" xlink:href="holx-20200926.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_d4d2fced-6578-44b2-a5e8-976368026573" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_96ff81b2-217a-4a45-86c7-f17bb43d6e67" xlink:href="holx-20200926.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_96ff81b2-217a-4a45-86c7-f17bb43d6e67" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_036674e9-06f6-4af5-b4a3-c5a2d8ffb813" xlink:href="holx-20200926.xsd#holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_036674e9-06f6-4af5-b4a3-c5a2d8ffb813" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_6c2ba1e5-fd8d-4c77-9edc-830a8f8123ef" xlink:href="holx-20200926.xsd#holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_6c2ba1e5-fd8d-4c77-9edc-830a8f8123ef" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3887820f-2e3e-40e2-b811-20f2342f5f44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensation_3887820f-2e3e-40e2-b811-20f2342f5f44" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_cb5dc76e-843e-4442-8610-bb1e6595afe0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_cb5dc76e-843e-4442-8610-bb1e6595afe0" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_f24deb11-5825-4590-837c-dccaa21c2760" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_f24deb11-5825-4590-837c-dccaa21c2760" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRSharesRepurchasedduringtheperiod_832833c2-0f05-49f5-ba99-ba0edbcc2058" xlink:href="holx-20200926.xsd#holx_ASRSharesRepurchasedduringtheperiod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_ASRSharesRepurchasedduringtheperiod_832833c2-0f05-49f5-ba99-ba0edbcc2058" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRAuthorized_c28aaef5-79f9-4ee0-b57e-7fdc38d6fb78" xlink:href="holx-20200926.xsd#holx_ASRAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_ASRAuthorized_c28aaef5-79f9-4ee0-b57e-7fdc38d6fb78" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountpaidduringtheperiodunderASRAgreement_945fcf3b-18f6-4d17-a3c2-37a257966f3e" xlink:href="holx-20200926.xsd#holx_AmountpaidduringtheperiodunderASRAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_AmountpaidduringtheperiodunderASRAgreement_945fcf3b-18f6-4d17-a3c2-37a257966f3e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchseAuthorizationDateAxis_e3c4235a-5fb3-4394-9c08-40bbe82c0574" xlink:href="holx-20200926.xsd#holx_ShareRepurchseAuthorizationDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_holx_ShareRepurchseAuthorizationDateAxis_e3c4235a-5fb3-4394-9c08-40bbe82c0574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AuthorizationDateDomain_e3c4235a-5fb3-4394-9c08-40bbe82c0574_default" xlink:href="holx-20200926.xsd#holx_AuthorizationDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis_e3c4235a-5fb3-4394-9c08-40bbe82c0574" xlink:to="loc_holx_AuthorizationDateDomain_e3c4235a-5fb3-4394-9c08-40bbe82c0574_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AuthorizationDateDomain_c6e5ec52-adf7-401f-9596-c7a9a754844c" xlink:href="holx-20200926.xsd#holx_AuthorizationDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis_e3c4235a-5fb3-4394-9c08-40bbe82c0574" xlink:to="loc_holx_AuthorizationDateDomain_c6e5ec52-adf7-401f-9596-c7a9a754844c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Jun212016Member_1abc754e-f619-45d6-bcf5-30783f314d3b" xlink:href="holx-20200926.xsd#holx_Jun212016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_AuthorizationDateDomain_c6e5ec52-adf7-401f-9596-c7a9a754844c" xlink:to="loc_holx_Jun212016Member_1abc754e-f619-45d6-bcf5-30783f314d3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Dec112019Member_b7a1b5cb-fe8c-4650-b047-815e3e406d73" xlink:href="holx-20200926.xsd#holx_Dec112019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_AuthorizationDateDomain_c6e5ec52-adf7-401f-9596-c7a9a754844c" xlink:to="loc_holx_Dec112019Member_b7a1b5cb-fe8c-4650-b047-815e3e406d73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d5e6b92a-4225-4ddb-a308-89d2ca1b57d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_us-gaap_PlanNameAxis_d5e6b92a-4225-4ddb-a308-89d2ca1b57d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d5e6b92a-4225-4ddb-a308-89d2ca1b57d6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d5e6b92a-4225-4ddb-a308-89d2ca1b57d6" xlink:to="loc_us-gaap_PlanNameDomain_d5e6b92a-4225-4ddb-a308-89d2ca1b57d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3be2be5d-bc8a-4a25-88bc-65bb7567d124" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d5e6b92a-4225-4ddb-a308-89d2ca1b57d6" xlink:to="loc_us-gaap_PlanNameDomain_3be2be5d-bc8a-4a25-88bc-65bb7567d124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandEightEquityPlanMember_f7b3cce3-602c-4cae-9686-518bc696fae5" xlink:href="holx-20200926.xsd#holx_TwoThousandEightEquityPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3be2be5d-bc8a-4a25-88bc-65bb7567d124" xlink:to="loc_holx_TwoThousandEightEquityPlanMember_f7b3cce3-602c-4cae-9686-518bc696fae5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember_f20f1a96-bbdb-4f1e-a9ab-48c9d64b1f52" xlink:href="holx-20200926.xsd#holx_SemiAnnualEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3be2be5d-bc8a-4a25-88bc-65bb7567d124" xlink:to="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember_f20f1a96-bbdb-4f1e-a9ab-48c9d64b1f52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bb683f0b-e543-4ea0-b1a7-666947ca222d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_us-gaap_AwardTypeAxis_bb683f0b-e543-4ea0-b1a7-666947ca222d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb683f0b-e543-4ea0-b1a7-666947ca222d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bb683f0b-e543-4ea0-b1a7-666947ca222d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb683f0b-e543-4ea0-b1a7-666947ca222d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bb683f0b-e543-4ea0-b1a7-666947ca222d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_88583f3f-ab47-4eb7-a82d-e6bedd71557e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_us-gaap_StockOptionMember_88583f3f-ab47-4eb7-a82d-e6bedd71557e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_95abd138-089b-4729-9329-00c216d1b8f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_95abd138-089b-4729-9329-00c216d1b8f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bf9dcfd1-8244-4e06-9737-4c47f6de78ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_us-gaap_PerformanceSharesMember_bf9dcfd1-8244-4e06-9737-4c47f6de78ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember_b754e7d3-3ea3-4718-8158-96269b41d03f" xlink:href="holx-20200926.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_holx_MarketBasedStockUnitsMember_b754e7d3-3ea3-4718-8158-96269b41d03f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_63b66ca9-b9da-4510-bb2b-bc13fbb89b9c" xlink:href="holx-20200926.xsd#holx_PSUFreeCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_holx_PSUFreeCashFlowMember_63b66ca9-b9da-4510-bb2b-bc13fbb89b9c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8270f9d7-e697-467d-b28d-438fa16955c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_us-gaap_RestrictedStockMember_8270f9d7-e697-467d-b28d-438fa16955c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f9548858-8e70-4e76-9d54-60481db08d39" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_srt_RangeAxis_f9548858-8e70-4e76-9d54-60481db08d39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f9548858-8e70-4e76-9d54-60481db08d39_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f9548858-8e70-4e76-9d54-60481db08d39" xlink:to="loc_srt_RangeMember_f9548858-8e70-4e76-9d54-60481db08d39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c3184935-5652-4dd7-9998-fd5ec1743d96" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f9548858-8e70-4e76-9d54-60481db08d39" xlink:to="loc_srt_RangeMember_c3184935-5652-4dd7-9998-fd5ec1743d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ace52342-d766-4261-8420-8816b866a8ea" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c3184935-5652-4dd7-9998-fd5ec1743d96" xlink:to="loc_srt_MinimumMember_ace52342-d766-4261-8420-8816b866a8ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3df56f63-24da-4927-953a-9ed6ffb870be" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c3184935-5652-4dd7-9998-fd5ec1743d96" xlink:to="loc_srt_MaximumMember_3df56f63-24da-4927-953a-9ed6ffb870be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_8f894892-60bf-4c37-b4b1-ba72dc9d3f13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_8f894892-60bf-4c37-b4b1-ba72dc9d3f13" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_8f894892-60bf-4c37-b4b1-ba72dc9d3f13_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8f894892-60bf-4c37-b4b1-ba72dc9d3f13" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_8f894892-60bf-4c37-b4b1-ba72dc9d3f13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a47e56f0-9043-4dc8-8be9-1474faac1863" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8f894892-60bf-4c37-b4b1-ba72dc9d3f13" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a47e56f0-9043-4dc8-8be9-1474faac1863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_June132019PlanMember_11498d12-f5c1-4b30-a908-454ddf5661a7" xlink:href="holx-20200926.xsd#holx_June132019PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a47e56f0-9043-4dc8-8be9-1474faac1863" xlink:to="loc_holx_June132019PlanMember_11498d12-f5c1-4b30-a908-454ddf5661a7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="extended" id="i08b0409f7c6f4870b96bb902d9718a88_StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbac25ba-b1b7-43a6-9fbb-f814be46d357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e512a48a-81aa-40c0-be1b-12d872af18c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbac25ba-b1b7-43a6-9fbb-f814be46d357" xlink:to="loc_us-gaap_ShareBasedCompensation_e512a48a-81aa-40c0-be1b-12d872af18c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f4121e57-a700-464e-8e12-27aac87187f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbac25ba-b1b7-43a6-9fbb-f814be46d357" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f4121e57-a700-464e-8e12-27aac87187f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7be8c260-cbb8-45a4-a47b-b705c20c3f00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f4121e57-a700-464e-8e12-27aac87187f5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7be8c260-cbb8-45a4-a47b-b705c20c3f00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7be8c260-cbb8-45a4-a47b-b705c20c3f00_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7be8c260-cbb8-45a4-a47b-b705c20c3f00" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7be8c260-cbb8-45a4-a47b-b705c20c3f00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7be8c260-cbb8-45a4-a47b-b705c20c3f00" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d4b4cb86-50ae-4a29-8c36-16e415ba8768" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_CostOfSalesMember_d4b4cb86-50ae-4a29-8c36-16e415ba8768" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a262f883-1c78-491f-b767-32556cbf9a21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a262f883-1c78-491f-b767-32556cbf9a21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_2086dbff-2ca2-4db5-9b3c-92f2ee91ba77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_2086dbff-2ca2-4db5-9b3c-92f2ee91ba77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c5235907-b14b-4a85-b88c-4e9e853d58e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c5235907-b14b-4a85-b88c-4e9e853d58e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_fd4d3a52-3704-46a1-be03-76d63c363c18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_RestructuringChargesMember_fd4d3a52-3704-46a1-be03-76d63c363c18" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" xlink:type="extended" id="i7f4cd87d17054e16af6c4a0afec52f9f_StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="extended" id="i1a3acc0474e04351919360089c8bc73d_StockholdersEquityandStockBasedCompensationStockOptionActivityDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f91e29c-fae8-44b8-804c-bd92b518e91d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2b5794cc-8b21-47ec-9bb4-3480fb6d863b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f91e29c-fae8-44b8-804c-bd92b518e91d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2b5794cc-8b21-47ec-9bb4-3480fb6d863b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b53313c-79bd-402f-ad2b-28bf1d7ca770" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f91e29c-fae8-44b8-804c-bd92b518e91d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b53313c-79bd-402f-ad2b-28bf1d7ca770" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_397c9b4e-e6f1-4545-b821-e01025812a95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b53313c-79bd-402f-ad2b-28bf1d7ca770" xlink:to="loc_us-gaap_AwardTypeAxis_397c9b4e-e6f1-4545-b821-e01025812a95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397c9b4e-e6f1-4545-b821-e01025812a95_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_397c9b4e-e6f1-4545-b821-e01025812a95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397c9b4e-e6f1-4545-b821-e01025812a95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07099d88-463b-412c-8146-cbc09bd4e310" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_397c9b4e-e6f1-4545-b821-e01025812a95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07099d88-463b-412c-8146-cbc09bd4e310" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_89a73bc0-9174-4aef-ab7d-2823aaed813c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07099d88-463b-412c-8146-cbc09bd4e310" xlink:to="loc_us-gaap_PerformanceSharesMember_89a73bc0-9174-4aef-ab7d-2823aaed813c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember_f65c214d-a6ee-4fdd-af5f-c6ad83cec2cd" xlink:href="holx-20200926.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07099d88-463b-412c-8146-cbc09bd4e310" xlink:to="loc_holx_MarketBasedStockUnitsMember_f65c214d-a6ee-4fdd-af5f-c6ad83cec2cd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" xlink:type="extended" id="i816085b81131426b84df90df99a05f6b_StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="extended" id="ib6b23d88f0a647d7bc7e02842ccf469b_StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d76433be-e7ad-4bac-97f8-04ba1ddcb9de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d76433be-e7ad-4bac-97f8-04ba1ddcb9de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d66c9e27-4d86-4d84-bb14-9967ba43904f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d66c9e27-4d86-4d84-bb14-9967ba43904f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4dd704c2-ba95-4dda-a3e7-c3dfde4cab33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4dd704c2-ba95-4dda-a3e7-c3dfde4cab33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_6ddef7ac-5613-45c1-82eb-6466a708ad6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_6ddef7ac-5613-45c1-82eb-6466a708ad6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_ae40cc4f-4465-4fdd-be5f-063eb3f7af48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_ae40cc4f-4465-4fdd-be5f-063eb3f7af48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c89e49d-61bd-4839-9089-3da740914cba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d76433be-e7ad-4bac-97f8-04ba1ddcb9de" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c89e49d-61bd-4839-9089-3da740914cba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_22e51c88-ab59-4ae4-bc5d-3d60a5abb160" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c89e49d-61bd-4839-9089-3da740914cba" xlink:to="loc_us-gaap_AwardTypeAxis_22e51c88-ab59-4ae4-bc5d-3d60a5abb160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e51c88-ab59-4ae4-bc5d-3d60a5abb160_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_22e51c88-ab59-4ae4-bc5d-3d60a5abb160" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e51c88-ab59-4ae4-bc5d-3d60a5abb160_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_684c9a1b-eb90-4588-b1b5-76c648a8d51d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_22e51c88-ab59-4ae4-bc5d-3d60a5abb160" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_684c9a1b-eb90-4588-b1b5-76c648a8d51d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeStockPurchasePlanMember_90dcbf02-1649-4b23-a49c-b685a8c8ad09" xlink:href="holx-20200926.xsd#holx_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_684c9a1b-eb90-4588-b1b5-76c648a8d51d" xlink:to="loc_holx_EmployeeStockPurchasePlanMember_90dcbf02-1649-4b23-a49c-b685a8c8ad09" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/A401kPlan" xlink:type="simple" xlink:href="holx-20200926.xsd#A401kPlan"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/A401kPlan" xlink:type="extended" id="i654136c07e204fb1a5726381ffdf38fb_A401kPlan"/>
  <link:roleRef roleURI="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#A401kPlanAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail" xlink:type="extended" id="i3d3b6ea8148e4f6793854aae8f637d28_A401kPlanAdditionalInformationDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#DeferredCompensationPlanAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="extended" id="ia0efecf0ccdf43e9ba6ae24e7b63e360_DeferredCompensationPlanAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_9a021242-f3a3-4b76-8ce3-d322a50cb6e4" xlink:href="holx-20200926.xsd#holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_9a021242-f3a3-4b76-8ce3-d322a50cb6e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_dc73a800-1d5f-48de-a1da-cfa4dd56868e" xlink:href="holx-20200926.xsd#holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_dc73a800-1d5f-48de-a1da-cfa4dd56868e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeContributionsVestedPercentage_51313a95-dfea-4ea5-83a3-352e6ba670ab" xlink:href="holx-20200926.xsd#holx_EmployeeContributionsVestedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_EmployeeContributionsVestedPercentage_51313a95-dfea-4ea5-83a3-352e6ba670ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsPercentVestedAnnually_bedf02ae-8e6d-4e42-8a6a-d9972ff1aef5" xlink:href="holx-20200926.xsd#holx_EmployerContributionsPercentVestedAnnually"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_EmployerContributionsPercentVestedAnnually_bedf02ae-8e6d-4e42-8a6a-d9972ff1aef5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsVestingPeriod_8c5695de-3d21-4658-9561-c283813573ce" xlink:href="holx-20200926.xsd#holx_EmployerContributionsVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_EmployerContributionsVestingPeriod_8c5695de-3d21-4658-9561-c283813573ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_424e2518-78c8-413c-b776-10c766f6b0f3" xlink:href="holx-20200926.xsd#holx_NonqualifiedDeferredCompensationPlanAnnualContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_424e2518-78c8-413c-b776-10c766f6b0f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InvestmentInGroupLifeInsuranceContracts_9c64fc11-8e4c-42a4-8787-4497428c273b" xlink:href="holx-20200926.xsd#holx_InvestmentInGroupLifeInsuranceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_InvestmentInGroupLifeInsuranceContracts_9c64fc11-8e4c-42a4-8787-4497428c273b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_6d1831d2-5bdd-4c68-9db2-47767630543f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_6d1831d2-5bdd-4c68-9db2-47767630543f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_56d13c7b-5b02-46fa-8ef1-6bc1f1d6228f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_56d13c7b-5b02-46fa-8ef1-6bc1f1d6228f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_eb61ced0-fef0-4542-899e-ae48756288ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_56d13c7b-5b02-46fa-8ef1-6bc1f1d6228f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_eb61ced0-fef0-4542-899e-ae48756288ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_eb61ced0-fef0-4542-899e-ae48756288ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_eb61ced0-fef0-4542-899e-ae48756288ba" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_eb61ced0-fef0-4542-899e-ae48756288ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_55561423-0d3c-43ce-81ae-87ecd185c9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_eb61ced0-fef0-4542-899e-ae48756288ba" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_55561423-0d3c-43ce-81ae-87ecd185c9e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_76af3995-068e-4e65-be69-8e8115ffe20a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_55561423-0d3c-43ce-81ae-87ecd185c9e4" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_76af3995-068e-4e65-be69-8e8115ffe20a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_50d9b0af-40e2-4567-aaf2-0f13af3eb19d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_56d13c7b-5b02-46fa-8ef1-6bc1f1d6228f" xlink:to="loc_us-gaap_VestingAxis_50d9b0af-40e2-4567-aaf2-0f13af3eb19d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_50d9b0af-40e2-4567-aaf2-0f13af3eb19d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_50d9b0af-40e2-4567-aaf2-0f13af3eb19d" xlink:to="loc_us-gaap_VestingDomain_50d9b0af-40e2-4567-aaf2-0f13af3eb19d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_035b6d7d-9ece-4bd6-800c-d561ab76332e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_50d9b0af-40e2-4567-aaf2-0f13af3eb19d" xlink:to="loc_us-gaap_VestingDomain_035b6d7d-9ece-4bd6-800c-d561ab76332e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OneThirdAnnuallyMember_a554cd0f-e91a-40f3-9623-d3bd6a3bf910" xlink:href="holx-20200926.xsd#holx_OneThirdAnnuallyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_035b6d7d-9ece-4bd6-800c-d561ab76332e" xlink:to="loc_holx_OneThirdAnnuallyMember_a554cd0f-e91a-40f3-9623-d3bd6a3bf910" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20200926.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended" id="i1b27af8136f64af396c9c934a450184d_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#CommitmentsandContingenciesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesTables" xlink:type="extended" id="i027e18ca4cd84aa4892e8a2b7640c701_CommitmentsandContingenciesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="extended" id="ib47a09175b734538a789548ebaa24fbd_CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LitigationandRelatedMatters" xlink:type="simple" xlink:href="holx-20200926.xsd#LitigationandRelatedMatters"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LitigationandRelatedMatters" xlink:type="extended" id="i23234f4f9c6b4345b3ad37dffa583eb3_LitigationandRelatedMatters"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#LitigationandOtherMattersAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="extended" id="i2937909405914926bd960817434de35c_LitigationandOtherMattersAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8c2a28c4-5642-4ba7-b325-bf1440c8a730" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_58c19c12-11b9-4ead-9771-4eae10bd92ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c2a28c4-5642-4ba7-b325-bf1440c8a730" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_58c19c12-11b9-4ead-9771-4eae10bd92ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_a4435dd5-ef2e-476a-a639-3bf6742ebf0b" xlink:href="holx-20200926.xsd#holx_LegalAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c2a28c4-5642-4ba7-b325-bf1440c8a730" xlink:to="loc_holx_LegalAccrual_a4435dd5-ef2e-476a-a639-3bf6742ebf0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c2a28c4-5642-4ba7-b325-bf1440c8a730" xlink:to="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_abbc5a8b-0517-4334-8fa2-8df4c19919a7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:to="loc_dei_LegalEntityAxis_abbc5a8b-0517-4334-8fa2-8df4c19919a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_abbc5a8b-0517-4334-8fa2-8df4c19919a7_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_abbc5a8b-0517-4334-8fa2-8df4c19919a7" xlink:to="loc_dei_EntityDomain_abbc5a8b-0517-4334-8fa2-8df4c19919a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c283b42b-646d-4598-a732-f644979aa93f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_abbc5a8b-0517-4334-8fa2-8df4c19919a7" xlink:to="loc_dei_EntityDomain_c283b42b-646d-4598-a732-f644979aa93f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_5abe36a3-0847-40df-afb4-c30efc8a2c5c" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c283b42b-646d-4598-a732-f644979aa93f" xlink:to="loc_holx_MedicalAestheticsBusinessMember_5abe36a3-0847-40df-afb4-c30efc8a2c5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0a03acf3-934b-473c-a1e7-638e3d2d7ea6" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:to="loc_srt_LitigationCaseAxis_0a03acf3-934b-473c-a1e7-638e3d2d7ea6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0a03acf3-934b-473c-a1e7-638e3d2d7ea6_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_0a03acf3-934b-473c-a1e7-638e3d2d7ea6" xlink:to="loc_srt_LitigationCaseTypeDomain_0a03acf3-934b-473c-a1e7-638e3d2d7ea6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_70b03815-a793-4677-9e40-7dc879c0a082" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_0a03acf3-934b-473c-a1e7-638e3d2d7ea6" xlink:to="loc_srt_LitigationCaseTypeDomain_70b03815-a793-4677-9e40-7dc879c0a082" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CompanyVs.MinervaSurgicalInc.Member_3086f88a-f16d-46d6-b9ea-cd424d179ba7" xlink:href="holx-20200926.xsd#holx_CompanyVs.MinervaSurgicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_70b03815-a793-4677-9e40-7dc879c0a082" xlink:to="loc_holx_CompanyVs.MinervaSurgicalInc.Member_3086f88a-f16d-46d6-b9ea-cd424d179ba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9e89e97e-6dd7-47f6-8a91-7eabc6ba2e05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:to="loc_us-gaap_LitigationStatusAxis_9e89e97e-6dd7-47f6-8a91-7eabc6ba2e05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9e89e97e-6dd7-47f6-8a91-7eabc6ba2e05_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_9e89e97e-6dd7-47f6-8a91-7eabc6ba2e05" xlink:to="loc_us-gaap_LitigationStatusDomain_9e89e97e-6dd7-47f6-8a91-7eabc6ba2e05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_b130165a-fea2-4d52-8719-dcd90af3c5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_9e89e97e-6dd7-47f6-8a91-7eabc6ba2e05" xlink:to="loc_us-gaap_LitigationStatusDomain_b130165a-fea2-4d52-8719-dcd90af3c5f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_c59e5d0c-c8e5-45f2-9be2-8498451167c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_b130165a-fea2-4d52-8719-dcd90af3c5f3" xlink:to="loc_us-gaap_JudicialRulingMember_c59e5d0c-c8e5-45f2-9be2-8498451167c1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20200926.xsd#Disposition"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended" id="iafa48aa8ab45453782a39acf838a3243_Disposition"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionTables" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DispositionTables" xlink:type="extended" id="i468e51c421d64b1fafcfd34bebc32f24_DispositionTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="extended" id="ie6e679a205a0445296051d1374ee4d3f_DispositionAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a9cd6720-00d2-4010-9f9e-a08558f69a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a9cd6720-00d2-4010-9f9e-a08558f69a3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_db52fc5a-2910-4a84-a71e-3126e4575e60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_db52fc5a-2910-4a84-a71e-3126e4575e60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_ddb68b1d-7836-413b-bc5d-e1b4b747a462" xlink:href="holx-20200926.xsd#holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_ddb68b1d-7836-413b-bc5d-e1b4b747a462" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TransitionServicesAgreementTerm_a9a9ea0f-b7a1-4e0d-82ef-d74ecb11c882" xlink:href="holx-20200926.xsd#holx_TransitionServicesAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_holx_TransitionServicesAgreementTerm_a9a9ea0f-b7a1-4e0d-82ef-d74ecb11c882" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily_503fc598-8517-40df-8bc3-45a0c3022da2" xlink:href="holx-20200926.xsd#holx_IndemnificationLiabily"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_holx_IndemnificationLiabily_503fc598-8517-40df-8bc3-45a0c3022da2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_72974144-5e4b-491d-940c-c01755ed0a77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_us-gaap_AssetImpairmentCharges_72974144-5e4b-491d-940c-c01755ed0a77" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Expensesfromdisposition_16575c5c-8531-45ed-962e-8864d1a33a5c" xlink:href="holx-20200926.xsd#holx_Expensesfromdisposition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_holx_Expensesfromdisposition_16575c5c-8531-45ed-962e-8864d1a33a5c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_51dc8ca1-6603-4067-a1c7-c44e38b6e17b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_51dc8ca1-6603-4067-a1c7-c44e38b6e17b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_51dc8ca1-6603-4067-a1c7-c44e38b6e17b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_51dc8ca1-6603-4067-a1c7-c44e38b6e17b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_51dc8ca1-6603-4067-a1c7-c44e38b6e17b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0ecd8f8-530a-47b6-b248-679c17fb0bee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_51dc8ca1-6603-4067-a1c7-c44e38b6e17b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0ecd8f8-530a-47b6-b248-679c17fb0bee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_50302495-f6ab-434a-86d3-7be5a5b5f741" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0ecd8f8-530a-47b6-b248-679c17fb0bee" xlink:to="loc_holx_MedicalAestheticsBusinessMember_50302495-f6ab-434a-86d3-7be5a5b5f741" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_da90a83a-995f-4f8c-b694-bcf3b2abe6ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_da90a83a-995f-4f8c-b694-bcf3b2abe6ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_da90a83a-995f-4f8c-b694-bcf3b2abe6ff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_da90a83a-995f-4f8c-b694-bcf3b2abe6ff" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_da90a83a-995f-4f8c-b694-bcf3b2abe6ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_38a9fd65-702e-4552-bf32-2cde18974a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_da90a83a-995f-4f8c-b694-bcf3b2abe6ff" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_38a9fd65-702e-4552-bf32-2cde18974a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a00886c0-266c-43cb-ab7b-2c22ade725f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_38a9fd65-702e-4552-bf32-2cde18974a5a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a00886c0-266c-43cb-ab7b-2c22ade725f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a89da0e3-0aa8-4658-b3ca-7c66cacaeba9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a89da0e3-0aa8-4658-b3ca-7c66cacaeba9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a89da0e3-0aa8-4658-b3ca-7c66cacaeba9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a89da0e3-0aa8-4658-b3ca-7c66cacaeba9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a89da0e3-0aa8-4658-b3ca-7c66cacaeba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2a5758c1-98c1-43ee-a96e-ad56e016fc44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a89da0e3-0aa8-4658-b3ca-7c66cacaeba9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2a5758c1-98c1-43ee-a96e-ad56e016fc44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d93fe1c7-41f5-4a0e-b232-f36a1b6d02c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2a5758c1-98c1-43ee-a96e-ad56e016fc44" xlink:to="loc_us-gaap_CostOfSalesMember_d93fe1c7-41f5-4a0e-b232-f36a1b6d02c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_00d5f371-92b2-4091-bd9d-1c2a175a4f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2a5758c1-98c1-43ee-a96e-ad56e016fc44" xlink:to="loc_us-gaap_OperatingExpenseMember_00d5f371-92b2-4091-bd9d-1c2a175a4f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ca5605fb-f1a0-46a6-9767-3422608d0e37" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:to="loc_srt_RangeAxis_ca5605fb-f1a0-46a6-9767-3422608d0e37" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ca5605fb-f1a0-46a6-9767-3422608d0e37_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ca5605fb-f1a0-46a6-9767-3422608d0e37" xlink:to="loc_srt_RangeMember_ca5605fb-f1a0-46a6-9767-3422608d0e37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e1690066-64fc-46fe-ab79-271e4d4ca78a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ca5605fb-f1a0-46a6-9767-3422608d0e37" xlink:to="loc_srt_RangeMember_e1690066-64fc-46fe-ab79-271e4d4ca78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_01b9a829-5565-49ae-99d3-eed6f2290b9e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e1690066-64fc-46fe-ab79-271e4d4ca78a" xlink:to="loc_srt_MinimumMember_01b9a829-5565-49ae-99d3-eed6f2290b9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a131f2a-01cd-40b4-9feb-53ae55781aa4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e1690066-64fc-46fe-ab79-271e4d4ca78a" xlink:to="loc_srt_MaximumMember_6a131f2a-01cd-40b4-9feb-53ae55781aa4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="ibc0f3ba139bd4d0d862a95e7aec4b6ad_DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_02c01ded-1790-4273-8bd8-ffaf85e06513" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_02c01ded-1790-4273-8bd8-ffaf85e06513" xlink:to="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_72e89e53-f2eb-47c6-82d7-291e436b711c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_72e89e53-f2eb-47c6-82d7-291e436b711c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_9b2d19ab-7e25-4703-9815-cf8cee2da517" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_9b2d19ab-7e25-4703-9815-cf8cee2da517" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b15fb452-1c51-44f8-9e10-03a80b7d34c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b15fb452-1c51-44f8-9e10-03a80b7d34c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e7f2a43b-3019-403c-a427-fae693955c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e7f2a43b-3019-403c-a427-fae693955c2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_815b47da-7575-4df4-a672-fe4ac24fac18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_815b47da-7575-4df4-a672-fe4ac24fac18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ff921c5c-390d-46e4-b3fd-85ff12371cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ff921c5c-390d-46e4-b3fd-85ff12371cd6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_196b1b1d-4a56-49dc-a2ac-dba40aeb6c55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_196b1b1d-4a56-49dc-a2ac-dba40aeb6c55" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_36931f61-68bf-4a78-9190-745cf607d228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_36931f61-68bf-4a78-9190-745cf607d228" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_02c01ded-1790-4273-8bd8-ffaf85e06513" xlink:to="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_fee2689d-124b-464d-9daf-44bd5b5b2a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_fee2689d-124b-464d-9daf-44bd5b5b2a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_6bcfd566-7145-4c22-9ad4-f284eea126ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_6bcfd566-7145-4c22-9ad4-f284eea126ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_08ae05dd-d672-43e2-908b-367128ba6a30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_08ae05dd-d672-43e2-908b-367128ba6a30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_43be133f-c9b6-4927-8c31-4a034aeeb8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_43be133f-c9b6-4927-8c31-4a034aeeb8ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cebe506c-66a6-453f-9405-9fbe72296f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_02c01ded-1790-4273-8bd8-ffaf85e06513" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cebe506c-66a6-453f-9405-9fbe72296f7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4202d895-943b-4d01-bd9c-83263ff21420" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cebe506c-66a6-453f-9405-9fbe72296f7e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4202d895-943b-4d01-bd9c-83263ff21420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4202d895-943b-4d01-bd9c-83263ff21420_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4202d895-943b-4d01-bd9c-83263ff21420" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4202d895-943b-4d01-bd9c-83263ff21420_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_77589063-4445-426b-954c-bb29a7645a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4202d895-943b-4d01-bd9c-83263ff21420" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_77589063-4445-426b-954c-bb29a7645a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_31a09251-cccd-4805-aab7-99ab0a9aeb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_77589063-4445-426b-954c-bb29a7645a5f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_31a09251-cccd-4805-aab7-99ab0a9aeb4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8cb3527-5cfa-4d71-b7e5-950857872700" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cebe506c-66a6-453f-9405-9fbe72296f7e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8cb3527-5cfa-4d71-b7e5-950857872700" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d8cb3527-5cfa-4d71-b7e5-950857872700_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8cb3527-5cfa-4d71-b7e5-950857872700" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d8cb3527-5cfa-4d71-b7e5-950857872700_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fb77d96-6c9c-4e38-b432-e23720fb4c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8cb3527-5cfa-4d71-b7e5-950857872700" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fb77d96-6c9c-4e38-b432-e23720fb4c6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_96030de5-b3f5-4137-8f4b-1c9ff9beca1d" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fb77d96-6c9c-4e38-b432-e23720fb4c6b" xlink:to="loc_holx_MedicalAestheticsBusinessMember_96030de5-b3f5-4137-8f4b-1c9ff9beca1d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" xlink:type="extended" id="ib687f6e9267441ff8661a729897624d5_DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended" id="i18a39ee514624f6a95b3263672a4f10a_BusinessSegmentsandGeographicInformation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended" id="i4a2ad03eb7634599b15324365b0bbfec_BusinessSegmentsandGeographicInformationTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended" id="ie2fda532282743afb651dc67b60496a3_BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_4c460e95-11d3-4f4d-8f99-a97b1bcdcfb5" xlink:href="holx-20200926.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2170a2ef-b120-4a8b-8d99-db3beef9a29a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_4c460e95-11d3-4f4d-8f99-a97b1bcdcfb5" xlink:to="loc_us-gaap_NumberOfReportableSegments_2170a2ef-b120-4a8b-8d99-db3beef9a29a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c8762d48-07df-4bc3-8592-1b7bec036947" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_4c460e95-11d3-4f4d-8f99-a97b1bcdcfb5" xlink:to="loc_us-gaap_Revenues_c8762d48-07df-4bc3-8592-1b7bec036947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureTable_4499acbe-93f0-4aa3-bc90-a8ce9924bc1a" xlink:href="holx-20200926.xsd#holx_SegmentReportingDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_4c460e95-11d3-4f4d-8f99-a97b1bcdcfb5" xlink:to="loc_holx_SegmentReportingDisclosureTable_4499acbe-93f0-4aa3-bc90-a8ce9924bc1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_459879fd-c46f-4cc6-89b3-6d990446e18b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SegmentReportingDisclosureTable_4499acbe-93f0-4aa3-bc90-a8ce9924bc1a" xlink:to="loc_srt_ConsolidationItemsAxis_459879fd-c46f-4cc6-89b3-6d990446e18b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_459879fd-c46f-4cc6-89b3-6d990446e18b_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_459879fd-c46f-4cc6-89b3-6d990446e18b" xlink:to="loc_srt_ConsolidationItemsDomain_459879fd-c46f-4cc6-89b3-6d990446e18b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6c4b538a-4d95-487b-842d-50cc8231962f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_459879fd-c46f-4cc6-89b3-6d990446e18b" xlink:to="loc_srt_ConsolidationItemsDomain_6c4b538a-4d95-487b-842d-50cc8231962f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_5d6105e0-1e51-4989-a46b-8b2098fd8343" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6c4b538a-4d95-487b-842d-50cc8231962f" xlink:to="loc_us-gaap_IntersegmentEliminationMember_5d6105e0-1e51-4989-a46b-8b2098fd8343" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended" id="i64249728de644afbb859fec45b58a5cd_BusinessSegmentsandGeographicInformationSegmentInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e23fc340-f416-4f8f-bc3b-9b9557936467" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_Revenues_e23fc340-f416-4f8f-bc3b-9b9557936467" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b9d6948b-2ff6-4dc6-9259-5699767cd856" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_OperatingIncomeLoss_b9d6948b-2ff6-4dc6-9259-5699767cd856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_a0cb7710-8f7b-4a1c-8bbd-d6b2123288ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_a0cb7710-8f7b-4a1c-8bbd-d6b2123288ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_63eeb04e-71f9-46c7-85aa-f989b29b4595" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_63eeb04e-71f9-46c7-85aa-f989b29b4595" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_515abe1c-1a05-4910-bf49-33739db16df0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_Assets_515abe1c-1a05-4910-bf49-33739db16df0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27af2eb2-a6dd-4e6a-838d-791f451c57fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27af2eb2-a6dd-4e6a-838d-791f451c57fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6785ac9a-a189-410e-b110-158a83dba312" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27af2eb2-a6dd-4e6a-838d-791f451c57fb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6785ac9a-a189-410e-b110-158a83dba312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6785ac9a-a189-410e-b110-158a83dba312_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6785ac9a-a189-410e-b110-158a83dba312" xlink:to="loc_us-gaap_SegmentDomain_6785ac9a-a189-410e-b110-158a83dba312_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6785ac9a-a189-410e-b110-158a83dba312" xlink:to="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_27cd7d1c-4f1a-4089-b90a-61003555305d" xlink:href="holx-20200926.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_DiagnosticsMember_27cd7d1c-4f1a-4089-b90a-61003555305d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_71132258-a7da-454e-afad-c5fc2ad54531" xlink:href="holx-20200926.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_BreastHealthMember_71132258-a7da-454e-afad-c5fc2ad54531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_fa1d1a10-8f97-4dda-b616-877e9da53dac" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_MedicalAestheticsMember_fa1d1a10-8f97-4dda-b616-877e9da53dac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_86bfa117-a65c-4cee-82c9-19db397a04fe" xlink:href="holx-20200926.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_SkeletalHealthMember_86bfa117-a65c-4cee-82c9-19db397a04fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_d61b9e95-832e-4f77-88e5-4aa0a2e48ee7" xlink:href="holx-20200926.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_GynSurgicalMember_d61b9e95-832e-4f77-88e5-4aa0a2e48ee7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_48e03a60-300c-4d3e-abc9-610b131174f1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27af2eb2-a6dd-4e6a-838d-791f451c57fb" xlink:to="loc_srt_ConsolidationItemsAxis_48e03a60-300c-4d3e-abc9-610b131174f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_48e03a60-300c-4d3e-abc9-610b131174f1_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_48e03a60-300c-4d3e-abc9-610b131174f1" xlink:to="loc_srt_ConsolidationItemsDomain_48e03a60-300c-4d3e-abc9-610b131174f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e157c3c5-8e1a-497f-9aff-cb07e5c963f2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_48e03a60-300c-4d3e-abc9-610b131174f1" xlink:to="loc_srt_ConsolidationItemsDomain_e157c3c5-8e1a-497f-9aff-cb07e5c963f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_1f22f698-88ca-43a9-89ed-62756e8ed7df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_e157c3c5-8e1a-497f-9aff-cb07e5c963f2" xlink:to="loc_us-gaap_CorporateNonSegmentMember_1f22f698-88ca-43a9-89ed-62756e8ed7df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended" id="i7139c0d38d12427cb8f4972d504dcfbc_BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_94cb3a83-81be-4461-b99c-04933987c0f6" xlink:href="holx-20200926.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_6b661ec8-3707-4e46-a9b8-7a691620007e" xlink:href="holx-20200926.xsd#holx_PercentageOfRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_94cb3a83-81be-4461-b99c-04933987c0f6" xlink:to="loc_holx_PercentageOfRevenues_6b661ec8-3707-4e46-a9b8-7a691620007e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_6e304d22-893a-4d4d-9af2-8b7e8f7750af" xlink:href="holx-20200926.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_94cb3a83-81be-4461-b99c-04933987c0f6" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_6e304d22-893a-4d4d-9af2-8b7e8f7750af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9900470b-9e8d-409b-988a-dcfded072f99" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_6e304d22-893a-4d4d-9af2-8b7e8f7750af" xlink:to="loc_srt_StatementGeographicalAxis_9900470b-9e8d-409b-988a-dcfded072f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9900470b-9e8d-409b-988a-dcfded072f99_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9900470b-9e8d-409b-988a-dcfded072f99" xlink:to="loc_srt_SegmentGeographicalDomain_9900470b-9e8d-409b-988a-dcfded072f99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9900470b-9e8d-409b-988a-dcfded072f99" xlink:to="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3f20547e-f94a-455d-8d53-b7dd9df829a4" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:to="loc_country_US_3f20547e-f94a-455d-8d53-b7dd9df829a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_12075705-beb9-408c-b7e4-e7dd8f838e48" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:to="loc_srt_EuropeMember_12075705-beb9-408c-b7e4-e7dd8f838e48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_e4c1a325-0bee-47d3-98ec-c496d7cbb9ca" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:to="loc_srt_AsiaPacificMember_e4c1a325-0bee-47d3-98ec-c496d7cbb9ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_5286a0c7-c257-4b18-9e2e-d00c64505a5e" xlink:href="holx-20200926.xsd#holx_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:to="loc_holx_AllOtherCountriesMember_5286a0c7-c257-4b18-9e2e-d00c64505a5e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="extended" id="i2d64b742ccee4316a2314beb2db9fab7_BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_a4474c2f-17de-49a8-8b7f-96fdaef1e444" xlink:href="holx-20200926.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8f469f9c-e4be-4b28-9265-13ea50bb43b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_a4474c2f-17de-49a8-8b7f-96fdaef1e444" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8f469f9c-e4be-4b28-9265-13ea50bb43b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_22dc47df-d1e2-4a6f-90a3-c5ee20028ed4" xlink:href="holx-20200926.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_a4474c2f-17de-49a8-8b7f-96fdaef1e444" xlink:to="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_22dc47df-d1e2-4a6f-90a3-c5ee20028ed4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_35870712-9769-453f-918d-78c5374b7ed7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_22dc47df-d1e2-4a6f-90a3-c5ee20028ed4" xlink:to="loc_srt_StatementGeographicalAxis_35870712-9769-453f-918d-78c5374b7ed7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_35870712-9769-453f-918d-78c5374b7ed7_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_35870712-9769-453f-918d-78c5374b7ed7" xlink:to="loc_srt_SegmentGeographicalDomain_35870712-9769-453f-918d-78c5374b7ed7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_35870712-9769-453f-918d-78c5374b7ed7" xlink:to="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_23fd7714-eeed-4249-94ff-adcd3634fc13" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:to="loc_country_US_23fd7714-eeed-4249-94ff-adcd3634fc13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR_7dd3e359-aa99-45ae-a6bb-a5d3a13ee9b2" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_CR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:to="loc_country_CR_7dd3e359-aa99-45ae-a6bb-a5d3a13ee9b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_73a31f11-1553-446a-b2d2-50af62ba7b1f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:to="loc_srt_EuropeMember_73a31f11-1553-446a-b2d2-50af62ba7b1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_781d3dd5-38ec-4a67-b046-9a635d410888" xlink:href="holx-20200926.xsd#holx_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:to="loc_holx_AllOtherCountriesMember_781d3dd5-38ec-4a67-b046-9a635d410888" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilities"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities" xlink:type="extended" id="i6588dd668ff840ceb4878ee49160bb13_AccruedExpensesandOtherLongTermLiabilities"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables" xlink:type="extended" id="i147a23b22da249f9be07d7d9820cfafd_AccruedExpensesandOtherLongTermLiabilitiesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="extended" id="i7dd75c85068d4001813d57fc0e432205_AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="extended" id="i10b6014693b94c5095f6e55302d0ed63_AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefits" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefits"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefits" xlink:type="extended" id="ica751ef7e6ff417e8fc4750b9b98cc30_PensionandOtherEmployeeBenefits"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables" xlink:type="extended" id="ibf32881dbf034ff8a739644f21b09585_PensionandOtherEmployeeBenefitsTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="extended" id="if033d98b5073494da79579cf478e47be_PensionandOtherEmployeeBenefitsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_f186ff02-7afe-4fe2-a8af-43836cd9e034" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_f186ff02-7afe-4fe2-a8af-43836cd9e034" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_dc6c3dd9-8ae8-4ce6-b8d0-6088b9f8f440" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_dc6c3dd9-8ae8-4ce6-b8d0-6088b9f8f440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_62015fde-ded4-41b6-a67b-f2e5115be7ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_62015fde-ded4-41b6-a67b-f2e5115be7ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards_b2a45f74-f8cb-45bc-9ac9-4a2f4a617be9" xlink:href="holx-20200926.xsd#holx_ProjectedBenefitObligationForLongTermServiceAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:to="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards_b2a45f74-f8cb-45bc-9ac9-4a2f4a617be9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9d7c0b96-ee81-47fb-aa86-2163cb2739a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9d7c0b96-ee81-47fb-aa86-2163cb2739a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9fd8a020-877b-41aa-bc9b-5d601b4fbbd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9d7c0b96-ee81-47fb-aa86-2163cb2739a5" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9fd8a020-877b-41aa-bc9b-5d601b4fbbd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9fd8a020-877b-41aa-bc9b-5d601b4fbbd5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9fd8a020-877b-41aa-bc9b-5d601b4fbbd5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9fd8a020-877b-41aa-bc9b-5d601b4fbbd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2a296970-1996-4579-81df-6e9c554cabdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9fd8a020-877b-41aa-bc9b-5d601b4fbbd5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2a296970-1996-4579-81df-6e9c554cabdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_05df3a96-8224-42e8-819f-67e643d917bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2a296970-1996-4579-81df-6e9c554cabdb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_05df3a96-8224-42e8-819f-67e643d917bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="extended" id="ia114322c1fd04a0595ea027aba9fcb01_PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="extended" id="i24849236e04b437594ea672d13b2cfb6_PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" xlink:type="extended" id="i99d6c91a9d7f4080b209a4a36900b8e8_PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" xlink:type="extended" id="i928f887d4366447db06955cc7b21478e_PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited" xlink:type="simple" xlink:href="holx-20200926.xsd#QuarterlyStatementofOperationsInformationUnaudited"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited" xlink:type="extended" id="i92bff0f9bf1743a6b5038458daf67bfc_QuarterlyStatementofOperationsInformationUnaudited"/>
  <link:roleRef roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#QuarterlyStatementofOperationsInformationUnauditedDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail" xlink:type="extended" id="ifbaf0c5173924c2b8324bec36a6c5ab1_QuarterlyStatementofOperationsInformationUnauditedDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail" xlink:type="extended" id="i9c8d1d45f3dc4de9a3173d78eb25f80d_QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfFourthQuarterEventsLineItems_63b5bdc2-9ab4-450f-9781-73077817e93e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfFourthQuarterEventsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_9e3e998c-1dc1-4700-a6c5-0be0a73356fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfFourthQuarterEventsLineItems_63b5bdc2-9ab4-450f-9781-73077817e93e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_9e3e998c-1dc1-4700-a6c5-0be0a73356fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_46820690-f76d-4b54-a549-e16ee48b6add" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfFourthQuarterEventsLineItems_63b5bdc2-9ab4-450f-9781-73077817e93e" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_46820690-f76d-4b54-a549-e16ee48b6add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable_1572c4de-ccf5-4a71-b25c-f95a97be5789" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EffectOfFourthQuarterEventsLineItems_63b5bdc2-9ab4-450f-9781-73077817e93e" xlink:to="loc_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable_1572c4de-ccf5-4a71-b25c-f95a97be5789" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5d7270e4-0de1-4a80-86c5-102f22046a02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable_1572c4de-ccf5-4a71-b25c-f95a97be5789" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5d7270e4-0de1-4a80-86c5-102f22046a02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d7270e4-0de1-4a80-86c5-102f22046a02_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5d7270e4-0de1-4a80-86c5-102f22046a02" xlink:to="loc_us-gaap_SegmentDomain_5d7270e4-0de1-4a80-86c5-102f22046a02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ec5bd491-146b-43db-ab5a-19dddc6d6dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5d7270e4-0de1-4a80-86c5-102f22046a02" xlink:to="loc_us-gaap_SegmentDomain_ec5bd491-146b-43db-ab5a-19dddc6d6dc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_fac293bb-bc9c-467f-a6c3-5aa773acaf95" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ec5bd491-146b-43db-ab5a-19dddc6d6dc4" xlink:to="loc_holx_MedicalAestheticsBusinessMember_fac293bb-bc9c-467f-a6c3-5aa773acaf95" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>holx-20200926_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f4bb5493-eda8-449d-a170-7314862f7798,g:08da96e9-86db-4711-b125-e777b2cffbcd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_110e4dc4-0ff9-4e18-8c16-f9d9f72e114b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4388daab-838b-4c43-a07d-c37dd6fa8978_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e2623f3-669e-4884-81a8-0d0e0df019b4_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04d48e9a-d91c-46f1-9a47-4846794ef84f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3b1c9e53-97f1-4b71-9b35-6d11caf9880b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c9933f4a-4c24-427f-a1d5-af08975c1df0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_1fe10186-5823-451c-82f7-ecfa40fabbde_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_63db9988-11ef-466b-a82b-8fa8c9443fc4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_7066c978-760e-4e82-b618-1b0e28cc367b_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity component from convertible notes repurchase, net of taxes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_38489ad8-9fee-462e-82c4-19ed83b05bb2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to APIC, equity component of convertible debt</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_40d307f9-671b-4abf-b182-aa3f100268bd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs&#160;(Level&#160;3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NotionalAmount_6dabf419-6286-4384-badf-d98675631946_terseLabel_en-US" xlink:label="lab_holx_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_holx_NotionalAmount_label_en-US" xlink:label="lab_holx_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_holx_NotionalAmount_documentation_en-US" xlink:label="lab_holx_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount" xlink:href="holx-20200926.xsd#holx_NotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NotionalAmount" xlink:to="lab_holx_NotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsLeaseLiability_a1dd824c-f485-4246-8123-26e3c822b762_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets lease liability</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsLeaseLiability_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets lease liability</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsLeaseLiability_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets lease liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsLeaseLiability" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsLeaseLiability" xlink:to="lab_holx_DeferredTaxAssetsLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6d8ca244-c972-492f-bbd0-725af7026d6e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRentNoncurrent_920b4316-25c0-44b8-a250-eadbc2799031_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedRentNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued lease obligation&#8212;long-term</link:label>
    <link:label id="lab_us-gaap_AccruedRentNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRentNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rent, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedRentNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRentNoncurrent" xlink:to="lab_us-gaap_AccruedRentNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_403da812-d48b-4e45-ba81-f229694328c1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ddad151b-26db-4997-a63a-9d4d6765b253_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dcc611c1-2035-4a55-b3f5-f152ff484800_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was included in contract liability at prior year end</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b5bf90f8-d94c-46ca-a0c2-8a39de275e1b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_8e63af9f-9ad6-4fa4-845a-308d5db5353e_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional outstanding shares purchased (in shares)</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_label_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Shares</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_documentation_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:href="holx-20200926.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:to="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_7cf3da3c-e7ce-40da-ba18-c3215a11feda_terseLabel_en-US" xlink:label="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of vesting for RSUs granted to employees</link:label>
    <link:label id="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_label_en-US" xlink:label="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Vesting For Restricted Stock Units Granted To Employees</link:label>
    <link:label id="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_documentation_en-US" xlink:label="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of restricted stock units that vest annually per the terms of the typical restricted stock unit grant arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:href="holx-20200926.xsd#holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:to="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_b9290b28-7217-4cc0-8e52-49633161e6d4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_bcc07405-507f-4c52-9b9b-44acb6b689ac_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_94e84e5a-21f1-4c4f-9a6b-7fc0e5ddd572_terseLabel_en-US" xlink:label="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 28, 2019</link:label>
    <link:label id="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_655406d0-3dab-4509-b969-8e5fdb44efa1_verboseLabel_en-US" xlink:label="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 26, 2020</link:label>
    <link:label id="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:href="holx-20200926.xsd#holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:to="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_c611056a-deba-4e1c-b042-e267fe0fb6b6_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_362e77c4-7d76-480d-bed7-fdab4e11dc64_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_9c923ce8-550f-4211-b748-5daeb8d00eb8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligations Disclosure</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_c64217f5-8725-42b5-87e5-f2e80917bf54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other activity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_aae14e93-f4af-4801-9bcc-916b7603f162_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastHealthMember_d447e863-6c13-403f-8a00-3ce2233b8700_terseLabel_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health</link:label>
    <link:label id="lab_holx_BreastHealthMember_label_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health [Member]</link:label>
    <link:label id="lab_holx_BreastHealthMember_documentation_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember" xlink:href="holx-20200926.xsd#holx_BreastHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastHealthMember" xlink:to="lab_holx_BreastHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_7c2bce81-c673-49cb-81f2-59ca51f8b3e9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d4914496-44b9-437d-8528-b409c75e09ba_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_be7a9099-739d-4285-8672-8055682b0421_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_cab0703c-b616-4bc1-bf5f-d594fd7b2d84_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_be25ad72-c8ac-4d96-9199-c6d7b29ccf2e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_807a3480-7d70-49c0-9b62-bfd13d4ef449_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_ede15bf9-8337-400f-98a1-2208daa5b6de_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_a769951f-ef1e-4def-8931-3a0ffdfb24a8_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_96be31c5-8f4a-4e7a-a7a7-23a40804cd62_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_c57937de-2145-4c50-aebf-0686f35f070e_terseLabel_en-US" xlink:label="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage price of principal amount for repurchase of senior notes</link:label>
    <link:label id="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_label_en-US" xlink:label="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Price of Principal Amount for Repurchase of Senior Notes</link:label>
    <link:label id="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_documentation_en-US" xlink:label="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Price of Principal Amount for Repurchase of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:href="holx-20200926.xsd#holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:to="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_b10d6294-0e8a-4545-b126-0ec418990037_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_d77f2fb6-8dfc-4f72-9b69-e6ae448b0802_negatedTerseLabel_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of interest rate caps</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_74a880f6-f2f2-4d75-b222-0a01504ed30f_terseLabel_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of interest rate caps</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_label_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_documentation_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements aggregate premium payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:href="holx-20200926.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:to="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_133c36e7-5f2a-40d1-b4b1-442e78e4327b_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fec302b5-c314-4a7c-bc17-fc02066298ce_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 28, 2019</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8903b047-3bd0-4e95-a0f6-51a2aef12079_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_b58502d7-9cb8-47dc-bc6b-13225f9438a3_terseLabel_en-US" xlink:label="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of common stock price for ESPP</link:label>
    <link:label id="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_label_en-US" xlink:label="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Purchase Price Of Common Stock Lower Than Fair Market Value Of Common Stock On Date Of Purchase</link:label>
    <link:label id="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_documentation_en-US" xlink:label="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage applied to the lower of the common stock price at the beginning of the plan period and end of the plan period to determine the number of shares to be issued under the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:href="holx-20200926.xsd#holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:to="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_74d338fd-f6e2-49e5-a0c7-4ddd46617d21_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_36d74d81-9478-4e08-9c71-d8ba88993b27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_85dc0974-ab3f-41ff-89a6-865be2142853_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b180fda9-14fb-42b1-895c-afcc07877ef7_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5a3e831e-a22e-4185-b7e4-a09640a44b73_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfRevenues_4927ba0d-480f-4b61-ab6d-fba5e2109bd4_terseLabel_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_label_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_documentation_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues" xlink:href="holx-20200926.xsd#holx_PercentageOfRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfRevenues" xlink:to="lab_holx_PercentageOfRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_edde5499-8563-42da-8df7-cfa254c15221_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_61021d24-e961-43a3-bebd-1bfac2fd262b_terseLabel_en-US" xlink:label="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units (in shares)</link:label>
    <link:label id="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_label_en-US" xlink:label="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Common Stock Equivalents From Assumed Exercise Of Stock Options And Restricted Stock Units</link:label>
    <link:label id="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_documentation_en-US" xlink:label="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:href="holx-20200926.xsd#holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:to="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_93207db8-9393-488b-8243-2debb5531da1_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c0ebc311-ed0e-4dea-beb0-8ea7b7c86ce2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ac3a209c-a8ab-4bc1-a355-772089ba479d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_691574df-d426-427b-a7d3-eb86867e8e6a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions related to reserves acquired from acquisitions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616_ebc059a2-50ab-4630-8316-50e31d5275d7_terseLabel_en-US" xlink:label="lab_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decease in accumulated deficit resulting from adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616_label_en-US" xlink:label="lab_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decease in accumulated deficit resulting from adoption of ASCU 2016-16</link:label>
    <link:label id="lab_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616_documentation_en-US" xlink:label="lab_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decease in accumulated deficit resulting from adoption of ASCU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616" xlink:href="holx-20200926.xsd#holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616" xlink:to="lab_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e3ad2f87-9f01-43be-87bd-b871e88e00e3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TwoThousandEightEquityPlanMember_f24607f2-268d-4877-b824-fab368bb7149_terseLabel_en-US" xlink:label="lab_holx_TwoThousandEightEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2008 Equity Plan</link:label>
    <link:label id="lab_holx_TwoThousandEightEquityPlanMember_label_en-US" xlink:label="lab_holx_TwoThousandEightEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eight Equity Plan [Member]</link:label>
    <link:label id="lab_holx_TwoThousandEightEquityPlanMember_documentation_en-US" xlink:label="lab_holx_TwoThousandEightEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eight Equity Plan [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandEightEquityPlanMember" xlink:href="holx-20200926.xsd#holx_TwoThousandEightEquityPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwoThousandEightEquityPlanMember" xlink:to="lab_holx_TwoThousandEightEquityPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_eda3a9e2-098a-4eac-b991-06c81b8f4cb0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_ea16a584-44d2-43c1-a3d8-ab5fb790b506_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseBorrowings" xlink:to="lab_us-gaap_InterestExpenseBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_c9c3cf29-e853-4824-ab02-5ae0adeb154b_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Propertyclosurebenefit_7c48a7d5-7107-4bcc-bcbe-f8b4f43da64b_terseLabel_en-US" xlink:label="lab_holx_Propertyclosurebenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property closure benefit</link:label>
    <link:label id="lab_holx_Propertyclosurebenefit_label_en-US" xlink:label="lab_holx_Propertyclosurebenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property closure benefit</link:label>
    <link:label id="lab_holx_Propertyclosurebenefit_documentation_en-US" xlink:label="lab_holx_Propertyclosurebenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property closure benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Propertyclosurebenefit" xlink:href="holx-20200926.xsd#holx_Propertyclosurebenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Propertyclosurebenefit" xlink:to="lab_holx_Propertyclosurebenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeaseReceivable_d3e37b57-f782-4e1f-89a2-41daee8ab4f1_terseLabel_en-US" xlink:label="lab_holx_LeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease receivable</link:label>
    <link:label id="lab_holx_LeaseReceivable_label_en-US" xlink:label="lab_holx_LeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Receivable</link:label>
    <link:label id="lab_holx_LeaseReceivable_documentation_en-US" xlink:label="lab_holx_LeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseReceivable" xlink:href="holx-20200926.xsd#holx_LeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeaseReceivable" xlink:to="lab_holx_LeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_dacb7c5c-9c5f-4e42-afed-f73ff4d80299_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_52d7332c-7180-46f2-a11b-d3ac83f2e094_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4378fb5-866a-49c6-aa28-cb665c76204f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_221e4ed9-5c43-4011-9bd9-c1749ae2cfdf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_a7a1a13b-0a10-4392-a7d7-af8e44a475c2_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9bd684b8-5fb3-4f3f-9d84-564047e67f67_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_2761c479-a1a6-43d1-8263-9a163583d7b8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c7fc1489-9d3f-4eb9-87b4-95d6913353f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_84cd7525-7155-4c82-911f-1c5cfc07689c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_645f5c0b-7f3c-428e-90fb-bfd8f9861363_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd5455b9-fd08-4d17-8393-90855b9f2f7e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_632770b6-6a03-4e8f-9304-5fab2a95cdce_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastImagingMember_d05431f7-dde9-4d23-aa38-4e1106fd8dce_terseLabel_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging</link:label>
    <link:label id="lab_holx_BreastImagingMember_label_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:label id="lab_holx_BreastImagingMember_documentation_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember" xlink:href="holx-20200926.xsd#holx_BreastImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastImagingMember" xlink:to="lab_holx_BreastImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_c5ef4ef1-9259-4c25-859c-428c6789fdb8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_042b67c1-7b32-44ad-872a-a08f1c323a7c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_4d2cb53f-29c7-4fcd-80cf-06259610cffb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 13 and 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_758c3ca7-b277-49c1-9ec1-6f1a69c19956_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_60b497c6-3832-4741-b1a9-398c5c9e24d1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_dc3db38b-582f-42a9-a527-07f9cbb9a97c_terseLabel_en-US" xlink:label="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss)</link:label>
    <link:label id="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_label_en-US" xlink:label="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount</link:label>
    <link:label id="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_documentation_en-US" xlink:label="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:href="holx-20200926.xsd#holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:to="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_32d477d9-b8ae-4bc0-915d-bd8e9fe3b99b_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment losses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_806dfcb9-7567-4b9b-bf26-53a0ba391073_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment losses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_a9f0baf6-8548-473d-b584-74e150f95116_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d7b63856-a490-4d97-a09f-6e1dde440b46_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8a4c2e1c-b8d3-40f5-aafa-c68025360882_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_8f414583-c6f9-4308-87ea-b09ce535e451_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_31aef10a-4406-4302-bbce-3a3f39d5ed41_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_48aa05cd-9b28-4c56-9c44-71e715a57f3f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquityMethodInvestmentAndLoansToAcquiree_b898ac85-14b4-4e7f-93a3-89996ac9c360_verboseLabel_en-US" xlink:label="lab_holx_EquityMethodInvestmentAndLoansToAcquiree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-method investment and loans to SSI (Note 5)</link:label>
    <link:label id="lab_holx_EquityMethodInvestmentAndLoansToAcquiree_label_en-US" xlink:label="lab_holx_EquityMethodInvestmentAndLoansToAcquiree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment And Loans To Acquiree</link:label>
    <link:label id="lab_holx_EquityMethodInvestmentAndLoansToAcquiree_documentation_en-US" xlink:label="lab_holx_EquityMethodInvestmentAndLoansToAcquiree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment And Loans To Acquiree</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquityMethodInvestmentAndLoansToAcquiree" xlink:href="holx-20200926.xsd#holx_EquityMethodInvestmentAndLoansToAcquiree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquityMethodInvestmentAndLoansToAcquiree" xlink:to="lab_holx_EquityMethodInvestmentAndLoansToAcquiree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_38293b31-635a-49f7-b6e9-0b9798710bb1_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising cost</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_a2b58559-5d83-4af3-b0ae-91fec67e9fc5_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset obtained in exchange for finance lease liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_8083b9a3-d75f-4719-9d59-02d634c2bf91_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SecuredTermLoanMember_3084b30e-2d23-420e-a08e-1d48d3516cdc_terseLabel_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_label_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan [Member]</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_documentation_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember" xlink:href="holx-20200926.xsd#holx_SecuredTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SecuredTermLoanMember" xlink:to="lab_holx_SecuredTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_1490a7ec-a617-4f05-9763-7d5e766d10fb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0d36a0fa-113d-4a91-8c67-478efc45b413_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_f40ad6d5-323d-438e-932a-3acc22549cd2_totalLabel_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal restructuring charges</link:label>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_abc9ad14-fb0a-4677-acca-528c9b2d7acc_terseLabel_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal restructuring charges</link:label>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_label_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Under Exit Or Disposal Plan</link:label>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_documentation_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring charges under exit or disposal plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:href="holx-20200926.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:to="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_be04e16e-c1a6-4c62-89d7-be7dece7c5f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation, period of vest term granted to employees, years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_58ebe002-6d92-404d-840c-b4b2a4d61d50_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_455fa1b8-f268-4c1b-bc7e-2c884ffa3805_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation over time</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DevelopedTechnologyMember_47581303-e048-4e99-8731-a5340ef88ae9_terseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology [Member]</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_label_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology [Member]</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember" xlink:href="holx-20200926.xsd#holx_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DevelopedTechnologyMember" xlink:to="lab_holx_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_7d3f8715-37d6-44f9-a2a1-f5ef13aab5b9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_971abfe8-502e-4bfa-9e71-4c1ccdfde0df_terseLabel_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Target Number Of Shares Issued Based On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum target number percentage of shares issued based on stock performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:href="holx-20200926.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:to="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_57e1a7de-6ecb-4bdb-87db-8f7f2a59ef4e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeOptionMember" xlink:to="lab_us-gaap_ForeignExchangeOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_0c7b883a-894d-4ba5-bf1b-d1a1f207df33_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_cecd0392-aeb3-403b-8b18-dfe6c0eb9a8d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_20d20ba0-75b8-4c74-89a6-7dd7c255826c_terseLabel_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_label_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships Contracts [Member]</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_documentation_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember" xlink:href="holx-20200926.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CustomerRelationshipsContractsMember" xlink:to="lab_holx_CustomerRelationshipsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_5da44db1-4751-48c8-a2c7-5764f390fd35_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, discount rate</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_df426142-a558-43dd-bea7-c1ff613c7680_verboseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value discount rate (percent)</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_09807b03-d104-460b-b196-858344d63d05_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_24667fa9-ee3a-4049-9f87-3bf9b2a411b7_terseLabel_en-US" xlink:label="lab_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development reclassified to developed technology</link:label>
    <link:label id="lab_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_label_en-US" xlink:label="lab_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development reclassified to developed technology</link:label>
    <link:label id="lab_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_documentation_en-US" xlink:label="lab_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development reclassified to developed technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology" xlink:href="holx-20200926.xsd#holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology" xlink:to="lab_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_26ed5607-991c-4bb1-9fd8-23a244db4a68_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_e2f8f1f6-1917-4aac-82ae-9b9eb3f4857e_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_9d37e0d0-5729-4423-ab4d-ac785a7bb8b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost &#8211; 37,609 and 24,639 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_bc6243bc-1ed7-4829-a78c-88cb233af6e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to extinguish convertible notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_ba1a16c5-1a84-41e1-819d-64946e12b941_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of convertible debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_416a48b7-85b6-4f99-bfae-6f22577b36a2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_f2aaefcc-db0f-4616-99e7-02c0f9912fb8_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Black-Scholes Model Weighted Average Assumptions Used to Estimate Fair Value of Shares to Be Issued as of Grant Date</link:label>
    <link:label id="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Assumptions For Employee Stock Purchase Plan [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of significant assumptions used during the year to estimate the fair value of employee stock purchase plan shares, including, but not limited to: (a) expected term, (b) expected volatility, (c) risk-free interest rate, and (d) dividend yield.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:href="holx-20200926.xsd#holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:to="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_d4031e2d-c24c-4b46-82eb-cb49286f6f35_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MarketBasedStockUnitsMember_4c14bd4f-3eee-49c9-898a-78dc5a567a24_terseLabel_en-US" xlink:label="lab_holx_MarketBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Stock Units</link:label>
    <link:label id="lab_holx_MarketBasedStockUnitsMember_label_en-US" xlink:label="lab_holx_MarketBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Stock Units [Member]</link:label>
    <link:label id="lab_holx_MarketBasedStockUnitsMember_documentation_en-US" xlink:label="lab_holx_MarketBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember" xlink:href="holx-20200926.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MarketBasedStockUnitsMember" xlink:to="lab_holx_MarketBasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a13d8e81-a6e6-4f02-bcba-fee1cbb724bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc8a85c3-a61d-4dce-8141-98d2e6e9d23b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrossUnrecognizedTaxBenefits_806e484f-e43a-4c01-87d3-688d6b656cf8_terseLabel_en-US" xlink:label="lab_holx_GrossUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits, excluding interest</link:label>
    <link:label id="lab_holx_GrossUnrecognizedTaxBenefits_label_en-US" xlink:label="lab_holx_GrossUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrecognized Tax Benefits</link:label>
    <link:label id="lab_holx_GrossUnrecognizedTaxBenefits_documentation_en-US" xlink:label="lab_holx_GrossUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the total unrecognized tax benefits, including interest, that if recognized would result in a reduction to the effective tax rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossUnrecognizedTaxBenefits" xlink:href="holx-20200926.xsd#holx_GrossUnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrossUnrecognizedTaxBenefits" xlink:to="lab_holx_GrossUnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_af0121a6-d9ab-4deb-955b-4120ef6363f0_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_UnusedCreditFacility_37a10364-d56e-4016-9e33-fff86bf5f5f1_terseLabel_en-US" xlink:label="lab_holx_UnusedCreditFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused credit facility</link:label>
    <link:label id="lab_holx_UnusedCreditFacility_label_en-US" xlink:label="lab_holx_UnusedCreditFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused credit facility</link:label>
    <link:label id="lab_holx_UnusedCreditFacility_documentation_en-US" xlink:label="lab_holx_UnusedCreditFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused credit facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UnusedCreditFacility" xlink:href="holx-20200926.xsd#holx_UnusedCreditFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_UnusedCreditFacility" xlink:to="lab_holx_UnusedCreditFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8387bdc3-4bf7-4e58-9beb-028255ca8ad4_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_48037a2b-f36d-4654-8f07-cb755ca63411_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d934153a-4bb1-455a-bc56-64efab2b4f81_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_0ca3acf9-56b1-4a1a-9049-37f754caea86_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterestCoverageRatio_bc333d46-282c-484b-b805-b5916811c09f_terseLabel_en-US" xlink:label="lab_holx_InterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest coverage ratio</link:label>
    <link:label id="lab_holx_InterestCoverageRatio_label_en-US" xlink:label="lab_holx_InterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Coverage Ratio</link:label>
    <link:label id="lab_holx_InterestCoverageRatio_documentation_en-US" xlink:label="lab_holx_InterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestCoverageRatio" xlink:href="holx-20200926.xsd#holx_InterestCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestCoverageRatio" xlink:to="lab_holx_InterestCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_b8e25edb-55e8-4936-add5-10dbd9b5a341_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_b7b6f591-736b-44e1-9b5b-57c91b2abee8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c8bacba3-6a06-4a97-ae44-d701454186be_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_1f129fe5-aacd-4107-9087-e34d75183135_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_90d5fba3-9def-47f7-be4e-e60cd721514f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b812cee9-c394-4d69-bcae-3860a6e976f2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of option exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_7b361ef5-799e-499d-9450-8f3a4cb638b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_01cd5945-ae6c-4e9d-a5c8-4acfe03fcc1f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2726c705-6d0c-431a-8927-1dd49c1b234f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 28, 2019</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_95e8875f-4b3a-4d6f-acb1-1b539d4fe4eb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 29, 2018</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_7b12acc4-d228-469f-be69-3f94864b8522_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges Taken Related to Restructuring Actions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4d26c33c-af71-4f2c-891d-ceb2476a8e7a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_50388f30-fdeb-4caa-84ab-5124922afba9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_1c2790c8-e67b-4185-9bc5-8797c5877b65_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_c4760efc-e3c7-420c-a448-d682f058c817_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_58b37e50-8cc1-4e02-83d0-e8ff6659ec51_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3dc7c8ca-0d52-4764-9e3e-6079660848d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c12d1948-bca2-44f2-b78b-f083f167aebc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_28cbbdf7-c01d-4f6c-987c-f92e256acf02_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of minimum tax withholdings on net share settlements of equity awards</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_label_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Tax Withholding Related To Vested And Released Restricted Stock Units</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_documentation_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:href="holx-20200926.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:to="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_6f01a0ed-f241-42c5-8f07-01666fdd1b5f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_5d2bae27-9d72-44c1-8f5d-14b2d6596920_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_98f7f494-658f-4227-a4b4-f1d58ff85b08_terseLabel_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_label_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_documentation_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware" xlink:href="holx-20200926.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ManufacturingEquipmentAndSoftware" xlink:to="lab_holx_ManufacturingEquipmentAndSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ac259cbc-1bbb-483d-9e95-0f9f10ed7f38_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise&#160;Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_49beee11-9e9d-4dc8-bb9f-588fb24f88de_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f582170f-c491-4601-b108-f7627ad45d0c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EmployeeStockPurchasePlanMember_6d091b9f-b1b7-40f8-be85-eba3cafb7386_terseLabel_en-US" xlink:label="lab_holx_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_holx_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_holx_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_holx_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_holx_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeStockPurchasePlanMember" xlink:href="holx-20200926.xsd#holx_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmployeeStockPurchasePlanMember" xlink:to="lab_holx_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_a4a943cb-8965-4246-9441-5dc03653afac_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ReductionOfWorkforceExpenses_c88c8d69-75ed-4268-91aa-ca827714adc9_terseLabel_en-US" xlink:label="lab_holx_ReductionOfWorkforceExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce reductions</link:label>
    <link:label id="lab_holx_ReductionOfWorkforceExpenses_label_en-US" xlink:label="lab_holx_ReductionOfWorkforceExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction Of Workforce Expenses</link:label>
    <link:label id="lab_holx_ReductionOfWorkforceExpenses_documentation_en-US" xlink:label="lab_holx_ReductionOfWorkforceExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents severance and related benefit charges for the termination of employees under an exit or disposal activity. Charges are recorded either as one-time termination benefits, which are recognized ratable over the required service period to receive such benefit, or under an ongoing benefit plan arrangement once the charge is probable and reasonably estimable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses" xlink:href="holx-20200926.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ReductionOfWorkforceExpenses" xlink:to="lab_holx_ReductionOfWorkforceExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_db9da5fe-5f9d-4cf9-9720-32a46c739e35_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_e75508b9-c124-4449-96ea-05ab702fbaeb_terseLabel_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension period</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_label_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Extension Period</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_documentation_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeasesExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:to="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_86c65a77-14a5-400c-8d59-c611635281ce_terseLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal:</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_b3d0d2af-cb64-420a-9d7b-1d55ae42629c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_006615de-36de-4490-b94f-98735cc36448_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_8302d4f4-0a70-4382-a692-0b77fd473548_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management's Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_abdd0194-52b0-4065-b9c2-370e2c5bfea3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operations</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_78c581f4-6bab-4aff-9342-65018c79e3ea_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsAbstract_301efcbe-ff84-4a81-9955-731a52854538_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationRelatedCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsAbstract" xlink:to="lab_us-gaap_CompensationRelatedCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_f7e764ba-a227-452a-9545-edaef571188b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_6be0116d-89d9-4bc1-9242-b0e6323227f9_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion allocable to newly acquired shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d8178ff0-80e7-45aa-bc1e-797570e5d0cc_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_cfdbc4ec-691a-4ac5-84bd-6406ecdce34f_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized net actuarial gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_d9b1dd95-8bfa-4833-a5ce-886b3b8f392f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_a6446a03-7084-4afb-94e2-2c9f62391663_terseLabel_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</link:label>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_label_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</link:label>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_documentation_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:href="holx-20200926.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:to="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_32b04ac4-177f-4126-bcb5-18ddda87a8d6_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareTable_0d247910-2259-447d-ad8a-268b28b6e112_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_label_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_documentation_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable" xlink:href="holx-20200926.xsd#holx_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareTable" xlink:to="lab_holx_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_9c20f54c-9563-4d02-b81b-767ae58d2b68_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_4ade7981-8884-44db-aff7-c7a9de1b3cea_negatedTerseLabel_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_label_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_documentation_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts" xlink:href="holx-20200926.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Purchaseofinsurancecontracts" xlink:to="lab_holx_Purchaseofinsurancecontracts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_064b6349-6657-414b-a001-9dbd189ec26b_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering price, percent of face value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_label_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_documentation_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:href="holx-20200926.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:to="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_d763537b-7581-4fbb-9979-48a564d46b7a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_acb2ffba-21a7-41cd-9b06-68528a6ecbcc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_e034b173-31ce-4adf-a0d6-74b2b8f78331_terseLabel_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_label_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Goods Sold Impairment Of Intangible Assets</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_documentation_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:href="holx-20200926.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:to="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FinanceLeaseObligationsLongTermMember_a1b9199f-2ddf-4606-9a54-3dea28f81ce6_terseLabel_en-US" xlink:label="lab_holx_FinanceLeaseObligationsLongTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations - long term</link:label>
    <link:label id="lab_holx_FinanceLeaseObligationsLongTermMember_label_en-US" xlink:label="lab_holx_FinanceLeaseObligationsLongTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations - Long Term [Member]</link:label>
    <link:label id="lab_holx_FinanceLeaseObligationsLongTermMember_documentation_en-US" xlink:label="lab_holx_FinanceLeaseObligationsLongTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations - Long Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsLongTermMember" xlink:href="holx-20200926.xsd#holx_FinanceLeaseObligationsLongTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FinanceLeaseObligationsLongTermMember" xlink:to="lab_holx_FinanceLeaseObligationsLongTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_cdc5bf35-fb08-4a2c-bc01-cb84a4b1b559_terseLabel_en-US" xlink:label="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of vesting for stock options granted to employees</link:label>
    <link:label id="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_label_en-US" xlink:label="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Vesting For Stock Options Granted To Employees</link:label>
    <link:label id="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_documentation_en-US" xlink:label="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of stock options that vest annually per the terms of the typical stock option grant arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:href="holx-20200926.xsd#holx_PercentageOfVestingForStockOptionsGrantedToEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:to="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7e8ca080-76f4-4780-a4b0-9b5357b4c9ef_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dc1c96a2-83b9-4c6c-b695-f7823c45cb2d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5f5dc1fd-027a-459b-9246-fe36507a4486_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_826deabd-6282-4714-9bb4-cf60a859009b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_75799dae-51e2-46f6-95ee-a5fc5cc68a29_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_48aaa24d-378e-4481-924f-75c5452ad6c3_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign net operating loss expected to be expired unutilized</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:to="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_c5208fa5-171d-4786-9a39-1417d2a7a56c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_0ff92d92-4479-45be-a5a5-c36538f196a0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_530f2925-65bc-4a36-8403-6d6edb82b9eb_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_2e0a9a77-e946-4d7c-adb2-edb440b9f589_terseLabel_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_label_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_documentation_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember" xlink:href="holx-20200926.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcquiredintangibleassetsMember" xlink:to="lab_holx_AcquiredintangibleassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_9fd77529-5c87-4b34-b2e0-7aced34eb5b8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_035162cf-5a27-4f40-a0de-e63764906adc_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation - long term (capital lease obligation in 2019)</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d25c646c-8231-47e1-97eb-2f8590ce2603_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_e6f68ba3-d694-4636-b6ec-8ddc6a8cb62a_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASC606_a3c7ddd5-f712-453a-806c-aec96801ef55_negatedTerseLabel_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASC606" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASC 606</link:label>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASC606_label_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASC606" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASC 606</link:label>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASC606_documentation_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASC606" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASC 606</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASC606" xlink:href="holx-20200926.xsd#holx_AccountingstandardtransitionadjustmentASC606"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountingstandardtransitionadjustmentASC606" xlink:to="lab_holx_AccountingstandardtransitionadjustmentASC606" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SignificantAccountingPoliciesTable_37056028-bede-49b4-b406-161a8c37b047_terseLabel_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_holx_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_holx_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesTable" xlink:href="holx-20200926.xsd#holx_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SignificantAccountingPoliciesTable" xlink:to="lab_holx_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_8091d9a1-86f2-4038-97da-d6050bfed5cd_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Hologic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3539c510-ebe0-4501-8973-838a7bc56115_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_8c2d60ff-6e20-4606-9c36-057eb48aac27_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in tax resulting from:</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_1a2d822b-e1de-4ebf-b485-564faa4b50d8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SkeletalHealthMember_7340ccd1-b8e4-4229-99ca-58830100a088_terseLabel_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_label_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health [Member]</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_documentation_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember" xlink:href="holx-20200926.xsd#holx_SkeletalHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SkeletalHealthMember" xlink:to="lab_holx_SkeletalHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2c83f786-3728-4485-8236-f30d104505ba_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_59b72463-b13e-4f67-8d5e-1fa7143dd640_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CynosureMember_81aaa844-91be-417f-9f74-648a0f924bba_terseLabel_en-US" xlink:label="lab_holx_CynosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cynosure</link:label>
    <link:label id="lab_holx_CynosureMember_label_en-US" xlink:label="lab_holx_CynosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cynosure [Member]</link:label>
    <link:label id="lab_holx_CynosureMember_documentation_en-US" xlink:label="lab_holx_CynosureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cynosure [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember" xlink:href="holx-20200926.xsd#holx_CynosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CynosureMember" xlink:to="lab_holx_CynosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_57ad45a6-ba55-47eb-8a8e-49a5a9c61022_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember_e9b1a883-341b-4fc8-970a-608cd1ff1812_terseLabel_en-US" xlink:label="lab_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 29, 2012 Original Notes</link:label>
    <link:label id="lab_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember_label_en-US" xlink:label="lab_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February Twenty Nine Two Thousand Twelve Original Notes [Member]</link:label>
    <link:label id="lab_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember_documentation_en-US" xlink:label="lab_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February twenty nine two thousand twelve original notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember" xlink:href="holx-20200926.xsd#holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember" xlink:to="lab_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f75dd1c0-afcb-487b-8410-c6f776f02a07_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at September 26, 2020 (1)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock_2568a970-c3de-4ebe-ab0c-b7d33dcc4b09_terseLabel_en-US" xlink:label="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:label id="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="holx-20200926.xsd#holx_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_450a809f-06d9-4aef-889a-f72d12ba3701_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9d86e00c-2a35-40f0-bea0-297d18cf6699_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5207512f-3bd1-492d-a9e3-8813ab112f06_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_e89e4a9c-2f60-42f7-884d-0b6ea28cec54_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BloodScreeningMember_2f4460ec-5ec5-4fc9-9fda-afac3687897d_verboseLabel_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening</link:label>
    <link:label id="lab_holx_BloodScreeningMember_label_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:label id="lab_holx_BloodScreeningMember_documentation_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember" xlink:href="holx-20200926.xsd#holx_BloodScreeningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BloodScreeningMember" xlink:to="lab_holx_BloodScreeningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_c6d8bd4d-ce05-404e-a217-7a61e6047fa4_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal Per Quarter</link:label>
    <link:label id="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_label_en-US" xlink:label="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal Per Quarter</link:label>
    <link:label id="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal Per Quarter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:to="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_18d3c6b6-32bd-48ac-b195-aabf7ffc250a_terseLabel_en-US" xlink:label="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Earnings per Share resulted from adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_label_en-US" xlink:label="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Earnings per Share resulted from adoption of ASC 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_documentation_en-US" xlink:label="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Earnings per Share resulted from adoption of ASC 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:href="holx-20200926.xsd#holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:to="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_9b032603-38b9-4f91-ac82-fd49701ad335_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_7f04e75a-0145-4f3d-a434-31a9428ce9e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_39260fbc-d64b-4ca2-b6b4-2aa1e909f425_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_06dad7f1-63e4-4972-be86-83b32609b957_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4ba0d011-650d-40a5-a1af-571933619696_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b3ed62a2-b2f6-41af-9c8a-018407eb732f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_5934a358-e7d7-4af9-b9af-1542bb43e4c8_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_d30bfb69-0799-4026-95fe-47e3715e4f00_terseLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Non Deductible Expense Executive Compensation Cost</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to the difference in the deductibility or nondeductibility of executive compensation (i.e., those subject to Section 162(m) limitations), including equity-based compensation and salary and bonus compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:to="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_2c30f774-190f-484f-a907-550d04799ed9_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Improvements [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill_9aa9cff8-a17f-4d81-a4fd-c9e6f08c4167_terseLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible goodwill</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Non Deductible Goodwill</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Non Deductible Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" xlink:to="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_845db46f-c0ec-4ff9-b091-0bb401bbb5a6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_07603fab-7449-4e6f-ae53-56ad17c0eacc_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_f239a72c-de4e-44a0-b453-83903448dfa5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations, net of debt discount</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_62e3a011-6295-4ec5-a710-8e05f80e8576_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities (non-current)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c382d7fe-2f6e-4c57-97a1-8ce69645c067_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_a97c4574-c093-4eb1-9c40-5b77bfc38648_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ae66cca8-debc-4af5-a3f8-2f4489549f3a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_86ccafb0-8955-4b99-938d-c72c794fd5ec_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_226df632-7f22-4c3d-9d4a-451863173b7f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EmployerContributionsPercentVestedAnnually_c58ebab3-a5b9-4e84-a063-d4dedbbf3de2_terseLabel_en-US" xlink:label="lab_holx_EmployerContributionsPercentVestedAnnually" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent vested annually</link:label>
    <link:label id="lab_holx_EmployerContributionsPercentVestedAnnually_label_en-US" xlink:label="lab_holx_EmployerContributionsPercentVestedAnnually" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions, Percent Vested Annually</link:label>
    <link:label id="lab_holx_EmployerContributionsPercentVestedAnnually_documentation_en-US" xlink:label="lab_holx_EmployerContributionsPercentVestedAnnually" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions, Percent Vested Annually</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsPercentVestedAnnually" xlink:href="holx-20200926.xsd#holx_EmployerContributionsPercentVestedAnnually"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmployerContributionsPercentVestedAnnually" xlink:to="lab_holx_EmployerContributionsPercentVestedAnnually" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_7db4c5bc-eff9-4a56-96b8-e8cb0ac3e10e_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivative</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivatives Recorded in Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_c7391741-2657-4841-923e-3e9b7d20bb61_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current and Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_55d5bb02-ff30-4c7e-ae75-cbf67c49c4ce_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_8268ac87-334b-48cf-86f8-0e1124031490_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1d4e7b9b-a00a-44ce-8867-2572746dea16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_d0efe34a-06cf-447f-9751-f489716c6411_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_15aa0a48-5654-4029-9d57-d284203fde7c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_26bc7499-f2c8-4a50-82b5-38b6b31b79d9_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_8be699bc-b1cf-4a4c-ab64-3af85a3215c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Borrowings and Interest Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_cb4694dd-c8c9-4d4c-bb93-9e4b2e4fe1b3_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance charges</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1604ce84-dfb5-41f4-8826-cc02f8471222_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) provision at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_f85ceac7-2912-46b8-8243-f6453f91a7fa_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of redemption price, third period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Third Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Third Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_b57ec554-2191-4e80-b5c5-3863c9c0235e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) gain recognized, net of tax of $(8.3) million in 2020 and $1.2 million in 2019 for interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_464e6bbc-ea7f-4d5a-bba4-72d2139e6f06_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_69c002a5-3a5b-4ff6-bf0e-209d2618486a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b06d0f1c-7e84-4e52-8b03-3124669b1ef1_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, reserves</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MolecularDiagnosticsMember_89d02ca4-818a-41b4-ad8c-53db39333c67_terseLabel_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_label_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_documentation_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember" xlink:href="holx-20200926.xsd#holx_MolecularDiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MolecularDiagnosticsMember" xlink:to="lab_holx_MolecularDiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_dbfb9199-43b1-411d-9e47-f2b38ba96193_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense under Convertible Notes</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expense under convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:href="holx-20200926.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:to="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AdditionalPurchaseConsideration_127a17db-a576-4798-a9bb-2c5ee728758c_terseLabel_en-US" xlink:label="lab_holx_AdditionalPurchaseConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional purchase consideration</link:label>
    <link:label id="lab_holx_AdditionalPurchaseConsideration_label_en-US" xlink:label="lab_holx_AdditionalPurchaseConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional purchase consideration</link:label>
    <link:label id="lab_holx_AdditionalPurchaseConsideration_documentation_en-US" xlink:label="lab_holx_AdditionalPurchaseConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional purchase consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AdditionalPurchaseConsideration" xlink:href="holx-20200926.xsd#holx_AdditionalPurchaseConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AdditionalPurchaseConsideration" xlink:to="lab_holx_AdditionalPurchaseConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d69011ae-c04d-4fef-a7da-b57470d98390_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcessaHealthMember_5fde930d-7cf2-4660-b5cf-2ff16e87eecd_terseLabel_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health [Member]</link:label>
    <link:label id="lab_holx_AcessaHealthMember_label_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health [Member]</link:label>
    <link:label id="lab_holx_AcessaHealthMember_documentation_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcessaHealthMember" xlink:to="lab_holx_AcessaHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_10a74f22-643b-45e0-a1cb-27d016020e8e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0406d98-b04d-43ab-9935-49f5e3499e50_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c2dbd72a-cb9d-4344-b470-d18c46fd57fd_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_072f95c2-8fd8-475a-8623-a3d1eb2cbf18_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ada88340-ca29-4ab1-83c3-9bf3cca22481_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherGeographicRegionsMember_d959b2b0-4077-451b-b636-5dfd2f184875_terseLabel_en-US" xlink:label="lab_holx_OtherGeographicRegionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_OtherGeographicRegionsMember_label_en-US" xlink:label="lab_holx_OtherGeographicRegionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Regions [Member]</link:label>
    <link:label id="lab_holx_OtherGeographicRegionsMember_documentation_en-US" xlink:label="lab_holx_OtherGeographicRegionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Regions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherGeographicRegionsMember" xlink:href="holx-20200926.xsd#holx_OtherGeographicRegionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherGeographicRegionsMember" xlink:to="lab_holx_OtherGeographicRegionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_48ce6466-2e6f-4a97-8fc2-368243415428_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MedicalAestheticsMember_74590985-2f29-481b-a56b-04d26f58a224_terseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_label_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics [Member]</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_documentation_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MedicalAestheticsMember" xlink:to="lab_holx_MedicalAestheticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_00753259-a0c0-402a-b3ba-76fc3f7e53b4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_7a57f0ee-37d9-41db-a615-e29e7a0e8abd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_a9f04925-528d-4cae-9da3-33df23910a0b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_a247463d-61be-478d-9d8c-c5994b452182_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_ba080c67-630d-40f1-bd18-debacda69b4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Statement Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_3acb41eb-4c1e-4a7f-8ca0-f5832c40553d_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2021</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_04ec91c5-0dd5-4901-8a13-29396152f7cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_366427b2-0c46-457b-b98a-55f9905a626c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent holdbacks</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_536821fb-1c56-4561-ad18-495d75f2b6ac_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7f62c4d4-c5c7-42cb-9c60-323c2522bdc7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of RSUs vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_a42789f8-85e1-458f-a3b6-d357357150c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Capital Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_4549abbe-4aaa-49cd-bc00-61fe1d7c4892_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Five</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3073793d-80f7-4e5b-8031-43d138c8921a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_062615c3-ad32-4b32-9b12-94441d18a954_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4f7337da-1b46-4c80-b650-354af3d11aa6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DirectThirdPartyCostsinterestExpense_2adb9ba2-f2c8-4a5a-a5e3-ca4aff42503f_terseLabel_en-US" xlink:label="lab_holx_DirectThirdPartyCostsinterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-party costs recorded as interest</link:label>
    <link:label id="lab_holx_DirectThirdPartyCostsinterestExpense_label_en-US" xlink:label="lab_holx_DirectThirdPartyCostsinterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Third Party Costs interest Expense</link:label>
    <link:label id="lab_holx_DirectThirdPartyCostsinterestExpense_documentation_en-US" xlink:label="lab_holx_DirectThirdPartyCostsinterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Third Party Costs interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DirectThirdPartyCostsinterestExpense" xlink:href="holx-20200926.xsd#holx_DirectThirdPartyCostsinterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DirectThirdPartyCostsinterestExpense" xlink:to="lab_holx_DirectThirdPartyCostsinterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c8f2e95b-7853-481c-ade0-4821e7243409_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SegmentReportingDisclosureTable_1828e0dc-a249-4e39-ac5e-8d43783a80a1_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Table]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureTable_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Table]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureTable_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureTable" xlink:href="holx-20200926.xsd#holx_SegmentReportingDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureTable" xlink:to="lab_holx_SegmentReportingDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_80744db4-0658-42c7-a8d6-5c59f0e7e98a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_33dcb766-ab55-4413-882f-f49721ebde71_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2020Member_72717fa6-afd5-4d03-91cf-8a64be394d58_terseLabel_en-US" xlink:label="lab_holx_Fiscal2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020</link:label>
    <link:label id="lab_holx_Fiscal2020Member_label_en-US" xlink:label="lab_holx_Fiscal2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 [Member]</link:label>
    <link:label id="lab_holx_Fiscal2020Member_documentation_en-US" xlink:label="lab_holx_Fiscal2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020Member" xlink:href="holx-20200926.xsd#holx_Fiscal2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2020Member" xlink:to="lab_holx_Fiscal2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Revolver2017Member_736dab90-69fc-4fba-b0ad-f6e9db0457e4_terseLabel_en-US" xlink:label="lab_holx_Revolver2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Revolver</link:label>
    <link:label id="lab_holx_Revolver2017Member_label_en-US" xlink:label="lab_holx_Revolver2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver 2017 [Member]</link:label>
    <link:label id="lab_holx_Revolver2017Member_documentation_en-US" xlink:label="lab_holx_Revolver2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Revolver2017Member" xlink:href="holx-20200926.xsd#holx_Revolver2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Revolver2017Member" xlink:to="lab_holx_Revolver2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareLineItems_97f4f174-17e7-42f8-82fc-6436a17c55b2_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_label_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems" xlink:href="holx-20200926.xsd#holx_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareLineItems" xlink:to="lab_holx_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3318140f-7d45-4fbb-a82c-6a1cf957c432_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset_9d083d0b-6ca4-4974-b82c-125d919062ff_negatedTerseLabel_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset_label_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities right of use asset</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset_documentation_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities right of use asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:href="holx-20200926.xsd#holx_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:to="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_52d7dfc4-8cc8-446d-b923-7222e42abe41_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_d77b2b1e-6e70-4527-9245-075343825ed4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2029SeniorNotesMember_719dfd0f-b60c-4546-9860-80d8fcae5319_terseLabel_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember" xlink:href="holx-20200926.xsd#holx_A2029SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2029SeniorNotesMember" xlink:to="lab_holx_A2029SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616_e60e05e5-92f8-4187-b961-53b80a3eeef4_terseLabel_en-US" xlink:label="lab_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in deferred tax assets resulting from adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616_label_en-US" xlink:label="lab_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in deferred tax assets resulting from adoption of ASCU 2016-16</link:label>
    <link:label id="lab_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616_documentation_en-US" xlink:label="lab_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in deferred tax assets resulting from adoption of ASCU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616" xlink:href="holx-20200926.xsd#holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616" xlink:to="lab_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_61944d94-c825-4b8e-ae62-4a0bb63473a1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1a9d20ba-aa5f-4a41-a28a-f8a98481de3e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_4da16ec0-7133-4118-8aff-c9190ed892fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost and Related Actuarial Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_6e0e4cd5-9f86-4067-8d0b-530db6d00096_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under accounts receivable securitization agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_7df1a67e-edb1-4b55-9c81-16ed39423ea0_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under accounts receivable securitization agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Accounts Receivable Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:to="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_109df35d-4f5f-4f68-9269-966f901ee6d4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions_f9d72183-b264-4cd8-af59-fbab8f62f5da_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent holdback withheld under indemnification provisions</link:label>
    <link:label id="lab_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions_label_en-US" xlink:label="lab_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Withheld Under Indemnification Provisions</link:label>
    <link:label id="lab_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions_documentation_en-US" xlink:label="lab_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Withheld Under Indemnification Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions" xlink:href="holx-20200926.xsd#holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions" xlink:to="lab_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_8d9505b4-4c23-4975-95b7-e5aa7829f9c7_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_2593ac6a-926a-41aa-9909-b0083ea2aefb_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagnosticsMember_9767b6f8-cfff-4327-b859-64ea65c490f5_terseLabel_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_holx_DiagnosticsMember_label_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_holx_DiagnosticsMember_documentation_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember" xlink:href="holx-20200926.xsd#holx_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagnosticsMember" xlink:to="lab_holx_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_398e671b-6b17-40f9-957c-0d72b7ea1eaa_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_cee4a51b-0a1f-4952-a9f7-d3f65be74f3e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Purchase Price Allocation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_03b544d6-345e-4a69-b080-1b2a38d7a529_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ed5f7b65-9528-46cc-a4e0-712cf0f28cfd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recorded at acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_0eaa0935-e623-4a7d-b225-60144e9c00e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1eccd046-58a2-4269-b5c6-10ac165115ea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_952c1ea5-5ed6-416c-90b1-ca61193575d8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization_bdcd93d1-58f6-4d9f-93ee-a8235d2109b4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from accounts receivable securitization agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization_label_en-US" xlink:label="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Accounts Receivable Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:to="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_ff77eefc-5bff-4540-bba6-419ea898cf33_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_af7b449a-0877-47ff-ad43-620efa160144_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other non-cash taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_e2c5d8cf-14d6-468c-aa95-f0576f76750f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities (non-current)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Repaymentofacquireddebt_10ec4374-2a09-49d4-b504-bc5938b270ad_negatedTerseLabel_en-US" xlink:label="lab_holx_Repaymentofacquireddebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of acquired debt</link:label>
    <link:label id="lab_holx_Repaymentofacquireddebt_label_en-US" xlink:label="lab_holx_Repaymentofacquireddebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of acquired debt</link:label>
    <link:label id="lab_holx_Repaymentofacquireddebt_documentation_en-US" xlink:label="lab_holx_Repaymentofacquireddebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of acquired debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Repaymentofacquireddebt" xlink:href="holx-20200926.xsd#holx_Repaymentofacquireddebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Repaymentofacquireddebt" xlink:to="lab_holx_Repaymentofacquireddebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fb0d753c-4182-452d-8397-c5c83a880c1f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_bbee8741-3153-44fe-968b-80aefe3d202b_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional outstanding shares purchased, amount</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_label_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Value</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:href="holx-20200926.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:to="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_b5c49218-24a3-44cc-aab2-6c4dc679b5e9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_1722059f-67b7-459c-83b8-41231f5a29b4_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_686e3aba-0ca1-4756-894c-114f6cf75213_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed&#160;technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b0601f12-8d66-4086-abac-b70f122999ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_d0300a94-6682-4709-a627-43baa4878633_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract_8d66aeab-1223-4bea-9eb0-776d5b882783_terseLabel_en-US" xlink:label="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired tax positions:</link:label>
    <link:label id="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract_label_en-US" xlink:label="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits Increases [Abstract]</link:label>
    <link:label id="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract_documentation_en-US" xlink:label="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits increases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:href="holx-20200926.xsd#holx_UnrecognizedTaxBenefitsIncreasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:to="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9e936370-66fd-4545-8f0a-4bd16522d1ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_993243b9-c91a-4a85-9666-586a7a1edf63_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_9481a89a-107f-4b32-b812-8d0555e38eae_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_f51c4480-1516-468d-a2d2-97fdd170517b_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d1dc3df9-5d1a-4f04-ab65-3dcb6b6259df_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SuperSonicImagineMember_97c3f024-cec8-42e3-ad37-ebae375ad032_terseLabel_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_label_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_documentation_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SuperSonicImagineMember" xlink:to="lab_holx_SuperSonicImagineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreementMember_2f06cad9-b3e2-431d-a768-c463f1bd2678_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements [Member]</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreementMember_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreement [Member]</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreementMember_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:href="holx-20200926.xsd#holx_EquipmentUnderCustomerUsageAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ca040280-23e6-4878-81be-3d3afd2b693d_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_b83b3c9b-ce1f-42d7-bc1a-72ff5765cfaa_terseLabel_en-US" xlink:label="lab_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive Income loss Hedge</link:label>
    <link:label id="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_label_en-US" xlink:label="lab_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive Income loss Hedge</link:label>
    <link:label id="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_documentation_en-US" xlink:label="lab_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive Income loss Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:href="holx-20200926.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:to="lab_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccruedIncomeAndOtherTaxes_be9fb212-c224-47c7-8abd-9f3833da9aa3_terseLabel_en-US" xlink:label="lab_holx_AccruedIncomeAndOtherTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income and other taxes</link:label>
    <link:label id="lab_holx_AccruedIncomeAndOtherTaxes_label_en-US" xlink:label="lab_holx_AccruedIncomeAndOtherTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income And Other Taxes</link:label>
    <link:label id="lab_holx_AccruedIncomeAndOtherTaxes_documentation_en-US" xlink:label="lab_holx_AccruedIncomeAndOtherTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income and other taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedIncomeAndOtherTaxes" xlink:href="holx-20200926.xsd#holx_AccruedIncomeAndOtherTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccruedIncomeAndOtherTaxes" xlink:to="lab_holx_AccruedIncomeAndOtherTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EmployeeContributionsVestedPercentage_9c4ab0e2-6497-45fb-8949-eaab30ac749e_terseLabel_en-US" xlink:label="lab_holx_EmployeeContributionsVestedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions vested, percentage</link:label>
    <link:label id="lab_holx_EmployeeContributionsVestedPercentage_label_en-US" xlink:label="lab_holx_EmployeeContributionsVestedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Contributions Vested Percentage</link:label>
    <link:label id="lab_holx_EmployeeContributionsVestedPercentage_documentation_en-US" xlink:label="lab_holx_EmployeeContributionsVestedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions vested, percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeContributionsVestedPercentage" xlink:href="holx-20200926.xsd#holx_EmployeeContributionsVestedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmployeeContributionsVestedPercentage" xlink:to="lab_holx_EmployeeContributionsVestedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_23d296b5-6fce-4b81-8042-55089c4ce394_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_57e766c7-c736-4167-b678-673112c8dbb7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d47261cb-5f6c-4c16-96f7-dd770c91a17b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d268ed57-77a3-4f9c-be2f-889072d342ae_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_b16d46c8-c9a9-4aa2-b856-b7915390efa3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets disposed of</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionTable_5266320b-7f5b-48f7-a32a-9918619eb1c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Table]</link:label>
    <link:label id="lab_us-gaap_DebtConversionTable_label_en-US" xlink:label="lab_us-gaap_DebtConversionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionTable" xlink:to="lab_us-gaap_DebtConversionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreement2018Member_39a02b58-27f4-456e-aa4a-25563dada5aa_terseLabel_en-US" xlink:label="lab_holx_CreditAgreement2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreement2018Member_label_en-US" xlink:label="lab_holx_CreditAgreement2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2018 [Member]</link:label>
    <link:label id="lab_holx_CreditAgreement2018Member_documentation_en-US" xlink:label="lab_holx_CreditAgreement2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2018Member" xlink:href="holx-20200926.xsd#holx_CreditAgreement2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreement2018Member" xlink:to="lab_holx_CreditAgreement2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_2ff660ff-c077-46b2-a3ad-01ec035c20d5_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion allocable to loan repaymnet</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6c228a5c-8dd7-4030-bb29-a3662fa5184c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_eb025679-0c14-4918-9891-c78ea8c7529a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_fce98247-2d48-426d-bed8-8189cf265f3f_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_88fd7286-e775-4fb6-ace2-ce0cba1a6c1f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_74a6b90a-b165-4607-a3c7-7ce69c4d390a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_HealthBeaconsMember_36b7ebaa-7b4e-45ab-abca-43ea090eae3c_terseLabel_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_label_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_documentation_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember" xlink:href="holx-20200926.xsd#holx_HealthBeaconsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_HealthBeaconsMember" xlink:to="lab_holx_HealthBeaconsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_cadf9b7b-a3c3-44f9-9961-005f62584463_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing access fees</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_1d5c75aa-7ed4-4105-a853-aab2b0f3ebfd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfFourthQuarterEventsLineItems_8c9b381f-874f-4490-a7c7-2ad457734aa8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfFourthQuarterEventsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Fourth Quarter Events [Line Items]</link:label>
    <link:label id="lab_us-gaap_EffectOfFourthQuarterEventsLineItems_label_en-US" xlink:label="lab_us-gaap_EffectOfFourthQuarterEventsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Fourth Quarter Events [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfFourthQuarterEventsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfFourthQuarterEventsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfFourthQuarterEventsLineItems" xlink:to="lab_us-gaap_EffectOfFourthQuarterEventsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_3ee26ca9-1079-4e9c-b814-2d19d6de4d69_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_09359ad4-d407-459a-9cff-93a261e7bd5b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2017ActionsMember_a267a18b-d94c-4dd6-9eb0-99321712a3a2_terseLabel_en-US" xlink:label="lab_holx_Fiscal2017ActionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2017 Actions [Member]</link:label>
    <link:label id="lab_holx_Fiscal2017ActionsMember_label_en-US" xlink:label="lab_holx_Fiscal2017ActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2017 Actions [Member]</link:label>
    <link:label id="lab_holx_Fiscal2017ActionsMember_documentation_en-US" xlink:label="lab_holx_Fiscal2017ActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2017 Actions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2017ActionsMember" xlink:href="holx-20200926.xsd#holx_Fiscal2017ActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2017ActionsMember" xlink:to="lab_holx_Fiscal2017ActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_97f3c7c8-2944-4df3-a999-bc3fc38f57b0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_fcd40809-1f2f-482b-b471-baf8c56eef51_negatedLabel_en-US" xlink:label="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_label_en-US" xlink:label="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Expense Included Other Restructuring Costs</link:label>
    <link:label id="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_documentation_en-US" xlink:label="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation expense included other restructuring costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:href="holx-20200926.xsd#holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:to="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_42453e54-8a8f-4b3d-900a-8c25ec060673_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_01c3e36a-115e-4993-8d2f-73f8a38a45cc_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ca07aac2-317d-48e8-bfa2-aade2ce40d19_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_57f7bc31-91da-4c30-8dd5-a321985d37b1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_3e2e1a26-0fa9-4cae-8f89-e881c8dbc776_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c24bf174-55cd-4efa-8f83-74e3319d36c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) Related to Derivatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_db08b246-ea7c-4b93-9dd7-38d7f044f2aa_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:to="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_27eb9530-a4d9-45ec-8ba4-d194a5f3f949_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_a7d523ed-bf88-4d25-b130-2f39c282c408_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_9ec6d2b4-d17b-43df-8c88-ac041968bcb5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivative</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:to="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherTypeofRevenueMember_5c812918-6e74-4f24-a9d2-e8c4e16a42dc_terseLabel_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_label_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_documentation_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember" xlink:href="holx-20200926.xsd#holx_OtherTypeofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherTypeofRevenueMember" xlink:to="lab_holx_OtherTypeofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_f207865c-6b2f-4a38-8c2d-37b2bbda4c70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss reclassified from accumulated other comprehensive loss to the statement of operations, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_a672f222-697c-4ff7-b009-c925c2e26580_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions made by company</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TaxPositionsRelatedToPriorYearsAbstract_c5010861-97da-4ec9-aca5-9729618b8422_terseLabel_en-US" xlink:label="lab_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax positions related to prior years:</link:label>
    <link:label id="lab_holx_TaxPositionsRelatedToPriorYearsAbstract_label_en-US" xlink:label="lab_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Positions Related To Prior Years [Abstract]</link:label>
    <link:label id="lab_holx_TaxPositionsRelatedToPriorYearsAbstract_documentation_en-US" xlink:label="lab_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax positions related to prior years.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:href="holx-20200926.xsd#holx_TaxPositionsRelatedToPriorYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:to="lab_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_93450a35-930a-46e8-83f9-51a1152a13db_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps - derivative</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_9715e169-e61f-4880-9812-0f2e4b7857eb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in value of hedged interest rate caps, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_c7440d41-9869-4be5-ac5a-41ddf4bb5ce6_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_dbe83217-8ad7-4d6a-8366-28ad787c1aa0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_724ae5e2-d6dd-479a-9bd2-0d28138c7c18_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentNumberOfInstruments_f9369d92-6486-4b20-aa08-e10ec84d4359_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentNumberOfInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of debt instruments</link:label>
    <link:label id="lab_holx_DebtInstrumentNumberOfInstruments_label_en-US" xlink:label="lab_holx_DebtInstrumentNumberOfInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Instruments</link:label>
    <link:label id="lab_holx_DebtInstrumentNumberOfInstruments_documentation_en-US" xlink:label="lab_holx_DebtInstrumentNumberOfInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentNumberOfInstruments" xlink:href="holx-20200926.xsd#holx_DebtInstrumentNumberOfInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentNumberOfInstruments" xlink:to="lab_holx_DebtInstrumentNumberOfInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_940f5916-0e34-404a-ad99-8756432ae87f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_93742dae-546e-4e0d-b8fe-283fe8c05345_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_bc16407e-cb51-424a-8070-22c37623701e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_36ca664d-7c04-4e50-bc48-601a2f5a9ed8_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Reserves</link:label>
    <link:label id="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable And Reserves Policy Policy [Text Block]</link:label>
    <link:label id="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policy and disclosure of accounts receivable reserves, including activity in the account for the respective periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:href="holx-20200926.xsd#holx_AccountsReceivableAndReservesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:to="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASU201616_20b713b8-d433-40c7-b173-91d297d96802_negatedTerseLabel_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASU201616" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASU 2016-16</link:label>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASU201616_label_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASU 2016-16</link:label>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASU201616_documentation_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASU201616" xlink:href="holx-20200926.xsd#holx_AccountingstandardtransitionadjustmentASU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountingstandardtransitionadjustmentASU201616" xlink:to="lab_holx_AccountingstandardtransitionadjustmentASU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_7d817af3-bbdd-484e-839a-66bd810e87b5_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a13a163c-d89f-4714-832d-c173b89335d0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales price</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ConsumablesMember_b42a6a76-f9ee-49e4-b8d4-a21a82f6eaea_terseLabel_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_holx_ConsumablesMember_label_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_holx_ConsumablesMember_documentation_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember" xlink:href="holx-20200926.xsd#holx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ConsumablesMember" xlink:to="lab_holx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02929fa0-f43a-4d41-8a39-d9d6424b6eb6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_29da9785-d8a3-4b0e-a555-d5eea213bf2a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_4f008747-4a50-4b00-b132-706cdc22d76f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a06ed6db-2674-4eb3-8b5d-294fe040d5b7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_16a48cac-7f5e-4b1d-b8d9-f56715aad100_terseLabel_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Line Items]</link:label>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Line Items]</link:label>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_documentation_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:href="holx-20200926.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:to="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4c7a03a1-717e-40ba-b212-1219b5c5cf8c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2ee8c5d1-1605-4118-aa9a-850a8eb9cb99_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired tangible assets and liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616_8265f976-ee55-4f28-916c-6a9b5ae5b098_terseLabel_en-US" xlink:label="lab_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decease to prepaid taxes resulting from adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616_label_en-US" xlink:label="lab_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decease to prepaid taxes resulting from adoption of ASCU 2016-16</link:label>
    <link:label id="lab_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616_documentation_en-US" xlink:label="lab_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decease to prepaid taxes resulting from adoption of ASCU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616" xlink:href="holx-20200926.xsd#holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616" xlink:to="lab_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_bdc883a5-1809-47fa-a7a0-ea1db98c445b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherRestructuringPayments_bc057d95-2028-4394-ba49-a3e3d1963cf9_negatedLabel_en-US" xlink:label="lab_holx_OtherRestructuringPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other payments</link:label>
    <link:label id="lab_holx_OtherRestructuringPayments_label_en-US" xlink:label="lab_holx_OtherRestructuringPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Payments</link:label>
    <link:label id="lab_holx_OtherRestructuringPayments_documentation_en-US" xlink:label="lab_holx_OtherRestructuringPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to settle other restructuring charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherRestructuringPayments" xlink:href="holx-20200926.xsd#holx_OtherRestructuringPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherRestructuringPayments" xlink:to="lab_holx_OtherRestructuringPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_352554a9-9a27-454c-ac7e-29ac4c9bda49_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6ee34afe-fcae-4e99-aea0-7e9f72f4ee3c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GynSurgicalMember_2af7be5e-625a-4141-8bc7-a3cf404cbbcd_terseLabel_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_label_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_documentation_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN surgical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember" xlink:href="holx-20200926.xsd#holx_GynSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GynSurgicalMember" xlink:to="lab_holx_GynSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermARSecuritizationProgram_3a5d74c5-b5f1-4897-bad7-d891dbd6d469_terseLabel_en-US" xlink:label="lab_holx_TermARSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of accounts receivable securitization program</link:label>
    <link:label id="lab_holx_TermARSecuritizationProgram_label_en-US" xlink:label="lab_holx_TermARSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term AR Securitization Program</link:label>
    <link:label id="lab_holx_TermARSecuritizationProgram_documentation_en-US" xlink:label="lab_holx_TermARSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Accounts Receivable Securitization Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermARSecuritizationProgram" xlink:href="holx-20200926.xsd#holx_TermARSecuritizationProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermARSecuritizationProgram" xlink:to="lab_holx_TermARSecuritizationProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_3f3064a4-38ab-4adc-9a01-c9933ec22af9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal restructuring</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_a7afb35b-29c7-4db3-af7e-9bf2329e71f1_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment period for contingent consideration</link:label>
    <link:label id="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_label_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Period for Payment of Contingent Consideration Liability</link:label>
    <link:label id="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_documentation_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Period for Payment of Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:href="holx-20200926.xsd#holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:to="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_25bc6acd-4f01-4c95-8c8e-5f1999e2460c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Agreements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8678c9eb-7a00-477e-acaa-4d5bd935028a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_0dd4219a-4bb3-460e-ad21-4e84a66741a4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_0d8d76d3-0b4f-4743-8da2-054435247142_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b797a6d2-70b7-408b-8cfa-e6b7113ed909_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_0a89cab5-b6aa-4395-98f1-d46c31d54b14_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation over time (percent)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a1fbd930-c67d-4781-a223-e8dbbde120aa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_4b31a3ce-4b09-48a0-9d34-fd877b46c855_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative contract period, or less</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5ecaf799-ca9d-4872-af13-e8948d905109_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at September 28, 2019</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_59183947-b7d8-417e-8c56-abc4b2e4b3a8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_8c50c1d3-710f-4cf7-9f99-9dd1d199c10f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_d2d5ce5e-45b1-473c-8f3b-d2c97d8c63d5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f6bd1bb4-181a-43a6-a5d2-036a0982c53a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_562076d5-f1cd-4bb4-9e82-e503b0b5742e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_JudicialRulingMember_e89278d9-9753-4160-845c-67f186e6d320_terseLabel_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling</link:label>
    <link:label id="lab_us-gaap_JudicialRulingMember_label_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_JudicialRulingMember" xlink:to="lab_us-gaap_JudicialRulingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_bc932769-5281-4104-b5de-50693426c731_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_1ffc7f1e-0a09-4252-b498-e443f0e0e037_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_36af5be3-4902-4314-bbf5-2bddfd71685e_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_ff38fe0b-9f2a-42ee-8529-8f9bc8430ef4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_0e89d5ed-34d3-45e6-91c4-e165a00a6595_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_9a7a82d6-6bdf-48fd-812e-cd1f831f44b7_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_84113ada-8ed5-49f3-a700-c9606b5dc4fc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_2ced32ad-6fea-4972-a646-2da3f8737147_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs&#160;(Level&#160;2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_11bfb437-f4ae-4701-a844-a24a9a06d072_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_85aa1d49-800f-4db1-aef8-da11fbfef472_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire in Process Research and Development</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_99e404e8-1715-4b04-8b41-40cfacb2a7c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss Recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_4d15ba68-0b0b-46d0-a46f-c16988b16e41_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e76d5107-63a5-4174-b4f9-127cd0ccc253_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SignificantAccountingPoliciesLineItems_1db64bb3-0296-4bfb-8dd8-e74af94c4bba_terseLabel_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_holx_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_holx_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesLineItems" xlink:href="holx-20200926.xsd#holx_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems" xlink:to="lab_holx_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_00f1a69d-662c-4cde-9192-433e14f22dbb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumBorrowingUnderSecuritizationProgram_75cb5de5-962a-4242-b809-a6f8b961e5e7_terseLabel_en-US" xlink:label="lab_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing under securitization program</link:label>
    <link:label id="lab_holx_MaximumBorrowingUnderSecuritizationProgram_label_en-US" xlink:label="lab_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Borrowing Under Securitization Program</link:label>
    <link:label id="lab_holx_MaximumBorrowingUnderSecuritizationProgram_documentation_en-US" xlink:label="lab_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing under securitization program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:href="holx-20200926.xsd#holx_MaximumBorrowingUnderSecuritizationProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:to="lab_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_5dded859-d17a-4cce-b40f-25a4ac07f87c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_44f22808-96c2-4e86-8500-622138910217_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable_8e961fc8-c5e7-4ea4-a8eb-09eecff26bb9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Fourth Quarter Events [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Fourth Quarter Events [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable" xlink:to="lab_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_440c35ba-d530-4dea-ad56-a34df42b089a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_17dd3d3a-0187-4fa0-86c9-6edbf009b5ae_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State net operating loss expected to be expired unutilized</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized State</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of state net operating losses the company believes will expire unutilized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:to="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c40a689d-27c2-4d02-ae56-5fcf797c8d0b_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_48adf670-4bc3-4ec8-ad42-6283d4ad7899_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_bc0aa4e3-3b34-40e3-a46a-edb5482c01ea_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_638a4c09-de88-4554-8374-24ace6b6bf68_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f8be6cea-ed6f-4c40-ba36-8a2e5b1803d1_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_8a2c3d71-945c-44fb-a50b-8279a5e7e3d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning&#160;of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_cddde1ee-2eb4-4f97-839c-e556d0355897_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at&#160;End of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b4e2bdb1-6551-42ac-b5d0-6ba212ab5666_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_3b2bdfae-5fce-40bd-96a0-2c6c74451fad_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_c1e901d9-d606-47e5-812f-676ea7d79df4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncomeTaxesLineItems_b001d652-9525-4bb3-a9d0-7e59c150eb97_terseLabel_en-US" xlink:label="lab_holx_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_holx_IncomeTaxesLineItems_label_en-US" xlink:label="lab_holx_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_holx_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_holx_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesLineItems" xlink:href="holx-20200926.xsd#holx_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncomeTaxesLineItems" xlink:to="lab_holx_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e33d80c0-0898-4722-bf21-5b5e98ffe354_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_7966a8ac-8cef-4e6a-a185-ebfa3bb20890_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1234e922-b3f6-4915-94d7-75bb170fe5c5_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_ca27d596-8094-44d7-a41c-fba9a292b00b_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</link:label>
    <link:label id="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_label_en-US" xlink:label="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</link:label>
    <link:label id="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_documentation_en-US" xlink:label="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:href="holx-20200926.xsd#holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:to="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_fd08664e-8433-496a-8045-a2b954f12781_terseLabel_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, operating and finance lease, remaining lease term</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Lease, Remaining Lease Term</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_documentation_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:to="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_0c8e25e3-d804-48a6-8005-256b275188b1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_7c763a66-417e-4349-94b3-a61235fd2f14_terseLabel_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember" xlink:href="holx-20200926.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareRepurchaseProgramMember" xlink:to="lab_holx_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_3aadf9c9-11a6-4cc2-850c-0a6dc3bf676e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Four</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_41cf9117-1365-47ee-86f6-0240deb8e6e3_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_86dd45ee-8218-44d8-a7e1-8f1130e887ff_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionLineItems_048f8ddc-be38-428e-a782-f86a68aca1c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtConversionLineItems_label_en-US" xlink:label="lab_us-gaap_DebtConversionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionLineItems" xlink:to="lab_us-gaap_DebtConversionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e77f6847-cbbb-458a-bfa8-bb4185ae3f60_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OneThirdAnnuallyMember_0c82df68-0b71-4b80-969e-849d7cb971f3_terseLabel_en-US" xlink:label="lab_holx_OneThirdAnnuallyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Third Annually [Member]</link:label>
    <link:label id="lab_holx_OneThirdAnnuallyMember_label_en-US" xlink:label="lab_holx_OneThirdAnnuallyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Third Annually [Member]</link:label>
    <link:label id="lab_holx_OneThirdAnnuallyMember_documentation_en-US" xlink:label="lab_holx_OneThirdAnnuallyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Third Annually [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OneThirdAnnuallyMember" xlink:href="holx-20200926.xsd#holx_OneThirdAnnuallyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OneThirdAnnuallyMember" xlink:to="lab_holx_OneThirdAnnuallyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_bd67a8ec-9521-4969-9f7e-9278075dbe43_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in accumulated balances of other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_891f11c0-7432-4840-91c3-b9ed5bd08954_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocationDomain_a5593647-76e8-480a-9eb0-2c72dfddcf37_terseLabel_en-US" xlink:label="lab_dei_LocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Location [Domain]</link:label>
    <link:label id="lab_dei_LocationDomain_label_en-US" xlink:label="lab_dei_LocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocationDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocationDomain" xlink:to="lab_dei_LocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_39fe29f9-f3bd-412b-bc26-e85d28799bb2_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Fifth Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_eb030f42-c344-4bf4-9e4d-a5e1862cec97_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period available for common stock to be repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_ba6df291-395f-4791-a37a-473cbfb44a17_terseLabel_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash tender offer price per share</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_label_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_documentation_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:href="holx-20200926.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:to="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_07bcbdc6-9cdb-46fc-9cb9-fde220061883_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on derivatives, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableFromSecuritization_0c380240-a32b-462b-bc00-7912df33db22_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from securitization</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableFromSecuritization_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable from Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableFromSecuritization" xlink:to="lab_us-gaap_AccountsReceivableFromSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_0284227b-fcde-4fa7-a9b9-1b36186d8c04_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged&#160;to Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1528b11c-9d51-4fd7-9486-81e4b758d39e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, weighted average grant date fair value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9451b13e-c2c7-4555-9193-0a6e446d3e7d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period of unrecognized stock-based compensation, years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_7eb2a0b4-9da0-4579-a94f-529d638ffdcf_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_5c3e2903-c9b5-4299-8b5b-0dde4ad8b655_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_de7f2540-73e1-4aa7-a756-f5e4e6fb53b5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_693d9ef7-ae37-418b-8fac-867dc60021aa_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Debtinstrumentremainingtoberedeemed_f28a8136-6c0a-43e4-b0f6-9760f485a0fe_terseLabel_en-US" xlink:label="lab_holx_Debtinstrumentremainingtoberedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument remaining to be redeemed</link:label>
    <link:label id="lab_holx_Debtinstrumentremainingtoberedeemed_label_en-US" xlink:label="lab_holx_Debtinstrumentremainingtoberedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument remaining to be redeemed</link:label>
    <link:label id="lab_holx_Debtinstrumentremainingtoberedeemed_documentation_en-US" xlink:label="lab_holx_Debtinstrumentremainingtoberedeemed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument remaining to be redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Debtinstrumentremainingtoberedeemed" xlink:href="holx-20200926.xsd#holx_Debtinstrumentremainingtoberedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Debtinstrumentremainingtoberedeemed" xlink:to="lab_holx_Debtinstrumentremainingtoberedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BasePrincipalAmountForAccretionValue_cae39c51-20a6-4619-9edb-21c928ceca0b_terseLabel_en-US" xlink:label="lab_holx_BasePrincipalAmountForAccretionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal accretion</link:label>
    <link:label id="lab_holx_BasePrincipalAmountForAccretionValue_label_en-US" xlink:label="lab_holx_BasePrincipalAmountForAccretionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Principal Amount For Accretion Value</link:label>
    <link:label id="lab_holx_BasePrincipalAmountForAccretionValue_documentation_en-US" xlink:label="lab_holx_BasePrincipalAmountForAccretionValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of principal accretion at the applicable rate pursuant to the terms of the debt agreement, which is recorded as interest expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasePrincipalAmountForAccretionValue" xlink:href="holx-20200926.xsd#holx_BasePrincipalAmountForAccretionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BasePrincipalAmountForAccretionValue" xlink:to="lab_holx_BasePrincipalAmountForAccretionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_f22c0e43-4aef-4c03-a778-0ad1ae327f43_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternationalMember_c4eba660-8e7a-4485-8685-7517c838e17b_terseLabel_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_holx_InternationalMember_label_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_holx_InternationalMember_documentation_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember" xlink:href="holx-20200926.xsd#holx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternationalMember" xlink:to="lab_holx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_WarrantyTermForProducts_02a48434-caa2-4569-86c3-c57acd516043_terseLabel_en-US" xlink:label="lab_holx_WarrantyTermForProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Term</link:label>
    <link:label id="lab_holx_WarrantyTermForProducts_label_en-US" xlink:label="lab_holx_WarrantyTermForProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Term For Products</link:label>
    <link:label id="lab_holx_WarrantyTermForProducts_documentation_en-US" xlink:label="lab_holx_WarrantyTermForProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Term For Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WarrantyTermForProducts" xlink:href="holx-20200926.xsd#holx_WarrantyTermForProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_WarrantyTermForProducts" xlink:to="lab_holx_WarrantyTermForProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_a5e43403-2a2e-4f49-8358-908ce849268f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_4b75d7ac-1e6c-4bf5-b7db-53e10b095d67_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_f0ad4396-ef23-43f8-8f17-1bdd7941187b_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_4c5d8a81-c6f5-49ca-8e18-74a8bb5cac6a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_43c3d406-d0c1-4ecb-99de-5cc55d1fa304_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ab59e54f-8fd1-4c4c-a1e0-001896fddf46_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_52d516ca-a1c7-4557-b8ad-838e84d8944f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations and Acquisition of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations and Other Purchase of Business Transactions, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:to="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_4d3a1f5a-e844-497d-bd37-b6d7465d4b19_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InvestmentInGroupLifeInsuranceContracts_20ac9e72-6e7a-41ca-88f3-b6b0ca030ed5_terseLabel_en-US" xlink:label="lab_holx_InvestmentInGroupLifeInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in group life insurance contracts</link:label>
    <link:label id="lab_holx_InvestmentInGroupLifeInsuranceContracts_label_en-US" xlink:label="lab_holx_InvestmentInGroupLifeInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment In Group Life Insurance Contracts</link:label>
    <link:label id="lab_holx_InvestmentInGroupLifeInsuranceContracts_documentation_en-US" xlink:label="lab_holx_InvestmentInGroupLifeInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of group life insurance contracts at the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InvestmentInGroupLifeInsuranceContracts" xlink:href="holx-20200926.xsd#holx_InvestmentInGroupLifeInsuranceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InvestmentInGroupLifeInsuranceContracts" xlink:to="lab_holx_InvestmentInGroupLifeInsuranceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2025SeniorNotesMember_0ccfd1cb-62bc-4f57-8d5e-121fe32fa336_terseLabel_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2025SeniorNotesMember" xlink:to="lab_holx_A2025SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AllOtherCountriesMember_8d990344-ee08-4da0-8458-5d05d13c69c1_terseLabel_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_label_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_documentation_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember" xlink:href="holx-20200926.xsd#holx_AllOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AllOtherCountriesMember" xlink:to="lab_holx_AllOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_1eb46492-9690-4811-9cc8-c4b6732c9d7b_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_dc875821-58ed-4537-8323-7cbdb5b5ca63_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_06ef16eb-018a-496f-9dc9-7a6d32ce8b3c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards_bd98bce8-2c72-4aa7-bb36-118745fac297_terseLabel_en-US" xlink:label="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation for long-term service awards</link:label>
    <link:label id="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards_label_en-US" xlink:label="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Benefit Obligation For Long Term Service Awards</link:label>
    <link:label id="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards_documentation_en-US" xlink:label="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Benefit Obligation For Long Term Service Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:href="holx-20200926.xsd#holx_ProjectedBenefitObligationForLongTermServiceAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:to="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_fbfdb511-a2c9-414b-88ba-6060d3011123_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_40f342cb-9bb3-43ed-aa39-0ced455f7918_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on interest rate swap</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_6099d6c2-0c4b-4045-9be7-d51d148de7e5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CashSeverancePayments_27bf9e6e-eed8-4cb7-a6c9-3efb3bde5b5c_negatedLabel_en-US" xlink:label="lab_holx_CashSeverancePayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance payments</link:label>
    <link:label id="lab_holx_CashSeverancePayments_label_en-US" xlink:label="lab_holx_CashSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Severance Payments</link:label>
    <link:label id="lab_holx_CashSeverancePayments_documentation_en-US" xlink:label="lab_holx_CashSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashSeverancePayments" xlink:href="holx-20200926.xsd#holx_CashSeverancePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CashSeverancePayments" xlink:to="lab_holx_CashSeverancePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_5d4ad115-17d3-4161-8616-d509a4e33563_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_26e12179-304f-4b26-acf5-f7f0193080ee_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a4333a68-6db0-4970-bdd8-990c3418b937_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0c225928-c35f-4f0d-a5a4-c9b2c0df8157_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to cash flows used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_00014e61-3b53-4561-aba6-240334759877_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_19216b08-5cdf-421f-9051-54bd503adf67_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_fadae3b5-90db-466e-ab99-344612187b23_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_d47b0b1b-53b8-4d30-a6ab-8dc2a8251cf6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_3eb9bf96-6819-4867-946f-53967532933c_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_890825e5-fd4c-4c5b-bef2-f31a1902fcc7_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_9ac15645-0fdf-42f3-8531-a739282a9695_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_d66bd4cc-493f-4fe9-9ab7-ae2123de78d1_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_94e5501e-43ff-4d4f-840d-decd6d38ec10_verboseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_37cb2c9e-b0a8-4e57-8246-01e30b648698_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreementPriorMember_31ad9c48-2589-40b2-9479-3685cf742006_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementPriorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementPriorMember_label_en-US" xlink:label="lab_holx_CreditAgreementPriorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Prior [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementPriorMember_documentation_en-US" xlink:label="lab_holx_CreditAgreementPriorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Prior [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember" xlink:href="holx-20200926.xsd#holx_CreditAgreementPriorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementPriorMember" xlink:to="lab_holx_CreditAgreementPriorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermLoanMember_cac2ecae-aade-42d0-82b5-2a2daee8a322_terseLabel_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_holx_TermLoanMember_label_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_holx_TermLoanMember_documentation_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember" xlink:href="holx-20200926.xsd#holx_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermLoanMember" xlink:to="lab_holx_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_753eb628-1da9-4a04-b470-a29ab70fc81a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_14cd2da4-84f7-4650-8445-967e883f9f0e_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TransitionServicesAgreementTerm_ffaf77b7-f968-4139-b733-1d64eabee0c5_terseLabel_en-US" xlink:label="lab_holx_TransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition services agreement term</link:label>
    <link:label id="lab_holx_TransitionServicesAgreementTerm_label_en-US" xlink:label="lab_holx_TransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement Term</link:label>
    <link:label id="lab_holx_TransitionServicesAgreementTerm_documentation_en-US" xlink:label="lab_holx_TransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TransitionServicesAgreementTerm" xlink:href="holx-20200926.xsd#holx_TransitionServicesAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TransitionServicesAgreementTerm" xlink:to="lab_holx_TransitionServicesAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NonIncomeTaxLoss_e3f64d6b-238b-406a-bc67-e5fa7f7bd049_terseLabel_en-US" xlink:label="lab_holx_NonIncomeTaxLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-income tax loss</link:label>
    <link:label id="lab_holx_NonIncomeTaxLoss_label_en-US" xlink:label="lab_holx_NonIncomeTaxLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Income Tax Loss</link:label>
    <link:label id="lab_holx_NonIncomeTaxLoss_documentation_en-US" xlink:label="lab_holx_NonIncomeTaxLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Income Tax Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonIncomeTaxLoss" xlink:href="holx-20200926.xsd#holx_NonIncomeTaxLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NonIncomeTaxLoss" xlink:to="lab_holx_NonIncomeTaxLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_f8e7f8ec-ffd3-4861-b524-94a556075140_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d37a664b-aa80-49ce-90a4-548945b985d7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_cb497709-99a4-4ca7-bfa5-32f3721bc614_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_38f63929-cff7-415e-b9d9-43d8f1f09ab8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_81807894-785a-4f32-9cf4-6862059297f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Credit Agreements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_da01ffaf-fcad-41f8-a392-bc9d2cf69f77_terseLabel_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss Income Policy [Policy Text Block]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss Income Policy [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:href="holx-20200926.xsd#holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:to="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_a9794046-c7ab-4756-99f5-41923172758b_terseLabel_en-US" xlink:label="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in deferred tax liabilities due to ASU 2016-16</link:label>
    <link:label id="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_label_en-US" xlink:label="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in deferred tax liabilities due to ASC 2016-16</link:label>
    <link:label id="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_documentation_en-US" xlink:label="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in deferred tax liabilities due to ASC 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:href="holx-20200926.xsd#holx_DecreaseindeferredtaxliabilitiesduetoASC201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:to="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_715599ba-87be-497a-b39c-6d6023c885ef_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TwothousandeighteenMember_c5818452-987c-47cd-a988-e17bdbf96da3_terseLabel_en-US" xlink:label="lab_holx_TwothousandeighteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2018 charges:</link:label>
    <link:label id="lab_holx_TwothousandeighteenMember_label_en-US" xlink:label="lab_holx_TwothousandeighteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand eighteen [Member]</link:label>
    <link:label id="lab_holx_TwothousandeighteenMember_documentation_en-US" xlink:label="lab_holx_TwothousandeighteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand eighteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwothousandeighteenMember" xlink:href="holx-20200926.xsd#holx_TwothousandeighteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwothousandeighteenMember" xlink:to="lab_holx_TwothousandeighteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_6eea7ea5-e70c-4ebb-9f5a-9f3e61c2e12c_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4881de09-f107-494d-b44d-ce194a9db748_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d3105786-64e2-476d-bf50-b7b2c3fdf9dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less - accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2012NotesMember_9982d0e6-85fe-435a-a9a4-2a6f1a4b5004_terseLabel_en-US" xlink:label="lab_holx_A2012NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Notes</link:label>
    <link:label id="lab_holx_A2012NotesMember_label_en-US" xlink:label="lab_holx_A2012NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Notes [Member]</link:label>
    <link:label id="lab_holx_A2012NotesMember_documentation_en-US" xlink:label="lab_holx_A2012NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2012NotesMember" xlink:href="holx-20200926.xsd#holx_A2012NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2012NotesMember" xlink:to="lab_holx_A2012NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_c31e3634-a657-4d79-b363-afb9e5cc5260_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_3e1e99c2-c179-43c9-8b26-a49be86be5c5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LongLivedAssetsPolicyPolicyTextBlock_34a0db31-172c-4bd6-9891-80c0cda6635a_terseLabel_en-US" xlink:label="lab_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_holx_LongLivedAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Lived Assets Policy [Policy Text Block]</link:label>
    <link:label id="lab_holx_LongLivedAssetsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Lived Assets Policy [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:href="holx-20200926.xsd#holx_LongLivedAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:to="lab_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ddfd4760-9a99-43cf-a7f3-1901f5e0e5a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneous_a1bf13b1-f8a7-49b9-bca6-123e1f06cb88_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneous_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous" xlink:to="lab_us-gaap_OtherAssetsMiscellaneous" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_56430307-93b7-4f7e-8c80-e2ef32506c96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_58474bd5-6ff4-4588-88c3-a02353c1d13f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_88b881d6-0a0c-42a9-8132-032b47f7ec83_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_1ac8986f-4b07-440b-b3f9-ea12e4caa531_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of redemption price, second period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Second Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Second Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_15195109-8cd0-4822-a76f-ee1a33357646_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears_eb6f9057-e4f8-495c-bb28-4ae7d37de5a1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Receivable, in Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_12d29839-500c-4bb8-a3b0-025709212552_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_7959d0eb-7130-46e3-b1af-d348f8e369d4_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_97ffd5d4-0304-4976-ad5c-44571c41cdb8_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_b953b456-c2f0-4034-873d-012fe697a045_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_01f0a37b-385f-4f03-b2cf-c262b0a61b73_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion allocable to fair value of noncontrolling interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_3f75c097-a8ed-4eae-878d-ee60720e1d2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disposed Business, Income from Operations and Assets held-for-sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RevenueMember_f986eaa1-338b-47e3-9c40-0c83c05f1386_terseLabel_en-US" xlink:label="lab_holx_RevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues [Member]</link:label>
    <link:label id="lab_holx_RevenueMember_label_en-US" xlink:label="lab_holx_RevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Member]</link:label>
    <link:label id="lab_holx_RevenueMember_documentation_en-US" xlink:label="lab_holx_RevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevenueMember" xlink:href="holx-20200926.xsd#holx_RevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevenueMember" xlink:to="lab_holx_RevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_ab65ed77-4715-4a27-96d1-bdb048eda7b0_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_d6bd971f-fe12-4c9a-aac8-aaca4208cc4a_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcessaMember_86854080-2987-484d-8605-d2e438927362_terseLabel_en-US" xlink:label="lab_holx_AcessaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa</link:label>
    <link:label id="lab_holx_AcessaMember_label_en-US" xlink:label="lab_holx_AcessaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa [Member]</link:label>
    <link:label id="lab_holx_AcessaMember_documentation_en-US" xlink:label="lab_holx_AcessaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaMember" xlink:href="holx-20200926.xsd#holx_AcessaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcessaMember" xlink:to="lab_holx_AcessaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_7c4a670b-aebf-4a57-b438-6d1a212eb455_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_e40a355e-fbb1-4c3e-9d51-883a91fad268_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 295,107 and 292,323 shares issued, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrossStateLossCarryforwards_04790779-4a53-4620-ace4-6c3fd3bce4ab_terseLabel_en-US" xlink:label="lab_holx_GrossStateLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross state loss carryforwards</link:label>
    <link:label id="lab_holx_GrossStateLossCarryforwards_label_en-US" xlink:label="lab_holx_GrossStateLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross state loss carryforwards</link:label>
    <link:label id="lab_holx_GrossStateLossCarryforwards_documentation_en-US" xlink:label="lab_holx_GrossStateLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross state loss carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossStateLossCarryforwards" xlink:href="holx-20200926.xsd#holx_GrossStateLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrossStateLossCarryforwards" xlink:to="lab_holx_GrossStateLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_00214a11-3117-4d70-98c1-2519928ca075_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_f60e8c11-a6b6-42fc-a96a-38c60837bfc7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_b95fd0d3-f111-4910-ac1b-5317e25c7bc1_terseLabel_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:to="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_a736c435-2bbe-492b-a16d-4f26dc842e8e_terseLabel_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee contributions from annual bonus, percentage</link:label>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_label_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Employee Contributions From Annual Bonus Percentage To Dcp</link:label>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_documentation_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee contributions from annual bonus percentage to dcp.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:href="holx-20200926.xsd#holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:to="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_b8e6eae2-3263-4e59-b109-b141d0a251ed_terseLabel_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee contributions from base salary, percentage</link:label>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_label_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Employee Contributions From Base Salary Percentage To Dcp</link:label>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_documentation_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee contributions from base salary percentage to dcp.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:href="holx-20200926.xsd#holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:to="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_0df7458a-ebd5-436b-a3c4-d42dbcebaea8_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_e06d4f18-e88a-43df-af4d-d540a3c06978_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_64c859cd-ecbd-4864-8111-403930828c16_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_e7e5cebc-9590-48b4-a6ec-03aa2cc136ac_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_c72c0c8a-17c3-493d-9086-493a25cb1826_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_bce134b6-17e7-4662-ac51-a0d6b190fa4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_46d80586-1159-4cff-ba5a-76b78c83096c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_ae8a6f02-bc7b-4016-8a36-5f8b0f878dd0_totalLabel_en-US" xlink:label="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash paid for amounts included in the measurement of lease liabilities</link:label>
    <link:label id="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_label_en-US" xlink:label="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability</link:label>
    <link:label id="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_documentation_en-US" xlink:label="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:href="holx-20200926.xsd#holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:to="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c1b5da53-25e9-4da6-a9cc-2cc57084ef6d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_35564d5f-4403-4d10-a604-2fe87223e824_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_04aa9002-cafe-4247-b16c-83d568993d95_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_ae9293d0-4620-4d32-b42f-484c4ea570ef_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_731340a4-08d6-4294-8f47-36ac0ced9c9a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_d8fbc4a4-a4bf-4a2c-8663-e8c475a85bf4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual&#160;Life (in Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_6b2beece-40c0-442d-9389-0486bb72d028_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8a4c1131-0110-4d1f-9a95-db5b7ff61c72_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_4c999640-ee91-4f39-b4bb-b22a17330e41_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension plan, liabilities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_bb8c4e55-6c66-4643-8e49-ba37d27ca796_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_9c97050a-6be6-4010-9cd6-9a7f2ef9873a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_c37da828-9480-4f5a-b095-641779702529_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Jun212016Member_9f0a96f3-4f93-400b-a77f-9eb9890404b7_terseLabel_en-US" xlink:label="lab_holx_Jun212016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jun 21 2016</link:label>
    <link:label id="lab_holx_Jun212016Member_label_en-US" xlink:label="lab_holx_Jun212016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jun 21 2016 [Member]</link:label>
    <link:label id="lab_holx_Jun212016Member_documentation_en-US" xlink:label="lab_holx_Jun212016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 21 2016 authorization of repurchase of Company's outstanding common stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Jun212016Member" xlink:href="holx-20200926.xsd#holx_Jun212016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Jun212016Member" xlink:to="lab_holx_Jun212016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_2e636d54-f7a5-4d61-9f08-d0e604974325_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f1b9409e-c376-44f0-88e4-ba256fc4b43c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxesReacquisitionofEquityComponent_801f7973-de7b-46de-a545-17641655c999_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxesReacquisitionofEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes, reacquisition of equity component</link:label>
    <link:label id="lab_holx_DeferredTaxesReacquisitionofEquityComponent_label_en-US" xlink:label="lab_holx_DeferredTaxesReacquisitionofEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Taxes, Reacquisition of Equity Component</link:label>
    <link:label id="lab_holx_DeferredTaxesReacquisitionofEquityComponent_documentation_en-US" xlink:label="lab_holx_DeferredTaxesReacquisitionofEquityComponent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Taxes, Reacquisition of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxesReacquisitionofEquityComponent" xlink:href="holx-20200926.xsd#holx_DeferredTaxesReacquisitionofEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxesReacquisitionofEquityComponent" xlink:to="lab_holx_DeferredTaxesReacquisitionofEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccruedInterest_18984530-9d30-4570-adc2-d28a6d52f166_terseLabel_en-US" xlink:label="lab_holx_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_holx_AccruedInterest_label_en-US" xlink:label="lab_holx_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_holx_AccruedInterest_documentation_en-US" xlink:label="lab_holx_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedInterest" xlink:href="holx-20200926.xsd#holx_AccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccruedInterest" xlink:to="lab_holx_AccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_dab1c4b1-7e5c-4576-9453-80a11eb19c91_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DistributionRightsMember_1fca7e1e-de7c-4ccc-8af1-96009d3cd903_terseLabel_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution agreement</link:label>
    <link:label id="lab_us-gaap_DistributionRightsMember_label_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DistributionRightsMember" xlink:to="lab_us-gaap_DistributionRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d7f4ab49-5858-4de6-8612-54d1a61a8aa8_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_a4248b09-c873-4873-a044-5fe924036ca6_terseLabel_en-US" xlink:label="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in other comprehensive income [Abstract]</link:label>
    <link:label id="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_label_en-US" xlink:label="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in other comprehensive income [Abstract]</link:label>
    <link:label id="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_documentation_en-US" xlink:label="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in other comprehensive income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:href="holx-20200926.xsd#holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:to="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2020ChargesMember_eb6990d9-888f-4810-bdee-32f7d51b5017_terseLabel_en-US" xlink:label="lab_holx_Fiscal2020ChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 charges</link:label>
    <link:label id="lab_holx_Fiscal2020ChargesMember_label_en-US" xlink:label="lab_holx_Fiscal2020ChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 charges [Member]</link:label>
    <link:label id="lab_holx_Fiscal2020ChargesMember_documentation_en-US" xlink:label="lab_holx_Fiscal2020ChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember" xlink:href="holx-20200926.xsd#holx_Fiscal2020ChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2020ChargesMember" xlink:to="lab_holx_Fiscal2020ChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_d33ef309-adc1-4a0a-aada-f9e7d28689e0_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State:</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_fdea9c77-ebbe-4efd-94ce-7fc357eb9b26_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_52d8791f-71c1-4dc3-ac1a-22e911020d60_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_79c4247d-05c6-41b8-94e5-ceaae6e1d17f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_a792fe7f-fb66-4113-97e0-708fae549b25_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of redemption price, fifth period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fifth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fifth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_71ac0304-4093-4d11-8fa8-ed0af3eb98c8_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_96548519-e64e-495b-85db-8159250437f5_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_9758e49e-d958-4e55-a0ce-6a973dd76a4f_negatedLabel_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Manufacture Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:href="holx-20200926.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FaxitronMember_8810f7a1-0836-41e1-9b48-357e49dfb817_terseLabel_en-US" xlink:label="lab_holx_FaxitronMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Faxitron</link:label>
    <link:label id="lab_holx_FaxitronMember_label_en-US" xlink:label="lab_holx_FaxitronMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Faxitron [Member]</link:label>
    <link:label id="lab_holx_FaxitronMember_documentation_en-US" xlink:label="lab_holx_FaxitronMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Faxitron [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FaxitronMember" xlink:to="lab_holx_FaxitronMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_88b06fc2-ce63-4f21-af0f-b63e32cb6d59_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_5af0aef5-f2a1-44a8-b65c-7fe6c31cc11c_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2018ActionMember_745cd3b4-20dd-42bd-919c-4a0fe175084f_terseLabel_en-US" xlink:label="lab_holx_Fiscal2018ActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2018 Actions</link:label>
    <link:label id="lab_holx_Fiscal2018ActionMember_label_en-US" xlink:label="lab_holx_Fiscal2018ActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2018 Action [Member]</link:label>
    <link:label id="lab_holx_Fiscal2018ActionMember_documentation_en-US" xlink:label="lab_holx_Fiscal2018ActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2018 Action [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember" xlink:href="holx-20200926.xsd#holx_Fiscal2018ActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2018ActionMember" xlink:to="lab_holx_Fiscal2018ActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_7d24cfb3-31cd-438e-9002-f9df928a3ba4_terseLabel_en-US" xlink:label="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of award vested upon meeting defined market based criteria</link:label>
    <link:label id="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_label_en-US" xlink:label="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Award Vested Upon Meeting Defined Market Based Criteria</link:label>
    <link:label id="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_documentation_en-US" xlink:label="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of award vested upon meeting defined market based criteria</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:href="holx-20200926.xsd#holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:to="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_3e42206a-0262-4816-a1a1-26da11629928_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_074f48dc-9149-4546-b28a-d600306e65d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Deferred Compensation Plan [Member]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_b7f40476-b2ea-4688-b5f4-4019f634cd6c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FinanceLeaseObligationsShortTermMember_7d928f04-7241-40e0-a49a-d7a2fe97419f_terseLabel_en-US" xlink:label="lab_holx_FinanceLeaseObligationsShortTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations - short term</link:label>
    <link:label id="lab_holx_FinanceLeaseObligationsShortTermMember_label_en-US" xlink:label="lab_holx_FinanceLeaseObligationsShortTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations - Short Term [Member]</link:label>
    <link:label id="lab_holx_FinanceLeaseObligationsShortTermMember_documentation_en-US" xlink:label="lab_holx_FinanceLeaseObligationsShortTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations - Short Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsShortTermMember" xlink:href="holx-20200926.xsd#holx_FinanceLeaseObligationsShortTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FinanceLeaseObligationsShortTermMember" xlink:to="lab_holx_FinanceLeaseObligationsShortTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BedfordMember_cd5768f9-79eb-4fee-ae1b-411b36fec108_terseLabel_en-US" xlink:label="lab_holx_BedfordMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bedford</link:label>
    <link:label id="lab_holx_BedfordMember_label_en-US" xlink:label="lab_holx_BedfordMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bedford [Member]</link:label>
    <link:label id="lab_holx_BedfordMember_documentation_en-US" xlink:label="lab_holx_BedfordMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bedford [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BedfordMember" xlink:href="holx-20200926.xsd#holx_BedfordMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BedfordMember" xlink:to="lab_holx_BedfordMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_717c04f4-735e-446a-b3f9-f164626fa7d6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxLiabilitiesDebtDiscount_a8ccd19d-4775-44b9-a4c6-ea17e7a6d0ae_negatedLabel_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and deferrals</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesDebtDiscount_label_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Debt Discount</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesDebtDiscount_documentation_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount as of the balance sheet of the estimated future tax effects attributable to the debt discount on the convertible notes and related impact from the convertible notes exchanges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesDebtDiscount" xlink:href="holx-20200926.xsd#holx_DeferredTaxLiabilitiesDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxLiabilitiesDebtDiscount" xlink:to="lab_holx_DeferredTaxLiabilitiesDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_9f05bac5-f941-47dd-b30e-1d14039d1058_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f7973372-7ff5-498d-9276-54a15d757bad_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions related to change in estimate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_c6193473-91ed-4bf8-a48d-9246263df8d4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. tax on foreign earnings</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_963be719-d271-4538-aebd-8fed250e0795_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2bb1c84e-8b1b-48e0-9d4c-e9c454fbf19b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares (in millions)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_b51162e8-5375-4bf4-a5e5-f288db6fe0c8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_a4bfb217-f4ea-460b-ae76-de72dd90bede_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_098d0b1f-4184-4aba-bf94-ff942396a5bf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ConvertibleNotesMember_9d457cf0-e785-476e-ae69-2f9c16ce8525_terseLabel_en-US" xlink:label="lab_holx_ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_holx_ConvertibleNotesMember_label_en-US" xlink:label="lab_holx_ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes [Member]</link:label>
    <link:label id="lab_holx_ConvertibleNotesMember_documentation_en-US" xlink:label="lab_holx_ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConvertibleNotesMember" xlink:href="holx-20200926.xsd#holx_ConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ConvertibleNotesMember" xlink:to="lab_holx_ConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e80f2612-27cc-4960-a86f-78ca186109aa_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_80fc6249-63a9-4754-bd1a-52d530f4e433_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation in excess of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_33450232-a38a-4aaf-b499-0c0d02cade47_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short and long-term debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_52a8b40f-7501-4be5-bcd1-52fe37bc4787_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized value of common shares to be repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_d986886c-2e2d-4185-9585-246b55293ac6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_2f0d0b56-3372-4d71-b8f6-d1bbf8131812_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_88218c5e-dac2-4860-a9e0-4d5ae4931074_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_23be1ff6-48a3-4348-9b09-e46505c532c2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MedicalAestheticsBusinessMember_5ff0d2fa-42fc-4404-9fdc-fd3804e7181d_terseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics Business</link:label>
    <link:label id="lab_holx_MedicalAestheticsBusinessMember_label_en-US" xlink:label="lab_holx_MedicalAestheticsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics Business [Member]</link:label>
    <link:label id="lab_holx_MedicalAestheticsBusinessMember_documentation_en-US" xlink:label="lab_holx_MedicalAestheticsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MedicalAestheticsBusinessMember" xlink:to="lab_holx_MedicalAestheticsBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_dbd1275b-b32f-47ef-9e6c-cb6b7b75945e_totalLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal, Total</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8603b006-3419-4aa9-9c87-2d129088988f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_ad2d7063-bb94-445b-920e-ff57274034ed_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_eafc9e1b-0661-4285-802c-5f875fa1c578_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_eb3b484f-d611-4af7-bb92-31663a766345_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EmsorMember_ed34ebc4-3295-45a7-847e-233b14124770_terseLabel_en-US" xlink:label="lab_holx_EmsorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emsor</link:label>
    <link:label id="lab_holx_EmsorMember_label_en-US" xlink:label="lab_holx_EmsorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emsor [Member]</link:label>
    <link:label id="lab_holx_EmsorMember_documentation_en-US" xlink:label="lab_holx_EmsorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emsor [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmsorMember" xlink:href="holx-20200926.xsd#holx_EmsorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmsorMember" xlink:to="lab_holx_EmsorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_d007e4d5-6947-4411-824a-e13ff0124b2d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityByLocationAxis_ee2e76a0-4599-4d03-a81d-f688a91dd4a6_terseLabel_en-US" xlink:label="lab_dei_EntityByLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity by Location [Axis]</link:label>
    <link:label id="lab_dei_EntityByLocationAxis_label_en-US" xlink:label="lab_dei_EntityByLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity by Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityByLocationAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityByLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityByLocationAxis" xlink:to="lab_dei_EntityByLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_e58ef211-3c38-4756-aac6-352cffb07229_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProfitSharingFourZeroOneKPlanTextBlock_902923e3-a31a-42d9-b184-7d00e5ee5886_terseLabel_en-US" xlink:label="lab_holx_ProfitSharingFourZeroOneKPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit Sharing 401(k) Plan</link:label>
    <link:label id="lab_holx_ProfitSharingFourZeroOneKPlanTextBlock_label_en-US" xlink:label="lab_holx_ProfitSharingFourZeroOneKPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit Sharing Four Zero One K Plan [Text Block]</link:label>
    <link:label id="lab_holx_ProfitSharingFourZeroOneKPlanTextBlock_documentation_en-US" xlink:label="lab_holx_ProfitSharingFourZeroOneKPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit Sharing Four Zero One K plan [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProfitSharingFourZeroOneKPlanTextBlock" xlink:href="holx-20200926.xsd#holx_ProfitSharingFourZeroOneKPlanTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProfitSharingFourZeroOneKPlanTextBlock" xlink:to="lab_holx_ProfitSharingFourZeroOneKPlanTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_3de6866b-1c85-40ce-8d3d-7b4c272d818d_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c1a5950c-bfdd-4cc5-9463-c3d9191446d2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e0c26fbc-4eea-4d04-85a5-b459fce638fb_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_4687742b-4b46-4d4a-a6f3-a31e4a60a000_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_8f5dd788-0d33-42bf-a5f7-a7039d20a1ec_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CR_e0100eec-b793-4feb-8428-ce77a4cb54b2_terseLabel_en-US" xlink:label="lab_country_CR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costa Rica</link:label>
    <link:label id="lab_country_CR_label_en-US" xlink:label="lab_country_CR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COSTA RICA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_CR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CR" xlink:to="lab_country_CR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_5de70d97-d7fc-4de4-8181-94806f3e7126_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmortizationOfDeferredFinancingCosts_1f938331-22e4-4f01-994a-d0f388f03717_terseLabel_en-US" xlink:label="lab_holx_AmortizationOfDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_holx_AmortizationOfDeferredFinancingCosts_label_en-US" xlink:label="lab_holx_AmortizationOfDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Deferred Financing Costs</link:label>
    <link:label id="lab_holx_AmortizationOfDeferredFinancingCosts_documentation_en-US" xlink:label="lab_holx_AmortizationOfDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The component of interest expense representing the periodic charge against earnings to reflect amortization of debt issuance costs over the life of the related debt instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationOfDeferredFinancingCosts" xlink:href="holx-20200926.xsd#holx_AmortizationOfDeferredFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmortizationOfDeferredFinancingCosts" xlink:to="lab_holx_AmortizationOfDeferredFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_b7d578a6-83ac-4123-8dca-0d3199ab3c5c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_4c568ec1-7f83-4535-94b9-1ae6d33b5b98_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:href="holx-20200926.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4f2c3858-ae26-4a65-a785-286f6993170f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_029f7cf4-f04c-4372-8653-cc846481079e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_ebeb7400-746f-4872-a12f-db43e5c671c6_totalLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State, Total</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_e6226153-bd7d-41eb-9af2-9fce49fa4cf9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of senior long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TwoThousandSevenNotesMember_56e7aae9-4a78-4fd7-a159-58ba608b9345_terseLabel_en-US" xlink:label="lab_holx_TwoThousandSevenNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2007 Notes</link:label>
    <link:label id="lab_holx_TwoThousandSevenNotesMember_label_en-US" xlink:label="lab_holx_TwoThousandSevenNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seven Notes [Member]</link:label>
    <link:label id="lab_holx_TwoThousandSevenNotesMember_documentation_en-US" xlink:label="lab_holx_TwoThousandSevenNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand seven notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSevenNotesMember" xlink:href="holx-20200926.xsd#holx_TwoThousandSevenNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwoThousandSevenNotesMember" xlink:to="lab_holx_TwoThousandSevenNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_004d7d5c-a3c0-4ccc-926d-f16757db0728_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_375dc8d2-9124-48ea-8732-6cee313828b7_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_080a064f-30c3-4eb4-b480-bd37d26637d4_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of the end of the fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_efbfd555-5377-447e-a330-1fa446bc0f53_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a2b9b4a9-07b9-4111-adef-ddf4040bf912_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_1b1c394b-6dc2-4365-a6f3-d1f61e35d7c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under revolving credit line</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_3fe5eadc-6d4c-4db8-9646-ec386f78f645_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under revolving credit line</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherOperatingCostReductionsMember_0184455b-cef8-4bf1-9175-f999b7c1b528_terseLabel_en-US" xlink:label="lab_holx_OtherOperatingCostReductionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous Other Charges</link:label>
    <link:label id="lab_holx_OtherOperatingCostReductionsMember_label_en-US" xlink:label="lab_holx_OtherOperatingCostReductionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Cost Reductions [Member]</link:label>
    <link:label id="lab_holx_OtherOperatingCostReductionsMember_documentation_en-US" xlink:label="lab_holx_OtherOperatingCostReductionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating cost reductions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherOperatingCostReductionsMember" xlink:href="holx-20200926.xsd#holx_OtherOperatingCostReductionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherOperatingCostReductionsMember" xlink:to="lab_holx_OtherOperatingCostReductionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f5e654e6-f59c-4b17-90dd-4e4380a04e02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_33580450-457d-4c2c-b86e-956d51812127_terseLabel_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in foreign currency translation adjustment</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_label_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_documentation_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:href="holx-20200926.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:to="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_ccfa31da-308f-42bf-96da-50dc1501e2ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_6b1c2c7d-1700-461b-b7f2-04527b10fc33_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU No. 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_d11de013-b628-4cd2-9bff-8a99aa612cf3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c195ab2c-61a2-424f-9515-c366c8d62496_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_a34db70e-9ed1-4aef-af41-0e4a95487e09_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage redemption price, sixth period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Redemption Price Sixth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Redemption Price Sixth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:to="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentAndSoftwareMember_dcff3a90-ae42-472b-bbbf-2fcad0382aaa_terseLabel_en-US" xlink:label="lab_holx_EquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment and Software [Member]</link:label>
    <link:label id="lab_holx_EquipmentAndSoftwareMember_label_en-US" xlink:label="lab_holx_EquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment And Software [Member]</link:label>
    <link:label id="lab_holx_EquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_holx_EquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment And Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentAndSoftwareMember" xlink:href="holx-20200926.xsd#holx_EquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentAndSoftwareMember" xlink:to="lab_holx_EquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_41a9e894-0fd9-4a9b-a063-73229de81c33_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_0a8e8942-8d4d-46e9-b7d5-37805f424569_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FocalTherapeuticsInc.Member_9b814d4a-f4b6-4ea7-9929-780d267961f2_terseLabel_en-US" xlink:label="lab_holx_FocalTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Focal Therapeutics</link:label>
    <link:label id="lab_holx_FocalTherapeuticsInc.Member_label_en-US" xlink:label="lab_holx_FocalTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Focal Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_holx_FocalTherapeuticsInc.Member_documentation_en-US" xlink:label="lab_holx_FocalTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Focal Therapeutics, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FocalTherapeuticsInc.Member" xlink:to="lab_holx_FocalTherapeuticsInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_950d1e37-e5d9-4bee-a198-e5acac929fad_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ce90f1d-1281-43f0-aef1-10a4c0c0322d_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RepaymentofSeniorNotes_5b755b71-9b60-4a09-86d0-5609b46fbdca_negatedTerseLabel_en-US" xlink:label="lab_holx_RepaymentofSeniorNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:label id="lab_holx_RepaymentofSeniorNotes_label_en-US" xlink:label="lab_holx_RepaymentofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:label id="lab_holx_RepaymentofSeniorNotes_documentation_en-US" xlink:label="lab_holx_RepaymentofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentofSeniorNotes" xlink:href="holx-20200926.xsd#holx_RepaymentofSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RepaymentofSeniorNotes" xlink:to="lab_holx_RepaymentofSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e2f214cc-2c6a-4281-a315-2ce320449a06_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_302bb25c-9ac3-4c23-a542-24b03435531a_terseLabel_en-US" xlink:label="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense for the DCP discretionary contributions</link:label>
    <link:label id="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_label_en-US" xlink:label="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Deferred Compensation Plan Annual Contribution</link:label>
    <link:label id="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_documentation_en-US" xlink:label="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified deferred compensation plan annual contribution.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:href="holx-20200926.xsd#holx_NonqualifiedDeferredCompensationPlanAnnualContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:to="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4dbb3c5f-5a11-455b-bcc1-f472399fd96e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_e60d5c61-69e3-4a4d-a687-d2fe679e1955_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_d29a7f1b-326d-4adc-afe5-caffe3792e6f_terseLabel_en-US" xlink:label="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Service and Other Revenues</link:label>
    <link:label id="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Service And Other Revenues Policy [Policy Text Block]</link:label>
    <link:label id="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of the costs comprising costs of service and other revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:href="holx-20200926.xsd#holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:to="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f64e5b83-1cdd-4231-bbc8-19a2d00cb8d3_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_785747b7-3068-4e26-a41e-4f65001dfd1f_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0c1d40e7-5339-4a39-8f87-a5fa4c133351_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e4a9a952-dc6a-4b98-9a75-92c0977dbe7a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4e27b2df-89de-43a6-8c02-21c4030b031d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_8a29c053-5fec-402f-ba10-3326158a8868_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AlphaImagingMember_07e34bc6-e789-4f70-bf26-b1e2cedb24b9_terseLabel_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging</link:label>
    <link:label id="lab_holx_AlphaImagingMember_label_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:label id="lab_holx_AlphaImagingMember_documentation_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember" xlink:href="holx-20200926.xsd#holx_AlphaImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AlphaImagingMember" xlink:to="lab_holx_AlphaImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Purchaseobligationthereafter_d9b5483e-4a63-4c07-9293-93decaeb6697_terseLabel_en-US" xlink:label="lab_holx_Purchaseobligationthereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_holx_Purchaseobligationthereafter_label_en-US" xlink:label="lab_holx_Purchaseobligationthereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation thereafter</link:label>
    <link:label id="lab_holx_Purchaseobligationthereafter_documentation_en-US" xlink:label="lab_holx_Purchaseobligationthereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseobligationthereafter" xlink:href="holx-20200926.xsd#holx_Purchaseobligationthereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Purchaseobligationthereafter" xlink:to="lab_holx_Purchaseobligationthereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_294cb0f2-752a-4e75-988b-4832e9e21ed6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessLicensesMember_bbc8d804-ee9e-44fd-902e-b8b0c66fb023_terseLabel_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_label_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Licenses [Member]</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_documentation_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember" xlink:href="holx-20200926.xsd#holx_BusinessLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessLicensesMember" xlink:to="lab_holx_BusinessLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_c4721f2d-aeb6-48e0-8131-c212f91af378_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_1928566f-8b34-4da2-89b0-a20f5cfb9185_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_80aeea56-b798-4e8a-aeeb-0ad7f71b6beb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_5d68d8f4-40ce-44d6-9423-c95df0a90e23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_379877f6-764e-4610-accc-bb911f4ee972_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_4b842c64-d4b7-4764-b599-c58a393b8b71_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2028SeniorNotesMember_486eb39d-9f31-4d20-b39f-84eb34c1ab04_terseLabel_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028SeniorNotesMember" xlink:to="lab_holx_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_91503647-99cb-4b28-aefa-2629d149ef91_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awarded damages</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_1c345fe5-41ae-45ee-8cb1-09a0d2fd2b0f_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_af788819-e736-45d3-bbb1-06fa206c03d2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_7ea7d038-b872-4fbc-b084-503afb04f606_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_de925fde-8498-4802-a600-30ebb9941cf3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f16cea4f-cec3-4e5f-bdca-3157c988f121_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_91e83000-8438-4d83-85da-ca0d88647054_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets arising from entering into new operating lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_238610a4-9c66-4b65-b79a-d45c49966571_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities (current)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProceedsfromSeniorNotes_57ab2a81-4b3c-491c-acfe-7153dd121c7c_terseLabel_en-US" xlink:label="lab_holx_ProceedsfromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Senior Notes</link:label>
    <link:label id="lab_holx_ProceedsfromSeniorNotes_label_en-US" xlink:label="lab_holx_ProceedsfromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Senior Notes</link:label>
    <link:label id="lab_holx_ProceedsfromSeniorNotes_documentation_en-US" xlink:label="lab_holx_ProceedsfromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsfromSeniorNotes" xlink:href="holx-20200926.xsd#holx_ProceedsfromSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsfromSeniorNotes" xlink:to="lab_holx_ProceedsfromSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_040be849-c3b1-416f-b6a8-7bdc086e7e2a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_f821a4f0-7871-4efb-8f90-7098fcfd8dbc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_0d46b285-e385-468a-8f03-ca2690fc572f_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_e05bdae5-d9e7-4c4e-9a45-40125de55c64_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_ebe8b064-a8ae-4331-ad65-8e2c96cb7a8b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_06ea778c-9158-411d-a0eb-9fb2db6be073_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0c47b82b-d477-4c0b-98b4-1c8e4367bf55_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DistributionagreementMember_23016f33-bda2-4fd0-ac10-9cfda3e11c8c_terseLabel_en-US" xlink:label="lab_holx_DistributionagreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution agreement [Member]</link:label>
    <link:label id="lab_holx_DistributionagreementMember_label_en-US" xlink:label="lab_holx_DistributionagreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution agreement [Member]</link:label>
    <link:label id="lab_holx_DistributionagreementMember_documentation_en-US" xlink:label="lab_holx_DistributionagreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember" xlink:href="holx-20200926.xsd#holx_DistributionagreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DistributionagreementMember" xlink:to="lab_holx_DistributionagreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f483781-44dc-48e5-b64b-e619e71a5ac9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_c72663b0-26ec-4daa-a6c1-c126ec274112_negatedLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Benefit Expense Research And Development</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation benefit expense research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:to="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_c410e361-1606-4613-b52a-5bc9866935ed_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes principal amount</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d8f12af2-afd3-437c-a2d5-e55b9fa9481d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/ forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_7619df57-e0aa-4270-98dc-b6188a5b4544_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_c2f8572b-f22c-4a16-a305-71ddebd2903f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_label_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect of New Accounting Principle in Period of Adoption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:to="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_2e49d51e-ef4a-40b4-9a85-1e2923908772_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_4f00d840-cd5c-46d1-b7ec-ce35ab3b7631_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_421d3480-684e-4171-8fd9-eb76fac8c765_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f6461379-01c6-42be-a357-44b5b981b5be_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_d8c57ce3-c36b-4d34-aa8e-4d0d6721c706_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncomeTaxesTable_8490ddc2-81ed-4d0a-a7d2-ae98c720483f_terseLabel_en-US" xlink:label="lab_holx_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_holx_IncomeTaxesTable_label_en-US" xlink:label="lab_holx_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_holx_IncomeTaxesTable_documentation_en-US" xlink:label="lab_holx_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesTable" xlink:href="holx-20200926.xsd#holx_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncomeTaxesTable" xlink:to="lab_holx_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_44bcd88a-baaf-4018-bd08-6d3ed405c506_terseLabel_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_label_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_documentation_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember" xlink:href="holx-20200926.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterventionalBreastSolutionsMember" xlink:to="lab_holx_InterventionalBreastSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_642ef640-dd9b-43d7-9b67-00630d2e36a0_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_bec01258-5b4b-4a06-834e-37fede6e8255_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit carry forwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1753872c-8d15-4104-bdaa-a82ef0ead4a0_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) reclassified from accumulated other comprehensive income (loss) to the statement of operations</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_cdedb4ed-3dd0-48d9-9257-c44c1862cec0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8d0693ba-699f-4ee5-afdc-eb713266c0a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Components of the Company's Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_a67cfb71-839b-41c7-8e34-86a985d60fd4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_93245f07-8a74-4648-8d8b-43c4de36f4d3_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3c9f57fe-b517-4350-b720-ac3b1bd247dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Pertaining to Stock Options Granted and Related Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f9db928e-1ab7-4ede-b28c-6a52d0cbebe8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesMember_b4772ed9-bcbb-4628-8d12-307030b08316_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesMember_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesMember" xlink:to="lab_us-gaap_RestructuringChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_155524c2-a9bf-4125-bf3e-99f5b4153f42_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Fourth Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_74fb746f-3cf0-4039-bf95-65c75acd68e7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_2baac954-dea8-40ac-a0e3-6f9e7c2395b5_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Program</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_label_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_documentation_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableSecuritizationMember" xlink:to="lab_holx_AccountsReceivableSecuritizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_18258d5b-f66c-47c8-8f36-ad9a7f7d8a0d_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_62bf5923-dbc7-464f-9e4d-3e818302d035_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September 28, 2019</link:label>
    <link:label id="lab_us-gaap_Goodwill_886f43bc-3e54-4f41-8b85-a749feeaca37_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_52b4d265-e525-4191-b703-e62bf894634c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Unit Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_0c8e5cbb-b350-4dd5-b667-1aa905b031b0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_185b3d88-788a-4aa3-8c9a-4dd60e7a3cdd_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_a8525e64-4885-4063-a5f9-eb94193542eb_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense in Consolidated Statement of Operations</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:href="holx-20200926.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:to="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CompanyVs.MinervaSurgicalInc.Member_f117b4d8-f8e6-4b3d-a8a6-62f0bab8e6ef_terseLabel_en-US" xlink:label="lab_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Vs. Minerva Surgical, Inc.</link:label>
    <link:label id="lab_holx_CompanyVs.MinervaSurgicalInc.Member_label_en-US" xlink:label="lab_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Vs. Minerva Surgical, Inc. [Member]</link:label>
    <link:label id="lab_holx_CompanyVs.MinervaSurgicalInc.Member_documentation_en-US" xlink:label="lab_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Vs. Minerva Surgical, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:href="holx-20200926.xsd#holx_CompanyVs.MinervaSurgicalInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:to="lab_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_8f7892df-839e-478f-915d-df9af5a70ea3_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_b4635a84-f7a7-46e6-8d83-e8488b43970a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_46dd0778-adfc-4b85-b98c-7163ade11e64_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit related to stock based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_9fedbc76-86e2-472a-926d-fe9f8fe4ae5f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree (as a percent)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_a378c485-5b0d-499a-a356-114cd01afde9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_c8308df1-4c3a-44ee-9458-98d700c16387_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_fbea4313-6d9e-497d-ba08-1fefe1b66f43_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.00% accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_aa529d7a-d354-46e9-9acc-58b417a2d2c1_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreement2017Member_56d2b39e-10f2-46b9-b505-6290ffdcdc1a_terseLabel_en-US" xlink:label="lab_holx_CreditAgreement2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreement2017Member_label_en-US" xlink:label="lab_holx_CreditAgreement2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2017 [Member]</link:label>
    <link:label id="lab_holx_CreditAgreement2017Member_documentation_en-US" xlink:label="lab_holx_CreditAgreement2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member" xlink:href="holx-20200926.xsd#holx_CreditAgreement2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreement2017Member" xlink:to="lab_holx_CreditAgreement2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreementMember_69584e06-3d6f-40a5-b92f-78566647a0bf_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_label_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember" xlink:href="holx-20200926.xsd#holx_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementMember" xlink:to="lab_holx_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_73635296-d5f1-4fbd-a59b-f05d73646d4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_e0cc997c-f89f-468b-989f-62ed8363b520_terseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_ac18329b-e0cd-4b0a-8fdf-69015e5fccb0_verboseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowed principal under credit agreement</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_label_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount Of Borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_documentation_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings" xlink:href="holx-20200926.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalAmountOfBorrowings" xlink:to="lab_holx_PrincipalAmountOfBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_4aa11782-5132-420f-8573-d04e6770a2f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_21436055-14ec-4164-bb28-91566580502a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_632e7c7d-5480-4261-afec-ec525a84e566_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b42d2adb-517e-464f-a758-ccacb1ee1cfb_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_68c8116e-254d-47c8-a429-7e2ce0745346_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_bf1b4d6f-a9aa-449c-a1f0-6f3d086873c5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGoodwillBySegmentTableTextBlock_e999fb8e-3874-419e-9403-17c7855ac0c4_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGoodwillBySegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of Goodwill Activity by Reportable Segment</link:label>
    <link:label id="lab_holx_ScheduleOfGoodwillBySegmentTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfGoodwillBySegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Goodwill By Segment Table [Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfGoodwillBySegmentTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfGoodwillBySegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of goodwill by segment table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGoodwillBySegmentTableTextBlock" xlink:href="holx-20200926.xsd#holx_ScheduleOfGoodwillBySegmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGoodwillBySegmentTableTextBlock" xlink:to="lab_holx_ScheduleOfGoodwillBySegmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CytologyPerinatalMember_7ce9180e-fe98-4060-b6a4-4ca13fd0b424_terseLabel_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_label_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_documentation_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember" xlink:href="holx-20200926.xsd#holx_CytologyPerinatalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CytologyPerinatalMember" xlink:to="lab_holx_CytologyPerinatalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_7f951d93-bb40-4898-9bb2-ab293dec00c4_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7709690f-e92c-4e4c-be9b-79e25a87fea5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_4f45ee27-b289-47be-bb90-674c5aeff7fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_16434df4-df67-4a69-b611-b699edeb4999_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportionate share of net loss of equity method investment</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ComprehensiveIncome_2486bd1f-616d-4f14-8f35-bb5a4e7aaa94_terseLabel_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to Hologic</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_label_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_documentation_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome" xlink:href="holx-20200926.xsd#holx_ComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ComprehensiveIncome" xlink:to="lab_holx_ComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_3b0fa49b-0510-4339-ab14-3b80a35d5dbc_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:href="holx-20200926.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e4534193-e25b-4148-9400-7588734855f4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_2111df1d-6d7d-433c-a012-413ea1f9e1ca_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_a6e5499d-ae6f-43b6-827e-d263ad96c05e_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2ffab791-fbe1-427e-a5d2-4285aa662995_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_410ee335-47ba-40e2-8fb6-02ca50134dbb_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_6fe6b6a9-6f8d-45be-9b90-f6f7bdbb771a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_fdf6e2d9-4057-45b2-a34e-436f5281b76b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_60fd177d-db65-4777-b5d2-6ebaec556c21_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_386f60a2-2a0f-4732-931a-f970b356c68e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less reserves of $31.6 and $17.8, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_84ceeb30-3f06-4199-b093-9c657a0cee53_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_883cacad-b8cc-4a73-b10d-131539b16510_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_f0aeab55-68ef-4e29-9d4b-c80b40737741_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_97dfd069-b8b3-44db-83c9-29a8ff7b36d5_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmendedRevolver2018Member_99615c32-362e-4843-a424-834f780ad0ee_terseLabel_en-US" xlink:label="lab_holx_AmendedRevolver2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Amended Revolver</link:label>
    <link:label id="lab_holx_AmendedRevolver2018Member_label_en-US" xlink:label="lab_holx_AmendedRevolver2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Revolver 2018 [Member]</link:label>
    <link:label id="lab_holx_AmendedRevolver2018Member_documentation_en-US" xlink:label="lab_holx_AmendedRevolver2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Revolver 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedRevolver2018Member" xlink:href="holx-20200926.xsd#holx_AmendedRevolver2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedRevolver2018Member" xlink:to="lab_holx_AmendedRevolver2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_39f6ec7a-09cd-4dbd-8612-92497dc34847_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign:</link:label>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_833aacbb-4893-42ac-bb36-bcdb4740e964_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9f704b51-3bec-4b6a-aae6-1aa38fb8f475_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_079a2e5a-96f6-4f4e-a223-99f78215fb3f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_6f95cdfb-126d-4f76-9c09-0a72cc50ed82_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_12d580f7-a07a-4fda-a569-b61bf8d75513_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2022</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Second Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_d6c2b4a0-d21e-434a-b074-04ea0501b54a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Taxpaidoninterestrateswaps_ed676c13-0a24-4264-9164-0d04b3a3a498_terseLabel_en-US" xlink:label="lab_holx_Taxpaidoninterestrateswaps" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax paid on interest rate swaps</link:label>
    <link:label id="lab_holx_Taxpaidoninterestrateswaps_label_en-US" xlink:label="lab_holx_Taxpaidoninterestrateswaps" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax paid on interest rate swaps</link:label>
    <link:label id="lab_holx_Taxpaidoninterestrateswaps_documentation_en-US" xlink:label="lab_holx_Taxpaidoninterestrateswaps" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax paid on interest rate swaps</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Taxpaidoninterestrateswaps" xlink:href="holx-20200926.xsd#holx_Taxpaidoninterestrateswaps"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Taxpaidoninterestrateswaps" xlink:to="lab_holx_Taxpaidoninterestrateswaps" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternalusesoftwareMember_833acf85-45b5-4f67-915c-16ded50c8926_terseLabel_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_label_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_documentation_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember" xlink:href="holx-20200926.xsd#holx_InternalusesoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternalusesoftwareMember" xlink:to="lab_holx_InternalusesoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_June132019PlanMember_41a92a32-9778-4f7e-b17d-56045fb567ca_terseLabel_en-US" xlink:label="lab_holx_June132019PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 13, 2019 Plan [Member]</link:label>
    <link:label id="lab_holx_June132019PlanMember_label_en-US" xlink:label="lab_holx_June132019PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 13, 2019 Plan [Member]</link:label>
    <link:label id="lab_holx_June132019PlanMember_documentation_en-US" xlink:label="lab_holx_June132019PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 13, 2019 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_June132019PlanMember" xlink:href="holx-20200926.xsd#holx_June132019PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_June132019PlanMember" xlink:to="lab_holx_June132019PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3584b6ce-57b6-4367-b4b3-510fc618dc8d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MakeWholeProvision_31634423-a8a7-4081-ada6-ab5156557c38_terseLabel_en-US" xlink:label="lab_holx_MakeWholeProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Make whole provision</link:label>
    <link:label id="lab_holx_MakeWholeProvision_label_en-US" xlink:label="lab_holx_MakeWholeProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Make Whole Provision</link:label>
    <link:label id="lab_holx_MakeWholeProvision_documentation_en-US" xlink:label="lab_holx_MakeWholeProvision" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Make Whole Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MakeWholeProvision" xlink:href="holx-20200926.xsd#holx_MakeWholeProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MakeWholeProvision" xlink:to="lab_holx_MakeWholeProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e59a84c2-3cac-4d0a-b026-d274109ca61d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears_cdea955a-3e9a-49dd-b343-cfe940ca48a6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Receivable, in Four Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4cc345e-f343-4e55-9474-4ad2b65a3236_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d6dd6930-4283-4217-84c7-4fa547e8c2e8_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_d90be0d8-1a8c-4951-9c9f-89c18c2f9181_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_ec7cf150-b3a1-4e3a-af27-8a0062e253a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax_126744ba-b1b8-4d8d-8e54-ac7c09532baa_terseLabel_en-US" xlink:label="lab_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment tax effect</link:label>
    <link:label id="lab_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax_label_en-US" xlink:label="lab_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect Of New Accounting Principle In Period Of Adoption, Tax</link:label>
    <link:label id="lab_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax_documentation_en-US" xlink:label="lab_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect Of New Accounting Principle In Period Of Adoption, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax" xlink:href="holx-20200926.xsd#holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax" xlink:to="lab_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2d7a83f9-bb25-4a9e-867f-7f03b7ccdd76_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_71be01e2-58c7-44a8-85d4-b64505027428_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_f04a1e0b-0978-45d5-87d7-2194ab40ee75_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_d30b728d-7418-4493-a9cb-700e2f2b70ba_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Hologic</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_0671e3bc-d446-4692-b690-0497d86d52e5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_a3392c92-0fe3-41a3-87c8-2af2462398bf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_3ef580fd-1a61-4fc4-ad25-ad0c17a0dfba_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_acb26fcf-e50a-494c-9ab7-74d7e2e9faa5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_83e2409f-a0e1-4ad7-8ca4-c721d9d1a359_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_fc288ace-04dc-4b18-9014-d2569367abee_terseLabel_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Target Number Of Shares Issued On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum target number percentage of shares that would be issued based on stock price performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:href="holx-20200926.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:to="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_e7bff80c-6fba-443b-8303-02c67b1c2821_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_2ed86d41-2c07-4dd6-a2f0-7bb859db71d8_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified deferred compensation plan</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Nonqualified Deferred Compensation Plan</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The tax effect as of the balance sheet date of the amount of future tax deductions arising from the Company's nonqualified deferred compensation plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:to="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_461e5526-cfac-4580-b227-9483a4832202_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_9ce7dd54-0320-43cf-bc73-460281673e03_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_80701f38-bd19-4af8-b321-60b6c6fa1f1d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_d39e3145-2aa6-4d7f-8d56-37331431e8fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2042NotesMember_9baa9992-7412-4845-98f2-78fb9894d61e_terseLabel_en-US" xlink:label="lab_holx_A2042NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2042 Notes</link:label>
    <link:label id="lab_holx_A2042NotesMember_label_en-US" xlink:label="lab_holx_A2042NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2042 Notes [Member]</link:label>
    <link:label id="lab_holx_A2042NotesMember_documentation_en-US" xlink:label="lab_holx_A2042NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2042 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2042NotesMember" xlink:href="holx-20200926.xsd#holx_A2042NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2042NotesMember" xlink:to="lab_holx_A2042NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3716c844-0998-4483-aa2f-9207b4fc9af6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_708c8c98-08ee-427c-becf-d29386bad5a0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Future Minimum Payments Due Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_1f181de4-b438-4161-97a9-a95bea14e162_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_4bac2208-9c56-4921-9efc-678413b54840_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost - interest cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_e259e7ab-faf3-4dff-bb5e-ae7fea2bace7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_d0775be8-bf8f-4eec-833e-aeba03f36228_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_d67dfd7b-2df1-410e-993e-3c3e9c6e029a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Pension Benefit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_0f8fdc28-5d3f-4179-8fef-1ba4b07f6a79_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Options and stock units [Member]</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_d4867340-ca4e-4e3f-a955-b3292544ba38_terseLabel_en-US" xlink:label="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Net Income resulted from adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_label_en-US" xlink:label="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Net Income resulted from adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_documentation_en-US" xlink:label="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Net Income resulted from adoption of ASU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:href="holx-20200926.xsd#holx_IncreasetoNetIncomeresultedfromadoptionofASU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:to="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_0e185e58-aab2-4354-b7f5-06ccbacc9a41_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7876b290-72db-44d8-8ffb-ba4889355e16_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_f74ab7eb-3a9e-4e8e-9220-3e12be2fc1ff_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_e280b1dc-30ee-4573-bf7f-d4ced3c0c7ac_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4aeafb8c-71a7-4ee1-8887-e2350e79e8a7_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Propertyclosurecostpayment_a26dbc99-6a73-4b3e-ba28-6a820cc5096a_terseLabel_en-US" xlink:label="lab_holx_Propertyclosurecostpayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property closure cost payment</link:label>
    <link:label id="lab_holx_Propertyclosurecostpayment_label_en-US" xlink:label="lab_holx_Propertyclosurecostpayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property closure cost payment</link:label>
    <link:label id="lab_holx_Propertyclosurecostpayment_documentation_en-US" xlink:label="lab_holx_Propertyclosurecostpayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property closure cost payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Propertyclosurecostpayment" xlink:href="holx-20200926.xsd#holx_Propertyclosurecostpayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Propertyclosurecostpayment" xlink:to="lab_holx_Propertyclosurecostpayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_851c8378-4366-4386-ab02-369f2cc18e6b_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Third Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_2c44958c-b8b6-4b85-95d6-c3a908c37a22_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_5cf17352-7243-4a5b-9e91-bb4ca1b00a92_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PSUFreeCashFlowMember_a984702d-32a9-4b48-b67f-a91a269dfaf3_terseLabel_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_label_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_documentation_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember" xlink:href="holx-20200926.xsd#holx_PSUFreeCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PSUFreeCashFlowMember" xlink:to="lab_holx_PSUFreeCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_1075c2ce-1bbf-4fc4-b1dc-521f2a5e4e11_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of secured debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_44de8ad3-7a96-4f69-ba91-0ba616da645d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at September 26, 2020 (1)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_6d562ceb-df55-4c24-8545-e22d9ed680bd_terseLabel_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period with option to terminate lease</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_label_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Lease, Period With Option To Terminate</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_documentation_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Lease, Period With Option To Terminate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:to="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_688981c7-08e0-4103-84a6-59a1962515b9_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_224808de-3aff-46c8-84a8-6b453638b3c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_096929f5-8828-4cfb-9a86-e2d8498fd65d_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_87693b5e-5661-41a8-912e-29292ffbf993_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableAllowanceReduction_33cf9fb4-c50b-447a-ba77-a8c6fa17add5_negatedLabel_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceReduction" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write- offs and Payments</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceReduction_label_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceReduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Allowance Reduction</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceReduction_documentation_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceReduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents reduction to the allowance for doubtful accounts primarily from collection of previously reserved accounts and the elimination of an account from the ledger accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceReduction" xlink:href="holx-20200926.xsd#holx_AccountsReceivableAllowanceReduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableAllowanceReduction" xlink:to="lab_holx_AccountsReceivableAllowanceReduction" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit_f78de2b8-ad1f-46be-b11c-8ebba867502e_negatedTerseLabel_en-US" xlink:label="lab_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisional estimate of tax benefit as result of Tax Cuts and Jobs Act</link:label>
    <link:label id="lab_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts And Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts And Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:href="holx-20200926.xsd#holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:to="lab_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_41db0c6d-9b4a-40d7-8310-f64be92d0b38_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ExpectedFutureSeveranceCharges_09ef1792-2730-4acd-955d-8dac84b286b1_terseLabel_en-US" xlink:label="lab_holx_ExpectedFutureSeveranceCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future severance charges</link:label>
    <link:label id="lab_holx_ExpectedFutureSeveranceCharges_label_en-US" xlink:label="lab_holx_ExpectedFutureSeveranceCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future severance charges</link:label>
    <link:label id="lab_holx_ExpectedFutureSeveranceCharges_documentation_en-US" xlink:label="lab_holx_ExpectedFutureSeveranceCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future severance charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ExpectedFutureSeveranceCharges" xlink:href="holx-20200926.xsd#holx_ExpectedFutureSeveranceCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ExpectedFutureSeveranceCharges" xlink:to="lab_holx_ExpectedFutureSeveranceCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrossForeignLossCarryforwards_1b3128da-6c49-4db3-a6f0-8718f318c3d1_terseLabel_en-US" xlink:label="lab_holx_GrossForeignLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross foreign loss carryforwards</link:label>
    <link:label id="lab_holx_GrossForeignLossCarryforwards_label_en-US" xlink:label="lab_holx_GrossForeignLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross foreign loss carryforwards</link:label>
    <link:label id="lab_holx_GrossForeignLossCarryforwards_documentation_en-US" xlink:label="lab_holx_GrossForeignLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross foreign loss carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossForeignLossCarryforwards" xlink:href="holx-20200926.xsd#holx_GrossForeignLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrossForeignLossCarryforwards" xlink:to="lab_holx_GrossForeignLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_62dbe19a-a6a0-4804-a48b-931abae6a026_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_a66a7284-dda7-421e-8b49-3c3822435245_terseLabel_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease revenue as a percentage of total</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_label_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_documentation_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:href="holx-20200926.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:to="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c4e09ff8-0115-443a-a53c-fff0c495f0d6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities disposed of</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate_40a73376-01ee-4242-b482-a11febba9573_terseLabel_en-US" xlink:label="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of forfeiture rates</link:label>
    <link:label id="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate_label_en-US" xlink:label="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Percentage Of Forfeiture Rate</link:label>
    <link:label id="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate_documentation_en-US" xlink:label="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture rate applied to equity awards issued to certain employee groups to determine stock-based compensation expense for the period. The rate is based on an analysis of historical employee exercise and terminations patterns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:href="holx-20200926.xsd#holx_ShareBasedCompensationPercentageOfForfeitureRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:to="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_f34b576c-2e35-45f0-b918-97ac8e36094c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_b8f96cd8-be84-4825-a876-cd52780f7d2b_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems" xlink:href="holx-20200926.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureLineItems" xlink:to="lab_holx_SegmentReportingDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b3b1467f-5a93-4d9c-8efa-bc5864bccaa5_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ASRAuthorized_8c3a37b1-43a8-4a56-92b2-5df53d5ac0dc_terseLabel_en-US" xlink:label="lab_holx_ASRAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Authorized</link:label>
    <link:label id="lab_holx_ASRAuthorized_label_en-US" xlink:label="lab_holx_ASRAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Authorized</link:label>
    <link:label id="lab_holx_ASRAuthorized_documentation_en-US" xlink:label="lab_holx_ASRAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRAuthorized" xlink:href="holx-20200926.xsd#holx_ASRAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ASRAuthorized" xlink:to="lab_holx_ASRAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b567c739-d990-43b7-9689-70ee8817d124_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_abf5db9d-611d-4d83-94cc-eea9d62fd092_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_09fe9dde-d721-47fd-8637-16bc89e9bc6a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_9b6b169e-0f05-45ff-b154-b0a1cbabf645_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_db16cf7a-6578-4917-92b8-11f17d1621df_terseLabel_en-US" xlink:label="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final sales price</link:label>
    <link:label id="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_label_en-US" xlink:label="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Final Sales Price</link:label>
    <link:label id="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_documentation_en-US" xlink:label="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Final Sales Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:href="holx-20200926.xsd#holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:to="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_4632f580-ab75-4cb1-bd1d-9ade94178832_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a413f57e-3fdc-4582-8253-d3f808cbfce1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_502e9ac7-ee83-46f6-b37a-0ad5232aab78_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps - derivative</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_415004bd-335a-402f-91ba-9c04c17b11d6_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_8894f15c-bd9f-43ca-8ecc-6dfc264f1084_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1b82510f-e1c8-47b2-b58d-cb1f6ddd403a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 to 2030</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_fab181e9-178a-4ade-8eff-8a6c01fd564c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_9476eced-1a69-4bf9-96b8-710d94c6104d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_74d6916f-8691-4fbb-837a-49321951ecc3_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, estimated useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_2141b59a-724e-40eb-8855-6f67d79518f7_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:href="holx-20200926.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AuthorizationDateDomain_6166547e-94bf-4453-a9d0-fb14dace6efe_terseLabel_en-US" xlink:label="lab_holx_AuthorizationDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorization Date [Domain]</link:label>
    <link:label id="lab_holx_AuthorizationDateDomain_label_en-US" xlink:label="lab_holx_AuthorizationDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorization Date [Domain]</link:label>
    <link:label id="lab_holx_AuthorizationDateDomain_documentation_en-US" xlink:label="lab_holx_AuthorizationDateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Authorization Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AuthorizationDateDomain" xlink:href="holx-20200926.xsd#holx_AuthorizationDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AuthorizationDateDomain" xlink:to="lab_holx_AuthorizationDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d9b484c1-4100-4941-a210-35a647fcfce8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_2e5f5f25-bdb4-4cf7-8705-5735b5310747_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b6a4d27a-cfb7-4ca7-b872-2f2cb5eb741d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_64ede95f-2e04-4b93-85af-b0a40840d2b7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest_4dd81709-7c88-4f41-99cd-39f5fef5ae80_terseLabel_en-US" xlink:label="lab_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price as percentage of principle amount plus accrued and unpaid interest</link:label>
    <link:label id="lab_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest_label_en-US" xlink:label="lab_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Price As Percentage Of Principal Amount Plus Accrued And Unpaid Interest</link:label>
    <link:label id="lab_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest_documentation_en-US" xlink:label="lab_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price as percentage of principal amount plus accrued and unpaid interest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" xlink:href="holx-20200926.xsd#holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" xlink:to="lab_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_1b537ad7-8cfe-4fa3-be4b-0293010402a2_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_2fd356b3-a88a-4a0f-afd7-c336ed8b82b5_terseLabel_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital equipment, components and software</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_label_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:href="holx-20200926.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:to="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_3dfa1f8d-86ac-403d-bd3a-5ce6f1f1ad9c_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e17a13fc-e12c-4941-a0df-61d7ff01ef82_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesCapitalAbstract_62c02647-dce3-4d06-b809-db2c86733a61_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_us-gaap_LeasesCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesCapitalAbstract" xlink:to="lab_us-gaap_LeasesCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_a0873b4a-56b6-426b-a153-b7045d42a0b5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_1502e549-6536-4188-b1d0-b2f163fa5b5e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Reserve Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_3b2e390d-267b-4b42-a15e-d3d715ebcb17_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_259d6253-dd40-4d29-b4d8-57581307da0a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_79f29e06-a886-419b-8efd-482bf74a89d8_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Statement of Operations Information (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_3663e207-af18-40b1-abf2-6878d5484661_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d1ef031f-50b9-448b-a5ed-b0f0873e659a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_c15d7b3d-f48b-4f04-a10d-9adc9c9adf97_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_d3637f18-2ba4-4acd-a47e-77a0e211f149_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Holdback_b6fd4fb4-0ed4-42f4-9f36-bf170212f9e7_terseLabel_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_label_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_documentation_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback" xlink:href="holx-20200926.xsd#holx_Holdback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Holdback" xlink:to="lab_holx_Holdback" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_UKIntangibleassets_fb6d7c21-902f-4d6c-901f-d58bb712a055_terseLabel_en-US" xlink:label="lab_holx_UKIntangibleassets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UK Intangible assets</link:label>
    <link:label id="lab_holx_UKIntangibleassets_label_en-US" xlink:label="lab_holx_UKIntangibleassets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UK Intangible assets</link:label>
    <link:label id="lab_holx_UKIntangibleassets_documentation_en-US" xlink:label="lab_holx_UKIntangibleassets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UK Intangible assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UKIntangibleassets" xlink:href="holx-20200926.xsd#holx_UKIntangibleassets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_UKIntangibleassets" xlink:to="lab_holx_UKIntangibleassets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtheractionMember_6595a04d-3355-4cab-9ad8-7f3005bc72b2_terseLabel_en-US" xlink:label="lab_holx_OtheractionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other action [Member]</link:label>
    <link:label id="lab_holx_OtheractionMember_label_en-US" xlink:label="lab_holx_OtheractionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other action [Member]</link:label>
    <link:label id="lab_holx_OtheractionMember_documentation_en-US" xlink:label="lab_holx_OtheractionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other action [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtheractionMember" xlink:href="holx-20200926.xsd#holx_OtheractionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtheractionMember" xlink:to="lab_holx_OtheractionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_b5788367-e273-4b32-9965-b5f3183f402a_negatedTerseLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of Cynosure</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax reconciliation loss on sale of Cynosure</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax reconciliation loss on sale of Cynosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:to="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_9f34d94c-2ca4-41cb-a02a-60c215cf00d5_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal net operating loss expected to be expired unutilized</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Federal</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of federal net operating losses the company believes will expire unutilized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:to="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_c9f9e83c-6876-405a-866a-387d8121e2bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments/Accruals</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Purchaseofcostmethodinvestment_437aef49-03dc-48bc-8d93-cc2a50b6748c_negatedTerseLabel_en-US" xlink:label="lab_holx_Purchaseofcostmethodinvestment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of cost method investment</link:label>
    <link:label id="lab_holx_Purchaseofcostmethodinvestment_label_en-US" xlink:label="lab_holx_Purchaseofcostmethodinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of cost method investment</link:label>
    <link:label id="lab_holx_Purchaseofcostmethodinvestment_documentation_en-US" xlink:label="lab_holx_Purchaseofcostmethodinvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of cost method investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofcostmethodinvestment" xlink:href="holx-20200926.xsd#holx_Purchaseofcostmethodinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Purchaseofcostmethodinvestment" xlink:to="lab_holx_Purchaseofcostmethodinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtDiscountReallocatedUponDebtModification_8277260b-8ed2-450c-b253-6ad1f4f4e65f_terseLabel_en-US" xlink:label="lab_holx_DebtDiscountReallocatedUponDebtModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount reallocated upon debt modification</link:label>
    <link:label id="lab_holx_DebtDiscountReallocatedUponDebtModification_label_en-US" xlink:label="lab_holx_DebtDiscountReallocatedUponDebtModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Discount, Reallocated Upon Debt Modification</link:label>
    <link:label id="lab_holx_DebtDiscountReallocatedUponDebtModification_documentation_en-US" xlink:label="lab_holx_DebtDiscountReallocatedUponDebtModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Discount, Reallocated Upon Debt Modification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtDiscountReallocatedUponDebtModification" xlink:href="holx-20200926.xsd#holx_DebtDiscountReallocatedUponDebtModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtDiscountReallocatedUponDebtModification" xlink:to="lab_holx_DebtDiscountReallocatedUponDebtModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_38158734-404c-4d23-832d-732f97d8c027_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LegalAccrual_a0bd3bec-0b5d-4436-bd78-9cc776047f1f_terseLabel_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_label_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_documentation_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual" xlink:href="holx-20200926.xsd#holx_LegalAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LegalAccrual" xlink:to="lab_holx_LegalAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_11e4f028-c1e3-4da2-9309-eae308f93053_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears_10647e35-3ae7-46a6-8f46-70ed50d677ec_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2022</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Receivable, in Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_aac3bafe-d991-429e-875b-a32fab1c1e20_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_252bcfc1-24fb-4dac-8948-a4dcb0a6bd1c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a0d13022-2455-4b7d-a3dc-c6e4ce605987_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_529c38bb-e487-4bde-b3cc-2e0ca2a1372c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_c78b8942-ee63-4285-bf4e-3009948476f0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c8ab55bc-07d7-4790-99ce-22eedcb70e4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ad7fbba1-3127-4cfc-bc4b-7d42d13596aa_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_580ae8ae-dfff-4334-9c36-e2974d95ac7d_terseLabel_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition</link:label>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_label_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]</link:label>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_documentation_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:href="holx-20200926.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:to="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_adcff60b-0a12-48da-99b7-132c24fcfb5d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity and Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_6ca7b634-e237-48dd-a646-fbafc8eef620_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic production activities deduction</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_73928a10-cb43-4ff2-abbe-cfd77155a087_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at September 26, 2020 (1)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_ac00cbad-8425-4d36-ad1a-3915beb9fb4a_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired shares</link:label>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_label_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Shares Acquired</link:label>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_documentation_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Shares Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired" xlink:href="holx-20200926.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationSharesAcquired" xlink:to="lab_holx_BusinessCombinationSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CostMethodEquityInvestments_7c461736-f84c-4012-ace9-90dda4812a47_terseLabel_en-US" xlink:label="lab_holx_CostMethodEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost-method equity investments</link:label>
    <link:label id="lab_holx_CostMethodEquityInvestments_label_en-US" xlink:label="lab_holx_CostMethodEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Method Equity Investments</link:label>
    <link:label id="lab_holx_CostMethodEquityInvestments_documentation_en-US" xlink:label="lab_holx_CostMethodEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate carrying value of the Company's cost-method investments at the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostMethodEquityInvestments" xlink:href="holx-20200926.xsd#holx_CostMethodEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CostMethodEquityInvestments" xlink:to="lab_holx_CostMethodEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_2795aafe-ecdd-440c-bbd2-5841c902c5b1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_348fc5cd-311c-4453-bca1-48e28984a029_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repurchase of) Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:to="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_ebdbd423-2f02-4c7a-83c3-3968a859f9af_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_0ca36b99-f2c9-49a9-8c07-4a0d5fa7f48b_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_cbe2b2ec-c61e-4f6b-bcae-4e16aeac428f_terseLabel_en-US" xlink:label="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount with unlimited carry forward periods</link:label>
    <link:label id="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_label_en-US" xlink:label="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss And Tax Credit Carryforwards With Unlimited Expiration Period</link:label>
    <link:label id="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_documentation_en-US" xlink:label="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and tax credit carry forwards with unlimited expiration period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:href="holx-20200926.xsd#holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:to="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentHoldbackMember_1ef14627-da91-4037-88ab-d97d08dd753c_terseLabel_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_label_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback [Member]</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_documentation_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember" xlink:href="holx-20200926.xsd#holx_ContingentHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentHoldbackMember" xlink:to="lab_holx_ContingentHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentConsiderationMember_8cc657a6-af61-43ae-921e-2cdf4cb705e4_terseLabel_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_label_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration [Member]</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember" xlink:href="holx-20200926.xsd#holx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentConsiderationMember" xlink:to="lab_holx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_b3458dbc-856e-4092-b1cb-a725de035c6d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_310ff769-bdf5-4fdc-aa14-96a21929d212_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0584afe0-7ee1-4672-a028-f983a12d404d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_95a8c26b-8cea-4628-b978-5bbc78e14ecb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4a85e327-31b9-468a-b5b4-745e6bf5a276_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rates</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmendedCreditFacility2018Member_ce0ee4af-ddb6-42ad-b6fd-e4ac0da26f45_terseLabel_en-US" xlink:label="lab_holx_AmendedCreditFacility2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Amended Credit Facility</link:label>
    <link:label id="lab_holx_AmendedCreditFacility2018Member_label_en-US" xlink:label="lab_holx_AmendedCreditFacility2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Facility 2018 [Member]</link:label>
    <link:label id="lab_holx_AmendedCreditFacility2018Member_documentation_en-US" xlink:label="lab_holx_AmendedCreditFacility2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Facility 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedCreditFacility2018Member" xlink:href="holx-20200926.xsd#holx_AmendedCreditFacility2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedCreditFacility2018Member" xlink:to="lab_holx_AmendedCreditFacility2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NovemberEighteenTwoThousandTenOriginalNotesMember_d29f8573-d1e7-4bfb-95e9-1a3c642f85f9_terseLabel_en-US" xlink:label="lab_holx_NovemberEighteenTwoThousandTenOriginalNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 18, 2010 Original Notes</link:label>
    <link:label id="lab_holx_NovemberEighteenTwoThousandTenOriginalNotesMember_label_en-US" xlink:label="lab_holx_NovemberEighteenTwoThousandTenOriginalNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November Eighteen Two Thousand Ten Original Notes [Member]</link:label>
    <link:label id="lab_holx_NovemberEighteenTwoThousandTenOriginalNotesMember_documentation_en-US" xlink:label="lab_holx_NovemberEighteenTwoThousandTenOriginalNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November eighteen two thousand ten original notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NovemberEighteenTwoThousandTenOriginalNotesMember" xlink:href="holx-20200926.xsd#holx_NovemberEighteenTwoThousandTenOriginalNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NovemberEighteenTwoThousandTenOriginalNotesMember" xlink:to="lab_holx_NovemberEighteenTwoThousandTenOriginalNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e9498107-3f02-4112-8b89-101837192311_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share attributable to Hologic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_287e3d9d-736f-435a-9501-b7f994cdba11_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_a0ee4901-89d1-452b-bd1b-09a21a6c143b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_9f17c494-162f-4321-8c63-dc486c4644d3_terseLabel_en-US" xlink:label="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares that may be issued under Employee Stock Purchase Plan</link:label>
    <link:label id="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Issuable Under Employee Stock Purchase Plan</link:label>
    <link:label id="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issuable under employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:href="holx-20200926.xsd#holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:to="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_1a390bcf-496c-4b44-8d84-eec90c1bdb8f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments and non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3590c826-d42a-438e-ac32-ec2436897c6f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4b196f05-6671-45a1-86bc-3c4b89682200_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_10ba974d-bc3e-43bd-ac08-c9ad180ee0c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_be4fc9aa-f219-4f33-8587-d559d1ac1caf_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ae700f46-f3b5-436b-bae7-5d62c2989c19_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c26e2152-a865-4f9c-929c-3d9f645c2674_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_ff67f9cd-6d63-42b3-9913-fd99117c2638_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense on sublease rentals</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Sublease Rentals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_294e1ed5-f2ae-4507-9636-8b71584afe4e_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation (capital lease obligation in 2019)</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3958cf93-e9cb-42ce-b1fc-b9511cc38a68_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3573fa0e-2955-4b4f-b0f7-81c85c38946d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7ab19675-9eb3-4cb2-9a45-50fdb674f0cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f48e0f29-ae3f-4e78-9617-2258137669b3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FundingOfLoansToSSI_b1b6e914-0c2f-45d0-be00-6a4996406c9a_negatedTerseLabel_en-US" xlink:label="lab_holx_FundingOfLoansToSSI" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans to SSI</link:label>
    <link:label id="lab_holx_FundingOfLoansToSSI_label_en-US" xlink:label="lab_holx_FundingOfLoansToSSI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding Of Loans To SSI</link:label>
    <link:label id="lab_holx_FundingOfLoansToSSI_documentation_en-US" xlink:label="lab_holx_FundingOfLoansToSSI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans to SSI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FundingOfLoansToSSI" xlink:href="holx-20200926.xsd#holx_FundingOfLoansToSSI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FundingOfLoansToSSI" xlink:to="lab_holx_FundingOfLoansToSSI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_af616924-e6b0-4878-9161-1289c9c136ff_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ASRSharesRepurchasedduringtheperiod_82fc536b-ff1d-4f7c-9b65-8b31098ff193_terseLabel_en-US" xlink:label="lab_holx_ASRSharesRepurchasedduringtheperiod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Shares Repurchased during the period</link:label>
    <link:label id="lab_holx_ASRSharesRepurchasedduringtheperiod_label_en-US" xlink:label="lab_holx_ASRSharesRepurchasedduringtheperiod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Shares Repurchased during the period</link:label>
    <link:label id="lab_holx_ASRSharesRepurchasedduringtheperiod_documentation_en-US" xlink:label="lab_holx_ASRSharesRepurchasedduringtheperiod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Shares Repurchased during the period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRSharesRepurchasedduringtheperiod" xlink:href="holx-20200926.xsd#holx_ASRSharesRepurchasedduringtheperiod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ASRSharesRepurchasedduringtheperiod" xlink:to="lab_holx_ASRSharesRepurchasedduringtheperiod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_03a07351-bb72-4d0b-80a9-b7bbf6029739_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_ddc9804e-b2b8-4797-9134-584b08307a26_totalLabel_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign, Total</link:label>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_6a759a57-0d05-4d95-8f19-920dce3e623d_terseLabel_en-US" xlink:label="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum range of present value of cash flow (percent)</link:label>
    <link:label id="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_label_en-US" xlink:label="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Range of Present Value of Cash Flow Percentage</link:label>
    <link:label id="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_documentation_en-US" xlink:label="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Range of Present Value of Cash Flow Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:href="holx-20200926.xsd#holx_MaximumRangeofPresentValueofCashFlowPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:to="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_7db34566-b0a6-454c-a4ed-c63d7a6b692f_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of redemption price, fourth period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fourth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fourth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_69766ce3-dd1d-49f0-b5e4-40f3f8fba2c8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ac7b0ac6-92da-4cc5-be70-bf9ce5902afc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_e8ce21fd-19eb-42b7-8c35-00b56b8c8796_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_9e6994a9-ad15-46d1-9c5a-9d6a793ed218_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_207a99a4-06b1-4d46-99b5-bcb4638faf73_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmountpaidduringtheperiodunderASRAgreement_5192b5c0-2880-46a1-824e-d6526ff0e3d5_terseLabel_en-US" xlink:label="lab_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount paid during the period under ASR Agreement</link:label>
    <link:label id="lab_holx_AmountpaidduringtheperiodunderASRAgreement_label_en-US" xlink:label="lab_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount paid during the period under ASR Agreement</link:label>
    <link:label id="lab_holx_AmountpaidduringtheperiodunderASRAgreement_documentation_en-US" xlink:label="lab_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount paid during the period under ASR Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:href="holx-20200926.xsd#holx_AmountpaidduringtheperiodunderASRAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:to="lab_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TepnelMember_21569afd-f6fa-4270-a500-6d6e033b733b_terseLabel_en-US" xlink:label="lab_holx_TepnelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tepnel [Member]</link:label>
    <link:label id="lab_holx_TepnelMember_label_en-US" xlink:label="lab_holx_TepnelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tepnel [Member]</link:label>
    <link:label id="lab_holx_TepnelMember_documentation_en-US" xlink:label="lab_holx_TepnelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tepnel</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TepnelMember" xlink:href="holx-20200926.xsd#holx_TepnelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TepnelMember" xlink:to="lab_holx_TepnelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_fbed7075-10fa-4bc0-afa0-2caaa7ee83b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_16c3948a-d9b9-4399-b809-da33826e4fd1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Term Debt By Maturity Table</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a99cc6f5-2551-420d-8542-87430930086d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_cc9af00a-2060-4a00-9f1f-1951a07624f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_23499974-ec9f-40ac-a940-5fef86a18d01_totalLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_32410519-865f-4045-9436-c540e385357e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3bebcb6b-647c-4441-8d2d-7f67b826ab4d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2b641557-9c7b-4f63-8f90-ef1addd6b10c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from product and services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_13fc8ae7-05c6-43f9-a23d-1c359e2692f2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 28, 2019</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_58475e65-1967-4da6-9259-08b3fa841010_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7ef30d36-0ed7-4928-a67e-08db507a8313_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of&#160;Shares (in millions)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_17f6059d-89c2-4584-9273-a1db8156a62e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_dedde9e3-f06e-4dd3-956f-c6b0a0635634_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_242fb867-d6f6-44e7-8b8a-b8ae817945fa_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_eaddb691-3c20-4f77-946a-b6f9b5db853c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_99d63563-32fd-4494-b9f6-fa57824e2f1f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_bb1a953b-9787-456f-b679-22a2b9b6e7d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_aa204374-9f35-441a-987f-eb158a7331f2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_078a3ec1-c2e7-4c44-b334-1398949e1163_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in pension plans, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2013NotesMember_73cec705-fb0a-44ce-a522-5524123528f8_terseLabel_en-US" xlink:label="lab_holx_A2013NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Notes</link:label>
    <link:label id="lab_holx_A2013NotesMember_label_en-US" xlink:label="lab_holx_A2013NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Notes [Member]</link:label>
    <link:label id="lab_holx_A2013NotesMember_documentation_en-US" xlink:label="lab_holx_A2013NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2013NotesMember" xlink:href="holx-20200926.xsd#holx_A2013NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2013NotesMember" xlink:to="lab_holx_A2013NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_0747d224-bc5a-45bd-814c-e20aea19ea33_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_c29db36b-bf4d-436a-8ce5-9bbdf9185876_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2020ActionMember_283f7f0b-674f-4771-b90c-64c01907cd88_terseLabel_en-US" xlink:label="lab_holx_Fiscal2020ActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 Action</link:label>
    <link:label id="lab_holx_Fiscal2020ActionMember_label_en-US" xlink:label="lab_holx_Fiscal2020ActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 Action [Member]</link:label>
    <link:label id="lab_holx_Fiscal2020ActionMember_documentation_en-US" xlink:label="lab_holx_Fiscal2020ActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember" xlink:href="holx-20200926.xsd#holx_Fiscal2020ActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2020ActionMember" xlink:to="lab_holx_Fiscal2020ActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_55259afd-ed1c-426d-a4b4-a21a1e98cd59_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_eb176a80-8b9d-4383-a76e-06f0d9015746_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_15af40a0-d825-49dc-a203-44f2c2571075_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_65143cf4-19f2-431a-9a83-329658e8db40_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0c4f6add-e53b-4cc0-a09c-a521bf547fd1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_72ab2c76-f150-49ec-8be9-819df8882725_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_147bd0f2-baaa-4b8d-8234-bdb26f55b8b8_terseLabel_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cliff vesting period from grant date</link:label>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_label_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date</link:label>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_documentation_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:href="holx-20200926.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:to="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_f475a4ed-7375-4295-87f0-2e9fcddc1693_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_fe9125d7-92c8-453b-b2c8-975e7e25c5d8_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Impairmentofintangibleassetsandequipment_809fabb0-dca9-406c-87e6-5b0513ea2cfd_terseLabel_en-US" xlink:label="lab_holx_Impairmentofintangibleassetsandequipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_holx_Impairmentofintangibleassetsandequipment_label_en-US" xlink:label="lab_holx_Impairmentofintangibleassetsandequipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_holx_Impairmentofintangibleassetsandequipment_documentation_en-US" xlink:label="lab_holx_Impairmentofintangibleassetsandequipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Impairmentofintangibleassetsandequipment" xlink:href="holx-20200926.xsd#holx_Impairmentofintangibleassetsandequipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Impairmentofintangibleassetsandequipment" xlink:to="lab_holx_Impairmentofintangibleassetsandequipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_7ea53f19-3912-4657-a2e3-01256ed7ffd1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities (current)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7d9d7628-365e-4f34-95e1-e644a6deec9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Basic and Diluted Share Amounts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_e1198b2b-f954-4320-85c7-d93a7003e34e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit line</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_f267bc0c-7199-4b64-8c1d-682b1ddee86d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other temporary differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_dfe08c71-cc02-44b3-966d-21f98a6389f3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_ee2a30a4-cd19-413a-b57b-502268f107be_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a7871cb4-5d2e-427f-ba69-c3d47c2d63cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b3e6368b-4d39-4548-977b-1b56e1f980e5_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_c1898583-7d47-4202-a284-f90c6739d16b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_9035fe5e-594a-422b-840a-57972b6d26f3_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements/ Adjustments</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_ef679c62-6079-43eb-b9d7-2ab69df2d15c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest accrued on unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_437ae2e3-6375-4872-a172-496c0a19ecdc_terseLabel_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value (in millions)</link:label>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:href="holx-20200926.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d1ac7e2c-aefd-42b9-8379-8511ecf705fb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b175dff3-6e60-4c9d-8a7d-ab7b5713db3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_158deef3-6262-4361-8187-33c9123cfabc_terseLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to changes in unrecognized tax benefits recorded in the statement of operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:to="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_8c3f0412-9fbe-445b-a50e-00af2c98eb38_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2022SeniorNotesMember_91df948e-b3f7-4228-81e2-8aa3780e2064_terseLabel_en-US" xlink:label="lab_holx_A2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Senior Notes</link:label>
    <link:label id="lab_holx_A2022SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2022SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2022SeniorNotesMember" xlink:href="holx-20200926.xsd#holx_A2022SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2022SeniorNotesMember" xlink:to="lab_holx_A2022SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_372af81e-0aae-4f92-acda-369b125441cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable_856397a3-6229-47a4-8b02-d9485ad16c49_terseLabel_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Table]</link:label>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Table]</link:label>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable_documentation_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:href="holx-20200926.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:to="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2019ActionMember_7f94c723-8ae7-4067-9886-d28344a0027b_verboseLabel_en-US" xlink:label="lab_holx_Fiscal2019ActionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 Actions</link:label>
    <link:label id="lab_holx_Fiscal2019ActionMember_f652e2b4-5c1b-4fb2-9d61-2ecc6a8bd7d3_terseLabel_en-US" xlink:label="lab_holx_Fiscal2019ActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 Actions</link:label>
    <link:label id="lab_holx_Fiscal2019ActionMember_label_en-US" xlink:label="lab_holx_Fiscal2019ActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 Action [Member]</link:label>
    <link:label id="lab_holx_Fiscal2019ActionMember_documentation_en-US" xlink:label="lab_holx_Fiscal2019ActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 Action [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember" xlink:href="holx-20200926.xsd#holx_Fiscal2019ActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2019ActionMember" xlink:to="lab_holx_Fiscal2019ActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter_424efa3a-a0ef-46cb-aa72-dae5d1cd3e08_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Receivable, Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_803119cf-fe77-4e2e-8a4c-131181265507_terseLabel_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_documentation_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:to="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_614bf33c-c062-47d2-b09e-9402b90b1338_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_4501f6ef-12bf-4db8-a2e2-6436ab63766c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentOfContingentConsideration_8f8c04b1-f279-4e5e-be92-43aa2e2973f7_terseLabel_en-US" xlink:label="lab_holx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_holx_PaymentOfContingentConsideration_label_en-US" xlink:label="lab_holx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Contingent Consideration</link:label>
    <link:label id="lab_holx_PaymentOfContingentConsideration_documentation_en-US" xlink:label="lab_holx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the cash payment of contingent consideration to the former shareholders of the acquired company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentOfContingentConsideration" xlink:href="holx-20200926.xsd#holx_PaymentOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentOfContingentConsideration" xlink:to="lab_holx_PaymentOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NetOperatingLossCarryforwardsMember_07be04bd-229e-40ba-8eff-4e2d2530fd80_terseLabel_en-US" xlink:label="lab_holx_NetOperatingLossCarryforwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Losses Carryforwards</link:label>
    <link:label id="lab_holx_NetOperatingLossCarryforwardsMember_label_en-US" xlink:label="lab_holx_NetOperatingLossCarryforwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryforwards [Member]</link:label>
    <link:label id="lab_holx_NetOperatingLossCarryforwardsMember_documentation_en-US" xlink:label="lab_holx_NetOperatingLossCarryforwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryforwards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossCarryforwardsMember" xlink:href="holx-20200926.xsd#holx_NetOperatingLossCarryforwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NetOperatingLossCarryforwardsMember" xlink:to="lab_holx_NetOperatingLossCarryforwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e836dfc4-2f3b-48d7-8d39-f9d61e768b1e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at September 26, 2020 (1)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5b3a71bd-e34b-455a-944c-4cdb8beb8b3b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TaxPositionsRelatedToCurrentYearAbstract_9fdd158f-17a1-440c-9984-83a468f817a2_terseLabel_en-US" xlink:label="lab_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax positions related to current year:</link:label>
    <link:label id="lab_holx_TaxPositionsRelatedToCurrentYearAbstract_label_en-US" xlink:label="lab_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Positions Related To Current Year [Abstract]</link:label>
    <link:label id="lab_holx_TaxPositionsRelatedToCurrentYearAbstract_documentation_en-US" xlink:label="lab_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax positions related to current year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:href="holx-20200926.xsd#holx_TaxPositionsRelatedToCurrentYearAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:to="lab_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616_8aa43778-bf07-4f4d-a005-dbb16cbd0367_terseLabel_en-US" xlink:label="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to income tax expense adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616_label_en-US" xlink:label="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to income tax expense adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616_documentation_en-US" xlink:label="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to income tax expense adoption of ASU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:href="holx-20200926.xsd#holx_IncreasetoincometaxexpenseadoptionofASU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:to="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_adc85191-4387-43ea-8e43-cdd69ced0418_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Long Lived Assets Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Long Lived Assets Held-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:to="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c21546d4-e092-4a08-a597-829df7ca79fb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_30b645d1-69b7-4222-af17-ff654b6013f6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_8c380e71-d398-467f-8f85-4275a84d05be_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments on the Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_71a4cee6-d9ef-4fb0-be9b-8ee10534c7b3_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:to="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b826cb68-1b43-4973-94b2-aecb390e7406_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_8a26ed7c-ac5b-4cca-91ba-6250929c0fdb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_5fdaf560-6e67-49f2-a72e-5f404ec472eb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:to="lab_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_f39d7dfa-d6cc-4752-a2d0-8fc2c80d5635_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in-Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_a2fe1794-3792-4415-8758-1d8bf1a0eac7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_ca116468-5cf8-4946-8128-a6b45065b137_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss recognized in other comprehensive income (loss), net</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtIssuanceCostsReallocatedUponDebtModification_ca25e652-c784-43a8-a0e0-7bd8dd1ed1d8_terseLabel_en-US" xlink:label="lab_holx_DebtIssuanceCostsReallocatedUponDebtModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs reallocated upon debt modification</link:label>
    <link:label id="lab_holx_DebtIssuanceCostsReallocatedUponDebtModification_label_en-US" xlink:label="lab_holx_DebtIssuanceCostsReallocatedUponDebtModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Reallocated Upon Debt Modification</link:label>
    <link:label id="lab_holx_DebtIssuanceCostsReallocatedUponDebtModification_documentation_en-US" xlink:label="lab_holx_DebtIssuanceCostsReallocatedUponDebtModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Reallocated Upon Debt Modification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtIssuanceCostsReallocatedUponDebtModification" xlink:href="holx-20200926.xsd#holx_DebtIssuanceCostsReallocatedUponDebtModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtIssuanceCostsReallocatedUponDebtModification" xlink:to="lab_holx_DebtIssuanceCostsReallocatedUponDebtModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_74c205d3-63f4-40e8-ab49-cb6f24df2694_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in unrealized holding gains and losses on available-for-sale securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_55dde6f6-b9c2-4e74-a6ac-58c5353b8d72_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember_02f74134-c7e7-4d89-b990-c90fe508de48_terseLabel_en-US" xlink:label="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Semi Annual Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Semi Annual Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:href="holx-20200926.xsd#holx_SemiAnnualEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:to="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IndemnificationLiabily_3c9fc350-56e5-481d-a329-860b7fc08a2c_terseLabel_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:label id="lab_holx_IndemnificationLiabily_label_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:label id="lab_holx_IndemnificationLiabily_documentation_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily" xlink:href="holx-20200926.xsd#holx_IndemnificationLiabily"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IndemnificationLiabily" xlink:to="lab_holx_IndemnificationLiabily" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bac55331-8f8c-48d6-83a9-cf28219b2706_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent_72106a22-2822-4e76-a4ea-72e808d24563_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Expensesfromdisposition_4815b6da-d505-471e-8a43-b81e26425eb7_terseLabel_en-US" xlink:label="lab_holx_Expensesfromdisposition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from disposition</link:label>
    <link:label id="lab_holx_Expensesfromdisposition_label_en-US" xlink:label="lab_holx_Expensesfromdisposition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from disposition</link:label>
    <link:label id="lab_holx_Expensesfromdisposition_documentation_en-US" xlink:label="lab_holx_Expensesfromdisposition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from disposition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Expensesfromdisposition" xlink:href="holx-20200926.xsd#holx_Expensesfromdisposition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Expensesfromdisposition" xlink:to="lab_holx_Expensesfromdisposition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9346ff2e-6b71-48b5-8a46-2beef1f9b634_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_6ea28fa2-8997-4f0d-a90e-5839400ce26b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_ae9d1569-ebb5-42bc-8832-4829909c981b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_16d7ad91-e66c-4e94-a7db-c2b54beb3051_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for income tax uncertainties</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cce3272c-d6e6-41f2-b237-41c9a5de7cb4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_24d0dce6-c332-4098-8866-1c9f9e229c41_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_3892cf63-b7be-4a07-8b8b-ae8454fec8fa_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of accrued interest on Convertible Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5b7f0524-86a6-4307-b906-5f0b5da84f8b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_0d089780-08ba-4d84-ab59-efffa72471d3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a1f30ed2-0c39-4d0e-970c-4d4aac16d7ee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_e73fadcf-c7f0-441a-b406-15561f56bb21_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_097f20a5-26c5-479c-8f74-5b4d5e5afbd6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity of the Company's Unrecognized Income Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0384277d-e8b1-4797-acd3-d411f00bdbf9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1ab59fa7-066f-4b09-8bd5-7e136551c213_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_c90108e9-02f6-469a-8b0b-2c4164687ca0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_859c462e-e6f5-45b4-b875-ec6a3e558edc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_2bc4a348-39fe-4dcb-80af-2fc39f81e940_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Four Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4aabb2f8-fd02-407f-a1fe-116128243a1c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_9559f36c-6ea2-404e-89b4-5cf7ff2aafe1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and divestiture charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_637ef783-4322-4a08-a951-8edc357c465f_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_088181d9-637a-42ab-bdc8-c49d3f593b2e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_4cb1e5ca-4c25-4c9f-b0eb-06df02d206d9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_96fde810-1266-4571-bfda-73b2db16b0d4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost_c9437129-1012-439e-aa95-b249b8a65bc4_terseLabel_en-US" xlink:label="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost_label_en-US" xlink:label="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost, Interest cost</link:label>
    <link:label id="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost_documentation_en-US" xlink:label="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost, Interest cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:href="holx-20200926.xsd#holx_ComponentsofNetPeriodicBenefitCostInterestcost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:to="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EmployerContributionsVestingPeriod_fd2c7d94-5419-4a7d-9fc2-5ea689503c5e_terseLabel_en-US" xlink:label="lab_holx_EmployerContributionsVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions, vesting period, years</link:label>
    <link:label id="lab_holx_EmployerContributionsVestingPeriod_label_en-US" xlink:label="lab_holx_EmployerContributionsVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions Vesting Period</link:label>
    <link:label id="lab_holx_EmployerContributionsVestingPeriod_documentation_en-US" xlink:label="lab_holx_EmployerContributionsVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The vesting period for discretionary employer contributions, which vest ratably on an annual basis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsVestingPeriod" xlink:href="holx-20200926.xsd#holx_EmployerContributionsVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmployerContributionsVestingPeriod" xlink:to="lab_holx_EmployerContributionsVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_b0c027db-bd9e-46c5-ba2d-80304feda602_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_107d4659-e347-4c60-a9de-8cc1d8cebd96_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_98ea373c-b5f6-4c6f-a6c7-3dbf6b2a1548_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_e4f3f888-dca9-44ec-8444-3216d750cf83_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_33bb848d-bae1-40bd-b23b-a57994eba240_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_4dcd62d8-e35c-4fe2-8ef2-2a6a83de3393_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LybertyWayMember_69b5df03-5d2a-4cac-8381-3e9ea64b0d8d_terseLabel_en-US" xlink:label="lab_holx_LybertyWayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyberty Way [Member]</link:label>
    <link:label id="lab_holx_LybertyWayMember_label_en-US" xlink:label="lab_holx_LybertyWayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyberty Way [Member]</link:label>
    <link:label id="lab_holx_LybertyWayMember_documentation_en-US" xlink:label="lab_holx_LybertyWayMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyberty Way [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LybertyWayMember" xlink:href="holx-20200926.xsd#holx_LybertyWayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LybertyWayMember" xlink:to="lab_holx_LybertyWayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_ea8456c8-26b3-4260-aa80-91c681438a06_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_ba57cc76-15d4-4e52-b4ae-0b16d2fa3725_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#160;Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeverageRatioMaximum_deca1e57-71c2-4820-9138-c8aa27addfe5_terseLabel_en-US" xlink:label="lab_holx_LeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio maximum</link:label>
    <link:label id="lab_holx_LeverageRatioMaximum_label_en-US" xlink:label="lab_holx_LeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Maximum</link:label>
    <link:label id="lab_holx_LeverageRatioMaximum_documentation_en-US" xlink:label="lab_holx_LeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeverageRatioMaximum" xlink:href="holx-20200926.xsd#holx_LeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeverageRatioMaximum" xlink:to="lab_holx_LeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3be3fede-8f30-4619-ba8c-ca12e65a213b_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lapses in statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_eab86705-e8a5-4662-b262-aebcb34ef562_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_5f25b2a2-f99b-422a-a06f-034c2257341f_terseLabel_en-US" xlink:label="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Long-Term Liabilities</link:label>
    <link:label id="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_label_en-US" xlink:label="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Long Term Liabilities [Text Block]</link:label>
    <link:label id="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_documentation_en-US" xlink:label="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Long-Term Liabilities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:href="holx-20200926.xsd#holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:to="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_a1d704ac-2645-42b5-ab1a-85a80e111823_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_974a5c39-99d8-418c-a8eb-0882355293c2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at September 28, 2019</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cd9e9c4e-3baa-4c8c-be19-4fce88d7e199_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6794cf75-0363-40b5-bf15-f5db2ec2e5bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_4642eff8-c717-41e1-b67e-2919ded3ccae_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_c8de9768-0a1b-4383-b019-5f1d3023c32c_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_fa3d2a91-c4f9-47d2-b0c2-70e06f4ec13d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_2451dc52-7eb5-4996-98c7-8bd3e856634d_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_1507ff20-b0f8-4952-9e8b-aeca7702dde0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_3ff0c859-f5e5-44e7-b85f-613d2286a427_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_6cec942a-f1fe-44f1-a9f5-330435034b21_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_5244b569-ad96-4f4a-a0aa-1666d6dbea3e_terseLabel_en-US" xlink:label="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension in Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension in Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_documentation_en-US" xlink:label="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension in Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:href="holx-20200926.xsd#holx_PensioninAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_69be072d-c705-4fb6-ac3a-4793af914ca6_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_b2e77b16-a223-4557-bd22-5a6734629a19_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_e400665c-b0f3-43af-8994-15e1adc0e216_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges Taken Related to Accrued Restructuring Actions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2022NotesMember_39040f69-fc21-4486-b667-9c0f16d9d83a_terseLabel_en-US" xlink:label="lab_holx_A2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Senior Notes</link:label>
    <link:label id="lab_holx_A2022NotesMember_label_en-US" xlink:label="lab_holx_A2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Notes [Member]</link:label>
    <link:label id="lab_holx_A2022NotesMember_documentation_en-US" xlink:label="lab_holx_A2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2022NotesMember" xlink:href="holx-20200926.xsd#holx_A2022NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2022NotesMember" xlink:to="lab_holx_A2022NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FacilityClosureCosts_a48647ee-eb30-4c7b-84e9-20409e114a0e_terseLabel_en-US" xlink:label="lab_holx_FacilityClosureCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility closure costs</link:label>
    <link:label id="lab_holx_FacilityClosureCosts_label_en-US" xlink:label="lab_holx_FacilityClosureCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closure Costs</link:label>
    <link:label id="lab_holx_FacilityClosureCosts_documentation_en-US" xlink:label="lab_holx_FacilityClosureCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts" xlink:href="holx-20200926.xsd#holx_FacilityClosureCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FacilityClosureCosts" xlink:to="lab_holx_FacilityClosureCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c6a3e3b0-af32-47d5-a9df-8cc9fa1d8faa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_ff356205-3a38-4047-838e-b1202bebe00a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_47f1a001-121a-43a5-a939-97fe2de58e6b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost - amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_7c07eeac-eb4a-4822-8d25-7eff8559e792_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc82deb3-42f7-4358-a5f4-f9c0a96747ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_bf04f87d-d284-4d25-bf14-56070b8ac456_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2019chargesMember_57fa50b8-85a2-4506-9cb6-81e2c5f99f62_terseLabel_en-US" xlink:label="lab_holx_Fiscal2019chargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 charges:</link:label>
    <link:label id="lab_holx_Fiscal2019chargesMember_label_en-US" xlink:label="lab_holx_Fiscal2019chargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 charges [Member]</link:label>
    <link:label id="lab_holx_Fiscal2019chargesMember_documentation_en-US" xlink:label="lab_holx_Fiscal2019chargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember" xlink:href="holx-20200926.xsd#holx_Fiscal2019chargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2019chargesMember" xlink:to="lab_holx_Fiscal2019chargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_0dbcbc57-0797-42ea-91dc-6858869c66c5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TaxCreditCarryforwardMember_544b28d7-24c6-4a38-b87c-5ce58a92b098_terseLabel_en-US" xlink:label="lab_holx_TaxCreditCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward</link:label>
    <link:label id="lab_holx_TaxCreditCarryforwardMember_label_en-US" xlink:label="lab_holx_TaxCreditCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Member]</link:label>
    <link:label id="lab_holx_TaxCreditCarryforwardMember_documentation_en-US" xlink:label="lab_holx_TaxCreditCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxCreditCarryforwardMember" xlink:href="holx-20200926.xsd#holx_TaxCreditCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxCreditCarryforwardMember" xlink:to="lab_holx_TaxCreditCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8de4fbb9-7798-453c-bd6e-caa953073cf4_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c0378e2b-dfac-4299-93fa-0a8acb4e7aee_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_07ffcab6-6ef4-4bd0-93f6-3abd1d4517b8_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in unrecognized tax benefits is reasonably possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_4c4fbde7-7801-407b-8f09-617e4ea42f53_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RevolverMember_ab02f98e-958e-484f-9a59-b11456d1cd44_terseLabel_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver</link:label>
    <link:label id="lab_holx_RevolverMember_label_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:label id="lab_holx_RevolverMember_documentation_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember" xlink:href="holx-20200926.xsd#holx_RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevolverMember" xlink:to="lab_holx_RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_934231b7-e3ee-4937-aaf3-d89e4bcba683_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8b1cf9cb-1f74-4277-833f-a1cefd174466_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RemainingLeaseBalance_74c3b1fb-70ea-4619-9a75-c414f438bb90_terseLabel_en-US" xlink:label="lab_holx_RemainingLeaseBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease balance</link:label>
    <link:label id="lab_holx_RemainingLeaseBalance_label_en-US" xlink:label="lab_holx_RemainingLeaseBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease balance</link:label>
    <link:label id="lab_holx_RemainingLeaseBalance_documentation_en-US" xlink:label="lab_holx_RemainingLeaseBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RemainingLeaseBalance" xlink:href="holx-20200926.xsd#holx_RemainingLeaseBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RemainingLeaseBalance" xlink:to="lab_holx_RemainingLeaseBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_f28eb1ad-58a3-4dbf-b402-e1a0446a0b60_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_d6569e63-8450-44d3-bd6f-a4fb9b8376be_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Software Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e70c30c3-092a-4d5b-96df-23051c72d446_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_267dcb39-89b4-4929-a904-ce339779c8a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:to="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GoodwillNotAtRiskOfFailingImpairment_9d7e2685-ceb6-4078-aafc-c330870fe9a0_terseLabel_en-US" xlink:label="lab_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill not at risk of failing impairment</link:label>
    <link:label id="lab_holx_GoodwillNotAtRiskOfFailingImpairment_label_en-US" xlink:label="lab_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill not at risk of failing impairment</link:label>
    <link:label id="lab_holx_GoodwillNotAtRiskOfFailingImpairment_documentation_en-US" xlink:label="lab_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill not at risk of failing impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:href="holx-20200926.xsd#holx_GoodwillNotAtRiskOfFailingImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:to="lab_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_65f53b33-9041-4238-be6e-507af54adbc9_terseLabel_en-US" xlink:label="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers with balance greater than specified percentage</link:label>
    <link:label id="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_label_en-US" xlink:label="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customers With Balance Greater Than Specified Percentage</link:label>
    <link:label id="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_documentation_en-US" xlink:label="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers with balance greater than specified percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:href="holx-20200926.xsd#holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:to="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_6d4fe0f2-94bc-4c95-aa89-89a0d837e06f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_df51588c-4084-423d-8aec-114235b1c880_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_ff1e9655-ffaf-4575-9829-2b43b9754014_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_48033b9d-b458-444f-9e9a-7ec535322aaf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_da7d61a7-a0e9-4d82-be7f-b6641ad538ca_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_91776c95-cd24-473a-afbc-975b3bb901c3_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet_f088b7c3-eb8b-4506-b214-b058391f7e03_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible assets and liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets And Liabilities, Net</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets And Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherAssetsPolicyPolicyTextBlock_5864f41d-e0e8-4852-94c8-826a9da0a591_terseLabel_en-US" xlink:label="lab_holx_OtherAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_holx_OtherAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_OtherAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Policy [Policy Text Block]</link:label>
    <link:label id="lab_holx_OtherAssetsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_OtherAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Policy [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherAssetsPolicyPolicyTextBlock" xlink:href="holx-20200926.xsd#holx_OtherAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherAssetsPolicyPolicyTextBlock" xlink:to="lab_holx_OtherAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareRepurchseAuthorizationDateAxis_a93ccc39-671b-4f73-bb1e-0e3f4a744638_terseLabel_en-US" xlink:label="lab_holx_ShareRepurchseAuthorizationDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchse Authorization Date [Axis]</link:label>
    <link:label id="lab_holx_ShareRepurchseAuthorizationDateAxis_label_en-US" xlink:label="lab_holx_ShareRepurchseAuthorizationDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchse Authorization Date [Axis]</link:label>
    <link:label id="lab_holx_ShareRepurchseAuthorizationDateAxis_documentation_en-US" xlink:label="lab_holx_ShareRepurchseAuthorizationDateAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Authorization Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchseAuthorizationDateAxis" xlink:href="holx-20200926.xsd#holx_ShareRepurchseAuthorizationDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis" xlink:to="lab_holx_ShareRepurchseAuthorizationDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_896f7ed0-29cb-4165-a26d-db53f31d9373_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/ forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_8fc77d53-42ab-4da0-9f33-71f889d7950c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock under employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_a3f1bc5a-17ee-4ff7-b470-54d50ab9934f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_386d1f26-7586-49d0-8a21-3415532224e6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-competition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7f842e4a-ad27-4330-8f78-d9fa7f976aea_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TwoThousandSeventeenMember_64df6c8f-6459-40c9-9d38-74478a46ba8c_terseLabel_en-US" xlink:label="lab_holx_TwoThousandSeventeenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2017 charges:</link:label>
    <link:label id="lab_holx_TwoThousandSeventeenMember_label_en-US" xlink:label="lab_holx_TwoThousandSeventeenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen [Member]</link:label>
    <link:label id="lab_holx_TwoThousandSeventeenMember_documentation_en-US" xlink:label="lab_holx_TwoThousandSeventeenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSeventeenMember" xlink:href="holx-20200926.xsd#holx_TwoThousandSeventeenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwoThousandSeventeenMember" xlink:to="lab_holx_TwoThousandSeventeenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_a4bcf8b1-2cab-4655-8f70-d44d6a3d6abb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares related to:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_fd058b4f-1710-441e-8432-cde907fbf526_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_19ecbba6-75ef-4c75-bc5f-193081ff71aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_f7318219-fb85-4b0c-8a7b-471c1e2d27cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DivestitureCharges_f7c7c737-7e6c-4d52-a643-e87c2051888b_terseLabel_en-US" xlink:label="lab_holx_DivestitureCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture charges</link:label>
    <link:label id="lab_holx_DivestitureCharges_label_en-US" xlink:label="lab_holx_DivestitureCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture charges</link:label>
    <link:label id="lab_holx_DivestitureCharges_documentation_en-US" xlink:label="lab_holx_DivestitureCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges" xlink:href="holx-20200926.xsd#holx_DivestitureCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DivestitureCharges" xlink:to="lab_holx_DivestitureCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_30ec2b9b-85b3-47e5-9e93-f73072e9d837_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_36988d77-64bb-4a14-b19c-232c0be4c346_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f0dee4ce-d38b-4b5f-bd2f-5784e6370c13_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_848b742b-dcbd-4905-af1f-ca1bae8abbf4_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7491762c-a1a1-409b-8af3-be7250df2d06_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant-Date&#160;Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_8e2458ce-622b-43d9-8012-2d6749a260bb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f28406af-c3ee-438e-be88-f63c52a37897_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Hologic's stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_1af0749d-e36d-4415-b06f-57a64c42b690_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_dd828e1c-6601-4ef3-8a4e-1f127179d21f_negatedLabel_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation&#160;and amortization</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_label_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Depreciation And Amortization</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount as of the balance sheet date of the estimated future tax effects attributable to amortization of intangible assets, and to a lesser extent, depreciation of property and equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:href="holx-20200926.xsd#holx_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OfferingPriceofPrincipalAmount_69a691bd-7075-4dc2-9717-7a4c4bc866ee_terseLabel_en-US" xlink:label="lab_holx_OfferingPriceofPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering price of principal amount</link:label>
    <link:label id="lab_holx_OfferingPriceofPrincipalAmount_label_en-US" xlink:label="lab_holx_OfferingPriceofPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering Price of Principal Amount</link:label>
    <link:label id="lab_holx_OfferingPriceofPrincipalAmount_documentation_en-US" xlink:label="lab_holx_OfferingPriceofPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering Price of Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OfferingPriceofPrincipalAmount" xlink:href="holx-20200926.xsd#holx_OfferingPriceofPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OfferingPriceofPrincipalAmount" xlink:to="lab_holx_OfferingPriceofPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bbcdf27c-4556-4f2d-80aa-869f4a417c17_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_09f587f4-ad81-44b8-9b70-87a056266404_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LitigationAndOtherMattersTextBlock_512514d3-0dd5-49ca-a03a-165dfc9579a4_terseLabel_en-US" xlink:label="lab_holx_LitigationAndOtherMattersTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Related Matters</link:label>
    <link:label id="lab_holx_LitigationAndOtherMattersTextBlock_label_en-US" xlink:label="lab_holx_LitigationAndOtherMattersTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation And Other Matters [Text Block]</link:label>
    <link:label id="lab_holx_LitigationAndOtherMattersTextBlock_documentation_en-US" xlink:label="lab_holx_LitigationAndOtherMattersTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation And Other Matters [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LitigationAndOtherMattersTextBlock" xlink:href="holx-20200926.xsd#holx_LitigationAndOtherMattersTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LitigationAndOtherMattersTextBlock" xlink:to="lab_holx_LitigationAndOtherMattersTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_075a57bf-b207-4e22-9561-2c1fe97e7504_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_a96c1d09-fb7c-4f95-b6c4-fd69916bd446_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_1bfd86a4-d78d-448b-b02d-962d5176e236_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_082686e6-0057-4603-9dea-395af6407fbc_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_33242725-0389-4925-930e-790a4a996eee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e8421aaf-8847-4543-ac4b-cbaa032bacce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableReserveDivested_ad52c8f4-9c12-474e-84b5-6eac45375384_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableReserveDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable reserve divested</link:label>
    <link:label id="lab_holx_AccountsReceivableReserveDivested_label_en-US" xlink:label="lab_holx_AccountsReceivableReserveDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable reserve divested</link:label>
    <link:label id="lab_holx_AccountsReceivableReserveDivested_documentation_en-US" xlink:label="lab_holx_AccountsReceivableReserveDivested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable reserve divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableReserveDivested" xlink:href="holx-20200926.xsd#holx_AccountsReceivableReserveDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableReserveDivested" xlink:to="lab_holx_AccountsReceivableReserveDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_83dd604e-9fc1-48a0-b317-f5ec1d73eb05_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_039ffffa-f247-41c4-86c1-fcc28418a1f1_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_6b7dac06-5ccc-40b8-9050-3fda43aec7a6_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_dc7cb7ff-541a-4918-a53a-972e68ce379e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_50ac5417-b82e-4a83-80e6-ee1b6b3e01dd_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_2d25cc5a-6d67-4944-89d8-6b9866489d55_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember_a88dd209-86e8-4fa1-ac60-f60814ef341a_terseLabel_en-US" xlink:label="lab_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 14, 2013 Original Notes</link:label>
    <link:label id="lab_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember_label_en-US" xlink:label="lab_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February Fourteen Two Thousand And Thirteen Original Notes [Member]</link:label>
    <link:label id="lab_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember_documentation_en-US" xlink:label="lab_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February fourteen two thousand and thirteen original notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember" xlink:href="holx-20200926.xsd#holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember" xlink:to="lab_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalizedsoftwareMember_22351ca2-8ec3-4835-8a51-2578c9a4bd19_terseLabel_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_label_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember" xlink:href="holx-20200926.xsd#holx_CapitalizedsoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalizedsoftwareMember" xlink:to="lab_holx_CapitalizedsoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_8432241f-8868-4ae3-85f3-57c2aff11431_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_fadb65c6-4af0-4040-af81-d8d1a04a37be_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_ce174014-203b-4a96-b995-4d85fa904097_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_4ee46b81-f5cf-49ee-9aff-099bf24af32e_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ef5f49bb-a8cb-4d37-9a67-8c85f8134c68_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_74a4b0d3-143b-46f4-9e85-d0153dd633c8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued_d89f3b4e-1fa8-48f9-9de5-de39ce88b0b7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_e5f94a07-e3bd-4fee-bc3f-5adf215fa74a_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life insurance contracts</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_aa268abb-5a38-48ad-a6da-2cccf64efe47_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in pension plans, net of taxes of $0.1 in 2020, $0.3 in 2019, and $(0.6) in 2018</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_196e78ff-d0d0-4933-bf89-45cffbe188b3_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to minimum pension liability, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_bdebf487-b2eb-4c84-ad90-46e194ba7c2a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_c1875ef5-ad96-4aa9-bc12-4de12ba4bb9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_fadbc7d1-41d6-4bfa-9b25-91bb7642fd24_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_49bfaa10-7236-4544-8072-919256b2abaf_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_45719f89-8d16-4a6c-9b50-c924756adc80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CashEquivalentsMaturityPeriod_bcccb127-bf59-489a-81a7-4494b9b22bf4_terseLabel_en-US" xlink:label="lab_holx_CashEquivalentsMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Maturity Period</link:label>
    <link:label id="lab_holx_CashEquivalentsMaturityPeriod_label_en-US" xlink:label="lab_holx_CashEquivalentsMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Maturity Period</link:label>
    <link:label id="lab_holx_CashEquivalentsMaturityPeriod_documentation_en-US" xlink:label="lab_holx_CashEquivalentsMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of time from the date of acquisition for liquid investments in debt securities to be categorized as cash in the consolidated balance sheet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashEquivalentsMaturityPeriod" xlink:href="holx-20200926.xsd#holx_CashEquivalentsMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CashEquivalentsMaturityPeriod" xlink:to="lab_holx_CashEquivalentsMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_3a30d304-93f2-4b82-a16b-58d1c714c460_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_d658ea00-5498-4003-acf2-10cd48720484_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2086f978-5607-4d89-8cfc-4bad75984a4e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ff8d6724-7a67-4701-bafe-ba8068e45bcb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Dec112019Member_cb335d8a-8b7e-47e8-a59e-dffb1d928de4_terseLabel_en-US" xlink:label="lab_holx_Dec112019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dec 11, 2019 [Member]</link:label>
    <link:label id="lab_holx_Dec112019Member_label_en-US" xlink:label="lab_holx_Dec112019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dec 11, 2019 [Member]</link:label>
    <link:label id="lab_holx_Dec112019Member_documentation_en-US" xlink:label="lab_holx_Dec112019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dec 11, 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Dec112019Member" xlink:href="holx-20200926.xsd#holx_Dec112019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Dec112019Member" xlink:to="lab_holx_Dec112019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_61f6790a-f0d3-46ae-8b2d-07ab85e1f2c8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_1df9acb0-819e-4be9-a576-eaa801fbf34d_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_8770852e-c769-4469-ab52-e5426c5cebd1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReceivable" xlink:to="lab_us-gaap_IncomeTaxReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_1ac10383-6a69-4bca-8db1-463f93ebb241_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Benefit Obligations, Plan Assets, Funded Status and Related Actuarial Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_99ef82f1-3a35-4795-a1b0-b5136da837c2_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, gross</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermLoan2017Member_84867358-b10d-4264-9ed4-efb35d107de3_terseLabel_en-US" xlink:label="lab_holx_TermLoan2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Term Loan</link:label>
    <link:label id="lab_holx_TermLoan2017Member_label_en-US" xlink:label="lab_holx_TermLoan2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan 2017 [Member]</link:label>
    <link:label id="lab_holx_TermLoan2017Member_documentation_en-US" xlink:label="lab_holx_TermLoan2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoan2017Member" xlink:href="holx-20200926.xsd#holx_TermLoan2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermLoan2017Member" xlink:to="lab_holx_TermLoan2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_a74343fa-07c3-406b-a844-3d714ce44019_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_5d735e25-d6fb-4282-9d46-069340543c6a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_60fc274e-e944-4aa4-af40-4c7ce71c421c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_c3c004d6-ecba-432e-aaa9-6a4917047f8c_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion allocable to equity method investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears_99b0b856-c2c2-4f49-b4d1-eaf5188ae7af_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Receivable, in Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_2a46d526-c431-46c3-98c9-6526a1ed2367_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership of outstanding shares (as a percent)</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_label_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_documentation_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage" xlink:href="holx-20200926.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationOwnershipPercentage" xlink:to="lab_holx_BusinessCombinationOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_248bef41-3d61-4adc-ad55-00dbb4104a97_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_2d7b6043-e51a-404d-abe9-4fe152197e2b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_StateLossCarryforwardExpectedToUnutilize_4140b66e-a56e-4399-b79e-76f29cb85285_terseLabel_en-US" xlink:label="lab_holx_StateLossCarryforwardExpectedToUnutilize" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">state loss carryforward expected to unutilize</link:label>
    <link:label id="lab_holx_StateLossCarryforwardExpectedToUnutilize_label_en-US" xlink:label="lab_holx_StateLossCarryforwardExpectedToUnutilize" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">state loss carryforward expected to unutilize</link:label>
    <link:label id="lab_holx_StateLossCarryforwardExpectedToUnutilize_documentation_en-US" xlink:label="lab_holx_StateLossCarryforwardExpectedToUnutilize" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">state loss carryforward expected to unutilize</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_StateLossCarryforwardExpectedToUnutilize" xlink:href="holx-20200926.xsd#holx_StateLossCarryforwardExpectedToUnutilize"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_StateLossCarryforwardExpectedToUnutilize" xlink:to="lab_holx_StateLossCarryforwardExpectedToUnutilize" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmendedTermLoan2018Member_0aacd71d-fb89-41ba-81ad-52950336ea57_terseLabel_en-US" xlink:label="lab_holx_AmendedTermLoan2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Amended Term Loan</link:label>
    <link:label id="lab_holx_AmendedTermLoan2018Member_label_en-US" xlink:label="lab_holx_AmendedTermLoan2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan 2018 [Member]</link:label>
    <link:label id="lab_holx_AmendedTermLoan2018Member_documentation_en-US" xlink:label="lab_holx_AmendedTermLoan2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoan2018Member" xlink:href="holx-20200926.xsd#holx_AmendedTermLoan2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedTermLoan2018Member" xlink:to="lab_holx_AmendedTermLoan2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_40b252da-f0ec-48e5-bef6-356f88125f0c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>holx-20200926_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f4bb5493-eda8-449d-a170-7314862f7798,g:08da96e9-86db-4711-b125-e777b2cffbcd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20200926.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fa250c4a-2183-4073-b8cf-55b6a3b5b7b0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_DocumentType_fa250c4a-2183-4073-b8cf-55b6a3b5b7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_b79220bf-f500-4aec-86de-35e782d64804" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_DocumentAnnualReport_b79220bf-f500-4aec-86de-35e782d64804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1daffe8a-4839-4971-b4eb-ad8ef4625538" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_DocumentPeriodEndDate_1daffe8a-4839-4971-b4eb-ad8ef4625538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_3875322d-95ec-4827-a7b1-a56b7098575c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_DocumentTransitionReport_3875322d-95ec-4827-a7b1-a56b7098575c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_031f7f83-7cbe-4fba-8178-bb178f7b2adc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityFileNumber_031f7f83-7cbe-4fba-8178-bb178f7b2adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_75fcaee4-3629-4194-84bf-0c4c38f00e7d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityRegistrantName_75fcaee4-3629-4194-84bf-0c4c38f00e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_85ede868-dd1c-4e7d-92ed-f254adc39fdd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityCentralIndexKey_85ede868-dd1c-4e7d-92ed-f254adc39fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_87318ac9-b1aa-461b-8f6f-fc86a7bb51a4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_CurrentFiscalYearEndDate_87318ac9-b1aa-461b-8f6f-fc86a7bb51a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_91033452-f1bb-40b7-9d8a-98da9d0b9799" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_DocumentFiscalYearFocus_91033452-f1bb-40b7-9d8a-98da9d0b9799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d70edbd7-14cc-486c-9051-df296ab86005" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d70edbd7-14cc-486c-9051-df296ab86005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e4d80d23-a746-4a8a-9db7-8275ccd01cdd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_AmendmentFlag_e4d80d23-a746-4a8a-9db7-8275ccd01cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_de49c49a-bb70-40be-987e-f6895df9c2c6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityIncorporationStateCountryCode_de49c49a-bb70-40be-987e-f6895df9c2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f10ca879-36d6-4d22-9b20-7db7e72f9fd0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityTaxIdentificationNumber_f10ca879-36d6-4d22-9b20-7db7e72f9fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_75d85d23-2602-4a67-94e3-d59fe69e922f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityAddressAddressLine1_75d85d23-2602-4a67-94e3-d59fe69e922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_23027cb4-16b5-4773-b375-b68788652af6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityAddressCityOrTown_23027cb4-16b5-4773-b375-b68788652af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_15f1b062-0fb3-4524-9494-279c669cd08f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityAddressStateOrProvince_15f1b062-0fb3-4524-9494-279c669cd08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4d17dde7-fe83-4c22-8ffd-54a82c0e171f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityAddressPostalZipCode_4d17dde7-fe83-4c22-8ffd-54a82c0e171f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e550d0d2-ac6f-4d7c-92fd-fe41c7e0872a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_CityAreaCode_e550d0d2-ac6f-4d7c-92fd-fe41c7e0872a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_503a8191-f739-45ef-9b32-90d496b970e5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_LocalPhoneNumber_503a8191-f739-45ef-9b32-90d496b970e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_eb85f7d0-3d01-4724-9f39-973c3aa9765b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_Security12bTitle_eb85f7d0-3d01-4724-9f39-973c3aa9765b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6bdb6ea0-a75c-48d6-8165-8f4071608d0e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_TradingSymbol_6bdb6ea0-a75c-48d6-8165-8f4071608d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_0704cbed-cbe8-483e-85cd-a1b378cf5b96" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_SecurityExchangeName_0704cbed-cbe8-483e-85cd-a1b378cf5b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_d7f29916-1a01-4a42-8bcf-554c83869e7c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_d7f29916-1a01-4a42-8bcf-554c83869e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_8ce2e576-8263-4ca1-9a65-8360e936d0bf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityVoluntaryFilers_8ce2e576-8263-4ca1-9a65-8360e936d0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_dd45defd-ce64-4596-aed8-f31c36f147c4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityCurrentReportingStatus_dd45defd-ce64-4596-aed8-f31c36f147c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_527cb1aa-9f81-4716-a26e-f32a6817ed1a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityInteractiveDataCurrent_527cb1aa-9f81-4716-a26e-f32a6817ed1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_22b37907-4d17-4f5e-9073-f56eb6aa9072" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityFilerCategory_22b37907-4d17-4f5e-9073-f56eb6aa9072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_13268add-eb92-40e8-8431-cfa979bada63" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntitySmallBusiness_13268add-eb92-40e8-8431-cfa979bada63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_14204ddf-f1a8-4262-abe1-5785b0ba33c9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityEmergingGrowthCompany_14204ddf-f1a8-4262-abe1-5785b0ba33c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_bbb17f64-37cd-4306-af7b-48c3bf76dc08" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_IcfrAuditorAttestationFlag_bbb17f64-37cd-4306-af7b-48c3bf76dc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6b9919d7-db40-4c8f-ad03-d72b7860fcef" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityShellCompany_6b9919d7-db40-4c8f-ad03-d72b7860fcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_3ac3ea16-9f90-4caf-b3b9-ee866ff55ae0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityPublicFloat_3ac3ea16-9f90-4caf-b3b9-ee866ff55ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9df42ea4-3985-4fe2-bd6e-924a6c3e5125" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9df42ea4-3985-4fe2-bd6e-924a6c3e5125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_aba376e8-aed8-4363-9c91-396a1479bdd0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ad12c10-c9af-466a-99d4-cfcf83c7ee89" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_aba376e8-aed8-4363-9c91-396a1479bdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_2803ff1d-cadb-4e1e-bbf3-42163a9c375e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_359e321b-9046-4ec5-8611-fbccd0accf1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2803ff1d-cadb-4e1e-bbf3-42163a9c375e" xlink:to="loc_us-gaap_StatementTable_359e321b-9046-4ec5-8611-fbccd0accf1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b4f78db2-c635-4843-80d1-3f60bad6b0b6" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_359e321b-9046-4ec5-8611-fbccd0accf1b" xlink:to="loc_srt_ProductOrServiceAxis_b4f78db2-c635-4843-80d1-3f60bad6b0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4d76dbad-e50a-44c9-b96c-247c23007488" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b4f78db2-c635-4843-80d1-3f60bad6b0b6" xlink:to="loc_srt_ProductsAndServicesDomain_4d76dbad-e50a-44c9-b96c-247c23007488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_6c5b99b6-9a67-437a-b8ce-af02cd1bee96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4d76dbad-e50a-44c9-b96c-247c23007488" xlink:to="loc_us-gaap_ProductMember_6c5b99b6-9a67-437a-b8ce-af02cd1bee96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ba1024a2-e1c5-4353-ba87-8bb503b80361" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4d76dbad-e50a-44c9-b96c-247c23007488" xlink:to="loc_us-gaap_ServiceMember_ba1024a2-e1c5-4353-ba87-8bb503b80361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_359e321b-9046-4ec5-8611-fbccd0accf1b" xlink:to="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6eeef100-6930-409a-9945-ef37690d314e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_RevenuesAbstract_6eeef100-6930-409a-9945-ef37690d314e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_52ea6660-d02a-460b-a01e-d26c42298d58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_6eeef100-6930-409a-9945-ef37690d314e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_52ea6660-d02a-460b-a01e-d26c42298d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_55e7f84f-16fd-45e4-8724-a13c5da7ebda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_55e7f84f-16fd-45e4-8724-a13c5da7ebda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_4edd962d-172a-4fb4-98b2-d6dff65c74bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_4edd962d-172a-4fb4-98b2-d6dff65c74bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_f0f20764-cade-4b2a-92b3-62e5af28f8d0" xlink:href="holx-20200926.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_db44a6c0-a9cc-44b9-ab2c-21333ba0f3b1" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_f0f20764-cade-4b2a-92b3-62e5af28f8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b0a4d93d-48cb-45da-a8f8-317f536ed57e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_GrossProfit_b0a4d93d-48cb-45da-a8f8-317f536ed57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_fba1b65a-2669-418e-b6b9-67ab5f3bc0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_fba1b65a-2669-418e-b6b9-67ab5f3bc0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_ece72044-f5a5-4d61-85b9-d32a45466a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_SellingAndMarketingExpense_ece72044-f5a5-4d61-85b9-d32a45466a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_448c5bd6-17ac-4477-94bf-ae5009f3da9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_448c5bd6-17ac-4477-94bf-ae5009f3da9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a08f0ba6-bd98-4364-999e-bc7cebab8357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a08f0ba6-bd98-4364-999e-bc7cebab8357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1223471d-21e1-4558-864e-5fd1e1419e74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1223471d-21e1-4558-864e-5fd1e1419e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_96e890f4-0a6f-44cf-ac3a-0c4a57ffafac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_96e890f4-0a6f-44cf-ac3a-0c4a57ffafac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_31f57ba0-17f4-4a4d-895a-2286c36496c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_RestructuringCharges_31f57ba0-17f4-4a4d-895a-2286c36496c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4f188a8a-b02f-45b3-8dfa-3d14cacf23ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1e3bebfb-55da-4ea3-937e-7b98ea5f70e2" xlink:to="loc_us-gaap_OperatingExpenses_4f188a8a-b02f-45b3-8dfa-3d14cacf23ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4b204674-8175-4fbf-bca5-0d112d7a0f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_OperatingIncomeLoss_4b204674-8175-4fbf-bca5-0d112d7a0f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5fd7c1b5-8306-4874-84aa-9b59ca26d884" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5fd7c1b5-8306-4874-84aa-9b59ca26d884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_da049c53-33b8-453b-b662-5ab2455bd1d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_InterestExpense_da049c53-33b8-453b-b662-5ab2455bd1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_45ddcbc7-8ebf-426e-995e-d7e3aeaf306a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_45ddcbc7-8ebf-426e-995e-d7e3aeaf306a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0b099381-9b4d-44e2-854f-c284c275de2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0b099381-9b4d-44e2-854f-c284c275de2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_268b3964-4362-4dee-8f52-6e22d9612a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_268b3964-4362-4dee-8f52-6e22d9612a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_37e8f305-9bf5-4a94-98a6-25d5761f29ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_37e8f305-9bf5-4a94-98a6-25d5761f29ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_535e0023-cc4d-4560-bd3a-1dbac2a641cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_ProfitLoss_535e0023-cc4d-4560-bd3a-1dbac2a641cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_a8597b93-3d18-4827-9006-f4d749ef753d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_a8597b93-3d18-4827-9006-f4d749ef753d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b6323cb-40b2-4842-b494-83f9d04c55fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_NetIncomeLoss_1b6323cb-40b2-4842-b494-83f9d04c55fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8e92581d-01e4-43f7-9d29-5796185395cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8e92581d-01e4-43f7-9d29-5796185395cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_42a4ea63-1ab9-43ff-872d-19affb8fde86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8e92581d-01e4-43f7-9d29-5796185395cf" xlink:to="loc_us-gaap_EarningsPerShareBasic_42a4ea63-1ab9-43ff-872d-19affb8fde86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4a237dea-d3b1-49ff-b876-bf956ed909d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8e92581d-01e4-43f7-9d29-5796185395cf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4a237dea-d3b1-49ff-b876-bf956ed909d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7761d3a7-58a4-4960-a3e1-cb89b7c5471f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2c314a9-07ae-4ad8-91e9-f871ccbd7016" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7761d3a7-58a4-4960-a3e1-cb89b7c5471f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_450dd8a3-f0db-4369-b75c-bac5977485c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7761d3a7-58a4-4960-a3e1-cb89b7c5471f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_450dd8a3-f0db-4369-b75c-bac5977485c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80526d37-6b5d-4ffa-8ab1-ad394eb0ddd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7761d3a7-58a4-4960-a3e1-cb89b7c5471f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80526d37-6b5d-4ffa-8ab1-ad394eb0ddd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e65d09e-b93a-47e8-a3a8-c1fe9022d179" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2b8c965a-56d8-401f-8191-d6a59b8693a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e65d09e-b93a-47e8-a3a8-c1fe9022d179" xlink:to="loc_us-gaap_StatementTable_2b8c965a-56d8-401f-8191-d6a59b8693a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_df795111-b1f1-414c-9ff3-265d93388c43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2b8c965a-56d8-401f-8191-d6a59b8693a9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_df795111-b1f1-414c-9ff3-265d93388c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4c4c90e6-2857-43d7-8de0-8ccb7d927063" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_df795111-b1f1-414c-9ff3-265d93388c43" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4c4c90e6-2857-43d7-8de0-8ccb7d927063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_1cfd5d08-a608-4e70-9c2c-311152999809" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4c4c90e6-2857-43d7-8de0-8ccb7d927063" xlink:to="loc_us-gaap_InterestRateCapMember_1cfd5d08-a608-4e70-9c2c-311152999809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e4a0a179-7257-4009-86b8-579d1dcda53c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2b8c965a-56d8-401f-8191-d6a59b8693a9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e4a0a179-7257-4009-86b8-579d1dcda53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e3450d2f-70ae-4e22-bff0-9865577cbf80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e4a0a179-7257-4009-86b8-579d1dcda53c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e3450d2f-70ae-4e22-bff0-9865577cbf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_07074539-d4e5-4876-8c43-db68f3147341" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e3450d2f-70ae-4e22-bff0-9865577cbf80" xlink:to="loc_us-gaap_InterestRateSwapMember_07074539-d4e5-4876-8c43-db68f3147341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2b8c965a-56d8-401f-8191-d6a59b8693a9" xlink:to="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6224e636-eba3-420f-8e89-c17851ec74f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_ProfitLoss_6224e636-eba3-420f-8e89-c17851ec74f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_ff58e32e-4100-41d9-a667-3b1dce161e3e" xlink:href="holx-20200926.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_ff58e32e-4100-41d9-a667-3b1dce161e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_28e9f3a2-c194-4961-a3ad-8a5ad4b961f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_28e9f3a2-c194-4961-a3ad-8a5ad4b961f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3476e0f9-bdaa-4731-810a-2ea6baa6b71b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3476e0f9-bdaa-4731-810a-2ea6baa6b71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_d80115d8-551a-4ab2-9eaf-611d3591f94a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_d80115d8-551a-4ab2-9eaf-611d3591f94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a4f68792-36d6-4321-b11d-1debaeb62d68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a4f68792-36d6-4321-b11d-1debaeb62d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_1c691efe-4330-46fb-bf2e-46772b2f0f48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_1c691efe-4330-46fb-bf2e-46772b2f0f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fb4b1ffa-4dba-4de0-8160-bd03b67d387b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fb4b1ffa-4dba-4de0-8160-bd03b67d387b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_05299af5-9558-4da0-90d0-db5593b2b87f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_05299af5-9558-4da0-90d0-db5593b2b87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_c4f124aa-2497-47fa-bbf1-473984e5adae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_c4f124aa-2497-47fa-bbf1-473984e5adae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_7b39890a-a19e-4d05-bd62-e9ecb0d2d691" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_7b39890a-a19e-4d05-bd62-e9ecb0d2d691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_f8c2c039-7bd1-4f66-8bf6-ccf2f6f29b19" xlink:href="holx-20200926.xsd#holx_ComprehensiveIncome"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c1ebf5d-c806-4f15-b6e6-9c8600f0094b" xlink:to="loc_holx_ComprehensiveIncome_f8c2c039-7bd1-4f66-8bf6-ccf2f6f29b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_541103ae-f815-4ae0-8517-fe219ac7715e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_49dd4126-a2ad-4e26-81a8-3b945a02ebb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_541103ae-f815-4ae0-8517-fe219ac7715e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_49dd4126-a2ad-4e26-81a8-3b945a02ebb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_fbf482c1-f72f-4f4b-bdb4-5d6056324636" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_541103ae-f815-4ae0-8517-fe219ac7715e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_fbf482c1-f72f-4f4b-bdb4-5d6056324636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Taxpaidoninterestrateswaps_0d7bfaa8-abf0-4874-b068-81ca65abb6d8" xlink:href="holx-20200926.xsd#holx_Taxpaidoninterestrateswaps"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_541103ae-f815-4ae0-8517-fe219ac7715e" xlink:to="loc_holx_Taxpaidoninterestrateswaps_0d7bfaa8-abf0-4874-b068-81ca65abb6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_048cf73c-f237-4b6f-bd53-45151aae5052" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_541103ae-f815-4ae0-8517-fe219ac7715e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_048cf73c-f237-4b6f-bd53-45151aae5052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5ed0e1df-b9e2-4f13-88be-892e01e7e8e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ff98c9c5-2bf4-42e8-8406-cb09d8163b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5ed0e1df-b9e2-4f13-88be-892e01e7e8e7" xlink:to="loc_us-gaap_AssetsAbstract_ff98c9c5-2bf4-42e8-8406-cb09d8163b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8f7a91f9-6d7d-495d-b861-1ee289e00707" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff98c9c5-2bf4-42e8-8406-cb09d8163b0b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8f7a91f9-6d7d-495d-b861-1ee289e00707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d6c6c85c-3360-4964-963b-b130023b38c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8f7a91f9-6d7d-495d-b861-1ee289e00707" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d6c6c85c-3360-4964-963b-b130023b38c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c735287a-19e4-4c8e-b4f6-277b36dc63a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8f7a91f9-6d7d-495d-b861-1ee289e00707" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c735287a-19e4-4c8e-b4f6-277b36dc63a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_133711e2-2f23-401f-a614-f14d5cb89d44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8f7a91f9-6d7d-495d-b861-1ee289e00707" xlink:to="loc_us-gaap_InventoryNet_133711e2-2f23-401f-a614-f14d5cb89d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_056127c8-d22a-49af-91e1-ef8441cd99cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8f7a91f9-6d7d-495d-b861-1ee289e00707" xlink:to="loc_us-gaap_PrepaidTaxes_056127c8-d22a-49af-91e1-ef8441cd99cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cab515fa-5245-4db6-9273-3d4964c4df03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8f7a91f9-6d7d-495d-b861-1ee289e00707" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cab515fa-5245-4db6-9273-3d4964c4df03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bdda8607-f16d-468c-b87d-3609fac00a23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8f7a91f9-6d7d-495d-b861-1ee289e00707" xlink:to="loc_us-gaap_AssetsCurrent_bdda8607-f16d-468c-b87d-3609fac00a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d18d3930-dc37-4b3c-b824-c47e694a3fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff98c9c5-2bf4-42e8-8406-cb09d8163b0b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d18d3930-dc37-4b3c-b824-c47e694a3fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8492e920-d1cd-4a41-8c06-4741371bfbde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff98c9c5-2bf4-42e8-8406-cb09d8163b0b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8492e920-d1cd-4a41-8c06-4741371bfbde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1c2ad2e6-0d5b-48d6-9c4e-468e4852736c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff98c9c5-2bf4-42e8-8406-cb09d8163b0b" xlink:to="loc_us-gaap_Goodwill_1c2ad2e6-0d5b-48d6-9c4e-468e4852736c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c4507a0b-0e40-4e97-b01b-9954a6009d03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff98c9c5-2bf4-42e8-8406-cb09d8163b0b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c4507a0b-0e40-4e97-b01b-9954a6009d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_090ed675-34a5-4387-9859-4b653a81f1d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff98c9c5-2bf4-42e8-8406-cb09d8163b0b" xlink:to="loc_us-gaap_Assets_090ed675-34a5-4387-9859-4b653a81f1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5ed0e1df-b9e2-4f13-88be-892e01e7e8e7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1bb72d21-ad28-4ddd-aa39-29398ff100d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1bb72d21-ad28-4ddd-aa39-29398ff100d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_30b9e99d-fc9b-494b-b456-add7350b607a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb72d21-ad28-4ddd-aa39-29398ff100d3" xlink:to="loc_us-gaap_LongTermDebtCurrent_30b9e99d-fc9b-494b-b456-add7350b607a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_975f016d-2a48-42d7-808f-6dff3c69ac28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb72d21-ad28-4ddd-aa39-29398ff100d3" xlink:to="loc_us-gaap_AccountsPayableCurrent_975f016d-2a48-42d7-808f-6dff3c69ac28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5f2f886c-5617-46b2-90ee-82e8e60d7d27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb72d21-ad28-4ddd-aa39-29398ff100d3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5f2f886c-5617-46b2-90ee-82e8e60d7d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_779c4cb5-8ae8-4704-89d7-968c7902fccd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb72d21-ad28-4ddd-aa39-29398ff100d3" xlink:to="loc_us-gaap_DeferredRevenueCurrent_779c4cb5-8ae8-4704-89d7-968c7902fccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_640daec5-4a16-44cb-93e1-796149954ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb72d21-ad28-4ddd-aa39-29398ff100d3" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_640daec5-4a16-44cb-93e1-796149954ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_99e9f4f4-35f2-4103-a8bd-aa7db8b4ee14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb72d21-ad28-4ddd-aa39-29398ff100d3" xlink:to="loc_us-gaap_LiabilitiesCurrent_99e9f4f4-35f2-4103-a8bd-aa7db8b4ee14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c4fb610b-ee0d-4d36-b9a3-3425b865365b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c4fb610b-ee0d-4d36-b9a3-3425b865365b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_dd4f9f78-e7af-4d5f-a7cd-674766e4a8d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_dd4f9f78-e7af-4d5f-a7cd-674766e4a8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_96de14d0-43ef-42bb-9007-f2119852cf68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_96de14d0-43ef-42bb-9007-f2119852cf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_4974a6dd-76fe-4b59-a010-764157002d96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_4974a6dd-76fe-4b59-a010-764157002d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1c0a1bf6-8e7c-46c5-8ac1-f9b2b8b3e642" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1c0a1bf6-8e7c-46c5-8ac1-f9b2b8b3e642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_79ad3bcc-533a-49ea-abaf-35e17671e6f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_79ad3bcc-533a-49ea-abaf-35e17671e6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_152b24c2-ce75-4d43-a9ea-bb2690cb498e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1a8dcd2b-22c8-4166-94df-2e5ebb2f9b94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_PreferredStockValue_1a8dcd2b-22c8-4166-94df-2e5ebb2f9b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8ff85a0b-7770-4404-af0c-674f91be38a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_CommonStockValue_8ff85a0b-7770-4404-af0c-674f91be38a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_33a4fb67-ae00-4420-8d26-82d80b89c669" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_33a4fb67-ae00-4420-8d26-82d80b89c669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cc94ccd5-aa8c-4915-8198-a5f8963e8165" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cc94ccd5-aa8c-4915-8198-a5f8963e8165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_14403d4a-0317-4b99-89dc-3751f80119be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_TreasuryStockValue_14403d4a-0317-4b99-89dc-3751f80119be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1d834806-348a-4e54-9b8f-d75fbc4302a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1d834806-348a-4e54-9b8f-d75fbc4302a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c7f7f107-a13c-4a13-8b12-1831303608e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_StockholdersEquity_c7f7f107-a13c-4a13-8b12-1831303608e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f613d754-7272-483e-bc8e-befb3ea3333e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_MinorityInterest_f613d754-7272-483e-bc8e-befb3ea3333e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d00638c6-6c64-49cd-b524-ea439b5e712f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d00638c6-6c64-49cd-b524-ea439b5e712f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_68be751a-33f5-4182-b67e-9cae823efc7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141065f2-14bb-44e4-8036-3f3c74cca59c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_68be751a-33f5-4182-b67e-9cae823efc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_fdfc3bff-1be8-4256-82c7-d9303570eb4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a11f646e-f107-4777-bd28-2b8f3ebd9f44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fdfc3bff-1be8-4256-82c7-d9303570eb4a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a11f646e-f107-4777-bd28-2b8f3ebd9f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8d1847dc-baa9-4880-9692-bb9531ae413b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fdfc3bff-1be8-4256-82c7-d9303570eb4a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8d1847dc-baa9-4880-9692-bb9531ae413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_71256599-d30e-4499-a7cc-e3f5670d1f40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fdfc3bff-1be8-4256-82c7-d9303570eb4a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_71256599-d30e-4499-a7cc-e3f5670d1f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_acf83cbb-3bf2-4047-b524-0166e1c28036" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fdfc3bff-1be8-4256-82c7-d9303570eb4a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_acf83cbb-3bf2-4047-b524-0166e1c28036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_95c20b4c-2954-4cf8-ad79-84580467e931" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fdfc3bff-1be8-4256-82c7-d9303570eb4a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_95c20b4c-2954-4cf8-ad79-84580467e931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_466019c4-ab85-4040-880c-7ec954db19ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fdfc3bff-1be8-4256-82c7-d9303570eb4a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_466019c4-ab85-4040-880c-7ec954db19ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_98186e19-dae9-4cf7-86f8-9cd72a36249e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fdfc3bff-1be8-4256-82c7-d9303570eb4a" xlink:to="loc_us-gaap_CommonStockSharesIssued_98186e19-dae9-4cf7-86f8-9cd72a36249e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_a57bb34b-f490-440d-868c-3aebd9511cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fdfc3bff-1be8-4256-82c7-d9303570eb4a" xlink:to="loc_us-gaap_TreasuryStockShares_a57bb34b-f490-440d-868c-3aebd9511cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0bbff4b9-fae2-4850-a345-743f37a40530" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0bbff4b9-fae2-4850-a345-743f37a40530" xlink:to="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ba9d4596-0913-4f4d-bd2e-94a6307701b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ba9d4596-0913-4f4d-bd2e-94a6307701b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ba9d4596-0913-4f4d-bd2e-94a6307701b7" xlink:to="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c7f7e6cd-43c8-4bb2-8f5d-1207a8edc6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_CommonStockMember_c7f7e6cd-43c8-4bb2-8f5d-1207a8edc6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f5ea7494-2ef2-4604-8a80-d7fdb6f1c750" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f5ea7494-2ef2-4604-8a80-d7fdb6f1c750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b35fd9d0-f1c7-4d33-9a1b-0ad70481cfbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_RetainedEarningsMember_b35fd9d0-f1c7-4d33-9a1b-0ad70481cfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b31cd8-7b02-4fc4-820f-0100a32403fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b31cd8-7b02-4fc4-820f-0100a32403fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_b3f0cdad-b592-4c60-ac40-545ea6e927f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_TreasuryStockMember_b3f0cdad-b592-4c60-ac40-545ea6e927f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_79d95fd3-d8e5-47de-851f-7c024676e4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_36d65f50-6c23-4514-807f-58ceb0764cae" xlink:to="loc_us-gaap_NoncontrollingInterestMember_79d95fd3-d8e5-47de-851f-7c024676e4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f17bec48-f3a4-4c10-86e3-ecad40568a46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f17bec48-f3a4-4c10-86e3-ecad40568a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f0519db6-9393-4923-9e8d-7575630c8727" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f17bec48-f3a4-4c10-86e3-ecad40568a46" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f0519db6-9393-4923-9e8d-7575630c8727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_f551d10d-0fa8-4815-ad5b-93db010af8fc" xlink:href="holx-20200926.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f0519db6-9393-4923-9e8d-7575630c8727" xlink:to="loc_holx_ShareRepurchaseProgramMember_f551d10d-0fa8-4815-ad5b-93db010af8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f8138da0-c848-4055-94ac-e178f3f28162" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f8138da0-c848-4055-94ac-e178f3f28162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f48c0771-a4d9-4778-8192-01df7a55b017" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f8138da0-c848-4055-94ac-e178f3f28162" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f48c0771-a4d9-4778-8192-01df7a55b017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_d84e166a-b701-42a7-8370-4750a7177dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_f48c0771-a4d9-4778-8192-01df7a55b017" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_d84e166a-b701-42a7-8370-4750a7177dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1694f307-4053-4798-9ba8-07109c5f3c6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_68539bb7-5e1b-45af-8f8f-c48d86a32005" xlink:to="loc_us-gaap_StatementLineItems_1694f307-4053-4798-9ba8-07109c5f3c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1694f307-4053-4798-9ba8-07109c5f3c6f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_64963bf3-aca5-477f-99c1-0d081262b1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_SharesIssued_64963bf3-aca5-477f-99c1-0d081262b1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a80e9ed-2d49-4051-9b19-16377dee8974" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a80e9ed-2d49-4051-9b19-16377dee8974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASC606_26ecfb59-891c-4942-8d89-c91905bd3ca8" xlink:href="holx-20200926.xsd#holx_AccountingstandardtransitionadjustmentASC606"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_holx_AccountingstandardtransitionadjustmentASC606_26ecfb59-891c-4942-8d89-c91905bd3ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASU201616_fae1147c-7f58-4dde-a1cd-ba3b805d4926" xlink:href="holx-20200926.xsd#holx_AccountingstandardtransitionadjustmentASU201616"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_holx_AccountingstandardtransitionadjustmentASU201616_fae1147c-7f58-4dde-a1cd-ba3b805d4926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_555711be-e055-4c4c-bc39-c8cfbd4e1a76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_555711be-e055-4c4c-bc39-c8cfbd4e1a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4a81a424-fba2-47cc-af6e-c23fc3baeacd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4a81a424-fba2-47cc-af6e-c23fc3baeacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_43fb2476-0bdd-4ef7-9c78-757be2821d80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_43fb2476-0bdd-4ef7-9c78-757be2821d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2ba320d3-0d02-4248-8615-7987363bfd96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2ba320d3-0d02-4248-8615-7987363bfd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f3cced9e-210a-46e0-b5f5-b06d78e725e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f3cced9e-210a-46e0-b5f5-b06d78e725e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_36262a40-defc-4ff2-af12-7966d7a5541a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_36262a40-defc-4ff2-af12-7966d7a5541a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcb6a7b1-c123-4042-a9cd-80ba6ee8d2f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcb6a7b1-c123-4042-a9cd-80ba6ee8d2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1ca0ea32-b0a1-4f57-9965-50a94d4c4cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1ca0ea32-b0a1-4f57-9965-50a94d4c4cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_dde09d53-237f-44f3-823f-f3099e78fe09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_dde09d53-237f-44f3-823f-f3099e78fe09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_8ccf8292-1da0-41c8-b8a2-43906add05d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_8ccf8292-1da0-41c8-b8a2-43906add05d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ea290315-ac05-4418-9eb0-a18a413eb4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ea290315-ac05-4418-9eb0-a18a413eb4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_fd57e79e-2207-4f7c-aaa0-921b56994889" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_fd57e79e-2207-4f7c-aaa0-921b56994889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_4889cec6-1d4b-4424-a1d5-b647639e859e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_4889cec6-1d4b-4424-a1d5-b647639e859e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_c2817c80-4170-4699-ba43-29853b068c46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_c2817c80-4170-4699-ba43-29853b068c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_56e52540-9d97-4b9b-9012-96976ba77098" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_56e52540-9d97-4b9b-9012-96976ba77098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5ed9fa2f-c5d8-4f62-a247-849dacab0e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5ed9fa2f-c5d8-4f62-a247-849dacab0e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9e2a39fb-965f-41d6-b0af-9a4e3dc5746b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_ProfitLoss_9e2a39fb-965f-41d6-b0af-9a4e3dc5746b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_03975575-142f-4e9f-a2ba-1989564117aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_03975575-142f-4e9f-a2ba-1989564117aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_288be744-cb48-4791-be11-973bd2869b53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_288be744-cb48-4791-be11-973bd2869b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_efd6bea8-b57b-4a69-b382-5a713f51dd30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_efd6bea8-b57b-4a69-b382-5a713f51dd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_425d968d-0c2b-49d0-a7fa-352ba0090f98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_SharesIssued_425d968d-0c2b-49d0-a7fa-352ba0090f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5655b700-69ea-4d3b-a940-3871b72c73aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1c743ff8-a1ab-4cf7-b648-eddd9ef79ccb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5655b700-69ea-4d3b-a940-3871b72c73aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20200926.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_55d2e514-c713-444d-8056-337941f9d50c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_025166a6-b7e7-47ba-bdeb-a046542b922e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55d2e514-c713-444d-8056-337941f9d50c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_025166a6-b7e7-47ba-bdeb-a046542b922e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fca5a99e-e63f-4c5c-a76a-3a7e095b9e9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_025166a6-b7e7-47ba-bdeb-a046542b922e" xlink:to="loc_us-gaap_ProfitLoss_fca5a99e-e63f-4c5c-a76a-3a7e095b9e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_025166a6-b7e7-47ba-bdeb-a046542b922e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6254cee2-29fc-4496-81d9-3b2f3300bc12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_us-gaap_Depreciation_6254cee2-29fc-4496-81d9-3b2f3300bc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_48c803d9-10d9-4596-9ed7-5394ca6e6fea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_us-gaap_AdjustmentForAmortization_48c803d9-10d9-4596-9ed7-5394ca6e6fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2acb18ee-bdf3-4bdb-b836-4b2e95e5e82c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2acb18ee-bdf3-4bdb-b836-4b2e95e5e82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4b110cfd-eb18-4e7b-ab01-45b5dbfc676b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_us-gaap_ShareBasedCompensation_4b110cfd-eb18-4e7b-ab01-45b5dbfc676b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a477aea6-3f63-4f94-99bc-27067e30e390" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a477aea6-3f63-4f94-99bc-27067e30e390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b10e9bb4-7215-48e6-8c35-855abc9cc09c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b10e9bb4-7215-48e6-8c35-855abc9cc09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Impairmentofintangibleassetsandequipment_1fe8789d-7e19-4951-87e5-3d5a16845640" xlink:href="holx-20200926.xsd#holx_Impairmentofintangibleassetsandequipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_holx_Impairmentofintangibleassetsandequipment_1fe8789d-7e19-4951-87e5-3d5a16845640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6339d695-769d-4a8d-8f6d-ce294eeab4c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6339d695-769d-4a8d-8f6d-ce294eeab4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_fcb6a9de-f1a9-4cf9-89d2-57534ba780df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_fcb6a9de-f1a9-4cf9-89d2-57534ba780df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4e7f77dd-d5f7-4571-ba8a-f9b12795d0f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5b316680-ea28-425c-9862-6c35a5eb2686" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4e7f77dd-d5f7-4571-ba8a-f9b12795d0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f144de99-7290-408c-a01a-7d21a8e32690" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4e7f77dd-d5f7-4571-ba8a-f9b12795d0f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f144de99-7290-408c-a01a-7d21a8e32690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f7bb703f-495a-49cf-938e-ca805d316956" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4e7f77dd-d5f7-4571-ba8a-f9b12795d0f4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f7bb703f-495a-49cf-938e-ca805d316956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_4a000c64-2268-4017-96c5-ecb239fdd111" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4e7f77dd-d5f7-4571-ba8a-f9b12795d0f4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_4a000c64-2268-4017-96c5-ecb239fdd111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_987d72c3-81c6-4b83-b69d-c3092e43bcb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4e7f77dd-d5f7-4571-ba8a-f9b12795d0f4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_987d72c3-81c6-4b83-b69d-c3092e43bcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8253b773-c1c4-4a48-816e-7b8b7d16d2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4e7f77dd-d5f7-4571-ba8a-f9b12795d0f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8253b773-c1c4-4a48-816e-7b8b7d16d2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_68ce038b-2209-4700-9fe4-c70ff9eb7401" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4e7f77dd-d5f7-4571-ba8a-f9b12795d0f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_68ce038b-2209-4700-9fe4-c70ff9eb7401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_405dee4b-1ff1-48b4-b1e4-e17a005c415c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4e7f77dd-d5f7-4571-ba8a-f9b12795d0f4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_405dee4b-1ff1-48b4-b1e4-e17a005c415c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9548bd96-8b3f-400e-ab44-0ddebda5a937" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_025166a6-b7e7-47ba-bdeb-a046542b922e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9548bd96-8b3f-400e-ab44-0ddebda5a937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55d2e514-c713-444d-8056-337941f9d50c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b94345a8-b0d9-4ad4-ad44-492f2f8a489c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b94345a8-b0d9-4ad4-ad44-492f2f8a489c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ccc9921d-9ddd-44ee-a873-e063c4f5bded" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ccc9921d-9ddd-44ee-a873-e063c4f5bded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_4c85a99c-4e5d-48e7-9537-fe00d64eab1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_4c85a99c-4e5d-48e7-9537-fe00d64eab1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FundingOfLoansToSSI_7ba9bbde-a512-4f66-ab1c-5037c50b9da8" xlink:href="holx-20200926.xsd#holx_FundingOfLoansToSSI"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_holx_FundingOfLoansToSSI_7ba9bbde-a512-4f66-ab1c-5037c50b9da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e6095-0d6e-4445-a262-6b4678a491b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e6095-0d6e-4445-a262-6b4678a491b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_18147d74-0c3a-463c-bf90-baec8bad6a6c" xlink:href="holx-20200926.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_18147d74-0c3a-463c-bf90-baec8bad6a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofcostmethodinvestment_c7e407bc-7db2-446b-b829-bef32dae8a1c" xlink:href="holx-20200926.xsd#holx_Purchaseofcostmethodinvestment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_holx_Purchaseofcostmethodinvestment_c7e407bc-7db2-446b-b829-bef32dae8a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts_9df76b33-4bdc-451b-b041-9b8dd7a663f6" xlink:href="holx-20200926.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_holx_Purchaseofinsurancecontracts_9df76b33-4bdc-451b-b041-9b8dd7a663f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_84d9f6c4-824b-4951-81c6-35565ec75b8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_84d9f6c4-824b-4951-81c6-35565ec75b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_911862d2-783c-4450-bc57-26ac058336ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_911862d2-783c-4450-bc57-26ac058336ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fa68fd7c-3d22-43cc-8033-98c6881d7570" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab1e03d8-82f3-4b3e-89e9-489367ed7ce7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fa68fd7c-3d22-43cc-8033-98c6881d7570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55d2e514-c713-444d-8056-337941f9d50c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_3e310809-9aa3-421f-8d23-17664a6b68ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_3e310809-9aa3-421f-8d23-17664a6b68ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_27305931-a626-4682-897b-8b4726042055" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_27305931-a626-4682-897b-8b4726042055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsfromSeniorNotes_306a0fe3-609d-4272-990c-de0018231999" xlink:href="holx-20200926.xsd#holx_ProceedsfromSeniorNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_holx_ProceedsfromSeniorNotes_306a0fe3-609d-4272-990c-de0018231999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentofSeniorNotes_91e2d5c3-2cbd-4a36-a655-652963decbd4" xlink:href="holx-20200926.xsd#holx_RepaymentofSeniorNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_holx_RepaymentofSeniorNotes_91e2d5c3-2cbd-4a36-a655-652963decbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_451c6025-acaa-4013-bdd3-dc9b64e942b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_451c6025-acaa-4013-bdd3-dc9b64e942b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Repaymentofacquireddebt_b1caacbe-7e1e-4392-bde2-a2b7b65dcb13" xlink:href="holx-20200926.xsd#holx_Repaymentofacquireddebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_holx_Repaymentofacquireddebt_b1caacbe-7e1e-4392-bde2-a2b7b65dcb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c7ce0378-e438-4255-a34b-9f6ca55c32b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c7ce0378-e438-4255-a34b-9f6ca55c32b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_f9cff965-73af-4001-b00b-42d074f94f99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_f9cff965-73af-4001-b00b-42d074f94f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_afb8426d-84b0-4657-b79b-a0bc7ab553f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_afb8426d-84b0-4657-b79b-a0bc7ab553f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_271b66bb-2ef2-4e57-91c2-880bc2cf0f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_271b66bb-2ef2-4e57-91c2-880bc2cf0f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_d622bbac-64cc-4d0a-9947-b615dd607325" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_d622bbac-64cc-4d0a-9947-b615dd607325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1fe0df31-fbd5-49d1-bb71-c2203c6f069a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1fe0df31-fbd5-49d1-bb71-c2203c6f069a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_176deaa6-cf0e-4e4d-bb74-7f0edf5c3f43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_176deaa6-cf0e-4e4d-bb74-7f0edf5c3f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8f3c4e67-f463-43b4-9242-f0a86c09fe4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8f3c4e67-f463-43b4-9242-f0a86c09fe4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_48716984-0a57-42d5-bd24-7171c6e6c985" xlink:href="holx-20200926.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_48716984-0a57-42d5-bd24-7171c6e6c985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_838f373f-7ea0-49aa-a3d4-8d8ac4a6ac03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_838f373f-7ea0-49aa-a3d4-8d8ac4a6ac03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_94ad0f0b-91fe-48d2-bc74-ea394f059679" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_94ad0f0b-91fe-48d2-bc74-ea394f059679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_f5c1e51b-04c6-4aba-bece-0bfb99d06252" xlink:href="holx-20200926.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_f5c1e51b-04c6-4aba-bece-0bfb99d06252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_080238b4-5bb9-49f3-968d-da5231d84ade" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27772459-60c2-4933-9b1a-90e2b3329a08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_080238b4-5bb9-49f3-968d-da5231d84ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6da4f5b5-c8c7-446e-ad09-b0d1ad5e8382" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55d2e514-c713-444d-8056-337941f9d50c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6da4f5b5-c8c7-446e-ad09-b0d1ad5e8382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_98bec27b-d1a2-453a-8b46-46a92d9f7745" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55d2e514-c713-444d-8056-337941f9d50c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_98bec27b-d1a2-453a-8b46-46a92d9f7745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fcc111cf-c085-4c0d-86f7-364ff4a8d7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55d2e514-c713-444d-8056-337941f9d50c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fcc111cf-c085-4c0d-86f7-364ff4a8d7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_209fdd43-e927-4cd1-b76d-5f84e64d0437" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55d2e514-c713-444d-8056-337941f9d50c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_209fdd43-e927-4cd1-b76d-5f84e64d0437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Operations" xlink:type="simple" xlink:href="holx-20200926.xsd#Operations"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Operations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_15733c90-c35d-472d-9428-1f5cdcc195b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d0117183-104c-4088-96d0-5c02e3420138" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_15733c90-c35d-472d-9428-1f5cdcc195b4" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d0117183-104c-4088-96d0-5c02e3420138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OperationsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#OperationsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_01204630-6f34-4ec3-82fa-6c6fee5643a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_f4e33420-4f4a-4148-930b-4eab8e96c0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_01204630-6f34-4ec3-82fa-6c6fee5643a3" xlink:to="loc_us-gaap_NumberOfOperatingSegments_f4e33420-4f4a-4148-930b-4eab8e96c0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_5f5809e1-cd08-4f6e-8093-a5b0a672415a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_01204630-6f34-4ec3-82fa-6c6fee5643a3" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_5f5809e1-cd08-4f6e-8093-a5b0a672415a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_1d7e358a-bfec-43f0-9630-bd7c91a6d483" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_01204630-6f34-4ec3-82fa-6c6fee5643a3" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_1d7e358a-bfec-43f0-9630-bd7c91a6d483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_17027072-571a-489c-ae41-ff1d5b0cc41c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_01204630-6f34-4ec3-82fa-6c6fee5643a3" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_17027072-571a-489c-ae41-ff1d5b0cc41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a3aa5b7-79d6-4acd-b6d8-85fc494fe9a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_01204630-6f34-4ec3-82fa-6c6fee5643a3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a3aa5b7-79d6-4acd-b6d8-85fc494fe9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UnusedCreditFacility_27d56a24-a30e-48eb-a84b-465f9df84a09" xlink:href="holx-20200926.xsd#holx_UnusedCreditFacility"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_01204630-6f34-4ec3-82fa-6c6fee5643a3" xlink:to="loc_holx_UnusedCreditFacility_27d56a24-a30e-48eb-a84b-465f9df84a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a2bb1524-919f-4f5a-b41d-d40804ec9498" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_5afa4dc1-0c3b-414c-8198-9189577b3ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a2bb1524-919f-4f5a-b41d-d40804ec9498" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_5afa4dc1-0c3b-414c-8198-9189577b3ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_10a2f728-e454-4a8f-85cb-39813e10faf6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_10a2f728-e454-4a8f-85cb-39813e10faf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_29022010-bace-440e-94bc-9d072058e472" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_UseOfEstimates_29022010-bace-440e-94bc-9d072058e472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a210f874-7138-42d4-a4a1-caa385bdb49a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a210f874-7138-42d4-a4a1-caa385bdb49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_dcbc6215-a538-4533-bc84-54909220d0eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_dcbc6215-a538-4533-bc84-54909220d0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_f7b0aac9-4aaa-4ec6-9439-0c24581b96d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_f7b0aac9-4aaa-4ec6-9439-0c24581b96d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_411624c4-7593-465a-9456-24e2589f112d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_411624c4-7593-465a-9456-24e2589f112d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongLivedAssetsPolicyPolicyTextBlock_04d00699-c05c-45e3-8141-70e4fecc53a0" xlink:href="holx-20200926.xsd#holx_LongLivedAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_holx_LongLivedAssetsPolicyPolicyTextBlock_04d00699-c05c-45e3-8141-70e4fecc53a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_4de818fa-10a5-4366-926e-93e9869bb87a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_4de818fa-10a5-4366-926e-93e9869bb87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherAssetsPolicyPolicyTextBlock_c8547174-3cc2-4e3c-97ee-c49c2ea3a2cc" xlink:href="holx-20200926.xsd#holx_OtherAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_holx_OtherAssetsPolicyPolicyTextBlock_c8547174-3cc2-4e3c-97ee-c49c2ea3a2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_cf678cf4-aeae-4970-a972-1c64790e4106" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_cf678cf4-aeae-4970-a972-1c64790e4106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b5606e0f-73a6-441e-8e78-e4cdbf78da22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b5606e0f-73a6-441e-8e78-e4cdbf78da22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_6273f115-381d-4728-b646-0b8cd53224b9" xlink:href="holx-20200926.xsd#holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_6273f115-381d-4728-b646-0b8cd53224b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_b8cef2fb-f993-4fc6-89b1-5c9f6f63cd00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_b8cef2fb-f993-4fc6-89b1-5c9f6f63cd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_bf4d511b-932a-4056-ac23-754fe36c3564" xlink:href="holx-20200926.xsd#holx_AccountsReceivableAndReservesPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_bf4d511b-932a-4056-ac23-754fe36c3564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_cc35da61-0598-4ca6-9524-463f013f9aae" xlink:href="holx-20200926.xsd#holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_cc35da61-0598-4ca6-9524-463f013f9aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a700a898-59fa-4b45-916a-d8dd9e4036e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a700a898-59fa-4b45-916a-d8dd9e4036e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_8f49f33d-88d7-47a0-90a7-67352c4cdd1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_8f49f33d-88d7-47a0-90a7-67352c4cdd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_54a7a14e-ee01-4ccc-bce0-b6d85f4f986c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_54a7a14e-ee01-4ccc-bce0-b6d85f4f986c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_b7beb94d-b5e1-4537-a0d3-de24e804122b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44cc6a9b-3d19-4e23-91a2-977465094b00" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_b7beb94d-b5e1-4537-a0d3-de24e804122b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_6386e09a-4742-4132-9c07-3d4f44452d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_6386e09a-4742-4132-9c07-3d4f44452d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_33eb44f0-78c9-4964-a013-2598e67235fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_33eb44f0-78c9-4964-a013-2598e67235fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_bb458a3d-7d48-400d-8ad8-62672c269f33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_bb458a3d-7d48-400d-8ad8-62672c269f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_dd3a53e4-884e-4332-9bd8-fdc27f1e3f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_dd3a53e4-884e-4332-9bd8-fdc27f1e3f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_4037f327-21f3-4609-889f-74694f3ff17d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_4037f327-21f3-4609-889f-74694f3ff17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGoodwillBySegmentTableTextBlock_711d8c48-4b8b-484c-8732-ab1a1a66e733" xlink:href="holx-20200926.xsd#holx_ScheduleOfGoodwillBySegmentTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_holx_ScheduleOfGoodwillBySegmentTableTextBlock_711d8c48-4b8b-484c-8732-ab1a1a66e733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_98a10dce-bb37-4bdf-9a0d-f1a549169e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_98a10dce-bb37-4bdf-9a0d-f1a549169e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_e2092d27-5873-4505-8602-c2228db8c73d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_e2092d27-5873-4505-8602-c2228db8c73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0bfbd8e0-90bf-4c81-be06-89062d25e5b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0bfbd8e0-90bf-4c81-be06-89062d25e5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1cd707df-cfb5-460c-8866-040cf607fbba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1cd707df-cfb5-460c-8866-040cf607fbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_a8fff1cf-2026-49c2-a297-7f9d9d24d27f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_a8fff1cf-2026-49c2-a297-7f9d9d24d27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_e578bc35-661a-4d54-99fd-53b9dc5e6182" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_e578bc35-661a-4d54-99fd-53b9dc5e6182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_6afaacb5-3ef8-4d65-814e-36a2877de2de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_6afaacb5-3ef8-4d65-814e-36a2877de2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_bce2a513-583a-4c9a-b5b1-fcb92291d8f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_bce2a513-583a-4c9a-b5b1-fcb92291d8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_ade35028-9556-4227-8a54-f3cb3488fd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a617b19d-85af-430c-85f6-08ba8eb90524" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_ade35028-9556-4227-8a54-f3cb3488fd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6fdb0cd1-7583-483a-a1e4-39e8a55d94f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:href="holx-20200926.xsd#holx_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6fdb0cd1-7583-483a-a1e4-39e8a55d94f1" xlink:to="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8808645-60df-4658-851b-1bf318fcb668" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8808645-60df-4658-851b-1bf318fcb668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a33b7762-3629-4084-9482-baf4edf04544" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8808645-60df-4658-851b-1bf318fcb668" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a33b7762-3629-4084-9482-baf4edf04544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_80fce343-b69a-4744-bb82-26cc56f7c598" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a33b7762-3629-4084-9482-baf4edf04544" xlink:to="loc_holx_MedicalAestheticsBusinessMember_80fce343-b69a-4744-bb82-26cc56f7c598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_9b219737-f1e6-4012-b00f-ddd2d353af7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_9b219737-f1e6-4012-b00f-ddd2d353af7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_449f714f-474f-49b7-b513-d94488c652e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_9b219737-f1e6-4012-b00f-ddd2d353af7d" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_449f714f-474f-49b7-b513-d94488c652e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b1dc99cd-6475-4c41-a910-d9a5e2a77ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_449f714f-474f-49b7-b513-d94488c652e1" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b1dc99cd-6475-4c41-a910-d9a5e2a77ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_75dbe432-fc5d-4381-90ce-5751ea1921e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_75dbe432-fc5d-4381-90ce-5751ea1921e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1adfa3c-bb61-4876-826d-4422eab135ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_75dbe432-fc5d-4381-90ce-5751ea1921e4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1adfa3c-bb61-4876-826d-4422eab135ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ac7687ba-a65e-41f3-913f-d41b877dd3a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1adfa3c-bb61-4876-826d-4422eab135ba" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ac7687ba-a65e-41f3-913f-d41b877dd3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6c9ac22f-61dc-4c9c-9fb8-7dac89a69357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6c9ac22f-61dc-4c9c-9fb8-7dac89a69357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_594987ac-d6c0-4f3e-942c-e3d96bf23031" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6c9ac22f-61dc-4c9c-9fb8-7dac89a69357" xlink:to="loc_us-gaap_SegmentDomain_594987ac-d6c0-4f3e-942c-e3d96bf23031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_afc5c9dc-e15e-4d9f-99a0-7bbc787dece5" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_594987ac-d6c0-4f3e-942c-e3d96bf23031" xlink:to="loc_holx_MedicalAestheticsMember_afc5c9dc-e15e-4d9f-99a0-7bbc787dece5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b664ce9a-7d28-4315-9eaa-b8ca484e9605" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b664ce9a-7d28-4315-9eaa-b8ca484e9605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b664ce9a-7d28-4315-9eaa-b8ca484e9605" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_389a554a-9c56-463f-9559-ad3454ec678c" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_FocalTherapeuticsInc.Member_389a554a-9c56-463f-9559-ad3454ec678c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_05bf3dfa-e55b-4bac-81e5-a861157417b3" xlink:href="holx-20200926.xsd#holx_CynosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_CynosureMember_05bf3dfa-e55b-4bac-81e5-a861157417b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmsorMember_079cb765-dad5-48e6-9268-4294ec05135d" xlink:href="holx-20200926.xsd#holx_EmsorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_EmsorMember_079cb765-dad5-48e6-9268-4294ec05135d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_4d5d1899-07cf-4fb2-bed0-3092d49a85eb" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_FaxitronMember_4d5d1899-07cf-4fb2-bed0-3092d49a85eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_33f3505c-3ab2-48fb-9c5e-73c58c174312" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5e2edcb-5a84-4a98-9139-70e28e6bc389" xlink:to="loc_holx_AcessaHealthMember_33f3505c-3ab2-48fb-9c5e-73c58c174312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_97dabbc3-23a5-4b52-835f-1d23cd906c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_FinancialInstrumentAxis_97dabbc3-23a5-4b52-835f-1d23cd906c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d330eceb-0580-4cf2-a64f-2c25bd18baeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_97dabbc3-23a5-4b52-835f-1d23cd906c2d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d330eceb-0580-4cf2-a64f-2c25bd18baeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c360ecc6-5d3b-470e-9623-c139b44cb519" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d330eceb-0580-4cf2-a64f-2c25bd18baeb" xlink:to="loc_us-gaap_InterestRateCapMember_c360ecc6-5d3b-470e-9623-c139b44cb519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f8da2ce7-b0d3-4637-aab0-bf5ed2a4fb8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d330eceb-0580-4cf2-a64f-2c25bd18baeb" xlink:to="loc_us-gaap_InterestRateSwapMember_f8da2ce7-b0d3-4637-aab0-bf5ed2a4fb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3c2c60c2-1bfa-461b-b980-d2f042d709d3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_srt_RangeAxis_3c2c60c2-1bfa-461b-b980-d2f042d709d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ebdcc926-02cb-4a7b-bd70-e5b50bcc12df" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3c2c60c2-1bfa-461b-b980-d2f042d709d3" xlink:to="loc_srt_RangeMember_ebdcc926-02cb-4a7b-bd70-e5b50bcc12df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6ce97583-f261-466b-9913-63f42bddd7d3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ebdcc926-02cb-4a7b-bd70-e5b50bcc12df" xlink:to="loc_srt_MinimumMember_6ce97583-f261-466b-9913-63f42bddd7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9203f631-ebca-4a55-aed8-70ae15f69cc4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ebdcc926-02cb-4a7b-bd70-e5b50bcc12df" xlink:to="loc_srt_MaximumMember_9203f631-ebca-4a55-aed8-70ae15f69cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b9cdf22e-0933-45ab-a864-c4d22d5a0057" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b9cdf22e-0933-45ab-a864-c4d22d5a0057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a22e9080-3ba2-4dfd-99d6-2d002de2dce4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b9cdf22e-0933-45ab-a864-c4d22d5a0057" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a22e9080-3ba2-4dfd-99d6-2d002de2dce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_d7493501-b0f9-4639-9f35-254166f595ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a22e9080-3ba2-4dfd-99d6-2d002de2dce4" xlink:to="loc_us-gaap_AccountsReceivableMember_d7493501-b0f9-4639-9f35-254166f595ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevenueMember_d7b7352d-6614-4acc-85ab-420089ce0ed9" xlink:href="holx-20200926.xsd#holx_RevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a22e9080-3ba2-4dfd-99d6-2d002de2dce4" xlink:to="loc_holx_RevenueMember_d7b7352d-6614-4acc-85ab-420089ce0ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_70d0bc04-c970-4e23-abbd-23cb0bbe30d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_70d0bc04-c970-4e23-abbd-23cb0bbe30d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_70d0bc04-c970-4e23-abbd-23cb0bbe30d4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_97d636c0-00ae-4156-bc17-3f2b39144545" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_97d636c0-00ae-4156-bc17-3f2b39144545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember_e1e3fb27-80fe-4737-8153-9f51103243a9" xlink:href="holx-20200926.xsd#holx_DistributionagreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_holx_DistributionagreementMember_e1e3fb27-80fe-4737-8153-9f51103243a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4906408f-626f-43cb-b738-5ab8accf3e55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4906408f-626f-43cb-b738-5ab8accf3e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ea574b51-de57-4af4-b289-7a8d62769a63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_us-gaap_TradeNamesMember_ea574b51-de57-4af4-b289-7a8d62769a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_2feff5d2-6825-4f7d-95d1-a8c1f636e24d" xlink:href="holx-20200926.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_holx_DevelopedTechnologyMember_2feff5d2-6825-4f7d-95d1-a8c1f636e24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_4995ec71-03b6-46c0-ab0c-d3136a8fc1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f29ec99e-a222-4118-81a3-c0317242b351" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_4995ec71-03b6-46c0-ab0c-d3136a8fc1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b825c2a2-b9a6-4f95-af18-208159dcc55b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b825c2a2-b9a6-4f95-af18-208159dcc55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b825c2a2-b9a6-4f95-af18-208159dcc55b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_de5f5775-a1ec-409d-96cb-6bbdde360635" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:to="loc_us-gaap_TradeNamesMember_de5f5775-a1ec-409d-96cb-6bbdde360635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_fcb68357-0e99-442c-ab03-e41d98944d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_fcb68357-0e99-442c-ab03-e41d98944d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_5b11aa17-80dc-4c99-afa7-9a2ac2ab6fda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72f36809-c44a-4912-b3d4-05295b8e6b39" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_5b11aa17-80dc-4c99-afa7-9a2ac2ab6fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:href="holx-20200926.xsd#holx_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_28881e35-4f67-47ae-a305-64f838deb910" xlink:to="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7120210d-366a-4e10-8bfe-0f205c340a13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7120210d-366a-4e10-8bfe-0f205c340a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_6f1ffaa1-e579-4b05-9300-22f649d60b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_6f1ffaa1-e579-4b05-9300-22f649d60b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1fa73fce-fed8-43c0-9961-40269891a183" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1fa73fce-fed8-43c0-9961-40269891a183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_2d7bdf06-ab06-4d6e-b6cb-698b00243b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_AssetImpairmentCharges_2d7bdf06-ab06-4d6e-b6cb-698b00243b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_33961b64-8e24-4a10-952a-5c222362addc" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_33961b64-8e24-4a10-952a-5c222362addc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3d23a940-9489-46de-881c-5fdfac4b56da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3d23a940-9489-46de-881c-5fdfac4b56da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashEquivalentsMaturityPeriod_991443ca-1369-4d49-91cc-b749e6f6c463" xlink:href="holx-20200926.xsd#holx_CashEquivalentsMaturityPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_CashEquivalentsMaturityPeriod_991443ca-1369-4d49-91cc-b749e6f6c463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c09edb29-6633-4ece-8489-eda31a3b7edd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c09edb29-6633-4ece-8489-eda31a3b7edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_7ce43f8a-34ff-4d85-9e57-3d86df386f9f" xlink:href="holx-20200926.xsd#holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_7ce43f8a-34ff-4d85-9e57-3d86df386f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_da83e291-3e8d-4239-94af-39c1d3b470aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_da83e291-3e8d-4239-94af-39c1d3b470aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_1cc450f9-34ff-4b39-80f5-590f6b9e038d" xlink:href="holx-20200926.xsd#holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_1cc450f9-34ff-4b39-80f5-590f6b9e038d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8711a739-913d-420c-af9f-e933668f80a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8711a739-913d-420c-af9f-e933668f80a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0f480ecd-270f-4a00-8c15-9f1aa32d0c2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0f480ecd-270f-4a00-8c15-9f1aa32d0c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d9367730-1340-404b-9e7f-0d6ad3abb46f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d9367730-1340-404b-9e7f-0d6ad3abb46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_361db683-d303-476b-968d-54ce92f6933e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_Goodwill_361db683-d303-476b-968d-54ce92f6933e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_77e3fc44-3c1c-4939-b8b6-c6e64a46d060" xlink:href="holx-20200926.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_77e3fc44-3c1c-4939-b8b6-c6e64a46d060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_c63c4025-551a-49fa-a94a-cbf49b337206" xlink:href="holx-20200926.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_PrincipalAmountOfBorrowings_c63c4025-551a-49fa-a94a-cbf49b337206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_5ff46eec-d7d9-49f9-8b3b-3080b6138212" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_5ff46eec-d7d9-49f9-8b3b-3080b6138212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_cbf2c2a8-4a91-4d0e-82ef-6d38221aaa1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_cbf2c2a8-4a91-4d0e-82ef-6d38221aaa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_efcf35ba-31ef-4cdd-9b4b-397f1d980f03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_DerivativeTermOfContract_efcf35ba-31ef-4cdd-9b4b-397f1d980f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_bfe86ed2-a0bf-4807-8952-bb2f481d7e26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_bfe86ed2-a0bf-4807-8952-bb2f481d7e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_e25055b2-fdca-4361-81ce-6c2afa4d198c" xlink:href="holx-20200926.xsd#holx_NotionalAmount"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_NotionalAmount_e25055b2-fdca-4361-81ce-6c2afa4d198c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WarrantyTermForProducts_70333b57-d182-4e38-a754-c3a3508ad92f" xlink:href="holx-20200926.xsd#holx_WarrantyTermForProducts"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_WarrantyTermForProducts_70333b57-d182-4e38-a754-c3a3508ad92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_5506f05b-c37a-43bf-b1c9-a5f9fc5c24f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_AdvertisingExpense_5506f05b-c37a-43bf-b1c9-a5f9fc5c24f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bd53c98c-6c0a-4fe3-9af6-e30f311ab95b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bd53c98c-6c0a-4fe3-9af6-e30f311ab95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3685a5ed-a51e-42ca-870f-61d31acd6c3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3685a5ed-a51e-42ca-870f-61d31acd6c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TransitionServicesAgreementTerm_b62a58e8-34cf-4ca8-8631-2efb3434d6c9" xlink:href="holx-20200926.xsd#holx_TransitionServicesAgreementTerm"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_holx_TransitionServicesAgreementTerm_b62a58e8-34cf-4ca8-8631-2efb3434d6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_e8f59ea8-e1f0-428e-8854-fa7785d10d93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_e8f59ea8-e1f0-428e-8854-fa7785d10d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_1f647a75-4f5c-4d18-9983-e4123e4eb1ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_1f647a75-4f5c-4d18-9983-e4123e4eb1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_0740f9f1-9bba-4d0d-bbad-900e20b7f9df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_d508e46a-ad3a-478d-9c73-dce0f9106992" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_0740f9f1-9bba-4d0d-bbad-900e20b7f9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_356bcc13-7df1-4c6e-b040-890c3bc05763" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_394b7c5c-a056-4986-85e3-8e93ecab77e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_356bcc13-7df1-4c6e-b040-890c3bc05763" xlink:to="loc_us-gaap_IncomeTaxesPaid_394b7c5c-a056-4986-85e3-8e93ecab77e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_5ab91cdf-5909-4e1f-a932-aa0cd21d69af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_356bcc13-7df1-4c6e-b040-890c3bc05763" xlink:to="loc_us-gaap_InterestPaid_5ab91cdf-5909-4e1f-a932-aa0cd21d69af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8a96bb7e-5fda-49dc-bc2d-11a7a344c511" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_59423b86-bce7-4441-bdce-c073ed7842a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8a96bb7e-5fda-49dc-bc2d-11a7a344c511" xlink:to="loc_us-gaap_InventoryRawMaterials_59423b86-bce7-4441-bdce-c073ed7842a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_dad5f056-8435-4c05-8dbd-20e6a47167a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8a96bb7e-5fda-49dc-bc2d-11a7a344c511" xlink:to="loc_us-gaap_InventoryWorkInProcess_dad5f056-8435-4c05-8dbd-20e6a47167a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_7eb795c7-315a-43bd-8972-ec6b053d1600" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8a96bb7e-5fda-49dc-bc2d-11a7a344c511" xlink:to="loc_us-gaap_InventoryFinishedGoods_7eb795c7-315a-43bd-8972-ec6b053d1600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fa70c9a4-67b8-41b8-b947-067a3ef2b1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8a96bb7e-5fda-49dc-bc2d-11a7a344c511" xlink:to="loc_us-gaap_InventoryNet_fa70c9a4-67b8-41b8-b947-067a3ef2b1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_06db2be6-3258-4d2b-a01f-ad7f7bec043f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9704803-e160-4884-8b0e-5cba94a08ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06db2be6-3258-4d2b-a01f-ad7f7bec043f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9704803-e160-4884-8b0e-5cba94a08ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3851495-acca-4943-9b3c-2cbeba6c4d19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9704803-e160-4884-8b0e-5cba94a08ae5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3851495-acca-4943-9b3c-2cbeba6c4d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3851495-acca-4943-9b3c-2cbeba6c4d19" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentAndSoftwareMember_8640374d-f884-439c-b1bd-f21ef63032d1" xlink:href="holx-20200926.xsd#holx_EquipmentAndSoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:to="loc_holx_EquipmentAndSoftwareMember_8640374d-f884-439c-b1bd-f21ef63032d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreementMember_31c8cdf8-339e-425f-aaf9-f5aa93e9578f" xlink:href="holx-20200926.xsd#holx_EquipmentUnderCustomerUsageAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreementMember_31c8cdf8-339e-425f-aaf9-f5aa93e9578f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_4094d198-3e3f-4e42-a191-39f209c8617a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_4094d198-3e3f-4e42-a191-39f209c8617a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c776a399-e57a-4908-97a6-2c494ac06de9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_884ca229-f43b-43e7-8ccd-3e0dc54acfbc" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c776a399-e57a-4908-97a6-2c494ac06de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ca74f93-1389-4964-bbb5-c638e59e1d5c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9704803-e160-4884-8b0e-5cba94a08ae5" xlink:to="loc_srt_RangeAxis_1ca74f93-1389-4964-bbb5-c638e59e1d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84775ab6-dfa3-435b-bb24-eb457eb48b07" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1ca74f93-1389-4964-bbb5-c638e59e1d5c" xlink:to="loc_srt_RangeMember_84775ab6-dfa3-435b-bb24-eb457eb48b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2d8140e1-344b-458a-a8b3-5918d24dadf8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_84775ab6-dfa3-435b-bb24-eb457eb48b07" xlink:to="loc_srt_MinimumMember_2d8140e1-344b-458a-a8b3-5918d24dadf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dcd04ae5-bad0-416c-8837-9edbc301ef87" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_84775ab6-dfa3-435b-bb24-eb457eb48b07" xlink:to="loc_srt_MaximumMember_dcd04ae5-bad0-416c-8837-9edbc301ef87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9704803-e160-4884-8b0e-5cba94a08ae5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_25ffe9dc-9cca-4461-8206-6cb73140241b" xlink:href="holx-20200926.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_25ffe9dc-9cca-4461-8206-6cb73140241b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_ceca5345-d4d9-4caf-8019-0731e74baeab" xlink:href="holx-20200926.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_ceca5345-d4d9-4caf-8019-0731e74baeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_fbcc4937-0a65-46db-a829-579fc903704d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_fbcc4937-0a65-46db-a829-579fc903704d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_3c312c6c-329f-4f5e-9bb8-703042ad1ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_3c312c6c-329f-4f5e-9bb8-703042ad1ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_925611b1-eae0-4f6c-a3b9-717ea26def59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_Land_925611b1-eae0-4f6c-a3b9-717ea26def59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_03a49d64-c20d-4ca8-a338-6cfce4637907" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_03a49d64-c20d-4ca8-a338-6cfce4637907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3bec301b-4fd9-40e7-bdb8-68a10a3d65e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3bec301b-4fd9-40e7-bdb8-68a10a3d65e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_214bc797-6718-4b28-89d7-f90301983081" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_214bc797-6718-4b28-89d7-f90301983081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6ed059e5-ce50-4f0a-9f54-577815f64252" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6ed059e5-ce50-4f0a-9f54-577815f64252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5d015212-e4df-461e-a208-798cc80c32a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbb02a29-536a-4db3-8bc6-7999b8ec7530" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5d015212-e4df-461e-a208-798cc80c32a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ba844d17-b677-46a2-a666-79a45ebb92f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ba844d17-b677-46a2-a666-79a45ebb92f6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4f1acd17-e850-4a8d-bc38-5229f3c8f92c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4f1acd17-e850-4a8d-bc38-5229f3c8f92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4202e02e-e3e4-4540-892b-ff2f37d999e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4f1acd17-e850-4a8d-bc38-5229f3c8f92c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4202e02e-e3e4-4540-892b-ff2f37d999e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_3d698ae6-e7a7-4150-96e4-167b38b50fbb" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4202e02e-e3e4-4540-892b-ff2f37d999e9" xlink:to="loc_holx_FocalTherapeuticsInc.Member_3d698ae6-e7a7-4150-96e4-167b38b50fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_e7e14a49-8a03-4e12-81d1-2bb8352ff144" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4202e02e-e3e4-4540-892b-ff2f37d999e9" xlink:to="loc_holx_AcessaHealthMember_e7e14a49-8a03-4e12-81d1-2bb8352ff144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5ee94043-d5cc-4b85-9f5c-aedec7f384cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5ee94043-d5cc-4b85-9f5c-aedec7f384cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4543383d-0fc4-4f0e-bc6d-0affb1c28d64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5ee94043-d5cc-4b85-9f5c-aedec7f384cb" xlink:to="loc_us-gaap_SegmentDomain_4543383d-0fc4-4f0e-bc6d-0affb1c28d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_10ee6da6-c9ff-4c99-bd50-583ccbbb03df" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4543383d-0fc4-4f0e-bc6d-0affb1c28d64" xlink:to="loc_holx_MedicalAestheticsMember_10ee6da6-c9ff-4c99-bd50-583ccbbb03df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_c4aa67a6-c951-4e6b-855e-22a383739bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_c4aa67a6-c951-4e6b-855e-22a383739bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_c4aa67a6-c951-4e6b-855e-22a383739bd8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_872dfa67-bc67-4c4a-8f1c-c5a623a9a116" xlink:href="holx-20200926.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:to="loc_holx_DevelopedTechnologyMember_872dfa67-bc67-4c4a-8f1c-c5a623a9a116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d85355fd-d3b2-4ffb-b486-13cbaf80a816" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d85355fd-d3b2-4ffb-b486-13cbaf80a816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_91ca1926-ebdb-4889-aadf-78d523f9ab3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:to="loc_us-gaap_TradeNamesMember_91ca1926-ebdb-4889-aadf-78d523f9ab3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_464e6838-d475-48d6-8df3-ab9f113bf9fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5e882bb4-03f3-4856-a679-4ec0c8058549" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_464e6838-d475-48d6-8df3-ab9f113bf9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_15543993-9544-43e3-82da-76d0729a61b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_15543993-9544-43e3-82da-76d0729a61b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_15543993-9544-43e3-82da-76d0729a61b7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_addbbde2-cb17-4d1a-b760-5b456b6bbf14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_addbbde2-cb17-4d1a-b760-5b456b6bbf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_aaf79380-b9f1-48ec-8aed-0c9526cc59fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_aaf79380-b9f1-48ec-8aed-0c9526cc59fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_2452b80a-b63e-4ac6-a38c-56d9cbf99ac9" xlink:href="holx-20200926.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_CustomerRelationshipsContractsMember_2452b80a-b63e-4ac6-a38c-56d9cbf99ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_35ce0e59-e906-4135-b0fc-ef97fb5e31e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_TradeNamesMember_35ce0e59-e906-4135-b0fc-ef97fb5e31e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_5989b2c5-2cf8-4e94-bd85-0d7b14850410" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_DistributionRightsMember_5989b2c5-2cf8-4e94-bd85-0d7b14850410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d638b076-4123-4f84-a404-d4220729a705" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d638b076-4123-4f84-a404-d4220729a705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_ff276b89-3ecc-442a-bab6-3bebd0c76ad1" xlink:href="holx-20200926.xsd#holx_BusinessLicensesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_BusinessLicensesMember_ff276b89-3ecc-442a-bab6-3bebd0c76ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_f9b2538d-8d2c-4409-9dfd-82d01c12aad8" xlink:href="holx-20200926.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_AcquiredintangibleassetsMember_f9b2538d-8d2c-4409-9dfd-82d01c12aad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_7b9fba74-cc62-4d11-8769-3adf4accbeaa" xlink:href="holx-20200926.xsd#holx_InternalusesoftwareMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_InternalusesoftwareMember_7b9fba74-cc62-4d11-8769-3adf4accbeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_17d2b3de-78a2-4947-8b77-e7f4b0318de3" xlink:href="holx-20200926.xsd#holx_CapitalizedsoftwareMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb91a066-49e2-446f-80a3-17ea7263842d" xlink:to="loc_holx_CapitalizedsoftwareMember_17d2b3de-78a2-4947-8b77-e7f4b0318de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_73b2af51-de70-4887-ba10-3366791e8818" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_78223d6d-97c7-402a-954b-db41ed6aea27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_78223d6d-97c7-402a-954b-db41ed6aea27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_37485c11-16f7-4c90-bca7-c365279677a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_37485c11-16f7-4c90-bca7-c365279677a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_71625baf-e34b-43f5-966b-6ac50e72fef3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_us-gaap_AssetImpairmentCharges_71625baf-e34b-43f5-966b-6ac50e72fef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b9609e18-9a2b-48fc-a79b-6936ca9fcbb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b9609e18-9a2b-48fc-a79b-6936ca9fcbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_52cac4ce-7d78-411b-95cc-fd3e81e89425" xlink:href="holx-20200926.xsd#holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fad1b498-6d1f-4b08-99e7-8b56f975eb5e" xlink:to="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_52cac4ce-7d78-411b-95cc-fd3e81e89425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e2283cae-f711-472c-a1e5-a10a3acef465" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2283cae-f711-472c-a1e5-a10a3acef465" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b6881827-0fe6-45fa-b71e-7ebff4e36573" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b6881827-0fe6-45fa-b71e-7ebff4e36573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b6881827-0fe6-45fa-b71e-7ebff4e36573" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember_2b03e819-71d2-42a8-9ad2-dde8df105c78" xlink:href="holx-20200926.xsd#holx_DistributionagreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_holx_DistributionagreementMember_2b03e819-71d2-42a8-9ad2-dde8df105c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e895bac7-4b83-43cb-a136-ca977f6c640c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e895bac7-4b83-43cb-a136-ca977f6c640c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_acb8aa24-ec21-4193-b527-45af87a9314c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_us-gaap_TradeNamesMember_acb8aa24-ec21-4193-b527-45af87a9314c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_258ff8a6-06df-424a-b2a1-bf3b52dc5ad5" xlink:href="holx-20200926.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_holx_DevelopedTechnologyMember_258ff8a6-06df-424a-b2a1-bf3b52dc5ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_632ad5cb-80ba-40aa-9fc2-cfb3f897a46c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_632ad5cb-80ba-40aa-9fc2-cfb3f897a46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_a58df637-6621-4a47-bd23-4cf3e2be4ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4d2b9903-76c6-4efa-ae3f-647601608851" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_a58df637-6621-4a47-bd23-4cf3e2be4ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_aeb59737-5e74-4914-a7a5-e0937c04d0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_aeb59737-5e74-4914-a7a5-e0937c04d0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b1baec1a-6122-4019-b675-f5a7f9938d44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_aeb59737-5e74-4914-a7a5-e0937c04d0fa" xlink:to="loc_us-gaap_SegmentDomain_b1baec1a-6122-4019-b675-f5a7f9938d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_ca445ec7-e979-4709-82e2-0ba9b8bfc564" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b1baec1a-6122-4019-b675-f5a7f9938d44" xlink:to="loc_holx_MedicalAestheticsMember_ca445ec7-e979-4709-82e2-0ba9b8bfc564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d0acf118-3100-4ea7-8540-829bfeef673c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d0acf118-3100-4ea7-8540-829bfeef673c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4dc94b0-35de-49a8-8ff4-d4b9e3c7bee5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d0acf118-3100-4ea7-8540-829bfeef673c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4dc94b0-35de-49a8-8ff4-d4b9e3c7bee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_3b0d8ab8-0b2a-417e-8147-9e873ad7c95a" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4dc94b0-35de-49a8-8ff4-d4b9e3c7bee5" xlink:to="loc_holx_AcessaHealthMember_3b0d8ab8-0b2a-417e-8147-9e873ad7c95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_e44225eb-a2d0-40c1-a8af-8f4d1ce0dcd6" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4dc94b0-35de-49a8-8ff4-d4b9e3c7bee5" xlink:to="loc_holx_FocalTherapeuticsInc.Member_e44225eb-a2d0-40c1-a8af-8f4d1ce0dcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32a3ebf5-136e-4125-a4ac-1077ed072e5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32a3ebf5-136e-4125-a4ac-1077ed072e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32a3ebf5-136e-4125-a4ac-1077ed072e5f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a0a7c30d-abfd-4fd0-8828-ce1f808d739d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a0a7c30d-abfd-4fd0-8828-ce1f808d739d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_24eb41fd-6c9d-43a5-8eda-450c80622ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:to="loc_us-gaap_TradeNamesMember_24eb41fd-6c9d-43a5-8eda-450c80622ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1c50a8c2-2ccb-4e6d-bd85-3f1e4162b91a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f88a3798-0170-4c8a-9e85-8b9cc14756ac" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1c50a8c2-2ccb-4e6d-bd85-3f1e4162b91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6d2db15e-6f97-4c4d-81e3-0fb32445f193" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_faa61c43-42e5-4728-9c5a-5281f4137eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:to="loc_us-gaap_AssetImpairmentCharges_faa61c43-42e5-4728-9c5a-5281f4137eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d084e251-d319-49fb-8cd7-d1e8d700f410" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d084e251-d319-49fb-8cd7-d1e8d700f410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_389d5bfd-9960-48d8-b147-1ecb40ce2c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_389d5bfd-9960-48d8-b147-1ecb40ce2c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_33956ae6-72a6-4432-b563-e44260643818" xlink:href="holx-20200926.xsd#holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d9640a16-c563-4635-b502-f934154bbdbd" xlink:to="loc_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology_33956ae6-72a6-4432-b563-e44260643818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_084c3d03-49ce-4b72-bb2a-a33c1b0f0e11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7932722e-f42f-4ac0-aa5a-a81a7132d333" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_084c3d03-49ce-4b72-bb2a-a33c1b0f0e11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7932722e-f42f-4ac0-aa5a-a81a7132d333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dc9ce072-96ab-4eda-a826-aff6f0b50389" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_084c3d03-49ce-4b72-bb2a-a33c1b0f0e11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dc9ce072-96ab-4eda-a826-aff6f0b50389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_19ae44cf-8d62-4f82-9fe9-993975740b59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_084c3d03-49ce-4b72-bb2a-a33c1b0f0e11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_19ae44cf-8d62-4f82-9fe9-993975740b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_919595f6-8231-44e2-9e92-60ea8e36ee17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_084c3d03-49ce-4b72-bb2a-a33c1b0f0e11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_919595f6-8231-44e2-9e92-60ea8e36ee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_eb181f17-61a3-4fc8-bc54-dbd9e911c750" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_084c3d03-49ce-4b72-bb2a-a33c1b0f0e11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_eb181f17-61a3-4fc8-bc54-dbd9e911c750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c78e5e4f-effd-4d7b-93ba-56422dd8d311" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_0d337e57-0388-4c02-ab00-745f61c83cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c78e5e4f-effd-4d7b-93ba-56422dd8d311" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_0d337e57-0388-4c02-ab00-745f61c83cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_af6729fa-bcd3-4d81-a7d6-3044fcaa0687" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0d337e57-0388-4c02-ab00-745f61c83cdf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_af6729fa-bcd3-4d81-a7d6-3044fcaa0687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_af6729fa-bcd3-4d81-a7d6-3044fcaa0687" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_0dd87ec7-2ee0-408f-b794-87099bdc314a" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:to="loc_holx_FaxitronMember_0dd87ec7-2ee0-408f-b794-87099bdc314a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_78756646-a490-4d8c-87b8-5c4731ef7385" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:to="loc_holx_SuperSonicImagineMember_78756646-a490-4d8c-87b8-5c4731ef7385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_6cb515fc-51a6-4d94-9f8e-1de99cef2901" xlink:href="holx-20200926.xsd#holx_HealthBeaconsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:to="loc_holx_HealthBeaconsMember_6cb515fc-51a6-4d94-9f8e-1de99cef2901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_1d929034-74c6-4370-9a96-209d7e18306d" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768c103c-c39d-4754-9bb8-4e1f8fdd88a7" xlink:to="loc_holx_AcessaHealthMember_1d929034-74c6-4370-9a96-209d7e18306d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ea2eb3d1-69e6-48c4-98c1-036d979a45d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0d337e57-0388-4c02-ab00-745f61c83cdf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ea2eb3d1-69e6-48c4-98c1-036d979a45d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ea2eb3d1-69e6-48c4-98c1-036d979a45d3" xlink:to="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_214e3e7a-7081-49c5-b0ea-b32832bebf96" xlink:href="holx-20200926.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:to="loc_holx_DiagnosticsMember_214e3e7a-7081-49c5-b0ea-b32832bebf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_078d02b7-2b8f-443d-8c4a-fb8db1c69f50" xlink:href="holx-20200926.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:to="loc_holx_BreastHealthMember_078d02b7-2b8f-443d-8c4a-fb8db1c69f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_3828578e-bfd2-43d9-a899-2367eb6563a7" xlink:href="holx-20200926.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:to="loc_holx_GynSurgicalMember_3828578e-bfd2-43d9-a899-2367eb6563a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_d77e6439-dd13-4f4b-875c-7988d9eb9856" xlink:href="holx-20200926.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5fb1363b-4dad-4cab-a255-dcee0c4ab75e" xlink:to="loc_holx_SkeletalHealthMember_d77e6439-dd13-4f4b-875c-7988d9eb9856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_986c2d69-ae8a-49c2-9844-098a3d625749" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0d337e57-0388-4c02-ab00-745f61c83cdf" xlink:to="loc_us-gaap_GoodwillLineItems_986c2d69-ae8a-49c2-9844-098a3d625749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_986c2d69-ae8a-49c2-9844-098a3d625749" xlink:to="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7ed334cb-a3a3-4896-9a82-e9b64111502f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:to="loc_us-gaap_Goodwill_7ed334cb-a3a3-4896-9a82-e9b64111502f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8f655bd3-df8e-409c-869d-e293c3a79b77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8f655bd3-df8e-409c-869d-e293c3a79b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_55082499-8231-4fae-92aa-eaccb2e646c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_55082499-8231-4fae-92aa-eaccb2e646c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf9d6ef2-bee7-413b-b064-727a5190e648" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_448ed417-cb78-4853-8605-ca34542a2e88" xlink:to="loc_us-gaap_Goodwill_cf9d6ef2-bee7-413b-b064-727a5190e648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a3ed393e-2108-48e0-8959-8d737f815bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d53f5392-a434-4502-b3e3-82d18f2aded4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a3ed393e-2108-48e0-8959-8d737f815bd1" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d53f5392-a434-4502-b3e3-82d18f2aded4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ed5439ae-9492-40cf-9548-e772b826d70f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d53f5392-a434-4502-b3e3-82d18f2aded4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ed5439ae-9492-40cf-9548-e772b826d70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b69fc7fd-c62a-4635-b8ff-97aafca2f9c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ed5439ae-9492-40cf-9548-e772b826d70f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b69fc7fd-c62a-4635-b8ff-97aafca2f9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_ea162b38-c86b-408e-80cd-be29ac8c502c" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b69fc7fd-c62a-4635-b8ff-97aafca2f9c4" xlink:to="loc_holx_FocalTherapeuticsInc.Member_ea162b38-c86b-408e-80cd-be29ac8c502c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_ac22ae3b-135e-4c49-abfb-87470889a0fa" xlink:href="holx-20200926.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b69fc7fd-c62a-4635-b8ff-97aafca2f9c4" xlink:to="loc_holx_AcessaHealthMember_ac22ae3b-135e-4c49-abfb-87470889a0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d53f5392-a434-4502-b3e3-82d18f2aded4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_db5acd5c-baac-42ad-9445-b3adf873ccb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_db5acd5c-baac-42ad-9445-b3adf873ccb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_32e8700a-87db-4fba-a69f-58e4db3bd3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:to="loc_us-gaap_Goodwill_32e8700a-87db-4fba-a69f-58e4db3bd3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1625988f-2676-406a-82db-616997e6e0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1625988f-2676-406a-82db-616997e6e0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GoodwillNotAtRiskOfFailingImpairment_ed6771b9-9c4a-459e-942f-0a87792aa378" xlink:href="holx-20200926.xsd#holx_GoodwillNotAtRiskOfFailingImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_74593df2-90ec-4a01-8431-033d027dc05f" xlink:to="loc_holx_GoodwillNotAtRiskOfFailingImpairment_ed6771b9-9c4a-459e-942f-0a87792aa378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_110f0113-f4e1-4127-b10f-53ff882d3166" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_3173728b-845b-493f-8fa8-ec55e96d97a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_110f0113-f4e1-4127-b10f-53ff882d3166" xlink:to="loc_us-gaap_IncomeTaxReceivable_3173728b-845b-493f-8fa8-ec55e96d97a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3424c456-0a46-4407-8434-d8bd45c1f8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_110f0113-f4e1-4127-b10f-53ff882d3166" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3424c456-0a46-4407-8434-d8bd45c1f8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_419278c2-1b25-4014-a0a3-de3be2cee8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_110f0113-f4e1-4127-b10f-53ff882d3166" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_419278c2-1b25-4014-a0a3-de3be2cee8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ae6f1692-8023-44ac-939a-1b3643144278" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_110f0113-f4e1-4127-b10f-53ff882d3166" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ae6f1692-8023-44ac-939a-1b3643144278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostMethodEquityInvestments_80c2bd23-99bf-46e5-9c5d-97c13f6a94ed" xlink:href="holx-20200926.xsd#holx_CostMethodEquityInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_110f0113-f4e1-4127-b10f-53ff882d3166" xlink:to="loc_holx_CostMethodEquityInvestments_80c2bd23-99bf-46e5-9c5d-97c13f6a94ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquityMethodInvestmentAndLoansToAcquiree_110f0f8a-ba1c-4a12-985c-55eb0cb5acdd" xlink:href="holx-20200926.xsd#holx_EquityMethodInvestmentAndLoansToAcquiree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_110f0113-f4e1-4127-b10f-53ff882d3166" xlink:to="loc_holx_EquityMethodInvestmentAndLoansToAcquiree_110f0f8a-ba1c-4a12-985c-55eb0cb5acdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_129d4c57-3291-4c00-a8c7-c557258da0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_110f0113-f4e1-4127-b10f-53ff882d3166" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_129d4c57-3291-4c00-a8c7-c557258da0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b90d7a8f-972b-4b3c-942f-c2a94fc27746" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_110f0113-f4e1-4127-b10f-53ff882d3166" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b90d7a8f-972b-4b3c-942f-c2a94fc27746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7fce9c08-3ebc-4439-98d9-2dfebe18568c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7fce9c08-3ebc-4439-98d9-2dfebe18568c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_21d34810-d6b0-47f9-b203-035eead9afa3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_21d34810-d6b0-47f9-b203-035eead9afa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8ef393e6-d310-474a-b5ef-c81ad04bf7a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21d34810-d6b0-47f9-b203-035eead9afa3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8ef393e6-d310-474a-b5ef-c81ad04bf7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a47f0d75-ee65-44db-84f4-84b30da556a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a47f0d75-ee65-44db-84f4-84b30da556a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89dfbd04-15ed-4f85-a2ab-57643425737b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a47f0d75-ee65-44db-84f4-84b30da556a8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89dfbd04-15ed-4f85-a2ab-57643425737b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e111da4c-85ca-4022-9e13-2436bbccf1e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89dfbd04-15ed-4f85-a2ab-57643425737b" xlink:to="loc_us-gaap_InterestRateSwapMember_e111da4c-85ca-4022-9e13-2436bbccf1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_dc79d82d-cf67-4a56-b124-b8a1bcae772b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89dfbd04-15ed-4f85-a2ab-57643425737b" xlink:to="loc_us-gaap_InterestRateCapMember_dc79d82d-cf67-4a56-b124-b8a1bcae772b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b7ef945f-abd6-46ba-87b9-8d681943a359" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b7ef945f-abd6-46ba-87b9-8d681943a359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4b5d9916-f5dd-4c8b-87ea-c019886bca61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b7ef945f-abd6-46ba-87b9-8d681943a359" xlink:to="loc_us-gaap_EquityComponentDomain_4b5d9916-f5dd-4c8b-87ea-c019886bca61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_94ac311b-e96a-4b38-aa89-7b04abf2ddd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4b5d9916-f5dd-4c8b-87ea-c019886bca61" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_94ac311b-e96a-4b38-aa89-7b04abf2ddd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_7b42c242-f4ec-4678-ad94-d49c8cfca9b6" xlink:href="holx-20200926.xsd#holx_PensioninAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4b5d9916-f5dd-4c8b-87ea-c019886bca61" xlink:to="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_7b42c242-f4ec-4678-ad94-d49c8cfca9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_080d2ee7-c62d-4c88-99c2-a3fcb7967b63" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a88aab2c-9c6c-4bba-9570-0e153b51cee7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a88aab2c-9c6c-4bba-9570-0e153b51cee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_d08932d2-b991-4881-bcb7-1048640efc35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_d08932d2-b991-4881-bcb7-1048640efc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_5487007d-5f7e-4a85-9620-12c7446c2bb3" xlink:href="holx-20200926.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_5487007d-5f7e-4a85-9620-12c7446c2bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b1fa972c-62d4-481f-98c7-02858c5e048a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b1fa972c-62d4-481f-98c7-02858c5e048a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_996c870c-7c7b-4877-b320-31f3585b7920" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_996c870c-7c7b-4877-b320-31f3585b7920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_f77b7347-de14-4b4b-84c4-d2b84e4831ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_f77b7347-de14-4b4b-84c4-d2b84e4831ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c5c04f83-4581-4134-9633-c65078b37af7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c5c04f83-4581-4134-9633-c65078b37af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_430a3a69-2085-4aaf-8473-71207ccfe766" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_430a3a69-2085-4aaf-8473-71207ccfe766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_691e383e-00a7-4efe-a4ad-361210786ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_691e383e-00a7-4efe-a4ad-361210786ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_8f864836-687c-4324-a385-b96b3d9fc621" xlink:href="holx-20200926.xsd#holx_NotionalAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_65fda4df-cd5b-42d6-adda-45efef95269d" xlink:to="loc_holx_NotionalAmount_8f864836-687c-4324-a385-b96b3d9fc621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_557bd567-c8eb-4fad-8b15-893f6d06a2f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ff8a541b-6406-411e-96e8-c0fc33d0d82b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_557bd567-c8eb-4fad-8b15-893f6d06a2f4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ff8a541b-6406-411e-96e8-c0fc33d0d82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c6a0663f-d356-4eaa-b2e0-b88f20b33ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ff8a541b-6406-411e-96e8-c0fc33d0d82b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c6a0663f-d356-4eaa-b2e0-b88f20b33ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6a024b31-fb59-41b1-9ca0-e0af2b247720" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c6a0663f-d356-4eaa-b2e0-b88f20b33ba1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6a024b31-fb59-41b1-9ca0-e0af2b247720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d3edcf15-025c-4ec6-b3b8-ae8fb4e2cdea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6a024b31-fb59-41b1-9ca0-e0af2b247720" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d3edcf15-025c-4ec6-b3b8-ae8fb4e2cdea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_381e1686-9a4a-4060-bb97-c5486bfffdae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6a024b31-fb59-41b1-9ca0-e0af2b247720" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_381e1686-9a4a-4060-bb97-c5486bfffdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_baff3b08-af71-4241-93d3-316271786bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ff8a541b-6406-411e-96e8-c0fc33d0d82b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_baff3b08-af71-4241-93d3-316271786bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_963d692a-21f5-4cf0-825b-d79f48843627" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_baff3b08-af71-4241-93d3-316271786bcd" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_963d692a-21f5-4cf0-825b-d79f48843627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_666b4824-02ed-4415-8f0c-b9467fb68cac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_baff3b08-af71-4241-93d3-316271786bcd" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_666b4824-02ed-4415-8f0c-b9467fb68cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9ff1b688-c658-4c56-8a10-65025457ead2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9ff1b688-c658-4c56-8a10-65025457ead2" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ad03544b-851e-4816-8e0f-b8470ae5ba59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ad03544b-851e-4816-8e0f-b8470ae5ba59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dc437339-c781-49ad-8025-378c2f4585b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ad03544b-851e-4816-8e0f-b8470ae5ba59" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dc437339-c781-49ad-8025-378c2f4585b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5825e450-886c-4c37-a689-431783f165dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dc437339-c781-49ad-8025-378c2f4585b3" xlink:to="loc_us-gaap_InterestRateSwapMember_5825e450-886c-4c37-a689-431783f165dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f790977f-a774-4a5c-a007-6ce354ea4c93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f790977f-a774-4a5c-a007-6ce354ea4c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f790977f-a774-4a5c-a007-6ce354ea4c93" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_e973e261-493f-43e3-89ae-9b2a5e81d9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:to="loc_us-gaap_InterestRateCapMember_e973e261-493f-43e3-89ae-9b2a5e81d9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_86ad4686-f35d-440e-8475-2f19ab967f37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_86ad4686-f35d-440e-8475-2f19ab967f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_90214d72-fb1a-4fa9-a444-9a89464c7efb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_90214d72-fb1a-4fa9-a444-9a89464c7efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c8b28a0d-a0e1-41c9-b04f-9565273016e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d9bb623-aea8-4deb-8ee3-fd0e3663e7b6" xlink:to="loc_us-gaap_InterestRateSwapMember_c8b28a0d-a0e1-41c9-b04f-9565273016e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9b40cb7e-97c9-4825-a553-12f0c1e0628d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9b40cb7e-97c9-4825-a553-12f0c1e0628d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9b40cb7e-97c9-4825-a553-12f0c1e0628d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0b9cde31-4c7a-498e-b82b-c2166323c9a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0b9cde31-4c7a-498e-b82b-c2166323c9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_5d6c0ef3-6693-42fa-b4e9-dd51e3f0e5d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:to="loc_us-gaap_OtherAssetsMember_5d6c0ef3-6693-42fa-b4e9-dd51e3f0e5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_68f918c0-eef2-4635-8d0f-779faf294b41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_68f918c0-eef2-4635-8d0f-779faf294b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_afbe0330-3497-446f-8380-5ff02f7627b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0cfe1bb-ea22-4db8-9896-bbdda65a51d0" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_afbe0330-3497-446f-8380-5ff02f7627b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1f88544d-ded6-4e6b-ba47-17b49d27961d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:to="loc_us-gaap_HedgingDesignationAxis_1f88544d-ded6-4e6b-ba47-17b49d27961d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bf6f8c6e-844c-4387-ad3c-2530b15c04aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1f88544d-ded6-4e6b-ba47-17b49d27961d" xlink:to="loc_us-gaap_HedgingDesignationDomain_bf6f8c6e-844c-4387-ad3c-2530b15c04aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_53d29c9a-1fc3-44e9-bb0c-d8eb019de70f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_bf6f8c6e-844c-4387-ad3c-2530b15c04aa" xlink:to="loc_us-gaap_NondesignatedMember_53d29c9a-1fc3-44e9-bb0c-d8eb019de70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0b22985d-31a3-4853-ac22-50b6fceade6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c2dd2bd-c992-4f2f-9424-68d67fde9e5b" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0b22985d-31a3-4853-ac22-50b6fceade6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_bc80e4c2-c16d-4ca9-9f61-6a4b1c55df52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0b22985d-31a3-4853-ac22-50b6fceade6e" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_bc80e4c2-c16d-4ca9-9f61-6a4b1c55df52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_cbd91459-844a-4c3d-afe3-949b5aa0bb86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0b22985d-31a3-4853-ac22-50b6fceade6e" xlink:to="loc_us-gaap_DerivativeLiabilities_cbd91459-844a-4c3d-afe3-949b5aa0bb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_9d24c913-649e-456b-9df2-d568354fc013" xlink:href="holx-20200926.xsd#holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_9d24c913-649e-456b-9df2-d568354fc013" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f17899a6-ddf1-4cc7-ae2a-5d1fc519fe7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f17899a6-ddf1-4cc7-ae2a-5d1fc519fe7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_33d3ecad-b15d-4103-b2ed-44aeeee47e81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f17899a6-ddf1-4cc7-ae2a-5d1fc519fe7f" xlink:to="loc_us-gaap_EquityComponentDomain_33d3ecad-b15d-4103-b2ed-44aeeee47e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_afd18d3a-d8f2-4ba8-bdf5-d47f8341c56c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_33d3ecad-b15d-4103-b2ed-44aeeee47e81" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_afd18d3a-d8f2-4ba8-bdf5-d47f8341c56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_23258e75-f842-4962-b1e1-ee816e347455" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_23258e75-f842-4962-b1e1-ee816e347455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa24be6-96c4-4caa-a397-bdb0b85330aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_23258e75-f842-4962-b1e1-ee816e347455" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa24be6-96c4-4caa-a397-bdb0b85330aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_efc53921-283e-4cd5-b1c2-1f938c94162f" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa24be6-96c4-4caa-a397-bdb0b85330aa" xlink:to="loc_holx_FocalTherapeuticsInc.Member_efc53921-283e-4cd5-b1c2-1f938c94162f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d5ea7fdc-3932-4d53-8edb-7357c0092b72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d5ea7fdc-3932-4d53-8edb-7357c0092b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d1582a2-2a64-4964-8504-e51e15b7257c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d5ea7fdc-3932-4d53-8edb-7357c0092b72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d1582a2-2a64-4964-8504-e51e15b7257c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_08e8bf0f-7116-4cb3-b309-db29aba9b4cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d1582a2-2a64-4964-8504-e51e15b7257c" xlink:to="loc_us-gaap_TradeNamesMember_08e8bf0f-7116-4cb3-b309-db29aba9b4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a1d1aec6-5368-4047-80f2-fa8fab21e397" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a1d1aec6-5368-4047-80f2-fa8fab21e397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b213012-b84b-48d9-b8ea-7d0fd6f21fce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1d1aec6-5368-4047-80f2-fa8fab21e397" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b213012-b84b-48d9-b8ea-7d0fd6f21fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_efa24279-ecf8-45f2-9ed0-0b8271ba71cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b213012-b84b-48d9-b8ea-7d0fd6f21fce" xlink:to="loc_us-gaap_InterestRateSwapMember_efa24279-ecf8-45f2-9ed0-0b8271ba71cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_00c7ce96-74bc-40b1-8233-2d15804271ba" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_4c05bab8-d37c-4dd4-85f0-33d687580016" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_4c05bab8-d37c-4dd4-85f0-33d687580016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e46ae4e8-8996-4b6e-9c17-2c3f303713c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e46ae4e8-8996-4b6e-9c17-2c3f303713c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c5147ded-fd85-410c-8401-ae0c590df643" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c5147ded-fd85-410c-8401-ae0c590df643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_200b5f0e-e374-4132-88a9-302e1b806236" xlink:href="holx-20200926.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b79bab8c-a874-4e04-9e2f-8d3550234210" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_200b5f0e-e374-4132-88a9-302e1b806236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5e6be72a-6e4a-4e39-be3c-ca3dca933ffb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_bc7c3e12-e525-474c-bf32-e35bfe9c6107" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5e6be72a-6e4a-4e39-be3c-ca3dca933ffb" xlink:to="loc_us-gaap_DerivativeTable_bc7c3e12-e525-474c-bf32-e35bfe9c6107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b40ed29d-fccf-4560-be03-59e3284508ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_bc7c3e12-e525-474c-bf32-e35bfe9c6107" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b40ed29d-fccf-4560-be03-59e3284508ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2c4f2a26-efe0-41b0-b85e-407f8ef84303" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b40ed29d-fccf-4560-be03-59e3284508ac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2c4f2a26-efe0-41b0-b85e-407f8ef84303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c6bf1446-06e0-4a72-b2ba-367f29b26546" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2c4f2a26-efe0-41b0-b85e-407f8ef84303" xlink:to="loc_us-gaap_InterestRateCapMember_c6bf1446-06e0-4a72-b2ba-367f29b26546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ea680788-3697-49a3-a2e4-761adb1b2f77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2c4f2a26-efe0-41b0-b85e-407f8ef84303" xlink:to="loc_us-gaap_InterestRateSwapMember_ea680788-3697-49a3-a2e4-761adb1b2f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_75393afc-9b44-447f-9f78-9b9cb4da8a88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_bc7c3e12-e525-474c-bf32-e35bfe9c6107" xlink:to="loc_us-gaap_DerivativeLineItems_75393afc-9b44-447f-9f78-9b9cb4da8a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_09a13d74-0abb-4063-ad58-dd92a14b871d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75393afc-9b44-447f-9f78-9b9cb4da8a88" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_09a13d74-0abb-4063-ad58-dd92a14b871d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7f32612e-63c5-4f14-a6fe-6391e6844d25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f8159bd4-dc87-4543-b40f-ac31eed18dde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7f32612e-63c5-4f14-a6fe-6391e6844d25" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f8159bd4-dc87-4543-b40f-ac31eed18dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0468b1ff-4cff-4768-a700-4cba5e592a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f8159bd4-dc87-4543-b40f-ac31eed18dde" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0468b1ff-4cff-4768-a700-4cba5e592a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9e2bcdd1-ada2-4147-812a-da250e122225" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0468b1ff-4cff-4768-a700-4cba5e592a7f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9e2bcdd1-ada2-4147-812a-da250e122225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ffbd04c1-787d-4a25-94c2-625c1d31a33f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9e2bcdd1-ada2-4147-812a-da250e122225" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ffbd04c1-787d-4a25-94c2-625c1d31a33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_a96667f8-04dd-4d44-be25-d8d6b29ca7ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9e2bcdd1-ada2-4147-812a-da250e122225" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_a96667f8-04dd-4d44-be25-d8d6b29ca7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e54dd441-5a4c-4797-a4d6-d8439aa3d2ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f8159bd4-dc87-4543-b40f-ac31eed18dde" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e54dd441-5a4c-4797-a4d6-d8439aa3d2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_d510ad05-f913-4208-bd4a-52da74917d07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e54dd441-5a4c-4797-a4d6-d8439aa3d2ec" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_d510ad05-f913-4208-bd4a-52da74917d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7b29c9ab-5194-4a34-9744-d949510f2a98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5db46f96-e8f6-4159-b393-500312fdfb9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7b29c9ab-5194-4a34-9744-d949510f2a98" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5db46f96-e8f6-4159-b393-500312fdfb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e4dcb04f-d89d-4727-877d-e254efe09c5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5db46f96-e8f6-4159-b393-500312fdfb9a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e4dcb04f-d89d-4727-877d-e254efe09c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_264510b0-e35f-4d3a-aa19-1a95385113cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5db46f96-e8f6-4159-b393-500312fdfb9a" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_264510b0-e35f-4d3a-aa19-1a95385113cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableReserveDivested_64007d8c-0376-4fe7-9cbd-964d74cb86fe" xlink:href="holx-20200926.xsd#holx_AccountsReceivableReserveDivested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5db46f96-e8f6-4159-b393-500312fdfb9a" xlink:to="loc_holx_AccountsReceivableReserveDivested_64007d8c-0376-4fe7-9cbd-964d74cb86fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceReduction_bdc75512-0d79-4cf7-9afa-f8205a8767dc" xlink:href="holx-20200926.xsd#holx_AccountsReceivableAllowanceReduction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5db46f96-e8f6-4159-b393-500312fdfb9a" xlink:to="loc_holx_AccountsReceivableAllowanceReduction_bdc75512-0d79-4cf7-9afa-f8205a8767dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_a7be7bad-a14b-4bc0-a305-61f2b88cfc96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5db46f96-e8f6-4159-b393-500312fdfb9a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_a7be7bad-a14b-4bc0-a305-61f2b88cfc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1554e5a9-588c-487b-95f3-f999362b80ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_0fe89e1f-28b1-4b58-9966-7b5967c65899" xlink:href="holx-20200926.xsd#holx_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1554e5a9-588c-487b-95f3-f999362b80ef" xlink:to="loc_holx_EarningsPerShareTable_0fe89e1f-28b1-4b58-9966-7b5967c65899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6570b2fa-4fb9-4475-a2d2-ea16bcfcc4cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_0fe89e1f-28b1-4b58-9966-7b5967c65899" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6570b2fa-4fb9-4475-a2d2-ea16bcfcc4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b340582e-9c4c-426d-93f6-fd35694740bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6570b2fa-4fb9-4475-a2d2-ea16bcfcc4cf" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b340582e-9c4c-426d-93f6-fd35694740bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_5aaecfdf-c8dd-4d06-a199-b30971f624b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b340582e-9c4c-426d-93f6-fd35694740bc" xlink:to="loc_us-gaap_StockCompensationPlanMember_5aaecfdf-c8dd-4d06-a199-b30971f624b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConvertibleNotesMember_8046d265-4b57-469e-a054-7d3890e5f0f4" xlink:href="holx-20200926.xsd#holx_ConvertibleNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b340582e-9c4c-426d-93f6-fd35694740bc" xlink:to="loc_holx_ConvertibleNotesMember_8046d265-4b57-469e-a054-7d3890e5f0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:href="holx-20200926.xsd#holx_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_0fe89e1f-28b1-4b58-9966-7b5967c65899" xlink:to="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf9a0f0c-0c57-482c-abaf-b31491f124f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf9a0f0c-0c57-482c-abaf-b31491f124f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_32b38473-fc60-4177-8ff3-3c1267361894" xlink:href="holx-20200926.xsd#holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:to="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_32b38473-fc60-4177-8ff3-3c1267361894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ebc472c4-f775-4592-ab88-a18c202c924d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ebc472c4-f775-4592-ab88-a18c202c924d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_fecf4729-1a65-4661-a665-f84cc43c5e96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_97ba6437-d874-467c-8d71-273589347d4a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_fecf4729-1a65-4661-a665-f84cc43c5e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_47610952-c03c-4808-8f89-e66e72db1b71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_fecf4729-1a65-4661-a665-f84cc43c5e96" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_47610952-c03c-4808-8f89-e66e72db1b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#SummaryofSignificantAccountingPoliciesProductWarrantyDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9a86da49-1370-4bb3-bfa0-8431c470c703" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8be5876e-5718-485a-8e52-6fadbfbeb8bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a86da49-1370-4bb3-bfa0-8431c470c703" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8be5876e-5718-485a-8e52-6fadbfbeb8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_3fa5fd2c-87c4-481b-a491-a60aaac00a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8be5876e-5718-485a-8e52-6fadbfbeb8bb" xlink:to="loc_us-gaap_ProductWarrantyAccrual_3fa5fd2c-87c4-481b-a491-a60aaac00a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_305d89a0-265d-4a76-8ffa-6ce4ca27676d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8be5876e-5718-485a-8e52-6fadbfbeb8bb" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_305d89a0-265d-4a76-8ffa-6ce4ca27676d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_4b30f908-c9e6-4394-a37e-2ae5d30af777" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8be5876e-5718-485a-8e52-6fadbfbeb8bb" xlink:to="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_4b30f908-c9e6-4394-a37e-2ae5d30af777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_94dbc3eb-8432-47b9-acec-f2a7b5fb0d06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8be5876e-5718-485a-8e52-6fadbfbeb8bb" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_94dbc3eb-8432-47b9-acec-f2a7b5fb0d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_28fded75-73ad-4d16-838b-8fea0b93d2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8be5876e-5718-485a-8e52-6fadbfbeb8bb" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_28fded75-73ad-4d16-838b-8fea0b93d2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_54bf540e-e00e-4e3b-8e36-cd1947d21ace" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8be5876e-5718-485a-8e52-6fadbfbeb8bb" xlink:to="loc_us-gaap_ProductWarrantyAccrual_54bf540e-e00e-4e3b-8e36-cd1947d21ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNotes" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueNotes"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_edb85115-0c6c-4a7b-b574-9580a4e09a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5f330e0b-953c-4674-b62f-f0ed8347c07d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_edb85115-0c6c-4a7b-b574-9580a4e09a6e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5f330e0b-953c-4674-b62f-f0ed8347c07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_85a55499-7d80-473d-91e5-667498807c1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_d757e5da-806d-4958-a77a-481c18014961" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_85a55499-7d80-473d-91e5-667498807c1c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_d757e5da-806d-4958-a77a-481c18014961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1906fc63-d679-46af-a23b-0614c92ad304" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac43eed7-b92e-4506-afe6-56304d952a80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1906fc63-d679-46af-a23b-0614c92ad304" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac43eed7-b92e-4506-afe6-56304d952a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4b993eca-bb9c-461b-ad61-64c9e43e754d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac43eed7-b92e-4506-afe6-56304d952a80" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4b993eca-bb9c-461b-ad61-64c9e43e754d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_493e4722-a98c-4a1f-8b62-1373527c2f43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4b993eca-bb9c-461b-ad61-64c9e43e754d" xlink:to="loc_us-gaap_EquityComponentDomain_493e4722-a98c-4a1f-8b62-1373527c2f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1c31d25e-1239-43f2-bbee-bd07e0918d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_493e4722-a98c-4a1f-8b62-1373527c2f43" xlink:to="loc_us-gaap_RetainedEarningsMember_1c31d25e-1239-43f2-bbee-bd07e0918d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_82acd79f-a53d-4630-8c5f-cf9ac306359a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac43eed7-b92e-4506-afe6-56304d952a80" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_82acd79f-a53d-4630-8c5f-cf9ac306359a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8911a794-593b-43a4-9ad9-944e1629d3c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_82acd79f-a53d-4630-8c5f-cf9ac306359a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8911a794-593b-43a4-9ad9-944e1629d3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_1a88ec58-075a-49cd-ab87-a9f78f3985e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8911a794-593b-43a4-9ad9-944e1629d3c5" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_1a88ec58-075a-49cd-ab87-a9f78f3985e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac43eed7-b92e-4506-afe6-56304d952a80" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_904ca97a-2a52-4d87-b463-9103b6cef3e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_904ca97a-2a52-4d87-b463-9103b6cef3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax_37e303fb-a159-4d3e-808e-f80fd4018078" xlink:href="holx-20200926.xsd#holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:to="loc_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax_37e303fb-a159-4d3e-808e-f80fd4018078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ca050517-e1ac-466f-a190-0bd3bba52fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ca050517-e1ac-466f-a190-0bd3bba52fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_9a44d2c7-a721-488f-ae21-1500f1b8d268" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_19fb72bd-8f54-44a6-b5a5-3ca2aae8de0b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_9a44d2c7-a721-488f-ae21-1500f1b8d268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueBusinessRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b4d77b64-d313-4a37-a155-27bfbe04d8b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b4d77b64-d313-4a37-a155-27bfbe04d8b1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3b52da39-c240-45e8-8e39-dacfed241c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3b52da39-c240-45e8-8e39-dacfed241c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3b52da39-c240-45e8-8e39-dacfed241c5a" xlink:to="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_ff38a5f2-c0bb-40aa-b72b-243ffde77ab2" xlink:href="holx-20200926.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:to="loc_holx_DiagnosticsMember_ff38a5f2-c0bb-40aa-b72b-243ffde77ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_266bce31-9c9c-4ceb-b599-c46d5da89d55" xlink:href="holx-20200926.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:to="loc_holx_BreastHealthMember_266bce31-9c9c-4ceb-b599-c46d5da89d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_9e1ab62d-67b7-42b3-9f94-b9d6038b13ad" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:to="loc_holx_MedicalAestheticsMember_9e1ab62d-67b7-42b3-9f94-b9d6038b13ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_681b80ba-4872-42d8-b000-2080daad81d3" xlink:href="holx-20200926.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_09395c1b-e021-403a-b5b9-2e30a768b66f" xlink:to="loc_holx_SkeletalHealthMember_681b80ba-4872-42d8-b000-2080daad81d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d821c49f-ee05-4656-858e-51ec2801b8c3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:to="loc_srt_ProductOrServiceAxis_d821c49f-ee05-4656-858e-51ec2801b8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d821c49f-ee05-4656-858e-51ec2801b8c3" xlink:to="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_d978215b-9f95-41ce-ade7-0780a91e682e" xlink:href="holx-20200926.xsd#holx_CytologyPerinatalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_CytologyPerinatalMember_d978215b-9f95-41ce-ade7-0780a91e682e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_60017af4-0050-46ae-9ab6-3b128d1e0518" xlink:href="holx-20200926.xsd#holx_MolecularDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_MolecularDiagnosticsMember_60017af4-0050-46ae-9ab6-3b128d1e0518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_ccb5572e-5835-4034-86f3-68bcb366722b" xlink:href="holx-20200926.xsd#holx_BloodScreeningMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_BloodScreeningMember_ccb5572e-5835-4034-86f3-68bcb366722b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_fd295b55-b5e7-4bb2-a087-365627af8053" xlink:href="holx-20200926.xsd#holx_BreastImagingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_BreastImagingMember_fd295b55-b5e7-4bb2-a087-365627af8053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_df334e02-6f19-48c9-beed-ad394b84d5f9" xlink:href="holx-20200926.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f1a456f-e73a-4106-b142-7e3c52db6be5" xlink:to="loc_holx_InterventionalBreastSolutionsMember_df334e02-6f19-48c9-beed-ad394b84d5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b22c341e-296b-4d6d-8454-a59861c42fd9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:to="loc_srt_StatementGeographicalAxis_b22c341e-296b-4d6d-8454-a59861c42fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8863a0bb-8df7-436e-9429-ad3b131a1da3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b22c341e-296b-4d6d-8454-a59861c42fd9" xlink:to="loc_srt_SegmentGeographicalDomain_8863a0bb-8df7-436e-9429-ad3b131a1da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_794d426c-7713-4b63-9584-d116b168970e" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8863a0bb-8df7-436e-9429-ad3b131a1da3" xlink:to="loc_country_US_794d426c-7713-4b63-9584-d116b168970e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_c17a2de5-6036-4d55-9400-daa71e4547d4" xlink:href="holx-20200926.xsd#holx_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8863a0bb-8df7-436e-9429-ad3b131a1da3" xlink:to="loc_holx_InternationalMember_c17a2de5-6036-4d55-9400-daa71e4547d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_54ff10eb-8518-405a-bad9-a844bcc2b8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9ccae328-b2a4-4449-879c-f904b794c579" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_54ff10eb-8518-405a-bad9-a844bcc2b8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_57bb3221-1ee6-4630-8395-d200c8dba91b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_54ff10eb-8518-405a-bad9-a844bcc2b8d7" xlink:to="loc_us-gaap_Revenues_57bb3221-1ee6-4630-8395-d200c8dba91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueGeographicalRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8da2f243-bd03-4441-8095-06f7ab81cda7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8b2959b5-a1c7-4b49-816a-16726ee2d2b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8da2f243-bd03-4441-8095-06f7ab81cda7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8b2959b5-a1c7-4b49-816a-16726ee2d2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_11565aef-feed-4144-9e44-a42fd5b47cc2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8b2959b5-a1c7-4b49-816a-16726ee2d2b5" xlink:to="loc_srt_ProductOrServiceAxis_11565aef-feed-4144-9e44-a42fd5b47cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_67663ccf-3f04-4ec9-83b9-652905e61543" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_11565aef-feed-4144-9e44-a42fd5b47cc2" xlink:to="loc_srt_ProductsAndServicesDomain_67663ccf-3f04-4ec9-83b9-652905e61543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f09648bb-2ac1-48a6-82ad-b3317082fb08" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8b2959b5-a1c7-4b49-816a-16726ee2d2b5" xlink:to="loc_srt_StatementGeographicalAxis_f09648bb-2ac1-48a6-82ad-b3317082fb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f09648bb-2ac1-48a6-82ad-b3317082fb08" xlink:to="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_51146e55-a9b6-46ea-8181-6484b0adce17" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:to="loc_country_US_51146e55-a9b6-46ea-8181-6484b0adce17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_db8c4193-e8e5-439c-9ef4-510496c64732" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:to="loc_srt_EuropeMember_db8c4193-e8e5-439c-9ef4-510496c64732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_bc1264e8-14be-49df-80ce-332f2e318321" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:to="loc_srt_AsiaPacificMember_bc1264e8-14be-49df-80ce-332f2e318321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherGeographicRegionsMember_1a901599-c13a-48e9-bc08-349c2523d282" xlink:href="holx-20200926.xsd#holx_OtherGeographicRegionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7fa7cb5f-ab57-4e3c-896a-fd941bd879e1" xlink:to="loc_holx_OtherGeographicRegionsMember_1a901599-c13a-48e9-bc08-349c2523d282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ed97fe5f-01be-41cf-b15a-1176d86c069e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8b2959b5-a1c7-4b49-816a-16726ee2d2b5" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_ed97fe5f-01be-41cf-b15a-1176d86c069e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1215d8f7-5fa8-4776-afcd-aa64db53d38b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ed97fe5f-01be-41cf-b15a-1176d86c069e" xlink:to="loc_us-gaap_Revenues_1215d8f7-5fa8-4776-afcd-aa64db53d38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueRevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_70e2aa97-86d2-40df-9808-4fb06e6dc807" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_70e2aa97-86d2-40df-9808-4fb06e6dc807" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_adcc1f0d-d664-4c82-b38b-512962097ecf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:to="loc_srt_ProductOrServiceAxis_adcc1f0d-d664-4c82-b38b-512962097ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_adcc1f0d-d664-4c82-b38b-512962097ecf" xlink:to="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4c83f5e8-93fa-4182-b455-dc19859eee28" xlink:href="holx-20200926.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4c83f5e8-93fa-4182-b455-dc19859eee28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_46d123df-fca7-4da4-b1da-74ca03eb872d" xlink:href="holx-20200926.xsd#holx_ConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:to="loc_holx_ConsumablesMember_46d123df-fca7-4da4-b1da-74ca03eb872d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_46b71f11-db99-4b90-bfa6-0df827bdc6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:to="loc_us-gaap_ServiceMember_46b71f11-db99-4b90-bfa6-0df827bdc6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_7c3d562c-fcaa-4c62-b05c-edf74155fa2b" xlink:href="holx-20200926.xsd#holx_OtherTypeofRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c3aa3c5c-1748-42b4-bb7d-44360eee22bf" xlink:to="loc_holx_OtherTypeofRevenueMember_7c3d562c-fcaa-4c62-b05c-edf74155fa2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e545e7f1-d90f-4359-b3ba-00d5637356bd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:to="loc_srt_StatementGeographicalAxis_e545e7f1-d90f-4359-b3ba-00d5637356bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7a38f919-43c4-4829-acb4-4a1387a09237" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e545e7f1-d90f-4359-b3ba-00d5637356bd" xlink:to="loc_srt_SegmentGeographicalDomain_7a38f919-43c4-4829-acb4-4a1387a09237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9035ea0d-bd51-4d6d-b956-43581638748f" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7a38f919-43c4-4829-acb4-4a1387a09237" xlink:to="loc_country_US_9035ea0d-bd51-4d6d-b956-43581638748f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_aa2395e4-5ab2-453c-be44-71ca2dff339c" xlink:href="holx-20200926.xsd#holx_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7a38f919-43c4-4829-acb4-4a1387a09237" xlink:to="loc_holx_InternationalMember_aa2395e4-5ab2-453c-be44-71ca2dff339c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1f7198ef-4e2e-49d8-ad8a-af7d936f3836" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1f7198ef-4e2e-49d8-ad8a-af7d936f3836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_31183347-b183-4423-acb1-3e181e7aea8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1f7198ef-4e2e-49d8-ad8a-af7d936f3836" xlink:to="loc_us-gaap_SegmentDomain_31183347-b183-4423-acb1-3e181e7aea8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_98363bd0-3947-4f3d-abaa-7961c24998ec" xlink:href="holx-20200926.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_31183347-b183-4423-acb1-3e181e7aea8e" xlink:to="loc_holx_GynSurgicalMember_98363bd0-3947-4f3d-abaa-7961c24998ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_7aea7960-e582-416d-84b6-e0edb4319065" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca247204-502e-4d00-8c09-5f1f52cdb9ca" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_7aea7960-e582-416d-84b6-e0edb4319065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4f1e462e-4090-4e7c-b69d-c829e11cf67f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7aea7960-e582-416d-84b6-e0edb4319065" xlink:to="loc_us-gaap_Revenues_4f1e462e-4090-4e7c-b69d-c829e11cf67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueRemainingPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_413a849d-4a5b-45ea-90ad-4d3dc7cd122a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_27a0feae-3900-45a5-9361-4fe93d294cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_413a849d-4a5b-45ea-90ad-4d3dc7cd122a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_27a0feae-3900-45a5-9361-4fe93d294cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b1543832-91ff-4082-a637-fc1bea46881f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_27a0feae-3900-45a5-9361-4fe93d294cf7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b1543832-91ff-4082-a637-fc1bea46881f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_27a0feae-3900-45a5-9361-4fe93d294cf7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_bfc1f2cf-5e49-47b3-a559-e73199675cac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_bfc1f2cf-5e49-47b3-a559-e73199675cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c411c2e5-c6e6-4385-9961-b8a4391a2d95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ce7b3263-503b-475d-9617-9c6e156ecfc1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c411c2e5-c6e6-4385-9961-b8a4391a2d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="holx-20200926.xsd#RevenueRemainingPerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20200926.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_156e3398-cef2-46c4-a8b1-9eb0a3282fef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_786505ce-0d4c-420d-82fc-fc9e8acc64d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_156e3398-cef2-46c4-a8b1-9eb0a3282fef" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_786505ce-0d4c-420d-82fc-fc9e8acc64d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock_4507f54b-367d-44bb-8e9d-51ddd6b5b18c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_156e3398-cef2-46c4-a8b1-9eb0a3282fef" xlink:to="loc_us-gaap_LessorSalesTypeLeasesTextBlock_4507f54b-367d-44bb-8e9d-51ddd6b5b18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_d3536828-3b35-4348-abf6-e2011a444bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_156e3398-cef2-46c4-a8b1-9eb0a3282fef" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_d3536828-3b35-4348-abf6-e2011a444bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_f3d84d5f-3d7f-4b47-a6f0-5f8fef8a3f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_156e3398-cef2-46c4-a8b1-9eb0a3282fef" xlink:to="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_f3d84d5f-3d7f-4b47-a6f0-5f8fef8a3f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0af1a791-eb63-495a-a256-0b24348d30e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsAndLiabilitiesLesseeTableTextBlock_5680bd2d-2aa8-4268-92e6-87cc9b164231" xlink:href="holx-20200926.xsd#holx_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0af1a791-eb63-495a-a256-0b24348d30e4" xlink:to="loc_holx_AssetsAndLiabilitiesLesseeTableTextBlock_5680bd2d-2aa8-4268-92e6-87cc9b164231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_0f4844c2-3ac3-40b0-83a8-6037ad54514d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0af1a791-eb63-495a-a256-0b24348d30e4" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_0f4844c2-3ac3-40b0-83a8-6037ad54514d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_036401c2-f5a5-46e4-ae04-213121057f66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0af1a791-eb63-495a-a256-0b24348d30e4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_036401c2-f5a5-46e4-ae04-213121057f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_dee95bd1-84cf-4a12-81db-3caca3570508" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0af1a791-eb63-495a-a256-0b24348d30e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_dee95bd1-84cf-4a12-81db-3caca3570508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_e8ef543a-68fc-4dc0-a212-426ad52fdfc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0af1a791-eb63-495a-a256-0b24348d30e4" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_e8ef543a-68fc-4dc0-a212-426ad52fdfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_edd5410c-3e12-434d-8945-fd1b9b575348" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4510c99c-4a50-4101-b79f-2fb923794977" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_edd5410c-3e12-434d-8945-fd1b9b575348" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4510c99c-4a50-4101-b79f-2fb923794977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_644124cb-9abd-4b26-91a5-abaf5fdbc796" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4510c99c-4a50-4101-b79f-2fb923794977" xlink:to="loc_srt_RangeAxis_644124cb-9abd-4b26-91a5-abaf5fdbc796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf0d655b-0d5a-420b-900e-8124e27a6c05" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_644124cb-9abd-4b26-91a5-abaf5fdbc796" xlink:to="loc_srt_RangeMember_bf0d655b-0d5a-420b-900e-8124e27a6c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_da58a14d-f584-4372-8d2e-331f8eff24c7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bf0d655b-0d5a-420b-900e-8124e27a6c05" xlink:to="loc_srt_MinimumMember_da58a14d-f584-4372-8d2e-331f8eff24c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3c46fdfc-f9a7-40b9-97e1-cdde44321fed" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bf0d655b-0d5a-420b-900e-8124e27a6c05" xlink:to="loc_srt_MaximumMember_3c46fdfc-f9a7-40b9-97e1-cdde44321fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4d1cc665-c0a3-4d8c-8ced-04cc2d7754c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4510c99c-4a50-4101-b79f-2fb923794977" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4d1cc665-c0a3-4d8c-8ced-04cc2d7754c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0e349d16-8eed-4f8e-a131-4e86ccf3774c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4d1cc665-c0a3-4d8c-8ced-04cc2d7754c4" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0e349d16-8eed-4f8e-a131-4e86ccf3774c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_663863ee-8571-4a9c-a93b-6e8f3d761f92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_0e349d16-8eed-4f8e-a131-4e86ccf3774c" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_663863ee-8571-4a9c-a93b-6e8f3d761f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_bf0388d2-9e9e-4fda-a226-7087613ff24a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_2b603295-65f9-43b8-ba37-2ad1ff41f5b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6a31d2cc-69e3-4378-a640-27f86283d22d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4510c99c-4a50-4101-b79f-2fb923794977" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_72d07812-2f9b-409e-8b06-94a01a0dcc22" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_72d07812-2f9b-409e-8b06-94a01a0dcc22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_cd34326c-cd2c-4511-b109-317e783ea17e" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_cd34326c-cd2c-4511-b109-317e783ea17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_0c23409c-a2f8-4542-b322-39163d519419" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeasesExtensionPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_0c23409c-a2f8-4542-b322-39163d519419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_5a4a289d-1190-430d-8771-ca6894aabd9e" xlink:href="holx-20200926.xsd#holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_5a4a289d-1190-430d-8771-ca6894aabd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b29a7da0-5b36-4b2c-82b4-534ba5b30514" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b29a7da0-5b36-4b2c-82b4-534ba5b30514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_bb50fdda-7a74-401d-9517-0e3885bc7afc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_bb50fdda-7a74-401d-9517-0e3885bc7afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_d4489d7f-1795-43a9-8486-27409b59e49d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_d4489d7f-1795-43a9-8486-27409b59e49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue_3693d0e0-0cea-4917-be1c-a551bfffe23e" xlink:href="holx-20200926.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LeaseRevenuePercentageOfTotalRevenue_3693d0e0-0cea-4917-be1c-a551bfffe23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3038ad96-9918-450f-bbe2-e72b6e41360a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3038ad96-9918-450f-bbe2-e72b6e41360a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseReceivable_c8808cf3-90de-4ca5-9994-375aab7df43d" xlink:href="holx-20200926.xsd#holx_LeaseReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_holx_LeaseReceivable_c8808cf3-90de-4ca5-9994-375aab7df43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_20a8e157-bf31-4d3a-8f63-f4fbc120ca32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_20a8e157-bf31-4d3a-8f63-f4fbc120ca32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a305c6bc-bd5a-42d4-8fe2-347ac268c565" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a305c6bc-bd5a-42d4-8fe2-347ac268c565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_e5106199-3bc4-434a-906a-46bd2b7823d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_e5106199-3bc4-434a-906a-46bd2b7823d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_279905d0-5679-4287-8e0b-4056f5c7db6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeaseLiability_279905d0-5679-4287-8e0b-4056f5c7db6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4a523670-5667-49b3-b68a-c46b6624d0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseLiability_4a523670-5667-49b3-b68a-c46b6624d0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d1296377-4b10-4bfb-95e2-ff8f582c164f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d1296377-4b10-4bfb-95e2-ff8f582c164f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_133473c9-d497-40a3-be2c-f16497167f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_133473c9-d497-40a3-be2c-f16497167f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_c29e5a0d-b629-45b6-a310-8de7a7f540d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_c29e5a0d-b629-45b6-a310-8de7a7f540d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_2d8fc1a4-d096-4462-9d06-299f9bd1e1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f4d4f202-5c2d-4735-b0f9-2144ab748f28" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_2d8fc1a4-d096-4462-9d06-299f9bd1e1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7696b9ae-fa86-42c3-be83-9e47c199f9db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_3a175356-a0b0-40e8-802a-f7f88a3a52f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7696b9ae-fa86-42c3-be83-9e47c199f9db" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_3a175356-a0b0-40e8-802a-f7f88a3a52f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_86f4c596-1db2-4f3f-9b91-0e391a7944e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3a175356-a0b0-40e8-802a-f7f88a3a52f0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_86f4c596-1db2-4f3f-9b91-0e391a7944e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_86f4c596-1db2-4f3f-9b91-0e391a7944e1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_bf52cdfa-5b28-4f95-971c-1e93a81e0083" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_us-gaap_OtherAssetsMember_bf52cdfa-5b28-4f95-971c-1e93a81e0083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_a5885cbd-f41d-4323-8ff7-bbd3146298bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_a5885cbd-f41d-4323-8ff7-bbd3146298bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d01779d8-82fb-4591-b5b6-79a14c7b5c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d01779d8-82fb-4591-b5b6-79a14c7b5c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsShortTermMember_9eea3575-36cf-438a-973f-63c69bd6fd43" xlink:href="holx-20200926.xsd#holx_FinanceLeaseObligationsShortTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_holx_FinanceLeaseObligationsShortTermMember_9eea3575-36cf-438a-973f-63c69bd6fd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsLongTermMember_6f55ce8a-d058-4b21-97ae-79f67ec8c7e3" xlink:href="holx-20200926.xsd#holx_FinanceLeaseObligationsLongTermMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6566e045-8087-49b0-b019-7246031f35c3" xlink:to="loc_holx_FinanceLeaseObligationsLongTermMember_6f55ce8a-d058-4b21-97ae-79f67ec8c7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3a175356-a0b0-40e8-802a-f7f88a3a52f0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_60725eb3-e6d3-453a-b245-2b231912ae2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_60725eb3-e6d3-453a-b245-2b231912ae2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_16482daf-9699-4f68-8a4a-f40df6a346c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_16482daf-9699-4f68-8a4a-f40df6a346c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_602721f0-cc5c-4ff0-8909-5450017befd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_602721f0-cc5c-4ff0-8909-5450017befd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_b2c45174-9c13-4de8-aa3c-a4d99818ee55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_b2c45174-9c13-4de8-aa3c-a4d99818ee55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d2a4103e-ac67-421f-8667-866c8e07616c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d2a4103e-ac67-421f-8667-866c8e07616c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_376aa2c0-2547-47ee-ada2-8efa7366ffe2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_376aa2c0-2547-47ee-ada2-8efa7366ffe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8d487b72-da79-4e1e-8e2b-67d5e45f9373" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8d487b72-da79-4e1e-8e2b-67d5e45f9373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_66d2ace1-2ef4-4a82-9a70-29115a73d839" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_66d2ace1-2ef4-4a82-9a70-29115a73d839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c26cd2b6-91f6-4549-8c97-0810e605a076" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c26cd2b6-91f6-4549-8c97-0810e605a076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ac992165-4b1b-4967-99ab-2386860f3196" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ac992165-4b1b-4967-99ab-2386860f3196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_8583b03b-1acc-47c1-967e-e727a7e3e242" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_8583b03b-1acc-47c1-967e-e727a7e3e242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_692288f5-1877-49c2-8290-6f454f7e8e67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_00778b54-f5b7-45a4-a2e9-3727a0b17ade" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_692288f5-1877-49c2-8290-6f454f7e8e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2233344b-20cd-463b-84be-79cde39e67d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_5e91a67a-addf-4ee8-9429-0542e40d4e31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2233344b-20cd-463b-84be-79cde39e67d8" xlink:to="loc_us-gaap_OperatingLeaseCost_5e91a67a-addf-4ee8-9429-0542e40d4e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6a299bd5-f9d4-406a-a93f-3f77e7fdf761" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2233344b-20cd-463b-84be-79cde39e67d8" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6a299bd5-f9d4-406a-a93f-3f77e7fdf761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_cbc967cf-a3d5-4a73-b7de-17b15e14a2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2233344b-20cd-463b-84be-79cde39e67d8" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_cbc967cf-a3d5-4a73-b7de-17b15e14a2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_dad1415d-4f81-4112-a822-d1e2975d2fb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2233344b-20cd-463b-84be-79cde39e67d8" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_dad1415d-4f81-4112-a822-d1e2975d2fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_14413c94-82c5-4e5b-9d85-eec761c6681a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2233344b-20cd-463b-84be-79cde39e67d8" xlink:to="loc_us-gaap_OperatingLeasePayments_14413c94-82c5-4e5b-9d85-eec761c6681a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_bb5a22ec-95e4-4923-a595-07963b7a0448" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2233344b-20cd-463b-84be-79cde39e67d8" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_bb5a22ec-95e4-4923-a595-07963b7a0448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_1c20f124-057e-4155-8aff-88f87219d2fa" xlink:href="holx-20200926.xsd#holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2233344b-20cd-463b-84be-79cde39e67d8" xlink:to="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_1c20f124-057e-4155-8aff-88f87219d2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5a57aa5e-40bc-41ac-b9d9-2ec52d1e50df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2233344b-20cd-463b-84be-79cde39e67d8" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5a57aa5e-40bc-41ac-b9d9-2ec52d1e50df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesLeaseLiabilityMaturitySchedule2020Details"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fe283a71-0014-40d9-9a1a-53829f59d823" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe283a71-0014-40d9-9a1a-53829f59d823" xlink:to="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_17101054-495b-4485-a225-bb3ccdb3c213" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_17101054-495b-4485-a225-bb3ccdb3c213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ef43b68f-fcd8-456c-b774-322ce743d12f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ef43b68f-fcd8-456c-b774-322ce743d12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1bea81d9-55e2-4da1-9678-2f7630840a42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1bea81d9-55e2-4da1-9678-2f7630840a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3b189c64-037b-4d6a-bf0a-cc1fcb8167ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3b189c64-037b-4d6a-bf0a-cc1fcb8167ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_269816d4-e47b-4127-9231-793a119c5684" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_269816d4-e47b-4127-9231-793a119c5684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_41325301-fa85-4995-933d-01aac453463e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_41325301-fa85-4995-933d-01aac453463e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bef320c5-f8b5-432b-a1b5-9fa7c3d98a63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bef320c5-f8b5-432b-a1b5-9fa7c3d98a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b81ffe25-3635-49be-865d-19e700ee0b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b81ffe25-3635-49be-865d-19e700ee0b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b7b44e42-fc0d-48af-b592-e75ff7144f73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7f7a7c1f-62b6-42b2-b819-0c7337d01ce6" xlink:to="loc_us-gaap_OperatingLeaseLiability_b7b44e42-fc0d-48af-b592-e75ff7144f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe283a71-0014-40d9-9a1a-53829f59d823" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_19630709-ac35-4e59-b1d1-488a080b2c89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_19630709-ac35-4e59-b1d1-488a080b2c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_8e06e7b5-1d15-435e-ae1c-f28227cb6a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_8e06e7b5-1d15-435e-ae1c-f28227cb6a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e606142f-824a-4a1a-bbfd-a2a19b23855a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e606142f-824a-4a1a-bbfd-a2a19b23855a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fa358666-8977-4641-a682-5bd59a4f7db4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fa358666-8977-4641-a682-5bd59a4f7db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f803278f-bcfd-4eeb-98f4-2296fc158084" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f803278f-bcfd-4eeb-98f4-2296fc158084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_303f80cf-75e3-45d4-bc02-7c0b9d74085c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_303f80cf-75e3-45d4-bc02-7c0b9d74085c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3592a9b4-c079-4311-b428-0682aa8a1e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3592a9b4-c079-4311-b428-0682aa8a1e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9609a192-27c9-4a1f-9c6c-657c4026daf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9609a192-27c9-4a1f-9c6c-657c4026daf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3aa53bd9-08f2-4f28-ad5b-5989360aa2bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1f45161f-8b7b-48c3-83d5-a1a5a4930a32" xlink:to="loc_us-gaap_FinanceLeaseLiability_3aa53bd9-08f2-4f28-ad5b-5989360aa2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesLeaseLiabilityMaturitySchedule2020Details_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesLeaseLiabilityMaturitySchedule2019Details"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_859153c1-6fc5-4593-a29e-ff8965ef22d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_cb200f2d-8d4a-4a42-a710-635bc2bc4802" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_859153c1-6fc5-4593-a29e-ff8965ef22d6" xlink:to="loc_us-gaap_LeasesOperatingAbstract_cb200f2d-8d4a-4a42-a710-635bc2bc4802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_f9de6c15-be1f-43a3-aa77-c9890fac145b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_cb200f2d-8d4a-4a42-a710-635bc2bc4802" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_f9de6c15-be1f-43a3-aa77-c9890fac145b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9f4f000b-4644-4f0d-ac39-71182aee45f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_cb200f2d-8d4a-4a42-a710-635bc2bc4802" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9f4f000b-4644-4f0d-ac39-71182aee45f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_90643de4-321a-453b-ba74-a95c404112d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_cb200f2d-8d4a-4a42-a710-635bc2bc4802" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_90643de4-321a-453b-ba74-a95c404112d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_c116632b-d1b6-47ef-bdcd-274ea640f411" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_cb200f2d-8d4a-4a42-a710-635bc2bc4802" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_c116632b-d1b6-47ef-bdcd-274ea640f411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_a9b05752-f3a7-4154-9ab3-e24da67a6c53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_cb200f2d-8d4a-4a42-a710-635bc2bc4802" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_a9b05752-f3a7-4154-9ab3-e24da67a6c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_03623501-8708-4899-9082-189a537193a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_cb200f2d-8d4a-4a42-a710-635bc2bc4802" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_03623501-8708-4899-9082-189a537193a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_fe862cf3-24eb-4178-9179-4c0de9d2b01e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_cb200f2d-8d4a-4a42-a710-635bc2bc4802" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_fe862cf3-24eb-4178-9179-4c0de9d2b01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesCapitalAbstract_0d657983-c7b9-4502-bbec-bd75548a4a55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesCapitalAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_859153c1-6fc5-4593-a29e-ff8965ef22d6" xlink:to="loc_us-gaap_LeasesCapitalAbstract_0d657983-c7b9-4502-bbec-bd75548a4a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_bbf558f2-c7e6-4d6d-b89f-ea739336b6de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesCapitalAbstract_0d657983-c7b9-4502-bbec-bd75548a4a55" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_bbf558f2-c7e6-4d6d-b89f-ea739336b6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_075ac9cb-f9aa-4ea9-b5e1-4f3e28ad7014" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesCapitalAbstract_0d657983-c7b9-4502-bbec-bd75548a4a55" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_075ac9cb-f9aa-4ea9-b5e1-4f3e28ad7014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_3b52643d-0c5f-4591-b1d1-252fc240c77f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesCapitalAbstract_0d657983-c7b9-4502-bbec-bd75548a4a55" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_3b52643d-0c5f-4591-b1d1-252fc240c77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_8698351f-024a-4759-a601-c5c2eafa1af3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesCapitalAbstract_0d657983-c7b9-4502-bbec-bd75548a4a55" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_8698351f-024a-4759-a601-c5c2eafa1af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_7e5e12ac-28b9-4c21-a074-3f7af6841a11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesCapitalAbstract_0d657983-c7b9-4502-bbec-bd75548a4a55" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_7e5e12ac-28b9-4c21-a074-3f7af6841a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_a5deb79a-6505-4ede-9046-9f36fe63e8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesCapitalAbstract_0d657983-c7b9-4502-bbec-bd75548a4a55" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_a5deb79a-6505-4ede-9046-9f36fe63e8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_301fa692-4540-4c0a-ae69-8aebf929f03c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesCapitalAbstract_0d657983-c7b9-4502-bbec-bd75548a4a55" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_301fa692-4540-4c0a-ae69-8aebf929f03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1f545430-16f8-415f-8d83-b403ae85dbda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent_173656a0-0166-42f8-900c-c6c3083997a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1f545430-16f8-415f-8d83-b403ae85dbda" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent_173656a0-0166-42f8-900c-c6c3083997a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears_f1c60ea3-a887-4d0a-82b5-384f05e33016" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1f545430-16f8-415f-8d83-b403ae85dbda" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears_f1c60ea3-a887-4d0a-82b5-384f05e33016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears_5c534412-b66c-43c0-b536-2071cd5bab3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1f545430-16f8-415f-8d83-b403ae85dbda" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears_5c534412-b66c-43c0-b536-2071cd5bab3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears_36a4e511-1a90-47ff-82cf-6d9363d4703b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1f545430-16f8-415f-8d83-b403ae85dbda" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears_36a4e511-1a90-47ff-82cf-6d9363d4703b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears_06bdf8b7-236b-459a-817a-7b07c5e812fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1f545430-16f8-415f-8d83-b403ae85dbda" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears_06bdf8b7-236b-459a-817a-7b07c5e812fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter_0691863a-4ab8-4ce1-aa12-8fdace644ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1f545430-16f8-415f-8d83-b403ae85dbda" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter_0691863a-4ab8-4ce1-aa12-8fdace644ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_02982c89-9239-4639-867c-75d7679f8ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1f545430-16f8-415f-8d83-b403ae85dbda" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_02982c89-9239-4639-867c-75d7679f8ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_2e156bdb-721c-4849-8ff4-13d5cb8d0802" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_86c7538b-c71e-4294-bcde-b12a9e01bb09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2e156bdb-721c-4849-8ff4-13d5cb8d0802" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_86c7538b-c71e-4294-bcde-b12a9e01bb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5be99ff4-9082-4d5d-b26a-6db69fd2969c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_07ada461-28f5-4354-b0d9-8278e6c22461" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5be99ff4-9082-4d5d-b26a-6db69fd2969c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_07ada461-28f5-4354-b0d9-8278e6c22461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fb61bce3-2985-45b4-bb3b-9d0cb25acc41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_07ada461-28f5-4354-b0d9-8278e6c22461" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fb61bce3-2985-45b4-bb3b-9d0cb25acc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fb61bce3-2985-45b4-bb3b-9d0cb25acc41" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_6aaba386-6e78-441c-bfb0-bd0c81f5b21c" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:to="loc_holx_FocalTherapeuticsInc.Member_6aaba386-6e78-441c-bfb0-bd0c81f5b21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_181e43c5-90b5-4810-a9ed-31e45844a9fe" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:to="loc_holx_SuperSonicImagineMember_181e43c5-90b5-4810-a9ed-31e45844a9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_60702871-84e2-4d69-9719-24ab456dc148" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:to="loc_holx_FaxitronMember_60702871-84e2-4d69-9719-24ab456dc148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaMember_14f878e9-bce0-40b7-89af-cbfa7ada52ee" xlink:href="holx-20200926.xsd#holx_AcessaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0533119-6483-4940-9c78-9361f20a6457" xlink:to="loc_holx_AcessaMember_14f878e9-bce0-40b7-89af-cbfa7ada52ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1f57fbe2-befc-4788-a68c-b53f76ca3205" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_07ada461-28f5-4354-b0d9-8278e6c22461" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1f57fbe2-befc-4788-a68c-b53f76ca3205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_399d55c5-f166-46f8-ad8f-0e698652fcd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1f57fbe2-befc-4788-a68c-b53f76ca3205" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_399d55c5-f166-46f8-ad8f-0e698652fcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3e715dd8-d4c1-4c7e-8ec1-c916e41a710c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3e715dd8-d4c1-4c7e-8ec1-c916e41a710c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_dc3b6948-c996-4c1e-987f-2cc766a5fc4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_dc3b6948-c996-4c1e-987f-2cc766a5fc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_dc3b6948-c996-4c1e-987f-2cc766a5fc4d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaMember_d6dc7b92-4fc7-4725-b93b-d0321eba3496" xlink:href="holx-20200926.xsd#holx_AcessaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_AcessaMember_d6dc7b92-4fc7-4725-b93b-d0321eba3496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_3376c1e1-8358-4c9b-9c55-c4184e73bb34" xlink:href="holx-20200926.xsd#holx_HealthBeaconsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_HealthBeaconsMember_3376c1e1-8358-4c9b-9c55-c4184e73bb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_5c4fd7e6-7572-4bda-a427-c14e0dbbcd80" xlink:href="holx-20200926.xsd#holx_AlphaImagingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_AlphaImagingMember_5c4fd7e6-7572-4bda-a427-c14e0dbbcd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_58368008-74de-4784-90cc-0bf752a45441" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_SuperSonicImagineMember_58368008-74de-4784-90cc-0bf752a45441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_6f3109db-84f1-4fd8-a7a5-f6be6b4420bd" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_FocalTherapeuticsInc.Member_6f3109db-84f1-4fd8-a7a5-f6be6b4420bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_884350ac-f403-4c3c-aa43-242bd49ece56" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_FaxitronMember_884350ac-f403-4c3c-aa43-242bd49ece56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmsorMember_df22a456-468d-41fd-8d6a-f8d4eeef80fe" xlink:href="holx-20200926.xsd#holx_EmsorMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11f2034f-0e19-4a39-9286-9dbba2a3f56e" xlink:to="loc_holx_EmsorMember_df22a456-468d-41fd-8d6a-f8d4eeef80fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b2b174a-2836-4d1c-8f8e-94f5288f5d47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b2b174a-2836-4d1c-8f8e-94f5288f5d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b2b174a-2836-4d1c-8f8e-94f5288f5d47" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_50ccfb03-1025-43e9-b2f3-db11d48d900a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_50ccfb03-1025-43e9-b2f3-db11d48d900a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_9bbe4939-de19-41fc-855e-6dacf284285f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_9bbe4939-de19-41fc-855e-6dacf284285f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_67ec83ee-a821-4b32-92c4-a619d9288671" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_67ec83ee-a821-4b32-92c4-a619d9288671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c15b3f2f-b840-48fa-8b87-e3dca7f46469" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c17283b-e123-49a6-814b-47bc8b0b696f" xlink:to="loc_us-gaap_TradeNamesMember_c15b3f2f-b840-48fa-8b87-e3dca7f46469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a96820ea-20e7-4558-bc8f-f39b750b1850" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a96820ea-20e7-4558-bc8f-f39b750b1850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_0c5876e5-6689-4815-a34e-d149fbfbe61d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a96820ea-20e7-4558-bc8f-f39b750b1850" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_0c5876e5-6689-4815-a34e-d149fbfbe61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_4a8e5816-2a9e-4678-a4f2-542bc4630f0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_0c5876e5-6689-4815-a34e-d149fbfbe61d" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_4a8e5816-2a9e-4678-a4f2-542bc4630f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d41d875b-e195-41ac-98ce-2c3f72069b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d41d875b-e195-41ac-98ce-2c3f72069b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_154eb651-9edc-4a80-98c7-ed007345995c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d41d875b-e195-41ac-98ce-2c3f72069b4a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_154eb651-9edc-4a80-98c7-ed007345995c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_a1e8ec51-e7ed-44d0-a8a9-6ba262f5598e" xlink:href="holx-20200926.xsd#holx_ContingentHoldbackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_154eb651-9edc-4a80-98c7-ed007345995c" xlink:to="loc_holx_ContingentHoldbackMember_a1e8ec51-e7ed-44d0-a8a9-6ba262f5598e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b4682c8f-fc2a-44d2-9e44-06469814b98d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_srt_RangeAxis_b4682c8f-fc2a-44d2-9e44-06469814b98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d4981116-d87a-4746-aaf4-aa1e7d9a8c63" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b4682c8f-fc2a-44d2-9e44-06469814b98d" xlink:to="loc_srt_RangeMember_d4981116-d87a-4746-aaf4-aa1e7d9a8c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_06a1f183-6b54-4cc8-9bc9-c3ad89a78908" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d4981116-d87a-4746-aaf4-aa1e7d9a8c63" xlink:to="loc_srt_MinimumMember_06a1f183-6b54-4cc8-9bc9-c3ad89a78908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_24c12df7-24ae-494f-af8b-b880c11d6f3c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d4981116-d87a-4746-aaf4-aa1e7d9a8c63" xlink:to="loc_srt_MaximumMember_24c12df7-24ae-494f-af8b-b880c11d6f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f958da73-d476-4a63-a1cd-2d4be0c04992" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f958da73-d476-4a63-a1cd-2d4be0c04992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4c737125-12d6-48b9-8eb8-4ecb1aa9d32b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f958da73-d476-4a63-a1cd-2d4be0c04992" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4c737125-12d6-48b9-8eb8-4ecb1aa9d32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_b35b061f-7e4e-4003-b6d6-1e64ebe19593" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4c737125-12d6-48b9-8eb8-4ecb1aa9d32b" xlink:to="loc_us-gaap_OtherIncomeMember_b35b061f-7e4e-4003-b6d6-1e64ebe19593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_642f54e0-a0d4-47d8-9827-276d18bab123" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2f79ae8d-b764-4a5d-86f6-5231ece1377b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2f79ae8d-b764-4a5d-86f6-5231ece1377b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f71b2818-08ff-4b38-b671-71a3dec8b852" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f71b2818-08ff-4b38-b671-71a3dec8b852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_4ae03416-6682-43b8-a3c9-3cd8ad012989" xlink:href="holx-20200926.xsd#holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_4ae03416-6682-43b8-a3c9-3cd8ad012989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_82fb8fea-3415-48cb-80e3-c3d5ca477657" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_82fb8fea-3415-48cb-80e3-c3d5ca477657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_86209e4a-53ac-4cf8-9d77-d77e8122b714" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_86209e4a-53ac-4cf8-9d77-d77e8122b714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_6b6fcd59-71e0-493f-a69c-8990612106a6" xlink:href="holx-20200926.xsd#holx_Holdback"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_Holdback_6b6fcd59-71e0-493f-a69c-8990612106a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9ebbf1b-7e75-4bdd-a607-ff1efc97126a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9ebbf1b-7e75-4bdd-a607-ff1efc97126a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_43bf0710-107e-4393-9d9f-462edbe53a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_Goodwill_43bf0710-107e-4393-9d9f-462edbe53a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2459896b-211c-49ae-a630-fc310b2fa80d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2459896b-211c-49ae-a630-fc310b2fa80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_2598db13-8eda-49eb-a82e-b2a7a3c5d677" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_2598db13-8eda-49eb-a82e-b2a7a3c5d677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b5583b4c-fa07-4a1b-99c3-c41a26835421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b5583b4c-fa07-4a1b-99c3-c41a26835421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_6bfef7ed-f68c-49fd-92d3-66f5eb089db9" xlink:href="holx-20200926.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_6bfef7ed-f68c-49fd-92d3-66f5eb089db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_aa06a90b-27c4-4551-ba7f-422146f56b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_aa06a90b-27c4-4551-ba7f-422146f56b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired_21966ff0-e9e7-4580-9ec7-f24ecefe8374" xlink:href="holx-20200926.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationSharesAcquired_21966ff0-e9e7-4580-9ec7-f24ecefe8374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_aa1c4a30-d41d-4c79-b309-2127f81500e8" xlink:href="holx-20200926.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_aa1c4a30-d41d-4c79-b309-2127f81500e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_c581bebc-e6b5-4925-8443-1fd121db00dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_c581bebc-e6b5-4925-8443-1fd121db00dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_0246f3a7-62e6-4541-b1f9-3ce6b2ba95b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_0246f3a7-62e6-4541-b1f9-3ce6b2ba95b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_43dd15df-4aa0-474f-b9e6-85e5eee05469" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_43dd15df-4aa0-474f-b9e6-85e5eee05469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_ce8c059f-c6d8-4de2-b5ac-9f47f99a781d" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_ce8c059f-c6d8-4de2-b5ac-9f47f99a781d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_897e4afe-91c8-4397-85d7-f79a87f71638" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_897e4afe-91c8-4397-85d7-f79a87f71638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_e03ce3fa-8423-44c8-990b-bf83b0a23d3e" xlink:href="holx-20200926.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_e03ce3fa-8423-44c8-990b-bf83b0a23d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a8d361d0-bb57-4f0f-8033-baac77d48701" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a8d361d0-bb57-4f0f-8033-baac77d48701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet_07f4ac0a-34ed-47fc-8192-5353548d6ec6" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet_07f4ac0a-34ed-47fc-8192-5353548d6ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a8060df7-1a87-4820-8834-1fafa1f26a49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a8060df7-1a87-4820-8834-1fafa1f26a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_cfcf5091-6a82-49ff-822c-f14ff00a931b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_cfcf5091-6a82-49ff-822c-f14ff00a931b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions_2ed94eed-ea1f-4083-bd43-01056f36202f" xlink:href="holx-20200926.xsd#holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions_2ed94eed-ea1f-4083-bd43-01056f36202f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentOfContingentConsideration_de22b998-a8dd-4127-944f-82ba1dbacf8b" xlink:href="holx-20200926.xsd#holx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_PaymentOfContingentConsideration_de22b998-a8dd-4127-944f-82ba1dbacf8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AdditionalPurchaseConsideration_d187ac12-8044-46b5-9d0f-0814738d419c" xlink:href="holx-20200926.xsd#holx_AdditionalPurchaseConsideration"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_AdditionalPurchaseConsideration_d187ac12-8044-46b5-9d0f-0814738d419c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_8b4499ef-6d68-4b59-bb26-55a8e77bfcd8" xlink:href="holx-20200926.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_8b4499ef-6d68-4b59-bb26-55a8e77bfcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_c5dc05a1-3d7d-409c-ad70-eb2cf09cf729" xlink:href="holx-20200926.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1e6fee8-5937-41f5-a38f-6b69509c4526" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_c5dc05a1-3d7d-409c-ad70-eb2cf09cf729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationAcessaDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_739cfcc1-4a29-4141-a54b-d8ee2cc5642c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bdcc675d-f76e-40d3-a2af-784ee2729278" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_739cfcc1-4a29-4141-a54b-d8ee2cc5642c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bdcc675d-f76e-40d3-a2af-784ee2729278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9ee24c51-84fa-44de-abbb-ad0530d7d205" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bdcc675d-f76e-40d3-a2af-784ee2729278" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9ee24c51-84fa-44de-abbb-ad0530d7d205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22b8b57c-6d32-4d35-90df-40ad6f42e251" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ee24c51-84fa-44de-abbb-ad0530d7d205" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22b8b57c-6d32-4d35-90df-40ad6f42e251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaMember_7efe1b41-c9ce-4e36-ab9b-bdcb26d5fd22" xlink:href="holx-20200926.xsd#holx_AcessaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22b8b57c-6d32-4d35-90df-40ad6f42e251" xlink:to="loc_holx_AcessaMember_7efe1b41-c9ce-4e36-ab9b-bdcb26d5fd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0737b6d1-3255-44a6-8136-459f746323fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bdcc675d-f76e-40d3-a2af-784ee2729278" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0737b6d1-3255-44a6-8136-459f746323fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dfdc8181-43b9-4bd8-88da-4c4409930b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0737b6d1-3255-44a6-8136-459f746323fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dfdc8181-43b9-4bd8-88da-4c4409930b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a56d3e2a-25b5-4ca5-b0c8-90326e38f991" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dfdc8181-43b9-4bd8-88da-4c4409930b0d" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a56d3e2a-25b5-4ca5-b0c8-90326e38f991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4536c4bb-ac9c-44b8-8180-713f45b9b10b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dfdc8181-43b9-4bd8-88da-4c4409930b0d" xlink:to="loc_us-gaap_TradeNamesMember_4536c4bb-ac9c-44b8-8180-713f45b9b10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bdcc675d-f76e-40d3-a2af-784ee2729278" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c2c6255d-d798-4aa1-b014-f7e17094899b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c2c6255d-d798-4aa1-b014-f7e17094899b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_655d940a-640f-414e-bbc3-8cc81b4e5cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_655d940a-640f-414e-bbc3-8cc81b4e5cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dc197667-a336-41c8-afc4-d9a574d50f58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dc197667-a336-41c8-afc4-d9a574d50f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_01bf65f5-9532-415b-9734-cc132e5cc1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_01bf65f5-9532-415b-9734-cc132e5cc1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5d4ea596-f7a8-4130-b294-6262d4ba75e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5d4ea596-f7a8-4130-b294-6262d4ba75e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0eca6595-8a5d-40bf-a860-fdaae39bde84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0eca6595-8a5d-40bf-a860-fdaae39bde84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dd71ce0b-1fa8-412a-821a-8dc1bd4432e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_Goodwill_dd71ce0b-1fa8-412a-821a-8dc1bd4432e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8045aeb0-760c-4018-88a5-57833b411372" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_56de6050-190c-40e5-8269-1c1db266cf29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8045aeb0-760c-4018-88a5-57833b411372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9872bee8-8d2c-4902-b67c-bd97c4441a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f151bc0-67e2-49f9-965e-8b3e601d1365" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9872bee8-8d2c-4902-b67c-bd97c4441a9d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f151bc0-67e2-49f9-965e-8b3e601d1365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_43585a04-7731-49fe-b85f-307e4d074838" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f151bc0-67e2-49f9-965e-8b3e601d1365" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_43585a04-7731-49fe-b85f-307e4d074838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24566ba0-8d56-4ef8-aa9b-5c4e0feeeaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_43585a04-7731-49fe-b85f-307e4d074838" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24566ba0-8d56-4ef8-aa9b-5c4e0feeeaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_9372a432-9e91-4848-9ec3-2f5202af7c7b" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24566ba0-8d56-4ef8-aa9b-5c4e0feeeaa3" xlink:to="loc_holx_SuperSonicImagineMember_9372a432-9e91-4848-9ec3-2f5202af7c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f151bc0-67e2-49f9-965e-8b3e601d1365" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6e2e62ec-aca6-4f87-b94c-6a6a98953bca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6e2e62ec-aca6-4f87-b94c-6a6a98953bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8683f8f8-ce53-40ed-8f87-db84f5ece143" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8683f8f8-ce53-40ed-8f87-db84f5ece143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1aeec56d-b2af-4019-b030-ac66638c0ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1aeec56d-b2af-4019-b030-ac66638c0ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f65538b3-c980-47aa-a7f4-6ca2346ac482" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f65538b3-c980-47aa-a7f4-6ca2346ac482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1d678f39-543b-4b67-8c09-19d6b72bf701" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1d678f39-543b-4b67-8c09-19d6b72bf701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_9e958fa6-c546-4b97-a1d1-644001a35f09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_9e958fa6-c546-4b97-a1d1-644001a35f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_e1fba439-969b-40c4-8b45-f38ab6aef5b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_e1fba439-969b-40c4-8b45-f38ab6aef5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_426f5bbc-4f39-4cac-a06d-de7c30459a67" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_426f5bbc-4f39-4cac-a06d-de7c30459a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_b2dc22d6-2087-415d-8646-0297222e689c" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_b2dc22d6-2087-415d-8646-0297222e689c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_9be3c49b-5139-4274-b565-a96995e21ff1" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_9be3c49b-5139-4274-b565-a96995e21ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_948c5102-cf61-4a90-89ae-9e74e800f818" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_948c5102-cf61-4a90-89ae-9e74e800f818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_10244f64-38ae-4307-8c27-ac531e684ad9" xlink:href="holx-20200926.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_10244f64-38ae-4307-8c27-ac531e684ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_99bf94aa-8ce6-4560-85c3-710e3a778a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_99bf94aa-8ce6-4560-85c3-710e3a778a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a73a5a55-e9a9-481d-baf8-2d728a8e518b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_Goodwill_a73a5a55-e9a9-481d-baf8-2d728a8e518b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a6e3430a-e050-4231-ab13-c47eec754afc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_43c380cc-1b82-4df2-acaa-3b6f219cdb80" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a6e3430a-e050-4231-ab13-c47eec754afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_40ff8655-913d-4951-910c-a4344a4c81b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2b44e9a-cec1-4805-979c-e3350a4572e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_40ff8655-913d-4951-910c-a4344a4c81b7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2b44e9a-cec1-4805-979c-e3350a4572e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_81d5771a-3a4b-41e6-aa2b-02184401c34e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2b44e9a-cec1-4805-979c-e3350a4572e6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_81d5771a-3a4b-41e6-aa2b-02184401c34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01b28e84-5470-467e-b37c-59e6484445e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81d5771a-3a4b-41e6-aa2b-02184401c34e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01b28e84-5470-467e-b37c-59e6484445e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_4a7d75ee-64bf-4a34-8046-3304b9fbf947" xlink:href="holx-20200926.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01b28e84-5470-467e-b37c-59e6484445e6" xlink:to="loc_holx_FocalTherapeuticsInc.Member_4a7d75ee-64bf-4a34-8046-3304b9fbf947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c5045cd-0937-415d-a834-97289bb7725e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2b44e9a-cec1-4805-979c-e3350a4572e6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c5045cd-0937-415d-a834-97289bb7725e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c5045cd-0937-415d-a834-97289bb7725e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_60bceb52-85f4-47f6-8374-5dc4240530e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_60bceb52-85f4-47f6-8374-5dc4240530e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_928a43a1-c6fa-4328-ac8c-54cb6b6fb1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_928a43a1-c6fa-4328-ac8c-54cb6b6fb1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_0d2d77a6-106c-4a7b-8e93-4c799b110b1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52d78890-2c2b-4a32-9548-0560da63623b" xlink:to="loc_us-gaap_TradeNamesMember_0d2d77a6-106c-4a7b-8e93-4c799b110b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2b44e9a-cec1-4805-979c-e3350a4572e6" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_cda3186e-7175-4207-b0db-c6e10fdeeee4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_cda3186e-7175-4207-b0db-c6e10fdeeee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b412fedf-7455-45a6-a677-44de539daaac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b412fedf-7455-45a6-a677-44de539daaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9b7350dc-d75c-4ed4-b7bd-2901d6c00937" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9b7350dc-d75c-4ed4-b7bd-2901d6c00937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_7c9dfc4a-1370-404a-bf33-e58f3eb7422c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_7c9dfc4a-1370-404a-bf33-e58f3eb7422c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_734b4569-a9db-4f36-a5b3-e75b0d017064" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_734b4569-a9db-4f36-a5b3-e75b0d017064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_07c1ef5c-5839-4a0d-9405-914101d41e31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_07c1ef5c-5839-4a0d-9405-914101d41e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d3268878-628a-4931-93c6-f8faadec802b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d3268878-628a-4931-93c6-f8faadec802b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_169a2347-3ec1-4af7-9523-dd3ac5523503" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_169a2347-3ec1-4af7-9523-dd3ac5523503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c6befe5c-7dd5-4767-b9ea-80a182df008f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_Goodwill_c6befe5c-7dd5-4767-b9ea-80a182df008f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c77b8e3d-4548-4248-b924-c0cf1f0bbf10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50b9051c-f7c2-473e-ad13-615c987235d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c77b8e3d-4548-4248-b924-c0cf1f0bbf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessCombinationsPurchasePriceAllocationFaxitronDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_475bbe69-c8ee-4b47-94aa-b7e42458b169" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e88bd571-bf50-442c-8405-16e99683425c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_475bbe69-c8ee-4b47-94aa-b7e42458b169" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e88bd571-bf50-442c-8405-16e99683425c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0bf8431f-aa1f-4a01-822d-92b7a2d8fa1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e88bd571-bf50-442c-8405-16e99683425c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0bf8431f-aa1f-4a01-822d-92b7a2d8fa1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_364a636f-01a4-4258-a0d5-6297a8a471c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0bf8431f-aa1f-4a01-822d-92b7a2d8fa1e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_364a636f-01a4-4258-a0d5-6297a8a471c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FaxitronMember_87b3de2f-7213-41ae-936d-05597018adcb" xlink:href="holx-20200926.xsd#holx_FaxitronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_364a636f-01a4-4258-a0d5-6297a8a471c6" xlink:to="loc_holx_FaxitronMember_87b3de2f-7213-41ae-936d-05597018adcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_df6ee9f0-d22b-4898-8766-001e493629e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e88bd571-bf50-442c-8405-16e99683425c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_df6ee9f0-d22b-4898-8766-001e493629e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_df6ee9f0-d22b-4898-8766-001e493629e2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_35b1abfe-1a23-4a43-83f1-8239b2e609b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_35b1abfe-1a23-4a43-83f1-8239b2e609b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c91b6df4-6e0e-4a4a-b4d3-cfa385500f3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c91b6df4-6e0e-4a4a-b4d3-cfa385500f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4fa43345-dac0-4c5e-aac6-8428a4094d99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4fa43345-dac0-4c5e-aac6-8428a4094d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b0411ec7-f970-4ef5-ab8f-923b448accff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04746aed-6429-498d-a2d8-3d8ca300f457" xlink:to="loc_us-gaap_TradeNamesMember_b0411ec7-f970-4ef5-ab8f-923b448accff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e88bd571-bf50-442c-8405-16e99683425c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d53883e0-b065-4170-aa5e-9d911fce8e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d53883e0-b065-4170-aa5e-9d911fce8e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_367858ab-c096-4a86-8843-cc0ee9201688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_367858ab-c096-4a86-8843-cc0ee9201688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1af2b40e-d9ad-4521-a154-ebd1351d4120" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1af2b40e-d9ad-4521-a154-ebd1351d4120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_23dddd8b-191d-42e0-9c2d-fa3fe50f3cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_23dddd8b-191d-42e0-9c2d-fa3fe50f3cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_68b0207c-3434-4573-b2b8-e7db5b606ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_68b0207c-3434-4573-b2b8-e7db5b606ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f8e2d5c9-8e62-4e5e-8c35-9afcae4bf905" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f8e2d5c9-8e62-4e5e-8c35-9afcae4bf905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_48f0bce4-aed7-4c85-946e-0ee65f9ef197" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_48f0bce4-aed7-4c85-946e-0ee65f9ef197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_61fb9dfd-bae0-4de5-b100-4801e6eadf1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_61fb9dfd-bae0-4de5-b100-4801e6eadf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_50e605fe-7cbb-42c9-8286-132b3948c72a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_50e605fe-7cbb-42c9-8286-132b3948c72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_083b559a-3c28-47a9-b581-9c7d209dad5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_Goodwill_083b559a-3c28-47a9-b581-9c7d209dad5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20deafda-40c8-4d49-ac85-f890cdd54cec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1753a0c-e6e6-4fc3-9814-10a6f96d2a4a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20deafda-40c8-4d49-ac85-f890cdd54cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#EquityMethodInvestmentDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_82628044-3dc7-4176-8c0c-8f70e32e1edf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7e1ffdd9-480c-4213-8283-239ec6b18f31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_82628044-3dc7-4176-8c0c-8f70e32e1edf" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7e1ffdd9-480c-4213-8283-239ec6b18f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_35735db9-e57d-4447-a4ba-69173d4638da" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7e1ffdd9-480c-4213-8283-239ec6b18f31" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_35735db9-e57d-4447-a4ba-69173d4638da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5c8a021f-5279-4f16-8586-93d3524d1098" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_35735db9-e57d-4447-a4ba-69173d4638da" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5c8a021f-5279-4f16-8586-93d3524d1098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_49b44e2d-e21a-4b72-a6ff-2f2dda7f01ca" xlink:href="holx-20200926.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5c8a021f-5279-4f16-8586-93d3524d1098" xlink:to="loc_holx_SuperSonicImagineMember_49b44e2d-e21a-4b72-a6ff-2f2dda7f01ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5ef8344f-f535-4837-9a54-b15959dd32b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7e1ffdd9-480c-4213-8283-239ec6b18f31" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5ef8344f-f535-4837-9a54-b15959dd32b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_206e1ab1-a62e-458b-ae1a-f09b8e2d8244" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5ef8344f-f535-4837-9a54-b15959dd32b6" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_206e1ab1-a62e-458b-ae1a-f09b8e2d8244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ad39bac0-7c1a-4510-bb36-a112156cfcd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5ef8344f-f535-4837-9a54-b15959dd32b6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ad39bac0-7c1a-4510-bb36-a112156cfcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12b906df-9cd2-435b-8ae5-d4151f14f885" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_92081de5-7b68-4dc5-b3e1-e1e89dcf4828" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12b906df-9cd2-435b-8ae5-d4151f14f885" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_92081de5-7b68-4dc5-b3e1-e1e89dcf4828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6aceba4e-0933-4ecd-ac8f-13a2326b1732" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12b906df-9cd2-435b-8ae5-d4151f14f885" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6aceba4e-0933-4ecd-ac8f-13a2326b1732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ea67afc6-02b5-40c3-80d2-8158eb6ac497" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ea67afc6-02b5-40c3-80d2-8158eb6ac497" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_901419dd-a267-42d6-ba6a-1b1466e95571" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_901419dd-a267-42d6-ba6a-1b1466e95571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_901419dd-a267-42d6-ba6a-1b1466e95571" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember_0ff4c2c1-ba40-47f4-97c1-ab093f1153c8" xlink:href="holx-20200926.xsd#holx_Fiscal2019ActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_Fiscal2019ActionMember_0ff4c2c1-ba40-47f4-97c1-ab093f1153c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember_ff1a7407-36e6-424f-b34c-6468312aae71" xlink:href="holx-20200926.xsd#holx_Fiscal2018ActionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_Fiscal2018ActionMember_ff1a7407-36e6-424f-b34c-6468312aae71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtheractionMember_1998d066-67d3-46e5-979d-d007d0eb1358" xlink:href="holx-20200926.xsd#holx_OtheractionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_OtheractionMember_1998d066-67d3-46e5-979d-d007d0eb1358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember_fcb42a46-267d-46ca-9687-b017cd1e3949" xlink:href="holx-20200926.xsd#holx_Fiscal2020ActionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_Fiscal2020ActionMember_fcb42a46-267d-46ca-9687-b017cd1e3949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020Member_9727b4be-b23b-4302-8eb6-23a1a77d5f64" xlink:href="holx-20200926.xsd#holx_Fiscal2020Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6dd4e19e-41df-4965-88a1-7e41c3abc764" xlink:to="loc_holx_Fiscal2020Member_9727b4be-b23b-4302-8eb6-23a1a77d5f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ebd01cc9-f333-44a1-ab89-129d8ff52643" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:to="loc_us-gaap_RestructuringPlanAxis_ebd01cc9-f333-44a1-ab89-129d8ff52643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_ebd01cc9-f333-44a1-ab89-129d8ff52643" xlink:to="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSeventeenMember_2b51418a-c11d-4c15-847d-0b4bff492193" xlink:href="holx-20200926.xsd#holx_TwoThousandSeventeenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_TwoThousandSeventeenMember_2b51418a-c11d-4c15-847d-0b4bff492193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwothousandeighteenMember_afb58f92-03ea-40bf-8941-44bc5b7cdeca" xlink:href="holx-20200926.xsd#holx_TwothousandeighteenMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_TwothousandeighteenMember_afb58f92-03ea-40bf-8941-44bc5b7cdeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_6cb791f6-813b-4395-a861-bbe0a3ad6282" xlink:href="holx-20200926.xsd#holx_Fiscal2019chargesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_Fiscal2019chargesMember_6cb791f6-813b-4395-a861-bbe0a3ad6282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020Member_0e0e564f-a77f-405b-ba33-88c2cddd8a33" xlink:href="holx-20200926.xsd#holx_Fiscal2020Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_Fiscal2020Member_0e0e564f-a77f-405b-ba33-88c2cddd8a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember_d2ae8d1e-5457-4938-9fa1-305f4eefef58" xlink:href="holx-20200926.xsd#holx_Fiscal2020ChargesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_fce01184-726c-4292-9bc2-1bbd23db0b74" xlink:to="loc_holx_Fiscal2020ChargesMember_d2ae8d1e-5457-4938-9fa1-305f4eefef58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7865baff-60a8-4ac7-a671-75b9953d0e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7865baff-60a8-4ac7-a671-75b9953d0e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c3f6bdd6-d1c1-4f9d-9e33-d41f55e79e47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7865baff-60a8-4ac7-a671-75b9953d0e1a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c3f6bdd6-d1c1-4f9d-9e33-d41f55e79e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_fcd9d95b-f489-4610-90e2-3ab30a1302d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c3f6bdd6-d1c1-4f9d-9e33-d41f55e79e47" xlink:to="loc_us-gaap_RestructuringChargesMember_fcd9d95b-f489-4610-90e2-3ab30a1302d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20653155-0234-45c6-8ba3-0f20ba1f5c3d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_f51b213e-d926-410a-9361-9d8baa2d2ae8" xlink:href="holx-20200926.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:to="loc_holx_ReductionOfWorkforceExpenses_f51b213e-d926-410a-9361-9d8baa2d2ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_32625e23-42fd-4b6a-869d-58873fe9db8e" xlink:href="holx-20200926.xsd#holx_DivestitureCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:to="loc_holx_DivestitureCharges_32625e23-42fd-4b6a-869d-58873fe9db8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_bef91c67-1e09-4e1a-b8cb-25544b8fe3ec" xlink:href="holx-20200926.xsd#holx_FacilityClosureCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:to="loc_holx_FacilityClosureCosts_bef91c67-1e09-4e1a-b8cb-25544b8fe3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_0703c6ef-d955-4ed4-b62f-5f8fd6581c8d" xlink:href="holx-20200926.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5420b1fc-7892-4fae-9ac5-97d8f011366d" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_0703c6ef-d955-4ed4-b62f-5f8fd6581c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c05e9602-0113-4333-be94-e68d5179fbbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c05e9602-0113-4333-be94-e68d5179fbbe" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_483ac3cb-2778-49e4-896d-7b77c7c8bebe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:to="loc_us-gaap_RestructuringPlanAxis_483ac3cb-2778-49e4-896d-7b77c7c8bebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_483ac3cb-2778-49e4-896d-7b77c7c8bebe" xlink:to="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember_1363829a-6c40-4e79-89bd-78eff581dae6" xlink:href="holx-20200926.xsd#holx_Fiscal2020ChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:to="loc_holx_Fiscal2020ChargesMember_1363829a-6c40-4e79-89bd-78eff581dae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_eaf16d76-6e21-4bd6-b363-c3dc6360290a" xlink:href="holx-20200926.xsd#holx_Fiscal2019chargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:to="loc_holx_Fiscal2019chargesMember_eaf16d76-6e21-4bd6-b363-c3dc6360290a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwothousandeighteenMember_4fabb933-89cf-4d3f-abb7-feceed93c044" xlink:href="holx-20200926.xsd#holx_TwothousandeighteenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:to="loc_holx_TwothousandeighteenMember_4fabb933-89cf-4d3f-abb7-feceed93c044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSeventeenMember_a9079f28-1a3b-4647-ac00-d3606fbd85be" xlink:href="holx-20200926.xsd#holx_TwoThousandSeventeenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_450842f0-11a9-4013-9b03-2d3772e78c0f" xlink:to="loc_holx_TwoThousandSeventeenMember_a9079f28-1a3b-4647-ac00-d3606fbd85be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5510617b-72c2-48dd-bdca-e4e94beef70c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5510617b-72c2-48dd-bdca-e4e94beef70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5510617b-72c2-48dd-bdca-e4e94beef70c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember_8f644711-2014-4c74-afaf-6e6b1a0d729c" xlink:href="holx-20200926.xsd#holx_Fiscal2020ActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_Fiscal2020ActionMember_8f644711-2014-4c74-afaf-6e6b1a0d729c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember_696b904f-504c-4d78-b18e-0a7dc4651f28" xlink:href="holx-20200926.xsd#holx_Fiscal2019ActionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_Fiscal2019ActionMember_696b904f-504c-4d78-b18e-0a7dc4651f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember_21b593c5-5334-44c7-a010-a279b878dd3b" xlink:href="holx-20200926.xsd#holx_Fiscal2018ActionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_Fiscal2018ActionMember_21b593c5-5334-44c7-a010-a279b878dd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherOperatingCostReductionsMember_9c3280ef-fea9-4ccc-ab5e-7cf304d3c4f1" xlink:href="holx-20200926.xsd#holx_OtherOperatingCostReductionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_OtherOperatingCostReductionsMember_9c3280ef-fea9-4ccc-ab5e-7cf304d3c4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2017ActionsMember_2eb85966-8192-4dd3-a322-5abe4498a9c2" xlink:href="holx-20200926.xsd#holx_Fiscal2017ActionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3f512123-9d37-4bf6-9e25-93e05cc2e1d2" xlink:to="loc_holx_Fiscal2017ActionsMember_2eb85966-8192-4dd3-a322-5abe4498a9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bdb922f0-644d-4078-b021-e4b0b8b7f764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bdb922f0-644d-4078-b021-e4b0b8b7f764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2a1a96da-0bd4-44c7-86b3-3c0f76ea24b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bdb922f0-644d-4078-b021-e4b0b8b7f764" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2a1a96da-0bd4-44c7-86b3-3c0f76ea24b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_40b57bd0-3a7b-4ee2-b844-67aa5cb614fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2a1a96da-0bd4-44c7-86b3-3c0f76ea24b9" xlink:to="loc_us-gaap_RestructuringChargesMember_40b57bd0-3a7b-4ee2-b844-67aa5cb614fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c8599add-9541-4df9-88f5-ed973a17534b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41457f41-c72c-46f5-a64c-fcb8845e6f9d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_c8599add-9541-4df9-88f5-ed973a17534b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c8599add-9541-4df9-88f5-ed973a17534b" xlink:to="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f0b25c7d-13ef-413f-8f80-6aa119871faa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_us-gaap_RestructuringReserve_f0b25c7d-13ef-413f-8f80-6aa119871faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_d1ccb55e-7bed-4204-b40f-e37d115fe94d" xlink:href="holx-20200926.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_d1ccb55e-7bed-4204-b40f-e37d115fe94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_481e1da3-065e-49cf-a39d-4c82e1670a70" xlink:href="holx-20200926.xsd#holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_481e1da3-065e-49cf-a39d-4c82e1670a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashSeverancePayments_088236cd-cc43-43f5-8284-e8eeb700ce3c" xlink:href="holx-20200926.xsd#holx_CashSeverancePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_holx_CashSeverancePayments_088236cd-cc43-43f5-8284-e8eeb700ce3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherRestructuringPayments_fcf31dd3-c175-4166-8c06-867baed71751" xlink:href="holx-20200926.xsd#holx_OtherRestructuringPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_holx_OtherRestructuringPayments_fcf31dd3-c175-4166-8c06-867baed71751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7cc311a4-7cd5-4090-8a4f-19717f951142" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_35d377fe-635f-4617-be33-99a934fd7a7e" xlink:to="loc_us-gaap_RestructuringReserve_7cc311a4-7cd5-4090-8a4f-19717f951142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#RestructuringChargesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bd369536-3e78-477f-8df8-8a27535bb0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bd369536-3e78-477f-8df8-8a27535bb0b7" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d7d8fa58-21d8-4958-a892-516574cc68d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d7d8fa58-21d8-4958-a892-516574cc68d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d1392684-c933-4a45-8353-489ddc2de652" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d7d8fa58-21d8-4958-a892-516574cc68d6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d1392684-c933-4a45-8353-489ddc2de652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_41c89ef7-c967-4340-b678-294ad3c51b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1392684-c933-4a45-8353-489ddc2de652" xlink:to="loc_us-gaap_RestructuringChargesMember_41c89ef7-c967-4340-b678-294ad3c51b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_bfdfae82-0de0-46ea-86f3-cc3f160026b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:to="loc_us-gaap_RestructuringPlanAxis_bfdfae82-0de0-46ea-86f3-cc3f160026b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_bfdfae82-0de0-46ea-86f3-cc3f160026b1" xlink:to="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_a4e6f29b-997e-48b1-98fa-5c0f44362472" xlink:href="holx-20200926.xsd#holx_CynosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_holx_CynosureMember_a4e6f29b-997e-48b1-98fa-5c0f44362472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BedfordMember_4c711785-f4d1-43df-8393-ce1bc746dd52" xlink:href="holx-20200926.xsd#holx_BedfordMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_holx_BedfordMember_4c711785-f4d1-43df-8393-ce1bc746dd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_298cfda9-779a-4213-b9eb-e045074e7b7d" xlink:href="holx-20200926.xsd#holx_InternationalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_holx_InternationalMember_298cfda9-779a-4213-b9eb-e045074e7b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_5118fa6c-3df8-44ba-97d6-92171bc5aa1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_us-gaap_RestructuringChargesMember_5118fa6c-3df8-44ba-97d6-92171bc5aa1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LybertyWayMember_4d3a81d6-e1f3-4e60-9037-e8e5660fb9c3" xlink:href="holx-20200926.xsd#holx_LybertyWayMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_71aeeccd-be6e-4814-a439-823045e3c3f3" xlink:to="loc_holx_LybertyWayMember_4d3a81d6-e1f3-4e60-9037-e8e5660fb9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityByLocationAxis_4e15fc73-9f91-4db8-9173-2aaa5efeb9f4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityByLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:to="loc_dei_EntityByLocationAxis_4e15fc73-9f91-4db8-9173-2aaa5efeb9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocationDomain_236c8f35-f288-4d9e-ab93-f5ac38379d6d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityByLocationAxis_4e15fc73-9f91-4db8-9173-2aaa5efeb9f4" xlink:to="loc_dei_LocationDomain_236c8f35-f288-4d9e-ab93-f5ac38379d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TepnelMember_75d34bac-6f10-4407-afc7-dbeb1645176e" xlink:href="holx-20200926.xsd#holx_TepnelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LocationDomain_236c8f35-f288-4d9e-ab93-f5ac38379d6d" xlink:to="loc_holx_TepnelMember_75d34bac-6f10-4407-afc7-dbeb1645176e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_9793b609-506b-4b66-8bd1-41ac4d511b7e" xlink:href="holx-20200926.xsd#holx_CynosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LocationDomain_236c8f35-f288-4d9e-ab93-f5ac38379d6d" xlink:to="loc_holx_CynosureMember_9793b609-506b-4b66-8bd1-41ac4d511b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_83f45789-766f-4cf8-bae9-c785d6b9606d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_c8f2b6e7-abb9-4a88-8e41-44be6a06f376" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_us-gaap_SeveranceCosts1_c8f2b6e7-abb9-4a88-8e41-44be6a06f376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_3efcd535-bee3-4c77-82ae-31487b28f2a4" xlink:href="holx-20200926.xsd#holx_FacilityClosureCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_FacilityClosureCosts_3efcd535-bee3-4c77-82ae-31487b28f2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Propertyclosurecostpayment_44c6af2e-d0d0-4b34-b046-b87f123fb7e7" xlink:href="holx-20200926.xsd#holx_Propertyclosurecostpayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_Propertyclosurecostpayment_44c6af2e-d0d0-4b34-b046-b87f123fb7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Propertyclosurebenefit_6292d7f9-761e-4e1a-82f9-880a98856099" xlink:href="holx-20200926.xsd#holx_Propertyclosurebenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_Propertyclosurebenefit_6292d7f9-761e-4e1a-82f9-880a98856099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_1a595dca-3899-4a9e-956c-232cacca5fb8" xlink:href="holx-20200926.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_ReductionOfWorkforceExpenses_1a595dca-3899-4a9e-956c-232cacca5fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_d532a8f3-856b-4676-8938-7f070035368d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_d532a8f3-856b-4676-8938-7f070035368d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ExpectedFutureSeveranceCharges_b31378b9-ef50-4e38-90a3-0c517a8a263d" xlink:href="holx-20200926.xsd#holx_ExpectedFutureSeveranceCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_ExpectedFutureSeveranceCharges_b31378b9-ef50-4e38-90a3-0c517a8a263d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RemainingLeaseBalance_3a00addb-e080-46a8-ad6c-a9dc0fe54075" xlink:href="holx-20200926.xsd#holx_RemainingLeaseBalance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_RemainingLeaseBalance_3a00addb-e080-46a8-ad6c-a9dc0fe54075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_f13e9a5c-37b0-41b0-97f3-52899fb7e5d1" xlink:href="holx-20200926.xsd#holx_DivestitureCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c49f1298-d418-4e7f-addb-21c275fb58f3" xlink:to="loc_holx_DivestitureCharges_f13e9a5c-37b0-41b0-97f3-52899fb7e5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2b01c9ee-405a-4cca-b1d4-27f9a4c1ba53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_4b38d6e2-1e20-49e9-97b7-d0331207cbfd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2b01c9ee-405a-4cca-b1d4-27f9a4c1ba53" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_4b38d6e2-1e20-49e9-97b7-d0331207cbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_eaa43d10-d9f8-4e66-b46e-27bce904ddf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_a45ac8ad-3ea6-4877-9567-6e1439db5468" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaa43d10-d9f8-4e66-b46e-27bce904ddf0" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_a45ac8ad-3ea6-4877-9567-6e1439db5468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_07f43c40-ac00-4866-9218-39501c5f7b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaa43d10-d9f8-4e66-b46e-27bce904ddf0" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_07f43c40-ac00-4866-9218-39501c5f7b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_c1e7b0ba-d412-41be-b92f-d2e099a2b949" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaa43d10-d9f8-4e66-b46e-27bce904ddf0" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_c1e7b0ba-d412-41be-b92f-d2e099a2b949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_32414fd2-27f7-428b-9fa0-19ce674a0eae" xlink:href="holx-20200926.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaa43d10-d9f8-4e66-b46e-27bce904ddf0" xlink:to="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_32414fd2-27f7-428b-9fa0-19ce674a0eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_966621d2-73e0-42f9-849c-8d7f0f1a36bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_558bc6d8-e9a3-4c40-9896-03a3b9aac31f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_966621d2-73e0-42f9-849c-8d7f0f1a36bc" xlink:to="loc_us-gaap_DebtInstrumentTable_558bc6d8-e9a3-4c40-9896-03a3b9aac31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_29856fd9-cfe2-4246-bf98-c29df865eb19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_558bc6d8-e9a3-4c40-9896-03a3b9aac31f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_29856fd9-cfe2-4246-bf98-c29df865eb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_29856fd9-cfe2-4246-bf98-c29df865eb19" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_5c7f4b76-3596-4533-b1fa-646bec42e410" xlink:href="holx-20200926.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_TermLoanMember_5c7f4b76-3596-4533-b1fa-646bec42e410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_38ad1c5b-1987-4471-81eb-c29177ff2cc3" xlink:href="holx-20200926.xsd#holx_RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_RevolverMember_38ad1c5b-1987-4471-81eb-c29177ff2cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_fc1db549-b796-453b-9187-a34012c29b6f" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_fc1db549-b796-453b-9187-a34012c29b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_598140b0-0f9d-48a7-a0ee-c4d4a2d5eca6" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_A2025SeniorNotesMember_598140b0-0f9d-48a7-a0ee-c4d4a2d5eca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_cf845588-85b3-4cf7-98a7-211033809b2e" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86e8cbbb-ba96-4cbf-b795-93f9d7242efa" xlink:to="loc_holx_A2028SeniorNotesMember_cf845588-85b3-4cf7-98a7-211033809b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_558bc6d8-e9a3-4c40-9896-03a3b9aac31f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8dc202ca-cb1c-48e1-a070-730178070ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:to="loc_us-gaap_LongTermDebtCurrent_8dc202ca-cb1c-48e1-a070-730178070ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c576d14c-780c-4dbd-b942-b2ee9e0bfa57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c576d14c-780c-4dbd-b942-b2ee9e0bfa57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_42bdf5f9-d7c4-4eb4-9149-ae4296d694f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97ab654e-6e56-4e94-a464-e3e869475a68" xlink:to="loc_us-gaap_LongTermDebt_42bdf5f9-d7c4-4eb4-9149-ae4296d694f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d13955c4-71dd-4706-b2b1-a1c35bca4f5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e50cf100-d8aa-464b-a3cc-a39db3f430b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d13955c4-71dd-4706-b2b1-a1c35bca4f5a" xlink:to="loc_us-gaap_DebtInstrumentTable_e50cf100-d8aa-464b-a3cc-a39db3f430b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8ff5c903-bb66-4822-b396-ac8db2965d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e50cf100-d8aa-464b-a3cc-a39db3f430b9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8ff5c903-bb66-4822-b396-ac8db2965d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8ff5c903-bb66-4822-b396-ac8db2965d2d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_bc4e783f-d422-464c-a855-227fd6014f72" xlink:href="holx-20200926.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:to="loc_holx_TermLoanMember_bc4e783f-d422-464c-a855-227fd6014f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_cde88fcc-85a5-4e59-b8c7-d314d08e04c2" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_cde88fcc-85a5-4e59-b8c7-d314d08e04c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_06d528a1-be28-4b80-8dac-92effe23b2e9" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:to="loc_holx_A2025SeniorNotesMember_06d528a1-be28-4b80-8dac-92effe23b2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_ce651c8b-7463-44c5-87c2-b2cfaf60f4f5" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86352a6b-4520-44fd-8aee-df52d722ce28" xlink:to="loc_holx_A2028SeniorNotesMember_ce651c8b-7463-44c5-87c2-b2cfaf60f4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e50cf100-d8aa-464b-a3cc-a39db3f430b9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ebdef8f7-3460-48c9-9420-479a37cae4e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ebdef8f7-3460-48c9-9420-479a37cae4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c6948ac2-18fe-4000-9083-520ba734e9eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c6948ac2-18fe-4000-9083-520ba734e9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5013be3d-4ef3-4f75-96e4-84fa160746c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5013be3d-4ef3-4f75-96e4-84fa160746c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_28371d64-00ff-48f4-ac80-d0a85889f9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_28371d64-00ff-48f4-ac80-d0a85889f9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_422589eb-5346-496b-a964-293bd290a999" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_422589eb-5346-496b-a964-293bd290a999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_999fd3e6-8e15-4c06-9907-4535d281bfb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_999fd3e6-8e15-4c06-9907-4535d281bfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_88304fa9-dcf1-4845-8695-3dd7ca0f1bde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c003f8c-f16c-494e-aed5-19774a2af74f" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_88304fa9-dcf1-4845-8695-3dd7ca0f1bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ccc1c712-c844-48ab-956f-3532661475dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e47a00a2-6035-4eb2-be35-78aa776d04bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ccc1c712-c844-48ab-956f-3532661475dc" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e47a00a2-6035-4eb2-be35-78aa776d04bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_af8b0ffc-2205-4918-9726-d9423c013c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e47a00a2-6035-4eb2-be35-78aa776d04bb" xlink:to="loc_us-gaap_DebtInstrumentAxis_af8b0ffc-2205-4918-9726-d9423c013c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_af8b0ffc-2205-4918-9726-d9423c013c2a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2018Member_9dff0c18-20d2-4a28-b1cc-5e0ae9b7cac0" xlink:href="holx-20200926.xsd#holx_CreditAgreement2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:to="loc_holx_CreditAgreement2018Member_9dff0c18-20d2-4a28-b1cc-5e0ae9b7cac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member_d0d00403-c042-4776-9ce0-c6c08e04c128" xlink:href="holx-20200926.xsd#holx_CreditAgreement2017Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:to="loc_holx_CreditAgreement2017Member_d0d00403-c042-4776-9ce0-c6c08e04c128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember_97bb78de-76a3-4f55-8690-297d108b7280" xlink:href="holx-20200926.xsd#holx_CreditAgreementPriorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e85a7cd-76e9-4665-80f4-e7335ae3760a" xlink:to="loc_holx_CreditAgreementPriorMember_97bb78de-76a3-4f55-8690-297d108b7280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e47a00a2-6035-4eb2-be35-78aa776d04bb" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_5f20bd96-7048-4553-9d2f-aeae0008ff0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:to="loc_us-gaap_InterestExpenseBorrowings_5f20bd96-7048-4553-9d2f-aeae0008ff0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b4b312fd-c7e8-47e8-9c59-1e0c508f3e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b4b312fd-c7e8-47e8-9c59-1e0c508f3e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_242a9c0f-1142-4a37-bdeb-475656a4b5ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_242a9c0f-1142-4a37-bdeb-475656a4b5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_fa0fc2ff-785a-4b8a-bae4-75e6b5644694" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cd2a901b-25c6-4495-8b7d-3161503c80b9" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_fa0fc2ff-785a-4b8a-bae4-75e6b5644694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_871d5063-8997-4483-8f16-179f5c3228f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_871d5063-8997-4483-8f16-179f5c3228f3" xlink:to="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e2c31643-f834-4406-864a-76cd63498e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e2c31643-f834-4406-864a-76cd63498e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e2c31643-f834-4406-864a-76cd63498e3d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember_9edda31c-4514-4b49-b7f2-c68d2b19cd25" xlink:href="holx-20200926.xsd#holx_SecuredTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_SecuredTermLoanMember_9edda31c-4514-4b49-b7f2-c68d2b19cd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_c25d2d96-3b51-41da-8e3a-0278a30152ed" xlink:href="holx-20200926.xsd#holx_RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_RevolverMember_c25d2d96-3b51-41da-8e3a-0278a30152ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9976bdee-ec92-49f2-90b9-aba3c75dc431" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_us-gaap_LineOfCreditMember_9976bdee-ec92-49f2-90b9-aba3c75dc431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1265e120-7576-4f45-a514-589bd7d25968" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_us-gaap_SeniorNotesMember_1265e120-7576-4f45-a514-589bd7d25968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSevenNotesMember_4cbff681-dc18-47d0-96d2-ba916f559d99" xlink:href="holx-20200926.xsd#holx_TwoThousandSevenNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_TwoThousandSevenNotesMember_4cbff681-dc18-47d0-96d2-ba916f559d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NovemberEighteenTwoThousandTenOriginalNotesMember_6f346ef7-62d8-4913-b2a2-06f3afc121f6" xlink:href="holx-20200926.xsd#holx_NovemberEighteenTwoThousandTenOriginalNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_NovemberEighteenTwoThousandTenOriginalNotesMember_6f346ef7-62d8-4913-b2a2-06f3afc121f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember_ef6373c8-bbb6-410e-add8-1d0041f0e1d7" xlink:href="holx-20200926.xsd#holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember_ef6373c8-bbb6-410e-add8-1d0041f0e1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember_46e77333-b6cb-4d27-ac01-cb3d1ea24d0c" xlink:href="holx-20200926.xsd#holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember_46e77333-b6cb-4d27-ac01-cb3d1ea24d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_0ed58781-5ee2-47db-9d60-c93138dd449c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_0ed58781-5ee2-47db-9d60-c93138dd449c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_436ea3ee-ca0f-43ec-848f-0b589c15550c" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_436ea3ee-ca0f-43ec-848f-0b589c15550c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_a0a854cb-ba6e-48bb-82a8-f9f89a11c97f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3d0c498e-4ecc-48fb-8561-f779a0628a96" xlink:to="loc_us-gaap_ConvertibleDebtMember_a0a854cb-ba6e-48bb-82a8-f9f89a11c97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_54145159-7a69-482b-9d9e-7c0c0fe7b50e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_DebtInstrumentAxis_54145159-7a69-482b-9d9e-7c0c0fe7b50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_54145159-7a69-482b-9d9e-7c0c0fe7b50e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoan2018Member_8ef6ece0-d949-4e21-aa02-2079589ec738" xlink:href="holx-20200926.xsd#holx_AmendedTermLoan2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_AmendedTermLoan2018Member_8ef6ece0-d949-4e21-aa02-2079589ec738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedRevolver2018Member_61bb97f6-7830-4223-b0ca-41cb560a26a3" xlink:href="holx-20200926.xsd#holx_AmendedRevolver2018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_AmendedRevolver2018Member_61bb97f6-7830-4223-b0ca-41cb560a26a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedCreditFacility2018Member_9af741e7-99af-4002-933b-0c72a1d9162c" xlink:href="holx-20200926.xsd#holx_AmendedCreditFacility2018Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_AmendedCreditFacility2018Member_9af741e7-99af-4002-933b-0c72a1d9162c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member_b5ac096f-725b-4178-869f-ed3cad460bb3" xlink:href="holx-20200926.xsd#holx_CreditAgreement2017Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_CreditAgreement2017Member_b5ac096f-725b-4178-869f-ed3cad460bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoan2017Member_b0b208f0-3e88-4533-b6d6-f8c4f477a6d1" xlink:href="holx-20200926.xsd#holx_TermLoan2017Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_TermLoan2017Member_b0b208f0-3e88-4533-b6d6-f8c4f477a6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Revolver2017Member_5c9966ab-8695-4af0-92ed-bc1fa120f163" xlink:href="holx-20200926.xsd#holx_Revolver2017Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_Revolver2017Member_5c9966ab-8695-4af0-92ed-bc1fa120f163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember_a6801c78-1337-4ab6-9e47-c2b56db0f0fd" xlink:href="holx-20200926.xsd#holx_CreditAgreementPriorMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_CreditAgreementPriorMember_a6801c78-1337-4ab6-9e47-c2b56db0f0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_60d3ec1c-4b47-46ec-b1a8-eaf29bc4a68b" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2025SeniorNotesMember_60d3ec1c-4b47-46ec-b1a8-eaf29bc4a68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_19a35472-02e6-49fe-b6b7-c05ce44c907c" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2028SeniorNotesMember_19a35472-02e6-49fe-b6b7-c05ce44c907c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2022NotesMember_a5ac0c4f-36f8-4c2d-9e99-f0ddbe9dcd27" xlink:href="holx-20200926.xsd#holx_A2022NotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2022NotesMember_a5ac0c4f-36f8-4c2d-9e99-f0ddbe9dcd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConvertibleNotesMember_4aca742c-eb10-4493-8b9a-5647d60e9b29" xlink:href="holx-20200926.xsd#holx_ConvertibleNotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_ConvertibleNotesMember_4aca742c-eb10-4493-8b9a-5647d60e9b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2012NotesMember_1f748c6a-9314-41f3-87cb-8a141a777474" xlink:href="holx-20200926.xsd#holx_A2012NotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2012NotesMember_1f748c6a-9314-41f3-87cb-8a141a777474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2013NotesMember_f1b8a6f5-1b8f-4480-980d-dbce688e9a66" xlink:href="holx-20200926.xsd#holx_A2013NotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2013NotesMember_f1b8a6f5-1b8f-4480-980d-dbce688e9a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_66392dda-32bf-4d82-89ab-af704f6b3eea" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_66392dda-32bf-4d82-89ab-af704f6b3eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2042NotesMember_982ff5a0-a5be-4888-80d6-026c0d34ef16" xlink:href="holx-20200926.xsd#holx_A2042NotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2042NotesMember_982ff5a0-a5be-4888-80d6-026c0d34ef16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_ee69fd11-b719-4de3-8dc4-be5ec7ca0aa7" xlink:href="holx-20200926.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de036b6f-0e1f-4277-b542-3658454c78b7" xlink:to="loc_holx_A2029SeniorNotesMember_ee69fd11-b719-4de3-8dc4-be5ec7ca0aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_265873af-2ef2-433c-acf5-8db72f948030" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_FinancialInstrumentAxis_265873af-2ef2-433c-acf5-8db72f948030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_43b5480d-4cb5-48b1-a245-bb4f01db27f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_265873af-2ef2-433c-acf5-8db72f948030" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_43b5480d-4cb5-48b1-a245-bb4f01db27f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandSevenNotesMember_e42ad1be-cf0c-4920-9576-1e60c1d68cd1" xlink:href="holx-20200926.xsd#holx_TwoThousandSevenNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_43b5480d-4cb5-48b1-a245-bb4f01db27f8" xlink:to="loc_holx_TwoThousandSevenNotesMember_e42ad1be-cf0c-4920-9576-1e60c1d68cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2712d7ef-c385-4b84-af85-2c2f9a4e980c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_VariableRateAxis_2712d7ef-c385-4b84-af85-2c2f9a4e980c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_04953f21-674b-4884-9c4a-80e88ebec0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_2712d7ef-c385-4b84-af85-2c2f9a4e980c" xlink:to="loc_us-gaap_VariableRateDomain_04953f21-674b-4884-9c4a-80e88ebec0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ea78b9e9-cdda-4c7d-bcd3-04c4d92ad473" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_04953f21-674b-4884-9c4a-80e88ebec0a3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ea78b9e9-cdda-4c7d-bcd3-04c4d92ad473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c7db34fd-ba1f-4b99-ae8d-125e62b76fba" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_srt_StatementScenarioAxis_c7db34fd-ba1f-4b99-ae8d-125e62b76fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_17d130c3-b5ac-4c57-b57f-8e300f841322" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_c7db34fd-ba1f-4b99-ae8d-125e62b76fba" xlink:to="loc_srt_ScenarioUnspecifiedDomain_17d130c3-b5ac-4c57-b57f-8e300f841322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_f3b1a32d-06fa-4c3d-86e1-382e5c9af1f0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_17d130c3-b5ac-4c57-b57f-8e300f841322" xlink:to="loc_srt_ScenarioForecastMember_f3b1a32d-06fa-4c3d-86e1-382e5c9af1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3f1752ad-0a9c-4c33-9343-e3dbd6832316" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3f1752ad-0a9c-4c33-9343-e3dbd6832316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3f1752ad-0a9c-4c33-9343-e3dbd6832316" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_535e06d3-2d81-43f2-8c5c-857d5859d765" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_535e06d3-2d81-43f2-8c5c-857d5859d765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e0d25340-8354-4f2f-afe9-98436420f750" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e0d25340-8354-4f2f-afe9-98436420f750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_666caa31-de22-4f4a-9188-4c405fcb6698" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_666caa31-de22-4f4a-9188-4c405fcb6698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_fbff6fa5-9691-4a69-86e0-fed876e4d64b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_fbff6fa5-9691-4a69-86e0-fed876e4d64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_41ab8166-f1f4-48bc-882c-4375355e0838" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_e9e8ef61-c065-4808-b8be-f91f6741c055" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_41ab8166-f1f4-48bc-882c-4375355e0838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7a55bc99-fa4b-47f5-a15d-42756a749a50" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_srt_RangeAxis_7a55bc99-fa4b-47f5-a15d-42756a749a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1c6908bc-3f8f-4003-bc29-cc8e04e87fd7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7a55bc99-fa4b-47f5-a15d-42756a749a50" xlink:to="loc_srt_RangeMember_1c6908bc-3f8f-4003-bc29-cc8e04e87fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9ae9d74f-9b81-4f0d-b172-0ad5c5a44b3b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1c6908bc-3f8f-4003-bc29-cc8e04e87fd7" xlink:to="loc_srt_MinimumMember_9ae9d74f-9b81-4f0d-b172-0ad5c5a44b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2edb77ae-79a0-4393-b839-3b81916e6188" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1c6908bc-3f8f-4003-bc29-cc8e04e87fd7" xlink:to="loc_srt_MaximumMember_2edb77ae-79a0-4393-b839-3b81916e6188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e7b4b536-fb87-42be-9290-d673cd2eaf1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e7b4b536-fb87-42be-9290-d673cd2eaf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fd378900-d4ce-4c95-b0b8-a3cbedb25827" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e7b4b536-fb87-42be-9290-d673cd2eaf1f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fd378900-d4ce-4c95-b0b8-a3cbedb25827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_349c19e7-ddba-44cf-ad24-57bb341412ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_fd378900-d4ce-4c95-b0b8-a3cbedb25827" xlink:to="loc_us-gaap_SubsequentEventMember_349c19e7-ddba-44cf-ad24-57bb341412ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f61d5641-093e-4d12-a5eb-1bcb8ab43483" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4d996214-4942-4a53-ae1f-ae65d8b685c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4d996214-4942-4a53-ae1f-ae65d8b685c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1eda578b-9592-47e4-8764-2a10b3007334" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1eda578b-9592-47e4-8764-2a10b3007334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_cb1c7acb-9b64-4193-8359-f3b5d01b96da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_cb1c7acb-9b64-4193-8359-f3b5d01b96da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cf474d6c-3d64-4e45-b859-ec2d0c91ccec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cf474d6c-3d64-4e45-b859-ec2d0c91ccec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_843ce2c0-9d30-4ad8-b5cd-ecce8cfa6d81" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_843ce2c0-9d30-4ad8-b5cd-ecce8cfa6d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_ac6b2f8a-c5f9-4886-8d3a-260458f98c7e" xlink:href="holx-20200926.xsd#holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_ac6b2f8a-c5f9-4886-8d3a-260458f98c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeverageRatioMaximum_8ea372d4-04e4-43cf-9261-2eafbe4ea3c7" xlink:href="holx-20200926.xsd#holx_LeverageRatioMaximum"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_LeverageRatioMaximum_8ea372d4-04e4-43cf-9261-2eafbe4ea3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestCoverageRatio_eacbee4f-0961-463c-93a7-375237db3e33" xlink:href="holx-20200926.xsd#holx_InterestCoverageRatio"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_InterestCoverageRatio_eacbee4f-0961-463c-93a7-375237db3e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f228921-8355-4a3c-a0cb-eb7072f15fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f228921-8355-4a3c-a0cb-eb7072f15fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentNumberOfInstruments_42205f7b-5122-4f4f-8088-ec46c8b96d11" xlink:href="holx-20200926.xsd#holx_DebtInstrumentNumberOfInstruments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentNumberOfInstruments_42205f7b-5122-4f4f-8088-ec46c8b96d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_a7c58f46-513a-4cb6-a681-beb17aa4c0ca" xlink:href="holx-20200926.xsd#holx_MaximumRangeofPresentValueofCashFlowPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_a7c58f46-513a-4cb6-a681-beb17aa4c0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DirectThirdPartyCostsinterestExpense_a4d3f2f6-303a-4168-a78d-08000a1f019b" xlink:href="holx-20200926.xsd#holx_DirectThirdPartyCostsinterestExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DirectThirdPartyCostsinterestExpense_a4d3f2f6-303a-4168-a78d-08000a1f019b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cde91fb9-4674-4bfb-be8f-4066738abf95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cde91fb9-4674-4bfb-be8f-4066738abf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_50707dae-fe27-459b-b99a-bde124672886" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_50707dae-fe27-459b-b99a-bde124672886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_e18ce4bf-646a-400c-a441-9ed2efc20e04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_e18ce4bf-646a-400c-a441-9ed2efc20e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2a30622f-5751-4e81-b8b3-bebc0e6074f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2a30622f-5751-4e81-b8b3-bebc0e6074f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtIssuanceCostsReallocatedUponDebtModification_f6a930d9-d878-40d7-ab1f-f839f9a2a85b" xlink:href="holx-20200926.xsd#holx_DebtIssuanceCostsReallocatedUponDebtModification"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtIssuanceCostsReallocatedUponDebtModification_f6a930d9-d878-40d7-ab1f-f839f9a2a85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtDiscountReallocatedUponDebtModification_0467210a-8e4f-4c4b-a1c3-a44082f10287" xlink:href="holx-20200926.xsd#holx_DebtDiscountReallocatedUponDebtModification"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtDiscountReallocatedUponDebtModification_0467210a-8e4f-4c4b-a1c3-a44082f10287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_8f5b848f-20c9-4a96-ae01-27476f332b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_8f5b848f-20c9-4a96-ae01-27476f332b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_9af3201d-78a9-411a-bb95-6c4d910d6edb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_SeniorNotes_9af3201d-78a9-411a-bb95-6c4d910d6edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_a72d3936-daa0-4fe0-92ba-48a464e0c9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_a72d3936-daa0-4fe0-92ba-48a464e0c9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_9e9c8aab-5c2f-4127-89cf-d92e23e6f4f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_InterestExpenseDebt_9e9c8aab-5c2f-4127-89cf-d92e23e6f4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_5f0f33c4-42b3-43da-bfe3-20a705727c4a" xlink:href="holx-20200926.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_PrincipalAmountOfBorrowings_5f0f33c4-42b3-43da-bfe3-20a705727c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_4dc128a2-5945-4134-aa90-25232fd0a563" xlink:href="holx-20200926.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_4dc128a2-5945-4134-aa90-25232fd0a563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OfferingPriceofPrincipalAmount_77db770d-ae94-45bd-95a2-294f7c7e4b72" xlink:href="holx-20200926.xsd#holx_OfferingPriceofPrincipalAmount"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_OfferingPriceofPrincipalAmount_77db770d-ae94-45bd-95a2-294f7c7e4b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MakeWholeProvision_e69a8b8b-3eb4-46a6-9f68-fc478d2ca110" xlink:href="holx-20200926.xsd#holx_MakeWholeProvision"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_MakeWholeProvision_e69a8b8b-3eb4-46a6-9f68-fc478d2ca110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_e449e931-cc06-4546-b988-339a7e4e3660" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_e449e931-cc06-4546-b988-339a7e4e3660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_605c1799-480b-4f32-a09b-7eaa3fb83fae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_605c1799-480b-4f32-a09b-7eaa3fb83fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_ebbe9ece-b73c-4c01-a323-e19c1731b0b3" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_ebbe9ece-b73c-4c01-a323-e19c1731b0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_6d8823d1-f235-4f8e-9306-ba9c17d238c0" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_6d8823d1-f235-4f8e-9306-ba9c17d238c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_933439d9-8d29-4060-a022-df6f11d16df5" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_933439d9-8d29-4060-a022-df6f11d16df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_3a04d8bf-049b-4153-9e8f-7b2047be556c" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_3a04d8bf-049b-4153-9e8f-7b2047be556c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest_4e2839d2-6968-4229-8c96-d9b2133ad6b2" xlink:href="holx-20200926.xsd#holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest_4e2839d2-6968-4229-8c96-d9b2133ad6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_9420aa6a-e506-4755-b8f1-7c568f23e86c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_9420aa6a-e506-4755-b8f1-7c568f23e86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxesReacquisitionofEquityComponent_24f4122a-4c55-4d61-b041-f8f792d47ffc" xlink:href="holx-20200926.xsd#holx_DeferredTaxesReacquisitionofEquityComponent"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DeferredTaxesReacquisitionofEquityComponent_24f4122a-4c55-4d61-b041-f8f792d47ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Debtinstrumentremainingtoberedeemed_42a41c8b-2a05-4f0c-80c1-d79e0bcca741" xlink:href="holx-20200926.xsd#holx_Debtinstrumentremainingtoberedeemed"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_Debtinstrumentremainingtoberedeemed_42a41c8b-2a05-4f0c-80c1-d79e0bcca741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_b094e7e1-bd68-4b85-b1a7-2695584c4774" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_b094e7e1-bd68-4b85-b1a7-2695584c4774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermARSecuritizationProgram_03b5fb4e-1ca6-4adc-80ea-34bbd293f79e" xlink:href="holx-20200926.xsd#holx_TermARSecuritizationProgram"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_TermARSecuritizationProgram_03b5fb4e-1ca6-4adc-80ea-34bbd293f79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization_19a9f5a3-f910-4f16-9fd8-80483e2112e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_AccountsReceivableFromSecuritization_19a9f5a3-f910-4f16-9fd8-80483e2112e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumBorrowingUnderSecuritizationProgram_587ee2fe-c7f4-4b74-8f29-8b4f918498b9" xlink:href="holx-20200926.xsd#holx_MaximumBorrowingUnderSecuritizationProgram"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_MaximumBorrowingUnderSecuritizationProgram_587ee2fe-c7f4-4b74-8f29-8b4f918498b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ae3caba8-90f7-4e4e-ac85-7003763138ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ae3caba8-90f7-4e4e-ac85-7003763138ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_4a861951-8833-4c8f-9694-4c4b6fc9b8fd" xlink:href="holx-20200926.xsd#holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_4a861951-8833-4c8f-9694-4c4b6fc9b8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_689cf195-2401-4c80-86ce-07a4a25dc1ba" xlink:href="holx-20200926.xsd#holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_689cf195-2401-4c80-86ce-07a4a25dc1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_7b8d44d7-8f53-4ee6-bf30-e42bb4229f29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_7b8d44d7-8f53-4ee6-bf30-e42bb4229f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_e2d24a47-fe52-41d1-aa60-ce8069189212" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_RepaymentsOfDebt_e2d24a47-fe52-41d1-aa60-ce8069189212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_45fd6e38-5e6e-4c09-b7a0-c8e735e8a7cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_45fd6e38-5e6e-4c09-b7a0-c8e735e8a7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_fa3e5387-3522-4a31-bd10-2b0b331e53a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca3f468b-7688-4e85-aaad-ffa29b680c37" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_fa3e5387-3522-4a31-bd10-2b0b331e53a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1332210d-4f66-4efc-b3cb-8c77da8514a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9bff292e-6c39-4201-a986-0cda0dade32a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1332210d-4f66-4efc-b3cb-8c77da8514a5" xlink:to="loc_us-gaap_DebtInstrumentTable_9bff292e-6c39-4201-a986-0cda0dade32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_02b587dc-18ba-4733-a8b8-28630effff43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9bff292e-6c39-4201-a986-0cda0dade32a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_02b587dc-18ba-4733-a8b8-28630effff43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_03dad57d-0b47-4afc-9cbb-9aafffc293a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_02b587dc-18ba-4733-a8b8-28630effff43" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_03dad57d-0b47-4afc-9cbb-9aafffc293a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_32c086e7-af4c-49c4-b442-39d456eb1b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_03dad57d-0b47-4afc-9cbb-9aafffc293a9" xlink:to="loc_us-gaap_SeniorNotesMember_32c086e7-af4c-49c4-b442-39d456eb1b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9477ebff-057a-4610-8a7a-d841ea91a18a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9bff292e-6c39-4201-a986-0cda0dade32a" xlink:to="loc_us-gaap_DebtInstrumentAxis_9477ebff-057a-4610-8a7a-d841ea91a18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9477ebff-057a-4610-8a7a-d841ea91a18a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_2dbbe2ef-caf1-45e9-943e-becd0b164e33" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:to="loc_holx_A2028SeniorNotesMember_2dbbe2ef-caf1-45e9-943e-becd0b164e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_09339a49-b69e-4dbf-af4b-73f3bba8f47b" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:to="loc_holx_A2025SeniorNotesMember_09339a49-b69e-4dbf-af4b-73f3bba8f47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2022SeniorNotesMember_74adc951-6c63-4a34-b440-88e1fe110165" xlink:href="holx-20200926.xsd#holx_A2022SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18ef041a-d573-49b1-8c98-ddac7a50683e" xlink:to="loc_holx_A2022SeniorNotesMember_74adc951-6c63-4a34-b440-88e1fe110165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9bff292e-6c39-4201-a986-0cda0dade32a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_24de15d1-0fae-41e8-9be2-49563eaa4524" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:to="loc_us-gaap_InterestExpenseBorrowings_24de15d1-0fae-41e8-9be2-49563eaa4524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_08bebffa-7737-4ce7-b99f-33ec2f3f7829" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_08bebffa-7737-4ce7-b99f-33ec2f3f7829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6d36ab8a-7ba0-4923-8b5c-aa0cad6c6b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0eac20aa-fd72-4f5f-bdcb-c546d380b869" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6d36ab8a-7ba0-4923-8b5c-aa0cad6c6b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_970a7c55-d002-4a35-ae0b-def6fa6fbe17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionTable_d195fe01-d521-49b8-9df4-e24fe68094e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_970a7c55-d002-4a35-ae0b-def6fa6fbe17" xlink:to="loc_us-gaap_DebtConversionTable_d195fe01-d521-49b8-9df4-e24fe68094e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e4aacaee-3ca2-4c8f-bd59-2b8edaff7e11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionTable_d195fe01-d521-49b8-9df4-e24fe68094e1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e4aacaee-3ca2-4c8f-bd59-2b8edaff7e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f10fd1e1-4aab-4096-989d-1aac04fc2a46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4aacaee-3ca2-4c8f-bd59-2b8edaff7e11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f10fd1e1-4aab-4096-989d-1aac04fc2a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_caed14aa-72e1-464d-ab7c-d665a3e52352" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f10fd1e1-4aab-4096-989d-1aac04fc2a46" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_caed14aa-72e1-464d-ab7c-d665a3e52352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionTable_d195fe01-d521-49b8-9df4-e24fe68094e1" xlink:to="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_93e0340f-3e85-49bb-a2bd-52ebb536e1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_93e0340f-3e85-49bb-a2bd-52ebb536e1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationOfDeferredFinancingCosts_028441b3-ba26-47d1-be88-af315b687b99" xlink:href="holx-20200926.xsd#holx_AmortizationOfDeferredFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_holx_AmortizationOfDeferredFinancingCosts_028441b3-ba26-47d1-be88-af315b687b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasePrincipalAmountForAccretionValue_40092d2b-9bd6-486c-a153-8dff3b40c53e" xlink:href="holx-20200926.xsd#holx_BasePrincipalAmountForAccretionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_holx_BasePrincipalAmountForAccretionValue_40092d2b-9bd6-486c-a153-8dff3b40c53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1fb89260-4546-472a-a4db-bdf827427fba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1fb89260-4546-472a-a4db-bdf827427fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1dd1d7a1-8cbf-4c62-a531-e82edde0d0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1dd1d7a1-8cbf-4c62-a531-e82edde0d0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_2d4a9cd1-2393-4088-852f-047efce0054e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_InterestExpenseDebt_2d4a9cd1-2393-4088-852f-047efce0054e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cec27676-2c2a-4167-9db9-6144f6eac396" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_6819f55e-9063-4211-b350-5469a2516a15" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cec27676-2c2a-4167-9db9-6144f6eac396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8f5812a0-3b8b-402b-b217-fca86e0468b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ec005c11-d0e7-402a-9203-faea5da62e38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8f5812a0-3b8b-402b-b217-fca86e0468b2" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ec005c11-d0e7-402a-9203-faea5da62e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_72adf61d-cb8e-4db3-9214-7957c11a7502" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_72adf61d-cb8e-4db3-9214-7957c11a7502" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1637034c-46bc-4f23-8b42-1c1a4bd7457a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1637034c-46bc-4f23-8b42-1c1a4bd7457a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1637034c-46bc-4f23-8b42-1c1a4bd7457a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_0117adec-5b4c-4da1-b794-e8574d24c3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_us-gaap_InterestRateCapMember_0117adec-5b4c-4da1-b794-e8574d24c3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6f5ef5c1-a74f-4099-8a63-1e5926f51759" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_us-gaap_InterestRateSwapMember_6f5ef5c1-a74f-4099-8a63-1e5926f51759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_0e8d5b03-b345-4b7f-a363-186d9b48207d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_us-gaap_StockOptionMember_0e8d5b03-b345-4b7f-a363-186d9b48207d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_173b34d3-d3be-4fd6-8932-388f7295a28e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_173b34d3-d3be-4fd6-8932-388f7295a28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_3f1a9354-30c3-4cb7-9b19-22bf31c2b6c1" xlink:href="holx-20200926.xsd#holx_ContingentConsiderationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d44bdd37-004b-456f-9410-73835bbb55ae" xlink:to="loc_holx_ContingentConsiderationMember_3f1a9354-30c3-4cb7-9b19-22bf31c2b6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a32f72a7-40f8-4adb-830f-cc7691397c63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a32f72a7-40f8-4adb-830f-cc7691397c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_be3721bc-48fa-4de0-a40e-0d13075ccb52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a32f72a7-40f8-4adb-830f-cc7691397c63" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_be3721bc-48fa-4de0-a40e-0d13075ccb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_1f5b53e1-ef37-4961-9dc9-a347b852da2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_be3721bc-48fa-4de0-a40e-0d13075ccb52" xlink:to="loc_us-gaap_AssetsMember_1f5b53e1-ef37-4961-9dc9-a347b852da2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0950f8f5-4ef2-42e8-9634-d53583822231" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0950f8f5-4ef2-42e8-9634-d53583822231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0950f8f5-4ef2-42e8-9634-d53583822231" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1cf2e71f-d319-496a-80af-9d0c9eeda2e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1cf2e71f-d319-496a-80af-9d0c9eeda2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2c5606de-0eb2-4ecb-8ac8-5bdde59f2ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2c5606de-0eb2-4ecb-8ac8-5bdde59f2ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3099e870-8a67-4f10-bf4c-5a01826fe3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dbc8e788-b9f3-4dd4-af6d-d8e8098a8d72" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3099e870-8a67-4f10-bf4c-5a01826fe3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4660cc2b-2d83-43bb-9db0-774a0a144423" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_01f8abee-535b-4487-a768-48b903aad830" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4660cc2b-2d83-43bb-9db0-774a0a144423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4660cc2b-2d83-43bb-9db0-774a0a144423" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_635acf82-6989-4590-9d19-41c452f8c0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_635acf82-6989-4590-9d19-41c452f8c0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_fc034a9e-ad58-4df1-8dfa-5456149a17f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_fc034a9e-ad58-4df1-8dfa-5456149a17f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e1b50080-f12b-4ec1-9498-c24cc1963b07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_23e12169-793e-4c92-9362-2719d462201b" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e1b50080-f12b-4ec1-9498-c24cc1963b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_07847eac-d375-4311-9740-6ed7a174e438" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4660cc2b-2d83-43bb-9db0-774a0a144423" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_07847eac-d375-4311-9740-6ed7a174e438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_97acf56c-bbfc-4d5c-9ca0-bcc4cabc68e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_07847eac-d375-4311-9740-6ed7a174e438" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_97acf56c-bbfc-4d5c-9ca0-bcc4cabc68e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_359b3f8c-7f02-4f4e-9d14-2462b7731db5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_359b3f8c-7f02-4f4e-9d14-2462b7731db5" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2d25b9f2-8404-42ad-827e-7656151120e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2d25b9f2-8404-42ad-827e-7656151120e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d539ac6e-f530-4564-8cf6-399da923c4da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2d25b9f2-8404-42ad-827e-7656151120e1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d539ac6e-f530-4564-8cf6-399da923c4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_9c3acf83-b2d7-4a1f-8bbb-cb758f383e38" xlink:href="holx-20200926.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d539ac6e-f530-4564-8cf6-399da923c4da" xlink:to="loc_holx_AcquiredintangibleassetsMember_9c3acf83-b2d7-4a1f-8bbb-cb758f383e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_2057e635-719c-4f89-a172-3fa1446a190c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d539ac6e-f530-4564-8cf6-399da923c4da" xlink:to="loc_us-gaap_EquipmentMember_2057e635-719c-4f89-a172-3fa1446a190c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8cd67c01-75b1-4988-965c-2629092ce19b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8cd67c01-75b1-4988-965c-2629092ce19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_64e15c1e-e24b-44bf-a3b8-6a1b04f4384e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8cd67c01-75b1-4988-965c-2629092ce19b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_64e15c1e-e24b-44bf-a3b8-6a1b04f4384e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2022SeniorNotesMember_6453c5b3-757e-4f0c-8463-b0f56df98199" xlink:href="holx-20200926.xsd#holx_A2022SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_64e15c1e-e24b-44bf-a3b8-6a1b04f4384e" xlink:to="loc_holx_A2022SeniorNotesMember_6453c5b3-757e-4f0c-8463-b0f56df98199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_6d79a12f-ca87-439a-9e74-b7a362431f30" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_64e15c1e-e24b-44bf-a3b8-6a1b04f4384e" xlink:to="loc_holx_A2028SeniorNotesMember_6d79a12f-ca87-439a-9e74-b7a362431f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_f5f076dd-9327-46ef-ae0c-7673fb682028" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_A2028SeniorNotesMember_6d79a12f-ca87-439a-9e74-b7a362431f30" xlink:to="loc_holx_A2025SeniorNotesMember_f5f076dd-9327-46ef-ae0c-7673fb682028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1bdfc5a9-b7e4-461d-98c0-9bb75593bf7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1bdfc5a9-b7e4-461d-98c0-9bb75593bf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f32dfd5-5b33-4db3-b429-3720da34d100" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1bdfc5a9-b7e4-461d-98c0-9bb75593bf7a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f32dfd5-5b33-4db3-b429-3720da34d100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b57e1583-0929-4efa-8929-b8ec68ec8ad1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f32dfd5-5b33-4db3-b429-3720da34d100" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b57e1583-0929-4efa-8929-b8ec68ec8ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f76d8936-26f2-4d1e-92ff-ca2c655b580b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_DebtInstrumentAxis_f76d8936-26f2-4d1e-92ff-ca2c655b580b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f76d8936-26f2-4d1e-92ff-ca2c655b580b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_f1f85502-d3b6-483a-a511-7bf7a28bcf81" xlink:href="holx-20200926.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:to="loc_holx_CreditAgreementMember_f1f85502-d3b6-483a-a511-7bf7a28bcf81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_55e9763c-2b51-4621-a0d6-77e4e384075f" xlink:href="holx-20200926.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_55e9763c-2b51-4621-a0d6-77e4e384075f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_c550b6c5-2b25-4936-acd0-856a57094fa1" xlink:href="holx-20200926.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1e62ad-6136-4523-a8cf-3d1221f6fe2c" xlink:to="loc_holx_A2028SeniorNotesMember_c550b6c5-2b25-4936-acd0-856a57094fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_96a33305-8236-4ad1-b59e-f8fdc1b1bfbf" xlink:href="holx-20200926.xsd#holx_A2025SeniorNotesMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4772910c-0180-4e45-a3c3-adf425b77405" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4772910c-0180-4e45-a3c3-adf425b77405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e4c9e295-cbcb-4ccb-a28d-75b4b9a5add8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4772910c-0180-4e45-a3c3-adf425b77405" xlink:to="loc_us-gaap_SegmentDomain_e4c9e295-cbcb-4ccb-a28d-75b4b9a5add8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_e81813b6-3e78-41b0-9394-409188162c4d" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e4c9e295-cbcb-4ccb-a28d-75b4b9a5add8" xlink:to="loc_holx_MedicalAestheticsBusinessMember_e81813b6-3e78-41b0-9394-409188162c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1d8f0b90-07c1-4b81-98b4-b526fed600ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1d8f0b90-07c1-4b81-98b4-b526fed600ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86d3f6c9-61e4-4029-b7e1-17df219a6ef9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1d8f0b90-07c1-4b81-98b4-b526fed600ca" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86d3f6c9-61e4-4029-b7e1-17df219a6ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_d391f160-87ff-4e6c-a27e-07522d47baf2" xlink:href="holx-20200926.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86d3f6c9-61e4-4029-b7e1-17df219a6ef9" xlink:to="loc_holx_AcquiredintangibleassetsMember_d391f160-87ff-4e6c-a27e-07522d47baf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_97aff2db-3f80-47d1-b1ef-a63b2a0165d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86d3f6c9-61e4-4029-b7e1-17df219a6ef9" xlink:to="loc_us-gaap_EquipmentMember_97aff2db-3f80-47d1-b1ef-a63b2a0165d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_69c8596c-4e44-4cf0-b702-ff19f1649f12" xlink:to="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_aac2849d-8012-483e-bc72-58bb2714ea00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_aac2849d-8012-483e-bc72-58bb2714ea00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_64a5db31-bb90-46e1-9776-849f383ded8f" xlink:href="holx-20200926.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_holx_PrincipalAmountOfBorrowings_64a5db31-bb90-46e1-9776-849f383ded8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1a762584-ec3a-4112-bad7-974d6c4e2cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1a762584-ec3a-4112-bad7-974d6c4e2cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2c6e5b69-8bf3-40c3-8011-be445b830283" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2c6e5b69-8bf3-40c3-8011-be445b830283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3f77737e-d7f4-4513-8dda-53e7361a2165" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3f77737e-d7f4-4513-8dda-53e7361a2165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_0b82450a-5524-475e-a8f8-fc2002acc9ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_f8b95aeb-b751-4891-842c-fe8f192dbcfa" xlink:to="loc_us-gaap_AssetImpairmentCharges_0b82450a-5524-475e-a8f8-fc2002acc9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c596fd72-a992-4ece-b115-bed62eb9f6e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70aca721-dd13-4bd1-b422-1533fe1b6b70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c596fd72-a992-4ece-b115-bed62eb9f6e5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70aca721-dd13-4bd1-b422-1533fe1b6b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_d8cdd0f9-e554-44ad-a75e-2c10a38edfdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c596fd72-a992-4ece-b115-bed62eb9f6e5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_d8cdd0f9-e554-44ad-a75e-2c10a38edfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_00fedd1a-0796-456f-98e4-c0eb00efa075" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c596fd72-a992-4ece-b115-bed62eb9f6e5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_00fedd1a-0796-456f-98e4-c0eb00efa075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_59eae0e0-504a-43c4-858a-43146de87077" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c596fd72-a992-4ece-b115-bed62eb9f6e5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_59eae0e0-504a-43c4-858a-43146de87077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_de8019d0-7f52-4f77-b036-a8bd7cb2b185" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c596fd72-a992-4ece-b115-bed62eb9f6e5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_de8019d0-7f52-4f77-b036-a8bd7cb2b185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2189dd1c-fdab-471a-8f0c-d50c68880f80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_3ec56c9d-0268-4a7e-9903-e32919c773fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2189dd1c-fdab-471a-8f0c-d50c68880f80" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_3ec56c9d-0268-4a7e-9903-e32919c773fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_a57d6ba7-523c-4b7e-bdd0-405b723470cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2189dd1c-fdab-471a-8f0c-d50c68880f80" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_a57d6ba7-523c-4b7e-bdd0-405b723470cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b7a86e8b-0bf3-416f-96b6-ff4407117847" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2189dd1c-fdab-471a-8f0c-d50c68880f80" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b7a86e8b-0bf3-416f-96b6-ff4407117847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_7c458977-f7ec-4a79-b0e8-e336e298cdea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2189dd1c-fdab-471a-8f0c-d50c68880f80" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_7c458977-f7ec-4a79-b0e8-e336e298cdea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_0b5cb3d1-75ab-474c-928f-a94555ee74af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2189dd1c-fdab-471a-8f0c-d50c68880f80" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_0b5cb3d1-75ab-474c-928f-a94555ee74af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b82f8e3a-ef74-47f8-b06d-c4795598de56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f9cd59a9-1063-4b2c-824a-658e9980d006" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b82f8e3a-ef74-47f8-b06d-c4795598de56" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f9cd59a9-1063-4b2c-824a-658e9980d006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d64c1919-5708-4939-a422-ed1f71ae9b89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b82f8e3a-ef74-47f8-b06d-c4795598de56" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d64c1919-5708-4939-a422-ed1f71ae9b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a42945c-bc40-4644-aae8-f0cc3b50d9bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b82f8e3a-ef74-47f8-b06d-c4795598de56" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a42945c-bc40-4644-aae8-f0cc3b50d9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesProvisionforIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7eaa5163-2eed-4685-bcdb-09b3194aff54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_90a86f57-5ad3-45fe-b543-dfe91ca92e33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7eaa5163-2eed-4685-bcdb-09b3194aff54" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_90a86f57-5ad3-45fe-b543-dfe91ca92e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_7fcb19f0-6cb9-4d20-b7ef-0d841780de18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_90a86f57-5ad3-45fe-b543-dfe91ca92e33" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_7fcb19f0-6cb9-4d20-b7ef-0d841780de18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_40fea635-e83d-4f1e-bd21-9cafa5ee4d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_90a86f57-5ad3-45fe-b543-dfe91ca92e33" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_40fea635-e83d-4f1e-bd21-9cafa5ee4d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_23dc791d-fe85-4561-9668-070185017e7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_90a86f57-5ad3-45fe-b543-dfe91ca92e33" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_23dc791d-fe85-4561-9668-070185017e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_a0ede730-f638-42a3-935b-e2a68ee995fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7eaa5163-2eed-4685-bcdb-09b3194aff54" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_a0ede730-f638-42a3-935b-e2a68ee995fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ffbce585-62c5-4386-94cb-1a90c17e68f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_a0ede730-f638-42a3-935b-e2a68ee995fe" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ffbce585-62c5-4386-94cb-1a90c17e68f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_64e7519e-25d8-4974-85f9-0f47f22d492a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_a0ede730-f638-42a3-935b-e2a68ee995fe" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_64e7519e-25d8-4974-85f9-0f47f22d492a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_4c9eab70-7a06-4a6c-9534-92528ef8bc2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_a0ede730-f638-42a3-935b-e2a68ee995fe" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_4c9eab70-7a06-4a6c-9534-92528ef8bc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_8056c3d8-8ee7-4ae7-8fe8-d08e533e46f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7eaa5163-2eed-4685-bcdb-09b3194aff54" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_8056c3d8-8ee7-4ae7-8fe8-d08e533e46f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_16072d40-0478-4bac-ab78-df4f1b5cafc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_8056c3d8-8ee7-4ae7-8fe8-d08e533e46f6" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_16072d40-0478-4bac-ab78-df4f1b5cafc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_23b00bf0-4d5f-4762-aecc-22fd4dab8ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_8056c3d8-8ee7-4ae7-8fe8-d08e533e46f6" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_23b00bf0-4d5f-4762-aecc-22fd4dab8ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_93cceb03-e968-4d40-8000-fcbd30dc2ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_8056c3d8-8ee7-4ae7-8fe8-d08e533e46f6" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_93cceb03-e968-4d40-8000-fcbd30dc2ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_939e7953-0c4f-490f-9935-92755af01ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7eaa5163-2eed-4685-bcdb-09b3194aff54" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_939e7953-0c4f-490f-9935-92755af01ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4dadb698-9270-4013-ae00-bd917a840345" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4dadb698-9270-4013-ae00-bd917a840345" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d3e6bcb0-0970-4e25-bee3-023ff3514f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d3e6bcb0-0970-4e25-bee3-023ff3514f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_26ab639a-8c69-40d7-bfbf-9733edcba3a6" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_26ab639a-8c69-40d7-bfbf-9733edcba3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_d884fdd8-b950-4a8a-b2b8-a0e01889d258" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_d884fdd8-b950-4a8a-b2b8-a0e01889d258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_817a4d12-434f-4332-9c76-edd04082b9e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_817a4d12-434f-4332-9c76-edd04082b9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_5511bd88-d2c5-40fd-9a3e-75b6be0737ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_5511bd88-d2c5-40fd-9a3e-75b6be0737ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_45f69480-2bb5-46d9-a3aa-2658e63deb6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_45f69480-2bb5-46d9-a3aa-2658e63deb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill_c3c2ebd4-fcfd-4f6e-b58d-4625db0efec9" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill_c3c2ebd4-fcfd-4f6e-b58d-4625db0efec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_a35ca481-3362-4c5d-bfbc-83dcacb203de" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_a35ca481-3362-4c5d-bfbc-83dcacb203de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_9d2581a4-4a89-4a3c-a095-5e86ba163d16" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_9d2581a4-4a89-4a3c-a095-5e86ba163d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_0e70271c-0b33-44f1-a32d-d8f7ecf5974e" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_0e70271c-0b33-44f1-a32d-d8f7ecf5974e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_d5fca0dd-4510-4683-a021-57025475de6b" xlink:href="holx-20200926.xsd#holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_d5fca0dd-4510-4683-a021-57025475de6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_01a20c30-efc0-4e70-baff-3bd88750f1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_01a20c30-efc0-4e70-baff-3bd88750f1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_46d594da-b255-438e-a72a-20309174924e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_46d594da-b255-438e-a72a-20309174924e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_94d499a5-6699-4d4c-be04-82fac6bd0b6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_94d499a5-6699-4d4c-be04-82fac6bd0b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_df78e160-84ec-4789-93df-e16ee6f34d68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_df78e160-84ec-4789-93df-e16ee6f34d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a4b7017-5244-493d-a336-6d93666763f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_17a08013-ef45-462d-baec-40fc49e27005" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a4b7017-5244-493d-a336-6d93666763f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1a03124c-b8bf-4993-b5ca-539a066e9230" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1a03124c-b8bf-4993-b5ca-539a066e9230" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a2714c29-e449-4ab0-a137-c024c958d964" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a2714c29-e449-4ab0-a137-c024c958d964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_3505339b-40c8-45ca-a536-90b35b823342" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_3505339b-40c8-45ca-a536-90b35b823342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_3d1e4697-44d5-4795-a82a-890426aa5386" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_3d1e4697-44d5-4795-a82a-890426aa5386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_99326185-fab5-438c-a207-dc61fdfe1579" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_99326185-fab5-438c-a207-dc61fdfe1579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UKIntangibleassets_d5e0bd00-f0e8-46be-875b-20ed38bd5f48" xlink:href="holx-20200926.xsd#holx_UKIntangibleassets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_holx_UKIntangibleassets_d5e0bd00-f0e8-46be-875b-20ed38bd5f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2b30d634-c320-4cf4-b277-fd9d1581ae87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2b30d634-c320-4cf4-b277-fd9d1581ae87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_accef074-5f43-4429-aa46-c51ee0ba9839" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_accef074-5f43-4429-aa46-c51ee0ba9839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_abddbc5d-0660-42e1-952e-474fb54f500d" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_abddbc5d-0660-42e1-952e-474fb54f500d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsLeaseLiability_a54be5c8-b857-44d6-8601-7fdeac1f8e73" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_holx_DeferredTaxAssetsLeaseLiability_a54be5c8-b857-44d6-8601-7fdeac1f8e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_69c381db-4fe4-44bf-a179-e62d9150a418" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_69c381db-4fe4-44bf-a179-e62d9150a418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f23137f4-ec6e-4a17-8f4e-fdbbc7951ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_f23137f4-ec6e-4a17-8f4e-fdbbc7951ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d0c94291-532f-4657-84c3-91d64af5f7c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d0c94291-532f-4657-84c3-91d64af5f7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1e052438-4288-40c0-a278-85c82c06895c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1e052438-4288-40c0-a278-85c82c06895c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53810fe6-140a-4d03-8db3-92f39c377793" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53810fe6-140a-4d03-8db3-92f39c377793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_741c3c7d-aa9f-4599-bf49-53ddf3b01b88" xlink:href="holx-20200926.xsd#holx_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53810fe6-140a-4d03-8db3-92f39c377793" xlink:to="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_741c3c7d-aa9f-4599-bf49-53ddf3b01b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset_34b12e53-d9c8-4512-9a4a-547b49974d26" xlink:href="holx-20200926.xsd#holx_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53810fe6-140a-4d03-8db3-92f39c377793" xlink:to="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset_34b12e53-d9c8-4512-9a4a-547b49974d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesDebtDiscount_ded4ebf7-5b10-4f3c-800e-c89e08188875" xlink:href="holx-20200926.xsd#holx_DeferredTaxLiabilitiesDebtDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53810fe6-140a-4d03-8db3-92f39c377793" xlink:to="loc_holx_DeferredTaxLiabilitiesDebtDiscount_ded4ebf7-5b10-4f3c-800e-c89e08188875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e951f6f6-f3e0-45eb-909c-08f164ee142a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e951f6f6-f3e0-45eb-909c-08f164ee142a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_e677a113-608a-4be7-8057-ec9d3352538d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7a649305-99b9-455e-8e1e-54f9f83fefad" xlink:to="loc_us-gaap_DeferredTaxLiabilities_e677a113-608a-4be7-8057-ec9d3352538d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_85df7303-ae20-4867-911c-db0657f350fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:href="holx-20200926.xsd#holx_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85df7303-ae20-4867-911c-db0657f350fd" xlink:to="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_79e8e257-ce46-40da-ac0a-641d56f35bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_79e8e257-ce46-40da-ac0a-641d56f35bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_79e8e257-ce46-40da-ac0a-641d56f35bb4" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_47af23d9-ca73-41a3-90d4-ce9dcfe8eaea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:to="loc_us-gaap_DomesticCountryMember_47af23d9-ca73-41a3-90d4-ce9dcfe8eaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_ae57cadc-6679-4181-908a-5c2b335504e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_ae57cadc-6679-4181-908a-5c2b335504e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_14bfbc17-efba-4fac-811c-963d238a5ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d18305e2-08e2-457e-9dc1-9cea51e6c15d" xlink:to="loc_us-gaap_ForeignCountryMember_14bfbc17-efba-4fac-811c-963d238a5ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7255f269-752c-4f17-83b4-ca12dddbbe1e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_srt_RangeAxis_7255f269-752c-4f17-83b4-ca12dddbbe1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2e5cb34b-ac4f-4750-88c5-00e5db0631fa" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7255f269-752c-4f17-83b4-ca12dddbbe1e" xlink:to="loc_srt_RangeMember_2e5cb34b-ac4f-4750-88c5-00e5db0631fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_732a4916-d7ad-4393-a393-2b6d3de0fd85" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2e5cb34b-ac4f-4750-88c5-00e5db0631fa" xlink:to="loc_srt_MaximumMember_732a4916-d7ad-4393-a393-2b6d3de0fd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_b8e9562a-1d16-4ff3-9fbc-b239edec1848" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_b8e9562a-1d16-4ff3-9fbc-b239edec1848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_3089dfc4-d2c4-4a16-92ed-31bd8c1b38d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_b8e9562a-1d16-4ff3-9fbc-b239edec1848" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_3089dfc4-d2c4-4a16-92ed-31bd8c1b38d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossCarryforwardsMember_4f71cd26-5880-4dc9-8614-c0f022b81e37" xlink:href="holx-20200926.xsd#holx_NetOperatingLossCarryforwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_3089dfc4-d2c4-4a16-92ed-31bd8c1b38d7" xlink:to="loc_holx_NetOperatingLossCarryforwardsMember_4f71cd26-5880-4dc9-8614-c0f022b81e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxCreditCarryforwardMember_f1378cd7-3d45-4643-95ad-ab4159f225db" xlink:href="holx-20200926.xsd#holx_TaxCreditCarryforwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_3089dfc4-d2c4-4a16-92ed-31bd8c1b38d7" xlink:to="loc_holx_TaxCreditCarryforwardMember_f1378cd7-3d45-4643-95ad-ab4159f225db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7d6e665f-ee7c-4b18-ac00-4fc7321ceb24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7d6e665f-ee7c-4b18-ac00-4fc7321ceb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bfc29945-91ca-4787-b497-d64d467a52db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7d6e665f-ee7c-4b18-ac00-4fc7321ceb24" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bfc29945-91ca-4787-b497-d64d467a52db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_713f29aa-9e97-4446-b350-746e27535c29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bfc29945-91ca-4787-b497-d64d467a52db" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_713f29aa-9e97-4446-b350-746e27535c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d0f29a40-97dd-4727-ba27-a153c978cecc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d0f29a40-97dd-4727-ba27-a153c978cecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7da8bc37-55d7-4367-8a7f-ff0690b4594d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d0f29a40-97dd-4727-ba27-a153c978cecc" xlink:to="loc_us-gaap_SegmentDomain_7da8bc37-55d7-4367-8a7f-ff0690b4594d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_318e1740-d838-46e3-bf6d-4be9e5de0d99" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7da8bc37-55d7-4367-8a7f-ff0690b4594d" xlink:to="loc_holx_MedicalAestheticsMember_318e1740-d838-46e3-bf6d-4be9e5de0d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:href="holx-20200926.xsd#holx_IncomeTaxesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_38588127-5fb8-4140-bb3b-5f07fe233c2c" xlink:to="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit_fa64574e-6e87-4513-8108-ce3f801773eb" xlink:href="holx-20200926.xsd#holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit_fa64574e-6e87-4513-8108-ce3f801773eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_fce475d4-1afd-48a0-9013-520853fd036e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_fce475d4-1afd-48a0-9013-520853fd036e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_fcdd0bbc-4613-47e0-b295-f751b0d21f55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_OperatingLossCarryforwards_fcdd0bbc-4613-47e0-b295-f751b0d21f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_8f3f798f-a3a5-4e9d-8658-9dad642f7af5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_8f3f798f-a3a5-4e9d-8658-9dad642f7af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_933ece14-58dd-40af-b200-76f520b61885" xlink:href="holx-20200926.xsd#holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_933ece14-58dd-40af-b200-76f520b61885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_8c5c5996-59a1-4e72-a25d-42adec4cf0c4" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_8c5c5996-59a1-4e72-a25d-42adec4cf0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_77b1e9a3-05e1-4666-8997-e1c94a89270d" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_77b1e9a3-05e1-4666-8997-e1c94a89270d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_118c3c84-3161-4eec-94ed-cba43cdd4b29" xlink:href="holx-20200926.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_118c3c84-3161-4eec-94ed-cba43cdd4b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossUnrecognizedTaxBenefits_7fc7d179-50d5-49aa-9287-b1fd934b0558" xlink:href="holx-20200926.xsd#holx_GrossUnrecognizedTaxBenefits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_GrossUnrecognizedTaxBenefits_7fc7d179-50d5-49aa-9287-b1fd934b0558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_30bc2786-f57a-47cb-abf8-1efe68d5b9b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_30bc2786-f57a-47cb-abf8-1efe68d5b9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_3c01d38a-dcc1-459d-a27d-f41c48e790dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_3c01d38a-dcc1-459d-a27d-f41c48e790dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d3f9add3-6bba-40aa-8abe-f6be187b6e28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d3f9add3-6bba-40aa-8abe-f6be187b6e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_d2b4cb6b-eb59-40b3-8a34-14b79d9e9f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_d2b4cb6b-eb59-40b3-8a34-14b79d9e9f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued_b84e49f1-9574-4292-9419-ed81a94f9e74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued_b84e49f1-9574-4292-9419-ed81a94f9e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616_c8605a7f-7894-4af7-9299-72e171d1a148" xlink:href="holx-20200926.xsd#holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616_c8605a7f-7894-4af7-9299-72e171d1a148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616_3b61cab6-9276-4a2a-8db8-ff1068e2b40c" xlink:href="holx-20200926.xsd#holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616_3b61cab6-9276-4a2a-8db8-ff1068e2b40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616_0681feb5-322d-4644-a674-e1f863b8c6d5" xlink:href="holx-20200926.xsd#holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616_0681feb5-322d-4644-a674-e1f863b8c6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616_3ceb7882-4a13-428f-8a4e-5638a7b3614a" xlink:href="holx-20200926.xsd#holx_IncreasetoincometaxexpenseadoptionofASU201616"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616_3ceb7882-4a13-428f-8a4e-5638a7b3614a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_2e043692-fe85-49d1-bdf4-2fff170cf4d9" xlink:href="holx-20200926.xsd#holx_DecreaseindeferredtaxliabilitiesduetoASC201616"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_2e043692-fe85-49d1-bdf4-2fff170cf4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_614c1a0a-24b0-468c-aedd-3e33efa61f85" xlink:href="holx-20200926.xsd#holx_IncreasetoNetIncomeresultedfromadoptionofASU201616"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_614c1a0a-24b0-468c-aedd-3e33efa61f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_e44767b8-33c1-40f4-b4fd-99881cdce7b1" xlink:href="holx-20200926.xsd#holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_e44767b8-33c1-40f4-b4fd-99881cdce7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonIncomeTaxLoss_67e386f6-b8c4-4a91-bceb-1b148822495c" xlink:href="holx-20200926.xsd#holx_NonIncomeTaxLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_NonIncomeTaxLoss_67e386f6-b8c4-4a91-bceb-1b148822495c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_a890cde5-0ee9-4f1a-8245-98eba0456083" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_a890cde5-0ee9-4f1a-8245-98eba0456083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_StateLossCarryforwardExpectedToUnutilize_186c0127-995f-4136-9eab-1eea4fc11143" xlink:href="holx-20200926.xsd#holx_StateLossCarryforwardExpectedToUnutilize"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_StateLossCarryforwardExpectedToUnutilize_186c0127-995f-4136-9eab-1eea4fc11143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_42a2783b-9853-4384-a928-69f4c4473af6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_42a2783b-9853-4384-a928-69f4c4473af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossStateLossCarryforwards_902a3c0f-f0d3-44bc-82f0-cd08807ff8ff" xlink:href="holx-20200926.xsd#holx_GrossStateLossCarryforwards"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_GrossStateLossCarryforwards_902a3c0f-f0d3-44bc-82f0-cd08807ff8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossForeignLossCarryforwards_749a38b7-d511-4166-b675-9bb3e785fd0d" xlink:href="holx-20200926.xsd#holx_GrossForeignLossCarryforwards"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_3c93d728-278f-4bc9-b781-90b32703f633" xlink:to="loc_holx_GrossForeignLossCarryforwards_749a38b7-d511-4166-b675-9bb3e785fd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ef073803-34a2-49fc-96f9-52baba78bf0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_a823e321-fe70-45b7-bafb-2be355786eaa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef073803-34a2-49fc-96f9-52baba78bf0b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_a823e321-fe70-45b7-bafb-2be355786eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxPositionsRelatedToCurrentYearAbstract_1ec43c3d-99f6-45f1-b755-c33b11bcf6e5" xlink:href="holx-20200926.xsd#holx_TaxPositionsRelatedToCurrentYearAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef073803-34a2-49fc-96f9-52baba78bf0b" xlink:to="loc_holx_TaxPositionsRelatedToCurrentYearAbstract_1ec43c3d-99f6-45f1-b755-c33b11bcf6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_cd84a26f-1d47-4e7b-b295-6384bfde9362" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToCurrentYearAbstract_1ec43c3d-99f6-45f1-b755-c33b11bcf6e5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_cd84a26f-1d47-4e7b-b295-6384bfde9362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_5af3aeed-84e6-49ee-9839-48db3f0e712b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToCurrentYearAbstract_1ec43c3d-99f6-45f1-b755-c33b11bcf6e5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_5af3aeed-84e6-49ee-9839-48db3f0e712b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_01c9015d-60eb-4185-9325-b1a22eb36d70" xlink:href="holx-20200926.xsd#holx_TaxPositionsRelatedToPriorYearsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef073803-34a2-49fc-96f9-52baba78bf0b" xlink:to="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_01c9015d-60eb-4185-9325-b1a22eb36d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_ca1b7b47-3abd-43fb-898b-d3905524c15a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_01c9015d-60eb-4185-9325-b1a22eb36d70" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_ca1b7b47-3abd-43fb-898b-d3905524c15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_ef333010-b3c3-487f-9297-baab5007cffa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_01c9015d-60eb-4185-9325-b1a22eb36d70" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_ef333010-b3c3-487f-9297-baab5007cffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_ec9a2b75-b62b-4118-8434-209b02d59cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_01c9015d-60eb-4185-9325-b1a22eb36d70" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_ec9a2b75-b62b-4118-8434-209b02d59cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_f76ce8cb-fa0e-49a6-8252-fe30795bb134" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_01c9015d-60eb-4185-9325-b1a22eb36d70" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_f76ce8cb-fa0e-49a6-8252-fe30795bb134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract_2f930e94-f896-47bd-92fd-08c159b7c5ca" xlink:href="holx-20200926.xsd#holx_UnrecognizedTaxBenefitsIncreasesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef073803-34a2-49fc-96f9-52baba78bf0b" xlink:to="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract_2f930e94-f896-47bd-92fd-08c159b7c5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_7620e148-5891-4803-8209-27f1e64964c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract_2f930e94-f896-47bd-92fd-08c159b7c5ca" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_7620e148-5891-4803-8209-27f1e64964c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_bdf6ea9a-5bc3-497c-aba3-5a08da3b4702" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef073803-34a2-49fc-96f9-52baba78bf0b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_bdf6ea9a-5bc3-497c-aba3-5a08da3b4702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55c6f60f-6003-4556-8677-629eb0b76f03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fa9588e2-bd17-4a82-894c-cc800d12a235" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55c6f60f-6003-4556-8677-629eb0b76f03" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fa9588e2-bd17-4a82-894c-cc800d12a235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08461e57-28ae-43f1-b15a-379b319002b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_ccf5d2f9-ee4c-4f6b-9abd-dbebec1adf4d" xlink:href="holx-20200926.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08461e57-28ae-43f1-b15a-379b319002b5" xlink:to="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_ccf5d2f9-ee4c-4f6b-9abd-dbebec1adf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_064c1fc8-986a-4d4a-960b-1868a9ba826d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08461e57-28ae-43f1-b15a-379b319002b5" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_064c1fc8-986a-4d4a-960b-1868a9ba826d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_75567cc7-cb90-4caa-b22b-456c6fdea581" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08461e57-28ae-43f1-b15a-379b319002b5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_75567cc7-cb90-4caa-b22b-456c6fdea581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_5087ef6a-b7f5-4af7-a766-9cfa3754c7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08461e57-28ae-43f1-b15a-379b319002b5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_5087ef6a-b7f5-4af7-a766-9cfa3754c7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_765966ab-d4c3-4213-ad8b-742e54310bcc" xlink:href="holx-20200926.xsd#holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08461e57-28ae-43f1-b15a-379b319002b5" xlink:to="loc_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_765966ab-d4c3-4213-ad8b-742e54310bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_306f0150-3476-4a41-bab9-69c76d155825" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_306f0150-3476-4a41-bab9-69c76d155825" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchseAuthorizationDateAxis_e3c4235a-5fb3-4394-9c08-40bbe82c0574" xlink:href="holx-20200926.xsd#holx_ShareRepurchseAuthorizationDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_holx_ShareRepurchseAuthorizationDateAxis_e3c4235a-5fb3-4394-9c08-40bbe82c0574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AuthorizationDateDomain_c6e5ec52-adf7-401f-9596-c7a9a754844c" xlink:href="holx-20200926.xsd#holx_AuthorizationDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis_e3c4235a-5fb3-4394-9c08-40bbe82c0574" xlink:to="loc_holx_AuthorizationDateDomain_c6e5ec52-adf7-401f-9596-c7a9a754844c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Jun212016Member_1abc754e-f619-45d6-bcf5-30783f314d3b" xlink:href="holx-20200926.xsd#holx_Jun212016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AuthorizationDateDomain_c6e5ec52-adf7-401f-9596-c7a9a754844c" xlink:to="loc_holx_Jun212016Member_1abc754e-f619-45d6-bcf5-30783f314d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Dec112019Member_b7a1b5cb-fe8c-4650-b047-815e3e406d73" xlink:href="holx-20200926.xsd#holx_Dec112019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AuthorizationDateDomain_c6e5ec52-adf7-401f-9596-c7a9a754844c" xlink:to="loc_holx_Dec112019Member_b7a1b5cb-fe8c-4650-b047-815e3e406d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d5e6b92a-4225-4ddb-a308-89d2ca1b57d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_us-gaap_PlanNameAxis_d5e6b92a-4225-4ddb-a308-89d2ca1b57d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3be2be5d-bc8a-4a25-88bc-65bb7567d124" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d5e6b92a-4225-4ddb-a308-89d2ca1b57d6" xlink:to="loc_us-gaap_PlanNameDomain_3be2be5d-bc8a-4a25-88bc-65bb7567d124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandEightEquityPlanMember_f7b3cce3-602c-4cae-9686-518bc696fae5" xlink:href="holx-20200926.xsd#holx_TwoThousandEightEquityPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3be2be5d-bc8a-4a25-88bc-65bb7567d124" xlink:to="loc_holx_TwoThousandEightEquityPlanMember_f7b3cce3-602c-4cae-9686-518bc696fae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember_f20f1a96-bbdb-4f1e-a9ab-48c9d64b1f52" xlink:href="holx-20200926.xsd#holx_SemiAnnualEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3be2be5d-bc8a-4a25-88bc-65bb7567d124" xlink:to="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember_f20f1a96-bbdb-4f1e-a9ab-48c9d64b1f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bb683f0b-e543-4ea0-b1a7-666947ca222d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_us-gaap_AwardTypeAxis_bb683f0b-e543-4ea0-b1a7-666947ca222d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bb683f0b-e543-4ea0-b1a7-666947ca222d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_88583f3f-ab47-4eb7-a82d-e6bedd71557e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_us-gaap_StockOptionMember_88583f3f-ab47-4eb7-a82d-e6bedd71557e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_95abd138-089b-4729-9329-00c216d1b8f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_95abd138-089b-4729-9329-00c216d1b8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bf9dcfd1-8244-4e06-9737-4c47f6de78ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_us-gaap_PerformanceSharesMember_bf9dcfd1-8244-4e06-9737-4c47f6de78ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember_b754e7d3-3ea3-4718-8158-96269b41d03f" xlink:href="holx-20200926.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_holx_MarketBasedStockUnitsMember_b754e7d3-3ea3-4718-8158-96269b41d03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_63b66ca9-b9da-4510-bb2b-bc13fbb89b9c" xlink:href="holx-20200926.xsd#holx_PSUFreeCashFlowMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_holx_PSUFreeCashFlowMember_63b66ca9-b9da-4510-bb2b-bc13fbb89b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8270f9d7-e697-467d-b28d-438fa16955c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_402126b1-e661-405f-beee-b10d26a9d043" xlink:to="loc_us-gaap_RestrictedStockMember_8270f9d7-e697-467d-b28d-438fa16955c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f9548858-8e70-4e76-9d54-60481db08d39" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_srt_RangeAxis_f9548858-8e70-4e76-9d54-60481db08d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c3184935-5652-4dd7-9998-fd5ec1743d96" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f9548858-8e70-4e76-9d54-60481db08d39" xlink:to="loc_srt_RangeMember_c3184935-5652-4dd7-9998-fd5ec1743d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ace52342-d766-4261-8420-8816b866a8ea" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c3184935-5652-4dd7-9998-fd5ec1743d96" xlink:to="loc_srt_MinimumMember_ace52342-d766-4261-8420-8816b866a8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3df56f63-24da-4927-953a-9ed6ffb870be" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c3184935-5652-4dd7-9998-fd5ec1743d96" xlink:to="loc_srt_MaximumMember_3df56f63-24da-4927-953a-9ed6ffb870be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_8f894892-60bf-4c37-b4b1-ba72dc9d3f13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_8f894892-60bf-4c37-b4b1-ba72dc9d3f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a47e56f0-9043-4dc8-8be9-1474faac1863" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8f894892-60bf-4c37-b4b1-ba72dc9d3f13" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a47e56f0-9043-4dc8-8be9-1474faac1863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_June132019PlanMember_11498d12-f5c1-4b30-a908-454ddf5661a7" xlink:href="holx-20200926.xsd#holx_June132019PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a47e56f0-9043-4dc8-8be9-1474faac1863" xlink:to="loc_holx_June132019PlanMember_11498d12-f5c1-4b30-a908-454ddf5661a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8af75128-43fd-466e-ab06-e5cbb463b5a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6005ff3c-f345-402c-84d9-0a22ba683f79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6005ff3c-f345-402c-84d9-0a22ba683f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8312d884-1aa5-4c41-a66e-4c92ebcd0125" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8312d884-1aa5-4c41-a66e-4c92ebcd0125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_412ff85c-2948-4e18-804d-0bc5475c2f88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_412ff85c-2948-4e18-804d-0bc5475c2f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_f0dcc479-1a5b-4e77-94ea-5adf538535de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_f0dcc479-1a5b-4e77-94ea-5adf538535de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4b35f59b-487b-4e22-a3b0-ffbf5a78c52d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4b35f59b-487b-4e22-a3b0-ffbf5a78c52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_0158a216-4a58-41ac-ad7b-969dce7105eb" xlink:href="holx-20200926.xsd#holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_0158a216-4a58-41ac-ad7b-969dce7105eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9e1d2307-b487-4f1c-a8f9-330236615982" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9e1d2307-b487-4f1c-a8f9-330236615982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_2b4f199a-1c28-4853-b234-ef83d4ef12e7" xlink:href="holx-20200926.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_2b4f199a-1c28-4853-b234-ef83d4ef12e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_a16770de-c41c-46e5-8e44-cd24d7e81b3f" xlink:href="holx-20200926.xsd#holx_PercentageOfVestingForStockOptionsGrantedToEmployees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_a16770de-c41c-46e5-8e44-cd24d7e81b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_99a49168-88aa-48af-9948-d0fc0740910a" xlink:href="holx-20200926.xsd#holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_99a49168-88aa-48af-9948-d0fc0740910a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate_f4f021c5-5255-49b4-be30-4c4c7f4ec9e6" xlink:href="holx-20200926.xsd#holx_ShareBasedCompensationPercentageOfForfeitureRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate_f4f021c5-5255-49b4-be30-4c4c7f4ec9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_daf2a6d8-a97a-4331-86e9-3509ba9f051b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_daf2a6d8-a97a-4331-86e9-3509ba9f051b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a322a981-f0cf-48ad-998f-55bf68b7a3d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a322a981-f0cf-48ad-998f-55bf68b7a3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_54915ef8-c126-41dd-9fdc-5a9d3d4974fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_54915ef8-c126-41dd-9fdc-5a9d3d4974fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22c36d3e-02c6-4cc2-89a3-1a05ff9798d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22c36d3e-02c6-4cc2-89a3-1a05ff9798d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_21d77911-f53c-4be5-bea8-26191ccc3308" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_21d77911-f53c-4be5-bea8-26191ccc3308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8302c16d-7e9c-4e47-8fac-741b488ae2ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8302c16d-7e9c-4e47-8fac-741b488ae2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dee715c2-f0a1-4571-86f8-edfbcb631f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dee715c2-f0a1-4571-86f8-edfbcb631f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_d6ae5712-13aa-4473-947c-e0c3b925109f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_d6ae5712-13aa-4473-947c-e0c3b925109f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_d4d2fced-6578-44b2-a5e8-976368026573" xlink:href="holx-20200926.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_d4d2fced-6578-44b2-a5e8-976368026573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_96ff81b2-217a-4a45-86c7-f17bb43d6e67" xlink:href="holx-20200926.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_96ff81b2-217a-4a45-86c7-f17bb43d6e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_036674e9-06f6-4af5-b4a3-c5a2d8ffb813" xlink:href="holx-20200926.xsd#holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_036674e9-06f6-4af5-b4a3-c5a2d8ffb813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_6c2ba1e5-fd8d-4c77-9edc-830a8f8123ef" xlink:href="holx-20200926.xsd#holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_6c2ba1e5-fd8d-4c77-9edc-830a8f8123ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3887820f-2e3e-40e2-b811-20f2342f5f44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ShareBasedCompensation_3887820f-2e3e-40e2-b811-20f2342f5f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_cb5dc76e-843e-4442-8610-bb1e6595afe0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_cb5dc76e-843e-4442-8610-bb1e6595afe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_f24deb11-5825-4590-837c-dccaa21c2760" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_f24deb11-5825-4590-837c-dccaa21c2760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRSharesRepurchasedduringtheperiod_832833c2-0f05-49f5-ba99-ba0edbcc2058" xlink:href="holx-20200926.xsd#holx_ASRSharesRepurchasedduringtheperiod"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_ASRSharesRepurchasedduringtheperiod_832833c2-0f05-49f5-ba99-ba0edbcc2058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRAuthorized_c28aaef5-79f9-4ee0-b57e-7fdc38d6fb78" xlink:href="holx-20200926.xsd#holx_ASRAuthorized"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_ASRAuthorized_c28aaef5-79f9-4ee0-b57e-7fdc38d6fb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountpaidduringtheperiodunderASRAgreement_945fcf3b-18f6-4d17-a3c2-37a257966f3e" xlink:href="holx-20200926.xsd#holx_AmountpaidduringtheperiodunderASRAgreement"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b00e2ce1-628c-4c95-ba44-713aafd17f1b" xlink:to="loc_holx_AmountpaidduringtheperiodunderASRAgreement_945fcf3b-18f6-4d17-a3c2-37a257966f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c37687a-26ee-4172-90f0-29f8c0f47c47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f4121e57-a700-464e-8e12-27aac87187f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c37687a-26ee-4172-90f0-29f8c0f47c47" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f4121e57-a700-464e-8e12-27aac87187f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7be8c260-cbb8-45a4-a47b-b705c20c3f00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f4121e57-a700-464e-8e12-27aac87187f5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7be8c260-cbb8-45a4-a47b-b705c20c3f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7be8c260-cbb8-45a4-a47b-b705c20c3f00" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d4b4cb86-50ae-4a29-8c36-16e415ba8768" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_CostOfSalesMember_d4b4cb86-50ae-4a29-8c36-16e415ba8768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a262f883-1c78-491f-b767-32556cbf9a21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a262f883-1c78-491f-b767-32556cbf9a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_2086dbff-2ca2-4db5-9b3c-92f2ee91ba77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_2086dbff-2ca2-4db5-9b3c-92f2ee91ba77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c5235907-b14b-4a85-b88c-4e9e853d58e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c5235907-b14b-4a85-b88c-4e9e853d58e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_fd4d3a52-3704-46a1-be03-76d63c363c18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5818c05-e728-4cfb-a9dd-744727c4935d" xlink:to="loc_us-gaap_RestructuringChargesMember_fd4d3a52-3704-46a1-be03-76d63c363c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbac25ba-b1b7-43a6-9fbb-f814be46d357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f4121e57-a700-464e-8e12-27aac87187f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbac25ba-b1b7-43a6-9fbb-f814be46d357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e512a48a-81aa-40c0-be1b-12d872af18c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbac25ba-b1b7-43a6-9fbb-f814be46d357" xlink:to="loc_us-gaap_ShareBasedCompensation_e512a48a-81aa-40c0-be1b-12d872af18c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31a70655-7416-4662-ab90-d2511857e1a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b6a4382f-7b9c-4f9f-a56b-cad0e94e30fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31a70655-7416-4662-ab90-d2511857e1a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b6a4382f-7b9c-4f9f-a56b-cad0e94e30fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0f67c724-d288-4aa5-9faf-804a029dd16e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31a70655-7416-4662-ab90-d2511857e1a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0f67c724-d288-4aa5-9faf-804a029dd16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_f849aefc-7553-42c5-9b0e-fe3593521ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31a70655-7416-4662-ab90-d2511857e1a1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_f849aefc-7553-42c5-9b0e-fe3593521ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f6c2f947-f22a-4672-9cc5-d27eccaee5ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31a70655-7416-4662-ab90-d2511857e1a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f6c2f947-f22a-4672-9cc5-d27eccaee5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_cc42126b-7700-4416-a4ec-cb5c2179b413" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f6c2f947-f22a-4672-9cc5-d27eccaee5ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_cc42126b-7700-4416-a4ec-cb5c2179b413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_94bbb9cf-fafc-464f-9705-95f8f9a4d70d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f6c2f947-f22a-4672-9cc5-d27eccaee5ad" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_94bbb9cf-fafc-464f-9705-95f8f9a4d70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_788f41d8-c190-4dd3-89d8-46b239e70203" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f6c2f947-f22a-4672-9cc5-d27eccaee5ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_788f41d8-c190-4dd3-89d8-46b239e70203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_30f0a9ae-af79-43f4-b817-279dfb1cb081" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f6c2f947-f22a-4672-9cc5-d27eccaee5ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_30f0a9ae-af79-43f4-b817-279dfb1cb081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24dc1676-a8f9-4be5-a120-4a38de6c340e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b53313c-79bd-402f-ad2b-28bf1d7ca770" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24dc1676-a8f9-4be5-a120-4a38de6c340e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b53313c-79bd-402f-ad2b-28bf1d7ca770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_397c9b4e-e6f1-4545-b821-e01025812a95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b53313c-79bd-402f-ad2b-28bf1d7ca770" xlink:to="loc_us-gaap_AwardTypeAxis_397c9b4e-e6f1-4545-b821-e01025812a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07099d88-463b-412c-8146-cbc09bd4e310" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_397c9b4e-e6f1-4545-b821-e01025812a95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07099d88-463b-412c-8146-cbc09bd4e310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_89a73bc0-9174-4aef-ab7d-2823aaed813c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07099d88-463b-412c-8146-cbc09bd4e310" xlink:to="loc_us-gaap_PerformanceSharesMember_89a73bc0-9174-4aef-ab7d-2823aaed813c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember_f65c214d-a6ee-4fdd-af5f-c6ad83cec2cd" xlink:href="holx-20200926.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07099d88-463b-412c-8146-cbc09bd4e310" xlink:to="loc_holx_MarketBasedStockUnitsMember_f65c214d-a6ee-4fdd-af5f-c6ad83cec2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f91e29c-fae8-44b8-804c-bd92b518e91d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b53313c-79bd-402f-ad2b-28bf1d7ca770" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f91e29c-fae8-44b8-804c-bd92b518e91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2b5794cc-8b21-47ec-9bb4-3480fb6d863b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f91e29c-fae8-44b8-804c-bd92b518e91d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2b5794cc-8b21-47ec-9bb4-3480fb6d863b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d722251f-4677-40d4-a95f-45ebb0cdd9d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24dc1676-a8f9-4be5-a120-4a38de6c340e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d722251f-4677-40d4-a95f-45ebb0cdd9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b7f4052c-04ff-4ccc-a916-5c14c174e441" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d722251f-4677-40d4-a95f-45ebb0cdd9d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b7f4052c-04ff-4ccc-a916-5c14c174e441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c7f57cfa-411e-4305-b6a8-dcaca9aada56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d722251f-4677-40d4-a95f-45ebb0cdd9d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c7f57cfa-411e-4305-b6a8-dcaca9aada56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_339387a8-bd04-44b2-92e7-254b68a41582" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d722251f-4677-40d4-a95f-45ebb0cdd9d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_339387a8-bd04-44b2-92e7-254b68a41582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0dd33500-28ea-42ec-8d2e-9d11905b4757" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d722251f-4677-40d4-a95f-45ebb0cdd9d3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0dd33500-28ea-42ec-8d2e-9d11905b4757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cebbb8a4-d5e2-4eb6-a6be-7ae5c2f66e66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d722251f-4677-40d4-a95f-45ebb0cdd9d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cebbb8a4-d5e2-4eb6-a6be-7ae5c2f66e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c12529c1-c6cb-4a5e-a418-e0cc436c3386" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d722251f-4677-40d4-a95f-45ebb0cdd9d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c12529c1-c6cb-4a5e-a418-e0cc436c3386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_ae9ce56d-27cf-4a82-9596-95707dc3cee1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d722251f-4677-40d4-a95f-45ebb0cdd9d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_ae9ce56d-27cf-4a82-9596-95707dc3cee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ebaa2617-e243-4c9a-a59b-21111d04e42c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24dc1676-a8f9-4be5-a120-4a38de6c340e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ebaa2617-e243-4c9a-a59b-21111d04e42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1b46dae-ca38-45d2-960a-af9566af5b13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ebaa2617-e243-4c9a-a59b-21111d04e42c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1b46dae-ca38-45d2-960a-af9566af5b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f8ee5518-e73b-467a-bc7a-a97ebd3a76e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ebaa2617-e243-4c9a-a59b-21111d04e42c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f8ee5518-e73b-467a-bc7a-a97ebd3a76e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_da6398d0-c6c6-424a-ae50-3bf944a6089f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ebaa2617-e243-4c9a-a59b-21111d04e42c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_da6398d0-c6c6-424a-ae50-3bf944a6089f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2e3a34e6-18b6-4798-9c05-452cdd034e85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ebaa2617-e243-4c9a-a59b-21111d04e42c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2e3a34e6-18b6-4798-9c05-452cdd034e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e075fb6d-43b8-4cde-a4eb-382701c97c30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ebaa2617-e243-4c9a-a59b-21111d04e42c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e075fb6d-43b8-4cde-a4eb-382701c97c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ff073c3b-30d2-4656-98f5-02663e9f6ef6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ebaa2617-e243-4c9a-a59b-21111d04e42c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ff073c3b-30d2-4656-98f5-02663e9f6ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6f559bd6-42da-42c4-9513-6341c344bf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ebaa2617-e243-4c9a-a59b-21111d04e42c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6f559bd6-42da-42c4-9513-6341c344bf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92db15b1-b664-43b3-93ea-3f54d96bb608" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24dc1676-a8f9-4be5-a120-4a38de6c340e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92db15b1-b664-43b3-93ea-3f54d96bb608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_aee88d57-1215-49b7-829e-b8f0a21242c2" xlink:href="holx-20200926.xsd#holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92db15b1-b664-43b3-93ea-3f54d96bb608" xlink:to="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_aee88d57-1215-49b7-829e-b8f0a21242c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a3d13e6e-ae06-4d45-a76b-ea68bf5ae885" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92db15b1-b664-43b3-93ea-3f54d96bb608" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a3d13e6e-ae06-4d45-a76b-ea68bf5ae885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1b638465-3936-4ad1-955c-a93eb2671874" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92db15b1-b664-43b3-93ea-3f54d96bb608" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1b638465-3936-4ad1-955c-a93eb2671874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_5cbcf327-3ef4-4fa5-8f8b-b9d862851cd7" xlink:href="holx-20200926.xsd#holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92db15b1-b664-43b3-93ea-3f54d96bb608" xlink:to="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_5cbcf327-3ef4-4fa5-8f8b-b9d862851cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_0cbbfdbb-2881-48b8-a030-d92ac94b76ad" xlink:href="holx-20200926.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24dc1676-a8f9-4be5-a120-4a38de6c340e" xlink:to="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_0cbbfdbb-2881-48b8-a030-d92ac94b76ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a8a6c604-6e80-414d-9c43-b823696d2e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_0cbbfdbb-2881-48b8-a030-d92ac94b76ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a8a6c604-6e80-414d-9c43-b823696d2e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0e8bcc71-8a40-4a27-ad7f-dd72ff8fe32f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_0cbbfdbb-2881-48b8-a030-d92ac94b76ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0e8bcc71-8a40-4a27-ad7f-dd72ff8fe32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e0142d2f-416f-4b3d-bbdd-46d4a2476e63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_0cbbfdbb-2881-48b8-a030-d92ac94b76ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e0142d2f-416f-4b3d-bbdd-46d4a2476e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6f895946-90d3-4960-8e0f-1d016a490d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_0cbbfdbb-2881-48b8-a030-d92ac94b76ad" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6f895946-90d3-4960-8e0f-1d016a490d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_fadedae4-f2eb-46c0-af52-148cde7e49a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_0cbbfdbb-2881-48b8-a030-d92ac94b76ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_fadedae4-f2eb-46c0-af52-148cde7e49a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_503b633d-e1df-43d7-a546-60da087d5c87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c61e0fe5-b5a6-4aa7-bd9b-0ae826d8332c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_503b633d-e1df-43d7-a546-60da087d5c87" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c61e0fe5-b5a6-4aa7-bd9b-0ae826d8332c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2f93078a-67e8-4f5d-872f-cb92482cd778" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_503b633d-e1df-43d7-a546-60da087d5c87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2f93078a-67e8-4f5d-872f-cb92482cd778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ad797525-824a-4f29-814d-a3652df1b29c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2f93078a-67e8-4f5d-872f-cb92482cd778" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ad797525-824a-4f29-814d-a3652df1b29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3958ece4-df52-4868-972f-e4096bdb08e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2f93078a-67e8-4f5d-872f-cb92482cd778" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3958ece4-df52-4868-972f-e4096bdb08e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a61e7480-d2f3-4217-b7db-9af26c30072f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2f93078a-67e8-4f5d-872f-cb92482cd778" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a61e7480-d2f3-4217-b7db-9af26c30072f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_05e4d366-b5e3-4a71-92a8-9127ab06b713" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2f93078a-67e8-4f5d-872f-cb92482cd778" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_05e4d366-b5e3-4a71-92a8-9127ab06b713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5b3a74d0-50d8-4e89-a51f-e21181ca7b85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2f93078a-67e8-4f5d-872f-cb92482cd778" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5b3a74d0-50d8-4e89-a51f-e21181ca7b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d780cb0a-f700-4a5d-8d20-2c4aa1a04f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_503b633d-e1df-43d7-a546-60da087d5c87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d780cb0a-f700-4a5d-8d20-2c4aa1a04f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6f384908-0a46-4419-b772-1d22f01cc854" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d780cb0a-f700-4a5d-8d20-2c4aa1a04f4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6f384908-0a46-4419-b772-1d22f01cc854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e2f08f95-4310-4237-8261-934b3e78427a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d780cb0a-f700-4a5d-8d20-2c4aa1a04f4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e2f08f95-4310-4237-8261-934b3e78427a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_6dd4e0d0-af38-4b7a-938f-0b0ff72f9943" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d780cb0a-f700-4a5d-8d20-2c4aa1a04f4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_6dd4e0d0-af38-4b7a-938f-0b0ff72f9943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_87863f14-292c-42b1-b39c-a5824dc558b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d780cb0a-f700-4a5d-8d20-2c4aa1a04f4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_87863f14-292c-42b1-b39c-a5824dc558b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9057e695-6c83-4422-a25c-4ce2fc8b6fff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d780cb0a-f700-4a5d-8d20-2c4aa1a04f4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9057e695-6c83-4422-a25c-4ce2fc8b6fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f97d8656-b39c-4a2b-8018-2d78340d8345" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c89e49d-61bd-4839-9089-3da740914cba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f97d8656-b39c-4a2b-8018-2d78340d8345" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c89e49d-61bd-4839-9089-3da740914cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_22e51c88-ab59-4ae4-bc5d-3d60a5abb160" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c89e49d-61bd-4839-9089-3da740914cba" xlink:to="loc_us-gaap_AwardTypeAxis_22e51c88-ab59-4ae4-bc5d-3d60a5abb160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_684c9a1b-eb90-4588-b1b5-76c648a8d51d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_22e51c88-ab59-4ae4-bc5d-3d60a5abb160" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_684c9a1b-eb90-4588-b1b5-76c648a8d51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeStockPurchasePlanMember_90dcbf02-1649-4b23-a49c-b685a8c8ad09" xlink:href="holx-20200926.xsd#holx_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_684c9a1b-eb90-4588-b1b5-76c648a8d51d" xlink:to="loc_holx_EmployeeStockPurchasePlanMember_90dcbf02-1649-4b23-a49c-b685a8c8ad09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d76433be-e7ad-4bac-97f8-04ba1ddcb9de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c89e49d-61bd-4839-9089-3da740914cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d76433be-e7ad-4bac-97f8-04ba1ddcb9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d76433be-e7ad-4bac-97f8-04ba1ddcb9de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d66c9e27-4d86-4d84-bb14-9967ba43904f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d66c9e27-4d86-4d84-bb14-9967ba43904f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4dd704c2-ba95-4dda-a3e7-c3dfde4cab33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4dd704c2-ba95-4dda-a3e7-c3dfde4cab33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_6ddef7ac-5613-45c1-82eb-6466a708ad6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_6ddef7ac-5613-45c1-82eb-6466a708ad6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_ae40cc4f-4465-4fdd-be5f-063eb3f7af48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b8197cd2-03b9-4bf4-b02b-7150e65cd9e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_ae40cc4f-4465-4fdd-be5f-063eb3f7af48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/A401kPlan" xlink:type="simple" xlink:href="holx-20200926.xsd#A401kPlan"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/A401kPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_24aa47dc-c5ce-41f0-8c9e-f219bebc8916" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProfitSharingFourZeroOneKPlanTextBlock_73c92522-c126-4d5e-b291-00fe016ce3c5" xlink:href="holx-20200926.xsd#holx_ProfitSharingFourZeroOneKPlanTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_24aa47dc-c5ce-41f0-8c9e-f219bebc8916" xlink:to="loc_holx_ProfitSharingFourZeroOneKPlanTextBlock_73c92522-c126-4d5e-b291-00fe016ce3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#A401kPlanAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_be988365-1b72-45fa-9a7d-18ed703d0a61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_b677366f-e618-43b8-9823-f8bcd2e50a25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_be988365-1b72-45fa-9a7d-18ed703d0a61" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_b677366f-e618-43b8-9823-f8bcd2e50a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_48b52fb7-b3a2-40bb-ad63-dc13fde615ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract_be988365-1b72-45fa-9a7d-18ed703d0a61" xlink:to="loc_us-gaap_AdvertisingExpense_48b52fb7-b3a2-40bb-ad63-dc13fde615ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#DeferredCompensationPlanAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsAbstract_cd419ce8-8eae-40f8-a0e7-f4a2ed63d975" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationRelatedCostsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_56d13c7b-5b02-46fa-8ef1-6bc1f1d6228f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationRelatedCostsAbstract_cd419ce8-8eae-40f8-a0e7-f4a2ed63d975" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_56d13c7b-5b02-46fa-8ef1-6bc1f1d6228f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_eb61ced0-fef0-4542-899e-ae48756288ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_56d13c7b-5b02-46fa-8ef1-6bc1f1d6228f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_eb61ced0-fef0-4542-899e-ae48756288ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_55561423-0d3c-43ce-81ae-87ecd185c9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_eb61ced0-fef0-4542-899e-ae48756288ba" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_55561423-0d3c-43ce-81ae-87ecd185c9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_76af3995-068e-4e65-be69-8e8115ffe20a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_55561423-0d3c-43ce-81ae-87ecd185c9e4" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_76af3995-068e-4e65-be69-8e8115ffe20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_50d9b0af-40e2-4567-aaf2-0f13af3eb19d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_56d13c7b-5b02-46fa-8ef1-6bc1f1d6228f" xlink:to="loc_us-gaap_VestingAxis_50d9b0af-40e2-4567-aaf2-0f13af3eb19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_035b6d7d-9ece-4bd6-800c-d561ab76332e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_50d9b0af-40e2-4567-aaf2-0f13af3eb19d" xlink:to="loc_us-gaap_VestingDomain_035b6d7d-9ece-4bd6-800c-d561ab76332e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OneThirdAnnuallyMember_a554cd0f-e91a-40f3-9623-d3bd6a3bf910" xlink:href="holx-20200926.xsd#holx_OneThirdAnnuallyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_035b6d7d-9ece-4bd6-800c-d561ab76332e" xlink:to="loc_holx_OneThirdAnnuallyMember_a554cd0f-e91a-40f3-9623-d3bd6a3bf910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_56d13c7b-5b02-46fa-8ef1-6bc1f1d6228f" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_9a021242-f3a3-4b76-8ce3-d322a50cb6e4" xlink:href="holx-20200926.xsd#holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_9a021242-f3a3-4b76-8ce3-d322a50cb6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_dc73a800-1d5f-48de-a1da-cfa4dd56868e" xlink:href="holx-20200926.xsd#holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_dc73a800-1d5f-48de-a1da-cfa4dd56868e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeContributionsVestedPercentage_51313a95-dfea-4ea5-83a3-352e6ba670ab" xlink:href="holx-20200926.xsd#holx_EmployeeContributionsVestedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_EmployeeContributionsVestedPercentage_51313a95-dfea-4ea5-83a3-352e6ba670ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsPercentVestedAnnually_bedf02ae-8e6d-4e42-8a6a-d9972ff1aef5" xlink:href="holx-20200926.xsd#holx_EmployerContributionsPercentVestedAnnually"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_EmployerContributionsPercentVestedAnnually_bedf02ae-8e6d-4e42-8a6a-d9972ff1aef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsVestingPeriod_8c5695de-3d21-4658-9561-c283813573ce" xlink:href="holx-20200926.xsd#holx_EmployerContributionsVestingPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_EmployerContributionsVestingPeriod_8c5695de-3d21-4658-9561-c283813573ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_424e2518-78c8-413c-b776-10c766f6b0f3" xlink:href="holx-20200926.xsd#holx_NonqualifiedDeferredCompensationPlanAnnualContribution"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_424e2518-78c8-413c-b776-10c766f6b0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InvestmentInGroupLifeInsuranceContracts_9c64fc11-8e4c-42a4-8787-4497428c273b" xlink:href="holx-20200926.xsd#holx_InvestmentInGroupLifeInsuranceContracts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_holx_InvestmentInGroupLifeInsuranceContracts_9c64fc11-8e4c-42a4-8787-4497428c273b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_6d1831d2-5bdd-4c68-9db2-47767630543f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_9c972c27-bf9d-4ac2-aae4-dedf5b67c16e" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_6d1831d2-5bdd-4c68-9db2-47767630543f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20200926.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c62e75c-54e8-42de-a958-aa1ae7148c95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d3b3b478-787b-49f9-89ef-e9c75b7fdeb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c62e75c-54e8-42de-a958-aa1ae7148c95" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d3b3b478-787b-49f9-89ef-e9c75b7fdeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b7b07651-6cfb-4c6b-8828-0137ee958b4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_bfb63ea4-8098-4dd3-910a-2da34eac536f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b7b07651-6cfb-4c6b-8828-0137ee958b4f" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_bfb63ea4-8098-4dd3-910a-2da34eac536f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a001064-b6d8-4788-9f4a-6d627decdd3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_04516a1f-fa25-48d8-82d1-a247bfbec09d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a001064-b6d8-4788-9f4a-6d627decdd3b" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_04516a1f-fa25-48d8-82d1-a247bfbec09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_2f6971f0-3510-4624-8054-7f7426687ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a001064-b6d8-4788-9f4a-6d627decdd3b" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_2f6971f0-3510-4624-8054-7f7426687ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_5b550e74-3f4d-4e59-b308-8bfc40916e65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a001064-b6d8-4788-9f4a-6d627decdd3b" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_5b550e74-3f4d-4e59-b308-8bfc40916e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_c8b4f70d-7b54-4827-ae44-0404cd6bd4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a001064-b6d8-4788-9f4a-6d627decdd3b" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_c8b4f70d-7b54-4827-ae44-0404cd6bd4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_3bc736ab-50fd-459f-b2c5-2a3126158ac2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a001064-b6d8-4788-9f4a-6d627decdd3b" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_3bc736ab-50fd-459f-b2c5-2a3126158ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseobligationthereafter_ae159d5e-418a-4c2d-beb3-9ba91d336def" xlink:href="holx-20200926.xsd#holx_Purchaseobligationthereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a001064-b6d8-4788-9f4a-6d627decdd3b" xlink:to="loc_holx_Purchaseobligationthereafter_ae159d5e-418a-4c2d-beb3-9ba91d336def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_4e577d96-c0dc-4001-adfe-40a5cd8bf607" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a001064-b6d8-4788-9f4a-6d627decdd3b" xlink:to="loc_us-gaap_PurchaseObligation_4e577d96-c0dc-4001-adfe-40a5cd8bf607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LitigationandRelatedMatters" xlink:type="simple" xlink:href="holx-20200926.xsd#LitigationandRelatedMatters"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LitigationandRelatedMatters" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2444f459-e388-4dce-8019-32bef32834da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LitigationAndOtherMattersTextBlock_ccd2fe07-faf8-42c3-a489-eddc0208c810" xlink:href="holx-20200926.xsd#holx_LitigationAndOtherMattersTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2444f459-e388-4dce-8019-32bef32834da" xlink:to="loc_holx_LitigationAndOtherMattersTextBlock_ccd2fe07-faf8-42c3-a489-eddc0208c810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#LitigationandOtherMattersAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_38efe204-418f-4374-a634-15b1230d8a99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_38efe204-418f-4374-a634-15b1230d8a99" xlink:to="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_abbc5a8b-0517-4334-8fa2-8df4c19919a7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:to="loc_dei_LegalEntityAxis_abbc5a8b-0517-4334-8fa2-8df4c19919a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c283b42b-646d-4598-a732-f644979aa93f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_abbc5a8b-0517-4334-8fa2-8df4c19919a7" xlink:to="loc_dei_EntityDomain_c283b42b-646d-4598-a732-f644979aa93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_5abe36a3-0847-40df-afb4-c30efc8a2c5c" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c283b42b-646d-4598-a732-f644979aa93f" xlink:to="loc_holx_MedicalAestheticsBusinessMember_5abe36a3-0847-40df-afb4-c30efc8a2c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0a03acf3-934b-473c-a1e7-638e3d2d7ea6" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:to="loc_srt_LitigationCaseAxis_0a03acf3-934b-473c-a1e7-638e3d2d7ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_70b03815-a793-4677-9e40-7dc879c0a082" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_0a03acf3-934b-473c-a1e7-638e3d2d7ea6" xlink:to="loc_srt_LitigationCaseTypeDomain_70b03815-a793-4677-9e40-7dc879c0a082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CompanyVs.MinervaSurgicalInc.Member_3086f88a-f16d-46d6-b9ea-cd424d179ba7" xlink:href="holx-20200926.xsd#holx_CompanyVs.MinervaSurgicalInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_70b03815-a793-4677-9e40-7dc879c0a082" xlink:to="loc_holx_CompanyVs.MinervaSurgicalInc.Member_3086f88a-f16d-46d6-b9ea-cd424d179ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9e89e97e-6dd7-47f6-8a91-7eabc6ba2e05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:to="loc_us-gaap_LitigationStatusAxis_9e89e97e-6dd7-47f6-8a91-7eabc6ba2e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_b130165a-fea2-4d52-8719-dcd90af3c5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_9e89e97e-6dd7-47f6-8a91-7eabc6ba2e05" xlink:to="loc_us-gaap_LitigationStatusDomain_b130165a-fea2-4d52-8719-dcd90af3c5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_c59e5d0c-c8e5-45f2-9be2-8498451167c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_b130165a-fea2-4d52-8719-dcd90af3c5f3" xlink:to="loc_us-gaap_JudicialRulingMember_c59e5d0c-c8e5-45f2-9be2-8498451167c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8c2a28c4-5642-4ba7-b325-bf1440c8a730" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_93be0785-017b-408d-be51-24e89ac71f76" xlink:to="loc_us-gaap_LossContingenciesLineItems_8c2a28c4-5642-4ba7-b325-bf1440c8a730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_58c19c12-11b9-4ead-9771-4eae10bd92ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c2a28c4-5642-4ba7-b325-bf1440c8a730" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_58c19c12-11b9-4ead-9771-4eae10bd92ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_a4435dd5-ef2e-476a-a639-3bf6742ebf0b" xlink:href="holx-20200926.xsd#holx_LegalAccrual"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c2a28c4-5642-4ba7-b325-bf1440c8a730" xlink:to="loc_holx_LegalAccrual_a4435dd5-ef2e-476a-a639-3bf6742ebf0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20200926.xsd#Disposition"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_a3438e5d-2c5e-4fc9-a5eb-2fb249ce1023" xlink:href="holx-20200926.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_fd7d4601-1fac-47bc-ad4f-f3ae8713e974" xlink:href="holx-20200926.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_a3438e5d-2c5e-4fc9-a5eb-2fb249ce1023" xlink:to="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_fd7d4601-1fac-47bc-ad4f-f3ae8713e974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionTables" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_82e343e3-2684-4712-900a-d09959088f9b" xlink:href="holx-20200926.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_edc0fefb-1cd8-4c21-8a2a-0a201afa8de9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_82e343e3-2684-4712-900a-d09959088f9b" xlink:to="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_edc0fefb-1cd8-4c21-8a2a-0a201afa8de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_03d5b8a0-9f7b-42cd-8688-612b7966ff15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_82e343e3-2684-4712-900a-d09959088f9b" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_03d5b8a0-9f7b-42cd-8688-612b7966ff15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_189de4eb-59cb-4833-bf4a-c1028c0f5c41" xlink:href="holx-20200926.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_189de4eb-59cb-4833-bf4a-c1028c0f5c41" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_51dc8ca1-6603-4067-a1c7-c44e38b6e17b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_51dc8ca1-6603-4067-a1c7-c44e38b6e17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0ecd8f8-530a-47b6-b248-679c17fb0bee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_51dc8ca1-6603-4067-a1c7-c44e38b6e17b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0ecd8f8-530a-47b6-b248-679c17fb0bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_50302495-f6ab-434a-86d3-7be5a5b5f741" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0ecd8f8-530a-47b6-b248-679c17fb0bee" xlink:to="loc_holx_MedicalAestheticsBusinessMember_50302495-f6ab-434a-86d3-7be5a5b5f741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_da90a83a-995f-4f8c-b694-bcf3b2abe6ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_da90a83a-995f-4f8c-b694-bcf3b2abe6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_38a9fd65-702e-4552-bf32-2cde18974a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_da90a83a-995f-4f8c-b694-bcf3b2abe6ff" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_38a9fd65-702e-4552-bf32-2cde18974a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a00886c0-266c-43cb-ab7b-2c22ade725f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_38a9fd65-702e-4552-bf32-2cde18974a5a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a00886c0-266c-43cb-ab7b-2c22ade725f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a89da0e3-0aa8-4658-b3ca-7c66cacaeba9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a89da0e3-0aa8-4658-b3ca-7c66cacaeba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2a5758c1-98c1-43ee-a96e-ad56e016fc44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a89da0e3-0aa8-4658-b3ca-7c66cacaeba9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2a5758c1-98c1-43ee-a96e-ad56e016fc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d93fe1c7-41f5-4a0e-b232-f36a1b6d02c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2a5758c1-98c1-43ee-a96e-ad56e016fc44" xlink:to="loc_us-gaap_CostOfSalesMember_d93fe1c7-41f5-4a0e-b232-f36a1b6d02c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_00d5f371-92b2-4091-bd9d-1c2a175a4f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2a5758c1-98c1-43ee-a96e-ad56e016fc44" xlink:to="loc_us-gaap_OperatingExpenseMember_00d5f371-92b2-4091-bd9d-1c2a175a4f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ca5605fb-f1a0-46a6-9767-3422608d0e37" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:to="loc_srt_RangeAxis_ca5605fb-f1a0-46a6-9767-3422608d0e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e1690066-64fc-46fe-ab79-271e4d4ca78a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ca5605fb-f1a0-46a6-9767-3422608d0e37" xlink:to="loc_srt_RangeMember_e1690066-64fc-46fe-ab79-271e4d4ca78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_01b9a829-5565-49ae-99d3-eed6f2290b9e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e1690066-64fc-46fe-ab79-271e4d4ca78a" xlink:to="loc_srt_MinimumMember_01b9a829-5565-49ae-99d3-eed6f2290b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a131f2a-01cd-40b4-9feb-53ae55781aa4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e1690066-64fc-46fe-ab79-271e4d4ca78a" xlink:to="loc_srt_MaximumMember_6a131f2a-01cd-40b4-9feb-53ae55781aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62efec82-cac5-4b82-85a3-e0c68130785a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a9cd6720-00d2-4010-9f9e-a08558f69a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a9cd6720-00d2-4010-9f9e-a08558f69a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_db52fc5a-2910-4a84-a71e-3126e4575e60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_db52fc5a-2910-4a84-a71e-3126e4575e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_ddb68b1d-7836-413b-bc5d-e1b4b747a462" xlink:href="holx-20200926.xsd#holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_ddb68b1d-7836-413b-bc5d-e1b4b747a462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TransitionServicesAgreementTerm_a9a9ea0f-b7a1-4e0d-82ef-d74ecb11c882" xlink:href="holx-20200926.xsd#holx_TransitionServicesAgreementTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_holx_TransitionServicesAgreementTerm_a9a9ea0f-b7a1-4e0d-82ef-d74ecb11c882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily_503fc598-8517-40df-8bc3-45a0c3022da2" xlink:href="holx-20200926.xsd#holx_IndemnificationLiabily"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_holx_IndemnificationLiabily_503fc598-8517-40df-8bc3-45a0c3022da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_72974144-5e4b-491d-940c-c01755ed0a77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_us-gaap_AssetImpairmentCharges_72974144-5e4b-491d-940c-c01755ed0a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Expensesfromdisposition_16575c5c-8531-45ed-962e-8864d1a33a5c" xlink:href="holx-20200926.xsd#holx_Expensesfromdisposition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7154bf0-6041-408e-9585-f69b08d98f3b" xlink:to="loc_holx_Expensesfromdisposition_16575c5c-8531-45ed-962e-8864d1a33a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1138a437-d9b7-4ccc-a9f4-8b704f3ae943" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cebe506c-66a6-453f-9405-9fbe72296f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1138a437-d9b7-4ccc-a9f4-8b704f3ae943" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cebe506c-66a6-453f-9405-9fbe72296f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4202d895-943b-4d01-bd9c-83263ff21420" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cebe506c-66a6-453f-9405-9fbe72296f7e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4202d895-943b-4d01-bd9c-83263ff21420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_77589063-4445-426b-954c-bb29a7645a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4202d895-943b-4d01-bd9c-83263ff21420" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_77589063-4445-426b-954c-bb29a7645a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_31a09251-cccd-4805-aab7-99ab0a9aeb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_77589063-4445-426b-954c-bb29a7645a5f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_31a09251-cccd-4805-aab7-99ab0a9aeb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8cb3527-5cfa-4d71-b7e5-950857872700" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cebe506c-66a6-453f-9405-9fbe72296f7e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8cb3527-5cfa-4d71-b7e5-950857872700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fb77d96-6c9c-4e38-b432-e23720fb4c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8cb3527-5cfa-4d71-b7e5-950857872700" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fb77d96-6c9c-4e38-b432-e23720fb4c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_96030de5-b3f5-4137-8f4b-1c9ff9beca1d" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fb77d96-6c9c-4e38-b432-e23720fb4c6b" xlink:to="loc_holx_MedicalAestheticsBusinessMember_96030de5-b3f5-4137-8f4b-1c9ff9beca1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_02c01ded-1790-4273-8bd8-ffaf85e06513" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cebe506c-66a6-453f-9405-9fbe72296f7e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_02c01ded-1790-4273-8bd8-ffaf85e06513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_02c01ded-1790-4273-8bd8-ffaf85e06513" xlink:to="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_72e89e53-f2eb-47c6-82d7-291e436b711c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_72e89e53-f2eb-47c6-82d7-291e436b711c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_9b2d19ab-7e25-4703-9815-cf8cee2da517" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_9b2d19ab-7e25-4703-9815-cf8cee2da517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b15fb452-1c51-44f8-9e10-03a80b7d34c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b15fb452-1c51-44f8-9e10-03a80b7d34c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e7f2a43b-3019-403c-a427-fae693955c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e7f2a43b-3019-403c-a427-fae693955c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_815b47da-7575-4df4-a672-fe4ac24fac18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_815b47da-7575-4df4-a672-fe4ac24fac18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ff921c5c-390d-46e4-b3fd-85ff12371cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ff921c5c-390d-46e4-b3fd-85ff12371cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_196b1b1d-4a56-49dc-a2ac-dba40aeb6c55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_196b1b1d-4a56-49dc-a2ac-dba40aeb6c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_36931f61-68bf-4a78-9190-745cf607d228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ad6df1b-aed1-453f-9dd1-ab0fa53dcfc7" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_36931f61-68bf-4a78-9190-745cf607d228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_02c01ded-1790-4273-8bd8-ffaf85e06513" xlink:to="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_fee2689d-124b-464d-9daf-44bd5b5b2a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_fee2689d-124b-464d-9daf-44bd5b5b2a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_6bcfd566-7145-4c22-9ad4-f284eea126ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_6bcfd566-7145-4c22-9ad4-f284eea126ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_08ae05dd-d672-43e2-908b-367128ba6a30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_08ae05dd-d672-43e2-908b-367128ba6a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_43be133f-c9b6-4927-8c31-4a034aeeb8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_7a9dc8f4-7506-41a2-a5c3-cc35e546b00c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_43be133f-c9b6-4927-8c31-4a034aeeb8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9498db90-f513-4113-975c-04a34a791230" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_fe6cb616-cfbe-4d05-b760-7a1d637c9afa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9498db90-f513-4113-975c-04a34a791230" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_fe6cb616-cfbe-4d05-b760-7a1d637c9afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d8fa3333-e395-40b7-bd75-2adfc7f82540" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_650c67c6-fdc4-4d5d-8e5f-e68b6c4d7078" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d8fa3333-e395-40b7-bd75-2adfc7f82540" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_650c67c6-fdc4-4d5d-8e5f-e68b6c4d7078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_44c1d3c2-0aa5-441b-9b04-feae33b6b802" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8abaffbe-ab55-44c6-9145-09974d41382c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_44c1d3c2-0aa5-441b-9b04-feae33b6b802" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8abaffbe-ab55-44c6-9145-09974d41382c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_57aff9e6-024a-496d-947c-a724e9b8ed61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_44c1d3c2-0aa5-441b-9b04-feae33b6b802" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_57aff9e6-024a-496d-947c-a724e9b8ed61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_b2e305a8-184b-4512-bb99-2248f5898ebe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_44c1d3c2-0aa5-441b-9b04-feae33b6b802" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_b2e305a8-184b-4512-bb99-2248f5898ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c94fc2b9-04ae-43ae-bed9-b9da59cc3c83" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureTable_4499acbe-93f0-4aa3-bc90-a8ce9924bc1a" xlink:href="holx-20200926.xsd#holx_SegmentReportingDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c94fc2b9-04ae-43ae-bed9-b9da59cc3c83" xlink:to="loc_holx_SegmentReportingDisclosureTable_4499acbe-93f0-4aa3-bc90-a8ce9924bc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_459879fd-c46f-4cc6-89b3-6d990446e18b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureTable_4499acbe-93f0-4aa3-bc90-a8ce9924bc1a" xlink:to="loc_srt_ConsolidationItemsAxis_459879fd-c46f-4cc6-89b3-6d990446e18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6c4b538a-4d95-487b-842d-50cc8231962f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_459879fd-c46f-4cc6-89b3-6d990446e18b" xlink:to="loc_srt_ConsolidationItemsDomain_6c4b538a-4d95-487b-842d-50cc8231962f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_5d6105e0-1e51-4989-a46b-8b2098fd8343" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6c4b538a-4d95-487b-842d-50cc8231962f" xlink:to="loc_us-gaap_IntersegmentEliminationMember_5d6105e0-1e51-4989-a46b-8b2098fd8343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_4c460e95-11d3-4f4d-8f99-a97b1bcdcfb5" xlink:href="holx-20200926.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureTable_4499acbe-93f0-4aa3-bc90-a8ce9924bc1a" xlink:to="loc_holx_SegmentReportingDisclosureLineItems_4c460e95-11d3-4f4d-8f99-a97b1bcdcfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2170a2ef-b120-4a8b-8d99-db3beef9a29a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_4c460e95-11d3-4f4d-8f99-a97b1bcdcfb5" xlink:to="loc_us-gaap_NumberOfReportableSegments_2170a2ef-b120-4a8b-8d99-db3beef9a29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c8762d48-07df-4bc3-8592-1b7bec036947" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_4c460e95-11d3-4f4d-8f99-a97b1bcdcfb5" xlink:to="loc_us-gaap_Revenues_c8762d48-07df-4bc3-8592-1b7bec036947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e2befa47-78de-493c-8903-9d2703ac1408" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27af2eb2-a6dd-4e6a-838d-791f451c57fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e2befa47-78de-493c-8903-9d2703ac1408" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27af2eb2-a6dd-4e6a-838d-791f451c57fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6785ac9a-a189-410e-b110-158a83dba312" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27af2eb2-a6dd-4e6a-838d-791f451c57fb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6785ac9a-a189-410e-b110-158a83dba312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6785ac9a-a189-410e-b110-158a83dba312" xlink:to="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_27cd7d1c-4f1a-4089-b90a-61003555305d" xlink:href="holx-20200926.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_DiagnosticsMember_27cd7d1c-4f1a-4089-b90a-61003555305d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_71132258-a7da-454e-afad-c5fc2ad54531" xlink:href="holx-20200926.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_BreastHealthMember_71132258-a7da-454e-afad-c5fc2ad54531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_fa1d1a10-8f97-4dda-b616-877e9da53dac" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_MedicalAestheticsMember_fa1d1a10-8f97-4dda-b616-877e9da53dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_86bfa117-a65c-4cee-82c9-19db397a04fe" xlink:href="holx-20200926.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_SkeletalHealthMember_86bfa117-a65c-4cee-82c9-19db397a04fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_d61b9e95-832e-4f77-88e5-4aa0a2e48ee7" xlink:href="holx-20200926.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_411ee645-4f86-483d-9ea1-65b5ac3e1c93" xlink:to="loc_holx_GynSurgicalMember_d61b9e95-832e-4f77-88e5-4aa0a2e48ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_48e03a60-300c-4d3e-abc9-610b131174f1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27af2eb2-a6dd-4e6a-838d-791f451c57fb" xlink:to="loc_srt_ConsolidationItemsAxis_48e03a60-300c-4d3e-abc9-610b131174f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e157c3c5-8e1a-497f-9aff-cb07e5c963f2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_48e03a60-300c-4d3e-abc9-610b131174f1" xlink:to="loc_srt_ConsolidationItemsDomain_e157c3c5-8e1a-497f-9aff-cb07e5c963f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_1f22f698-88ca-43a9-89ed-62756e8ed7df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_e157c3c5-8e1a-497f-9aff-cb07e5c963f2" xlink:to="loc_us-gaap_CorporateNonSegmentMember_1f22f698-88ca-43a9-89ed-62756e8ed7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27af2eb2-a6dd-4e6a-838d-791f451c57fb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e23fc340-f416-4f8f-bc3b-9b9557936467" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_Revenues_e23fc340-f416-4f8f-bc3b-9b9557936467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b9d6948b-2ff6-4dc6-9259-5699767cd856" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_OperatingIncomeLoss_b9d6948b-2ff6-4dc6-9259-5699767cd856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_a0cb7710-8f7b-4a1c-8bbd-d6b2123288ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_a0cb7710-8f7b-4a1c-8bbd-d6b2123288ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_63eeb04e-71f9-46c7-85aa-f989b29b4595" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_63eeb04e-71f9-46c7-85aa-f989b29b4595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_515abe1c-1a05-4910-bf49-33739db16df0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a9cb3857-8efa-42f9-95ac-c096fb011423" xlink:to="loc_us-gaap_Assets_515abe1c-1a05-4910-bf49-33739db16df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bd71b174-de72-47a7-bf8b-c166b17c6da6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_6e304d22-893a-4d4d-9af2-8b7e8f7750af" xlink:href="holx-20200926.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bd71b174-de72-47a7-bf8b-c166b17c6da6" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_6e304d22-893a-4d4d-9af2-8b7e8f7750af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9900470b-9e8d-409b-988a-dcfded072f99" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_6e304d22-893a-4d4d-9af2-8b7e8f7750af" xlink:to="loc_srt_StatementGeographicalAxis_9900470b-9e8d-409b-988a-dcfded072f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9900470b-9e8d-409b-988a-dcfded072f99" xlink:to="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3f20547e-f94a-455d-8d53-b7dd9df829a4" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:to="loc_country_US_3f20547e-f94a-455d-8d53-b7dd9df829a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_12075705-beb9-408c-b7e4-e7dd8f838e48" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:to="loc_srt_EuropeMember_12075705-beb9-408c-b7e4-e7dd8f838e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_e4c1a325-0bee-47d3-98ec-c496d7cbb9ca" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:to="loc_srt_AsiaPacificMember_e4c1a325-0bee-47d3-98ec-c496d7cbb9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_5286a0c7-c257-4b18-9e2e-d00c64505a5e" xlink:href="holx-20200926.xsd#holx_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_248033d2-ed14-4dc5-b867-8efba76b6a8a" xlink:to="loc_holx_AllOtherCountriesMember_5286a0c7-c257-4b18-9e2e-d00c64505a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_94cb3a83-81be-4461-b99c-04933987c0f6" xlink:href="holx-20200926.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_6e304d22-893a-4d4d-9af2-8b7e8f7750af" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsLineItems_94cb3a83-81be-4461-b99c-04933987c0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_6b661ec8-3707-4e46-a9b8-7a691620007e" xlink:href="holx-20200926.xsd#holx_PercentageOfRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_94cb3a83-81be-4461-b99c-04933987c0f6" xlink:to="loc_holx_PercentageOfRevenues_6b661ec8-3707-4e46-a9b8-7a691620007e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="holx-20200926.xsd#BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_39036d09-9446-4128-973c-02c96661617a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_22dc47df-d1e2-4a6f-90a3-c5ee20028ed4" xlink:href="holx-20200926.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_39036d09-9446-4128-973c-02c96661617a" xlink:to="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_22dc47df-d1e2-4a6f-90a3-c5ee20028ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_35870712-9769-453f-918d-78c5374b7ed7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_22dc47df-d1e2-4a6f-90a3-c5ee20028ed4" xlink:to="loc_srt_StatementGeographicalAxis_35870712-9769-453f-918d-78c5374b7ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_35870712-9769-453f-918d-78c5374b7ed7" xlink:to="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_23fd7714-eeed-4249-94ff-adcd3634fc13" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:to="loc_country_US_23fd7714-eeed-4249-94ff-adcd3634fc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR_7dd3e359-aa99-45ae-a6bb-a5d3a13ee9b2" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_CR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:to="loc_country_CR_7dd3e359-aa99-45ae-a6bb-a5d3a13ee9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_73a31f11-1553-446a-b2d2-50af62ba7b1f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:to="loc_srt_EuropeMember_73a31f11-1553-446a-b2d2-50af62ba7b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_781d3dd5-38ec-4a67-b046-9a635d410888" xlink:href="holx-20200926.xsd#holx_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cacf11d7-9f05-4789-a6fe-e32a277a6a5c" xlink:to="loc_holx_AllOtherCountriesMember_781d3dd5-38ec-4a67-b046-9a635d410888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_a4474c2f-17de-49a8-8b7f-96fdaef1e444" xlink:href="holx-20200926.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_22dc47df-d1e2-4a6f-90a3-c5ee20028ed4" xlink:to="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_a4474c2f-17de-49a8-8b7f-96fdaef1e444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8f469f9c-e4be-4b28-9265-13ea50bb43b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_a4474c2f-17de-49a8-8b7f-96fdaef1e444" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8f469f9c-e4be-4b28-9265-13ea50bb43b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilities"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0cd59a9e-7117-470a-9ade-3ce87b890bab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_e29bedee-aee8-4f71-b147-28612daee919" xlink:href="holx-20200926.xsd#holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0cd59a9e-7117-470a-9ade-3ce87b890bab" xlink:to="loc_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_e29bedee-aee8-4f71-b147-28612daee919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_374d1df1-566c-47e0-8c9e-48fbf237ec4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_aa775034-1879-41d0-a386-bb94ac9c41e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_374d1df1-566c-47e0-8c9e-48fbf237ec4e" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_aa775034-1879-41d0-a386-bb94ac9c41e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock_b1e59c4f-ffd9-4439-99c7-54abf897da71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_374d1df1-566c-47e0-8c9e-48fbf237ec4e" xlink:to="loc_us-gaap_OtherLiabilitiesTableTextBlock_b1e59c4f-ffd9-4439-99c7-54abf897da71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_dc3baab1-0371-44c0-afda-88cb236271ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_c1725ceb-ece9-446d-908d-0fc05c1303a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_dc3baab1-0371-44c0-afda-88cb236271ad" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_c1725ceb-ece9-446d-908d-0fc05c1303a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_1e80f6ff-09b6-438c-92c4-5fea2a26543f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_c1725ceb-ece9-446d-908d-0fc05c1303a6" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_1e80f6ff-09b6-438c-92c4-5fea2a26543f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedIncomeAndOtherTaxes_cf4c9dca-f691-4589-a3e2-13862fc685ae" xlink:href="holx-20200926.xsd#holx_AccruedIncomeAndOtherTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_c1725ceb-ece9-446d-908d-0fc05c1303a6" xlink:to="loc_holx_AccruedIncomeAndOtherTaxes_cf4c9dca-f691-4589-a3e2-13862fc685ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_26518770-83a7-43d0-8b77-42db72184188" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_c1725ceb-ece9-446d-908d-0fc05c1303a6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_26518770-83a7-43d0-8b77-42db72184188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedInterest_d3c3553a-0b2c-4bae-8611-c06a7b947ba7" xlink:href="holx-20200926.xsd#holx_AccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_c1725ceb-ece9-446d-908d-0fc05c1303a6" xlink:to="loc_holx_AccruedInterest_d3c3553a-0b2c-4bae-8611-c06a7b947ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_10f9fb13-5a0e-4e13-9bd9-9cc191ce879d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_c1725ceb-ece9-446d-908d-0fc05c1303a6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_10f9fb13-5a0e-4e13-9bd9-9cc191ce879d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d2a59474-ff6f-40c2-bf88-76329612a39a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_c1725ceb-ece9-446d-908d-0fc05c1303a6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d2a59474-ff6f-40c2-bf88-76329612a39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_67b9bc89-a149-44ba-a9c6-5e8f36a07bde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_67b9bc89-a149-44ba-a9c6-5e8f36a07bde" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_61b7bd0d-d901-42e7-a3f2-841d817505d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_61b7bd0d-d901-42e7-a3f2-841d817505d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_47f002a9-b058-4f1d-beca-d73af7b109f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_47f002a9-b058-4f1d-beca-d73af7b109f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_be791998-22c4-4c4a-baec-e0feb3fed0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_be791998-22c4-4c4a-baec-e0feb3fed0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_91ffa202-3fe9-4193-8d9a-65bd7b151c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_91ffa202-3fe9-4193-8d9a-65bd7b151c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentNoncurrent_e329bb3a-96ca-486e-a480-b935004d1764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedRentNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:to="loc_us-gaap_AccruedRentNoncurrent_e329bb3a-96ca-486e-a480-b935004d1764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_19f04fa8-e33b-4dc0-93da-e98e900f19d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_19f04fa8-e33b-4dc0-93da-e98e900f19d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_8e8cc7b1-74fe-4197-a092-d7fbc24929e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_8e8cc7b1-74fe-4197-a092-d7fbc24929e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d50a4fc2-8e6d-48da-8331-a754f4b107ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_45975e11-81e2-4ee7-8080-36091a4190f9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d50a4fc2-8e6d-48da-8331-a754f4b107ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefits" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefits"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c5b3a3cf-c9e8-478f-9184-0f9fdb289611" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b4b5b4ef-886f-4e26-a3d8-14ad9b4c11c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c5b3a3cf-c9e8-478f-9184-0f9fdb289611" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b4b5b4ef-886f-4e26-a3d8-14ad9b4c11c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e6f7ba86-51c5-40b2-a7d0-8e1e19e108f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_5388e717-250e-423c-80f5-72a4dfb2d5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e6f7ba86-51c5-40b2-a7d0-8e1e19e108f0" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_5388e717-250e-423c-80f5-72a4dfb2d5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_8db2f5c2-4d82-4f4a-bc15-1454585479a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e6f7ba86-51c5-40b2-a7d0-8e1e19e108f0" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_8db2f5c2-4d82-4f4a-bc15-1454585479a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_335c8b81-6f12-4fcc-86a6-e910a26baabc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e6f7ba86-51c5-40b2-a7d0-8e1e19e108f0" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_335c8b81-6f12-4fcc-86a6-e910a26baabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_6ce86b5b-fade-48d7-8fbe-4221ee5f5b66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e6f7ba86-51c5-40b2-a7d0-8e1e19e108f0" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_6ce86b5b-fade-48d7-8fbe-4221ee5f5b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_1eea05ff-285b-400f-843f-6b5ad1e1bd03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9d7c0b96-ee81-47fb-aa86-2163cb2739a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_1eea05ff-285b-400f-843f-6b5ad1e1bd03" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9d7c0b96-ee81-47fb-aa86-2163cb2739a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9fd8a020-877b-41aa-bc9b-5d601b4fbbd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9d7c0b96-ee81-47fb-aa86-2163cb2739a5" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9fd8a020-877b-41aa-bc9b-5d601b4fbbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2a296970-1996-4579-81df-6e9c554cabdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9fd8a020-877b-41aa-bc9b-5d601b4fbbd5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2a296970-1996-4579-81df-6e9c554cabdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_05df3a96-8224-42e8-819f-67e643d917bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2a296970-1996-4579-81df-6e9c554cabdb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_05df3a96-8224-42e8-819f-67e643d917bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9d7c0b96-ee81-47fb-aa86-2163cb2739a5" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_f186ff02-7afe-4fe2-a8af-43836cd9e034" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_f186ff02-7afe-4fe2-a8af-43836cd9e034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_dc6c3dd9-8ae8-4ce6-b8d0-6088b9f8f440" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_dc6c3dd9-8ae8-4ce6-b8d0-6088b9f8f440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_62015fde-ded4-41b6-a67b-f2e5115be7ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_62015fde-ded4-41b6-a67b-f2e5115be7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards_b2a45f74-f8cb-45bc-9ac9-4a2f4a617be9" xlink:href="holx-20200926.xsd#holx_ProjectedBenefitObligationForLongTermServiceAwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_3b93458d-e299-4d33-8f57-f953a35af312" xlink:to="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards_b2a45f74-f8cb-45bc-9ac9-4a2f4a617be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_53c65693-2b7d-4ee5-8edd-f0bd9f325a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_53c65693-2b7d-4ee5-8edd-f0bd9f325a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_9a8d0860-9898-454f-a44b-59dd956b7ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_9a8d0860-9898-454f-a44b-59dd956b7ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_83352936-a2d1-427d-b356-58c12ab113d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_83352936-a2d1-427d-b356-58c12ab113d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_f236ed3e-2f84-439b-9f40-0e20e2dbc633" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_f236ed3e-2f84-439b-9f40-0e20e2dbc633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_8fede2c6-2aa0-4ddc-ab13-7bfda9b3d151" xlink:href="holx-20200926.xsd#holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_8fede2c6-2aa0-4ddc-ab13-7bfda9b3d151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_0757899d-fb7e-4738-bde5-e19c4fa84f24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_0757899d-fb7e-4738-bde5-e19c4fa84f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_8d433940-e370-436a-8fe9-2f7337ba3625" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_8d433940-e370-436a-8fe9-2f7337ba3625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_54e202f3-5085-4650-8029-c2fd2c0c174d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_54e202f3-5085-4650-8029-c2fd2c0c174d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_04ad8ca4-62e1-4c4e-a7bb-3aefd91d1f91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_04ad8ca4-62e1-4c4e-a7bb-3aefd91d1f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3cb45450-93c2-4aff-83c4-2c8b7d2eb510" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd5e96d8-5bed-4e4d-a785-0950ea82a307" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3cb45450-93c2-4aff-83c4-2c8b7d2eb510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dcc30cf3-d9ec-48d0-8202-d472e66f2c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_c014466c-1f41-4190-b62e-3cb7090a5db9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dcc30cf3-d9ec-48d0-8202-d472e66f2c2c" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_c014466c-1f41-4190-b62e-3cb7090a5db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost_85565191-3ccb-4a13-9681-796a97595b0f" xlink:href="holx-20200926.xsd#holx_ComponentsofNetPeriodicBenefitCostInterestcost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dcc30cf3-d9ec-48d0-8202-d472e66f2c2c" xlink:to="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost_85565191-3ccb-4a13-9681-796a97595b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ec2c438c-7795-43b4-9486-3fcdf4565510" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dcc30cf3-d9ec-48d0-8202-d472e66f2c2c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ec2c438c-7795-43b4-9486-3fcdf4565510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_eac5259e-f0b2-4c85-bae2-8f0eb4c19225" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dcc30cf3-d9ec-48d0-8202-d472e66f2c2c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_eac5259e-f0b2-4c85-bae2-8f0eb4c19225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_904f16e7-9d40-46d1-8c36-1f6686b3e055" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dcc30cf3-d9ec-48d0-8202-d472e66f2c2c" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_904f16e7-9d40-46d1-8c36-1f6686b3e055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2f52e5f1-744b-4321-9531-6fad74e5cbda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dcc30cf3-d9ec-48d0-8202-d472e66f2c2c" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2f52e5f1-744b-4321-9531-6fad74e5cbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_f48f8f30-d1a1-4a6f-99f9-64ab6f598fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_eec6dfcf-f096-4520-9746-f2590c74dabe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_f48f8f30-d1a1-4a6f-99f9-64ab6f598fb2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_eec6dfcf-f096-4520-9746-f2590c74dabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_80b2c4b2-ee3f-4013-8a39-acf4ccbb61b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_f48f8f30-d1a1-4a6f-99f9-64ab6f598fb2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_80b2c4b2-ee3f-4013-8a39-acf4ccbb61b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_a7cf53ec-20cc-47e5-9a00-79dd96ad1f24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_f48f8f30-d1a1-4a6f-99f9-64ab6f598fb2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_a7cf53ec-20cc-47e5-9a00-79dd96ad1f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_c1f041c8-efcd-420a-94eb-182edb5813e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_54e93213-5db5-4ecb-bf92-d1a17c54d740" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_c1f041c8-efcd-420a-94eb-182edb5813e6" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_54e93213-5db5-4ecb-bf92-d1a17c54d740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_143b66c1-2075-4991-b42c-875b34ed7976" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_c1f041c8-efcd-420a-94eb-182edb5813e6" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_143b66c1-2075-4991-b42c-875b34ed7976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_14cc8e16-576b-4414-bf99-8b2e88c9da97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_c1f041c8-efcd-420a-94eb-182edb5813e6" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_14cc8e16-576b-4414-bf99-8b2e88c9da97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_72ad880a-6dc3-401f-8f5c-a30af2fb2089" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_c1f041c8-efcd-420a-94eb-182edb5813e6" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_72ad880a-6dc3-401f-8f5c-a30af2fb2089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_ba3611a4-99e2-4c7c-ac35-b7ae0d7f61df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_c1f041c8-efcd-420a-94eb-182edb5813e6" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_ba3611a4-99e2-4c7c-ac35-b7ae0d7f61df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_93ace1ac-f697-48e4-a24e-9efa78d916db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_c1f041c8-efcd-420a-94eb-182edb5813e6" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_93ace1ac-f697-48e4-a24e-9efa78d916db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited" xlink:type="simple" xlink:href="holx-20200926.xsd#QuarterlyStatementofOperationsInformationUnaudited"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_46665dc8-a290-4bdd-b2ad-68501b98b6b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_70bea522-38f6-4a6a-a8eb-e8f2dce3fe28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_46665dc8-a290-4bdd-b2ad-68501b98b6b9" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_70bea522-38f6-4a6a-a8eb-e8f2dce3fe28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#QuarterlyStatementofOperationsInformationUnauditedDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f49a79b5-8c2e-4290-b564-f9a015adfe9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f49a79b5-8c2e-4290-b564-f9a015adfe9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4db584b0-1286-4087-91f3-d8e747bd511b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4db584b0-1286-4087-91f3-d8e747bd511b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b7573915-2b3a-4f38-8e92-c851986aa12f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b7573915-2b3a-4f38-8e92-c851986aa12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_43abaefd-5a53-4013-9fb6-020be1c14eca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_43abaefd-5a53-4013-9fb6-020be1c14eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cbfe2d69-50d1-4e85-be48-0d1d29abf2f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:to="loc_us-gaap_Revenues_cbfe2d69-50d1-4e85-be48-0d1d29abf2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0fc0772b-6bd3-4680-9678-3a128bc8dddf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:to="loc_us-gaap_GrossProfit_0fc0772b-6bd3-4680-9678-3a128bc8dddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_59660b95-dba7-4723-9bff-3e0133b38c85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:to="loc_us-gaap_NetIncomeLoss_59660b95-dba7-4723-9bff-3e0133b38c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9805ca6f-cdcb-497b-a975-52353898c53d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9805ca6f-cdcb-497b-a975-52353898c53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_b6947a7a-1298-4bbc-9e54-3c9c04b46f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24179667-bc4d-49dc-946b-c0d7c05a0af9" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_b6947a7a-1298-4bbc-9e54-3c9c04b46f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail" xlink:type="simple" xlink:href="holx-20200926.xsd#QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_9d113492-f3a8-4767-97ee-20f367ff6086" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable_1572c4de-ccf5-4a71-b25c-f95a97be5789" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_9d113492-f3a8-4767-97ee-20f367ff6086" xlink:to="loc_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable_1572c4de-ccf5-4a71-b25c-f95a97be5789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5d7270e4-0de1-4a80-86c5-102f22046a02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable_1572c4de-ccf5-4a71-b25c-f95a97be5789" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5d7270e4-0de1-4a80-86c5-102f22046a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ec5bd491-146b-43db-ab5a-19dddc6d6dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5d7270e4-0de1-4a80-86c5-102f22046a02" xlink:to="loc_us-gaap_SegmentDomain_ec5bd491-146b-43db-ab5a-19dddc6d6dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_fac293bb-bc9c-467f-a6c3-5aa773acaf95" xlink:href="holx-20200926.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ec5bd491-146b-43db-ab5a-19dddc6d6dc4" xlink:to="loc_holx_MedicalAestheticsBusinessMember_fac293bb-bc9c-467f-a6c3-5aa773acaf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfFourthQuarterEventsLineItems_63b5bdc2-9ab4-450f-9781-73077817e93e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfFourthQuarterEventsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable_1572c4de-ccf5-4a71-b25c-f95a97be5789" xlink:to="loc_us-gaap_EffectOfFourthQuarterEventsLineItems_63b5bdc2-9ab4-450f-9781-73077817e93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_9e3e998c-1dc1-4700-a6c5-0be0a73356fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfFourthQuarterEventsLineItems_63b5bdc2-9ab4-450f-9781-73077817e93e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_9e3e998c-1dc1-4700-a6c5-0be0a73356fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_46820690-f76d-4b54-a549-e16ee48b6add" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfFourthQuarterEventsLineItems_63b5bdc2-9ab4-450f-9781-73077817e93e" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_46820690-f76d-4b54-a549-e16ee48b6add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>holx-20200926_g1.jpg
<TEXT>
begin 644 holx-20200926_g1.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ?C"7\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX'04 =?117/>*OB+X4\"-;+XE\3Z-X>:Z#&!=5U"*U,H7&XKYC#=C(SCID4
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M\'_^#ZU_^.4?\-"?"S_HI?@__P 'UK_\<H ] HK&\.^,_#_C"$RZ#KNFZW$
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MNP)7((STR#0!T]%>?_\ #0GPL_Z*7X/_ /!]:_\ QRC_ (:$^%G_ $4OP?\
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M ..4 >@45Y__ ,-"?"S_ **7X/\ _!]:_P#QRC_AH3X6?]%+\'_^#ZU_^.4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#ELY"K^DO_!1#XFW7PI_8_\ B%JE@\D6HWMJFD6\D9VLAN9%A=@>Q$;N01W
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ML?T:_P""M7Q,N?A]^R+J&GV4[6]SXHU.WT5FCX;R2'FE'T98"A]G([U^;?\
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M>B&*-RI4E8X53Y2K$%79P02#D<5<_P""JG_)CGC[_KMIO_I?;T ?F7_P2?\
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MGG^W%'^UEX,O-)\1+;V7Q$T)%:^AMUV1WMN2%6ZC7^'YOE=1PK%2,!P!H?\
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M:7%]Y4ZE66.XNIIX^#T!213^- 'Y$_\ !33_ )/C^)__ %VL?_2"VJE\*?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=5UVTM[F&SMP0A:.20,F^1Y3@CD*A]*_-O6M2\2_M#_&BZO/*-_XJ\9:V3'
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MTL_]\L#VS]'^//''AOX=>$]0U_Q;JUEHN@VD3-<W5_($CVX/R\_>)Z!1DL>
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MC0?DHH _ERAA:XFCB09=V"J/<G%?7G_#I_\ :2_Z%#3_ /P=VG_QRODK2?\
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M7;_P&O5?^"&O_(*^,G_7;2?_ $&\K=_X+;0QV_PF^&,42+'%'K%PJ(HP% @
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MA_#?P+IWPP^'_AOPCI*;--T/3X-/@XP66- FX_[1QDGN237XR?\ !(+X+_\
M"Q/VEIO%UW;^;I7@NQ:\#,,K]LF#10*?^ ^<X]XA7[?T ?E!_P %RO\ D*_!
MO_KCJW_H5G7Q=^S#^QAX_P#VM(/$4W@B;1XDT%K=+O\ M:Z>$DS"0ILVQMG_
M %39Z=J^T?\ @N5_R%?@W_UQU;_T*SJU_P $0]7L=+TOXPB]O;>T+S:3M\^5
M4W86[SC)YZB@#Q7_ (<V_'O_ )_/!_\ X-)?_C%:OA/_ () ?'71?%.C:A<7
M?A$V]I>PW$FS4Y2VU'#' \GK@5^RG_"6:'_T&=/_ / J/_&C_A+-#_Z#.G_^
M!4?^- &M145K=0WT"SV\T=Q"WW9(F#*><<$5+0 4444 ?SU_\%(?^3VOBE_U
M^V__ *205^O_ /P3>_Y,E^%O_7E<?^E<]?D!_P %(?\ D]KXI?\ 7[;_ /I)
M!7Z__P#!-[_DR7X6_P#7E<?^E<] 'TK7\ZG[?%O-;_MD?%E)^7.MR./]UE5E
M_P#'2*_HKK\6O^"QGP+OO!WQVLOB5;6S-H7BVUCAFN$0[8KZ",1E&/0%HEC9
M?7;)_=)H _1?_@G5J%MJ7[%?PLEM65HTTZ2%MASATN)4<?7<IKZ.K\A_^"4?
M[;WA[X::;<_"+Q_JD6C:9<7;7>A:O>2!+>&23'FVTCDXC5F&]6/&YG!(RM?K
MG!=0W5LEQ#+'+;R*'26-@R,I&001P1CO0!YU^TQ?P:7^SE\4[JY8+!%X6U1G
MW>GV23C\>GXU_.Q\#+::]^-GP^M[=BMQ-XAT^.-@,D,;F, X^M?J)_P5._;C
M\+V_PYU/X/>"-8M];U_6&6+6[S3Y1)#8VRL&:'S%.#*Y4*5!.U=X;!(KY"_X
M);_ V\^+O[5&@ZPULS:#X-8:W>W!3*"5#_HT>>@8R[6 ](G/:@#]ZJ\4_;6_
MY-'^+W_8LWW_ **:O:Z\4_;6_P"31_B]_P!BS??^BFH _"S]BG_D[CX0_P#8
MS6/_ *-6OZ/J_G!_8I_Y.X^$/_8S6/\ Z-6OZ/J ,/QQXPTWX>^#==\3ZQ-Y
M&E:-8S7]U)Z1Q(7;'O@<#UK^:?QIXLU/XY?&#5?$&JW=M:ZGXHUAIY;B\G$5
MO;M-+QND; 2- P&3@*J^@K]=_P#@L5\<O^$#^ >F^ ;"X\O5/&5WBX56PRV-
MN5DDZ<C=(85]QO'K7Y<_LX_LD_$3]JBZUR'P'86ERNBI$]Y->W(@C3S2P102
M.6.QSCT4T ?N!X&^,G[.W@7X5Z+X!MOBW\/+C0=-TJ/2/)D\36.)HEB$;;QY
MO)<9)]2QK\#OBQX9LOAK\7/$NC>'==M=:TS2M4E33-9TN[2>*>!7S#*DL9*D
M[=I.#PV1U%?4'_#H?]H;_H&^'_\ P<)_A7E?[0W[#/Q6_9A\*Z?XB\;Z;8Q:
M1>W@L4N+"\6X"S%&=5; XR$;'^Z: /W,_9/^-D/[0G[/O@SQNLBM?7UDL6HH
MN!LO(CY<XQV!=68#^ZRGO7XS_P#!53_D^/Q]_P!<=-_](+>OHW_@BM\=#8Z[
MXO\ A+J%QB&^3^W=)1VX\Y L=R@]2R>4V/2)S7SE_P %5/\ D^/Q]_UQTW_T
M@MZ /T__ ."5?_)CG@'_ *[:E_Z7W%?6M?'7_!+?Q!I=A^Q'X#@N=2L[>99M
M2W1RSHK#-_.1D$U]7_\ "6:'_P!!G3__  *C_P : -:BL^U\0:7?SK!;:E9W
M$S9VQQ3HS' R< &M"@ K\ ?^"H__ "?9\3?^X9_Z:[2OW^K\ ?\ @J/_ ,GV
M?$W_ +AG_IKM* .&\$_L1?&_XD> =-\:^&/ %YK?AK4HY);6\L[JW=I5CD:-
M_P!WYGF AT88*@G&1D8KQO6-%O\ P]JUUI>K65QI>I6DK07-I>1-%+!(IPRN
MC#<I!Z@C-?OW_P $R_\ DQSX8?\ 7&^_]+[FO"O^"L/[&:?$;P?+\8/"-@O_
M  E.@P?\3NW@3YK^Q4?ZW ZR0@=>ICSS\BB@#R_]A/\ X)H_#;XE:7I'Q(\0
M^/\ 3_B/HJMG^P-'ADBMTN%P3'=-)MD.,\QE$SP<E3@_K''&D,:QQJJ(H"JJ
MC  '0 5_.[^Q'^U=JG[*'QDL];$DT_A/4BEIK^G)DB:WSQ*J_P#/2,DLIZGY
MER YK^A;0]<L/$VBV&KZ5=Q7^F7\$=U:W4#;HYHG4,CJ>X(((^M 'X"?\%-/
M^3X_B?\ ]=K'_P!(+:M3X*_\$R_B]\>OACHGCSPU<^&X]$UA97MEOK^2.8".
M5XFW*(F ^:-NYXQ67_P4T_Y/C^)__7:Q_P#2"VK]6?\ @FKXBTJQ_8C^&4%Q
MJ=G;S+#>[HY;A%8?Z?<GD$T ?GA_PYM^/?\ S^>#_P#P:2__ !BOH7]A#_@G
M+\5OV;_VBM*\;^++CP[)HUK975NZZ=?22S;I(BJX4Q*,9//-?I)_PEFA_P#0
M9T__ ,"H_P#&E_X2S1#P-9T\G_KZ3_&@#5K)\6?\BKK/_7E-_P"BVK6K)\6?
M\BKK/_7E-_Z+:@#^8+PG_P C5HW_ %^P_P#HQ:_J3K^6SPG_ ,C5HW_7[#_Z
M,6OZDZ "OY]_^"FRE?VY/B>&!!\ZQ//OI]M7]!%?A)_P5N\'W/AS]LW7=3FB
M9(/$&F6&H0R'.'"0+;''T:W/^30!^HG_  3;D63]B/X6E2&'V.Y''J+R<']:
M^EZ_/_\ X)'_ +2'A;Q-\ ]-^%MWJMK8^+_#EQ<K!I]Q*J2WMM+,\ZR1 GY]
MID=6"Y*A5)X85]Q>-_'7A[X:^&;WQ#XIUFST'1+-#)/>WTHC10 3@9ZL<<*,
MDG@ F@#^=_\ ;6_Y.X^+W_8S7W_HUJ_=/]BG_DT?X0_]BS8_^BEK^?SX\>/H
M/BI\;/'GC"U1H[/7-<O-0MTD&&6&29FC!]PI7-?T5?LY^%+GP+^S]\-?#M[$
M8;[2_#>G6ES&PP5F2VC60$?[P:@#\1?^"H__ "?9\3?^X9_Z:[2N&\$_L1?&
M_P")'@'3?&OACP!>:WX:U*.26UO+.ZMW:58Y&C?]WYGF AT88*@G&1D8KN?^
M"H__ "?9\3?^X9_Z:[2OU>_X)E_\F.?##_KC??\ I?<T ?@)K&BW_A[5KK2]
M6LKC2]2M)6@N;2\B:*6"13AE=&&Y2#U!&:_3;]A/_@FC\-OB5I>D?$CQ#X_T
M_P"(^BJV?[ T>&2*W2X7!,=TTFV0XSS&43/!R5.#ZA_P5A_8S3XC>#Y?C!X1
ML%_X2G08/^)W;P)\U_8J/];@=9(0.O4QYY^117YX?L1_M7:I^RA\9+/6Q)-/
MX3U(I::_IR9(FM\\2JO_ #TC)+*>I^9<@.: /Z(HXTAC6.-51% 5548  Z "
MOP#_ ."H_P#R?9\3?^X9_P"FNTK]\-#URP\3:+8:OI5W%?Z9?P1W5K=0-NCF
MB=0R.I[@@@CZU^!__!4?_D^SXF_]PS_TUVE 'VAX\_9.'[2O_!-'X4ZAHMIY
MOCKPMX=COM+\M?GNHMF9K7WWA0R_[:*. QKX+_8<_:?N_P!E3X[:=KMP\Q\+
M:@1I^OV:@G=;,W^M"]WB;#CN0&7C<:_:W]A7_DS_ .$G_8OV_P#*ORW_ ."K
M'[)G_"E/BP/B#X>LO*\&>,)WDE6)<)9:D<M+'[+(,R+[^8  %% 'E?\ P4BU
M&UUC]M+XC7]C<17EE='3YX+B%P\<L;:=;,KJPX(((((]:_:;]BG_ )-'^$/_
M &+-C_Z*6OYR+R^N-0F66ZGDN)%CCB#RL6(1$"(N3V5550.P %?T;_L4_P#)
MH_PA_P"Q9L?_ $4M 'K;>'M+DU^/7&TVT;6H[9K)-1,"_:%@9E=HA)C<$+*K
M%<XRH-/;1-.DUB/5FL+5M5C@:V2^,*F=8BP8QA\;@I(!*YQD U=HH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** /@_\ ;R_X)GV/[1FI7'COP#<VF@>/W0?;;:ZRMIJNU<*6(!,<V !OP0V!
MNQ]ZOR^\0_L>_M#?"?695E^&GC&TNH5):]T.SENX@H()/GVV],< _>[5_1C1
M0!_.OX%_83_:!^*6L)#:_#+Q%9/,^7OO$-J^G1#/)<O<;=PQ_=R3V!-?KA^P
MC^P)HW[(^DW.M:M=P>(?B)J4/DW6I0H1!9PY!,%ON ;!(!9R 6VCA0,'ZXHH
M *^#/VZO^"8^G?M%:Q<^.O %Y:>'/'DPS?6UWE;+5"%P'8J"8I< #< 0V/F
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MY_X5WKEWXRT>PU2U\0VGEJ989Q]CC25_FQ^^$#2#!/4CM7ZQT4 ?GG_P2+^
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MQ?\ '/1?A]K_ (#\.77B/6]*N+FQN[:Q4&3[/*JNCG)'RJT3#ZRUX7_P3/\
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ME8 X_P!E@?QKWFB@ KB_C%\'_"WQW^'NJ^"_&&GC4-$U! &53MEA<'*2QO\
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M ()H_LYZE^SO^SC!;>(]-?2_%VO7TNI:G:S >9  ?+AB)'I&@?'8RM7UC10
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHUR-SLQ"@9')Y(&2/@;]HJ-;?_@L)\%'B41O+H]L79>"QS?KSZ_* /H*N_\
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M7E#6&B0[BD*,Q1'D" NY9P0L:\MM;E>,^2S?M@?M:?!G3X/%_P 8_@5I+>
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MM+-&OE2.?=FC8_C7E_\ P5.O(K;]AGXB1R-M>XDTV*,>K#4;9\?DK?E72?\
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M5P<A@GVE<Y_"@#VS]KC]OA_@=\0M*^%WP]\(3?$7XHZDJ.-,A9O*M0XW('"
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MS)N&<':P(SR>?>K5K:PV-M%;V\,=O;PH(XX8E"HB@8"@#@ #C H _,G]B_\
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MN<_-R.HP0>:^I-8T33O$%DUGJEA:ZE:,0QM[R%98R1T.U@1D5\S_ +5O[/\
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M )( /HVBOS%\=:E^W;\)_A8WQEUGQ_X?OK&S@CU'4?!XL+<M;6Q(8HX$"@[
M1NV2[P,X8XK[B_99^/5I^TM\#/#7C^VM/[.FU"-X[RQW;A;W,;F.50>Z[E)4
MGG:RYP: /2-=\/Z7XHTN?3-9TVSU?39QB6SOH$FAD .0&1@0>?45Q/AG]F_X
M3>"]935] ^&/@_1=5C?S([VPT*UAFB. /D=4!3IT4CN>YKQ7_@I5\?O&G[.'
MP!TSQ1X$U&'3-9G\06]@\TUK'<*87@N'9=K@C.Z-.>O%> >"-6_X*#_$+P7H
M'BG2-?\ ";Z3KFGV^IV;30V*.89HUDC++Y7!VL,CM0!^E]%?ESXV_: _;N_9
MHT>3QC\0/#F@^)?"=K(JWA2"VD2%"<;F-JZR(#G =@5!QD<X/W=^R_\ M$Z'
M^U%\']*\=:'"]EYS-;7VGR/O>RNDQYD18 ;A\RL&P,JZG )P #UBBBOE?_@I
M!\>?&7[.O[/=OXJ\#:A#INM/K=M9---;1W"^4\<S,-K@CJB\X[4 ?5%%>=?L
MY^,M5^(GP!^'/BC7)UN=9UGP_8W]Y,D:QJ\TL".[!5  !8G@<5Z+0 45\)?\
M$Z?VJOB/^T-\2_B[H_C?5[?4K#P[+"NG1PV44!C#33H<E%!;B->OI7W;0 44
M44 %%%% !117Q#_P3U_:@^(7[0'Q*^->C^-=5@U&P\,7T$&F1PV<4!B5IKI&
M!**"W$2=<]/>@#[>HKYB_:-_;(D^"_[0'PG^$^F^'UU#4_&FH62W&I74N(;6
MUENO(;8B\O*<-C)"KP?FZ5<_X*#?&CQ7\ ?V:=7\8>"[Z+3M>M[ZT@CGFMTG
M4))*%8;'!'(/I0!](T5YE^S+XWU?XE?L]_#OQ5K\ZW6M:QHEK>WDR1K&KRO&
M&8A5  Y/0"O3: "BBB@ HK\^OCW_ ,%#_&GBGXN7/P?_ &:?"T/C+Q7;/+!?
M:W<()+>%T.',(WJFU&X,TIV9X 8$$XC?#+_@HM8V;:XOQ-\,7UZ$R=%"66]\
M '8 ;-803C;D..<\@<T ?I!17P_^QK_P4 U;XI?$2]^#_P 8/#Z>#?BI9,\4
M2QQM%#?/&I:1"C$^7*%4N,$HXR5QP#]P4 %%%% !1110 4444 %%%% !17S]
M^VC^USH_[(7POCU^ZLO[8\0:G,UIH^D^9L$TH7<TDC=1&@QN(&264<;LCY(T
M6Q_X*%_''2[?Q1;^(M%^'FFWJ+/::3/';6S"-QD'9Y,TJ\8^65MP]!0!^G%%
M?F##^VM^T;^QK\0M#T+]I71K/Q)X1U60QQ^(M-AB678I >2)H J/L# F-T5R
M,'(SD_IM87]OJEC;7MG/'<VES&LT,T3;DD1@"K ]P00<T 6**** "BBB@ HH
MHH **** "BOB']M#]J#XA?!O]J7X%^"O"VJP67A[Q5?6L&JV\EG%*TRO?1PL
M [*67Y&(^4CUKWG]K;4OBMI/P6U"Y^"]I]M\>+=6XMX?+@DS$9!YIQ,=GW<]
M>?2@#V6BN*^"EUXNO?A'X0N/'L/D>-)-,@;6(ML:[;HH/,&(_E'S9^[Q7:T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7E'[4'[0>D_LQ?!G6_'FJV[7[6FV"R
MT]7V-=W4AQ'%NP=HZL3@X56.">#ZO7D?[4GQ@^'WP.^$=_XG^)%G;ZKHD<BP
M0:7-;1W#WURP;9#'&_REB YR< *&)X!H ^/_  #>_MT_M/>";;QKI/C+P?\
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M-@0<L,\G% 'J?_!9[_DU#1/^QML__26[KZ@_9._Y-9^#?_8F:-_Z0PU\O_\
M!9[_ )-0T3_L;;/_ -);NO&O@W_P1Z\'_$WX0^!_&%U\0M<LKGQ#H5CJTMM#
M9PLD3SVZ2E%).2 7(&?2@#[J_;(^+G@KX6?L^^.3XOU.QA_M'1;NRM-+N)5\
MZ_EEB:-(HXR<OEF&2!@#). #7S;_ ,$7_".JZ'^S?XCUF^CF@L=:\0226"2
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MQF-<M&DO=!0I;&$W"^6H!BBY SGY?Q-<]^WA_P I+/V9/^NVE_\ IT>O:O\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^*_\
M@JQ\ ?%_QT^ .EOX,L;C6=2\.ZJ-1ETBU!>:ZA:-XV,2 ?.ZE@=HY*[\9. ?
MM2B@#\[/A7_P5<\,:5X!T;PQJGPJ\='QUI=C#92Z+H^FQR0O)&FS*9D5T0E.
MACRN<#=@FOG?XPP_&WQ!^U[\&OCG\3O E]X9T2\UVQ-CH]O$]S/I.FVEW$["
MX55RC$3._P ^TEB_RJ  /V;HH _/+_@L[X:U?Q-\'? ,.CZ5?:K-'KTCO'8V
M[S,J_9W&2%!P,U]\^%5:/PQHZLI5ELX0588(.P<5J44 ?F]>>%]9/_!:*QUH
M:1?'1QII4ZA]F?[/G^QG7'F8V_>XZ]>*['_@HO\ LS^.-<\8>"?CS\)+.34/
M'G@QHQ<:9;H7ENX(Y3+&R(.9"K-(K)U='P/NX/WA10!^=EC_ ,%<SX@T./0-
M$^#'BV^^+<D?DKH*P![5;@X7)8'SBH;/R^6#@8W#J.%_X)A^!OB#X5_;$^+U
MU\1-,O;?Q!=:7-+J%Y-$WE2W<EY#)(%DQL8Y9ONDC@XR.:_4VB@ KC/C+\+=
M*^-GPL\3^!=:+)IVN63VCS(H9H6/*2J#P61PKC/=179T4 ?D5\,OBA^T-_P3
M)GO_  -XI^'EU\0/AFET\UC?V(D$$>]N7@N51Q&'.6,,J@[LD;<DMZ!J/_!8
MK6O&D4FD?#'X(:QK7B:9?*A6XN'N1%,<XS!!$7D''W=R'WK]-:* /AS_ ()S
M_LH>-OAGK/C3XP?%C,7Q&\:,^ZR9E,EK!)+YTK2[3M#R2!#L'W%C4<$E5\:^
M-'PK^*7[#'[7NM?'CX=^&+KQQX!\4332:SIMDK22Q?:'$EQ%($4L@\T>9'*%
M*CA6[AOU(HH _,SQY_P5*\3?&CP[<^#O@K\'O$-]XPU1&L99M3M5N8[+>NUC
MY2!E<@-UE*H."P(R*\&T7]GOX^_\$U?$7@[XNV6F6_B:UU"$66OZ3I8:9;<2
MR+_H<Q4'[Q$>V9 5$J[>1M\S]K*3KUH ^!O^"K5OKOQ$_8T\(75MX8U6VU6[
MU_3[R?1?)\^ZLRUI<EDD$6X94L%)!QFOJK]EFTGT_P#9C^$-K=0R6US#X/T>
M.6&9"KQN+*$%6!Y!!!!!KU"B@ HHHH *^)/^"O.@ZGXB_93M+32=.N]4NAXD
MLW,%G TS[1%/D[5!..1S[U]MT4 >2_LCV=QIW[+?PDM;N"2UNH?"NFQRPS(4
M=&%M&"K*>00>QKUJBB@#\RO^"2OA76_#OQB^/,VJZ/J&F0W$UN89+RU>)9<7
M%T?E+ 9X(Z>HKHOVVOV?_B1\*_VD-$_:>^#>D2^(M0M8T'B+18 9))5CC$)8
M1CYGCD@PC! 60H' .25_1.B@#\\M3_X+ :1=:')IN@?"#QK<_$5HPD6B75LG
MV=9F&!ET8RL W81*6Q_">GH?_!/'X3?&;P_8>*?'_P :?$>O2:SXFF,EEX7U
M+4)GBTY&D+R2&W+F.)W.T*H *(F.-Q4?95% 'Y%>#_%GB/\ X)K_ +7/Q0UW
MQ]X'UOQ#X(\6SW$EMXBTJ 2LT;3FX1D=RJ,V'*R1EU(8 \@#/L'Q:_:P^(7[
M:_@76/AO\!/A;XEL[#7+9[35?%WBJ!;*U@M6!61(R&=29%RN=V[!;"9Y7]%:
M* /@;_@CA'J&A_L_^+_#>L:7?Z3JMEXFDNVM[ZT> F&:V@5&&X#/SPRCCI@5
MR_\ P2E\+ZSX?^,7[1DVJ:1?:;#=:E;-!)>6SQ+*!<7Q)0L!NX(Z>HK](:*
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MF_9+^!/A;P[\7/AUXFU3PL^GQWWAGQ/H<23QS6<P+QP2,[JH*%MOW]P&!MP
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **^??VI/VV/AW^R[H.I+JNKV.I^,
MX;87%GX42Y9+BZ)/RJS)')Y((R0SKCBM+]F?]L#X>?M/>&=/N/#VN6$7B=K*
M.YU+PUY[&YL9"H\R/YTC,JHQ*^8J[3P>XH ]PHJGK&LZ?X>TNYU+5;ZVTS3K
M5#)/>7DRQ0Q(.K.[$!1[DUX1'_P4"_9WDUC^S!\5]"%SNV;V:18,_P#78IY>
M/?=B@#Z#HJMINI6>M:?;7^GW4%]8W,:RP75M()(I4(R&5E)# CH17GWQ3_:2
M^&/P2U.RT[QUXSTSPS?7D)N+>"^<AI(PQ4L  >,@C\* /2J*^?\ _AOS]GG_
M **QX?\ ^_K_ /Q->Y:%KEAXFT/3]8TNZCO=,U"WCN[6ZB^Y-#(H=''L5(/X
MT 7J*\)US]NCX!>&_$DF@ZA\4] BU..1H9%29I(HW4X96E13&I!!'+#FO:=%
MUK3_ !)I-GJNDWUOJ>F7D2SVUY:2K+%-&PRKHRDA@1W% %VBBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5YA^TO_P D2\1_]NW_ *4Q
M5Z?7F'[2_P#R1+Q'_P!NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO]G!CO$WC#7I+V=0?[D<9EVG'\)*XZ<5^TMK:06-NL%M#';PKG;'$@51DY.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,
M/VE_^2)>(_\ MV_]*8J]/KS#]I?_ )(EXC_[=O\ TIBH ]/HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CN+
MB*SMY9YY4@@B4O))(P544#)))X  [U)7QO\ \%(/V9?BQ^TWX4\)Z+\.M?M+
M/2;>ZE.L:1>736T=UN">5*S*IWK'A_D/]\$ D< &)^TI_P %8_A=\'6N](\%
M?\7)\31Y3.GS!--A;_;N<'S,<'$08'D%E-?"UWXL_:R_X*2:E+:6$5\/!\DF
MR2WL0=.T&  \B20G]\1UVLTCCL*^T?V:O^"1/P[^&'V36/B1<+\1/$4>'^Q.
MICTJ%NN/*^]-C_IH=I_N"OO/3]/M=)L8+*QMH;*SMT$<-O;QB..- ,!54#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2_
M_)$O$?\ V[?^E,5>GUYA^TO_ ,D2\1_]NW_I3%0!Z?1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW;#^.:4_,YY/4X&<  <4 >B4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:VMK;J%CAB10J(H'0!0 ![5=HHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KS#]I?_DB7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_ -*8J /3Z***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5I&L64.H6<V"/,AE0.C8/3*L.* ->BBB@ HHHH **** "BBB@ HHHH ****
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MY\2541Q<^7:ZP1_%#G[DOK$3SU3(RJ@'W#1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,
MP12S$*H&23T%>9?'K]I#P!^S7X3;7O'6N1Z=&X86MA%B2\O7 ^Y#$#ECTR3A
M5R-S <U^2'QL_;,^-_\ P4 \9-\//AGHFHZ5X9NB470-(<^=<Q9QYE]<< 1\
M\J2L8R =Q :@#]0]#_;F^"OB;XS0_##2?&EMJ7B>=C%"UK&\EG+,.?)2X \M
MGP#T.,C&=W%>]5\(?L0_\$P=%_9XUC3?'7CG4(_$OCZV7S+6VM@18:8[*02N
M1F:0 G#D #/"Y :ON^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV<2Q0PH.BJH& *TJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=\.OV7O#9U/QIK*QWTJ%K+1+/$E_>G_IG%D87(Y=B%'<YP*_)WXG_M,_'_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!1Y%SY<2J%../-?UKYQ^$OP7_;M^!?AN70/ ?A[5O#FDRW#74EO;'2V\R5@
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M /)$O$?_ &[?^E,5>GUYA^TO_P D2\1_]NW_ *4Q4 >GT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<B,,JRL.""""".M $]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#DB7B/_MV_]*8J]/KS#]I?_DB7B/\ [=O_ $IBH ]/HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\8/ _P )['[7XR\7:+X8A*[E_M2^C@:0?["L=SGV4$UY9\)?V\?@M\</B<?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2__)$O$?\ V[?^E,5>
MGUYA^TO_ ,D2\1_]NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*Y)W)NZ '[F45XW^S?\ M9_#K]J3PW_:/@S5P=1A0-?:'>8COK(G^_'DY7/
M=25/3.<@>R4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KS#]I?\ Y(EXC_[=O_2F*O3Z\P_:7_Y(EXC_ .W;_P!*8J /3Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **;)(D,
M;22,J(H+,S'  '4DU^?G[7W_  5C\)_"I;[PQ\*OLOC7Q:NZ*75B2VEV+="0
MP/\ I#CT0[/5C@K0!];_ !Z_:0\ ?LU^$VU[QUKD>G1N&%K818DO+UP/N0Q
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M#RR267& #LW  ,*^@** "BJ&O:U:^&]#U'5[YF2RL+:2ZG95+$1HI9B .2<
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MWE_;]6U697FE5,[454551 68X R<\EL#'O=%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5YA^TO\ \D2\1_\ ;M_Z4Q5Z?7F'[2__ "1+Q'_V[?\ I3%0!Z?1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M& %/F,"<M@,PX4 ^TZJ:MJUCH&EW>IZG>0:?IUG$T]S=W4@CBAC4$L[L3A5
M!))X&*MU\&?\%&OBAHFM?$CX5? SQ%XKM_!_@SQ%.=9\7:C//Y .GQ.?)@W]
MA+)'(N>S(A/ - '3R?MO^/\ XV:Q=V/[.7PFF\:Z+:RF&7QKXEN/[.TEG!P1
M"K;6F'T8,.,I@YIL_P :/VQ_AW;G5?%GP6\'^-](B&^XMO!&IRQ7J)M!.U)7
MD,C+R-J*23TXYKW#X>_';X%V>@:;H7@[XA^!(=+LH4M[33=.UNT A3HJ",/D
M=.XR>:]%M_&GAZZA2:'7=,FB<962.\C96'J"&YH \]_9U_:?\$?M->'+O4/"
MMS<6NI:=)Y&JZ#JD8AU#3I<D;)H\G )!PP)!P1G(('K=?"/[9*Z+^S[\6_ O
M[27@Z^L[:YAU.'1/&MG8S+C4]-G.WSI%4_,\9  )!))B)_U8KZSO_CU\,M+9
MEO?B+X3LV5=Y%QKEJA"^O,G3WH [NBLSPWXFT?QEHMKK&@:M8ZYI%TI:#4--
MN4N()@"02DB$JPR".#VK3H **_/W]L#_ (*KQ_L[_%+6OAWX;\"-KVM:2(EN
M]2U2\-O;K(\22@)$JEI%VR+\Q9.<X!&#7RC<?\% OVO_ -HB9[?P!I%S9VTA
MV,G@SPXTX4?[4T@F9/=@R].U '[2:MK%AH.GRWVIWUMIUE",R7-W*L4:#U+,
M0!^-?,7Q=_X*:? 'X2K-%_PEZ^,-3CZ6/A6,7N[_ +;9$(_[^9]J_/S2?^";
M_P"U5^T9J$6J?$G7&TQ&;?Y_C#6WO)U4_P!R*,R;?]UBGX5],?"?_@BW\./#
M<D-UX]\5ZOXTG7!:SLD&G6A/=6P7D8>X=/I0!Y;X@_X+3>,?$7C;2].^'_PL
ML9;&:[CA%GJ4\UU?WP9@ D0AV".1LX'$O)'!Z5^K]C<27=C;SRP/:RR1J[P2
M$%HR0"5..,CIQZ5P?PL_9Y^&GP3MEB\#^"=&\..J[#=6MJIN7'H\[9D?_@3&
MO0Z (KFVAO+>6WN(DG@E0QR12*&5U(P5(/!!':JNAZ!IGAC3(=-T?3;32=.A
M&(K2Q@6&)/\ =10 /P%7Z* "BJ&M:]IGAK3Y+_5]1M-*L8_OW5[.L,2_5F(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %>8?M+_\D2\1_P#;M_Z4Q5Z?7F'[2_\ R1+Q
M'_V[?^E,5 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN474KM-. W<"21P#Z 5Z[0 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY\+W?V_2=0OKJX":EH\NWRI!"L@C++E-QV\&4+_"U?HEX'^"/P\^&4BR>$?
MWAWPU,H(\[2M+@MY3D8.710QR/4T ?/O_!1"^_:&@\%>&;?X"6UV[7-S.NMS
MZ4L9OHU"H8!'O^ZA/F[F7G*H,@$Y^!X_^">_[87QZ?S/'>L7%K#,P?=XQ\3M
M<C_OW$TQ7'8;1CTK]KZ* /"?V/?V<[_]G']GW3_AWXAUR/Q3/')<23NB,+=%
MF8DPQAN2@R>H&2S' S7G'AO_ ()3_LY^']8N;^;PG?:R))3+%:ZEJL[06^3D
M*JHR[E'3]X7]\U]>T4 <7\/?@MX!^$T+)X,\&:%X7+)L>32]/B@DD7T=U4,_
M0?>)Z5VE%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7F'[2_\ R1+Q'_V[?^E,5>GUYA^T
MO_R1+Q'_ -NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8'C?Q]X;^&OAZXUWQ
M7KNG^'M'MQF2\U&X6&,'L 6/+'LHY/85OU^6G[2G_!.?X\?M,?M0:]JNN>,-
M/3P%+<M)I>I75RTHL;,GY;>*T7&)%  /*JY!8ODF@#6_:._X+,Z'HGVG2/@W
MH?\ PD%X,I_PD6N1O%:+[Q6^1))]7,>"/NL*^=?"7[+/[47_  4"URW\4>.]
M4OM-\/2-YD.J>)RT%NB'K]CLU R".A550]WK]'/V<?\ @G+\'OV=6M=2M](/
MB[Q5#AO[=U]5F>-Q_%#%CRXL'H0"X_OFOJ.@#Y-_9Q_X)H?![]G_ .R:E<:7
M_P )SXKAPW]L:_&LB1OZPV_,<>#R"=SCL]?65%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?.'[<'[6$_[*_P .
M]+N]"TF'Q'XUUV]%II&CRJ["14&^>5E0ABJ+@<'[TB=LU]'9QR>!7YR^ ?CM
M\./BI^U]XP^-GQ \;Z!H7@SP9%)X:\#V>JW\4;WC#(N[Z*(G<X.Y@&53D2J.
ML= 'W%\#_BUI/QU^$_ACQWHC#[!K5FMQY6[<8)?NRPL?[R2*Z'W6NYK\MOV7
M_P!L[X0?LP_&KXE_#Z/QE%=_!_5=176?#.JVMK/)#ITTQ43VC+LW! 2,, 5
MB))RYK[L_::_:1T3]F;X-W?Q"U*PN==LTDA@MK73V4&XDE/R?.>%7&26YX'
M)(% 'KM%?DCXF_X+A>(;AG'A[X5:98+R%;4]6DNB?0D)''CZ9_&OJ[_@G?\
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M@5VQZ9(H _(WP=_P68^+?B+QQH6FK\._#.IVMY=Q6\FG:;#=F]N-S@;86,S
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KS#]I?_DB7B/\ [=O_ $IBKT^O,/VE_P#DB7B/_MV_]*8J /3Z***
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MO"GAF*XUU%PWB#5L75^Q[E7(Q%GN(U0'N#7N] !1110 4444 %%%% !1110
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M@*!P !V%/HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?:O+\J[BDD\V2,%(R%C;Y68-G'%?.7C[_@KE\5?'4-EX4^$OA2'PX[1):P7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***9+*D,;R2,$C0%F9C@ #J30!%J&H6NDV<UY?7,-G:0KNDN+B0
M1QH/5F)P!]:=9WEOJ-I#=6D\=U:S()(IH7#HZD9#*PX(([BOQ$_:(_;"^,O[
M9=Q\2[;P;<R:-\(?#]C)=WFGP[(?,L5D"I)<N?G>20E?W:G:/3"LQZ7]DO\
M:\^-7[-?Q#^&O@3QV;KQ!\.O$&EZ=<V%G)$L\EIIMRH6WN+>11N"QDA6C;(
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M^-U50(\/YC, HP$8 =!0!]%T5^*VD?M"_MR?&#P7KGQC\-:K?1^#=(DGE?\
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M &W/$,_AOX8:7J6@Z4S -I_A /&\:GH;F_."@/(SNB0]"*_5[]EOPCX\\!_
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MA#B-, ')/W3]'?M@?\$^?"W[7WC+P[XDU;Q-JOAZ]TJU-A*MC&DJ7%OO:10
MWW'#.WS<Y!QC@&OJRB@#XZ^'O_!)_P#9Z\#>7)>Z!J7C"ZCP1-K^I.PSZF.'
MRT(]F4BOK;0M"TWPOHUEI&CV%MI>EV42P6UE9Q+%##&HPJ(B@!0!V%7Z* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM'FTGP9X:TOPOILTYN9;72K5($DE*A2[!0,MA5&3V4>E=3110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQG QFOBO]KS_ ()>^$?VE/&$_C30=?E\"^+KK:;Z2.T%S:7K*,"1HPR,DA
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MT^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=310!QGP\^#/@/X2VGV?P9X.T3PPA7:S:98QPR2?[[@;G/NQ-=G110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45!>W
MUOIMI-=7<\5K;0J7DFF<(B*.I9CP![FODGXX?\%2/@;\'?M%II^MR>/M;C!
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M7W[\)O@'\._@7I?V#P'X0TOPW$R[))K6'-Q,/^FDS9DD_P"!,:[^B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KS#]I?_DB7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_ -*8J /3Z***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS7C/A/\ 95_;C^-7B33M:\0>)/$7AI8YTEBU#Q%XB:$6Q# [DMHW9U(ZX\L
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!?A#I_V+P5X2T?PQ 5VO_9MFD3R#_;<#<YX'+$GB@#\>K']C7]L+]KZ[AO\
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MUH\Z8Q=0Z;$;CCIF9@7/XM7IE%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %>8?M+_\ )$O$?_;M_P"E,5>GUYA^TO\ \D2\1_\ ;M_Z4Q4 >GT444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116)XL\
M<>'/ .F_VCXG\0:7X<T_./M6K7L=K%GTWR,!^M &W14%C?6VIV5O>6=Q%=VE
MQ&LT-Q X>.1&&596'!!!!!'!!J>@ KQ[XK_M??!OX)^='XO^(6C:??19W:=;
MS?:KP$=C!"&D&?=0*_-GXP_!7]NC]HCXE>)-'U3^U[+P\+V:)(X=6CT_1O(W
ME4*(K@S)M P2KO@\\DUUGPH_X(CW$@AN?B5\0TAZ>9IWA:WW''M<S  '_MD:
M .N^+'_!;#PEI/GVOP[\"ZEX@G&574-<F6R@!_O"--[N/8F,U\YW/[7W[9/[
M7%Q):^!;76+#2YF*%/!6FM:P1G./FO6RZ'MS,!7Z5?"G_@GC\ _A"T,^F^ ;
M'6=1CQ_Q,/$1.H2%AT8++F-&]T1:^BK:VAL[>."WB2""-0J1QJ%55'0 #H*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O,/VE_^2)>(_\ MV_]*8J]/KS#
M]I?_ )(EXC_[=O\ TIBH ]/HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCX>FFQYTVK7[ZOJ/KR$8HW?K,*_9FWMXK6".&"-(88U"I'&H554<  #H*DH
MX/X$_".R^ _PC\,> =.U"[U6ST.U^SI>7Q!EE)9G8G' &YCM4?=4 <XKO***
M "BBB@ HHHH **S-0\3:/I-];V=]JUC9WEPP6&WN+E(Y)6)P JDY8D^E8?Q6
M^+7A/X)>";WQ9XUUF'0]"M,+)<RJS%F/W41%!9V/95!- '7T5\&^,/\ @LK\
M#]!$B:-IOBKQ-,,[&M[&.WA.#W:616 /^X:]C_8S_;7T#]LC2?%%QI/A^_\
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MI%JGA4Q1:GI,N?,@W1R2$N"S[ 5QF4G.56OU'C;S(U;!7<,X88(^M #J***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC&#ED4$Y[DGFNPHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK1S+\SFW:XOYP?\ :RD:D_1S7MOA#_@B+X"L3&?%'Q&\0ZUCEAI5I!8!N/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>OI_PG_R*NC?]>4/_HM: -:BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?\I9[#_LEA_]+WJU_P *!_:Y_P"CJ-/_ /"$T_\ ^(K3^!_[)?Q'\(_M%/\
M%SXF_%BW^(>LKX??P_ EOH,6G%8C,LJD^40I"G?_  Y._K@8H ^K:*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNC!T895E.01ZBOR!U;_@B'XYA+_V9\2O#UV 1L^UV4\&?7.W?COZ_A7-S?\
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MH?\ A<6G_P 8ILO[67[1\,;R/^R%J"H@+,?^$XM. /\ MWK["JIJW_(*O?\
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MULUL([FWU">WS"KNZJ5C< X:1^<9Y^E>[T4 ?'__  Z?_9M_Z%#4/_!W=_\
MQRC_ (=/_LV_]"AJ'_@[N_\ XY7V!10!\@+_ ,$H/V;58$^#[]@#T.MWF#_Y
M$KZ[M[>.TMXH(4$<,2A$1>BJ!@#\JDHH **** "BBB@ HHHH **** "BBB@
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M/$'_ (7(_P#DBG+^QS^WEHJO<V&O>*A/C;ML_'RQR,"1D9-THQWY/:OVGHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O,/VE_^2)>(_P#MV_\ 2F*O3Z\P_:7_ .2)>(_^W;_TIBH ]/HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#F?B!\,_"?Q6T--&\9>'-,\3Z4D
MRW"6>J6R3QK*H(#@,#A@&89'.&([UYU_PQ3\!/\ HD/@_P#\%,7^%>UT4 >*
M?\,4_ 3_ *)#X/\ _!3%_A1_PQ3\!/\ HD/@_P#\%,7^%>UT4 8G@SP3X?\
MAUX<M= \+Z-8^']$M=WD:?IT"PPQ[F+,0J@ $LQ)]22:VZ** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KS#]I?_DB7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_ -*8
MJ /3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "O,/VE_^2)>(_\ MV_]*8J]/KS#]I?_
M )(EXC_[=O\ TIBH ]/HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\P_:7_Y(EXC_P"W
M;_TIBKT^O,/VE_\ DB7B/_MV_P#2F*@#T^BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MS#]I?_DB7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_ -*8J /3Z*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O,/VE_^2)>(_\ MV_]*8J]/KS#]I?_ )(EXC_[=O\ TIBH
M ]/HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\P_:7_Y(EXC_P"W;_TIBKT^O,/VE_\
MDB7B/_MV_P#2F*@#T^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP%\3/^"FGB:Z^)UZL'PZL-9;3]49FFQY-E;>4T0\C]YEY82OR<Y?M0!]U_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KRN^_9S\-ZA^T;IWQIDOM57Q38Z*="CLUEB^Q& O(VYD\O?OS(W(<
M#@<5ZI10 4444 %%%% !1110 4444 %>8?M+_P#)$O$?_;M_Z4Q5Z?7F'[2_
M_)$O$?\ V[?^E,5 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2_\ R1+Q'_V[
M?^E,5>GUYA^TO_R1+Q'_ -NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA
M^TO_ ,D2\1_]NW_I3%7I]>8?M+_\D2\1_P#;M_Z4Q4 >GT444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %>8?M+_P#)$O$?_;M_Z4Q5Z?7F'[2__)$O$?\ V[?^E,5 'I]%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7F'[2_\ R1+Q'_V[?^E,5>GUYA^TO_R1+Q'_
M -NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5YA^TO_ ,D2\1_]NW_I3%7I
M]>8?M+_\D2\1_P#;M_Z4Q4 >GT444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>8?M+_P#)
M$O$?_;M_Z4Q5Z?7F'[2__)$O$?\ V[?^E,5 'I]%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7F'[2_\ R1+Q'_V[?^E,5>GUYA^TO_R1+Q'_ -NW_I3%0!Z?1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5YA^TO_ ,D2\1_]NW_I3%7I]>8?M+_\D2\1_P#;M_Z4
MQ4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5^6/[9O_!13QWXH^(7C/X._!C08[RRTZVO;#6=8^S-<7$BQQL+M
MHAD+%'$!(#(P.2N05&,_J=7X+_%&Z\7?L*_M5_%B&_T$W^G^++#5],MYKK<B
MW6GWQ+)/#)@@NA\O=C/*.AQG- '>_LE_\%%OB)^S3I/@/PSX_P!#&I?"R_22
M2RU"2W=+Q;=KF02SQ2YQ.$D\W*,,_+MW+Q7ZN_M!?M!>&OV=?@_JGQ"UUVN]
M.MD06MO:L"][-)Q%%&>GS$YSV4,W.*^*O^"=OQD_9]^(/P1^&WPS\7Q^';_X
MC:"MY;VEGXFTJ-WS-=2R[;6:5"I+*R916#$K]TX%97_!;KQ"^E_#OX4>&+?;
M#8WFHWEZ8(_E7-O%%&F%'& +EA[9H \P;_@J%^U)XDTO4O'_ (?^'6F#X?Z=
M,R37$>A7=S8PC(PLUR)!EE!4,RE!EAPN0*_03]BW]K[1?VOOAK/K=I9?V-XA
MTJ5+76-)+[Q#(RY22-NIB?#;<X(*,#G&3SG['?@73KC_ ()Z^#_#IM8YK+5O
M"UQ]HA*@"4W(E>0'L<F1AS7P5_P11\27%E^T-XST(.PL]0\,O=.@/!DANH A
M(]EFDY]_>@#]FZ*** "O,/VE_P#DB7B/_MV_]*8J]/KS#]I?_DB7B/\ [=O_
M $IBH ]/HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9OA^UN)9+GRDN9!)"-P"6Z/*KL=FXD$_=)R/U"^/7[.OA;X_?!74/AKJL/\
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MO^A<_P#)ZY_^.4?\,T?#;_H7/_)ZY_\ CE>GT4 >8?\ #-'PV_Z%S_R>N?\
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M ">N?_CE>GT4 >8?\,T?#;_H7/\ R>N?_CE'_#-'PV_Z%S_R>N?_ (Y7I]%
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M_P"A<_\ )ZY_^.5Z?10!YA_PS1\-O^A<_P#)ZY_^.4?\,T?#;_H7/_)ZY_\
MCE>GT4 >8?\ #-'PV_Z%S_R>N?\ XY1_PS1\-O\ H7/_ ">N?_CE>GT4 >8?
M\,T?#;_H7/\ R>N?_CE'_#-'PV_Z%S_R>N?_ (Y7I]% 'F'_  S1\-O^A<_\
MGKG_ ..4?\,T?#;_ *%S_P GKG_XY7I]% 'F'_#-'PV_Z%S_ ,GKG_XY1_PS
M1\-O^A<_\GKG_P".5Z?10!YA_P ,T?#;_H7/_)ZY_P#CE'_#-'PV_P"A<_\
M)ZY_^.5Z?10!YA_PS1\-O^A<_P#)ZY_^.4?\,T?#;_H7/_)ZY_\ CE>GT4 >
M8?\ #-'PV_Z%S_R>N?\ XY1_PS1\-O\ H7/_ ">N?_CE>GT4 >8?\,T?#;_H
M7/\ R>N?_CE'_#-'PV_Z%S_R>N?_ (Y7I]% 'F'_  S1\-O^A<_\GKG_ ..4
M?\,T?#;_ *%S_P GKG_XY7I]% 'F'_#-'PV_Z%S_ ,GKG_XY1_PS1\-O^A<_
M\GKG_P".5Z?10!YA_P ,T?#;_H7/_)ZY_P#CE'_#-'PV_P"A<_\ )ZY_^.5Z
M?10!YA_PS1\-O^A<_P#)ZY_^.4?\,T?#;_H7/_)ZY_\ CE>GT4 >8?\ #-'P
MV_Z%S_R>N?\ XY1_PS1\-O\ H7/_ ">N?_CE>GT4 >8?\,T?#;_H7/\ R>N?
M_CE'_#-'PV_Z%S_R>N?_ (Y7I]% 'F'_  S1\-O^A<_\GKG_ ..4?\,T?#;_
M *%S_P GKG_XY7I]% 'F'_#-'PV_Z%S_ ,GKG_XY1_PS1\-O^A<_\GKG_P".
M5Z?10!YA_P ,T?#;_H7/_)ZY_P#CE'_#-'PV_P"A<_\ )ZY_^.5Z?10!YA_P
MS1\-O^A<_P#)ZY_^.4?\,T?#;_H7/_)ZY_\ CE>GT4 >8?\ #-'PV_Z%S_R>
MN?\ XY1_PS1\-O\ H7/_ ">N?_CE>GT4 >8?\,T?#;_H7/\ R>N?_CE'_#-'
MPV_Z%S_R>N?_ (Y7I]% 'F'_  S1\-O^A<_\GKG_ ..4?\,T?#;_ *%S_P G
MKG_XY7I]% 'F'_#-'PV_Z%S_ ,GKG_XY1_PS1\-O^A<_\GKG_P".5Z?10!YA
M_P ,T?#;_H7/_)ZY_P#CE'_#-'PV_P"A<_\ )ZY_^.5Z?10!YA_PS1\-O^A<
M_P#)ZY_^.4?\,T?#;_H7/_)ZY_\ CE>GT4 >8?\ #-'PV_Z%S_R>N?\ XY1_
MPS1\-O\ H7/_ ">N?_CE>GT4 >8?\,T?#;_H7/\ R>N?_CE'_#-'PV_Z%S_R
M>N?_ (Y7I]% 'F'_  S1\-O^A<_\GKG_ ..4?\,T?#;_ *%S_P GKG_XY7I]
M% 'F'_#-'PV_Z%S_ ,GKG_XY1_PS1\-O^A<_\GKG_P".5Z?10!YA_P ,T?#;
M_H7/_)ZY_P#CE'_#-'PV_P"A<_\ )ZY_^.5Z?10!YA_PS1\-O^A<_P#)ZY_^
M.4?\,T?#;_H7/_)ZY_\ CE>GT4 >8?\ #-'PV_Z%S_R>N?\ XY1_PS1\-O\
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M^.5Z?10!YA_PS1\-O^A<_P#)ZY_^.4?\,T?#;_H7/_)ZY_\ CE>GT4 >8?\
M#-'PV_Z%S_R>N?\ XY1_PS1\-O\ H7/_ ">N?_CE>GT4 >8?\,T?#;_H7/\
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MO^A<_P#)ZY_^.4?\,T?#;_H7/_)ZY_\ CE>GT4 >8?\ #-'PV_Z%S_R>N?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "H;RSM]1LY[2[@CNK6>-HI8)D#I(C#
M#*RG@@@D$'KFIJ* *&A:!IGA?2H-+T;3;32-,MP1#9V,"PPQY)8[44 #))/
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M3D$>HKS/XM_M-?"WX$S6\'COQOI7AV[N%WQ6<TADN&7^_P"3&&?;_M8QQUH
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M:<=#7I_B3Q)IG@_P]J6NZU>1Z=I&FV\EW=W<QPD,**6=V]@ 3^% &E17S_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX(J?&S4]6TWQM\+]2NY+JRTQ(]8TI)'+>0COY=Q&N>B;C$P X!9S_%7U[^S
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MA5&!^@J>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCQSXJ\)ZQ\+;SQ=HVL31E%MQ*L%Q*FY8Y[:Y2-U(93\R%=W"@A""" <IHO\
M:/\ P3I_X*%)H&E:W<77AJ#4K6TO&E;'VK2[I8W*R@ !GC60'. -\0(P.*_3
MK_@I%\1O^%:_L;_$*XBDV7FKVR:' .F[[2XBD'_?DRG\*_&3]JO6/B/\0/V@
M)_%'Q#T)O#'BKQ.EK?V^DE"KVML0(K9#&?F4A(EX<!CU(&ZOT+_X+*>)+WQ)
M;_"#X4:0WFZAX@UA[PVX//F#9;V^?9FN)?\ OB@#UW]A&P@_9M_X)WV7B_4K
M*6<QZ3J/C*]MX,+)-'M>9 I/&6@BB )[GTK\Z/VM/VG_ (P?MH^$=1\6/X>G
M\.?![PW=QHMK;N3;_:9&"(99FV_:)OFZ*N$4YVC)+?N!I/@#1=-^'5GX(FLH
M;_P];Z4FC/9748>*:U6$0F-T/!5D&"#P02*^3?\ @JMH]AH'[#>L:=I=E;Z;
MI]MJ&GQP6EI$L442B<8544 */8"@#+_X(V_\FCWG_8S7O_HJWKY1_P""K%_J
M7C?]M;P=X+\1ZK)HW@^.TT^&UGE.(;>*YF*W%T >,@@@D]H0.U?5W_!&W_DT
M>\_[&:]_]%6]> ?\%8OBMI7Q:^,/AGX'^&?!]EK7CBTN+:#^W9-PNH9[HH8[
M.$JP!5@\9;S-P^<8 (W4 9'_  4?_84^$'[-WP/T#Q/X)EO=,UUM3BL#!>:@
M;C^THVB<N^UNCJ45LIA<,1MY7'WC_P $[/%?B'QG^QM\-]3\3R7%QJGV6>W6
MXNB3)-!%<RQP.<\G]TB#)R6 #9.:_+#]HW]@'XJ_LP^"="^(/BV^T7Q]X=TN
M:"&\T];JZDBLU9P$B<'RV\EF(0F-E.6'3(-?K5^Q7\>M!_:(_9\\/^(] T>'
MPY%9@Z3<Z+;#]S830JH,4> /W>QHV7T5P#R#0![I1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y/^U;\4;WX
M+_LY_$#QIIA5=4TO2I'LG9-ZI<.1'$Q'<!W4X]J]8KBOC5\+[/XT_";Q9X&O
M[AK2VU[3Y;(W*+N:%F'R2 =]K!6QWQ0!^2G_  3@_8G\(?M<Z3XY\<_$R]U;
M5?(U#[%##!=F)Y+AT$LL\LG+,WSICG&2Q.[C''^!Y-3_ .">O_!10>$]-UJ>
M\\.)JUKIEZTAP+O3;M8G7S0, O&LRMD #?&<8!Q73_ 'XF?'/_@FCXM\4^#-
M;^%-[XLTK5YT>**#S5AEN%4JDUM<I&ZNKJ1N0KN^51\A!!^>/VB]5^(WC;]I
MK_A)OB%HC>'/&'B6>RU"/2C&5>UA8)';(8R=RD1QIPWS'@D F@#]AO\ @IU\
M1O\ A7?[&OC;RWV7FN^3H<'OY[CS1_WY6:O,O@G\,_B+X!_X)9Z;I/PNTZ>Y
M^(_B/3?[1M_L]Q%;2(+V<.95>5U"LMHPP0=VX+CGIPG_  6&UJ\\<^)O@I\'
M=)DW7NNZHUV\/7]X[I:VS8^LMQ^5?I%X?T2U\,Z#INCV*>78Z?;1VD"?W8XT
M"*/R H _+G]C;_@D[IGB+P7K6J_'?1]:TOQ ]ZUM9:1#>I$(X!&A\\O&6WLS
M.P S@>7R#GCQ7]F6TU#]EW_@ILO@#PEJUUJ.B-KLWAZY4LI-U9L"0)L8!:(A
M6) 'S1' &<5]U_\ !0'_ (*$:9^S'I,W@_PC);ZM\3KV'A20\6CQL/EFF'>0
M@Y2,^S-\N _BG_!+/]C?Q"OBB3]H#XDP3?VE?K+/H,%^2;F9Y]WFW\H/(WJS
M!,\L)&? &PD \C_X*@7&H?$3]O#PEX&\3ZM+HO@]4TRSM;F9@L-K;W4BBYNA
MGCAMP+'_ )X@'[M:?_!2G]AOX1_LT_![PQXD\#R7FEZU<:HFG/9WE^UQ]OB,
M+N\H#<AE*)DKA?WF,<K6S_P50^)NF?'+X[>&_@=X0\&V.L^.;&YM[-O$,A*W
M*3W&UDM(F#!?+ D5G,FX L<!2I8^(_M'?L$_%+]E?PKX?^(/B^\T3XA^'-.N
M(;>[L1=74D5L"WR12 ^6_DL?DS&RG) XR#0!^KW[ OBS7_&W['OPRU?Q-)/-
MK$NGO$\USDR2Q13RQ0NQ/)+1)&VX]<YYSFOCS]@('X\?\%!OCI\7''GZ=IIG
MMK*3'3SIO*MCGU^SVT@_&OHKPK^UYH7B[_@GWX@^*WAS3HO##:+H-U8+I$)
MBT^^BC\J&&,@ ;-S0E<#[KKP#D5PG_!&WX<GPK^S#J/B>:/;<>*-:FFC?&-U
MO ! @_"19_SH Y+]MS]N;XFW'Q<UG]GCX+>%KP>+B8[2XUJU;S;IA+ DI%LH
M&(=JR#=,Y^7!(V8#5\M?\$H]-N]%_;D73]0&+^TT[4X+@;MW[Q0%;GOR#S7[
M7Z9X0T+1=:U76+#1K"RU?575[^_@MD2>[945%,K@;GPJJHR3@ 5^-G_!-_\
MY2.>(/\ N-_^C#0!]8_\%BOC)K'P]^ .B>%M&NI+)_%VH/;7LL>0S6D*!Y(P
MPZ;G:('U4,.A->3_ +/_ /P2H\ _%?\ 9'T7Q'>ZGJ</Q!\2:7_:=GJ2W&+6
MT=P6@C,(!W)C9O)RQRV"O 'U'_P4>_97U;]J+X&Q6GAD+)XN\/W?]HZ=:R.J
M+=@J4E@W-PI*D,I/&Y #@$D?%7P)_;4_:(^$_P *[3X&Z?\ !?5-4\9Z?$VG
M:1J5S:W$4MG&S,$,L!CVOY9;"N710JKNS@D@$O\ P1E^.6L:/\3O$/PFU"[D
MET/4;*74[&VD8D6UY$RB0(.P>-F+>\2^]?K]7X1?\$N=%U#1_P!O3P]I]P +
MC3XM5AO A#C*VTR'YAP1OQSW_&OW=H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OQ3_: ^W_ML?\%-$^&N
MMZM<VGAJPU>70;>.WP#;VUJCR7)C#9'F2-%+\Y!ZKP0H%?M97Y)_MK_LY_%#
M]G7]K6#]H;X8Z'=>)M*N+]-6E2UMVN#:714K<131I\_DR+N.\8P)&7((!(!Q
MO_!2#]A;PK^R?X=\'?$'X:WNI:7:2ZDFF3VUQ=M))%=>6\T-Q%)PRG$,F>>"
M%*XYK])?V&_C;??M _LP^#/%NKR>=KK0O8ZE)@ R7$#M$TAQQEPJR''&7K\M
MOVVOVH_BO^UM\)=+U+4_AC<> ?AWH-]#-+<W$DD@O;^1'CCV221Q[@$,I"(I
MVAB68_+7T5^Q5\0)_A'_ ,$J_B-XL,OD36LNK&PD/R[9I(XH8>>_[YA_*@"I
M_P $YP?CK^W-\=_C&X\[3[9IK:Q=AP!<W!$!![E;>U*_\"]Q7+>*/V'?C)^U
M'^V]J6M_&#0M6T7X=W5_<F*^AOK:;R=.BWFUMH_+D<1[AL!..KNQ^8U]!_\
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M?B-XCOM<\4>']1\$:O:M VFZ?<SO,\J29@N2C1*BL%## 8\2G^Z*^7OV0_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* /Q6^&/_!3R'X=_L97'PCF\,7UQXQMM,NM%L-561%M5AE\P+(XSO#QK)@*
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MCYZ_;2N6\2?"KP5XRU-=2U_P?H.N:BJ+&MWJ6F07$H4$D*'=2< DX&>YKJ:
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MAF0]&1U)##Z&@#1HJGK&KV/A_2;S4]3NX=/TZSA>XN;NYD$<4,:*69W8\!0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBO.OC7^T)\/OV=_#L>M>/_ !+:Z!:S,4MHG#2W%RPQD10H"[XR,D#"Y&2!
M0!Z+17PPO_!8[X!MJ/V8V_BY8?\ G\.E1^5UQT\[?[_=_P *^E_@;^TS\-?V
MC=)DOO /BFTUEX5W7-B<PW=L,XS) X#J,\!L;3V)H ]0HHKYV_:$_;W^#W[-
M6N?V#XJURXO/$2JKRZ/HUN;FX@5@"IDY")D$$!F!(((&* /HFBOECX'?\%*O
M@A\>/$UGX<TO6;[P_KUZRQVECXAM1;&XD8@"-)%9XRY) "E@6/"YKZGH **^
M=OV@OV\OA3^S-XWM_"GC:[U2#5[BQCU!%LK!IT\EW=%.X'KF-N/I7F?_  ]X
M_9Y_Z"7B ?\ <'?_ !H ^U:*\%^#/[='P2^/FOKH7A'QO;SZ[(<0Z;J%O+9S
M3\$_NA*JB0X!.$)( )(Q7O5 !117R_\ %K_@HW\&_@K\3M5\!>)KW6(O$.FR
M117"6VFM+&&DC21<.#S\LBT ?4%%%>"?M%?MM?#+]EWQ!I6B^.KK4H+[4K4W
MEN+&Q:=3&'*')!X.0>* />Z*YKX;?$'2/BMX#T+Q?H#S2:-K-JEY:-/&8W,;
M=-R]C[5TM !1110 4444 %%<-\:OC)X;^ /PXU/QQXMEN(=!TYH5G>TA,T@,
MDJQ)A1U^9UKF_P!G3]J7P)^U)HNKZIX%N+ZXM-*N$MKDWUJ8"'9=PP">1B@#
MUVBN?\4?$#PUX+O-&L]=URQTJ\UF[2PTVVN9E66\G<@+'$G5SDC.!P.3@4WX
MA^.]*^&'@77?%NN/+'H^BV<E]=M!'YCB)%+,57N<#I0!T5%>%?LY_MG?#;]J
M;5-:L/ ESJ5Q<:1#'/="^LF@ 5V*K@D\\J:]UH **** "BBOE?XO?\%,O@+\
M'=:GT:[\3S>)=5MW*7%MX;MOM:PL."&ERL1(((*AR01R!0!]445\=?#7_@J]
M^S_\1=7MM-GUG5/!]Q<$+&_B2R$$.X]FEC>1$_WG8+[U]@6US#>6\5Q;RI/!
M*@DCEC8,KJ1D,"."".] $M%%% !1110 4444 %%%% !117)?%#XL>$/@OX3N
M/$WC?Q!9^'-$@(4W5VQ^=R"0D: %I'(!PB L<'CB@#K:*^&M0_X+&? *SU,V
ML,?BR_@W%?MMOI2"+ _BP\JO@_[N?:O>O@+^V1\)/VDI'M?!/BN"YU>,%GT>
M]1K6]VCDLL3X+J!U9-P'<B@#VNBBB@ HHHH **** "BBB@ HHHH **^:?B+_
M ,%"?A#\+?C#<_#/7;S5H_%-O=6]G)'!IS20^9,D;QX?/3$J9/;FO7?C5\9/
M#?P!^'&I^./%LMQ#H.G-"L[VD)FD!DE6),*.OS.M '<T5Y%^SI^U+X$_:DT7
M5]4\"W%]<6FE7"6UR;ZU,!#LNX8!/(Q7KM !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !117FO[2/Q3U/X)_ WQAXXT?0G\2:EHMG]HATU-V)
M"752S;>=B!B[8_A1NG6@#TJBOQ7?_@M9\;2S;?"O@ +G@-I]\2!]?ME)_P /
MJ_C?_P!"M\/_ /P77W_R90!^U-%?BM_P^K^-_P#T*WP__P#!=??_ "91_P /
MJ_C?_P!"M\/_ /P77W_R90!^U-?-_P#P45\:Z_\ #S]C7XB:]X8UB\T'6[9+
M&.#4=/F:&>$27]M$^QUY4E'<9!!&>"*_.;_A]7\;_P#H5OA__P""Z^_^3*\_
M^/7_  5 ^*?[1/PGUWX>^)- \'V6BZQY'GSZ79W4=POE3QSKL9[EU&6B4'*G
M@GH>0 ?I_P#\,"_]7&_M ?\ A<__ &BC_A@7_JXW]H#_ ,+G_P"T5\ ?\/J_
MC?\ ]"M\/_\ P77W_P F4?\ #ZOXW_\ 0K?#_P#\%U]_\F4 ?5WQI^"VO?LQ
M^+?@?KV@_'#XN^)#K?Q*T7P]?:;XI\5->V4UI.TIE5HA&FXD1A>21ACQG!'W
MW7X+?%[_ (*@?%/XT?\ "%?VWH'@^U_X1/Q-9>*['^S[.Z3S+JUW^6DN^Y;,
M1\P[@NUC@885Z!_P^K^-_P#T*WP__P#!=??_ "90!^U-%?BM_P /J_C?_P!"
MM\/_ /P77W_R91_P^K^-_P#T*WP__P#!=??_ "90!^U-%?BM_P /J_C?_P!"
MM\/_ /P77W_R91_P^K^-_P#T*WP__P#!=??_ "90!^U-%?FW^PS_ ,%,?B3^
MTK\=M/\  ?BCP;H0T^]MKB9M2\/P7$1LO+B:0/*))9048J(_X?FD7Z'])* /
MR5_X+C?\C5\)/^O+4O\ T9;U]P?\$\?^3+?A5_V#&_\ 1\M?#_\ P7&_Y&KX
M2?\ 7EJ7_HRWKPSX,_ ?]M;Q1\,?#^J_#C4_&</@BZ@+Z7'IWCB*R@$6]@=D
M!NT*#<&XVCUH ^\_^"R7_)H]G_V,UE_Z*N*Y3_@B7_R0+QU_V,Q_])8*^$_V
MEO@[^UAX$^'4>I?&J_\ %5SX/-]%"B:SXNCU2#[25<QGR5N9#NVA\-MXYYYK
M[L_X(E_\D"\=?]C,?_26"@#[6^,GQZ\ _L_^&UUWQ]XEM/#UA(Q2 3;I)KAP
M,E8HD!=R.^T'&><5\Q67_!8+]GVZU:.TEG\2V=NS[3?S:3F%1_>(1VDQ]$)]
MJ_/#XV:UKO[=?[?C>&)=2DM=.NM>;P_IF[YUL;""1@SJO3<5224CNS8SCD?H
MIXT_X))_ G5_AE/H/A_1[S0_$L=L5M/$K:C/-.9]O#S1LWENI8#<JHO!.W:3
MF@#ZT^'_ ,1/#/Q4\*V?B3PCK=GX@T.[!,-[92;T)'!4]U8'@J0"#U K\6?^
M"PO_ "> _P#V+]C_ #EK0_X)2_&'7OA+^U1_PK6\N)!H?B8W-A=V+,6CBO8(
MW>.91V;]TT9(ZAQG[HQG_P#!87_D\!_^Q?L?YRT ?MGX3./"NC$\#[%#_P"B
MQ7S+\5O^"GWP#^$^OSZ+/XCN_$NHVSF*XC\.VANHX6!P0925C8]?N,V,'.*X
M3_@IO\<M5^$/['^B:5H5S)9:GXN,&D/<PMM>.U\@O/@^K +'])&YKYX_X)E_
M\$_? 'QH^&5Q\2_B582^((+J]EL]+T?[1+! J1$!YI#&RL[%]RA<[0%.0Q/R
M@'W+\!?^"@/P7_:*UJ+0_#?B.33_ !%,2(='UNW-K//C/$9R4<X!.U6+8'2O
MHVOQ _X*7?L;^'_V3?%GA'Q7\.);S2?#^M22*EBUS)))IUW#L=6BF8E]K!@1
MN8LK(QW8( _03X5_M6:QXC_X)RW'Q@NI4D\6:7X;OA+-,@VR7]MYD*2,O0[W
M1'(''SD<=* .I^/7_!0CX+?L[^(I/#WB+Q!/J7B&$9N-+T.W^U2V_/25LA$;
MOL+!L8..1G-\/_\ !2CX%^)OACKWC:S\0W8M="$+:CI4MFRZA"LLR0HXBSAT
MWR("R,P&1D@G%?F7_P $V?V:=$_:T^.7B34OB&;C6M&T:W_M.]MFF=6O[N:4
MA1*ZD-M.)7;!!) '0FO>/^"HG[#7P[^$OPFL_B/\.M&'A>6VOX;#4]/M97:V
MGAEW;9 K$[75U0<8!#<C(% 'Z&_L\?M*>"_VH/".H>)/ T]Y/IEC?-I\S7UL
M8'$PC20@*3R-LB\_6OACX$Z;^R7'^VI92^$M5\<2_%'^W=0,4%\J_8?M6V?S
M@?W8^3'F8Y]*[#_@B?\ \FV^,O\ L;9O_2.UKXJ_9,_Y2A:7_P!C;K'_ *!=
M4 ?N+XQ\::#\/?#=]X@\2ZO9Z'HMBGF7%]?3"**,>Y/<G@ <DD 9)KY"U3_@
MKW^SUI^J"U@OO$6IP9Q]MM=(80CWQ(R/_P".U\K?\%J/C!JFH?$[PG\,X+K;
MH.FZ:FM7-NA_UEW*\L:E_79&@V_]=F]J^G_@G_P2Y^"4/P*T*Q\6>&&UOQ1J
M6FQ7&H:TUY/'/'<21AF$(5PJ*A;"C;SM&[/- 'T_\%?C]X"_:&\+MK_@'Q%;
MZ]8QL([A$#1SVSD9"2Q. R'KC(P<$@D<UZ%7P%^Q)_P3E\<_LH_&"?Q=<?$7
M3KK1I[>:SNM%LK25_ML+9,1=V9 CHP1LA6Z,HX8FOOV@ HHHH _ #]J3_E(Y
MXF_['.U_]&15^X'QR^.'A?\ 9Y^'MUXT\82W4.AVTT4$CV<!FDW2-M7"CW-?
MA_\ M2?\I'/$W_8YVO\ Z,BK]-?^"MG_ "9;X@_[">G_ /H\4 =G9_\ !13X
M'7'PCD^(UQXFFT[0?[0ETN""[M'6\NKB-(W=8H!EG $T>6^Z-W)%<]\+?^"I
M'P$^*7B:RT&'7-2\.ZA>S+;VW]O6)@BED8@*OFHSHF2<9<J,U\0_\$H_V1?!
M'Q^M_%WBWX@Z:?$6FZ)<16&G:3/*ZVPF="\LKJI&XA?+ !XY)() QYQ_P5&_
M9Q\'?LZ_'#18? M@='T77=)6^;35D9X[>997C?RRQ)"L%5MI)P2V,#  !^[M
M?,?QJ_X*.? WX%^(KKP_K'B6;6-=M#MN;'0;8W9A;G*/("(PXQRN_<.X%<I\
M:/C[XA^'/_!,G2/B!;ZBP\7ZEX/T5([YSF3[5>0VZ23 _P!]1))(#ZJ*^*?^
M"5O[&W@C]H9?%_C/XAZ<VOZ9I-S%866F2321Q23LADDDD*$%MJF,!<X^9B0>
M* /T'^!?_!1#X)?M >([?P[H/B*?2_$-T=MKIFN6QM9+EN?EC;)C9O\ 9#;C
MG@&OI:OS5^//_!'NQ\4?%#3]<^$NO67PZT$0H]Q:3-<7$D%TKD^;;\Y QM."
MXPR\8!X_17PKI^I:3X8TBRUG4EUG5[:TBAO-12#R%NIE0!Y1'N;9N8%MNXXS
MC)H U:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **_*W]J7_@J]\5O@U\=O%W@G0O _ANRT[0[
MU[.)_$%M=2W%RJ_=G!2>-0CCYEP#\K#DUP?@G_@LY\9=6\6:38WO@+PEK-O<
MW,<+6&CVEY%=S[F V1,UQ(-YS@90\D4 ?L=17@/[;W[1.O\ [+_P)N_&WAOP
MY'XCU%+V&SV7(<V]JK[LSS!"&* J%X(^:1>:_-3_ (?5_&__ *%;X?\ _@NO
MO_DR@#]J:*^1?^"=_P"V-XM_:^\)^++[Q9X7L=$N-#N;>&*_TI)4M+SS%<LB
MK(SD/'L!;YSQ*G3O\S_M2_\ !5[XK?!KX[>+O!.A>!_#=EIVAWKV<3^(+:ZE
MN+E5^[."D\:A''S+@'Y6')H _5*OS:_:@_:W^)UI^T-K'B+X;O=7?PK^#,]I
M#XPM[63$>I37$NRXC(_C\M<KS_JV1WZ8KY^C_P""T7QMO%EMCX5\$^9/&T43
M6=C>+*DC#",NZY<$@D'!4YZ5]/\ C#2=1_8*_P""=DRS^$H?&_BCQ)-GQ8NH
M[Y(//OD;[1)<E"&9$4)!D,,L5.1DT ?>GAGQ)IWC#P[I>O:/=)?:3J=K'>6E
MS']V6&10Z,/8J0:TZ_!3X#?\%0OBY^SY\,=+\":+IOA?6M'TPR?9)M<M+F6X
MB1W+^7NCN(P44L< C(!QG  'Z8_\$[_VQO%O[7WA/Q9?>+/"]CHEQH=S;PQ7
M^E)*EI>>8KED59&<AX]@+?.>)4Z=P#ZZHK\K?VI?^"KWQ6^#7QV\7>"="\#^
M&[+3M#O7LXG\06UU+<7*K]V<%)XU"./F7 /RL.37!^"?^"SGQEU;Q9I-C>^
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M\TA_A15+,?R!K^?W]E3X+Z+^V3^T)XO?QSX@F\+:(UK>^(]0U2*:*(I(]S&
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M+]H[X7^)/&WQ#AO[V Z@^DZ9:V=XUN(]D2-).2O+-NE4*"=OR-E3FO,/V?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG(!XQ^U?_P %;E^'OQ*TG1/@TOA_QUI4-NW]JWEW#/)%).S#9';R)(F=H'+
M,IW@#D&OL/QI^TA;_!']G;1_B9\4M)N=*GDMK-M2TO2(_/>UN)PO[H!V7.UF
MVG)[&O+O@'_P2^^#'P%\56GB:&'5O%VOV;K-9W'B&XCDBM)5.1)'%'&B[@<$
M%]^" 1@\U[K\?O@/X;_:0^&]WX(\6/?1Z-=3PW#MITRQ3;HV#+AF5AC(YXH
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MQ-^S7XRB^'&J:MI/C2UMUO=/ET6Y>"YE\IU:2)2A#$O&)% !R6*XYQ7YK?\
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MM=-U.]C@S(2T<+17>TCJB>?(^>FV//:O:/V;_P#@F_\ "']FWQ!#XCTVUO\
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MHD@1.>\H]:K?L$_M_?"CX<_LBZ;H'C?Q+%HOB'PDES#_ &=)%(TU]$97EA,
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M5Z7_ ,%O/^26?#3_ +#-Q_Z(%?57[,O[$?P\_9.U;7=0\$S:U+<:Q!';W/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3>/_ (+1^&IK&Z\)6;7;ZPUV'2Y :!=HCV K_KQSN/W?>OH*OF/X2_M::O\
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M$;PQ:^ _B/X?D8Q:;#.SQW<2\2;"W5ERKC&0R.&' )J/Q?\ MJ:WKG[6NG_
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MHKYI_87_ &LM0_:Z\"^*/$5_HEGH@TK66TV!+.1W$L8B20.V[D$[^GM7TM0
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M0@)8@$\>U>0ZE^VQ^TAXXTR;QI\+/V=VU'X:!3+:7VM7(6_OX!R)HX%E5]K
M9&Q)!C!!- 'WS17SY^QC^V!HW[7WP_O]7M=+D\/Z_H]PMIJVD2RB7R7924D1
ML F-\-C<H(*.,'&3Y]^T9^W9K7A#XPQ_!SX-^!'^)GQ,$8DO8VF\NST\%5<!
MR,;CM8%B714W*"Q)( ![5^U+^T!;_LQ_!G5OB#=:+)X@AT^:WA-A#<"!G\V5
M8P=Y5L8W9Z=J[+X6>.$^)WPQ\(>,8K1M/B\0Z/9ZNMH\GF& 3P)*$+8&XKOQ
MG SCI7Y?_MW?M0_%*_\ V?=>^&OQL^$[> M?UB2TN='U72[I;O3KSR;F-Y8R
MRNX1@@SC>Q]0N1G[D^%?Q2T+X)_L'_#OQQXDEDAT71? >CW$_E+N=S]B@5(T
M'=G=E49P,L,D#F@#Z$HKX'\,_M>?M8?%/08O&O@?]G;29? UU&;BQ74=91+V
MZAY(= TL9.1@C$6#_#NR*]O_ &.OVQ-,_:NT+7XIM!N?!_C+PW<BTUKP_=R;
MV@8E@'5BJD@LCJ0R@JRD'L2 ?1-%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 </XRUGX<>+
MM4'PW\4W_AG6-3U2,L/">JS6\T]TBJ9"WV5R68!5+9V\8S7YR>(_^"=?@?XF
M?M5?&#PMX*O;OX;W'AO2M)U/1&TV1GMXKJX20R;U8EPI9%(V,NWL,<5[1^W;
M^S;\1F^,/@C]H7X,V::QXU\+HEM>Z&WWKN!2^&1<C?E998W0$,59=O(KP/PU
M^V1\6Y_VA?BQKGA+X >)S\0?$6BZ58G1+JWF8:-)"DB^?< PJ3&Q?*[A&#CK
M0!](_P#!+_\ :$\9?%WX?^,O"'Q O)-5\5>!-233Y=2GDWS3POY@02M_&ZO#
M*N\\L-N>02?M:OE?_@GM^RKK'[,GPKU23Q=<I<^.O%-[_:6L"*02) 0"(X=X
MX=AN=F8<;G(&0 3]44 ?G5_P2C_Y*G^U%_V,T'_H^_J[_P %K-*GNOV;O"-]
M&I:*T\4Q++@?=#VMR 3[94#\16__ ,$VOA1XR^&WQ&_:)O/%7AG5/#]KK7B"
M&XTV;4+9HENXQ->DO&2/F&)$.1_>'K7TC^U-\!;/]I7X%^)O -S<)97&H1+)
M8WKKD6UU&P>)SWV[E"MCG:S =: /2M"U2+7-#T_48"K07EO'<1E>A5U##'X&
MOSVU3.O?\%I='^SC>-%\--]IV?P;K"7&[_P(3\Q3?AE^U!^T5^S7X M/AKXS
M_9W\3^/-:T&(:9I&N^'DEEM+V&-0L0D>.&0<(OWP<L!\RJ0QKT/]A']FOQ]H
MGQ!\<_'GXR0QV?Q'\9CR8=*0@_V?:%D8JV&8*2(X45,DHD0!)+$  \_^#*MX
M9_X+(?&"VNOE.J^&LVY88W[HM.EX^@C<?\!-?='Q?U.+1?A+XVU&<JL-IHE[
M<.S= J0.QS[8%?*'[:G[/?Q&TWXT>#_VBO@M90ZOXT\.6_V+5/#\G74;;YUR
MHXWMLED1AD-@(5Y6O./C1^T!^T/^UOX*N/A/X,^ 'B?X=2ZZ!9Z[KOB02PVU
MO;G_ %L22/%&NUE(RW+%"P5"6!H [O\ X(WZ9-8?LCW4\J,J7OB:]N(B1PRB
M*WCR/;=&P_ U]D_$+_D0?$W_ &#+G_T4U<Q^SM\%]._9Y^"_A7X?Z9-]JAT:
MUV2W17:;B=V:2:7&3@-([D#)P"!GBNL\<6LU]X*\06UO&TUQ-I]Q''&@RSL8
MV  'J2: /RF_9=_Y1#_'/_L)WW_HBQK[-_X)AZ#:Z#^Q'\.S;QHLEZMY>7$B
MJ 9)'O)AEO4A51<^BBOFS]G;X$_$/P[_ ,$P?C#X*U3P9K5AXMU+4+R2ST6X
MLW2ZN%:&T"E(R,D$HXX_NFOKS]@OPAK?@+]D?X<Z!XCTJZT36K*TG2YL+Z(Q
M30L;F9@&4\C(8'\: /F?XS1K#_P64^##(H1I/#3%V48+'R-3&3Z\ #Z"ND_X
M*O?#_4=/\#^!OC;X:CV>)?ASK4%RTR@_\>TDJ%2V.H6=(>/21ZL_%KX4>,M6
M_P""JGPF\<67AG5+KP?IWA]K>[UR*V9K2"3RM1&QY,8!S+'Q_MCUK[#^)G@'
M3OBG\//$G@_5UW:;KFGS6$QQDJLB%=P_VE)##W H ^$_^"B?QL/QJ^"'P<^'
MG@2;S-0^,5Y8W4<0;)6SS&ZK(!T_?20DD_\ /&3T./-O^"FWA2[\%^)OV6OA
MAX3T:'5=-TO_ $33-)O9$CMM1G66TACBF+,J_-M 9F('[YCD9)J__P $]?V5
M?BCIW[0UGK/Q8T/4;'2/ACI$^D>')+^!DBGDDN9R&A8\2(HFN&##H&B[ 5]2
M_P#!0#]D_5OVFOA_H-]X/O(].^(?A&].H:)<33&%7W;3)%O .QB8XF5N@:,9
M(!) !YVOQL_;O50!^SQX/ '  UVV_P#D^L/]AGX'_'+P9^U=\3/'_P 2/A[:
M>"= \9Z=--<6^GZG:7%L+XW$3J!''/(_(-PV2,98\\\V=&_;P_:#\.>&TT+Q
M/^RSXPU;QY#%Y7V[2[:?^SKJ0?*924A<(N=I(5V!SPR@BN\_8G^!_P 8+&3Q
MYX_^-GB/5;;Q!XT+K!X7M=3D\C2(78L755D9(Y.5";?FC5>6W,P !X-IO[/O
M[4O[!WB#Q*/@=::5\1OAGJ-\VH)HMX%::$D ?-$9(Y/,"JJ9B=MX525'0=_\
M#/V_O"WQ$^.6B>$OC)\(O^%9_%>01V.G:IJ5EO=I&8B.%6EB6: .SL$&64EC
M\PW<\G\,?B!^T7^PGJGB7P=XP^&OBSXY>#IK^2_TSQ7H\DU[<K&5 )D(64JI
M5 2DA0JV[!8$&G)X#^*W[>7[4'PV\?>*OA??_"/X?> YTNT_MW='J%_(DRS!
M C(CD,\2#[H55WD,2P% &C^U#_RED_9X_P"P,G_HV_KF?^"O%YKFK?&#]GKP
MWI>E0ZT9[^:6TTN\E6.UU"Z>XM8TAE+,JA3@*2Q  E/(YKM?^"@?P[^)GAO]
MI;X1_'3P#X&OOB!!X8@%I=Z7I4;RW!*RR. 4C5GVLLSC<JL%(Y'(STG[1_P/
M\8?MW?LV^!?&UAX;N_A?\7-!NIM2TW1=9G>.:V/F[7A:1HT*LX@@E1BBX(4'
M )( *R_&S]N]5 '[/'@\ < #7;;_ .3ZXC]E'X1_'WX7_'KXU_%'QU\/K7P1
MIWB?P]?7YAT[4[2XMQJ2NDL>V..>1^?W[988RQYYYZ31OV\/V@_#GAM-"\3_
M ++/C#5O'D,7E?;M+MI_[.NI!\IE)2%PBYVDA78'/#*"*]#_ &&?@S\8-#U#
MQI\2/C9KM]_PD/BZ4M!X1^W/+9Z9"7+DF(.T:L?E55&2B*022[  'FW_  1;
MT>R3]G+Q?KBA9=7U#Q5-#>71YD98[:W:-&;J<&61O^VA]:R_^"VGA_3KCX$^
M!-<DBC.K6GB3[%!(1\XAFM9GE /IN@BS]!6/X6\'_&+_ ()K_%+Q?%X/^'>J
M?%KX)^)+K[=;VVAAY+S39 #@%$5RI5<*S%-CJD9W*05KS;]MW2_VD/VS/"6C
M>(H_@]KGA3PEH^H"UL/"LD4LVJW4LL3M)>31;%*QH(EC&Y1@S8!;+8 /UYHH
MHH _./\ 9]AB\8?\%>/C=J>LQ*VHZ+HSKIT4HR8E465N)4],Q,1QVF/K7W[X
M_P##^F>+/ OB'1=:BCGTC4-/GM;N.9=R&)XV5\CZ$U\6?M3?L]_$_P"%O[2U
MC^TI\$-(B\3ZF]JMIXE\+&0B2^C""(O&H(W QK'E5.Y7B1PKY8#GOB=^U=^T
M5^T)X0U#X>?#W]G3Q9X&UK686L;_ %[Q$)((+&-UQ((Y)(HD#%&!#EL@'*H3
M@T 8/_!*_6KR^_8:^+NGS[GM;&^U+[.S'(4/I\3,@] "-WU<UVO_  1>T&UT
M_P#9?\0:FD:?;-0\3W EFV@,4CM[=40GN 2Y'^^:]G_9_P#V7O\ AFC]D/5?
MA_:R+K'B&[TZ^N]1FM4.VYOIH"I6,8!*@+'&N1DA <#.!Q__  2L^&OBKX5_
MLR76B^,/#^H>&M6;Q!=W LM3MVAE,;10!7VL,X)5N?8T >7?\%+(UC_:L_9%
ME50LI\2@&0##$"^T\@9]LG\S7Z+5\+?\% /A1XR^('[1G[,.K^&_#.J:YI>@
M^(/M&J7EC;-+'91_;+%M\K 84;8W.3V4^E?=- 'F'[27P!T']ICX0ZSX#U]V
MMH;P++:W\<8>2RN4.8YE!(R0<@C(W*S+D9KXV^'?PI_;K^!^AVWP[\-:UX)\
M0^%[(&UTS7=6DWO96Z\1C! DP!C"E)=N-H)  KZP_; ^">K_ !^^ GB'PIX=
MU:71/$A"7>F7D<SQ#[1&<B-F4@A77=&3VWYP<8KY;\$_MG?M ?"[P!I?@;Q)
M^S)XT\2>.M)MDTY-4LHY7L+WRU"+.\L<+KG[I8JQ4GG<N> #R+X1_!&]^'/_
M  5<\%:3?^(;KQIXEL](N=<\4ZW<87SKZ>SN2S*H^Y&/.MU5?3'3.!]%?&+_
M (O;_P %+OA/X+7_ $C1_AOHT_BO4$'1+J0@0@^ZL+1A_OFMG]AO]F'QMX/\
M8>,?C;\8Y(7^*WC0>6]C"59=,M-RGRLJ2NX^7$-H)V+$@W$EJB_8;\)ZWXF^
M-/[0?QC\2Z-J&E7'B/Q -)TA-4M7MYO[/M5Q&ZJX!VLA@&<8S$<=#0!]A:EJ
M5IH^GW5_?W4-E8VL33SW-Q((XXHU!+.S'A5 !))X %?FU\7OVA/'W_!0SQMJ
M'P;^ JRZ3\-(F\KQ-XZN(V1)X<X*)T(C;!Q&,/+WV1A\]=_P5<3XR^.O#?AW
MX=_#3PAK^M^'M11[W7KO1K.282[7 AMF91PN0SLO?"=ASYK\'?VA/VB?@1\/
MM+\&^#_V1+S3M'L(P.+6\,EQ)@;YI6V_/(Q&2Q^@P   #] OV?O@%X4_9M^&
MFG^"_"-JT5C;_O;BZFP9[VX8 //*PZLV![      5^8?["_[._AWXM?ML?&6
M+QY8QZM9>$M6OKJ/0;T[H);QKV2,221'B0(%;@C&67/H?N#]D[]HCXU?&+QE
MK&F?$SX-W/PWTFUT_P"TVVH3Q3H)YO,1?*S( /NLS<<_+7E'QL^ OQ0_9O\
MVI+_ /:&^"WAY/'&FZ_";?Q/X-B?9<2;MADDAX).YXTDRH+*^?E9&( !T?\
MP4>_99^'?B#]F#Q9XEL/"^D:#XD\,6HU"QU+3;..V?:CKOA<H!O1DW  YP<$
M>_0?!S]I34K7_@F[8?%S7[M[G6]/\,W1-S<_?N;JW>6VA+'N9)(TR>Y;/>O#
M_CI\5_C[^W%X<'PF\&_!'Q)\,M#U2:-==\0>,(I+:-84<,44M&HP&4%@F]V
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M^IKG/^"O%YKFK?&#]GKPWI>E0ZT9[^:6TTN\E6.UU"Z>XM8TAE+,JA3@*2Q
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M?8/[<GA/6?'/[)WQ(T+P_IEUK.LWVGK';6-E$9)IF\Z,X51R3@$_A7$?"?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[;]E?X&Z3X'2\34M2$LE]J=]$I5)[J3&\J#SM551!GDA 3C.*]LHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_!GQC\2O#VH>*O@;86K0W>GVZEH1>EYB^X$A2Q7[,^UB/,6%EZ UT/BSPO\
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MI6L893'<[ <%O*D"N5&1SC'(KU*OS>_X*5?LV>%_@QX#T3XX_"S1['P#XO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/%G_  3G_9T\:>(9=:U+X9V*7TTIFE%A>75G#(QSG,4,J(!GGA1S]3D XO\
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MR:S\03-K.HR3<R/!,NR $GJ#%B3GO,U>!_M@_%[P;_P4%^*'PB^"_P ++O\
MX2>T_M<ZIKFNP6DL2V-LJ[9 C2(I.(VD9OX2PB7)8X'Z=Z;IUMH^G6MA90);
M6=K$L$$,8PL<:@*J@>@  _"@#\E/V$+'X._!WQM\0?@C^T%X4\&1^,-.UAIM
M.UGQ9I=K+'<1^6J&);B9#L4A$E0%@&\YL<]?:?VK/BQ^S)\"X=%T?P1\&OA?
M\3_'NJWL=M#X>TG1+&4HC9&7>*%]KEMJJF-S%LXP*^N_C-^S'\+OV@EM?^%@
M>#;#Q%-:J4@NI#)!<1J>JB:)ED"YYV[L9YZU@_!W]BOX*_ ;64UCP7X"L=.U
MF-=J:E=2S7EQ'D8)C>=W,9(R#LVY!(Z<4 ?&/_!3_4[S3[/]G7P#K=N?AY\*
M]3GC7Q#9Z(P^RV81K96@4HBJ5MXVE* * >NSY1CWJ#P+^QC^SKX(_P"$H33O
MAZ=/L[<307L\L&K7<_R[E\DR-)))(W;9R<^E?2_Q,^%/A'XR^%9O#?C;P_9>
M(]%E82&UO4SL< @.C##(X!(#*00">>37CW@7_@GC^SQ\.=<AUC1_AII[W\,@
MEA?4[JYOTC8="J7$CKD'D'&<X.>!0!\E_P#!(#Q,GBCXP_M$:H;-M,?5KNTU
M%+%UVM"CSWC[,?[/F**ZO_@DE_R-/[1O_8S1?^AW=?:_ACX#^ _!GQ*U[Q_H
MGAV'3O%VO1F+4M2AFES<J2K'<A;9G**<A0>#ZG*_"_X$^!/@O<Z_<>"_#T.A
M3:]<"[U)H997^T2@L0QWLV.7?ICK0!WM5-6TV#6M*O=/N5WVUW"]O*OJKJ5(
M_(FK=% 'Y%_L(6/P=^#OC;X@_!']H+PIX,C\8:=K#3:=K/BS2[66.XC\M4,2
MW$R'8I")*@+ -YS8YZ^T_M6?%C]F3X%PZ+H_@CX-?"_XG^/=5O8[:'P]I.B6
M,I1&R,N\4+[7+;55,;F+9Q@5]=_&;]F/X7?M!+:_\+ \&V'B*:U4I!=2&2"X
MC4]5$T3+(%SSMW8SSUK!^#O[%?P5^ VLIK'@OP%8Z=K,:[4U*ZEFO+B/(P3&
M\[N8R1D'9MR"1TXH ^/O^"K6GKI?PE_9^LUT2S\-"#6(X_[%T\J;>P(@C!@B
M*JJE$/R@A5& .!TK]+ZX+XL? GP)\<K;2;?QSX>A\00Z5<?:[)9I98_)EP!N
M&QESP.^:[V@#\ZO^":'_ "=-^UW_ -C-_P"WVHUS/[+7CC2OV*?VUOC3\-OB
M+>1^&]'\97JZKH6LZB_E6LBB:=X09#\J[TG92Q(4/ 5R"<5]_?#WX$^!/A3X
MD\4^(/"GAZ'1]8\47'VO6+J*65S=R[Y'W,'8@?-+(?E ^]]*@^,G[/?PZ_:"
MT>WTWX@^$['Q);VY+6\DV^*>#.-WES1LLB X&0K ' SF@#XO_P""KG[4W@:X
M_9YOOAQX<\1:=XD\0>(+FU>YATFZ2X6SM89DF,DK(2%)DCB4*2"=Q/05Z5XX
M_P"43%M_V2S3O_2"&O3/#'[!?P&\(>#=;\+Z;\.[%=)UN.*+4O/N+B:>Y2.5
M9D4S/(9%42(C;58 E1QP*]2O/A3X4U#X8K\.[C1XI?!BZ;'I TDR.$^R(@C2
M+=NW8"J!G.>.M 'Y;_$7_E"GX!_["8_].5U7Z:?L]_\ ) OAI_V+.F?^DL=9
MM_\ LP_"_5/A#8_"ZZ\)6TW@*RD\VWT4SS".-_,:3(8/O^^['EN]>B:%HECX
M9T/3]'TRW6TTW3[>.TM;=22(XHU"HH)))PH Y/:@#\^/@K_RF2^-7_8LK_Z)
MTNL/Q?X@@_8<_P""EVL>.O%D<MK\-?B9IS0G6%A=H;.=C$S[]H.66:#) Z)<
M!L'%?>FC_ GP)H/Q8U?XF6'AZ&V\<ZM;_9+[6%EE,DT6(QM*EM@XABZ*/N_6
MOFG]HS]JKPEX1_:'7X._'3P-I+?"K6+.*]TOQ)JL+7-N\P09\R,HP&V3>N]2
M"F4)P&S0!3_;D_;H^%VF_LY^+M!\'>,M'\:>*/$^E3Z9:66@W:WAABFC*332
MM&2(@D3.V&P<@<=2-_\ X)/_ /)DOA#_ *_=1_\ 2N6O!OVC?B5^R7\&?@7X
MVTOX.67A75/'GBW3;C1+-/#:_;+A5N1Y<I,WS>6@5B0@(W$*H'I]>_L'_"O5
M?@Q^R;\/?"VN6[VFLPVDMY=V\G#PR7$\EQY;#LRB4*1ZJ: /?*_-23]IKQ3^
MQ;^W/X[TGXR^(/$6J?"[Q>6O=!OKF:>[M=-C:0O&(8B3M2,.\+K&-WRHV",9
M_2NN4^)'PI\'_%_P^VB>-?#>F^)M+W;UM]1MUD$;?WT)Y1L?Q*0>>M 'G]Q^
MVO\  2UT./5G^+W@]K5U#B./5HGN,$9Y@4F0'V*YKXH_9:U2']J+_@IIXN^,
M_@C3+JR^'^D6+0R:E+ 8A>S&T6V0,#T=SND"\$+&I8!CS],Q_P#!+W]F>/4E
MO!\-P2IW"!M:U Q;MV<E3/SZ;?NX[5]%^"? GAWX;>';;0/"NB6/A_1K;_56
M.G0+#$I/4X4<D]R>3WH _,;XWZ+X*_9U_P""F%]XI^+WA;2=;^%WQ!T_]Q=Z
MQIL=_;6<_EPJ\I1T8!UFAY(&0EQGD9!^BOC1XC_8X^$'PPU#Q<?"'PAUV06S
MR:;INEZ3IEQ-J,V#LCC6-&."V 7QM49)-?4WQ&^&/A3XN>%[CP[XRT"Q\1Z+
M.0S6E]$'4,.CJ>J,.S*01ZUXEX9_X)P_LX^$]?36++X8V,UW')YJ)J%Y=7D"
MGCCR9I6C(SS@J>OI@4 >)ZSX@MO&G_!+GXC>*;3X5:+\(;?6].GNX=%T.&.&
M*YCWQHETRI%'@N%XR#E%1@Q# "[_ ,$R/VLOA_JG[-?A_P $:[XITOP_XJ\+
MI-;36>K7:6QGM_,>2.:(N0'4(X4X)*E"3@%<^X_M\1I#^QE\5HXU5$71&554
M8  =, "O"_V2?V0_A#^T-^QK\)=0\>^"K/6M3@T^>)-0CFFM;G8+R<A&DA=&
M91DX#$@9..M 'GOQ@\7:;^VU_P %#_A)X=\ W$?B#PI\.)1JVK:W:-YEH62>
M.:15<<,I,,$092=S.<<+FM[_ (*Z7<6@^*/V<_$%X_E:=IGB.>2XE8':BA[-
MR2?]V)ORK[?^$7P+\!? 7P^^B^ ?"]CX:L)"&F%JK-+.P& 997)DD(!."[$C
M-6?BO\'?!?QR\)R>&O'7A^U\1Z*[B46]SN4QN 0'1T(=&P2-RD'!(SS0!\:?
M\%/=!TS]I7]D>+QA\.-8TOQE:^$M874+FYT6[CNT%OY+).H:,D;D\R%V4\A5
M)(KI_@%XH_8]^-7POTSQ(W@_X1Z)J2VB-JVF:KH^F6LUC,%'FAEDC7*!B<2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&H6Z3P3)_=>-P58>Q%,\-^&='\&Z':Z-H&DV.AZ/:*5M]/TVV2WMX026(2-
M%4$DG@=2:TZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGYYP%;RQ[1"@#ZFFF2WB>65UCB12S.YP% Y))["OA*Z_X*"?$KXT^-->T/\
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M[.GP5C\7^$M'N&MG\0Z]=BVCNV&>8U>2( D;2$W,X!4LJ[@*3XT6_B#X"_\
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M]C(0X5@&!&0 ?I)12*P900<@\@BN6^*GQ*T7X._#GQ#XU\0RM#H^B6;W<^P
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MD 8&0[ G.#6;\>OCAX:_9U^%^K^.?%<TB:9IZJJP6ZAIKF9CMCAC!(RS'U(
M&22 ":[JQ6X6RMQ=LCW0C42M']TO@;B/;.:^0O\ @JA\$?%7QN_9C6W\(6<^
MJZEH.L0ZU)IELN^6ZA2&:)Q&HY9U\X,%')"L "2!0!Y5HO[8/[9/QOLH?$GP
ML^ FBV?A"YQ-9RZ_/B6XBSD,'EN;<.C#'*)SV:NK^"__  44\56/Q>TKX5?M
M"?#H_#7Q7JS1Q:?J5MO%E/(Y*Q@J[/A&<;!(LCKN.#MP2(_V>_\ @JY\&-:\
M':'HGC2>\^'OB"QM(;*XANK&22R,B($/E/$&*IQTD5-O3G&3ZS\5/@W\$_\
M@H#I?AG4HO&(UE?#5R]Q:W_A'5+?SHC(%S'*=CE1E$;&%.5'OD ^F:^#;_\
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M  ]\]XM+E\2*T]S?A"58Y$4F1N&"0B*#D N5- 'Z%T5\8_LZ_M@?$"U^.K_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOVHM;^,]KX1T'5->>\F?2VUC4+.XBL8<E8!%&TN%,<>%4]026^]S7K']L?\
M!1C_ * 7@_\ [[L?_CM 'M7_  5"T"?Q!^Q'\01;*SRV?V*\*KW1+R$N?P3<
M?PKT#]BC7H?$7[(_PANX'$B1^&;&S++_ 'H(EA8?@T9'X5K_  Z\,^*OB'^S
MU;^'OC586C^)-9TZYL?$%G9,GDLLC2)M4H2HS$5Y!X/O7QY\._A;^UK^Q/;Z
MGX)^&^@:'\8_AR;AYM&;4;V.TN; R,205>:/ +-EE!9<Y8%,M0 ?MI9\5_\
M!2;]F+P[:'SKO3WBU66-3RL8NFE)/_ ;5S^%?HO7Q7^R7^R7\0;7XV:Y\??C
MO>V5W\2-1B:WT[2-/<20:1$R[" 1E0PC'EJ%9@%9RS.SDC[4H \3^(7[6_@K
MX9_M!>#?@_K5MJR>)/%<*3V-['!$;%=[RHBR2&0,&9XF4!4;EE]:A^*7[$/P
M-^,4DT_B3X<:.U_*2SZAIL;6%RS'^)I("A<_[^:Y7]N#]C&W_:P\+Z-=:1K
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M\NCW6HV/B*TN-3T/2[J..WT#3;6[@EC5"SDS,^ZY<A2Y^4?,2P  /J#]M_\
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M \/^&/\ P29^ ?PWUR'5;FPUKQI- XDBA\37J2P*PZ9BACB5Q_LN&![BI?\
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MG^T3^UOX*_9BUGP1I_C&VU9_^$MO'L[.ZT^")X+<HT2N\[/(FQ!YR'@,<!L
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MEWV,'0J&VD,!DYOCWX#_ +4'[=6M:%HOQ?TK1_A%\+M/NDOKG3-+O8[J[O&
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MK8[UEWP^5DQJ)_N^?]\D<\]J^D: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYKZ]HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N>^(7@FT^)'@?6_"]_>:AI]
MEJUJ]I-<Z5<FWN8T88)CD'W3CZ@C((()%=#10!@> _ NA_#+P;H_A7PU8)IF
MA:3;+:VEK&20B*.Y/+$G)+$DDDD\FM^BB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#YS_;6_9*/[57@O0X]*UX^%_&7AJ]_M'1-5*LT<<AV[D<+
MR 2B$,O*E%.#R#XI=^'?^"@&M:2?#$NN_#O3%DB%O)XJMB1<8QAI  APQ&>5
MA&#R,<&OO>B@#P;]CG]E#2?V2?AC+X>MM1?7=<U*Y^W:OK$B;/M,Q4* JY)5
M% P 2226)^]@>\T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
@4 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>holx-20200926_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:holx="http://www.hologic.com/20200926"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="holx-20200926.xsd" xlink:type="simple"/>
    <context id="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i618d0cdeac854d4092ca21e44cfcda3b_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ic2880c96e3234c25bfd593a102de3acd_I20201112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-11-12</instant>
        </period>
    </context>
    <context id="i0d41300e13ae45ef8bfefa0d42f63c4c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i3c26ccbfa54e4fe0839a4a6c78466347_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ia549e6971a604015a25803b16c10a03b_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i794e99945f544149a4dfb0dc4430defe_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i76b85f8e0cc641d6811b0f647a80c0b4_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i688ec76adf1140acaab8d25b511667aa_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ib3117997fe434239b20f6cf308ee6614_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i6199234c2a9d4588aa6dd0e453b067ee_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i7d2a775a080b412fa3dafce51e6d15ba_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i1cc3451a488c432f89410a83c10d5d44_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="id3c092381c12421482497e088d638a81_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i08aaa1dc14eb440ab123d505e79e47ec_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i009d515470734764a45e17ec26571fe8_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i319b89b955fe451e88544cf9b525eb59_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i7928b977a78c48f7a935d7a39083e59e_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i03175a6288164c5db9844f6e6247dd76_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="icb9f527854bf4eb285447a902fcd7098_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i84c88a850d71453097932f0bcbe84825_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="if3680c6a61084f738e0282f1f1563837_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i50a8cec88f63482ca86e8907428a7f7a_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ic930cb3d51304cadbaffbad6e4174a9f_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i95ca35177efc4ae98f89b9162289d0f8_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="if6afd02343ba40d68f7f7d2d38b8d6bb_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i2fdee7361ebc4584bbc3a5cfe6444f08_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i03e40fe371564654b09f93a1ae599923_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i0174c6f539e747949d68830c151f307c_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="ie46091349b474da791e8169a5e898ab5_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i57069c8fd22f43268f97f2c41b7f2a8d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i2d8bd96d523f45339390f0f694678659_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ibdbdc18a2bcb43a3bdf8e6c1cf19d396_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="if1a27903b45f460e8b58b329d59f97d8_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i21125621c43043b5a43f09df6f874b52_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i71115cc05c394a8a980ec543ca44bc53_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id804545a264447f98e68c02862888397_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i7c166eb8bb6741edb7c59919ec94dfc7_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i5a4d7c88b3174a34837a1c0045f15e4d_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iadd2a9a1773e4a9b84d417b384632c4a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id050245a51244dfdad49743f31133eb8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i032815f3d67a43c29b8c166834679ea4_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i36030839f7884303bb258fae716235dd_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1957ccc6b7a54f27a19bf968742bbf75_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i94e21961902342f58ae493fd44252348_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i49a3d6edcda84d5e8d51e6886159c6f0_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ibc54b6fd6f2747fb9422322da3ef9079_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iaa08cbf6d272455e8f8d4fc150075d1e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i75f2f7acec1c4c4aa787e72d606b369e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i31584edc599f43b4b1edbb086c4349e5_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ibce62cc16e0d420ab20aa0dd17c08716_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i8f2b3be1822c481ea0d7d8b6f100c51b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i3f897a5c14ce46fcb14ced01b6827380_D20170322-20170322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2017-03-22</startDate>
            <endDate>2017-03-22</endDate>
        </period>
    </context>
    <context id="i8f6314cda1fe40489c80c8c7c917a7b8_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ifcc5fcf2f538489bae3a4254ce198ccf_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i5a4fb96be7934eb29629fbdb7e72fd0f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iff73c4f9e92e403e8fd1003738851496_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i552f7643b15a4fdd94f4b733fd38a0ef_D20180701-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i8d5133bbb5b643cfb4039e7683d511b2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i01e39e16ad0d4d43bded461c3c400be6_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i284a1c2b8fc740deac2cf49770588de2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentUnderCustomerUsageAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ifba3583f30724dd495ffe080e345c8e2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentUnderCustomerUsageAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i64ce780d2bc74dc48f001fe80ae1ff75_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i5ab13270771d45d3b753d44c0a05c023_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia576d0947dd14fb899e60c78615447af_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if8383367e78c40ac903ab338ea02c2d8_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i26ac442ab8104d62a507939b10fa969a_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8c09129ca98843beadfd374cfab77639_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i957c4bc90df349dc9fad1b82c2de15a1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i12c940cf715b419190f1afe48785d4c8_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i5d996d37cd674a338e18e859a3513b71_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i07c8b5f4261041a985e22dbcc3ec25a6_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i7d0f493e80c8407b9a276a3459c6e266_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i860ddac9336c4aa397d8f6b67401b31c_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i68050ea428a94c1688589a99714f38cc_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic2a5caec8822438c887854c7fefc3007_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ie69340311e9a4b308c4862870d12638e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i17f074670baa4f1d934cf4b17758e8d5_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id6a066f4761243508c40140e40ef6af9_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i302abd2449094a9093740c9423c08c05_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i04d58cdf3b9742bab6c632b1c6bde482_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i58479218662d4362a06891b6d76a89ee_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ic0db0cb781464d528ec7ee04920ecb28_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id8f4cbe1c0914b04bceeebc3cbe0bb61_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="iea670c4c01544dafa2cba9693bceb1e2_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie1f5a289dcef4642b1a31621e515e16e_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i16c34f677a2d4f08b3c7c62af376754c_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ic47589113cf749b8b8b586c11fd7976e_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i61c55e342da24eee9282df815b492d78_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i51211784b29941399cb1944d9f011a2a_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i89813ed8f2ea44b085d80d8ab6c4fc94_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i41cbe32e1f1041339f89ddea6ec9c266_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i744c7283185f454f92fabd0f80a0ef92_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ie578122249b043b0bdb831bf79737e98_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i5dd76668352442978fe04a0c59a5c795_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6223b3508b8c463aa3289a1a509edccc_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1bfbe4fe947c43a4a22bb3f6c17cb1cd_D20171231-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-31</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="iae131a61f51b418f8d16b147c4f2e986_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6724b08a2857420f938843bdf83228a2_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i52f401bcab374c9da21ba458593af4a7_I20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-01</instant>
        </period>
    </context>
    <context id="i58ab6ed21a0e49acb17f46bb533a208d_I20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-01</instant>
        </period>
    </context>
    <context id="i72959050a334423eb15ca612ed289237_I20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-01</instant>
        </period>
    </context>
    <context id="ie4eb2eab1b56414c8fbb0c756bf25fdd_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ic5548619644d4005832478fe4f7a75d0_D20171231-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2017-12-31</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i169afb67581f4042a9907e319c8aaee1_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i0b9b859e952c4dc086ae9de8f3020603_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i294e83c0d77f4a76b4cb43739eaeaf9f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ie5bea17c720745bbbe2f47855b322570_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i4dc3eeb5d8a7429f994641e93253a6bd_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i69dbc69319c941ca9448d21361773988_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i7e140addb4a24ea78dd4c7f462c399ba_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i96ce5d4500f64edfa02758b406d21f90_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if7876712181a4f0394252851c3247e89_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i988d23f94723457db513c5aa1234acc7_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib8b49a0c00624209ae298e13d31a8705_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib231ff2385b64b9ca2bb871bcfec1dc3_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="icf0c977d98c5446ca36e0ca5d209a7e5_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6d5aea5a6dce4ff3a0ea7a9f0a6e7e04_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i34dc1d8ed3e448048896ea6acd36bec6_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i4a8e80b3d02048368499f2fc987b666c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia8c69c195a394e1abb1f0343c9c25508_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i66e0c7ded43e4ffc9af56c596610e242_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i339a5d0289c34c65ac5ba8480d1803a2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i437292e8142d4d96839af5869cecaab3_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i305c6e69d9584df69b07d0c58b68dc88_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="if85520f01ace43129ad7669c2083f920_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0bbb9f4ee2a14c8a8ff8db71fcca17b1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0e1f1b09ac83442a8c991f025f87c36c_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="iafc353efac2f474997f4ab38d4cd03dd_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i7c9b833795a14c34b98fd573a5bb02aa_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic2febf310c33479bb7213e376d43d131_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">holx:PensioninAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ice34049f21724d2a89b07c75c6bfe1a0_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i96d2d76048144084a688883b4c23ca74_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i49fd9cd9c1a44756877deaf8449c4ce5_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">holx:PensioninAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i8acf153e8175463d854199e3d5b100f5_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i2dd3354045a94ad6bc4f7dec67555173_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2018-12-29</endDate>
        </period>
    </context>
    <context id="iaa82070dc0674b2b93dfb59c5365695c_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic3eb72f6ddde4172af624dbe36bc89d5_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if4a7fbf31ef34d35a542b3139d2d97b4_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i61680decf3094210970e74b87feb098a_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i21e0c51c686947c9a4167c8b13e37d11_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i27a6303307844b9ebc5be9434c2819ad_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ie21e889f681c47ca83ea648b1fe24ff2_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i059452d2deb54b2cb9873ef23f27c960_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia7aa80690b724dda81b234de06742f9c_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id438b62a9541447d91c50df6ab64b0c1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7dfd4338227d46fc8dfbceb1cff06631_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i6d44b346ba2949ff849a666fdf96eb13_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib23d81f77fd54000b2214c1d2555f31c_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ia0150d6d7caa4efe85607759c805b3e2_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic52f7f7067a847028ef4c89e9a861db1_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ica6b881644254b8fae9fbb03c69fdc79_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ieb6934bac52449f8aa6c53b295caf5db_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="if04f766e5e7f41629fd5954a52f9482d_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6599845afc5441e58d23ed545c1c2d90_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ie4ca89e21b3c4afa91bf0c9de4dead2b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i304856dff4354c09a218d0c4abcec6b1_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i826045fe76ba4dfba8d2b77577790871_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i51127895ec4446f88b062df8c3424fed_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="icc65f9a1944847ea81ab96621f47b0ce_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8333f1fcd3424edeb40667341d0ef184_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i3e78594f4bdd44c39236b9e9233d4e5d_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i93d07ccd1813413cb535430965ca43e1_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ife0a4b80cdd24c8182c3da3c0ac3badd_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="id1dc4960757847fa975cbc5ef31a88f8_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ibce772764f914f9883988915d86d6810_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8d1559cdd9cb44c1af1d7faf1f2cef88_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="if521ee7691434488a8c4a940762af9c0_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="if06ae85100604f48a0354fb2181504ee_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="i7d08665ff5e7428b92f2f87f995f6523_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id8a91b66ec814b6bb11ea904156f4239_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i95cf893d7ec14704bea7fa6c16427a5b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i83bb398da9034ac4a5154a80046899ad_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ie7ee31ee47384d66a52b606454a9d4ab_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ibddc782db0444af8bb871d7496ee5746_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i590c2022b4324ab994b2164138508d88_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="iaf8dc695c92a4feca4702aef44167616_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i6bb5a21e92604faebf807887f9102015_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ie8a58cf3c461492482d5dcd9b88379ed_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if4781b8d56e34db4ac93197bd725223a_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i104ac377ebbd4e05bcb47bf521f5ce4d_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1facf79e2182457ba4133a1ec0ba491c_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i28a65a25ce95429a82c5b19cf486e81d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i3e1e43e160f844f3be9e65aaa9ae3159_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i50934cec2c9c407b8ea520ce4db8e3b7_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i42a30e107b544ef4b4edea002da71960_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i4ca63f8d157f42aba21c14ee7c153d70_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i592f0856c5084a32af46ff3a1e046ee9_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="icd3b478fa0f24dc3aa889f9a058d9d98_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i4da82173bd744edb84691e936f7ccda0_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i5464405dc015456e9897532307f11895_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i9ddddff86b3044d7b0fc9b7b2b963bf1_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i19d3c5f4df704cddbdd7827a6451b621_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ifc133df909ca464f9c8e3787dcfe2475_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="idc84af9eb3104cfdb19db77db92ed7b4_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i00e65a49339a4f9bb26bf6c415e08e18_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i9c33876277774ccea23ac78561fc07e0_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i2fc5ccd5fc274beeb5b3be51f76cd623_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia4cf0729ec2044dcae9c2f4801fd2420_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i9c664f83a3cb4954bc77a1877cfdc72c_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i2e2f531aee5246619095d14dc0f8b6bf_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i309e38f390b74c389c1f84c1b4db88ec_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ieec8d0273727499c80a7201ea239a090_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if95130eeb1d844f0a7c10fea2f52bf39_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i2f3886c217574265bcf1ad1049b1aa4c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id1a29accf22242549a492fab1782cb94_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i2a1ccd58830248da8f29187c9cdd3079_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iff15a89761f34f66a3761888623b4f23_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i0833ea6babff4e13aa4c24c6994f576a_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i65e9eb24efa944359e8a021229406acd_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ic60ae0c151b445a292490043ea13881d_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i1fba52a0614b49c585ea7cb3df44be14_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8471b299d850453f8bfca6a20cd0512b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i828ebe5b8d494e04936a9b538c0e1948_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia999e530e95c420abe9226d29b3d86e0_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i8ee90fa905a04d32957b8acbaa2c1bfc_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ifaafb7ab1c0441ec87d9abecb35da291_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i006de4dd9201414fb767930e647b4405_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="iadefe10680934f5580492d9dea95bf7d_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i60a5014f96a34cdab508fb56b98ac1d4_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="iadcf8aa033b9410c824f6c8d1cf3ad39_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i60b04cfb9cc74ed9bb9c61e376dc2794_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i962c11ce0c514729be1b050aa28ff2e0_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i1e9161faf1934aa3accab7a9fad64784_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i512a078a5a374931bada540cfa1a291e_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i83a4bfcac8ba430ba82768a85a67c700_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i47df0fbe43fe4e708bd87bf78a6c73aa_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i9aeae7e636114e169ab5ca6cd732bffd_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i939dcccc02d247098b6f0021c007686c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ibbc8d674b6954826ab5d78856d5fc97d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i667ad16a082a4c12a8188f400249f907_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i96c41424e4c4429f833f974caca3e9d0_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i640618ae1089409aa397c0b1d6630ba7_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i67b306ed18214b529569e273c6cbc1b2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i24e8f75e7420456aa25cbce56e1e8320_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id5d4c49bd355481485ca7470fc27601a_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i60c82065c41f4b4c993bb38268ef4b55_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i790335fe6b504d0694a773e693b48987_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i1410a37395f9458e8fa278adf018a579_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ie06d07afd66d4433896cd49ac429b433_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ifb8cafb83e0443fd9f04b2a54be10659_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i98a1be5bf1eb40548cf881d45cfa3212_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id1af779ff4d349c0bb004322df29066a_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i1c3b64e5f16145bab3d37ee0bbc5df6e_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i374d2bf4a31b4fada151536edc6446b7_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i4d7773a142f248d98fc047e667923b9a_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ic0b1fbf643bf4d87a0f62662f56e72a9_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8eb202acec0f4f65bc34389e2af40e3c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i22ccaf1b86dd4ce1975c67773f6132e3_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i68690342c39340df929646cbbb4d0fb5_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i6a86961b941f4c698ca817317ebb55f1_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ia95060407ff54c468b06a661c8fabc25_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i65a03228708e48bd91808873ac0aef49_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i9775b97e92684b93a13c7004b3787bb9_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i52f05bd0d07b41cc91cc734c6e8aabd4_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i9f2349edc55c45de9425f98b0200d5a7_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic693f14699ba4968bcb36cc7b8b023a7_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i6acedc8e09c84b2e89c7f0cc800be0dd_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ibb0fdba95bf14963b575eed35c0be6b7_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia889c74fa094451886ddf4da8cfb8b39_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i404bb6871a4c4ab480a92c1a5f85724a_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ic42c9ec0a387465384f173e101feaa39_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i37a58071a6be4fa68958f54a1146729c_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i105ba05d0c354f20b5883424ecfbbfeb_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ia619a463826c4b1aaca754c1bbd0a455_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iad9d09e7d14346609c65daa29e0cc27a_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ibe6d7468b24745749de9948726eabd87_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ibb6352a521944f2fb02cc1dcea86de83_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ifb8e030e4bcb4d11b83c486a8c3deb7f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i6ca6c2bd19e94add871a8ae7f87f8147_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ie9ec2f408f84441f8be19c8da6fe2ecd_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id732b75e70474fdd99cfef04a578daac_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id940ceae94cd453190bd3a93d6db3048_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6f509287fa7d48aba904c4bc91d15c97_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i60dfb47aa97248bd8efcffeb6e4c16e7_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id022bc111cb949abb3f669ff592a75c9_I20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-09-29</instant>
        </period>
    </context>
    <context id="i22479589b7d74fc680fef5abcd3d9de8_I20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-29</instant>
        </period>
    </context>
    <context id="i570d6e2471dd4d25a99fe27c526db531_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i32158b5e90814831821e7b0a2eb47b70_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i63fa7301a7954f429d5733f26da0769e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ica831abf5b804562b479ecb7d6da8ff9_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7ba215b8102842d7a0db14145f80c875_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsLongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic439fbf0ea984bcba40c13f6cae3a03b_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="i60c64e349e7248b4926861f03af3baf7_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="i6628d4bd404a4b39ae1f8755ac19e156_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="i64e80cf41696467c9ffc4409327aade0_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="idf4c2cfcfc8644a2ac89ad085cbdce46_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="ib6e062bb74fb4a87a11ce9920ba3bf95_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="i1d09efae7507467987336d04e3509634_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i862a3c45416648d297e125475abce254_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie33a898c5926488b9bf6ad622a0bd9a1_D20191230-20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2019-12-30</endDate>
        </period>
    </context>
    <context id="i13b5b561b723452ba061ef7677378758_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i4c2998316cac4e238f728957efe3c4b1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic533d50defe448fdb707c6f87a49077f_I20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="i22886537724e44318a4d4b7a40157a84_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="i90fc1953e74547ef8567e85c0335320d_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id37fc47d83b14b95b70cbb4ef25f42b3_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="ie68d86ac2e6a4c928f6d1a734e19ab2a_D20190728-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-28</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="ib35735436ab04420aac409cb3a577c1d_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="icb6add9e14054057a65ac31b811fae48_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i06df67bcc2a94911a7069e16ec48fb7a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i36b884f4d126493b8f8989d941004da4_I20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-21</instant>
        </period>
    </context>
    <context id="i13dcce25b11542068d5ad5a656336c29_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="if2090212e7314cac8f3f33afb4394112_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i2576885bfe07425f9e425c469ebe8367_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i02f15446f52343a9adfc4e8ef6c280fb_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="ia43db9b88a3d4ca894ba73187fb33e22_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="i781dbf5ddcb549d383a457e18753ded3_I20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-01</instant>
        </period>
    </context>
    <context id="i9c2a49b788f14bf48455c95dcf507a9e_I20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="ie9c201c0913b44d98e588a279d1fe985_D20191001-20191001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-01</endDate>
        </period>
    </context>
    <context id="ica9f97800f804e4a9d1eae5069d40e02_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6eb9aadeebec4587b35023639ede565a_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="ieefe5f2ec3a649449b7f480aa2fad0c5_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="ie12b0a99842a4517ba08e440afbc7c60_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="i847787c89a874c6892ea179463d444ff_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="i17ca3ee0e1d24409acd2b837d6b9f512_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i22cb2f3e35b1476184e3b5ea02888210_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="ib017ae2e40794fb6b06de53aea426df5_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i6140a77a89524e3f94a9becd6d726c2d_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="idf55a89911c2418c862ba56b871a233c_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iece20c91b1524a47b452db31a8c50766_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i8e553e7d9bfc4efaafc3811a17018296_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id3a1dcaf42754d9c9a3ff74faf8f61fd_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ie9c4512920904aa3814e9c7a9fd62545_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ibec87245e37445459f0a3ed8735ffec3_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="ib9b201cf75b8459db2ad76cb990ec129_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="ie8f378dddadb4b4fac57b2fbc214b4c9_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i045b09a2ab1943b59f87d6eb5f4942ef_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i3d6a98785a404f99847c50b43c96a34d_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i78dfbab8f2fc4de39f7b4e445e2589f2_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="id9916a6d68484e70bff8c6d8f2a2e4ad_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i266eecec31bc4b7d8dcaf10d0b94db47_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FaxitronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i4079f996b6274dfb9512d61934ca5bd0_D20171211-20171211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:EmsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-11</startDate>
            <endDate>2017-12-11</endDate>
        </period>
    </context>
    <context id="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:EmsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-11</instant>
        </period>
    </context>
    <context id="icb2ff4168e384034bbf5532623a74329_D20171211-20171211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:EmsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-11</startDate>
            <endDate>2017-12-11</endDate>
        </period>
    </context>
    <context id="if04a98f140e34852950c49c8a2573bae_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i7847ac8d91804cd389031be4f03425da_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i44573f3f88454bfc98195170bba8514d_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i40fdaceff578441ea2d62d53dd29115e_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i2966db0031f44886b68900666c4010d4_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i7eba256d6a1542db8c06d5ffa4b20a07_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="icb6630fc5f65496eaec9acaa3d5c7aba_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i585bf0cfe60944f78c6482f3beb7d14b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia99af639d7f84346aca75ba9ef329ad7_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i7ad1871e11b04ce3a9b3d2d7995b3439_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia488122214b14db38171d7681cd5d254_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i9cef01ab57d64322aacba4e684ef1326_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i84c64923b6e84649978c4e2b356e67ae_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i245b71f07dc5421b90a64dfe2ca519cf_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i7917afc51a284eb389f470fc51464390_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i8c335097c1214c7b8b5089dfca5b78e6_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="id214db94d871423c97d744696fba6ee9_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i383968572a2740c4b1b1c3a6102235ad_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="ibd8fe4ad3af14cb080a973256cf16e71_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i04a33f36d28a4ad59b7fcbc84448ad87_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i1545ced1b6bf4384a44fd70aaf8d5dc0_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="ided55a75f2a34ea9b423f3093d7e3bf2_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i82fe25951b1d47608e534a368540c8f7_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i4caceec0ff464ef58e11ca526344ce87_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ia41126a20c7047088eb9a490e7b9aaaf_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="icdfa048e3caf49b6b54a8569a1e075b7_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i5f7c0803ecd34f7192e3525b7d33f970_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i9e85e552551046dd94bb25760309804f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i092a31ade66f4c8eba80fb2ee0565ae7_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i405e231a699e41a6b9f765aee4c70e34_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i107f31108f574bb2985391d4a79fc410_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i13214cc3feb64fcf927862343c34707b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i644ee2acfbde47e4a5410d9be6acf9cd_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7bf13b4f96464ec4bab32a562712a405_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i9a3bbfc15f424fce8faf36fa3102c868_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7ff6affa1f43454fb0e3a3b5001fa866_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia7868b801a844b96ba9f57ab9d96e829_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i9a76896977394657b24f892dabfb2d28_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i3b403fb32e214730a66931c9f20f7ee5_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityByLocationAxis">holx:TepnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ia9ffe8cc379041dc95ec1a2845bdef3c_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityByLocationAxis">holx:CynosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i18bb9b460f2948c6b33b79494de5a775_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i7d2600bf769f47179667bb435345373d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i75761de28d1343d2a77be06b0d507b3d_D20171001-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:LybertyWayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i762786f0664c4c22b2ae67f6b01c9bd8_D20180930-20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:LybertyWayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2018-12-29</endDate>
        </period>
    </context>
    <context id="i4b4bd78551ab435bb3059282b0371b60_D20171001-20171230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-12-30</endDate>
        </period>
    </context>
    <context id="i0932a399229f47ac83074c5e06bbc0c6_D20170402-20170701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-02</startDate>
            <endDate>2017-07-01</endDate>
        </period>
    </context>
    <context id="i520af16098c04865986cb5e430b160c5_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="if2da745af2d74be6a6328bb22fc1c348_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="idb22b22b518245c5af080bc07bace384_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i3fd7ad15f5e24a678e288eb53e978668_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i60d56d6d8a714585ac83977c31d4ab60_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id80a9b5c1e0a48b8a0ad99dbff5d9c5b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6e1b2436330a4b7a9a2624f5cd7ca5cf_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id57204513f2e4047bb34a203195e5e4a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i9495f528a35e4d6db0680ff16dda56e4_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i15c014abf52b48b3b4f228ca2997399b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="idfc9503585304f80b0bda5108dc6141d_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i855bab3266d4415c8e89b6d9be79edb6_I20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-17</instant>
        </period>
    </context>
    <context id="i643139a0070945419368a19ab57e080d_I20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-17</instant>
        </period>
    </context>
    <context id="if777467cbe914235ad2b43c07ebb9e28_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="iebc8390a06a94a30a7711d90782cbfff_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="i890f64beadb143b09f67fea3c0b0f562_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="i832ef0aa8ca34dfab05f2e95257c6146_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="i3f1547ab54254a239a247c8a112272c3_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="i25098fcc693a4912b794f37a396afce9_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib968be61a4094d0eb0f1daf52ff7d843_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditFacility2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i594b4573152b448cb7a66c5d84a63dbb_D20220625-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditFacility2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-25</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="idb75a80924734ad9834561c374f802e1_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i5e8f4af13fc243f99fc0c25b9dbb20b3_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="idde9cb65eaea4006b4a3a0e5a2272ddd_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i25f90cd313c948d2a108a87d9a94999a_I20171003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:TermLoan2017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-03</instant>
        </period>
    </context>
    <context id="i1b9bbbdde31f436aa1a5765b37448a8b_I20171003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:Revolver2017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-03</instant>
        </period>
    </context>
    <context id="i4663f101db0a4ba091c45be3b47b7c37_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:Revolver2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="i8c5d81b35a2241da877d3e4a3da33071_I20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8bbf0b9e21774990be085b97a15bbd5a_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iee1d3923c6ba4dc4829757b7a7580a3e_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i974288f6285044128c2b4e1690e36c23_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ibfd0405aae91417aae27ed964af861e1_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i7ecb1b74ff6b4d1b9db466141397e214_I20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="i7afb5a8c40684333859218062faaf200_D20180930-20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2018-12-29</endDate>
        </period>
    </context>
    <context id="ifa285bba80d14c0cba66dd5448fb5440_I20171010">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-10</instant>
        </period>
    </context>
    <context id="ic272797ead73491a9d8ada44c35c9e1c_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iad5df08e269f4792a90def353802fc8b_I20180119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-19</instant>
        </period>
    </context>
    <context id="i06ed0e83b77e4dac8ff73405d8588a14_I20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-28</instant>
        </period>
    </context>
    <context id="i1e0434291a6f4c76aa8fb300ab8d179c_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i1fd7482e7e024b1d8623378c63515cb0_D20180119-20180119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-19</startDate>
            <endDate>2018-01-19</endDate>
        </period>
    </context>
    <context id="i0594ade531b74789862cd43513f6fea7_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i4a0afc09611c426282e6aac4be10661a_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="if3d6e02785004a0d8d101ecf6ec84b38_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i2c177c25617f48bdac09172a3df4017c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic678ac46fcb54d49b964689428ff6dc3_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iee80a400131f496b9f303169165255f9_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i208ccf38964e488ba11badb451812ff1_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i625f89ab8266425986dabfe1ea7cce94_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i949893e5021e4b72b6e04ed4c620d53a_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i53165e60abab42ee834675a6c4488642_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i181188c2b11e4f169032adefb6546ee2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i04f56e3fa2a540c0b6ff0e3af30ebd18_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ic79a7b8640a04f25812f29fbf9199284_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i91a5f72252c948bd9ae64687e324075a_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i053c6045e0324fa0adf4cc3c967de7c3_I20180215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-15</instant>
        </period>
    </context>
    <context id="i6263cf3be0e74b85ba827b9b7dd3bcc5_D20181230-20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-30</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="ie4300b435e3a4c91a4ec915b5cdebce4_I20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="i7c7d1f23582b432c91b2a801b77b2fff_I20071210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandSevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2007-12-10</instant>
        </period>
    </context>
    <context id="i56b1e7b3625d4668b6803a4af269897d_I20101118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandSevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-11-18</instant>
        </period>
    </context>
    <context id="i91ddc0c2de1e45d59da01228f7057b59_I20101118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:NovemberEighteenTwoThousandTenOriginalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-11-18</instant>
        </period>
    </context>
    <context id="i9c1f5e115c2b4f279149b8ef1e703af0_I20120229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandSevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-02-29</instant>
        </period>
    </context>
    <context id="ie58aa7f211694a7f95581b9c6ccdee6c_I20120229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-02-29</instant>
        </period>
    </context>
    <context id="i9671b6718f6540d09891ee6161cbe7e2_I20130214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandSevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-14</instant>
        </period>
    </context>
    <context id="ib7243cd452dc4ea3a000e9653cbfe838_I20130214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-14</instant>
        </period>
    </context>
    <context id="i11258e03918544b983db64585b8a57d3_D20160925-20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-09-25</startDate>
            <endDate>2017-09-30</endDate>
        </period>
    </context>
    <context id="i5b2cfabcfcd5475e8db2636fdfd71b6a_D20160925-20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2013NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-09-25</startDate>
            <endDate>2017-09-30</endDate>
        </period>
    </context>
    <context id="i2dec2acad41c49ebadf65a9fe79a16cf_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i82d36f9b38d44e27b3125f3ed8fc2179_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if2f74c33a2674954819e52e2acf2aaac_I20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="ic93b7c0c776447f09fd2252ab71327a8_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="i024d7046a83a4ae88bd3445fe4d74f1e_D20181230-20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-30</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="i4ec620e29d184821ba41fb6c0d5e4744_I20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-29</instant>
        </period>
    </context>
    <context id="iafbd2a1d68ff4c35b4234cfba95c6ccf_I20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2013NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-29</instant>
        </period>
    </context>
    <context id="i2c7d3a787bc64690aad62c65bab997c8_D20180930-20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2013NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2018-12-29</endDate>
        </period>
    </context>
    <context id="i821e7870d37a477694bc08b8bbc795c9_D20180930-20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2012NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2018-12-29</endDate>
        </period>
    </context>
    <context id="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ie2bbe4541be240b88496af586754a36c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia2da5b318239428794fe8166e45245a4_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id9d2a93700d14286b21749a928e012e8_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6eb2ee0310c54acaa58b9b3c9ff34788_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iba4c5eec04f245b89eebd5d83438a62c_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ic6ba005a39094d34834366256211a18d_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ic9c5c02cb6674ecaa58ca75f0fce481a_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="if4a62771e5894787a4fdaf44eca8d691_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i3d1dbd5a9ccd498d8398ec990203070a_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i41746832831b4728af50d9772e03b7d7_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i9b6105964ce549019e14f33028ca3323_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i2c15de09124143ea8a8d715fc0b85a09_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ie5f7f09624f1434eb681cb9758d19eb0_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ida7278d273404326ba040e840b670dbf_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i4c634ae6117f4462bbe028987d490806_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i90fd61a9da9e4ce2a983dd400f24501b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0ea11973d1af4316b1f3c636f82b9cf5_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0666efcb300b4877b0616c64336ca6bb_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id307307c5904493785fe09305537074f_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i2e49a76f02bc4a9a9d1333c24ffbf535_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia7c95670b0ba433f9c62a89eb2e10a1b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i4ef55f270ba4439e93dee1c6e0b97d71_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iaf733f9b57054072ba3f09920206c6a8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="if62353ddace04e659ec61002adae44d8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0649c66c33ae4abdab88cfc48ee8e0d4_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i494b1a50020e4595a4944efc9524702e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i68139d7bb5fe4486ae433c49b7b0574b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic2397882191544728c3e25abcecedd2d_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie5f94ddfbab141ca9fd6143ef82e2729_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ibd832222fbea4e8a87ad22cac73a787b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7ff8a401caf348ccba10912b17de5ff3_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i3500b3aa228e41f5a89f346d0296c04b_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i1d97a6111f044441be4473a086df1d40_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i173b234856a64d389d94ce9755869ba6_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i0172a062a11d4a9b9ff8ce7f340127e5_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ib8cc4295af424a959b5d571941ae558b_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i2e5807a53cf54cc88b9b54d32079f6fe_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i52321d5b7f4c43e0a78b02f5e2f66d46_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i4ed21b822c534ff5bac482a2f45adb03_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i6a6bc74d82454a129b9c287e500fb859_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i0a09695c32df4cd28cb1bcb683a730eb_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i6aaaf1ae6a5547bc9c542f11e36741ed_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i72dae67f6ad547c18f4306ab436421f8_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ia9cf7097d00744cb8193ee46040dab6f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i4c79ca9a01124b35bef6eba993c991c6_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i8a00d43da17d4cf2a160f87d1575594f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id123129c423e45f0bbc343073fa91e2a_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ibe5b12d49cf249b58198f0ed8726f8b1_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i1e18b40497764e718b638209aca9eb1e_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="icba5dbf998314e0387202bf4eb404a3f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i17ba19a80b3e451d950ab549195d0151_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i7975507c75e442eca0e695649ed6acd8_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i3d9bb748a0d64e65b6a66c49ad23d0a5_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ic9bcf8515f054405a36ddfe578351f4c_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i4434900ec76643218f461bb16c843300_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i5082098bb8404831baa99e0bb0a4ab26_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-12-30</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="i73c475cf26a140439e4b7915e83f35fb_D20181230-20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-30</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="i216e053a60db43869c143b5ae19d8870_D20181230-20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-30</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="id6475457bf9c44539a19af401366b4fa_D20171231-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-31</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i84d0c5013ed249be85fc1ea500342cb0_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib5afd9d954b4489889417286bf08a16e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie2070f7d8bb34bab958a30daea1bbd42_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="icfd0cb53981e490ea162a76a039de64a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i99e5be2075214d609076dc73419bf0c8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i9f5ae045d54044febe4e33ec32c959c3_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie7d5ec4cbaba458ca1b77246243d3989_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">holx:NetOperatingLossCarryforwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ibd756bca5be3431186e7d993f7bc13be_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">holx:TaxCreditCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic48110a0e8a642a6b8ca649bef79b27e_D20180701-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i4df61e30f2e54979bf7daad2c81da1e8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i47e07aff515740c893c4234255dbd894_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic5fc614f9e5f468fa0553b7f4576669e_D20171231-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-31</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i87614e59ad424355a0cfa527678f7644_I20160621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Jun212016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-06-21</instant>
        </period>
    </context>
    <context id="i567472971b68464e8f2541822940d766_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Jun212016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i2ffa5f4f0fd34c458b8ea83bfee55899_I20160613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2016-06-13</instant>
        </period>
    </context>
    <context id="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="id87938771f4f4dbea1c6111f383adb40_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:June132019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i344d60e17e06466e9922242e3ef82b89_I20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-11</instant>
        </period>
    </context>
    <context id="i70de3cec1a1146a9ab433c3d475cc634_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i236a8bf2139a42498b9343877c328ea5_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ie6f4f0e51b7443bd94ce48cf225a28d3_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:TwoThousandEightEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ied1237c55f6c496982f5cf0a7ad5371b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i3b8a865cdda34642b4c153cb74f8c7c8_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i65ece6ed881340c0983a4d9a30e84a4f_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ia8fb000016144a92804e2ae8b96faa97_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i760d62d34b6c4e3d9fd83595b9544c75_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iec0c47dbd6d148fd815d60b69a3d1af1_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="iec342e530b5b4e5cbbfb80a971db360b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if9277765060a44848fd3c1bf6489f2f8_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i63c9f52dca544401a06085cc4efa3e15_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="if09747d2102e4179be4850c578ac2e26_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i58a4ba4198cf4304a5d2849a8cd03384_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i27273d926f654c129c15a62dc39b61d9_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="iae964ccd43014ae6a1f6c43ed006fd89_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i95e9ea3fbbd84b0ca265d809ab74762a_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="id0f1f9a60e324df19c668bddb5052108_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ib5d1f26c41db4389981295f374b306d4_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1c2c9561d23a4512999038eae996412d_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i09b6196b4174420b8327b0919e55fd26_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ice730bb0ac124aad881fa4077c12c6df_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i2e8fd89d9b9f477a8ed2176e6f8d2ed8_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i4b926d761276461084bf3fb001bd3488_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i104ee4ba76c74aed9b201714d5f8ce04_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i43643c78c5974a028da555a478aa52e7_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="iec34ce09c17f4512b3a712e8d193c4ce_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i9d45047c3cf742559c39657d33045548_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia847fce0b90344668cafc984721d53fe_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i29db4dc36329440196aa20118733f489_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i938586f669074d699e349df7bfd5a870_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i26da8197478a4c5594b3a0e032588eea_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i2faaf0252c0e495f89cf1661f67bfe89_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i8fce35bd4c5b47ffb3ff0ea7000a3d6b_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i4bfbce83a3f04755b0b598f232407953_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if28b5094554845ab80d0c3c9b07c0ebd_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i15f3d181c2484886bc4ceaa42ec74fc4_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i9cdd3310d03c410ca044b216790a4efd_D20120301-20120331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-03-01</startDate>
            <endDate>2012-03-31</endDate>
        </period>
    </context>
    <context id="i03f873eba04440daa1996d87fcc393ff_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ia8a80c13b2f643e4ba3bad6e12f15dce_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ie56ea29037024f99b13b9416f137590f_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="if304b540b69e455f95347a24194deea2_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ife111ee530c544909f65a587ba76bf81_D20131201-20131231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2013-12-01</startDate>
            <endDate>2013-12-31</endDate>
        </period>
    </context>
    <context id="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i89dc067ea55a42809194d94e740c9bee_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">holx:OneThirdAnnuallyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i4f373267ff8f45d1911298976ebff835_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i7c7afed9db584308a9e0b366c0c10595_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ib6c043d4da794f2fa73ea7b9a2d37948_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i8e43de73b36940809bd154646af2ad6b_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i2e92294f2cda48528702362448bfea27_D20180727-20180727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">holx:CompanyVs.MinervaSurgicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-27</startDate>
            <endDate>2018-07-27</endDate>
        </period>
    </context>
    <context id="i0114d332bb424de8ad15f9a123dde503_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic44cf4cf70a04fdb8f94550d3bfe376d_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="ic289be57c33044b29af60557d0832bb1_D20191120-20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-20</startDate>
            <endDate>2019-11-20</endDate>
        </period>
    </context>
    <context id="idb517eaea5304290a5928b03c9057b33_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic0a23c124e8840a1a8dcbc946578856b_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="icb5e44232158447d887e2d49f5bc7e16_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ie9dabb1d61574d2cab21bd7863b8df8b_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i67c6559862da4a42b4a96b86727df860_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i1250d182bbb64e628b8bb4c093917a38_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ib7ee604a08d9432db6b6ba59a610c36f_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i7514ebbfb861409a9489e0c250534728_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i6dcaf3ae16134f4ca7481e8ef0375fed_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i7906857f1349431c8b718e5f5bc62d21_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i4fb0d5ec5a3d40e791cd77fed8adb08f_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i79dbfa348b4b4250b64c8e02c8ba3ef5_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i8b57161c436e4f6eb5e739380ff16c77_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="icfe6d8929f8f4eb6b145835c10a13bfc_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i11802e38f47f4fc3810df7e5a6f3b7f2_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="if32c7c1cad54473c92473002d9ec70e2_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i6ff4e72158d04b05abd672b5cdb231cd_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="ia04cebdd8bba46d7a211ca6aa1dca44f_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i4a1f0fc50e2e42c4bf2f36b322f42bb2_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ia19f8ef5fe114be8ae437ed2b272af87_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i37cc679d8c4e4a0585fbc179881a744b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i8c4387e1e2e64a7ea880cc5c3543acd3_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ibbeba5af33fd49de80e3ad69f10870d4_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="ia6be6be2339044138fe1152c23d299af_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib8efe51ef6dc4ed2a908a1cb2c698d12_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="id99c49be9fbe42c6bb3e8f1497f9525a_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="ib2d7bf9f967242eaba9ddd491ab703ed_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7d1106e7081e4cabb0de079d952b614f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ie488bc746f864b9cabc2df04f892e4ae_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i26440a4dc78a4e2f9d24bd4827a7712e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic343686a6d7c4439b1715ce8372cb1b6_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i931d24edcf44412ebaf8ac5e6dc89022_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i6455cb9268744d129ad43c18c13a0b49_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iafd22066f01e475cb0434fb76714ac0f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i127aa7477232423cb1285753b3416534_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i3dbb50a9fc7a4683852d6c1668547edc_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i77fd19f2aabe44c188795c7adbdd651f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i9562418944fb4261a833f679ae6db905_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i6cc490c87029449399e9fbd9f9732f85_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i129bb08ac6114158bac9490c19681bde_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="i7f382276eec44239bdc0d3cebf1f2d75_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>holx:Segment</measure>
    </unit>
    <unit id="customer">
        <measure>holx:Customer</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="debt_instrument">
        <measure>holx:debt_instrument</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF8yLTEtMS0xLTA_60d90d53-915f-494b-ae95-47b84f171267">0000859737</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF8zLTEtMS0xLTA_9df90387-efa4-48be-b753-6237e3007892">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF80LTEtMS0xLTA_d6dffb4d-56c9-4cdf-ab34-384bcc3dadc3">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF81LTEtMS0xLTA_e9bc2480-8ddc-4fc5-92bb-8599f29d3fec">FY</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N180L2ZyYWc6NWY1NTIzYzU2YjJkNGJjYWE5OWYyMjc0NWZmZjM2NTMvdGFibGU6YjU3M2U1MjNhNzM4NDZhNjllYjJkYzgxYWMzMGE3NjQvdGFibGVyYW5nZTpiNTczZTUyM2E3Mzg0NmE2OWViMmRjODFhYzMwYTc2NF82LTEtMS0xLTA_69661694-c7f1-41c6-af38-e7d86d151f46">--09-26</dei:CurrentFiscalYearEndDate>
    <holx:WarrantyTermForProducts
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM5NjU4_08c7a977-3e74-4ea4-ab24-1584cb253ab9">P1Y</holx:WarrantyTermForProducts>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ie9ec2f408f84441f8be19c8da6fe2ecd_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzItMi0xLTEtMA_dbc9583d-1d41-47b6-aada-7cab33c5f74f">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="id732b75e70474fdd99cfef04a578daac_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzMtMi0xLTEtMA_23db73e8-5082-4111-86d3-c46174f867d5">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="id940ceae94cd453190bd3a93d6db3048_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzQtMi0xLTEtMA_ad91072a-4255-4ad6-aae2-f57ea6b9b2e9">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i6f509287fa7d48aba904c4bc91d15c97_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzUtMi0xLTEtMA_4ddc10a3-9a09-4d05-b567-135c73003dd4">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i60dfb47aa97248bd8efcffeb6e4c16e7_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDgvZnJhZzo2NWY2OTg0YjRiN2Q0N2Q1YTY5MjU5Yzg0OTM4MmUwOS90YWJsZTpiNWUxNTRjMmZhYzY0ZDQ0OGE0MjY5MjkyNTcwYzJiYy90YWJsZXJhbmdlOmI1ZTE1NGMyZmFjNjRkNDQ4YTQyNjkyOTI1NzBjMmJjXzYtMi0xLTEtMA_241a53f0-5beb-4a91-b348-f1a1ccd5833a"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c">us-gaap:LiabilitiesAbstract</us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4">us-gaap:LiabilitiesAbstract</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af">us-gaap:OtherAssets</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf">us-gaap:OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib5d1f26c41db4389981295f374b306d4_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM1OTU_52c76a56-1dfb-4edb-afc4-0cd46b21920e">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <holx:PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria
      contextRef="ife111ee530c544909f65a587ba76bf81_D20131201-20131231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzgvZnJhZzphNjUwNjM2NTc5NmY0M2NkOTJlOTg3ZGZkMTMyZDE1Ni90YWJsZToyOTg3YTBjNDVkNWI0YTM3OTc4YjMzNDJmNzZmMDFhMS90YWJsZXJhbmdlOjI5ODdhMGM0NWQ1YjRhMzc5NzhiMzM0MmY3NmYwMWExXzAtMS0xLTEtMA_6694f192-c0d8-4ed3-90b7-495579ca19f2"
      unitRef="number">0.3333</holx:PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria>
    <holx:EmployerContributionsPercentVestedAnnually
      contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODcvZnJhZzpkZThhNzFhNjUxNWY0NzdhYTk5MzVkNzdlNjk0MTdmMC90ZXh0cmVnaW9uOmRlOGE3MWE2NTE1ZjQ3N2FhOTkzNWQ3N2U2OTQxN2YwXzU4_e65b27c9-a236-421d-9881-84dff81ca375"
      unitRef="number">0.3333</holx:EmployerContributionsPercentVestedAnnually>
    <holx:TransitionServicesAgreementTerm
      contextRef="ic0a23c124e8840a1a8dcbc946578856b_D20200628-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczODg_f503a2d8-b974-4218-b6e9-25fc199ad879">P3M</holx:TransitionServicesAgreementTerm>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMC0xLTEtMTkyODM_140646f7-9eab-40d5-8cc6-927f67371b99">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzQtMC0xLTEtMTkzODg_736c4b8f-a57e-416d-9e6e-a6211fed51d8">us-gaap:OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTY5_349b1ed8-2ae6-4f1b-9317-7291459090eb">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6N2MyOGUyMjYwNDJkNDNiNTkzMDc5OTY0NzczYjEwOTYvdGFibGVyYW5nZTo3YzI4ZTIyNjA0MmQ0M2I1OTMwNzk5NjQ3NzNiMTA5Nl8wLTAtMS0xLTA_1066b7b7-ef09-48ea-9cd8-caf7bb44480d">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18xOTU_3c1ddd27-ef8a-4d5b-bbe9-33ad39e50f55">2020-09-26</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6NjQ0YWNiYWE1MTc1NDUxOGJmYzM5NzE2ODgzZWRjZDEvdGFibGVyYW5nZTo2NDRhY2JhYTUxNzU0NTE4YmZjMzk3MTY4ODNlZGNkMV8wLTAtMS0xLTA_2533d79f-c164-40e2-aa07-1f02b4dfead7">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc1_fb5432f8-098f-45d1-b733-5f46526375b8">1-36214</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc2_23a9113a-b345-4a89-b4b8-1051b2744b68">HOLOGIC, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGNkMDFmMTdjZGMyNDZmYmJhMzBjNWZmYWM3MjNkMzQvdGFibGVyYW5nZTowY2QwMWYxN2NkYzI0NmZiYmEzMGM1ZmZhYzcyM2QzNF8wLTAtMS0xLTA_df770045-f111-462a-ad7b-d2641d87befa">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGNkMDFmMTdjZGMyNDZmYmJhMzBjNWZmYWM3MjNkMzQvdGFibGVyYW5nZTowY2QwMWYxN2NkYzI0NmZiYmEzMGM1ZmZhYzcyM2QzNF8wLTItMS0xLTA_57e098cb-079f-4926-8d07-89db3263db16">04-2902449</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc3_31c7f062-5d61-4ea8-8639-0d38cf97fade">250 Campus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc4_26e21203-261d-4c1b-a231-a74a35241f2d">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc5_b95ce53c-5a4d-4255-ac58-e40e8ae32ecf">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTcw_1bd0c279-7727-4d08-a917-2bfca7d01352">01752</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTgw_136e062c-2a24-49bc-b474-09cf41da35cf">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTY3_accc0371-d43c-4ce2-811e-030cbeccbd02">263-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MTMyMTU4YjkyZWQ5NDdjNTg2M2FjMzNkMzgyYjJmMWQvdGFibGVyYW5nZToxMzIxNThiOTJlZDk0N2M1ODYzYWMzM2QzODJiMmYxZF8yLTAtMS0xLTA_b97eb6b5-ff91-4d07-8665-c15de471a97b">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MTMyMTU4YjkyZWQ5NDdjNTg2M2FjMzNkMzgyYjJmMWQvdGFibGVyYW5nZToxMzIxNThiOTJlZDk0N2M1ODYzYWMzM2QzODJiMmYxZF8yLTEtMS0xLTA_098aa1f0-3cf3-4fa2-94f5-735ffe6c8b8c">HOLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MTMyMTU4YjkyZWQ5NDdjNTg2M2FjMzNkMzgyYjJmMWQvdGFibGVyYW5nZToxMzIxNThiOTJlZDk0N2M1ODYzYWMzM2QzODJiMmYxZF8yLTItMS0xLTA_5ab42dc3-c1f5-43d9-a086-8f09fb0dcf9d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTY4_5adda3e7-bede-49a9-913a-0036a4181601">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTY2_347941d6-1be0-4d45-ad31-0cdc486f0048">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTcx_191c1fda-d20e-40a2-81bc-60d66ecb335e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTcy_2c4a64d8-2c86-4a83-b198-972017c569fb">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGI3MTE0NmMzZDczNDBmOTg5MDU4NzZmZWI4NzNhNzgvdGFibGVyYW5nZTowYjcxMTQ2YzNkNzM0MGY5ODkwNTg3NmZlYjg3M2E3OF8wLTAtMS0xLTA_36865c6f-4783-4b6c-8c05-a9cc56bf0ad6">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGI3MTE0NmMzZDczNDBmOTg5MDU4NzZmZWI4NzNhNzgvdGFibGVyYW5nZTowYjcxMTQ2YzNkNzM0MGY5ODkwNTg3NmZlYjg3M2E3OF8xLTctMS0xLTA_ba3bd213-78e0-4909-85d8-4d6904492d5d">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGFibGU6MGI3MTE0NmMzZDczNDBmOTg5MDU4NzZmZWI4NzNhNzgvdGFibGVyYW5nZTowYjcxMTQ2YzNkNzM0MGY5ODkwNTg3NmZlYjg3M2E3OF8yLTctMS0xLTA_80e64589-0940-49d1-b15e-b95fd06c71cb">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18xOTI0MTQ1MzQ5MDM1NA_8a3929a1-e5d5-4d85-aee2-84737e974f7c">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTcz_0a651a05-6755-4df0-914a-2c3e8aef0a5a">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i618d0cdeac854d4092ca21e44cfcda3b_I20200328"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18yNTkz_9b8a36f1-d87d-42ec-8fdf-b5672445dacf"
      unitRef="usd">8530248376</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ic2880c96e3234c25bfd593a102de3acd_I20201112"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18yNjk2_91ddad5e-1d36-414e-97f0-ad2cfa745aea"
      unitRef="shares">257009683</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xL2ZyYWc6Zjk5YWU0MmJkNDY1NGU4NWI1N2YxOGYxNWJlODFjYzMvdGV4dHJlZ2lvbjpmOTlhZTQyYmQ0NjU0ZTg1YjU3ZjE4ZjE1YmU4MWNjM18zMTc0_16f97dd1-3bae-4fb8-ad6c-f54b0cb30487">Portions of the registrant&#x2019;s Proxy Statement for the registrant&#x2019;s annual meeting of stockholders to be filed within 120 days of the end of its fiscal year ended September&#160;26, 2020 are incorporated into Part III (Items 10, 11, 12, 13 and 14) of this Annual Report on Form&#160;10-K where indicated.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0d41300e13ae45ef8bfefa0d42f63c4c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMtMi0xLTEtMA_840a39f8-cbab-43e0-a11a-0ef12019911c"
      unitRef="usd">3227000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3c26ccbfa54e4fe0839a4a6c78466347_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMtNC0xLTEtMA_37225f1d-7402-4fbc-8437-0146b6bff8d8"
      unitRef="usd">2771300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia549e6971a604015a25803b16c10a03b_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMtNi0xLTEtMA_76574913-feb1-454d-85c3-c89d4593645f"
      unitRef="usd">2643900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i794e99945f544149a4dfb0dc4430defe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzQtMi0xLTEtMA_eae6021d-ea60-4823-8585-817f64b5726c"
      unitRef="usd">549400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i76b85f8e0cc641d6811b0f647a80c0b4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzQtNC0xLTEtMA_c7b7cfb6-bcab-4f4e-830a-fc438160e3d8"
      unitRef="usd">596000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i688ec76adf1140acaab8d25b511667aa_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzQtNi0xLTEtMA_779c63b1-c08d-4a8e-8e13-86164518557b"
      unitRef="usd">574000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzUtMi0xLTEtMA_dd722cb6-b0e0-431c-a382-195bc9ecb2b7"
      unitRef="usd">3776400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzUtNC0xLTEtMA_6bf38b9a-9dfb-4b15-8db9-584b413c0a22"
      unitRef="usd">3367300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzUtNi0xLTEtMA_8035c724-91dd-4ce1-8643-91630e1e22de"
      unitRef="usd">3217900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0d41300e13ae45ef8bfefa0d42f63c4c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzctMi0xLTEtMA_3eb919f9-580c-45b4-b2c9-da775cef80bb"
      unitRef="usd">953700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3c26ccbfa54e4fe0839a4a6c78466347_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzctNC0xLTEtMA_b4e2ecdb-0db4-4c06-94f7-bc6da5455d09"
      unitRef="usd">948700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia549e6971a604015a25803b16c10a03b_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzctNi0xLTEtMA_6f83ce7b-cfaa-4fc8-a496-090838cb03f0"
      unitRef="usd">886600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzgtMi0xLTEtMA_c0f01fc6-c83d-4074-bf8f-4bcb24e043d8"
      unitRef="usd">253200000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzgtNC0xLTEtMA_ed4f4255-ca5d-494c-b256-91ca7f5f5b15"
      unitRef="usd">318500000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzgtNi0xLTEtMA_42ef50d7-5f5a-4e8a-a6f4-0d37303f9083"
      unitRef="usd">319400000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssets
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzktMi0xLTEtMA_63462447-ea95-4f2c-8e50-f9349c275517"
      unitRef="usd">25800000</holx:CostOfGoodsSoldImpairmentOfIntangibleAssets>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssets
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzktNC0xLTEtMA_609c377d-3732-44b3-aba6-003881fe890f"
      unitRef="usd">578700000</holx:CostOfGoodsSoldImpairmentOfIntangibleAssets>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssets
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzktNi0xLTEtMA_2bb53ee9-01e7-40d0-bd15-d4cc3d40d553"
      unitRef="usd">0</holx:CostOfGoodsSoldImpairmentOfIntangibleAssets>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i794e99945f544149a4dfb0dc4430defe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEwLTItMS0xLTA_e6f0ddec-a58d-409b-9a5a-b8ee775a01bc"
      unitRef="usd">316200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i76b85f8e0cc641d6811b0f647a80c0b4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEwLTQtMS0xLTA_f917f57e-1997-444c-9a06-de4fd7115424"
      unitRef="usd">350500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i688ec76adf1140acaab8d25b511667aa_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEwLTYtMS0xLTA_997cb8a2-e7d1-4966-a130-93579c5a2143"
      unitRef="usd">315200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzExLTItMS0xLTA_4b25cab8-1df6-4559-8924-44cec6795e8f"
      unitRef="usd">2227500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzExLTQtMS0xLTA_fb6c93f4-04c8-4573-a1b5-5da0eabed9d3"
      unitRef="usd">1170900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzExLTYtMS0xLTA_23b1b563-c71b-4e89-8f62-df6181e2cd43"
      unitRef="usd">1696700000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEzLTItMS0xLTA_23b6718a-9421-486f-940e-0151f892922a"
      unitRef="usd">222500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEzLTQtMS0xLTA_9f6fdfc9-b444-4791-86a0-7b071dfb530e"
      unitRef="usd">232200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzEzLTYtMS0xLTA_5d5f9f34-b506-43c7-9498-929e3171e8d6"
      unitRef="usd">218700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE0LTItMS0xLTA_da90f9a1-7551-4c3a-80ea-924394d30e92"
      unitRef="usd">484600000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE0LTQtMS0xLTA_797ac249-c22a-4936-8dde-3ad35774814b"
      unitRef="usd">564900000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE0LTYtMS0xLTA_783ac4bf-6375-49b6-bc25-a0574275c523"
      unitRef="usd">544600000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE1LTItMS0xLTA_d1023d27-a372-4352-a468-8557909f6bc1"
      unitRef="usd">356000000.0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE1LTQtMS0xLTA_e2d16b2d-a921-40bd-b77b-fa63dd09cc84"
      unitRef="usd">332300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE1LTYtMS0xLTA_6eacdf2a-81dc-48e3-8433-7868b499fe1b"
      unitRef="usd">366100000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE2LTItMS0xLTA_46760c28-53d5-4343-85ed-0d97be157455"
      unitRef="usd">39700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE2LTQtMS0xLTA_1e3947a0-417b-43f5-b6f0-ba14dc8f018f"
      unitRef="usd">52000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE2LTYtMS0xLTA_33122baf-0179-4a68-8ab3-ef98c97be958"
      unitRef="usd">59300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE3LTItMS0xLTA_22fd9678-7994-40b4-ad68-62a5de7bfe61"
      unitRef="usd">4400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE3LTQtMS0xLTA_7f1c5ba9-c6a8-4660-8cd9-a41ab2749780"
      unitRef="usd">106700000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzE3LTYtMS0xLTA_e36bffa5-e323-4a61-b813-2b7988f51a4a"
      unitRef="usd">46000000.0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzIwLTItMS0xLTA_1cf84bcc-8494-492d-a727-4aa5864312c1"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzIwLTQtMS0xLTA_7d308e19-c7be-4405-8461-0f17e1ff50d5"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzIwLTYtMS0xLTA_1843205d-ef88-4888-ab57-536fb8bcbd80"
      unitRef="usd">685700000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:RestructuringCharges
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI0LTItMS0xLTA_cda715ef-1f39-41e2-adec-89854c7e2361"
      unitRef="usd">15300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI0LTQtMS0xLTA_2bb5149e-0327-4169-830a-d5a1755c0afb"
      unitRef="usd">6600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI0LTYtMS0xLTA_24f9ac76-52f0-42b6-a5a0-7bbc5315f7cd"
      unitRef="usd">14200000</us-gaap:RestructuringCharges>
    <us-gaap:OperatingExpenses
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI1LTItMS0xLTA_03494229-100c-43b4-9152-51d066f2f4c6"
      unitRef="usd">1122500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI1LTQtMS0xLTA_b7d55a6a-f7c6-4a7b-b821-050c41199a42"
      unitRef="usd">1294700000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI1LTYtMS0xLTA_5f6d15bc-12bb-41fc-b4bc-c732fd5ffd99"
      unitRef="usd">1934600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI2LTItMS0xLTA_04db1e73-22e7-4216-9281-826fbfb41a7b"
      unitRef="usd">1105000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI2LTQtMS0xLTA_8f87dfaa-58af-4819-bd2b-73cb805551f9"
      unitRef="usd">-123800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI2LTYtMS0xLTA_5c011724-52b0-4dfb-92ef-618eafd956eb"
      unitRef="usd">-237900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI3LTItMS0xLTA_71e43554-0a83-47a3-b656-13a91d348a08"
      unitRef="usd">4300000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI3LTQtMS0xLTA_fb69591d-e398-4466-8696-603c5ccbf0e1"
      unitRef="usd">4600000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI3LTYtMS0xLTA_bcfb5463-5d3c-4832-8efb-d9b3ea53115d"
      unitRef="usd">6300000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI4LTItMS0xLTA_8cf407c7-87a3-4574-a6da-82c0e6a91146"
      unitRef="usd">116500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI4LTQtMS0xLTA_6e9c381e-0972-4602-9c5d-530e1946352b"
      unitRef="usd">140800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI4LTYtMS0xLTA_72be97ad-ff32-4946-a3d7-a15657fd0e00"
      unitRef="usd">148700000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI5LTItMS0xLTA_85c50eef-fd93-459f-ab76-bc402b29bfcf"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI5LTQtMS0xLTA_bccb311b-d92c-4939-90dd-7d8c733b0116"
      unitRef="usd">-800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzI5LTYtMS0xLTA_af6d9cb3-34c3-493e-8f4d-09305078e857"
      unitRef="usd">-45900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMwLTItMS0xLTA_529427f3-cb43-4ee8-a181-007f827d2bc3"
      unitRef="usd">9100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMwLTQtMS0xLTA_4fd6c526-adf1-4eeb-ace1-8b15c366390d"
      unitRef="usd">3100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMwLTYtMS0xLTA_f70ac073-61ec-4f88-96e5-4632ba082d9d"
      unitRef="usd">7600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMxLTItMS0xLTA_a5691244-5edd-4dad-a0c4-511126b4b946"
      unitRef="usd">1001900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMxLTQtMS0xLTA_1f1e513e-62d5-4e99-9649-e18c2f50fc93"
      unitRef="usd">-257700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMxLTYtMS0xLTA_b7739538-812d-4881-9862-e14cfac32009"
      unitRef="usd">-418600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMyLTItMS0xLTA_91785c3d-aeaa-4a82-a9bc-743378c808cc"
      unitRef="usd">-108600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMyLTQtMS0xLTA_7d046dd3-08cd-4a87-a692-6a57e7600577"
      unitRef="usd">-54100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMyLTYtMS0xLTA_31701d3a-62c4-4dce-b3f4-366fb8d9ddee"
      unitRef="usd">-307300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMzLTItMS0xLTA_1b74c0ee-fed2-431d-9316-e02281d1d8d1"
      unitRef="usd">1110500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMzLTQtMS0xLTA_1acbdfbd-34c7-45d2-bc37-a565af0fc741"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzMzLTYtMS0xLTA_81210d42-8042-4ade-a2f3-8bcd3b35c2c5"
      unitRef="usd">-111300000</us-gaap:ProfitLoss>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM0LTItMS0xLTEyMjA_c729818b-03fd-44a7-a572-62ab189b1db1"
      unitRef="usd">-4700000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM0LTQtMS0xLTEyMjA_4ebf056e-2bd2-4bdb-8bd6-af2f92dd00bb"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM0LTYtMS0xLTEyMjA_e333796f-7110-4b02-b7d5-b1ce0f48f174"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTItMS0xLTEwNzMw_054bc051-af3a-4cc5-aef3-d3f1e051d2f7"
      unitRef="usd">1115200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTQtMS0xLTEwNzMz_80466197-076e-4863-af69-0e4546c11dff"
      unitRef="usd">-203600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTYtMS0xLTEwNzM2_e45571cc-0076-4e13-9f9c-34b054ac57b5"
      unitRef="usd">-111300000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTItMS0xLTA_56e1738f-cf25-4110-ab63-21753767332a"
      unitRef="usdPerShare">4.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTQtMS0xLTA_ae9d8669-1b58-4620-b26c-70a121380255"
      unitRef="usdPerShare">-0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM1LTYtMS0xLTA_adf48c95-cef0-495b-9d10-dfbdf1d89261"
      unitRef="usdPerShare">-0.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM2LTItMS0xLTA_014efd4e-0797-47b7-92b3-20c854902083"
      unitRef="usdPerShare">4.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM2LTQtMS0xLTA_a90f8f0b-db92-4ab2-88a7-ffb4d401b5cc"
      unitRef="usdPerShare">-0.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM2LTYtMS0xLTA_843f59d2-c254-49ec-a395-02794d579000"
      unitRef="usdPerShare">-0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM4LTItMS0xLTA_de0dd35f-4f1f-453d-923a-4ab0462ba9c2"
      unitRef="shares">262727000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM4LTQtMS0xLTA_e427ae2f-4849-4476-b4e3-0db50435b065"
      unitRef="shares">269413000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM4LTYtMS0xLTA_a7fe682c-ce44-4536-8abc-edad5910c810"
      unitRef="shares">275105000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM5LTItMS0xLTA_0db0c280-14bb-48b0-8511-7cb6b7e69df7"
      unitRef="shares">264613000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM5LTQtMS0xLTA_feb35c31-e764-4dc2-a08e-b6a9889910e7"
      unitRef="shares">269413000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTIvZnJhZzozNThmMWE3YmVkZjc0YTg2ODdjY2ZjZWYyZjdiNzg3Ny90YWJsZTowY2Y1MGUyZGY3YmI0ZTFjODJkNjFlZWM0YWZlMzA5OS90YWJsZXJhbmdlOjBjZjUwZTJkZjdiYjRlMWM4MmQ2MWVlYzRhZmUzMDk5XzM5LTYtMS0xLTA_76c8863b-5c76-4d3a-894a-2c195c0a109a"
      unitRef="shares">275105000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzItMi0xLTEtMA_9138be34-cbee-470f-ae5c-593c47d5d93c"
      unitRef="usd">1110500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzItNC0xLTEtMA_cd44113d-e4ba-41cb-b38b-1e607f3d62a2"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzItNi0xLTEtMA_e4acc75c-17c3-4cb8-b716-dfdf2c315937"
      unitRef="usd">-111300000</us-gaap:ProfitLoss>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzMtMi0xLTEtMA_7099bc3a-0b52-4306-bd6f-ed82eba1ff4a"
      unitRef="usd">18500000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzMtNC0xLTEtMA_20d4d5d5-08c1-4a0a-848e-1aaabf1d1eae"
      unitRef="usd">-14800000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzMtNi0xLTEtMA_b3cb2a59-08a4-4082-87a6-8918238d6254"
      unitRef="usd">-8100000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjc4NjVlNjhkY2JjZjQwMWQ4NDBmMjk0MGZmNWJjOTY0XzkzNDU4NDg4MzYyMTI_56783bfc-9a77-43de-94e8-cceda1478812"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzYtMi0xLTEtMA_79a8933b-3b3b-4002-b867-54d818b17324"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzYtNC0xLTEtMA_006e1f2e-0b36-40ee-a630-59e8231e7216"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzYtNi0xLTEtMA_f5c89626-cfb0-47c9-94ce-11bba24b91f3"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctMC0xLTEtMC90ZXh0cmVnaW9uOmVjYzc1ZjcxMzQzYTQyMzE5MTQ4ZmJjY2JkOWNmMzBkXzkzNDU4NDg4MzYxOTI_58f333e8-8fa8-4837-b799-dbd5c07482ff"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctMC0xLTEtMC90ZXh0cmVnaW9uOmVjYzc1ZjcxMzQzYTQyMzE5MTQ4ZmJjY2JkOWNmMzBkXzkzNDU4NDg4MzYxOTk_05faca64-1f5c-4729-9071-2fc477e54e91"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctMC0xLTEtMC90ZXh0cmVnaW9uOmVjYzc1ZjcxMzQzYTQyMzE5MTQ4ZmJjY2JkOWNmMzBkXzkzNDU4NDg4MzYyMDg_bc1a9c4c-d186-4565-83ad-81f2a562179f"
      unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctMi0xLTEtMA_a7e1c2d6-056d-4a93-b97e-a3148c246524"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctNC0xLTEtMA_c646e732-de41-45a6-8cb6-480a7ac1e898"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzctNi0xLTEtMA_4529f66b-a57a-49f5-bf29-0204754d7dd0"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <holx:Taxpaidoninterestrateswaps
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjIxYjE4OTk5ZmM1NTQ5MTE4ZDM1N2FiZTJjOWI2ZmI4XzkzNDU4NDg4MzYyMTU_bab11ac0-2b36-41d7-bead-a3671f1213af"
      unitRef="usd">-8300000</holx:Taxpaidoninterestrateswaps>
    <holx:Taxpaidoninterestrateswaps
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjIxYjE4OTk5ZmM1NTQ5MTE4ZDM1N2FiZTJjOWI2ZmI4XzkzNDU4NDg4MzYyMjI_740196dd-405a-4aca-96b0-edcb63f33c17"
      unitRef="usd">1200000</holx:Taxpaidoninterestrateswaps>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtMi0xLTEtMA_981c08d8-fa78-47c1-bc17-3e70b6352632"
      unitRef="usd">-27600000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtNC0xLTEtMA_6e1e0b95-2b93-4e04-8464-6d9ab36c6016"
      unitRef="usd">3500000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ib3117997fe434239b20f6cf308ee6614_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzgtNi0xLTEtMA_423b3049-1add-440e-8919-9b1300ef2c60"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzktMC0xLTEtMC90ZXh0cmVnaW9uOjVhYjFjNGM4NThkZTRjMWZiZTYwYmU3MDcyZGYwMzdkXzkzNDU4NDg4MzYyMTE_aba31b79-6eb3-465f-8760-f408f11d3cc4"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzktMC0xLTEtMC90ZXh0cmVnaW9uOjVhYjFjNGM4NThkZTRjMWZiZTYwYmU3MDcyZGYwMzdkXzkzNDU4NDg4MzYyMTg_8ea1f4eb-16ce-4d2b-a698-82cd58419454"
      unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzktMC0xLTEtMC90ZXh0cmVnaW9uOjVhYjFjNGM4NThkZTRjMWZiZTYwYmU3MDcyZGYwMzdkXzkzNDU4NDg4MzYyMjc_7f0dc62c-3b69-41dc-9b2c-7ff92c4a9ff6"
      unitRef="usd">-5000000.0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i6199234c2a9d4588aa6dd0e453b067ee_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEwLTItMS0xLTA_de4b533c-43d9-429a-bcc5-990a13ce40ad"
      unitRef="usd">-500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i7d2a775a080b412fa3dafce51e6d15ba_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEwLTQtMS0xLTA_9ae1cd63-b6bf-41c9-9c9d-efe1e04e23e8"
      unitRef="usd">-8000000.0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i1cc3451a488c432f89410a83c10d5d44_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEwLTYtMS0xLTA_07d01c90-8473-43a1-a395-fbbdc7331bdc"
      unitRef="usd">-5700000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzExLTItMS0xLTA_b7bde9f1-14a1-4d85-8155-83df7e8183b9"
      unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzExLTQtMS0xLTA_aac9bf63-c1bd-4f6b-b9c2-d89a6e5cf813"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzExLTYtMS0xLTA_617b9623-2958-4b50-be8e-8e8c7e0b5f9d"
      unitRef="usd">-3600000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEyLTItMS0xLTA_a2b22fbb-db73-41c0-9d1d-be6ef015ba57"
      unitRef="usd">-7400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEyLTQtMS0xLTA_6b6e4781-ebef-41c3-a7e1-3f8ef128e9cd"
      unitRef="usd">-16800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEyLTYtMS0xLTA_cc6e2d66-ff2b-46dc-90e6-eef6b1978c19"
      unitRef="usd">-9300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEzLTItMS0xLTA_e5d0b35f-aa63-42b3-a951-c66ec6b586cd"
      unitRef="usd">1103100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEzLTQtMS0xLTA_54300396-1aa8-4587-bb81-cc7dfb136045"
      unitRef="usd">-220400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzEzLTYtMS0xLTA_a050d314-505a-4de5-94f1-6b86b3ef5088"
      unitRef="usd">-120600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE1LTItMS0xLTEyMjc_b0e24f1f-5eab-40d6-bf1e-5e74f9eee9f7"
      unitRef="usd">-4700000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE1LTQtMS0xLTEyMjc_4ebf056e-2bd2-4bdb-8bd6-af2f92dd00bb"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE1LTYtMS0xLTEyMjc_e333796f-7110-4b02-b7d5-b1ce0f48f174"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE2LTItMS0xLTExNTY0_3811ad07-7771-45e8-9216-f5d47781a2b5"
      unitRef="usd">4700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE2LTQtMS0xLTExNTc0_ec17f563-d271-4c6b-86fb-6e748214e557"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE2LTYtMS0xLTExNTc2_175a8309-62eb-495f-8972-aa778371d778"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <holx:ComprehensiveIncome
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE3LTItMS0xLTExNTY3_5211c5ff-f319-4f97-92ba-21f97528965b"
      unitRef="usd">1107800000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE3LTQtMS0xLTExNTcw_6275bc92-a2ce-4289-9f3a-088f1d952232"
      unitRef="usd">-220400000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMTUvZnJhZzpjM2U5Yzg4OGRmMGM0NjlhOWQ4ZGUwZjljZDJhZWFjNS90YWJsZTpiMTk2Mzg3ZWNmYzY0ODMwYWNiOGM4ZTYzZWY5MmU4My90YWJsZXJhbmdlOmIxOTYzODdlY2ZjNjQ4MzBhY2I4YzhlNjNlZjkyZTgzXzE3LTYtMS0xLTExNTcy_978f5c19-69aa-4355-a1c2-70580d9e2075"
      unitRef="usd">-120600000</holx:ComprehensiveIncome>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMtMS0xLTEtMA_70f7bbaf-07ad-4179-97cb-81188ad5979c"
      unitRef="usd">701000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMtMy0xLTEtMA_bafc8f25-b28b-4781-9078-dfcc55ea92be"
      unitRef="usd">601800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjUyYjVhZjc3NzQ4YjQ5ZDA5YWU5ODVmNGUzY2E0MzNmXzkzNDU4NDg4MzYxNzI_66ae13f8-47cb-4bd3-8c08-2839c1f68f37"
      unitRef="usd">31600000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjUyYjVhZjc3NzQ4YjQ5ZDA5YWU5ODVmNGUzY2E0MzNmXzkzNDU4NDg4MzYxODA_80d16cc2-a99f-4146-b084-419dfb003f7b"
      unitRef="usd">17800000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzUtMS0xLTEtMA_b900f62a-7feb-4598-ab39-cabe1aad3d76"
      unitRef="usd">1028900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzUtMy0xLTEtMA_99e63c4d-834b-4eea-a796-b2c0430ec565"
      unitRef="usd">648700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzYtMS0xLTEtMA_fde63635-1b91-48d1-939d-4e2a3ddd755a"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzYtMy0xLTEtMA_d99f5fa6-e6ff-4c75-ba32-5e2d93c9292e"
      unitRef="usd">444900000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzgtMS0xLTEtMA_9bfab2ec-76db-433e-b68c-280314f81fd7"
      unitRef="usd">38800000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzgtMy0xLTEtMA_ffc7e54f-64e5-4718-a96e-485f6e3de9a5"
      unitRef="usd">34900000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzktMS0xLTEtMA_cb5e102d-6005-4844-908f-2a8bab4ec1f4"
      unitRef="usd">58500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzktMy0xLTEtMA_10f7c4d7-828c-4b4d-af7a-d32669f696b4"
      unitRef="usd">62800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzExLTEtMS0xLTA_b8b487e9-6ba2-49de-8060-a29a1909ab21"
      unitRef="usd">2222300000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzExLTMtMS0xLTA_ee44b276-4d1e-4c5f-a0f6-9412219aa832"
      unitRef="usd">1793100000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzEyLTEtMS0xLTA_caaf6f38-9715-4ba3-85f2-b93a69002398"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzEyLTMtMS0xLTA_9677eb0c-5542-438e-a20d-71956051aeff"
      unitRef="usd">470900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzEzLTEtMS0xLTA_85cd86e8-4c06-4d42-91b7-f3a7e3b3c89f"
      unitRef="usd">1307500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzEzLTMtMS0xLTA_c4192231-4dba-473c-89d7-12bf2824657b"
      unitRef="usd">1459800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE0LTEtMS0xLTA_8ad86443-3199-44e3-99f7-032f289db733"
      unitRef="usd">2657900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE0LTMtMS0xLTA_10cfd652-02dc-4d97-b167-9c33616593d0"
      unitRef="usd">2563700000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE1LTEtMS0xLTA_0b22dfa2-18f6-43a8-908d-d58fbb2d09dc"
      unitRef="usd">516600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE1LTMtMS0xLTA_10b7b324-c3d5-4435-8a52-fc4dcd4808dc"
      unitRef="usd">154600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE2LTEtMS0xLTA_5ebc497a-7531-4ec3-ad99-0c4f0c35e066"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE2LTMtMS0xLTA_c240baa5-2fdc-444c-9abc-f61aba151bc5"
      unitRef="usd">6442100000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE5LTEtMS0xLTA_3f872025-efb7-4172-9a1d-87f52c0ef593"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzE5LTMtMS0xLTA_037febfa-ed7f-46c0-bfc6-199fd200dc1c"
      unitRef="usd">271400000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIwLTEtMS0xLTA_22faac34-9044-4808-9f4f-b0c4c71caa4b"
      unitRef="usd">178800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIwLTMtMS0xLTA_c4c53b7f-f0e1-472b-8e08-a2f712cd14ce"
      unitRef="usd">186500000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIxLTEtMS0xLTA_cdcc2302-1c6c-4dab-b572-621f9dbf6f42"
      unitRef="usd">547600000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIxLTMtMS0xLTA_2a85c234-c19e-4d62-8c78-bac1915e653d"
      unitRef="usd">430900000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIyLTEtMS0xLTA_6cf6ab1f-f505-4703-9be7-d3840cf302a2"
      unitRef="usd">186100000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzIyLTMtMS0xLTA_eb89a036-c346-40c6-a198-c649272e98ab"
      unitRef="usd">179500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI0LTEtMS0xLTA_ff8e097a-d514-4ad5-b1e4-8c7f57c8ca8d"
      unitRef="usd">1900000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI0LTMtMS0xLTA_df3b62e4-7d94-4f69-8365-335d305cc977"
      unitRef="usd">1800000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI1LTEtMS0xLTA_40b5f33e-3579-40ee-a9fc-b2920c80996e"
      unitRef="usd">1239300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI1LTMtMS0xLTA_36ee6ad5-77b3-4ebd-9664-73cf5ae89de4"
      unitRef="usd">1070100000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI2LTEtMS0xLTA_359e59e6-c0e7-4121-ad14-010ce4a02558"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI2LTMtMS0xLTA_cd45fe8d-9e9f-44dd-bd40-6c896e6323cd"
      unitRef="usd">2783600000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI3LTEtMS0xLTA_8688186e-aa5c-483f-a720-57adaa1365e6"
      unitRef="usd">17400000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI3LTMtMS0xLTA_0b6235fe-9179-4cf5-8ecf-9d90c351126e"
      unitRef="usd">19200000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI4LTEtMS0xLTA_74c543df-f1b5-49d3-8b7b-00097e336c59"
      unitRef="usd">201800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI4LTMtMS0xLTA_2b9c7f7f-0759-477d-833e-2afe017d4448"
      unitRef="usd">275300000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI5LTEtMS0xLTA_81bf8b5f-fd2f-43fc-befb-133ecc45cdcb"
      unitRef="usd">12900000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzI5LTMtMS0xLTA_ba053b15-097a-4d11-9882-5e33be27ec01"
      unitRef="usd">15800000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMwLTEtMS0xLTA_c0a3640d-9c6a-4c99-8a6d-9bcc292c60dd"
      unitRef="usd">303200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMwLTMtMS0xLTA_0d3b9519-9f00-41cc-8c8e-caa44bf3c125"
      unitRef="usd">162400000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMxLTEtMS0xLTA_af75e81d-e235-4be5-ac45-38d79736fc58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMxLTMtMS0xLTA_2ee86000-37e6-49a8-83d9-08d1d2fbb9e6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTgx_38b42173-48d7-4b75-9fa8-69dd9771576b"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTgx_604837e6-bfec-47c3-8b8e-95fc58e673b6"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTk0_074d78a0-919d-439d-aaef-0bcffbd54c44"
      unitRef="shares">1623000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTk0_25dca06c-f05f-4958-9e72-9d7c6f0ab5e7"
      unitRef="shares">1623000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTk4_0f1d4bed-b7c6-49e6-a06a-c69061ce7f0a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MTdlZDkyODhjYzY0MGVjYjQwZGIzZGI3NjI2MWM1YV85MzQ1ODQ4ODM2MTk4_9087c10b-5c68-4eaf-a930-735ee0df01ed"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTEtMS0xLTA_b5d293a4-ef48-4cf3-b341-7c5f853834bd"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzMzLTMtMS0xLTA_5d5a98b2-44ee-4ba7-9776-d1a3a9e31b7a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjEx_acc3b1ae-f39c-4291-8bdb-e30bfb01a240"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjEx_d4d05fef-a661-471c-9a25-cac1bcaf5bed"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjIy_595d05ef-3c17-437a-ab22-a73e0222d8e8"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjIy_be17f234-660c-4011-ae22-d273e0f7410c"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjMy_70e48138-e321-4d53-aade-1225af0bda14"
      unitRef="shares">295107000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjoxODczMjBjYmUxNTY0Y2I0OWFlYzk5OWY0Njk1NDM1YV85MzQ1ODQ4ODM2MjQy_b9a02728-8ce9-42dc-abf7-809be86745bb"
      unitRef="shares">292323000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTEtMS0xLTA_a12a5b08-3d29-4835-bd51-ee191c8412ad"
      unitRef="usd">2900000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM0LTMtMS0xLTA_5baac526-5290-4de5-b54b-2cd638e0bd80"
      unitRef="usd">2900000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM1LTEtMS0xLTA_4d17ff58-50c4-410e-ac8d-d4ebc8a137a9"
      unitRef="usd">5904800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM1LTMtMS0xLTA_b243c4dd-4136-4346-bdb9-f430636c0d69"
      unitRef="usd">5769800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM2LTEtMS0xLTA_75cc01bb-3bf1-495e-bf15-cb4aebd816b1"
      unitRef="usd">-1573200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM2LTMtMS0xLTA_15b50a34-132a-49ba-b416-c41b897da105"
      unitRef="usd">-2688700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo3NzY0ZDViM2U3MWQ0ZjVjYTRhNzY5MGMwZDM1ZWMyZl85MzQ1ODQ4ODM2MTcw_953df5b1-60bd-4c5c-9d1d-79c83f7880b3"
      unitRef="shares">37609000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo3NzY0ZDViM2U3MWQ0ZjVjYTRhNzY5MGMwZDM1ZWMyZl85MzQ1ODQ4ODM2MTc5_50870157-0cd3-4374-8bde-ebd0018e96b6"
      unitRef="shares">24639000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM3LTEtMS0xLTA_055b34a6-a74c-4c06-b1d6-4198325821dd"
      unitRef="usd">1579600000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM3LTMtMS0xLTA_48002483-818a-4644-9338-08195b0a1c3b"
      unitRef="usd">926000000.0</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM4LTEtMS0xLTA_04fbb2fc-5ee4-4e6e-912f-23fef79c56cc"
      unitRef="usd">-49700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM4LTMtMS0xLTA_c5a122d8-4c0b-4670-9f4e-c482c0189f91"
      unitRef="usd">-42300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM5LTEtMS0xLTA_abb27cbb-ea0f-4590-b3db-d72517817ceb"
      unitRef="usd">2705200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzM5LTMtMS0xLTA_92518861-ae47-4d98-9633-cb9b8e7f2c9b"
      unitRef="usd">2115700000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQwLTEtMS0xLTExNDY_14098bc6-cdd6-4453-94cd-311c8e065882"
      unitRef="usd">2100000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQwLTMtMS0xLTExNDY_84a59682-8514-4af6-b489-52709a1d5846"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQxLTEtMS0xLTEwODcx_b0c64bf5-d055-4dd2-b071-6b8435978510"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQxLTMtMS0xLTEwODc1_253af585-b50a-4d1d-9720-151910509943"
      unitRef="usd">2115700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQwLTEtMS0xLTA_08c91d67-7fe0-4145-8331-447d4ea17bd4"
      unitRef="usd">7195800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjEvZnJhZzo3YmFiMjQ1ZTQ4NTE0OWU0Yjc0Y2Q5Mzk2ZTMwZmVjNy90YWJsZTo0ZmRlNGIwMDQwYmI0YWQzYmY1M2VkY2U4MWRlMDZmNS90YWJsZXJhbmdlOjRmZGU0YjAwNDBiYjRhZDNiZjUzZWRjZTgxZGUwNmY1XzQwLTMtMS0xLTA_74b0d0e9-4620-4d1c-b3eb-8ceb7d0f6f5d"
      unitRef="usd">6442100000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i08aaa1dc14eb440ab123d505e79e47ec_I20170930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTItMS0xLTA_39a80dda-ea27-4c1a-81f5-c7f513ec33c5"
      unitRef="shares">287853000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i08aaa1dc14eb440ab123d505e79e47ec_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTQtMS0xLTA_4dd72e82-bc57-4325-a5ad-690eb83941c4"
      unitRef="usd">2900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i009d515470734764a45e17ec26571fe8_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTYtMS0xLTA_4ebe1de5-45d4-47db-970b-2670a3735162"
      unitRef="usd">5630800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i319b89b955fe451e88544cf9b525eb59_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTgtMS0xLTA_5c2160b1-f53e-4e3a-b62e-dd5ebb32b257"
      unitRef="usd">-2382700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7928b977a78c48f7a935d7a39083e59e_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTEwLTEtMS0w_bd127aad-f901-4427-894a-b7e3c078f3ad"
      unitRef="usd">-16200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i03175a6288164c5db9844f6e6247dd76_I20170930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTEyLTEtMS0w_9b292bf7-21f3-4230-8e01-5f373d556024"
      unitRef="shares">12560000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03175a6288164c5db9844f6e6247dd76_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTE0LTEtMS0w_64700916-f93e-4d88-8c93-9c0cdb63f787"
      unitRef="usd">-450100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icb9f527854bf4eb285447a902fcd7098_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzItMTgtMS0xLTE1NTQ1_c5d36e98-eac1-4bb3-9d3a-f704ea7c5687"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84c88a850d71453097932f0bcbe84825_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTE4LTEtMS0w_0a1f355d-2fd9-4b9e-85d8-af04f1709cb3"
      unitRef="usd">2784700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if3680c6a61084f738e0282f1f1563837_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE4LTItMS0xLTA_95f9bc47-189e-4a1e-a878-26443248e3a9"
      unitRef="shares">795000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE4LTYtMS0xLTA_56a20c4d-d980-4b1a-8fe3-ed0cec19d106"
      unitRef="usd">17300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE4LTE4LTEtMS0w_65d5ff4b-156b-4570-9b5f-c5e9cecc8f25"
      unitRef="usd">17300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="if3680c6a61084f738e0282f1f1563837_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE5LTItMS0xLTA_60a588ec-2204-4113-8bac-eb99a13f2f41"
      unitRef="shares">804000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE5LTYtMS0xLTA_7c786faa-c53f-429e-b3d9-308d106cdb44"
      unitRef="usd">-16700000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE5LTE4LTEtMS0w_df1596db-1607-444c-9e9b-d997ac62636e"
      unitRef="usd">-16700000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if3680c6a61084f738e0282f1f1563837_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIwLTItMS0xLTA_9b6d73d2-602a-43cb-85bd-bff4a5ba449e"
      unitRef="shares">448000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIwLTYtMS0xLTA_f9e95056-4d41-4920-be6a-bffa98719465"
      unitRef="usd">15600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIwLTE4LTEtMS0w_75351266-37d3-4e7d-b683-582e988bec29"
      unitRef="usd">15600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIxLTYtMS0xLTA_05ccb6a2-9bab-4607-b1d9-c5e8656ea23b"
      unitRef="usd">65000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIxLTE4LTEtMS0w_322ffbb6-38c7-4649-907a-0f78afe5c0b5"
      unitRef="usd">65000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i3d6a1986d92f453984d55b9a06b6c031_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIzLTYtMS0xLTA_8a37a621-47e6-4762-b92b-a545561582f9"
      unitRef="usd">-40700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzIzLTE4LTEtMS0w_c2f1f37d-734e-4de9-becb-e7aa085dabd8"
      unitRef="usd">-40700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:ProfitLoss
      contextRef="i50a8cec88f63482ca86e8907428a7f7a_D20171001-20180929"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI0LTgtMS0xLTA_40aba8ad-4482-42ed-8b9e-8dfd7e7842c9"
      unitRef="usd">-111300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI0LTE4LTEtMS0w_b0fc4011-9227-4d54-9909-606c4a58573d"
      unitRef="usd">-111300000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI1LTEwLTEtMS0w_53ade7db-c731-43d2-95ba-769e569a68de"
      unitRef="usd">-8100000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI1LTE4LTEtMS0w_daf5758f-c02e-4f6b-afdd-aab303b0c766"
      unitRef="usd">-8100000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI2LTEwLTEtMS0w_49ccff99-543e-45b2-8d6b-487241c20344"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI2LTE4LTEtMS0w_41b1b96b-e9a2-41f7-a1a0-16a111c51d26"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic930cb3d51304cadbaffbad6e4174a9f_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI3LTEyLTEtMS0w_8af2b44e-0df8-4912-bc68-15562d029e3b"
      unitRef="shares">7252000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ic930cb3d51304cadbaffbad6e4174a9f_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI3LTE0LTEtMS0w_d73c6ca2-0ef7-42a9-8054-287f50804cba"
      unitRef="usd">275800000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI3LTE4LTEtMS0w_7ddff5f8-4b3d-400a-90b5-cf9f87fb09d2"
      unitRef="usd">275800000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI4LTEwLTEtMS0w_590e7e58-f805-4e46-9887-20cd81728f00"
      unitRef="usd">-5700000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzI4LTE4LTEtMS0w_89b411d4-9e5f-4808-bd09-8c2c34a9d863"
      unitRef="usd">-5700000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMwLTEwLTEtMS0w_d19c31f5-6e43-459d-a730-398acd6e9734"
      unitRef="usd">-3600000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMwLTE4LTEtMS0w_4ae7eeda-bfe4-4b4c-a368-aa21a3d42821"
      unitRef="usd">-3600000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i8fd709993dd442dda3a69099fdd949e7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMxLTEwLTEtMS0w_1224448b-5578-4065-b572-54c0698b33e9"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMxLTE4LTEtMS0w_10baf807-418b-447d-9c4c-c35ad8b9f6c6"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i95ca35177efc4ae98f89b9162289d0f8_I20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTItMS0xLTA_2c904651-89ff-40ec-85a5-496f402008ea"
      unitRef="shares">289900000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95ca35177efc4ae98f89b9162289d0f8_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTQtMS0xLTA_65a1e30f-8321-4cf4-9337-44ded8c015e0"
      unitRef="usd">2900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if6afd02343ba40d68f7f7d2d38b8d6bb_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTYtMS0xLTA_59bde5cf-36b5-479e-9ee2-af84f1d41121"
      unitRef="usd">5671300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2fdee7361ebc4584bbc3a5cfe6444f08_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTgtMS0xLTA_66243ff0-2328-4778-86d9-c6e7aaef1065"
      unitRef="usd">-2494000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03e40fe371564654b09f93a1ae599923_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTEwLTEtMS0w_7724350d-8c85-4730-bce6-bd43a5866cb8"
      unitRef="usd">-25500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i0174c6f539e747949d68830c151f307c_I20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTEyLTEtMS0w_5a993a46-5170-490a-b82e-c07976cd5be5"
      unitRef="shares">19812000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0174c6f539e747949d68830c151f307c_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTE0LTEtMS0w_733cb484-97d0-4131-9e1a-2dbc8f8096df"
      unitRef="usd">-725900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie46091349b474da791e8169a5e898ab5_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzE3LTE4LTEtMS0xNTU0Mg_35a5dd16-226b-4cfe-a979-ff5082ca8269"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTE4LTEtMS0w_d1a2e662-dbff-4072-938b-2423975edf1d"
      unitRef="usd">2428800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <holx:AccountingstandardtransitionadjustmentASC606
      contextRef="i57069c8fd22f43268f97f2c41b7f2a8d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMzLTgtMS0xLTA_f6377091-bae1-4c3d-b142-e8247b3d30f3"
      unitRef="usd">-6400000</holx:AccountingstandardtransitionadjustmentASC606>
    <holx:AccountingstandardtransitionadjustmentASC606
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMzLTE4LTEtMS0w_ed8b1405-ea73-4cc6-bc76-69faaae2b6e2"
      unitRef="usd">-6400000</holx:AccountingstandardtransitionadjustmentASC606>
    <holx:AccountingstandardtransitionadjustmentASU201616
      contextRef="i57069c8fd22f43268f97f2c41b7f2a8d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM0LTgtMS0xLTA_95fbb42a-2eef-4b1b-8318-87c0b8ca4711"
      unitRef="usd">-2500000</holx:AccountingstandardtransitionadjustmentASU201616>
    <holx:AccountingstandardtransitionadjustmentASU201616
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM0LTE4LTEtMS0w_da841f99-c939-4e16-9b99-8a8ff6ac7ba8"
      unitRef="usd">-2500000</holx:AccountingstandardtransitionadjustmentASU201616>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2d8bd96d523f45339390f0f694678659_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTItMS0xLTA_418de46c-2020-499b-b12e-cb746e25ee11"
      unitRef="shares">1304000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTYtMS0xLTA_a960aeaa-3997-47a9-bc02-2ae5cf1ac552"
      unitRef="usd">32800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTE4LTEtMS0w_1e630bee-7bca-47e8-b500-7325536090ee"
      unitRef="usd">32800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i2d8bd96d523f45339390f0f694678659_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTItMS0xLTA_7a9073c9-0cec-4d32-bb0a-8366562a2a1a"
      unitRef="shares">645000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTYtMS0xLTA_03744327-b22a-480b-9cc1-25b492390159"
      unitRef="usd">-12800000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTE4LTEtMS0w_f0965677-4405-4923-b055-8e9c5c9c7d45"
      unitRef="usd">-12800000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i2d8bd96d523f45339390f0f694678659_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTItMS0xLTA_e2263fb0-103c-4ca1-a7fd-89c5e21d6457"
      unitRef="shares">474000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTYtMS0xLTA_edd0a326-b88b-44e7-b57b-2b2254a2f725"
      unitRef="usd">16500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTE4LTEtMS0w_84b16423-6eb3-4ecd-b012-cc73a7e52b1b"
      unitRef="usd">16500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i53b488c8ef8348de92924cc5a7663c22_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM4LTYtMS0xLTA_81030829-94eb-4984-a134-eacfec6cf93a"
      unitRef="usd">62000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM4LTE4LTEtMS0w_a2f9ca56-4681-45e7-a2ba-c541f337deb6"
      unitRef="usd">62000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="i57069c8fd22f43268f97f2c41b7f2a8d_D20180930-20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTgtMS0xLTA_996681da-256a-4ac6-9891-d956c8ed521f"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTE4LTEtMS0w_dfb1a62b-380b-4f69-b23c-2ac985192572"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQwLTEwLTEtMS0w_1f33b281-3d2d-4709-a475-0e88e45bc5e6"
      unitRef="usd">-14800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQwLTE4LTEtMS0w_8b39fc05-1122-470e-afdc-449396ecd971"
      unitRef="usd">-14800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQxLTEwLTEtMS0w_aa9c85ca-aa00-4445-8c48-0c112d03d2ff"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQxLTE4LTEtMS0w_9c4fb1bb-6c1c-490e-b9b8-e9db7571dee6"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibdbdc18a2bcb43a3bdf8e6c1cf19d396_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTEyLTEtMS0w_55593979-e9e8-4534-b603-79f33e1b4cbd"
      unitRef="shares">4826000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ibdbdc18a2bcb43a3bdf8e6c1cf19d396_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTE0LTEtMS0w_63fa5047-4bb1-40e6-b7c2-bd7be406a16d"
      unitRef="usd">200100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTE4LTEtMS0w_5193a441-1b4b-40d0-89a3-f60c0358e77d"
      unitRef="usd">200100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTEwLTEtMS0w_1e23e596-7859-4b68-a718-cf9d24b1457d"
      unitRef="usd">-8000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTE4LTEtMS0w_82621c82-b6f4-42b7-af63-ca0cd28084ff"
      unitRef="usd">-8000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ0LTEwLTEtMS0w_c58e167e-a9a8-45d0-9fce-8c359aab6f37"
      unitRef="usd">3500000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ0LTE4LTEtMS0w_6bc013f6-3310-4c65-8506-ddacf95bdb32"
      unitRef="usd">3500000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="iddd3d4c507194ee78a80a72efcf02283_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ1LTEwLTEtMS0w_6561924c-b3ff-44c2-9b58-d50e1d167453"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ1LTE4LTEtMS0w_25902720-210f-4fb3-a021-09e49cb9e399"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:SharesIssued
      contextRef="if1a27903b45f460e8b58b329d59f97d8_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTItMS0xLTA_b3973d4e-aaee-4f8b-920e-be9dc6eaa5a3"
      unitRef="shares">292323000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1a27903b45f460e8b58b329d59f97d8_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTQtMS0xLTA_31033f78-ab7a-4f08-90e5-c4ee19d1b914"
      unitRef="usd">2900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i21125621c43043b5a43f09df6f874b52_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTYtMS0xLTA_d0758f08-c825-44bd-b3d8-3fe55da35769"
      unitRef="usd">5769800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71115cc05c394a8a980ec543ca44bc53_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTgtMS0xLTA_25ce1667-1f7a-4201-acfb-63913f3ff0dc"
      unitRef="usd">-2688700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id804545a264447f98e68c02862888397_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTEwLTEtMS0w_bd5a2d15-3be8-4b72-a00a-b9fd4badb014"
      unitRef="usd">-42300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i7c166eb8bb6741edb7c59919ec94dfc7_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTEyLTEtMS0w_ae7b2e77-97d1-4431-a40a-28e6e7d3f980"
      unitRef="shares">24638000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c166eb8bb6741edb7c59919ec94dfc7_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTE0LTEtMS0w_4e2e440b-9d13-4be7-999d-9660b436a6ca"
      unitRef="usd">-926000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icb9f527854bf4eb285447a902fcd7098_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMyLTE4LTEtMS0xNTUzNg_5d581f61-ce71-4706-b484-b30d0330cf03"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTE4LTEtMS0w_04588bad-9336-4a49-bb10-563e9ac5499e"
      unitRef="usd">2115700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i5a4d7c88b3174a34837a1c0045f15e4d_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMzLTE4LTEtMS0xNTUyOQ_7819b19c-ba66-414c-a14b-d7a0d7da09b6"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzMzLTIwLTEtMS0xNDg2MA_98fed2c5-39e7-475b-a2ab-41133c9be1f6"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="iadd2a9a1773e4a9b84d417b384632c4a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM0LTgtMS0xLTE0ODEw_05bcab10-c6a7-49e8-b6fe-94eb0d138a48"
      unitRef="usd">-300000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="id050245a51244dfdad49743f31133eb8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM0LTIwLTEtMS0xNDg2MQ_55e2ec03-d5c6-4891-ab02-373c02c8e962"
      unitRef="usd">-300000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i032815f3d67a43c29b8c166834679ea4_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTItMS0xLTE0Nzc0_0697040b-8586-4f6a-afa8-e55ed4b4d7b5"
      unitRef="shares">1761000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTYtMS0xLTE0Nzk4_8a7e99d1-331c-4465-ae07-7dccb034b979"
      unitRef="usd">48300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM1LTIwLTEtMS0xNDg2NA_0f5beaed-8660-4018-b50a-10c949f6f49b"
      unitRef="usd">48300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i032815f3d67a43c29b8c166834679ea4_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTItMS0xLTE0Nzc2_094b0472-5499-43bc-89ef-dca84f6d5cf2"
      unitRef="shares">611000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTYtMS0xLTkxNDE_d007ccee-79f6-4fb9-a5c5-6570b909711b"
      unitRef="usd">-14200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM2LTIwLTEtMS0xNDg2Ng_fb2b4fd9-1f66-476d-a05b-d4de034e6921"
      unitRef="usd">-14200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i032815f3d67a43c29b8c166834679ea4_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTItMS0xLTE0Nzc4_780c28c3-0134-44b8-958d-da7a9b001042"
      unitRef="shares">412000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTYtMS0xLTE0ODAy_a4cd3c86-3dfc-4436-9124-d3073f92050e"
      unitRef="usd">17600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM3LTIwLTEtMS0xNDg2Nw_4fc0ca3f-8710-4c9c-a690-eb45c415da1f"
      unitRef="usd">17600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib1fd1446c44b4cd49849ce6cc2ff2915_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM4LTYtMS0xLTkxMzk_311bc01a-165c-4486-a674-357068823da2"
      unitRef="usd">83300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM4LTIwLTEtMS0xNDg3MA_6c55eb31-ead8-460d-8b03-bc05a0b69032"
      unitRef="usd">83300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="i36030839f7884303bb258fae716235dd_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTgtMS0xLTkxODI_3e614886-aef0-4414-b603-dbadfb21ce18"
      unitRef="usd">1115200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5a4d7c88b3174a34837a1c0045f15e4d_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTE4LTEtMS0xNDg5MA_f5b5c92f-44f3-4410-80cb-12959ab37914"
      unitRef="usd">-4700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzM5LTIwLTEtMS0xNDg3Mg_2282fdc2-2965-409c-98ee-69236b29aaf4"
      unitRef="usd">1110500000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQwLTEwLTEtMS0xNDgxNA_49dec108-9892-4a1f-a726-d303539701e0"
      unitRef="usd">18500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQwLTIwLTEtMS0xNDg3NA_3bda1a54-7559-4f9e-b8ea-15fd2c3102a2"
      unitRef="usd">18500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQxLTEwLTEtMS0xNDgxNQ_eb3179e8-cbc0-405c-8580-f3de3b9d04df"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQxLTIwLTEtMS0xNDg3Ng_7ae94b43-03bd-473d-81f1-378667995bb0"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1957ccc6b7a54f27a19bf968742bbf75_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTEyLTEtMS0xNDg5Mg_ca1144f9-f50e-41d7-98da-b1db7b9363a2"
      unitRef="shares">9064000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i1957ccc6b7a54f27a19bf968742bbf75_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTE0LTEtMS0xNDg5OA_7821a85b-2403-4ab3-ac06-d423a03235b3"
      unitRef="usd">448600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQyLTIwLTEtMS0xNDg3OA_676877ff-7e09-4bd9-a6c2-08a2e0e7895d"
      unitRef="usd">448600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i94e21961902342f58ae493fd44252348_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTEyLTEtMS0xNDg5Mw_163c27aa-d984-4818-875e-b3aa8aa25367"
      unitRef="shares">3907000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i94e21961902342f58ae493fd44252348_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTE0LTEtMS0xNDkwMA_41bd63fd-1b04-4281-9c85-2599343369a7"
      unitRef="usd">205000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i49a3d6edcda84d5e8d51e6886159c6f0_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQzLTIwLTEtMS0xNDg4MA_3bcb2c1f-e06a-43e5-af77-e26981f4742e"
      unitRef="usd">205000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ0LTEwLTEtMS0xNDgxOA_9831111f-6a02-46dc-b6d2-2acd807255ea"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ0LTIwLTEtMS0xNDg4MQ_b3ae05fc-975b-4fb5-9713-717c20b222b5"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ1LTEwLTEtMS0xNDgxOQ_364f8b5a-3fa1-4dea-b978-2ecfeecbdc19"
      unitRef="usd">-27600000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ1LTIwLTEtMS0xNDg4NA_0b868a54-82c4-4a0f-b6f1-7887030074cc"
      unitRef="usd">-27600000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i9b322cc8b11749b29e4e9666c25cad0c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ2LTEwLTEtMS0xNDgyMg_112ac7d0-53c6-4f3e-90c7-d22886ed99f2"
      unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ2LTIwLTEtMS0xNDg4Ng_bfcc462e-867a-4752-8689-1ff4b7ff30bb"
      unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i5a4d7c88b3174a34837a1c0045f15e4d_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTE4LTEtMS0xNTUyMA_dd9be4b3-b13d-4b20-864d-e6e138b919d3"
      unitRef="usd">1800000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ3LTIwLTEtMS0xNDg4OA_9fedfbdf-99f3-49cc-8314-6147a760bb2a"
      unitRef="usd">1800000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="ibc54b6fd6f2747fb9422322da3ef9079_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTItMS0xLTE0ODMy_518ddf9b-4373-468a-800d-2b9bcf83c034"
      unitRef="shares">295107000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc54b6fd6f2747fb9422322da3ef9079_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTQtMS0xLTE0ODM0_3863a33b-b2fd-492c-b059-fad7ca8344f7"
      unitRef="usd">2900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa08cbf6d272455e8f8d4fc150075d1e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTYtMS0xLTkyMjA_769ed2b9-b24b-49bf-abb9-791e3dbb95ef"
      unitRef="usd">5904800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75f2f7acec1c4c4aa787e72d606b369e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTgtMS0xLTkyMTg_68866479-aed8-4aca-ae0f-519cf8c76224"
      unitRef="usd">-1573200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31584edc599f43b4b1edbb086c4349e5_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTEwLTEtMS0xNDg0MA_d3714676-49e6-4340-acfd-64e5dd815a01"
      unitRef="usd">-49700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ibce62cc16e0d420ab20aa0dd17c08716_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTEyLTEtMS0xNDg0Mg_2d145713-8fc2-4eba-8330-8d5b21c85648"
      unitRef="shares">37609000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibce62cc16e0d420ab20aa0dd17c08716_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTE0LTEtMS0xNDg0NA_8d9a654f-d300-4f8c-be2c-237180450697"
      unitRef="usd">-1579600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f2b3be1822c481ea0d7d8b6f100c51b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTE4LTEtMS0xNDg0Ng_d113a965-dcc2-4e75-b790-6c7ac4340ed6"
      unitRef="usd">2100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMjcvZnJhZzpmYjkwZjI2NTYzY2Q0MzY2OGEwNGYzNWJlODJkYTcxZS90YWJsZTpjODk1MzdkOTU4MDg0ZjhlYTlhYzJhYWIwNmU4ZDdiOC90YWJsZXJhbmdlOmM4OTUzN2Q5NTgwODRmOGVhOWFjMmFhYjA2ZThkN2I4XzQ4LTIwLTEtMS0xNDg0OQ_c70a7649-1f7a-4093-960e-3789be8f58a0"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMtMS0xLTEtMA_9a1ae78a-cfca-4e60-bff4-3e70d417eb22"
      unitRef="usd">1110500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMtMy0xLTEtMA_6305f581-fb29-45e6-9288-a68a3092b8dc"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMtNS0xLTEtMA_8365dc9d-9d8b-4b35-854f-628012451fed"
      unitRef="usd">-111300000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUtMS0xLTEtMA_2cadc93f-613c-4699-b257-50e045dff997"
      unitRef="usd">83100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUtMy0xLTEtMA_532e2667-93b8-49e1-b7fb-c0c39b7789b9"
      unitRef="usd">92500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUtNS0xLTEtMA_73ac0db1-2a6c-464e-b97d-995511fe9d1e"
      unitRef="usd">101600000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYtMS0xLTEtMA_b368e7ab-8639-40a2-8155-06a7907c5b52"
      unitRef="usd">292900000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYtMy0xLTEtMA_da88d4b4-a855-4310-af94-a917e1c816d7"
      unitRef="usd">370600000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYtNS0xLTEtMA_53f0d298-0a92-461c-8afd-ffb9a806a1f4"
      unitRef="usd">378700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzgtMS0xLTEtMA_2c6370ab-2d5a-451b-baa7-33e4d1651e71"
      unitRef="usd">83300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzgtMy0xLTEtMA_7672225f-2d3e-4c2d-881c-b57d26b95bd7"
      unitRef="usd">62000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzgtNS0xLTEtMA_98110298-f7d4-48e2-8ad4-750133b45185"
      unitRef="usd">65000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEwLTEtMS0xLTA_3cf0d27c-773c-49c0-97bc-9debbd1aa9a6"
      unitRef="usd">-94400000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEwLTMtMS0xLTA_93ec2167-b1bf-4a88-aa1b-cc3434b61d59"
      unitRef="usd">-235700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEwLTUtMS0xLTA_6d65204d-43f8-4275-88a5-557d5a2fda20"
      unitRef="usd">-477300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEyLTEtMS0xLTA_cee0e58f-af22-4fea-8eff-4093dce501f2"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEyLTMtMS0xLTA_c656eb36-de75-41c4-8dba-ad9791f3e8e5"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEyLTUtMS0xLTA_e4cc570a-b4aa-43cf-bb46-7957929c7a84"
      unitRef="usd">685700000</us-gaap:GoodwillImpairmentLoss>
    <holx:Impairmentofintangibleassetsandequipment
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEzLTEtMS0xLTA_79e7ebdc-a2d7-4947-9234-b877e5d34b6d"
      unitRef="usd">30200000</holx:Impairmentofintangibleassetsandequipment>
    <holx:Impairmentofintangibleassetsandequipment
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEzLTMtMS0xLTA_29564bad-a6ac-4e59-9a3f-6772e5130a05"
      unitRef="usd">685400000</holx:Impairmentofintangibleassetsandequipment>
    <holx:Impairmentofintangibleassetsandequipment
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzEzLTUtMS0xLTA_f12e488e-9163-4c95-bd1a-527a0532e5f4"
      unitRef="usd">46000000.0</holx:Impairmentofintangibleassetsandequipment>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzE4LTEtMS0xLTA_4766aa31-371c-403f-9ede-1121b0f5937a"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzE4LTMtMS0xLTA_050800c4-d7f2-455b-8260-f4c286064fc3"
      unitRef="usd">-800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzE4LTUtMS0xLTA_88fbdd57-0acd-4e64-b1eb-23bc12d32e56"
      unitRef="usd">-45900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzIzLTEtMS0xLTA_190b13ba-93c0-45c9-b3b9-6576379369c2"
      unitRef="usd">-27300000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzIzLTMtMS0xLTA_fad301ed-b2c7-4ed8-ada4-ca66220abc3a"
      unitRef="usd">-33800000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzIzLTUtMS0xLTA_65fa871e-8cd8-4d8e-9d5f-829d1ce613a9"
      unitRef="usd">-24800000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI1LTEtMS0xLTA_73b03104-6e0d-4449-b3ec-a7c081617e31"
      unitRef="usd">427100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI1LTMtMS0xLTA_2c2563e3-52fa-4697-8133-e99b1f575cc4"
      unitRef="usd">76500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI1LTUtMS0xLTA_7adfb452-1274-41b2-b231-264c4a091256"
      unitRef="usd">38200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI2LTEtMS0xLTA_28e35eb1-6c17-41fd-b09c-718e666f6fd7"
      unitRef="usd">25300000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI2LTMtMS0xLTA_eb827d77-4941-485d-99d4-7fd321ba0409"
      unitRef="usd">63000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI2LTUtMS0xLTA_7ecc0762-6c5d-4734-930f-381361e6d4d4"
      unitRef="usd">50600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI3LTEtMS0xLTA_fcb1b42f-57d3-485d-891f-011670e05a7d"
      unitRef="usd">3800000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI3LTMtMS0xLTA_4e20eabe-0be3-46ba-a40b-b5babb08e8de"
      unitRef="usd">3200000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI3LTUtMS0xLTA_a88ad0d6-5771-4d12-82fa-e1b295698e36"
      unitRef="usd">9400000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI4LTEtMS0xLTA_52d41896-bea0-4aa0-a16d-d758bc74ca4c"
      unitRef="usd">286200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI4LTMtMS0xLTA_ea5e89c5-5f91-4d6f-9d06-ea1068d32731"
      unitRef="usd">6000000.0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI4LTUtMS0xLTA_ca21c0ec-71f8-41ae-9ed6-93d93b9dda47"
      unitRef="usd">4200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI5LTEtMS0xLTA_10327168-4d70-4b0c-aa00-6ae4ebc4f2cb"
      unitRef="usd">-4900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI5LTMtMS0xLTA_710c996d-fc19-4f2d-8fee-19eea83c6734"
      unitRef="usd">-5500000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzI5LTUtMS0xLTA_e16fd2a4-df88-4fd1-a11a-e6dd616ba294"
      unitRef="usd">23900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMwLTEtMS0xLTA_252f1c6f-9a6d-48c3-9341-785d2cadb666"
      unitRef="usd">96000000.0</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMwLTMtMS0xLTA_083eaa8b-51af-4463-b93e-f7e762483cd4"
      unitRef="usd">-16500000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMwLTUtMS0xLTA_39e8c94a-4adf-41a3-9a6f-e6e810bfbd2d"
      unitRef="usd">53800000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMxLTEtMS0xLTA_333eb06f-e0d5-400b-89ad-fc56431cd655"
      unitRef="usd">15000000.0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMxLTMtMS0xLTA_1eb4a84d-1176-4d68-abc3-893e68647136"
      unitRef="usd">14400000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMxLTUtMS0xLTA_dae0b018-3f8e-4159-8a5d-c9e2fd73e87d"
      unitRef="usd">-1500000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMyLTEtMS0xLTA_c8ab4086-3fb5-4eb1-abd5-cc236fe9981c"
      unitRef="usd">896600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMyLTMtMS0xLTA_70258c6e-f64f-4242-90ea-f1f190200172"
      unitRef="usd">649500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzMyLTUtMS0xLTA_1abc8986-92e2-4d33-80eb-e8103f17875c"
      unitRef="usd">732900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM0LTEtMS0xLTA_41ff7fc0-22af-442e-a52a-eab5e9abcee0"
      unitRef="usd">119400000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM0LTMtMS0xLTA_9f6ce184-295e-464d-b474-9c08d454b81c"
      unitRef="usd">110600000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM0LTUtMS0xLTA_08cf25f3-df30-4a5f-b9a7-56fef4f4e7ec"
      unitRef="usd">76500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM2LTEtMS0xLTA_a6e158a9-a1bc-4306-99fb-11c6ab81a182"
      unitRef="usd">139300000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM2LTMtMS0xLTA_565739fc-f1d2-4fec-a1ec-f07510ed5cfb"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM2LTUtMS0xLTA_47266239-f05b-4d23-87cf-17b32e996897"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM3LTEtMS0xLTA_2638f4e6-3918-4b1b-8d7d-cf227d4587e6"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM3LTMtMS0xLTA_2d301796-8658-4a15-9d72-67ea92f19752"
      unitRef="usd">18200000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM3LTUtMS0xLTA_273e0503-b290-45c6-bcf0-49146a50caa5"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <holx:FundingOfLoansToSSI
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM4LTEtMS0xLTA_f05ce790-7a40-4db0-b8c7-bcfcdabb1c6c"
      unitRef="usd">0</holx:FundingOfLoansToSSI>
    <holx:FundingOfLoansToSSI
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM4LTMtMS0xLTA_97fba08d-f40c-4352-8d92-8bbb876cd011"
      unitRef="usd">28400000</holx:FundingOfLoansToSSI>
    <holx:FundingOfLoansToSSI
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM4LTUtMS0xLTA_a142923f-28dc-4104-ac12-7145e389f144"
      unitRef="usd">0</holx:FundingOfLoansToSSI>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM5LTEtMS0xLTA_ae812832-62e4-492f-9948-8a5fc22f74b2"
      unitRef="usd">98300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM5LTMtMS0xLTA_63d4be9a-53f8-42ab-b95f-64a2d635025c"
      unitRef="usd">57000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzM5LTUtMS0xLTA_7a4e8b59-3126-4f80-aaf0-0b8d4cfc0866"
      unitRef="usd">58400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQwLTEtMS0xLTA_1774b917-7c1f-498c-b847-8882e75502a4"
      unitRef="usd">58100000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQwLTMtMS0xLTA_681560ee-07ec-4778-a071-068673f65a20"
      unitRef="usd">52100000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQwLTUtMS0xLTA_96e583b4-02da-4298-b758-c67a9331715d"
      unitRef="usd">47200000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:Purchaseofcostmethodinvestment
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQyLTEtMS0xLTA_094a514f-c0d4-434d-aff4-ac4053cef6e5"
      unitRef="usd">0</holx:Purchaseofcostmethodinvestment>
    <holx:Purchaseofcostmethodinvestment
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQyLTMtMS0xLTA_825fadeb-e7d8-4183-855f-ae3d6c35bcc5"
      unitRef="usd">3000000.0</holx:Purchaseofcostmethodinvestment>
    <holx:Purchaseofcostmethodinvestment
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQyLTUtMS0xLTA_c5bde7ee-9663-4bf0-8b77-fb3e48ec8bff"
      unitRef="usd">6000000.0</holx:Purchaseofcostmethodinvestment>
    <holx:Purchaseofinsurancecontracts
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ0LTEtMS0xLTA_5e21226a-ab7c-4cba-9e36-3ec1c1484cb6"
      unitRef="usd">2400000</holx:Purchaseofinsurancecontracts>
    <holx:Purchaseofinsurancecontracts
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ0LTMtMS0xLTA_19a59080-a037-4f20-8ca0-a92d419a4cf8"
      unitRef="usd">0</holx:Purchaseofinsurancecontracts>
    <holx:Purchaseofinsurancecontracts
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ0LTUtMS0xLTA_108a91b8-c582-4465-a422-82880ca15468"
      unitRef="usd">0</holx:Purchaseofinsurancecontracts>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ3LTEtMS0xLTA_5fb70eae-0c7a-4649-b630-31cba88a0298"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ3LTMtMS0xLTA_5fbb5fb9-bddc-4ef6-9d6e-40ab92eb1a7f"
      unitRef="usd">4500000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ3LTUtMS0xLTA_b60fcc38-0470-4eea-b3b4-0b2c7cd05b92"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ5LTEtMS0xLTA_a845d002-3de0-4015-b1af-1f08fd74defb"
      unitRef="usd">2700000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ5LTMtMS0xLTA_086e7982-53a1-4d29-8b64-36b9a71a022e"
      unitRef="usd">6900000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzQ5LTUtMS0xLTA_29495fa2-6cba-4347-9473-df162101947c"
      unitRef="usd">7100000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUwLTEtMS0xLTA_d1716793-484a-438c-89c6-2697c0edcb32"
      unitRef="usd">-141600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUwLTMtMS0xLTA_d628142c-f15d-447b-98f8-583c5ee3c048"
      unitRef="usd">-280700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUwLTUtMS0xLTA_992c4f21-3244-4a52-8273-f2af27c70c07"
      unitRef="usd">-195200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUyLTEtMS0xLTA_ca89f64c-0438-4c14-a35a-f9c8f0bf8447"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUyLTMtMS0xLTA_d36aab47-70a3-465f-9e48-089ebac934c9"
      unitRef="usd">1500000000.0</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUyLTUtMS0xLTA_857f53c3-dd4f-445e-8862-733431649f73"
      unitRef="usd">1500000000.0</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUzLTEtMS0xLTA_2c204cd7-7437-44d5-ae5f-d8ec71e533f3"
      unitRef="usd">37500000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUzLTMtMS0xLTA_d9c88502-1f01-448a-ba18-c37259bc52ba"
      unitRef="usd">1462500000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzUzLTUtMS0xLTA_607f3c31-e56b-4617-88c0-fcecadd20ea8"
      unitRef="usd">1359400000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <holx:ProceedsfromSeniorNotes
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU0LTEtMS0xLTA_13f5d057-bfec-47da-8b04-9939a066f1f4"
      unitRef="usd">0</holx:ProceedsfromSeniorNotes>
    <holx:ProceedsfromSeniorNotes
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU0LTMtMS0xLTA_d353be08-798c-46a9-8991-d72c29ab6785"
      unitRef="usd">0</holx:ProceedsfromSeniorNotes>
    <holx:ProceedsfromSeniorNotes
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU0LTUtMS0xLTA_e99bd259-bc38-4f27-9a7e-38b861951688"
      unitRef="usd">1350000000.0</holx:ProceedsfromSeniorNotes>
    <holx:RepaymentofSeniorNotes
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU1LTEtMS0xLTA_c5170796-5ced-4778-8d79-09019d324b3a"
      unitRef="usd">0</holx:RepaymentofSeniorNotes>
    <holx:RepaymentofSeniorNotes
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU1LTMtMS0xLTA_7cd0cdbe-150f-4618-8259-da4b696ab468"
      unitRef="usd">0</holx:RepaymentofSeniorNotes>
    <holx:RepaymentofSeniorNotes
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU1LTUtMS0xLTA_4c2df064-ccd1-4024-bca4-9d8d39244c79"
      unitRef="usd">1037700000</holx:RepaymentofSeniorNotes>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU2LTEtMS0xLTA_f52514c4-364d-4830-a54e-ead2ffb1ca7b"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU2LTMtMS0xLTA_5690c009-cc7f-4ea1-b099-d7c677c49774"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU2LTUtMS0xLTA_e3db023f-234c-4984-9305-63e85698307f"
      unitRef="usd">546200000</us-gaap:RepaymentsOfConvertibleDebt>
    <holx:Repaymentofacquireddebt
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU3LTEtMS0xLTA_f115b033-b151-47cf-8be3-aa1eee2ac26a"
      unitRef="usd">8300000</holx:Repaymentofacquireddebt>
    <holx:Repaymentofacquireddebt
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU3LTMtMS0xLTA_96415177-d02d-4b24-bb77-3a2c87333a97"
      unitRef="usd">2500000</holx:Repaymentofacquireddebt>
    <holx:Repaymentofacquireddebt
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU3LTUtMS0xLTA_6df23ed6-19aa-4e85-b312-5bbcf1a87adf"
      unitRef="usd">3300000</holx:Repaymentofacquireddebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU4LTEtMS0xLTA_66d374f9-adfa-491e-acf0-6ec634db20f2"
      unitRef="usd">750000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU4LTMtMS0xLTA_47da30f4-a4f9-4e9f-ad2f-972eddf4a163"
      unitRef="usd">480000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU4LTUtMS0xLTA_e6064e86-bcbd-42e6-9bf3-cc8076db8609"
      unitRef="usd">1150000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU5LTEtMS0xLTA_07ffd9d3-83a3-4b0e-8b42-09e0be065ad4"
      unitRef="usd">500000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU5LTMtMS0xLTA_4655fe4b-ed04-4d85-b47c-c48bc61955c5"
      unitRef="usd">780000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzU5LTUtMS0xLTA_1ec818f8-38f3-4e28-ab75-7f2950902669"
      unitRef="usd">1195000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYwLTEtMS0xLTA_bc997bed-ec4d-4479-b0b1-116b6cf05413"
      unitRef="usd">16000000.0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYwLTMtMS0xLTA_7cfb96ab-0c9b-44e1-a9f5-bafa0c3a0c83"
      unitRef="usd">43000000.0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYwLTUtMS0xLTA_3636c901-f1eb-44b8-a465-eb0334c39666"
      unitRef="usd">34000000.0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYxLTEtMS0xLTA_edd0e0e3-d139-4814-86fc-15c984d84710"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYxLTMtMS0xLTA_3dbe79c1-3d93-45e2-a22b-47cc144e48c6"
      unitRef="usd">34000000.0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYxLTUtMS0xLTA_7aaee804-0850-44b4-9fd3-7244da9351bd"
      unitRef="usd">9000000.0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTEtMS0xLTEyODk_d8865e07-0800-4482-a8d0-ef8e9347d3ff"
      unitRef="usd">1800000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTMtMS0xLTEyODk_6d55b55e-bb99-4638-a3ae-3320e84cc2c7"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTUtMS0xLTEyODk_beb537b0-1416-4425-a403-81df43dbfccb"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTEtMS0xLTA_8bc30aab-9d7b-49b4-9697-d3d9531aee45"
      unitRef="usd">653600000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTMtMS0xLTA_54f37c26-afc3-4cc6-8218-1ac4b7a76316"
      unitRef="usd">200100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYyLTUtMS0xLTA_394b0bdf-202f-4903-9ce0-f785cfbc3455"
      unitRef="usd">275800000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYzLTEtMS0xLTA_453dfd3f-fc56-4010-9ab2-96080bc6cbe4"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYzLTMtMS0xLTA_e214be40-2ab1-4131-b27a-28ff139b421a"
      unitRef="usd">2700000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzYzLTUtMS0xLTA_c5e51092-5e95-469f-b5af-78308a5234b4"
      unitRef="usd">23500000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY0LTEtMS0xLTA_4674a34a-2a30-49a4-ad85-530b98295066"
      unitRef="usd">24300000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY0LTMtMS0xLTA_0332a668-0ac4-4ca5-be20-3fb42e04958b"
      unitRef="usd">6500000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY0LTUtMS0xLTA_f347ffc8-9ac2-4b61-aca2-91b8a77fea29"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY1LTEtMS0xLTA_5e485293-3771-484d-855d-ae737c098a9f"
      unitRef="usd">0</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY1LTMtMS0xLTA_bf628c75-929c-4b92-9ddb-f58bff847e9a"
      unitRef="usd">1500000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY1LTUtMS0xLTA_45e0e756-897a-4dfa-8595-a266c15f59ee"
      unitRef="usd">3700000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY3LTEtMS0xLTA_921e5a39-88fb-4870-9c04-00513f48d67e"
      unitRef="usd">65600000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY3LTMtMS0xLTA_f880d7bc-393e-4a6b-89b2-5e3a0bfa7ae2"
      unitRef="usd">49800000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY3LTUtMS0xLTA_30d48553-dc69-4502-aea5-198289e71a69"
      unitRef="usd">33200000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTEtMS0xLTEwMTg2_57649b4d-c400-461e-8a6f-b8d56dde7f06"
      unitRef="usd">14300000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTMtMS0xLTEwMTg2_5c80ef9d-a1bd-47dc-af51-0ab8eb51e559"
      unitRef="usd">12800000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTUtMS0xLTEwMTg2_1776da33-5cd1-445f-a290-52a5acbfeeb0"
      unitRef="usd">16700000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY5LTEtMS0xLTA_ed9f6bb5-19eb-478a-a297-29b235c6a608"
      unitRef="usd">1700000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY5LTMtMS0xLTA_822152c3-b604-4ea4-a970-3d7ea88d2825"
      unitRef="usd">1700000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzY5LTUtMS0xLTA_a1204ec8-2cc5-4a41-8683-6eef5ce85289"
      unitRef="usd">1700000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTEtMS0xLTA_d99d1679-21c8-4c43-aec5-ce5dc0102488"
      unitRef="usd">-659900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTMtMS0xLTA_162db0da-d07a-43fe-8d74-1252460c62a3"
      unitRef="usd">-431500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcxLTUtMS0xLTA_eae1e711-4500-4a9b-bfe0-af27fbf3cbe1"
      unitRef="usd">-404800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcyLTEtMS0xLTA_e0b5f82e-98ea-4f02-aced-c720c08310c7"
      unitRef="usd">4100000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcyLTMtMS0xLTA_19a0b28e-a64d-4cf7-8afe-1657b8c2c487"
      unitRef="usd">-2200000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzcyLTUtMS0xLTA_e6c3d604-9492-4b7f-839a-019ad47255f1"
      unitRef="usd">-6800000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzczLTEtMS0xLTA_82463c1f-e055-4fd2-99b6-89f2eecb5761"
      unitRef="usd">99200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzczLTMtMS0xLTA_28a7f470-6838-41cf-bfba-da52ca95e235"
      unitRef="usd">-64900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4XzczLTUtMS0xLTA_46b4ef2e-a88d-49cb-bf15-e7b61fefeee4"
      unitRef="usd">126100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc0LTEtMS0xLTA_2ae05d67-8f52-4395-b584-0e84183d0853"
      unitRef="usd">601800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc0LTMtMS0xLTA_34b1f24e-6370-4b09-8820-b255106102b3"
      unitRef="usd">666700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i84c88a850d71453097932f0bcbe84825_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc0LTUtMS0xLTA_12b1fb29-143a-4428-a484-49cbd6c1af63"
      unitRef="usd">540600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc1LTEtMS0xLTA_aa333845-333f-4c78-b6b6-ba7efef96201"
      unitRef="usd">701000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc1LTMtMS0xLTA_d249ce74-1a4a-4f8b-ba75-d347ae14f087"
      unitRef="usd">601800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzAvZnJhZzpkODNlYzc0YmFmNTM0NGNlODQwN2NjNGZjNGU0NGEwYS90YWJsZTo5N2ViYjkyMjM2ZmQ0NTE0YjU5ZDNlYzhlZDdiYmFlOC90YWJsZXJhbmdlOjk3ZWJiOTIyMzZmZDQ1MTRiNTlkM2VjOGVkN2JiYWU4Xzc1LTUtMS0xLTA_576f73c9-1813-4a79-8d4a-80c8745eea01"
      unitRef="usd">666700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzM4Mw_1c7f145e-b286-46e5-8b28-155c7d9986e2">Operations&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hologic, Inc. (the &#x201c;Company&#x201d; or &#x201c;Hologic&#x201d;) develops, manufactures and supplies premium diagnostics products, medical imaging systems, and surgical products with an emphasis on women's health and well-being through early detection and treatment. Until December 30, 2019, the Company's product portfolio included light-based aesthetic and medical treatment systems sold by its former Medical Aesthetics business. The Company completed the sale of its Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). During the second, third and fourth quarters of fiscal 2020, the Company operated in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;COVID-19 Considerations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pandemic caused by the spread of the novel strain of coronavirus disease 2019 ("COVID-19") has created significant volatility, uncertainty and economic disruption in the markets the Company sells its products into, primarily the U.S., Europe and Asia-Pacific. In the second, third and fourth quarters of fiscal 2020, the spread of COVID-19 has negatively impacted business and healthcare activity globally. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As healthcare systems respond to the increasing demands of managing COVID-19 and the resulting economic uncertainties, governments around the world have imposed measures designed to reduce the transmission of COVID-19, and individuals are responding to the fears of contracting COVID-19. In particular, elective procedures and exams have been and continue to be delayed or cancelled, there has been a significant reduction in physician office visits, and hospitals have postponed or cancelled capital purchases as well as limited or eliminated services, however in the second half of the third quarter of fiscal 2020, the Company started to see a recovery of elective procedures and exams, which continued into the fourth quarter. The reductions in testing and procedures have had, and the Company believes will continue to have, a negative impact on the Company's operating results and cash flows. However, the impact of the Company's commercial release of its COVID-19 assays more than offset these negative impacts, as the Company generated significant revenue from the sales of these assays in the third and fourth quarters of fiscal 2020. The negative effects of COVID-19 and the associated economic disruptions were felt primarily beginning in the second half of March in many of the Company's end-markets and earlier in Asia, primarily China, and the impact to the Company's legacy products in the third fiscal quarter was significant. The impact to its legacy products was less severe in the fourth quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company's results of operations and cash flows in the third and fourth quarter of fiscal 2020 were positively impacted by the sale of its COVID-19 assays, the COVID-19 pandemic could have an adverse impact on its operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: the severity and duration of the COVID-19 pandemic; continued demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products; the COVID-19 pandemic&#x2019;s impact on the U.S. and international healthcare system, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental responses to the COVID-19 pandemic and associated economic disruptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to adversely affecting demand for the Company's products, other than its COVID-19 assays, COVID-19 and associated economic disruptions could continue to have an adverse impact on the Company's supply chains and distribution systems, including as a result of impacts associated with preventive and precautionary measures that it, other businesses and governments have taken and will take. A reduction or interruption in any of the Company's manufacturing processes could have a material adverse effect on its business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that the uncertainty surrounding global financial markets and deteriorating worldwide macroeconomic conditions resulting from the pandemic have caused and may continue to cause the purchasers of medical equipment to decrease their medical equipment purchasing and procurement activities. Additionally, the pandemic has caused and may further cause constrictions in world credit markets that have caused and could cause its customers to experience increased difficulty in paying their existing obligations to the Company or in securing the financing necessary to purchase the Company's products. Economic uncertainty has resulted and may continue to result in cost-conscious consumers focusing on acute care rather than wellness, which may also continue to adversely affect demand for the Company's products (other than the Company's COVID-19 assays).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Company assessed the potential longer term economic and capital market uncertainties resulting from the COVID-19 pandemic, at the end of March 2020 the Company suspended its accounts receivable securitization program and borrowed $750.0&#160;million under its revolver. The Company used $250.0&#160;million of these proceeds to pay off all amounts then &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;owed under its accounts receivable securitization agreement and retained the balance as cash reserve. As of the end of fiscal 2020, the Company repaid $500.0&#160;million of the $750.0&#160;million borrowed under its revolver. As of September 26, 2020 the Company had an additional $1.25&#160;billion available under its revolver and $701.0&#160;million of cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In response to the negative impact of COVID-19 on the Company's business, in April 2020 the Company initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but the Company also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances employee terminations. Further, in April 2020, the Company had shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of its products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased, and the majority of the impacted manufacturing facilities are back to pre-COVID levels.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has also taken measures to ensure the safety of its employees and to comply with governmental orders. These measures could require that the Company's employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in its commercial and marketing activities.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i3f897a5c14ce46fcb14ced01b6827380_D20170322-20170322"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzI4Nw_70f4a5f6-eaa5-47fa-b09d-6ec5b1990b75"
      unitRef="segment">4</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1NDIxMjI_f9761d96-ae46-4f26-983b-bf58f9fa034a"
      unitRef="usd">750000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1NDIxMzg_c4fb28d1-3125-4c27-a857-c520c3c72776"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1MzM5Nzk_1b6a964a-34df-453e-a11d-cb5b68f7d9f7"
      unitRef="usd">500000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1MzM5OTU_5dbd987e-64b4-4f6c-af80-09f920242104"
      unitRef="usd">750000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <holx:UnusedCreditFacility
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1MzQwNTE_b82c0782-2a24-4559-8333-cb93b1c2d6d1"
      unitRef="usd">1250000000</holx:UnusedCreditFacility>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzYvZnJhZzplZTcwYmQwZjUzNDU0OTdlYThmNmNhYTk5YTgzMTEyNS90ZXh0cmVnaW9uOmVlNzBiZDBmNTM0NTQ5N2VhOGY2Y2FhOTlhODMxMTI1XzQzOTgwNDY1MzQwMzU_c0d4c221-f735-47b3-98d0-c44bd7b7680f"
      unitRef="usd">701000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE5MjQxNDUzNzE2NDA0_83bb14c4-3419-48dc-b9da-a2d2ff8c0d7b">Summary of Significant Accounting Policies&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned and majority owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#x2019;s fiscal year ends on the last Saturday in September. Fiscal 2020, 2019 and 2018 ended on September&#160;26, 2020, September&#160;28, 2019 and September&#160;29, 2018, respectively. Fiscal 2020, 2019 and 2018 were 52-week years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Subsequent Events Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events recorded in the consolidated financial statements as of and for the year ended September&#160;26, 2020. Subsequent to September 26, 2020, the Company's issued its 2029 Notes on September 28, 2020 and used the proceeds and cash on hand to pay off its 2025 Notes. For additional information, refer to Note 7.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Management&#x2019;s Estimates and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#x2019;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#x2019;s net deferred tax assets and related valuation allowances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#x2019;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customers are principally located in the United States, Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;26, 2020. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was one customer with a balance greater than 10% of accounts receivable as of September&#160;26, 2020, at 11.9%. There were no customers with a balance greater than 10% of accounts receivable as of September&#160;28, 2019. There were no customers that represented greater than 10% of consolidated revenues for fiscal years 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Suppliers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company purchases certain components of its products from a single or small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which could adversely affect results of operations; however, management believes that suitable replacement suppliers could be obtained in such an event.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Statement Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.674%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the period for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the period for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Financing Activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#x2019;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#x2019;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;10 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;8 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#x2013;35 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of the Original Term of Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;or Estimated Useful Life&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#x2013;7 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less - accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(658.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment&#x2014;Impairment or Disposal of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Combinations and Acquisition of Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company accounts for the acquisition of a business in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets and Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are initially recorded at fair value and stated net of accumulated amortization and impairments. The Company amortizes its intangible assets that have finite lives using either the straight-line method, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be utilized. Amortization is recorded over the estimated useful lives ranging from 2 to 30 years. The Company evaluates the recoverability of its definite lived intangible assets whenever events or changes in circumstances or business conditions indicate that the carrying value of these assets may not be recoverable based on expectations of future undiscounted cash flows for each asset group. If the carrying value of an asset or asset group exceeds its undiscounted cash flows, the Company estimates the fair value of the assets, generally utilizing a discounted cash flow analysis based on the present value of estimated future cash flows to be generated by the assets using a risk-adjusted discount rate. To estimate the fair value of the assets, the Company uses market participant assumptions pursuant to ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite lived intangible assets, such as IPR&amp;amp;D assets, are required to be tested for impairment annually, or more frequently if indicators of impairment are present. The Company&#x2019;s annual impairment test date is as of the first day of its fourth quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,927.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,654.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,704.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,276.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,786.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,326.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Medical Aesthetics Impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal 2020, the Company's Medical Aesthetics business met the criteria to be designated as assets held-for-sale. As a result, the Company recorded a $30.2&#160;million charge to record the asset group at fair value less costs to sell. In addition, developed technology, customer lists, trade names, and distribution agreement related to Medical Aesthetics of $24.1&#160;million, $0.9&#160;million, $2.0&#160;million, and $1.2&#160;million, respectively, were reclassified accordingly in the Company's Consolidated Balance Sheet to assets held-for-sale as of December 28, 2019 and subsequently disposed of in the second quarter of fiscal 2020. See Note 15 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019, the Company identified indicators of impairment for its Medical Aesthetics reporting unit as a result of reductions in forecasts during the year, and in connection with the Company&#x2019;s efforts to sell the business that began prior to the end of fiscal 2019. In performing the undiscounted cash flow analysis pursuant to ASC 360, the expected undiscounted cash flows of the asset group were determined using a probability-weighted approach taking into consideration the planned disposition, which was deemed to be highly probable as of the balance sheet date. Based on this analysis, the undiscounted cash flows were not sufficient to recover the carrying value of the asset group. As a result, the Company was required to perform Step 3 of the impairment test and determine the fair value of the asset group. The Company executed a definitive agreement on November 20, 2019 to sell the business. Although this agreement was signed subsequent to the balance sheet date, the Company concluded that it provided evidence regarding the estimate of fair value of the asset group at September 28, 2019 and that there were no events that occurred between September 28, 2019 and the date the Company entered into the definitive agreement that would significantly affect the fair value of the asset group. As a result, the Company recorded total impairment charges of $685.4&#160;million in fiscal 2019. The impairment charge was allocated to the long-lived assets as follows: $576.9 million to developed technology, $22.4 million to customer relationships, $48.6 million to trade names, $27.7 million to distribution agreements and $9.8 million to equipment. On November 20, 2019, this asset group met the assets held-for-sale criteria and was recorded at fair value less the costs to sell as noted above. See Note 15. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2018, the Company abandoned an in-process research and development project acquired in the Cynosure acquisition and recorded an impairment charge of $46.0&#160;million. The Company abandoned the project as a result of unsuccessful clinical results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2020, the Company acquired Acessa Health, Inc. and recorded $127.0&#160;million of developed technology and $1.2&#160;million of trade names based on its preliminary purchase accounting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2019, the Company acquired Focal Therapeutics, Inc. and recorded $83.1 million of developed technology, $11.4 million of in-process research and development and $2.7 million of trade names. In the fourth quarter of fiscal 2019, the Company obtained FDA approval for the in-process research and development project and reclassified this value to developed technology. During fiscal 2019, the two in-process research and development projects acquired in the Faxitron acquisition aggregating $5.5 million were completed and reclassified to developed technology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense related to developed technology is classified as cost of product revenues&#x2014;amortization of intangible assets. Amortization expense related to customer relationships, contracts, trade names, distribution agreements, and business licenses is classified as a component of amortization of intangible assets within operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated amortization expense at September&#160;26, 2020 for each of the five succeeding fiscal years was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 350), the Company tests goodwill for impairment annually at the reporting unit level and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying value. Events that could indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate, operational performance of the business or key personnel, and an adverse action or assessment by a regulator. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the impairment test, the Company utilizes the single-step approach prescribed under Accounting Standards Update No. 2017-04,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASU 2017-04) . This approach requires a comparison of the carrying value of each reporting unit to its estimated fair value and to the extent the carrying value exceeds the fair value a charge is recorded up to the amount of goodwill in the reporting unit. To estimate the fair value of its reporting units, the Company primarily utilizes the income approach. The income approach is based on a DCF analysis and calculates the fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting the after-tax cash flows to present value using a risk-adjusted discount rate. Assumptions used in the DCF require significant judgment, including judgment about appropriate discount rates and terminal values, growth rates, and the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amount and timing of expected future cash flows. The forecasted cash flows are based on the Company&#x2019;s most recent budget and strategic plan and for years beyond this period, the Company&#x2019;s estimates are based on assumed growth rates expected as of the measurement date. The Company believes its assumptions are consistent with the plans and estimates used to manage the underlying businesses. The discount rates used are intended to reflect the risks inherent in future cash flow projections and are based on estimates of the weighted-average cost of capital (&#x201c;WACC&#x201d;) of market participants relative to each respective reporting unit. The market approach considers comparable market data based on multiples of revenue or earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) and is primarily used as a corroborative analysis to the results of the DCF analysis. The Company believes its assumptions used to determine the fair value of its reporting units are reasonable. If different assumptions were used, particularly with respect to forecasted cash flows, terminal values, WACCs, or market multiples, different estimates of fair value may result and there could be the potential that an impairment charge could result. Actual operating results and the related cash flows of the reporting units could differ from the estimated operating results and related cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducted its fiscal 2020 impairment test for its reporting units on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of June 28, 2020, and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of the Company's reporting units had fair values exceeding their carrying values. For illustrative purposes, had the fair value of each of the reporting units been lower by 10%, all of the reporting units would still have passed the goodwill impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;26, 2020, the Company believes that its reporting units, with goodwill aggregating $2.6&#160;billion, were not at risk of failing the goodwill impairment test based on its current forecasts and qualitative assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2019, the Company used the qualitative approach as of June 29, 2019 to assess its goodwill for impairment. Under this approach the Company considered a number of factors, including the amount by which the previous quantitative test's fair value exceeded the carrying value of the reporting units, the forecasts in the Company's strategic plan compared to the forecast used in the previous quantitative test, an evaluation of discount rates, long-term growth rates including the terminal year rate, if tax rates would have significantly changed, an evaluation of current economic factors for both the worldwide economy and specifically the medical device industry, and any significant changes in customer and supplier relationships. The Company weighed these factors to determine if it was more likely than not that the fair value of the reporting unit exceeded its carrying value. If after performing a qualitative assessment, indicators are present, or the Company identified factors that cause it to believe it is appropriate to perform a more precise calculation of fair value, the Company would have moved beyond the qualitative assessment and perform a quantitative impairment test. As a result of completing the qualitative assessment for each of its reporting units for fiscal 2019, the Company concluded that it was more likely than not that the fair value of each reporting exceeded its carrying value by a significant amount and a quantitative test was unnecessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2018, in connection with commencing its company-wide annual budgeting and strategic planning process, evaluating its current operating performance of its Medical Aesthetics reporting unit, and abandoning an in-process research and development project, the Company reduced its short term and long term revenue and operating income forecasts and determined that indicators of impairment existed in its Medical Aesthetics reporting unit. The Medical Aesthetics reporting unit was solely comprised of the Cynosure business, which the Company acquired on March 22, 2017. The updated forecast reflected significantly reduced volume and market penetration projections resulting in lower short-term and long-term profitability than expected at the time of the Cynosure acquisition. As a result of those events and circumstances at that time, the Company determined that it was more likely than not that this change would reduce the fair value of the reporting unit below its carrying amount. To estimate the fair value of the reporting unit, the Company utilized the DCF analysis. The forecasted cash flows were based on the Company's most recent budget and strategic plan and for period beyond the strategic plan, the Company's estimates were based on assumed growth rates expected as of the measurement date. The Company believed its assumptions were consistent with the plans and estimates used to manage the underlying business. The discount rate used is intended to reflect the risks inherent in future cash flow projections and was based on an estimate of the weighted average cost of capital (WACC) of market participants relative to the reporting unit. The basis of fair value for Medical Aesthetics assumed the reporting unit would be purchased or sold in a non-taxable transaction, and the discount rate of 12.0% applied to the after-tax cash flows was consistent with that used in the purchase accounting performed in fiscal 2017. As a result of this analysis, the fair value of the Medical Aesthetic reporting unit was significantly below its carrying value, and the Company recorded a goodwill impairment charge of $685.7 million during the second quarter of fiscal 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the goodwill impairment test in the second quarter of fiscal 2018, the Company also performed an impairment test of this reporting unit&#x2019;s long-lived assets. This impairment evaluation was based on expectations of future undiscounted cash flows compared to the carrying value of the long-lived assets. The Company&#x2019;s cash flow estimates were consistent with those used in the goodwill impairment test discussed above. Based on this analysis, the undiscounted cash flows &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the Medical Aesthetics long-lived assets were in excess of their carrying value and thus deemed to not be impaired. The Company believed its procedures for estimating future cash flows were reasonable and consistent with market conditions at the time of estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducted its 2018 impairment test on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of July 1, 2018 and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. As a result of completing Step 1, all of the Company's reporting units had fair values exceeding their carrying values, and as such, Step 2 of the impairment test was not required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of goodwill activity by reportable segment from September&#160;28, 2019 to September&#160;26, 2020 is as follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:130.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:57.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:57.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Breast&#160;Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;GYN&#160;Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Skeletal&#160;Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,014.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,563.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SuperSonic Imagine acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Beacons acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acessa Health acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,063.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,657.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost-method equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-method investment and loans to SSI (Note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax receivable primarily relates to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. The right of use assets were recorded in connection with the adoption of ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#x2019;s Nonqualified Deferred Compensation Plan (&#x201c;DCP&#x201d;) and are recorded at their cash surrender value (see Note 12 for further discussion). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred for the research and development of the Company&#x2019;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for the development costs of software embedded in the Company&#x2019;s products in accordance with ASC 985, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#x2019;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimate useful life and recorded within cost of revenues - product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s foreign subsidiaries are translated in accordance with ASC 830, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Matters.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#x2019;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income, net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss) as a separate component of stockholders&#x2019; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income, net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#x2019; equity. The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Charges (gains) reclassified to statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Cap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income, net in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5 million, which was the initial fair value of the instruments recorded in the Company&#x2019;s financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical terms of the interest rate caps were designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payments on $1.0 billion of principal, which ended on December 27, 2019 for the contracts entered into in fiscal 2018, and which will end on December 23, 2020 for the interest rate cap agreements entered into in fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;26, 2020, the Company determined that the existence of hedge ineffectiveness, if any, was immaterial and all changes in the fair value of the interest rate caps were recorded within AOCI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020, 2019 and 2018, interest expense of $2.3 million, $3.1 million and $3.6 million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The Company expects to similarly reclassify approximately $0.5 million from AOCI to the Consolidated Statements of Operations in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate fair value of these interest rate caps was $0.0 million and $0.1 million at September&#160;26, 2020 and September&#160;28, 2019, respectively, and is included in both Prepaid expenses and other current assets and Other assets on the Company&#x2019;s Consolidated Balance Sheet. Refer to Note 8 &#x201c;Fair Value Measurements&#x201d; for related fair value disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in accumulated other comprehensive income (loss) and were a loss, net of taxes, of $27.6&#160;million and a gain, net of taxes, of $3.5&#160;million for the years ended September 26, 2020 and September 28, 2019, respectively. The fair value of this derivative was in a liability position of $31.2 million as of September 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Foreign Currency Contracts and Foreign Currency Option Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28. 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 29. 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 26, 2020, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with a notional amount of $172.6 million. As of September 26, 2020, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $380.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instrument Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:23pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.842%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Operations for derivative instruments for which the Company did not elect hedge accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.926%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not classified as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable and Reserves&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records reserves for doubtful accounts based upon a specific review of all outstanding invoices, known collection issues and historical experience. The Company regularly evaluates the collectability of its trade accounts receivables and performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and its assessment of the customer&#x2019;s current credit worthiness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable reserve activity for fiscal 2020, 2019 and 2018 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Costs and&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-&lt;br/&gt;offs and&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cost of Service and Other Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#x2019;s professional services&#x2019; employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for share-based payments in accordance with ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 718)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#x2019;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, as a result of the adoption of ASU 2016-09 in fiscal 2017, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options, restricted stock units and convertible debt for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts for fiscal 2020, 2019, and 2018 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options and stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In those reporting periods in which the Company has reported net income, anti-dilutive shares generally are comprised of those stock options that either have an exercise price above the average stock price for the period or the stock options&#x2019; combined exercise price and average unrecognized stock compensation expense upon exercise is greater than the average stock price. In those reporting periods in which the Company has a net loss, anti-dilutive shares are comprised of the impact of those number of shares that would have been dilutive had the Company had net income plus the number of common stock equivalents that would be anti-dilutive had the company had net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally offers a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM5NjU4_08c7a977-3e74-4ea4-ab24-1584cb253ab9"&gt;one&lt;/span&gt;-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#x2019;s warranty reserves include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity for fiscal 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&#160;End&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $15.6 million, $29.5 million and $26.9 million for fiscal 2020, 2019 and 2018, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2017, the FASB issued ASU No. 2017-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 815): Targeted Improvements to Accounting for Hedging Activities.&#160;The guidance requires certain changes to the presentation of hedge accounting in the financial statements and also simplifies the application of hedge accounting and expands the strategies that qualify for hedge accounting.&#160;The Company adopted the standard in the first quarter of fiscal 2020. The adoption of ASU 2017-12 did not have a material effect on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and subsequently a number of improvements. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-13, as well as all codification improvements in ASU 2019-04, ASU 2019-10, ASU 2019-11 and ASU 2020-03, on its consolidated financial position and results of operations. The Company expects the adoption to primarily be applicable to its accounts receivable and does not believe the impact will be material to its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, the FASB issued ASU No. 2019-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in that Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. For entities that have adopted the amendments in Update 2018-07, the updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2019-08 on its consolidated financial position and results of operations but does not expect the adoption to have a material impact to its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Board is issuing this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;those fiscal years, beginning after December 15, 2020. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board is issuing this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-03,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Codification Improvements to Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board is issuing this Update to clarify or improve the Codification, as well as, make the Codification easier to understand and apply by eliminating inconsistencies. This update is to improve various financial instruments Topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process. For entities that have adopted the amendments in Update 2020-03, the updated guidance is effective for all entities beginning in fiscal 2021. The Company is currently evaluating the impact of the adoption of ASU 2020-03 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board is issuing this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTY5_32557a1a-4a9b-48a0-973e-1b927197fb0a">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned and majority owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#x2019;s fiscal year ends on the last Saturday in September. Fiscal 2020, 2019 and 2018 ended on September&#160;26, 2020, September&#160;28, 2019 and September&#160;29, 2018, respectively. Fiscal 2020, 2019 and 2018 were 52-week years.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzE4_35a7ac7c-2c9e-4410-828d-021d1b85c8bc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Management&#x2019;s Estimates and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#x2019;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#x2019;s net deferred tax assets and related valuation allowances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#x2019;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzI4_750ad777-010e-41ed-8f93-bbe0316b4532">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <holx:CashEquivalentsMaturityPeriod
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzQw_9a439204-ba78-4288-9749-c327193b2975">three months or less</holx:CashEquivalentsMaturityPeriod>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzAy_b362919e-d815-488b-ba5c-735bb5e67e46">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customers are principally located in the United States, Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;26, 2020. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.&lt;/span&gt;&lt;/div&gt;There was one customer with a balance greater than 10% of accounts receivable as of September&#160;26, 2020, at 11.9%. There were no customers with a balance greater than 10% of accounts receivable as of September&#160;28, 2019. There were no customers that represented greater than 10% of consolidated revenues for fiscal years 2020, 2019 and 2018</us-gaap:ConcentrationRiskCreditRisk>
    <holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU0MzM_891b8b5b-add1-4afb-98f5-a51ffc0fddd6"
      unitRef="customer">1</holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8f6314cda1fe40489c80c8c7c917a7b8_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU0NzM_10301916-c785-4bad-ae58-c0e6416c25db"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzkzNDU4NDkwNDcyMTI_c890be53-9622-4d87-a327-389642d53ffb"
      unitRef="customer">0</holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifcc5fcf2f538489bae3a4254ce198ccf_D20180930-20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzkzNDU4NDkwNDcyMDg_c948c54e-41a2-4f18-9a2e-98fc22c2c18d"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5a4fb96be7934eb29629fbdb7e72fd0f_D20180930-20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU1NjM_65cc4ee7-6a17-4b70-9437-f024068e3ae6"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iff73c4f9e92e403e8fd1003738851496_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU1NjM_be9fef20-2651-42a0-b837-c686984b3ef3"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i552f7643b15a4fdd94f4b733fd38a0ef_D20180701-20180929"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzU1NjM_f7fa4910-453f-4ca2-a38d-085484e73adc"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjQ0_4bb24251-aa3c-4e1c-a3a5-98d8da51fb19">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Statement Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.674%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the period for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the period for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Financing Activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:IncomeTaxesPaid
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzItMi0xLTEtMA_d6429850-059d-47cb-9c6b-c7bce1dbf41f"
      unitRef="usd">265900000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzItNC0xLTEtMA_6994b5ac-9764-4b56-956c-db8f0983cd7f"
      unitRef="usd">180600000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzItNi0xLTEtMA_e36097f4-0c24-4b08-a7a1-81b877904674"
      unitRef="usd">178200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaid
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzMtMi0xLTEtMA_ae580ad9-0ba5-4713-8a5f-083cab48a8f6"
      unitRef="usd">109500000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzMtNC0xLTEtMA_9c555c36-ede6-423a-adf4-f9cb54df0395"
      unitRef="usd">132500000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmMzRiMWVhNDcyODI0Y2JhOTJhZTc5MDhhM2NjZDY5Ny90YWJsZXJhbmdlOmYzNGIxZWE0NzI4MjRjYmE5MmFlNzkwOGEzY2NkNjk3XzMtNi0xLTEtMA_c4138992-8261-4c45-b5dc-cdf6131e1cd6"
      unitRef="usd">122100000</us-gaap:InterestPaid>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5ODEz_824d8c89-9051-416b-9303-14a73ab7cff0">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#x2019;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#x2019;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njgz_239aa1fe-4745-4632-86e7-965edd4c43ca">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzEtMi0xLTEtMA_231fd047-fbb9-4dbe-a1a6-b27fb1282d7d"
      unitRef="usd">152300000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzEtNC0xLTEtMA_a8376169-9743-446b-8e9f-c43ecd65e4a0"
      unitRef="usd">166100000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzItMi0xLTEtMA_079c5f92-69f5-44ae-85e5-3fa3f0365be8"
      unitRef="usd">46500000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzItNC0xLTEtMA_8c64ab41-64a8-4b3b-8441-0afe1dd624d7"
      unitRef="usd">54500000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzMtMi0xLTEtMA_1122c817-edeb-4a8d-af80-deabc3582cfc"
      unitRef="usd">196300000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzMtNC0xLTEtMA_3ba59133-19bb-4652-a0e2-ce3b47fcc77a"
      unitRef="usd">224300000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzQtMi0xLTEtMA_63277f7f-9ba9-4b30-81de-6905dd7f4f76"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNmFjNGJhZjc0MjE0ODk2OWJkODRlMTQzZDZiYjU5ZC90YWJsZXJhbmdlOmQ2YWM0YmFmNzQyMTQ4OTY5YmQ4NGUxNDNkNmJiNTlkXzQtNC0xLTEtMA_93716bfd-13f8-4caa-ba8a-57863566913b"
      unitRef="usd">444900000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjIz_dddc960d-1728-419a-a4e1-3396defbcd43">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;10 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;8 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#x2013;35 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of the Original Term of Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;or Estimated Useful Life&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#x2013;7 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less - accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(658.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTc3_67b0d745-00a8-4a8f-aa3f-4d933a79fb84">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;10 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;8 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#x2013;35 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of the Original Term of Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;or Estimated Useful Life&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#x2013;7 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less - accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(658.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8d5133bbb5b643cfb4039e7683d511b2_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzEtMS0xLTEtMTY4MjUvdGV4dHJlZ2lvbjo1ZjQ1NWFlYmFhODE0ZjNiOTA3ZTFkMDVlYjgwYTM3OF85MzQ1ODQ4ODM2MTEz_21647d19-166e-4070-953a-449fabd5386b">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i01e39e16ad0d4d43bded461c3c400be6_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzEtMS0xLTEtMTY4MjUvdGV4dHJlZ2lvbjo1ZjQ1NWFlYmFhODE0ZjNiOTA3ZTFkMDVlYjgwYTM3OF85MzQ1ODQ4ODM2MTE5_a31dc260-0fe1-41c6-b0c9-d07892fbe6e4">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzEtMy0xLTEtMA_b9a49365-d5f5-4fff-955b-7c8efa929c01"
      unitRef="usd">460700000</holx:ManufacturingEquipmentAndSoftware>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzEtNS0xLTEtMA_5cbb6908-55ab-4234-8fb9-e5e0373c1f7e"
      unitRef="usd">379200000</holx:ManufacturingEquipmentAndSoftware>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i284a1c2b8fc740deac2cf49770588de2_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzItMS0xLTEtMTY4MzEvdGV4dHJlZ2lvbjo0NGY2YjAzNjMxZjg0NTdjOWMzNzE2ODE3YmM0YTNlYl85MzQ1ODQ4ODM2MTI3_a3b3595d-7ca1-4bb7-ac5c-721330d59f05">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ifba3583f30724dd495ffe080e345c8e2_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzItMS0xLTEtMTY4MzEvdGV4dHJlZ2lvbjo0NGY2YjAzNjMxZjg0NTdjOWMzNzE2ODE3YmM0YTNlYl85MzQ1ODQ4ODM2MTMy_acea8581-1446-4e50-9625-f5bb722f3f7f">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzItMy0xLTEtMA_808f021b-0f86-46e0-9c59-bf82cff78fc4"
      unitRef="usd">456800000</holx:EquipmentUnderCustomerUsageAgreements>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzItNS0xLTEtMA_d4368125-98e6-43a9-a542-4a994823e207"
      unitRef="usd">427500000</holx:EquipmentUnderCustomerUsageAgreements>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i64ce780d2bc74dc48f001fe80ae1ff75_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzMtMS0xLTEtMTY4MzgvdGV4dHJlZ2lvbjowNDgzMzRjNjM4NDQ0NTc1ODJhNWMyNmYxZjRhNGIzZV85MzQ1ODQ4ODM2MTIx_91f140ce-636a-44d4-89cc-b9819e67f8d3">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5ab13270771d45d3b753d44c0a05c023_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzMtMS0xLTEtMTY4MzgvdGV4dHJlZ2lvbjowNDgzMzRjNjM4NDQ0NTc1ODJhNWMyNmYxZjRhNGIzZV85MzQ1ODQ4ODM2MTI3_79968881-f2e7-4b5d-af32-af3fcd9dd6cb">P35Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzMtMy0xLTEtMA_cbada85e-a43d-4924-8549-b8ef7fe33c74"
      unitRef="usd">167300000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzMtNS0xLTEtMA_91ce90e4-520e-47f6-bf2f-224c1ac9162b"
      unitRef="usd">196700000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzQtMy0xLTEtMA_70ed1e22-76c6-4761-851a-b4d943cc8d78"
      unitRef="usd">44300000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzQtNS0xLTEtMA_1945c7ab-ba78-4cf2-a426-a25cb3ee1ad6"
      unitRef="usd">61700000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:Land
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzUtMy0xLTEtMA_8b0a9eee-3609-4a96-8e64-08b5b6799754"
      unitRef="usd">40700000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzUtNS0xLTEtMA_0ccf0e89-2735-413c-ba5e-c341a4080410"
      unitRef="usd">46300000</us-gaap:Land>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia576d0947dd14fb899e60c78615447af_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzYtMS0xLTEtMTY4NTUvdGV4dHJlZ2lvbjpjNmMyYzM5NTQ5MjM0OGMzOWFjYjNhNmUzMGE3NDYxNF85MzQ1ODQ4ODM2MTEy_deacd995-4b2f-4d07-9c33-e12cab9be3dc">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if8383367e78c40ac903ab338ea02c2d8_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzYtMS0xLTEtMTY4NTUvdGV4dHJlZ2lvbjpjNmMyYzM5NTQ5MjM0OGMzOWFjYjNhNmUzMGE3NDYxNF85MzQ1ODQ4ODM2MTE3_63821d8a-c56d-4273-ac92-9568152b9e5f">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzYtMy0xLTEtMA_dad76e17-595c-4c3d-8775-eaddf5cc3d6c"
      unitRef="usd">16100000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzYtNS0xLTEtMA_78304c63-b686-4710-b48d-40710682f1ab"
      unitRef="usd">17500000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzctMy0xLTEtMA_37513641-7e8c-4b58-a5af-304c89d7b9c5"
      unitRef="usd">1185900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzctNS0xLTEtMA_77f86058-0894-4ef6-a55d-f627d1199443"
      unitRef="usd">1128900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzgtMy0xLTEtMA_a44ae655-72e1-4430-b5e6-c238d8658516"
      unitRef="usd">694400000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzgtNS0xLTEtMA_8507830d-6414-47a8-8cea-fd4ba2d6cee9"
      unitRef="usd">658000000.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzktMy0xLTEtMA_d6d40c73-604d-4948-8ad0-bce3032848fe"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxNDE2ZjRiNmQ1MGM0NjcwODdhN2M0MzUzYjcxZjFmMy90YWJsZXJhbmdlOjE0MTZmNGI2ZDUwYzQ2NzA4N2E3YzQzNTNiNzFmMWYzXzktNS0xLTEtMA_e5310fd2-04ac-4a58-838e-8179428e22a8"
      unitRef="usd">470900000</us-gaap:PropertyPlantAndEquipmentNet>
    <holx:LongLivedAssetsPolicyPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzAx_fc1e02a8-2745-4d23-b115-aeef1df80bbb">Long-Lived Assets&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment&#x2014;Impairment or Disposal of Long-Lived Assets&lt;/span&gt; (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique.</holx:LongLivedAssetsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzMx_a5454a4b-604e-4eb7-b86e-e2124fafe85d">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Combinations and Acquisition of Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company accounts for the acquisition of a business in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, &lt;/span&gt;&lt;/div&gt;the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets.The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names</us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i26ac442ab8104d62a507939b10fa969a_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzExNDMw_4c6a647f-4455-47b7-9da7-642cb6bbd108">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8c09129ca98843beadfd374cfab77639_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzExNDM2_04a5590d-c475-4929-8a35-4f20ca7842d0">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njc3_a9f2c71d-c0d2-4076-81b7-9ccae05a6c0d">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,927.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,654.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,704.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,276.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,786.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,326.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i957c4bc90df349dc9fad1b82c2de15a1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzMtMi0xLTEtMA_9d307a62-4a4f-463e-9210-29c2e2255511"
      unitRef="usd">4054000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i957c4bc90df349dc9fad1b82c2de15a1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzMtNC0xLTEtMA_f9d8d4e0-de49-47c3-83c5-5a38b7fa6b61"
      unitRef="usd">2907200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i12c940cf715b419190f1afe48785d4c8_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzMtNi0xLTEtMA_9e650723-54bb-4ac5-8601-e7d0ba596b77"
      unitRef="usd">3927700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i12c940cf715b419190f1afe48785d4c8_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzMtOC0xLTEtMA_ddd31ad5-5441-421a-afca-58d19fa520d3"
      unitRef="usd">2654800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5d996d37cd674a338e18e859a3513b71_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzUtMi0xLTEtMA_ce7d9e61-2a24-4036-a25f-6b58d9fd4874"
      unitRef="usd">549100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5d996d37cd674a338e18e859a3513b71_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzUtNC0xLTEtMA_f1608dd8-ab97-40e4-a8b5-1ae170ab2d9d"
      unitRef="usd">477800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i07c8b5f4261041a985e22dbcc3ec25a6_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzUtNi0xLTEtMA_90457e4b-b25c-4763-b759-d6fae7f0739b"
      unitRef="usd">525500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i07c8b5f4261041a985e22dbcc3ec25a6_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzUtOC0xLTEtMA_6ef9a7fd-7f75-46fc-917a-5dc382c63eb1"
      unitRef="usd">447500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7d0f493e80c8407b9a276a3459c6e266_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzYtMi0xLTEtMA_1a2b0447-b5d8-406c-8416-940e446dbacf"
      unitRef="usd">245500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7d0f493e80c8407b9a276a3459c6e266_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzYtNC0xLTEtMA_e1f41fc7-6b4c-4b70-b1c3-431f47ac4e29"
      unitRef="usd">181200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i860ddac9336c4aa397d8f6b67401b31c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzYtNi0xLTEtMA_ba3114fb-9cdd-4bd6-8aa8-4fda84043f31"
      unitRef="usd">245400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i860ddac9336c4aa397d8f6b67401b31c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzYtOC0xLTEtMA_ecb1190f-c430-49e1-8a85-fc1b2060eaed"
      unitRef="usd">171100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i68050ea428a94c1688589a99714f38cc_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzctMi0xLTEtMA_b8147519-349f-4cb4-86fb-bc67c226cd25"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i68050ea428a94c1688589a99714f38cc_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzctNC0xLTEtMA_b09ce222-f63b-40ed-be77-ca9b6904a4a1"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic2a5caec8822438c887854c7fefc3007_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzctNi0xLTEtMA_16f68d57-80dd-4aad-b04e-6f887eb47d95"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic2a5caec8822438c887854c7fefc3007_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzctOC0xLTEtMA_3bcee761-7dbb-4103-bd14-0b7d7dd0f0cd"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie69340311e9a4b308c4862870d12638e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzgtMi0xLTEtMA_913c7673-2001-406e-bedb-c7e3bb52c7f0"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie69340311e9a4b308c4862870d12638e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzgtNC0xLTEtMA_a245bdd0-c1a3-4337-b73f-bf5906feb514"
      unitRef="usd">1300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i17f074670baa4f1d934cf4b17758e8d5_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzgtNi0xLTEtMA_67773541-d8ab-41a1-8757-b86902f26f98"
      unitRef="usd">1400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i17f074670baa4f1d934cf4b17758e8d5_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzgtOC0xLTEtMA_f0926627-b1ae-40f5-bd38-587138292f62"
      unitRef="usd">900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id6a066f4761243508c40140e40ef6af9_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzktMi0xLTEtMA_168b3559-013e-4685-8d7d-755935c4019f"
      unitRef="usd">2400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id6a066f4761243508c40140e40ef6af9_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzktNC0xLTEtMA_99749144-08f7-47d6-a736-3c1d6f8eee3e"
      unitRef="usd">2300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i302abd2449094a9093740c9423c08c05_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzktNi0xLTEtMA_f574dcdd-a505-4862-bf32-63332c8f5c7e"
      unitRef="usd">2300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i302abd2449094a9093740c9423c08c05_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzktOC0xLTEtMA_5770bc06-908b-498b-bcfb-1492f4635e3e"
      unitRef="usd">2200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i04d58cdf3b9742bab6c632b1c6bde482_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEwLTItMS0xLTA_39a03372-8441-4102-bf5b-cc2f432fcc21"
      unitRef="usd">4852500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i04d58cdf3b9742bab6c632b1c6bde482_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEwLTQtMS0xLTA_074cc1f4-21d8-4cb3-ab6f-6f4621e9ed17"
      unitRef="usd">3569800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i58479218662d4362a06891b6d76a89ee_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEwLTYtMS0xLTA_d42c61c0-427d-4847-b7c9-447e44f520f2"
      unitRef="usd">4704800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i58479218662d4362a06891b6d76a89ee_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEwLTgtMS0xLTA_d6d914cd-61a9-425b-8664-647962b61ff9"
      unitRef="usd">3276500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic0db0cb781464d528ec7ee04920ecb28_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEyLTItMS0xLTA_99c2a05c-4288-4fb0-bd3a-1c0fe3aacdec"
      unitRef="usd">51800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic0db0cb781464d528ec7ee04920ecb28_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEyLTQtMS0xLTA_672eedcb-1cf1-4c27-adda-c95b212200c3"
      unitRef="usd">43200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id8f4cbe1c0914b04bceeebc3cbe0bb61_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEyLTYtMS0xLTA_7f0c8d3f-1f32-46fb-8fe1-cc37e5d4814e"
      unitRef="usd">53900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id8f4cbe1c0914b04bceeebc3cbe0bb61_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEyLTgtMS0xLTA_e839812b-1b0f-415b-914f-6772137d4d5e"
      unitRef="usd">43400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iea670c4c01544dafa2cba9693bceb1e2_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEzLTItMS0xLTA_3dcbfec3-6a25-459c-9d70-b4c06feb49a4"
      unitRef="usd">26800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iea670c4c01544dafa2cba9693bceb1e2_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEzLTQtMS0xLTA_f634697d-46d0-46d1-aca1-1abcfedbd16f"
      unitRef="usd">10600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie1f5a289dcef4642b1a31621e515e16e_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEzLTYtMS0xLTA_995ffce8-f76b-427f-b4c7-256c7ede4aa7"
      unitRef="usd">27900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie1f5a289dcef4642b1a31621e515e16e_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzEzLTgtMS0xLTA_f9869d0c-72cc-4807-a290-c4101f22685b"
      unitRef="usd">6900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzE0LTItMS0xLTA_26ab215d-a63a-4289-8c66-f60875a7ed37"
      unitRef="usd">4931100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzE0LTQtMS0xLTA_cb026e46-c3d0-46d0-a5c0-e4c329e7b548"
      unitRef="usd">3623600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzE0LTYtMS0xLTA_3c821e25-108a-4f45-847f-bc2f428441e3"
      unitRef="usd">4786600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo4N2RlZDQ3Y2ZiZmI0OWM3YTMxY2M2M2QzZTZmZjk4Mi90YWJsZXJhbmdlOjg3ZGVkNDdjZmJmYjQ5YzdhMzFjYzYzZDNlNmZmOTgyXzE0LTgtMS0xLTA_4bfa9096-e245-4323-b710-a4cca92b04f1"
      unitRef="usd">3326800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="i16c34f677a2d4f08b3c7c62af376754c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4ODc_35ea27e4-a0d3-4fa2-8be5-090fa6d5286f"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ic47589113cf749b8b8b586c11fd7976e_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4NzI_3376bfce-d3c8-4933-94bf-a5bd402cb51b"
      unitRef="usd">24100000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i61c55e342da24eee9282df815b492d78_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4MzA_33ebc8db-ac02-48bc-a5e1-eafc619eef6d"
      unitRef="usd">900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i51211784b29941399cb1944d9f011a2a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4NDQ_d0b6662f-961c-4f37-ac9c-e6b4f42c0011"
      unitRef="usd">2000000.0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i89813ed8f2ea44b085d80d8ab6c4fc94_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY1NjQ4NTg_98ebec6f-118f-4e19-bad4-494be0f78e46"
      unitRef="usd">1200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTAyNDU_97856844-08bd-4cc8-98f1-a25bdff0ac4b"
      unitRef="usd">685400000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:AssetImpairmentCharges
      contextRef="i41cbe32e1f1041339f89ddea6ec9c266_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MDE2_3542bdb3-ca4d-4cf4-ab00-376cd2a8a196"
      unitRef="usd">576900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i744c7283185f454f92fabd0f80a0ef92_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MDQ0_b1909a98-3253-4a02-b056-38e014a544bd"
      unitRef="usd">22400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ie578122249b043b0bdb831bf79737e98_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MDc0_21d7043b-cc42-41f9-a9fd-49c344f6b5c6"
      unitRef="usd">48600000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i5dd76668352442978fe04a0c59a5c795_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MDkz_b124e784-0a7f-4349-b12e-3b6c3569c297"
      unitRef="usd">27700000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i6223b3508b8c463aa3289a1a509edccc_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE0MTI3_4d05e922-648c-4d5f-a41d-b96d58d3c50c"
      unitRef="usd">9800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1bfbe4fe947c43a4a22bb3f6c17cb1cd_D20171231-20180331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTAyNjI_2f748af3-de56-4777-95e8-dea3e1a764f6"
      unitRef="usd">46000000.0</us-gaap:AssetImpairmentCharges>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="iae131a61f51b418f8d16b147c4f2e986_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTAzMzE_1f70f375-723a-4229-920e-2abf7cf5b26d"
      unitRef="usd">127000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i6724b08a2857420f938843bdf83228a2_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTAzNDc_c941cdb1-e42a-4f28-986a-801532d590e2"
      unitRef="usd">1200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i52f401bcab374c9da21ba458593af4a7_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE1MzMx_f9b014a5-e833-4d23-9c73-0e0993043d2a"
      unitRef="usd">83100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i58ab6ed21a0e49acb17f46bb533a208d_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE1MzU5_9f3e75ad-c64a-4875-bb82-677c4daf1992"
      unitRef="usd">11400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i72959050a334423eb15ca612ed289237_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE1NDA1_76248fee-238f-441c-a1bf-c6b67b464831"
      unitRef="usd">2700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <holx:Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology
      contextRef="ie4eb2eab1b56414c8fbb0c756bf25fdd_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzE1NzIz_dd1fe849-0d3c-4ff7-8ef7-ae4dd68abfba"
      unitRef="usd">5500000</holx:Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjYx_1746a93c-ff02-4503-9395-08be6948e129">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated amortization expense at September&#160;26, 2020 for each of the five succeeding fiscal years was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzAtMS0xLTEtMA_9dcb013e-e3c5-4137-bb16-ab1437a0c8ba"
      unitRef="usd">283500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzEtMS0xLTEtMA_695ffb92-eac6-4654-9039-a1fa5eb852eb"
      unitRef="usd">273100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzItMS0xLTEtMA_37c3bade-7cfc-4742-8f1d-610a2372eb9b"
      unitRef="usd">176000000.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzMtMS0xLTEtMA_837a0ed5-c8d2-4afb-bab3-63077fc19463"
      unitRef="usd">164600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo1YzcxOGJiMTIzOGQ0Mjk4YWE0Y2U0MzliODNjNzI5ZS90YWJsZXJhbmdlOjVjNzE4YmIxMjM4ZDQyOThhYTRjZTQzOWI4M2M3MjllXzQtMS0xLTEtMA_1c1636a2-0ac4-4e68-b773-67359dcc6f85"
      unitRef="usd">151100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <holx:GoodwillNotAtRiskOfFailingImpairment
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY2OTM2NDk_70d2ba8e-931c-4462-ac4d-20521bd18380"
      unitRef="usd">2600000000</holx:GoodwillNotAtRiskOfFailingImpairment>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic5548619644d4005832478fe4f7a75d0_D20171231-20180331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzExNTQ0ODcyMjExNTIx_778c0ef2-0340-4ff6-a969-55f811e56a5c"
      unitRef="usd">685700000</us-gaap:GoodwillImpairmentLoss>
    <holx:ScheduleOfGoodwillBySegmentTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzMy_dd9e2d07-8f20-4ced-8fbf-8214cd1db5e0">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of goodwill activity by reportable segment from September&#160;28, 2019 to September&#160;26, 2020 is as follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:130.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:57.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:57.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Breast&#160;Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;GYN&#160;Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Skeletal&#160;Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,014.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,563.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SuperSonic Imagine acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Beacons acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acessa Health acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,063.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,657.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfGoodwillBySegmentTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i169afb67581f4042a9907e319c8aaee1_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtMS0xLTEtMA_94ef120c-3016-476d-8834-4fb7b18fe28e"
      unitRef="usd">819200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0b9b859e952c4dc086ae9de8f3020603_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtMy0xLTEtMA_a0bdb88c-a20b-40b7-a545-eed06380c886"
      unitRef="usd">722200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i294e83c0d77f4a76b4cb43739eaeaf9f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtNy0xLTEtMA_d6127b05-8b88-4eb7-9968-25d22c72659c"
      unitRef="usd">1014200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie5bea17c720745bbbe2f47855b322570_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtOS0xLTEtMA_6ebec40f-84b2-475c-9714-aa5be206f22d"
      unitRef="usd">8100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzEtMTEtMS0xLTA_d9a355a0-ac7e-47b0-9b0a-d440e307ff5f"
      unitRef="usd">2563700000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4dc3eeb5d8a7429f994641e93253a6bd_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtMS0xLTEtMA_efa66b41-e56d-4f06-8853-6c2a94063c2e"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i69dbc69319c941ca9448d21361773988_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtMy0xLTEtMA_9f2fcd29-c428-4f20-b73f-ef81cd269bcc"
      unitRef="usd">34300000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7e140addb4a24ea78dd4c7f462c399ba_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtNy0xLTEtMA_ca99672e-79e0-482b-884e-2f48e01b21ed"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i96ce5d4500f64edfa02758b406d21f90_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtOS0xLTEtMA_677b8d6f-6171-456b-b4d3-97c966c5f0ec"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if7876712181a4f0394252851c3247e89_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzQtMTEtMS0xLTA_9fc1d1ce-045a-4ae0-b459-7bb3a6c6e2e8"
      unitRef="usd">34300000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i988d23f94723457db513c5aa1234acc7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtMS0xLTEtMA_c963b01c-76d0-4705-b00d-71517b881f34"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib8b49a0c00624209ae298e13d31a8705_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtMy0xLTEtMA_b344fdb1-d81d-4614-ba6b-6f2a361483b4"
      unitRef="usd">6200000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib231ff2385b64b9ca2bb871bcfec1dc3_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtNy0xLTEtMA_3a858b86-974d-4653-93af-98f10067eb3b"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="icf0c977d98c5446ca36e0ca5d209a7e5_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtOS0xLTEtMA_1884fac6-7ab7-4d94-ae2e-09a6f2cd0600"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6d5aea5a6dce4ff3a0ea7a9f0a6e7e04_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzUtMTEtMS0xLTA_f646a7fa-f9e7-466a-baf0-6fa48cee5b16"
      unitRef="usd">6200000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i34dc1d8ed3e448048896ea6acd36bec6_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMS0xLTEtMTQ3MTg_20de3eef-1b86-4bd8-8aca-c370aba7481e"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4a8e80b3d02048368499f2fc987b666c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMy0xLTEtMTQ3NTM_06bb252e-20c2-4d24-85a3-18c8c9c711d1"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia8c69c195a394e1abb1f0343c9c25508_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctNS0xLTEtMzc4Mg_f9033519-1466-4d0e-84a0-386f156a80ac"
      unitRef="usd">48400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i66e0c7ded43e4ffc9af56c596610e242_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctNy0xLTEtMTQ3NzA_9e8ac672-cb24-4894-9608-e946934a6b59"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i339a5d0289c34c65ac5ba8480d1803a2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctOS0xLTEtMTQ3MTY_4153d2bc-f30a-4f92-a2a0-386174a87e85"
      unitRef="usd">48400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMS0xLTEtMA_d4e664f9-f6e2-4a82-a4a4-5f0e89266a5d"
      unitRef="usd">2400000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMy0xLTEtMA_58e03e6a-ff24-4418-9bde-e7ff0a3f90a6"
      unitRef="usd">2100000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctNy0xLTEtMA_c919531f-fa88-474a-b026-83dfebda0826"
      unitRef="usd">800000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctOS0xLTEtMA_15ac2ab2-dd63-4dd2-ba2e-55bbedf2a0a5"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzctMTEtMS0xLTA_914a26c5-151c-4800-ae5b-2f4e32f5dbb6"
      unitRef="usd">5300000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i437292e8142d4d96839af5869cecaab3_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtMS0xLTEtMA_9263b1a5-24ce-4e6e-b139-ffe5bf2e2237"
      unitRef="usd">821600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i305c6e69d9584df69b07d0c58b68dc88_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtMy0xLTEtMA_222e8a0e-9e7d-43d0-bcd2-617e5a554fa5"
      unitRef="usd">764800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if85520f01ace43129ad7669c2083f920_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtNy0xLTEtMA_4d6ce615-7993-4fe8-b434-58e474b864ca"
      unitRef="usd">1063400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0bbb9f4ee2a14c8a8ff8db71fcca17b1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtOS0xLTEtMA_7abd1a57-f3f7-48f5-bf01-9d7b5372bb5d"
      unitRef="usd">8100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphMDk5OTdhYzJhMjE0NGU4YTViY2UyMTE1NTU3Y2QzOC90YWJsZXJhbmdlOmEwOTk5N2FjMmEyMTQ0ZThhNWJjZTIxMTU1NTdjZDM4XzgtMTEtMS0xLTA_c7b0bfc4-64f2-46e0-8b70-f83463d043f8"
      unitRef="usd">2657900000</us-gaap:Goodwill>
    <holx:OtherAssetsPolicyPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjA1_698f571e-f2fe-4ff9-bc14-b48c71cc288c">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost-method equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-method investment and loans to SSI (Note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax receivable primarily relates to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. The right of use assets were recorded in connection with the adoption of ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#x2019;s Nonqualified Deferred Compensation Plan (&#x201c;DCP&#x201d;) and are recorded at their cash surrender value (see Note 12 for further discussion).</holx:OtherAssetsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5ODAz_efba5c93-66cb-420b-864e-27ea70d8390f">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost-method equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-method investment and loans to SSI (Note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:IncomeTaxReceivable
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzMtMi0xLTEtNjM3OQ_c5cb73c8-a7f6-449d-ade7-928d9161c3a4"
      unitRef="usd">325700000</us-gaap:IncomeTaxReceivable>
    <us-gaap:IncomeTaxReceivable
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzMtNC0xLTEtNjM3OQ_81429a0b-5be3-4040-be1e-154521527599"
      unitRef="usd">0</us-gaap:IncomeTaxReceivable>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzQtMi0xLTEtMTA2NzA_3eed18a0-06c0-4c76-b2fd-797ceaad6306"
      unitRef="usd">80700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzQtNC0xLTEtMTA2NzA_7b2a90b1-9888-4db2-85da-319241bc32a6"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzMtMi0xLTEtMA_a4ef45de-76a3-4d98-957e-5a9de1753ff9"
      unitRef="usd">49300000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzMtNC0xLTEtMA_ac018c63-87f9-48f6-bb17-40ec39c89555"
      unitRef="usd">44600000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzQtMi0xLTEtMA_8008d5b7-6699-4a49-8d73-e0726f4ede77"
      unitRef="usd">15500000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzQtNC0xLTEtMA_d0ce4f92-f3f0-41fd-b227-7b0368d4a575"
      unitRef="usd">17200000</us-gaap:DeferredIncomeTaxAssetsNet>
    <holx:CostMethodEquityInvestments
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzgtMi0xLTEtMA_438a250f-0d63-40fb-9d72-1cc07215428d"
      unitRef="usd">11400000</holx:CostMethodEquityInvestments>
    <holx:CostMethodEquityInvestments
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzgtNC0xLTEtMA_1ff315d7-8126-4c8e-9722-4cb4190b87eb"
      unitRef="usd">11400000</holx:CostMethodEquityInvestments>
    <holx:EquityMethodInvestmentAndLoansToAcquiree
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzEwLTItMS0xLTA_edff48cb-a163-4d28-b86a-8bd8241b4de6"
      unitRef="usd">0</holx:EquityMethodInvestmentAndLoansToAcquiree>
    <holx:EquityMethodInvestmentAndLoansToAcquiree
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzEwLTQtMS0xLTA_6be54ee8-95d7-4d4c-8cf6-17d00db80666"
      unitRef="usd">42700000</holx:EquityMethodInvestmentAndLoansToAcquiree>
    <us-gaap:OtherAssetsMiscellaneous
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzExLTItMS0xLTA_8898d472-2b3c-4b36-bc96-dc6a94b26945"
      unitRef="usd">34000000.0</us-gaap:OtherAssetsMiscellaneous>
    <us-gaap:OtherAssetsMiscellaneous
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzExLTQtMS0xLTA_5b592866-97f2-4f10-9073-ddc6bfabe24a"
      unitRef="usd">38700000</us-gaap:OtherAssetsMiscellaneous>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzEyLTItMS0xLTA_5c0c8ef2-a1d6-420f-96d0-28151913df3e"
      unitRef="usd">516600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTplOGMwZmMzNDAxZmI0ZWQ2YWUxN2Q4NDVhZDIyOGNiNC90YWJsZXJhbmdlOmU4YzBmYzM0MDFmYjRlZDZhZTE3ZDg0NWFkMjI4Y2I0XzEyLTQtMS0xLTA_be0fcc8f-98e7-498c-9a83-e993696c1f9c"
      unitRef="usd">154600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTk4_766e3fce-af38-4c2c-a354-503d9a23aa7a">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred for the research and development of the Company&#x2019;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for the development costs of software embedded in the Company&#x2019;s products in accordance with ASC 985, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#x2019;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimate useful life and recorded within cost of revenues - product.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njgw_4c733847-747d-4e01-9bf8-b5e700e072f7">Foreign Currency Translation&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s foreign subsidiaries are translated in accordance with ASC 830, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Matters.&lt;/span&gt; The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#x2019;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income, net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss) as a separate component of stockholders&#x2019; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income, net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njg0_f66c535c-89cc-4d28-a409-2b088ca3e6d9">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#x2019; equity. The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Charges (gains) reclassified to statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Njcy_e11642a4-1206-4348-bf8f-1c3e02b20414">The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Charges (gains) reclassified to statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMS0xLTEtMA_00fd5d78-bb29-404e-a15a-4cc8a12abc19"
      unitRef="usd">-41400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMy0xLTEtMA_76aade2f-7881-4d59-bc74-23874ba9ca3f"
      unitRef="usd">1700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItNS0xLTEtMA_3f738773-518d-4f12-a0f2-4dd316124dfc"
      unitRef="usd">-2700000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="i0e1f1b09ac83442a8c991f025f87c36c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItNy0xLTEtMA_3b50972a-d54b-413e-b46d-7968da5e8be5"
      unitRef="usd">3500000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItOS0xLTEtMA_48a7effa-b3a6-4aa5-aa23-301d7f22e611"
      unitRef="usd">-42300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTEtMS0xLTA_f27c2cf4-e1e6-48d2-99b7-cd973cbfc966"
      unitRef="usd">-26600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTUtMS0xLTA_a7894b13-e1db-4d24-8c3d-ed836572e860"
      unitRef="usd">1100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTctMS0xLTA_cb5328c5-c01f-4006-b971-3f31680fe7c7"
      unitRef="usd">2200000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="iafc353efac2f474997f4ab38d4cd03dd_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTctMS0xLTE2MzM_1bd3369e-48bc-4227-9118-32f43dd62ba2"
      unitRef="usd">0</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzItMTktMS0xLTA_d4b22199-b1f0-45e0-9bda-beffa5d9ea97"
      unitRef="usd">-25500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMS0xLTEtMA_8c1f1f14-6398-4d73-9417-eef1204ff837"
      unitRef="usd">18500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMy0xLTEtMA_a7e1c2d6-056d-4a93-b97e-a3148c246524"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtNS0xLTEtMA_656db8bb-7d36-4434-86a3-45b4701d7383"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtNy0xLTEtMA_3c9b33a2-c588-4874-b9b6-384c4c09e44f"
      unitRef="usd">-27600000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtOS0xLTEtMA_fcdc0599-22dc-4651-948e-ab64d96f4e1f"
      unitRef="usd">-9700000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTEtMS0xLTA_52ea2e19-782b-48cd-995a-bba378ec0912"
      unitRef="usd">-14800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTUtMS0xLTA_c646e732-de41-45a6-8cb6-480a7ac1e898"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTctMS0xLTA_2d5bac23-21ad-4247-9d98-3f72294f9650"
      unitRef="usd">-8000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTctMS0xLTE2MzM_8c19d91d-013f-46b3-884b-9c4ba62000b5"
      unitRef="usd">3500000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzMtMTktMS0xLTA_229a529c-82f9-42fe-b46e-bddc801704f6"
      unitRef="usd">-19900000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7c9b833795a14c34b98fd573a5bb02aa_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMS0xLTEtMA_459d2ea0-f630-4ae9-bae3-4f8d91f73ef8"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic2febf310c33479bb7213e376d43d131_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMy0xLTEtMA_abedd080-aaa7-4735-8d22-337c9f47015d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ice34049f21724d2a89b07c75c6bfe1a0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtNS0xLTEtMA_2700e7b2-942a-4996-a398-c2762c26880e"
      unitRef="usd">2300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtNy0xLTEtMA_b3e3f32d-d81c-4c8d-8a0d-5d423d50fc08"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtOS0xLTEtMA_a5bed582-675a-4003-83da-001e41fed4ab"
      unitRef="usd">2300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i96d2d76048144084a688883b4c23ca74_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTEtMS0xLTA_0224c034-3984-4dd5-80a6-21835ece4f08"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i49fd9cd9c1a44756877deaf8449c4ce5_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTUtMS0xLTA_bd32e007-dcde-454b-ac51-ed8d1325c208"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8acf153e8175463d854199e3d5b100f5_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTctMS0xLTA_746d9814-15c3-4a1b-afa0-4341db9dace8"
      unitRef="usd">3100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTctMS0xLTE2MzM_8e6fecd8-32c3-4e35-ad59-035525b30c13"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzQtMTktMS0xLTA_056053d3-1492-4b1e-8a75-5ae44c6f6daa"
      unitRef="usd">3100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMS0xLTEtMA_6e861a66-d2a9-4506-af5a-c3c0716d4972"
      unitRef="usd">-22900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMy0xLTEtMA_1ebe4a7e-e861-4d3c-bb05-914f164be6ff"
      unitRef="usd">1800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtNS0xLTEtMA_20bdb955-88c5-4378-aeca-edf2a9a1d94d"
      unitRef="usd">-900000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="i2dd3354045a94ad6bc4f7dec67555173_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtNy0xLTEtMA_207120d4-6c7f-4aeb-abb5-3801df75d712"
      unitRef="usd">-24100000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtOS0xLTEtMA_3ae5fbfe-b543-464d-b7d8-768272ed5b3a"
      unitRef="usd">-49700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTEtMS0xLTA_00fd5d78-bb29-404e-a15a-4cc8a12abc19"
      unitRef="usd">-41400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTUtMS0xLTA_76aade2f-7881-4d59-bc74-23874ba9ca3f"
      unitRef="usd">1700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTctMS0xLTA_3f738773-518d-4f12-a0f2-4dd316124dfc"
      unitRef="usd">-2700000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="i0e1f1b09ac83442a8c991f025f87c36c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTctMS0xLTE1NjAx_70bf248e-1a89-429b-bf59-ef052660dc7c"
      unitRef="usd">3500000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiMWUyMDRlYzZmYmQ0NTIxOTYyMzA3MmJhNTFjZjQ4ZC90YWJsZXJhbmdlOmIxZTIwNGVjNmZiZDQ1MjE5NjIzMDcyYmE1MWNmNDhkXzUtMTktMS0xLTA_c08ae597-e91b-4f24-a69c-0aa36da78526"
      unitRef="usd">-42300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzMz_95d1b4bf-fbac-4d57-9351-b148c04547b2">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Cap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income, net in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5 million, which was the initial fair value of the instruments recorded in the Company&#x2019;s financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical terms of the interest rate caps were designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payments on $1.0 billion of principal, which ended on December 27, 2019 for the contracts entered into in fiscal 2018, and which will end on December 23, 2020 for the interest rate cap agreements entered into in fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;26, 2020, the Company determined that the existence of hedge ineffectiveness, if any, was immaterial and all changes in the fair value of the interest rate caps were recorded within AOCI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020, 2019 and 2018, interest expense of $2.3 million, $3.1 million and $3.6 million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The Company expects to similarly reclassify approximately $0.5 million from AOCI to the Consolidated Statements of Operations in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate fair value of these interest rate caps was $0.0 million and $0.1 million at September&#160;26, 2020 and September&#160;28, 2019, respectively, and is included in both Prepaid expenses and other current assets and Other assets on the Company&#x2019;s Consolidated Balance Sheet. Refer to Note 8 &#x201c;Fair Value Measurements&#x201d; for related fair value disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in accumulated other comprehensive income (loss) and were a loss, net of taxes, of $27.6&#160;million and a gain, net of taxes, of $3.5&#160;million for the years ended September 26, 2020 and September 28, 2019, respectively. The fair value of this derivative was in a liability position of $31.2 million as of September 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Foreign Currency Contracts and Foreign Currency Option Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28. 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 29. 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 26, 2020, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with a notional amount of $172.6 million. As of September 26, 2020, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $380.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instrument Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:23pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.842%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Operations for derivative instruments for which the Company did not elect hedge accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.926%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not classified as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MzAxMzc_e4a7383b-f280-47e4-9f85-1a839371065c"
      unitRef="usd">3700000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:PrincipalAmountOfBorrowings
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMwNjQ2_439569f4-7159-49bb-beef-a29080a48d81"
      unitRef="usd">1000000000.0</holx:PrincipalAmountOfBorrowings>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxMDkx_b7bde9f1-14a1-4d85-8155-83df7e8183b9"
      unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxMDk1_cd8f3055-3e21-493f-8873-4fa841194ed4"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxMTAy_3abf9564-b313-4ed0-a26a-7ab57f6149d4"
      unitRef="usd">-3600000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxMzA1_949303cb-6a4a-4143-aea3-386a050871a8"
      unitRef="usd">500000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="iaa82070dc0674b2b93dfb59c5365695c_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxNDQ3_108d54e5-4642-40bc-b96c-ceeb77cc79fb"
      unitRef="usd">0.0</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="ic3eb72f6ddde4172af624dbe36bc89d5_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxNDU0_f46bad8a-fd01-40ec-9576-d8a44ff748b8"
      unitRef="usd">100000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMxOTk1_c5c2356e-41cb-4029-95b3-e257bb4d7b43"
      unitRef="usd">1000000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMyMDcw_414dcd87-dcd1-425f-8728-22a2b521c617"
      unitRef="usd">1000000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <holx:PrincipalAmountOfBorrowings
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMyNDg0_439569f4-7159-49bb-beef-a29080a48d81"
      unitRef="usd">1000000000.0</holx:PrincipalAmountOfBorrowings>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i607038a0d32848a084cf3a6708c68b0e_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTA0NTM_45daf7e9-0d29-4335-8ac6-64733f42c7d4"
      unitRef="usd">-27600000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ia80c169d1770453da956a9b1afcca83d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQzOTgwNDY3MTA0Njg_a6a7aa74-ddbe-4529-83a8-fc8a512c2401"
      unitRef="usd">3500000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="i2dd3354045a94ad6bc4f7dec67555173_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzMyNjUw_49dac984-1ed6-4e47-b337-8c273bc152ce"
      unitRef="usd">31200000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:DerivativeTermOfContract
      contextRef="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzkzNDU4NDkwNTc3Mzg_d37581b2-a456-496d-a9b1-5278d9187a18">P1Y</us-gaap:DerivativeTermOfContract>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzkzNDU4NDkwNTc3MjY_9043de89-e227-43c2-bd2d-2f51027435c4">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28. 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 29. 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzMtMS0xLTEtNjQ0MA_26050f93-5a97-43fb-bcbe-3a78f76fc015"
      unitRef="usd">700000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="if4a7fbf31ef34d35a542b3139d2d97b4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzMtMy0xLTEtMTg5MTY_81d494ad-218d-492f-b117-db4bad64e7a5"
      unitRef="usd">11000000.0</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i61680decf3094210970e74b87feb098a_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzMtNS0xLTEtMTg5MTY_91cfc2d8-7cd0-4277-9232-7456812c1076"
      unitRef="usd">-1300000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i21e0c51c686947c9a4167c8b13e37d11_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzQtMS0xLTEtMTg5MTY_7118a653-687b-47f6-90b4-5b6ac2d31a72"
      unitRef="usd">-1900000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i27a6303307844b9ebc5be9434c2819ad_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzQtMy0xLTEtMTg5MTY_fe570e1a-e4a6-443a-b309-395c72877c02"
      unitRef="usd">0</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="ie21e889f681c47ca83ea648b1fe24ff2_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzQtNS0xLTEtMTg5MTY_9a75e565-471f-4742-af61-54dac9e99386"
      unitRef="usd">0</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzUtMS0xLTEtMTg5MTY_b5fd1cab-d7a6-4785-8ed5-44b1663eeb82"
      unitRef="usd">-1200000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzUtMy0xLTEtMTg5MTY_2ee4a371-d418-4fe3-abc3-d37f8269f461"
      unitRef="usd">11000000.0</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzUtNS0xLTEtMTg5MTY_b810ac8a-a165-4b05-b8d1-dbacedc233a6"
      unitRef="usd">-1300000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzgtMS0xLTEtMzU5Mw_abdbc4df-7032-4ac1-9d05-0aa1c58e8865"
      unitRef="usd">-200000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="if4a7fbf31ef34d35a542b3139d2d97b4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzgtMy0xLTEtMTg5MTY_9493f2fd-3d42-4373-b5b5-8964ebc56afd"
      unitRef="usd">-2200000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i61680decf3094210970e74b87feb098a_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzgtNS0xLTEtMTg5MTY_c771084b-78ab-4c7c-ad89-48a7f5ca001b"
      unitRef="usd">6600000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i21e0c51c686947c9a4167c8b13e37d11_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzktMS0xLTEtMTg5MTY_90a5a184-1c13-4a5d-9a3f-c6f08c4c0d13"
      unitRef="usd">4000000.0</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i27a6303307844b9ebc5be9434c2819ad_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzktMy0xLTEtMTg5MTY_6710d6e1-04e1-4080-ac67-cf584ad6fc65"
      unitRef="usd">100000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="ie21e889f681c47ca83ea648b1fe24ff2_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzktNS0xLTEtMTg5MTY_66fed802-2e19-425d-adeb-9bd37ebb4942"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzEwLTEtMS0xLTE4OTE2_ebe50698-4f8d-4764-946f-82852a4e2843"
      unitRef="usd">3800000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzEwLTMtMS0xLTE4OTE2_308f50b6-7cb5-405d-a7a8-9935d2bd400a"
      unitRef="usd">-2100000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTphZDU3NWQ3MWFiNmY0YWNjYTkyMjY1YjQ5YWYyYTA1OS90YWJsZXJhbmdlOmFkNTc1ZDcxYWI2ZjRhY2NhOTIyNjViNDlhZjJhMDU5XzEwLTUtMS0xLTE4OTE2_064e6846-2feb-4343-a5ea-722d1e210238"
      unitRef="usd">6600000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <holx:NotionalAmount
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM0NjQ0_b47b2b9f-f2d0-4a0a-b4e3-13008ef874e2"
      unitRef="usd">172600000</holx:NotionalAmount>
    <holx:NotionalAmount
      contextRef="i2dd3354045a94ad6bc4f7dec67555173_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM0OTI1_93c2cafa-13b1-4c69-b4cb-d75dbabe79b9"
      unitRef="usd">380200000</holx:NotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzQ5_e08b01ab-59ff-4c67-86a6-0cdd0a9f4d10">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:23pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i059452d2deb54b2cb9873ef23f27c960_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzMtMy0xLTEtMA_72bda84f-fcd8-4208-8b1d-37e44c141bcf"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ia7aa80690b724dda81b234de06742f9c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzMtNS0xLTEtMA_079f8620-fffe-44b6-a229-e4ccbf2aefc6"
      unitRef="usd">100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="id438b62a9541447d91c50df6ab64b0c1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzUtMy0xLTEtMA_4a9d55be-e2b4-435c-8141-cbb2c29bc8d3"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i7dfd4338227d46fc8dfbceb1cff06631_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzUtNS0xLTEtMA_491789fa-8d8f-49d8-8d4f-767e8d86d6e5"
      unitRef="usd">4700000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzYtMy0xLTEtMA_d0925ab2-bdc5-4f6a-8cc9-f1e2586eaafa"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzYtNS0xLTEtMA_e77856b7-0a06-421b-ab49-55f59914d8e2"
      unitRef="usd">4800000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i6d44b346ba2949ff849a666fdf96eb13_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzktMy0xLTEtMA_d92b8996-4941-49fd-ac7d-90c99bf99bcd"
      unitRef="usd">1100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ib23d81f77fd54000b2214c1d2555f31c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzktNS0xLTEtMA_38947686-26ed-4e8b-9d79-6d9445b13a89"
      unitRef="usd">900000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ia0150d6d7caa4efe85607759c805b3e2_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzEwLTMtMS0xLTA_c20a066c-5136-46e6-8176-1bda78ec2784"
      unitRef="usd">10100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ic52f7f7067a847028ef4c89e9a861db1_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzEwLTUtMS0xLTA_e487f41d-d958-4e50-b55f-1531fe5bfdf4"
      unitRef="usd">2000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ica6b881644254b8fae9fbb03c69fdc79_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzExLTMtMS0xLTA_4843438a-84a9-480e-8a82-4634995709b1"
      unitRef="usd">11200000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ieb6934bac52449f8aa6c53b295caf5db_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzExLTUtMS0xLTA_b8082365-4d86-4d19-a634-a05361059309"
      unitRef="usd">2900000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="if04f766e5e7f41629fd5954a52f9482d_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE1LTMtMS0xLTExODcx_6869fa84-53fe-48c8-b6d2-33ee96b33f7d"
      unitRef="usd">8200000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i6599845afc5441e58d23ed545c1c2d90_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE1LTUtMS0xLTExODcz_f2f745d1-2953-4413-ad80-e4fb3df29863"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ie4ca89e21b3c4afa91bf0c9de4dead2b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE2LTMtMS0xLTExODYy_09fabe9c-a38d-45a5-844b-d0fc50b5a88f"
      unitRef="usd">23000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i304856dff4354c09a218d0c4abcec6b1_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE2LTUtMS0xLTExODY2_f8fae6b7-1bf4-48f5-8548-9fb63438e05b"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeLiabilities
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE3LTMtMS0xLTExODc1_38d0a082-be1c-489a-abb9-69082f127721"
      unitRef="usd">31200000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE3LTUtMS0xLTExODc3_549dc3c3-2df5-47e6-90ba-abc7834ee622"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i826045fe76ba4dfba8d2b77577790871_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE1LTMtMS0xLTA_6f7e6b4a-c32e-49b5-88fe-2766d2891b76"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i51127895ec4446f88b062df8c3424fed_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZToxOWY1ZjE5NzYwYjI0NDNjYmViNzc3ZDRlODJmYjkyZC90YWJsZXJhbmdlOjE5ZjVmMTk3NjBiMjQ0M2NiZWI3NzdkNGU4MmZiOTJkXzE1LTUtMS0xLTA_d6c31e7f-0cf3-44ba-89cf-490ca1395dbb"
      unitRef="usd">100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjEz_efc91c40-d0d4-471d-bb11-0eb5c864a4ed">&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.842%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="icc65f9a1944847ea81ab96621f47b0ce_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzItMS0xLTEtMA_d2e8f053-b7cb-467c-9509-7bf6e003e69c"
      unitRef="usd">-27600000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i8333f1fcd3424edeb40667341d0ef184_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzItMy0xLTEtMA_b70e9854-d2d8-49fc-9625-f7103dcee959"
      unitRef="usd">3500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i3e78594f4bdd44c39236b9e9233d4e5d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzItNS0xLTEtMA_409f1beb-2a6f-41bf-b928-d2a94551ced1"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i6199234c2a9d4588aa6dd0e453b067ee_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzMtMS0xLTEtMA_5150da19-6843-4f41-a17d-19e2ff3f8c6d"
      unitRef="usd">-500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i7d2a775a080b412fa3dafce51e6d15ba_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzMtMy0xLTEtMA_9ae1cd63-b6bf-41c9-9c9d-efe1e04e23e8"
      unitRef="usd">-8000000.0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i1cc3451a488c432f89410a83c10d5d44_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzMtNS0xLTEtMA_07d01c90-8473-43a1-a395-fbbdc7331bdc"
      unitRef="usd">-5700000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzQtMS0xLTEtMA_e274658e-895f-4461-b57b-f4e6a194a455"
      unitRef="usd">-28100000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzQtMy0xLTEtMA_20df2fe3-4893-49f2-bbbb-02b6d5d5bc98"
      unitRef="usd">-4500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpjOGYzNWI0NWU2Y2Y0Y2RhYjI3ZDc2NmFiNWM1MmE4Zi90YWJsZXJhbmdlOmM4ZjM1YjQ1ZTZjZjRjZGFiMjdkNzY2YWI1YzUyYThmXzQtNS0xLTEtMA_c2253f3a-1dda-4cb5-8d25-ed3d6b6ce75c"
      unitRef="usd">-5700000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5ODA0_4828f0f7-bff5-474f-9d6d-347fdc29ab12">&lt;div style="margin-top:18pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Operations for derivative instruments for which the Company did not elect hedge accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.926%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not classified as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i2b814b39e0b94870a02fa477c0211873_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzItMi0xLTEtMA_176665b8-4bd9-42cc-90c1-518fa141f720"
      unitRef="usd">500000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="if4a7fbf31ef34d35a542b3139d2d97b4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzItNC0xLTEtMA_baa83b8f-56c2-42f8-b1b6-faba9bb9c2cf"
      unitRef="usd">8800000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i61680decf3094210970e74b87feb098a_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzItNi0xLTEtMA_f381df5c-411e-4c33-a03a-10998b4bec78"
      unitRef="usd">5300000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i21e0c51c686947c9a4167c8b13e37d11_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzMtMi0xLTEtMA_3ea97c39-5455-437b-afb3-1a1b3e8127a9"
      unitRef="usd">2100000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i27a6303307844b9ebc5be9434c2819ad_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzMtNC0xLTEtMA_9848804d-7d2e-4c4e-a1f9-cec5d7ba1d63"
      unitRef="usd">100000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="ie21e889f681c47ca83ea648b1fe24ff2_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzMtNi0xLTEtMA_b463ea65-d45d-4d0c-91d4-b7093a53a61a"
      unitRef="usd">0</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzQtMi0xLTEtMA_b6813dde-d616-4fee-8c46-5fc2f80371b3"
      unitRef="usd">2600000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzQtNC0xLTEtMA_2a26e135-7b96-433f-aebc-d2c64d46b096"
      unitRef="usd">8900000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpiN2NlZGRlNDRkZjA0NjVlOGM2ZTMyYmM2MTg5MjIyOC90YWJsZXJhbmdlOmI3Y2VkZGU0NGRmMDQ2NWU4YzZlMzJiYzYxODkyMjI4XzQtNi0xLTEtMA_51e42e31-0393-4cc7-8f88-5875681c97f0"
      unitRef="usd">5300000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <holx:AccountsReceivableAndReservesPolicyPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTU2_c2fb49e8-0634-41b0-8cd0-80627d70a782">Accounts Receivable and Reserves&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records reserves for doubtful accounts based upon a specific review of all outstanding invoices, known collection issues and historical experience. The Company regularly evaluates the collectability of its trade accounts receivables and performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and its assessment of the customer&#x2019;s current credit worthiness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable reserve activity for fiscal 2020, 2019 and 2018 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Costs and&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-&lt;br/&gt;offs and&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:AccountsReceivableAndReservesPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzAw_a79fe837-4edb-41e5-b1ff-ff51a486df95">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable reserve activity for fiscal 2020, 2019 and 2018 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Costs and&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-&lt;br/&gt;offs and&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItMi0xLTEtMA_4fc77273-7143-4e9e-ba67-664636788baf"
      unitRef="usd">17800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItNC0xLTEtMA_c903328a-5dd0-4efa-8eb0-f006910be673"
      unitRef="usd">26800000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableReserveDivested
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItNi0xLTEtNjE0NQ_e97c055b-1b50-4aee-9460-0fa9cbccc6f7"
      unitRef="usd">-5800000</holx:AccountsReceivableReserveDivested>
    <holx:AccountsReceivableAllowanceReduction
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItNi0xLTEtMA_581de41e-390d-4de4-839c-f01ed8f63946"
      unitRef="usd">7200000</holx:AccountsReceivableAllowanceReduction>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzItOC0xLTEtMA_ea6fb65e-7b5c-4516-a890-2615fd12a014"
      unitRef="usd">31600000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtMi0xLTEtMA_0bd52b03-5e5e-49d2-85f9-ac150aa4bb33"
      unitRef="usd">16200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtNC0xLTEtMA_c080d4b3-7b87-413c-b238-918acd729bae"
      unitRef="usd">4400000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableReserveDivested
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtNi0xLTEtNjE0OQ_eefdfdcc-53fd-40f4-afe8-898dfaa04207"
      unitRef="usd">0</holx:AccountsReceivableReserveDivested>
    <holx:AccountsReceivableAllowanceReduction
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtNi0xLTEtMA_7463d013-4973-4f5f-92f5-4a32b1d1f38d"
      unitRef="usd">2800000</holx:AccountsReceivableAllowanceReduction>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzMtOC0xLTEtMA_fd06cff8-1c79-4a32-85e4-0dbe9f51ce88"
      unitRef="usd">17800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i84c88a850d71453097932f0bcbe84825_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtMi0xLTEtMA_9af4d461-7130-4dc4-833c-932de594e7fb"
      unitRef="usd">9800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtNC0xLTEtMA_59353272-e324-42b5-85e8-84e73bab935c"
      unitRef="usd">7000000.0</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableReserveDivested
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtNi0xLTEtNjE1Mw_7a17db6e-b5cf-45b9-a72b-84fa137ff93f"
      unitRef="usd">0</holx:AccountsReceivableReserveDivested>
    <holx:AccountsReceivableAllowanceReduction
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtNi0xLTEtMA_1a865b80-cd24-4750-8b80-c3887c23850e"
      unitRef="usd">600000</holx:AccountsReceivableAllowanceReduction>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpmZTNlMmVkOWJkNGU0OWNiOTgzZTU1NjkwOGUxYjUxOC90YWJsZXJhbmdlOmZlM2UyZWQ5YmQ0ZTQ5Y2I5ODNlNTU2OTA4ZTFiNTE4XzQtOC0xLTEtMA_001d50fb-dd34-4f32-b8c9-bbdafe14779d"
      unitRef="usd">16200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <holx:CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjI3_d5dd59de-256a-476b-89db-d6c20ccd98bb">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cost of Service and Other Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#x2019;s professional services&#x2019; employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.&lt;/span&gt;&lt;/div&gt;</holx:CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjY2_2a58d860-e342-4561-bba0-752c67a52e99">Stock-Based Compensation&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for share-based payments in accordance with ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 718)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt; As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#x2019;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, as a result of the adoption of ASU 2016-09 in fiscal 2017, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5Nzg0_6a499764-9edf-4970-9b09-860e2f9ff3ea">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options, restricted stock units and convertible debt for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzA5_ef060e2d-9428-49af-97b1-416254842f82">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts for fiscal 2020, 2019, and 2018 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options and stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzEtMi0xLTEtMA_de0dd35f-4f1f-453d-923a-4ab0462ba9c2"
      unitRef="shares">262727000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzEtNC0xLTEtMA_e427ae2f-4849-4476-b4e3-0db50435b065"
      unitRef="shares">269413000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzEtNi0xLTEtMA_a7fe682c-ce44-4536-8abc-edad5910c810"
      unitRef="shares">275105000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzItMi0xLTEtMA_39c70f75-4745-481e-a854-4083a5848f8a"
      unitRef="shares">1886000</holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits>
    <holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzItNC0xLTEtMA_31c1542b-5a57-4bf1-af3c-cc1cb7d15a09"
      unitRef="shares">0</holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits>
    <holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzItNi0xLTEtMA_5504272c-6a4b-4b81-9354-d2f338927c42"
      unitRef="shares">0</holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzQtMi0xLTEtMA_ea80fc1e-01d3-4700-a5ce-b09de2a47620"
      unitRef="shares">264613000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzQtNC0xLTEtMA_3c7139be-1654-4a0e-aa8d-cbbdf330dd60"
      unitRef="shares">269413000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzQtNi0xLTEtMA_ae149438-26a2-4dbf-91ae-dde45dcb9d00"
      unitRef="shares">275105000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i93d07ccd1813413cb535430965ca43e1_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzYtMi0xLTEtMA_8a90efd8-e0d3-4364-b611-0464511608e1"
      unitRef="shares">1158000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ife0a4b80cdd24c8182c3da3c0ac3badd_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzYtNC0xLTEtMA_9d95fdef-d790-409c-b030-d9fc698b7caa"
      unitRef="shares">4098000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id1dc4960757847fa975cbc5ef31a88f8_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzYtNi0xLTEtMA_9f3f1fe5-28d7-4a52-ba22-dced30dcefbc"
      unitRef="shares">5073000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibce772764f914f9883988915d86d6810_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzctMi0xLTEtMA_5709f6fc-945a-49fd-8d74-5727de91718a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8d1559cdd9cb44c1af1d7faf1f2cef88_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzctNC0xLTEtMA_9251a7a5-4013-44b9-8f01-d7b35970df5c"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if521ee7691434488a8c4a940762af9c0_D20171001-20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTo0NTkwZGJiMzUzYmY0NTdlYjIzNjgzY2NlY2Q0ZTJlOC90YWJsZXJhbmdlOjQ1OTBkYmIzNTNiZjQ1N2ViMjM2ODNjY2VjZDRlMmU4XzctNi0xLTEtMA_c6555b65-2b53-41b6-ae5b-0fc9718218c8"
      unitRef="shares">703000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NzU3_2679f5d1-d01d-433c-9861-b53062e871f9">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally offers a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM5NjU4_08c7a977-3e74-4ea4-ab24-1584cb253ab9"&gt;one&lt;/span&gt;-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#x2019;s warranty reserves include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity for fiscal 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&#160;End&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NTg1_411bfd64-b890-402d-bb92-82d42ddd8d40">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity for fiscal 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&#160;End&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItMi0xLTEtMA_359dab85-bdbc-40c1-9c9c-5f7179e54e4b"
      unitRef="usd">13900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItNi0xLTEtMA_9c577f87-281d-4557-983b-f9678c71e6e9"
      unitRef="usd">11700000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItOC0xLTEtMTcxMw_da16981f-f323-45dc-be25-e624fd639dca"
      unitRef="usd">500000</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItMTAtMS0xLTE3MDA_c681ce48-1b63-4289-b05e-895d34bec12a"
      unitRef="usd">-6100000</us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItOC0xLTEtMA_5280f015-0771-4e41-8cde-86921da68420"
      unitRef="usd">10100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzItMTAtMS0xLTA_2a497561-3320-41b9-b33d-df2160b0dccd"
      unitRef="usd">9900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtMi0xLTEtMA_b6e7d176-6da6-4425-a16c-e0daeb38203e"
      unitRef="usd">15900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtNi0xLTEtMA_f9d41508-f257-424b-aef2-83afbef319f2"
      unitRef="usd">14100000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtOC0xLTEtMTcxMw_ad971a5f-4be6-414f-af48-82e432338364"
      unitRef="usd">0</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtMTAtMS0xLTE3MDQ_842b0866-bc5d-473e-8b26-e16285a03ad7"
      unitRef="usd">0</us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtOC0xLTEtMA_3423a615-36e5-4705-9d7e-3af48405d3b6"
      unitRef="usd">16100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90YWJsZTpkNzY1YWI5Zjg5Yjc0OTE3YTE3YTQ0MjRkNjI0NDhkMC90YWJsZXJhbmdlOmQ3NjVhYjlmODliNzQ5MTdhMTdhNDQyNGQ2MjQ0OGQwXzMtMTAtMS0xLTA_69b88154-3fac-44dc-9ee9-811d85b82b15"
      unitRef="usd">13900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQ5NjIy_0c6eb182-83ee-42bf-9da1-248e905eb73c">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $15.6 million, $29.5 million and $26.9 million for fiscal 2020, 2019 and 2018, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQwMzU2_e54b101b-5430-4f11-9326-f4aa5110acbe"
      unitRef="usd">15600000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQwMzYw_5ea2cbd3-9eab-41bd-97f8-03d2daca258b"
      unitRef="usd">29500000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzQwMzY3_50165826-2f1d-42a7-bb52-1b7a972c27e5"
      unitRef="usd">26900000</us-gaap:AdvertisingExpense>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzE3NDY0_ba39cb1b-43d9-4f09-a4f0-9bc96f780ee0">Revenue&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2014, the FASB issued ASC 606. The Company adopted the standard, which superseded ASC Topic 605, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 605), as of September 30, 2018 using the modified retrospective method for contracts that were not complete as of September 30, 2018. Under this method, the Company recognized the cumulative effect of initially applying the standard to its open contracts and recorded an adjustment to decrease the opening balance of accumulated deficit within stockholders' equity by $6.4 million, which is net of taxes of $2.4 million, as of September 30, 2018 (the first day of fiscal 2019). The cumulative effect adjustment was primarily due to the Company applying the principles of ASC 606 to contracts for which the Company had deferred revenue as of September 29, 2018 for collectability uncertainty and providing extended payment terms resulting in the fee not being fixed or determinable under ASC 605. Under ASC 606, revenue from certain arrangements may be recognized earlier than under ASC 605 as a result of the ability to apply additional judgment in evaluating collectability and the elimination of the requirement to assess whether a fee is fixed or determinable, specifically as it relates to providing customers with extended payment terms. Results for reporting periods beginning September 30, 2018 and after are presented in accordance with ASC 606. Prior period results were not adjusted and will continue to be reported in accordance with the legacy GAAP requirements of ASC 605. As the adoption of this standard did not have a material impact on the Company&#x2019;s revenue recorded for the years ended September 28, 2019 and September 29, 2018, transitional disclosures have not been presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. Prior to the Cynosure divestiture, the Company also generated revenue from the sale and service of medical aesthetic treatment systems. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,582.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,536.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;831.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,417.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.510%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,536.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,417.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,786.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,666.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefit of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's contracts typically do not provide the right to return product. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of September 26, 2020, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $635.6 million. These remaining performance obligations primarily relate to extended warranty and support and maintenance obligations in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately 39% of this amount as revenue in 2021, 28% in 2022, 19% in 2023, 10% in 2024, and 4% thereafter. The Company has applied the practical expedient to not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments and, until December 30, 2019, the divested Medical Aesthetics segment. Contract liabilities are classified as other current liabilities and other long-term liabilities on the Consolidated Balance Sheets. The Company recognized revenue of $106.2&#160;million and $158.9 million in the years ended September 26, 2020 and September 28, 2019, respectively, that was included in the contract liability balance at September 28, 2019 and September 29, 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Practical Expedients&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;With the adoption of ASC 606, the Company elected to apply certain permitted practical expedients. In evaluating the cumulative-effect adjustment to retained earnings, the Company adopted the standard only for contracts that were not complete as of the date of adoption. For contracts that were modified prior to the adoption date, the Company elected to present the aggregate effect of all contract modifications in determining the transaction price and for the allocation to the satisfied and unsatisfied performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition under ASC 605 (prior to the adoption of ASC 606, which applies to fiscal 2018)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under ASC 605, the Company recognized product revenue upon shipment provided that there was persuasive evidence of an arrangement, there were no uncertainties regarding acceptance, the sales price was fixed or determinable, and collection of the resulting receivable was reasonably assured. Generally, the Company&#x2019;s product arrangements for capital equipment sales, primarily in its Breast Health, Medical Aesthetics and Skeletal Health reporting segments, were multiple-element arrangements, including services, such as installation, training and support and maintenance, and multiple products. Based on the terms and conditions of the product arrangements, the Company believed that these services and undelivered products could be accounted for separately from the delivered product element as the Company&#x2019;s delivered products have value to its customers on a stand-alone basis. Accordingly, revenue for services not yet performed at the time of product delivery were deferred and recognized as such services were performed. The relative selling price of any undelivered products was also deferred at the time of shipment and recognized as revenue when these products were delivered. There was no customer right of return in the Company&#x2019;s sales agreements for its capital equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Service revenues primarily consist of amounts recorded under service and maintenance contracts and repairs not covered under warranty, installation and training, and shipping and handling costs billed to customers. Service and maintenance contract revenues were recognized ratably over the term of the contract. Other service revenues were recognized as the services were completed using the specific performance method. Service and other revenue also included royalties which were recognized in the period the payments were due to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For revenue arrangements with multiple deliverables, the Company recorded revenue as separate units of accounting if the delivered items had value to the customer on a stand-alone basis and the delivery or performance of the undelivered items was considered probable and substantially within the Company&#x2019;s control. Some of the Company&#x2019;s products have both software and non-software components that function together to deliver the product&#x2019;s essential functionality. The Company determined that except for its computer-aided detection (&#x201c;CAD&#x201d;) products and C-View and Intelligent 2D products, the software element in its other products was not within the scope of the software revenue recognition rules, ASC 985-605, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software&#x2014;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company determined that given the significance of the software component&#x2019;s functionality to its CAD, C-View and Intelligent 2D components, which are sold by its Breast Health segment, these products were within the scope of the software revenue recognition rules. The Company evaluated the appropriate revenue recognition treatment of it hardware products, including its Dimensions digital mammography systems, which had both software and non-software components that function together to deliver the products&#x2019; essential functionality (i.e., it is a tangible product), and determined they were not within the scope of ASC&#160;985-605.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company was required to allocate revenue to its multiple element arrangements based on the relative fair value of each element&#x2019;s selling price. The Company typically determined the selling price of its products based on its best estimate of selling prices (&#x201c;ESP&#x201d;) and services based on vendor-specific objective evidence of selling price (&#x201c;VSOE&#x201d;). The Company determined VSOE based on its normal pricing and discounting practices for the specific product or service when sold on a stand-alone basis. In determining VSOE, the Company&#x2019;s policy was to require a substantial majority of selling prices for a product or service to be within a reasonably narrow range. The Company also considered the class of customer, method of distribution, and the geographies into which its products and services were sold when determining VSOE. If VSOE could not be established, which could occur in instances when a product or service had not been sold separately, stand-alone sales were too infrequent, or product pricing was not within a relatively narrow range, the Company would generally establish the selling price using ESP to allocate arrangement consideration. The objective of ESP was to determine the price at which the Company would typically transact a stand-alone sale of the product or service. ESP was determined by considering a number of factors including Company pricing policies, internal costs and gross margin objectives, method of distribution, information gathered from experience in customer negotiations, market research and information, recent technological trends, competitive landscape and geographies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For those arrangements accounted for under the software revenue recognition rules, ASC 985-605 generally required revenue earned on software arrangements involving multiple elements to be allocated to each element based on their relative VSOE of fair value. If VSOE did not exist for a delivered element, the residual method was applied in which the arrangement consideration was allocated to the undelivered elements based on their VSOE with the remaining consideration recognized as revenue for the delivered elements. For multiple-element software arrangements where VSOE of fair value of Post-Contract Customer Support (&#x201c;PCS&#x201d;) had been established, the Company recognized revenue using the residual method at the time all other revenue recognition criteria were met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;While the majority of its instruments are placed at customer sites, in certain instances the Company sold instruments to its clinical diagnostics customers and recorded sales of these instruments upon shipment or delivery, depending on the terms of the arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Within its Diagnostics business, and to a lesser extent, its GYN Surgical business, the Company provided its instrumentation (for example, the ThinPrep Processor, ThinPrep Imaging System, and the Panther and Tigris systems) and certain other hardware to customers without requiring them to purchase the equipment or enter into a lease. The Company installed the instrumentation or equipment at the customer&#x2019;s site and recovered the cost of providing the instrumentation or equipment in the amount it charged for its diagnostic tests, assays and other disposables. Customers entered into a customer usage agreement and typically committed to purchasing minimum quantities of disposable products at a stated price over a defined contract term, which was typically between three and five years. Revenue was recognized over the term of the customer usage agreement as tests, assays and other disposable products are shipped or delivered, depending on the customer's arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="if06ae85100604f48a0354fb2181504ee_I20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzUxNQ_00f534c0-28e9-4987-9bd3-f704390a0e2e"
      unitRef="usd">-6400000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <holx:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax
      contextRef="if06ae85100604f48a0354fb2181504ee_I20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzU0NA_1c104636-f408-4c4d-b509-3965be50caa0"
      unitRef="usd">-2400000</holx:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzE3NDYz_de0c221e-83f6-45a1-ae78-019f89cccd9e">The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,582.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,536.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;831.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,417.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.510%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,536.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,417.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,786.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,666.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i7d08665ff5e7428b92f2f87f995f6523_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMi0xLTEtMA_21788013-c6f3-4f35-b577-efe318651e78"
      unitRef="usd">266300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id8a91b66ec814b6bb11ea904156f4239_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMy0xLTEtMA_65a7f740-8582-492c-ba79-ade57aba31bd"
      unitRef="usd">143800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i95cf893d7ec14704bea7fa6c16427a5b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtNC0xLTEtMA_2c440bd8-a748-4272-ac81-01d49f2a0577"
      unitRef="usd">410100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i83bb398da9034ac4a5154a80046899ad_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtNi0xLTEtMA_a92ce41e-f069-4b17-bb0b-475709e08d26"
      unitRef="usd">312900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie7ee31ee47384d66a52b606454a9d4ab_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtNy0xLTEtMA_2dc744cb-fce2-4522-bcda-2a0b56f911c1"
      unitRef="usd">159100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibddc782db0444af8bb871d7496ee5746_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtOC0xLTEtMA_27ddedc9-2c2e-4c57-8a06-bb74a8fcdbcf"
      unitRef="usd">472000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i590c2022b4324ab994b2164138508d88_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMTAtMS0xLTA_93bf13de-9a0d-477d-a7ba-498b745571d5"
      unitRef="usd">322900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf8dc695c92a4feca4702aef44167616_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMTEtMS0xLTA_b558ebf0-044d-4466-9bb6-50d2757f4f54"
      unitRef="usd">157400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6bb5a21e92604faebf807887f9102015_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzMtMTItMS0xLTA_511d49ce-1d50-4e6a-a1a5-fa9ec63e6323"
      unitRef="usd">480300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie8a58cf3c461492482d5dcd9b88379ed_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMi0xLTEtMA_42566017-517f-431e-a381-e1a0cdac66fa"
      unitRef="usd">1272500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if4781b8d56e34db4ac93197bd725223a_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMy0xLTEtMA_4f689718-b502-411c-b846-18318f8cc6b5"
      unitRef="usd">375900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i104ac377ebbd4e05bcb47bf521f5ce4d_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtNC0xLTEtMA_ff0103a3-23cc-4d95-a4db-e9b05548b4fe"
      unitRef="usd">1648400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1facf79e2182457ba4133a1ec0ba491c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtNi0xLTEtMA_36db9085-0357-430b-a343-cce59a0f0d97"
      unitRef="usd">549900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28a65a25ce95429a82c5b19cf486e81d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtNy0xLTEtMA_ae441298-1148-4f7e-91db-9be35cc0085f"
      unitRef="usd">125100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e1e43e160f844f3be9e65aaa9ae3159_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtOC0xLTEtMA_3e33965a-456b-4ab2-b333-9c738169b231"
      unitRef="usd">675000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i50934cec2c9c407b8ea520ce4db8e3b7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMTAtMS0xLTA_3f7d70b9-0635-442e-80b9-e00996de58c4"
      unitRef="usd">503400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i42a30e107b544ef4b4edea002da71960_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMTEtMS0xLTA_4a9a5d78-8a1a-456f-9306-401ae31f8ee7"
      unitRef="usd">108400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ca63f8d157f42aba21c14ee7c153d70_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzQtMTItMS0xLTA_8a31676b-f92b-41a9-845e-fc395fbfe207"
      unitRef="usd">611800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i592f0856c5084a32af46ff3a1e046ee9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMi0xLTEtMA_446c8c6d-90f9-4f50-bd0d-f78e4b439ab6"
      unitRef="usd">43600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icd3b478fa0f24dc3aa889f9a058d9d98_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMy0xLTEtMA_bb4ccc18-1e9a-4600-b28b-d595b05874bc"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4da82173bd744edb84691e936f7ccda0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtNC0xLTEtMA_d49146f0-b944-436e-80e5-8215f790fbf2"
      unitRef="usd">43600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5464405dc015456e9897532307f11895_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtNi0xLTEtMA_fe54933d-6a71-4f97-b249-0dba44e96280"
      unitRef="usd">58500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ddddff86b3044d7b0fc9b7b2b963bf1_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtNy0xLTEtMA_41f1bee7-d09e-47ac-9820-48aa73039905"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i19d3c5f4df704cddbdd7827a6451b621_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtOC0xLTEtMA_1941e684-3af7-464d-aa40-57539335f53b"
      unitRef="usd">58500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifc133df909ca464f9c8e3787dcfe2475_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMTAtMS0xLTA_71e14193-f060-4c0c-98a9-1053de240ec0"
      unitRef="usd">55300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idc84af9eb3104cfdb19db77db92ed7b4_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMTEtMS0xLTA_1cd45ca1-a322-4aab-81c2-ec6d1a7bb52d"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00e65a49339a4f9bb26bf6c415e08e18_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzUtMTItMS0xLTA_c2a0478d-0c4e-4714-952b-a2c39dfbe0b8"
      unitRef="usd">55300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9c33876277774ccea23ac78561fc07e0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMi0xLTEtMA_2b33bad2-42b8-428d-b32c-06e3fefdc1b2"
      unitRef="usd">1582400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2fc5ccd5fc274beeb5b3be51f76cd623_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMy0xLTEtMA_afd12943-ff7b-4de2-9b5b-02a6e0139bdd"
      unitRef="usd">519700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtNC0xLTEtMA_791ddfba-543c-4a8b-b0b5-52db06b6bf8d"
      unitRef="usd">2102100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia4cf0729ec2044dcae9c2f4801fd2420_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtNi0xLTEtMA_ec39e660-e096-463b-836d-f8893d3f865c"
      unitRef="usd">921300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9c664f83a3cb4954bc77a1877cfdc72c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtNy0xLTEtMA_c74837c5-4f44-41ac-bce6-3bf603912660"
      unitRef="usd">284200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtOC0xLTEtMA_eb98a262-0063-46c8-a2f4-8f789185d25a"
      unitRef="usd">1205500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2e2f531aee5246619095d14dc0f8b6bf_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMTAtMS0xLTA_4313d817-b70a-4a6c-b65e-e1f80a2bdf28"
      unitRef="usd">881600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i309e38f390b74c389c1f84c1b4db88ec_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMTEtMS0xLTA_f5433fcc-861b-4979-b0e5-d2b828341671"
      unitRef="usd">265800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzYtMTItMS0xLTA_050bd97a-68f7-4e61-a17d-7dce5dd7abc4"
      unitRef="usd">1147400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieec8d0273727499c80a7201ea239a090_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMi0xLTEtMA_ba2346d0-cd2d-40f4-ae1f-c8fa76a51796"
      unitRef="usd">722000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if95130eeb1d844f0a7c10fea2f52bf39_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMy0xLTEtMA_23a5ebc5-2ab8-472c-8c64-695ee674e019"
      unitRef="usd">231600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f3886c217574265bcf1ad1049b1aa4c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktNC0xLTEtMA_03a8395b-df4e-48b6-8312-17b5888b583a"
      unitRef="usd">953600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id1a29accf22242549a492fab1782cb94_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktNi0xLTEtMA_d4a4d9b4-3613-4fa5-ab07-9b945cdb3639"
      unitRef="usd">853100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a1ccd58830248da8f29187c9cdd3079_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktNy0xLTEtMA_267b6a64-81ee-4014-918c-dbe23d716332"
      unitRef="usd">241500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iff15a89761f34f66a3761888623b4f23_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktOC0xLTEtMA_126e3841-f7cf-4d34-aa4b-750f7c109014"
      unitRef="usd">1094600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0833ea6babff4e13aa4c24c6994f576a_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMTAtMS0xLTA_6d3dedc1-de9b-4d87-8d29-3af6d00f6c71"
      unitRef="usd">782000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i65e9eb24efa944359e8a021229406acd_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMTEtMS0xLTA_44606412-f62f-4237-9baf-3709f4f52aa9"
      unitRef="usd">234500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic60ae0c151b445a292490043ea13881d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzktMTItMS0xLTA_ba53ea9f-3ec3-4c81-a2f2-ded5d33dd170"
      unitRef="usd">1016500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1fba52a0614b49c585ea7cb3df44be14_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTItMS0xLTA_10a705e5-1d7f-4836-9274-dec8cfefe7bc"
      unitRef="usd">166600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8471b299d850453f8bfca6a20cd0512b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTMtMS0xLTA_df473946-b205-4921-8c8e-12bb6ea03f08"
      unitRef="usd">31700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i828ebe5b8d494e04936a9b538c0e1948_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTQtMS0xLTA_60130dde-dceb-4d94-8940-81042a4dfe5e"
      unitRef="usd">198300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia999e530e95c420abe9226d29b3d86e0_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTYtMS0xLTA_f92ca9dc-d9b2-4f3f-9ffb-fb6eecc059e4"
      unitRef="usd">184800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ee90fa905a04d32957b8acbaa2c1bfc_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTctMS0xLTA_db859f6d-7e0c-4a18-a2f4-0b1975d05cf7"
      unitRef="usd">34800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifaafb7ab1c0441ec87d9abecb35da291_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTgtMS0xLTA_1939aa0e-90ff-4238-b44f-97fd0bcb1a20"
      unitRef="usd">219600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i006de4dd9201414fb767930e647b4405_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTEwLTEtMS0w_89e4558d-7fa6-44f4-9a14-c840e73edd30"
      unitRef="usd">169400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iadefe10680934f5580492d9dea95bf7d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTExLTEtMS0w_5d43a8c0-0f7b-4580-ae31-67e35e8459d3"
      unitRef="usd">32300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60a5014f96a34cdab508fb56b98ac1d4_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEwLTEyLTEtMS0w_0254cbd2-3086-4abe-bced-c19bde72d82c"
      unitRef="usd">201700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iadcf8aa033b9410c824f6c8d1cf3ad39_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTItMS0xLTA_94d71759-714e-4412-882d-5d686caba53a"
      unitRef="usd">888600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60b04cfb9cc74ed9bb9c61e376dc2794_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTMtMS0xLTA_d24423af-33c0-46f3-8d2a-b637b64b72c5"
      unitRef="usd">263300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTQtMS0xLTA_40f592a6-ee30-4741-a174-8800e4808b06"
      unitRef="usd">1151900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i962c11ce0c514729be1b050aa28ff2e0_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTYtMS0xLTA_02de7f67-2b2a-4e09-a7aa-6b56c80d0bed"
      unitRef="usd">1037900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1e9161faf1934aa3accab7a9fad64784_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTctMS0xLTA_04ece261-0320-49bf-bd68-2cf9f3e1fa22"
      unitRef="usd">276300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTgtMS0xLTA_c07346bc-d6b3-4a5c-baad-b872a1cc2596"
      unitRef="usd">1314200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i83a4bfcac8ba430ba82768a85a67c700_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTEwLTEtMS0w_d76e504e-b533-4254-8f0a-bad37e048fa5"
      unitRef="usd">951400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i47df0fbe43fe4e708bd87bf78a6c73aa_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTExLTEtMS0w_3c80c3a0-0f5f-4f10-a438-74a5a6bf529f"
      unitRef="usd">266800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzEyLTEyLTEtMS0w_6e02ed70-044b-41a7-9bcc-81e8bdcea0b5"
      unitRef="usd">1218200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9aeae7e636114e169ab5ca6cd732bffd_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTItMS0xLTA_cbeda397-7e29-4634-beaf-ef11c5a2f445"
      unitRef="usd">310100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i939dcccc02d247098b6f0021c007686c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTMtMS0xLTA_ebc30fe2-f0db-4769-afd5-3aa6b4bb0645"
      unitRef="usd">66000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTQtMS0xLTA_feb172cb-5689-4f74-97c7-5be359adf231"
      unitRef="usd">376100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibbc8d674b6954826ab5d78856d5fc97d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTYtMS0xLTA_42635825-aae0-4184-8fb4-4f018cd2446d"
      unitRef="usd">362800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i667ad16a082a4c12a8188f400249f907_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTctMS0xLTA_5bd9b69b-f706-42fc-8554-360854d85a7b"
      unitRef="usd">74400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTgtMS0xLTA_22046f05-fb94-4962-89ff-1d6dda3e8e28"
      unitRef="usd">437200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i96c41424e4c4429f833f974caca3e9d0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTEwLTEtMS0w_293b7ecb-2425-43e0-bcbe-13f6c6d0e6fd"
      unitRef="usd">352800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i640618ae1089409aa397c0b1d6630ba7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTExLTEtMS0w_16143d34-8cf8-4083-9726-061e0bf60436"
      unitRef="usd">69200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE2LTEyLTEtMS0w_549d8143-073c-4aed-9887-33359b5211e0"
      unitRef="usd">422000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i67b306ed18214b529569e273c6cbc1b2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTItMS0xLTEwNTc2_2bc334ba-77b0-442c-894b-535af0de76bd"
      unitRef="usd">51200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24e8f75e7420456aa25cbce56e1e8320_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTMtMS0xLTEwNTc2_15984e98-ae29-413a-8606-95f8825a66cb"
      unitRef="usd">29800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTQtMS0xLTEwNTc2_0873bc80-9e29-42a5-b0b5-51343dc1b7ae"
      unitRef="usd">81000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id5d4c49bd355481485ca7470fc27601a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTYtMS0xLTEwNTc2_4a9fb7b0-76c4-476d-ad88-12c2f37b475b"
      unitRef="usd">58600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60c82065c41f4b4c993bb38268ef4b55_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTctMS0xLTEwNTc2_4aab930f-cb89-4730-ae64-f0e2825f45bc"
      unitRef="usd">36200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTgtMS0xLTEwNTc2_bb26e886-1e79-4587-abc3-bd8eff370549"
      unitRef="usd">94800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1410a37395f9458e8fa278adf018a579_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTEwLTEtMS0xMDU3Ng_d8656f96-7c90-477f-8462-bdaab1cfce34"
      unitRef="usd">59400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie06d07afd66d4433896cd49ac429b433_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTExLTEtMS0xMDU3Ng_f1b5a7d1-6ae1-4fd3-9490-d9cd3d964597"
      unitRef="usd">31800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE3LTEyLTEtMS0xMDU3Ng_03a50a41-7c34-43f8-bd70-c133d0e493ed"
      unitRef="usd">91200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb8cafb83e0443fd9f04b2a54be10659_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTItMS0xLTg3MjU_317ad225-2f39-40c3-b4ba-666e525c13b8"
      unitRef="usd">30900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i98a1be5bf1eb40548cf881d45cfa3212_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTMtMS0xLTg3MjU_0a4e010b-79a0-4e7f-a742-7c035846fc08"
      unitRef="usd">34400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTQtMS0xLTg3MjU_01515dcc-e861-4b8d-a9fc-a517c609af58"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id1af779ff4d349c0bb004322df29066a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTYtMS0xLTg3MjU_92edf2fb-660d-46ff-b2fb-5e483f442e3e"
      unitRef="usd">155400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1c3b64e5f16145bab3d37ee0bbc5df6e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTctMS0xLTg3MjU_1e892a9f-7cd5-4c89-b07f-85b028f59fb9"
      unitRef="usd">160200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTgtMS0xLTg3MjU_5d209ca9-0330-4c31-ac08-eaa9d2f92e32"
      unitRef="usd">315600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i374d2bf4a31b4fada151536edc6446b7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTEwLTEtMS04NzI1_4de33db1-f5db-4b72-9404-53b4526a54f9"
      unitRef="usd">172400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4d7773a142f248d98fc047e667923b9a_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTExLTEtMS04NzI1_0840c7a2-1ccd-48fc-80c2-2acc4492172a"
      unitRef="usd">166700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE4LTEyLTEtMS04NzI1_dafb9961-e6cd-4ac7-81c5-acd203f7860d"
      unitRef="usd">339100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0b1fbf643bf4d87a0f62662f56e72a9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTItMS0xLTA_05f10964-09ca-4bcb-ab66-18a16e1f3012"
      unitRef="usd">2863200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8eb202acec0f4f65bc34389e2af40e3c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTMtMS0xLTA_0c60c53d-2bbe-4dce-88e9-1de618a48da7"
      unitRef="usd">913200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTQtMS0xLTA_bd668945-52b5-4143-b5f7-94b3c35e6c81"
      unitRef="usd">3776400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i22ccaf1b86dd4ce1975c67773f6132e3_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTYtMS0xLTA_23f5e34d-41e9-4ac6-b2f8-0453bb50ceac"
      unitRef="usd">2536000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i68690342c39340df929646cbbb4d0fb5_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTctMS0xLTA_6937e301-4edc-4bd5-ace1-8e79ccf0d841"
      unitRef="usd">831300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTgtMS0xLTA_a8dcc05c-46f7-4ebb-8813-0e123b1ae63d"
      unitRef="usd">3367300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a86961b941f4c698ca817317ebb55f1_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTEwLTEtMS0w_93409cc6-a309-4c70-b5d6-628a7d85f720"
      unitRef="usd">2417600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia95060407ff54c468b06a661c8fabc25_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTExLTEtMS0w_896b1b61-f7f8-483c-a6fb-6c28f0794d4e"
      unitRef="usd">800300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo2NDNhNmIxNGJiMTU0YjBhOWM2MjNjNTAyNGQ1ZTJhNC90YWJsZXJhbmdlOjY0M2E2YjE0YmIxNTRiMGE5YzYyM2M1MDI0ZDVlMmE0XzE5LTEyLTEtMS0w_ad7df712-6c69-48d1-9add-cb2ce04e61b4"
      unitRef="usd">3217900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0b1fbf643bf4d87a0f62662f56e72a9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzItNS0xLTEtMA_0e33c26a-abd4-41e7-804e-5a87752efa81"
      unitRef="usd">2863200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i22ccaf1b86dd4ce1975c67773f6132e3_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzItNi0xLTEtMA_61a668b7-1041-4b32-9e0f-473a6739d0a6"
      unitRef="usd">2536000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a86961b941f4c698ca817317ebb55f1_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzItNy0xLTEtMA_0da14541-6a07-4811-97ce-bd07e703abcd"
      unitRef="usd">2417600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i65a03228708e48bd91808873ac0aef49_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzMtNS0xLTEtMA_70306c9f-e0ba-40e9-90b5-fc6dc5cc3123"
      unitRef="usd">569800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9775b97e92684b93a13c7004b3787bb9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzMtNi0xLTEtMA_638a3b10-ace2-44ef-bef2-72c3b9497d0c"
      unitRef="usd">396000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i52f05bd0d07b41cc91cc734c6e8aabd4_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzMtNy0xLTEtMA_b4fccb12-53d9-44ad-93ca-d77f9b23853d"
      unitRef="usd">377500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f2349edc55c45de9425f98b0200d5a7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzQtNS0xLTEtMA_098b716b-22ae-468d-a29c-63e094165da9"
      unitRef="usd">226800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic693f14699ba4968bcb36cc7b8b023a7_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzQtNi0xLTEtMA_35f30578-f497-4e4a-91cc-6509e87a3cea"
      unitRef="usd">286000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6acedc8e09c84b2e89c7f0cc800be0dd_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzQtNy0xLTEtMA_ddb21cde-51ef-40b4-abc9-da18bbf2760a"
      unitRef="usd">275600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibb0fdba95bf14963b575eed35c0be6b7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzUtNS0xLTEtMA_a2b42ee2-f591-4696-bea3-86b87e3ea4f6"
      unitRef="usd">116600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia889c74fa094451886ddf4da8cfb8b39_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzUtNi0xLTEtMA_1de46df0-b8c1-48ea-bb07-b3f7e669066c"
      unitRef="usd">149300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i404bb6871a4c4ab480a92c1a5f85724a_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzUtNy0xLTEtMA_4d8e0c55-8dd5-4c9b-9566-9cafac7ba8a1"
      unitRef="usd">147200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzYtNS0xLTEtMA_1c4af9f1-e2cb-44ee-b9f2-11b777d01b3c"
      unitRef="usd">3776400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzYtNi0xLTEtMA_6a4c40fa-b11d-4e8e-b210-7912688a9d90"
      unitRef="usd">3367300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo5ODliY2QxZWUxYjk0ZGU2OTkwOTc2NzQ0NzM1YmRlNi90YWJsZXJhbmdlOjk4OWJjZDFlZTFiOTRkZTY5OTA5NzY3NDQ3MzViZGU2XzYtNy0xLTEtMA_cacebd3e-6fd5-40ee-ae5b-2799441353dc"
      unitRef="usd">3217900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic42c9ec0a387465384f173e101feaa39_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNS0xLTEtMTAxNTY_2082e120-bf2d-4045-897c-89bfc44b956f"
      unitRef="usd">2561100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i37a58071a6be4fa68958f54a1146729c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNi0xLTEtMTAxNTY_9abf34a1-0ab1-41ea-af65-e3460e16f9d5"
      unitRef="usd">1786400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i105ba05d0c354f20b5883424ecfbbfeb_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNy0xLTEtMTAxNTY_29aaafab-330d-4b6d-a8ef-da34d89d9e93"
      unitRef="usd">1666700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia619a463826c4b1aaca754c1bbd0a455_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNS0xLTEtMA_c61135c4-45db-4274-90a7-4f543c018173"
      unitRef="usd">665900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad9d09e7d14346609c65daa29e0cc27a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNi0xLTEtMA_6c88802b-1017-43c2-8eb3-3a73ba3e8ce1"
      unitRef="usd">984900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe6d7468b24745749de9948726eabd87_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzItNy0xLTEtMA_ff0bbe0c-3572-4f4d-a317-5ea85add18cc"
      unitRef="usd">977200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i794e99945f544149a4dfb0dc4430defe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzQtNS0xLTEtMA_55b1e0cb-a7c8-4bd0-8fa0-ef55bc5ab842"
      unitRef="usd">516600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76b85f8e0cc641d6811b0f647a80c0b4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzQtNi0xLTEtMA_758c4d99-78f5-416a-b989-57e5361c2cb2"
      unitRef="usd">568300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i688ec76adf1140acaab8d25b511667aa_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzQtNy0xLTEtMA_6cf923b6-4daa-4d70-b424-74412c199635"
      unitRef="usd">551800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibb6352a521944f2fb02cc1dcea86de83_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzUtNS0xLTEtMA_6d027f87-82dc-491c-a2f4-d95632a7cad9"
      unitRef="usd">32800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb8e030e4bcb4d11b83c486a8c3deb7f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzUtNi0xLTEtMA_93975560-8b99-4936-aa6d-576e4f2d0eb7"
      unitRef="usd">27700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ca6c2bd19e94add871a8ae7f87f8147_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzUtNy0xLTEtMA_396443db-3c0e-46b4-bcb5-855c0ff239cb"
      unitRef="usd">22200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzYtNS0xLTEtMA_fde7e7be-9ac0-44bd-a3f0-70ff9f78a94c"
      unitRef="usd">3776400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzYtNi0xLTEtMA_2d4db676-b12d-4966-93c1-35e124c3ceed"
      unitRef="usd">3367300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90YWJsZTo4OTY2YTdmM2I4MDc0M2VjYjAxNTEzMjExZTZlNWVmZC90YWJsZXJhbmdlOjg5NjZhN2YzYjgwNzQzZWNiMDE1MTMyMTFlNmU1ZWZkXzYtNy0xLTEtMA_2ed26656-0834-408d-abaa-ce04c3060145"
      unitRef="usd">3217900000</us-gaap:Revenues>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzc4Mzc_da6e28cb-5cca-4c2b-8b5a-1cd1e861cb78"
      unitRef="usd">635600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ie9ec2f408f84441f8be19c8da6fe2ecd_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgwOTg_9201e6a2-4e81-49dd-b28f-f0951ffb4b88"
      unitRef="number">0.39</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="id732b75e70474fdd99cfef04a578daac_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgxMzY_6fbaa33e-aa1f-4e0e-8ad0-ca6fbc6357ed"
      unitRef="number">0.28</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="id940ceae94cd453190bd3a93d6db3048_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgxNDg_36a71a44-ee49-4407-8658-fc6d8a6d9a79"
      unitRef="number">0.19</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i6f509287fa7d48aba904c4bc91d15c97_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgxNjA_2f0e3d40-e25c-4786-8046-f4879bd2255d"
      unitRef="number">0.10</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i60dfb47aa97248bd8efcffeb6e4c16e7_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzgxNzY_1ac13848-fb61-4ed4-a0e1-3f22f36e3230"
      unitRef="number">0.04</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNDUvZnJhZzo2MmE5NmU0NzA3Nzc0YzI1OGFhYjU1NDAxZmU5NjQwMC90ZXh0cmVnaW9uOjYyYTk2ZTQ3MDc3NzRjMjU4YWFiNTU0MDFmZTk2NDAwXzk1MDQ_04cb0265-5939-47bb-ab10-dad2362ed8cc"
      unitRef="usd">158900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjMy_29092f43-4134-48f8-812c-8b01d099f2ae">Leases&lt;div style="margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to as ASC 842. The purpose of ASU 2016-02 is to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, is effective for public entities for annual periods beginning after December 15, 2018, including interim periods within those annual periods and was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, Leases (Topic 842): Targeted Improvements. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements. Prior periods are presented in accordance with the lease guidance under ASC Topic 840, Leases (ASC 840). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;have a significant amount of sales-type leases. Under ASC 840, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c"&gt;96.6&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4"&gt;21.0&#160;million&lt;/span&gt;, respectively. This includes recording the Company&#x2019;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements are included within the total amount recognized upon adoption of the new lease standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee Activity - Leases where Hologic is the Lessee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 15 years, some of which may include options to extend the leases for up to 20 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;26, 2020. The Company's lease classified as a capital lease in fiscal 2019 is now classified as a finance lease on the balance sheet as of September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;26, 2020 was 2.62%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The finance lease was previously recorded as a capital lease in the consolidated balance at September 28, 2019, and the short-term and long-term liabilities were $1.8&#160;million and $19.2&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.010%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity - Leases where Hologic is the Lessor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 4% of the Company&#x2019;s consolidated revenue for the twelve months ended September&#160;26, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the disposition of the Medical Aesthetics business, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease, included in property, plant and equipment, and recorded a lease receivable, which was $19.3&#160;million as of September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company subleases a portion of a building it owns and some of its rented facilities and has received aggregate rental income of $2.0 million, $2.7 million and $2.6 million in fiscal 2020, 2019 and 2018, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjMy_38888da8-0228-4520-986f-e711ca972e6f">Leases&lt;div style="margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to as ASC 842. The purpose of ASU 2016-02 is to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, is effective for public entities for annual periods beginning after December 15, 2018, including interim periods within those annual periods and was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, Leases (Topic 842): Targeted Improvements. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements. Prior periods are presented in accordance with the lease guidance under ASC Topic 840, Leases (ASC 840). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;have a significant amount of sales-type leases. Under ASC 840, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c"&gt;96.6&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4"&gt;21.0&#160;million&lt;/span&gt;, respectively. This includes recording the Company&#x2019;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements are included within the total amount recognized upon adoption of the new lease standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee Activity - Leases where Hologic is the Lessee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 15 years, some of which may include options to extend the leases for up to 20 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;26, 2020. The Company's lease classified as a capital lease in fiscal 2019 is now classified as a finance lease on the balance sheet as of September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;26, 2020 was 2.62%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The finance lease was previously recorded as a capital lease in the consolidated balance at September 28, 2019, and the short-term and long-term liabilities were $1.8&#160;million and $19.2&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.010%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity - Leases where Hologic is the Lessor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 4% of the Company&#x2019;s consolidated revenue for the twelve months ended September&#160;26, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the disposition of the Medical Aesthetics business, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease, included in property, plant and equipment, and recorded a lease receivable, which was $19.3&#160;million as of September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company subleases a portion of a building it owns and some of its rented facilities and has received aggregate rental income of $2.0 million, $2.7 million and $2.6 million in fiscal 2020, 2019 and 2018, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LessorSalesTypeLeasesTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjMy_9e4a9fdb-3733-4ef6-b1b3-0857e0464161">Leases&lt;div style="margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to as ASC 842. The purpose of ASU 2016-02 is to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, is effective for public entities for annual periods beginning after December 15, 2018, including interim periods within those annual periods and was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, Leases (Topic 842): Targeted Improvements. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements. Prior periods are presented in accordance with the lease guidance under ASC Topic 840, Leases (ASC 840). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;have a significant amount of sales-type leases. Under ASC 840, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c"&gt;96.6&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4"&gt;21.0&#160;million&lt;/span&gt;, respectively. This includes recording the Company&#x2019;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements are included within the total amount recognized upon adoption of the new lease standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee Activity - Leases where Hologic is the Lessee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 15 years, some of which may include options to extend the leases for up to 20 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;26, 2020. The Company's lease classified as a capital lease in fiscal 2019 is now classified as a finance lease on the balance sheet as of September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;26, 2020 was 2.62%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The finance lease was previously recorded as a capital lease in the consolidated balance at September 28, 2019, and the short-term and long-term liabilities were $1.8&#160;million and $19.2&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.010%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity - Leases where Hologic is the Lessor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 4% of the Company&#x2019;s consolidated revenue for the twelve months ended September&#160;26, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the disposition of the Medical Aesthetics business, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease, included in property, plant and equipment, and recorded a lease receivable, which was $19.3&#160;million as of September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company subleases a portion of a building it owns and some of its rented facilities and has received aggregate rental income of $2.0 million, $2.7 million and $2.6 million in fiscal 2020, 2019 and 2018, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LessorSalesTypeLeasesTextBlock>
    <us-gaap:OperatingLeasesOfLessorDisclosureTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjMy_f870a16d-7b72-42a1-8775-0b11d504c358">Leases&lt;div style="margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to as ASC 842. The purpose of ASU 2016-02 is to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, is effective for public entities for annual periods beginning after December 15, 2018, including interim periods within those annual periods and was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, Leases (Topic 842): Targeted Improvements. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements. Prior periods are presented in accordance with the lease guidance under ASC Topic 840, Leases (ASC 840). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;have a significant amount of sales-type leases. Under ASC 840, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c"&gt;96.6&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4"&gt;21.0&#160;million&lt;/span&gt;, respectively. This includes recording the Company&#x2019;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements are included within the total amount recognized upon adoption of the new lease standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee Activity - Leases where Hologic is the Lessee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 15 years, some of which may include options to extend the leases for up to 20 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;26, 2020. The Company's lease classified as a capital lease in fiscal 2019 is now classified as a finance lease on the balance sheet as of September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;26, 2020 was 2.62%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The finance lease was previously recorded as a capital lease in the consolidated balance at September 28, 2019, and the short-term and long-term liabilities were $1.8&#160;million and $19.2&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.010%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity - Leases where Hologic is the Lessor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 4% of the Company&#x2019;s consolidated revenue for the twelve months ended September&#160;26, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the disposition of the Medical Aesthetics business, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease, included in property, plant and equipment, and recorded a lease receivable, which was $19.3&#160;million as of September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company subleases a portion of a building it owns and some of its rented facilities and has received aggregate rental income of $2.0 million, $2.7 million and $2.6 million in fiscal 2020, 2019 and 2018, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OperatingLeasesOfLessorDisclosureTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NDgy_9413628f-2539-4ad3-87bc-6b0c5b228056"
      unitRef="usd">91700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTEw_2a432609-91cc-4e5b-8080-46c56df39e8a"
      unitRef="usd">10200000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_66c21da7-ee6c-486f-95e7-40eca7018660"
      unitRef="usd">96600000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="id022bc111cb949abb3f669ff592a75c9_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_0ba1b9fd-5309-4f7b-9fca-85ce8213fbf0"
      unitRef="usd">21000000.0</us-gaap:FinanceLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i22479589b7d74fc680fef5abcd3d9de8_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTk2_1ac8a9c5-35e8-49fb-96eb-74f644a42239"
      unitRef="usd">-32600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i22479589b7d74fc680fef5abcd3d9de8_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NjI1_b0fcd9c5-1639-44a9-a4af-4c263a742047"
      unitRef="usd">-35200000</us-gaap:OtherLiabilitiesNoncurrent>
    <holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNTYz_9f4f06fb-d68d-48cb-9a36-4c722c117e93">P1Y</holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate>
    <holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm
      contextRef="i26ac442ab8104d62a507939b10fa969a_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNTc0_97c68474-3490-43b8-8479-4f6ba8083e2a">P1Y</holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm>
    <holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm
      contextRef="i8c09129ca98843beadfd374cfab77639_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNTg1_e1d7a42f-87f6-4c13-94f7-27ab1725ac14">P15Y</holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm>
    <holx:LesseeOperatingAndFinanceLeasesExtensionPeriod
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjQ2_25912838-a71f-4dcd-8fd8-6c3129a06ff5">P20Y</holx:LesseeOperatingAndFinanceLeasesExtensionPeriod>
    <holx:LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2MTEw_0ea8c27c-728f-49d8-aa3c-74f4382eb760"
      unitRef="number">0.0262</holx:LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent>
    <holx:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjUy_b7693120-1331-4223-93cc-536f94b286c1">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.010%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</holx:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i570d6e2471dd4d25a99fe27c526db531_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTMtMS0xLTM4Nzk_3ad76ed7-729d-4761-9486-007e46f6d2ff"
      unitRef="usd">80700</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i32158b5e90814831821e7b0a2eb47b70_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTMtMS0xLTM4Nzk_ebccae36-211c-45d2-8eea-142e84c4a987"
      unitRef="usd">23500</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i63fa7301a7954f429d5733f26da0769e_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF83LTQtMS0xLTM4Nzk_a36a973d-5e09-4f06-ba78-e1a3bfd33bb8"
      unitRef="usd">1900</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ica831abf5b804562b479ecb7d6da8ff9_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTMtMS0xLTM4Nzk_7ef09ba5-03cb-4fef-b23e-e8b338285285"
      unitRef="usd">65600</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i7ba215b8102842d7a0db14145f80c875_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF85LTQtMS0xLTM4Nzk_502ac779-7e3a-4e04-abb1-f48511cae720"
      unitRef="usd">17400</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2MTYz_45aaede5-eb6c-473d-9b5c-43a5fc02d29d"
      unitRef="usd">1800000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2MTc3_01076c36-c7c0-4832-b9e9-6dca5c5ac32b"
      unitRef="usd">19200000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6M2Q4NDhhYzhmZDZkNDM3NWEwNjcxYTIzZTM1Y2E4MmEvdGFibGVyYW5nZTozZDg0OGFjOGZkNmQ0Mzc1YTA2NzFhMjNlMzVjYTgyYV8yLTItMS0xLTIxMg_681cd066-6753-4e00-bb68-39e2c48fe9c5">P5Y6M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6M2Q4NDhhYzhmZDZkNDM3NWEwNjcxYTIzZTM1Y2E4MmEvdGFibGVyYW5nZTozZDg0OGFjOGZkNmQ0Mzc1YTA2NzFhMjNlMzVjYTgyYV8yLTMtMS0xLTIxMg_c8b19f07-6af2-4f97-9d2c-78428e9b700b">P7Y7M20D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6M2Q4NDhhYzhmZDZkNDM3NWEwNjcxYTIzZTM1Y2E4MmEvdGFibGVyYW5nZTozZDg0OGFjOGZkNmQ0Mzc1YTA2NzFhMjNlMzVjYTgyYV8zLTItMS0xLTM5Mjc_750a4d96-0625-455c-b6b0-468b525310f1"
      unitRef="number">0.020</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6M2Q4NDhhYzhmZDZkNDM3NWEwNjcxYTIzZTM1Y2E4MmEvdGFibGVyYW5nZTozZDg0OGFjOGZkNmQ0Mzc1YTA2NzFhMjNlMzVjYTgyYV8zLTMtMS0xLTM5Mjc_e6efb3bc-d631-4dab-8443-d2dcdc074a84"
      unitRef="number">0.051</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjU4_f58be50d-d645-4e1f-b2e1-e19fd3b2c6d4">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF8xLTItMS0xLTM5NjU_575d8753-11d9-476c-8fa7-042a1f397fab"
      unitRef="usd">27500</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF8yLTItMS0xLTM5NjU_8d611193-6cf5-463e-a872-ae8b0ddbd533"
      unitRef="usd">300</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF8zLTItMS0xLTM5NjU_f00f6b9b-f2e7-404a-95dc-ccf589122471"
      unitRef="usd">1000.0</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF81LTItMS0xLTM5Njk_de33031d-6c78-436e-a8b4-6162151ef960"
      unitRef="usd">1000.0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:OperatingLeasePayments
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF82LTItMS0xLTM5Njk_880092b2-a157-408c-bb60-9ae5eeb8041d"
      unitRef="usd">23900</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF83LTItMS0xLTM5Njk_497d24b6-37d7-4022-9ae8-74f0e5fb5754"
      unitRef="usd">1700</us-gaap:FinanceLeasePrincipalPayments>
    <holx:OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF84LTItMS0xLTM5Njk_24fea4bb-0adc-4e41-85a0-acdc88aa7596"
      unitRef="usd">26600</holx:OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6Yjc4MzNkMjA3NDViNGE3YmJjNjdkZjYzOTdkNWJjNDQvdGFibGVyYW5nZTpiNzgzM2QyMDc0NWI0YTdiYmM2N2RmNjM5N2Q1YmM0NF8xMC0yLTEtMS0zOTcx_6d48684e-eaa7-4dbf-919b-d4d35848996c"
      unitRef="usd">13300</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQzODc3_46096385-ce02-492f-8289-4e822c62795c"
      unitRef="usd">23100000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQzODc3_4609d514-e4dc-4dcf-8575-b10f5eaf2138"
      unitRef="usd">23100000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjU5_1204091e-a389-4aa9-be7f-4e039b2df865">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjU5_df80c994-6866-489a-85c9-373fd79422ba">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8xLTItMS0xLTM5OTI_71b35ecd-0461-43c8-8221-28e2aa54902d"
      unitRef="usd">25000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8xLTMtMS0xLTM5OTI_37dd8cb6-a334-40e7-91ce-cfff579bbe34"
      unitRef="usd">2800</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8yLTItMS0xLTM5OTI_475ebb36-e37b-4643-a629-57e8b03f7e19"
      unitRef="usd">20300</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8yLTMtMS0xLTM5OTI_01fb368e-5930-469c-812e-b813bb366a7b"
      unitRef="usd">3000.0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8zLTItMS0xLTM5OTI_592f8c81-91e4-4674-96aa-72b45e2942b8"
      unitRef="usd">13800</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV8zLTMtMS0xLTM5OTI_8b65c49e-00e9-4ea5-8d18-dcbf797a155c"
      unitRef="usd">3000.0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV80LTItMS0xLTM5OTI_f5e95691-e1c6-4347-9900-3ca9cad693e4"
      unitRef="usd">11100</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV80LTMtMS0xLTM5OTI_342c3ca3-8380-40d9-bdde-a7f458a6e090"
      unitRef="usd">3000.0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV81LTItMS0xLTE1Nzc4_819db018-150d-4594-8546-cfc00e0b8d47"
      unitRef="usd">8500</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV81LTMtMS0xLTE1Nzc4_b718323a-86e6-4101-8890-23e82629bfe6"
      unitRef="usd">3100</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV81LTItMS0xLTM5OTI_4b743dc9-e4a6-43f4-8314-cae5f8bd55bd"
      unitRef="usd">16000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV81LTMtMS0xLTM5OTI_e3fa41f4-c33d-4d36-a33a-6dce194567cb"
      unitRef="usd">8400</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV82LTItMS0xLTM5OTI_7dac1bbf-95d6-4847-b4b2-cb3f5f6939d0"
      unitRef="usd">94700</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV82LTMtMS0xLTM5OTI_5c1b90ee-7d2f-4114-bda4-fcf2668f2d0a"
      unitRef="usd">23300</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV83LTItMS0xLTM5OTI_b2ee3f0f-5836-430d-8d97-a8ec99951852"
      unitRef="usd">5600</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV83LTMtMS0xLTM5OTI_a53e7562-6748-4699-ad5b-3d8362df17aa"
      unitRef="usd">4000.0</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV84LTItMS0xLTM5OTI_8195c162-c7ba-47d0-abf4-bae08202310c"
      unitRef="usd">89100</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NTQ2Y2U5ZTk0YjMwNDc2OWI4OWZmZWY4YjVkYWExNzUvdGFibGVyYW5nZTo1NDZjZTllOTRiMzA0NzY5Yjg5ZmZlZjhiNWRhYTE3NV84LTMtMS0xLTM5OTI_4c1dc469-fdde-4ac2-bfdf-a9ca1db97d7b"
      unitRef="usd">19300</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8xLTItMS0xLTE1Nzg5_4ea2def6-6d32-4344-92ab-c895ca9e337e"
      unitRef="usd">20500</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8xLTMtMS0xLTE1Nzkx_ae11c2d0-d1b2-407a-b866-4caa0e30d0da"
      unitRef="usd">5800</us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8yLTItMS0xLTE1Nzg5_480675c9-4f3c-4b61-b6f8-9500e2f70f1e"
      unitRef="usd">17300</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8yLTMtMS0xLTE1Nzkx_390420b8-292e-4838-9fa5-3f65e330125d"
      unitRef="usd">5800</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8zLTItMS0xLTE1Nzg5_56485283-5da0-4dba-bb23-1d2737d0c942"
      unitRef="usd">13300</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml8zLTMtMS0xLTE1Nzkx_ca6ba648-f3c8-41fe-93f9-968170bb398f"
      unitRef="usd">6100</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml80LTItMS0xLTE1Nzg5_ccb74a0b-af03-45e9-a135-2e2a151cc2a7"
      unitRef="usd">6600</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml80LTMtMS0xLTE1Nzkx_1562bc72-9afd-47a8-8e53-3dc914442257"
      unitRef="usd">6200</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml81LTItMS0xLTE1Nzg5_7d429b77-e096-4742-9133-1f2511b93f64"
      unitRef="usd">5900</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml81LTMtMS0xLTE1Nzkx_56b8ac55-fd74-4449-b975-7980f964d586"
      unitRef="usd">5500</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml82LTItMS0xLTE1Nzg5_f32fe4fd-6233-485a-add0-35fc5965d0f0"
      unitRef="usd">14600</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueThereafter
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml82LTMtMS0xLTE1Nzkx_aaf58276-453a-46e4-8aa0-8ccdd2365a58"
      unitRef="usd">19500</us-gaap:CapitalLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml83LTItMS0xLTE1Nzg5_552fd04f-e353-4576-8285-9534e1cea5f6"
      unitRef="usd">78200</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6NDhmMjE0ZjMyZDkxNDdjODhjYjBhYzdjNDM1NzBmODIvdGFibGVyYW5nZTo0OGYyMTRmMzJkOTE0N2M4OGNiMGFjN2M0MzU3MGY4Ml83LTMtMS0xLTE1Nzkx_7c271a7b-8aaa-4e67-a475-e3bb1a932604"
      unitRef="usd">48900</us-gaap:CapitalLeasesFutureMinimumPaymentsDue>
    <holx:LeaseRevenuePercentageOfTotalRevenue
      contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQxNjU0_dd61c659-dc01-4f5a-8af6-1c1215d51e01"
      unitRef="number">0.04</holx:LeaseRevenuePercentageOfTotalRevenue>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2NDg1_b59266ec-4c9f-4230-a0bd-c652bb661593"
      unitRef="usd">10200000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <holx:LeaseReceivable
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV80Mzk4MDQ2NTE2NTAw_3061fd3f-ad6e-4bf8-9cfe-b087abab8aa5"
      unitRef="usd">19300000</holx:LeaseReceivable>
    <us-gaap:OperatingLeasesRentExpenseSubleaseRentals1
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV84MjQ2MzM3MjE0MTUw_39b541d3-e036-449f-917a-c6333bbfd93f"
      unitRef="usd">2000000.0</us-gaap:OperatingLeasesRentExpenseSubleaseRentals1>
    <us-gaap:OperatingLeasesRentExpenseSubleaseRentals1
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV84MjQ2MzM3MjE0MTU1_bb9f7f35-caad-4e5c-8b2b-6bb5c675c18a"
      unitRef="usd">2700000</us-gaap:OperatingLeasesRentExpenseSubleaseRentals1>
    <us-gaap:OperatingLeasesRentExpenseSubleaseRentals1
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV84MjQ2MzM3MjE0MTYz_88a1559a-3d97-4abc-939f-0199eb40205a"
      unitRef="usd">2600000</us-gaap:OperatingLeasesRentExpenseSubleaseRentals1>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODQzODc1_75373696-17ba-4fd6-8b34-85afa37b3b95">The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl8wLTEtMS0xLTY5NTE_d1b6ef99-db7b-4435-b101-65a6f4839c7a"
      unitRef="usd">3000000.0</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl8xLTEtMS0xLTY5NTE_3c1aeb87-62a8-48ce-9e42-a48bf788826a"
      unitRef="usd">3000000.0</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl8yLTEtMS0xLTY5NTE_794dd5aa-7bb0-4e26-aae0-5b35390f13f9"
      unitRef="usd">3000000.0</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFourYears
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl8zLTEtMS0xLTY5NTE_5abe8d6e-d6eb-4e32-83a3-29a543258905"
      unitRef="usd">2900000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl80LTEtMS0xLTY5NTE_b359b8b2-a362-4b9c-8098-b7f23a55da09"
      unitRef="usd">1900000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableThereafter
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl81LTEtMS0xLTY5NTE_26857ea3-50d6-46d8-aa0e-fcf8aa035f83"
      unitRef="usd">2600000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableThereafter>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivable
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6MDQyMmJiOWZiOTlmNDVmNmEwMWNlNjUzZGMzNWIwZTIvdGFibGVyYW5nZTowNDIyYmI5ZmI5OWY0NWY2YTAxY2U2NTNkYzM1YjBlMl82LTItMS0xLTE1Nzk1_4dea9c7c-91d2-4a67-ae63-eb89f412abf5"
      unitRef="usd">16400000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivable>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzE0MjA3_f961f383-6f08-4877-9911-f7fe7aade290">Business Combinations&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acessa Health&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$161.3&#160;million, which included a hold-back of $3.0&#160;million payable five months from the date of acquisition, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company has determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets has been estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows are based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill are based on synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical's sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Health Beacons&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's preliminary valuation, it has allocated $10.7&#160;million of the purchase price to the preliminary value of developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price has been allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Alpha Imaging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration which the Company has estimated at $0.9&#160;million. The contingent consideration is payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. Goodwill was immaterial. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SuperSonic Imagine&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine ("SSI") for $18.2&#160;million. SSI is a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#x20ac;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#x201c;VIE&#x201d;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting and included its proportionate share of SSI's net loss of $3.3&#160;million for the two months ended September 28, 2019 within Other income, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 21, 2019, the Company acquired an additional 7.6&#160;million common shares of SSI for $12.6&#160;million. As a result, the Company's ownership interest increased to approximately 78% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2&#160;million recorded in the first quarter of fiscal 2020. The total accounting purchase price was $69.3&#160;million, which consisted of $17.9&#160;million for the equity method investment in SSI, $12.6&#160;million for shares acquired on November 21, 2019, $30.2&#160;million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6&#160;million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1&#160;million outstanding shares in fiscal 2020 for $1.8&#160;million, and as of September 26, 2020, the Company owned approximately 81% of the outstanding shares of SSI.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to SSI's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. The Company has not yet obtained all of the information related to the fair value of the acquired assets and liabilities, primarily income taxes and recognition of uncertain tax positions, to finalize the purchase price allocation.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology, customer relationships, and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill are based on synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Focal Therapeutics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2018, the Company completed the acquisition of Focal Therapeutics, Inc. ("Focal") for a purchase price of $120.1&#160;million, which included hold-backs of $14.0&#160;million payable up to one year from the date of acquisition. In the second quarter of fiscal 2019, $1.5&#160;million of the hold-back was paid, and the remaining $12.5&#160;million was paid in the first quarter of fiscal 2020. Focal, headquartered in California, manufactures and markets its BioZorb marker, which is an implantable three-dimensional marker that helps clinicians overcome certain challenges in breast conserving surgery. Focal's results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Focal's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, in-process research and development ("IPR&amp;amp;D"), and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from&#160;15.5%&#160;to 16.5%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names was 11 years and 13 years, respectively. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the amount of goodwill were based on synergistic benefits that are expected to be realized from this acquisition. Benefits include the expectation of broadening the Company's Breast Health portfolio of products and technology. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Faxitron&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 31, 2018, the Company completed the acquisition of Faxitron Bioptics, LLC ("Faxitron") for a purchase price of $89.5 million, which included hold-backs of $11.7 million payable up to one year from the date of acquisition, and contingent consideration, which the Company estimated at $2.9 million as of the measurement date. Faxitron, headquartered in Tucson, Arizona, develops, manufactures, and markets digital radiography systems. The contingent consideration is payable upon meeting certain revenue growth metrics. In the fourth quarter of fiscal 2019, the Company increased the contingent consideration liability by $1.7 million based on updated projections, and the Company paid $5.0&#160;million in the second quarter of fiscal 2020. During fiscal 2019, the Company paid $6.5 million of the hold-backs and withheld the remainder of $5.2 million under the indemnification provisions of the purchase agreement, which the former shareholders had disputed. In the first quarter of fiscal 2020, the Company resolved this dispute and paid $4.1&#160;million to the former shareholders. Faxitron's results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Faxitron's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of July 31, 2018, as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Faxitron's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, in-process research and development ("IPR&amp;amp;D"), customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from&#160;17%&#160;to&#160;19%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for both developed technology and customer relationships is 9 years and for trade names it is 7 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill were based on synergistic benefits that are expected to be realized from this acquisition. Benefits include the expectation of broadening the Company's Breast Health portfolio of products and technology. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Emsor, S.A.&lt;/span&gt;&lt;/div&gt;On December 11, 2017, the Company completed the acquisition of Emsor S.A. ("Emsor") for a purchase price of $16.3 million, and contingent consideration, which the Company estimated at $4.9 million as of the measurement date. The contingent consideration was payable upon Emsor achieving predefined amounts of cumulative revenue over a two-year period from the date of acquisition. The contingent consideration was paid in the second quarter of fiscal 2020. Emsor was a distributor of the Company's Breast and Skeletal Health products in Spain and Portugal. Based on the Company's valuation, it allocated $4.6 million of the purchase price to the value of customer relationship intangible assets and $5.7 million to goodwill. The remaining $6.0 million of purchase price was allocated to acquired tangible assets and liabilities.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic439fbf0ea984bcba40c13f6cae3a03b_D20200823-20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA4NzU_7d311dce-9187-421f-96d9-dcf2402dc09b"
      unitRef="usd">161300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i60c64e349e7248b4926861f03af3baf7_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2MDk_1f32fac8-520f-48f3-9e02-6d496401f9ce"
      unitRef="usd">3000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability
      contextRef="i6628d4bd404a4b39ae1f8755ac19e156_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2NjY_d5c0ce3c-d997-4276-9f81-e2b113f6f921">P5M</holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2MjM_98a8b3c7-cd33-4c33-b42f-41637a729495"
      unitRef="usd">81800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i64e80cf41696467c9ffc4409327aade0_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk4OTU2MDQ3MDUwNDc_92caf90d-67ed-4cff-a927-1d15a0c4f2f0">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzAtMi0xLTEtNDMyMg_5634bf54-f4ca-450b-ab28-6c0b8f6d72f8"
      unitRef="usd">1.2</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzEtMi0xLTEtMTU4NzY_8335034d-43b4-42fe-aabb-cc57b2a8eb26"
      unitRef="usd">4.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzItMi0xLTEtMTU4NzY_367f167a-53dc-4c3e-b96f-cf024fe79d5a"
      unitRef="usd">4.4</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="idf4c2cfcfc8644a2ac89ad085cbdce46_I20200823"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzItMi0xLTEtNDMyMg_5238e5b7-3e78-48a8-8dcc-85ff91dca182"
      unitRef="usd">127.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ib6e062bb74fb4a87a11ce9920ba3bf95_I20200823"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzQtMi0xLTEtNDMyMg_1326fdbd-5842-445a-ab2e-b0f932d5ce3d"
      unitRef="usd">1.2</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzgtMi0xLTEtMTE2ODQ_712acbe7-19a2-4697-b193-86d15466ec2b"
      unitRef="usd">4.7</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzEwLTItMS0xLTk5ODg_b9fcd332-14ba-47a0-a203-d67586bd161b"
      unitRef="usd">20.2</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzUtMi0xLTEtNDMyMg_33b1772b-4350-4904-a19b-b2162d4eee31"
      unitRef="usd">48.4</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo0Y2E1ODc1YWRkZGI0N2U3OGI0N2FlMjI4NDAzZGI5ZS90YWJsZXJhbmdlOjRjYTU4NzVhZGRkYjQ3ZTc4YjQ3YWUyMjg0MDNkYjllXzYtMi0xLTEtNDMyMg_01a18155-5ee5-4d76-8247-6d157e33607d"
      unitRef="usd">161.3</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="ic439fbf0ea984bcba40c13f6cae3a03b_D20200823-20200823"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2Mzg_f8032829-ddc6-4476-a1dc-12e18a02cf05"
      unitRef="number">0.180</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic439fbf0ea984bcba40c13f6cae3a03b_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2ODU_585256c9-4c46-4967-a7f5-5c3b4e4b559b">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1d09efae7507467987336d04e3509634_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1ODM_986f2b50-34ca-4d7c-ac0e-80bc026124d4"
      unitRef="usd">19700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="i862a3c45416648d297e125475abce254_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1Nzk_2d891b82-0857-4d02-b68e-8af1eaa25ad7"
      unitRef="usd">2300000</holx:Holdback>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i862a3c45416648d297e125475abce254_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1OTE_81171914-42cd-44c7-b913-0c64d0e4e114"
      unitRef="usd">10700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i862a3c45416648d297e125475abce254_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1OTU_06d08936-b9c4-4229-9235-435718c62bd1"
      unitRef="usd">6200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i862a3c45416648d297e125475abce254_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1ODc_c632c2f2-b457-44cc-92a1-1e7f18006d46"
      unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ie33a898c5926488b9bf6ad622a0bd9a1_D20191230-20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc1OTk_294db286-d3a2-4fbd-b657-16d128a78f6d"
      unitRef="usd">18000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="i13b5b561b723452ba061ef7677378758_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MDc_22686315-ce4c-43d3-8514-45635eafe1ab"
      unitRef="usd">1000000.0</holx:Holdback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4c2998316cac4e238f728957efe3c4b1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MDM_19aac112-8906-4074-be0a-8844eea5162f"
      unitRef="usd">900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ic533d50defe448fdb707c6f87a49077f_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MTk_72fbcdda-dc9c-428c-a288-88a7a38d9579"
      unitRef="number">0.46</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i22886537724e44318a4d4b7a40157a84_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MTU_1b9032cb-ff4a-4deb-a8ee-7a7beee76195"
      unitRef="usd">18200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessAcquisitionCashTenderOfferPricePerShare
      contextRef="i90fc1953e74547ef8567e85c0335320d_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MjM_0b632d24-f7fc-4b6b-acc1-17f877845ff2"
      unitRef="usdPerShare">1.50</holx:BusinessAcquisitionCashTenderOfferPricePerShare>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="id37fc47d83b14b95b70cbb4ef25f42b3_I20191120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MzE_bd40b9cd-67ea-41b6-9770-f34451ec65bd"
      unitRef="number">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie68d86ac2e6a4c928f6d1a734e19ab2a_D20190728-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2Mjc_d4590ea0-326d-443d-b438-a78e8629b441"
      unitRef="usd">3300000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <holx:BusinessCombinationSharesAcquired
      contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2MzU_a040bb47-e71d-43fd-85a3-905b4e791520"
      unitRef="shares">7600000</holx:BusinessCombinationSharesAcquired>
    <holx:AdditionalPurchaseConsideration
      contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2Mzk_85a0a0a8-9176-4c05-be4b-3a7ac5b4a7cb"
      unitRef="usd">12600000</holx:AdditionalPurchaseConsideration>
    <holx:BusinessCombinationOwnershipPercentage
      contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NDM_b8f2ec55-bddb-43ef-b82b-e58899d583b7"
      unitRef="number">0.78</holx:BusinessCombinationOwnershipPercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="ic533d50defe448fdb707c6f87a49077f_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NDc_4ad93797-d027-43bf-97b2-a1adc2712e65"
      unitRef="number">0.46</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NTE_62b3468b-2059-41e3-86fe-a8d7510aa0c7"
      unitRef="usd">3200000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NTk_8a4f0658-663d-47c2-b2f5-e7209c7027b1"
      unitRef="usd">69300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment
      contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NTU_8b4350f8-e496-40d6-9790-9f34256ffe38"
      unitRef="usd">17900000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares
      contextRef="ib35735436ab04420aac409cb3a577c1d_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NjM_cd1cce3f-83f3-4b20-b070-2e99e26fe2f4"
      unitRef="usd">12600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment
      contextRef="i6ddaf3ec183f4472a9585cc8edc018f6_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2Njc_de486272-1e18-4302-b071-072d1117b72b"
      unitRef="usd">30200000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest
      contextRef="icb6add9e14054057a65ac31b811fae48_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NzE_db796751-91b8-4a9c-a1bd-d2f538d1e3ac"
      unitRef="usd">8600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest>
    <holx:BusinessCombinationAdditionalSharesAcquiredShares
      contextRef="if7876712181a4f0394252851c3247e89_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2Nzk_21e1e705-ded9-4920-8400-088521b1e03b"
      unitRef="shares">1100000</holx:BusinessCombinationAdditionalSharesAcquiredShares>
    <holx:BusinessCombinationAdditionalSharesAcquiredValue
      contextRef="if7876712181a4f0394252851c3247e89_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2NzU_72ddf80d-2b01-4808-8427-5087acfa0f96"
      unitRef="usd">1800000</holx:BusinessCombinationAdditionalSharesAcquiredValue>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i06df67bcc2a94911a7069e16ec48fb7a_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2ODM_ede0024a-b027-473d-9b88-1c05b995c3c4"
      unitRef="number">0.81</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="if7876712181a4f0394252851c3247e89_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2OTc_b466942e-e166-4982-bce7-4975735b2654">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to SSI's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzAtMS0xLTEtMTU5NzU_fae62a81-3383-4d94-9bab-7895b1a25d4a"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzEtMS0xLTEtMTU5NzU_be9e7571-c9a8-4157-b3c8-626285b8277c"
      unitRef="usd">7100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzItMS0xLTEtMTU5NzU_b6d0cc75-3b65-4637-a779-51a23bbfb0ed"
      unitRef="usd">10000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzMtMS0xLTEtMTU5NzU_b846b817-069a-40da-9e9b-857358342d64"
      unitRef="usd">6500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzQtMS0xLTEtMTU5NzU_976a4dec-a23d-49d6-85e6-fe45b4c4302c"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzUtMS0xLTEtMTU5NzU_50f96b88-2953-471a-a5c1-e050813f3d34"
      unitRef="usd">24500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzYtMS0xLTEtMTU5NzU_44d12628-bf37-4dcc-b72d-2be7180f03ba"
      unitRef="usd">1800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzctMS0xLTEtMTU5NzU_eb1757ba-3e47-4040-9956-df703d093dab"
      unitRef="usd">8800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzgtMS0xLTEtMTU5NzU_d1f40c4e-9fdb-419a-9368-db654110619f"
      unitRef="usd">3800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzEwLTEtMS0xLTE1OTc1_af29cfb9-d267-47c0-a66e-9f2e6a7dd258"
      unitRef="usd">38300000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzExLTEtMS0xLTE1OTc1_1cc3be26-b29d-49bb-b368-a317acf2b3fd"
      unitRef="usd">4000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzEyLTEtMS0xLTE1OTc1_91b5e295-ec5f-45a8-a8c9-e98201db386d"
      unitRef="usd">3000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzEzLTEtMS0xLTE1OTc1_a2e53bf4-acae-4e8d-9743-f57acf477a75"
      unitRef="usd">1900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzE0LTEtMS0xLTE1OTc1_b2dbdc6a-ca54-4186-8b01-2f515ff944a5"
      unitRef="usd">34300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i36b884f4d126493b8f8989d941004da4_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTpmMjcwOTA4Njk2MDM0YWIzOTI3NzY3ZjA5ZjA5OTA2Ny90YWJsZXJhbmdlOmYyNzA5MDg2OTYwMzRhYjM5Mjc3NjdmMDlmMDk5MDY3XzE1LTEtMS0xLTE1OTc1_4fa275e8-677e-4e1b-a009-485c93077ea8"
      unitRef="usd">69300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i13dcce25b11542068d5ad5a656336c29_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg2OTk_f404f454-b1bc-49d8-9a63-4afcf245d8ce"
      unitRef="number">0.120</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if2090212e7314cac8f3f33afb4394112_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NjA2NjQ_18531c64-4f56-4e28-b049-4f95bf5063aa">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2576885bfe07425f9e425c469ebe8367_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NjA2MjE_e1e6c8bd-0768-4c7b-b371-1dad591d4fc3">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i02f15446f52343a9adfc4e8ef6c280fb_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NjA2MzY_0b7142e5-09cc-49da-9611-ff8173e91ac3">P8Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia43db9b88a3d4ca894ba73187fb33e22_D20181001-20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzQzOTgwNDY1Mjk5MDY_c3cfbed1-87cc-4967-a491-56954f324910"
      unitRef="usd">120100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzQzOTgwNDY1Mjk5Mzk_0ab7501b-0cea-463f-9ff2-e85065c172db"
      unitRef="usd">14000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability
      contextRef="ia43db9b88a3d4ca894ba73187fb33e22_D20181001-20181001"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTExMzk_bae5e39a-19c1-48b0-9127-a389bd0fb989">P1Y</holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9c2a49b788f14bf48455c95dcf507a9e_I20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzQzOTgwNDY1NjQ4MTU_5721c9f7-ac54-4e4d-a871-5740effeaea6"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ie9c201c0913b44d98e588a279d1fe985_D20191001-20191001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzQzOTgwNDY1Mjk5MjM_9a44a3fd-31c0-48ae-b7f3-c6dd147e4f0f"
      unitRef="usd">12500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ica9f97800f804e4a9d1eae5069d40e02_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA4ODk_3ed12157-d814-4fd9-84cf-337e9bb59802">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzAtMS0xLTEtNDI1MQ_91b05f2f-099a-4d0c-bc30-9bd3ab746d60"
      unitRef="usd">2200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzEtMS0xLTEtNDI1MQ_5fca6bfa-04ea-44bf-9a7c-90978417ad37"
      unitRef="usd">2000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzItMS0xLTEtNDI1MQ_9327b8ff-9769-4a0b-aed9-4f0fdbbc80ee"
      unitRef="usd">7900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzMtMS0xLTEtNDI1MQ_fb6ca4a5-090f-4c11-8b1e-b390183d8126"
      unitRef="usd">500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzQtMS0xLTEtNDI1MQ_eff4de50-90b6-4330-8290-1b7a50c40a09"
      unitRef="usd">5600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzUtMS0xLTEtNDI1MQ_378a1879-d388-4af2-896f-bce050eae1f7"
      unitRef="usd">2500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i52f401bcab374c9da21ba458593af4a7_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzctMS0xLTEtNDI1Mw_cfef7dba-d1f9-4f8c-bfb1-7522bbaeff4a"
      unitRef="usd">83100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i58ab6ed21a0e49acb17f46bb533a208d_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzgtMS0xLTEtNDI1Mw_1333792c-1e35-4c44-8c86-14160f7ab26b"
      unitRef="usd">11400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i72959050a334423eb15ca612ed289237_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzktMS0xLTEtNDI1Mw_d6a44fb9-c57b-4776-9ff0-9d3c4f17742d"
      unitRef="usd">2700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzEwLTEtMS0xLTQyNTM_e9db5036-242e-48a5-b620-b94642545dc5"
      unitRef="usd">12700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzExLTEtMS0xLTQyNTM_8b619103-face-403f-897a-78fde0dde7c2"
      unitRef="usd">31100000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i781dbf5ddcb549d383a457e18753ded3_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZToxNGQ3NjIyNzRkZWY0MWNhOGFjYWE0ZmY4OWU0NWVhNy90YWJsZXJhbmdlOjE0ZDc2MjI3NGRlZjQxY2E4YWNhYTRmZjg5ZTQ1ZWE3XzEyLTEtMS0xLTQyNTM_ac1499e8-3eb7-4fda-a73b-a5189041d44a"
      unitRef="usd">120100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i6eb9aadeebec4587b35023639ede565a_D20181001-20181001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA4OTE_228037be-ed06-411f-b428-9d4a1ca19030"
      unitRef="number">0.155</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="ieefe5f2ec3a649449b7f480aa2fad0c5_D20181001-20181001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA4OTg_ca198e4b-5fb0-4417-9d80-2779fde485db"
      unitRef="number">0.165</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie12b0a99842a4517ba08e440afbc7c60_D20181001-20181001"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA5MjE_17515ed1-4d68-4946-8a4d-15cbb43e0caa">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i847787c89a874c6892ea179463d444ff_D20181001-20181001"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg4OTA5NDA_8b810dcc-6507-4929-b1c9-67d1681f3d98">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i17ca3ee0e1d24409acd2b837d6b9f512_D20180731-20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk0NTE_70ece8ef-76c9-4934-b165-29c7fb2b30ce"
      unitRef="usd">89500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i22cb2f3e35b1476184e3b5ea02888210_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk0ODQ_47bee4b8-7f0b-4c56-bd5e-7e71c3480674"
      unitRef="usd">11700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability
      contextRef="ib017ae2e40794fb6b06de53aea426df5_D20180731-20180731"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk1MDE_04b07055-2bdc-4922-8b43-0c67cac3e469">P1Y</holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzk1OTQ_6453e67c-18cc-4e59-8c25-59a3e73690f7"
      unitRef="usd">2900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="idf55a89911c2418c862ba56b871a233c_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzEwMDQ3_d063b984-5f7d-4fc9-852f-004138450926"
      unitRef="usd">1700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="iece20c91b1524a47b452db31a8c50766_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg3MjE_e27a46a6-e07a-43f7-b842-4db61e0dc56d"
      unitRef="usd">5000000.0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i8e553e7d9bfc4efaafc3811a17018296_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzEwMTE3_bf050aa0-f9da-4720-a574-8f63b831bb57"
      unitRef="usd">6500000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <holx:BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions
      contextRef="i8e553e7d9bfc4efaafc3811a17018296_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzEwMTY3_f8e2c4e9-e0cf-45a6-a180-8ae441108026"
      unitRef="usd">5200000</holx:BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions>
    <holx:PaymentOfContingentConsideration
      contextRef="id3a1dcaf42754d9c9a3ff74faf8f61fd_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NDg3MDc_9e2dceab-8bab-44e9-a967-fcd02663eae0"
      unitRef="usd">4100000</holx:PaymentOfContingentConsideration>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ie9c4512920904aa3814e9c7a9fd62545_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzE0MjAy_4328379e-fb2a-40b8-8cd6-71a4b0185d4a">The total purchase price was allocated to Faxitron's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of July 31, 2018, as set forth below:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzAtMS0xLTEtMA_492a0b53-d91b-448c-b0bb-9390dc6a1cad"
      unitRef="usd">2400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzEtMS0xLTEtMA_8990054b-f71f-40cb-9bef-b60b8c53a2b3"
      unitRef="usd">4000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzItMS0xLTEtMA_b7aa5670-8069-4b69-92c1-c87924acb4fb"
      unitRef="usd">5800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzMtMS0xLTEtMA_7573af69-62b7-465e-b2a1-8089fb213bf4"
      unitRef="usd">3100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzQtMS0xLTEtMA_910b9d8b-fb4a-414f-9001-6916b1b9637f"
      unitRef="usd">8800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzUtMS0xLTEtMA_bfdb26a0-359e-459c-b541-d9e6dc0b42f3"
      unitRef="usd">1900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzYtMS0xLTEtMA_ad68d6c2-4dd8-4080-853f-decde256cf6a"
      unitRef="usd">3300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ibec87245e37445459f0a3ed8735ffec3_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzgtMS0xLTEtMA_5fb57a33-9cbe-4691-92a3-20cf058f279f"
      unitRef="usd">44900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ib9b201cf75b8459db2ad76cb990ec129_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzktMS0xLTEtMA_838e6f78-44d1-4d70-a099-537ba3a21f3b"
      unitRef="usd">5500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ie8f378dddadb4b4fac57b2fbc214b4c9_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzEwLTEtMS0xLTA_765af85b-fd00-4504-a8f2-10f2bf46486b"
      unitRef="usd">500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i045b09a2ab1943b59f87d6eb5f4942ef_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzExLTEtMS0xLTA_9b92d04b-b97b-4520-be26-63768e1951aa"
      unitRef="usd">2300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzEyLTEtMS0xLTA_c2d80063-2bd5-4dea-81a4-442bc98df033"
      unitRef="usd">10600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzEzLTEtMS0xLTA_2ed3cbe8-3a36-41a0-b17d-4563d1ccf8a7"
      unitRef="usd">45600000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i6140a77a89524e3f94a9becd6d726c2d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90YWJsZTo3OWNhYThkZDkwMTA0NWYxYmRjMmU4M2IyMzQ2OTYzMC90YWJsZXJhbmdlOjc5Y2FhOGRkOTAxMDQ1ZjFiZGMyZTgzYjIzNDY5NjMwXzE0LTEtMS0xLTA_a6b46fec-2206-49c5-be97-65bcdda1aaf1"
      unitRef="usd">89500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i3d6a98785a404f99847c50b43c96a34d_D20180731-20180731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzExMDk3_abb61f5a-ae35-4004-bded-0d3f70d97168"
      unitRef="number">0.17</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i78dfbab8f2fc4de39f7b4e445e2589f2_D20180731-20180731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzExMTAz_74fe6630-fe5e-43e9-b59f-1078c716375f"
      unitRef="number">0.19</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id9916a6d68484e70bff8c6d8f2a2e4ad_D20180731-20180731"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzExNDI1_685e78cf-bf2e-44ce-ab36-047b2f9a3eb4">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i266eecec31bc4b7d8dcaf10d0b94db47_D20180731-20180731"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzExNDU0_673ab53d-5c5f-40af-a18b-0e07713543e9">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4079f996b6274dfb9512d61934ca5bd0_D20171211-20171211"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2ODc_79881808-2547-410c-afc4-8dd33f1d59ba"
      unitRef="usd">16300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2OTE_7be1dbf5-5233-400b-ac0c-a772f564dfeb"
      unitRef="usd">4900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability
      contextRef="icb2ff4168e384034bbf5532623a74329_D20171211-20171211"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzkzNDU4NDg5NjA2ODc_c2a01a65-8aaa-419d-8f5d-29baab2a26ee">P2Y</holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2OTU_1285c6a2-a29d-4d65-9954-f7bb2c7b50c8"
      unitRef="usd">4600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc3MDM_4d14f60d-cf9c-4e31-902d-633b91865c1f"
      unitRef="usd">5700000</us-gaap:Goodwill>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet
      contextRef="i86dbc7eaf3a94591b06b84ba65e3bfbf_I20171211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNTEvZnJhZzoyZGEzZjBmMTMzMmM0YWVjYjc3YzVkNTNhNzY1NmJjMS90ZXh0cmVnaW9uOjJkYTNmMGYxMzMyYzRhZWNiNzdjNWQ1M2E3NjU2YmMxXzgyNDYzMzczMDc2OTk_78556f0e-65aa-41f7-8f7b-ff8078dc9074"
      unitRef="usd">6000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzYzMzA_240858fe-5e8d-4717-8ce3-f9b950da733d">The following table displays charges taken related to restructuring actions in fiscal 2020, 2019 and 2018 and a rollforward of the charges to the accrued balances as of September&#160;26, 2020:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2020 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2019 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2018 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Restructuring Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2018 charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Workforce reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility closure costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2018 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019 charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Workforce reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility closure costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020 charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Workforce reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Divestiture charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <holx:ReductionOfWorkforceExpenses
      contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTEtMS0xLTEzOTUz_f3a7b4ce-f59a-4cf1-a129-63b2daa57ebd"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTEtMS0xLTA_8d13a8f7-7427-4d40-a256-2fc35505af01"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTMtMS0xLTA_7d711a79-8233-4e93-8b39-7c2719064dcf"
      unitRef="usd">11700000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i7847ac8d91804cd389031be4f03425da_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTctMS0xLTA_658c40fd-7bd3-4649-94d2-8e9510bb6341"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEwLTExLTEtMS0w_2cc62a7b-e5d4-4eb6-ac89-7ac0e53e5811"
      unitRef="usd">11700000</holx:ReductionOfWorkforceExpenses>
    <holx:FacilityClosureCosts
      contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTEtMS0xLTEzOTU4_b0da0485-29fa-4576-991b-4418ae4fca56"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTEtMS0xLTA_1859a341-5b7b-45b7-95e5-a21aeb74b3fa"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTMtMS0xLTA_f879813d-8bda-4dfb-80ad-b105363b79d9"
      unitRef="usd">900000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i7847ac8d91804cd389031be4f03425da_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTctMS0xLTA_fa54a94c-1c68-4364-9290-c151f2837f1d"
      unitRef="usd">1600000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzExLTExLTEtMS0w_e90f036c-9528-4fbf-a68b-18c94dd38091"
      unitRef="usd">2500000</holx:FacilityClosureCosts>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTEtMS0xLTEzOTYw_18d260f8-e92c-47a4-925e-88ac90d9bceb"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTEtMS0xLTA_9c854306-2342-4ff0-9dff-872506f2450e"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTMtMS0xLTA_a11bd0f1-f217-40f9-859f-6e5df881a1b1"
      unitRef="usd">12600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i7847ac8d91804cd389031be4f03425da_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTctMS0xLTA_80c864c8-0763-4dc6-8a44-370e45e82912"
      unitRef="usd">1600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzEzLTExLTEtMS0w_7a5801c8-e43f-4f5c-aedc-36dce031b4f4"
      unitRef="usd">14200000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTEtMS0xLTEzOTQ3_9ffa0d34-2e30-42ae-9747-f82cdf2ce3bc"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTEtMS0xLTA_e7d81f1d-cf41-4a70-8342-323a11929eaa"
      unitRef="usd">4000000.0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTMtMS0xLTA_ca9e3505-fc35-4d9b-bf43-ee12a8274970"
      unitRef="usd">1400000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i40fdaceff578441ea2d62d53dd29115e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTctMS0xLTA_1525cdb6-87fa-4b9a-aee2-93adbe3919f8"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE1LTExLTEtMS0w_7def55db-c339-4957-a118-8d77de46cdf0"
      unitRef="usd">5400000</holx:ReductionOfWorkforceExpenses>
    <holx:FacilityClosureCosts
      contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTEtMS0xLTEzOTQ5_de81c287-7129-4303-8d71-dbd45eeb101a"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTEtMS0xLTA_cf680f96-34fa-4667-87c5-cc1dbc5e7bdc"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTMtMS0xLTA_2ce2cde6-a46c-42c3-9d89-80958b70f220"
      unitRef="usd">-200000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i40fdaceff578441ea2d62d53dd29115e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTctMS0xLTA_6eedb836-2079-445d-84b0-70f8f79c824b"
      unitRef="usd">1400000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE2LTExLTEtMS0w_b28b1986-5044-49ea-88ad-56d20d349d07"
      unitRef="usd">1200000</holx:FacilityClosureCosts>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTEtMS0xLTEzOTUx_b8aa05f6-e239-4b29-aec2-9b53f3b0ce5e"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTEtMS0xLTA_1c5c11b5-8e21-4477-b524-2d2ae092898b"
      unitRef="usd">4000000.0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTMtMS0xLTA_55bc9da0-8f15-4089-a1f3-8d61e3d72657"
      unitRef="usd">1200000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i40fdaceff578441ea2d62d53dd29115e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTctMS0xLTA_8e32645e-d005-45da-a13e-fcdacd41c36a"
      unitRef="usd">1400000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE3LTExLTEtMS0w_ca015fb4-c676-4ae5-9758-6ed86a7d62cd"
      unitRef="usd">6600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i7eba256d6a1542db8c06d5ffa4b20a07_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTEtMS0xLTEzOTQy_65dcdb30-cb55-48f3-8db4-10b3d9689ea3"
      unitRef="usd">13200000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="icb6630fc5f65496eaec9acaa3d5c7aba_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTMtMS0xLTEzOTAx_422a02d5-940b-4d17-98c4-355c31bd4b74"
      unitRef="usd">300000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i585bf0cfe60944f78c6482f3beb7d14b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTUtMS0xLTEzOTA3_7a401d2f-d430-44ab-9f91-f9bd5468a4d7"
      unitRef="usd">-100000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="ia99af639d7f84346aca75ba9ef329ad7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTctMS0xLTEzOTEz_e8dab73b-fcb0-4697-be8c-68ac9d8a9dae"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i7ad1871e11b04ce3a9b3d2d7995b3439_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzE5LTExLTEtMS0xMzkxOQ_4815162c-75ae-4770-abfb-99d77bd8decb"
      unitRef="usd">13400000</holx:ReductionOfWorkforceExpenses>
    <holx:DivestitureCharges
      contextRef="i7eba256d6a1542db8c06d5ffa4b20a07_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTEtMS0xLTEzOTI1_ee11debe-80a2-401a-847d-874aac14fe9e"
      unitRef="usd">1900000</holx:DivestitureCharges>
    <holx:DivestitureCharges
      contextRef="icb6630fc5f65496eaec9acaa3d5c7aba_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTMtMS0xLTEzOTAz_51882956-64a7-4ae4-9382-b81b4d4c7467"
      unitRef="usd">0</holx:DivestitureCharges>
    <holx:DivestitureCharges
      contextRef="i585bf0cfe60944f78c6482f3beb7d14b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTUtMS0xLTEzOTA5_133e977b-de27-43f7-a60c-6ad5d52be825"
      unitRef="usd">0</holx:DivestitureCharges>
    <holx:DivestitureCharges
      contextRef="ia99af639d7f84346aca75ba9ef329ad7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTctMS0xLTEzOTE1_379c47ff-00cb-4fa7-b0ba-bec3bf16ba69"
      unitRef="usd">0</holx:DivestitureCharges>
    <holx:DivestitureCharges
      contextRef="i7ad1871e11b04ce3a9b3d2d7995b3439_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIwLTExLTEtMS0xMzkyMQ_377c0c67-63bf-4b67-a0cf-3bce3ffc8257"
      unitRef="usd">1900000</holx:DivestitureCharges>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i7eba256d6a1542db8c06d5ffa4b20a07_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTEtMS0xLTEzOTQ0_165753d0-2f6e-4265-9668-37b2eb0391a9"
      unitRef="usd">15100000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="icb6630fc5f65496eaec9acaa3d5c7aba_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTMtMS0xLTEzOTA1_d82414df-3313-4f0b-866f-2b7d8014882f"
      unitRef="usd">300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i585bf0cfe60944f78c6482f3beb7d14b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTUtMS0xLTEzOTEx_f7a30706-9095-45e1-bbbf-af80ca479e60"
      unitRef="usd">-100000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="ia99af639d7f84346aca75ba9ef329ad7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTctMS0xLTEzOTE3_a574621a-b825-446a-b2d9-8ab1fb1b6475"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i7ad1871e11b04ce3a9b3d2d7995b3439_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTplZjIyNDhlYTk3YmM0MjY5OTAxNmMyMGUwYmNlYTI3NC90YWJsZXJhbmdlOmVmMjI0OGVhOTdiYzQyNjk5MDE2YzIwZTBiY2VhMjc0XzIxLTExLTEtMS0xMzkyMw_91a0879c-f85d-4d67-a912-afccb3666d18"
      unitRef="usd">15300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzYzMjc_84af7b4a-6d3d-4e5e-8247-24b81e2f4a1c">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2020 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2019 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2018 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2017 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Previous Other Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Rollforward of Accrued Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2018 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Severance payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Severance payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Severance payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other payments and adjustments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="ia488122214b14db38171d7681cd5d254_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzItMS0xLTEtMTQwNTY_ffb2af82-0251-44a7-a64b-d613301a0e03"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9cef01ab57d64322aacba4e684ef1326_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctMS0xLTEtMA_25cf8a15-44eb-4049-ab47-09a284a4b5c0"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i84c64923b6e84649978c4e2b356e67ae_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctMy0xLTEtMA_def7006b-f292-4e76-aee2-f81c3b59ac1f"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i245b71f07dc5421b90a64dfe2ca519cf_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctNS0xLTEtMA_9c4b77ee-0c07-4359-a55f-1074de429e8b"
      unitRef="usd">7500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7917afc51a284eb389f470fc51464390_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctNy0xLTEtMA_e155c171-86fe-4617-b477-10750b371277"
      unitRef="usd">4000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8c335097c1214c7b8b5089dfca5b78e6_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctOS0xLTEtMA_6d69bc0d-e4d2-431f-a8b0-6d802b4f5419"
      unitRef="usd">11500000</us-gaap:RestructuringReserve>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzQtMS0xLTEtMTQwNjI_2eecd301-ef31-4c99-a550-c6f81b2335cc"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktMS0xLTEtMA_eb5b0029-e4da-42ac-84d3-e33b14312e19"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktMy0xLTEtMA_12c9b35a-0d77-467b-a11d-c5b030a5f2ed"
      unitRef="usd">12600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktNS0xLTEtMA_45405b1a-dc79-4faf-9877-932ff556c588"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktNy0xLTEtMA_c8fdcf0d-2f68-4733-bdca-7791f8d10420"
      unitRef="usd">1600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzktOS0xLTEtMA_8b7c2d8f-0bbd-4d30-8ad7-14a3ad900795"
      unitRef="usd">14200000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzUtMS0xLTEtMTQwNjU_4e989647-a66d-4a49-928f-136f3d7a8e6c"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTEtMS0xLTA_73a3c9bf-d410-4d51-ba3b-626eb1924b94"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTMtMS0xLTA_94dbe48b-eba0-4222-ad6f-6bfba0280ae5"
      unitRef="usd">1300000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTUtMS0xLTA_8983ce37-7dd1-49a5-b474-fece4dff4e0b"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTctMS0xLTA_0a7de33b-e71c-4aed-ab8d-a9caa6fd24c6"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTktMS0xLTA_7c07e53e-b4e2-48a5-a847-4788616ad314"
      unitRef="usd">1300000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:CashSeverancePayments
      contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzYtMS0xLTEtMTQwNjc_4aaa798c-1ef9-4091-9310-2867593c503a"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTEtMS0xLTA_fa9da56e-120c-4a81-8d86-c1fd30954e30"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTMtMS0xLTA_d848aab5-38d7-4062-980e-9f0c113d7a64"
      unitRef="usd">6800000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTUtMS0xLTA_9a8488c9-f4d3-4b99-8671-28a90e45ec16"
      unitRef="usd">6700000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTctMS0xLTA_23bdacd3-cedd-43b5-9f55-b373b0150750"
      unitRef="usd">200000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzExLTktMS0xLTA_7f3ed035-9e62-487f-85fe-0c86ca7689c4"
      unitRef="usd">13700000</holx:CashSeverancePayments>
    <holx:OtherRestructuringPayments
      contextRef="if04a98f140e34852950c49c8a2573bae_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzctMS0xLTEtMTQwNjk_1c4897f6-d3a5-4385-9d1a-b9f56198e893"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i5d484cada98c4e47ba39c081e9969cf0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTEtMS0xLTA_6837d63a-0956-4480-b854-88cdc793d938"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i185f5ae40f964bb3b69f6d02c0bb5775_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTMtMS0xLTA_080989ca-9fad-45c9-afc8-c84f852f77bc"
      unitRef="usd">200000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i51eda4320de2496aa832e8825712bd5e_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTUtMS0xLTA_139aea86-8c99-40e4-83a4-1aea5e51d3f3"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="icdf82c477842486a87b150e53b2d2bb0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTctMS0xLTA_144dcc7f-43c7-41c8-925d-2f846589ef24"
      unitRef="usd">1400000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i44573f3f88454bfc98195170bba8514d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTktMS0xLTA_b80a48a7-f8ed-490c-b79e-5da326856901"
      unitRef="usd">1600000</holx:OtherRestructuringPayments>
    <us-gaap:RestructuringReserve
      contextRef="id214db94d871423c97d744696fba6ee9_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzgtMS0xLTEtMTQwNzE_ec0d1d3e-a9ef-47cb-b56d-bfd41b6f32ed"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i383968572a2740c4b1b1c3a6102235ad_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTEtMS0xLTA_9147b706-72ca-4193-bafb-f1601adb5e01"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ibd8fe4ad3af14cb080a973256cf16e71_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTMtMS0xLTA_8856d16c-e62a-431b-8ddb-e995b39bc8b2"
      unitRef="usd">4300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i04a33f36d28a4ad59b7fcbc84448ad87_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTUtMS0xLTA_e9a85aa5-5c43-4d9e-acb7-3eef4eef1137"
      unitRef="usd">800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1545ced1b6bf4384a44fd70aaf8d5dc0_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTctMS0xLTA_1a98b851-7489-4771-98c7-37348ff58dd6"
      unitRef="usd">4000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ided55a75f2a34ea9b423f3093d7e3bf2_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTktMS0xLTA_6efbbf04-5962-46ee-bcf1-b20a08a21137"
      unitRef="usd">9100000</us-gaap:RestructuringReserve>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEwLTEtMS0xLTE0MDcz_08b81950-6b73-4e30-ad3a-0f3c3e1fe643"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTEtMS0xLTA_4b2a697b-4665-4a70-be53-69f353a307ec"
      unitRef="usd">4000000.0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTMtMS0xLTA_f4cab64b-8504-4443-9de8-90e6708b15b3"
      unitRef="usd">1200000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i82fe25951b1d47608e534a368540c8f7_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTUtMS0xLTA_9becf455-1add-4400-97a1-30c16302d06c"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i4caceec0ff464ef58e11ca526344ce87_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTctMS0xLTA_c79558db-3cc1-4261-b703-6143b8e6865b"
      unitRef="usd">1400000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE1LTktMS0xLTA_3af11d37-a742-4070-89dd-3ff159d38f22"
      unitRef="usd">6600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:CashSeverancePayments
      contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEyLTEtMS0xLTE0MDgw_950b2283-6c01-4b51-92d2-0ad47f33768d"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTEtMS0xLTA_6c701e8f-2a08-4e4b-ad0a-d4dac1dd77d0"
      unitRef="usd">3000000.0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTMtMS0xLTA_aec2690d-2573-455a-804f-24dbe86c0b57"
      unitRef="usd">3900000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i82fe25951b1d47608e534a368540c8f7_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTUtMS0xLTA_396facec-3fe9-4b98-a33b-7af11998f845"
      unitRef="usd">800000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i4caceec0ff464ef58e11ca526344ce87_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTctMS0xLTA_72bae1bc-9af6-4a12-8ba7-b3208ee092f7"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTktMS0xLTA_ecb90bd1-b63b-4cea-93b8-d28209ce6e26"
      unitRef="usd">7700000</holx:CashSeverancePayments>
    <holx:OtherRestructuringPayments
      contextRef="i69854f46befe4157a5c223e0b0d25e9c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzEzLTEtMS0xLTE0MDgy_36285bea-c6f4-4961-b258-027dc412045c"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i64d37ab2ccf94d4392fb49bf54898504_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTEtMS0xLTA_6f968750-00ea-4d2a-90b8-bfca57fab983"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i08561cdefdc7420a8bd7672c58e875da_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTMtMS0xLTA_e91f8f29-10fa-4a6e-b4f2-aa6221d6b853"
      unitRef="usd">500000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i82fe25951b1d47608e534a368540c8f7_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTUtMS0xLTA_af77984b-5cfc-4fed-9864-9614220e1dc9"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i4caceec0ff464ef58e11ca526344ce87_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTctMS0xLTA_5779b1eb-743c-4f9a-8096-53538c29b4c0"
      unitRef="usd">1600000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i2966db0031f44886b68900666c4010d4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTktMS0xLTA_206d1b5e-3636-4ccb-8be0-e3fc4286e2d8"
      unitRef="usd">2100000</holx:OtherRestructuringPayments>
    <us-gaap:RestructuringReserve
      contextRef="ia41126a20c7047088eb9a490e7b9aaaf_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE0LTEtMS0xLTE0MDg0_5c3ea22f-8483-4ec7-b489-af223d08273a"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="icdfa048e3caf49b6b54a8569a1e075b7_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTEtMS0xLTA_362a5fd4-9a1b-422e-889a-cd74745a9253"
      unitRef="usd">1000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i5f7c0803ecd34f7192e3525b7d33f970_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTMtMS0xLTA_8ccbd9f1-30fd-4988-9120-e8db59e634a9"
      unitRef="usd">1100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9e85e552551046dd94bb25760309804f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTUtMS0xLTA_33d0307b-1b98-4141-9692-66071fcd4634"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i092a31ade66f4c8eba80fb2ee0565ae7_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTctMS0xLTA_f9b09ab9-7401-43e5-8433-9b4ff4b7dda3"
      unitRef="usd">3800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i405e231a699e41a6b9f765aee4c70e34_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTktMS0xLTA_0ac08fcc-32d9-42e4-a8ef-59fe0256f92d"
      unitRef="usd">5900000</us-gaap:RestructuringReserve>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTEtMS0xLTE0MDMw_8330adc8-327d-4cf7-8130-aee7bfdfe78f"
      unitRef="usd">15100000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i107f31108f574bb2985391d4a79fc410_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTMtMS0xLTEzOTg2_f2ac33c5-953a-480d-91f6-0874997aea25"
      unitRef="usd">300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTUtMS0xLTEzOTk4_391fc639-a28f-4252-a916-b0adbe34bc78"
      unitRef="usd">-100000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTctMS0xLTE0MDA2_a2a1d58d-4836-4bd2-9e65-a63d95950de0"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTktMS0xLTE0MDE0_842c623a-0d68-4935-9a9f-79bd57e08871"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE2LTExLTEtMS0xNDAyMg_037d6290-8a16-4155-b8c9-cb7dee12f449"
      unitRef="usd">15300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTEtMS0xLTUyNDc_93015386-5e7b-488e-adc0-309f5517c784"
      unitRef="usd">7500000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i107f31108f574bb2985391d4a79fc410_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTMtMS0xLTEzOTky_26fd3852-4213-466f-8bf0-5cf41689ad95"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTUtMS0xLTE0MDAw_7f65569b-c99a-45fd-8621-0a87ae698fea"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTctMS0xLTE0MDA4_07bc4595-d05f-4c94-a433-f28f452cd480"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTktMS0xLTE0MDE2_c3f4b2fd-f401-4b59-bd48-e59dbcc0df1b"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE3LTExLTEtMS0xNDAyNA_f82baa4f-b7e5-4a64-b9f8-46fc991595eb"
      unitRef="usd">7500000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:CashSeverancePayments
      contextRef="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTEtMS0xLTE0MDQ4_20b66bf8-18aa-4bf4-8679-e8d388df6cf9"
      unitRef="usd">4400000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i107f31108f574bb2985391d4a79fc410_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTMtMS0xLTEzOTk0_a0b150f6-56da-46b5-8a17-dbb4dcf7b86e"
      unitRef="usd">1300000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTUtMS0xLTE0MDAy_7dddb3b2-8b63-4b5d-806a-9a9376d6d246"
      unitRef="usd">200000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTctMS0xLTE0MDEw_2e62472c-0ca2-45c4-80d6-17ac99ca0df8"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTktMS0xLTE0MDE4_7f6b6b21-511e-47df-9889-b8b787bbcb17"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE4LTExLTEtMS0xNDAyNg_ff70dcd0-a64d-4300-b95b-55dd5c44be9e"
      unitRef="usd">5900000</holx:CashSeverancePayments>
    <holx:OtherRestructuringPayments
      contextRef="icdfee9c5f4d949dfa973a5980c0beb25_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTEtMS0xLTY0OTM_6920a30e-2c9c-4fb9-aae0-6844ba66a472"
      unitRef="usd">-500000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i107f31108f574bb2985391d4a79fc410_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTMtMS0xLTEzOTk2_ee6276d9-cf9e-4c75-b97d-2cc5cc053dda"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i662f905f6be94c1daa7d692e77d849f9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTUtMS0xLTE0MDA0_83c3d122-21c7-4d47-affe-d1db38f78871"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i850fdf28d9bf4bfba03f3940027d3190_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTctMS0xLTE0MDEy_c10f9451-7845-4926-8ee2-679d6d3785db"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i9748fdeb393a436889e9c4fd02dbb2be_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTktMS0xLTE0MDIw_c7d0bf9c-46f2-4825-b1c4-91302f9ccdde"
      unitRef="usd">3800000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzE5LTExLTEtMS0xNDAyOA_00426201-2249-4ccc-a575-160a5ce3dbbe"
      unitRef="usd">3300000</holx:OtherRestructuringPayments>
    <us-gaap:RestructuringReserve
      contextRef="i13214cc3feb64fcf927862343c34707b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTEtMS0xLTE0MDU0_edbeb61f-5996-4da5-9099-9bdb670ff1b0"
      unitRef="usd">3700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i644ee2acfbde47e4a5410d9be6acf9cd_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTMtMS0xLTEzOTc0_f0538032-0c21-47aa-90d1-bbb2627f12cb"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7bf13b4f96464ec4bab32a562712a405_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTUtMS0xLTEzOTc2_9d23ce8c-5dd2-4034-ac01-a2ba05009f30"
      unitRef="usd">800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9a3bbfc15f424fce8faf36fa3102c868_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTctMS0xLTEzOTc4_1a728fcc-9643-478e-ac9d-233db05a026b"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7ff6affa1f43454fb0e3a3b5001fa866_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTktMS0xLTEzOTgw_55410072-6bf3-4f71-802d-0adce5edeeaa"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia7868b801a844b96ba9f57ab9d96e829_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90YWJsZTo0ZmJhNzUwNDg4OTI0NjZjOGNjYzkzYWJmODA1ODg0Ny90YWJsZXJhbmdlOjRmYmE3NTA0ODg5MjQ2NmM4Y2NjOTNhYmY4MDU4ODQ3XzIwLTExLTEtMS0xMzk4Mg_7b26a210-2f4b-4d9f-ae0e-aadfb7490235"
      unitRef="usd">4500000</us-gaap:RestructuringReserve>
    <holx:RemainingLeaseBalance
      contextRef="i9a76896977394657b24f892dabfb2d28_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzM1MTA_e9dda07b-7aff-4267-a343-fb63032550b1"
      unitRef="usd">3800000</holx:RemainingLeaseBalance>
    <us-gaap:SeveranceCosts1
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEyNTg_38b0d351-c698-4458-9f22-1c4580877eba"
      unitRef="usd">13400000</us-gaap:SeveranceCosts1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEyODg_19b3d772-9908-45dd-9441-f31288e0d51b"
      unitRef="usd">5000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <holx:ExpectedFutureSeveranceCharges
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEyNzM_aaaf7e63-5965-4d33-838b-aba69f6a8ae7"
      unitRef="usd">1700000</holx:ExpectedFutureSeveranceCharges>
    <holx:DivestitureCharges
      contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEzMDI_331c4f8f-46ef-49e4-a213-00515508a4d6"
      unitRef="usd">1900000</holx:DivestitureCharges>
    <holx:DivestitureCharges
      contextRef="i3b403fb32e214730a66931c9f20f7ee5_D20191229-20200328"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEzMTY_e48d0794-dad5-4a93-8126-ac9eabe60875"
      unitRef="usd">1300000</holx:DivestitureCharges>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="ia9ffe8cc379041dc95ec1a2845bdef3c_D20191229-20200328"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEzMzA_de78455c-6be4-4560-bd35-11894ae20581"
      unitRef="usd">2600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <holx:DivestitureCharges
      contextRef="ia9ffe8cc379041dc95ec1a2845bdef3c_D20191229-20200328"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzEzNDQ_4647adf0-9dca-41c9-bc81-1d2f890b6670"
      unitRef="usd">2000000.0</holx:DivestitureCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4Xzk4Nw_b776bdb3-0bbb-4767-8a57-22e0d164073a"
      unitRef="usd">4000000.0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzE3NDE_10c8924c-8352-4623-92de-c4c23b338b96"
      unitRef="usd">9000000.0</us-gaap:SeveranceCosts1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzE3OTA_330aab57-7409-4c67-b120-7b7df41faae8"
      unitRef="usd">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:SeveranceCosts1
      contextRef="i18bb9b460f2948c6b33b79494de5a775_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzIyNTM_de1bcbdc-1655-4f58-9b9d-9eca2080371d"
      unitRef="usd">2200000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i7d2600bf769f47179667bb435345373d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzI0MTg_c04170fd-9cd8-4eb8-8c13-afc8b2ea0107"
      unitRef="usd">1000000.0</us-gaap:SeveranceCosts1>
    <holx:FacilityClosureCosts
      contextRef="i75761de28d1343d2a77be06b0d507b3d_D20171001-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzM2MDU_a25aa9b8-a7fa-4cf0-8927-29c8ec885eff"
      unitRef="usd">900000</holx:FacilityClosureCosts>
    <holx:Propertyclosurecostpayment
      contextRef="i762786f0664c4c22b2ae67f6b01c9bd8_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzM3NTY_c0e510ee-8c47-41bb-be0e-404c6e825889"
      unitRef="usd">600000</holx:Propertyclosurecostpayment>
    <holx:Propertyclosurebenefit
      contextRef="i762786f0664c4c22b2ae67f6b01c9bd8_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzM3ODU_626c9f5e-3742-4e2a-bf5e-9995d664ef54"
      unitRef="usd">300000</holx:Propertyclosurebenefit>
    <holx:FacilityClosureCosts
      contextRef="i4b4bd78551ab435bb3059282b0371b60_D20171001-20171230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzUwNDg_e5c7966e-7bcf-451e-9ac5-a02969338e6c"
      unitRef="usd">3500000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i0932a399229f47ac83074c5e06bbc0c6_D20170402-20170701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzU1Mjk_7919ed34-9dc9-4abb-af5f-a502b3ae740a"
      unitRef="usd">1300000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i520af16098c04865986cb5e430b160c5_D20180401-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzU4MDc_71c7676f-0052-4664-8430-adb5b71f0e1f"
      unitRef="usd">1600000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="if2da745af2d74be6a6328bb22fc1c348_D20190331-20190629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzU5OTc_64fe0675-964c-442e-b367-5581c5e1e5fb"
      unitRef="usd">1400000</holx:FacilityClosureCosts>
    <holx:RemainingLeaseBalance
      contextRef="i9a76896977394657b24f892dabfb2d28_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjAvZnJhZzpiMDg1NWE5ZTMyMDQ0M2VkYjYxOGYyZDNjZjhiM2ZmOC90ZXh0cmVnaW9uOmIwODU1YTllMzIwNDQzZWRiNjE4ZjJkM2NmOGIzZmY4XzQzOTgwNDY1MzM1MjQ_bd25b1e2-0d6b-4d34-a0e7-55d5728edf1e"
      unitRef="usd">3800000</holx:RemainingLeaseBalance>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDg5_b7f29e32-ba2c-492a-84e1-46ff265683bb">Borrowings and Credit Agreements&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:82.456%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securitization Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,452.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The debt maturity schedule for the Company&#x2019;s obligations as of September&#160;26, 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026 and Thereafter &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,062.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2018 Amended and Restated Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement as of October 3, 2017 ("2017 Credit Agreement"). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit facilities under the 2018 Credit Agreement consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A $1.5 billion secured term loan ("2018 Term Loan") with a maturity date of December 17, 2023; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A secured revolving credit facility ("2018 Revolver"; together with the 2018 Term Loan, the "Amended Credit Facilities") under which the Company may borrow up to $1.5 billion, subject to certain sublimits, with a maturity date of December 17, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company initially borrowed $350 million under the 2018 Revolver. This initial borrowing, together with the net proceeds of the 2018 Term Loan, were used to repay the amounts outstanding under the term loan and revolving credit facility under the 2017 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the 2018 Credit Agreement bear interest, at the Company's option and in each case plus an applicable margin as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;2018 Term Loan&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: at the Base Rate, Eurocurrency Rate or LIBOR Daily Floating Rate,&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;2018 Revolver&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: if funded in U.S. dollars, the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate, and, if funded in an alternative currency, the Eurocurrency Rate; and if requested under the swing line sublimit, the Base Rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 26, 2020, the Company had $250.0&#160;million outstanding under the 2018 Revolver and the interest rate under the Term loan was 1.40%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable margin to the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate is subject to specified changes depending on the total net leverage ratio as defined in the 2018 Credit Agreement. The borrowings of the 2018 Term Loan initially bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate equal to 1.25%. The borrowings of the 2018 Revolver initially bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to 1.25%. The Company is also required to pay a quarterly commitment fee calculated on the undrawn committed amount available under the 2018 Revolver.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to make scheduled principal payments under the 2018 Term Loan in increasing amounts ranging from $9.375 million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $28.125 million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Term Loan after the scheduled principal payments, which is $1.2 billion, and any amounts outstanding under the 2018 Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, the Company may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by the Company,&#160;first, to the 2018 Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2018 Credit Facilities without premium or penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2018 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement requires the Company to maintain certain financial ratios. The 2018 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company and its U.S. subsidiaries, with certain exceptions. For example, borrowings under the 2018 Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under the Company's Accounts Receivable Securitization program. The 2018 Credit Agreement contains total net leverage ratio and interest coverage ratio financial covenants measured as of the last day of each fiscal quarter. The total net leverage ratio covenant was 5.00:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and remains as such until it decreases to 4.50:1.00 for the quarter ending June 25, 2022. The interest coverage ratio covenant was 3.75:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and remains as such for each quarter thereafter. The total net leverage ratio is defined as the ratio of the Company's consolidated net debt as of the quarter end to its consolidated adjusted EBITDA (as defined in the 2018 Credit Agreement) for the four-fiscal quarter period ending on the measurement date. The interest coverage ratio is defined as the ratio of the Company's consolidated adjusted EBITDA for the prior four-fiscal quarter period ending on the measurement date to adjusted consolidated cash interest expense (as defined in the 2018 Credit Agreement) for the same measurement period. The Company was in compliance with these covenants as of September 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2018 Credit Agreement for derivatives pursuant to ASC 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and identified embedded derivatives that required bifurcation as the features are not clearly and closely related to the host instrument. The embedded derivatives were a default provision, which could require additional interest payments, and a provision requiring contingent payments to compensate the lenders for changes in tax deductions. The Company determined that the fair value of these embedded derivatives was nominal as of September 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to ASC 470, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 470), the accounting related to entering into the 2018 Credit Agreement and using the proceeds to pay off the 2017 Credit Agreement was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2017 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $0.8 million in the first quarter of fiscal 2019. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;debt instruments before and after the transaction was less than 10%. We accounted for the amendments pursuant to ASC 470, subtopic 50-40, and third-party costs of $0.8 million related to this transaction were recorded as interest expense and $1.9 million was recorded as a reduction to debt representing deferred issuance costs and debt discount for fees paid directly to the lenders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2017 Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 3, 2017, the Company and certain of its domestic subsidiaries entered into an Amended and Restated Credit and Guaranty Agreement (the "2017 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto. The 2017 Credit Agreement amended and restated the Company's prior credit and guaranty agreement, originally dated as of May 29, 2015 (the "Prior Credit Agreement"). The proceeds under the 2017 Credit Agreement of $1.8 billion were used, among other things, to pay off the Term Loan of $1.32 billion and the Revolver then outstanding under the Company's Prior Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit facilities under the 2017 Credit Agreement consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A $1.5 billion secured term loan to the Company with a maturity date of October 3, 2022; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A secured revolving credit facility under which the Company could borrow up to $1.5 billion, subject to certain sublimits, with a maturity date of October 3, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of fiscal 2018, the Company borrowed $250.0 million under the revolver to cash settle the conversions of its 2.00% Convertible Senior Notes due 2042.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement, the 2017 Credit Agreement and the Prior Credit Agreement was as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to ASC 470, the accounting for entering into the 2017 Credit Agreement and using the proceeds to pay off the Prior Credit Agreement was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the Prior Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $1.0 million in the first quarter of fiscal 2018. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two debt instruments before and after the transaction was less than 10%. Pursuant to ASC 470, subtopic 50-40, third-party costs of $1.7 million related to this transaction were recorded as interest expense and $4.9 million was recorded as a reduction to debt representing deferred issuance costs and debt discount for fees paid directly to the lenders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;10, 2017, the Company completed a private placement of $350 million aggregate principal amount of its 4.375% Senior Notes due 2025 (the "2025 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2025 Senior Notes. On January 19, 2018, the Company completed a private placement and allocated an additional $600 million in aggregate principal amount to its 2025 Senior Notes pursuant to a supplement to the indenture governing the Company's existing 2025 Senior Notes at an offering price of 100% of the aggregate principal amount. As a result, the total aggregate principal balance of 2025 Senior Notes is $950 million. The 2025 Senior Notes were general senior unsecured obligations of the Company and were guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2025 Senior Notes were to mature on October&#160;15, 2025 and bore interest at the rate of 4.375%&#160;per year, payable semi-annually on April&#160;15 and October&#160;15 of each year, commencing on April&#160;15, 2018. On September 28, 2020 (in the first quarter of fiscal 2021), the Company completed a private placement of $950.0&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The proceeds from this offering and cash on hand were used to redeem the 2025 Senior Notes in full on October 15, 2020, at a redemption price of approximately $970.8&#160;million (equal to 102.2% of the aggregate principal amount of the 2025 Senior Notes). In the first quarter of fiscal 2021, the Company will complete the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis and record a debt extinguishment loss as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 19, 2018, the Company completed a private placement of $1.0 billion aggregate principal amount of senior notes and allocated $400 million in aggregate principal amount to its 4.625% Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2028 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to&#160;35%&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;104.625%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2028 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2028 Senior Notes, 2025 Senior Notes and 2022 Senior Notes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had 5.250% Senior Notes due 2022 (the &#x201c;2022 Senior Notes&#x201d;) outstanding and bore interest at the rate of 5.250%&#160;per year, payable semi-annually on January 15 and July 15 of each year. The Company used the net proceeds of the 2025 Senior Notes and the 2028 Senior Notes offering in January 2018 to redeem in full the 2022 Senior Notes in the aggregate principal amount of $1.0 billion on February 15, 2018 at an aggregate redemption price of $1.04 billion, including a make-whole provision payment $37.7 million. Since the Company planned to use the proceeds from the 2025 Senior Notes and the 2028 Senior Notes offering to redeem the 2022 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2022 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the second quarter of fiscal 2018 of $44.9 million, which comprised pro-rata amounts of the make-whole provision premium payment, debt discount and debt issuance costs. For the remaining 2022 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $2.6 million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $1.5 million and debt discount of $1.5 million related to the modified debt were allocated between the 2025 Senior Notes and 2028 Senior Notes on a pro-rata basis, and are being amortized over the life of the debt using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 28, 2019 and September 29, 2018, the Company had no Convertible Notes outstanding. The following describes the Convertible Note transactions during fiscal 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;10, 2007, the Company issued and sold $1.725 billion, at par, of 2.00% Convertible Senior Notes due December&#160;15, 2037 (&#x201c;2007 Notes&#x201d;). On November&#160;18, 2010, the Company entered into separate, privately-negotiated exchange agreements under which it retired $450.0 million in aggregate principal of its 2007 Notes for $450.0 million in aggregate principal of new 2.00% Convertible Exchange Senior Notes due December&#160;15, 2037 (&#x201c;2010 Notes&#x201d;). On February&#160;29, 2012, the Company entered into separate, privately-negotiated exchange agreements under which it retired $500.0 million in aggregate principal of the 2007 Notes for $500.0 million in aggregate principal of new 2.00% Convertible Senior Notes due March&#160;1, 2042 (&#x201c;2012 Notes&#x201d;). On February&#160;14, 2013, the Company entered into separate, privately-negotiated exchange agreements under which it retired $370.0 million in aggregate principal of the 2007 Notes for $370.0 million in aggregate principal of new 2.00% Convertible Senior Notes due December 15, 2043 (&#x201c;2013 Notes&#x201d;). The remaining 2007 Notes were redeemed in fiscal 2014. In fiscal 2017, all remaining 2010 Notes were either converted or surrendered for conversion. On various dates in fiscal 2017, the Company entered into privately negotiated repurchase transactions and extinguished $117.9&#160;million and $168.0&#160;million principal amount of the 2012 Notes and 2013 Notes, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2018, the Company announced that pursuant to the terms of the indenture for the 2012 Notes, holders of the 2012 Notes had the option of requiring the Company to repurchase their 2012 Notes on March 1, 2018 at a repurchase price payable in cash equal to&#160;100%&#160;of the accreted principal amount of the 2012 Notes, plus accrued and unpaid interest. The Company also announced on January 29, 2018 that, it had elected to redeem, on March 6, 2018, all of the then outstanding 2012 Notes at a redemption price payable in cash equal to&#160;100%&#160;of the accreted principal amount of the 2012 Notes, plus accrued and unpaid interest. Holders also had the right to convert their 2012 Notes. During the second quarter of fiscal 2018, 2012 Notes in aggregate original principal amount of&#160;$200.5 million&#160;were surrendered for conversion and the Company cash settled these conversions for&#160;$243.3 million&#160;during April 2018. As a result, on a gross basis,&#160;$42.8 million&#160;of the consideration paid was allocated to the reacquisition of the equity component of the original instrument, which was recorded net of deferred taxes of&#160;$12.0 million&#160;within additional paid-in-capital. The remaining&#160;$5.5 million&#160;in original principal amount of the 2012 Notes was redeemed by the Company on March 6, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 15, 2017, pursuant to the provisions of the indenture governing the Company's&#160;2013 Notes, the Company redeemed or repurchased an aggregate of&#160;$201.7 million&#160;in original principal amount of the 2013 Notes then outstanding for an aggregate repurchase price of&#160;$244.1 million, representing the then accreted principal amount of the 2013 Notes. The remaining&#160;$0.3 million&#160;in original principal amount of the 2013 Notes were converted, and the Company settled these conversions in cash in the second quarter of fiscal 2018.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On various dates during the first quarter of fiscal 2018, the Company entered into privately negotiated repurchase transactions and extinguished&#160;$39.3 million&#160;principal amount of its 2012 Notes for total payments of&#160;$52.8 million. This amount includes the conversion premium resulting from the Company's stock price on the date of the transactions being in excess of the conversion prices of&#160;$31.175. As a result, on a gross basis,&#160;$13.4 million&#160;of the consideration paid was allocated &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to the reacquisition of the equity component of the original instrument, which was recorded net of deferred taxes of&#160;$3.8 million&#160;within additional paid-in-capital.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense under the Convertible Notes was as follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:53.362%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00% accrued interest (cash)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable Securitization Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 25, 2016, the Company entered into a one-year $200.0 million accounts receivable securitization program (the "Securitization Program") with several of its wholly owned subsidiaries and certain financial institutions, which provides for annual renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the Securitization Program, the Company and certain of its wholly-owned subsidiaries sell their respective customer receivables to a bankruptcy remote special purpose entity, which is also a wholly-owned subsidiary of the Company. In addition, the Company also contributed a portion of its customer receivables to the special purpose entity in connection with its establishment. The Company retains servicing responsibility. The special purpose entity, as borrower, and the Company, as servicer, entered into a Credit and Security Agreement with several lenders pursuant to which the special purpose entity may borrow up to $200.0 million from the lenders, with the loans secured by the receivables. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. The entire amount available was borrowed in the third quarter of fiscal 2016. Borrowings outstanding under the Securitization Program bear interest at LIBOR plus the applicable margin of 0.7% and are included as a component of current liabilities in the Company's consolidated balance sheet, while the accounts receivable securing these obligations remain as a component of net receivables in the Company's consolidated balance sheet. The Company and the special purpose entity are operated and maintained as separate legal entities. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay other debts or liabilities of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In subsequent years, the Company amended the agreement to extend it for one-year periods and increase the borrowing capacity. The maximum borrowing amount increased to $250.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, the Company paid-off the total amount outstanding of $250.0&#160;million previously borrowed. On April 13, 2020, the Company amended the Credit and Security agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. As of September 26, 2020, the Company did not have any borrowings under this program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense under the Securitization Program was $3.1 million, $7.1 million and $5.4 million for fiscal 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit and Security Agreement contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, and an event of default upon a change of control of the Company. In addition, it contains financial covenants consistent with that of the Credit Agreement. As of September&#160;26, 2020, the Company was not required to be in compliance with the Credit and Security Agreement covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDY5_6687be60-d219-4008-9778-0e4460ff685f">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:82.456%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securitization Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,452.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2028 Senior Notes, 2025 Senior Notes and 2022 Senior Notes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtCurrent
      contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzItMS0xLTEtMA_2210d285-2def-462e-9a71-97946feffca0"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="idb22b22b518245c5af080bc07bace384_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzItMy0xLTEtMA_01cc8280-5746-4322-9192-c6afb375708e"
      unitRef="usd">37400000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3fd7ad15f5e24a678e288eb53e978668_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzMtMS0xLTEtMA_051b13c2-56bb-4fc5-b035-68e57728d782"
      unitRef="usd">250000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i60d56d6d8a714585ac83977c31d4ab60_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzMtMy0xLTEtMA_d916ad9c-266a-43ce-a543-e7de27ab6343"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="id80a9b5c1e0a48b8a0ad99dbff5d9c5b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzQtMS0xLTEtMA_6f042e21-bf86-499b-b938-1e12815a50c2"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6e1b2436330a4b7a9a2624f5cd7ca5cf_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzQtMy0xLTEtMA_a0087821-9108-407e-a25d-3c0675f71719"
      unitRef="usd">234000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzYtMS0xLTEtMA_3f872025-efb7-4172-9a1d-87f52c0ef593"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzYtMy0xLTEtMA_037febfa-ed7f-46c0-bfc6-199fd200dc1c"
      unitRef="usd">271400000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzgtMS0xLTEtMA_948b560d-c160-4428-b1b9-cc826f87a093"
      unitRef="usd">1379900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idb22b22b518245c5af080bc07bace384_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzgtMy0xLTEtMA_0b1b75b8-6237-40f2-851b-7626cdbe5971"
      unitRef="usd">1452400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzExLTEtMS0xLTA_196204ed-20eb-4df6-af16-c2f94cb4705f"
      unitRef="usd">939400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9495f528a35e4d6db0680ff16dda56e4_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzExLTMtMS0xLTA_11e8fd8c-1f3c-4a76-a158-0de251101a3f"
      unitRef="usd">937300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzEyLTEtMS0xLTA_e6589b5b-0a80-4d70-8824-fdb2b6c6d0bb"
      unitRef="usd">394600000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idfc9503585304f80b0bda5108dc6141d_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzEyLTMtMS0xLTA_1a77d15b-4a3c-404e-9cd1-859f65d2ba19"
      unitRef="usd">393900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzE0LTEtMS0xLTA_359e59e6-c0e7-4121-ad14-010ce4a02558"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzE0LTMtMS0xLTA_cd45fe8d-9e9f-44dd-bd40-6c896e6323cd"
      unitRef="usd">2783600000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzE1LTEtMS0xLTA_38879db3-a706-419d-8f13-f4be63cae315"
      unitRef="usd">3038800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTpmNjVjNWFhYjQ0NDM0OTgxOGEyOTZhMzYyZDliMTdkMy90YWJsZXJhbmdlOmY2NWM1YWFiNDQ0MzQ5ODE4YTI5NmEzNjJkOWIxN2QzXzE1LTMtMS0xLTA_2bfb57a2-aaac-43f2-aa32-c5291b4eebab"
      unitRef="usd">3055000000.0</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDcw_9fd7695a-6b63-4e1c-ae51-3246598c6bd6">&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The debt maturity schedule for the Company&#x2019;s obligations as of September&#160;26, 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026 and Thereafter &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,062.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtMi0xLTEtMA_b9d48f28-cab1-43b3-a575-2d4dc9257a53"
      unitRef="usd">75000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtNC0xLTEtMA_dcf163dc-7e02-4ccb-b0cd-981c207f9937"
      unitRef="usd">75000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtNi0xLTEtMA_3e451744-cd08-4aef-83fe-2370d9387843"
      unitRef="usd">112500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtOC0xLTEtMA_48d42013-6a7b-43ed-bbc8-f1d6c922fb0f"
      unitRef="usd">1200000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtMTAtMS0xLTA_13c9e61c-adc5-45ca-a081-f934017d1bed"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtMTItMS0xLTA_ccab034e-8f73-4403-97fa-df4d57ad55c8"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i553ef5d5d72d44eb936b60c8c3d9b5a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzEtMTQtMS0xLTA_95d04f5e-6154-412d-bc66-a23f5e969449"
      unitRef="usd">1462500000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtMi0xLTEtMA_73cbf36f-77dc-4df7-bcdb-d3947cb3a7f5"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtNC0xLTEtMA_76e816a7-d77b-426c-8646-8893c125adfb"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtNi0xLTEtMA_a64cf92f-2f61-4eed-96e0-4743abd3d5b4"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtOC0xLTEtMA_5600bc7d-cd40-4926-afab-d72dc0360ed3"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtMTAtMS0xLTA_07a3fa25-2ab8-46a1-9d76-06301695a3c4"
      unitRef="usd">950000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtMTItMS0xLTA_2fc3e76a-3c24-4bda-a7fe-d918fac7d6f2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="id57204513f2e4047bb34a203195e5e4a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzQtMTQtMS0xLTA_112d390d-25ad-4860-8ae1-ca8efc8e9e53"
      unitRef="usd">950000000.0</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtMi0xLTEtMA_e5874d2c-2a2a-4a61-8d80-e61b42725fec"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtNC0xLTEtMA_5256bf3d-9fc6-47c3-8656-a8f2a7c7c3d3"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtNi0xLTEtMA_240f2fe1-877b-488c-8cc8-e1d128d2bc70"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtOC0xLTEtMA_95cb1247-5f80-4bc4-941e-205d2a72bdb1"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtMTAtMS0xLTA_ad7c251f-f43a-4157-b837-b8025a2eb461"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtMTItMS0xLTA_272351d6-0a02-443b-bb53-329072533303"
      unitRef="usd">400000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i15c014abf52b48b3b4f228ca2997399b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzUtMTQtMS0xLTA_7c62f13d-88bd-4a19-af9b-7746debaa45e"
      unitRef="usd">400000000.0</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtMi0xLTEtMA_4cbc8131-8249-4ee8-a7d9-6bfe16a229b3"
      unitRef="usd">325000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtNC0xLTEtMA_e3179fa8-9a01-4e7f-805f-7cbad45ca80c"
      unitRef="usd">75000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtNi0xLTEtMA_27daba4e-9729-4e72-8f29-9fe8077c54ab"
      unitRef="usd">112500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtOC0xLTEtMA_4a8abc33-3cc6-4159-b21b-fc9c8f3e1f2c"
      unitRef="usd">1200000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtMTAtMS0xLTA_50423ea0-76d8-4686-a480-d78d24a04db1"
      unitRef="usd">950000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtMTItMS0xLTA_064a5b0b-1fce-43c7-8717-681b4802a6cf"
      unitRef="usd">400000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTowOWQ2NDA3M2Q4NWY0MTg1ODczYjBlODFhMmQ1NDAxYS90YWJsZXJhbmdlOjA5ZDY0MDczZDg1ZjQxODU4NzNiMGU4MWEyZDU0MDFhXzYtMTQtMS0xLTA_decccd06-dbfb-4e96-9033-98887fd3a04f"
      unitRef="usd">3062500000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i855bab3266d4415c8e89b6d9be79edb6_I20181217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzgyMw_eb2a4dd6-a61f-4175-8f40-5b05f1449a94"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i643139a0070945419368a19ab57e080d_I20181217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwOTc_37fd6526-3645-4e23-bd6b-0b4c8ed56f5c"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="if777467cbe914235ad2b43c07ebb9e28_D20181217-20181217"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEyMDY_e08e1845-d2d3-44ff-8dd4-55dfbe6dd8f7"
      unitRef="usd">350000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3fd7ad15f5e24a678e288eb53e978668_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NTgxMDc_98e63daf-70b7-4f8b-bb1a-ba75383a21c7"
      unitRef="usd">250000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3fd7ad15f5e24a678e288eb53e978668_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NjQxNzQ_8b3801a3-6650-4a08-a0ea-950aec4ca366"
      unitRef="number">0.0140</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iebc8390a06a94a30a7711d90782cbfff_D20181217-20181217"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI0NjA_4973ca5e-3222-4631-a92a-702d356e59d8"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i890f64beadb143b09f67fea3c0b0f562_D20181217-20181217"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI2MTQ_60f00f4a-9a3c-4542-a35a-f0be9d14a2d3"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter
      contextRef="i832ef0aa8ca34dfab05f2e95257c6146_D20181217-20181217"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4OTc_8416fa96-9870-4a75-aabe-4a94bed442be"
      unitRef="usd">9375000</holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter>
    <holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter
      contextRef="i3f1547ab54254a239a247c8a112272c3_D20181217-20181217"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI5OTM_9394b99e-4c35-4964-b7cd-9aab35c109be"
      unitRef="usd">28125000</holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter>
    <holx:DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments
      contextRef="i25098fcc693a4912b794f37a396afce9_I20200926"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzMyMjE_29614085-252a-4b04-94c8-5aaa2021ae59"
      unitRef="usd">1200000000</holx:DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments>
    <holx:LeverageRatioMaximum
      contextRef="ib968be61a4094d0eb0f1daf52ff7d843_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzU3MjM_526ef6f3-a428-4683-bcb0-fcbadc2c365b"
      unitRef="number">5.00</holx:LeverageRatioMaximum>
    <holx:LeverageRatioMaximum
      contextRef="i594b4573152b448cb7a66c5d84a63dbb_D20220625-20220625"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzU4NDA_857220fc-9d4c-443a-b67f-4b696ae89e39"
      unitRef="number">4.50</holx:LeverageRatioMaximum>
    <holx:InterestCoverageRatio
      contextRef="ib968be61a4094d0eb0f1daf52ff7d843_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzU5Mjc_2220672b-5ba3-4ed2-9f7a-df857625609d"
      unitRef="number">3.75</holx:InterestCoverageRatio>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzc3NjE_08adc5e1-a352-486e-9493-499500b493ad"
      unitRef="usd">800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <holx:DebtInstrumentNumberOfInstruments
      contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzc5Nzg_ede7538a-7c04-47d8-8ec1-b3d84dc7438a"
      unitRef="debt_instrument">2</holx:DebtInstrumentNumberOfInstruments>
    <holx:MaximumRangeofPresentValueofCashFlowPercentage
      contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzgwNDU_d0d59917-9235-4b1d-90d2-482bc891aff3"
      unitRef="number">0.10</holx:MaximumRangeofPresentValueofCashFlowPercentage>
    <holx:DirectThirdPartyCostsinterestExpense
      contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzgxNDM_7af39730-0f19-4e85-aff7-016ee9018f49"
      unitRef="usd">800000</holx:DirectThirdPartyCostsinterestExpense>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="idb75a80924734ad9834561c374f802e1_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzgyMTI_a43121f7-1f42-4e03-bd81-d03a694f6574"
      unitRef="usd">1900000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i5e8f4af13fc243f99fc0c25b9dbb20b3_D20190929-20200926"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzg5MTM_e417a33a-bc3f-42f5-b45a-7538aee437e7"
      unitRef="usd">1800000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="idde9cb65eaea4006b4a3a0e5a2272ddd_D20190929-20200926"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzg5NzU_0e136176-53e0-4b61-9f34-6e22e85d0961"
      unitRef="usd">1320000000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i25f90cd313c948d2a108a87d9a94999a_I20171003"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkxMzA_3095ba97-9257-44cb-9e76-77b0f74ffe7f"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1b9bbbdde31f436aa1a5765b37448a8b_I20171003"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkyOTE_3f7c5fd9-7799-4ec1-9267-3b654ccd240e"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i4663f101db0a4ba091c45be3b47b7c37_D20190331-20190629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzk0Mjk_39b1cff3-d60c-4d9b-bbf0-a81c9b8e018b"
      unitRef="usd">250000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8c5d81b35a2241da877d3e4a3da33071_I20190629"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5Xzk0ODk_2196e915-9dba-4543-ba81-9a971f233e62"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDgx_80317e03-a8d6-41b1-95cc-4498a46d8beb">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement, the 2017 Credit Agreement and the Prior Credit Agreement was as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzItMS0xLTEtMA_afcb3784-d4b3-42ae-8ff5-6094182abb53"
      unitRef="usd">46600000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i8bbf0b9e21774990be085b97a15bbd5a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzItMi0xLTEtMA_ffda1d60-c182-4fbd-8f44-fff750260141"
      unitRef="usd">67000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="iee1d3923c6ba4dc4829757b7a7580a3e_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzItMy0xLTEtMA_0c1d80e9-e602-4738-9a20-4a2808001767"
      unitRef="usd">60800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzMtMS0xLTEtMA_e6639935-6588-44f9-9090-4961a2cd694d"
      unitRef="usd">2500000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i8bbf0b9e21774990be085b97a15bbd5a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzMtMi0xLTEtMA_52af574c-ecd7-4a0c-a59b-06732ffb7be4"
      unitRef="usd">2600000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="iee1d3923c6ba4dc4829757b7a7580a3e_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzMtMy0xLTEtMA_6fdd17df-4e8a-4d68-b723-e11929a3f959"
      unitRef="usd">2600000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzQtMS0xLTEtMA_9b560f96-7fff-4a9b-8283-f504fad622a5"
      unitRef="number">0.0225</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i8bbf0b9e21774990be085b97a15bbd5a_D20180930-20190928"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzQtMi0xLTEtMA_e2af97c5-75fe-4c3b-83fb-90101ae5e1ab"
      unitRef="number">0.0379</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="iee1d3923c6ba4dc4829757b7a7580a3e_D20171001-20180929"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzQtMy0xLTEtMA_45feddde-b6b0-4b72-809c-da97ecef2dc8"
      unitRef="number">0.0323</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i974288f6285044128c2b4e1690e36c23_I20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzUtMS0xLTEtMA_1b46fb1a-ea8d-48a6-beb8-b61d58306529"
      unitRef="number">0.0140</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ibfd0405aae91417aae27ed964af861e1_I20190928"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzUtMi0xLTEtMA_c155bf42-812f-420f-a9bd-94f2c6284a05"
      unitRef="number">0.0343</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i7ecb1b74ff6b4d1b9db466141397e214_I20170930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZToxMzEwZjRhYjA2Yzc0MDczYjY3ZDQ1NzYzYjQxYThlYS90YWJsZXJhbmdlOjEzMTBmNGFiMDZjNzQwNzNiNjdkNDU3NjNiNDFhOGVhXzUtMy0xLTEtMA_d2e0e637-9741-4e52-89e1-d411f741c5dd"
      unitRef="number">0.0374</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7afb5a8c40684333859218062faaf200_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwNDEz_26ffa6f0-390c-4480-9a15-85713043a9bd"
      unitRef="usd">-1000000.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <holx:MaximumRangeofPresentValueofCashFlowPercentage
      contextRef="i7afb5a8c40684333859218062faaf200_D20180930-20181229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwNjk4_646b01b1-70bf-4097-9b9b-b6558dbbeb58"
      unitRef="number">0.10</holx:MaximumRangeofPresentValueofCashFlowPercentage>
    <holx:DirectThirdPartyCostsinterestExpense
      contextRef="i7afb5a8c40684333859218062faaf200_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwNzYw_f7b7e2a6-6fd5-43fb-b6fa-197da14f8723"
      unitRef="usd">1700000</holx:DirectThirdPartyCostsinterestExpense>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i7afb5a8c40684333859218062faaf200_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEwODI5_237ab852-b6eb-4f3f-8f6a-4243bbbabe36"
      unitRef="usd">4900000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:SeniorNotes
      contextRef="ifa285bba80d14c0cba66dd5448fb5440_I20171010"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExMDYx_c1f34583-4560-4a21-ab78-5971c3ce7c10"
      unitRef="usd">350000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic272797ead73491a9d8ada44c35c9e1c_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExMDk4_7f854334-9393-4924-9507-1e121c8048dd"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="ifa285bba80d14c0cba66dd5448fb5440_I20171010"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExMTcz_96187a2e-31f0-4bab-a26a-93b4b8105790"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <us-gaap:SeniorNotes
      contextRef="iad5df08e269f4792a90def353802fc8b_I20180119"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExMzI3_6e09a52e-e325-41af-8764-72c6ab8598f2"
      unitRef="usd">600000000</us-gaap:SeniorNotes>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="iad5df08e269f4792a90def353802fc8b_I20180119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExNTAy_e85e19a4-5841-4010-a70a-0c7875eb3927"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <holx:PrincipalAmountOfBorrowings
      contextRef="ic272797ead73491a9d8ada44c35c9e1c_I20200926"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExNjE1_ff2ee328-76e8-4d19-bc9b-92b876f7fcd5"
      unitRef="usd">950000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic272797ead73491a9d8ada44c35c9e1c_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzExODYw_00e863f4-7607-494c-a194-bf8e7696789a"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2MzM_9c6ef10b-0cab-47de-8c52-be4286528942"
      unitRef="usd">950000000.0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2NjU_1a02dd5e-6c8a-4aa7-8f7a-71ca4e094e8c"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i1e0434291a6f4c76aa8fb300ab8d179c_D20200928-20200928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2NDk_da90debd-eeb6-48da-872c-36721df89ccb"
      unitRef="usd">970800000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="i1e0434291a6f4c76aa8fb300ab8d179c_D20200928-20200928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4MDk_76f780a0-f395-4f63-8c11-48e7b0d0127c"
      unitRef="number">1.022</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="i1fd7482e7e024b1d8623378c63515cb0_D20180119-20180119"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzNDkw_28c2ef7e-56ad-4c4b-8b22-873551fa47a7"
      unitRef="usd">1000000000.0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzNTUw_9e773714-246b-47e0-9dea-f6d502116ede"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzNTkw_fa14150d-5f37-4712-a8b1-eb263cae24e8"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzNjY1_0b9a3366-8e96-4392-9a8e-9303689fcb5b"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzEzOTY5_ca99dd5b-82c8-428e-8346-f8cc3678a4bc"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0MTgw_446a21ad-8d56-47d5-8dab-aa2bcee6eec1"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0Mzgy_8ba4cd97-a4db-4e7d-9149-93860fb87aa0"
      unitRef="number">0.35</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <holx:DebtInstrumentPercentageOfRedemptionPriceSecondPeriod
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0NTg5_8c3be637-85b9-4839-a43a-341dcc0b6cf5"
      unitRef="number">1.04625</holx:DebtInstrumentPercentageOfRedemptionPriceSecondPeriod>
    <holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0ODI3_cbd01c6b-1921-4a2b-9886-98f57c8d4dc0"
      unitRef="number">1.02312</holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod>
    <holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0ODgz_9bfd5160-f3dc-4632-8ca0-83f7daa5548f"
      unitRef="number">1.01541</holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod>
    <holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0OTM5_5af1b85f-fc6f-4229-b104-3699f0b9e412"
      unitRef="number">1.00770</holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod>
    <holx:DebtInstrumentPercentageRedemptionPriceSixthPeriod
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE0OTg5_1d70fe53-09d8-448f-a54e-c55baa8b5f6f"
      unitRef="number">1</holx:DebtInstrumentPercentageRedemptionPriceSixthPeriod>
    <holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes
      contextRef="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE1MjMz_28d62789-4fca-4545-868c-dbe3ed809576"
      unitRef="number">1.01</holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0594ade531b74789862cd43513f6fea7_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtMS0xLTEtMA_2fdbcfec-badd-4bed-94ea-a7c29a0fc6aa"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtMy0xLTEtMA_2a4cc697-2aa6-4c01-bb05-8031edd43c44"
      unitRef="usd">19200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ia768ec9266ee4c41891b3359a2cc6b9b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtNC0xLTEtMA_d464bc84-a488-4f16-9a9c-14b85ab65528"
      unitRef="usd">700000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i4a0afc09611c426282e6aac4be10661a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtNi0xLTEtMA_1e015c10-778c-48b9-bb16-a49a4c8bc616"
      unitRef="usd">19200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i4a0afc09611c426282e6aac4be10661a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtNy0xLTEtMA_1e391af1-b4ba-4d7c-81dc-2ed96f23b6fc"
      unitRef="usd">700000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="if3d6e02785004a0d8d101ecf6ec84b38_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtOS0xLTEtMA_1af75efe-8e92-410f-9005-6f29bcbba2f2"
      unitRef="usd">13300000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="if3d6e02785004a0d8d101ecf6ec84b38_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzMtMTAtMS0xLTA_c62c6c6f-8c98-4aa2-ac66-c203e526300f"
      unitRef="usd">500000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic272797ead73491a9d8ada44c35c9e1c_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtMS0xLTEtMA_1135e985-0886-4157-a054-6d89d197250b"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i2c177c25617f48bdac09172a3df4017c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtMy0xLTEtMA_14646580-b25f-47a9-8708-8402383493b5"
      unitRef="usd">43500000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i2c177c25617f48bdac09172a3df4017c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtNC0xLTEtMA_b08c63e4-d782-44af-bf92-b3c4cfbeafff"
      unitRef="usd">2100000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ic678ac46fcb54d49b964689428ff6dc3_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtNi0xLTEtMA_d9f01a69-8f4f-4c5a-873e-2af264242fcb"
      unitRef="usd">43500000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ic678ac46fcb54d49b964689428ff6dc3_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtNy0xLTEtMA_3502bc0e-b875-4d89-9c3f-01db29f47686"
      unitRef="usd">2100000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="iee80a400131f496b9f303169165255f9_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtOS0xLTEtMA_61081687-ca5f-46f6-b466-a12d6d556c67"
      unitRef="usd">34700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="iee80a400131f496b9f303169165255f9_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzQtMTAtMS0xLTA_75635ef7-7ac7-46f5-9922-f52585994184"
      unitRef="usd">1600000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i208ccf38964e488ba11badb451812ff1_I20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtMS0xLTEtMA_78da0220-8b32-4fe5-8c14-b185fa9a68de"
      unitRef="number">0.05250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i625f89ab8266425986dabfe1ea7cce94_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtMy0xLTEtMA_560e36c1-d862-486c-be15-8b84b29b9357"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i625f89ab8266425986dabfe1ea7cce94_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtNC0xLTEtMA_c1a75edf-004e-49f7-813f-8b41035dbda1"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i949893e5021e4b72b6e04ed4c620d53a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtNi0xLTEtMA_9029accc-9c60-4662-ba95-6bc44ffd089d"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i949893e5021e4b72b6e04ed4c620d53a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtNy0xLTEtMA_0c686706-4560-4487-9722-816e6546cea7"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i53165e60abab42ee834675a6c4488642_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtOS0xLTEtMA_577f30b0-9434-4089-8dc7-ccd38ef6ab9d"
      unitRef="usd">21200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i53165e60abab42ee834675a6c4488642_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzUtMTAtMS0xLTA_7e16a574-4fb2-4127-9922-f24bac4ade3c"
      unitRef="usd">1500000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i181188c2b11e4f169032adefb6546ee2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtMy0xLTEtMA_0cb93904-fae5-45ee-8973-2beec55605a9"
      unitRef="usd">62700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i181188c2b11e4f169032adefb6546ee2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtNC0xLTEtMA_4b9342c6-e6fe-491e-a546-348c0923302c"
      unitRef="usd">2800000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i04f56e3fa2a540c0b6ff0e3af30ebd18_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtNi0xLTEtMA_48f25f50-ac8f-48ee-bf87-2d30cc7e8dad"
      unitRef="usd">62700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i04f56e3fa2a540c0b6ff0e3af30ebd18_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtNy0xLTEtMA_9ced70c3-7f66-48fb-b7e2-8b2bda43c525"
      unitRef="usd">2800000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ic79a7b8640a04f25812f29fbf9199284_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtOS0xLTEtMA_000b3998-e6fc-471b-b208-8b631109e436"
      unitRef="usd">69200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ic79a7b8640a04f25812f29fbf9199284_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTplYzg0ZTQ2ODU0MjA0Zjk0OGI0NDFjZDk5YjM3ZGU1Ni90YWJsZXJhbmdlOmVjODRlNDY4NTQyMDRmOTQ4YjQ0MWNkOTliMzdkZTU2XzYtMTAtMS0xLTA_55f60d43-a4f5-44c9-87dc-b06df613d295"
      unitRef="usd">3600000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i91a5f72252c948bd9ae64687e324075a_I20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE1ODUz_e1d5c426-fae5-4c6f-99cb-dcf0773e36cb"
      unitRef="number">0.05250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i91a5f72252c948bd9ae64687e324075a_I20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE1OTQ5_043e30a2-1edb-424f-aa15-cb03c2d1e7a9"
      unitRef="number">0.05250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i053c6045e0324fa0adf4cc3c967de7c3_I20180215"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE2MjEx_bc73f029-2038-4d1d-8ace-c8b4cecbc715"
      unitRef="usd">1000000000.0</us-gaap:SeniorNotes>
    <holx:OfferingPriceofPrincipalAmount
      contextRef="i053c6045e0324fa0adf4cc3c967de7c3_I20180215"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE2Mjcx_b1b843a2-67cf-452e-9ec1-29b9c57e0810"
      unitRef="usd">1040000000.00</holx:OfferingPriceofPrincipalAmount>
    <holx:MakeWholeProvision
      contextRef="i053c6045e0324fa0adf4cc3c967de7c3_I20180215"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE2MzE2_95460b0f-ceeb-494f-9283-d8ffd92bd0fc"
      unitRef="usd">37700000</holx:MakeWholeProvision>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6263cf3be0e74b85ba827b9b7dd3bcc5_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE2OTA2_6e705617-47b4-44d4-8af5-6f424edbac95"
      unitRef="usd">-44900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <holx:MaximumRangeofPresentValueofCashFlowPercentage
      contextRef="i6263cf3be0e74b85ba827b9b7dd3bcc5_D20181230-20190330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3MzE1_e4d04a59-6755-4236-8917-cdaf2548ae6b"
      unitRef="number">0.10</holx:MaximumRangeofPresentValueofCashFlowPercentage>
    <holx:DirectThirdPartyCostsinterestExpense
      contextRef="i6263cf3be0e74b85ba827b9b7dd3bcc5_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3Mzgx_486dcdbb-f083-4b19-bdf8-2a234accb651"
      unitRef="usd">2600000</holx:DirectThirdPartyCostsinterestExpense>
    <holx:DebtIssuanceCostsReallocatedUponDebtModification
      contextRef="ie4300b435e3a4c91a4ec915b5cdebce4_I20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3NDc4_eca2f286-e5f0-4cd1-bb81-8f9d6bab2880"
      unitRef="usd">1500000</holx:DebtIssuanceCostsReallocatedUponDebtModification>
    <holx:DebtDiscountReallocatedUponDebtModification
      contextRef="ie4300b435e3a4c91a4ec915b5cdebce4_I20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3NTAy_7b083550-2d2f-42ab-9f6e-2bd811474ea3"
      unitRef="usd">1500000</holx:DebtDiscountReallocatedUponDebtModification>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7c7d1f23582b432c91b2a801b77b2fff_I20071210"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3OTYx_1da38921-c539-4e99-a4ad-99d4125215cd"
      unitRef="usd">1725000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7c7d1f23582b432c91b2a801b77b2fff_I20071210"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE3OTc2_c9dedf39-85b2-49f3-a6f9-2bd82a273266"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i56b1e7b3625d4668b6803a4af269897d_I20101118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4MTYx_6c0e9444-e834-4198-824c-d19f2ca7f58b"
      unitRef="usd">450000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i91ddc0c2de1e45d59da01228f7057b59_I20101118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4MjA5_4ca9010b-d1b4-4215-a7ff-ebc5aad799ab"
      unitRef="usd">450000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i91ddc0c2de1e45d59da01228f7057b59_I20101118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4MjQy_c147dcf7-b2d5-4520-99b7-923de978b229"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9c1f5e115c2b4f279149b8ef1e703af0_I20120229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4NDM2_2bb76518-e301-4306-8c20-7c970eeb4a35"
      unitRef="usd">500000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie58aa7f211694a7f95581b9c6ccdee6c_I20120229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4NDg0_04a900dd-682b-49ef-afe3-dd34d2a83da4"
      unitRef="usd">500000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie58aa7f211694a7f95581b9c6ccdee6c_I20120229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4NTE3_07f686a9-3cad-4aaf-a52b-124e6bbd5831"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9671b6718f6540d09891ee6161cbe7e2_I20130214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4Njk4_deb37c83-98eb-4fe4-b60a-ff4a6d785680"
      unitRef="usd">370000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib7243cd452dc4ea3a000e9653cbfe838_I20130214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4NzQ2_6dddccdb-7dd1-4bb4-af15-4b4a4be4d336"
      unitRef="usd">370000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib7243cd452dc4ea3a000e9653cbfe838_I20130214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzE4Nzc5_2d1d2018-112c-4504-a396-34ba8703e58b"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i11258e03918544b983db64585b8a57d3_D20160925-20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2ODE_c02705cd-4093-443f-b635-42269da7c598"
      unitRef="usd">117900000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i5b2cfabcfcd5475e8db2636fdfd71b6a_D20160925-20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2OTc_001ef993-689e-40f1-b16a-2fc79afd51fe"
      unitRef="usd">168000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <holx:RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest
      contextRef="i2dec2acad41c49ebadf65a9fe79a16cf_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwMjg5_911d6483-5dea-46ab-8ed2-bd49285f61ce"
      unitRef="number">1</holx:RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest>
    <holx:RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest
      contextRef="i82d36f9b38d44e27b3125f3ed8fc2179_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwNTYx_a32b6cf7-10b7-49d4-8404-4e54a6a7ccd3"
      unitRef="number">1</holx:RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="if2f74c33a2674954819e52e2acf2aaac_I20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwODAx_83dd4443-10c3-49ac-b70c-d2790bdbc59d"
      unitRef="usd">200500000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="ic93b7c0c776447f09fd2252ab71327a8_D20190331-20190629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwODg3_ca01cb6b-a195-429a-98e6-30fa856c6d1a"
      unitRef="usd">243300000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i024d7046a83a4ae88bd3445fe4d74f1e_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIwOTQw_47567129-5157-41f9-b81e-8574c162dda2"
      unitRef="usd">42800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <holx:DeferredTaxesReacquisitionofEquityComponent
      contextRef="i024d7046a83a4ae88bd3445fe4d74f1e_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxMTAw_02c086d2-2947-41ab-909d-a442baab9250"
      unitRef="usd">12000000.0</holx:DeferredTaxesReacquisitionofEquityComponent>
    <holx:Debtinstrumentremainingtoberedeemed
      contextRef="i4ec620e29d184821ba41fb6c0d5e4744_I20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxMTUy_6613f065-57ea-44c0-9954-3c3bb20cbbba"
      unitRef="usd">5500000</holx:Debtinstrumentremainingtoberedeemed>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="iafbd2a1d68ff4c35b4234cfba95c6ccf_I20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxNDAy_e15882d2-da24-4772-ab9f-11da87ff6523"
      unitRef="usd">201700000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i2c7d3a787bc64690aad62c65bab997c8_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxNTA2_875b92e3-bcaf-49b8-9ec7-fe1bc1977054"
      unitRef="usd">244100000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iafbd2a1d68ff4c35b4234cfba95c6ccf_I20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxNTkx_d4cef696-9725-4df4-87bb-210dcfbc6a8a"
      unitRef="usd">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4ec620e29d184821ba41fb6c0d5e4744_I20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxODkx_736c6f57-ce6d-4076-8f37-2408758a80e3"
      unitRef="usd">39300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i821e7870d37a477694bc08b8bbc795c9_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIxOTUx_2c2b69f6-0d03-45e4-950e-e63093bd415f"
      unitRef="usd">52800000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i4ec620e29d184821ba41fb6c0d5e4744_I20181229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIyMTE2_57eec60a-7d61-4238-be7d-3510ff40e12b"
      unitRef="usdPerShare">31.175</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIyMTUx_971fedff-5d13-4e97-9191-1143a4f4b07f"
      unitRef="usd">13400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <holx:DeferredTaxesReacquisitionofEquityComponent
      contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzIyMzEx_b8b951bc-6753-4dbd-a582-7dcc50ce7954"
      unitRef="usd">3800000</holx:DeferredTaxesReacquisitionofEquityComponent>
    <holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI4NDcy_be79deaa-4dcb-4dbf-a8f4-b42f3533f76b">&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense under the Convertible Notes was as follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:53.362%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00% accrued interest (cash)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzItNS0xLTEtMA_64590be2-b48a-4353-8fed-dbac75e813b3"
      unitRef="usd">3500000</us-gaap:AmortizationOfDebtDiscountPremium>
    <holx:AmortizationOfDeferredFinancingCosts
      contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzMtNS0xLTEtMA_23898f43-208e-44e2-8b1e-d0f264b6c9eb"
      unitRef="usd">200000</holx:AmortizationOfDeferredFinancingCosts>
    <holx:BasePrincipalAmountForAccretionValue
      contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzQtNS0xLTEtMA_47b555ca-9f5d-44db-af64-6451eabde70a"
      unitRef="usd">1600000</holx:BasePrincipalAmountForAccretionValue>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzUtNS0xLTEtMA_72c2528c-a472-4dad-a0b1-206aa1d6d9da"
      unitRef="usd">5300000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzYtNS0xLTEtMA_4eda8a01-df4c-4405-874f-9547cb6cc4d2"
      unitRef="usd">1800000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebt
      contextRef="i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90YWJsZTo3YzliYWQ5ZGVmOGQ0ZDIwYmU4MGNiYWE0MGUxYjA3Ni90YWJsZXJhbmdlOjdjOWJhZDlkZWY4ZDRkMjBiZTgwY2JhYTQwZTFiMDc2XzctNS0xLTEtMA_079d3f86-9944-4837-97f3-d2f2d150e231"
      unitRef="usd">7100000</us-gaap:InterestExpenseDebt>
    <holx:TermARSecuritizationProgram
      contextRef="ie2bbe4541be240b88496af586754a36c_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4OTk_a98d3942-6f85-42e2-826a-2451028352d3">P1Y</holx:TermARSecuritizationProgram>
    <us-gaap:AccountsReceivableFromSecuritization
      contextRef="ia2da5b318239428794fe8166e45245a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI1NTU3_aa1351c9-1611-457e-b6c0-1dcf3c58db5b"
      unitRef="usd">200000000.0</us-gaap:AccountsReceivableFromSecuritization>
    <holx:MaximumBorrowingUnderSecuritizationProgram
      contextRef="ia2da5b318239428794fe8166e45245a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI2MzU5_6537586f-598b-42ba-ab7c-7ccfb4692dee"
      unitRef="usd">200000000.0</holx:MaximumBorrowingUnderSecuritizationProgram>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie2bbe4541be240b88496af586754a36c_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI2ODE5_961e0fd0-7468-41f7-bd7b-cb7d9b9e3142"
      unitRef="number">0.007</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia2da5b318239428794fe8166e45245a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI3Njcw_af675e31-bf1c-43db-b2f9-0d8e36e14fb7"
      unitRef="usd">250000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfDebt
      contextRef="id9d2a93700d14286b21749a928e012e8_D20200628-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2MTc_17edefd4-48e4-4fcb-96ce-1828c880edb6"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ie2bbe4541be240b88496af586754a36c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI3OTAz_a5d07a28-bc3e-4ae7-bc94-0e0157bf34ca"
      unitRef="usd">3100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i6eb2ee0310c54acaa58b9b3c9ff34788_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI3OTA3_5fad1043-ccda-4cec-861d-90f5b515d59a"
      unitRef="usd">7100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="iba4c5eec04f245b89eebd5d83438a62c_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzI3OTE0_b10f0eb3-e6ee-4bf1-9ba5-2af39aa55449"
      unitRef="usd">5400000</us-gaap:InterestExpenseDebt>
    <us-gaap:SeniorNotes
      contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2MDM_bbd54c21-d132-4e75-bed5-7745946f7171"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzQzOTgwNDY1NzU2NzM_248f6882-3d54-46b5-b574-33efb346d0eb"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NzA_960d132f-f98b-4bad-bdf3-a6acf68c90e2"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i06ed0e83b77e4dac8ff73405d8588a14_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NzY_0375673f-7161-4252-8436-9ddbc14afb14"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ic6ba005a39094d34834366256211a18d_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NTg_258547df-5a5f-4eb2-a14e-18735972f775"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ic9c5c02cb6674ecaa58ca75f0fce481a_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4MTc_eb2d9bf5-f4a2-45ec-a1e3-206b52a1e4e9"
      unitRef="number">0.40</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="if4a62771e5894787a4fdaf44eca8d691_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4MjI_038d0f79-6357-495c-b371-ba896c824973"
      unitRef="number">1.03250</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i3d1dbd5a9ccd498d8398ec990203070a_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4MzI_282ca6b6-9100-449a-bef2-43d160d5d162"
      unitRef="number">1.01625</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i41746832831b4728af50d9772e03b7d7_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NDI_7df90e95-d761-4999-aefe-c4cc3b8db292"
      unitRef="number">1.00813</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i9b6105964ce549019e14f33028ca3323_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NTI_5ae37796-646b-4ac5-b648-e0234672fbce"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i2c15de09124143ea8a8d715fc0b85a09_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjMvZnJhZzo0ZTYxOWUyOWU1Mjc0MmYwOTA1MjRjYjkyYjE5MDJmOS90ZXh0cmVnaW9uOjRlNjE5ZTI5ZTUyNzQyZjA5MDUyNGNiOTJiMTkwMmY5XzkzNDU4NDg5MDA4NjQ_46e8644a-cf08-4b0c-a1b8-2e6fc7d323e5"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQ3MzM_f0ae789c-87d4-47be-bcee-f3be54b44761">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps - derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:484.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:183.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:72.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:42pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate caps - derivative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps - derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the years ended September 26, 2020, September 28, 2019, and September 29, 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.510%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments/Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ie5f7f09624f1434eb681cb9758d19eb0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzctMS0xLTEtMA_ee2b96fa-7249-4dfd-90f4-852085384958"
      unitRef="usd">10100000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ida7278d273404326ba040e840b670dbf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzctMy0xLTEtMA_ecf178d4-7232-448c-a141-cfd63da5485b"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i4c634ae6117f4462bbe028987d490806_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzctNS0xLTEtMA_da96d181-cd2d-4407-a404-9d8eed995a0f"
      unitRef="usd">10100000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i90fd61a9da9e4ce2a983dd400f24501b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzctNy0xLTEtMA_4aaf9c6a-df06-42da-a503-4439acc5d04f"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i0ea11973d1af4316b1f3c636f82b9cf5_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzgtMS0xLTEtMA_0e13cb9b-0b04-4fd8-a8d0-4a82095d9185"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i0666efcb300b4877b0616c64336ca6bb_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzgtMy0xLTEtMA_c9b47630-6b02-47b4-bf40-2b0926ffc617"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="id307307c5904493785fe09305537074f_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzgtNS0xLTEtMA_1430faa6-e8f1-4dc3-95a9-08dea2cad87c"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i2e49a76f02bc4a9a9d1333c24ffbf535_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzgtNy0xLTEtMA_94299e94-8a2c-417a-be7c-d076341307da"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzktMS0xLTEtMA_3b0c395f-91b8-4fee-b7ce-b599ea29d4a9"
      unitRef="usd">11200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia7c95670b0ba433f9c62a89eb2e10a1b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzktMy0xLTEtMA_d6e4b762-d1de-48d0-b4ca-63b5f91ecc8a"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i4ef55f270ba4439e93dee1c6e0b97d71_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzktNS0xLTEtMA_fbb9cb08-9b40-4c0c-821d-993837e754ea"
      unitRef="usd">11200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="iaf733f9b57054072ba3f09920206c6a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzktNy0xLTEtMA_bb5b9913-399e-44b9-9cf7-0b265d39d22a"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="if62353ddace04e659ec61002adae44d8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzExLTEtMS0xLTA_a83d0c56-e641-4a2f-9646-4cc1175c5256"
      unitRef="usd">81800000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i0649c66c33ae4abdab88cfc48ee8e0d4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzExLTMtMS0xLTA_0c1a8f5c-d568-470b-bbcb-ee89b92eb9ac"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i494b1a50020e4595a4944efc9524702e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzExLTUtMS0xLTA_67e4a44b-32e1-4a7e-a3a7-3f6665050b70"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i68139d7bb5fe4486ae433c49b7b0574b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzExLTctMS0xLTA_a76482a6-5138-48aa-9df6-0839f5c1d595"
      unitRef="usd">81800000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2dd3354045a94ad6bc4f7dec67555173_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEyLTEtMS0xLTQ3ODE_9ff26662-b188-4ee1-8fdf-48cb04c57650"
      unitRef="usd">31200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ic2397882191544728c3e25abcecedd2d_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEyLTMtMS0xLTEyNTE0_0bb1c17c-7204-40e8-8bee-a9d160af6993"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie5f94ddfbab141ca9fd6143ef82e2729_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEyLTUtMS0xLTEyNTE3_49866683-7f3b-43a9-a1e9-9f30cd03eb9e"
      unitRef="usd">31200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibd832222fbea4e8a87ad22cac73a787b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEyLTctMS0xLTEyNTIw_84e623fd-aeb8-4825-a680-f2176f4838f1"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEzLTEtMS0xLTA_8787683e-4241-43a5-8d91-9fb7da211196"
      unitRef="usd">113000000.0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ia7c95670b0ba433f9c62a89eb2e10a1b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEzLTMtMS0xLTA_b6a71a52-d392-4ed7-a07f-06c16b2a1a58"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i4ef55f270ba4439e93dee1c6e0b97d71_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEzLTUtMS0xLTA_11c02f19-cf64-41bc-a14b-c782f2492bc8"
      unitRef="usd">31200000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="iaf733f9b57054072ba3f09920206c6a8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpmOTVlY2ZiMzBkZmI0M2NiOTZlZDgxYTE1MzE0Y2Y0MC90YWJsZXJhbmdlOmY5NWVjZmIzMGRmYjQzY2I5NmVkODFhMTUzMTRjZjQwXzEzLTctMS0xLTA_48ff63b3-1211-4b15-8b38-8a054a5f21cf"
      unitRef="usd">81800000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="i7ff8a401caf348ccba10912b17de5ff3_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzQtMS0xLTEtMA_d1c4f54e-4c05-4e44-b989-7d2204d47418"
      unitRef="usd">100000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="i3500b3aa228e41f5a89f346d0296c04b_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzQtMy0xLTEtMA_ae99ba9f-10c1-4b78-8f6b-8f38f0451a51"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="i1d97a6111f044441be4473a086df1d40_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzQtNS0xLTEtMA_9484c5e4-ade5-477a-bc53-86c31792210f"
      unitRef="usd">100000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="i173b234856a64d389d94ce9755869ba6_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzQtNy0xLTEtMA_8709ed32-c172-4ebb-b229-e1308f378d99"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0e1f1b09ac83442a8c991f025f87c36c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtMS0xLTEtMjIzMA_c00f6f84-3cf4-40cc-8d19-39674c68a9d7"
      unitRef="usd">4700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0172a062a11d4a9b9ff8ce7f340127e5_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtMy0xLTEtMTI1MjY_f779148e-ebaf-4735-a797-096b2e716195"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib8cc4295af424a959b5d571941ae558b_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtNS0xLTEtMTI1MzA_eb975990-6cb8-4dd5-99ac-cf68355b1084"
      unitRef="usd">4700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2e5807a53cf54cc88b9b54d32079f6fe_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtNy0xLTEtMTI1MzQ_38da6ed5-90d0-415c-8f7b-94ffb40d1b2a"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i52321d5b7f4c43e0a78b02f5e2f66d46_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtMS0xLTEtMTI1MjQ_f01a1665-b95b-4344-a68f-029f4f1c470f"
      unitRef="usd">2000000.0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i4ed21b822c534ff5bac482a2f45adb03_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtMy0xLTEtMTI1Mjg_3360562c-9f11-4f2d-9784-d38a1f385429"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i6a6bc74d82454a129b9c287e500fb859_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtNS0xLTEtMTI1MzI_9ee25789-e965-4f4f-b267-aeedb7a2be7c"
      unitRef="usd">2000000.0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i0a09695c32df4cd28cb1bcb683a730eb_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtNy0xLTEtMTI1MzY_c036c4cf-9aa3-4aed-a6c7-173a5f7a7002"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i6aaaf1ae6a5547bc9c542f11e36741ed_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtMS0xLTEtMA_97fb0839-7678-40f4-a274-fe62e5badc05"
      unitRef="usd">900000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i72dae67f6ad547c18f4306ab436421f8_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtMy0xLTEtMA_0861d0c3-1961-4a61-a919-214d7ecc5bd8"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia9cf7097d00744cb8193ee46040dab6f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtNS0xLTEtMA_bb28972b-e358-4e38-8321-a98069a1c1ec"
      unitRef="usd">900000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i4c79ca9a01124b35bef6eba993c991c6_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzUtNy0xLTEtMA_80d9ea25-27b3-4251-b3a5-7fe2ba537899"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtMS0xLTEtMA_9ec705e9-83c5-4bad-9dbc-94137d31066e"
      unitRef="usd">7700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i8a00d43da17d4cf2a160f87d1575594f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtMy0xLTEtMA_37b98c8b-19e8-431b-9b6f-6f95ad5e4051"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id123129c423e45f0bbc343073fa91e2a_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtNS0xLTEtMA_4171cb5c-24bf-4a4f-b571-ec3abd03ffa3"
      unitRef="usd">7700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibe5b12d49cf249b58198f0ed8726f8b1_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzYtNy0xLTEtMA_a3e32269-deae-4a2a-bf1e-b793e46d6041"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i1e18b40497764e718b638209aca9eb1e_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzgtMS0xLTEtMA_a5a73b58-7148-499e-9225-3e602cd5be5e"
      unitRef="usd">9100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="icba5dbf998314e0387202bf4eb404a3f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzgtMy0xLTEtMA_ddf0a75f-3147-42de-bd81-89f501d14890"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i17ba19a80b3e451d950ab549195d0151_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzgtNS0xLTEtMA_b60c49e9-8d5a-463e-b223-8efd2c3c7138"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i7975507c75e442eca0e695649ed6acd8_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzgtNy0xLTEtMA_95f2ed73-1159-4b0f-abae-2c8f8d2acf93"
      unitRef="usd">9100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i3d9bb748a0d64e65b6a66c49ad23d0a5_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzktMS0xLTEtMA_7ef79cf4-d18c-4749-bb4f-59d3ada82e4c"
      unitRef="usd">100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ic9bcf8515f054405a36ddfe578351f4c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzktMy0xLTEtMA_cf0d609d-8a87-417f-9d30-da9781a483b8"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i4434900ec76643218f461bb16c843300_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzktNS0xLTEtMA_0de66ca0-0fa2-4bcf-b05f-2dcd9e4925cf"
      unitRef="usd">100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i5082098bb8404831baa99e0bb0a4ab26_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzktNy0xLTEtMA_e9bbfe00-d4d7-429a-9050-c4fdc6010408"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzEwLTEtMS0xLTA_da682cb7-411c-4903-9bf5-3de2c1a1d3ec"
      unitRef="usd">9200000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i8a00d43da17d4cf2a160f87d1575594f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzEwLTMtMS0xLTA_cdbb9843-cf9f-4c44-99aa-1bbe0f1e216d"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="id123129c423e45f0bbc343073fa91e2a_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzEwLTUtMS0xLTA_efebd02c-2fec-4109-91e1-a4b1ebd276e5"
      unitRef="usd">100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ibe5b12d49cf249b58198f0ed8726f8b1_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTpiMGIzYmZhNzI4Y2E0MDJiOGIwMzEwMzEzNDMwODQ1OC90YWJsZXJhbmdlOmIwYjNiZmE3MjhjYTQwMmI4YjAzMTAzMTM0MzA4NDU4XzEwLTctMS0xLTA_1425c02a-c5d2-4a56-815c-12589a78e8b0"
      unitRef="usd">9100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzEtMi0xLTEtODE0OA_3b8c230b-4be1-4c47-b227-55716a51c936"
      unitRef="usd">9100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzItNC0xLTEtMTg5Mjc_a4fb5306-c152-4ed9-9713-7ede45e2c021"
      unitRef="usd">7800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i84c88a850d71453097932f0bcbe84825_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzItNi0xLTEtMTg5Mjk_4c851779-2ae9-4eb2-a4f6-b6baeacf4c93"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzItMi0xLTEtMTA3NzA_4bd1a4b8-f262-4eeb-89a3-d39c345befef"
      unitRef="usd">82700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzMtNC0xLTEtMTg5Mjc_77d87ded-6e72-4d5e-be1c-cc6a8ceaf502"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzMtNi0xLTEtMTg5Mjk_9be3e3d2-9c43-49b5-b6d8-d0acf07f4cde"
      unitRef="usd">7800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzQtMi0xLTEtMTg5MjU_c79d6a21-03b5-450f-a422-9e2123a651b3"
      unitRef="usd">300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzQtNC0xLTEtMTg5Mjc_d30a4cc8-85fc-4a38-991e-21034e6e53bb"
      unitRef="usd">1700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzQtNi0xLTEtMTg5Mjk_47769f1c-7873-4565-bc44-f5221cf0b6e8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzUtMi0xLTEtMTg5MjU_6a368554-8976-42c3-a3be-12993cbd2aee"
      unitRef="usd">10300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzUtNC0xLTEtMTg5Mjc_ebe58121-a911-4a0e-afa5-91ba1d2c5c4f"
      unitRef="usd">400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzUtNi0xLTEtMTg5Mjk_97245c26-35fb-45b4-a99a-4629f5b10980"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzYtMi0xLTEtMTg5MjU_f04b9966-811a-4667-898a-4b05ef1e123c"
      unitRef="usd">81800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzYtNC0xLTEtMTg5Mjc_92a465c9-902e-4118-bc72-db5ecb2f77e9"
      unitRef="usd">9100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90YWJsZTphZjUxYWZkYmEzZTE0MjczOWE4ZWM2Zjc2ODZhZGNmNi90YWJsZXJhbmdlOmFmNTFhZmRiYTNlMTQyNzM5YThlYzZmNzY4NmFkY2Y2XzYtNi0xLTEtMTg5Mjk_c042c49c-79a0-4cee-8f68-d27f71a4383e"
      unitRef="usd">7800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:AssetImpairmentCharges
      contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzOTgwNDY1MjA2Mzc_9b913464-bfbe-4a81-bf59-7f2f73e36175"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzkzNDU4NDg4NDczODA_bfabff39-67ca-442c-99d0-c626bacddf1b"
      unitRef="usd">685400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i73c475cf26a140439e4b7915e83f35fb_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzOTgwNDY1MjA2MjE_ca531648-fc1a-40d7-a707-f59fd6815b8c"
      unitRef="usd">675600000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i216e053a60db43869c143b5ae19d8870_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzOTgwNDY1MjA1OTA_5e361913-aa7c-4e55-8ba1-4040c022df41"
      unitRef="usd">9800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id6475457bf9c44539a19af401366b4fa_D20171231-20180331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzOTgwNDY1MjA2MDQ_a840eb8e-fb4b-49ec-be0c-213d3d321b16"
      unitRef="usd">685700000</us-gaap:GoodwillImpairmentLoss>
    <holx:PrincipalAmountOfBorrowings
      contextRef="i84d0c5013ed249be85fc1ea500342cb0_I20200926"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQzMDA_9ac5d6da-bc25-406f-b601-d3d7fb4637fc"
      unitRef="usd">1710000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib5afd9d954b4489889417286bf08a16e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQ2MTQ_45f5f96c-2aa2-46fc-9be4-6194eea1a8e7"
      unitRef="usd">971500000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie2070f7d8bb34bab958a30daea1bbd42_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNjkvZnJhZzpmY2ExYjhiZGNmYWE0MmVhOTJkOTllMzliMjkwMTg4MS90ZXh0cmVnaW9uOmZjYTFiOGJkY2ZhYTQyZWE5MmQ5OWUzOWIyOTAxODgxXzQ2MjE_3ff05039-1fd6-4ee8-a1a8-6fcffc237e1a"
      unitRef="usd">419100000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzE0MDIy_ff3f27a4-711c-424b-9020-a6c0757e725b">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s income (loss) before income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(581.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzItMi0xLTEtMA_85d11bc9-63f4-4c25-bf26-abe40d8e8c00"
      unitRef="usd">921100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzItNC0xLTEtMA_790f1aad-d8ef-4ece-a757-6307e0c7601c"
      unitRef="usd">-174300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzItNi0xLTEtMA_2834f6c7-8f60-4cf4-8c18-45a4619c666a"
      unitRef="usd">-581900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzMtMi0xLTEtMA_bdfc5221-691b-4c86-86ee-ad4dd293e081"
      unitRef="usd">80800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzMtNC0xLTEtMA_acc8694c-9cc8-423a-8246-7333597b5f34"
      unitRef="usd">-83400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzMtNi0xLTEtMA_1b55642e-273f-45f5-8cfa-3002a33ac828"
      unitRef="usd">163300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzQtMi0xLTEtMA_7c66641c-146c-4b9c-9adf-1b20b998a80c"
      unitRef="usd">1001900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzQtNC0xLTEtMA_c18fbc58-ed3a-4c7b-bef2-de8c7ba590be"
      unitRef="usd">-257700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo5ZWU1NDIyNzUyZDY0YjNiODczNGMyZmNiYmJmNzc0MS90YWJsZXJhbmdlOjllZTU0MjI3NTJkNjRiM2I4NzM0YzJmY2JiYmY3NzQxXzQtNi0xLTEtMA_b77d6958-226c-45ab-92d5-16f081f0502c"
      unitRef="usd">-418600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzE0MDEw_ff390e60-a32e-48a2-89ca-1f7c0472c4ab">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The benefit for income taxes contained the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzMtMi0xLTEtMA_7165388a-5b3b-4f0a-a5eb-6c8d15726105"
      unitRef="usd">-62100000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzMtNC0xLTEtMA_e45c265f-5753-4726-856f-fb52728ae32d"
      unitRef="usd">142900000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzMtNi0xLTEtMA_eca3025c-9fa4-4101-a21e-4374725384d9"
      unitRef="usd">137100000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzQtMi0xLTEtMA_d7c97c4e-2eb8-47d5-93b6-1d085cfff0a9"
      unitRef="usd">-76600000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzQtNC0xLTEtMA_5524bc1b-76e6-4cea-b14e-37d1ec8e0924"
      unitRef="usd">-189900000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzQtNi0xLTEtMA_7ed25a64-41ae-4d85-81c2-8e546096890c"
      unitRef="usd">-461900000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzUtMi0xLTEtMA_6a2f9293-6cf4-4445-98a9-f2d96038962b"
      unitRef="usd">-138700000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzUtNC0xLTEtMA_0466eb98-cf7e-40aa-908a-00cec7222f69"
      unitRef="usd">-47000000.0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzUtNi0xLTEtMA_ae812f84-1eac-40e7-b901-20ceab2d39d8"
      unitRef="usd">-324800000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzctMi0xLTEtMA_6f8bf1df-521f-462a-b60e-b4d8cb35e118"
      unitRef="usd">33900000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzctNC0xLTEtMA_195ed324-4a1d-4f0d-bc06-5f4c793441d1"
      unitRef="usd">22100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzctNi0xLTEtMA_4ca9a440-cd68-49b2-906e-4800b7c5f2c8"
      unitRef="usd">11000000.0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzgtMi0xLTEtMA_f78f98c0-0c74-4712-b770-fe06b3251967"
      unitRef="usd">-12500000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzgtNC0xLTEtMA_10af7d85-1ee5-4f5c-a285-ef3a774470ee"
      unitRef="usd">-41000000.0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzgtNi0xLTEtMA_7276cfe9-21f4-4e43-bbc0-e5590ed97302"
      unitRef="usd">-11300000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzktMi0xLTEtMA_2d63c131-7235-40f5-9a0b-fd946c08cce0"
      unitRef="usd">21400000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzktNC0xLTEtMA_7649c53b-2046-4175-aca4-f936271fb332"
      unitRef="usd">-18900000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzktNi0xLTEtMA_cb7dd6f2-bc78-40a1-8c7b-b1dc346471c2"
      unitRef="usd">-300000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzExLTItMS0xLTA_92278782-aa36-4025-818d-66945ddc40e8"
      unitRef="usd">14000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzExLTQtMS0xLTA_a53a589d-d7b5-49d2-9ec9-ee83e69647ef"
      unitRef="usd">16500000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzExLTYtMS0xLTA_4abd0a4a-11f7-4068-99b0-5009b7610c28"
      unitRef="usd">21900000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEyLTItMS0xLTA_4c20086a-e99c-4e14-9396-921265eef3bc"
      unitRef="usd">-5300000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEyLTQtMS0xLTA_2a88fe23-4fe9-4795-9c97-3098304ab77f"
      unitRef="usd">-4700000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEyLTYtMS0xLTA_c29c668e-2856-476e-890c-27477cc2037d"
      unitRef="usd">-4100000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEzLTItMS0xLTA_c60dc639-40b7-4817-89ae-5dc37cb5b9f6"
      unitRef="usd">8700000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEzLTQtMS0xLTA_1090cc46-3c0e-4905-858a-f7b7f091c815"
      unitRef="usd">11800000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzEzLTYtMS0xLTA_ea2932b4-a4d9-4566-a2e0-418f72bbd835"
      unitRef="usd">17800000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzE0LTItMS0xLTA_91785c3d-aeaa-4a82-a9bc-743378c808cc"
      unitRef="usd">-108600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzE0LTQtMS0xLTA_7d046dd3-08cd-4a87-a692-6a57e7600577"
      unitRef="usd">-54100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo3YzdkZmZhOThkNTM0ZjU4YjU3NDg2YTg2N2UyNDg4Ni90YWJsZXJhbmdlOjdjN2RmZmE5OGQ1MzRmNThiNTc0ODZhODY3ZTI0ODg2XzE0LTYtMS0xLTA_31701d3a-62c4-4dce-b3f4-366fb8d9ddee"
      unitRef="usd">-307300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEzOTky_abd8d50e-b019-444c-a151-692cd4fb9bc8">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax benefit differed from the tax benefit computed at the U.S. federal statutory rate due to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.187%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) provision at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in tax resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on sale of Cynosure&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic production activities deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. tax on foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax reform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzItMi0xLTEtMA_dbc4b957-a88c-497a-b3ea-a096c88ddb16"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzItNC0xLTEtMA_a0bf66de-9264-4e2d-b8e0-79a5449ee104"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzItNi0xLTEtMA_c5b76555-8060-4d1b-a568-19f33ada535b"
      unitRef="number">0.245</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzQtMi0xLTEtMA_3d913d54-1441-4cad-bc2b-d51a4bf9f671"
      unitRef="number">0.313</holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure>
    <holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzQtNC0xLTEtMA_842bb276-e75a-4103-b927-1360a3ddf049"
      unitRef="number">0</holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure>
    <holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzQtNi0xLTEtMA_c683d7ce-efb6-43ba-acc5-4b5d9d615052"
      unitRef="number">0</holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzUtMi0xLTEtMA_1c67122e-05be-4db8-b25f-3bea0b937189"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzUtNC0xLTEtMA_c899da37-eb3e-4dd8-90c2-298dd3a1b453"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzUtNi0xLTEtMA_ab47f401-a58c-4f68-90a7-88ad13d39e77"
      unitRef="number">-0.031</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzYtMi0xLTEtMA_80bd5756-df91-4d6d-aa02-cc6c785b7717"
      unitRef="number">0.029</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzYtNC0xLTEtMA_0e6b617a-e380-450b-bbce-6192c6080f15"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzYtNi0xLTEtMA_112da5ff-6c55-4a35-a5ab-c400dbc946b3"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzctMi0xLTEtMA_df2d19c7-f155-4e3a-945f-476fa2709d52"
      unitRef="number">0.026</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzctNC0xLTEtMA_2f30b3d8-19b3-4c71-8379-c648536d3da3"
      unitRef="number">-0.021</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzctNi0xLTEtMA_b834f68a-b6b8-4216-a9d5-c272546b907d"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzgtMi0xLTEtMA_b887e0e6-8e83-46a6-9e35-f198fbfaebfa"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzgtNC0xLTEtMA_7415af96-4bb7-425a-a711-8c3895b8d1a2"
      unitRef="number">0.038</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzgtNi0xLTEtMA_3fa16083-6b6e-4431-a540-e5639336a7e6"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges>
    <holx:EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzktMi0xLTEtMA_3a22bead-b66b-45a0-8cd8-9ed6da2e2af4"
      unitRef="number">0</holx:EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill>
    <holx:EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzktNC0xLTEtMA_340d3d41-9904-47f8-9f27-7b7572fb4956"
      unitRef="number">0</holx:EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill>
    <holx:EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzktNi0xLTEtMA_4a62ab13-360f-41f5-9803-499b8132c3a0"
      unitRef="number">-0.394</holx:EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill>
    <holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEwLTItMS0xLTA_87ccf28b-1864-48b2-93bf-67a18d3e3f60"
      unitRef="number">0.006</holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment>
    <holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEwLTQtMS0xLTA_ab846914-8c7b-42a5-a813-ec46d23bbce3"
      unitRef="number">-0.033</holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment>
    <holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEwLTYtMS0xLTA_6677b7a3-d5cf-4e37-95a5-6b0f4faf82fa"
      unitRef="number">-0.019</holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzExLTItMS0xLTA_15630bc6-ae0d-4995-a526-3ded39789091"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzExLTQtMS0xLTA_8428d0c4-5b41-4f3f-92c5-750ac757840d"
      unitRef="number">-0.020</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzExLTYtMS0xLTA_9e64e21e-54f9-4521-801c-8353e5501c6c"
      unitRef="number">0.827</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
    <holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEyLTItMS0xLTA_88f7e540-6509-4295-8c47-242127f3ef1b"
      unitRef="number">0</holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits>
    <holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEyLTQtMS0xLTA_1f43b173-cae3-450f-b35f-cdb27ae6e6bd"
      unitRef="number">0.001</holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits>
    <holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzEyLTYtMS0xLTA_f78ac5a8-c278-427c-acab-b3efa5a924ee"
      unitRef="number">-0.018</holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits>
    <holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE2LTItMS0xLTA_a297e31a-021a-4887-931e-7707b8e12d28"
      unitRef="number">0.004</holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost>
    <holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE2LTQtMS0xLTA_4dc43e2e-55eb-4a3a-bc7e-656a631913af"
      unitRef="number">-0.008</holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost>
    <holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE2LTYtMS0xLTA_cd2f5579-fd6d-412e-b819-3146f891fd4f"
      unitRef="number">-0.003</holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE3LTItMS0xLTA_48d7b613-66c7-40bd-b9de-6b7eeaf49c11"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE3LTQtMS0xLTA_793c6728-64bd-415f-8607-8b5e8a699748"
      unitRef="number">-0.054</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE3LTYtMS0xLTA_bc5761d9-bf17-4d73-9527-70dcfb10a627"
      unitRef="number">-0.052</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE4LTItMS0xLTA_c4cfb1ed-0d1b-4358-b971-802fdd650adb"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE4LTQtMS0xLTA_c685125e-f80e-4fe3-99c4-2945d302c289"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE4LTYtMS0xLTA_779032ba-534b-4001-b35f-3d3a40e8109a"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE5LTItMS0xLTA_e713c861-4f72-4de3-a5f8-8db3c640457b"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE5LTQtMS0xLTA_67c86cbe-9b55-402e-ab5a-77a858aca0fb"
      unitRef="number">-0.095</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzE5LTYtMS0xLTA_2234f631-4ab5-418f-a8b8-37c8dbcc8c91"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIwLTItMS0xLTA_8a99b53e-a06c-459e-819b-31212d0efb18"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIwLTQtMS0xLTA_c9618047-9528-4684-a936-0843ac158de4"
      unitRef="number">-0.031</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIwLTYtMS0xLTA_0ec1ea9b-986d-444d-a97f-2df2b2a40f96"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIxLTItMS0xLTA_b09b3178-0ebf-4f24-a4dc-49ac30f56399"
      unitRef="number">-0.108</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIxLTQtMS0xLTA_902f8eee-391a-4eca-b0a5-a8b84f841a1d"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTpiYjAwZTdlZWI3ZjA0ZjA2YjdlOTAzNGRiYzRmNDg2OS90YWJsZXJhbmdlOmJiMDBlN2VlYjdmMDRmMDZiN2U5MDM0ZGJjNGY0ODY5XzIxLTYtMS0xLTA_3f7fa85f-cf38-4dfc-bd0a-b6ddee72a176"
      unitRef="number">0.734</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzOTgwNDY1NDMzNTk_74cc7692-3087-4c46-918b-90c0d9ba88b5"
      unitRef="usd">313400000</us-gaap:OtherTaxExpenseBenefit>
    <holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzE3NjM_4450413b-ebeb-49d3-8821-89d3f2858f9e"
      unitRef="usd">-346200000</holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit>
    <holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit
      contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzOTgwNDY1NDMzNDM_ba6ee315-c4ce-4e23-9d2c-0198fd11f042"
      unitRef="usd">-341200000</holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEzOTkz_e7b7ec2c-ee33-46d4-b69b-111d8e32e42f">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s significant deferred tax assets and liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UK intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified deferred compensation plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&#160;and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferrals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(258.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzItMi0xLTEtMA_c7883265-6aa6-49cc-89f8-dd7e536c1d82"
      unitRef="usd">81100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzItNC0xLTEtMA_bd852c9b-b82f-4b3d-a339-0c121ea058f6"
      unitRef="usd">34500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzMtMi0xLTEtMA_2a5fd986-40a1-4ab5-8c3a-ec8ce53459a8"
      unitRef="usd">57000000.0</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzMtNC0xLTEtMA_009214f5-49cf-40c6-be30-015889e16729"
      unitRef="usd">6400000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzQtMi0xLTEtMA_d1334a8f-5eb7-4c2f-99c3-fb58a3032de4"
      unitRef="usd">24900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzQtNC0xLTEtMA_778367c7-31f1-4331-b835-820d19a893bf"
      unitRef="usd">24700000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzUtMi0xLTEtMA_2da4373a-af18-45c4-9508-cb814c8d83e5"
      unitRef="usd">33200000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzUtNC0xLTEtMA_42c028a6-6111-498f-ae8b-2e1358989144"
      unitRef="usd">22700000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <holx:UKIntangibleassets
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzYtMi0xLTEtMA_b2b1ee0a-86ea-4502-8847-e57b6c55cd8a"
      unitRef="usd">0</holx:UKIntangibleassets>
    <holx:UKIntangibleassets
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzYtNC0xLTEtMA_67fa1e46-62e6-4429-8822-ac55f555f88b"
      unitRef="usd">25400000</holx:UKIntangibleassets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzctMi0xLTEtMA_5d1b6630-d078-42f3-aa9c-c09d1158913d"
      unitRef="usd">18600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzctNC0xLTEtMA_0df7e60f-c688-4010-8b94-c5bcf1bd444a"
      unitRef="usd">20900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzgtMi0xLTEtMA_6ea332ff-5c88-4e6a-97ab-7527838bea5f"
      unitRef="usd">10200000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzgtNC0xLTEtMA_e8bfe0b5-1ba6-4e8e-b817-75f69524e30d"
      unitRef="usd">14800000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzktMi0xLTEtMA_d5031256-5f2c-4eca-acd2-a79053c8b794"
      unitRef="usd">14400000</holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan>
    <holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzktNC0xLTEtMA_187e8e87-ded7-460c-b6e7-b225d27e1fad"
      unitRef="usd">12900000</holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan>
    <holx:DeferredTaxAssetsLeaseLiability
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEwLTItMS0xLTEyMTgy_598f93d6-a39b-4b1d-a9d3-f8056dbad6d4"
      unitRef="usd">17300000</holx:DeferredTaxAssetsLeaseLiability>
    <holx:DeferredTaxAssetsLeaseLiability
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEwLTQtMS0xLTEyMTg2_6873223d-8790-4cdf-b532-d28a80feb976"
      unitRef="usd">0</holx:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEwLTItMS0xLTA_c984d40b-ddfd-4827-be28-e0e9644991a9"
      unitRef="usd">25200000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEwLTQtMS0xLTA_1bfed8b7-7f24-440e-a2a5-dbaab672513d"
      unitRef="usd">17800000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzExLTItMS0xLTA_9a00db84-cbbe-4d24-bc58-cc857dfa1780"
      unitRef="usd">281900000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzExLTQtMS0xLTA_62e19e34-4425-49ad-a228-a03a362b56bc"
      unitRef="usd">180100000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEyLTItMS0xLTA_15a7dc91-312e-49b9-9a55-958f43199013"
      unitRef="usd">118500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEyLTQtMS0xLTA_4af40abf-8fde-4325-a5b4-c803b7769a34"
      unitRef="usd">60700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEzLTItMS0xLTA_2ba47f79-d7c7-4d29-885d-94f49a6af3b1"
      unitRef="usd">163400000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzEzLTQtMS0xLTA_ae04548f-2e62-475c-93e1-2809a7f0f473"
      unitRef="usd">119400000</us-gaap:DeferredTaxAssetsNet>
    <holx:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE1LTItMS0xLTA_c33cac85-df26-46b9-9b7a-8e481bbfd9d8"
      unitRef="usd">333900000</holx:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <holx:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE1LTQtMS0xLTA_efa4e247-8b3e-4eba-8289-a8400a36ed67"
      unitRef="usd">373000000.0</holx:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <holx:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE4LTItMS0xLTEyNTkx_46370428-702c-45bc-a238-ef7a5af00fbe"
      unitRef="usd">15800000</holx:DeferredTaxLiabilitiesRightOfUseAsset>
    <holx:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE4LTQtMS0xLTEyNTk1_636a7c92-56f1-426a-9254-a4e0a1e0af73"
      unitRef="usd">0</holx:DeferredTaxLiabilitiesRightOfUseAsset>
    <holx:DeferredTaxLiabilitiesDebtDiscount
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE2LTItMS0xLTA_bbcea328-7b83-4da5-8698-8ae211faadd8"
      unitRef="usd">0</holx:DeferredTaxLiabilitiesDebtDiscount>
    <holx:DeferredTaxLiabilitiesDebtDiscount
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE2LTQtMS0xLTA_4a87e63f-2ec6-4f3f-99c8-8da443a32ed6"
      unitRef="usd">4500000</holx:DeferredTaxLiabilitiesDebtDiscount>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE5LTItMS0xLTA_b395eb3d-ffb5-4659-94d0-220c5524df05"
      unitRef="usd">349700000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzE5LTQtMS0xLTA_ca3a4ea9-5cdd-470b-b0dc-6420716d050c"
      unitRef="usd">377500000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzIwLTItMS0xLTA_8332e2a7-9008-4f52-9d4b-cef00c9c4187"
      unitRef="usd">186300000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo0MTYwNGZlZmNhZTU0ZjczYjgwNjk5ODMzMThjMTcwNi90YWJsZXJhbmdlOjQxNjA0ZmVmY2FlNTRmNzNiODA2OTk4MzMxOGMxNzA2XzIwLTQtMS0xLTA_03232685-6025-4ceb-8007-0625786eef2a"
      unitRef="usd">258100000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQwMjI_29424c86-99e3-429a-bbc7-3d05504fd28f"
      unitRef="usd">57800000</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:OperatingLossCarryforwards
      contextRef="icfd0cb53981e490ea162a76a039de64a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQyMzg_60b73e45-39dd-449e-b6c6-69b416160a9c"
      unitRef="usd">40100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i99e5be2075214d609076dc73419bf0c8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQyNDI_97e86dea-1d23-4873-8f0c-27229a9ca8b5"
      unitRef="usd">44500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i9f5ae045d54044febe4e33ec32c959c3_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQyNTA_153f23c0-05f7-4dbd-97c9-3ac85ba28e3e"
      unitRef="usd">207100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="icfd0cb53981e490ea162a76a039de64a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzMzA_475c3434-cbd3-49bd-a7b7-4c4018d1a628"
      unitRef="usd">5000000.0</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i99e5be2075214d609076dc73419bf0c8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzMzQ_9e67e2f9-8c15-4e4a-b9a8-b96fd9bf010d"
      unitRef="usd">4500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i9f5ae045d54044febe4e33ec32c959c3_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzNDI_fb52c13c-14ee-4ef6-8065-afa5f5b902e6"
      unitRef="usd">1200000</us-gaap:TaxCreditCarryforwardAmount>
    <holx:GrossStateLossCarryforwards
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTM3MjY_a81cc6dd-1796-49f4-a480-cf91f9dbb258"
      unitRef="usd">0.0</holx:GrossStateLossCarryforwards>
    <holx:GrossForeignLossCarryforwards
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTM3MTE_e6d944dc-78c6-4bab-b455-810ce99d11e9"
      unitRef="usd">32200000</holx:GrossForeignLossCarryforwards>
    <holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod
      contextRef="ie7d5ec4cbaba458ca1b77246243d3989_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ0NzQ_c8380931-7cff-45b8-954a-1d22d60dacef"
      unitRef="usd">22500000</holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod>
    <holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod
      contextRef="ibd756bca5be3431186e7d993f7bc13be_D20190929-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ0OTI_437556b0-98cb-4486-a725-2f5f75156760"
      unitRef="usd">3400000</holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod>
    <us-gaap:OperatingLossCarryforwards
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTM4Mzc_f58fb841-be0b-4cb2-86a5-e1e20241e1fc"
      unitRef="usd">32200000</us-gaap:OperatingLossCarryforwards>
    <holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ2MDk_4a88c12a-8199-4cdc-b094-966a164b07ed"
      unitRef="usd">4500000</holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal>
    <holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ2MTM_5125522c-b141-4d0f-8ac1-00b8d5a17e4a"
      unitRef="usd">74600000</holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState>
    <holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ2MjE_69053e88-0998-4d2d-8368-2a1986301358"
      unitRef="usd">47200000</holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign>
    <holx:StateLossCarryforwardExpectedToUnutilize
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTM5Mzg_9fa31259-f67b-420a-b18c-47e4b5b21e9b"
      unitRef="usd">26100000</holx:StateLossCarryforwardExpectedToUnutilize>
    <holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit
      contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzOTgwNDY1NDMzNzY_af6d7b60-611e-4f9a-bd2f-0463e2a1e881"
      unitRef="usd">-341200000</holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit>
    <holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit
      contextRef="ic48110a0e8a642a6b8ca649bef79b27e_D20180701-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQzOTgwNDY1NjEwNDQ_660a4ee9-014b-4b92-af7a-dc78119c6e67"
      unitRef="usd">-346400000</holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit>
    <holx:GrossUnrecognizedTaxBenefits
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ3Mzk_27450021-49eb-4563-b2cb-86e557ccc234"
      unitRef="usd">197100000</holx:GrossUnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ4MDY_ecee2fd6-068d-4292-8493-ee5690527847"
      unitRef="usd">184900000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <holx:GrossUnrecognizedTaxBenefits
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ4OTg_0ece6e64-f533-4ff8-987f-988d9cc3152c"
      unitRef="usd">101600000</holx:GrossUnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzQ5NjU_50a9aa6c-2d36-4671-9530-2fdb0987fd91"
      unitRef="usd">87300000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzUwNDE_f880ad8f-ca03-4388-a052-0ceec16f0a30"
      unitRef="usd">95500000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i4df61e30f2e54979bf7daad2c81da1e8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzU0MjY_8efcbae3-e491-4403-a4e1-b22893ddc119"
      unitRef="usd">1300000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEzOTk1_9d7e5358-35dc-4c7c-ad72-4fb7df11d8b5">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unrecognized income tax benefits activity for fiscal 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax positions related to current year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax positions related to prior years:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions related to change in estimate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lapses in statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired tax positions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions related to reserves acquired from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of the end of the fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzEtMi0xLTEtMA_f2861051-b375-4f20-8574-65b1968da346"
      unitRef="usd">101600000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzEtNC0xLTEtMA_acee4737-88d4-415d-abde-453cf0e445dd"
      unitRef="usd">89500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzMtMi0xLTEtMA_58c77286-fb9e-4f62-b6ec-24e16cfd42a9"
      unitRef="usd">109600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzMtNC0xLTEtMA_acbb2a8e-5915-46be-8bbc-c2c5ca163975"
      unitRef="usd">22700000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzQtMi0xLTEtMA_f4cc0588-4e3a-4373-b6cc-0b25e594c39c"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzQtNC0xLTEtMA_dfafe1a3-1b74-4b39-bce1-eb6ecd5bac51"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzYtMi0xLTEtMA_57a57744-4ec1-4d1a-b813-ebc6681eb1fd"
      unitRef="usd">1500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzYtNC0xLTEtMA_25b18e54-d060-4926-9bcb-add128ba8484"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzctMi0xLTEtMA_e357c3cb-4ec3-4414-a5f6-5d5349290844"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzctNC0xLTEtMA_fd9a3c8e-9841-428b-8827-fdd3cf2b51e7"
      unitRef="usd">4800000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzgtMi0xLTEtMA_b0f674df-8f09-4f65-9b86-6c17f1ceee5a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzgtNC0xLTEtMA_4a2d582f-09b1-48ef-abef-d480d9847403"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzktMi0xLTEtMA_6e37e2f6-fc70-4571-a5d9-6d54a835bc0d"
      unitRef="usd">15600000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzktNC0xLTEtMA_00b6057e-511c-4b85-9678-f62159d42adc"
      unitRef="usd">5800000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzExLTItMS0xLTA_430f91f1-7839-4974-9624-24add6d43662"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzExLTQtMS0xLTA_e9115501-baa7-4a50-aa69-6980cbdf95ba"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzEyLTItMS0xLTA_50af8c39-90a5-49ef-9017-2c4d21bc288c"
      unitRef="usd">197100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90YWJsZTo4NGRlNzYzZWRlMTU0NTJmYTcyZmExYTlkOGIzZjhkZC90YWJsZXJhbmdlOjg0ZGU3NjNlZGUxNTQ1MmZhNzJmYTFhOWQ4YjNmOGRkXzEyLTQtMS0xLTA_bc955309-1f38-41d1-baf4-18e89c119aec"
      unitRef="usd">101600000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzU3ODI_155a45a7-3152-4863-aff8-a67d6de7da69"
      unitRef="usd">11900000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzU3OTE_ea0030f9-2ceb-4901-b0a8-732e088cdfdc"
      unitRef="usd">11100000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzU4MTk_bb278b8e-2920-457d-966a-516e34101e2a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued>
    <holx:IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzExNzY5_7f639f71-03e3-410f-9c7d-b62ee444ce5c"
      unitRef="usd">2900000</holx:IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616>
    <holx:DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzExODEw_5a8edd77-3944-43a1-b6c2-64de6a16af77"
      unitRef="usd">2500000</holx:DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616>
    <holx:DeceasetoprepaidtaxesresultingfromadoptionofASCU201616
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzExODQ5_140e77a7-8078-446a-8f9c-cfdb0fcb9473"
      unitRef="usd">400000</holx:DeceasetoprepaidtaxesresultingfromadoptionofASCU201616>
    <holx:IncreasetoincometaxexpenseadoptionofASU201616
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEyMDQ3_4d5957a7-39b1-41e6-bf62-ec8dabb91d55"
      unitRef="usd">27800000</holx:IncreasetoincometaxexpenseadoptionofASU201616>
    <holx:DecreaseindeferredtaxliabilitiesduetoASC201616
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEyMTI2_23528adb-f38c-4020-86b4-fc41f578fe02"
      unitRef="usd">37700000</holx:DecreaseindeferredtaxliabilitiesduetoASC201616>
    <holx:IncreasetoNetIncomeresultedfromadoptionofASU201616
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEyMjc4_194ce866-cf82-4492-8154-1869c13ed532"
      unitRef="usd">9900000</holx:IncreasetoNetIncomeresultedfromadoptionofASU201616>
    <holx:IncreasetoEarningsperShareresultedfromadoptionofASC201616
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEyMjg1_21fcf2f2-2274-4708-8c39-a31bd08faf7e"
      unitRef="usdPerShare">0.04</holx:IncreasetoEarningsperShareresultedfromadoptionofASC201616>
    <holx:NonIncomeTaxLoss
      contextRef="i47e07aff515740c893c4234255dbd894_D20200628-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzEzNTk3_46c20c59-2532-4b10-8929-6dcf6b55ff98"
      unitRef="usd">-2900000</holx:NonIncomeTaxLoss>
    <holx:NonIncomeTaxLoss
      contextRef="ic5fc614f9e5f468fa0553b7f4576669e_D20171231-20180331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzIvZnJhZzo1NDhmODFkZDljZmQ0NTZiYTM5ODczZGZhNzM3NjU4OS90ZXh0cmVnaW9uOjU0OGY4MWRkOWNmZDQ1NmJhMzk4NzNkZmE3Mzc2NTg5XzgyNDYzMzcyNTI3MDc_9b4eb213-2b59-406a-87eb-1562294419e6"
      unitRef="usd">-4000000.0</holx:NonIncomeTaxLoss>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4OTE_dc582b2c-2c1f-4edb-a8cd-985cc5ffaed8">Stockholders' Equity and Stock-Based Compensation&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 21, 2016, the Company's Board of Directors authorized the repurchase of up to $500.0 million of the Company's outstanding common stock over the next five years. During fiscal 2018, the Company repurchased 5.0 million shares of its common stock for a total consideration of $187.3 million under this authorization. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 13, 2018, the Board of Directors authorized another share repurchase plan to repurchase up to $500.0 million of the Company's outstanding common stock. This share repurchase plan, which replaced the prior plan, was effective August 1, 2018 and expired March 27, 2020. Under this authorization, during the fourth quarter of 2018, the Company repurchased 2.3 million shares of its common stock for total consideration of $88.5 million. During fiscal 2019, the Company repurchased 4.8 million shares of its common stock for total consideration of $200.1 million. During the first and second quarters of fiscal 2020, the Company repurchased 3.9&#160;million shares of its common stock for a total consideration of $210.9&#160;million. As of March 28, 2020, the Company had completed this authorization. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 11, 2019, the Board of Directors authorized a new share repurchase plan to repurchase up to $500.0&#160;million of the Company's outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020 the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020. Under this revised authorization during fiscal 2020, the Company repurchased 5.1&#160;million shares of its common stock for a total consideration of $237.7&#160;million. As of September 26, 2020, $262.4&#160;million was available under this authorization. Subsequent to September 26, 2020, the Company repurchased 1.1 million shares of its common stock for $74.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 19, 2019, the Board of Directors authorized the Company to repurchase up to $205 million of its outstanding shares pursuant to an accelerated share repurchase ("ASR") agreement. On November 22, 2019, the Company executed the ASR agreement with Goldman Sachs &amp;amp; Co. ("Goldman Sachs") pursuant to which the Company repurchased $205&#160;million of the Company's common stock. The initial delivery of approximately 80% of the shares under the ASR was 3.3&#160;million shares for which the Company initially allocated $164.0&#160;million of the $205&#160;million paid to Goldman Sachs during the first quarter of fiscal 2020. The Company evaluated the nature of the forward contract aspect of the ASR under ASC 815 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and concluded equity classification was appropriate. Final settlement of the transaction under the ASR occurred in the second quarter of fiscal 2020. At settlement, Goldman Sachs delivered an additional 0.6&#160;million shares of the Company's common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Compensation Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has one share-based compensation plan pursuant to which awards are currently being issued&#x2014;the 2008 amended and restated Equity Incentive Plan (&#x201c;2008 Equity Plan&#x201d;). The purpose of the 2008 Equity Plan is to provide stock options, restricted stock units and other equity interests in the Company to employees, officers, directors, consultants and advisors of the Company and any other person who is determined by the Board of Directors to have made (or is expected to make) contributions to the Company. The 2008 Equity Plan is administered by the Board of Directors of the Company, and a total of 31.5 million shares were reserved for issuance under this plan. As of September&#160;26, 2020, the Company had 5.7 million shares available for future grant under the 2008 Equity Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Operations in fiscal 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Grant-Date Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The Company considers a number of factors to determine the fair value of options including the assistance of an outside valuation adviser. Information pertaining to stock options granted during fiscal 2020, 2019 and 2018 and related assumptions are noted in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. In projecting expected stock price volatility, the Company uses a combination of historical stock price volatility and implied volatility from observable market prices of similar equity instruments. The Company estimated the expected life of stock options based on historical experience using employee exercise and option expiration data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-Based Compensation Expense Attribution&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the straight-line attribution method to recognize stock-based compensation expense for stock options and restricted stock units ("RSUs"). The vesting term of stock options is generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM1OTU_52c76a56-1dfb-4edb-afc4-0cd46b21920e"&gt;four&lt;/span&gt; or five years with annual vesting of 25% and 20%&#160;per year, respectively, on the anniversary of the grant date, and RSUs generally vest over three years with annual vesting at 33% per year on the anniversary of the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company's accounting policy is to estimate forfeitures at the time awards are granted and revise, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based on an analysis of historical forfeitures, the Company has determined a specific forfeiture rate for certain employee groups and has &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;applied forfeiture rates ranging from 0% to 6.0% as of September&#160;26, 2020 depending on the specific employee group. This analysis is re-evaluated annually and the forfeiture rate adjusted as necessary. Ultimately, the actual stock-based compensation expense recognized will only be for those stock options and RSUs that vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense related to stock options was $15.5 million, $14.1 million, and $14.3 million in fiscal 2020, 2019 and 2018, respectively. Stock compensation expense related to stock units, including RSUs, performance stock units ("PSUs"), free cash flow performance stock units ("FCFs") and market stock units ("MSUs") was $63.3 million, $43.7 million, and $46.5 million in fiscal 2020, 2019 and 2018, respectively. The related tax benefit recorded in the Consolidated Statements of Operations was $9.5 million, $8.9 million and $11.7 million in fiscal 2020, 2019 and 2018, respectively. At September&#160;26, 2020, there was $19.5 million and $50.0 million of unrecognized compensation expense related to stock options and RSUs, respectively, to be recognized over a weighted average period of 2.3 years and 1.7 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Based Payment Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all stock option activity under the Company&#x2019;s stock option plans for the year ended September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/ forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest at September 26, 2020 (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;This represents the number of vested stock options as of September&#160;26, 2020 plus the unvested outstanding options at September&#160;26, 2020 expected to vest in the future, adjusted for estimated forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019 and 2018, the total intrinsic value of options exercised (i.e., the difference between the market price on the date of exercise and the price paid by the employee to exercise the options) was $26.1 million and $15.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s RSU, PSU, FCF and MSU activity during the year ended September&#160;26, 2020 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-vested Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-Date&#160;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of RSUs vested includes shares withheld on behalf of employees to satisfy minimum statutory tax withholding requirements. The Company pays the minimum statutory tax withholding requirement on behalf of its employees. During fiscal 2020, 2019 and 2018 the total fair value of RSUs and PSUs vested was $34.9 million, $34.6 million and $38.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted 0.6&#160;million, 0.9&#160;million and 0.8&#160;million RSUs during fiscal 2020, 2019 and 2018, respectively. In addition, included in the above chart, the Company also granted 0.1 million, 0.1 million and 0.6 million PSUs during fiscal &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020, 2019, and 2018 respectively, to members of the Company's senior management team, which includes additional shares issued upon achieving metrics within the performance criteria. The PSUs were valued at $45.38, $40.97 and $40.86 per share based on the ending stock price on the date of grant in fiscal 2020, 2019 and 2018, respectively. Each recipient of the PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three year performance period provided the Company&#x2019;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million, 0.1 million and 0.3 million MSUs during fiscal 2020, 2019 and 2018, respectively, to its senior management team. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $43.54, $55.13 and $49.44 per share using the Monte Carlo simulation model in fiscal 2020, 2019 and 2018, respectively. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Hologic, Inc. 2012 Employee Stock Purchase Plan (&#x201c;2012 ESPP&#x201d;) provides for the granting of up to 2.5 million shares of the Company&#x2019;s common stock to eligible employees. The 2012 ESPP plan period is semi-annual and allows participants to purchase the Company&#x2019;s common stock at 85% of the lower of (i)&#160;the market value per share of the common stock on the first day of the offering period or (ii)&#160;the market value per share of the common stock on the purchase date. Stock-based compensation expense in fiscal 2020, 2019 and 2018 was $4.5 million, $4.2 million and $4.0 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i87614e59ad424355a0cfa527678f7644_I20160621"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzE4NQ_31f5f2e6-8ef7-4aa0-a229-eea5618b5e7a"
      unitRef="usd">500000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i567472971b68464e8f2541822940d766_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzI0NA_b9ec47bc-e243-4889-b21e-625f18ef931a">P5Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQxMQ_de337e20-8207-48e0-acb9-8936f82e5895"
      unitRef="shares">5000000.0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ3MA_a875e8af-b11b-46f6-8815-c37e20f3ff18"
      unitRef="usd">187300000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i2ffa5f4f0fd34c458b8ea83bfee55899_I20160613"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYwMg_0276defc-e29f-43f1-bd87-c9e3c28678d9"
      unitRef="usd">500000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg1MQ_71fa5d61-9ad0-444a-bb72-dd2a8e5ad399"
      unitRef="shares">2300000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="ic48110a0e8a642a6b8ca649bef79b27e_D20180701-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkxMA_eebf8e28-707d-4f32-9473-7d1c10c0fb11"
      unitRef="usd">88500000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzk1OA_68c49f85-ec94-44b3-96f1-c786443b7a0b"
      unitRef="shares">4800000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzEwMTU_549ade0a-df06-4613-8aa7-4dc81a72ad47"
      unitRef="usd">200100000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id87938771f4f4dbea1c6111f383adb40_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MjkxNDk_77c26292-4316-44f8-a9a0-0a6a0915924a"
      unitRef="shares">3900000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="id87938771f4f4dbea1c6111f383adb40_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MjkxNjI_dc328007-3939-41b7-8876-5936667f9b33"
      unitRef="usd">210900000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i344d60e17e06466e9922242e3ef82b89_I20191211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MjkxNzg_fefa74ff-356d-4347-bf3d-ae23efff197e"
      unitRef="usd">500000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i70de3cec1a1146a9ab433c3d475cc634_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg3NTY_0d12e238-0fa7-4c8b-ae8d-bdd38582a1ee"
      unitRef="shares">5100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i70de3cec1a1146a9ab433c3d475cc634_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg4NTY_59b2ac1c-e8a2-4692-b557-f4b00d386949"
      unitRef="usd">237700000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i236a8bf2139a42498b9343877c328ea5_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg4Mjc_3915ac6b-2fdc-4507-8310-3eca195ec23f"
      unitRef="usd">262400000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <holx:ASRAuthorized
      contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg3Njg_e8e4afcb-4b7d-4438-9e58-61dd6400c537"
      unitRef="usd">205</holx:ASRAuthorized>
    <holx:ASRAuthorized
      contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg4MTM_56c109ea-519b-419f-8a10-5af17fd5261e"
      unitRef="usd">205000000</holx:ASRAuthorized>
    <holx:AmountpaidduringtheperiodunderASRAgreement
      contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg3NzA_05131825-3625-4963-a54d-3610afa95002"
      unitRef="usd">164000000.0</holx:AmountpaidduringtheperiodunderASRAgreement>
    <holx:ASRAuthorized
      contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg3ODY_987b486d-6568-4954-ad8b-18af712004a7"
      unitRef="usd">205000000</holx:ASRAuthorized>
    <holx:ASRSharesRepurchasedduringtheperiod
      contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1Mjg4NDM_6ce01564-93fb-45ea-80ff-a2cad39c2e7c"
      unitRef="usd">600000</holx:ASRSharesRepurchasedduringtheperiod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ie6f4f0e51b7443bd94ce48cf225a28d3_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzIyMzc_b57ac03e-b7df-49bb-9089-96442b773857"
      unitRef="shares">31500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ie6f4f0e51b7443bd94ce48cf225a28d3_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzIzMTc_376b57d5-3843-4ef6-9cbd-3c55511e88a4"
      unitRef="shares">5700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg2OTQ_bd268358-0e83-4fcd-9d31-db11b2704158">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Operations in fiscal 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="ied1237c55f6c496982f5cf0a7ad5371b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzEtMi0xLTEtMA_b0828cf2-5ab5-423b-a40d-0d617c4810aa"
      unitRef="usd">6700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3b8a865cdda34642b4c153cb74f8c7c8_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzEtNC0xLTEtMA_9a53fe2a-220e-4b0e-a9fa-5ecdef17c85a"
      unitRef="usd">7100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i65ece6ed881340c0983a4d9a30e84a4f_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzEtNi0xLTEtMA_92073ede-04bf-4b54-a3f8-659a5e6489a9"
      unitRef="usd">8300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia8fb000016144a92804e2ae8b96faa97_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzItMi0xLTEtMA_cd280f8d-9b97-45a8-b16a-51b0b578c400"
      unitRef="usd">8000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i760d62d34b6c4e3d9fd83595b9544c75_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzItNC0xLTEtMA_1496b812-1c68-476f-b4ec-64f6409549b4"
      unitRef="usd">9200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iec0c47dbd6d148fd815d60b69a3d1af1_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzItNi0xLTEtMA_5919453b-c014-4086-a799-ae7815a8fd7f"
      unitRef="usd">9500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iec342e530b5b4e5cbbfb80a971db360b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzMtMi0xLTEtMA_2fac1492-6c79-4f25-b122-0fedacd2263e"
      unitRef="usd">10200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if9277765060a44848fd3c1bf6489f2f8_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzMtNC0xLTEtMA_9c6b100c-f620-4525-aa29-5e4a7f72f3b7"
      unitRef="usd">10200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i63c9f52dca544401a06085cc4efa3e15_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzMtNi0xLTEtMA_e64d5ed1-1a16-49b6-9d99-2cdaa4cb7140"
      unitRef="usd">10300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if09747d2102e4179be4850c578ac2e26_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzQtMi0xLTEtMA_081c2e6f-0110-494c-a020-d9f4028278ad"
      unitRef="usd">50900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i58a4ba4198cf4304a5d2849a8cd03384_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzQtNC0xLTEtMA_c1b3610b-04ad-441a-9e84-fe87891a8923"
      unitRef="usd">35500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i27273d926f654c129c15a62dc39b61d9_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzQtNi0xLTEtMA_a467a0d8-5d12-422f-b267-75175f21f87f"
      unitRef="usd">35600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iae964ccd43014ae6a1f6c43ed006fd89_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzUtMi0xLTEtMA_b2e943bd-72ae-47ce-8360-05759905dc3c"
      unitRef="usd">7500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i95e9ea3fbbd84b0ca265d809ab74762a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzUtNC0xLTEtMA_5229df41-41e5-4800-a05e-837943d6c220"
      unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id0f1f9a60e324df19c668bddb5052108_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzUtNi0xLTEtMA_f87f24c5-c21f-46d1-9407-c440506c3024"
      unitRef="usd">1300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzYtMi0xLTEtMA_a9ab3909-7620-40fc-8657-8fde909385f1"
      unitRef="usd">83300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzYtNC0xLTEtMA_4444271d-4a6a-4ca7-aa0f-870c25c735a3"
      unitRef="usd">62000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1N2EyZDk4NGQ0N2Y0OWMwOTk5MzBiZTIxYmVkNTVhYy90YWJsZXJhbmdlOjU3YTJkOTg0ZDQ3ZjQ5YzA5OTkzMGJlMjFiZWQ1NWFjXzYtNi0xLTEtMA_6d8b3c5e-f072-4be1-bebd-e198f155ee2c"
      unitRef="usd">65000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg2NzY_964f60d0-ceb7-4736-88db-e045464fdf16">Information pertaining to stock options granted during fiscal 2020, 2019 and 2018 and related assumptions are noted in the following table:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzItMi0xLTEtMA_5864bed1-3ea7-4eb7-a604-0b1b76fe2210"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzItNC0xLTEtMA_627a9d9b-0223-4fc6-bb3e-102de3ce28c7"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzItNi0xLTEtMA_295425ce-1072-49ef-8aa7-8f6cbeb3f459"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzMtMi0xLTEtMA_07dcd311-2ac2-4a7f-ae4b-5d7b009eea2b"
      unitRef="usdPerShare">45.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzMtNC0xLTEtMA_9c01bc3d-3a39-427e-9d8d-863c1dcfd5f8"
      unitRef="usdPerShare">41.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzMtNi0xLTEtMA_6e61672c-213c-4715-9915-8a2702916478"
      unitRef="usdPerShare">40.76</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzQtMi0xLTEtMA_87186ae0-cb29-43c4-a99e-46544ad6ed0e"
      unitRef="usdPerShare">13.92</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzQtNC0xLTEtMA_8d9332d9-44b7-4ac9-884d-0a75d0a81317"
      unitRef="usdPerShare">13.54</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzQtNi0xLTEtMA_6d681397-ad23-4027-8d43-99b6519ed6d9"
      unitRef="usdPerShare">12.98</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzYtMi0xLTEtMA_d3bf5707-b7be-41fb-8508-f64e0d988a4d"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzYtNC0xLTEtMA_826e7f8f-9b1c-4bd6-84fd-827c3cf82749"
      unitRef="number">0.030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzYtNi0xLTEtMA_b5934830-3c9a-463c-b064-43cfa3d286ae"
      unitRef="number">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzctMi0xLTEtMA_2833b285-e0c5-40b5-a538-40fe31cc2174">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzctNC0xLTEtMA_eceb8c06-55db-4634-bac1-3513f49e5335">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzctNi0xLTEtMA_83a1a5b4-7a44-4050-a429-37258cf37c4d">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzgtMi0xLTEtMA_eec9c569-d33a-4f35-a808-5b06cf03e6e6"
      unitRef="number">0.336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzgtNC0xLTEtMA_0893bf09-13d5-4b6b-9148-d1587694d33b"
      unitRef="number">0.343</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzgtNi0xLTEtMA_40bec5b3-43c7-46c1-ae51-f961f3ae0f27"
      unitRef="number">0.353</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzktMi0xLTEtMA_a266b9c4-6b65-4f44-8e01-991e36b6e527"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzktNC0xLTEtMA_fea216bd-a27b-4396-858d-9c527d86c246"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo1ZDk2OGMxZTczNDA0Y2FmYjI3YjkzYWRlYTg1MjM1MC90YWJsZXJhbmdlOjVkOTY4YzFlNzM0MDRjYWZiMjdiOTNhZGVhODUyMzUwXzktNi0xLTEtMA_018be374-982c-4e1a-ac4c-8df8caa4c859"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1c2c9561d23a4512999038eae996412d_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4ODc_6ccc50a7-ad08-4d2a-b149-0d66b802c76b">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <holx:PercentageOfVestingForStockOptionsGrantedToEmployees
      contextRef="ib5d1f26c41db4389981295f374b306d4_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM2MzM_c60893d9-e6a6-4771-860a-b9610f6fe79f"
      unitRef="number">0.25</holx:PercentageOfVestingForStockOptionsGrantedToEmployees>
    <holx:PercentageOfVestingForStockOptionsGrantedToEmployees
      contextRef="i1c2c9561d23a4512999038eae996412d_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM2NDA_4d98d913-82cd-4180-afc4-4855058a5c48"
      unitRef="number">0.20</holx:PercentageOfVestingForStockOptionsGrantedToEmployees>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4ODg_5bec3966-965b-4082-a35f-7e8677681ee0">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <holx:PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees
      contextRef="i09b6196b4174420b8327b0919e55fd26_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM3NzI_dd83f58d-5cdc-4c12-b026-5e5e01452519"
      unitRef="number">0.33</holx:PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees>
    <holx:ShareBasedCompensationPercentageOfForfeitureRate
      contextRef="i26ac442ab8104d62a507939b10fa969a_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzODg_092f9489-b4ad-4a6b-8a91-2aa25f593037"
      unitRef="number">0</holx:ShareBasedCompensationPercentageOfForfeitureRate>
    <holx:ShareBasedCompensationPercentageOfForfeitureRate
      contextRef="i8c09129ca98843beadfd374cfab77639_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTQ_5b94967b-4bb6-43ea-b32a-4ab1b3531884"
      unitRef="number">0.060</holx:ShareBasedCompensationPercentageOfForfeitureRate>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ice730bb0ac124aad881fa4077c12c6df_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ3Mjg_751adfe5-000c-4e33-a4ef-23c924a27b88"
      unitRef="usd">15500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2e8fd89d9b9f477a8ed2176e6f8d2ed8_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ3MzI_e299cc6c-f471-4970-a6af-5ff8c372d3c7"
      unitRef="usd">14100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4b926d761276461084bf3fb001bd3488_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ3NDA_aa45ed9d-fa50-4797-8a49-af46034be291"
      unitRef="usd">14300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ5MTg_b9e46652-a9d6-4965-9b61-cf7823ba0f27"
      unitRef="usd">63300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i104ee4ba76c74aed9b201714d5f8ce04_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ5MjI_e2a88151-e07d-47d9-ad4b-78ba0af31069"
      unitRef="usd">43700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i43643c78c5974a028da555a478aa52e7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQ5MzA_9c5e7497-6d59-4761-90dd-93b22e92a0e5"
      unitRef="usd">46500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUwNTQ_298158f1-1766-4910-ac3a-253109aa1b94"
      unitRef="usd">9500000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUwNTg_6ec17272-6b09-4a87-b390-01060229cffa"
      unitRef="usd">8900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUwNjU_028b0517-913b-470e-8f91-19621fbed876"
      unitRef="usd">11700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iec34ce09c17f4512b3a712e8d193c4ce_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUxMjg_bb24d834-c11c-4c36-bb68-6df7daa664ef"
      unitRef="usd">19500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i9d45047c3cf742559c39657d33045548_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUxMzU_66e238f3-7e52-46d1-ab4e-e745784b390b"
      unitRef="usd">50000000.0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ice730bb0ac124aad881fa4077c12c6df_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUyNzU_9add0e32-90a7-47fe-b756-a2b3f072a463">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzUyODg_8f0f3184-7b70-4779-a002-f2343966b233">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg3MDE_5f961a9c-b0c1-4721-91bd-4ced38838b56">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all stock option activity under the Company&#x2019;s stock option plans for the year ended September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/ forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest at September 26, 2020 (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;This represents the number of vested stock options as of September&#160;26, 2020 plus the unvested outstanding options at September&#160;26, 2020 expected to vest in the future, adjusted for estimated forfeitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzEtMi0xLTEtMA_f8109d1e-f2cd-40fc-8981-b1ca01b84179"
      unitRef="shares">5500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzEtNC0xLTEtMA_ae492b8d-8dee-44bb-9f8e-80395181b036"
      unitRef="usdPerShare">35.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzEtNi0xLTEtMA_50d32b90-eb34-4850-a56c-306b995657eb">P6Y1M6D</holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzEtOC0xLTEtMA_a4fbd03b-97cf-4b8d-8879-cd14b4aa57db"
      unitRef="usd">78400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzItMi0xLTEtMA_a40bdaa4-47f2-4016-b84e-8455001e3f2a"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzItNC0xLTEtMA_e8d10029-bf22-4c16-87f8-043723ba8eb3"
      unitRef="usdPerShare">45.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzMtMi0xLTEtMA_b39ebf87-4087-44aa-9560-28e30dfec2c3"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzMtNC0xLTEtMA_1ad8756d-0849-426f-8199-4db1f2d7471b"
      unitRef="usdPerShare">42.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzQtMi0xLTEtMA_51633511-64b6-4fb0-975c-7bbde7ea154e"
      unitRef="shares">1800000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzQtNC0xLTEtMA_0a422bf3-8f92-4ef4-a74b-2c5725c9af6d"
      unitRef="usdPerShare">27.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzQtOC0xLTEtMA_0a3a8f06-ad4b-4b99-836b-5c75b2ff3294"
      unitRef="usd">44800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzUtMi0xLTEtMA_977fec56-69e0-4c2d-86ec-88fe5850e254"
      unitRef="shares">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzUtNC0xLTEtMA_761d5c71-13ef-44dd-b09e-c58abbc04bed"
      unitRef="usdPerShare">40.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzUtNi0xLTEtMA_3e26c9e6-6f58-4130-baae-d25589980422">P7Y</holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzUtOC0xLTEtMA_8a5a869f-5617-4f3f-b0d3-b56a4523d22d"
      unitRef="usd">109500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzYtMi0xLTEtMA_39885875-e6e5-44fb-9152-51c27d4840a9"
      unitRef="shares">2200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzYtNC0xLTEtMA_ab423d0e-a6bf-4e26-ab25-5b30e918dcb5"
      unitRef="usdPerShare">37.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzYtNi0xLTEtMA_b734c70c-a7c1-4b8b-bb70-3851f08e9553">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzYtOC0xLTEtMA_fa35d8b3-07e6-445b-9981-780f100dcbcb"
      unitRef="usd">57200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzctMi0xLTEtMA_24c42ba5-fdf6-4102-a7dd-48341cadf5fe"
      unitRef="shares">4500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzctNC0xLTEtMA_99b23fee-1d51-458b-a853-0319510c1722"
      unitRef="usdPerShare">40.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzctNi0xLTEtMA_d6bc9fe7-a779-4b1b-ab8c-255d53a3f0da">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTplNzQxMTczZWNkZjI0MzI0ODMwMjAzNWFlM2MyZjExZi90YWJsZXJhbmdlOmU3NDExNzNlY2RmMjQzMjQ4MzAyMDM1YWUzYzJmMTFmXzctOC0xLTEtMA_52fd646a-317e-40d3-90d2-25e95378c8c6"
      unitRef="usd">108900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzU4NDY_f7f965cc-e7e3-4c25-9b06-02f13ecfe22b"
      unitRef="usd">26100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzU4NTM_20005131-7ed2-498e-9ccc-c734b3fb21ee"
      unitRef="usd">15200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg2OTA_a5585e35-6ce8-49fa-83a7-183443ef23ef">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s RSU, PSU, FCF and MSU activity during the year ended September&#160;26, 2020 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-vested Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-Date&#160;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzEtMi0xLTEtMA_287f646e-b50a-494a-979a-57bdfb2ccbff"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzEtNC0xLTEtMA_a291c830-f923-4880-a818-d7c745287cc1"
      unitRef="usdPerShare">42.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzItMi0xLTEtMA_04a70ede-9ba3-464e-9675-e9168bf5f8e0"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzItNC0xLTEtMA_7b9fef6b-eebc-46c1-869b-2f4f2064b6f2"
      unitRef="usdPerShare">45.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzMtMi0xLTEtMA_af883ff1-e40f-465f-9472-7d333caf8c8d"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzMtNC0xLTEtMA_4361269b-9879-4a00-8f12-8095e0403aa0"
      unitRef="usdPerShare">38.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzQtMi0xLTEtMA_7c3ea5af-49c3-4b73-a951-a2c9ef276dc5"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzQtNC0xLTEtMA_ec1b4e0a-3eb4-45fe-bf2f-c2bf4c4e660b"
      unitRef="usdPerShare">42.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzUtMi0xLTEtMA_47bada09-799c-4e22-8c96-cc527aca5bdc"
      unitRef="shares">2400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZTo5NWE2ZjJiNzc4ZjE0ZGE1YjIxMGI1ZTQ2YzQyNjNhNy90YWJsZXJhbmdlOjk1YTZmMmI3NzhmMTRkYTViMjEwYjVlNDZjNDI2M2E3XzUtNC0xLTEtMA_822c264c-7d1e-4400-9af3-56c7cc1a9322"
      unitRef="usdPerShare">44.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i3681d78e942f48e4a18a6bdc2a4d0e14_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYyNzg_142222a6-fe76-476e-bc1c-541688369592"
      unitRef="usd">34900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i104ee4ba76c74aed9b201714d5f8ce04_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYyODI_86f55e12-12e6-4bec-b130-40c5f344f8ce"
      unitRef="usd">34600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i43643c78c5974a028da555a478aa52e7_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYyODk_72c2f5ea-d5ad-44f7-95fe-f86ec752f9f1"
      unitRef="usd">38900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia847fce0b90344668cafc984721d53fe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2MzI_5256e4d2-418b-4c9d-8311-c607d613a0d2"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i29db4dc36329440196aa20118733f489_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2NDU_59c2c6bb-4fa6-47a1-ab2c-b7f496eee8ff"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i938586f669074d699e349df7bfd5a870_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2NTg_9e3230a8-1720-4a2a-8fa4-3ee7569e0b52"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i26da8197478a4c5594b3a0e032588eea_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYzNTY_962feb72-c153-4a7b-90cc-f314ab15e73f"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2faaf0252c0e495f89cf1661f67bfe89_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYzNjM_7ae2c64f-812f-412f-b083-9e156e96c4e7"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8fce35bd4c5b47ffb3ff0ea7000a3d6b_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzYzNzA_40b8ee1d-5572-4a13-869e-e6052040c193"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i26da8197478a4c5594b3a0e032588eea_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2NzE_c0a6cd72-9a71-421a-b980-6ee0d83c4855"
      unitRef="usdPerShare">45.38</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i2faaf0252c0e495f89cf1661f67bfe89_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2ODE_5dfecd53-5af2-45da-bf33-5d65472250b3"
      unitRef="usdPerShare">40.97</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i8fce35bd4c5b47ffb3ff0ea7000a3d6b_D20171001-20180929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MzI2ODk_b9d9bf46-f7c5-4c17-bbb8-283119000645"
      unitRef="usdPerShare">40.86</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzY2MzA_ac535bd4-97f7-44a0-b4d2-c58a1291c63b"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzY2Mzc_85f19a30-0a8e-42ec-97f0-92ca71b0d155"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4ODk_40c68acf-0a57-48ce-8ad8-d533c97620e8">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i4bfbce83a3f04755b0b598f232407953_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzQzOTgwNDY1MjQ3MDQ_29412ed7-4d78-4087-a24b-eab40fc7587d"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTgwMTY_ddcde8fb-ac00-457b-89d7-8ed2f40488fc">P3Y</holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzcyOTA_4083cfca-928e-4328-ab0c-bafef7533f57"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if28b5094554845ab80d0c3c9b07c0ebd_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzcyOTQ_86091c64-ae1c-4ca4-9122-f030bf760073"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i15f3d181c2484886bc4ceaa42ec74fc4_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzczMDE_4f21e616-c071-4742-9fd2-a17b14fd77c6"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc0NDM_7e3daa5e-bdd3-4ea8-86b0-52aa84316875"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc0NTA_47c57859-da1e-4a99-9b10-78edfe300db4"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc2Njk_43f13941-c8da-4d42-b5f6-972ec41ed190"
      unitRef="usdPerShare">43.54</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="if28b5094554845ab80d0c3c9b07c0ebd_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc2NzM_6f2f3e10-f235-4cdb-b266-db1f5f9c6880"
      unitRef="usdPerShare">55.13</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i15f3d181c2484886bc4ceaa42ec74fc4_D20171001-20180929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzc2ODA_33dda1e6-de4f-4e6a-a538-59fb54a1ba03"
      unitRef="usdPerShare">49.44</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate
      contextRef="iacb7b936f52240ecbdb7c53ae7d28726_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzkzNDU4NDg4NTQ4OTA_9ac3a47f-a01e-4290-a477-5abab1f0f5ab">P3Y</holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate>
    <holx:NumberOfSharesIssuableUnderEmployeeStockPurchasePlan
      contextRef="i9cdd3310d03c410ca044b216790a4efd_D20120301-20120331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzgwNTg_fb877be8-3bc2-429d-90f9-6ffb93c73799"
      unitRef="shares">2500000</holx:NumberOfSharesIssuableUnderEmployeeStockPurchasePlan>
    <holx:PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase
      contextRef="i9cdd3310d03c410ca044b216790a4efd_D20120301-20120331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzgyMjg_3b7c8e77-a8e2-4882-983a-d326ead1b2f6"
      unitRef="number">0.85</holx:PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase>
    <us-gaap:ShareBasedCompensation
      contextRef="i03f873eba04440daa1996d87fcc393ff_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg0NzY_c496bf55-a089-4e99-9abd-20326d74d5dc"
      unitRef="usd">4500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia8a80c13b2f643e4ba3bad6e12f15dce_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg0ODA_43088191-8ea8-4a57-999e-10562773cba0"
      unitRef="usd">4200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie56ea29037024f99b13b9416f137590f_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg0ODc_6ea52e84-0687-4be8-8ff2-482f70133210"
      unitRef="usd">4000000.0</us-gaap:ShareBasedCompensation>
    <holx:ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzg2OTI_62c539bf-a08a-4ea3-9fb2-5ff4e1fccba5">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzItMi0xLTEtMA_721299bf-89d7-426d-9639-ae9e564d21e8"
      unitRef="number">0.0132</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzItNC0xLTEtMA_7c4e987d-89fd-4c4d-9be8-de6b7a8d4f3e"
      unitRef="number">0.0227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if304b540b69e455f95347a24194deea2_D20171001-20180929"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzItNi0xLTEtMA_bff854e1-a077-44f8-a55b-e57d195631ef"
      unitRef="number">0.0162</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzMtMi0xLTEtMA_8af27cb9-7e7c-43a8-a23f-1db52bbc946a">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzMtNC0xLTEtMA_ef08d1d9-2c2b-418c-8284-6c0eb59adb89">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if304b540b69e455f95347a24194deea2_D20171001-20180929"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzMtNi0xLTEtMA_eea6d823-7fd4-4b8a-8b72-219fe52d30ab">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzQtMi0xLTEtMA_d6b63db2-5a75-43d2-8b4a-8f7b525e4825"
      unitRef="number">0.269</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzQtNC0xLTEtMA_26769ece-f2df-4900-8a5f-d34e65b68af3"
      unitRef="number">0.271</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="if304b540b69e455f95347a24194deea2_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzQtNi0xLTEtMA_eecd5ac9-776e-4c73-baba-2334d72fb5f5"
      unitRef="number">0.250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzUtMi0xLTEtMA_9bcb9791-992b-4ad0-a75c-3652a04ea0c6"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i53788023c01b402f86ba636f4418a0c7_D20180930-20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzUtNC0xLTEtMA_8fa5a627-d606-4469-a321-4d8533e2ed5d"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="if304b540b69e455f95347a24194deea2_D20171001-20180929"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90YWJsZToxZmVmN2M2NmQwZTQ0OWU5OTQxOTY0YzUyZTk1NDlmNi90YWJsZXJhbmdlOjFmZWY3YzY2ZDBlNDQ5ZTk5NDE5NjRjNTJlOTU0OWY2XzUtNi0xLTEtMA_ebfe2324-cb3f-4f07-966d-522fab07698f"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <holx:ProfitSharingFourZeroOneKPlanTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODEvZnJhZzozODg3NzVhNGVhMzk0ZWRkYjY1YTE5NjhhNzQ0N2RiYy90ZXh0cmVnaW9uOjM4ODc3NWE0ZWEzOTRlZGRiNjVhMTk2OGE3NDQ3ZGJjXzE5Nw_42755769-aea2-40ad-9d17-a0e34a7ebb22">401(k) PlanThe Company's U.S. employees have access to a qualified 401(k) defined contribution plan. The Company made contributions of $19.6 million, $19.2 million and $18.6 million for fiscal 2020, 2019 and 2018, respectively.</holx:ProfitSharingFourZeroOneKPlanTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODEvZnJhZzozODg3NzVhNGVhMzk0ZWRkYjY1YTE5NjhhNzQ0N2RiYy90ZXh0cmVnaW9uOjM4ODc3NWE0ZWEzOTRlZGRiNjVhMTk2OGE3NDQ3ZGJjXzE0NQ_240ebd3d-2e84-4a5b-9acc-c71512ce45a6"
      unitRef="usd">19600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODEvZnJhZzozODg3NzVhNGVhMzk0ZWRkYjY1YTE5NjhhNzQ0N2RiYy90ZXh0cmVnaW9uOjM4ODc3NWE0ZWEzOTRlZGRiNjVhMTk2OGE3NDQ3ZGJjXzE0OQ_a396126a-90f1-4394-823b-8262a7c2d5a5"
      unitRef="usd">19200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODEvZnJhZzozODg3NzVhNGVhMzk0ZWRkYjY1YTE5NjhhNzQ0N2RiYy90ZXh0cmVnaW9uOjM4ODc3NWE0ZWEzOTRlZGRiNjVhMTk2OGE3NDQ3ZGJjXzE1Ng_ad81c348-848b-4d13-9241-bdc407826b19"
      unitRef="usd">18600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <holx:MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp
      contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzM3Nw_f5b87b1a-b682-4540-9260-e57bd32c0377"
      unitRef="number">0.75</holx:MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp>
    <holx:MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp
      contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzQxMg_d7fcbbbb-5cc8-43df-b94e-6b67a946d75a"
      unitRef="number">1</holx:MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp>
    <holx:EmployeeContributionsVestedPercentage
      contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzQ4NA_5e9016df-b400-4a25-aefa-c93edb619d68"
      unitRef="number">1</holx:EmployeeContributionsVestedPercentage>
    <holx:EmployerContributionsVestingPeriod
      contextRef="i89dc067ea55a42809194d94e740c9bee_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzkzNDU4NDg4Mzk4NDI_91d98935-5fa6-4c84-8964-16f14c55f06d">P3Y</holx:EmployerContributionsVestingPeriod>
    <holx:EmployerContributionsVestingPeriod
      contextRef="i89dc067ea55a42809194d94e740c9bee_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzkzNDU4NDg4Mzk4NDE_cc47945a-8959-4dbe-81ed-4a438e1ad573">P3Y</holx:EmployerContributionsVestingPeriod>
    <holx:NonqualifiedDeferredCompensationPlanAnnualContribution
      contextRef="i483253a9fb124537b3e55eaefd37cf58_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE3ODY_2c343d70-f946-4ad8-8967-f30ba92b76ce"
      unitRef="usd">3100000</holx:NonqualifiedDeferredCompensationPlanAnnualContribution>
    <holx:NonqualifiedDeferredCompensationPlanAnnualContribution
      contextRef="i4f373267ff8f45d1911298976ebff835_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE3OTA_eb38c64a-7e0e-4caa-988d-243191aca039"
      unitRef="usd">2700000</holx:NonqualifiedDeferredCompensationPlanAnnualContribution>
    <holx:NonqualifiedDeferredCompensationPlanAnnualContribution
      contextRef="i7c7afed9db584308a9e0b366c0c10595_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE3OTc_44f353b2-e74d-4344-a3e6-82b5cd221e1e"
      unitRef="usd">2900000</holx:NonqualifiedDeferredCompensationPlanAnnualContribution>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE5ODg_90b7310c-b676-40bf-9b19-77918d34f17e"
      unitRef="usd">57700000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzE5OTU_036e389d-5ea3-44f5-b13f-6af9b8ebe0ec"
      unitRef="usd">51900000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <holx:InvestmentInGroupLifeInsuranceContracts
      contextRef="ib6c043d4da794f2fa73ea7b9a2d37948_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzIzMDI_2eddb08f-bcf5-40a9-a4a7-132955344f04"
      unitRef="usd">49300000</holx:InvestmentInGroupLifeInsuranceContracts>
    <holx:InvestmentInGroupLifeInsuranceContracts
      contextRef="i8e43de73b36940809bd154646af2ad6b_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODQvZnJhZzo1ODE0NDhmZjE1ODY0YWEwYTc3ODkzYjE5ZjhmNWU2ZS90ZXh0cmVnaW9uOjU4MTQ0OGZmMTU4NjRhYTBhNzc4OTNiMTlmOGY1ZTZlXzIzMDk_00dcdac8-d16c-463a-9541-0031f146fe6b"
      unitRef="usd">44600000</holx:InvestmentInGroupLifeInsuranceContracts>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90ZXh0cmVnaW9uOjc0OTZmYWEzYzE0MzQyMmFhZjU4OTIyMTk5NTQ5YWZmXzQ4Nzg_59fc9029-ce74-438c-a219-52a1a4f5dab1">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain non-cancelable purchase obligations primarily related to inventory purchases and diagnostics instruments, primarily Panther systems, and to a lesser extent other operating expense commitments. These obligations are not recorded in the Consolidated Balance Sheets. For reasons of quality assurance, sole source availability or cost effectiveness, certain key components and raw materials and instruments are available only from a sole supplier and the Company has certain long-term supply contracts to assure continuity of supply. At September&#160;26, 2020, non-cancelable purchase commitments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90ZXh0cmVnaW9uOjc0OTZmYWEzYzE0MzQyMmFhZjU4OTIyMTk5NTQ5YWZmXzQ4NTU_8a07ba4f-8b37-4145-8d9d-f154c4457d94">At September&#160;26, 2020, non-cancelable purchase commitments are as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzAtMS0xLTEtMA_aff81fee-83ee-4557-a39d-d53ea01ff7f4"
      unitRef="usd">267700000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzEtMS0xLTEtMA_21a3d422-2096-4398-864d-10f7cad0cb96"
      unitRef="usd">10200000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzItMS0xLTEtMA_9663128b-a9e7-4165-b5c6-6caaa58d9842"
      unitRef="usd">700000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligationDueInFourthYear
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzMtMS0xLTEtMA_8a5ce909-0f3f-4e06-a743-124ca5e0d26c"
      unitRef="usd">700000</us-gaap:PurchaseObligationDueInFourthYear>
    <us-gaap:PurchaseObligationDueInFifthYear
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzQtMS0xLTEtMA_fb423eb0-5b9a-4981-b397-6f4d364277f4"
      unitRef="usd">400000</us-gaap:PurchaseObligationDueInFifthYear>
    <holx:Purchaseobligationthereafter
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzUtMS0xLTEtMA_4e1279ec-6afc-4565-ad87-4a0ac5854f3a"
      unitRef="usd">100000</holx:Purchaseobligationthereafter>
    <us-gaap:PurchaseObligation
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTAvZnJhZzo3NDk2ZmFhM2MxNDM0MjJhYWY1ODkyMjE5OTU0OWFmZi90YWJsZTpkMGIzM2VhZDRiM2U0MDQ1ODk3OTBmZWNlZTNiMzZlOS90YWJsZXJhbmdlOmQwYjMzZWFkNGIzZTQwNDU4OTc5MGZlY2VlM2IzNmU5XzYtMS0xLTEtMA_fa9afa51-25fa-40df-b180-36824cd93c33"
      unitRef="usd">279800000</us-gaap:PurchaseObligation>
    <holx:LitigationAndOtherMattersTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTMvZnJhZzoxODE4ZTc0ZTQxMjI0MjhjOTIyMTc2NDc0MzI2MDU1Zi90ZXh0cmVnaW9uOjE4MThlNzRlNDEyMjQyOGM5MjIxNzY0NzQzMjYwNTVmXzEzMzQw_8073d1de-6428-415c-9ac0-c271a2b09175">Litigation and Related Matters&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#x201c;Minerva&#x201d;) in the United States District Court for the District of Delaware, alleging that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#x2019;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#x2019;s motion for a preliminary injunction on its patent claims and denied Minerva&#x2019;s request for preliminary injunction related to the Company&#x2019;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#x2018;183 and &#x2018;348 patents. The Court also granted the Company&#x2019;s motion for summary judgment on assignor estoppel, which bars Minerva&#x2019;s invalidity defenses or any reliance on collateral findings regarding invalidity from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review proceedings. The Court also denied all of Minerva&#x2019;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#x2019;s infringement; (2) found that Minerva&#x2019;s infringement was not willful; and (3) found for the Company regarding Minerva&#x2019;s counterclaims. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the &#x2018;348 patent. On April 11, 2016, Minerva filed a petition for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#x2018;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#x2019;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#x2019;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#x2018;348 patent. The Court of Appeals also denied the Company&#x2019;s motion for a permanent injunction and ongoing royalties for infringement of the &#x2018;183 patent. The Court of Appeals denied Minerva&#x2019;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#x2019;s petition for Supreme Court review, which was filed on September 30, 2020. On November 5, 2020, the Company opposed Minerva&#x2019;s petition and filed a counter petition for Supreme Court review.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#x201c;Cytyc&#x201d;) in the United States District Court for the Northern District of California alleging that the Company&#x2019;s and Cytyc&#x2019;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#x2019;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#x2019; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. On March 9, 2020, Minerva elected to withdraw its claim for lost profits damages&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; The original trial date of July 20, 2020 was vacated due to circumstances surrounding the COVID-19 pandemic. On October 21, 2020, the Court entered an amended case schedule and set a new trial date of August 9, 2021. The parties submitted a joint status report on September 25, 2020. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 8, 2020, the Company filed suit against Minerva in the United States District Court for the District of Delaware, alleging that Minerva&#x2019;s redesigned endometrial ablation device infringes U.S. Patent 9,095,348 (the '348 patent). A trial is set to begin on August 23, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On February 3, 2017, bioM&#xe9;rieux, S.A. and bioM&#xe9;rieux, Inc. (collectively &#x201c;bioM&#xe9;rieux&#x201d;) filed suit against the Company in the United States District Court for the Middle District of North Carolina ("MDNC"), alleging that the Company&#x2019;s HIV products, including blood screening products previously manufactured by the Company for its former blood screening &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;partner Grifols Diagnostic Solutions Inc. ("Grifols USA"), infringe U.S. Patent Nos. 8,697,352 and 9,074,262. On January 3, 2018, the MDNC Court granted the parties&#x2019; consent motion to transfer the case to Delaware. On June 11, 2019, the Court issued a claim construction ruling regarding the disputed terms in the patents. Motions for summary judgment were filed by the parties on September 30, 2019, and a hearing on these motions was held on December 18, 2019. A six-day trial concluded on February 25, 2020, with the jury finding that all claims of U.S. Patent No. 8,697,352 are invalid (U.S. Patent No. 9,074,262 was dropped from the case by bioM&#xe9;rieux prior to trial). On March 18, 2020, the parties agreed to a settlement under which bioM&#xe9;rieux agreed to dismiss all claims with prejudice and to waive the filing of post-trial motions and pursuing an appeal in exchange for a de minimis payment from the Company and Grifols USA.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 15, the Company has agreed to indemnify CD&amp;amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $8.5&#160;million accrued as of September 26, 2020, but this amount could become greater if some or all of the cases which it is indemnifying have an adverse result.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Legal costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</holx:LitigationAndOtherMattersTextBlock>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i2e92294f2cda48528702362448bfea27_D20180727-20180727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTMvZnJhZzoxODE4ZTc0ZTQxMjI0MjhjOTIyMTc2NDc0MzI2MDU1Zi90ZXh0cmVnaW9uOjE4MThlNzRlNDEyMjQyOGM5MjIxNzY0NzQzMjYwNTVmXzE5NTE_a0622c2a-2fbe-45b6-b09c-d0f1ab1dcc63"
      unitRef="usd">4800000</us-gaap:LossContingencyDamagesAwardedValue>
    <holx:LegalAccrual
      contextRef="i0114d332bb424de8ad15f9a123dde503_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTMvZnJhZzoxODE4ZTc0ZTQxMjI0MjhjOTIyMTc2NDc0MzI2MDU1Zi90ZXh0cmVnaW9uOjE4MThlNzRlNDEyMjQyOGM5MjIxNzY0NzQzMjYwNTVmXzQzOTgwNDY1NTk3NTQ_6e8954d3-9f42-4146-86f4-f00f6cfeabe9"
      unitRef="usd">8500000</holx:LegalAccrual>
    <holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzUwNTQ_707c5ec6-2160-43c6-957d-86bbde94a6e9">Disposition&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sale of Medical Aesthetics&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp;amp; Rice ("CD&amp;amp;R") for a sales price of&#160;$205.0&#160;million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4&#160;million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczODg_f503a2d8-b974-4218-b6e9-25fc199ad879"&gt;three&lt;/span&gt; to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or that will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;amp;R, the Company recorded an impairment charge of $30.2&#160;million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8&#160;million was allocated to cost of product revenues and $4.4&#160;million to operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets and liabilities of the disposed business at the date of disposition were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.169%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets disposed of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities disposed of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss from operations of the disposed business presented below represents the operating loss of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business. As noted above, the Company is performing a number of transition services and the financial impact from these services are not included in the amounts presented below. In addition, the Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition, which it will continue to report in the Medical Aesthetics reportable segment. Subsequent to the disposition, the Company recorded additional expenses of $6.2&#160;million primarily for accelerated stock compensation, inventory reserves under the manufacturing supply agreement, and legal expenses and settlements, which are not included in the below amounts. Loss from operations of the disposed business for the years ended September&#160;26, 2020 and September&#160;28, 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(781.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ic44cf4cf70a04fdb8f94550d3bfe376d_I20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwMzM_82a12680-b7a2-4f4e-8dc0-156c7151bc09"
      unitRef="usd">205000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ic289be57c33044b29af60557d0832bb1_D20191120-20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTI1MTI_c41e5d65-6d0f-47bf-94f0-12cc7514c74b"
      unitRef="usd">153400000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <holx:DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice
      contextRef="idb517eaea5304290a5928b03c9057b33_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczMzg_ee6ec03e-8449-4c83-81ff-4a811dbe2553"
      unitRef="usd">150000000.0</holx:DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice>
    <holx:TransitionServicesAgreementTerm
      contextRef="icb5e44232158447d887e2d49f5bc7e16_D20200628-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczNzM_bdb92fe3-7468-4b78-b05c-744a17526fa5">P15M</holx:TransitionServicesAgreementTerm>
    <holx:IndemnificationLiabily
      contextRef="idb517eaea5304290a5928b03c9057b33_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwNTA_85f02185-6116-44d7-9f72-742efb64ad29"
      unitRef="usd">10900000</holx:IndemnificationLiabily>
    <us-gaap:AssetImpairmentCharges
      contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwOTQ_95ddfba5-5cfa-482d-acf3-a9fcf17cf1ae"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ie9dabb1d61574d2cab21bd7863b8df8b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwNzk_c30f184d-7013-4ee4-aebe-fbe7e0f74c3c"
      unitRef="usd">25800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i67c6559862da4a42b4a96b86727df860_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzQzOTgwNDY1MjMwNjU_f461913a-ca87-4d01-bfa7-8d1eeebeb69f"
      unitRef="usd">4400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTI0ODE_7955c357-d73e-42a9-a6b0-13c3b51104b0">&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets and liabilities of the disposed business at the date of disposition were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.169%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets disposed of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities disposed of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzEtMi0xLTEtNDAyOA_81241999-c3c1-42b1-8d02-0e7c8d969ff6"
      unitRef="usd">10700</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzItMi0xLTEtNDAyOA_2da97304-a4e4-4ef5-8cb3-ee6c4cab6558"
      unitRef="usd">59600</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzMtMi0xLTEtNDAyOA_b53f4c55-e2e2-4a67-8710-f41ccc155381"
      unitRef="usd">90600</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzQtMi0xLTEtNDAyOA_3721f4fa-5faa-4830-9fce-1b65cbfb9d03"
      unitRef="usd">7700</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzUtMi0xLTEtNDAyOA_98e4d9ab-347a-46ac-9e04-ce160902d3ca"
      unitRef="usd">4000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzYtMi0xLTEtNDAyOA_d8adc42c-4f41-4faa-a789-21d8ae5031de"
      unitRef="usd">28200</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzctMi0xLTEtNDAyOA_540649d1-04db-4d77-8f61-8a175ab02de0"
      unitRef="usd">9800</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzgtMi0xLTEtNDAyOA_4eac528e-163e-4709-ac7d-d546991e4fee"
      unitRef="usd">210600</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzExLTItMS0xLTQwMzA_4addfb0f-850a-497a-b3ca-6eb491f6a04a"
      unitRef="usd">12300</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzEyLTItMS0xLTQwMzA_12244af4-d73a-4aa1-b735-e10a2fae3314"
      unitRef="usd">49000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzEzLTItMS0xLTQwMzA_33a4da7b-56f7-4e8b-8bef-bf8f9fcd964b"
      unitRef="usd">16600</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1250d182bbb64e628b8bb4c093917a38_I20200328"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTphMTliYTU1YmVkYmY0OGNlOGE5YzUzYmIwYzBmNmE4Zi90YWJsZXJhbmdlOmExOWJhNTViZWRiZjQ4Y2U4YTljNTNiYjBjMGY2YThmXzE3LTItMS0xLTQwMzA_5d880a50-04b3-412e-af6a-fac2c41dcee8"
      unitRef="usd">77900</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <holx:Expensesfromdisposition
      contextRef="ib7ee604a08d9432db6b6ba59a610c36f_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczMjQ_d1b93677-9808-4a53-9339-3e9969059b07"
      unitRef="usd">6200000</holx:Expensesfromdisposition>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTI0ODA_c3fdcf15-93bf-4f0e-8ae2-54b276fa88be">Loss from operations of the disposed business for the years ended September&#160;26, 2020 and September&#160;28, 2019 was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(781.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTo4ODAwMzE3ZjIzN2U0YzdiYjU2ZGY3NzJkZjAwYjI2MC90YWJsZXJhbmdlOjg4MDAzMTdmMjM3ZTRjN2JiNTZkZjc3MmRmMDBiMjYwXzMtNS0xLTEtNDA0Mw_b4b463be-5253-45aa-9d53-2ede3d920530"
      unitRef="usd">-46500</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90YWJsZTo4ODAwMzE3ZjIzN2U0YzdiYjU2ZGY3NzJkZjAwYjI2MC90YWJsZXJhbmdlOjg4MDAzMTdmMjM3ZTRjN2JiNTZkZjc3MmRmMDBiMjYwXzMtNi0xLTEtNDA0Mw_bd04499e-f18a-4001-ab60-d8835ddbdd84"
      unitRef="usd">-781200</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzI1MTg_bff92be6-5135-476e-acab-96d6f201f8ce">Business Segments and Geographic Information&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports segment information in accordance with ASC 280, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions about how to allocate resources and assess performance. The Company&#x2019;s chief operating decision maker is its chief executive officer, and the Company&#x2019;s reportable segments have been identified based on the types of products manufactured and the end markets to which the products are sold. Each reportable segment generates revenue from either the sale of medical equipment and related services and/or sale of disposable supplies, primarily used for diagnostic testing and surgical procedures. During the first quarter of fiscal 2020, and each of fiscal 2019 and 2018, the Company had five reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. The Company completed the sale of its Medical Aesthetics business on December 30, 2019, but has continued to incur operating expenses primarily related to indemnification provisions and other matters. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.&lt;/span&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Identifiable assets for the five reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its five reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues. Segment information for fiscal 2020, 2019, and 2018 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(781.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(844.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,276.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,442.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,457.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,442.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#x2019;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#x2019;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#x201c;Rest of world&#x201d; designation includes Canada, Latin America and the Middle East.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company&#x2019;s property, plant and equipment, net were geographically located as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costa Rica&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzE0Mzg_eaba9541-35b1-4a9a-8349-85b9b262bbf1"
      unitRef="segment">5</us-gaap:NumberOfReportableSegments>
    <us-gaap:Revenues
      contextRef="i7514ebbfb861409a9489e0c250534728_D20180930-20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzE3MTk_276babe0-dd8b-4943-8759-465d1fb1f4af"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6dcaf3ae16134f4ca7481e8ef0375fed_D20171001-20180929"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzE3MTk_785b3333-b1e5-4a50-9b43-7e7f77adc128"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7906857f1349431c8b718e5f5bc62d21_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzE3MTk_ee843421-0fa7-4e1e-bb07-4ac0e56e6c55"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzI1MjI_1aa050cf-57c4-4803-8500-5c0374896199">Segment information for fiscal 2020, 2019, and 2018 was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(781.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(844.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,276.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,442.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,457.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,442.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMtMi0xLTEtMA_cf073c34-9630-4392-b5a7-9b90e1d09a57"
      unitRef="usd">2102100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMtNC0xLTEtMA_27cc5306-86a9-4838-a440-01c65fd1a533"
      unitRef="usd">1205500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMtNi0xLTEtMA_57e44c69-b8a5-4494-9517-46d498333406"
      unitRef="usd">1147400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzQtMi0xLTEtMA_28b9c348-b3b5-4c4b-8a1f-0728627ebf1a"
      unitRef="usd">1151900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzQtNC0xLTEtMA_bafd83d3-02e3-4a24-a1c1-b61259d23cbb"
      unitRef="usd">1314200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzQtNi0xLTEtMA_909c38a1-5a0e-408a-8852-dbd32b392f7b"
      unitRef="usd">1218200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtMi0xLTEtNjY0Mg_1bbff9b2-0317-4e8e-9229-f1581438a85a"
      unitRef="usd">376100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtNC0xLTEtNjY0Mg_2f20cb1e-c511-4d7e-be61-da541eb93d2d"
      unitRef="usd">437200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtNi0xLTEtNjY0Mg_d3d12a19-1f56-4b63-9d4f-893788be90cd"
      unitRef="usd">422000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzYtMi0xLTEtMTA1ODY_0bbabfaa-5025-4379-a3ce-18571684660b"
      unitRef="usd">81000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzYtNC0xLTEtMTA1ODY_1d4025f7-e83e-4cd7-9933-e5c8da08e446"
      unitRef="usd">94800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzYtNi0xLTEtMTA1ODY_aa38ff9f-821e-4aad-b691-630163d9dca0"
      unitRef="usd">91200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtMi0xLTEtMA_469cfb00-8e6c-463f-a822-2a2c5d33a9a5"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtNC0xLTEtMA_ef02b4c1-5429-4ca9-916e-72e49e358fc5"
      unitRef="usd">315600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzUtNi0xLTEtMA_317b608d-3728-4944-a51c-1697af0a7b64"
      unitRef="usd">339100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzgtMi0xLTEtMA_e8c88956-55f5-4c60-b92f-78be4a0ce2a3"
      unitRef="usd">3776400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzgtNC0xLTEtMA_574bbecc-b7b0-42a3-b317-280fd3dc3bc9"
      unitRef="usd">3367300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzgtNi0xLTEtMA_392d1eae-da99-4224-950a-65569789107a"
      unitRef="usd">3217900000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEwLTItMS0xLTA_d38ce389-6b08-41c9-96b4-f9e7d6286108"
      unitRef="usd">929700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEwLTQtMS0xLTA_ffbbb39e-af03-47bc-90c7-e5c905761086"
      unitRef="usd">163100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEwLTYtMS0xLTA_2b2f104a-d69c-4288-a427-b52cd2ddb9b2"
      unitRef="usd">145500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzExLTItMS0xLTA_14db2787-7acf-4396-84a3-92905aa432c7"
      unitRef="usd">192800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzExLTQtMS0xLTA_cd5751f7-def5-4f05-99d4-404070abfaed"
      unitRef="usd">399300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzExLTYtMS0xLTA_0261ec6a-2254-4505-9a08-85984ba0718b"
      unitRef="usd">399700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTItMS0xLTY2ODU_7919db90-b54c-4595-a30e-abae7d1147f8"
      unitRef="usd">42000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTQtMS0xLTY2ODU_bc3a5e14-abb8-4e76-a4cc-62e786080659"
      unitRef="usd">99200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTYtMS0xLTY2ODU_4331ae9a-f5d2-4a95-b8ba-4ab72298fef8"
      unitRef="usd">58300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEzLTItMS0xLTEwNTk3_a1fbacf8-f97e-42f3-b504-c21ad146e828"
      unitRef="usd">-2400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEzLTQtMS0xLTEwNTk3_4e9e34b7-b819-43e0-a86a-c6af1556e697"
      unitRef="usd">-4200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEzLTYtMS0xLTEwNTk3_88f227b7-b1e5-4a51-98f9-c52f67142e80"
      unitRef="usd">3300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTItMS0xLTA_c687384c-0cde-4b05-8ffc-0912a41e1be0"
      unitRef="usd">-57100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTQtMS0xLTA_cfe6f4fb-9e6c-49fa-a5c3-4e9c2c889f4c"
      unitRef="usd">-781200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzEyLTYtMS0xLTA_385ac197-53b1-4106-8b5f-ef90516a7a33"
      unitRef="usd">-844700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE1LTItMS0xLTA_aa34c14b-c1fe-45af-a8aa-1c0e60bccff0"
      unitRef="usd">1105000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE1LTQtMS0xLTA_0a503878-6888-4eda-a22c-ea86eb53a61f"
      unitRef="usd">-123800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE1LTYtMS0xLTA_d3512083-b31b-4d0c-8531-c22439c68641"
      unitRef="usd">-237900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE3LTItMS0xLTA_9a5e36d9-b2cf-40bb-ac38-b10fe9f72fc7"
      unitRef="usd">237300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE3LTQtMS0xLTA_1c6a78a5-fe05-46b3-84ee-fe2c4a732ec5"
      unitRef="usd">246600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE3LTYtMS0xLTA_93398262-cb4b-4ca3-870e-90266c49b3f5"
      unitRef="usd">257300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE4LTItMS0xLTA_145ad9fd-3980-45dc-914c-20c544366e9c"
      unitRef="usd">48800000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE4LTQtMS0xLTA_a42ae2d1-997b-4037-8a16-afab6fb4dced"
      unitRef="usd">36800000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE4LTYtMS0xLTA_4b6740ea-3706-48bd-83eb-84c51d9819b8"
      unitRef="usd">22700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTItMS0xLTY3MDM_e715eeff-9b0c-4282-97a0-6beb58817cc8"
      unitRef="usd">85100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTQtMS0xLTY3MDM_4ec8c53c-f409-4e47-bfd5-4fd2f6f79c0c"
      unitRef="usd">87700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTYtMS0xLTY3MDM_27e34031-f04d-41eb-a1d1-6ba0ffc188bd"
      unitRef="usd">91600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIwLTItMS0xLTEwNjA3_d2fdd85b-1b48-436f-be45-d774477c35e0"
      unitRef="usd">700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIwLTQtMS0xLTEwNjA3_05b8521e-3088-4af5-8bd0-171196dc3058"
      unitRef="usd">600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIwLTYtMS0xLTEwNjA3_a793849a-dcbb-4bde-88f8-69bf2870552d"
      unitRef="usd">600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTItMS0xLTA_dc346b9c-222d-421c-9449-060a6f703a4a"
      unitRef="usd">4100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTQtMS0xLTA_142e7679-85af-46da-b166-4697400f8ac3"
      unitRef="usd">91400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzE5LTYtMS0xLTA_65fa8bb6-0d12-4190-918d-7b7ebba71485"
      unitRef="usd">108100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIyLTItMS0xLTA_62e0b37d-43b1-4774-8f1b-c7bee64786ca"
      unitRef="usd">376000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIyLTQtMS0xLTA_60bdb4e9-20f9-43c9-82a2-23bb44ede681"
      unitRef="usd">463100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzIyLTYtMS0xLTA_02add1e9-36bf-40cd-8028-c13455e6351b"
      unitRef="usd">480300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i6e68a596a8d24d07a8501edc218e3fa1_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI0LTItMS0xLTA_788efcfd-8294-4207-b2b1-b8c2645def46"
      unitRef="usd">110700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i91c2bd7cd81a4298a708b8b933b91f15_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI0LTQtMS0xLTA_512bacf9-7268-48cf-a2bd-e850d7789348"
      unitRef="usd">59200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if8d0e24b71d8466badbc60ee9a9c073d_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI0LTYtMS0xLTA_2e59286c-0e54-493e-9de8-8d4d28933fc7"
      unitRef="usd">57700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5bd85d81c4194b629cbb7fe12e3ab5b5_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI1LTItMS0xLTA_d65af542-416e-406e-93e0-36050174d661"
      unitRef="usd">22400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i512a078a5a374931bada540cfa1a291e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI1LTQtMS0xLTA_22b7e86f-d6e6-4223-a8a5-24a6faf63741"
      unitRef="usd">18300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i013abbf952f74ed3be8f801ac7db0e66_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI1LTYtMS0xLTA_b99f55bc-312f-415c-af53-1f252d053338"
      unitRef="usd">14800000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i052304c1a59348398b8de6a3c87fe3ac_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTItMS0xLTY3MTU_f55dc985-3249-4b05-9506-fc87c2862c93"
      unitRef="usd">17900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="idd49b5764efe47be8ca057cae93d0633_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTQtMS0xLTY3MTU_67fb9709-a61e-4f29-9884-7db0ee9c351d"
      unitRef="usd">15700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i02497310a32f4bf5b3a99f314d209cb2_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTYtMS0xLTY3MTU_a26f63b7-dde3-4b29-b089-bf941b510d46"
      unitRef="usd">13100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i463f3215033345d48cf5e29cb5ee1b1c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI3LTItMS0xLTEwNjE2_854dd9fd-9c1f-43fd-943d-a3030d4a7a39"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i790335fe6b504d0694a773e693b48987_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI3LTQtMS0xLTEwNjE2_347ada45-4533-4522-a186-3a8ae9d59664"
      unitRef="usd">1200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i425f6137e1e8473eb98976d5cb427d2b_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI3LTYtMS0xLTEwNjE2_61d233c3-9af3-4e38-8d76-ba5bdccb76da"
      unitRef="usd">3300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i24871ba653fd485dbfc089eb67f06391_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTItMS0xLTA_4227af4e-e8fa-45e8-9d61-2e6b146ef384"
      unitRef="usd">1400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ifd194fbe449c47058880ed86e0fbc347_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTQtMS0xLTA_a55ed84d-9f16-4889-b75c-213acc09a504"
      unitRef="usd">7000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8651c2c2fc00408fa78a0c61513edf91_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI2LTYtMS0xLTA_56b90051-2eee-4a27-a339-60a3158eea69"
      unitRef="usd">9400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4fb0d5ec5a3d40e791cd77fed8adb08f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI5LTItMS0xLTA_3b44d791-0005-4004-aa50-b8bf11210e0a"
      unitRef="usd">3800000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i79dbfa348b4b4250b64c8e02c8ba3ef5_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI5LTQtMS0xLTA_ab0f749a-89b4-4ba6-a960-a4a1d48559a3"
      unitRef="usd">7700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8b57161c436e4f6eb5e739380ff16c77_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzI5LTYtMS0xLTA_272cacfd-663a-4d60-8ab5-d456e4ced940"
      unitRef="usd">7300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMwLTItMS0xLTA_8d7744be-a1cd-4812-aef2-4fcc258c31eb"
      unitRef="usd">156400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMwLTQtMS0xLTA_3e62feb0-be5e-42e2-a1a8-8e0221e61606"
      unitRef="usd">109100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMwLTYtMS0xLTA_ef24eee3-c178-4efc-bdbc-bfcc5c998bea"
      unitRef="usd">105600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Assets
      contextRef="i437292e8142d4d96839af5869cecaab3_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMzLTItMS0xLTE1Mjcy_7f9b1f66-c064-4d93-8155-0016cf9becc2"
      unitRef="usd">2161400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i169afb67581f4042a9907e319c8aaee1_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMzLTQtMS0xLTE1Mjcy_487d0274-7394-4fed-be7c-a38c0e903293"
      unitRef="usd">2276600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="icfe6d8929f8f4eb6b145835c10a13bfc_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzMzLTYtMS0xLTE1Mjcy_3e974cf1-f5b8-4de5-b644-ab29ae7d600a"
      unitRef="usd">2442900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i305c6e69d9584df69b07d0c58b68dc88_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM0LTItMS0xLTE1Mjcy_72e7fbc9-ea52-42cd-a7e5-0eb2083ffb23"
      unitRef="usd">1200900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0b9b859e952c4dc086ae9de8f3020603_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM0LTQtMS0xLTE1Mjcy_5c3fc53c-4898-46c5-b064-08822e1c7652"
      unitRef="usd">1127800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i11802e38f47f4fc3810df7e5a6f3b7f2_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM0LTYtMS0xLTE1Mjcy_9f5da535-013e-4363-88ac-41ce0d66c6ae"
      unitRef="usd">972400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if85520f01ace43129ad7669c2083f920_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM1LTItMS0xLTE1Mjcy_f83f4c27-2ad1-49e5-b183-bfced7d206b7"
      unitRef="usd">1438700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i294e83c0d77f4a76b4cb43739eaeaf9f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM1LTQtMS0xLTE1Mjcy_8a7334aa-705f-4b07-a99c-422d589290b9"
      unitRef="usd">1328600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if32c7c1cad54473c92473002d9ec70e2_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM1LTYtMS0xLTE1Mjcy_aa926dce-87cd-4e18-b57f-d7b6a00eae99"
      unitRef="usd">1414900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0bbb9f4ee2a14c8a8ff8db71fcca17b1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM2LTItMS0xLTE1Mjcy_2f2ffad6-398f-4354-81dd-60b9aaa7f8f2"
      unitRef="usd">38900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie5bea17c720745bbbe2f47855b322570_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM2LTQtMS0xLTE1Mjcy_ee27e867-67bb-4a08-bd1a-a71c9f1c346c"
      unitRef="usd">27300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6ff4e72158d04b05abd672b5cdb231cd_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM2LTYtMS0xLTE1Mjcy_64f830e1-f887-4a2a-94b1-593782769fee"
      unitRef="usd">30300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia04cebdd8bba46d7a211ca6aa1dca44f_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM3LTItMS0xLTE1Mjcy_f2789af4-f453-4cbd-aa99-462853e96d1b"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4a1f0fc50e2e42c4bf2f36b322f42bb2_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM3LTQtMS0xLTE1Mjcy_73bc5ecd-9afe-460e-9d99-649bd1cb7433"
      unitRef="usd">159300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia19f8ef5fe114be8ae437ed2b272af87_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM3LTYtMS0xLTE1Mjcy_611be294-c0dd-4f17-bb78-b3f51b91f399"
      unitRef="usd">913300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i37cc679d8c4e4a0585fbc179881a744b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM4LTItMS0xLTE1Mjcy_9ac94f75-252f-42a1-a31c-70d2f43ff2cc"
      unitRef="usd">2355900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8c4387e1e2e64a7ea880cc5c3543acd3_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM4LTQtMS0xLTE1Mjcy_f6b6a32b-179c-46b4-9f58-9dddbd3972f8"
      unitRef="usd">1522500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibbeba5af33fd49de80e3ad69f10870d4_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM4LTYtMS0xLTE1Mjcy_bc47c60d-4a08-449e-8551-9040fa4c991e"
      unitRef="usd">1457100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM5LTItMS0xLTE1Mjcy_1a81dfa0-2860-4aa4-801c-cbe5e8195d6f"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM5LTQtMS0xLTE1Mjcy_e26f1553-5734-42e1-b70a-73e39e4c6964"
      unitRef="usd">6442100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTpkZmZmZWM5ODUzY2U0ZTAyYmYyOWNlMDMyM2ZjNDEzNS90YWJsZXJhbmdlOmRmZmZlYzk4NTNjZTRlMDJiZjI5Y2UwMzIzZmM0MTM1XzM5LTYtMS0xLTE1Mjcy_93fcf312-e973-41ba-b087-7dd4282fbbf7"
      unitRef="usd">7230900000</us-gaap:Assets>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzI1MTY_03f28192-8619-4d99-99e0-6d9d6992ec24">&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <holx:PercentageOfRevenues
      contextRef="ic0b1fbf643bf4d87a0f62662f56e72a9_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzItMi0xLTEtMA_5814a216-f1a2-461f-9e91-ab7b74479435"
      unitRef="number">0.758</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i22ccaf1b86dd4ce1975c67773f6132e3_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzItNC0xLTEtMA_84f90523-2681-4abe-bcc5-70fb9727faa9"
      unitRef="number">0.753</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i6a86961b941f4c698ca817317ebb55f1_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzItNi0xLTEtMA_c3f6c7ad-0584-4a65-a3fd-141ebc6e88c3"
      unitRef="number">0.751</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i65a03228708e48bd91808873ac0aef49_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzMtMi0xLTEtMA_f83b108b-c0dd-4a87-8aa9-5ca73257682c"
      unitRef="number">0.151</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i9775b97e92684b93a13c7004b3787bb9_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzMtNC0xLTEtMA_e7b27470-2092-4c3a-b3b8-1c933e461a60"
      unitRef="number">0.118</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i52f05bd0d07b41cc91cc734c6e8aabd4_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzMtNi0xLTEtMA_2a92b96f-bb8e-4c99-a261-ba39629d44ec"
      unitRef="number">0.117</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i9f2349edc55c45de9425f98b0200d5a7_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzQtMi0xLTEtMA_8fecca58-f47a-4145-872b-379892d3be95"
      unitRef="number">0.060</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ic693f14699ba4968bcb36cc7b8b023a7_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzQtNC0xLTEtMA_51496217-37de-4ea1-a4ca-52e2105bf6f2"
      unitRef="number">0.085</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i6acedc8e09c84b2e89c7f0cc800be0dd_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzQtNi0xLTEtMA_ffcbaa40-934b-4b3b-88ec-8307b0363c73"
      unitRef="number">0.086</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ia6be6be2339044138fe1152c23d299af_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzUtMi0xLTEtMA_ddde03a6-9e81-4688-a738-0f98d17fb63d"
      unitRef="number">0.031</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ib8efe51ef6dc4ed2a908a1cb2c698d12_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzUtNC0xLTEtMA_e8a559cd-e9a3-49d8-a81e-c143fe76eb26"
      unitRef="number">0.044</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="id99c49be9fbe42c6bb3e8f1497f9525a_D20171001-20180929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzUtNi0xLTEtMA_57f9e60e-36c9-431c-87f3-24b39deed9a8"
      unitRef="number">0.046</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzYtMi0xLTEtMA_928d2e42-51ae-4837-a421-19b9c12dc09c"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzYtNC0xLTEtMA_a6de8e27-92fb-4d44-8921-b51bacdea6e3"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZTo5NDg2NTQxODkxNTA0NmQ4YTk1NzA0ZmE3NjkzMmVmYy90YWJsZXJhbmdlOjk0ODY1NDE4OTE1MDQ2ZDhhOTU3MDRmYTc2OTMyZWZjXzYtNi0xLTEtMA_626352a9-75f4-4d65-82ee-6e31254491ab"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90ZXh0cmVnaW9uOmVjZDEzMTgxODUxYjRjMjJiY2ZmODQ5NzY4MzAzZTQ0XzI1MDQ_efba6d99-a2d6-400e-917d-066cf6073e20">The Company&#x2019;s property, plant and equipment, net were geographically located as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costa Rica&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib2d7bf9f967242eaba9ddd491ab703ed_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzEtMi0xLTEtMA_8498647c-909b-4b26-8a87-8554239c4652"
      unitRef="usd">383000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7d1106e7081e4cabb0de079d952b614f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzEtNC0xLTEtMA_3b7425d5-edc1-4cbc-ae57-b1e2d43ca0dc"
      unitRef="usd">355500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie488bc746f864b9cabc2df04f892e4ae_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzEtNi0xLTEtMA_8eab4756-1967-4bd1-a9ab-2fbf2b7086ae"
      unitRef="usd">366500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i26440a4dc78a4e2f9d24bd4827a7712e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzMtMi0xLTEtMA_c885660a-30b3-42e8-82f4-15c29fdba326"
      unitRef="usd">77500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic343686a6d7c4439b1715ce8372cb1b6_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzMtNC0xLTEtMA_503358b4-cb5e-4dbb-80c3-47e0ffea2d79"
      unitRef="usd">64400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i931d24edcf44412ebaf8ac5e6dc89022_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzMtNi0xLTEtMA_d7874c07-83bc-4f86-aed7-29fcefbe8576"
      unitRef="usd">62000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6455cb9268744d129ad43c18c13a0b49_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtMi0xLTEtMTE0OTI_8db0fc77-0f3f-436b-949d-ab1acbea2fd9"
      unitRef="usd">20800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iafd22066f01e475cb0434fb76714ac0f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtNC0xLTEtMTE0OTI_19bc2acb-13f5-4b23-b952-54a1463b40a3"
      unitRef="usd">33000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i127aa7477232423cb1285753b3416534_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtNi0xLTEtMTE0OTI_60aae4a6-2d68-4400-a8b8-38d94e5740ae"
      unitRef="usd">30900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3dbb50a9fc7a4683852d6c1668547edc_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtMi0xLTEtMA_0694312e-2716-4a34-a476-dbde02861274"
      unitRef="usd">10200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i77fd19f2aabe44c188795c7adbdd651f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtNC0xLTEtMA_56ea1a71-e2fb-4873-87b3-5ac6f6540773"
      unitRef="usd">18000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9562418944fb4261a833f679ae6db905_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzQtNi0xLTEtMA_4c383fc2-ce64-41d3-bda7-8917c67b08c9"
      unitRef="usd">18800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzUtMi0xLTEtMA_d7f6bb53-f561-4333-b1c0-18d0a47465f1"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzUtNC0xLTEtMA_7d189742-89d2-43be-8dfd-3812051efba4"
      unitRef="usd">470900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDIvZnJhZzplY2QxMzE4MTg1MWI0YzIyYmNmZjg0OTc2ODMwM2U0NC90YWJsZToyOWFhZWYwYTk0ZWE0NzkxOGEwNDdlNWM2MGIzNjgyNy90YWJsZXJhbmdlOjI5YWFlZjBhOTRlYTQ3OTE4YTA0N2U1YzYwYjM2ODI3XzUtNi0xLTEtMA_91fc90a6-1299-462c-9cf1-8e590c9e6743"
      unitRef="usd">478200000</us-gaap:PropertyPlantAndEquipmentNet>
    <holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90ZXh0cmVnaW9uOjAwN2NlY2E5NDE3MTQ3NTZiNTg5ZWYwNzNkZTdmZTEyXzE1Mw_e31d88e5-dd38-4e23-bbf9-0d34fbc2a08a">Accrued Expenses and Other Long-Term Liabilities&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other long-term liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMC0xLTEtMTkyODM_140646f7-9eab-40d5-8cc6-927f67371b99"&gt;Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&#160;Long-Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for income tax uncertainties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzQtMC0xLTEtMTkzODg_736c4b8f-a57e-416d-9e6e-a6211fed51d8"&gt;Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued lease obligation&#x2014;long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90ZXh0cmVnaW9uOjAwN2NlY2E5NDE3MTQ3NTZiNTg5ZWYwNzNkZTdmZTEyXzE2MA_2c6d9779-332f-4107-b6ce-6ecf46a02804">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other long-term liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMC0xLTEtMTkyODM_140646f7-9eab-40d5-8cc6-927f67371b99"&gt;Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzItMi0xLTEtMA_968dbd99-fcf7-46c2-a6b2-3a511ae9da76"
      unitRef="usd">262700000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzItNC0xLTEtMA_7e5e2992-1968-45eb-bf55-5e3a8506acb3"
      unitRef="usd">223400000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <holx:AccruedIncomeAndOtherTaxes
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzQtMi0xLTEtMA_84246a85-31e3-484a-b14e-a5e5d89b4515"
      unitRef="usd">125300000</holx:AccruedIncomeAndOtherTaxes>
    <holx:AccruedIncomeAndOtherTaxes
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzQtNC0xLTEtMA_e777e30f-623a-48f6-a486-aab64c88b562"
      unitRef="usd">56100000</holx:AccruedIncomeAndOtherTaxes>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMi0xLTEtMzc3MA_42fabbf7-77bb-4e6e-af2c-f75ea231d436"
      unitRef="usd">23500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtNC0xLTEtMzc3Ng_d6887f0c-d444-4554-ae27-43a8ab85ea43"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <holx:AccruedInterest
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzctMi0xLTEtMTE5NTk_609f28d2-9841-40ec-b16b-16bdbf98b54e"
      unitRef="usd">22100000</holx:AccruedInterest>
    <holx:AccruedInterest
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzctNC0xLTEtMTE5NjE_f8e5d61b-f72a-475e-bd17-54906992f9be"
      unitRef="usd">22600000</holx:AccruedInterest>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMi0xLTEtMA_43bf110d-e6da-47a0-ac83-632bc9ee7b4d"
      unitRef="usd">114000000.0</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtNC0xLTEtMA_ded3f57b-daf7-4064-bf1a-19186c2a7cd0"
      unitRef="usd">128800000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzctMi0xLTEtMA_cdcc2302-1c6c-4dab-b572-621f9dbf6f42"
      unitRef="usd">547600000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzctNC0xLTEtMA_2a85c234-c19e-4d62-8c78-bac1915e653d"
      unitRef="usd">430900000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90ZXh0cmVnaW9uOjAwN2NlY2E5NDE3MTQ3NTZiNTg5ZWYwNzNkZTdmZTEyXzE2MQ_e23396ad-2a46-4a4e-b7a9-22ce3cc94ca2">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&#160;Long-Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for income tax uncertainties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzQtMC0xLTEtMTkzODg_736c4b8f-a57e-416d-9e6e-a6211fed51d8"&gt;Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued lease obligation&#x2014;long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzItMi0xLTEtMA_e8d4ecaa-e155-4a68-972e-ff8537c00541"
      unitRef="usd">103700000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzItNC0xLTEtMA_55aa284b-8e32-4fb4-96e6-aa3e0f3665ed"
      unitRef="usd">106800000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzMtMi0xLTEtMTE1MDk_521bb944-7ed4-45de-be40-2b8121ebdec9"
      unitRef="usd">81800000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzMtNC0xLTEtMTE4NjA_d89ce777-2f88-4f3b-a22c-061657749eab"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzYtMi0xLTEtNTQwNw_56783088-3b0f-4da0-88a1-c365a7d38f9d"
      unitRef="usd">65600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzQtNC0xLTEtMTE4NTQ_2ea63032-0287-4f82-8b71-617cb5f5df10"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzUtMi0xLTEtMTE1NTg_7318dd84-87f0-43e6-982f-0a1e41127f50"
      unitRef="usd">23000000.0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzUtNC0xLTEtMTE1NTg_65e1ece0-7058-478a-8b9f-b97180466089"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzctMi0xLTEtMTE1MTU_352ea4e9-d16d-424a-ac2c-6bb2241e010c"
      unitRef="usd">11100000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzctNC0xLTEtMTE1MTU_2254381e-a6e7-4415-998f-67579b70db28"
      unitRef="usd">10200000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:AccruedRentNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzctMi0xLTEtMTE1NDE_738129b2-dd3b-4c65-b0c6-9d3bf4ce92db"
      unitRef="usd">0</us-gaap:AccruedRentNoncurrent>
    <us-gaap:AccruedRentNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzctNC0xLTEtMTE1NDE_0fe4c74a-f2f4-481f-8abe-2c447df5a5bf"
      unitRef="usd">33700000</us-gaap:AccruedRentNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzUtMi0xLTEtMA_fb356665-ff68-4848-8297-e25904581e2a"
      unitRef="usd">18000000.0</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzUtNC0xLTEtMA_4218d755-1e41-4ebc-b21e-34ffcf6ea955"
      unitRef="usd">11700000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzYtMi0xLTEtMA_c0a3640d-9c6a-4c99-8a6d-9bcc292c60dd"
      unitRef="usd">303200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzYtNC0xLTEtMA_0d3b9519-9f00-41cc-8c8e-caa44bf3c125"
      unitRef="usd">162400000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxODQ_fd051e23-41d7-4d32-9282-9e581dfb29a7">Pension and Other Employee Benefits&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain defined benefit pension plans covering the employees of its Hitec Imaging German subsidiary (the &#x201c;Pension Benefits&#x201d;).&#160;As of September&#160;26, 2020 and September&#160;28, 2019, the Company&#x2019;s pension liability was $10.9 million and $10.0 million, respectively, which is primarily recorded as a component of long-term liabilities in the Consolidated Balance Sheets. Under German law, there are no rules governing investment or statutory supervision of the pension plan. As such, there is no minimum funding requirement imposed on employers. Pension benefits are safeguarded by the Pension Guaranty Fund, a form of compulsory reinsurance that guarantees an employee will receive vested pension benefits in the event of insolvency. The pension plans were closed on December 31, 1997 and only eligible employees at that date could participate in the plans prior to closing to new participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#x2019;s German Pension Benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:49.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#x2019;s German Pension Benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Components of Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Net Periodic Benefit Cost Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The projected benefit obligation for the German Pension Benefits with projected benefit obligations in excess of plan assets was $10.9 million and $10.0 million at September&#160;26, 2020 and September&#160;28, 2019, respectively, and the accumulated benefit obligation for the German Pension Benefits was $10.9 million and $10.0 million at September&#160;26, 2020 and September&#160;28, 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also obligated to pay long-term service award benefits under the German Pension Benefits. The projected benefit obligation for long-term service awards was $0.1 million at both September&#160;26, 2020 and September&#160;28, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 to 2030&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains additional contractual pension benefits for its top German executive officers in the form of a defined contribution plan. These contributions were insignificant in fiscal 2020, 2019 and 2018. Additionally, the Company has Swiss pension plans, which were insignificant in fiscal 2020, 2019, and 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzI0MA_959f740f-2f3f-4571-89e9-b45d9b08337d"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities>
    <us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzI0Nw_a02d9b4f-7937-4e48-be46-96c4e684e2c7"
      unitRef="usd">10000000.0</us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxNjE_181d6ae9-8d87-4ff8-a2b6-ccdb78eb91a5">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#x2019;s German Pension Benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:49.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzItMi0xLTEtMA_409d5f19-e3e5-4cf3-b30d-3fb13c2c3990"
      unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzItNC0xLTEtMA_31f178ed-c5ef-4426-ac1a-46f1923b7b9f"
      unitRef="usd">9700000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i84c88a850d71453097932f0bcbe84825_I20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzItNi0xLTEtMA_022ec6dd-06e4-4c7c-9682-2cc988f8ef1b"
      unitRef="usd">9900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzMtMi0xLTEtMA_49a7e825-20cb-40a9-b717-0e3e3d826576"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzMtNC0xLTEtMA_41594d51-fb22-4b7f-8da7-50182021533b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzMtNi0xLTEtMA_fc9bbad7-ccf4-4aaa-989c-3b92cd733835"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzQtMi0xLTEtMA_a7c27030-0ee0-4df5-abd6-96a127a0a255"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzQtNC0xLTEtMA_3645e1fa-56fa-4175-b5a4-8ed2da19fd26"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzQtNi0xLTEtMA_007a0eaf-6612-4288-b9a8-521ab2a588cd"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzUtMi0xLTEtMA_a55abca0-3949-41f8-9435-c4aa61073c6c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzUtNC0xLTEtMA_a18835d4-dabd-426d-9643-78e859cd7501"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzUtNi0xLTEtMA_673c52d5-5bd0-48f2-9b55-f70ac1608064"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzYtMi0xLTEtMA_dd118bd2-bf08-48b9-a38e-0954cbdc8ac3"
      unitRef="usd">-500000</holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount>
    <holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzYtNC0xLTEtMA_0ae6064f-b55a-4fd6-97ee-201eb2936ae9"
      unitRef="usd">-1000000.0</holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount>
    <holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzYtNi0xLTEtMA_ebc5252b-1c43-4582-816e-251e1358b313"
      unitRef="usd">-100000</holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzctMi0xLTEtMA_88933d64-2686-4abb-864b-8e8160fe8d2f"
      unitRef="usd">-700000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzctNC0xLTEtMA_3c8d9940-4c61-4a75-85eb-8df9a75fa26a"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzctNi0xLTEtMA_de167143-37a1-44de-b40d-6effbeb9aa12"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzgtMi0xLTEtMA_c6534fa7-5717-4f7d-9998-da6cc1b8b46d"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzgtNC0xLTEtMA_d8049748-31de-47bf-ad2a-b1275504c901"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzgtNi0xLTEtMA_a32d9765-7bc3-4ec0-ace6-4e7348612326"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzktMi0xLTEtMA_a568b092-9840-4204-a285-c6d7f23e371e"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzktNC0xLTEtMA_6cf0703e-f7a0-428e-b7b6-08a71f62d866"
      unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzktNi0xLTEtMA_dee25ddd-9cbd-43bc-9197-c2ba863f539d"
      unitRef="usd">9700000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzEwLTItMS0xLTA_b13970e8-53ec-4843-9968-bbb0c24806fb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzEwLTQtMS0xLTA_c3190743-1567-42aa-b23e-28ad668741e6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzEwLTYtMS0xLTA_d717bfee-26d9-4a08-9671-773e0483b36e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzExLTItMS0xLTA_39c268df-1ee4-4729-a0c5-584eb2dc6e89"
      unitRef="usd">-10900000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzExLTQtMS0xLTA_c4818aab-c20c-4dab-b7b7-48bb39e4cf23"
      unitRef="usd">-10000000.0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTpmZjMxNDIyNWE4YjQ0ZDk0YWQ4Y2M5NTNjZTMwNzRjNi90YWJsZXJhbmdlOmZmMzE0MjI1YThiNDRkOTRhZDhjYzk1M2NlMzA3NGM2XzExLTYtMS0xLTA_db266f6a-9d42-4aa7-8e12-0c9279b5091e"
      unitRef="usd">-9700000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxODc_79ede1aa-146c-4993-bf48-8a0a2966dd5b">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#x2019;s German Pension Benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Components of Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzItMi0xLTEtMA_bc92839d-4ed4-4d1b-9900-f64b590d9676"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzItNC0xLTEtMA_607e6640-d641-4e1e-8c4d-7f3a27394b5f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzItNi0xLTEtMA_db526e2c-365d-413f-a46d-bc5f5d6ecc47"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <holx:ComponentsofNetPeriodicBenefitCostInterestcost
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzMtMi0xLTEtMA_ca02d16f-cbdc-47b1-a3ca-71238241c474"
      unitRef="usd">100000</holx:ComponentsofNetPeriodicBenefitCostInterestcost>
    <holx:ComponentsofNetPeriodicBenefitCostInterestcost
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzMtNC0xLTEtMA_02c132a0-776d-489a-9166-b8254957a0ba"
      unitRef="usd">200000</holx:ComponentsofNetPeriodicBenefitCostInterestcost>
    <holx:ComponentsofNetPeriodicBenefitCostInterestcost
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzMtNi0xLTEtMA_7fcab8ce-5298-44c5-b005-2cba62cfda8f"
      unitRef="usd">200000</holx:ComponentsofNetPeriodicBenefitCostInterestcost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzQtMi0xLTEtMA_a642f8d0-9de7-4824-96cf-b2f20a67582b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzQtNC0xLTEtMA_51962087-618a-4e8d-bdc3-580c9182ff06"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzQtNi0xLTEtMA_7d6ad21b-25f3-4bc5-9e41-991973052b13"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzUtMi0xLTEtMA_06532c82-f05e-45c0-aada-e66853bdf8a4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzUtNC0xLTEtMA_3d25b7b8-c530-45b0-b540-dbb933708719"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzUtNi0xLTEtMA_1f8991d3-121f-49ff-b125-cd6d0f5492e5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzYtMi0xLTEtMA_d80175d2-1b89-4f71-981d-7f0a64d000d1"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzYtNC0xLTEtMA_2f6d60db-62e4-48ef-9d7d-783113a5e6ed"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzYtNi0xLTEtMA_913289c3-394d-4755-8315-1349b0957ea4"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzctMi0xLTEtMA_6129920f-f2f9-453f-9879-2fd62edd5f47"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzctNC0xLTEtMA_21f1e267-97a6-4efa-affc-e0af7e34e562"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZToxODhjZDRmNmY4NzE0MjkxYWM3N2Q2MDYzOTUwZWIzNi90YWJsZXJhbmdlOjE4OGNkNGY2Zjg3MTQyOTFhYzc3ZDYwNjM5NTBlYjM2XzctNi0xLTEtMA_be28098f-f2c5-418f-813e-72e6459db6bf"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxODE_1b16b590-c911-44d4-8f2d-41e7a1b0ea25">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Net Periodic Benefit Cost Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzEtMi0xLTEtMA_dc66535b-7c0f-4af0-8282-56daef1915d2"
      unitRef="number">0.0080</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzEtNC0xLTEtMA_99a363d3-9778-4b63-b645-f84f834fc4d2"
      unitRef="number">0.0110</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzEtNi0xLTEtMA_450c5072-2b73-4953-a013-2d73b4f1d779"
      unitRef="number">0.0195</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzItMi0xLTEtMA_61d73d7f-28a3-48ed-a46c-b32f621c7160"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzItNC0xLTEtMA_bc6e6723-47b0-45fa-820a-7d57439496b9"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzItNi0xLTEtMA_a074121f-8844-46ea-b12a-e20c5a69be51"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzMtMi0xLTEtMA_86e965fb-cf72-45e9-8378-1851d9a44741"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i53783bdfd89947cea3fe7616237520d9_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzMtNC0xLTEtMA_c768df91-e868-4f97-bf35-6a015584bc10"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4NDY2NjE4NjgwMTE0MGYxOWI5ZDZjMTRkNjNkZDhmZi90YWJsZXJhbmdlOjg0NjY2MTg2ODAxMTQwZjE5YjlkNmMxNGQ2M2RkOGZmXzMtNi0xLTEtMA_2fe886e8-f680-42bb-b833-c34e8b6170eb"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i6cc490c87029449399e9fbd9f9732f85_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzEzNTE_6bcdfe14-8a20-4650-b043-ca1488bb3900"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i129bb08ac6114158bac9490c19681bde_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzEzNTg_d573e3cd-d597-4d82-891f-42b14ccfbe84"
      unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzE0NjQ_8fb28505-355d-44f8-b803-6d9e214ca8d3"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzE0NzE_406444e3-84ce-4ec8-a6c0-f582b7504f69"
      unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <holx:ProjectedBenefitObligationForLongTermServiceAwards
      contextRef="i6ac3ec9f123a403ea5b608168f3c2c18_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzE2NzQ_50f7d299-7af9-4c34-9691-ddd9206d7183"
      unitRef="usd">100000</holx:ProjectedBenefitObligationForLongTermServiceAwards>
    <holx:ProjectedBenefitObligationForLongTermServiceAwards
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzE2NzQ_f5b10c28-2c4c-48b0-8641-4eeede9b84fb"
      unitRef="usd">100000</holx:ProjectedBenefitObligationForLongTermServiceAwards>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90ZXh0cmVnaW9uOjM0YTUxMDIxOWM3NjQ2YWFhYzAxNDk5YTM0MzJhOTVkXzIxODI_754d832a-5b49-4685-a2a9-53f5a22bd475">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 to 2030&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzEtMS0xLTEtMA_17d9418f-29a7-47b0-bccb-45e849a02ba5"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzItMS0xLTEtMA_c74725e4-173b-498a-9c21-06ebea6c8dad"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzMtMS0xLTEtMA_81a4a020-fcb3-450f-97da-9fed807b9b14"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzQtMS0xLTEtMA_a49a7a47-619c-4076-9a7c-7fe786421526"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzUtMS0xLTEtMA_953ff06c-635d-4033-8408-9a317a377fa3"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="id3c092381c12421482497e088d638a81_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTEvZnJhZzozNGE1MTAyMTljNzY0NmFhYWMwMTQ5OWEzNDMyYTk1ZC90YWJsZTo4MTc2NTliZDRkNzc0NWJjODA1OTliMWMyMjc2Y2IwNS90YWJsZXJhbmdlOjgxNzY1OWJkNGQ3NzQ1YmM4MDU5OWIxYzIyNzZjYjA1XzYtMS0xLTEtMA_553a772f-c9ae-4c52-8fef-137e1f58132f"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzg0NQ_d189cf62-508f-4445-a1af-4d96ee5d498a">Quarterly Statement of Operations Information (Unaudited)&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of quarterly results of operations for fiscal 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.619%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;First&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fourth&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Hologic (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.619%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;First&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fourth&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;865.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.46)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Net income in the first quarter of fiscal 2020 included an intangible assets and equipment charge of $30.2&#160;million due to classifying the Medical Aesthetics business as assets held-for-sale. Net income also included a discrete tax benefit related to the disposition of this business of $312.2&#160;million related to its outside basis difference.&lt;/span&gt;&lt;/div&gt;(2)Net loss in the second quarter of fiscal 2019 included intangible asset and equipment impairment charges of $443.8 million. Net loss in the fourth quarter of fiscal 2019 included intangible asset and equipment impairment charges of $241.6 million.</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:Revenues
      contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzItMi0xLTEtMA_916b5300-33b1-48fc-b159-f4c269ee7e27"
      unitRef="usd">850500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzItNC0xLTEtMA_75b65d13-2c90-4040-86ad-ec26258a4def"
      unitRef="usd">756100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzItNi0xLTEtMA_ac26424a-4711-4cb5-9bdf-ae5f68fb5f3b"
      unitRef="usd">822900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzItOC0xLTEtMA_17cb02e1-e5f5-4b45-a527-0ec0f61d7b40"
      unitRef="usd">1347000000.0</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzMtMi0xLTEtMA_132a8f43-fd29-4cb7-b479-b458be833258"
      unitRef="usd">433800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzMtNC0xLTEtMA_20bdf753-15dc-4e5f-be81-c3754d5e2be0"
      unitRef="usd">395800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzMtNi0xLTEtMA_41a3ce92-be0a-4577-8e33-eae0dc6cc7b0"
      unitRef="usd">466100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzMtOC0xLTEtMA_9a3840d8-b049-4937-a695-df26006d509e"
      unitRef="usd">931800000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzQtMi0xLTEtMA_4870b528-2e15-4f2e-b63b-fc0a8af2fb64"
      unitRef="usd">386100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzQtNC0xLTEtMA_60acb51c-43f6-47d1-8476-01f2e4afcef3"
      unitRef="usd">96300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzQtNi0xLTEtMA_7de5b08c-2a38-4d33-9bb5-2d89b687410d"
      unitRef="usd">137900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzQtOC0xLTEtMA_aa1bcdae-7ce3-4efe-bd7c-70770b79e93e"
      unitRef="usd">495000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzUtMi0xLTEtMA_da67ab23-1c8b-4065-9089-99570c58172b"
      unitRef="usdPerShare">1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzUtNC0xLTEtMA_daa8d079-e307-42dd-9481-0f139154320a"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6f56b300b2e9416d82d1801136ddfd09_D20200329-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzUtNi0xLTEtMA_17946e4b-3a76-46f6-b5f0-76f6069e9d7f"
      unitRef="usdPerShare">0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTowMmNkMGFiMGRkMWQ0ZWU2ODg2YWFjM2I0NWRmOTMyMS90YWJsZXJhbmdlOjAyY2QwYWIwZGQxZDRlZTY4ODZhYWMzYjQ1ZGY5MzIxXzUtOC0xLTEtMA_08c591b5-5b26-40c8-87bb-63af5b2462d6"
      unitRef="usdPerShare">1.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:Revenues
      contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzItMi0xLTEtMA_ea7b326d-0eee-45a7-8e45-2d175b954b2d"
      unitRef="usd">830700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzItNC0xLTEtMA_8a9fe9de-fb30-4b21-bfb6-b02aa6761f32"
      unitRef="usd">818400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzItNi0xLTEtMA_bc0002cb-0291-45da-b6cd-90eab93b2bbd"
      unitRef="usd">852400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzItOC0xLTEtMA_0795794c-8436-4e47-a889-ff448a69353c"
      unitRef="usd">865800000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzMtMi0xLTEtMA_56a7eb5f-6806-4e32-a930-a70344b24fe1"
      unitRef="usd">434100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzMtNC0xLTEtMA_1d2b09de-a1ee-41be-8cd8-5a215b5d3719"
      unitRef="usd">42400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzMtNi0xLTEtMA_0135a47c-b923-4776-a6c7-84299de28723"
      unitRef="usd">444800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzMtOC0xLTEtMA_42b6e971-83c0-472b-9201-7d1616e2323c"
      unitRef="usd">249500000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzQtMi0xLTEtMA_9a5c1c92-d687-4e0a-904f-f78f9df6090a"
      unitRef="usd">98600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzQtNC0xLTEtMA_69f74f8d-d7b4-4c9e-bcce-65c3104cb605"
      unitRef="usd">-272600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzQtNi0xLTEtMA_6da56101-97e6-4a2b-b15b-20a637b4db58"
      unitRef="usd">93900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzQtOC0xLTEtMA_d0aeebdf-5699-4778-99b9-e478b3b7320f"
      unitRef="usd">-123500000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzUtMi0xLTEtMA_e3663024-2f97-4cdb-bdb1-4c9f5ad9dba8"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i302159f2cb6a4bc4abf40131890cd831_D20181230-20190330"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzUtNC0xLTEtMA_71b3f17b-a986-4391-bd2b-ac2fbf21a358"
      unitRef="usdPerShare">-1.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic97f89fe6d124e288a069c598f57bffa_D20190331-20190629"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzUtNi0xLTEtMA_2550850e-b307-4b01-88c9-7b7f19a90423"
      unitRef="usdPerShare">0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iafc80886dc0e4d41a0a3606997146d94_D20190630-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90YWJsZTo4NjNhYWZlNzdhOTE0OWEzOGIxMmEzNTRiODRkODA1Ny90YWJsZXJhbmdlOjg2M2FhZmU3N2E5MTQ5YTM4YjEyYTM1NGI4NGQ4MDU3XzUtOC0xLTEtMA_21ea7be3-89ce-4de4-808c-2583690fb131"
      unitRef="usdPerShare">-0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ife89599aa864444cb2cca46611fe19f0_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzQzOTgwNDY1MTI3MDQ_3c97d9fb-6be4-4071-a4e9-63e32c134822"
      unitRef="usd">30200000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i7f382276eec44239bdc0d3cebf1f2d75_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzQzOTgwNDY1MTM2Mjk_7bed6fa6-0f51-41ed-b05d-9cf50e4bc066"
      unitRef="usd">312200000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzI4Mg_1819de04-25df-4b4d-bda9-af7a01b5b61c"
      unitRef="usd">443800000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMTcvZnJhZzpmZTU2MzU0YWZkNGY0MTg3YjNhNDM3MzIyOTJjMGZhMS90ZXh0cmVnaW9uOmZlNTYzNTRhZmQ0ZjQxODdiM2E0MzczMjI5MmMwZmExXzM5NA_c5d155c3-0b54-4fdf-adc1-637a162675fa"
      unitRef="usd">241600000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244409675752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Nov. 12, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 26,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-36214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HOLOGIC, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000859737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2902449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">250 Campus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">263-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HOLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,530,248,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257,009,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s Proxy Statement for the registrant&#8217;s annual meeting of stockholders to be filed within 120 days of the end of its fiscal year ended September&#160;26, 2020 are incorporated into Part III (Items 10, 11, 12, 13 and 14) of this Annual Report on Form&#160;10-K where indicated.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479648216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from product and services</a></td>
<td class="nump">$ 3,776,400,000<span></span>
</td>
<td class="nump">$ 3,367,300,000<span></span>
</td>
<td class="nump">$ 3,217,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangible assets</a></td>
<td class="nump">253,200,000<span></span>
</td>
<td class="nump">318,500,000<span></span>
</td>
<td class="nump">319,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">25,800,000<span></span>
</td>
<td class="nump">578,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">2,227,500,000<span></span>
</td>
<td class="nump">1,170,900,000<span></span>
</td>
<td class="nump">1,696,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">222,500,000<span></span>
</td>
<td class="nump">232,200,000<span></span>
</td>
<td class="nump">218,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">484,600,000<span></span>
</td>
<td class="nump">564,900,000<span></span>
</td>
<td class="nump">544,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">356,000,000.0<span></span>
</td>
<td class="nump">332,300,000<span></span>
</td>
<td class="nump">366,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">39,700,000<span></span>
</td>
<td class="nump">52,000,000.0<span></span>
</td>
<td class="nump">59,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">106,700,000<span></span>
</td>
<td class="nump">46,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">685,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and divestiture charges</a></td>
<td class="nump">15,300,000<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
<td class="nump">14,200,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">1,122,500,000<span></span>
</td>
<td class="nump">1,294,700,000<span></span>
</td>
<td class="nump">1,934,600,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">1,105,000,000.0<span></span>
</td>
<td class="num">(123,800,000)<span></span>
</td>
<td class="num">(237,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(116,500,000)<span></span>
</td>
<td class="num">(140,800,000)<span></span>
</td>
<td class="num">(148,700,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="num">(45,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">9,100,000<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="nump">1,001,900,000<span></span>
</td>
<td class="num">(257,700,000)<span></span>
</td>
<td class="num">(418,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit for income taxes</a></td>
<td class="num">(108,600,000)<span></span>
</td>
<td class="num">(54,100,000)<span></span>
</td>
<td class="num">(307,300,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">1,110,500,000<span></span>
</td>
<td class="num">(203,600,000)<span></span>
</td>
<td class="num">(111,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(4,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Hologic</a></td>
<td class="nump">$ 1,115,200,000<span></span>
</td>
<td class="num">$ (203,600,000)<span></span>
</td>
<td class="num">$ (111,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income (loss) per common share attributable to Hologic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
<td class="num">$ (0.40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 4.21<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
<td class="num">$ (0.40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">262,727<span></span>
</td>
<td class="nump">269,413<span></span>
</td>
<td class="nump">275,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">264,613<span></span>
</td>
<td class="nump">269,413<span></span>
</td>
<td class="nump">275,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from product and services</a></td>
<td class="nump">$ 3,227,000,000.0<span></span>
</td>
<td class="nump">$ 2,771,300,000<span></span>
</td>
<td class="nump">$ 2,643,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">953,700,000<span></span>
</td>
<td class="nump">948,700,000<span></span>
</td>
<td class="nump">886,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from product and services</a></td>
<td class="nump">549,400,000<span></span>
</td>
<td class="nump">596,000,000.0<span></span>
</td>
<td class="nump">574,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">$ 316,200,000<span></span>
</td>
<td class="nump">$ 350,500,000<span></span>
</td>
<td class="nump">$ 315,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CostOfGoodsSoldImpairmentOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244491692408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,110.5<span></span>
</td>
<td class="num">$ (203.6)<span></span>
</td>
<td class="num">$ (111.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI', window );">Changes in foreign currency translation adjustment</a></td>
<td class="nump">18.5<span></span>
</td>
<td class="num">(14.8)<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Loss (gain) reclassified from accumulated other comprehensive income (loss) to the statement of operations</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in pension plans, net of taxes of $0.1 in 2020, $0.3 in 2019, and $(0.6) in 2018</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">(Loss) gain recognized, net of tax of $(8.3) million in 2020 and $1.2 million in 2019 for interest rate swaps</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Loss recognized in other comprehensive income (loss), net</a></td>
<td class="num">(28.1)<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(5.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statement of operations, net</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="num">(7.4)<span></span>
</td>
<td class="num">(16.8)<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">1,103.1<span></span>
</td>
<td class="num">(220.4)<span></span>
</td>
<td class="num">(120.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss attributable to noncontrolling interest</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ComprehensiveIncome', window );">Comprehensive income (loss) attributable to Hologic</a></td>
<td class="nump">1,107.8<span></span>
</td>
<td class="num">(220.4)<span></span>
</td>
<td class="num">(120.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">(Loss) gain recognized, net of tax of $(8.3) million in 2020 and $1.2 million in 2019 for interest rate swaps</a></td>
<td class="num">(27.6)<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Loss recognized in other comprehensive income (loss), net</a></td>
<td class="num">$ (0.5)<span></span>
</td>
<td class="num">$ (8.0)<span></span>
</td>
<td class="num">$ (5.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Comprehensive Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482593080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent', window );">Changes in unrealized holding gains and losses on available-for-sale securities, tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent', window );">Change in pension plans, tax</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Taxpaidoninterestrateswaps', window );">Tax paid on interest rate swaps</a></td>
<td class="num">(8.3)<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Changes in value of hedged interest rate caps, tax</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="num">$ (5.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Taxpaidoninterestrateswaps">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax paid on interest rate swaps</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Taxpaidoninterestrateswaps</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244411214936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 701.0<span></span>
</td>
<td class="nump">$ 601.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less reserves of $31.6 and $17.8, respectively</a></td>
<td class="nump">1,028.9<span></span>
</td>
<td class="nump">648.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">395.1<span></span>
</td>
<td class="nump">444.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">38.8<span></span>
</td>
<td class="nump">34.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">58.5<span></span>
</td>
<td class="nump">62.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,222.3<span></span>
</td>
<td class="nump">1,793.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">491.5<span></span>
</td>
<td class="nump">470.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,307.5<span></span>
</td>
<td class="nump">1,459.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,657.9<span></span>
</td>
<td class="nump">2,563.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">516.6<span></span>
</td>
<td class="nump">154.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">7,195.8<span></span>
</td>
<td class="nump">6,442.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">324.9<span></span>
</td>
<td class="nump">271.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">178.8<span></span>
</td>
<td class="nump">186.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">547.6<span></span>
</td>
<td class="nump">430.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">186.1<span></span>
</td>
<td class="nump">179.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Finance lease obligation (capital lease obligation in 2019)</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,239.3<span></span>
</td>
<td class="nump">1,070.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">2,713.9<span></span>
</td>
<td class="nump">2,783.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Finance lease obligation - long term (capital lease obligation in 2019)</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">201.8<span></span>
</td>
<td class="nump">275.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">303.2<span></span>
</td>
<td class="nump">162.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13 and 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 295,107 and 292,323 shares issued, respectively</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">5,904.8<span></span>
</td>
<td class="nump">5,769.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,573.2)<span></span>
</td>
<td class="num">(2,688.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 37,609 and 24,639 shares, respectively</a></td>
<td class="num">(1,579.6)<span></span>
</td>
<td class="num">(926.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(49.7)<span></span>
</td>
<td class="num">(42.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Hologic's stockholders&#8217; equity</a></td>
<td class="nump">2,705.2<span></span>
</td>
<td class="nump">2,115.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">2,707.3<span></span>
</td>
<td class="nump">2,115.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 7,195.8<span></span>
</td>
<td class="nump">$ 6,442.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capital lease obligation due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84164758&amp;loc=d3e45023-112735<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84164758&amp;loc=d3e45023-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31931-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6787-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5865-108316<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481879992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, reserves</a></td>
<td class="nump">$ 31.6<span></span>
</td>
<td class="nump">$ 17.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">1,623,000<span></span>
</td>
<td class="nump">1,623,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">295,107,000<span></span>
</td>
<td class="nump">292,323,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">37,609,000<span></span>
</td>
<td class="nump">24,639,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244406377064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Share Repurchase Program [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in-Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th">
<div>Treasury Stock [Member] </div>
<div>Share Repurchase Program [Member]</div>
</th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 30, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 30, 2017</a></td>
<td class="nump">$ 2,784,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">$ 5,630,800,000<span></span>
</td>
<td class="num">$ (2,382,700,000)<span></span>
</td>
<td class="num">$ (16,200,000)<span></span>
</td>
<td class="num">$ (450,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(16,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="nump">15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">65,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(275,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (275,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity component from convertible notes repurchase, net of taxes</a></td>
<td class="num">(40,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(8,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Adjustment to minimum pension liability, net</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Unrealized losses on derivatives, net of taxes</a></td>
<td class="num">(5,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statement of operations, net</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss) attributable to Hologic</a></td>
<td class="num">(111,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(111,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 29, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 29, 2018</a></td>
<td class="nump">2,428,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,671,300,000<span></span>
</td>
<td class="num">(2,494,000,000.0)<span></span>
</td>
<td class="num">(25,500,000)<span></span>
</td>
<td class="num">$ (725,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountingstandardtransitionadjustmentASC606', window );">Accounting standard transition adjustment - ASC 606</a></td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountingstandardtransitionadjustmentASU201616', window );">Accounting standard transition adjustment - ASU 2016-16</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(12,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">62,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(200,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(14,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Adjustment to minimum pension liability, net</a></td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Unrealized losses on derivatives, net of taxes</a></td>
<td class="num">(8,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss', window );">Unrealized gain on interest rate swap</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statement of operations, net</a></td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss) attributable to Hologic</a></td>
<td class="num">(203,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(203,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 28, 2019</a></td>
<td class="nump">$ 2,115,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,769,800,000<span></span>
</td>
<td class="num">(2,688,700,000)<span></span>
</td>
<td class="num">(42,300,000)<span></span>
</td>
<td class="num">$ (926,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 48,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(14,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="nump">17,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">83,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,064<span></span>
</td>
<td class="nump">3,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(448,600,000)<span></span>
</td>
<td class="num">$ (205,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (448,600,000)<span></span>
</td>
<td class="num">$ (205,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">18,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Adjustment to minimum pension liability, net</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Unrealized losses on derivatives, net of taxes</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss', window );">Unrealized gain on interest rate swap</a></td>
<td class="num">(27,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statement of operations, net</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss) attributable to Hologic</a></td>
<td class="nump">1,110,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,115,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,800,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling Interest, Increase from Business Combination</a></td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 26, 2020</a></td>
<td class="nump">2,707,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">$ 5,904,800,000<span></span>
</td>
<td class="num">(1,573,200,000)<span></span>
</td>
<td class="num">$ (49,700,000)<span></span>
</td>
<td class="num">$ (1,579,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Accounting standard transition adjustment | Accounting Standards Update 2018-01 [Member]</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountingstandardtransitionadjustmentASC606">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounting standard transition adjustment - ASC 606</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountingstandardtransitionadjustmentASC606</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountingstandardtransitionadjustmentASU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounting standard transition adjustment - ASU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountingstandardtransitionadjustmentASU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116855982&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479739080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,110,500,000<span></span>
</td>
<td class="num">$ (203,600,000)<span></span>
</td>
<td class="num">$ (111,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">83,100,000<span></span>
</td>
<td class="nump">92,500,000<span></span>
</td>
<td class="nump">101,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">292,900,000<span></span>
</td>
<td class="nump">370,600,000<span></span>
</td>
<td class="nump">378,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">83,300,000<span></span>
</td>
<td class="nump">62,000,000.0<span></span>
</td>
<td class="nump">65,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes and other non-cash taxes</a></td>
<td class="num">(94,400,000)<span></span>
</td>
<td class="num">(235,700,000)<span></span>
</td>
<td class="num">(477,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">685,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Impairmentofintangibleassetsandequipment', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">30,200,000<span></span>
</td>
<td class="nump">685,400,000<span></span>
</td>
<td class="nump">46,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">45,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments and non-cash items</a></td>
<td class="nump">27,300,000<span></span>
</td>
<td class="nump">33,800,000<span></span>
</td>
<td class="nump">24,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(427,100,000)<span></span>
</td>
<td class="num">(76,500,000)<span></span>
</td>
<td class="num">(38,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(25,300,000)<span></span>
</td>
<td class="num">(63,000,000.0)<span></span>
</td>
<td class="num">(50,600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="num">(3,800,000)<span></span>
</td>
<td class="num">(3,200,000)<span></span>
</td>
<td class="num">(9,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(286,200,000)<span></span>
</td>
<td class="num">(6,000,000.0)<span></span>
</td>
<td class="num">(4,200,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(4,900,000)<span></span>
</td>
<td class="num">(5,500,000)<span></span>
</td>
<td class="nump">23,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">96,000,000.0<span></span>
</td>
<td class="num">(16,500,000)<span></span>
</td>
<td class="nump">53,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="nump">14,400,000<span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">896,600,000<span></span>
</td>
<td class="nump">649,500,000<span></span>
</td>
<td class="nump">732,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="num">(119,400,000)<span></span>
</td>
<td class="num">(110,600,000)<span></span>
</td>
<td class="num">(76,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of business</a></td>
<td class="nump">139,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to Acquire Equity Method Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FundingOfLoansToSSI', window );">Loans to SSI</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(28,400,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(98,300,000)<span></span>
</td>
<td class="num">(57,000,000.0)<span></span>
</td>
<td class="num">(58,400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements', window );">Increase in equipment under customer usage agreements</a></td>
<td class="num">(58,100,000)<span></span>
</td>
<td class="num">(52,100,000)<span></span>
</td>
<td class="num">(47,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Purchaseofcostmethodinvestment', window );">Purchase of cost method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,000,000.0)<span></span>
</td>
<td class="num">(6,000,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Purchaseofinsurancecontracts', window );">Purchase of insurance contracts</a></td>
<td class="num">(2,400,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payments to Acquire in Process Research and Development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other activity</a></td>
<td class="num">(2,700,000)<span></span>
</td>
<td class="num">(6,900,000)<span></span>
</td>
<td class="num">(7,100,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(141,600,000)<span></span>
</td>
<td class="num">(280,700,000)<span></span>
</td>
<td class="num">(195,200,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,500,000,000.0<span></span>
</td>
<td class="nump">1,500,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(37,500,000)<span></span>
</td>
<td class="num">(1,462,500,000)<span></span>
</td>
<td class="num">(1,359,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProceedsfromSeniorNotes', window );">Proceeds from Senior Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,350,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RepaymentofSeniorNotes', window );">Repayment of Senior Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,037,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Payments to extinguish convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(546,200,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Repaymentofacquireddebt', window );">Repayment of acquired debt</a></td>
<td class="num">(8,300,000)<span></span>
</td>
<td class="num">(2,500,000)<span></span>
</td>
<td class="num">(3,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="nump">750,000,000.0<span></span>
</td>
<td class="nump">480,000,000.0<span></span>
</td>
<td class="nump">1,150,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments under revolving credit line</a></td>
<td class="num">(500,000,000.0)<span></span>
</td>
<td class="num">(780,000,000.0)<span></span>
</td>
<td class="num">(1,195,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromAccountsReceivableSecuritization', window );">Proceeds from accounts receivable securitization agreement</a></td>
<td class="nump">16,000,000.0<span></span>
</td>
<td class="nump">43,000,000.0<span></span>
</td>
<td class="nump">34,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization', window );">Repayments under accounts receivable securitization agreement</a></td>
<td class="num">(250,000,000.0)<span></span>
</td>
<td class="num">(34,000,000.0)<span></span>
</td>
<td class="num">(9,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock</a></td>
<td class="num">(653,600,000)<span></span>
</td>
<td class="num">(200,100,000)<span></span>
</td>
<td class="num">(275,800,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,700,000)<span></span>
</td>
<td class="num">(23,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment for Contingent Consideration Liability, Financing Activities</a></td>
<td class="num">(24,300,000)<span></span>
</td>
<td class="num">(6,500,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestRateCapAgreementsAggregatePremiumPayable', window );">Purchase of interest rate caps</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="num">(3,700,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Net proceeds from issuance of common stock under employee stock plans</a></td>
<td class="nump">65,600,000<span></span>
</td>
<td class="nump">49,800,000<span></span>
</td>
<td class="nump">33,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Payments under finance lease obligations</a></td>
<td class="num">(1,700,000)<span></span>
</td>
<td class="num">(1,700,000)<span></span>
</td>
<td class="num">(1,700,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits', window );">Payment of minimum tax withholdings on net share settlements of equity awards</a></td>
<td class="num">(14,300,000)<span></span>
</td>
<td class="num">(12,800,000)<span></span>
</td>
<td class="num">(16,700,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(659,900,000)<span></span>
</td>
<td class="num">(431,500,000)<span></span>
</td>
<td class="num">(404,800,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">4,100,000<span></span>
</td>
<td class="num">(2,200,000)<span></span>
</td>
<td class="num">(6,800,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">99,200,000<span></span>
</td>
<td class="num">(64,900,000)<span></span>
</td>
<td class="nump">126,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">601,800,000<span></span>
</td>
<td class="nump">666,700,000<span></span>
</td>
<td class="nump">540,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 701,000,000.0<span></span>
</td>
<td class="nump">$ 601,800,000<span></span>
</td>
<td class="nump">$ 666,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FundingOfLoansToSSI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loans to SSI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FundingOfLoansToSSI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Impairmentofintangibleassetsandequipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment of intangible assets and equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Impairmentofintangibleassetsandequipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestRateCapAgreementsAggregatePremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate cap agreements aggregate premium payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestRateCapAgreementsAggregatePremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsfromSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsfromSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Purchaseofcostmethodinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of cost method investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Purchaseofcostmethodinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Purchaseofinsurancecontracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of insurance contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Purchaseofinsurancecontracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RepaymentofSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RepaymentofSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Repaymentofacquireddebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of acquired debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Repaymentofacquireddebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from other long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404410744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Operations</a></td>
<td class="text">Operations<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic, Inc. (the &#8220;Company&#8221; or &#8220;Hologic&#8221;) develops, manufactures and supplies premium diagnostics products, medical imaging systems, and surgical products with an emphasis on women's health and well-being through early detection and treatment. Until December 30, 2019, the Company's product portfolio included light-based aesthetic and medical treatment systems sold by its former Medical Aesthetics business. The Company completed the sale of its Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). During the second, third and fourth quarters of fiscal 2020, the Company operated in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Considerations</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic caused by the spread of the novel strain of coronavirus disease 2019 ("COVID-19") has created significant volatility, uncertainty and economic disruption in the markets the Company sells its products into, primarily the U.S., Europe and Asia-Pacific. In the second, third and fourth quarters of fiscal 2020, the spread of COVID-19 has negatively impacted business and healthcare activity globally. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As healthcare systems respond to the increasing demands of managing COVID-19 and the resulting economic uncertainties, governments around the world have imposed measures designed to reduce the transmission of COVID-19, and individuals are responding to the fears of contracting COVID-19. In particular, elective procedures and exams have been and continue to be delayed or cancelled, there has been a significant reduction in physician office visits, and hospitals have postponed or cancelled capital purchases as well as limited or eliminated services, however in the second half of the third quarter of fiscal 2020, the Company started to see a recovery of elective procedures and exams, which continued into the fourth quarter. The reductions in testing and procedures have had, and the Company believes will continue to have, a negative impact on the Company's operating results and cash flows. However, the impact of the Company's commercial release of its COVID-19 assays more than offset these negative impacts, as the Company generated significant revenue from the sales of these assays in the third and fourth quarters of fiscal 2020. The negative effects of COVID-19 and the associated economic disruptions were felt primarily beginning in the second half of March in many of the Company's end-markets and earlier in Asia, primarily China, and the impact to the Company's legacy products in the third fiscal quarter was significant. The impact to its legacy products was less severe in the fourth quarter.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company's results of operations and cash flows in the third and fourth quarter of fiscal 2020 were positively impacted by the sale of its COVID-19 assays, the COVID-19 pandemic could have an adverse impact on its operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: the severity and duration of the COVID-19 pandemic; continued demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products; the COVID-19 pandemic&#8217;s impact on the U.S. and international healthcare system, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental responses to the COVID-19 pandemic and associated economic disruptions.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to adversely affecting demand for the Company's products, other than its COVID-19 assays, COVID-19 and associated economic disruptions could continue to have an adverse impact on the Company's supply chains and distribution systems, including as a result of impacts associated with preventive and precautionary measures that it, other businesses and governments have taken and will take. A reduction or interruption in any of the Company's manufacturing processes could have a material adverse effect on its business.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the uncertainty surrounding global financial markets and deteriorating worldwide macroeconomic conditions resulting from the pandemic have caused and may continue to cause the purchasers of medical equipment to decrease their medical equipment purchasing and procurement activities. Additionally, the pandemic has caused and may further cause constrictions in world credit markets that have caused and could cause its customers to experience increased difficulty in paying their existing obligations to the Company or in securing the financing necessary to purchase the Company's products. Economic uncertainty has resulted and may continue to result in cost-conscious consumers focusing on acute care rather than wellness, which may also continue to adversely affect demand for the Company's products (other than the Company's COVID-19 assays).</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company assessed the potential longer term economic and capital market uncertainties resulting from the COVID-19 pandemic, at the end of March 2020 the Company suspended its accounts receivable securitization program and borrowed $750.0&#160;million under its revolver. The Company used $250.0&#160;million of these proceeds to pay off all amounts then </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">owed under its accounts receivable securitization agreement and retained the balance as cash reserve. As of the end of fiscal 2020, the Company repaid $500.0&#160;million of the $750.0&#160;million borrowed under its revolver. As of September 26, 2020 the Company had an additional $1.25&#160;billion available under its revolver and $701.0&#160;million of cash on hand.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the negative impact of COVID-19 on the Company's business, in April 2020 the Company initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but the Company also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances employee terminations. Further, in April 2020, the Company had shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of its products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased, and the majority of the impacted manufacturing facilities are back to pre-COVID levels.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also taken measures to ensure the safety of its employees and to comply with governmental orders. These measures could require that the Company's employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in its commercial and marketing activities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405603624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned and majority owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#8217;s fiscal year ends on the last Saturday in September. Fiscal 2020, 2019 and 2018 ended on September&#160;26, 2020, September&#160;28, 2019 and September&#160;29, 2018, respectively. Fiscal 2020, 2019 and 2018 were 52-week years.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events Consideration</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events recorded in the consolidated financial statements as of and for the year ended September&#160;26, 2020. Subsequent to September 26, 2020, the Company's issued its 2029 Notes on September 28, 2020 and used the proceeds and cash on hand to pay off its 2025 Notes. For additional information, refer to Note 7.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Estimates and Uncertainties</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#8217;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#8217;s net deferred tax assets and related valuation allowances.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#8217;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers are principally located in the United States, Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;26, 2020. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was one customer with a balance greater than 10% of accounts receivable as of September&#160;26, 2020, at 11.9%. There were no customers with a balance greater than 10% of accounts receivable as of September&#160;28, 2019. There were no customers that represented greater than 10% of consolidated revenues for fiscal years 2020, 2019 and 2018.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Suppliers</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases certain components of its products from a single or small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which could adversely affect results of operations; however, management believes that suitable replacement suppliers could be obtained in such an event.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flow Statement Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.911%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration at acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#8217;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#8217;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"><tr><td style="width:1.0%"/><td style="width:52.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:36.030%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;10 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;8 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#8211;35 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the Original Term of Lease</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or Estimated Useful Life</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#8211;7 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(658.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred. </span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment&#8212;Impairment or Disposal of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique. </span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations and Acquisition of Intangible Assets</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company accounts for the acquisition of a business in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets and Goodwill</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are initially recorded at fair value and stated net of accumulated amortization and impairments. The Company amortizes its intangible assets that have finite lives using either the straight-line method, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be utilized. Amortization is recorded over the estimated useful lives ranging from 2 to 30 years. The Company evaluates the recoverability of its definite lived intangible assets whenever events or changes in circumstances or business conditions indicate that the carrying value of these assets may not be recoverable based on expectations of future undiscounted cash flows for each asset group. If the carrying value of an asset or asset group exceeds its undiscounted cash flows, the Company estimates the fair value of the assets, generally utilizing a discounted cash flow analysis based on the present value of estimated future cash flows to be generated by the assets using a risk-adjusted discount rate. To estimate the fair value of the assets, the Company uses market participant assumptions pursuant to ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite lived intangible assets, such as IPR&amp;D assets, are required to be tested for impairment annually, or more frequently if indicators of impairment are present. The Company&#8217;s annual impairment test date is as of the first day of its fourth quarter. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:36.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,704.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,276.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,786.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,326.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Aesthetics Impairment</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, the Company's Medical Aesthetics business met the criteria to be designated as assets held-for-sale. As a result, the Company recorded a $30.2&#160;million charge to record the asset group at fair value less costs to sell. In addition, developed technology, customer lists, trade names, and distribution agreement related to Medical Aesthetics of $24.1&#160;million, $0.9&#160;million, $2.0&#160;million, and $1.2&#160;million, respectively, were reclassified accordingly in the Company's Consolidated Balance Sheet to assets held-for-sale as of December 28, 2019 and subsequently disposed of in the second quarter of fiscal 2020. See Note 15 for additional information.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company identified indicators of impairment for its Medical Aesthetics reporting unit as a result of reductions in forecasts during the year, and in connection with the Company&#8217;s efforts to sell the business that began prior to the end of fiscal 2019. In performing the undiscounted cash flow analysis pursuant to ASC 360, the expected undiscounted cash flows of the asset group were determined using a probability-weighted approach taking into consideration the planned disposition, which was deemed to be highly probable as of the balance sheet date. Based on this analysis, the undiscounted cash flows were not sufficient to recover the carrying value of the asset group. As a result, the Company was required to perform Step 3 of the impairment test and determine the fair value of the asset group. The Company executed a definitive agreement on November 20, 2019 to sell the business. Although this agreement was signed subsequent to the balance sheet date, the Company concluded that it provided evidence regarding the estimate of fair value of the asset group at September 28, 2019 and that there were no events that occurred between September 28, 2019 and the date the Company entered into the definitive agreement that would significantly affect the fair value of the asset group. As a result, the Company recorded total impairment charges of $685.4&#160;million in fiscal 2019. The impairment charge was allocated to the long-lived assets as follows: $576.9 million to developed technology, $22.4 million to customer relationships, $48.6 million to trade names, $27.7 million to distribution agreements and $9.8 million to equipment. On November 20, 2019, this asset group met the assets held-for-sale criteria and was recorded at fair value less the costs to sell as noted above. See Note 15. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2018, the Company abandoned an in-process research and development project acquired in the Cynosure acquisition and recorded an impairment charge of $46.0&#160;million. The Company abandoned the project as a result of unsuccessful clinical results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Activity</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2020, the Company acquired Acessa Health, Inc. and recorded $127.0&#160;million of developed technology and $1.2&#160;million of trade names based on its preliminary purchase accounting. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2019, the Company acquired Focal Therapeutics, Inc. and recorded $83.1 million of developed technology, $11.4 million of in-process research and development and $2.7 million of trade names. In the fourth quarter of fiscal 2019, the Company obtained FDA approval for the in-process research and development project and reclassified this value to developed technology. During fiscal 2019, the two in-process research and development projects acquired in the Faxitron acquisition aggregating $5.5 million were completed and reclassified to developed technology.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to developed technology is classified as cost of product revenues&#8212;amortization of intangible assets. Amortization expense related to customer relationships, contracts, trade names, distribution agreements, and business licenses is classified as a component of amortization of intangible assets within operating expenses.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amortization expense at September&#160;26, 2020 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 350), the Company tests goodwill for impairment annually at the reporting unit level and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying value. Events that could indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate, operational performance of the business or key personnel, and an adverse action or assessment by a regulator. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the impairment test, the Company utilizes the single-step approach prescribed under Accounting Standards Update No. 2017-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2017-04) . This approach requires a comparison of the carrying value of each reporting unit to its estimated fair value and to the extent the carrying value exceeds the fair value a charge is recorded up to the amount of goodwill in the reporting unit. To estimate the fair value of its reporting units, the Company primarily utilizes the income approach. The income approach is based on a DCF analysis and calculates the fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting the after-tax cash flows to present value using a risk-adjusted discount rate. Assumptions used in the DCF require significant judgment, including judgment about appropriate discount rates and terminal values, growth rates, and the </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount and timing of expected future cash flows. The forecasted cash flows are based on the Company&#8217;s most recent budget and strategic plan and for years beyond this period, the Company&#8217;s estimates are based on assumed growth rates expected as of the measurement date. The Company believes its assumptions are consistent with the plans and estimates used to manage the underlying businesses. The discount rates used are intended to reflect the risks inherent in future cash flow projections and are based on estimates of the weighted-average cost of capital (&#8220;WACC&#8221;) of market participants relative to each respective reporting unit. The market approach considers comparable market data based on multiples of revenue or earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) and is primarily used as a corroborative analysis to the results of the DCF analysis. The Company believes its assumptions used to determine the fair value of its reporting units are reasonable. If different assumptions were used, particularly with respect to forecasted cash flows, terminal values, WACCs, or market multiples, different estimates of fair value may result and there could be the potential that an impairment charge could result. Actual operating results and the related cash flows of the reporting units could differ from the estimated operating results and related cash flows.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducted its fiscal 2020 impairment test for its reporting units on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of June 28, 2020, and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of the Company's reporting units had fair values exceeding their carrying values. For illustrative purposes, had the fair value of each of the reporting units been lower by 10%, all of the reporting units would still have passed the goodwill impairment test.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;26, 2020, the Company believes that its reporting units, with goodwill aggregating $2.6&#160;billion, were not at risk of failing the goodwill impairment test based on its current forecasts and qualitative assessment.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, the Company used the qualitative approach as of June 29, 2019 to assess its goodwill for impairment. Under this approach the Company considered a number of factors, including the amount by which the previous quantitative test's fair value exceeded the carrying value of the reporting units, the forecasts in the Company's strategic plan compared to the forecast used in the previous quantitative test, an evaluation of discount rates, long-term growth rates including the terminal year rate, if tax rates would have significantly changed, an evaluation of current economic factors for both the worldwide economy and specifically the medical device industry, and any significant changes in customer and supplier relationships. The Company weighed these factors to determine if it was more likely than not that the fair value of the reporting unit exceeded its carrying value. If after performing a qualitative assessment, indicators are present, or the Company identified factors that cause it to believe it is appropriate to perform a more precise calculation of fair value, the Company would have moved beyond the qualitative assessment and perform a quantitative impairment test. As a result of completing the qualitative assessment for each of its reporting units for fiscal 2019, the Company concluded that it was more likely than not that the fair value of each reporting exceeded its carrying value by a significant amount and a quantitative test was unnecessary.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2018, in connection with commencing its company-wide annual budgeting and strategic planning process, evaluating its current operating performance of its Medical Aesthetics reporting unit, and abandoning an in-process research and development project, the Company reduced its short term and long term revenue and operating income forecasts and determined that indicators of impairment existed in its Medical Aesthetics reporting unit. The Medical Aesthetics reporting unit was solely comprised of the Cynosure business, which the Company acquired on March 22, 2017. The updated forecast reflected significantly reduced volume and market penetration projections resulting in lower short-term and long-term profitability than expected at the time of the Cynosure acquisition. As a result of those events and circumstances at that time, the Company determined that it was more likely than not that this change would reduce the fair value of the reporting unit below its carrying amount. To estimate the fair value of the reporting unit, the Company utilized the DCF analysis. The forecasted cash flows were based on the Company's most recent budget and strategic plan and for period beyond the strategic plan, the Company's estimates were based on assumed growth rates expected as of the measurement date. The Company believed its assumptions were consistent with the plans and estimates used to manage the underlying business. The discount rate used is intended to reflect the risks inherent in future cash flow projections and was based on an estimate of the weighted average cost of capital (WACC) of market participants relative to the reporting unit. The basis of fair value for Medical Aesthetics assumed the reporting unit would be purchased or sold in a non-taxable transaction, and the discount rate of 12.0% applied to the after-tax cash flows was consistent with that used in the purchase accounting performed in fiscal 2017. As a result of this analysis, the fair value of the Medical Aesthetic reporting unit was significantly below its carrying value, and the Company recorded a goodwill impairment charge of $685.7 million during the second quarter of fiscal 2018.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the goodwill impairment test in the second quarter of fiscal 2018, the Company also performed an impairment test of this reporting unit&#8217;s long-lived assets. This impairment evaluation was based on expectations of future undiscounted cash flows compared to the carrying value of the long-lived assets. The Company&#8217;s cash flow estimates were consistent with those used in the goodwill impairment test discussed above. Based on this analysis, the undiscounted cash flows </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Medical Aesthetics long-lived assets were in excess of their carrying value and thus deemed to not be impaired. The Company believed its procedures for estimating future cash flows were reasonable and consistent with market conditions at the time of estimation.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducted its 2018 impairment test on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of July 1, 2018 and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. As a result of completing Step 1, all of the Company's reporting units had fair values exceeding their carrying values, and as such, Step 2 of the impairment test was not required. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of goodwill activity by reportable segment from September&#160;28, 2019 to September&#160;26, 2020 is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"><tr><td style="width:1.0pt"/><td style="width:130.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:57.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:57.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Breast&#160;Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GYN&#160;Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skeletal&#160;Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 28, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,563.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Beacons acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acessa Health acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:24pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,657.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"><tr><td style="width:1.0%"/><td style="width:40.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-method equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-method investment and loans to SSI (Note 5)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax receivable primarily relates to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. The right of use assets were recorded in connection with the adoption of ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#8217;s Nonqualified Deferred Compensation Plan (&#8220;DCP&#8221;) and are recorded at their cash surrender value (see Note 12 for further discussion). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Software Development Costs</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred for the research and development of the Company&#8217;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the development costs of software embedded in the Company&#8217;s products in accordance with ASC 985, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#8217;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimate useful life and recorded within cost of revenues - product.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries are translated in accordance with ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#8217;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income, net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss) as a separate component of stockholders&#8217; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income, net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (loss)</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#8217; equity. The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charges (gains) reclassified to statement of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income, net in the Consolidated Statements of Operations.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5 million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments on $1.0 billion of principal, which ended on December 27, 2019 for the contracts entered into in fiscal 2018, and which will end on December 23, 2020 for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;26, 2020, the Company determined that the existence of hedge ineffectiveness, if any, was immaterial and all changes in the fair value of the interest rate caps were recorded within AOCI.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, 2019 and 2018, interest expense of $2.3 million, $3.1 million and $3.6 million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The Company expects to similarly reclassify approximately $0.5 million from AOCI to the Consolidated Statements of Operations in the next twelve months.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of these interest rate caps was $0.0 million and $0.1 million at September&#160;26, 2020 and September&#160;28, 2019, respectively, and is included in both Prepaid expenses and other current assets and Other assets on the Company&#8217;s Consolidated Balance Sheet. Refer to Note 8 &#8220;Fair Value Measurements&#8221; for related fair value disclosures.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in accumulated other comprehensive income (loss) and were a loss, net of taxes, of $27.6&#160;million and a gain, net of taxes, of $3.5&#160;million for the years ended September 26, 2020 and September 28, 2019, respectively. The fair value of this derivative was in a liability position of $31.2 million as of September 26, 2020.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28. 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29. 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 26, 2020, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with a notional amount of $172.6 million. As of September 26, 2020, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $380.2 million.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:23pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:47.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.842%"><tr><td style="width:1.0%"/><td style="width:49.910%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.896%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Operations for derivative instruments for which the Company did not elect hedge accounting:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:32.926%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not classified as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain Recognized in Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable and Reserves</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves for doubtful accounts based upon a specific review of all outstanding invoices, known collection issues and historical experience. The Company regularly evaluates the collectability of its trade accounts receivables and performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and its assessment of the customer&#8217;s current credit worthiness.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable reserve activity for fiscal 2020, 2019 and 2018 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 29, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#8217;s professional services&#8217; employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based payments in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 718)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#8217;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, as a result of the adoption of ASU 2016-09 in fiscal 2017, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled. </span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options, restricted stock units and convertible debt for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts for fiscal 2020, 2019, and 2018 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In those reporting periods in which the Company has reported net income, anti-dilutive shares generally are comprised of those stock options that either have an exercise price above the average stock price for the period or the stock options&#8217; combined exercise price and average unrecognized stock compensation expense upon exercise is greater than the average stock price. In those reporting periods in which the Company has a net loss, anti-dilutive shares are comprised of the impact of those number of shares that would have been dilutive had the Company had net income plus the number of common stock equivalents that would be anti-dilutive had the company had net income.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally offers a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM5NjU4_08c7a977-3e74-4ea4-ab24-1584cb253ab9">one</span>-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#8217;s warranty reserves include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity for fiscal 2020 and 2019 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.489%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at&#160;End<br/>of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $15.6 million, $29.5 million and $26.9 million for fiscal 2020, 2019 and 2018, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, the FASB issued ASU No. 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 815): Targeted Improvements to Accounting for Hedging Activities.&#160;The guidance requires certain changes to the presentation of hedge accounting in the financial statements and also simplifies the application of hedge accounting and expands the strategies that qualify for hedge accounting.&#160;The Company adopted the standard in the first quarter of fiscal 2020. The adoption of ASU 2017-12 did not have a material effect on the Company's consolidated financial statements.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently a number of improvements. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-13, as well as all codification improvements in ASU 2019-04, ASU 2019-10, ASU 2019-11 and ASU 2020-03, on its consolidated financial position and results of operations. The Company expects the adoption to primarily be applicable to its accounts receivable and does not believe the impact will be material to its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in that Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. For entities that have adopted the amendments in Update 2018-07, the updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2019-08 on its consolidated financial position and results of operations but does not expect the adoption to have a material impact to its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board is issuing this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">those fiscal years, beginning after December 15, 2020. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board is issuing this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-03,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board is issuing this Update to clarify or improve the Codification, as well as, make the Codification easier to understand and apply by eliminating inconsistencies. This update is to improve various financial instruments Topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process. For entities that have adopted the amendments in Update 2020-03, the updated guidance is effective for all entities beginning in fiscal 2021. The Company is currently evaluating the impact of the adoption of ASU 2020-03 on its consolidated financial position and results of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board is issuing this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405742232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2014, the FASB issued ASC 606. The Company adopted the standard, which superseded ASC Topic 605, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 605), as of September 30, 2018 using the modified retrospective method for contracts that were not complete as of September 30, 2018. Under this method, the Company recognized the cumulative effect of initially applying the standard to its open contracts and recorded an adjustment to decrease the opening balance of accumulated deficit within stockholders' equity by $6.4 million, which is net of taxes of $2.4 million, as of September 30, 2018 (the first day of fiscal 2019). The cumulative effect adjustment was primarily due to the Company applying the principles of ASC 606 to contracts for which the Company had deferred revenue as of September 29, 2018 for collectability uncertainty and providing extended payment terms resulting in the fee not being fixed or determinable under ASC 605. Under ASC 606, revenue from certain arrangements may be recognized earlier than under ASC 605 as a result of the ability to apply additional judgment in evaluating collectability and the elimination of the requirement to assess whether a fee is fixed or determinable, specifically as it relates to providing customers with extended payment terms. Results for reporting periods beginning September 30, 2018 and after are presented in accordance with ASC 606. Prior period results were not adjusted and will continue to be reported in accordance with the legacy GAAP requirements of ASC 605. As the adoption of this standard did not have a material impact on the Company&#8217;s revenue recorded for the years ended September 28, 2019 and September 29, 2018, transitional disclosures have not been presented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. Prior to the Cynosure divestiture, the Company also generated revenue from the sale and service of medical aesthetic treatment systems. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"/><td style="width:2.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.980%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"><tr><td style="width:1.0%"/><td style="width:37.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.765%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.171%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"/><td style="width:32.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:20.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,666.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefit of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's contracts typically do not provide the right to return product. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September 26, 2020, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $635.6 million. These remaining performance obligations primarily relate to extended warranty and support and maintenance obligations in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately 39% of this amount as revenue in 2021, 28% in 2022, 19% in 2023, 10% in 2024, and 4% thereafter. The Company has applied the practical expedient to not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments and, until December 30, 2019, the divested Medical Aesthetics segment. Contract liabilities are classified as other current liabilities and other long-term liabilities on the Consolidated Balance Sheets. The Company recognized revenue of $106.2&#160;million and $158.9 million in the years ended September 26, 2020 and September 28, 2019, respectively, that was included in the contract liability balance at September 28, 2019 and September 29, 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical Expedients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;With the adoption of ASC 606, the Company elected to apply certain permitted practical expedients. In evaluating the cumulative-effect adjustment to retained earnings, the Company adopted the standard only for contracts that were not complete as of the date of adoption. For contracts that were modified prior to the adoption date, the Company elected to present the aggregate effect of all contract modifications in determining the transaction price and for the allocation to the satisfied and unsatisfied performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition under ASC 605 (prior to the adoption of ASC 606, which applies to fiscal 2018)</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 605, the Company recognized product revenue upon shipment provided that there was persuasive evidence of an arrangement, there were no uncertainties regarding acceptance, the sales price was fixed or determinable, and collection of the resulting receivable was reasonably assured. Generally, the Company&#8217;s product arrangements for capital equipment sales, primarily in its Breast Health, Medical Aesthetics and Skeletal Health reporting segments, were multiple-element arrangements, including services, such as installation, training and support and maintenance, and multiple products. Based on the terms and conditions of the product arrangements, the Company believed that these services and undelivered products could be accounted for separately from the delivered product element as the Company&#8217;s delivered products have value to its customers on a stand-alone basis. Accordingly, revenue for services not yet performed at the time of product delivery were deferred and recognized as such services were performed. The relative selling price of any undelivered products was also deferred at the time of shipment and recognized as revenue when these products were delivered. There was no customer right of return in the Company&#8217;s sales agreements for its capital equipment.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Service revenues primarily consist of amounts recorded under service and maintenance contracts and repairs not covered under warranty, installation and training, and shipping and handling costs billed to customers. Service and maintenance contract revenues were recognized ratably over the term of the contract. Other service revenues were recognized as the services were completed using the specific performance method. Service and other revenue also included royalties which were recognized in the period the payments were due to the Company.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For revenue arrangements with multiple deliverables, the Company recorded revenue as separate units of accounting if the delivered items had value to the customer on a stand-alone basis and the delivery or performance of the undelivered items was considered probable and substantially within the Company&#8217;s control. Some of the Company&#8217;s products have both software and non-software components that function together to deliver the product&#8217;s essential functionality. The Company determined that except for its computer-aided detection (&#8220;CAD&#8221;) products and C-View and Intelligent 2D products, the software element in its other products was not within the scope of the software revenue recognition rules, ASC 985-605, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software&#8212;Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company determined that given the significance of the software component&#8217;s functionality to its CAD, C-View and Intelligent 2D components, which are sold by its Breast Health segment, these products were within the scope of the software revenue recognition rules. The Company evaluated the appropriate revenue recognition treatment of it hardware products, including its Dimensions digital mammography systems, which had both software and non-software components that function together to deliver the products&#8217; essential functionality (i.e., it is a tangible product), and determined they were not within the scope of ASC&#160;985-605.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company was required to allocate revenue to its multiple element arrangements based on the relative fair value of each element&#8217;s selling price. The Company typically determined the selling price of its products based on its best estimate of selling prices (&#8220;ESP&#8221;) and services based on vendor-specific objective evidence of selling price (&#8220;VSOE&#8221;). The Company determined VSOE based on its normal pricing and discounting practices for the specific product or service when sold on a stand-alone basis. In determining VSOE, the Company&#8217;s policy was to require a substantial majority of selling prices for a product or service to be within a reasonably narrow range. The Company also considered the class of customer, method of distribution, and the geographies into which its products and services were sold when determining VSOE. If VSOE could not be established, which could occur in instances when a product or service had not been sold separately, stand-alone sales were too infrequent, or product pricing was not within a relatively narrow range, the Company would generally establish the selling price using ESP to allocate arrangement consideration. The objective of ESP was to determine the price at which the Company would typically transact a stand-alone sale of the product or service. ESP was determined by considering a number of factors including Company pricing policies, internal costs and gross margin objectives, method of distribution, information gathered from experience in customer negotiations, market research and information, recent technological trends, competitive landscape and geographies.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For those arrangements accounted for under the software revenue recognition rules, ASC 985-605 generally required revenue earned on software arrangements involving multiple elements to be allocated to each element based on their relative VSOE of fair value. If VSOE did not exist for a delivered element, the residual method was applied in which the arrangement consideration was allocated to the undelivered elements based on their VSOE with the remaining consideration recognized as revenue for the delivered elements. For multiple-element software arrangements where VSOE of fair value of Post-Contract Customer Support (&#8220;PCS&#8221;) had been established, the Company recognized revenue using the residual method at the time all other revenue recognition criteria were met.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;While the majority of its instruments are placed at customer sites, in certain instances the Company sold instruments to its clinical diagnostics customers and recorded sales of these instruments upon shipment or delivery, depending on the terms of the arrangement.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Within its Diagnostics business, and to a lesser extent, its GYN Surgical business, the Company provided its instrumentation (for example, the ThinPrep Processor, ThinPrep Imaging System, and the Panther and Tigris systems) and certain other hardware to customers without requiring them to purchase the equipment or enter into a lease. The Company installed the instrumentation or equipment at the customer&#8217;s site and recovered the cost of providing the instrumentation or equipment in the amount it charged for its diagnostic tests, assays and other disposables. Customers entered into a customer usage agreement and typically committed to purchasing minimum quantities of disposable products at a stated price over a defined contract term, which was typically between three and five years. Revenue was recognized over the term of the customer usage agreement as tests, assays and other disposable products are shipped or delivered, depending on the customer's arrangement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481168008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to as ASC 842. The purpose of ASU 2016-02 is to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, is effective for public entities for annual periods beginning after December 15, 2018, including interim periods within those annual periods and was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, Leases (Topic 842): Targeted Improvements. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements. Prior periods are presented in accordance with the lease guidance under ASC Topic 840, Leases (ASC 840). </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have a significant amount of sales-type leases. Under ASC 840, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c">96.6&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4">21.0&#160;million</span>, respectively. This includes recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements are included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 15 years, some of which may include options to extend the leases for up to 20 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;26, 2020. The Company's lease classified as a capital lease in fiscal 2019 is now classified as a finance lease on the balance sheet as of September&#160;26, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;26, 2020 was 2.62%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71">Accrued expenses</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The finance lease was previously recorded as a capital lease in the consolidated balance at September 28, 2019, and the short-term and long-term liabilities were $1.8&#160;million and $19.2&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"><tr><td style="width:1.0%"/><td style="width:52.168%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.010%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"><tr><td style="width:1.0%"/><td style="width:2.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 4% of the Company&#8217;s consolidated revenue for the twelve months ended September&#160;26, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the disposition of the Medical Aesthetics business, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease, included in property, plant and equipment, and recorded a lease receivable, which was $19.3&#160;million as of September&#160;26, 2020.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company subleases a portion of a building it owns and some of its rented facilities and has received aggregate rental income of $2.0 million, $2.7 million and $2.6 million in fiscal 2020, 2019 and 2018, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"><tr><td style="width:1.0%"/><td style="width:76.696%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to as ASC 842. The purpose of ASU 2016-02 is to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, is effective for public entities for annual periods beginning after December 15, 2018, including interim periods within those annual periods and was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, Leases (Topic 842): Targeted Improvements. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements. Prior periods are presented in accordance with the lease guidance under ASC Topic 840, Leases (ASC 840). </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have a significant amount of sales-type leases. Under ASC 840, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c">96.6&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4">21.0&#160;million</span>, respectively. This includes recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements are included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 15 years, some of which may include options to extend the leases for up to 20 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;26, 2020. The Company's lease classified as a capital lease in fiscal 2019 is now classified as a finance lease on the balance sheet as of September&#160;26, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;26, 2020 was 2.62%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71">Accrued expenses</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The finance lease was previously recorded as a capital lease in the consolidated balance at September 28, 2019, and the short-term and long-term liabilities were $1.8&#160;million and $19.2&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"><tr><td style="width:1.0%"/><td style="width:52.168%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.010%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"><tr><td style="width:1.0%"/><td style="width:2.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 4% of the Company&#8217;s consolidated revenue for the twelve months ended September&#160;26, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the disposition of the Medical Aesthetics business, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease, included in property, plant and equipment, and recorded a lease receivable, which was $19.3&#160;million as of September&#160;26, 2020.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company subleases a portion of a building it owns and some of its rented facilities and has received aggregate rental income of $2.0 million, $2.7 million and $2.6 million in fiscal 2020, 2019 and 2018, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"><tr><td style="width:1.0%"/><td style="width:76.696%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to as ASC 842. The purpose of ASU 2016-02 is to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, is effective for public entities for annual periods beginning after December 15, 2018, including interim periods within those annual periods and was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, Leases (Topic 842): Targeted Improvements. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements. Prior periods are presented in accordance with the lease guidance under ASC Topic 840, Leases (ASC 840). </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have a significant amount of sales-type leases. Under ASC 840, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c">96.6&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4">21.0&#160;million</span>, respectively. This includes recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements are included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 15 years, some of which may include options to extend the leases for up to 20 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;26, 2020. The Company's lease classified as a capital lease in fiscal 2019 is now classified as a finance lease on the balance sheet as of September&#160;26, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;26, 2020 was 2.62%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71">Accrued expenses</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The finance lease was previously recorded as a capital lease in the consolidated balance at September 28, 2019, and the short-term and long-term liabilities were $1.8&#160;million and $19.2&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"><tr><td style="width:1.0%"/><td style="width:52.168%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.010%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"><tr><td style="width:1.0%"/><td style="width:2.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 4% of the Company&#8217;s consolidated revenue for the twelve months ended September&#160;26, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the disposition of the Medical Aesthetics business, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease, included in property, plant and equipment, and recorded a lease receivable, which was $19.3&#160;million as of September&#160;26, 2020.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company subleases a portion of a building it owns and some of its rented facilities and has received aggregate rental income of $2.0 million, $2.7 million and $2.6 million in fiscal 2020, 2019 and 2018, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"><tr><td style="width:1.0%"/><td style="width:76.696%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to as ASC 842. The purpose of ASU 2016-02 is to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, is effective for public entities for annual periods beginning after December 15, 2018, including interim periods within those annual periods and was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, Leases (Topic 842): Targeted Improvements. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements. Prior periods are presented in accordance with the lease guidance under ASC Topic 840, Leases (ASC 840). </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have a significant amount of sales-type leases. Under ASC 840, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTM5_ece40640-c263-4082-b3a0-5c399df35d9c">96.6&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGV4dHJlZ2lvbjphMTRlNTA3NDIxZDU0NmQ5YTc2MmY3N2JkYzkzZTU4YV85MzQ1ODQ4ODU4NTY3_cff63ac9-9f97-445d-ae35-6884e888cfa4">21.0&#160;million</span>, respectively. This includes recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements are included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 15 years, some of which may include options to extend the leases for up to 20 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;26, 2020. The Company's lease classified as a capital lease in fiscal 2019 is now classified as a finance lease on the balance sheet as of September&#160;26, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;26, 2020 was 2.62%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71">Accrued expenses</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The finance lease was previously recorded as a capital lease in the consolidated balance at September 28, 2019, and the short-term and long-term liabilities were $1.8&#160;million and $19.2&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"><tr><td style="width:1.0%"/><td style="width:52.168%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.010%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"><tr><td style="width:1.0%"/><td style="width:2.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 4% of the Company&#8217;s consolidated revenue for the twelve months ended September&#160;26, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the disposition of the Medical Aesthetics business, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease, included in property, plant and equipment, and recorded a lease receivable, which was $19.3&#160;million as of September&#160;26, 2020.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company subleases a portion of a building it owns and some of its rented facilities and has received aggregate rental income of $2.0 million, $2.7 million and $2.6 million in fiscal 2020, 2019 and 2018, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"><tr><td style="width:1.0%"/><td style="width:76.696%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorSalesTypeLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's sales-type leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorSalesTypeLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph Note 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph Note 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405860152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$161.3&#160;million, which included a hold-back of $3.0&#160;million payable five months from the date of acquisition, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"><tr><td style="width:1.0%"/><td style="width:5.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:68.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.718%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company has determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets has been estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows are based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill are based on synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical's sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's preliminary valuation, it has allocated $10.7&#160;million of the purchase price to the preliminary value of developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price has been allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration which the Company has estimated at $0.9&#160;million. The contingent consideration is payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. Goodwill was immaterial. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine ("SSI") for $18.2&#160;million. SSI is a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting and included its proportionate share of SSI's net loss of $3.3&#160;million for the two months ended September 28, 2019 within Other income, net. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional 7.6&#160;million common shares of SSI for $12.6&#160;million. As a result, the Company's ownership interest increased to approximately 78% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2&#160;million recorded in the first quarter of fiscal 2020. The total accounting purchase price was $69.3&#160;million, which consisted of $17.9&#160;million for the equity method investment in SSI, $12.6&#160;million for shares acquired on November 21, 2019, $30.2&#160;million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6&#160;million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1&#160;million outstanding shares in fiscal 2020 for $1.8&#160;million, and as of September 26, 2020, the Company owned approximately 81% of the outstanding shares of SSI.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. The Company has not yet obtained all of the information related to the fair value of the acquired assets and liabilities, primarily income taxes and recognition of uncertain tax positions, to finalize the purchase price allocation.&#160;</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology, customer relationships, and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill are based on synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Focal Therapeutics</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Company completed the acquisition of Focal Therapeutics, Inc. ("Focal") for a purchase price of $120.1&#160;million, which included hold-backs of $14.0&#160;million payable up to one year from the date of acquisition. In the second quarter of fiscal 2019, $1.5&#160;million of the hold-back was paid, and the remaining $12.5&#160;million was paid in the first quarter of fiscal 2020. Focal, headquartered in California, manufactures and markets its BioZorb marker, which is an implantable three-dimensional marker that helps clinicians overcome certain challenges in breast conserving surgery. Focal's results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Focal's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, in-process research and development ("IPR&amp;D"), and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from&#160;15.5%&#160;to 16.5%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names was 11 years and 13 years, respectively. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the amount of goodwill were based on synergistic benefits that are expected to be realized from this acquisition. Benefits include the expectation of broadening the Company's Breast Health portfolio of products and technology. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Faxitron</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2018, the Company completed the acquisition of Faxitron Bioptics, LLC ("Faxitron") for a purchase price of $89.5 million, which included hold-backs of $11.7 million payable up to one year from the date of acquisition, and contingent consideration, which the Company estimated at $2.9 million as of the measurement date. Faxitron, headquartered in Tucson, Arizona, develops, manufactures, and markets digital radiography systems. The contingent consideration is payable upon meeting certain revenue growth metrics. In the fourth quarter of fiscal 2019, the Company increased the contingent consideration liability by $1.7 million based on updated projections, and the Company paid $5.0&#160;million in the second quarter of fiscal 2020. During fiscal 2019, the Company paid $6.5 million of the hold-backs and withheld the remainder of $5.2 million under the indemnification provisions of the purchase agreement, which the former shareholders had disputed. In the first quarter of fiscal 2020, the Company resolved this dispute and paid $4.1&#160;million to the former shareholders. Faxitron's results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Faxitron's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of July 31, 2018, as set forth below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Faxitron's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, in-process research and development ("IPR&amp;D"), customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from&#160;17%&#160;to&#160;19%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for both developed technology and customer relationships is 9 years and for trade names it is 7 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill were based on synergistic benefits that are expected to be realized from this acquisition. Benefits include the expectation of broadening the Company's Breast Health portfolio of products and technology. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emsor, S.A.</span></div>On December 11, 2017, the Company completed the acquisition of Emsor S.A. ("Emsor") for a purchase price of $16.3 million, and contingent consideration, which the Company estimated at $4.9 million as of the measurement date. The contingent consideration was payable upon Emsor achieving predefined amounts of cumulative revenue over a two-year period from the date of acquisition. The contingent consideration was paid in the second quarter of fiscal 2020. Emsor was a distributor of the Company's Breast and Skeletal Health products in Spain and Portugal. Based on the Company's valuation, it allocated $4.6 million of the purchase price to the value of customer relationship intangible assets and $5.7 million to goodwill. The remaining $6.0 million of purchase price was allocated to acquired tangible assets and liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404488120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Agreements</a></td>
<td class="text">Borrowings and Credit Agreements<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:82.456%"><tr><td style="width:1.0%"/><td style="width:67.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.970%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.973%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,452.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt maturity schedule for the Company&#8217;s obligations as of September&#160;26, 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:18.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.676%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026 and Thereafter </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement as of October 3, 2017 ("2017 Credit Agreement"). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2018 Credit Agreement consist of:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $1.5 billion secured term loan ("2018 Term Loan") with a maturity date of December 17, 2023; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility ("2018 Revolver"; together with the 2018 Term Loan, the "Amended Credit Facilities") under which the Company may borrow up to $1.5 billion, subject to certain sublimits, with a maturity date of December 17, 2023.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company initially borrowed $350 million under the 2018 Revolver. This initial borrowing, together with the net proceeds of the 2018 Term Loan, were used to repay the amounts outstanding under the term loan and revolving credit facility under the 2017 Credit Agreement.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2018 Credit Agreement bear interest, at the Company's option and in each case plus an applicable margin as follows: </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">2018 Term Loan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: at the Base Rate, Eurocurrency Rate or LIBOR Daily Floating Rate,&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">2018 Revolver</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: if funded in U.S. dollars, the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate, and, if funded in an alternative currency, the Eurocurrency Rate; and if requested under the swing line sublimit, the Base Rate.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 26, 2020, the Company had $250.0&#160;million outstanding under the 2018 Revolver and the interest rate under the Term loan was 1.40%.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable margin to the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate is subject to specified changes depending on the total net leverage ratio as defined in the 2018 Credit Agreement. The borrowings of the 2018 Term Loan initially bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate equal to 1.25%. The borrowings of the 2018 Revolver initially bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to 1.25%. The Company is also required to pay a quarterly commitment fee calculated on the undrawn committed amount available under the 2018 Revolver.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to make scheduled principal payments under the 2018 Term Loan in increasing amounts ranging from $9.375 million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $28.125 million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Term Loan after the scheduled principal payments, which is $1.2 billion, and any amounts outstanding under the 2018 Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, the Company may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by the Company,&#160;first, to the 2018 Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2018 Credit Facilities without premium or penalty.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement requires the Company to maintain certain financial ratios. The 2018 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company and its U.S. subsidiaries, with certain exceptions. For example, borrowings under the 2018 Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under the Company's Accounts Receivable Securitization program. The 2018 Credit Agreement contains total net leverage ratio and interest coverage ratio financial covenants measured as of the last day of each fiscal quarter. The total net leverage ratio covenant was 5.00:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and remains as such until it decreases to 4.50:1.00 for the quarter ending June 25, 2022. The interest coverage ratio covenant was 3.75:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and remains as such for each quarter thereafter. The total net leverage ratio is defined as the ratio of the Company's consolidated net debt as of the quarter end to its consolidated adjusted EBITDA (as defined in the 2018 Credit Agreement) for the four-fiscal quarter period ending on the measurement date. The interest coverage ratio is defined as the ratio of the Company's consolidated adjusted EBITDA for the prior four-fiscal quarter period ending on the measurement date to adjusted consolidated cash interest expense (as defined in the 2018 Credit Agreement) for the same measurement period. The Company was in compliance with these covenants as of September 26, 2020.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2018 Credit Agreement for derivatives pursuant to ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and identified embedded derivatives that required bifurcation as the features are not clearly and closely related to the host instrument. The embedded derivatives were a default provision, which could require additional interest payments, and a provision requiring contingent payments to compensate the lenders for changes in tax deductions. The Company determined that the fair value of these embedded derivatives was nominal as of September 26, 2020.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 470), the accounting related to entering into the 2018 Credit Agreement and using the proceeds to pay off the 2017 Credit Agreement was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2017 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $0.8 million in the first quarter of fiscal 2019. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt instruments before and after the transaction was less than 10%. We accounted for the amendments pursuant to ASC 470, subtopic 50-40, and third-party costs of $0.8 million related to this transaction were recorded as interest expense and $1.9 million was recorded as a reduction to debt representing deferred issuance costs and debt discount for fees paid directly to the lenders.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Agreement</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 3, 2017, the Company and certain of its domestic subsidiaries entered into an Amended and Restated Credit and Guaranty Agreement (the "2017 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto. The 2017 Credit Agreement amended and restated the Company's prior credit and guaranty agreement, originally dated as of May 29, 2015 (the "Prior Credit Agreement"). The proceeds under the 2017 Credit Agreement of $1.8 billion were used, among other things, to pay off the Term Loan of $1.32 billion and the Revolver then outstanding under the Company's Prior Credit Agreement. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2017 Credit Agreement consisted of:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $1.5 billion secured term loan to the Company with a maturity date of October 3, 2022; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility under which the Company could borrow up to $1.5 billion, subject to certain sublimits, with a maturity date of October 3, 2022.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2018, the Company borrowed $250.0 million under the revolver to cash settle the conversions of its 2.00% Convertible Senior Notes due 2042.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement, the 2017 Credit Agreement and the Prior Credit Agreement was as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"><tr><td style="width:1.0%"/><td style="width:36.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, the accounting for entering into the 2017 Credit Agreement and using the proceeds to pay off the Prior Credit Agreement was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the Prior Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $1.0 million in the first quarter of fiscal 2018. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two debt instruments before and after the transaction was less than 10%. Pursuant to ASC 470, subtopic 50-40, third-party costs of $1.7 million related to this transaction were recorded as interest expense and $4.9 million was recorded as a reduction to debt representing deferred issuance costs and debt discount for fees paid directly to the lenders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;10, 2017, the Company completed a private placement of $350 million aggregate principal amount of its 4.375% Senior Notes due 2025 (the "2025 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2025 Senior Notes. On January 19, 2018, the Company completed a private placement and allocated an additional $600 million in aggregate principal amount to its 2025 Senior Notes pursuant to a supplement to the indenture governing the Company's existing 2025 Senior Notes at an offering price of 100% of the aggregate principal amount. As a result, the total aggregate principal balance of 2025 Senior Notes is $950 million. The 2025 Senior Notes were general senior unsecured obligations of the Company and were guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2025 Senior Notes were to mature on October&#160;15, 2025 and bore interest at the rate of 4.375%&#160;per year, payable semi-annually on April&#160;15 and October&#160;15 of each year, commencing on April&#160;15, 2018. On September 28, 2020 (in the first quarter of fiscal 2021), the Company completed a private placement of $950.0&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The proceeds from this offering and cash on hand were used to redeem the 2025 Senior Notes in full on October 15, 2020, at a redemption price of approximately $970.8&#160;million (equal to 102.2% of the aggregate principal amount of the 2025 Senior Notes). In the first quarter of fiscal 2021, the Company will complete the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis and record a debt extinguishment loss as applicable.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 19, 2018, the Company completed a private placement of $1.0 billion aggregate principal amount of senior notes and allocated $400 million in aggregate principal amount to its 4.625% Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2028 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to&#160;35%&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;104.625%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2028 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2028 Senior Notes, 2025 Senior Notes and 2022 Senior Notes is as follows:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:20.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Senior Notes</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had 5.250% Senior Notes due 2022 (the &#8220;2022 Senior Notes&#8221;) outstanding and bore interest at the rate of 5.250%&#160;per year, payable semi-annually on January 15 and July 15 of each year. The Company used the net proceeds of the 2025 Senior Notes and the 2028 Senior Notes offering in January 2018 to redeem in full the 2022 Senior Notes in the aggregate principal amount of $1.0 billion on February 15, 2018 at an aggregate redemption price of $1.04 billion, including a make-whole provision payment $37.7 million. Since the Company planned to use the proceeds from the 2025 Senior Notes and the 2028 Senior Notes offering to redeem the 2022 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2022 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the second quarter of fiscal 2018 of $44.9 million, which comprised pro-rata amounts of the make-whole provision premium payment, debt discount and debt issuance costs. For the remaining 2022 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $2.6 million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $1.5 million and debt discount of $1.5 million related to the modified debt were allocated between the 2025 Senior Notes and 2028 Senior Notes on a pro-rata basis, and are being amortized over the life of the debt using the effective interest method.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 28, 2019 and September 29, 2018, the Company had no Convertible Notes outstanding. The following describes the Convertible Note transactions during fiscal 2018.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;10, 2007, the Company issued and sold $1.725 billion, at par, of 2.00% Convertible Senior Notes due December&#160;15, 2037 (&#8220;2007 Notes&#8221;). On November&#160;18, 2010, the Company entered into separate, privately-negotiated exchange agreements under which it retired $450.0 million in aggregate principal of its 2007 Notes for $450.0 million in aggregate principal of new 2.00% Convertible Exchange Senior Notes due December&#160;15, 2037 (&#8220;2010 Notes&#8221;). On February&#160;29, 2012, the Company entered into separate, privately-negotiated exchange agreements under which it retired $500.0 million in aggregate principal of the 2007 Notes for $500.0 million in aggregate principal of new 2.00% Convertible Senior Notes due March&#160;1, 2042 (&#8220;2012 Notes&#8221;). On February&#160;14, 2013, the Company entered into separate, privately-negotiated exchange agreements under which it retired $370.0 million in aggregate principal of the 2007 Notes for $370.0 million in aggregate principal of new 2.00% Convertible Senior Notes due December 15, 2043 (&#8220;2013 Notes&#8221;). The remaining 2007 Notes were redeemed in fiscal 2014. In fiscal 2017, all remaining 2010 Notes were either converted or surrendered for conversion. On various dates in fiscal 2017, the Company entered into privately negotiated repurchase transactions and extinguished $117.9&#160;million and $168.0&#160;million principal amount of the 2012 Notes and 2013 Notes, respectively.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2018, the Company announced that pursuant to the terms of the indenture for the 2012 Notes, holders of the 2012 Notes had the option of requiring the Company to repurchase their 2012 Notes on March 1, 2018 at a repurchase price payable in cash equal to&#160;100%&#160;of the accreted principal amount of the 2012 Notes, plus accrued and unpaid interest. The Company also announced on January 29, 2018 that, it had elected to redeem, on March 6, 2018, all of the then outstanding 2012 Notes at a redemption price payable in cash equal to&#160;100%&#160;of the accreted principal amount of the 2012 Notes, plus accrued and unpaid interest. Holders also had the right to convert their 2012 Notes. During the second quarter of fiscal 2018, 2012 Notes in aggregate original principal amount of&#160;$200.5 million&#160;were surrendered for conversion and the Company cash settled these conversions for&#160;$243.3 million&#160;during April 2018. As a result, on a gross basis,&#160;$42.8 million&#160;of the consideration paid was allocated to the reacquisition of the equity component of the original instrument, which was recorded net of deferred taxes of&#160;$12.0 million&#160;within additional paid-in-capital. The remaining&#160;$5.5 million&#160;in original principal amount of the 2012 Notes was redeemed by the Company on March 6, 2018.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 15, 2017, pursuant to the provisions of the indenture governing the Company's&#160;2013 Notes, the Company redeemed or repurchased an aggregate of&#160;$201.7 million&#160;in original principal amount of the 2013 Notes then outstanding for an aggregate repurchase price of&#160;$244.1 million, representing the then accreted principal amount of the 2013 Notes. The remaining&#160;$0.3 million&#160;in original principal amount of the 2013 Notes were converted, and the Company settled these conversions in cash in the second quarter of fiscal 2018.&#160;</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On various dates during the first quarter of fiscal 2018, the Company entered into privately negotiated repurchase transactions and extinguished&#160;$39.3 million&#160;principal amount of its 2012 Notes for total payments of&#160;$52.8 million. This amount includes the conversion premium resulting from the Company's stock price on the date of the transactions being in excess of the conversion prices of&#160;$31.175. As a result, on a gross basis,&#160;$13.4 million&#160;of the consideration paid was allocated </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the reacquisition of the equity component of the original instrument, which was recorded net of deferred taxes of&#160;$3.8 million&#160;within additional paid-in-capital.&#160;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense under the Convertible Notes was as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:53.362%"><tr><td style="width:1.0%"/><td style="width:75.612%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.188%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal accretion</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00% accrued interest (cash)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2016, the Company entered into a one-year $200.0 million accounts receivable securitization program (the "Securitization Program") with several of its wholly owned subsidiaries and certain financial institutions, which provides for annual renewals.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Securitization Program, the Company and certain of its wholly-owned subsidiaries sell their respective customer receivables to a bankruptcy remote special purpose entity, which is also a wholly-owned subsidiary of the Company. In addition, the Company also contributed a portion of its customer receivables to the special purpose entity in connection with its establishment. The Company retains servicing responsibility. The special purpose entity, as borrower, and the Company, as servicer, entered into a Credit and Security Agreement with several lenders pursuant to which the special purpose entity may borrow up to $200.0 million from the lenders, with the loans secured by the receivables. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. The entire amount available was borrowed in the third quarter of fiscal 2016. Borrowings outstanding under the Securitization Program bear interest at LIBOR plus the applicable margin of 0.7% and are included as a component of current liabilities in the Company's consolidated balance sheet, while the accounts receivable securing these obligations remain as a component of net receivables in the Company's consolidated balance sheet. The Company and the special purpose entity are operated and maintained as separate legal entities. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay other debts or liabilities of the Company.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In subsequent years, the Company amended the agreement to extend it for one-year periods and increase the borrowing capacity. The maximum borrowing amount increased to $250.0 million. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, the Company paid-off the total amount outstanding of $250.0&#160;million previously borrowed. On April 13, 2020, the Company amended the Credit and Security agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. As of September 26, 2020, the Company did not have any borrowings under this program.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense under the Securitization Program was $3.1 million, $7.1 million and $5.4 million for fiscal 2020, 2019 and 2018, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit and Security Agreement contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, and an event of default upon a change of control of the Company. In addition, it contains financial covenants consistent with that of the Credit Agreement. As of September&#160;26, 2020, the Company was not required to be in compliance with the Credit and Security Agreement covenants.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404442632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stockholders' Equity and Stock-Based Compensation</a></td>
<td class="text">Stockholders' Equity and Stock-Based Compensation<div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2016, the Company's Board of Directors authorized the repurchase of up to $500.0 million of the Company's outstanding common stock over the next five years. During fiscal 2018, the Company repurchased 5.0 million shares of its common stock for a total consideration of $187.3 million under this authorization. </span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 13, 2018, the Board of Directors authorized another share repurchase plan to repurchase up to $500.0 million of the Company's outstanding common stock. This share repurchase plan, which replaced the prior plan, was effective August 1, 2018 and expired March 27, 2020. Under this authorization, during the fourth quarter of 2018, the Company repurchased 2.3 million shares of its common stock for total consideration of $88.5 million. During fiscal 2019, the Company repurchased 4.8 million shares of its common stock for total consideration of $200.1 million. During the first and second quarters of fiscal 2020, the Company repurchased 3.9&#160;million shares of its common stock for a total consideration of $210.9&#160;million. As of March 28, 2020, the Company had completed this authorization. </span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, the Board of Directors authorized a new share repurchase plan to repurchase up to $500.0&#160;million of the Company's outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020 the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020. Under this revised authorization during fiscal 2020, the Company repurchased 5.1&#160;million shares of its common stock for a total consideration of $237.7&#160;million. As of September 26, 2020, $262.4&#160;million was available under this authorization. Subsequent to September 26, 2020, the Company repurchased 1.1 million shares of its common stock for $74.8 million.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2019, the Board of Directors authorized the Company to repurchase up to $205 million of its outstanding shares pursuant to an accelerated share repurchase ("ASR") agreement. On November 22, 2019, the Company executed the ASR agreement with Goldman Sachs &amp; Co. ("Goldman Sachs") pursuant to which the Company repurchased $205&#160;million of the Company's common stock. The initial delivery of approximately 80% of the shares under the ASR was 3.3&#160;million shares for which the Company initially allocated $164.0&#160;million of the $205&#160;million paid to Goldman Sachs during the first quarter of fiscal 2020. The Company evaluated the nature of the forward contract aspect of the ASR under ASC 815 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and concluded equity classification was appropriate. Final settlement of the transaction under the ASR occurred in the second quarter of fiscal 2020. At settlement, Goldman Sachs delivered an additional 0.6&#160;million shares of the Company's common stock.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Compensation Plans</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has one share-based compensation plan pursuant to which awards are currently being issued&#8212;the 2008 amended and restated Equity Incentive Plan (&#8220;2008 Equity Plan&#8221;). The purpose of the 2008 Equity Plan is to provide stock options, restricted stock units and other equity interests in the Company to employees, officers, directors, consultants and advisors of the Company and any other person who is determined by the Board of Directors to have made (or is expected to make) contributions to the Company. The 2008 Equity Plan is administered by the Board of Directors of the Company, and a total of 31.5 million shares were reserved for issuance under this plan. As of September&#160;26, 2020, the Company had 5.7 million shares available for future grant under the 2008 Equity Plan.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Operations in fiscal 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Grant-Date Fair Value</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The Company considers a number of factors to determine the fair value of options including the assistance of an outside valuation adviser. Information pertaining to stock options granted during fiscal 2020, 2019 and 2018 and related assumptions are noted in the following table:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted (in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. In projecting expected stock price volatility, the Company uses a combination of historical stock price volatility and implied volatility from observable market prices of similar equity instruments. The Company estimated the expected life of stock options based on historical experience using employee exercise and option expiration data.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation Expense Attribution</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the straight-line attribution method to recognize stock-based compensation expense for stock options and restricted stock units ("RSUs"). The vesting term of stock options is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xNzUvZnJhZzoxYzhiN2MzYTdkODA0Nzk0YTI3NWY3OThhZDk4YjZlZS90ZXh0cmVnaW9uOjFjOGI3YzNhN2Q4MDQ3OTRhMjc1Zjc5OGFkOThiNmVlXzM1OTU_52c76a56-1dfb-4edb-afc4-0cd46b21920e">four</span> or five years with annual vesting of 25% and 20%&#160;per year, respectively, on the anniversary of the grant date, and RSUs generally vest over three years with annual vesting at 33% per year on the anniversary of the grant date. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company's accounting policy is to estimate forfeitures at the time awards are granted and revise, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based on an analysis of historical forfeitures, the Company has determined a specific forfeiture rate for certain employee groups and has </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applied forfeiture rates ranging from 0% to 6.0% as of September&#160;26, 2020 depending on the specific employee group. This analysis is re-evaluated annually and the forfeiture rate adjusted as necessary. Ultimately, the actual stock-based compensation expense recognized will only be for those stock options and RSUs that vest.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to stock options was $15.5 million, $14.1 million, and $14.3 million in fiscal 2020, 2019 and 2018, respectively. Stock compensation expense related to stock units, including RSUs, performance stock units ("PSUs"), free cash flow performance stock units ("FCFs") and market stock units ("MSUs") was $63.3 million, $43.7 million, and $46.5 million in fiscal 2020, 2019 and 2018, respectively. The related tax benefit recorded in the Consolidated Statements of Operations was $9.5 million, $8.9 million and $11.7 million in fiscal 2020, 2019 and 2018, respectively. At September&#160;26, 2020, there was $19.5 million and $50.0 million of unrecognized compensation expense related to stock options and RSUs, respectively, to be recognized over a weighted average period of 2.3 years and 1.7 years, respectively.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment Activity</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all stock option activity under the Company&#8217;s stock option plans for the year ended September&#160;26, 2020:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares<br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/ forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest at September 26, 2020 (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This represents the number of vested stock options as of September&#160;26, 2020 plus the unvested outstanding options at September&#160;26, 2020 expected to vest in the future, adjusted for estimated forfeitures.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019 and 2018, the total intrinsic value of options exercised (i.e., the difference between the market price on the date of exercise and the price paid by the employee to exercise the options) was $26.1 million and $15.2 million, respectively.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s RSU, PSU, FCF and MSU activity during the year ended September&#160;26, 2020 is presented below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"><tr><td style="width:1.0%"/><td style="width:50.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-vested Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-Date&#160;Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of RSUs vested includes shares withheld on behalf of employees to satisfy minimum statutory tax withholding requirements. The Company pays the minimum statutory tax withholding requirement on behalf of its employees. During fiscal 2020, 2019 and 2018 the total fair value of RSUs and PSUs vested was $34.9 million, $34.6 million and $38.9 million, respectively.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 0.6&#160;million, 0.9&#160;million and 0.8&#160;million RSUs during fiscal 2020, 2019 and 2018, respectively. In addition, included in the above chart, the Company also granted 0.1 million, 0.1 million and 0.6 million PSUs during fiscal </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, 2019, and 2018 respectively, to members of the Company's senior management team, which includes additional shares issued upon achieving metrics within the performance criteria. The PSUs were valued at $45.38, $40.97 and $40.86 per share based on the ending stock price on the date of grant in fiscal 2020, 2019 and 2018, respectively. Each recipient of the PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three year performance period provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million, 0.1 million and 0.3 million MSUs during fiscal 2020, 2019 and 2018, respectively, to its senior management team. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $43.54, $55.13 and $49.44 per share using the Monte Carlo simulation model in fiscal 2020, 2019 and 2018, respectively. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hologic, Inc. 2012 Employee Stock Purchase Plan (&#8220;2012 ESPP&#8221;) provides for the granting of up to 2.5 million shares of the Company&#8217;s common stock to eligible employees. The 2012 ESPP plan period is semi-annual and allows participants to purchase the Company&#8217;s common stock at 85% of the lower of (i)&#160;the market value per share of the common stock on the first day of the offering period or (ii)&#160;the market value per share of the common stock on the purchase date. Stock-based compensation expense in fiscal 2020, 2019 and 2018 was $4.5 million, $4.2 million and $4.0 million, respectively.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"/><td style="width:42.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405529736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProfitSharingFourZeroOneKPlanTextBlock', window );">Profit Sharing 401(k) Plan</a></td>
<td class="text">401(k) PlanThe Company's U.S. employees have access to a qualified 401(k) defined contribution plan. The Company made contributions of $19.6 million, $19.2 million and $18.6 million for fiscal 2020, 2019 and 2018, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProfitSharingFourZeroOneKPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Profit Sharing Four Zero One K plan [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProfitSharingFourZeroOneKPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244403267560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain non-cancelable purchase obligations primarily related to inventory purchases and diagnostics instruments, primarily Panther systems, and to a lesser extent other operating expense commitments. These obligations are not recorded in the Consolidated Balance Sheets. For reasons of quality assurance, sole source availability or cost effectiveness, certain key components and raw materials and instruments are available only from a sole supplier and the Company has certain long-term supply contracts to assure continuity of supply. At September&#160;26, 2020, non-cancelable purchase commitments are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"/><td style="width:70.376%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.424%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405529736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation and Related Matters<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LitigationAndOtherMattersTextBlock', window );">Litigation and Related Matters</a></td>
<td class="text">Litigation and Related Matters<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the &#8216;348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review, which was filed on September 30, 2020. On November 5, 2020, the Company opposed Minerva&#8217;s petition and filed a counter petition for Supreme Court review.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. On March 9, 2020, Minerva elected to withdraw its claim for lost profits damages</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The original trial date of July 20, 2020 was vacated due to circumstances surrounding the COVID-19 pandemic. On October 21, 2020, the Court entered an amended case schedule and set a new trial date of August 9, 2021. The parties submitted a joint status report on September 25, 2020. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 8, 2020, the Company filed suit against Minerva in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s redesigned endometrial ablation device infringes U.S. Patent 9,095,348 (the '348 patent). A trial is set to begin on August 23, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 3, 2017, bioM&#233;rieux, S.A. and bioM&#233;rieux, Inc. (collectively &#8220;bioM&#233;rieux&#8221;) filed suit against the Company in the United States District Court for the Middle District of North Carolina ("MDNC"), alleging that the Company&#8217;s HIV products, including blood screening products previously manufactured by the Company for its former blood screening </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partner Grifols Diagnostic Solutions Inc. ("Grifols USA"), infringe U.S. Patent Nos. 8,697,352 and 9,074,262. On January 3, 2018, the MDNC Court granted the parties&#8217; consent motion to transfer the case to Delaware. On June 11, 2019, the Court issued a claim construction ruling regarding the disputed terms in the patents. Motions for summary judgment were filed by the parties on September 30, 2019, and a hearing on these motions was held on December 18, 2019. A six-day trial concluded on February 25, 2020, with the jury finding that all claims of U.S. Patent No. 8,697,352 are invalid (U.S. Patent No. 9,074,262 was dropped from the case by bioM&#233;rieux prior to trial). On March 18, 2020, the parties agreed to a settlement under which bioM&#233;rieux agreed to dismiss all claims with prejudice and to waive the filing of post-trial motions and pursuing an appeal in exchange for a de minimis payment from the Company and Grifols USA.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 15, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $8.5&#160;million accrued as of September 26, 2020, but this amount could become greater if some or all of the cases which it is indemnifying have an adverse result.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LitigationAndOtherMattersTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation And Other Matters [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LitigationAndOtherMattersTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405561720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract', window );"><strong>Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock', window );">Disposition</a></td>
<td class="text">Disposition<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Medical Aesthetics</span></div><div><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$205.0&#160;million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4&#160;million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xOTYvZnJhZzo1Mzc4YjA2OTY0NDI0Mjg1OTRlMzAyYWRkYTMzZTMwNS90ZXh0cmVnaW9uOjUzNzhiMDY5NjQ0MjQyODU5NGUzMDJhZGRhMzNlMzA1XzkzNDU4NDg4NTczODg_f503a2d8-b974-4218-b6e9-25fc199ad879">three</span> to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or that will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $30.2&#160;million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8&#160;million was allocated to cost of product revenues and $4.4&#160;million to operating expenses.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of the disposed business at the date of disposition were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.169%"><tr><td style="width:1.0%"/><td style="width:73.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets disposed of</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities disposed of</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations of the disposed business presented below represents the operating loss of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business. As noted above, the Company is performing a number of transition services and the financial impact from these services are not included in the amounts presented below. In addition, the Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition, which it will continue to report in the Medical Aesthetics reportable segment. Subsequent to the disposition, the Company recorded additional expenses of $6.2&#160;million primarily for accelerated stock compensation, inventory reserves under the manufacturing supply agreement, and legal expenses and settlements, which are not included in the below amounts. Loss from operations of the disposed business for the years ended September&#160;26, 2020 and September&#160;28, 2019 was as follows:</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"><tr><td style="width:1.0%"/><td style="width:47.412%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:23.385%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.317%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.386%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(781.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405748152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments and Geographic Information</a></td>
<td class="text">Business Segments and Geographic Information<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports segment information in accordance with ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions about how to allocate resources and assess performance. The Company&#8217;s chief operating decision maker is its chief executive officer, and the Company&#8217;s reportable segments have been identified based on the types of products manufactured and the end markets to which the products are sold. Each reportable segment generates revenue from either the sale of medical equipment and related services and/or sale of disposable supplies, primarily used for diagnostic testing and surgical procedures. During the first quarter of fiscal 2020, and each of fiscal 2019 and 2018, the Company had five reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. The Company completed the sale of its Medical Aesthetics business on December 30, 2019, but has continued to incur operating expenses primarily related to indemnification provisions and other matters. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.</span><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the five reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its five reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues. Segment information for fiscal 2020, 2019, and 2018 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"/><td style="width:52.954%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(781.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(844.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,276.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,442.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,457.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,442.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"/><td style="width:53.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company&#8217;s property, plant and equipment, net were geographically located as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"/><td style="width:53.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404477400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Long-Term Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock', window );">Accrued Expenses and Other Long-Term Liabilities</a></td>
<td class="text">Accrued Expenses and Other Long-Term Liabilities<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other long-term liabilities consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"/><td style="width:59.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income and other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMC0xLTEtMTkyODM_140646f7-9eab-40d5-8cc6-927f67371b99">Operating leases</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"/><td style="width:59.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#160;Long-Term Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for income tax uncertainties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzQtMC0xLTEtMTkzODg_736c4b8f-a57e-416d-9e6e-a6211fed51d8">Operating leases</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued lease obligation&#8212;long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Expenses And Other Long-Term Liabilities [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244406160104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension and Other Employee Benefits</a></td>
<td class="text">Pension and Other Employee Benefits<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain defined benefit pension plans covering the employees of its Hitec Imaging German subsidiary (the &#8220;Pension Benefits&#8221;).&#160;As of September&#160;26, 2020 and September&#160;28, 2019, the Company&#8217;s pension liability was $10.9 million and $10.0 million, respectively, which is primarily recorded as a component of long-term liabilities in the Consolidated Balance Sheets. Under German law, there are no rules governing investment or statutory supervision of the pension plan. As such, there is no minimum funding requirement imposed on employers. Pension benefits are safeguarded by the Pension Guaranty Fund, a form of compulsory reinsurance that guarantees an employee will receive vested pension benefits in the event of insolvency. The pension plans were closed on December 31, 1997 and only eligible employees at that date could participate in the plans prior to closing to new participants.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:49.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Benefit Obligation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Net Periodic Benefit Cost Assumptions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected benefit obligation for the German Pension Benefits with projected benefit obligations in excess of plan assets was $10.9 million and $10.0 million at September&#160;26, 2020 and September&#160;28, 2019, respectively, and the accumulated benefit obligation for the German Pension Benefits was $10.9 million and $10.0 million at September&#160;26, 2020 and September&#160;28, 2019, respectively. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also obligated to pay long-term service award benefits under the German Pension Benefits. The projected benefit obligation for long-term service awards was $0.1 million at both September&#160;26, 2020 and September&#160;28, 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"/><td style="width:70.376%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.424%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 to 2030</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains additional contractual pension benefits for its top German executive officers in the form of a defined contribution plan. These contributions were insignificant in fiscal 2020, 2019 and 2018. Additionally, the Company has Swiss pension plans, which were insignificant in fiscal 2020, 2019, and 2018.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404115960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Statement of Operations Information (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Statement of Operations Information (Unaudited)</a></td>
<td class="text">Quarterly Statement of Operations Information (Unaudited)<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of quarterly results of operations for fiscal 2020 and 2019:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.619%"><tr><td style="width:1.0%"/><td style="width:40.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.770%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Hologic (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per common share</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.619%"><tr><td style="width:1.0%"/><td style="width:40.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.770%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">865.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) (2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per common share</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.01)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.46)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net income in the first quarter of fiscal 2020 included an intangible assets and equipment charge of $30.2&#160;million due to classifying the Medical Aesthetics business as assets held-for-sale. Net income also included a discrete tax benefit related to the disposition of this business of $312.2&#160;million related to its outside basis difference.</span></div>(2)Net loss in the second quarter of fiscal 2019 included intangible asset and equipment impairment charges of $443.8 million. Net loss in the fourth quarter of fiscal 2019 included intangible asset and equipment impairment charges of $241.6 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244478603256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned and majority owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#8217;s fiscal year ends on the last Saturday in September. Fiscal 2020, 2019 and 2018 ended on September&#160;26, 2020, September&#160;28, 2019 and September&#160;29, 2018, respectively. Fiscal 2020, 2019 and 2018 were 52-week years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Management's Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Estimates and Uncertainties</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#8217;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#8217;s net deferred tax assets and related valuation allowances.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#8217;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers are principally located in the United States, Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;26, 2020. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.</span></div>There was one customer with a balance greater than 10% of accounts receivable as of September&#160;26, 2020, at 11.9%. There were no customers with a balance greater than 10% of accounts receivable as of September&#160;28, 2019. There were no customers that represented greater than 10% of consolidated revenues for fiscal years 2020, 2019 and 2018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#8217;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#8217;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"><tr><td style="width:1.0%"/><td style="width:52.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:36.030%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;10 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;8 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#8211;35 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the Original Term of Lease</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or Estimated Useful Life</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#8211;7 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(658.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongLivedAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text">Long-Lived Assets<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment&#8212;Impairment or Disposal of Long-Lived Assets</span> (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock', window );">Business Combinations and Acquisition of Intangible Assets</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations and Acquisition of Intangible Assets</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company accounts for the acquisition of a business in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, </span></div>the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets.The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherAssetsPolicyPolicyTextBlock', window );">Other Assets</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"><tr><td style="width:1.0%"/><td style="width:40.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-method equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-method investment and loans to SSI (Note 5)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax receivable primarily relates to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. The right of use assets were recorded in connection with the adoption of ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span>, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#8217;s Nonqualified Deferred Compensation Plan (&#8220;DCP&#8221;) and are recorded at their cash surrender value (see Note 12 for further discussion).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Research and Software Development Costs</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Software Development Costs</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred for the research and development of the Company&#8217;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the development costs of software embedded in the Company&#8217;s products in accordance with ASC 985, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#8217;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimate useful life and recorded within cost of revenues - product.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text">Foreign Currency Translation<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries are translated in accordance with ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters.</span> The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#8217;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income, net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss) as a separate component of stockholders&#8217; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income, net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (loss)</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#8217; equity. The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charges (gains) reclassified to statement of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income, net in the Consolidated Statements of Operations.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5 million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments on $1.0 billion of principal, which ended on December 27, 2019 for the contracts entered into in fiscal 2018, and which will end on December 23, 2020 for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;26, 2020, the Company determined that the existence of hedge ineffectiveness, if any, was immaterial and all changes in the fair value of the interest rate caps were recorded within AOCI.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, 2019 and 2018, interest expense of $2.3 million, $3.1 million and $3.6 million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The Company expects to similarly reclassify approximately $0.5 million from AOCI to the Consolidated Statements of Operations in the next twelve months.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of these interest rate caps was $0.0 million and $0.1 million at September&#160;26, 2020 and September&#160;28, 2019, respectively, and is included in both Prepaid expenses and other current assets and Other assets on the Company&#8217;s Consolidated Balance Sheet. Refer to Note 8 &#8220;Fair Value Measurements&#8221; for related fair value disclosures.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in accumulated other comprehensive income (loss) and were a loss, net of taxes, of $27.6&#160;million and a gain, net of taxes, of $3.5&#160;million for the years ended September 26, 2020 and September 28, 2019, respectively. The fair value of this derivative was in a liability position of $31.2 million as of September 26, 2020.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28. 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29. 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 26, 2020, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with a notional amount of $172.6 million. As of September 26, 2020, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $380.2 million.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:23pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:47.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.842%"><tr><td style="width:1.0%"/><td style="width:49.910%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.896%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Operations for derivative instruments for which the Company did not elect hedge accounting:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:32.926%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not classified as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain Recognized in Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock', window );">Accounts Receivable and Reserves</a></td>
<td class="text">Accounts Receivable and Reserves<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves for doubtful accounts based upon a specific review of all outstanding invoices, known collection issues and historical experience. The Company regularly evaluates the collectability of its trade accounts receivables and performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and its assessment of the customer&#8217;s current credit worthiness.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable reserve activity for fiscal 2020, 2019 and 2018 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 29, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock', window );">Cost of Service and Other Revenues</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#8217;s professional services&#8217; employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based payments in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 718)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span> As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#8217;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, as a result of the adoption of ASU 2016-09 in fiscal 2017, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options, restricted stock units and convertible debt for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Product Warranties</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally offers a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xMzkvZnJhZzo5YTcyOWNjZGUyYjU0YTIwYjEyNjZmNTk0ZmFjMmEyZi90ZXh0cmVnaW9uOjlhNzI5Y2NkZTJiNTRhMjBiMTI2NmY1OTRmYWMyYTJmXzM5NjU4_08c7a977-3e74-4ea4-ab24-1584cb253ab9">one</span>-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#8217;s warranty reserves include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity for fiscal 2020 and 2019 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.489%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at&#160;End<br/>of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $15.6 million, $29.5 million and $26.9 million for fiscal 2020, 2019 and 2018, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Policy and disclosure of accounts receivable reserves, including activity in the account for the respective periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountsReceivableAndReservesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Loss Income Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the costs comprising costs of service and other revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LongLivedAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long Lived Assets Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LongLivedAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Assets Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116873391&amp;loc=d3e408-128459<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=13988685&amp;loc=d3e8784-128493<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19347-109286<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481033064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Statement Information</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flow Statement Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.911%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration at acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"><tr><td style="width:1.0%"/><td style="width:52.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:36.030%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;10 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;8 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#8211;35 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the Original Term of Lease</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or Estimated Useful Life</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#8211;7 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(658.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:36.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,704.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,276.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,786.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,326.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amortization expense at September&#160;26, 2020 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGoodwillBySegmentTableTextBlock', window );">Rollforward of Goodwill Activity by Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of goodwill activity by reportable segment from September&#160;28, 2019 to September&#160;26, 2020 is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"><tr><td style="width:1.0pt"/><td style="width:130.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:57.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:57.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Breast&#160;Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GYN&#160;Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skeletal&#160;Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 28, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,563.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Beacons acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acessa Health acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:24pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,657.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"><tr><td style="width:1.0%"/><td style="width:40.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-method equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-method investment and loans to SSI (Note 5)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Changes in accumulated balances of other comprehensive income</a></td>
<td class="text">The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charges (gains) reclassified to statement of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss) Related to Derivatives</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28. 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29. 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments on the Consolidated Balance Sheets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:23pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:47.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Unrealized Loss Recognized in AOCI</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.842%"><tr><td style="width:1.0%"/><td style="width:49.910%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.896%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Gain (Loss) on Fair Value Hedges Recognized in Earnings</a></td>
<td class="text"><div style="margin-top:18pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Operations for derivative instruments for which the Company did not elect hedge accounting:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:32.926%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not classified as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain Recognized in Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Accounts Receivable Reserve Activity</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable reserve activity for fiscal 2020, 2019 and 2018 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 29, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Reconciliation of Basic and Diluted Share Amounts</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts for fiscal 2020, 2019, and 2018 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Product Warranty Activity</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity for fiscal 2020 and 2019 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.489%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at&#160;End<br/>of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGoodwillBySegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of goodwill by segment table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGoodwillBySegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244406160104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"/><td style="width:2.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.980%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"><tr><td style="width:1.0%"/><td style="width:37.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.765%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.171%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"/><td style="width:32.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:20.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,666.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404399480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Assets And Liabilities, Lessee</a></td>
<td class="text">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF8zLTItMS0xLTM4ODM_2b50aaee-57da-436a-bc70-e7c504e3e1af">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF82LTItMS0xLTM4ODU_09a4208c-50d5-4fbd-b946-e73a5b770e71">Accrued expenses</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18xODE2L2ZyYWc6YTE0ZTUwNzQyMWQ1NDZkOWE3NjJmNzdiZGM5M2U1OGEvdGFibGU6YTRmMTdjMTYyZWQ4NDNmODk1YjA5YzRlMDAxNTViNzAvdGFibGVyYW5nZTphNGYxN2MxNjJlZDg0M2Y4OTViMDljNGUwMDE1NWI3MF84LTItMS0xLTM4ODk_7ff4d642-b82a-4e9b-97f6-7a394e5211bf">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table>The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.380%"><tr><td style="width:1.0%"/><td style="width:52.168%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.010%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.508%"><tr><td style="width:1.0%"/><td style="width:2.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;26, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019 and 2018.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease, Liability, Maturity</a></td>
<td class="text">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:<div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;26, 2020:<div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For comparative purposes, the Company's future minimum lease payments as of September 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases</a></td>
<td class="text">The future minimum annual rental income payments under these sublease agreements at September&#160;26, 2020 are as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.941%"><tr><td style="width:1.0%"/><td style="width:76.696%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481555816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Purchase Price Allocation</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Purchase Price Allocation</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Purchase Price Allocation</a></td>
<td class="text">The total purchase price was allocated to Faxitron's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of July 31, 2018, as set forth below:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember', window );">Acessa</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Purchase Price Allocation</a></td>
<td class="text">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"><tr><td style="width:1.0%"/><td style="width:5.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:68.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.718%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404436632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Charges Taken Related to Restructuring Actions</a></td>
<td class="text">The following table displays charges taken related to restructuring actions in fiscal 2020, 2019 and 2018 and a rollforward of the charges to the accrued balances as of September&#160;26, 2020:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.596%"><tr><td style="width:1.0%"/><td style="width:34.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.781%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.460%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2018 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Restructuring Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2018 charges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2018 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Divestiture charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Charges Taken Related to Accrued Restructuring Actions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2018 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2017 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Previous Other Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Rollforward of Accrued Restructuring</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2017</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2018 restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 29, 2018</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 28, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments and adjustments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 26, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482383608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Company's Borrowings and Interest Expense</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:82.456%"><tr><td style="width:1.0%"/><td style="width:67.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.970%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.973%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,452.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2028 Senior Notes, 2025 Senior Notes and 2022 Senior Notes is as follows:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:20.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule Of Long Term Debt By Maturity Table</a></td>
<td class="text"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt maturity schedule for the Company&#8217;s obligations as of September&#160;26, 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:18.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.676%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026 and Thereafter </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Credit Agreements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement, the 2017 Credit Agreement and the Prior Credit Agreement was as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"><tr><td style="width:1.0%"/><td style="width:36.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock', window );">Interest Expense under Convertible Notes</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense under the Convertible Notes was as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:53.362%"><tr><td style="width:1.0%"/><td style="width:75.612%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.188%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal accretion</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00% accrued interest (cash)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expense under convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405557400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.444%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.915%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.225%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - derivative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:484.50pt"><tr><td style="width:1.0pt"/><td style="width:183.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:72.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 28, 2019</span></td></tr><tr style="height:42pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate caps - derivative</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - derivative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the years ended September 26, 2020, September 28, 2019, and September 29, 2018 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.980%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.510%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404208200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Income (Loss) Before Income Taxes</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income (loss) before income taxes consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"/><td style="width:42.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.500%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(581.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit for income taxes contained the following components:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"/><td style="width:42.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.500%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324.8)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit differed from the tax benefit computed at the U.S. federal statutory rate due to the following:</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.187%"><tr><td style="width:1.0%"/><td style="width:51.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) provision at federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in tax resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale of Cynosure</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic production activities deduction</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on foreign earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax reform</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Significant Components of the Company's Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s significant deferred tax assets and liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.648%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible accruals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified deferred compensation plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation&#160;and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discounts and deferrals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Activity of the Company's Unrecognized Income Tax Benefits</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unrecognized income tax benefits activity for fiscal 2020 and 2019 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.648%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax positions related to current year:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax positions related to prior years:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions related to change in estimate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapses in statutes of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired tax positions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions related to reserves acquired from acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of the end of the fiscal year</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=117331294&amp;loc=d3e36027-109320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482814936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock', window );">Stock-Based Compensation Expense in Consolidated Statement of Operations</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Operations in fiscal 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Information Pertaining to Stock Options Granted and Related Assumptions</a></td>
<td class="text">Information pertaining to stock options granted during fiscal 2020, 2019 and 2018 and related assumptions are noted in the following table:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted (in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all stock option activity under the Company&#8217;s stock option plans for the year ended September&#160;26, 2020:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares<br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/ forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest at September 26, 2020 (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This represents the number of vested stock options as of September&#160;26, 2020 plus the unvested outstanding options at September&#160;26, 2020 expected to vest in the future, adjusted for estimated forfeitures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Restricted Stock Unit Activity</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s RSU, PSU, FCF and MSU activity during the year ended September&#160;26, 2020 is presented below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"><tr><td style="width:1.0%"/><td style="width:50.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-vested Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-Date&#160;Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock', window );">Black-Scholes Model Weighted Average Assumptions Used to Estimate Fair Value of Shares to Be Issued as of Grant Date</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"/><td style="width:42.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of significant assumptions used during the year to estimate the fair value of employee stock purchase plan shares, including, but not limited to: (a) expected term, (b) expected volatility, (c) risk-free interest rate, and (d) dividend yield.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244496367912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock', window );">Unrecorded Unconditional Purchase Obligations Disclosure</a></td>
<td class="text">At September&#160;26, 2020, non-cancelable purchase commitments are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"/><td style="width:70.376%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.424%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unconditional purchase obligations that are not recognized as a liability on the balance sheet, including the nature and significant terms of an unconditional purchase obligation; the amount of the fixed and determinable portion of the obligation as of the date of the latest balance sheet presented in the aggregate and, if determinable, for each of the five succeeding fiscal years; the nature of any variable components of the obligation; the amount purchased under the obligation (for example, the take-or-pay or throughput contract) for the reporting period; and may include the amount of imputed interest necessary to reduce the obligation to present value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77896938&amp;loc=d3e25336-109308<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77896938&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404490248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract', window );"><strong>Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock', window );">Disclosure of Long Lived Assets Held-for-sale</a></td>
<td class="text"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of the disposed business at the date of disposition were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.169%"><tr><td style="width:1.0%"/><td style="width:73.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets disposed of</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities disposed of</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Disposed Business, Income from Operations and Assets held-for-sale</a></td>
<td class="text">Loss from operations of the disposed business for the years ended September&#160;26, 2020 and September&#160;28, 2019 was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"><tr><td style="width:1.0%"/><td style="width:47.412%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:23.385%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.317%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.386%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(781.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482383608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text">Segment information for fiscal 2020, 2019, and 2018 was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"/><td style="width:52.954%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(781.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(844.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,276.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,442.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,457.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,442.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Revenues by Geography</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"/><td style="width:53.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</a></td>
<td class="text">The Company&#8217;s property, plant and equipment, net were geographically located as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"/><td style="width:53.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8721-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244534270632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Long-Term Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other long-term liabilities consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"/><td style="width:59.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income and other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTozZDNmYTE3YzI1YTE0Nzc4ODJlZTk2ZGFhNjFiYTNmMS90YWJsZXJhbmdlOjNkM2ZhMTdjMjVhMTQ3Nzg4MmVlOTZkYWE2MWJhM2YxXzYtMC0xLTEtMTkyODM_140646f7-9eab-40d5-8cc6-927f67371b99">Operating leases</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Long-Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"/><td style="width:59.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#160;Long-Term Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for income tax uncertainties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhkZGI5NjRhN2EwMjRkNjNiOGU0MDA5OTcwZTcxOTk3L3NlYzo4ZGRiOTY0YTdhMDI0ZDYzYjhlNDAwOTk3MGU3MTk5N18yMDgvZnJhZzowMDdjZWNhOTQxNzE0NzU2YjU4OWVmMDczZGU3ZmUxMi90YWJsZTplYjFhMTllMTczODY0NWVhYWJiZjNlMzg0ZGI5MjdiYS90YWJsZXJhbmdlOmViMWExOWUxNzM4NjQ1ZWFhYmJmM2UzODRkYjkyN2JhXzQtMC0xLTEtMTkzODg_736c4b8f-a57e-416d-9e6e-a6211fed51d8">Operating leases</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued lease obligation&#8212;long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481999560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of Reconciliation of Benefit Obligations, Plan Assets, Funded Status and Related Actuarial Assumptions</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:49.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Benefit Obligation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of Net Periodic Benefit Cost and Related Actuarial Assumptions</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 29, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Net Periodic Benefit Cost Assumptions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Pension Benefit</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;26, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"/><td style="width:70.376%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.424%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 to 2030</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482249448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operations (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 22, 2017 </div>
<div>Segment</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | Segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750.0<span></span>
</td>
<td class="nump">$ 480.0<span></span>
</td>
<td class="nump">$ 1,150.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization', window );">Repayments under accounts receivable securitization agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.0<span></span>
</td>
<td class="nump">34.0<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments under revolving credit line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="nump">780.0<span></span>
</td>
<td class="nump">$ 1,195.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">701.0<span></span>
</td>
<td class="nump">$ 601.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_UnusedCreditFacility', window );">Unused credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_UnusedCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unused credit facility</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_UnusedCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244400488856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="7">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Mar. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 29, 2018</div></th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Sep. 29, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 11, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 139,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 241,600,000<span></span>
</td>
<td class="nump">$ 443,800,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">106,700,000<span></span>
</td>
<td class="nump">46,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 685,700,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">685,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashEquivalentsMaturityPeriod', window );">Cash Equivalents Maturity Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">three months or less<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,931,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,931,100,000<span></span>
</td>
<td class="nump">$ 4,786,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage', window );">Number of customers with balance greater than specified percentage | Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,623,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,623,600,000<span></span>
</td>
<td class="nump">$ 3,326,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,657,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,657,900,000<span></span>
</td>
<td class="nump">2,563,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestRateCapAgreementsAggregatePremiumPayable', window );">Purchase of interest rate caps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Principal amount of borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statement of operations, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_WarrantyTermForProducts', window );">Product Warranty Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="nump">29,500,000<span></span>
</td>
<td class="nump">26,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Increase to cash flows used in financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,600,000<span></span>
</td>
<td class="nump">280,700,000<span></span>
</td>
<td class="nump">195,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">(Loss) gain recognized, net of tax of $(8.3) million in 2020 and $1.2 million in 2019 for interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(8,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,500,000<span></span>
</td>
<td class="nump">245,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,200,000<span></span>
</td>
<td class="nump">171,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,054,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,054,000,000.0<span></span>
</td>
<td class="nump">3,927,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,907,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,907,200,000<span></span>
</td>
<td class="nump">$ 2,654,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Accounts receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Total revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">(Loss) gain recognized, net of tax of $(8.3) million in 2020 and $1.2 million in 2019 for interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,600,000)<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 31,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="nump">83,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="nump">$ 11,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology', window );">In process research and development reclassified to developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_EmsorMember', window );">Emsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Distribution agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,700,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,400,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600,000<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Developed Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576,900,000<span></span>
</td>
<td class="nump">$ 24,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative contract period, or less</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate | Focal Therapeutics | Minimum | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="nump">15.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate | Focal Therapeutics | Maximum | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="nump">16.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate | Faxitron | Minimum | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate | Faxitron | Maximum | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CashEquivalentsMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time from the date of acquisition for liquid investments in debt securities to be categorized as cash in the consolidated balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CashEquivalentsMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In process research and development reclassified to developed technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestRateCapAgreementsAggregatePremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate cap agreements aggregate premium payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestRateCapAgreementsAggregatePremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notional Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of customers with balance greater than specified percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Significant Accounting Policies [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_WarrantyTermForProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warranty Term For Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_WarrantyTermForProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80845-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724394-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=holx_RevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=holx_RevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_EmsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_EmsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479815976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">$ 265.9<span></span>
</td>
<td class="nump">$ 180.6<span></span>
</td>
<td class="nump">$ 178.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid during the period for interest</a></td>
<td class="nump">$ 109.5<span></span>
</td>
<td class="nump">$ 132.5<span></span>
</td>
<td class="nump">$ 122.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244406187160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Inventories (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 152.3<span></span>
</td>
<td class="nump">$ 166.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">46.5<span></span>
</td>
<td class="nump">54.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">196.3<span></span>
</td>
<td class="nump">224.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 395.1<span></span>
</td>
<td class="nump">$ 444.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244406352488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ManufacturingEquipmentAndSoftware', window );">Manufacturing Equipment And Software</a></td>
<td class="nump">$ 460.7<span></span>
</td>
<td class="nump">$ 379.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EquipmentUnderCustomerUsageAgreements', window );">Equipment Under Customer Usage Agreements</a></td>
<td class="nump">456.8<span></span>
</td>
<td class="nump">427.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and Improvements, Gross</a></td>
<td class="nump">167.3<span></span>
</td>
<td class="nump">196.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold Improvements, Gross</a></td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">61.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">40.7<span></span>
</td>
<td class="nump">46.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and Fixtures, Gross</a></td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">17.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">1,185.9<span></span>
</td>
<td class="nump">1,128.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less - accumulated depreciation and amortization</a></td>
<td class="num">(694.4)<span></span>
</td>
<td class="num">(658.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 491.5<span></span>
</td>
<td class="nump">$ 470.9<span></span>
</td>
<td class="nump">$ 478.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentAndSoftwareMember', window );">Equipment and Software [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentAndSoftwareMember', window );">Equipment and Software [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentUnderCustomerUsageAgreementMember', window );">Equipment Under Customer Usage Agreements [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentUnderCustomerUsageAgreementMember', window );">Equipment Under Customer Usage Agreements [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">35 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ManufacturingEquipmentAndSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ManufacturingEquipmentAndSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentUnderCustomerUsageAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentUnderCustomerUsageAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481808280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 4,931,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,786,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,623,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,326,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed&#160;technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,054,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,927,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,907,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,654,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">549,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">477,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">245,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">181,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember', window );">Distribution agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember', window );">Business licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember', window );">Acquired intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,852,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,704,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,569,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,276,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember', window );">Internal-use software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">51,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">43,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember', window );">Capitalized software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">26,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">10,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Developed Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">576,900,000<span></span>
</td>
<td class="nump">24,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">22,400,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">48,600,000<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Developed&#160;technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology', window );">In process research and development reclassified to developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Developed&#160;technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="nump">127,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In process research and development reclassified to developed technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244407530680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="nump">$ 127,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology', window );">In process research and development reclassified to developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember', window );">Distribution agreement [Member] | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">27,700,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">22,400,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember', window );">Trade names | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">48,600,000<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember', window );">Developed Technology [Member] | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">576,900,000<span></span>
</td>
<td class="nump">$ 24,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member] | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In process research and development reclassified to developed technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481172504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Fiscal 2021</a></td>
<td class="nump">$ 283.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2022</a></td>
<td class="nump">273.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2023</a></td>
<td class="nump">176.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2024</a></td>
<td class="nump">164.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Fiscal 2025</a></td>
<td class="nump">$ 151.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244406431432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 28, 2019</a></td>
<td class="nump">$ 2,563.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="nump">5.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">2,657.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 28, 2019</a></td>
<td class="nump">819.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">821.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 28, 2019</a></td>
<td class="nump">722.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">764.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 28, 2019</a></td>
<td class="nump">1,014.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">1,063.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 28, 2019</a></td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">34.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">34.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">6.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">6.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons | Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons | Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">6.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons | Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons | Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">48.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">48.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health [Member] | Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">SuperSonic Imagine acquisition</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481397128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,657,900,000<span></span>
</td>
<td class="nump">$ 2,563,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 685,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 685,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GoodwillNotAtRiskOfFailingImpairment', window );">Goodwill not at risk of failing impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GoodwillNotAtRiskOfFailingImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill not at risk of failing impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GoodwillNotAtRiskOfFailingImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482922376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Other Assets (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReceivable', window );">Income Taxes Receivable</a></td>
<td class="nump">$ 325,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">80,700,000<span></span>
</td>
<td class="nump">$ 91,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Life insurance contracts</a></td>
<td class="nump">49,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Manufacturing access fees</a></td>
<td class="nump">15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CostMethodEquityInvestments', window );">Cost-method equity investments</a></td>
<td class="nump">11,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EquityMethodInvestmentAndLoansToAcquiree', window );">Equity-method investment and loans to SSI (Note 5)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneous', window );">Other</a></td>
<td class="nump">34,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,700,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">$ 516,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CostMethodEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate carrying value of the Company's cost-method investments at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CostMethodEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EquityMethodInvestmentAndLoansToAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment And Loans To Acquiree</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EquityMethodInvestmentAndLoansToAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneous">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneous</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244490696024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="num">$ (22.9)<span></span>
</td>
<td class="num">$ (41.4)<span></span>
</td>
<td class="num">$ (26.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedothercomprehensiveIncomelossHedge', window );">Accumulated other comprehensive Income loss Hedge</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(49.7)<span></span>
</td>
<td class="num">(42.3)<span></span>
</td>
<td class="num">(25.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</a></td>
<td class="nump">18.5<span></span>
</td>
<td class="num">(14.8)<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other Comprehensive Income (Loss), before Reclassifications, before Tax</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="num">(19.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotionalAmount', window );">Notional Amount</a></td>
<td class="nump">172.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=holx_PensioninAccumulatedOtherComprehensiveIncomeMember', window );">Pension in Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedothercomprehensiveIncomelossHedge', window );">Accumulated other comprehensive Income loss Hedge</a></td>
<td class="num">(24.1)<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</a></td>
<td class="num">(27.6)<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotionalAmount', window );">Notional Amount</a></td>
<td class="nump">380.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedothercomprehensiveIncomelossHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated other comprehensive Income loss Hedge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedothercomprehensiveIncomelossHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notional Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724394-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=holx_PensioninAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=holx_PensioninAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482782840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet', window );">Gain (loss) on derivative</a></td>
<td class="num">$ (1.2)<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
<td class="num">$ (1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax', window );">Unrealized gain (loss) on derivative</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet', window );">Gain (loss) on derivative</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax', window );">Unrealized gain (loss) on derivative</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign Exchange Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet', window );">Gain (loss) on derivative</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax', window );">Unrealized gain (loss) on derivative</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate impact of foreign currency derivatives on earnings for the period. Includes impact of foreign currency cash flow hedge ineffectiveness and the ineffectiveness of fair value hedging derivatives and full change in fair value of the foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479655928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">31.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign Exchange Option | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Accrued expenses | Not Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Other long-term liabilities | Not Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">$ 23.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244407746632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedothercomprehensiveIncomelossHedge', window );">Accumulated other comprehensive Income loss Hedge</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</a></td>
<td class="num">(27.6)<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedothercomprehensiveIncomelossHedge', window );">Accumulated other comprehensive Income loss Hedge</a></td>
<td class="num">(24.1)<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedothercomprehensiveIncomelossHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated other comprehensive Income loss Hedge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedothercomprehensiveIncomelossHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724394-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482978280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Loss recognized in other comprehensive income (loss), net</a></td>
<td class="num">$ (28.1)<span></span>
</td>
<td class="num">$ (4.5)<span></span>
</td>
<td class="num">$ (5.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Loss recognized in other comprehensive income (loss), net</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
<td class="num">(5.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Loss recognized in other comprehensive income (loss), net</a></td>
<td class="num">$ (27.6)<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481021816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Gain (Loss) on Fair Value Hedges Recognized in Earnings</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="nump">$ 5.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Gain (Loss) on Fair Value Hedges Recognized in Earnings</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign Exchange Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Gain (Loss) on Fair Value Hedges Recognized in Earnings</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244497095720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Allowance for Doubtful Accounts Receivable [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 17,800,000<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Charged&#160;to Costs and Expenses</a></td>
<td class="nump">26,800,000<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">7,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountsReceivableReserveDivested', window );">Accounts receivable reserve divested</a></td>
<td class="num">(5,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountsReceivableAllowanceReduction', window );">Write- offs and Payments</a></td>
<td class="num">(7,200,000)<span></span>
</td>
<td class="num">(2,800,000)<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance&#160;at End of Period</a></td>
<td class="nump">$ 31,600,000<span></span>
</td>
<td class="nump">$ 17,800,000<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountsReceivableAllowanceReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents reduction to the allowance for doubtful accounts primarily from collection of previously reserved accounts and the elimination of an account from the ledger accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountsReceivableAllowanceReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountsReceivableReserveDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable reserve divested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountsReceivableReserveDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479507832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding (in shares)</a></td>
<td class="nump">262,727<span></span>
</td>
<td class="nump">269,413<span></span>
</td>
<td class="nump">275,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits', window );">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units (in shares)</a></td>
<td class="nump">1,886<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding (in shares)</a></td>
<td class="nump">264,613<span></span>
</td>
<td class="nump">269,413<span></span>
</td>
<td class="nump">275,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Options and stock units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">4,098<span></span>
</td>
<td class="nump">5,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=holx_ConvertibleNotesMember', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">703<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=holx_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=holx_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244580460056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Product Warranty (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">$ 13.9<span></span>
</td>
<td class="nump">$ 15.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Provisions</a></td>
<td class="nump">11.7<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition', window );">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease', window );">Standard Product Warranty Accrual, Period Increase (Decrease)</a></td>
<td class="num">(6.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Settlements/ Adjustments</a></td>
<td class="num">(10.1)<span></span>
</td>
<td class="num">(16.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at&#160;End of Period</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 13.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from a business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the standard product warranty accrual. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404181880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Estimated remaining performance obligation</a></td>
<td class="nump">$ 635.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in contract liability at prior year end</a></td>
<td class="nump">$ 158.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit | ASU No. 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Accounting standard transition adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax', window );">Accounting standard transition adjustment tax effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Effect Of New Accounting Principle In Period Of Adoption, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244408883336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Business Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,347.0<span></span>
</td>
<td class="nump">$ 822.9<span></span>
</td>
<td class="nump">$ 756.1<span></span>
</td>
<td class="nump">$ 850.5<span></span>
</td>
<td class="nump">$ 865.8<span></span>
</td>
<td class="nump">$ 852.4<span></span>
</td>
<td class="nump">$ 818.4<span></span>
</td>
<td class="nump">$ 830.7<span></span>
</td>
<td class="nump">$ 3,776.4<span></span>
</td>
<td class="nump">$ 3,367.3<span></span>
</td>
<td class="nump">$ 3,217.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,863.2<span></span>
</td>
<td class="nump">2,536.0<span></span>
</td>
<td class="nump">2,417.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">913.2<span></span>
</td>
<td class="nump">831.3<span></span>
</td>
<td class="nump">800.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,102.1<span></span>
</td>
<td class="nump">1,205.5<span></span>
</td>
<td class="nump">1,147.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,582.4<span></span>
</td>
<td class="nump">921.3<span></span>
</td>
<td class="nump">881.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519.7<span></span>
</td>
<td class="nump">284.2<span></span>
</td>
<td class="nump">265.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410.1<span></span>
</td>
<td class="nump">472.0<span></span>
</td>
<td class="nump">480.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266.3<span></span>
</td>
<td class="nump">312.9<span></span>
</td>
<td class="nump">322.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143.8<span></span>
</td>
<td class="nump">159.1<span></span>
</td>
<td class="nump">157.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,648.4<span></span>
</td>
<td class="nump">675.0<span></span>
</td>
<td class="nump">611.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,272.5<span></span>
</td>
<td class="nump">549.9<span></span>
</td>
<td class="nump">503.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375.9<span></span>
</td>
<td class="nump">125.1<span></span>
</td>
<td class="nump">108.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.6<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
<td class="nump">55.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.6<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
<td class="nump">55.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,151.9<span></span>
</td>
<td class="nump">1,314.2<span></span>
</td>
<td class="nump">1,218.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">888.6<span></span>
</td>
<td class="nump">1,037.9<span></span>
</td>
<td class="nump">951.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263.3<span></span>
</td>
<td class="nump">276.3<span></span>
</td>
<td class="nump">266.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">953.6<span></span>
</td>
<td class="nump">1,094.6<span></span>
</td>
<td class="nump">1,016.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">722.0<span></span>
</td>
<td class="nump">853.1<span></span>
</td>
<td class="nump">782.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231.6<span></span>
</td>
<td class="nump">241.5<span></span>
</td>
<td class="nump">234.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198.3<span></span>
</td>
<td class="nump">219.6<span></span>
</td>
<td class="nump">201.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166.6<span></span>
</td>
<td class="nump">184.8<span></span>
</td>
<td class="nump">169.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">34.8<span></span>
</td>
<td class="nump">32.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.3<span></span>
</td>
<td class="nump">315.6<span></span>
</td>
<td class="nump">339.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">155.4<span></span>
</td>
<td class="nump">172.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.4<span></span>
</td>
<td class="nump">160.2<span></span>
</td>
<td class="nump">166.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.0<span></span>
</td>
<td class="nump">94.8<span></span>
</td>
<td class="nump">91.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.2<span></span>
</td>
<td class="nump">58.6<span></span>
</td>
<td class="nump">59.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.8<span></span>
</td>
<td class="nump">$ 36.2<span></span>
</td>
<td class="nump">$ 31.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CytologyPerinatalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CytologyPerinatalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BloodScreeningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BloodScreeningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BreastImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BreastImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244618757960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Geographical Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,347.0<span></span>
</td>
<td class="nump">$ 822.9<span></span>
</td>
<td class="nump">$ 756.1<span></span>
</td>
<td class="nump">$ 850.5<span></span>
</td>
<td class="nump">$ 865.8<span></span>
</td>
<td class="nump">$ 852.4<span></span>
</td>
<td class="nump">$ 818.4<span></span>
</td>
<td class="nump">$ 830.7<span></span>
</td>
<td class="nump">$ 3,776.4<span></span>
</td>
<td class="nump">$ 3,367.3<span></span>
</td>
<td class="nump">$ 3,217.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,863.2<span></span>
</td>
<td class="nump">2,536.0<span></span>
</td>
<td class="nump">2,417.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569.8<span></span>
</td>
<td class="nump">396.0<span></span>
</td>
<td class="nump">377.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226.8<span></span>
</td>
<td class="nump">286.0<span></span>
</td>
<td class="nump">275.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_OtherGeographicRegionsMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116.6<span></span>
</td>
<td class="nump">$ 149.3<span></span>
</td>
<td class="nump">$ 147.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_OtherGeographicRegionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_OtherGeographicRegionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244409618280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue by Type (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,347.0<span></span>
</td>
<td class="nump">$ 822.9<span></span>
</td>
<td class="nump">$ 756.1<span></span>
</td>
<td class="nump">$ 850.5<span></span>
</td>
<td class="nump">$ 865.8<span></span>
</td>
<td class="nump">$ 852.4<span></span>
</td>
<td class="nump">$ 818.4<span></span>
</td>
<td class="nump">$ 830.7<span></span>
</td>
<td class="nump">$ 3,776.4<span></span>
</td>
<td class="nump">$ 3,367.3<span></span>
</td>
<td class="nump">$ 3,217.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376.1<span></span>
</td>
<td class="nump">437.2<span></span>
</td>
<td class="nump">422.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,863.2<span></span>
</td>
<td class="nump">2,536.0<span></span>
</td>
<td class="nump">2,417.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310.1<span></span>
</td>
<td class="nump">362.8<span></span>
</td>
<td class="nump">352.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">913.2<span></span>
</td>
<td class="nump">831.3<span></span>
</td>
<td class="nump">800.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International | Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.0<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">69.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember', window );">Capital equipment, components and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665.9<span></span>
</td>
<td class="nump">984.9<span></span>
</td>
<td class="nump">977.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_ConsumablesMember', window );">Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561.1<span></span>
</td>
<td class="nump">1,786.4<span></span>
</td>
<td class="nump">1,666.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">516.6<span></span>
</td>
<td class="nump">568.3<span></span>
</td>
<td class="nump">551.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 27.7<span></span>
</td>
<td class="nump">$ 22.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479119128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Remaining Performance Obligations (Details)<br></strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">39.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479923320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate', window );">Period with option to terminate lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod', window );">Extension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,100,000<span></span>
</td>
<td class="nump">$ 23,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeaseRevenuePercentageOfTotalRevenue', window );">Lease revenue as a percentage of total</a></td>
<td class="nump">0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use asset obtained in exchange for finance lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeaseReceivable', window );">Lease receivable</a></td>
<td class="nump">$ 19,300,000<span></span>
</td>
<td class="nump">19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1', window );">Rent expense on sublease rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">80,700,000<span></span>
</td>
<td class="nump">80,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">89,100<span></span>
</td>
<td class="nump">89,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">19,300<span></span>
</td>
<td class="nump">19,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="num">(491,500,000)<span></span>
</td>
<td class="num">(491,500,000)<span></span>
</td>
<td class="num">(470,900,000)<span></span>
</td>
<td class="num">$ (478,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="num">$ (303,200,000)<span></span>
</td>
<td class="num">$ (303,200,000)<span></span>
</td>
<td class="num">$ (162,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Statement of Financial Position [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:LiabilitiesAbstract<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:LiabilitiesAbstract<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm', window );">Lessee, operating and finance lease, remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm', window );">Lessee, operating and finance lease, remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeaseRevenuePercentageOfTotalRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Revenue, Percentage Of Total Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeaseRevenuePercentageOfTotalRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Lease, Period With Option To Terminate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Lease, Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Leases, Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LesseeOperatingAndFinanceLeasesExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseSubleaseRentals1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244407710136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">$ 80,700,000<span></span>
</td>
<td class="nump">$ 91,700,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (current)</a></td>
<td class="nump">$ 23,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherLiabilitiesNoncurrent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:OtherLiabilitiesNoncurrent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities (non-current)</a></td>
<td class="nump">$ 65,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases, weighted average remaining lease term</a></td>
<td class="text">5 years 6 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases, weighted average remaining lease term</a></td>
<td class="text">7 years 7 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases, weighted average discount rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases, weighted average discount rate</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherAssets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">$ 80,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (current)</a></td>
<td class="nump">23,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities (non-current)</a></td>
<td class="nump">65,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsShortTermMember', window );">Finance lease obligations - short term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsLongTermMember', window );">Finance lease obligations - long term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="nump">$ 17,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsShortTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsShortTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsLongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsLongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244484526200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Lease Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 27,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease cost - amortization of right-of-use assets</a></td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance lease cost - interest cost</a></td>
<td class="nump">1,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">23,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability', window );">Total cash paid for amounts included in the measurement of lease liabilities</a></td>
<td class="nump">26,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">ROU assets arising from entering into new operating lease obligations</a></td>
<td class="nump">$ 13,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244409677752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Liability Maturity Schedule 2020 (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 25,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">20,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">16,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">94,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(5,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">89,100<span></span>
</td>
<td class="nump">$ 96,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">3,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">3,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">3,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">23,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(4,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 19,300<span></span>
</td>
<td class="nump">$ 21,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482819096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Liability Maturity Schedule 2019 (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2021</a></td>
<td class="nump">$ 20,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2022</a></td>
<td class="nump">17,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2023</a></td>
<td class="nump">13,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2024</a></td>
<td class="nump">6,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2025</a></td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">14,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">78,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesCapitalAbstract', window );"><strong>Finance Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent', window );">2020</a></td>
<td class="nump">5,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears', window );">2021</a></td>
<td class="nump">5,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears', window );">2022</a></td>
<td class="nump">6,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears', window );">2023</a></td>
<td class="nump">6,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears', window );">2024</a></td>
<td class="nump">5,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">19,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">$ 48,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244406297112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Minimum Annual Rental Income Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent', window );">Fiscal 2021</a></td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears', window );">Fiscal 2022</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears', window );">Fiscal 2023</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears', window );">Fiscal 2024</a></td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears', window );">Fiscal 2025</a></td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter', window );">Thereafter</a></td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable', window );">Total</a></td>
<td class="nump">$ 16.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future minimum rental payments in aggregate as of the balance sheet date under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164653&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future rental payments receivable within one year of the balance sheet date under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164653&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future rental payments receivable within the fifth year from the balance sheet date under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164653&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future rental payments receivable within the fourth year from the balance sheet date under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164653&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future rental payments receivable within the third year from the balance sheet date under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164653&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future rental payments receivable within the second year from the balance sheet date under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164653&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future minimum lease payments receivable under operating leases for periods greater than five years following the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164653&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244396684152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 23, 2020</div></th>
<th class="th"><div>Dec. 30, 2019</div></th>
<th class="th"><div>Nov. 21, 2019</div></th>
<th class="th"><div>Oct. 01, 2019</div></th>
<th class="th"><div>Aug. 01, 2019</div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Dec. 11, 2017</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
<th class="th"><div>Nov. 20, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,459,800,000<span></span>
</td>
<td class="nump">$ 1,307,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,307,500,000<span></span>
</td>
<td class="nump">$ 1,459,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,563,700,000<span></span>
</td>
<td class="nump">2,657,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,657,900,000<span></span>
</td>
<td class="nump">2,563,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest', window );">Portion allocable to fair value of noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent holdbacks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,300,000<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember', window );">Acessa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 161,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 81,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value discount rate (percent)</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember', window );">Acessa | Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability', window );">Payment period for contingent consideration</a></td>
<td class="text">5 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember', window );">Acessa | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="nump">$ 127.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember', window );">Acessa | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Acquired tangible assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember', window );">Alpha Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value discount rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Identifiable intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare', window );">Cash tender offer price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationSharesAcquired', window );">Acquired shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationOwnershipPercentage', window );">Ownership of outstanding shares (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Equity interest in acquiree (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment', window );">Portion allocable to equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares', window );">Portion allocable to newly acquired shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment', window );">Portion allocable to loan repaymnet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AdditionalPurchaseConsideration', window );">Additional purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationAdditionalSharesAcquiredShares', window );">Additional outstanding shares purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationAdditionalSharesAcquiredValue', window );">Additional outstanding shares purchased, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Other Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (loss) from equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability', window );">Payment period for contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | In-process research and development | Measurement Input, Discount Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value discount rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | In-process research and development | Measurement Input, Discount Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value discount rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase in contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent holdbacks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron | Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability', window );">Payment period for contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent holdbacks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions', window );">Contingent holdback withheld under indemnification provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron | In-process research and development | Measurement Input, Discount Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value discount rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron | In-process research and development | Measurement Input, Discount Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value discount rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_EmsorMember', window );">Emsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet', window );">Tangible assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_EmsorMember', window );">Emsor | Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability', window );">Payment period for contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AdditionalPurchaseConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional purchase consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AdditionalPurchaseConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Cash Tender Offer Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessAcquisitionCashTenderOfferPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationAdditionalSharesAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Additional Shares Acquired, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationAdditionalSharesAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationAdditionalSharesAcquiredValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Additional Shares Acquired, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationAdditionalSharesAcquiredValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Withheld Under Indemnification Provisions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Period for Payment of Contingent Consideration Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets And Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Shares Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Holdback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Holdback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the cash payment of contingent consideration to the former shareholders of the acquired company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_EmsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_EmsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479785384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Purchase Price Allocation Acessa (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Aug. 23, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,657,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,563,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember', window );">Acessa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember', window );">Acessa | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember', window );">Acessa | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244407406808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Purchase Price Allocation SuperSonic Imagine (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Nov. 21, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,563.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt', window );">Short and long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479657016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Purchase Price Allocation Focal Therapeutics (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="nump">$ 2,563.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244409481896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Purchase Price Allocation Faxitron (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="nump">$ 2,563.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember', window );">Faxitron | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405747032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investment</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 18.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244484552632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020Member', window );">Fiscal 2020 | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember', window );">Fiscal 2019 Actions | Fiscal 2018 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember', window );">Fiscal 2019 Actions | Fiscal 2019 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember', window );">Fiscal 2019 Actions | Fiscal 2020 | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember', window );">Fiscal 2019 Actions | Fiscal 2020 charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember', window );">Fiscal 2018 Actions | Fiscal 2018 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember', window );">Fiscal 2018 Actions | Fiscal 2019 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember', window );">Fiscal 2018 Actions | Fiscal 2020 | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember', window );">Fiscal 2018 Actions | Fiscal 2020 charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember', window );">Other action [Member] | Fiscal 2018 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember', window );">Other action [Member] | Fiscal 2019 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember', window );">Other action [Member] | Fiscal 2020 | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember', window );">Fiscal 2020 Action | Fiscal 2018 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember', window );">Fiscal 2020 Action | Fiscal 2019 charges: | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember', window );">Fiscal 2020 Action | Fiscal 2020 | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember', window );">Fiscal 2020 Action | Fiscal 2020 charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DivestitureCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DivestitureCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FacilityClosureCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FacilityClosureCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ReductionOfWorkforceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents severance and related benefit charges for the termination of employees under an exit or disposal activity. Charges are recorded either as one-time termination benefits, which are recognized ratable over the required service period to receive such benefit, or under an ongoing benefit plan arrangement once the charge is probable and reasonably estimable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ReductionOfWorkforceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RestructuringChargesUnderExitOrDisposalPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total restructuring charges under exit or disposal plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RestructuringChargesUnderExitOrDisposalPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244408827752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail) - Restructuring Charges - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">$ 15.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="num">(7.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="num">(5.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="num">(3.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 charges | Fiscal 2020 Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">15.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="num">(7.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="num">(4.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 charges | Fiscal 2019 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 charges | Fiscal 2018 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 charges | Previous Other Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 charges | Fiscal 2017 Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 charges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 charges: | Fiscal 2020 Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 charges: | Fiscal 2019 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 charges: | Fiscal 2018 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 charges: | Previous Other Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 charges: | Fiscal 2017 Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 charges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 charges: | Fiscal 2020 Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 charges: | Fiscal 2019 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 charges: | Fiscal 2018 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 charges: | Previous Other Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 charges: | Fiscal 2017 Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember', window );">Fiscal 2017 charges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember', window );">Fiscal 2017 charges: | Fiscal 2020 Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember', window );">Fiscal 2017 charges: | Fiscal 2019 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember', window );">Fiscal 2017 charges: | Fiscal 2018 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember', window );">Fiscal 2017 charges: | Previous Other Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember', window );">Fiscal 2017 charges: | Fiscal 2017 Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CashSeverancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Severance payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CashSeverancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherRestructuringPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to settle other restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherRestructuringPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RestructuringChargesUnderExitOrDisposalPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total restructuring charges under exit or disposal plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RestructuringChargesUnderExitOrDisposalPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation expense included other restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtherOperatingCostReductionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_OtherOperatingCostReductionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2017ActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2017ActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244409920104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Dec. 29, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Jul. 01, 2017</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,400,000<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ExpectedFutureSeveranceCharges', window );">Expected future severance charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityByLocationAxis=holx_TepnelMember', window );">Tepnel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityByLocationAxis=holx_CynosureMember', window );">Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental cost</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_BedfordMember', window );">Bedford</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RemainingLeaseBalance', window );">Remaining lease balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_LybertyWayMember', window );">Lyberty Way [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Propertyclosurecostpayment', window );">Property closure cost payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Propertyclosurebenefit', window );">Property closure benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DivestitureCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DivestitureCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ExpectedFutureSeveranceCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected future severance charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ExpectedFutureSeveranceCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FacilityClosureCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FacilityClosureCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Propertyclosurebenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property closure benefit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Propertyclosurebenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Propertyclosurecostpayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property closure cost payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Propertyclosurecostpayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RemainingLeaseBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RemainingLeaseBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityByLocationAxis=holx_TepnelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityByLocationAxis=holx_TepnelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityByLocationAxis=holx_CynosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityByLocationAxis=holx_CynosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_BedfordMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_BedfordMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_LybertyWayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_LybertyWayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481712712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Company's Borrowings (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="nump">$ 324.9<span></span>
</td>
<td class="nump">$ 271.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">2,713.9<span></span>
</td>
<td class="nump">2,783.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">3,038.8<span></span>
</td>
<td class="nump">3,055.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">37.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">1,379.9<span></span>
</td>
<td class="nump">1,452.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="nump">250.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Securitization Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">234.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">939.4<span></span>
</td>
<td class="nump">937.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">$ 394.6<span></span>
</td>
<td class="nump">$ 393.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244407405960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 325.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">75.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">112.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">1,200.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">950.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2026 and Thereafter</a></td>
<td class="nump">400.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">3,062.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">75.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">75.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">112.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">1,200.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2026 and Thereafter</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">1,462.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">950.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2026 and Thereafter</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">950.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2026 and Thereafter</a></td>
<td class="nump">400.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">$ 400.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244408666184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2018Member', window );">2018 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 46.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member', window );">2017 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.43%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember', window );">Prior Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.74%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreement2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244390619896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 25, 2022</div></th>
<th class="th">
<div>Sep. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 17, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 19, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2019 </div>
<div>USD ($) </div>
<div>debt_instrument</div>
</th>
<th class="th">
<div>Jun. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 15, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 10, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 03, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 14, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 29, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 18, 2010 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 10, 2007 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="nump">$ 480,000,000.0<span></span>
</td>
<td class="nump">$ 1,150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">45,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">23,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Principal amount of borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">546,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxesReacquisitionofEquityComponent', window );">Deferred taxes, reacquisition of equity component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to APIC, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (40,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditFacility2018Member', window );">2018 Amended Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeverageRatioMaximum', window );">Leverage ratio maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestCoverageRatio', window );">Interest coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditFacility2018Member', window );">2018 Amended Credit Facility | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeverageRatioMaximum', window );">Leverage ratio maximum</a></td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member', window );">2017 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentNumberOfInstruments', window );">Number of debt instruments | debt_instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumRangeofPresentValueofCashFlowPercentage', window );">Maximum range of present value of cash flow (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DirectThirdPartyCostsinterestExpense', window );">Third-party costs recorded as interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted-average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.43%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_Revolver2017Member', window );">2017 Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember', window );">Prior Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumRangeofPresentValueofCashFlowPercentage', window );">Maximum range of present value of cash flow (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DirectThirdPartyCostsinterestExpense', window );">Third-party costs recorded as interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayments of secured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,320,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted-average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.74%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2022NotesMember', window );">2022 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumRangeofPresentValueofCashFlowPercentage', window );">Maximum range of present value of cash flow (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DirectThirdPartyCostsinterestExpense', window );">Third-party costs recorded as interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtIssuanceCostsReallocatedUponDebtModification', window );">Debt issuance costs reallocated upon debt modification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtDiscountReallocatedUponDebtModification', window );">Debt discount reallocated upon debt modification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_ConvertibleNotesMember', window );">Convertible Notes | 2007 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370,000,000.0<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="nump">$ 450,000,000.0<span></span>
</td>
<td class="nump">$ 1,725,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2012NotesMember', window );">2012 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 243,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxesReacquisitionofEquityComponent', window );">Deferred taxes, reacquisition of equity component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Debtinstrumentremainingtoberedeemed', window );">Debt instrument remaining to be redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to APIC, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31.175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2012NotesMember', window );">2012 Notes | Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest', window );">Redemption price as percentage of principle amount plus accrued and unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2012NotesMember', window );">2012 Notes | Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest', window );">Redemption price as percentage of principle amount plus accrued and unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2013NotesMember', window );">2013 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember', window );">Securitization Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TermARSecuritizationProgram', window );">Term of accounts receivable securitization program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableFromSecuritization', window );">Accounts receivable from securitization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumBorrowingUnderSecuritizationProgram', window );">Maximum borrowing under securitization program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2018 Amended Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2018 Amended Term Loan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter', window );">Debt Instrument, Periodic Payment, Principal Per Quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments', window );">Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2018 Amended Term Loan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter', window );">Debt Instrument, Periodic Payment, Principal Per Quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2018 Amended Term Loan | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2017 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | 2018 Amended Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | 2018 Amended Revolver | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | 2017 Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Principal amount of borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue', window );">Offering price, percent of face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 970,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of senior long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue', window );">Offering price, percent of face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod', window );">Percentage of redemption price, second period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod', window );">Percentage of redemption price, third period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.312%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.312%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod', window );">Percentage of redemption price, fourth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.541%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.541%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod', window );">Percentage of redemption price, fifth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod', window );">Percentage redemption price, sixth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes', window );">Percentage price of principal amount for repurchase of senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2022 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OfferingPriceofPrincipalAmount', window );">Offering price of principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,040,000,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MakeWholeProvision', window );">Make whole provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue', window );">Offering price, percent of face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period One | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period Two | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period Three | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.813%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period Four | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period Five | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_NovemberEighteenTwoThousandTenOriginalNotesMember', window );">November 18, 2010 Original Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember', window );">February 29, 2012 Original Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember', window );">February 14, 2013 Original Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Securitization Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2042 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtDiscountReallocatedUponDebtModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Discount, Reallocated Upon Debt Modification</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtDiscountReallocatedUponDebtModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentNumberOfInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Instruments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentNumberOfInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Offering Price, Percent Of Face Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentOfferingPricePercentOfFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Fifth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Fourth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Second Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Third Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Redemption Price Sixth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Principal Per Quarter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtIssuanceCostsReallocatedUponDebtModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Issuance Costs, Reallocated Upon Debt Modification</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtIssuanceCostsReallocatedUponDebtModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Debtinstrumentremainingtoberedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument remaining to be redeemed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Debtinstrumentremainingtoberedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxesReacquisitionofEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Taxes, Reacquisition of Equity Component</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxesReacquisitionofEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DirectThirdPartyCostsinterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Direct Third Party Costs interest Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DirectThirdPartyCostsinterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leverage Ratio Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MakeWholeProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Make Whole Provision</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MakeWholeProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumBorrowingUnderSecuritizationProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing under securitization program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumBorrowingUnderSecuritizationProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumRangeofPresentValueofCashFlowPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Range of Present Value of Cash Flow Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumRangeofPresentValueofCashFlowPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OfferingPriceofPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering Price of Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OfferingPriceofPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Price of Principal Amount for Repurchase of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption price as percentage of principal amount plus accrued and unpaid interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TermARSecuritizationProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Accounts Receivable Securitization Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TermARSecuritizationProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableFromSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount owed to the reporting entity by counterparties in securitized loan transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableFromSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditFacility2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedCreditFacility2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_Revolver2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_Revolver2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2022NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2022NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_TwoThousandSevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_TwoThousandSevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2012NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2012NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2013NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2013NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedTermLoan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_TermLoan2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_TermLoan2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedRevolver2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedRevolver2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_NovemberEighteenTwoThousandTenOriginalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_NovemberEighteenTwoThousandTenOriginalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2042NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2042NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482017160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 62.7<span></span>
</td>
<td class="nump">$ 62.7<span></span>
</td>
<td class="nump">$ 69.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">19.2<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 43.5<span></span>
</td>
<td class="nump">43.5<span></span>
</td>
<td class="nump">34.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2022 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">21.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2022SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2022SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481086008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail) - Convertible Notes Payable<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 29, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Debt Conversion [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmortizationOfDeferredFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BasePrincipalAmountForAccretionValue', window );">Principal accretion</a></td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">5.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">2.00% accrued interest</a></td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, net</a></td>
<td class="nump">$ 7.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmortizationOfDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The component of interest expense representing the periodic charge against earnings to reflect amortization of debt issuance costs over the life of the related debt instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmortizationOfDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BasePrincipalAmountForAccretionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of principal accretion at the applicable rate pursuant to the terms of the debt agreement, which is recorded as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BasePrincipalAmountForAccretionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244409652968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 11.2<span></span>
</td>
<td class="nump">$ 7.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">113.0<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">31.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">81.8<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate caps - derivative</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">31.2<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate caps - derivative</a></td>
<td class="nump">31.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">31.2<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Options | Assets | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Options | Assets | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Options | Assets | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Assets | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Assets | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Assets | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">81.8<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">contingent consideration | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">contingent consideration | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">contingent consideration | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244484510040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="nump">$ 11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200,000<span></span>
</td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal under credit agreement</a></td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">241,600,000<span></span>
</td>
<td class="nump">$ 443,800,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">106,700,000<span></span>
</td>
<td class="nump">$ 46,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 685,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 685,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 685,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Acquired intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal under credit agreement</a></td>
<td class="nump">1,710,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,710,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="nump">419,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">419,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="nump">$ 971,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 971,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244480983992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="nump">$ 7.8<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration recorded at acquisition</a></td>
<td class="nump">82.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments/Accruals</a></td>
<td class="num">(10.3)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="nump">$ 7.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405715608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income (Loss) Before Income Taxes (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 921.1<span></span>
</td>
<td class="num">$ (174.3)<span></span>
</td>
<td class="num">$ (581.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">80.8<span></span>
</td>
<td class="num">(83.4)<span></span>
</td>
<td class="nump">163.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="nump">$ 1,001.9<span></span>
</td>
<td class="num">$ (257.7)<span></span>
</td>
<td class="num">$ (418.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481057944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Provision for Income Taxes (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Federal:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="num">$ (62.1)<span></span>
</td>
<td class="nump">$ 142.9<span></span>
</td>
<td class="nump">$ 137.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(76.6)<span></span>
</td>
<td class="num">(189.9)<span></span>
</td>
<td class="num">(461.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal, Total</a></td>
<td class="num">(138.7)<span></span>
</td>
<td class="num">(47.0)<span></span>
</td>
<td class="num">(324.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>State:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">33.9<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(12.5)<span></span>
</td>
<td class="num">(41.0)<span></span>
</td>
<td class="num">(11.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">State, Total</a></td>
<td class="nump">21.4<span></span>
</td>
<td class="num">(18.9)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Foreign:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">16.5<span></span>
</td>
<td class="nump">21.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(5.3)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations', window );">Foreign, Total</a></td>
<td class="nump">8.7<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">$ (108.6)<span></span>
</td>
<td class="num">$ (54.1)<span></span>
</td>
<td class="num">$ (307.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)-(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481711928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Increase (decrease) in tax resulting from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax (benefit) provision at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">24.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure', window );">Loss on sale of Cynosure</a></td>
<td class="num">(31.30%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities', window );">Domestic production activities deduction</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">U.S. tax on foreign earnings</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="num">(2.10%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges', window );">Internal restructuring</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill', window );">Non-deductible goodwill</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(39.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment', window );">Tax credits</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent', window );">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.020)<span></span>
</td>
<td class="nump">0.827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(1.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost', window );">Compensation</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Change in deferred tax rate</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="num">(9.50%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(3.10%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="num">(10.80%)<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">73.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation benefit expense research and development.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to the difference in the deductibility or nondeductibility of executive compensation (i.e., those subject to Section 162(m) limitations), including equity-based compensation and salary and bonus compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Non Deductible Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to changes in unrecognized tax benefits recorded in the statement of operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax reconciliation loss on sale of Cynosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for qualified production activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244504401224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 81,100,000<span></span>
</td>
<td class="nump">$ 34,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital losses</a></td>
<td class="nump">57,000,000.0<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Non-deductible accruals</a></td>
<td class="nump">24,900,000<span></span>
</td>
<td class="nump">24,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Non-deductible reserves</a></td>
<td class="nump">33,200,000<span></span>
</td>
<td class="nump">22,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_UKIntangibleassets', window );">UK Intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">18,600,000<span></span>
</td>
<td class="nump">20,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">10,200,000<span></span>
</td>
<td class="nump">14,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan', window );">Nonqualified deferred compensation plan</a></td>
<td class="nump">14,400,000<span></span>
</td>
<td class="nump">12,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsLeaseLiability', window );">Deferred tax assets lease liability</a></td>
<td class="nump">17,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other temporary differences</a></td>
<td class="nump">25,200,000<span></span>
</td>
<td class="nump">17,800,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets, gross</a></td>
<td class="nump">281,900,000<span></span>
</td>
<td class="nump">180,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(118,500,000)<span></span>
</td>
<td class="num">(60,700,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">163,400,000<span></span>
</td>
<td class="nump">119,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation&#160;and amortization</a></td>
<td class="num">(333,900,000)<span></span>
</td>
<td class="num">(373,000,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxLiabilitiesRightOfUseAsset', window );">Right of use asset</a></td>
<td class="num">(15,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxLiabilitiesDebtDiscount', window );">Debt discounts and deferrals</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,500,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="num">(349,700,000)<span></span>
</td>
<td class="num">(377,500,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (186,300,000)<span></span>
</td>
<td class="num">$ (258,100,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax effect as of the balance sheet date of the amount of future tax deductions arising from the Company's nonqualified deferred compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxLiabilitiesDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount as of the balance sheet of the estimated future tax effects attributable to the debt discount on the convertible notes and related impact from the convertible notes exchanges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxLiabilitiesDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount as of the balance sheet date of the estimated future tax effects attributable to amortization of intangible assets, and to a lesser extent, depreciation of property and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxLiabilitiesRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities right of use asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxLiabilitiesRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_UKIntangibleassets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>UK Intangible assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_UKIntangibleassets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31931-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244408884536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 29, 2018</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit', window );">Provisional estimate of tax benefit as result of Tax Cuts and Jobs Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 341,200,000<span></span>
</td>
<td class="nump">$ 346,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease', window );">Decrease in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (57,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 32,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal', window );">Federal net operating loss expected to be expired unutilized</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState', window );">State net operating loss expected to be expired unutilized</a></td>
<td class="nump">74,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign', window );">Foreign net operating loss expected to be expired unutilized</a></td>
<td class="nump">47,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GrossUnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, excluding interest</a></td>
<td class="nump">197,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,100,000<span></span>
</td>
<td class="nump">$ 101,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefit that would impact effective tax rate</a></td>
<td class="nump">184,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,900,000<span></span>
</td>
<td class="nump">87,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Change in gross unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued', window );">Interest accrued on unrecognized tax benefits</a></td>
<td class="nump">11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900,000<span></span>
</td>
<td class="nump">11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued', window );">Income tax penalties accrued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616', window );">Increase in deferred tax assets resulting from adoption of ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616', window );">Decease in accumulated deficit resulting from adoption of ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616', window );">Decease to prepaid taxes resulting from adoption of ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncreasetoincometaxexpenseadoptionofASU201616', window );">Increase to income tax expense adoption of ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DecreaseindeferredtaxliabilitiesduetoASC201616', window );">Decrease in deferred tax liabilities due to ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616', window );">Increase to Net Income resulted from adoption of ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616', window );">Increase to Earnings per Share resulted from adoption of ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_StateLossCarryforwardExpectedToUnutilize', window );">state loss carryforward expected to unutilize</a></td>
<td class="nump">26,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital losses</a></td>
<td class="nump">57,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,000,000.0<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GrossStateLossCarryforwards', window );">Gross state loss carryforwards</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GrossForeignLossCarryforwards', window );">Gross foreign loss carryforwards</a></td>
<td class="nump">32,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Other Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NonIncomeTaxLoss', window );">Non-income tax loss</a></td>
<td class="num">(2,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=holx_NetOperatingLossCarryforwardsMember', window );">Net Operating Losses Carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod', window );">Amount with unlimited carry forward periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=holx_TaxCreditCarryforwardMember', window );">Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod', window );">Amount with unlimited carry forward periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in unrecognized tax benefits is reasonably possible</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">40,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Credit carry forwards</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Credit carry forwards</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">207,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Credit carry forwards</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decease in accumulated deficit resulting from adoption of ASCU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decease to prepaid taxes resulting from adoption of ASCU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DecreaseindeferredtaxliabilitiesduetoASC201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in deferred tax liabilities due to ASC 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DecreaseindeferredtaxliabilitiesduetoASC201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of federal net operating losses the company believes will expire unutilized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state net operating losses the company believes will expire unutilized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrossForeignLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross foreign loss carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrossForeignLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrossStateLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross state loss carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrossStateLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrossUnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total unrecognized tax benefits, including interest, that if recognized would result in a reduction to the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrossUnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase in deferred tax assets resulting from adoption of ASCU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase to Earnings per Share resulted from adoption of ASC 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase to Net Income resulted from adoption of ASU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncreasetoNetIncomeresultedfromadoptionofASU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncreasetoincometaxexpenseadoptionofASU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase to income tax expense adoption of ASU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncreasetoincometaxexpenseadoptionofASU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss and tax credit carry forwards with unlimited expiration period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NonIncomeTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Income Tax Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NonIncomeTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_StateLossCarryforwardExpectedToUnutilize">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>state loss carryforward expected to unutilize</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_StateLossCarryforwardExpectedToUnutilize</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts And Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense accrued for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=holx_NetOperatingLossCarryforwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=holx_NetOperatingLossCarryforwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=holx_TaxCreditCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=holx_TaxCreditCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482470072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of fiscal year</a></td>
<td class="nump">$ 101.6<span></span>
</td>
<td class="nump">$ 89.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TaxPositionsRelatedToCurrentYearAbstract', window );"><strong>Tax positions related to current year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions</a></td>
<td class="nump">109.6<span></span>
</td>
<td class="nump">22.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions', window );">Reductions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TaxPositionsRelatedToPriorYearsAbstract', window );"><strong>Tax positions related to prior years:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions related to change in estimate</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapses in statutes of limitations</a></td>
<td class="num">(15.6)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_UnrecognizedTaxBenefitsIncreasesAbstract', window );"><strong>Acquired tax positions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Additions related to reserves acquired from acquisitions</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance as of the end of the fiscal year</a></td>
<td class="nump">$ 197.1<span></span>
</td>
<td class="nump">$ 101.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TaxPositionsRelatedToCurrentYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax positions related to current year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TaxPositionsRelatedToCurrentYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TaxPositionsRelatedToPriorYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax positions related to prior years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TaxPositionsRelatedToPriorYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_UnrecognizedTaxBenefitsIncreasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized tax benefits increases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_UnrecognizedTaxBenefitsIncreasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244478902856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Mar. 31, 2012</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
<th class="th"><div>Dec. 11, 2019</div></th>
<th class="th"><div>Jun. 21, 2016</div></th>
<th class="th"><div>Jun. 13, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized value of common shares to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria', window );">Percentage of award vested upon meeting defined market based criteria</a></td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock-based compensation, period of vest term granted to employees, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate', window );">Cliff vesting period from grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of option exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,800,000<span></span>
</td>
<td class="nump">26,100,000<span></span>
</td>
<td class="nump">15,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,300,000<span></span>
</td>
<td class="nump">$ 62,000,000.0<span></span>
</td>
<td class="nump">$ 65,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,100,000<span></span>
</td>
<td class="nump">$ 187,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ASRSharesRepurchasedduringtheperiod', window );">ASR Shares Repurchased during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ASRAuthorized', window );">ASR Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmountpaidduringtheperiodunderASRAgreement', window );">Amount paid during the period under ASR Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_June132019PlanMember', window );">June 13, 2019 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationPercentageOfForfeitureRate', window );">Percentage of forfeiture rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationPercentageOfForfeitureRate', window );">Percentage of forfeiture rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,500,000<span></span>
</td>
<td class="nump">14,100,000<span></span>
</td>
<td class="nump">14,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period of unrecognized stock-based compensation, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock-based compensation, period of vest term granted to employees, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfVestingForStockOptionsGrantedToEmployees', window );">Percentage of vesting for stock options granted to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock-based compensation, period of vest term granted to employees, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfVestingForStockOptionsGrantedToEmployees', window );">Percentage of vesting for stock options granted to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock-based compensation, period of vest term granted to employees, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,300,000<span></span>
</td>
<td class="nump">43,700,000<span></span>
</td>
<td class="nump">46,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period of unrecognized stock-based compensation, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of RSUs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,900,000<span></span>
</td>
<td class="nump">$ 34,600,000<span></span>
</td>
<td class="nump">$ 38,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees', window );">Percentage of vesting for RSUs granted to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested, weighted average grant date fair value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.38<span></span>
</td>
<td class="nump">$ 40.97<span></span>
</td>
<td class="nump">$ 40.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember', window );">Market Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate', window );">Cliff vesting period from grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested, weighted average grant date fair value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43.54<span></span>
</td>
<td class="nump">$ 55.13<span></span>
</td>
<td class="nump">$ 49.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember', window );">PSU Free Cash Flow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=holx_TwoThousandEightEquityPlanMember', window );">2008 Equity Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=holx_SemiAnnualEmployeeStockPurchasePlanMember', window );">2012 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan', window );">Number of shares that may be issued under Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase', window );">Percentage of common stock price for ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareRepurchseAuthorizationDateAxis=holx_Jun212016Member', window );">Jun 21 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized value of common shares to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Period available for common stock to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareRepurchseAuthorizationDateAxis=holx_Dec112019Member', window );">Dec 11, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized value of common shares to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 237,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ASRAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASR Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ASRAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ASRSharesRepurchasedduringtheperiod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASR Shares Repurchased during the period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ASRSharesRepurchasedduringtheperiod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmountpaidduringtheperiodunderASRAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount paid during the period under ASR Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmountpaidduringtheperiodunderASRAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum target number percentage of shares issued based on stock performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum target number percentage of shares that would be issued based on stock price performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuable under employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of award vested upon meeting defined market based criteria</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage applied to the lower of the common stock price at the beginning of the plan period and end of the plan period to determine the number of shares to be issued under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of restricted stock units that vest annually per the terms of the typical restricted stock unit grant arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfVestingForStockOptionsGrantedToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of stock options that vest annually per the terms of the typical stock option grant arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfVestingForStockOptionsGrantedToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareBasedCompensationPercentageOfForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forfeiture rate applied to equity awards issued to certain employee groups to determine stock-based compensation expense for the period. The rate is based on an analysis of historical employee exercise and terminations patterns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareBasedCompensationPercentageOfForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow resulting from the entity's share transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_June132019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_June132019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=holx_TwoThousandEightEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=holx_TwoThousandEightEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=holx_SemiAnnualEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=holx_SemiAnnualEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareRepurchseAuthorizationDateAxis=holx_Jun212016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareRepurchseAuthorizationDateAxis=holx_Jun212016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareRepurchseAuthorizationDateAxis=holx_Dec112019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareRepurchseAuthorizationDateAxis=holx_Dec112019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244483111320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 83.3<span></span>
</td>
<td class="nump">$ 62.0<span></span>
</td>
<td class="nump">$ 65.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">50.9<span></span>
</td>
<td class="nump">35.5<span></span>
</td>
<td class="nump">35.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244501346984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (in shares)</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price</a></td>
<td class="nump">$ 45.96<span></span>
</td>
<td class="nump">$ 41.36<span></span>
</td>
<td class="nump">$ 40.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in usd per share)</a></td>
<td class="nump">$ 13.92<span></span>
</td>
<td class="nump">$ 13.54<span></span>
</td>
<td class="nump">$ 12.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rates</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">33.60%<span></span>
</td>
<td class="nump">34.30%<span></span>
</td>
<td class="nump">35.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244411306248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of&#160;Shares (in millions)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options exercisable at September 28, 2019</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled/ forfeited</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at September 26, 2020</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable at September 26, 2020</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest at September 26, 2020 (1)</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise&#160;Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options exercisable at September 28, 2019</a></td>
<td class="nump">$ 35.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">45.96<span></span>
</td>
<td class="nump">$ 41.36<span></span>
</td>
<td class="nump">$ 40.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled/ forfeited</a></td>
<td class="nump">42.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">27.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at September 29, 2018</a></td>
<td class="nump">40.37<span></span>
</td>
<td class="nump">$ 35.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable at September 26, 2020</a></td>
<td class="nump">37.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest at September 26, 2020 (1)</a></td>
<td class="nump">$ 40.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual&#160;Life (in Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife', window );">Options exercisable at September 28, 2019</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at September 26, 2020</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options vested and expected to vest at September 26, 2020 (1)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife', window );">Options outstanding at September 26, 2020</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value (in millions)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options exercisable at September 28, 2019</a></td>
<td class="nump">$ 78.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercised</a></td>
<td class="nump">44.8<span></span>
</td>
<td class="nump">$ 26.1<span></span>
</td>
<td class="nump">$ 15.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding at September 26, 2020</a></td>
<td class="nump">109.5<span></span>
</td>
<td class="nump">$ 78.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable at September 26, 2020</a></td>
<td class="nump">57.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options vested and expected to vest at September 26, 2020 (1)</a></td>
<td class="nump">$ 108.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember', window );">Market Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244505583480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to stock based compensation</a></td>
<td class="nump">$ 9.5<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="nump">$ 11.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Shares (in millions)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested at September 28, 2019</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested at September 26, 2020</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant-Date&#160;Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested at September 28, 2019</a></td>
<td class="nump">$ 42.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
<td class="nump">45.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested</a></td>
<td class="nump">38.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
<td class="nump">42.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested at September 26, 2020</a></td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="nump">$ 42.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482544760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rates</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">33.60%<span></span>
</td>
<td class="nump">34.30%<span></span>
</td>
<td class="nump">35.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_EmployeeStockPurchasePlanMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rates</a></td>
<td class="nump">1.32%<span></span>
</td>
<td class="nump">2.27%<span></span>
</td>
<td class="nump">1.62%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">26.90%<span></span>
</td>
<td class="nump">27.10%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244405722328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Plan - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Contributions made by company</a></td>
<td class="nump">$ 19.6<span></span>
</td>
<td class="nump">$ 19.2<span></span>
</td>
<td class="nump">$ 18.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising cost</a></td>
<td class="nump">$ 15.6<span></span>
</td>
<td class="nump">$ 29.5<span></span>
</td>
<td class="nump">$ 26.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244407476104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Compensation Plan - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent', window );">Deferred Compensation Liability, Current and Noncurrent</a></td>
<td class="nump">$ 57,700,000<span></span>
</td>
<td class="nump">$ 51,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Nonqualified Deferred Compensation Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp', window );">Maximum employee contributions from base salary, percentage</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp', window );">Maximum employee contributions from annual bonus, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EmployeeContributionsVestedPercentage', window );">Employee contributions vested, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EmployerContributionsPercentVestedAnnually', window );">Percent vested annually</a></td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NonqualifiedDeferredCompensationPlanAnnualContribution', window );">Compensation expense for the DCP discretionary contributions</a></td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InvestmentInGroupLifeInsuranceContracts', window );">Investment in group life insurance contracts</a></td>
<td class="nump">$ 49,300,000<span></span>
</td>
<td class="nump">$ 44,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Nonqualified Deferred Compensation Plan [Member] | One Third Annually [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EmployerContributionsVestingPeriod', window );">Contributions, vesting period, years</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EmployeeContributionsVestedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee contributions vested, percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EmployeeContributionsVestedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EmployerContributionsPercentVestedAnnually">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employer Contributions, Percent Vested Annually</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EmployerContributionsPercentVestedAnnually</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EmployerContributionsVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The vesting period for discretionary employer contributions, which vest ratably on an annual basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EmployerContributionsVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InvestmentInGroupLifeInsuranceContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash surrender value of group life insurance contracts at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InvestmentInGroupLifeInsuranceContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum employee contributions from annual bonus percentage to dcp.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum employee contributions from base salary percentage to dcp.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NonqualifiedDeferredCompensationPlanAnnualContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonqualified deferred compensation plan annual contribution.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NonqualifiedDeferredCompensationPlanAnnualContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=holx_OneThirdAnnuallyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=holx_OneThirdAnnuallyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481577464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Summary of Purchase Commitments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Fiscal 2021</a></td>
<td class="nump">$ 267.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">Fiscal 2022</a></td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">Fiscal 2023</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">Fiscal 2024</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFifthYear', window );">Fiscal 2025</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Purchaseobligationthereafter', window );">Thereafter</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Total</a></td>
<td class="nump">$ 279.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Purchaseobligationthereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase obligation thereafter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Purchaseobligationthereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the fifth fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the fourth fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the next fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the second fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the third fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404342616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation and Other Matters - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 27, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=holx_CompanyVs.MinervaSurgicalInc.Member', window );">Company Vs. Minerva Surgical, Inc. | Judicial Ruling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Awarded damages</a></td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LegalAccrual', window );">Legal Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LegalAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LegalAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=holx_CompanyVs.MinervaSurgicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=holx_CompanyVs.MinervaSurgicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MedicalAestheticsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MedicalAestheticsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481768840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 139,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember', window );">Operating Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Expensesfromdisposition', window );">Expenses from disposition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sales price</a></td>
<td class="nump">$ 205,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of businesses</a></td>
<td class="nump">$ 153,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice', window );">Final sales price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IndemnificationLiabily', window );">Indemnification liabily</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Disposed of by Sale | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TransitionServicesAgreementTerm', window );">Transition services agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Disposed of by Sale | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TransitionServicesAgreementTerm', window );">Transition services agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Final Sales Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Expensesfromdisposition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses from disposition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Expensesfromdisposition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IndemnificationLiabily">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification liabily</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IndemnificationLiabily</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TransitionServicesAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transition Services Agreement Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TransitionServicesAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244480810472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Disposition - Schedule of Assets and Liabilities Held for Sale (Details) - Disposed of by Sale - Medical Aesthetics Business<br></strong></div></th>
<th class="th">
<div>Mar. 28, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash</a></td>
<td class="nump">$ 10,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts Receivable</a></td>
<td class="nump">59,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventory</a></td>
<td class="nump">90,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">7,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="nump">4,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">28,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="nump">9,800<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets disposed of</a></td>
<td class="nump">210,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">12,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">49,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">16,600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities disposed of</a></td>
<td class="nump">$ 77,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244404445992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition - Schedule of Disposition Related Income Statement Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">$ (46,500)<span></span>
</td>
<td class="num">$ (781,200)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244409443784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,347,000,000.0<span></span>
</td>
<td class="nump">$ 822,900,000<span></span>
</td>
<td class="nump">$ 756,100,000<span></span>
</td>
<td class="nump">$ 850,500,000<span></span>
</td>
<td class="nump">$ 865,800,000<span></span>
</td>
<td class="nump">$ 852,400,000<span></span>
</td>
<td class="nump">$ 818,400,000<span></span>
</td>
<td class="nump">$ 830,700,000<span></span>
</td>
<td class="nump">$ 3,776,400,000<span></span>
</td>
<td class="nump">$ 3,367,300,000<span></span>
</td>
<td class="nump">$ 3,217,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SegmentReportingDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SegmentReportingDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244409612120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Segment Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 1,347.0<span></span>
</td>
<td class="nump">$ 822.9<span></span>
</td>
<td class="nump">$ 756.1<span></span>
</td>
<td class="nump">$ 850.5<span></span>
</td>
<td class="nump">$ 865.8<span></span>
</td>
<td class="nump">$ 852.4<span></span>
</td>
<td class="nump">$ 818.4<span></span>
</td>
<td class="nump">$ 830.7<span></span>
</td>
<td class="nump">$ 3,776.4<span></span>
</td>
<td class="nump">$ 3,367.3<span></span>
</td>
<td class="nump">$ 3,217.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,105.0<span></span>
</td>
<td class="num">(123.8)<span></span>
</td>
<td class="num">(237.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376.0<span></span>
</td>
<td class="nump">463.1<span></span>
</td>
<td class="nump">480.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156.4<span></span>
</td>
<td class="nump">109.1<span></span>
</td>
<td class="nump">105.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">7,195.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,442.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,195.8<span></span>
</td>
<td class="nump">6,442.1<span></span>
</td>
<td class="nump">7,230.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">2,355.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,522.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,355.9<span></span>
</td>
<td class="nump">1,522.5<span></span>
</td>
<td class="nump">1,457.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,102.1<span></span>
</td>
<td class="nump">1,205.5<span></span>
</td>
<td class="nump">1,147.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">929.7<span></span>
</td>
<td class="nump">163.1<span></span>
</td>
<td class="nump">145.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237.3<span></span>
</td>
<td class="nump">246.6<span></span>
</td>
<td class="nump">257.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.7<span></span>
</td>
<td class="nump">59.2<span></span>
</td>
<td class="nump">57.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">2,161.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,276.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,161.4<span></span>
</td>
<td class="nump">2,276.6<span></span>
</td>
<td class="nump">2,442.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,151.9<span></span>
</td>
<td class="nump">1,314.2<span></span>
</td>
<td class="nump">1,218.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192.8<span></span>
</td>
<td class="nump">399.3<span></span>
</td>
<td class="nump">399.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.8<span></span>
</td>
<td class="nump">36.8<span></span>
</td>
<td class="nump">22.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.4<span></span>
</td>
<td class="nump">18.3<span></span>
</td>
<td class="nump">14.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,200.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,127.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200.9<span></span>
</td>
<td class="nump">1,127.8<span></span>
</td>
<td class="nump">972.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.3<span></span>
</td>
<td class="nump">315.6<span></span>
</td>
<td class="nump">339.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57.1)<span></span>
</td>
<td class="num">(781.2)<span></span>
</td>
<td class="num">(844.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">91.4<span></span>
</td>
<td class="nump">108.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">159.3<span></span>
</td>
<td class="nump">913.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.0<span></span>
</td>
<td class="nump">94.8<span></span>
</td>
<td class="nump">91.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">38.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
<td class="nump">27.3<span></span>
</td>
<td class="nump">30.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376.1<span></span>
</td>
<td class="nump">437.2<span></span>
</td>
<td class="nump">422.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
<td class="nump">99.2<span></span>
</td>
<td class="nump">58.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.1<span></span>
</td>
<td class="nump">87.7<span></span>
</td>
<td class="nump">91.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">15.7<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">$ 1,438.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,328.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,438.7<span></span>
</td>
<td class="nump">$ 1,328.6<span></span>
</td>
<td class="nump">$ 1,414.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481979256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Revenues by Geography (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">75.80%<span></span>
</td>
<td class="nump">75.30%<span></span>
</td>
<td class="nump">75.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">15.10%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
<td class="nump">11.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">8.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGeographicalSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Geographical Segments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGeographicalSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244479748376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 491.5<span></span>
</td>
<td class="nump">$ 470.9<span></span>
</td>
<td class="nump">$ 478.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">383.0<span></span>
</td>
<td class="nump">355.5<span></span>
</td>
<td class="nump">366.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CR', window );">Costa Rica</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">20.8<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">77.5<span></span>
</td>
<td class="nump">64.4<span></span>
</td>
<td class="nump">62.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 10.2<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Geographic Information For Property Plant And Equipment [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GeographicInformationForPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481587416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Compensation and employee benefits</a></td>
<td class="nump">$ 262,700,000<span></span>
</td>
<td class="nump">$ 223,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccruedIncomeAndOtherTaxes', window );">Income and other taxes</a></td>
<td class="nump">125,300,000<span></span>
</td>
<td class="nump">56,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (current)</a></td>
<td class="nump">23,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccruedInterest', window );">Accrued interest</a></td>
<td class="nump">22,100,000<span></span>
</td>
<td class="nump">22,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">114,000,000.0<span></span>
</td>
<td class="nump">128,800,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 547,600,000<span></span>
</td>
<td class="nump">$ 430,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccruedIncomeAndOtherTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued income and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccruedIncomeAndOtherTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244482855560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other&#160;Long-Term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Reserve for income tax uncertainties</a></td>
<td class="nump">$ 103.7<span></span>
</td>
<td class="nump">$ 106.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">81.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities (non-current)</a></td>
<td class="nump">65.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Interest rate swap</a></td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRentNoncurrent', window );">Accrued lease obligation&#8212;long-term</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension liabilities</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">18.0<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 303.2<span></span>
</td>
<td class="nump">$ 162.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer) for contractual rent under lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481176616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities', window );">Defined benefit pension plan, liabilities</a></td>
<td class="num">$ (10.9)<span></span>
</td>
<td class="num">$ (10.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="num">(10.9)<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProjectedBenefitObligationForLongTermServiceAwards', window );">Projected benefit obligation for long-term service awards</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation in excess of plan assets</a></td>
<td class="num">$ (10.9)<span></span>
</td>
<td class="num">$ (10.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProjectedBenefitObligationForLongTermServiceAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Projected Benefit Obligation For Long Term Service Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProjectedBenefitObligationForLongTermServiceAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244480751848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="num">$ (10.0)<span></span>
</td>
<td class="num">$ (9.7)<span></span>
</td>
<td class="num">$ (9.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants&#8217; contributions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount', window );">Actuarial gain (loss)</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange gain</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="num">(10.9)<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
<td class="num">(9.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Benefit obligation at end of year</a></td>
<td class="num">$ (10.9)<span></span>
</td>
<td class="num">$ (10.0)<span></span>
</td>
<td class="num">$ (9.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244406063864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ComponentsofNetPeriodicBenefitCostInterestcost', window );">Interest cost</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Recognized net actuarial gain</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ComponentsofNetPeriodicBenefitCostInterestcost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Components of Net Periodic Benefit Cost, Interest cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ComponentsofNetPeriodicBenefitCostInterestcost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244406286024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract', window );"><strong>Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244481120376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2017</a></td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2018</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2019</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2020</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2021</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2026 to 2030</a></td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244504774536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Statement of Operations Information (Unaudited) - (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="9">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (108,600,000)<span></span>
</td>
<td class="num">$ (54,100,000)<span></span>
</td>
<td class="num">$ (307,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 685,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">685,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">$ 241,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 443,800,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">106,700,000<span></span>
</td>
<td class="nump">46,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="num">(45,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">1,347,000,000.0<span></span>
</td>
<td class="nump">$ 822,900,000<span></span>
</td>
<td class="nump">756,100,000<span></span>
</td>
<td class="nump">850,500,000<span></span>
</td>
<td class="nump">$ 865,800,000<span></span>
</td>
<td class="nump">$ 852,400,000<span></span>
</td>
<td class="nump">$ 818,400,000<span></span>
</td>
<td class="nump">$ 830,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,776,400,000<span></span>
</td>
<td class="nump">3,367,300,000<span></span>
</td>
<td class="nump">3,217,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">931,800,000<span></span>
</td>
<td class="nump">466,100,000<span></span>
</td>
<td class="nump">395,800,000<span></span>
</td>
<td class="nump">433,800,000<span></span>
</td>
<td class="nump">249,500,000<span></span>
</td>
<td class="nump">444,800,000<span></span>
</td>
<td class="nump">42,400,000<span></span>
</td>
<td class="nump">434,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,227,500,000<span></span>
</td>
<td class="nump">1,170,900,000<span></span>
</td>
<td class="nump">1,696,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 495,000,000.0<span></span>
</td>
<td class="nump">$ 137,900,000<span></span>
</td>
<td class="nump">$ 96,300,000<span></span>
</td>
<td class="nump">$ 386,100,000<span></span>
</td>
<td class="num">$ (123,500,000)<span></span>
</td>
<td class="nump">$ 93,900,000<span></span>
</td>
<td class="num">$ (272,600,000)<span></span>
</td>
<td class="nump">$ 98,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,115,200,000<span></span>
</td>
<td class="num">$ (203,600,000)<span></span>
</td>
<td class="num">$ (111,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in dollars per share)</a></td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="num">$ (0.46)<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="num">$ (1.01)<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.21<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
<td class="num">$ (0.40)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140244517173592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Statement of Operations Information (Unaudited) - (Narrative) (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfFourthQuarterEventsLineItems', window );"><strong>Effect of Fourth Quarter Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">$ 241.6<span></span>
</td>
<td class="nump">$ 443.8<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="nump">$ 106.7<span></span>
</td>
<td class="nump">$ 46.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfFourthQuarterEventsLineItems', window );"><strong>Effect of Fourth Quarter Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Other Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfFourthQuarterEventsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfFourthQuarterEventsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>135
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( (I"<5$'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "*0G%13,5?CN\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M3L,P#(=?!>7>NNG&OZCKA8D32$A, G&+$F^+:-(H,6KW]J1AZX3@ 7:,_<OG
MSY(;Y87J [Z$WF,@@_%JM)V+0OD5VQ-Y 1#5'JV,94JXU-SVP4I*S[ #+]6G
MW"'4574#%DEJ21(F8.%G(FL;K80***D/1[Q6,]Y_A2[#M +LT**C"+SDP-II
MHC^,70-GP 0C##;^%%#/Q%S]%YL[P([),9HY-0Q#.2QR+NW X?WYZ36O6Q@7
M23J%Z5<T@@X>5^PT^6WQL-X\LK:NZJK@O."WF^I.\'MQO?R87'_YG85MK\W6
M7+#Q2;!MX,]=M-]02P,$%     @ BD)Q49E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M..I@BP1+>F'Z%DL.DE5=D]:@SHP<BUB9PD3[G,BB!_+V]9#:@X_*5+S/NZP
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MF'<O8CKA.Y6EC+X()'=Y3L2/1YKQ_4,/]PXO7M/U1ND7[G2R)6NZH.K+]D7
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M5T>'T:3\B6=\G<96BI;&"WNC9M;-+#A[Y-IZM([(/39@N+L#>SKLA*]Z)US
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M/:6P&U/-\G'(H\9](PPE\[0@6>Q"WR=3"P?W@,+^L\B<"78K,J$$=^(9]YC
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M>3<8/)AGQ>IO<M]-Q,8 L(,/H-T ^F1 P'H&!-V X,D 2GL&L&X >WH%T3.
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MYSV0 #+_0Y!F2!N%I.\,J3W#1DJK3 D4$"#@ZJ250/)>O9:HX[[ECN >ZO@
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M<J@ ?AD1!#=^5/!;4AI%2OH#N@#6YPU-F0@M7@$N*.\"%,..AD2,EV=T'?J
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M!9B./>AAU#GQ:)ZL$"%C_&2@'>@"FT9J6<*0GG?)F%,:M3'/;CC*>&>D5.W
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MF#]R'/-60I7A^GQ"N0[#D%[$TW@%NH2AMHIS6$$R"TO..6,XT(^2GM4*>60
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M5XZ"=W9Y' %\]^"QP!$FAKI<3(W1V@SMSB_,5H8@+Z5# ?5(/2NHF2J/9D/
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MC XZ].QE\KM Q/30K<0+P[)\2&N/5?\?QEU)HTSUF;+_IU'7<?^/*[NG_Y[
MI:4M-N#%TM5LK(C\F 1GFF-W;%25.5Z6>$RJ-,B@)Z9Z<O6@Q\@<5JNM.S5N
MH")Z\ 5/>I.=K4=Z;4_DJZ-78-]&5U=&/_S]Y^B^K>0]$?<$417LN_Y1-D>9
M+2S#A=VGT?7TAO>W7<UF_'<:7TP7_.F:MT_-XN7EG(S#?4M:^)Y\M77TCH\
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MA/F Q,+8K[-_L'9^/]1.%PN?4]@SCO*M/_TE:.BB!?L*?LO02?<=*^*'NJN
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M(=PW'%>!6112D'XTYQW?J7F\ZY5"B:8(BESM;CJF4K'UB_XVNA^QRKG:9=7
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M%^@:<?2!BYMC)_DSGTDUYW3K2_&.9\8%G@T;V&; ]I#">W?H:5->V-)WQC>
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MY.H+)D&;X!&-/H_N*'L_'  ;TI,-R6<K6,+J$SN8JJRK!_P'[!V]EX-3G:D
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MO+DZ\;X1'VI3$4DQ-352!O\DYU26!N#[W)@Z/M "*V._,'NO_@M02P,$%
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M2!L=FO1S:W@6B#K7AKZ*C9KL((XDV#2KT@9IG-0 HFD\: N]),-970.5;RS
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MNBM?*NID"T\O4/=>N_(0[DY_81G%\#0?1QJHFQ!#SKR\?=,^N ..U73LK;@
M79 TA]E8/ON9U40AAFE'O9?,>*>Z6#.VJS<F9]N244LG6-,GCG/C/.*,3L>Y
MSV7ZJQ5[?I-"SX=^!MBC!6H,BC^),5I<[,$RLDV7T)&BEF4[H;VK?8BRAY9&
MQ35'/KOUF_8;+9/*%)%F%%/-)7U\I [Z;]U0*FG8F @X<MD2KF0:,XXI$],O
M(S*UD8&1;NK%$A0C74C6('$GJQOL>O9[*7CUSIEXZQ4B!%W/L'M4/B]Z9O5,
M.!/%W0H%P.IUJ5;N=%(X-)2)E-M0@DIJ<,D,5<8FK<H84MS$(AJ$DNJ(L=<C
MDY#V'%')XWB'2;,8F='I0CQV'LQD$;HN!-TO0",>P*AL72\0],II"9!0QXG)
M1&;W%^$Q.PXB71^8#EJ#%$8N%45_Y[,@C3^0<+2--0YRTC,GC\WE70_*?K10
M/@AWT:0'=\YG,?P6_SZXFT].VS^+=8B[4\?VXZZ#LI\3B(TY%3&+?73%A] 5
MS0A=T]\'7=/%YZ/KU+$GHJO%8;.IC[)I&V4?6C;<@68Z"$Q\3R<CK<J94<:G
M^0S*!L_I^=-85N9IC*/&_6S4@H,75>+E%2E1@XXAN&8WHN-M4JH"_$?,A^AP
M^<4!DCI"^D=SO?1*H$OI(*;SPY",4;3P.B*X:_GRRJ/.<&;5<J,Q:1;3(WN$
M&XQ/=A_4\/L-"(0$,/':'K/P;3PY"W2'@%FUJ:@W21,+Q\BY7UT0T4AYF<UB
MXQT@\6'AFX8<[LA1]J:!H9YLFFC*'\$AE T_L=\)G:W^/#R%V<&E#4,8/IY@
MZTGF-F@MNA0@5(]0H!$S=(>I7PH=-3N]=(?PFH.I5;M7UV>&WFSW/P,C?S3<
M8%+;S !TSP*?#R+1[- XZ'L]&)B,_&T'2LRV:?>'Z'C97N-9DKH85@TN]G65
MRZ9EUH9M?M<LZ==XAIDNNX)QH+B[@/VG(&@CWW-+1Z:-XWD^B[UJM0T;L%L:
M0#1'<!'7U)OF_%Z7VO4.Z]O!IIZ"(5N1RX:B#E--X&'#NZ [RUVA:8\5)Y],
MR!#%GK+"I+H*VGP0S@N%F;*]JI*LK?[/YQXIL./_$.5:.H4!-.8BO'^C(SXM
MEW5NF[G:RLZ%J3T:;ZB'R%>]80!N8*/0WZJH-$S_,$/Z378G8L$LV=4%%+2&
M&::6>J0U(:*/FH@^:+-S*N84A3#U*]4>82>>!#QP2R22SG2/.B(X+'U6O9V2
MU^@Q^FFC>0YUDGX];V"Z]+ VU/OCB0 984IINZ.72-RYIS[,K8!F"I>]-AK%
M:CF;E&&=Y.Z!"AE=5\7ZH^4AD[0P/-S**F@3,YMK$+3VE%BSI%H;'3*-QM%B
M?EPM1M/Q[%]$+4X]!7Z"5NR4&?S3-^W ON],0K?8!)[&=:OR$.98L,@Q[WG'
M[*5)8W+29C*.L5/<LJ0K4F!E9OB8PARO1Z80POH*[I7'..*)B*CLL@!M=,+-
M$_:>Z+>V6X^O1H@N#\AD JPD+["TP+;?Z[/KN45#]UYU85I_^J&Q9^,TW7/@
M GQ,?&+5XPXS[L%1/?^,6W/5!?*:JNS=-\QMI@ZMC5;GJ_DDQ&7@5(W%GX-K
M-YV0]4-Y]%@APWO1 Z^67!51I1=;F.MG9.EA3W,G[BK)/Y;UOEJC$=QA1JG_
M_A'O<C1VF0=@:-^(U',)3^!Z4ZT?KQ%J)S^5N\2I"S89C/YK4NA>@CPW?VB
M:(TSX4'"5>:.6(2Y5[[]1,OR5JWYV+C>HZKB*Y[X[2&L)/9V=WL@TMLA/>5I
M\6F+T[WSG>_M93?>J12?2^VQ2M\%:@Z[#6"B>QUN*%'.:IC91TV_#Y[=T^%-
M-M*G@;F(TW3CV0/_Q^&@@&<+# G"6BBR<=P01+=LN"L$5N1[&;/5&%2,@]3F
MGBGD\8.]2\=F\*U'T0\.O$R7H@0 F)L9\HIN5VA?^GC7$-F5)PX<\[L,;D'J
M/Z<YH"L[[79\2R8%<(2,SMVGL/)DO'CD$N#&:S"'- )K:2_GSQ1?7J::2NG
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MV +TMB>#M>@^$\H8N^NB9*P>%J&KTL#JY-(H/AN/6M):X_I><7#G>C#F0$7
MD8""GR )?L<2;9_+3=O\7&_4)E[:9%5QK$'E"#BW#M[7W5IDE2,^WA.HN7*E
MDV2X[',4LGA6J!Y0V WF+PO\G15YHF/&_2W!/^7UH-=/6\<Q&&4=-D/IC(U)
M=<4+2Y3X/:Y?WN8%QRVP(Y554/54S*#_J9B##9R*!?+!9XC-K(H6B3$NR;<<
M[A8(]I=!B/]3&!8&@Y(T)I7FBV)B!RH=-C_&XGN50<S$0=FB@L0&\*9$NL=3
MK(0?,]JS-%54VL0PQ]LN&("EC$FN,;^ (0WIA4K=[^DXSM\1>?P@M1&_(CVH
M3J"J"CI*L=19GE*J3'/$4()QXR(V>=#L.Y[M.$?'\[M9J"9XM'!6,;(HBLO&
MK8ZM[5;$D5'BJ5,@)1VB.!&/@0\1Y:$ 9!,>M_XH#B@3(.S9-B:'665*J9FS
M8]^.S!:K0,T^NML!B NN"6,,DE2I6X'"-.KU-G>UP"[),UZ(?U"+0M@0O>MG
M_EL+MZGWUJ6KIW_J"?P<NSEG+,YP^$/W?R[^SOU)%9\C;AFY5L323*0++MYA
MNU,QF0:7,WH%9OAU&,QGN_.L'W/5X1W/J1BAG SMZW1"KV%PN4 <:6SR0GS6
MQ9?S%;A@$^4%\<Z"!7P&-C7$SQ">]$R\KZ-IHE>*U>*6SAG7U/;_O!UTE^,$
M=$*A9#R&/V"M"1#_C+R#7MYI2DDXJ@>MDKAQCOXK(=7LEY$BLPU!A"=P%B6+
MRE"Z(L^SW'9#R9'@2X,9Z8CB->GEHJVC5$TNN][R,:,,^F\J[H"59H8=98^J
MU;8;C9W#(D;"9YL2"C$=SJ4)P/L780QKI%;=M227C/F2T@7'<ANG['2.HH4&
MU*27N6M3])P>-F12'>\W0M?U&B-[<M,4HQ4GJH+-XHA "V+F$=LZ+6A700*E
M\AAA<PGDJFSR]&X$M&=D)+G!.75:4?.WPU.%\BRVY5B4KS,4:H\G+,J*7:UK
MCK:'(3T_^7S["XHA:],[,B8%$8+9CO& N[5-&N"&U"KC.3+-*TNW#TK6"-_$
M/$D!4D,U'_ADBR8<<^,O-S7..!9;CEIN9,D1$&2L+J=\>D1*U,T&*BGFO0X>
M*#>J4A*:B0"2>/3@V&6-);+A2FEB%D7=A,$GRJ?)=5"TQJ44,!!Z)3(%_!;2
MP'L05HJV 6 5+F@,$E(%X/F;Q'JU@KSL%26[>BT+X'[=A ;Z)Y,'^'[/^;RU
M^B2JPSJEH.*+ZBAOBHU!A)O(IJW6!=8FK[8601M;<K$C]^86@JXS.)F1 JAM
M8<Q9@%=Y@.E!)N"#TZP[^4:N[MZN6]RHS<VC\[;>E%E6V=(WB^MRLZ.6C/]=
M%3:!MH<#?#3@L?9R9_*H=WE8OD<JA/1<*-DV*Q_<KN^1BUG86FS>/KZ)S?D[
MU('*WM/1M&7? _PY:7M%EJG36VWKX"@'Y=)I:YM]R8,3[8E"<009>(2)]!P0
MT)D'44#MAIH;#C4#P0DPDL5&K,!:CDSX\/8#-6I:'MO[_!,O:*TR\]HEL,ID
MW%8.SBJ3F5>U?)-5.'77ZLNO..],K73)8#!Q2\.>5A2PN)>=,UQXS7)[@B.O
M\/DF6:_*0X45/,+BQ]O;[C;M=:JKS(/YMR&TQGM7K $-7':\A^_5),I&RP!%
MS0!=8J"[%QPH\S)>E S"?^U EMN*U]W[5?J4:,//N^38/2( (0KJEW7DM_?X
M-+$M)?N57V?\ECLPUOGMQ>!!TOU"_&AKDH;T>K]=K==&K2E>U:3;D0^66);[
M&#N%@5,BH>$8P98JQ/DBF-C:BUO(0\>ZWY)K)2J^J(,C<?EA, +?#8-P!J9B
M>0[>'06+,Q&BQAN)"1'A6AJ_TROW(0R4V='Z\1PU(E6"HR$![7%]ZA4@"^DS
M#Q8C2A[X?3K'6_4"%#M=ONVG^P,+/B<-V4@DUK01B[R-/OO97D4TO0#N739U
MH]NO!^]#^6R;5':!*G,3?9,UT_?*N:-.7=5Q;V/0IC#"6<MWO9R_[^;0BQ#,
M7[AYHZEIA-HAVBU\58L"':C SK*\A,GQ4I7W2EG)?+9>)_#ZJJC#FMW]+49Q
MM]EUG)H43YRK'DX?.%E<2 ]GWBV(#8L >QLV>X&O?O:GU[UJ'!=A:2!NZ ?R
M"J^'_-%ZO-?X/NK'1$$<9*B'1D\>P;7S[-R=^ZUM4_W8 *GQ\BL7XKS!^ST[
MM*!%L3IOW)EZ,G#GV53\:J?"@R_/Q'A!!?&'7;^>71[>I_4XJJ7AZ&'(D;(%
M/U,6-]<F>%4TG3Y4G!NJ='$J2[61R8J/O6Z?<DY MBA6#_1,D4ZK5%!_N )7
M?>#TR0OD"7N&H?K.J#V%W58^6(_ZID6Z0A%-: 3;=9+=CDOK*=WN$-N#1MUX
MAF&0CB=M[A[PG[,N9L<+?\ NL:CU73<'/6N'#WO$8.A=^K-,CS:1^EM^;"\H
M:N[6$ABY1%H6$<ZY[)81,BER3\*1+^&H)V&K_\TQ"0>MU7>H0LI W7-9 J^C
MAT% %J5[?*I4,JT?&VF0ZEW!.-#:6PQ1;3G);S0J-@B% AO!R4+:F<!GHY&!
M3QDM[4&Q-MSF9EBP4YW")<<+XILXJ;GCF3BD&:WC;CP[!:XK>OQF22]^VA;8
M-W&^]Y*?F8GT5GM77RPOW1TD>JTI[=H^@J(6;QW,_Z-,[I9M;R1+:=:([FTT
MV'MUU<35SHVTJY:I'<;#B>IS./7MZCB>N\R)]ZX:@V%3Q?I9(<-E9*2/=69]
M*[>:7+0^/3*R/5,5=WWJ$&Q)-C:/UW7+,W7.DO;*DY2;<4H\1]8X(QMR%WHO
M#O>=!.6:/_DDOGOD#%2KFU,F;3L2 [&L[/A&TII2]1;Q#I/:=KHY2,\]2(%F
MG2@!>^ ,Y,TMZB9'#_&#AB^T-_"N6"@.U""2^/Q#^X2>2P-Q3[SVD#D=U#V>
M^JF6OFVYK&>A>\&"<Y%GOS8Z?%RY^DISBW1#SW;6(?71_9I^%MQAR?38D4_L
MV0W"+%E4I54BK><[9GCTXLK9@'>AOUOI&LD@-=TU/LUU]D7\MMGPZ7?DI,&W
M.]6G__?09B'7 Y!L^FN68O#>]J%92,]ACNMJTH(>GVEBX%9A1-,.4U;]G4Q$
M5R/(1--I,!J[3'093"9>)K+];5*"GIF&NM(D.77:&5'4<.9;N&_MC11-8_1/
M]OBZSF;]=]R_'Y3>UU6&;6K=- \:TUTXF?&'/,G7.AK0 PL!*1<>G],^R$ C
M;V]NZB<8ZDS6=@)80??$GGU^*MR],G\*Z*A"JD'N,5E[O^_$< ]U-!WU0J7Z
MW#9&[?4N]3]0M(#5:3@1/\% SU+4RCT%^8MIXT-8S/K.<WWF5X.6++=H<\.[
M3U-GWI-%L6QJM9S*3.['N_:/P>J_>_E&LYB?#7JTWWH4\);F3SK]NDE;ACI/
M:QMHQSA^<^=SG4B(=!O!^_%.<_G=A.3=^^DZ6W ?S;%9V6#(NS=MG;QM?.UT
MV:1_<_J[+XB?>O\Z#OGJ-:1[V%$P"X]=P0YAZ/K_OBO8<(:2Z!GUJ.@F-YSR
MM>X3KV#W?<'BPOMZ2ZJ0'>A+/(3_*BOM-UV:=YOO"5W9K\>TP^V7C#XAN>BL
M$(E:8>HPF$]/A+%?W+%_E/F6ORRSS,LR3_G7C4+F-30 GZ_RO*S_H V:;T^]
M^2]02P,$%     @ BD)Q4:KB+P!@ @  +@4  !D   !X;"]W;W)K<VAE971S
M+W-H965T,38N>&ULA51-;]LP#/TKA#%@&U#8CI.V:9$$:-H-VZ% T*S;8=A!
ML>E8J#Y<26Z:?S]*=EP76+*++5)\CX\2J=E.FR=;(3IXE4+9>50Y5U\GB<TK
ME,S&ND9%.Z4VDCDRS3:QM4%6!) 429:F%XED7$6+6?"MS&*F&R>XPI4!VTC)
MS'Z)0N_FT2@Z.![XMG+>D2QF-=OB&MUCO3)D)3U+P24JR[4"@^4\NAE=+R<^
M/@3\Y+BS@S7X2C9:/WGC>S&/4B\(!>;.,S#ZO> M"N&)2,9SQQGU*3UPN#ZP
M?PVU4RT;9O%6BU^\<-4\FD908,D:X1[T[AMV]9Q[OEP+&[ZP:V/'EQ'DC75:
M=F!2(+EJ_^RU.X<!8)H> 60=( NZVT1!Y1US;#$S>@?&1Q.;7X12 YK$<>4O
M9>T,[7+"N<4D'7UZ^@PKP=0L<43HW4G>@9<M.#L"'F5PKY6K+'Q1!1;O"1)2
MTLO)#G*6V4G&-=8Q9!=GD*59>H)OW)<W#GSC(WQW6)*G@%N2:?BF"9W@BX7?
M-QOK##7%GQ-I)GV:24@S.9)F973)':PK9KC:PG\.]337 /RC0E(N:Z;V'RT\
MQNL84-9"[Q$M5.P%J:ESM!:<!@;/#1.\Y%1M1U%TQ>?#XFOBC6' 3-U4X+L8
M"[J$#Z.K^((Z3@CRG 4S.YC 5$&>Z5L T/, );<Y$^'J_ 6.KD(<+:9G-+^V
MQC"!8A__Z\2300]+--LPJ99T-<JU[=Q[^\?@IIV!M_#V);EG9LNI"H$E0=/X
M\CP"TTYG:SA=AXG8:$?S%985/6AH? #MEUJ[@^$3]$_DXB]02P,$%     @
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MV5I<77\OJ^7E)Q8@5]8#!P7PB:2/E[I;%R,WJN .9()RMT#7D[O-K1^'B7H
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M;W)K<VAE971S+W-H965T,3DN>&ULG5AK;QLW%OTKA&"T#:#H9?E9VX ?;3=
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M5<VP& @:V?J6?QEX.%I01%]9D P+$H?;;^10ON667YYKM6>:9D,:/3A5W6J
MDRT9Y<YJC$JLLY?7O4&/,>Q.;,&U-8RW%?M!J*WFW4Z6['WK+0\*S^<6.]*Z
M>3E(O_;2DZ](CQ/V0;5V9]B[MA+55, <4$>\R0'O=?)-B7>B"UFR#%@2)=$W
MY*6C_JF3EWY5GE.;W8I.:2O;+?OGU=I8#6_YUS?$9Z/XS(G/_D_T?E,Z!>QK
MT_%27,P0D4;H>S'[K[9DO^P$NU%-Q]L'A!A18)@9*)%'\R3%3ZETQ=M2P$7M
MCEW=W;"DB +VC,*0_=P)S1V;9@2A!9,5'N5&BHIQPTKLJUHWJ#8 R? H=*>E
M$8ROD4#8'G!W$-%Q2!,!JZ0IM;"";60+()+74Y#8Y9[+FJ]K3%&:B7M>]WYL
M_< L="UW4FR8&N%5HI0NOS3\D] !PZ)#URMTT92M5GT7$ -#QV&"&5#NX!)6
M,5[7J@1,\&A4KTOAB>?&D#&PHP,*^L)CUO_\IR*)\S?F#Y"1;M(>9HDOHNPI
MFX&XC2P).&UE3XCU1G6,C*;8<:Q<"]$>&X126\6P'TFQ#YUP5NFTJOH2:X"\
MWR H>DW&&S83:)'*/PE,  />7#0P+B.K&U57(7O',?8<#=N*EE06!/5>M#TL
MIU7#!%P,:I,PPVM2E#6BDB5,+C[WLG-K"8<6-597C+Q?#J3/8<;#*OA,IXS?
MLN^Z6@H3 )\$;ED_L)ZT)E^I)-^VRE@$", X$Y!XT^NMVQ4JE:*"^B9D;WM-
MXP1N([6Q['//-7R7]MO 1S&=TI.WBB#%CP?BE>O'0Q$<VPQV 12RZ@FCO69O
M1X!0X!H%&/O^*'AM=P'[,%!S!>0[X:?\\-O?V-T!/6UX]PFUT.+%KYJXH0M&
MC(IJ0CFYW'/9;'U(,7"7MZ(4S1JZIU'@E LPC*!P 0[G@D4K<@[9EKT^\F_Q
M!><*A,:1+0ZF=+,KT;3PS-*'+]B_/P0=5%'..1#V(-U,%6E #%G)<^\3@/#!
M<RH61K<_^./@A<,^(US 5PWR4O4[:K+'*+Z4=5\)'PF;#8X91%F+S%%RLT.H
M<KTE9S,]' !TR-;R=BMI>TH*<-^&\N6_O88#'P';*E7M9>UM]FR-A)92.Z3C
M!JA6K>'#*<<O$EL]$6N<C_,2H6,D#6 92+*ZIY"&@@%9"Y$J*S[*J>"+\#>*
M^<?-:BS?^CECWZ-)D,]?61S:*)'V;6]Z2M%6-##2^R'7\%$9#\I'T6FO=Z"D
M<<3*%H:Q2KL ?LJ+>>3-PX'#P';V ;%>\R%5C(ECZC&;OH;S'=*W0>9%,45Q
M.>;/^20!_@K0J41R?E>06W(52![8D2<H<'&B(9!*A^]SPL#YGOY:Y>RIG_IG
M.-;=XQ)(A$XRD(_(0[YA>^YVW"AHNT=2^4UP;2B/ R>.5M:',IVOCMZ*R1O$
M_:(HC1R03%(3^XXE01PE88RG.$BB1;AP3W&6A]DT;U'O(@Y7:-,X"Q.:'Q=H
M)ZDKS9=.6);F&,J2)(R>IC)6Q.A<96'!5C$FG4A9RT68LC1>A$N6IBLG, UR
MB,[<4[K,,4Y/*)M ]//3P#^KE3$OGZJZ2E9A3NHM4Z]P1NH^47*5 %>Z6A&
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MP=ZBJ(&!,FC-Y]0A^O_+<:ZY3<G%2RR]X0;V(KJ(]'T0#-5F"G!)57VZ?"Z
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M/.Y=]K<VH'X3!-3%%?->.H;_X+G>(V.]@W5K_=].04-"'<:WP"1NMHY][N#
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MBF=2^@*[!/XP1K(]#Z._%7E)RCM/6 3BY($%>Q<_B4!B9(FFT0>X)^DR*).
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M0D.\\2')1DA"P8F 2V?D,*.E1)R?=*A32*<B;]I0Y#J;JNV2]U3/;N]]DX\
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MHS87DTM^MHAIO]_P1ZUV]N2?420KK3_2Y,WZ8A(2(-6HTI$%B>%.7:FF(4.
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M-6<1?00B2;&C +Y(4!@A[1O#S?/<!Q&13L 3[JD/HPRCR%(OC3B%76 M]@5
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MB$87+E2W&IT3*25E9C4^%;C.7MYR#,G R2<VE]R<GK<M@M*C=EP 7'F \ A
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MK4K<Y9HSY)$FX/.E4G8[( /EM[G+?P!02P,$%     @ BD)Q4:T<< ;P!
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MKD^JN=LW+T96[CX]DX8^#NXQ0XJ*L@.H?RZEV;Q8 ^TO+)-_ %!+ P04
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MV3P!W^<ISHSE"V]0_^UQ_B]02P,$%     @ BD)Q48#EIEYX @  8P4  !D
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M]AAATS767099(&1*%O^] 9T&\__3X/GX=Y+TX^#E"_R[0J,X;N> 3&E .U*
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MY)&YIG^7]P/7=OXM?-LZ4,=W9_@KHPT+8'W2MNYAP >L_QR=_@M02P,$%
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M^3+/V>:-^.:@[?>)G?T/4$L#!!0    ( (I"<5&T;MC=J0(  -L&   9
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M50_Q"JU(S4A%"LP4NBL*OF6*L!HM.24% 8FNT4J?H7)+P:"?V Z8XL+L7#Z
MPH1>:<C+Z@%=7ERA"T08^DDHU;62F:>T5./0*WI9]YVL\)0L:%T4IM]0Z(?^
M!'WQ%?J-H0>S0[JG$S1D*1RR%%I[T0E[4^GX?;>62NAC^.>,@VAP$%D'\0D'
MSWBOJZI $$PGT]71;RS=W,Q='B2A&V7>;IR5"52:NL& .M 6#]KBL]I>]3V\
M)NRZ%;P .:FN,S ;^8U3-_DD[AB4Q"/0@;9DT):<U?9(&-&'OT0UY^6DM.3(
M:S!+CQ)WC K#>(0Z$)<.XM*SXD979$I9>E2L:):,BM4I.T;%<>S./BGS1AW
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M8CHGRU1]X:L;6D_(+^U%/)75-UC5?=T>B)92\:P&:P\REJ]_R:^:B T #/8
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M.ZYT&[##4O==$,9!KQ><JY-A>D'?R=._4$L#!!0    ( (I"<5$R9BV/E@4
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MJ[0ZW B^%'GY@+F_4DH_GY0O:'>NS'\#4$L#!!0    ( (I"<5$")*AT$@,
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M[ 56$#),M64@YO6,4V3,$AD9OVM.KW%I@=OC#?O,Q6YB>20*IX+]H)G.Q][
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M.K5-<Z-N8L"U@?J>,C7P54<?W?7=;OP74$L#!!0    ( (I"<5&7\^2R4@4
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MJ##D+LOD5A@F5F0N.<L8:')U&-7D 3)@.[KD@$T-:@?X#1/(S#-YGX*AC']
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M@T!9 'XOI#2'CIV@>5A-_@)02P,$%     @ BD)Q46@[7>B; P  KPL  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3<N>&ULO59-;]LX$/TKA$XML(D^+,MV
M8!N([2Y:H-D:\>[V4/1 2V.+B$2Z)&5G__T.J8\HMJSFL-N+))+OS7#F<:B9
MGH1\4BF )L]YQM7,2;4^W+FNBE/(J;H5!^"XLA,RIQJ'<N^J@P2:6%*>N8'G
M16Y.&7?F4SNWEO.I*'3&.*PE446>4_G/ C)QFCF^4T\\LGVJS80[GQ[H'C:@
M_SJL)8[<QDK"<N"*"4XD[&;.O7^W\@-#L(B_&9Q4ZYN84+9"/)G!IV3F>&9'
MD$&LC0F*KR,L(<N,)=S'C\JHT_@TQ/9W;?UW&SP&LZ4*EB+[RA*=SIRQ0Q+8
MT2+3C^+T$:J AL9>+#)EG^1483V'Q(72(J_(N(.<\?)-GZM$M A^=(405(3@
MG!!>(0PJPN"MA+ BA#8S92@V#RNJZ7PJQ8E(@T9KYL,FT[(Q?,:-[ALM<94A
M3\\WI=Y$[,B&[3G;L9AR3>[C6!1<,[XG:Y&QF($B-^018L%CEC%J-4/.@BH6
M$\H3LF)9H2$AFY1*(/>YH2OR;@6:LNP]DI594/6+<?)G*@J%5#5U-49B]N/&
MU:X7Y:Z#*[OV _(@N$X5^< 32%X;<#$%31Z".@^+H-?B!@ZW)(A^(X$7>!T;
M6KZ%/C9T?])!7[V%/K'T<4\T@T;5@;4WN&+O Y4<M5-D#;)2Y-MGQ)!/&G+U
MO<=#V'@(K8?PBH=2^),M*U2='D'B-4%BD>=X,BJ1\9Y1&A4VQ^@=JZ??=^E=
M>HNL-W-7'>=!%(R"T=0]ME7H@DU"?_ :MNJ C8:^-VQ@KV(>-C$/>V/^>BU:
M+>(G C\*=J09F&._DR(G5.%EBFAX!ADS!:9>2J@XF/I1MFXP(5JRV)@M%PO.
M3.'TIVMX$: _'D=GR;H$>6=YZD.\2E'4I"CJ35%]"_QW!R/J4#R,SA5?=L$Z
M#D8'K.=@C)JH1[U1?VF%L[$B?FDIW);UVP/D6Y!]%3ANG(Y[:[P^C3=UBO'>
M9C>)$0#_I'6F)634Z*#%78_/2>-S\J8*Z/?Y$T4GEV?7'X[/]+P$A=[D#+2Z
M! V]T:!;2]][^2-ZO4$N!<?H--MF0/X0&E1/XOS6?];_97+YP8O7X/\7K/+1
M<Y$L?PY9=4!&WKE8;JN3R4'N;4>HB&U&RI]Y,]MTG?>VUSJ;7YANU'9(+V;*
M5O:!RCW#TLQ@AR:]VQ%>@K+L#LN!%@?;+VV%QN[+?J;848,T %S?"3P4U< X
M:'KT^;]02P,$%     @ BD)Q40U7;]<M P  \P@  !D   !X;"]W;W)K<VAE
M971S+W-H965T-3@N>&ULE59;;]HP%/XK1UDUK5)++D" #9"@W;0]5$)%W1ZF
M/;B) 6^.S6P'NG^_8YMF*22H>XEOY_)]Y_CX9+R7ZI?>4&K@J>!"3X*-,=OW
M8:BS#2V([L@M%7BRDJH@!I=J'>JMHB1W2@4/DRA*PX(P$4S';F^AIF-9&LX$
M72C095$0]6=.N=Q/@CAXWKAGZXVQ&^%TO"5KNJ3F8;M0N HK*SDKJ-!,"E!T
M-0EF\?N;D95W E\9W>O:'"R31RE_V<67?!)$%A#E-#/6 L%A1V\HY]80POA]
ML!E4+JUB??YL_9/CCEP>B:8WDG]CN=E,@F$ .5V1DIM[N?],#WSZUEXFN79?
MV!]DHP"R4AM9')010<&$'\G3(0XUA3AM44@."LFQ0J]%H7M0Z#JB'IFC=4L,
MF8Z5W(.RTFC-3EQLG#:R8<)F<6D4GC+4,].ESQ[(%2S96K 5RX@P,,LR60K#
MQ!H6DK.,40W7L% R+S,#WXA2*/4'WMU20QB_Q+.'Y2V\N[B$"V "[ACGF"0]
M#@UBM)["[(!G[O$D+7CB!.ZD,!L-'T5.\Y<&0B17,4R>&<Z3LQ:7=-N!)+V"
M)$JB!D WKU$?6O5X= 9.MPIXU]GKMMB[DSN*56!LF):&B)RH_#2P&']5$@[?
M[R7G@!=VCV(_SKCO5>Y[SGVOQ?V<<"(R^O9-G$8?B($Y73,A,,]^!Z_!@BHF
M\Z;,><M#9]F^#KMIW.U@3';U:#8(]6M"+T#W*]#]LZ Q/#NFVRZ4UQW5/<:=
MP1&L!J%>)VZ&E5:PTK.PJO3A !^?#+4WMC675S#+<V;?+@TK)0N8EQH-:HT"
MOTND9X^:^*4GT*-._XB>ETGK,LW<!A6WP>NXM=/Q%P6^B S;AZ;V,?"SRR86
M@Q,6UVDM 9[&X+4TAA6-X7D:U!CNZDV'&/^?^*"Z11/"X2G".#J!V"25MMVD
M405S]#]5Z4=\ .%L/8Y.2FUT4HZG,B]JUJ,-:_VCH&KMVJH&UP+\0UOM5IU[
MYAK6T?X<.[IOP/_,^-^!.Z+PH=' Z0I-1IT!%J3R+=8OC-RZ+O4H#?8\-]W@
M7PE55@#/5U*:YX5U4/WG3/\"4$L#!!0    ( (I"<5&BXX">[@(  )T'   9
M    >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;+5536_;, S]*X310PNL<>)\
M%TF -.FP FM1-.AV&'90;-K1*DN>)"?ML!\_2DZ\;DVR';:+K0^^QT>*HD8;
MI1_-"M'"4RZD&0<K:XN+,#3Q"G-F&JI 23NITCFS--59: J-+/&@7(11L]D+
M<\9E,!GYM3L]&:G2"B[Q3H,I\YSIYTL4:C,.6L%NX9YG*^L6PLFH8!DNT#X4
M=YIF8<V2\!REX4J"QG0<3%L7LZ&S]P8?.&[,BS&X2)9*/;K)=3(.FDX0"HRM
M8V#T6^,,A7!$)./KEC.H73K@R_&._:V/G6)9,H,S)3[RQ*[&P2" !%-6"GNO
M-N]P&T_7\<5*&/^%367;[P<0E\:J? LF!3F7U9\];?/P M#J'0!$6T#T.Z!S
M -#> MH^T$J9#VO.+)N,M-J =M;$Y@8^-QY-T7#I3G%A->URPMG)/:Y1E@CG
M<,NT9BZG<#I'R[@P9[3ZL)C#Z<D9G "7<,.%H-R;46C)M2,(XZV;R\I-=,!-
M*X(;)>W*P)5,,/F5("3-M?!H)_PR.LJXP*(!4>\-1,VHN4?0["_@[::#MP9'
MY+3K/+8]7_L WYP;EF4:,^:K4Z6PR^RG]V0*UQ9S\_F(HT[MJ.,==0XXNC*6
M4_5B0G?(W5(N,RA0^_LL8P2U%+P2L>^4*NZ!YW87?#WIM;N-WBA<[Y'4K25U
MCTK:1:HQ5IGDWTB;73$+&V:H:F)1THF[\HFI C3=6Q"<+;G@]AG(JM!<:7A&
MI@%ELD]T]Y7H5G?0&.X7W:M%]XZ*GL9QF9?"9W*.*8^YA>\P73S K6JXJNB<
M-X='SJM?^^G_W\(8U(X&?PI(E=*Z>C"6R81I.@;-J-]6_3+Y0MV$^J_==UD&
MK^NBT=F?X&&M9_AO](!E3X!I2HU]G[3A*VGGT2MMX8L.F*/._,-@P"NHFF&]
M6K\]4]]RPY_FU<-UPW3&I0&!*4&;C3Z5GZX>@VIB5>'[Z5)9ZLY^N*+W$[4S
MH/U4*;N;. ?UBSSY 5!+ P04    " "*0G%1W^^1?(P(  !R.   &0   'AL
M+W=O<FMS:&5E=',O<VAE970V,"YX;6RUFV]OFTH6QK\*LJY6]TJ[-O-_Z":1
MFJ:]3>Q(5:/NOECM"VI/'%0,6<#-K70__&),?( Y3#%7O$EL_)P99A[F-W,&
MN'A)LV_YDS&%]\<N3O++V5-1/+]9+/+UD]F%^3Q]-DGYRV.:[<*B_)IM%_ES
M9L)-%;2+%]3WY6(71LGLZJ(Z]BF[NDCW11PEYE/FY?O=+LQ^7)LX?;F<D=GK
M@<_1]JDX'%A<73R'6_-@BB_/G[+RV^)4RB;:F22/TL3+S./E["UYLPJJ@$KQ
MK\B\Y(W/WJ$I7]/TV^'+[>9RYA_.R,1F71R*",M_W\T[$\>'DLKS^%]=Z.Q4
MYR&P^?FU] ]5X\O&? US\RZ-_QUMBJ?+F9YY&_,8[N/B<_KRT=0-$H?RUFF<
M5W^]EZ-6\IFWWN=%NJN#RS/81<GQ?_A'W1&-@+(</(#6 ;0;T%<#JP/8T !>
M!_"A :(.$$,#9!T@AP:H.D -#=!U@!X:$-0!03= ]AGGOSKG#ZV#G,RVW.X-
M>;6;5'XOCA=6=57>A$5X=9&E+UYVT)?E'3Y4EW857UZ,47(8A0]%5OX:E7'%
MU6?SW21[X_W#N][GY6]Y[KT>^O7&%&$4Y[^5/WYYN/%^_>4W[Q<O2KS[*([+
M$91?+(KR# [E+-9U;=?'VFA/;<R[3Y/B*??>)QNS0>+OW/&$.@I8E$T_M9^^
MMO^:.DM\,,]SC\J_>]2G/G)"[]SA=_ND#%>]X3?N\/LP*\-U;_A[=_B-6;^&
MDP )_S"D[?WAOP]I>] ;_G% VYG?&WX[I.W'VC5V)?TUWY=_K>M60\+1DV]=
MQ>PTBEE5'NOKC"@/M]O,;,-J:DL?3X/X/ZM2ZMT69I?_UU$1/U7$JXJX&Q?H
MT#]&BBKR,/E_OR*,JXO%]^9P.HIT0Z0IG0=MU8VM4D+.25OU'BE+^'/15GU
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M[3*#"KS9<++!^>>-K:M%_->C@H*Y)(GXNR?0J HTR@.-^K<,[=(OF%[.S X
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M_>QR3\F&QBF O]^&(3O=I V4_UZ8_ =02P,$%     @ BD)Q48ET45_S @
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M&PEDGT L[UTAR_*!*AH.!=\@8:(UFAG8K=IL38YEYE:F2NA5IO-4.($U9"M
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M+:4=+G43#\($Z/68<W68F+ZR^%L@_ M02P,$%     @ BD)Q4?J8OB^5!0
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M+0Z.%>.BX3Z\BO&CJH1K+<:?U&T/ *FTQNN:(:":H%7DX%A)WE64VT^5DP-
M7A.\GINM%Q/T@I2_ZS165_@:QUMZ<+M?8,X=I4JSG2("]QAAMJUV>*LZM(-
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MX(H*CB0<EMX:WVSQS +<C'\HG%6KC>Q2]D)\LYV[=.D%-B-@D&@;@IC'"3;
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MSR==[)GKT)J+#J+>L]0- =B1*6!' '9D%-AYI L[TR!#@'C$3#Q+;4.L<4<
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MN4[/BA<<+&;P47JFV\-!\8>#Q2!.%#,;;%3I!*4XQH%]L%65'".\ YGV/%!
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MM10+<KN>\VQ;=[1/ T4 &#)$IVG;$!$K CA6W-0W#^44NDBC=7GJ)97N[+Z
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M0PNHW^=,'8WB16]0WJSW_@%02P,$%     @ BD)Q40Q(;30D P  ! D  !D
M  !X;"]W;W)K<VAE971S+W-H965T.#<N>&ULC5;;CMHP$/T5*^K#5NJ2"RQD
M*T "TJHK%6FUJVT?JCZ89 !W'9NU'6C_OF,GI($ Y05\F3-SCF?LR7 GU:M>
M QCR.^="C[RU,9N/OJ_3->14=^0&!.XLI<JIP:E:^7JC@&8.E',_"H*^GU,F
MO/'0K3VJ\5 6AC,!CXKH(L^I^C,%+G<C+_3V"T]LM39VP1\/-W0%SV!>-H\*
M9W[M)6,Y",VD( J6(V\2?DQB:^\,OC'8Z<:86"4+*5_MY"$;>8$E!!Q28SU0
M_-O"##BWCI#&6^73JT-:8'.\]_[9:4<M"ZIA)OEWEIGUR(L]DL&2%MP\R=T7
MJ/3<67^IY-K]DEUE&W@D+;21>05&!CD3Y3_]79U# Q#VSP"B"A = WIG -T*
MT+T6T*L /7<RI11W#@DU=#Q4<D>4M49O=N .TZ%1/A,V[<]&X2Y#G!E_IDR1
M;Y070.9 =:$ <VHTN26-G8G6@&M49.0KHPO&F6&@]X",O&@F5N1%R(4&M:4+
M#N1!; J$W"1@*./Z/3I\>4[(S;OWY!UA@LP9YYAW/?0-JK!<_+1B/"T91V<8
MAQ&92V'6FGP2&62'#GR47Y]!M#^#:731XS-L.B3J?R!1$ 4G",VN@<<6'MZ?
M@"?7P.\=/+Z@IEMGM.O\=?^?T83IE$N;(TU^3!;:*+QF/R_$Z-4Q>BY&[TR,
M*:R8$#;I"\JI2.%4&DL7L7-A7Y_M^+X3#OUM\V3;-H-.?&B3E#9W#9N@MCA@
M?U>SO[O(?H;E@]RQSDF*)<@R4-24SU@J%=84H08?I+>":6;73XDK(]PW2,51
M9W"DKC3JGV1>:FN[:>H_4->OU?4OJG/YW[K\T^P7OB#N0I_2T&\%#SK=(PEM
MF_!89M*_(/- PJ"6,+@HX9'^<:3]29JJ@O*3[ <M9K=AF_\)JZ#3.Q(PN%9
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M'N5'"W %D._WC(F7&S5 ^QFT_@]02P,$%     @ BD)Q4=[H3O ,!0  I!4
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M.V8:P/NU$/IP8SIH#F87_P-02P,$%     @ BD)Q40R,*AIB!   LQ   !D
M  !X;"]W;W)K<VAE971S+W-H965T.3$N>&ULE9AM<^,F$,>_"N-VVKN9<R20
M]>#4\<R=/3?-]-IFSDW[&DO89H+ !SA.^ND+DB(Y!=$T+V(A[ZY^K&#_BQ=G
M(1_4@1 -GFK&U<WDH/7Q.HI4>2 U5E?B2+CY9B=DC;49RGVDCI+@JG&J683B
M.(MJ3/EDN6CNW<GE0IPTHYS<2:!.=8WE\R?"Q/EF B<O-[[2_4';&]%R<<1[
MLB'Z_G@GS2CJHU2T)EQ1P8$DNYO)1WB]0HU#8_$G)6=U<0WL5+9"/-C!;74S
MB2T18:34-@0V'X]D11BSD0S'MR[HI'^F=;R\?HG^N9F\F<P6*[(2["]:Z</-
MI)B BNSPB>FOXOPSZ2:4VGBE8*KY#\Z=;3P!Y4EI47?.AJ"FO/W$3UTB+AS@
M;,0!=0[HK0Y)YY T$VW)FFFML<;+A11G(*VUB68OFMPTWF8VE-O7N-'2?$N-
MGU[>\E+4!/R!GX@"4["A>TYWM,1<@Y6HCX(3KA40NV:$^?./"JS)CDA)*NL$
M/BI%C 'F%?A"\98RJJF)]&Y--*;LO0EYOUF#=]^_7T3:X-J'1F6']JE%0R-H
M&W*\ BC[ %",8H_[ZBWNA76'\]?ND4E2GRG49PHU\9*1>/VTM9DV;J8=B)KT
M49,FZFPDZF]FIYH]*;&F? ^84 J46,IGLT'/6%;*E[8V8MI$M-OT<5E &-N_
M1?1XF2#7,)FEKPU?0<]ZZ%D0>H6/5&/6X!(O8NN?73PYS6,?HFN8S0*$:4^8
MAM,J^+0BU<D4B2TCIEB4\H29%S5U"-!L[D/U&>8!UJQGS?X/JR2*R$=_6C,'
M(4F0C]4U1"C$FO>L>9#U_A=PRS7F^S:MGEW0@N;.\_]-Z%J@-/3FBYZP"!)N
MM"@?IK:R5\"4-B-W"EO!\%$6#@,L,E\Z74,4SP.P\QYV'H2U%;0T-87ZLSAW
M^6+OZ_88SHH 'XP'>8C_:W%^,SO':(+)9_52 B\3"XX,>[/;17Y--?/A^RQ1
M*+_P0MY@D-]3M0$C9G4 ULG5LY<=ND1YXF5W+<>@!Z6!* C]NSX0"30Q^BM-
M;P4JNC.S(+ST5X4NVNN]Y%TG'DN8!Q?*H&,P+&2>1'\ >VD4PHN<N,@%])9=
MCRDL8AB"'G0,AH7L"U'J&CQB=FJ7,F:FK<4FSUYF5ZNF$!:I%]ICF\6A"@P'
M:8-A;?-FFA/M979%"V:)?Q-Z3.$\5)+AH' P>WOOQ(8^,=! P4&28%B3UL0<
M8$K:O,$?OH-9_)/M1G$MI*9_C]9^Z K0-$D2_Q+TV7;E8"PW@U[!L& U)R?;
M89]4IZA>7%>"IC MO+2NZ1CDH%,P+%1KLM6F#*E2G'C7[K=B,-)405>1'$S7
M9!KL3M$@6B@L6F/+;72;(%> ILELGOO2Z[7-\R#Y(%<H+%?V.%"]:;-TX-!I
M\:>FA_$JE<\6I86WDD87)TI[G/\5RSWE5CIWQCF^RDT4V9Z0VX$6Q^:0N17:
M'%F;RP/!%9'6P'R_$T*_#.RYM?^=8OD/4$L#!!0    ( (I"<5$UO#&[BP<
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MWWTSC=OXR!L[V_BP@Y;.L-1:V?=PW8<>Y!DR)#1/\I@9C@;X8@6/^AL@=QL
MBE:_;0 \O -XA@PZLE-\QT219/ZF_#K4'<-JU=W#Y;TN"0 K;!4;+4SA[L]
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M<*5'-KM,]50-P@CH[PGGZK Q!NHY??$;4$L#!!0    ( (I"<5$<+=07@PH
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M$R(2XZ=,-I0)<J#)'DS ]C(F.8@B<-:X]7ZYH1\ZP^!*K=6JV[E2:[$*G.'
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M965T.3@N>&ULK5=;;^(X%/XK5K;:;:4AB4.XS0(2E)G=?>BH*M/.PVH?##F
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M#]((X/>5$/IM8PB*?PK&_P-02P,$%     @ BD)Q46HC.CU= P  40T  !D
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M#P'*.N#Y6DISW-@ S3\G^0=02P,$%     @ BD)Q4<X@*$+. P  -PT  !H
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M0!JN)-%0S*.;_O7MS*WW"[YS.)BC-G%.-DH]N<[7[3Q*7$(@(+<N L/7,RQ
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MH.L6H#NFMTU9%5%]%V7/R6Y&@V$03/Q= ]EU27;=23:/(IFGN$7/$ '?L96
M)NX"9%#A[H\';=S]DKO?R?V0[B U4AV:&/LUQG'0RC@H&0>=C$\*,L9C A]H
M2!J*PI184@J/B5*HAC!7L4V*!C5%P];E'Y:"AE\(0FM4YG!!,L%2<^$$P7O.
M,S0MTZ1B6%-Q';2I&)4J1E]LA&'IAN/>=Z0_JA&'H["->5PRCSN9?[FU;R<=
MUZM@U,9)@Y-=!9VL+]*@F12L)#XY3J.7!/6\:7LETHIGTDZ_J/CA38=KT)/_
MT/#_CG+&#FWG^ A1S8:&O=9D3I9%NST+N54.IX/5R-VKE^ZXM7;IR<%HMX4M
M8 UX=F.\W]%/\N:\ZP9&!^V;>'(PVFUA126)RM7V53GU:RX^'(YK0OS*96P?
M-GAG;7BJB8 UQ@570P10Q5NAZ!B9N?MY)0W>]JZYQ?<5*#L!Q]=2FL^.O?++
M%]OL+U!+ P04    " "*0G%1.N>]Q6H"  !H!0  &@   'AL+W=O<FMS:&5E
M=',O<VAE970Q,#8N>&ULC5113]LP$/XK5K0'D("D:2D,M9%H.S2DH554; _3
M'MSDTE@XOLQV*=NOW]E.0X8HVDOB.]_W^;NS[R8[U(^F K#LN9;*3*/*VN8J
MCDU>0<W-&3:@:*=$77-+IM[$IM' "P^J99PFR3BNN5!1-O&^I<XFN+52*%AJ
M9K9US?7O&4C<3:-!M'?<BTUEG2/.)@W?P KL0[/49,4=2R%J4$:@8AK*:70]
MN)J/7+P/^"9@9WIKYC)9(SXZX[:81HD3!!)RZQ@X_9Y@#E(Z(I+QJ^6,NB,=
ML+_>L]_XW"F7-3<P1_E=%+::1I<1*Z#D6VGO<?<9VGS.'5^.TO@OV[6Q2<3R
MK;%8MV!24 L5_ORYK4,/,!@? *0M('T-&!T #%O T"<:E/FT%MSR;*)QQ[2+
M)C:W\+7Q:,I&*'>+*ZMI5Q#.9@MA&C3"E_24K>B1%%L)#$O6W[D'R2T4[%;E
M6 -;6;+H*BTYPD-R04<+L%Q(<TQ$#ZL%._IP/(DM:70GQ7FK9Q;TI ?T#%)V
MA\I6AGU2!13_$L247)=ANL]PEK[+N(+FC*7C$Y8F:?*&H/G_P"\=?/#Q'3G#
MKN!#SS<\P/=5;[@2?WS)3M@<E4$IBE!!K@JVU&"HLL%!UW C%%>YX/*EZH;]
MN%X;JZD%?KZC:-0I&GE%HP.*OJ QK-18,YH-VA]LWKJXP'+N6=QP>,I.1^/S
MA&KZU"_G&V$7EX.T%Q=4QKU'6X/>^%XV+,>MLN%V.V\W+JY]E[SRSVB,A*Y_
MH0DSZ([KC5"&22B),CF[(%4Z]'4P+#:^-=9HJ='\LJ)1"-H%T'Z):/>&.Z ;
MKME?4$L#!!0    ( (I"<5'0Y.?<=@,  $,-   :    >&PO=V]R:W-H965T
M<R]S:&5E=#$P-RYX;6RU5]MNVS@0_15"Z$,7V$8WZ^+ -A#'N=AUBR!&VX?%
M/M#2V!8JD5J2BEN@'U^2DE4GH65UL>L'BZ3..3,<#JGA:$_95[X#$.A;D1,^
MMG9"E)>VS9,=%)A?T!*(?+.AK,!"=MG6YB4#G&I2D=N>XX1V@3-B349Z[(%-
M1K02>4;@@2%>%05FWZ>0T_W8<JW#P&.VW0DU8$]&)=[""L2G\H')GMVJI%D!
MA&>4( :;L77E7BYCA=> SQGL^5$;J9FL*?VJ.O-T;#G*(<@A$4H!R\<37$.>
M*R'IQC^-IM6:5,3C]D']5L]=SF6-.5S3_$N6BMW8BBV4P@97N7BD^WMHYA,H
MO83F7/^C?8V-AA9**BYHT9"E!T5&ZB?^UL3AB."Y)PA>0_#Z$OR&X/<E#!K"
MH"\A: A!7T+8$,*^A*@A1'T)<4.(^Q*&#6'XDA"?6CCGL').7QMNN]B]5]L]
M++>KU]NN$TMGY0P+/!DQND=,X:6>:NC4UGR9C!E1FW EF'R;29Z83"LN1SA'
M*]C*O24XPB1%=T"W#)>[+$%S4N]TM67>H:LTS503Y\]>O)V!P%G^Q\@6TB>E
M;">-_6EMWSMAWT<?*!$[CFY("JF!O^CFNUZ'@"V#T4;$.T1DZG4JKJ"\0%[X
M)_(<S_FTFJ&W;TSSNNY6651$JD3G5&;=*A\PDRKQ.96;;I49) <5=WA:Y;9/
M7,ZJW/6)R_"<RGV/N/C..95YG[C4OL2G51:_GR_-9C*(O?]/@KSLH](UL6<[
MPV_/"E_+^B=E]:S0(Y24B8QLT2SC24YYQ0#]M91H-!=0\+\[; U:6P-M:W#"
MUL>J6 -#="._],H:7N> ^.&,^H%.1WA1"X=:6-4@3Y-@9#\9? E:7X).7Q[A
M"4@%W'2ZU<S@R)CK#R)'_UJK]8'Q&AI[WM" G+U&1D'H&I W!LW "0S(6P,R
M#&(#\LZDZ0T,R'L#THU-R+D!Z3N1 ;EXC?2C*#2)OC= _3#R#="E >JYT8O@
M/TN.L$V.L#,YYD0 XZ9L?"87M7+1_[['XM96_&_S>A&_"MC+Z)]%++L0M</V
M4>%2 -OJ<IRCA%9$U.=2.]I6_%>Z\'DQ/G4OYZYA?"%O"'5!_TN^OE[(3\@V
M(QSEL)&FG(M(^LGJDKWN"%KJLFE-A2S#=',G;SG %$"^WU J#AUEH+TW37X"
M4$L#!!0    ( (I"<5%GF8CUJP<  &$J   :    >&PO=V]R:W-H965T<R]S
M:&5E=#$P."YX;6R]6MMNVS@0_17!V(<6V-KB1;<@"= DS<5VL$6SW7TH]D&Q
M&5NH+'DE.FGWZY>ZQ)3$(<V@3?/0VO(Y0XV&/&<HZ?@I+[Z6:\:X\VV39N7)
M:,WY]F@R*1=KMHG+<;YEF?CE(2\V,1=?B]6DW!8L7M:D33K!KNM/-G&2C4Z/
MZV,?B]/C?,?3)&,?"Z?<;39Q\?V,I?G3R0B-G@]\2E9K7AV8G!YOXQ6[8_SS
M]F,AODWV49;)AF5EDF=.P1Y.1N_1T9P&%:%&_)6PI[+SV:E2N<_SK]67F^7)
MR*W.B*5LP:L0L?COD9VS-*TBB?/XMPTZVH]9$;N?GZ-?ULF+9.[CDIWGZ=_)
MDJ]/1N'(6;*'>)?R3_G3-6L3\JIXBSPMZW^=IQ;KCIS%KN3YIB6+,]@D6?-_
M_*V]$!V"B ,3<$O 0P+5$$A+(+8$VA*H+<%K"9XMP6\)OBTA: F!+2%L":$M
M(6H)T9#@ZPKG/E?.M1T#[8NM5%M+>2XWJNL]:296/2LO8AZ?'A?YDU-4>!&O
M^E!/[9HO)F.25:OPCA?BUT3P^.G9KA1'RM*Y8RNQN'CIQ-G2N6+YJHBWZV3A
MW&3-4J^6S+MG5._HFPO&XR1]*W[^?'?AO/GMK?.;DV3.;9*FXO?R>,+%B5;#
M31;M29TU)X4U)T6<VSSCZ]+YD"W9$N!/S7R$#0$FX@KM+Q-^ODQGV!CQCFW'
M#O9_=["+7>"$SLWTZ2X3]$!+OS#3;^-"T$,M_8.9?L$6SW04 ?1+F]SU]"N;
MW",M_=HB=^)JZ3<VN3>CA]!,^K&ZSW[LTLUMZ.#)]V8QV2]V4L<CVGC-ZOW$
MMGG!DVS56\=?Y@+NW'"V*?\Q#$;W@]%Z,*H9[,^<QZDPZD>6[1BD 0W=J^E5
ML_!XB@@-CB>/W775@,(.*,1X'/51%RHJ\/PQZJ,^ +$\=^SU49< RO?&81]U
M!<7"8]I'70,H% Y1-P"*N./!E9BJ*!($_C#8#( 1/QB3/FP.P# *.A>V5W-O
M7W//6/,_MJR(ZXF59(M\ Y5]VD3PNV5'[J (LP84=4#O$";#*LP!&";:+/Q]
M%KXQBPLF&MI%TJR*R@[C3;5<_JL/0"GY2DHD\ <9^<JI4I\,I^@<0(5NIWB]
M?()]/H$QG_-XFU1KD7T3O?LRX;N"0:8\#93!D:=., #E1DHB$,H;^W BX3Z1
MT)C(S5*H5_*0Q/<I<^*R9!QL+D)E[ !%RA*^5&$^I7B8R=0NVLPNVAR(AL5B
MU\S8:']A(G.%\T(H>LR90;>1*UM"]_5M G4Z4/13IF<;IGOM%$68 :!@**5S
M$*199 C+//#/F)UME.[@F'C>T-,N 1SRA/<-I')J&6]F&6\.X:@7=&9R__K(
MY@,1LZPF\2K+2YXL2M.\D?T%HK]@FDIK0V9O.]3/3)'J1ABYB@3, !S"0AR5
M0@ X1(..(/<SD?:&S/YFX])(=:((1\.5- -@"+ U"$:[&?<SD<:&S,[V8J=&
MJB]5#0,9I@7 J#_VAVD!,$^O)-+FD-GGK!51=1/12ZE%4F%>-,;#9 !45SK[
MN4AG0F9KLE7%"%@\/AIV'Y<0#@=*:::6\6:6\>80KO)WC7%C:;;8-5Z?LX+%
M)7>N69SRM>E.A?13C%Y?%[&T/6RVO8.ZB %#01Y2# K"$425B0KAL-A684TI
MI$%ALT'9Z&(;HC=XA)4V!("1*%)V81J89M%A:8W8O/=^L2ZV\?H;#S4K%45\
M95,&H$2;H<M)^B\V^Z^M*&+ AI6=^0Q B2FDU = T4["_52D 6.S 5MJ(@9<
M$[NNTBE".(2#86&FEO%FEO'F "X*L*X_P=+5L=G5;]DR68A*OV<E7[,#_2*6
MKHK#7Z"+TOBPV?@.ZZ)J*;ZGM"( BB!/\2<(1B)=TTZD/1&S/=EH8ANB=QNF
MMV%H,H%@08@4?8=P(:4Z!2'2&(EYH_EB523J/I&J::F@2/09;N=OV X#%.2&
MVF))*R9F*[:52 (XJ**0+:A[5VNXCP;B1+KE3SHWJ<TV;*F.;93N^;D#822
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MM6C>9VR^\'Q;OU-VGW.>;^J/:Q8O65$!Q.\/><Z?OU0#[-\J/?T?4$L#!!0
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MOP<?&7QHR29H[ F,7M"FI][SI,H _5P=F$*RO5U_?B@$W4C(Q5]+P+ )&)J
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M\10MJ!RQY4]<"3()3A@5YALLJUC/ 9.%D"RKP"J#C.3E+_JL"F$!8'  X%<
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M@7HB<33^&/D!?-R CP?![W@F"G#(PC6))H?/%:E@*Y^DA1#B..J#[4;&23C
M&C>L\2#K0PG25)AO$ /SH2/6ZN)1MI,2N.[MSK@#A*.XC[P;> (Y:9"30>1C
MJU&N08+2?71)EPZ'?71]@<E 72<-Y&2XKO;%]Y%-NJ\\K)KN,UI/)$[3 ;:T
M84L'V9Z%)JR/+>U\$?%XDO2Q=2/'47#9Q^:WMEU[Y/TF<D.Y,NVV-MK@8F),
M9'6,5!,M2K<3KX0V^[H;;LW)"](&F/6U$/HXL9M[<Y;/_P-02P,$%     @
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M@IM-U3=WW3&R<I??6AJ\2EUSAU\[H*P!CF^D- \=>Y^VWT^+?U!+ P04
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M4>.2X+I\:<J.586_K"?*TM7OFW-ZG%&[ )J?*F4W'7?_U\]]_P]02P,$%
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M<,H&IA-9"D,4-= 6XFYXT!L'']H"T0T+>V$K+/X?[&+XH</I8>/TL)/GZK'
MZH72*C"E$@2?48':$ZHU&-VF0C=?T O:57@?+'XS[)D*HT:%42?/#4;<UH5$
MYMB+M,LN3+8$FY!N385NNI,BO \6OQE6B> ?E=0<U,ZU)DU<DE>%IEEMNM_<
M%?T7ZPOLBE43^T=3M=1KJG8,'R*'+5(&O<\8+U6UJ6IB9.$*]T8:; -NF&%G
M!V4/X/Y62G.8V N:_PJSOU!+ P04    " "*0G%10KZ-9%D"   R!@  &@
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M0H0GB'[/V:Z 0*M'T*F#XV&HQ[,NTO/<"$#>=)&N&;- :8-.63P/DE<7A^T
M:M82L%@E<Z+.85/GL+?.,_JD$7W1C&]RIK9EP<WX5/#("=^53!=Q#I5R"> \
M/^Y)*&H2BGH3^EMH,^5(^DQY#@V0JZA;<]<+;2#(ZZC3[\AQ8DA#7:.A'T#S
MQ$T7&?FV#R!O >^!#Q7S#D#Z#B2X>P")(P@Y!Y!F/H/$WLW(#<, U#L =8/V
M)%D)!( Z..Q32-PH).Z?3Z71-]I)8=8+2"!QQW/L8JCNUUVD%X!=GW61;@SV
M\@:PZ8*ST6T7Z7@QI*0[P*;G03;O 20HI#D4)K@P+H P'2>$XOS4A6(<VM"
M6P+0(&Y/G6_D@>W7+QN[5R!_4'W80YP5<R'\=6)WEXVZ^FV9 %#LMJ5<Z02
MQ@$T/FX I!N!XKL%H.?8<4&I0 &X4*CWD%4G=* E=@Y9!3=<"ZA6&/O0*OL)
MC,!V(;M+L 88]^W/\-&G,.Y?1%F:FT];Q%^%8SZ#D;G(S)97F;V:41+C*!%I
M2J0J7Y9/8655SL+C$HRCJ"VJ+LH>^VY;3Q#*#=I:@CQZ;EM&7=2Y/?:"MH)
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M'@WR7-<; CD%D-,1(1<Q@9P!R-D+0IZ)2C2E#(9F8PE@ @"3T0"#H[D@D"F
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MRK8'N.T5;@^0VRO='F"W5[P]0.^@>@> WD'U#@"]@_FR#= [J-X!H'=0O0-
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MYF9!@-Y5]:X O:OJ70%Z-]6[ ?1NJG<#Z-U4[P;0NZG>#:!W4[T;0.^F>C>
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M+GAM;%!+ 0(4 Q0    ( (I"<5%,Q5^.[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( (I"<5&97)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ BD)Q48FOIZE^!@  W1D  !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( (I"<5$8<&O4-@<
M %@B   8              " @<(.  !X;"]W;W)K<VAE971S+W-H965T,BYX
M;6Q02P$"% ,4    " "*0G%1\O2(Q]8$  "+$@  &               @($N
M%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ BD)Q4>]O
MO^@$ P  * @  !@              ("!.AL  'AL+W=O<FMS:&5E=',O<VAE
M970T+GAM;%!+ 0(4 Q0    ( (I"<5&G8RAYY@8  /P;   8
M  " @70>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "*
M0G%19[:Q^P@#  "F"0  &               @(&0)0  >&PO=V]R:W-H965T
M<R]S:&5E=#8N>&UL4$L! A0#%     @ BD)Q467OX!Y."@  0#P  !@
M         ("!SB@  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0
M   ( (I"<5%F47%8L@H  %PT   8              " @5(S  !X;"]W;W)K
M<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "*0G%16\'@.+(+   7'P
M&               @($Z/@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!
M A0#%     @ BD)Q49CO &PV*   O84  !D              ("!(DH  'AL
M+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " "*0G%1]E='#3H:
M  #D3@  &0              @(&/<@  >&PO=V]R:W-H965T<R]S:&5E=#$Q
M+GAM;%!+ 0(4 Q0    ( (I"<5'0.Y&&0A   &BB   9              "
M@0"-  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ BD)Q
M4>L8CNLR$0  ]4,  !D              ("!>9T  'AL+W=O<FMS:&5E=',O
M<VAE970Q,RYX;6Q02P$"% ,4    " "*0G%1;DB+K6H<   9<P  &0
M        @('BK@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0
M   ( (I"<5$WMD ;XQ   $DU   9              " @8/+  !X;"]W;W)K
M<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ BD)Q4:KB+P!@ @  +@4
M !D              ("!G=P  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q0
M2P$"% ,4    " "*0G%1AM&I#%<#  !I!P  &0              @($TWP
M>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( (I"<5$<;2JJ
M70T  -(E   9              " @<+B  !X;"]W;W)K<VAE971S+W-H965T
M,3@N>&UL4$L! A0#%     @ BD)Q4;9ZMW$Z!P  X1$  !D
M ("!5O   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "*
M0G%1E"\:<08)  #!%0  &0              @('']P  >&PO=V]R:W-H965T
M<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( (I"<5'L= TM(@,  $L'   9
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M970R-2YX;6Q02P$"% ,4    " "*0G%1V_'A230%  !)"P  &0
M    @(%G/ $ >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (
M (I"<5%)APRFXP4  *<3   9              " @=)! 0!X;"]W;W)K<VAE
M971S+W-H965T,C<N>&UL4$L! A0#%     @ BD)Q4:T<< ;P!   ;1$  !D
M             ("![$<! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"
M% ,4    " "*0G%1DO*'@4\$  #!#0  &0              @($330$ >&PO
M=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( (I"<5%!02R8B04
M *T0   9              " @9E1 0!X;"]W;W)K<VAE971S+W-H965T,S N
M>&UL4$L! A0#%     @ BD)Q4;T57T0D!   "PL  !D              ("!
M65<! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " "*0G%1
M%>V_=%@'  "G$@  &0              @(&T6P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;%!+ 0(4 Q0    ( (I"<5% 0>)V608   (1   9
M      " @4-C 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%
M  @ BD)Q48#EIEYX @  8P4  !D              ("!TVD! 'AL+W=O<FMS
M:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "*0G%1+JC(A7P#  #U!P
M&0              @(&"; $ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+
M 0(4 Q0    ( (I"<5$]H:,KG04  "@-   9              " @35P 0!X
M;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ BD)Q4?Z%W Q'
M P  P <  !D              ("!"78! 'AL+W=O<FMS:&5E=',O<VAE970S
M-RYX;6Q02P$"% ,4    " "*0G%1OG./@Y\$  "8#0  &0
M@(&'>0$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( (I"
M<5'R!S?)%0,  !X)   9              " @5U^ 0!X;"]W;W)K<VAE971S
M+W-H965T,SDN>&UL4$L! A0#%     @ BD)Q43U$+F&N#   6TP  !D
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M=#0T+GAM;%!+ 0(4 Q0    ( (I"<5&Y_V51-P4  /89   9
M  " @="@ 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @
MBD)Q40>O<"A3 @  U04  !D              ("!/J8! 'AL+W=O<FMS:&5E
M=',O<VAE970T-BYX;6Q02P$"% ,4    " "*0G%1,F8MCY8%  #%(@  &0
M            @('(J $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4
M Q0    ( (I"<5$")*AT$@,  )0)   9              " @96N 0!X;"]W
M;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ BD)Q4;%OKFLN P
MYPD  !D              ("!WK$! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX
M;6Q02P$"% ,4    " "*0G%1E_/DLE(%  "Q&   &0              @(%#
MM0$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( (I"<5&[
MI%,2;@,  .0+   9              " @<RZ 0!X;"]W;W)K<VAE971S+W-H
M965T-3$N>&UL4$L! A0#%     @ BD)Q41X";*)'!   NA0  !D
M     ("!<;X! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (I"<5%H.UWHFP,  *\+   9              "
M@0+1 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ BD)Q
M40U7;]<M P  \P@  !D              ("!U-0! 'AL+W=O<FMS:&5E=',O
M<VAE970U."YX;6Q02P$"% ,4    " "*0G%1HN. GNX"  "=!P  &0
M        @($XV $ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0
M   ( (I"<5'?[Y%\C @  '(X   9              " @5W; 0!X;"]W;W)K
M<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ BD)Q4?)6$:GN P  G1
M !D              ("!(.0! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q0
M2P$"% ,4    " "*0G%1E:"$7P8%  !J&   &0              @(%%Z $
M>&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( (I"<5&)=%%?
M\P(  "(0   9              " @8+M 0!X;"]W;W)K<VAE971S+W-H965T
M-C,N>&UL4$L! A0#%     @ BD)Q4?J8OB^5!0  .A@  !D
M ("!K/ ! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " "*
M0G%1NV"X+8@$  #L%   &0              @(%X]@$ >&PO=V]R:W-H965T
M<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( (I"<5&!B.CX 0,  )<(   9
M          " @3?[ 0!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#
M%     @ BD)Q4?8F_[%* P  V P  !D              ("!;_X! 'AL+W=O
M<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " "*0G%1;-[TT-4"  #Q
M"0  &0              @('P 0( >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM
M;%!+ 0(4 Q0    ( (I"<5%^"%1Z5@(  '<&   9              " @?P$
M @!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ BD)Q44FX
M(UH##   ?$P  !D              ("!B0<" 'AL+W=O<FMS:&5E=',O<VAE
M970W,"YX;6Q02P$"% ,4    " "*0G%1-FXGM& #  "!"P  &0
M    @('#$P( >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    (
M (I"<5%7RA=+U ,   (-   9              " @5H7 @!X;"]W;W)K<VAE
M971S+W-H965T-S(N>&UL4$L! A0#%     @ BD)Q43E8J,#: P  * X  !D
M             ("!91L" 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"
M% ,4    " "*0G%1@6[_'!<$  #%#P  &0              @(%V'P( >&PO
M=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( (I"<5$]YNUW6 (
M ,$%   9              " @<0C @!X;"]W;W)K<VAE971S+W-H965T-S4N
M>&UL4$L! A0#%     @ BD)Q48"D: &.!@  (C$  !D              ("!
M4R8" 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " "*0G%1
MU(IG/[@)  ":20  &0              @($8+0( >&PO=V]R:W-H965T<R]S
M:&5E=#<W+GAM;%!+ 0(4 Q0    ( (I"<5%7T6^2;P0  !H4   9
M      " @0<W @!X;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%
M  @ BD)Q409H1;UX P  T@T  !D              ("!K3L" 'AL+W=O<FMS
M:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    " "*0G%1(4,^#-\#  #@$0
M&0              @(%</P( >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+
M 0(4 Q0    ( (I"<5%TZ(RU?0,  .T-   9              " @7)# @!X
M;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ BD)Q49&5$/:9
M$   Z&X  !D              ("!)D<" 'AL+W=O<FMS:&5E=',O<VAE970X
M,BYX;6Q02P$"% ,4    " "*0G%1D\6@-ZH#   F#P  &0
M@('V5P( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    ( (I"
M<5'M) =\U (  #8'   9              " @==; @!X;"]W;W)K<VAE971S
M+W-H965T.#0N>&UL4$L! A0#%     @ BD)Q47WW+,D0!P  +C4  !D
M         ("!XEX" 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q02P$"% ,4
M    " "*0G%1_XVU5?@$  !E%P  &0              @($I9@( >&PO=V]R
M:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( (I"<5$,2&TT) ,   0)
M   9              " @5AK @!X;"]W;W)K<VAE971S+W-H965T.#<N>&UL
M4$L! A0#%     @ BD)Q42QZ!UBX @  5@<  !D              ("!LVX"
M 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4    " "*0G%1(;$P
MJH<#   2#0  &0              @(&B<0( >&PO=V]R:W-H965T<R]S:&5E
M=#@Y+GAM;%!+ 0(4 Q0    ( (I"<5'>Z$[P# 4  *05   9
M  " @6!U @!X;"]W;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#%     @
MBD)Q40R,*AIB!   LQ   !D              ("!HWH" 'AL+W=O<FMS:&5E
M=',O<VAE970Y,2YX;6Q02P$"% ,4    " "*0G%1-;PQNXL'  "0)   &0
M            @($\?P( >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+ 0(4
M Q0    ( (I"<5%9(AU[H0,  +,+   9              " @?Z& @!X;"]W
M;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%     @ BD)Q41PMU!>#"@
M]3X  !D              ("!UHH" 'AL+W=O<FMS:&5E=',O<VAE970Y-"YX
M;6Q02P$"% ,4    " "*0G%1 ]"11< #   @#P  &0              @(&0
ME0( >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4 Q0    ( (I"<5$>
M#;50SP,  $0,   9              " @8>9 @!X;"]W;W)K<VAE971S+W-H
M965T.38N>&UL4$L! A0#%     @ BD)Q40?ZM/.5!0  ]QD  !D
M     ("!C9T" 'AL+W=O<FMS:&5E=',O<VAE970Y-RYX;6Q02P$"% ,4
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M,#$N>&UL4$L! A0#%     @ BD)Q4?25#!5A @  K08  !H
M ("!H[$" 'AL+W=O<FMS:&5E=',O<VAE970Q,#(N>&UL4$L! A0#%     @
MBD)Q4:@C=A1U @    8  !H              ("!/+0" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#,N>&UL4$L! A0#%     @ BD)Q44HLD3]#!   $!0  !H
M             ("!Z;8" 'AL+W=O<FMS:&5E=',O<VAE970Q,#0N>&UL4$L!
M A0#%     @ BD)Q4>;'Q20N P  O0D  !H              ("!9+L" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L! A0#%     @ BD)Q43KGO<5J
M @  : 4  !H              ("!RKX" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#8N>&UL4$L! A0#%     @ BD)Q4=#DY]QV P  0PT  !H
M ("!;,$" 'AL+W=O<FMS:&5E=',O<VAE970Q,#<N>&UL4$L! A0#%     @
MBD)Q46>9B/6K!P  82H  !H              ("!&L4" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#@N>&UL4$L! A0#%     @ BD)Q41/PT24* P  T P  !H
M             ("!_<P" 'AL+W=O<FMS:&5E=',O<VAE970Q,#DN>&UL4$L!
M A0#%     @ BD)Q48@<:M%  P  1PP  !H              ("!/] " 'AL
M+W=O<FMS:&5E=',O<VAE970Q,3 N>&UL4$L! A0#%     @ BD)Q4?:,C-BU
M @  UP<  !H              ("!M]," 'AL+W=O<FMS:&5E=',O<VAE970Q
M,3$N>&UL4$L! A0#%     @ BD)Q4:]9T',A P  2PD  !H
M ("!I-8" 'AL+W=O<FMS:&5E=',O<VAE970Q,3(N>&UL4$L! A0#%     @
MBD)Q45LH:Z+& @  ^@<  !H              ("!_=D" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,3,N>&UL4$L! A0#%     @ BD)Q42/3S\'/ P  .0T  !H
M             ("!^]P" 'AL+W=O<FMS:&5E=',O<VAE970Q,30N>&UL4$L!
M A0#%     @ BD)Q44+8_;0V P  TPD  !H              ("! N$" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,34N>&UL4$L! A0#%     @ BD)Q438:^3;)
M @  -P@  !H              ("!<.0" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,38N>&UL4$L! A0#%     @ BD)Q44*^C619 @  ,@8  !H
M ("!<><" 'AL+W=O<FMS:&5E=',O<VAE970Q,3<N>&UL4$L! A0#%     @
MBD)Q4<<*T0(T!0  ^!4  !H              ("! NH" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,3@N>&UL4$L! A0#%     @ BD)Q42=1 DTM P  8 D  !H
M             ("!;N\" 'AL+W=O<FMS:&5E=',O<VAE970Q,3DN>&UL4$L!
M A0#%     @ BD)Q463;F3YP @  (@X   T              ( !T_(" 'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " "*0G%1EXJ[',     3 @  "P
M        @ %N]0( 7W)E;',O+G)E;'-02P$"% ,4    " "*0G%1=JFI<N<'
M  !\3@  #P              @ %7]@( >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ BD)Q44GM%/9& P  UD4  !H              ( !:_X" 'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ BD)Q4=&1[QJ5 @
M 4,  !,              ( !Z0$# %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     '\ ?P $(P  KP0#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>682</ContextCount>
  <ElementCount>808</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>192</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Operations</Role>
      <ShortName>Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210031002 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210251003 - Disclosure - Revenue (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/RevenueNotes</Role>
      <ShortName>Revenue (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210321004 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210401005 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210521006 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210711007 - Disclosure - Stockholders' Equity and Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210791008 - Disclosure - 401(k) Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/A401kPlan</Role>
      <ShortName>401(k) Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210821009 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210851010 - Disclosure - Litigation and Related Matters</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LitigationandRelatedMatters</Role>
      <ShortName>Litigation and Related Matters</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210871011 - Disclosure - Disposition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Disposition</Role>
      <ShortName>Disposition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210921012 - Disclosure - Business Segments and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</Role>
      <ShortName>Business Segments and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210981013 - Disclosure - Accrued Expenses and Other Long-Term Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities</Role>
      <ShortName>Accrued Expenses and Other Long-Term Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>211021014 - Disclosure - Pension and Other Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefits</Role>
      <ShortName>Pension and Other Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>211091015 - Disclosure - Quarterly Statement of Operations Information (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited</Role>
      <ShortName>Quarterly Statement of Operations Information (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.hologic.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>230263002 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/RevenueNotes</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>230333003 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>230413004 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessCombinations</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>230483005 - Disclosure - Restructuring Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesTables</Role>
      <ShortName>Restructuring Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230533006 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BorrowingsandCreditArrangements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230603007 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230643008 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230723009 - Disclosure - Stockholders' Equity and Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230833010 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/CommitmentsandContingencies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230883011 - Disclosure - Disposition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionTables</Role>
      <ShortName>Disposition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Disposition</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230933012 - Disclosure - Business Segments and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables</Role>
      <ShortName>Business Segments and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230993013 - Disclosure - Accrued Expenses and Other Long-Term Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Long-Term Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>231033014 - Disclosure - Pension and Other Employee Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables</Role>
      <ShortName>Pension and Other Employee Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/PensionandOtherEmployeeBenefits</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>240024001 - Disclosure - Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OperationsDetails</Role>
      <ShortName>Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Operations</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>240064002 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>240074003 - Disclosure - Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>240084004 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>240094005 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>240104006 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>240114007 - Disclosure - Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>240124008 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>240134009 - Disclosure - Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240144010 - Disclosure - Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240154011 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240164012 - Disclosure - Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240174013 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240184014 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240194015 - Disclosure - Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240204016 - Disclosure - Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240214017 - Disclosure - Summary of Significant Accounting Policies - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240224018 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240234019 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240244020 - Disclosure - Summary of Significant Accounting Policies - Product Warranty (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Product Warranty (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240274021 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240284022 - Disclosure - Revenue - Business Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueBusinessRevenueDetails</Role>
      <ShortName>Revenue - Business Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240294023 - Disclosure - Revenue - Geographical Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueGeographicalRevenueDetails</Role>
      <ShortName>Revenue - Geographical Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240304024 - Disclosure - Revenue - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRevenuebyTypeDetails</Role>
      <ShortName>Revenue - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240314025 - Disclosure - Revenue - Remaining Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails</Role>
      <ShortName>Revenue - Remaining Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240344026 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240354027 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240364028 - Disclosure - Leases - Additional Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails</Role>
      <ShortName>Leases - Additional Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240374029 - Disclosure - Leases - Lease Liability Maturity Schedule 2020 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details</Role>
      <ShortName>Leases - Lease Liability Maturity Schedule 2020 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240384030 - Disclosure - Leases - Lease Liability Maturity Schedule 2019 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details</Role>
      <ShortName>Leases - Lease Liability Maturity Schedule 2019 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240394031 - Disclosure - Leases - Future Minimum Annual Rental Income Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails</Role>
      <ShortName>Leases - Future Minimum Annual Rental Income Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240424032 - Disclosure - Business Combinations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsNarrativeDetails</Role>
      <ShortName>Business Combinations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240434033 - Disclosure - Business Combinations - Purchase Price Allocation Acessa (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails</Role>
      <ShortName>Business Combinations - Purchase Price Allocation Acessa (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240444034 - Disclosure - Business Combinations - Purchase Price Allocation SuperSonic Imagine (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails</Role>
      <ShortName>Business Combinations - Purchase Price Allocation SuperSonic Imagine (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240454035 - Disclosure - Business Combinations - Purchase Price Allocation Focal Therapeutics (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails</Role>
      <ShortName>Business Combinations - Purchase Price Allocation Focal Therapeutics (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240464036 - Disclosure - Business Combinations - Purchase Price Allocation Faxitron (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails</Role>
      <ShortName>Business Combinations - Purchase Price Allocation Faxitron (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240474037 - Disclosure - Equity Method Investment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/EquityMethodInvestmentDetails</Role>
      <ShortName>Equity Method Investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240494038 - Disclosure - Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail</Role>
      <ShortName>Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240504039 - Disclosure - Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail</Role>
      <ShortName>Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240514040 - Disclosure - Restructuring Charges - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail</Role>
      <ShortName>Restructuring Charges - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240544041 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Company's Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240554042 - Disclosure - Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240564043 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240574044 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240584045 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240594046 - Disclosure - Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240614047 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240624048 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240634049 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240654050 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Income (Loss) Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240664051 - Disclosure - Income Taxes - Provision for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Provision for Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240674052 - Disclosure - Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240684053 - Disclosure - Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240694054 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240704055 - Disclosure - Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240734056 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240744057 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240754058 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240764059 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240774060 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240784061 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240804062 - Disclosure - 401(k) Plan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/A401kPlanAdditionalInformationDetail</Role>
      <ShortName>401(k) Plan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240814063 - Disclosure - Deferred Compensation Plan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail</Role>
      <ShortName>Deferred Compensation Plan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240844064 - Disclosure - Commitments and Contingencies - Summary of Purchase Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails</Role>
      <ShortName>Commitments and Contingencies - Summary of Purchase Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240864065 - Disclosure - Litigation and Other Matters - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail</Role>
      <ShortName>Litigation and Other Matters - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240894066 - Disclosure - Disposition - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionAdditionalInformationDetails</Role>
      <ShortName>Disposition - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240904067 - Disclosure - Disposition - Schedule of Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Disposition - Schedule of Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240914068 - Disclosure - Disposition - Schedule of Disposition Related Income Statement Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails</Role>
      <ShortName>Disposition - Schedule of Disposition Related Income Statement Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240944069 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240954070 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Segment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240964071 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail</Role>
      <ShortName>Business Segments and Geographic Information - Revenues by Geography (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240974072 - Disclosure - Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails</Role>
      <ShortName>Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>241004073 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail</Role>
      <ShortName>Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>241014074 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail</Role>
      <ShortName>Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>241044075 - Disclosure - Pension and Other Employee Benefits - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241054076 - Disclosure - Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241064077 - Disclosure - Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241074078 - Disclosure - Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>241084079 - Disclosure - Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>241104080 - Disclosure - Quarterly Statement of Operations Information (Unaudited) - (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail</Role>
      <ShortName>Quarterly Statement of Operations Information (Unaudited) - (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited</ParentRole>
      <Position>118</Position>
    </Report>
    <Report instance="holx-20200926.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>241114081 - Disclosure - Quarterly Statement of Operations Information (Unaudited) - (Narrative) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail</Role>
      <ShortName>Quarterly Statement of Operations Information (Unaudited) - (Narrative) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited</ParentRole>
      <Position>119</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="holx-20200926.htm">holx-20200926.htm</File>
    <File>holx-20200926.xsd</File>
    <File>holx-20200926_cal.xml</File>
    <File>holx-20200926_def.xml</File>
    <File>holx-20200926_lab.xml</File>
    <File>holx-20200926_pre.xml</File>
    <File>holxq4-2020ex1039.htm</File>
    <File>holxq4-2020ex211.htm</File>
    <File>holxq4-2020ex231.htm</File>
    <File>holxq4-2020ex311.htm</File>
    <File>holxq4-2020ex312.htm</File>
    <File>holxq4-2020ex321.htm</File>
    <File>holxq4-2020ex322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>holx-20200926_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>141
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "holx-20200926.htm": {
   "axisCustom": 1,
   "axisStandard": 44,
   "contextCount": 682,
   "dts": {
    "calculationLink": {
     "local": [
      "holx-20200926_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "holx-20200926_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "holx-20200926.htm"
     ]
    },
    "labelLink": {
     "local": [
      "holx-20200926_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "holx-20200926_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "holx-20200926.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 1148,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2019-01-31": 13,
    "http://www.hologic.com/20200926": 4,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 22
   },
   "keyCustom": 171,
   "keyStandard": 637,
   "memberCustom": 94,
   "memberStandard": 77,
   "nsprefix": "holx",
   "nsuri": "http://www.hologic.com/20200926",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://www.hologic.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210031002 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804062 - Disclosure - 401(k) Plan - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/A401kPlanAdditionalInformationDetail",
     "shortName": "401(k) Plan - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240814063 - Disclosure - Deferred Compensation Plan - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail",
     "shortName": "Deferred Compensation Plan - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844064 - Disclosure - Commitments and Contingencies - Summary of Purchase Commitments (Details)",
     "role": "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails",
     "shortName": "Commitments and Contingencies - Summary of Purchase Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i2e92294f2cda48528702362448bfea27_D20180727-20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864065 - Disclosure - Litigation and Other Matters - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail",
     "shortName": "Litigation and Other Matters - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i2e92294f2cda48528702362448bfea27_D20180727-20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894066 - Disclosure - Disposition - Additional Information (Details)",
     "role": "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
     "shortName": "Disposition - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ie9dabb1d61574d2cab21bd7863b8df8b_D20190929-20191228",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i1250d182bbb64e628b8bb4c093917a38_I20200328",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904067 - Disclosure - Disposition - Schedule of Assets and Liabilities Held for Sale (Details)",
     "role": "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Disposition - Schedule of Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i1250d182bbb64e628b8bb4c093917a38_I20200328",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914068 - Disclosure - Disposition - Schedule of Disposition Related Income Statement Information (Details)",
     "role": "http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails",
     "shortName": "Disposition - Schedule of Disposition Related Income Statement Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944069 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
     "shortName": "Business Segments and Geographic Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954070 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
     "shortName": "Business Segments and Geographic Information - Segment Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240964071 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
     "shortName": "Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210251003 - Disclosure - Revenue (Notes)",
     "role": "http://www.hologic.com/role/RevenueNotes",
     "shortName": "Revenue (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974072 - Disclosure - Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
     "shortName": "Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ib2d7bf9f967242eaba9ddd491ab703ed_I20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004073 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)",
     "role": "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail",
     "shortName": "Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUncertainTaxPositionsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014074 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)",
     "role": "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail",
     "shortName": "Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUncertainTaxPositionsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044075 - Disclosure - Pension and Other Employee Benefits - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail",
     "shortName": "Pension and Other Employee Benefits - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6ac3ec9f123a403ea5b608168f3c2c18_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054076 - Disclosure - Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail",
     "shortName": "Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i84c88a850d71453097932f0bcbe84825_I20170930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241064077 - Disclosure - Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail",
     "shortName": "Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:ComponentsofNetPeriodicBenefitCostInterestcost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241074078 - Disclosure - Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail",
     "shortName": "Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241084079 - Disclosure - Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail",
     "shortName": "Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241104080 - Disclosure - Quarterly Statement of Operations Information (Unaudited) - (Detail)",
     "role": "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail",
     "shortName": "Quarterly Statement of Operations Information (Unaudited) - (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241114081 - Disclosure - Quarterly Statement of Operations Information (Unaudited) - (Narrative) (Detail)",
     "role": "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail",
     "shortName": "Quarterly Statement of Operations Information (Unaudited) - (Narrative) (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i7f382276eec44239bdc0d3cebf1f2d75_D20190929-20191228",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210321004 - Disclosure - Leases",
     "role": "http://www.hologic.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210401005 - Disclosure - Business Combinations",
     "role": "http://www.hologic.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210521006 - Disclosure - Borrowings and Credit Arrangements",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangements",
     "shortName": "Borrowings and Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210711007 - Disclosure - Stockholders' Equity and Stock-Based Compensation",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation",
     "shortName": "Stockholders' Equity and Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ProfitSharingFourZeroOneKPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210791008 - Disclosure - 401(k) Plan",
     "role": "http://www.hologic.com/role/A401kPlan",
     "shortName": "401(k) Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ProfitSharingFourZeroOneKPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210821009 - Disclosure - Commitments and Contingencies",
     "role": "http://www.hologic.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:LitigationAndOtherMattersTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210851010 - Disclosure - Litigation and Related Matters",
     "role": "http://www.hologic.com/role/LitigationandRelatedMatters",
     "shortName": "Litigation and Related Matters",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:LitigationAndOtherMattersTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210871011 - Disclosure - Disposition",
     "role": "http://www.hologic.com/role/Disposition",
     "shortName": "Disposition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - Consolidated Statements of Income",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210921012 - Disclosure - Business Segments and Geographic Information",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation",
     "shortName": "Business Segments and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981013 - Disclosure - Accrued Expenses and Other Long-Term Liabilities",
     "role": "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities",
     "shortName": "Accrued Expenses and Other Long-Term Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211021014 - Disclosure - Pension and Other Employee Benefits",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefits",
     "shortName": "Pension and Other Employee Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211091015 - Disclosure - Quarterly Statement of Operations Information (Unaudited)",
     "role": "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited",
     "shortName": "Quarterly Statement of Operations Information (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230263002 - Disclosure - Revenue (Tables)",
     "role": "http://www.hologic.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230333003 - Disclosure - Leases (Tables)",
     "role": "http://www.hologic.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ica9f97800f804e4a9d1eae5069d40e02_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230413004 - Disclosure - Business Combinations (Tables)",
     "role": "http://www.hologic.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ica9f97800f804e4a9d1eae5069d40e02_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230483005 - Disclosure - Restructuring Charges (Tables)",
     "role": "http://www.hologic.com/role/RestructuringChargesTables",
     "shortName": "Restructuring Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230533006 - Disclosure - Borrowings and Credit Arrangements (Tables)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables",
     "shortName": "Borrowings and Credit Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230603007 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230643008 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.hologic.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230723009 - Disclosure - Stockholders' Equity and Stock-Based Compensation (Tables)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables",
     "shortName": "Stockholders' Equity and Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230833010 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.hologic.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230883011 - Disclosure - Disposition (Tables)",
     "role": "http://www.hologic.com/role/DispositionTables",
     "shortName": "Disposition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230933012 - Disclosure - Business Segments and Geographic Information (Tables)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables",
     "shortName": "Business Segments and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230993013 - Disclosure - Accrued Expenses and Other Long-Term Liabilities (Tables)",
     "role": "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables",
     "shortName": "Accrued Expenses and Other Long-Term Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231033014 - Disclosure - Pension and Other Employee Benefits (Tables)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables",
     "shortName": "Pension and Other Employee Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i3f897a5c14ce46fcb14ced01b6827380_D20170322-20170322",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240024001 - Disclosure - Operations (Details)",
     "role": "http://www.hologic.com/role/OperationsDetails",
     "shortName": "Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i3f897a5c14ce46fcb14ced01b6827380_D20170322-20170322",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical",
     "shortName": "Consolidated Statements of Comprehensive Income (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "idd880126ec8648d0b1d6bba157f678c0_D20171001-20180929",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064002 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "lang": "en-US",
      "name": "holx:CashEquivalentsMaturityPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074003 - Disclosure - Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084004 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventories (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094005 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail",
     "shortName": "Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104006 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i5d996d37cd674a338e18e859a3513b71_I20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ife89599aa864444cb2cca46611fe19f0_D20190929-20191228",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114007 - Disclosure - Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
     "shortName": "Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124008 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6ac3ec9f123a403ea5b608168f3c2c18_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134009 - Disclosure - Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
     "shortName": "Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144010 - Disclosure - Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
     "shortName": "Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-6",
      "lang": "en-US",
      "name": "holx:GoodwillNotAtRiskOfFailingImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "holx:OtherAssetsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154011 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "holx:OtherAssetsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164012 - Disclosure - Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
     "shortName": "Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174013 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184014 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194015 - Disclosure - Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
     "shortName": "Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204016 - Disclosure - Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "icc65f9a1944847ea81ab96621f47b0ce_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214017 - Disclosure - Summary of Significant Accounting Policies - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails",
     "shortName": "Summary of Significant Accounting Policies - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6ac3ec9f123a403ea5b608168f3c2c18_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224018 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail",
     "shortName": "Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i84c88a850d71453097932f0bcbe84825_I20170930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234019 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail",
     "shortName": "Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-3",
      "lang": "en-US",
      "name": "holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "us-gaap:StandardProductWarrantyPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6ac3ec9f123a403ea5b608168f3c2c18_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244020 - Disclosure - Summary of Significant Accounting Policies - Product Warranty (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail",
     "shortName": "Summary of Significant Accounting Policies - Product Warranty (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "us-gaap:StandardProductWarrantyPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274021 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://www.hologic.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284022 - Disclosure - Revenue - Business Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
     "shortName": "Revenue - Business Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i9c33876277774ccea23ac78561fc07e0_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294023 - Disclosure - Revenue - Geographical Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
     "shortName": "Revenue - Geographical Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i65a03228708e48bd91808873ac0aef49_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i3f7d8a1826a64ece9605d7fae43da9ed_D20200628-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304024 - Disclosure - Revenue - Revenue by Type (Details)",
     "role": "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
     "shortName": "Revenue - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i9aeae7e636114e169ab5ca6cd732bffd_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ie9ec2f408f84441f8be19c8da6fe2ecd_I20200926",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314025 - Disclosure - Revenue - Remaining Performance Obligations (Details)",
     "role": "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails",
     "shortName": "Revenue - Remaining Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ie9ec2f408f84441f8be19c8da6fe2ecd_I20200926",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344026 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.hologic.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "holx:OtherAssetsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354027 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364028 - Disclosure - Leases - Additional Lease Information (Details)",
     "role": "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
     "shortName": "Leases - Additional Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374029 - Disclosure - Leases - Lease Liability Maturity Schedule 2020 (Details)",
     "role": "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details",
     "shortName": "Leases - Lease Liability Maturity Schedule 2020 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6ac3ec9f123a403ea5b608168f3c2c18_I20190928",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384030 - Disclosure - Leases - Lease Liability Maturity Schedule 2019 (Details)",
     "role": "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details",
     "shortName": "Leases - Lease Liability Maturity Schedule 2019 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6ac3ec9f123a403ea5b608168f3c2c18_I20190928",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240394031 - Disclosure - Leases - Future Minimum Annual Rental Income Payments (Details)",
     "role": "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails",
     "shortName": "Leases - Future Minimum Annual Rental Income Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i08aaa1dc14eb440ab123d505e79e47ec_I20170930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i08aaa1dc14eb440ab123d505e79e47ec_I20170930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6ac3ec9f123a403ea5b608168f3c2c18_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424032 - Disclosure - Business Combinations - Narrative (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
     "shortName": "Business Combinations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "icb6add9e14054057a65ac31b811fae48_D20191121-20191121",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434033 - Disclosure - Business Combinations - Purchase Price Allocation Acessa (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
     "shortName": "Business Combinations - Purchase Price Allocation Acessa (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i89fdfa3f27cb4f1586760dc2fe2f410c_I20200823",
      "decimals": "1",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444034 - Disclosure - Business Combinations - Purchase Price Allocation SuperSonic Imagine (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails",
     "shortName": "Business Combinations - Purchase Price Allocation SuperSonic Imagine (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i36b884f4d126493b8f8989d941004da4_I20191121",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454035 - Disclosure - Business Combinations - Purchase Price Allocation Focal Therapeutics (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
     "shortName": "Business Combinations - Purchase Price Allocation Focal Therapeutics (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i781dbf5ddcb549d383a457e18753ded3_I20181001",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464036 - Disclosure - Business Combinations - Purchase Price Allocation Faxitron (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
     "shortName": "Business Combinations - Purchase Price Allocation Faxitron (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6140a77a89524e3f94a9becd6d726c2d_I20180731",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474037 - Disclosure - Equity Method Investment (Details)",
     "role": "http://www.hologic.com/role/EquityMethodInvestmentDetails",
     "shortName": "Equity Method Investment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i561f653f0fd84fb1b4d4d3d9f271272c_D20191229-20200328",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "holx:DivestitureCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494038 - Disclosure - Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)",
     "role": "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail",
     "shortName": "Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i44573f3f88454bfc98195170bba8514d_D20171001-20180929",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:ReductionOfWorkforceExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:RestructuringChargesUnderExitOrDisposalPlan",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504039 - Disclosure - Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)",
     "role": "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
     "shortName": "Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i538bbff8ad1044bd8a8c0dc97a060522_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514040 - Disclosure - Restructuring Charges - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
     "shortName": "Restructuring Charges - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544041 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
     "shortName": "Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554042 - Disclosure - Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
     "shortName": "Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564043 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ia3c1210ccdfc4f37a4b3b1c350c0bda2_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromLinesOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574044 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
     "shortName": "Borrowings and Credit Arrangements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:DeferredTaxesReacquisitionofEquityComponent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i181188c2b11e4f169032adefb6546ee2_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584045 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i181188c2b11e4f169032adefb6546ee2_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594046 - Disclosure - Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i58d88ac31091426e8eefd6335aa67a88_D20171001-20180929",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614047 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624048 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id6475457bf9c44539a19af401366b4fa_D20171231-20180331",
      "decimals": "5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6ac3ec9f123a403ea5b608168f3c2c18_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634049 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails",
     "shortName": "Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i84c88a850d71453097932f0bcbe84825_I20170930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654050 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail",
     "shortName": "Income Taxes - Income (Loss) Before Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664051 - Disclosure - Income Taxes - Provision for Income Taxes (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail",
     "shortName": "Income Taxes - Provision for Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Operations",
     "role": "http://www.hologic.com/role/Operations",
     "shortName": "Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674052 - Disclosure - Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail",
     "shortName": "Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684053 - Disclosure - Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail",
     "shortName": "Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694054 - Disclosure - Income Taxes - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i123c8f4db6fc40a0bd1416f05c0482d0_D20180930-20181229",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i6ac3ec9f123a403ea5b608168f3c2c18_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704055 - Disclosure - Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail",
     "shortName": "Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i4dfa6c3dc8054e7eb0474807a8ea7497_I20180929",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i2ffa5f4f0fd34c458b8ea83bfee55899_I20160613",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734056 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i2ffa5f4f0fd34c458b8ea83bfee55899_I20160613",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744057 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "ied1237c55f6c496982f5cf0a7ad5371b_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754058 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "id3c092381c12421482497e088d638a81_I20200926",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764059 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774060 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i97fde683011249b8b4a7a65c9163b4c7_D20190929-20200926",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784061 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20200926.htm",
      "contextRef": "i8badda8d71b34a90a88d5b95d5516075_D20190929-20200926",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 192,
   "tag": {
    "country_CR": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "COSTA RICA",
        "terseLabel": "Costa Rica"
       }
      }
     },
     "localname": "CR",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityByLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity by Location [Axis]",
        "terseLabel": "Entity by Location [Axis]"
       }
      }
     },
     "localname": "EntityByLocationAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A domain representing all geographic locations. Depending on the axis, it may contain members that are specific geographies, or synthetic entity-specific geographical groups.",
        "label": "Location [Domain]",
        "terseLabel": "Location [Domain]"
       }
      }
     },
     "localname": "LocationDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "holx_A2012NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2012 Notes [Member]",
        "label": "2012 Notes [Member]",
        "terseLabel": "2012 Notes"
       }
      }
     },
     "localname": "A2012NotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2013NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2013 Notes [Member]",
        "label": "2013 Notes [Member]",
        "terseLabel": "2013 Notes"
       }
      }
     },
     "localname": "A2013NotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2022NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2022 Notes [Member]",
        "label": "2022 Notes [Member]",
        "terseLabel": "2022 Senior Notes"
       }
      }
     },
     "localname": "A2022NotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2022SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2022 Senior Notes [Member]",
        "label": "2022 Senior Notes [Member]",
        "terseLabel": "2022 Senior Notes"
       }
      }
     },
     "localname": "A2022SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2025SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2025 Senior Notes [Member]",
        "label": "2025 Senior Notes [Member]",
        "terseLabel": "2025 Senior Notes"
       }
      }
     },
     "localname": "A2025SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2028 Senior Notes [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2029SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2029 Senior Notes",
        "label": "2029 Senior Notes [Member]",
        "terseLabel": "2029 Senior Notes"
       }
      }
     },
     "localname": "A2029SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2042NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2042 Notes [Member]",
        "label": "2042 Notes [Member]",
        "terseLabel": "2042 Notes"
       }
      }
     },
     "localname": "A2042NotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ASRAuthorized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASR Authorized",
        "label": "ASR Authorized",
        "terseLabel": "ASR Authorized"
       }
      }
     },
     "localname": "ASRAuthorized",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ASRSharesRepurchasedduringtheperiod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASR Shares Repurchased during the period",
        "label": "ASR Shares Repurchased during the period",
        "terseLabel": "ASR Shares Repurchased during the period"
       }
      }
     },
     "localname": "ASRSharesRepurchasedduringtheperiod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountingstandardtransitionadjustmentASC606": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting standard transition adjustment - ASC 606",
        "label": "Accounting standard transition adjustment - ASC 606",
        "negatedTerseLabel": "Accounting standard transition adjustment - ASC 606"
       }
      }
     },
     "localname": "AccountingstandardtransitionadjustmentASC606",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountingstandardtransitionadjustmentASU201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting standard transition adjustment - ASU 2016-16",
        "label": "Accounting standard transition adjustment - ASU 2016-16",
        "negatedTerseLabel": "Accounting standard transition adjustment - ASU 2016-16"
       }
      }
     },
     "localname": "AccountingstandardtransitionadjustmentASU201616",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableAllowanceReduction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents reduction to the allowance for doubtful accounts primarily from collection of previously reserved accounts and the elimination of an account from the ledger accounts.",
        "label": "Accounts Receivable Allowance Reduction",
        "negatedLabel": "Write- offs and Payments"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceReduction",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableAndReservesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Policy and disclosure of accounts receivable reserves, including activity in the account for the respective periods.",
        "label": "Accounts Receivable And Reserves Policy Policy [Text Block]",
        "terseLabel": "Accounts Receivable and Reserves"
       }
      }
     },
     "localname": "AccountsReceivableAndReservesPolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_AccountsReceivableReserveDivested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounts receivable reserve divested",
        "label": "Accounts receivable reserve divested",
        "terseLabel": "Accounts receivable reserve divested"
       }
      }
     },
     "localname": "AccountsReceivableReserveDivested",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableSecuritizationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounts Receivable Securitization [Member]",
        "label": "Accounts Receivable Securitization [Member]",
        "terseLabel": "Securitization Program"
       }
      }
     },
     "localname": "AccountsReceivableSecuritizationMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Expenses And Other Long-Term Liabilities [Text Block]",
        "label": "Accrued Expenses And Other Long Term Liabilities [Text Block]",
        "terseLabel": "Accrued Expenses and Other Long-Term Liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherLongTermLiabilitiesTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_AccruedIncomeAndOtherTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued income and other taxes.",
        "label": "Accrued Income And Other Taxes",
        "terseLabel": "Income and other taxes"
       }
      }
     },
     "localname": "AccruedIncomeAndOtherTaxes",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccruedInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued interest",
        "label": "Accrued interest",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "AccruedInterest",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Loss Income Policy [Text Block]",
        "label": "Accumulated Other Comprehensive Loss Income Policy [Policy Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_AccumulatedothercomprehensiveIncomelossHedge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive Income loss Hedge",
        "label": "Accumulated other comprehensive Income loss Hedge",
        "terseLabel": "Accumulated other comprehensive Income loss Hedge"
       }
      }
     },
     "localname": "AccumulatedothercomprehensiveIncomelossHedge",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AcessaHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Acessa Health",
        "label": "Acessa Health [Member]",
        "terseLabel": "Acessa Health [Member]"
       }
      }
     },
     "localname": "AcessaHealthMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AcessaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Acessa",
        "label": "Acessa [Member]",
        "terseLabel": "Acessa"
       }
      }
     },
     "localname": "AcessaMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AcquiredintangibleassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Acquired intangible assets [Member]",
        "label": "Acquired intangible assets [Member]",
        "terseLabel": "Acquired intangible assets [Member]"
       }
      }
     },
     "localname": "AcquiredintangibleassetsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AdditionalPurchaseConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional purchase consideration",
        "label": "Additional purchase consideration",
        "terseLabel": "Additional purchase consideration"
       }
      }
     },
     "localname": "AdditionalPurchaseConsideration",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AllOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All other countries.",
        "label": "All Other Countries [Member]",
        "terseLabel": "Rest of world"
       }
      }
     },
     "localname": "AllOtherCountriesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AlphaImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Alpha Imaging [Member]",
        "label": "Alpha Imaging [Member]",
        "terseLabel": "Alpha Imaging"
       }
      }
     },
     "localname": "AlphaImagingMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmendedCreditFacility2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amended Credit Facility 2018 [Member]",
        "label": "Amended Credit Facility 2018 [Member]",
        "terseLabel": "2018 Amended Credit Facility"
       }
      }
     },
     "localname": "AmendedCreditFacility2018Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmendedRevolver2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amended Revolver 2018 [Member]",
        "label": "Amended Revolver 2018 [Member]",
        "terseLabel": "2018 Amended Revolver"
       }
      }
     },
     "localname": "AmendedRevolver2018Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmendedTermLoan2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amended Term Loan 2018 [Member]",
        "label": "Amended Term Loan 2018 [Member]",
        "terseLabel": "2018 Amended Term Loan"
       }
      }
     },
     "localname": "AmendedTermLoan2018Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmortizationOfDeferredFinancingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The component of interest expense representing the periodic charge against earnings to reflect amortization of debt issuance costs over the life of the related debt instruments.",
        "label": "Amortization Of Deferred Financing Costs",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfDeferredFinancingCosts",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss recognized in other comprehensive income [Abstract]",
        "label": "Amount of loss recognized in other comprehensive income [Abstract]",
        "terseLabel": "Amount of loss recognized in other comprehensive income [Abstract]"
       }
      }
     },
     "localname": "AmountoflossrecognizedinothercomprehensiveincomeAbstract",
     "nsuri": "http://www.hologic.com/20200926",
     "xbrltype": "stringItemType"
    },
    "holx_AmountpaidduringtheperiodunderASRAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount paid during the period under ASR Agreement",
        "label": "Amount paid during the period under ASR Agreement",
        "terseLabel": "Amount paid during the period under ASR Agreement"
       }
      }
     },
     "localname": "AmountpaidduringtheperiodunderASRAgreement",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Assets And Liabilities, Lessee"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_AuthorizationDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Authorization Date [Axis]",
        "label": "Authorization Date [Domain]",
        "terseLabel": "Authorization Date [Domain]"
       }
      }
     },
     "localname": "AuthorizationDateDomain",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BasePrincipalAmountForAccretionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the amount of principal accretion at the applicable rate pursuant to the terms of the debt agreement, which is recorded as interest expense.",
        "label": "Base Principal Amount For Accretion Value",
        "terseLabel": "Principal accretion"
       }
      }
     },
     "localname": "BasePrincipalAmountForAccretionValue",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BedfordMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bedford [Member]",
        "label": "Bedford [Member]",
        "terseLabel": "Bedford"
       }
      }
     },
     "localname": "BedfordMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BloodScreeningMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Blood Screening [Member]",
        "label": "Blood Screening [Member]",
        "verboseLabel": "Blood Screening"
       }
      }
     },
     "localname": "BloodScreeningMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Breast health.",
        "label": "Breast Health [Member]",
        "terseLabel": "Breast Health"
       }
      }
     },
     "localname": "BreastHealthMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Breast Imaging [Member]",
        "label": "Breast Imaging [Member]",
        "terseLabel": "Breast Imaging"
       }
      }
     },
     "localname": "BreastImagingMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BusinessAcquisitionCashTenderOfferPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Cash Tender Offer Price Per Share",
        "label": "Business Acquisition, Cash Tender Offer Price Per Share",
        "terseLabel": "Cash tender offer price per share"
       }
      }
     },
     "localname": "BusinessAcquisitionCashTenderOfferPricePerShare",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "holx_BusinessCombinationAdditionalSharesAcquiredShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Additional Shares Acquired, Shares",
        "label": "Business Combination, Additional Shares Acquired, Shares",
        "terseLabel": "Additional outstanding shares purchased (in shares)"
       }
      }
     },
     "localname": "BusinessCombinationAdditionalSharesAcquiredShares",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_BusinessCombinationAdditionalSharesAcquiredValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Additional Shares Acquired, Value",
        "label": "Business Combination, Additional Shares Acquired, Value",
        "terseLabel": "Additional outstanding shares purchased, amount"
       }
      }
     },
     "localname": "BusinessCombinationAdditionalSharesAcquiredValue",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "terseLabel": "Portion allocable to equity method investment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "terseLabel": "Portion allocable to fair value of noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "terseLabel": "Portion allocable to loan repaymnet"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "terseLabel": "Portion allocable to newly acquired shares"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Withheld Under Indemnification Provisions",
        "label": "Business Combination, Contingent Consideration, Withheld Under Indemnification Provisions",
        "terseLabel": "Contingent holdback withheld under indemnification provisions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationWithheldUnderIndemnificationProvisions",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Ownership Percentage",
        "label": "Business Combination, Ownership Percentage",
        "terseLabel": "Ownership of outstanding shares (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationOwnershipPercentage",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Period for Payment of Contingent Consideration Liability",
        "label": "Business Combination, Period for Payment of Contingent Consideration Liability",
        "terseLabel": "Payment period for contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationPeriodforPaymentofContingentConsiderationLiability",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "terseLabel": "Identifiable intangible assets",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "negatedTerseLabel": "Short and long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "terseLabel": "Fair value, discount rate",
        "verboseLabel": "Fair value discount rate (percent)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets And Liabilities, Net",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets And Liabilities, Net",
        "terseLabel": "Tangible assets and liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAndLiabilitiesNet",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationSharesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Shares Acquired",
        "label": "Business Combination, Shares Acquired",
        "terseLabel": "Acquired shares"
       }
      }
     },
     "localname": "BusinessCombinationSharesAcquired",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_BusinessLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business licenses.",
        "label": "Business Licenses [Member]",
        "terseLabel": "Business licenses"
       }
      }
     },
     "localname": "BusinessLicensesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalEquipmentComponentsandSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Capital Equipment, Components and Software [Member]",
        "label": "Capital Equipment, Components and Software [Member]",
        "terseLabel": "Capital equipment, components and software"
       }
      }
     },
     "localname": "CapitalEquipmentComponentsandSoftwareMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalizedsoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Capitalized software [Member]",
        "label": "Capitalized software [Member]",
        "terseLabel": "Capitalized software [Member]"
       }
      }
     },
     "localname": "CapitalizedsoftwareMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CashEquivalentsMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time from the date of acquisition for liquid investments in debt securities to be categorized as cash in the consolidated balance sheet.",
        "label": "Cash Equivalents Maturity Period",
        "terseLabel": "Cash Equivalents Maturity Period"
       }
      }
     },
     "localname": "CashEquivalentsMaturityPeriod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_CashSeverancePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Severance payments.",
        "label": "Cash Severance Payments",
        "negatedLabel": "Severance payments"
       }
      }
     },
     "localname": "CashSeverancePayments",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CompanyVs.MinervaSurgicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Company Vs. Minerva Surgical, Inc. [Member]",
        "label": "Company Vs. Minerva Surgical, Inc. [Member]",
        "terseLabel": "Company Vs. Minerva Surgical, Inc."
       }
      }
     },
     "localname": "CompanyVs.MinervaSurgicalInc.Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ComponentsofNetPeriodicBenefitCostInterestcost": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of Net Periodic Benefit Cost, Interest cost",
        "label": "Components of Net Periodic Benefit Cost, Interest cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "ComponentsofNetPeriodicBenefitCostInterestcost",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ComprehensiveIncome": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Comprehensive Income",
        "label": "Comprehensive Income",
        "terseLabel": "Comprehensive income (loss) attributable to Hologic"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "contingent consideration",
        "label": "contingent consideration [Member]",
        "terseLabel": "contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentHoldbackMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent Holdback [Member]",
        "label": "Contingent Holdback [Member]",
        "terseLabel": "Holdback"
       }
      }
     },
     "localname": "ContingentHoldbackMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Convertible notes.",
        "label": "Convertible Notes [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CostMethodEquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate carrying value of the Company's cost-method investments at the balance sheet date.",
        "label": "Cost Method Equity Investments",
        "terseLabel": "Cost-method equity investments"
       }
      }
     },
     "localname": "CostMethodEquityInvestments",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CostOfGoodsSoldImpairmentOfIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.",
        "label": "Cost Of Goods Sold Impairment Of Intangible Assets",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "CostOfGoodsSoldImpairmentOfIntangibleAssets",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of the costs comprising costs of service and other revenues.",
        "label": "Cost Of Service And Other Revenues Policy [Policy Text Block]",
        "terseLabel": "Cost of Service and Other Revenues"
       }
      }
     },
     "localname": "CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_CreditAgreement2017Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Agreement 2017 [Member]",
        "label": "Credit Agreement 2017 [Member]",
        "terseLabel": "2017 Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreement2017Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CreditAgreement2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Agreement 2018 [Member]",
        "label": "Credit Agreement 2018 [Member]",
        "terseLabel": "2018 Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreement2018Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit agreement.",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CreditAgreementPriorMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Agreement Prior [Member]",
        "label": "Credit Agreement Prior [Member]",
        "terseLabel": "Prior Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementPriorMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cumulative Effect Of New Accounting Principle In Period Of Adoption, Tax",
        "label": "Cumulative Effect Of New Accounting Principle In Period Of Adoption, Tax",
        "terseLabel": "Accounting standard transition adjustment tax effect"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionTax",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CustomerRelationshipsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationships contracts.",
        "label": "Customer Relationships Contracts [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsContractsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CynosureMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cynosure [Member]",
        "label": "Cynosure [Member]",
        "terseLabel": "Cynosure"
       }
      }
     },
     "localname": "CynosureMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CytologyPerinatalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cytology &amp; Perinatal [Member]",
        "label": "Cytology &amp; Perinatal [Member]",
        "terseLabel": "Cytology &amp; Perinatal"
       }
      }
     },
     "localname": "CytologyPerinatalMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DebtDiscountReallocatedUponDebtModification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Discount, Reallocated Upon Debt Modification",
        "label": "Debt Discount, Reallocated Upon Debt Modification",
        "terseLabel": "Debt discount reallocated upon debt modification"
       }
      }
     },
     "localname": "DebtDiscountReallocatedUponDebtModification",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments",
        "label": "Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments",
        "terseLabel": "Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments"
       }
      }
     },
     "localname": "DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DebtInstrumentNumberOfInstruments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Number Of Instruments",
        "label": "Debt Instrument, Number Of Instruments",
        "terseLabel": "Number of debt instruments"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfInstruments",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "holx_DebtInstrumentOfferingPricePercentOfFaceValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Offering Price, Percent Of Face Value",
        "label": "Debt Instrument, Offering Price, Percent Of Face Value",
        "terseLabel": "Offering price, percent of face value"
       }
      }
     },
     "localname": "DebtInstrumentOfferingPricePercentOfFaceValue",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument Percentage Of Redemption Price Fifth Period",
        "label": "Debt Instrument Percentage Of Redemption Price Fifth Period",
        "terseLabel": "Percentage of redemption price, fifth period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfRedemptionPriceFifthPeriod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument Percentage Of Redemption Price Fourth Period",
        "label": "Debt Instrument Percentage Of Redemption Price Fourth Period",
        "terseLabel": "Percentage of redemption price, fourth period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfRedemptionPriceFourthPeriod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument Percentage Of Redemption Price Second Period",
        "label": "Debt Instrument Percentage Of Redemption Price Second Period",
        "terseLabel": "Percentage of redemption price, second period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfRedemptionPriceSecondPeriod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument Percentage Of Redemption Price Third Period",
        "label": "Debt Instrument Percentage Of Redemption Price Third Period",
        "terseLabel": "Percentage of redemption price, third period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfRedemptionPriceThirdPeriod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument Percentage Redemption Price Sixth Period",
        "label": "Debt Instrument Percentage Redemption Price Sixth Period",
        "terseLabel": "Percentage redemption price, sixth period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageRedemptionPriceSixthPeriod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Principal Per Quarter",
        "label": "Debt Instrument, Periodic Payment, Principal Per Quarter",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal Per Quarter"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipalPerQuarter",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DebtIssuanceCostsReallocatedUponDebtModification": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Issuance Costs, Reallocated Upon Debt Modification",
        "label": "Debt Issuance Costs, Reallocated Upon Debt Modification",
        "terseLabel": "Debt issuance costs reallocated upon debt modification"
       }
      }
     },
     "localname": "DebtIssuanceCostsReallocatedUponDebtModification",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Debtinstrumentremainingtoberedeemed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instrument remaining to be redeemed",
        "label": "Debt instrument remaining to be redeemed",
        "terseLabel": "Debt instrument remaining to be redeemed"
       }
      }
     },
     "localname": "Debtinstrumentremainingtoberedeemed",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Dec112019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Dec 11, 2019",
        "label": "Dec 11, 2019 [Member]",
        "terseLabel": "Dec 11, 2019 [Member]"
       }
      }
     },
     "localname": "Dec112019Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Decease in accumulated deficit resulting from adoption of ASCU 2016-16",
        "label": "Decease in accumulated deficit resulting from adoption of ASCU 2016-16",
        "terseLabel": "Decease in accumulated deficit resulting from adoption of ASU 2016-16"
       }
      }
     },
     "localname": "DeceaseinaccumulateddeficitresultingfromadoptionofASCU201616",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeceasetoprepaidtaxesresultingfromadoptionofASCU201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Decease to prepaid taxes resulting from adoption of ASCU 2016-16",
        "label": "Decease to prepaid taxes resulting from adoption of ASCU 2016-16",
        "terseLabel": "Decease to prepaid taxes resulting from adoption of ASU 2016-16"
       }
      }
     },
     "localname": "DeceasetoprepaidtaxesresultingfromadoptionofASCU201616",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DecreaseindeferredtaxliabilitiesduetoASC201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Decrease in deferred tax liabilities due to ASC 2016-16",
        "label": "Decrease in deferred tax liabilities due to ASC 2016-16",
        "terseLabel": "Decrease in deferred tax liabilities due to ASU 2016-16"
       }
      }
     },
     "localname": "DecreaseindeferredtaxliabilitiesduetoASC201616",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred tax assets lease liability",
        "label": "Deferred tax assets lease liability",
        "terseLabel": "Deferred tax assets lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiability",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The tax effect as of the balance sheet date of the amount of future tax deductions arising from the Company's nonqualified deferred compensation plan.",
        "label": "Deferred Tax Assets Nonqualified Deferred Compensation Plan",
        "terseLabel": "Nonqualified deferred compensation plan"
       }
      }
     },
     "localname": "DeferredTaxAssetsNonqualifiedDeferredCompensationPlan",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of federal net operating losses the company believes will expire unutilized.",
        "label": "Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Federal",
        "terseLabel": "Federal net operating loss expected to be expired unutilized"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign",
        "label": "Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign",
        "terseLabel": "Foreign net operating loss expected to be expired unutilized"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of state net operating losses the company believes will expire unutilized.",
        "label": "Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized State",
        "terseLabel": "State net operating loss expected to be expired unutilized"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxLiabilitiesDebtDiscount": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount as of the balance sheet of the estimated future tax effects attributable to the debt discount on the convertible notes and related impact from the convertible notes exchanges.",
        "label": "Deferred Tax Liabilities Debt Discount",
        "negatedLabel": "Debt discounts and deferrals"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDebtDiscount",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount as of the balance sheet date of the estimated future tax effects attributable to amortization of intangible assets, and to a lesser extent, depreciation of property and equipment.",
        "label": "Deferred Tax Liabilities Depreciation And Amortization",
        "negatedLabel": "Depreciation\u00a0and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxLiabilitiesRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Liabilities right of use asset",
        "label": "Deferred Tax Liabilities right of use asset",
        "negatedTerseLabel": "Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAsset",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxesReacquisitionofEquityComponent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Taxes, Reacquisition of Equity Component",
        "label": "Deferred Taxes, Reacquisition of Equity Component",
        "terseLabel": "Deferred taxes, reacquisition of equity component"
       }
      }
     },
     "localname": "DeferredTaxesReacquisitionofEquityComponent",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount",
        "label": "Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount",
        "terseLabel": "Actuarial gain (loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Developed technology.",
        "label": "Developed Technology [Member]",
        "terseLabel": "Developed Technology [Member]"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Diagnostics.",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DirectThirdPartyCostsinterestExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Direct Third Party Costs interest Expense",
        "label": "Direct Third Party Costs interest Expense",
        "terseLabel": "Third-party costs recorded as interest"
       }
      }
     },
     "localname": "DirectThirdPartyCostsinterestExpense",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Final Sales Price",
        "label": "Disposal Group, Including Discontinued Operation, Final Sales Price",
        "terseLabel": "Final sales price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]",
        "label": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract",
     "nsuri": "http://www.hologic.com/20200926",
     "xbrltype": "stringItemType"
    },
    "holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]",
        "label": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]",
        "terseLabel": "Disposition"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/Disposition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_DistributionagreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Distribution agreement [Member]",
        "label": "Distribution agreement [Member]",
        "terseLabel": "Distribution agreement [Member]"
       }
      }
     },
     "localname": "DistributionagreementMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DivestitureCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail": {
       "order": 3.0,
       "parentTag": "holx_RestructuringChargesUnderExitOrDisposalPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Divestiture charges",
        "label": "Divestiture charges",
        "terseLabel": "Divestiture charges"
       }
      }
     },
     "localname": "DivestitureCharges",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Earnings Per Share [Line Items]",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Earnings Per Share [Table]",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective income tax rate reconciliation benefit expense research and development.",
        "label": "Effective Income Tax Rate Reconciliation Benefit Expense Research And Development",
        "negatedLabel": "Tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to the difference in the deductibility or nondeductibility of executive compensation (i.e., those subject to Section 162(m) limitations), including equity-based compensation and salary and bonus compensation.",
        "label": "Effective Income Tax Rate Reconciliation Non Deductible Expense Executive Compensation Cost",
        "terseLabel": "Compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Non Deductible Goodwill",
        "label": "Effective Income Tax Rate Reconciliation, Non Deductible Goodwill",
        "terseLabel": "Non-deductible goodwill"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonDeductibleGoodwill",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to changes in unrecognized tax benefits recorded in the statement of operations",
        "label": "Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 15.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective income tax reconciliation loss on sale of Cynosure",
        "label": "Effective income tax reconciliation loss on sale of Cynosure",
        "negatedTerseLabel": "Loss on sale of Cynosure"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EmployeeContributionsVestedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee contributions vested, percentage.",
        "label": "Employee Contributions Vested Percentage",
        "terseLabel": "Employee contributions vested, percentage"
       }
      }
     },
     "localname": "EmployeeContributionsVestedPercentage",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member].",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EmployerContributionsPercentVestedAnnually": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employer Contributions, Percent Vested Annually",
        "label": "Employer Contributions, Percent Vested Annually",
        "terseLabel": "Percent vested annually"
       }
      }
     },
     "localname": "EmployerContributionsPercentVestedAnnually",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EmployerContributionsVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The vesting period for discretionary employer contributions, which vest ratably on an annual basis.",
        "label": "Employer Contributions Vesting Period",
        "terseLabel": "Contributions, vesting period, years"
       }
      }
     },
     "localname": "EmployerContributionsVestingPeriod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_EmsorMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Emsor [Member]",
        "label": "Emsor [Member]",
        "terseLabel": "Emsor"
       }
      }
     },
     "localname": "EmsorMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment And Software [Member]",
        "label": "Equipment And Software [Member]",
        "terseLabel": "Equipment and Software [Member]"
       }
      }
     },
     "localname": "EquipmentAndSoftwareMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EquipmentUnderCustomerUsageAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment Under Customer Usage Agreement [Member]",
        "label": "Equipment Under Customer Usage Agreement [Member]",
        "terseLabel": "Equipment Under Customer Usage Agreements [Member]"
       }
      }
     },
     "localname": "EquipmentUnderCustomerUsageAgreementMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Equipment Under Customer Usage Agreements",
        "terseLabel": "Equipment Under Customer Usage Agreements"
       }
      }
     },
     "localname": "EquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_EquityMethodInvestmentAndLoansToAcquiree": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment And Loans To Acquiree",
        "label": "Equity Method Investment And Loans To Acquiree",
        "verboseLabel": "Equity-method investment and loans to SSI (Note 5)"
       }
      }
     },
     "localname": "EquityMethodInvestmentAndLoansToAcquiree",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ExpectedFutureSeveranceCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected future severance charges",
        "label": "Expected future severance charges",
        "terseLabel": "Expected future severance charges"
       }
      }
     },
     "localname": "ExpectedFutureSeveranceCharges",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Expensesfromdisposition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expenses from disposition",
        "label": "Expenses from disposition",
        "terseLabel": "Expenses from disposition"
       }
      }
     },
     "localname": "Expensesfromdisposition",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_FacilityClosureCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail": {
       "order": 2.0,
       "parentTag": "holx_RestructuringChargesUnderExitOrDisposalPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.",
        "label": "Facility Closure Costs",
        "terseLabel": "Facility closure costs"
       }
      }
     },
     "localname": "FacilityClosureCosts",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_FaxitronMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Faxitron [Member]",
        "label": "Faxitron [Member]",
        "terseLabel": "Faxitron"
       }
      }
     },
     "localname": "FaxitronMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsTables",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "February fourteen two thousand and thirteen original notes.",
        "label": "February Fourteen Two Thousand And Thirteen Original Notes [Member]",
        "terseLabel": "February 14, 2013 Original Notes"
       }
      }
     },
     "localname": "FebruaryFourteenTwoThousandAndThirteenOriginalNotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "February twenty nine two thousand twelve original notes.",
        "label": "February Twenty Nine Two Thousand Twelve Original Notes [Member]",
        "terseLabel": "February 29, 2012 Original Notes"
       }
      }
     },
     "localname": "FebruaryTwentyNineTwoThousandTwelveOriginalNotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FinanceLeaseObligationsLongTermMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease Obligations - Long Term [Member]",
        "label": "Finance Lease Obligations - Long Term [Member]",
        "terseLabel": "Finance lease obligations - long term"
       }
      }
     },
     "localname": "FinanceLeaseObligationsLongTermMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FinanceLeaseObligationsShortTermMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease Obligations - Short Term [Member]",
        "label": "Finance Lease Obligations - Short Term [Member]",
        "terseLabel": "Finance lease obligations - short term"
       }
      }
     },
     "localname": "FinanceLeaseObligationsShortTermMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2017ActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal 2017 Actions [Member]",
        "label": "Fiscal 2017 Actions [Member]",
        "terseLabel": "Fiscal 2017 Actions [Member]"
       }
      }
     },
     "localname": "Fiscal2017ActionsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2018ActionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal 2018 Action [Member]",
        "label": "Fiscal 2018 Action [Member]",
        "terseLabel": "Fiscal 2018 Actions"
       }
      }
     },
     "localname": "Fiscal2018ActionMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2019ActionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal 2019 Action [Member]",
        "label": "Fiscal 2019 Action [Member]",
        "terseLabel": "Fiscal 2019 Actions",
        "verboseLabel": "Fiscal 2019 Actions"
       }
      }
     },
     "localname": "Fiscal2019ActionMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2019chargesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal 2019 charges",
        "label": "Fiscal 2019 charges [Member]",
        "terseLabel": "Fiscal 2019 charges:"
       }
      }
     },
     "localname": "Fiscal2019chargesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2020ActionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal 2020 Action",
        "label": "Fiscal 2020 Action [Member]",
        "terseLabel": "Fiscal 2020 Action"
       }
      }
     },
     "localname": "Fiscal2020ActionMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2020ChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal 2020 charges",
        "label": "Fiscal 2020 charges [Member]",
        "terseLabel": "Fiscal 2020 charges"
       }
      }
     },
     "localname": "Fiscal2020ChargesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal 2020",
        "label": "Fiscal 2020 [Member]",
        "terseLabel": "Fiscal 2020"
       }
      }
     },
     "localname": "Fiscal2020Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FocalTherapeuticsInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Focal Therapeutics, Inc. [Member]",
        "label": "Focal Therapeutics, Inc. [Member]",
        "terseLabel": "Focal Therapeutics"
       }
      }
     },
     "localname": "FocalTherapeuticsInc.Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsTables",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FundingOfLoansToSSI": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loans to SSI",
        "label": "Funding Of Loans To SSI",
        "negatedTerseLabel": "Loans to SSI"
       }
      }
     },
     "localname": "FundingOfLoansToSSI",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GeographicInformationForPropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Geographic Information For Property Plant And Equipment [Line Items]",
        "label": "Geographic Information For Property Plant And Equipment [Line Items]",
        "terseLabel": "Geographic Information For Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "GeographicInformationForPropertyPlantAndEquipmentLineItems",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_GeographicInformationForPropertyPlantAndEquipmentTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Geographic Information For Property Plant And Equipment [Table]",
        "label": "Geographic Information For Property Plant And Equipment [Table]",
        "terseLabel": "Geographic Information For Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "GeographicInformationForPropertyPlantAndEquipmentTable",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_GoodwillNotAtRiskOfFailingImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Goodwill not at risk of failing impairment",
        "label": "Goodwill not at risk of failing impairment",
        "terseLabel": "Goodwill not at risk of failing impairment"
       }
      }
     },
     "localname": "GoodwillNotAtRiskOfFailingImpairment",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GrossForeignLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross foreign loss carryforwards",
        "label": "Gross foreign loss carryforwards",
        "terseLabel": "Gross foreign loss carryforwards"
       }
      }
     },
     "localname": "GrossForeignLossCarryforwards",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GrossStateLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross state loss carryforwards",
        "label": "Gross state loss carryforwards",
        "terseLabel": "Gross state loss carryforwards"
       }
      }
     },
     "localname": "GrossStateLossCarryforwards",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GrossUnrecognizedTaxBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the total unrecognized tax benefits, including interest, that if recognized would result in a reduction to the effective tax rate.",
        "label": "Gross Unrecognized Tax Benefits",
        "terseLabel": "Gross unrecognized tax benefits, excluding interest"
       }
      }
     },
     "localname": "GrossUnrecognizedTaxBenefits",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GynSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "GYN surgical.",
        "label": "Gyn Surgical [Member]",
        "terseLabel": "Gyn Surgical [Member]"
       }
      }
     },
     "localname": "GynSurgicalMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_HealthBeaconsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Beacons [Member]",
        "label": "Health Beacons [Member]",
        "terseLabel": "Health Beacons"
       }
      }
     },
     "localname": "HealthBeaconsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Holdback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Holdback",
        "label": "Holdback",
        "terseLabel": "Holdback"
       }
      }
     },
     "localname": "Holdback",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Impairmentofintangibleassetsandequipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Impairment of intangible assets and equipment",
        "label": "Impairment of intangible assets and equipment",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "Impairmentofintangibleassetsandequipment",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase in deferred tax assets resulting from adoption of ASCU 2016-16",
        "label": "Increase in deferred tax assets resulting from adoption of ASCU 2016-16",
        "terseLabel": "Increase in deferred tax assets resulting from adoption of ASU 2016-16"
       }
      }
     },
     "localname": "IncreaseindeferredtaxassetsresultingfromadoptionofASCU201616",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase to Earnings per Share resulted from adoption of ASC 2016-16",
        "label": "Increase to Earnings per Share resulted from adoption of ASC 2016-16",
        "terseLabel": "Increase to Earnings per Share resulted from adoption of ASU 2016-16"
       }
      }
     },
     "localname": "IncreasetoEarningsperShareresultedfromadoptionofASC201616",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "holx_IncreasetoNetIncomeresultedfromadoptionofASU201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase to Net Income resulted from adoption of ASU 2016-16",
        "label": "Increase to Net Income resulted from adoption of ASU 2016-16",
        "terseLabel": "Increase to Net Income resulted from adoption of ASU 2016-16"
       }
      }
     },
     "localname": "IncreasetoNetIncomeresultedfromadoptionofASU201616",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IncreasetoincometaxexpenseadoptionofASU201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase to income tax expense adoption of ASU 2016-16",
        "label": "Increase to income tax expense adoption of ASU 2016-16",
        "terseLabel": "Increase to income tax expense adoption of ASU 2016-16"
       }
      }
     },
     "localname": "IncreasetoincometaxexpenseadoptionofASU201616",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IndemnificationLiabily": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indemnification liabily",
        "label": "Indemnification liabily",
        "terseLabel": "Indemnification liabily"
       }
      }
     },
     "localname": "IndemnificationLiabily",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process research and development reclassified to developed technology",
        "label": "In process research and development reclassified to developed technology",
        "terseLabel": "In process research and development reclassified to developed technology"
       }
      }
     },
     "localname": "Inprocessresearchanddevelopmentreclassifiedtodevelopedtechnology",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InterestCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest Coverage Ratio",
        "label": "Interest Coverage Ratio",
        "terseLabel": "Interest coverage ratio"
       }
      }
     },
     "localname": "InterestCoverageRatio",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_InterestRateCapAgreementsAggregatePremiumPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate cap agreements aggregate premium payable.",
        "label": "Interest Rate Cap Agreements Aggregate Premium Payable",
        "negatedTerseLabel": "Purchase of interest rate caps",
        "terseLabel": "Purchase of interest rate caps"
       }
      }
     },
     "localname": "InterestRateCapAgreementsAggregatePremiumPayable",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InternalusesoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Internal-use software [Member]",
        "label": "Internal-use software [Member]",
        "terseLabel": "Internal-use software [Member]"
       }
      }
     },
     "localname": "InternalusesoftwareMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InterventionalBreastSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interventional Breast Solutions [Member]",
        "label": "Interventional Breast Solutions [Member]",
        "terseLabel": "Interventional Breast Solutions"
       }
      }
     },
     "localname": "InterventionalBreastSolutionsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InvestmentInGroupLifeInsuranceContracts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash surrender value of group life insurance contracts at the balance sheet date.",
        "label": "Investment In Group Life Insurance Contracts",
        "terseLabel": "Investment in group life insurance contracts"
       }
      }
     },
     "localname": "InvestmentInGroupLifeInsuranceContracts",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Jun212016Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "June 21 2016 authorization of repurchase of Company's outstanding common stock [Member]",
        "label": "Jun 21 2016 [Member]",
        "terseLabel": "Jun 21 2016"
       }
      }
     },
     "localname": "Jun212016Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_June132019PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "June 13, 2019 Plan [Member]",
        "label": "June 13, 2019 Plan [Member]",
        "terseLabel": "June 13, 2019 Plan [Member]"
       }
      }
     },
     "localname": "June132019PlanMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_LeaseReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Receivable",
        "label": "Lease Receivable",
        "terseLabel": "Lease receivable"
       }
      }
     },
     "localname": "LeaseReceivable",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_LeaseRevenuePercentageOfTotalRevenue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Revenue, Percentage Of Total Revenue",
        "label": "Lease Revenue, Percentage Of Total Revenue",
        "terseLabel": "Lease revenue as a percentage of total"
       }
      }
     },
     "localname": "LeaseRevenuePercentageOfTotalRevenue",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LegalAccrual": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Legal Accrual",
        "label": "Legal Accrual",
        "terseLabel": "Legal Accrual"
       }
      }
     },
     "localname": "LegalAccrual",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating And Finance Lease, Period With Option To Terminate",
        "label": "Lessee, Operating And Finance Lease, Period With Option To Terminate",
        "terseLabel": "Period with option to terminate lease"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating And Finance Lease, Remaining Lease Term",
        "label": "Lessee, Operating And Finance Lease, Remaining Lease Term",
        "terseLabel": "Lessee, operating and finance lease, remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeaseRemainingLeaseTerm",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_LesseeOperatingAndFinanceLeasesExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating And Finance Leases, Extension Period",
        "label": "Lessee, Operating And Finance Leases, Extension Period",
        "terseLabel": "Extension period"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesExtensionPeriod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent",
        "label": "Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leverage Ratio Maximum",
        "label": "Leverage Ratio Maximum",
        "terseLabel": "Leverage ratio maximum"
       }
      }
     },
     "localname": "LeverageRatioMaximum",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LitigationAndOtherMattersTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation And Other Matters [Text Block]",
        "label": "Litigation And Other Matters [Text Block]",
        "terseLabel": "Litigation and Related Matters"
       }
      }
     },
     "localname": "LitigationAndOtherMattersTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LitigationandRelatedMatters"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_LongLivedAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long Lived Assets Policy [Text Block]",
        "label": "Long Lived Assets Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "LongLivedAssetsPolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_LybertyWayMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lyberty Way [Member]",
        "label": "Lyberty Way [Member]",
        "terseLabel": "Lyberty Way [Member]"
       }
      }
     },
     "localname": "LybertyWayMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MakeWholeProvision": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Make Whole Provision",
        "label": "Make Whole Provision",
        "terseLabel": "Make whole provision"
       }
      }
     },
     "localname": "MakeWholeProvision",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ManufacturingEquipmentAndSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.",
        "label": "Manufacturing Equipment And Software",
        "terseLabel": "Manufacturing Equipment And Software"
       }
      }
     },
     "localname": "ManufacturingEquipmentAndSoftware",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MarketBasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Market Based Stock Units [Member]",
        "label": "Market Based Stock Units [Member]",
        "terseLabel": "Market Based Stock Units"
       }
      }
     },
     "localname": "MarketBasedStockUnitsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MaximumBorrowingUnderSecuritizationProgram": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing under securitization program",
        "label": "Maximum Borrowing Under Securitization Program",
        "terseLabel": "Maximum borrowing under securitization program"
       }
      }
     },
     "localname": "MaximumBorrowingUnderSecuritizationProgram",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum employee contributions from annual bonus percentage to dcp.",
        "label": "Maximum Employee Contributions From Annual Bonus Percentage To Dcp",
        "terseLabel": "Maximum employee contributions from annual bonus, percentage"
       }
      }
     },
     "localname": "MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum employee contributions from base salary percentage to dcp.",
        "label": "Maximum Employee Contributions From Base Salary Percentage To Dcp",
        "terseLabel": "Maximum employee contributions from base salary, percentage"
       }
      }
     },
     "localname": "MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MaximumRangeofPresentValueofCashFlowPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum Range of Present Value of Cash Flow Percentage",
        "label": "Maximum Range of Present Value of Cash Flow Percentage",
        "terseLabel": "Maximum range of present value of cash flow (percent)"
       }
      }
     },
     "localname": "MaximumRangeofPresentValueofCashFlowPercentage",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum target number percentage of shares issued based on stock performance.",
        "label": "Maximum Target Number Of Shares Issued Based On Stock Performance In Percent",
        "terseLabel": "Maximum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MedicalAestheticsBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical Aesthetics Business [Member]",
        "label": "Medical Aesthetics Business [Member]",
        "terseLabel": "Medical Aesthetics Business"
       }
      }
     },
     "localname": "MedicalAestheticsBusinessMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MedicalAestheticsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical Aesthetics [Member]",
        "label": "Medical Aesthetics [Member]",
        "terseLabel": "Medical Aesthetics"
       }
      }
     },
     "localname": "MedicalAestheticsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum target number percentage of shares that would be issued based on stock price performance.",
        "label": "Minimum Target Number Of Shares Issued On Stock Performance In Percent",
        "terseLabel": "Minimum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MolecularDiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular Diagnostics [Member]",
        "label": "Molecular Diagnostics [Member]",
        "terseLabel": "Molecular Diagnostics"
       }
      }
     },
     "localname": "MolecularDiagnosticsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net operating loss and tax credit carry forwards with unlimited expiration period.",
        "label": "Net Operating Loss And Tax Credit Carryforwards With Unlimited Expiration Period",
        "terseLabel": "Amount with unlimited carry forward periods"
       }
      }
     },
     "localname": "NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NetOperatingLossCarryforwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Operating Loss Carryforwards [Member]",
        "label": "Net Operating Loss Carryforwards [Member]",
        "terseLabel": "Net Operating Losses Carryforwards"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_NonIncomeTaxLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-Income Tax Loss",
        "label": "Non-Income Tax Loss",
        "terseLabel": "Non-income tax loss"
       }
      }
     },
     "localname": "NonIncomeTaxLoss",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NonqualifiedDeferredCompensationPlanAnnualContribution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nonqualified deferred compensation plan annual contribution.",
        "label": "Nonqualified Deferred Compensation Plan Annual Contribution",
        "terseLabel": "Compensation expense for the DCP discretionary contributions"
       }
      }
     },
     "localname": "NonqualifiedDeferredCompensationPlanAnnualContribution",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NotionalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Notional Amount",
        "label": "Notional Amount",
        "terseLabel": "Notional Amount"
       }
      }
     },
     "localname": "NotionalAmount",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NovemberEighteenTwoThousandTenOriginalNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "November eighteen two thousand ten original notes.",
        "label": "November Eighteen Two Thousand Ten Original Notes [Member]",
        "terseLabel": "November 18, 2010 Original Notes"
       }
      }
     },
     "localname": "NovemberEighteenTwoThousandTenOriginalNotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of customers with balance greater than specified percentage.",
        "label": "Number Of Customers With Balance Greater Than Specified Percentage",
        "terseLabel": "Number of customers with balance greater than specified percentage"
       }
      }
     },
     "localname": "NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issuable under employee stock purchase plan.",
        "label": "Number Of Shares Issuable Under Employee Stock Purchase Plan",
        "terseLabel": "Number of shares that may be issued under Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "NumberOfSharesIssuableUnderEmployeeStockPurchasePlan",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_OfferingPriceofPrincipalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Offering Price of Principal Amount",
        "label": "Offering Price of Principal Amount",
        "terseLabel": "Offering price of principal amount"
       }
      }
     },
     "localname": "OfferingPriceofPrincipalAmount",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OneThirdAnnuallyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "One Third Annually [Member]",
        "label": "One Third Annually [Member]",
        "terseLabel": "One Third Annually [Member]"
       }
      }
     },
     "localname": "OneThirdAnnuallyMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability",
        "label": "Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability",
        "totalLabel": "Total cash paid for amounts included in the measurement of lease liabilities"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Assets Policy [Text Block]",
        "label": "Other Assets Policy [Policy Text Block]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsPolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI",
        "terseLabel": "Changes in foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherGeographicRegionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Geographic Regions [Member]",
        "label": "Other Geographic Regions [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "OtherGeographicRegionsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_OtherOperatingCostReductionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other operating cost reductions.",
        "label": "Other Operating Cost Reductions [Member]",
        "terseLabel": "Previous Other Charges"
       }
      }
     },
     "localname": "OtherOperatingCostReductionsMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_OtherRestructuringPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments to settle other restructuring charges.",
        "label": "Other Restructuring Payments",
        "negatedLabel": "Other payments"
       }
      }
     },
     "localname": "OtherRestructuringPayments",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherTypeofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Type of Revenue [Member]",
        "label": "Other Type of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherTypeofRevenueMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_OtheractionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other action [Member]",
        "label": "Other action [Member]",
        "terseLabel": "Other action [Member]"
       }
      }
     },
     "localname": "OtheractionMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PSUFreeCashFlowMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "PSU Free Cash Flow [Member]",
        "label": "PSU Free Cash Flow [Member]",
        "terseLabel": "PSU Free Cash Flow [Member]"
       }
      }
     },
     "localname": "PSUFreeCashFlowMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.",
        "label": "Payment For Tax Withholding Related To Vested And Released Restricted Stock Units",
        "negatedTerseLabel": "Payment of minimum tax withholdings on net share settlements of equity awards"
       }
      }
     },
     "localname": "PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the cash payment of contingent consideration to the former shareholders of the acquired company.",
        "label": "Payment Of Contingent Consideration",
        "terseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentOfContingentConsideration",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Payments To Manufacture Equipment Under Customer Usage Agreements",
        "negatedLabel": "Increase in equipment under customer usage agreements"
       }
      }
     },
     "localname": "PaymentsToManufactureEquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PensioninAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pension in Accumulated Other Comprehensive Income [Member]",
        "label": "Pension in Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Pension in Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "PensioninAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of award vested upon meeting defined market based criteria",
        "label": "Percentage Of Award Vested Upon Meeting Defined Market Based Criteria",
        "terseLabel": "Percentage of award vested upon meeting defined market based criteria"
       }
      }
     },
     "localname": "PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the percentage applied to the lower of the common stock price at the beginning of the plan period and end of the plan period to determine the number of shares to be issued under the employee stock purchase plan.",
        "label": "Percentage Of Purchase Price Of Common Stock Lower Than Fair Market Value Of Common Stock On Date Of Purchase",
        "terseLabel": "Percentage of common stock price for ESPP"
       }
      }
     },
     "localname": "PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentageOfRevenues": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of revenues.",
        "label": "Percentage Of Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "PercentageOfRevenues",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the percentage of restricted stock units that vest annually per the terms of the typical restricted stock unit grant arrangement.",
        "label": "Percentage Of Vesting For Restricted Stock Units Granted To Employees",
        "terseLabel": "Percentage of vesting for RSUs granted to employees"
       }
      }
     },
     "localname": "PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentageOfVestingForStockOptionsGrantedToEmployees": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the percentage of stock options that vest annually per the terms of the typical stock option grant arrangement.",
        "label": "Percentage Of Vesting For Stock Options Granted To Employees",
        "terseLabel": "Percentage of vesting for stock options granted to employees"
       }
      }
     },
     "localname": "PercentageOfVestingForStockOptionsGrantedToEmployees",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage Price of Principal Amount for Repurchase of Senior Notes",
        "label": "Percentage Price of Principal Amount for Repurchase of Senior Notes",
        "terseLabel": "Percentage price of principal amount for repurchase of senior notes"
       }
      }
     },
     "localname": "PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PrincipalAmountOfBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.",
        "label": "Principal Amount Of Borrowings",
        "terseLabel": "Principal amount of borrowings",
        "verboseLabel": "Borrowed principal under credit agreement"
       }
      }
     },
     "localname": "PrincipalAmountOfBorrowings",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProceedsfromSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from Senior Notes",
        "label": "Proceeds from Senior Notes",
        "terseLabel": "Proceeds from Senior Notes"
       }
      }
     },
     "localname": "ProceedsfromSeniorNotes",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProfitSharingFourZeroOneKPlanTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Profit Sharing Four Zero One K plan [Text Block]",
        "label": "Profit Sharing Four Zero One K Plan [Text Block]",
        "terseLabel": "Profit Sharing 401(k) Plan"
       }
      }
     },
     "localname": "ProfitSharingFourZeroOneKPlanTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/A401kPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ProjectedBenefitObligationForLongTermServiceAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Projected Benefit Obligation For Long Term Service Awards",
        "label": "Projected Benefit Obligation For Long Term Service Awards",
        "terseLabel": "Projected benefit obligation for long-term service awards"
       }
      }
     },
     "localname": "ProjectedBenefitObligationForLongTermServiceAwards",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Propertyclosurebenefit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Property closure benefit",
        "label": "Property closure benefit",
        "terseLabel": "Property closure benefit"
       }
      }
     },
     "localname": "Propertyclosurebenefit",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Propertyclosurecostpayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Property closure cost payment",
        "label": "Property closure cost payment",
        "terseLabel": "Property closure cost payment"
       }
      }
     },
     "localname": "Propertyclosurecostpayment",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Purchaseobligationthereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase obligation thereafter",
        "label": "Purchase obligation thereafter",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "Purchaseobligationthereafter",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Purchaseofcostmethodinvestment": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase of cost method investment",
        "label": "Purchase of cost method investment",
        "negatedTerseLabel": "Purchase of cost method investment"
       }
      }
     },
     "localname": "Purchaseofcostmethodinvestment",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Purchaseofinsurancecontracts": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase of insurance contracts",
        "label": "Purchase of insurance contracts",
        "negatedTerseLabel": "Purchase of insurance contracts"
       }
      }
     },
     "localname": "Purchaseofinsurancecontracts",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Redemption price as percentage of principal amount plus accrued and unpaid interest.",
        "label": "Redemption Price As Percentage Of Principal Amount Plus Accrued And Unpaid Interest",
        "terseLabel": "Redemption price as percentage of principle amount plus accrued and unpaid interest"
       }
      }
     },
     "localname": "RedemptionPriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterest",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_ReductionOfWorkforceExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail": {
       "order": 1.0,
       "parentTag": "holx_RestructuringChargesUnderExitOrDisposalPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents severance and related benefit charges for the termination of employees under an exit or disposal activity. Charges are recorded either as one-time termination benefits, which are recognized ratable over the required service period to receive such benefit, or under an ongoing benefit plan arrangement once the charge is probable and reasonably estimable.",
        "label": "Reduction Of Workforce Expenses",
        "terseLabel": "Workforce reductions"
       }
      }
     },
     "localname": "ReductionOfWorkforceExpenses",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RemainingLeaseBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remaining lease balance",
        "label": "Remaining lease balance",
        "terseLabel": "Remaining lease balance"
       }
      }
     },
     "localname": "RemainingLeaseBalance",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RepaymentofSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Repayment of Senior Notes",
        "label": "Repayment of Senior Notes",
        "negatedTerseLabel": "Repayment of Senior Notes"
       }
      }
     },
     "localname": "RepaymentofSeniorNotes",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Repaymentofacquireddebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Repayment of acquired debt",
        "label": "Repayment of acquired debt",
        "negatedTerseLabel": "Repayment of acquired debt"
       }
      }
     },
     "localname": "Repaymentofacquireddebt",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RestructuringChargesUnderExitOrDisposalPlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total restructuring charges under exit or disposal plan.",
        "label": "Restructuring Charges Under Exit Or Disposal Plan",
        "terseLabel": "Fiscal restructuring charges",
        "totalLabel": "Fiscal restructuring charges"
       }
      }
     },
     "localname": "RestructuringChargesUnderExitOrDisposalPlan",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue [Member]",
        "label": "Revenue [Member]",
        "terseLabel": "Total revenues [Member]"
       }
      }
     },
     "localname": "RevenueMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Revolver2017Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolver 2017 [Member]",
        "label": "Revolver 2017 [Member]",
        "terseLabel": "2017 Revolver"
       }
      }
     },
     "localname": "Revolver2017Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolver [Member]",
        "label": "Revolver [Member]",
        "terseLabel": "Revolver"
       }
      }
     },
     "localname": "RevolverMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of significant assumptions used during the year to estimate the fair value of employee stock purchase plan shares, including, but not limited to: (a) expected term, (b) expected volatility, (c) risk-free interest rate, and (d) dividend yield.",
        "label": "Schedule Of Assumptions For Employee Stock Purchase Plan [Table Text Block]",
        "terseLabel": "Black-Scholes Model Weighted Average Assumptions Used to Estimate Fair Value of Shares to Be Issued as of Grant Date"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Line Items]",
        "label": "Schedule Of Geographical Segments [Line Items]",
        "terseLabel": "Schedule Of Geographical Segments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsLineItems",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Table]",
        "label": "Schedule Of Geographical Segments [Table]",
        "terseLabel": "Schedule Of Geographical Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsTable",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfGoodwillBySegmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill by segment table.",
        "label": "Schedule Of Goodwill By Segment Table [Text Block]",
        "terseLabel": "Rollforward of Goodwill Activity by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillBySegmentTableTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of interest expense under convertible notes.",
        "label": "Schedule Of Interest Expense Under Convertible Notes [Table Text Block]",
        "terseLabel": "Interest Expense under Convertible Notes"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of share-based compensation expense.",
        "label": "Schedule Of Share Based Compensation Expense [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense in Consolidated Statement of Operations"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationExpenseTableTextBlock",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_SecuredTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Secured Term Loan [Member]",
        "label": "Secured Term Loan [Member]",
        "terseLabel": "Secured Term Loan"
       }
      }
     },
     "localname": "SecuredTermLoanMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SegmentReportingDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Segment Reporting Disclosure [Line Items]",
        "label": "Segment Reporting Disclosure [Line Items]",
        "terseLabel": "Segment Reporting Disclosure [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureLineItems",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SegmentReportingDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Segment Reporting Disclosure [Table]",
        "label": "Segment Reporting Disclosure [Table]",
        "terseLabel": "Segment Reporting Disclosure [Table]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTable",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SemiAnnualEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Semi Annual Employee Stock Purchase Plan [Member]",
        "label": "Semi Annual Employee Stock Purchase Plan [Member]",
        "terseLabel": "2012 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "SemiAnnualEmployeeStockPurchasePlanMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life",
        "terseLabel": "Options exercisable at September 28, 2019",
        "verboseLabel": "Options outstanding at September 26, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share based compensation expense included other restructuring costs.",
        "label": "Share Based Compensation Expense Included Other Restructuring Costs",
        "negatedLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationExpenseIncludedOtherRestructuringCosts",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ShareBasedCompensationPercentageOfForfeitureRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forfeiture rate applied to equity awards issued to certain employee groups to determine stock-based compensation expense for the period. The rate is based on an analysis of historical employee exercise and terminations patterns.",
        "label": "Share Based Compensation Percentage Of Forfeiture Rate",
        "terseLabel": "Percentage of forfeiture rates"
       }
      }
     },
     "localname": "ShareBasedCompensationPercentageOfForfeitureRate",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share Repurchase Program [Member]",
        "label": "Share Repurchase Program [Member]",
        "terseLabel": "Share Repurchase Program [Member]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ShareRepurchseAuthorizationDateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share Repurchase Authorization Date [Axis]",
        "label": "Share Repurchse Authorization Date [Axis]",
        "terseLabel": "Share Repurchse Authorization Date [Axis]"
       }
      }
     },
     "localname": "ShareRepurchseAuthorizationDateAxis",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date",
        "terseLabel": "Cliff vesting period from grant date"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value (in millions)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "terseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTable",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SkeletalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Skeletal health.",
        "label": "Skeletal Health [Member]",
        "terseLabel": "Skeletal Health"
       }
      }
     },
     "localname": "SkeletalHealthMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_StateLossCarryforwardExpectedToUnutilize": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "state loss carryforward expected to unutilize",
        "label": "state loss carryforward expected to unutilize",
        "terseLabel": "state loss carryforward expected to unutilize"
       }
      }
     },
     "localname": "StateLossCarryforwardExpectedToUnutilize",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SuperSonicImagineMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "SuperSonic Imagine [Member]",
        "label": "SuperSonic Imagine [Member]",
        "terseLabel": "SuperSonic Imagine"
       }
      }
     },
     "localname": "SuperSonicImagineMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails",
      "http://www.hologic.com/role/BusinessCombinationsTables",
      "http://www.hologic.com/role/EquityMethodInvestmentDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TaxCreditCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Credit Carryforward [Member]",
        "label": "Tax Credit Carryforward [Member]",
        "terseLabel": "Tax Credit Carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Cuts And Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit)",
        "label": "Tax Cuts And Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Provisional estimate of tax benefit as result of Tax Cuts and Jobs Act"
       }
      }
     },
     "localname": "TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_TaxPositionsRelatedToCurrentYearAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax positions related to current year.",
        "label": "Tax Positions Related To Current Year [Abstract]",
        "terseLabel": "Tax positions related to current year:"
       }
      }
     },
     "localname": "TaxPositionsRelatedToCurrentYearAbstract",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_TaxPositionsRelatedToPriorYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax positions related to prior years.",
        "label": "Tax Positions Related To Prior Years [Abstract]",
        "terseLabel": "Tax positions related to prior years:"
       }
      }
     },
     "localname": "TaxPositionsRelatedToPriorYearsAbstract",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_Taxpaidoninterestrateswaps": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax paid on interest rate swaps",
        "label": "Tax paid on interest rate swaps",
        "terseLabel": "Tax paid on interest rate swaps"
       }
      }
     },
     "localname": "Taxpaidoninterestrateswaps",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_TepnelMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tepnel",
        "label": "Tepnel [Member]",
        "terseLabel": "Tepnel [Member]"
       }
      }
     },
     "localname": "TepnelMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TermARSecuritizationProgram": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Accounts Receivable Securitization Program",
        "label": "Term AR Securitization Program",
        "terseLabel": "Term of accounts receivable securitization program"
       }
      }
     },
     "localname": "TermARSecuritizationProgram",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_TermLoan2017Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan 2017 [Member]",
        "label": "Term Loan 2017 [Member]",
        "terseLabel": "2017 Term Loan"
       }
      }
     },
     "localname": "TermLoan2017Member",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TransitionServicesAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Transition Services Agreement Term",
        "label": "Transition Services Agreement Term",
        "terseLabel": "Transition services agreement term"
       }
      }
     },
     "localname": "TransitionServicesAgreementTerm",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_TwoThousandEightEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand Eight Equity Plan [Member].",
        "label": "Two Thousand Eight Equity Plan [Member]",
        "terseLabel": "2008 Equity Plan"
       }
      }
     },
     "localname": "TwoThousandEightEquityPlanMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TwoThousandSevenNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two thousand seven notes.",
        "label": "Two Thousand Seven Notes [Member]",
        "terseLabel": "2007 Notes"
       }
      }
     },
     "localname": "TwoThousandSevenNotesMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TwoThousandSeventeenMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand Seventeen [Member]",
        "label": "Two Thousand Seventeen [Member]",
        "terseLabel": "Fiscal 2017 charges:"
       }
      }
     },
     "localname": "TwoThousandSeventeenMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TwothousandeighteenMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two thousand eighteen [Member]",
        "label": "Two thousand eighteen [Member]",
        "terseLabel": "Fiscal 2018 charges:"
       }
      }
     },
     "localname": "TwothousandeighteenMember",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_UKIntangibleassets": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "UK Intangible assets",
        "label": "UK Intangible assets",
        "terseLabel": "UK Intangible assets"
       }
      }
     },
     "localname": "UKIntangibleassets",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_UnrecognizedTaxBenefitsIncreasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrecognized tax benefits increases.",
        "label": "Unrecognized Tax Benefits Increases [Abstract]",
        "terseLabel": "Acquired tax positions:"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesAbstract",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_UnusedCreditFacility": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unused credit facility",
        "label": "Unused credit facility",
        "terseLabel": "Unused credit facility"
       }
      }
     },
     "localname": "UnusedCreditFacility",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/OperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_WarrantyTermForProducts": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warranty Term For Products",
        "label": "Warranty Term For Products",
        "terseLabel": "Product Warranty Term"
       }
      }
     },
     "localname": "WarrantyTermForProducts",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units",
        "label": "Weighted Average Common Stock Equivalents From Assumed Exercise Of Stock Options And Restricted Stock Units",
        "terseLabel": "Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units (in shares)"
       }
      }
     },
     "localname": "WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits",
     "nsuri": "http://www.hologic.com/20200926",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia-Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r183",
      "r192"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r195",
      "r319",
      "r322",
      "r610",
      "r611"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r197",
      "r319",
      "r323",
      "r612",
      "r615",
      "r616"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r279",
      "r570"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "ASU No. 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201801Member": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2018-01 Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842.",
        "label": "Accounting Standards Update 2018-01 [Member]",
        "terseLabel": "Accounting Standards Update 2018-01 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201801Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableFromSecuritization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount owed to the reporting entity by counterparties in securitized loan transactions.",
        "label": "Accounts Receivable from Securitization",
        "terseLabel": "Accounts receivable from securitization"
       }
      }
     },
     "localname": "AccountsReceivableFromSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r19",
      "r42",
      "r199",
      "r200",
      "r320"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less reserves of $31.6 and $17.8, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "auth_ref": [
      "r27",
      "r28",
      "r64"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Employee Benefits, Current",
        "terseLabel": "Compensation and employee benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedRentNoncurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer) for contractual rent under lease arrangements.",
        "label": "Accrued Rent, Noncurrent",
        "verboseLabel": "Accrued lease obligation\u2014long-term"
       }
      }
     },
     "localname": "AccruedRentNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r58",
      "r255"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less - accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r85",
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r82",
      "r87",
      "r89",
      "r90",
      "r525",
      "r533",
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r87",
      "r89",
      "r90"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r86",
      "r90",
      "r93",
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r83",
      "r90",
      "r93",
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average amortization period"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in-Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r133",
      "r243"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by new accounting pronouncement.",
        "label": "Adjustments for New Accounting Pronouncements [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Adjustments to APIC, equity component of convertible debt",
        "verboseLabel": "Reacquisition of equity component from convertible notes repurchase, net of taxes"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r371",
      "r373",
      "r407",
      "r408"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r411"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising cost"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/A401kPlanAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r373",
      "r400",
      "r406"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r201",
      "r207",
      "r209",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance\u00a0at End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning of Period"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r48",
      "r201",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, reserves"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Allowance for Doubtful Accounts Receivable [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r115",
      "r133",
      "r536"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r133",
      "r538"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r133",
      "r235",
      "r243"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted-average anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r133",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r188",
      "r577",
      "r598"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Identifiable assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r21",
      "r23",
      "r79"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r12",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets disposed of"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r374",
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r495",
      "r498"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r26",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and Improvements, Gross"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails",
      "http://www.hologic.com/role/BusinessCombinationsTables",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r452",
      "r453"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails",
      "http://www.hologic.com/role/BusinessCombinationsTables",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails",
      "http://www.hologic.com/role/BusinessCombinationsTables",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r463",
      "r464",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r132",
      "r468"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Increase in contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r462",
      "r465",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "negatedTerseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r416",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Identifiable intangible assets:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Identifiable intangible assets:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Acquired tangible assets and liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt",
        "negatedTerseLabel": "Long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Equity interest in acquiree (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock": {
     "auth_ref": [
      "r141",
      "r449",
      "r469"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control.",
        "label": "Business Combinations and Other Purchase of Business Transactions, Policy [Policy Text Block]",
        "terseLabel": "Business Combinations and Acquisition of Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r34",
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.",
        "label": "Capital Lease Obligations, Current",
        "terseLabel": "Finance lease obligation (capital lease obligation in 2019)"
       }
      }
     },
     "localname": "CapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeaseObligationsNoncurrent": {
     "auth_ref": [
      "r67",
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.",
        "label": "Capital Lease Obligations, Noncurrent",
        "terseLabel": "Finance lease obligation - long term (capital lease obligation in 2019)"
       }
      }
     },
     "localname": "CapitalLeaseObligationsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of minimum lease payments for capital leases.",
        "label": "Capital Leases, Future Minimum Payments Due",
        "terseLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "CapitalLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capital Leases, Future Minimum Payments Due, Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "CapitalLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of minimum lease payments for capital leases due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capital Leases, Future Minimum Payments Due in Five Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "CapitalLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capital Leases, Future Minimum Payments Due in Four Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "CapitalLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capital Leases, Future Minimum Payments Due in Three Years",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "CapitalLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capital Leases, Future Minimum Payments Due in Two Years",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "CapitalLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of minimum lease payments for capital leases due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capital Leases, Future Minimum Payments Due Thereafter",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "CapitalLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r17",
      "r55",
      "r135"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r31",
      "r136",
      "r142"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r129",
      "r135",
      "r140"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r129",
      "r532"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue": {
     "auth_ref": [
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of all asset derivatives designated as cash flow hedging instruments.",
        "label": "Cash Flow Hedge Derivative Instrument Assets at Fair Value",
        "terseLabel": "Cash Flow Hedge Derivative Instrument Assets at Fair Value"
       }
      }
     },
     "localname": "CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "auth_ref": [
      "r24",
      "r60"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.",
        "label": "Cash Surrender Value of Life Insurance",
        "terseLabel": "Life insurance contracts"
       }
      }
     },
     "localname": "CashSurrenderValueOfLifeInsurance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r69",
      "r278",
      "r586",
      "r605"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 13 and 14)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r277",
      "r287"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value \u2013 750,000 shares authorized; 295,107 and 292,323 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Compensation Related Costs [Abstract]",
        "terseLabel": "Compensation Related Costs [Abstract]"
       }
      }
     },
     "localname": "CompensationRelatedCostsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r96",
      "r98",
      "r99"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r176",
      "r177",
      "r529",
      "r530"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r176",
      "r177",
      "r529",
      "r530",
      "r613"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r173",
      "r594"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r176",
      "r177",
      "r529",
      "r530"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r142",
      "r475",
      "r484",
      "r485"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
        "label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was included in contract liability at prior year end"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r34",
      "r578",
      "r597",
      "r614"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes Payable"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods and services sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Costs of revenues:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
        "label": "Cumulative Effect of New Accounting Principle in Period of Adoption",
        "negatedTerseLabel": "Accounting standard transition adjustment"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r440",
      "r447"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r149",
      "r443"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r440",
      "r447"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Conversion [Line Items]",
        "terseLabel": "Debt Conversion [Line Items]"
       }
      }
     },
     "localname": "DebtConversionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtConversionTable": {
     "auth_ref": [
      "r138",
      "r139"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table that contains information on an original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion [Table]",
        "terseLabel": "Debt Conversion [Table]"
       }
      }
     },
     "localname": "DebtConversionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings and Credit Agreements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r578",
      "r581",
      "r597"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "verboseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r537",
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Debt instrument face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (percent)",
        "verboseLabel": "Percentage of accrued interest on Convertible Notes"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFiveMember": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Five [Member]",
        "terseLabel": "Period Five"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFiveMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Four [Member]",
        "terseLabel": "Period Four"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFourMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of principal amount of debt redeemed.",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "terseLabel": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r67",
      "r144",
      "r308",
      "r309",
      "r310",
      "r311",
      "r536",
      "r537",
      "r539",
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]",
        "terseLabel": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
        "label": "Deferred Compensation Liability, Current and Noncurrent",
        "terseLabel": "Deferred Compensation Liability, Current and Noncurrent"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r442",
      "r447"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r442",
      "r447"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Manufacturing access fees"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r143",
      "r442",
      "r447"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes and other non-cash taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r38",
      "r39",
      "r431",
      "r579",
      "r596"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r417",
      "r435"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r442",
      "r447"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "auth_ref": [
      "r414",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "terseLabel": "Capital losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax assets, gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r433"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r413",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r414",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other temporary differences"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r436",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r413",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r413",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Non-deductible accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r413",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Non-deductible reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r417",
      "r435"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities": {
     "auth_ref": [
      "r331",
      "r340",
      "r580",
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan",
        "negatedTerseLabel": "Defined benefit pension plan, liabilities"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r348",
      "r365",
      "r367"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]",
        "terseLabel": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r333"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedPeriodEndLabel": "Benefit obligation at end of year",
        "negatedPeriodStartLabel": "Benefit obligation at beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r338",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Plan participants\u2019 contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter",
        "terseLabel": "2026 to 2030"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in next fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months",
        "terseLabel": "2017"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in fifth fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in fourth fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in third fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in second fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r347",
      "r364",
      "r367"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r339",
      "r341",
      "r342",
      "r367"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r331",
      "r340"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Benefit obligation at end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r335",
      "r346",
      "r363",
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "negatedLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r344",
      "r361",
      "r367"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "auth_ref": [
      "r357",
      "r358",
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "negatedTerseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
     "auth_ref": [
      "r357",
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "negatedTerseLabel": "Projected benefit obligation in excess of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r349",
      "r366"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedLabel": "Recognized net actuarial gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r334",
      "r345",
      "r362",
      "r367"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail",
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r355",
      "r356",
      "r359",
      "r360",
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Contribution Plan [Abstract]",
        "terseLabel": "Defined Contribution Plan [Abstract]"
       }
      }
     },
     "localname": "DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Contributions made by company"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/A401kPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r133",
      "r253"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r496",
      "r497",
      "r503",
      "r508"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r492",
      "r496",
      "r503",
      "r508",
      "r509",
      "r514",
      "r515"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": {
     "auth_ref": [
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.",
        "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred",
        "terseLabel": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r80",
      "r81",
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r488",
      "r489",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r150",
      "r487",
      "r490",
      "r491",
      "r492",
      "r494",
      "r499",
      "r503",
      "r511",
      "r513",
      "r515"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Derivative contract period, or less"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r142",
      "r151",
      "r487",
      "r490",
      "r492",
      "r494",
      "r512"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology",
        "verboseLabel": "Developed\u00a0technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueNarrativeDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueNarrativeDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stockholders' Equity and Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).",
        "label": "Disclosure of Long Lived Assets Held-for-sale [Table Text Block]",
        "terseLabel": "Disclosure of Long Lived Assets Held-for-sale"
       }
      }
     },
     "localname": "DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r251",
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by Sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Sales price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r9"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "terseLabel": "Loss from operations"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r252",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DistributionRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.",
        "label": "Distribution Rights [Member]",
        "terseLabel": "Distribution agreement"
       }
      }
     },
     "localname": "DistributionRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income (loss) per common share attributable to Hologic:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r105",
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r167",
      "r589",
      "r609"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r105",
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r167",
      "r589",
      "r609"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted net income per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r142",
      "r164",
      "r165",
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectOfFourthQuarterEventsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Effect of Fourth Quarter Events [Line Items]",
        "terseLabel": "Effect of Fourth Quarter Events [Line Items]"
       }
      }
     },
     "localname": "EffectOfFourthQuarterEventsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r148",
      "r419",
      "r420"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Increase (decrease) in tax resulting from:"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r419",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Income tax (benefit) provision at federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r419",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r419",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Change in deferred tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities": {
     "auth_ref": [
      "r419",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for qualified production activity.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent",
        "negatedLabel": "Domestic production activities deduction"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r419",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "negatedLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges": {
     "auth_ref": [
      "r419",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to restructuring charges.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent",
        "terseLabel": "Internal restructuring"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r419",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 14.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": {
     "auth_ref": [
      "r419",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent",
        "terseLabel": "U.S. tax on foreign earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r419",
      "r420",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r402"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period of unrecognized stock-based compensation, years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "verboseLabel": "Tax benefit related to stock based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/RevenueNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of Debt, Amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r518",
      "r524"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r518",
      "r527",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r341",
      "r342",
      "r367",
      "r519",
      "r571"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r341",
      "r342",
      "r367",
      "r519",
      "r572"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Prices\u00a0in Active\u00a0Market\u00a0for Identical\u00a0Assets (Level\u00a01)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r341",
      "r342",
      "r367",
      "r519",
      "r573"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs\u00a0(Level\u00a02)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r341",
      "r342",
      "r367",
      "r519",
      "r574"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs\u00a0(Level\u00a03)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r518",
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Liabilities measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Contingent consideration recorded at acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payments/Accruals"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]",
        "terseLabel": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r147",
      "r418"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "Federal, Total"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Federal:"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r553",
      "r558",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance lease cost - interest cost"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r555",
      "r560"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails": {
       "order": 1.0,
       "parentTag": "holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Lease"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r551",
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities (current)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Finance Lease, Liability, Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liabilities (non-current)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due after fifth fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in next fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Next Twelve Months",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fifth fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fourth fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in third fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in second fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r554",
      "r560"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails": {
       "order": 2.0,
       "parentTag": "holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under finance lease.",
        "label": "Finance Lease, Right-of-Use Asset",
        "terseLabel": "Finance Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r553",
      "r558",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance lease cost - amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r563",
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases, weighted average discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r562",
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases, weighted average remaining lease term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r208",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months",
        "terseLabel": "Fiscal 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
        "terseLabel": "Fiscal 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
        "terseLabel": "Fiscal 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r236",
      "r239",
      "r242",
      "r246",
      "r576"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r242",
      "r576"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r236",
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r142",
      "r531",
      "r534"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).",
        "label": "Foreign Exchange Option [Member]",
        "terseLabel": "Foreign Exchange Option"
       }
      }
     },
     "localname": "ForeignExchangeOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Foreign Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "Foreign, Total"
       }
      }
     },
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Foreign Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Foreign:"
       }
      }
     },
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and Fixtures, Gross"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "terseLabel": "Gain (Loss) on Fair Value Hedges Recognized in Earnings"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesGainLossonFairValueHedgesRecognizedinEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet": {
     "auth_ref": [
      "r496",
      "r503",
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate impact of foreign currency derivatives on earnings for the period. Includes impact of foreign currency cash flow hedge ineffectiveness and the ineffectiveness of fair value hedging derivatives and full change in fair value of the foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivatives Recorded in Earnings, Net",
        "terseLabel": "Gain (loss) on derivative"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r133",
      "r304",
      "r305"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Debt extinguishment losses",
        "negatedTerseLabel": "Debt extinguishment loss",
        "terseLabel": "Debt extinguishment losses"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r225",
      "r227"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance at September 26, 2020",
        "periodStartLabel": "Balance at September 28, 2019",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "SuperSonic Imagine acquisition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and Intangible Asset Impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency and other adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r133",
      "r226",
      "r229",
      "r232"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charge",
        "verboseLabel": "Impairment of goodwill"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r492",
      "r509"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r133",
      "r247"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r103",
      "r133",
      "r186",
      "r204",
      "r587",
      "r607"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Proportionate share of net loss of equity method investment",
        "terseLabel": "Income (loss) from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r11",
      "r13",
      "r14",
      "r15",
      "r260",
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r187",
      "r448"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Benefit for income taxes",
        "totalLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReceivable": {
     "auth_ref": [
      "r54",
      "r595"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.",
        "label": "Income Taxes Receivable",
        "terseLabel": "Income Taxes Receivable"
       }
      }
     },
     "localname": "IncomeTaxReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r130",
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid during the period for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other activity"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r238",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r238",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r234",
      "r240"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r101",
      "r185",
      "r535",
      "r538",
      "r591"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseBorrowings": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate amount of interest expense on all borrowings.",
        "label": "Interest Expense, Borrowings",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r115",
      "r303"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense",
        "totalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "2.00% accrued interest"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate caps - derivative"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeAssetAtFairValue": {
     "auth_ref": [
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.",
        "label": "Interest Rate Cash Flow Hedge Asset at Fair Value",
        "terseLabel": "Interest rate caps - derivative"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap [Member]"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r18",
      "r77",
      "r220"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r30",
      "r78",
      "r142",
      "r168",
      "r221",
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r114",
      "r184"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value on a recurring basis",
        "verboseLabel": "Investments, fair value"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_JudicialRulingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation outcome that occurs as a result of judicial intervention, supervision, or approval.",
        "label": "Judicial Ruling [Member]",
        "terseLabel": "Judicial Ruling"
       }
      }
     },
     "localname": "JudicialRulingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r25",
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r26",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold Improvements, Gross"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases, Capital [Abstract]",
        "terseLabel": "Finance Lease"
       }
      }
     },
     "localname": "LeasesCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details",
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorSalesTypeLeasesTextBlock": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of lessor's sales-type leases.",
        "label": "Lessor, Sales-type Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorSalesTypeLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r47",
      "r583",
      "r603"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r10",
      "r12",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities disposed of"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Reserve for income tax uncertainties"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate at end of period",
        "verboseLabel": "Interest rate at end of period"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Weighted average interest rate",
        "verboseLabel": "Weighted-average interest rate (percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r62",
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r36",
      "r301",
      "r581",
      "r600"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current debt obligations, net of debt discount",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r153",
      "r297"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal after Year Five",
        "terseLabel": "2026 and Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r153",
      "r297"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r153",
      "r297"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r153",
      "r297"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r153",
      "r297"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r153",
      "r297"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "verboseLabel": "Total long-term debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r67",
      "r298"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseunderConvertibleNotesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r286",
      "r288",
      "r289"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r278",
      "r281",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Awarded damages"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r73",
      "r582",
      "r602"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "negatedTerseLabel": "Increase to cash flows used in financing activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r129",
      "r131",
      "r134"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r94",
      "r97",
      "r104",
      "r134",
      "r165",
      "r588",
      "r608"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to Hologic",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-competition agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.",
        "label": "Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable",
        "negatedTerseLabel": "Net loss attributable to noncontrolling interest",
        "terseLabel": "Net loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r313",
      "r456",
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Noncontrolling Interest, Increase from Business Combination"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/OperationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r90",
      "r100"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Loss recognized in other comprehensive income (loss), net"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating Expense"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r559",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r551"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r551"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities (current)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r551"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities (non-current)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease liability.",
        "label": "Operating Lease, Liability, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r556",
      "r560"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails": {
       "order": 3.0,
       "parentTag": "holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease, right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r563",
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases, weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r562",
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases, weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r540",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "terseLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r540",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r540",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r540",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r540",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r540",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r540",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future minimum rental payments in aggregate as of the balance sheet date under operating leases.",
        "label": "Operating Leases, Future Minimum Payments Receivable",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future rental payments receivable within one year of the balance sheet date under an operating lease.",
        "label": "Operating Leases, Future Minimum Payments Receivable, Current",
        "terseLabel": "Fiscal 2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future rental payments receivable within the fifth year from the balance sheet date under an operating lease.",
        "label": "Operating Leases, Future Minimum Payments Receivable, in Five Years",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future rental payments receivable within the fourth year from the balance sheet date under an operating lease.",
        "label": "Operating Leases, Future Minimum Payments Receivable, in Four Years",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future rental payments receivable within the third year from the balance sheet date under an operating lease.",
        "label": "Operating Leases, Future Minimum Payments Receivable, in Three Years",
        "terseLabel": "Fiscal 2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future rental payments receivable within the second year from the balance sheet date under an operating lease.",
        "label": "Operating Leases, Future Minimum Payments Receivable, in Two Years",
        "terseLabel": "Fiscal 2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableThereafter": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future minimum lease payments receivable under operating leases for periods greater than five years following the balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Receivable, Thereafter",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableThereafter",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": {
     "auth_ref": [
      "r541",
      "r542",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for lessor's operating leases.",
        "label": "Lessor, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "OperatingLeasesOfLessorDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseSubleaseRentals1": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.",
        "label": "Operating Leases, Rent Expense, Sublease Rentals",
        "terseLabel": "Rent expense on sublease rentals"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseSubleaseRentals1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r16",
      "r486"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Operations"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/Operations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r64"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r495",
      "r514"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneous": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other miscellaneous assets.",
        "label": "Other Assets, Miscellaneous",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneous",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent": {
     "auth_ref": [
      "r473",
      "r474",
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent",
        "terseLabel": "Changes in unrealized holding gains and losses on available-for-sale securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r85",
      "r87",
      "r473",
      "r479"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedLabel": "Adjustment to minimum pension liability, net",
        "negatedTerseLabel": "Changes in pension plans, net of taxes of $0.1 in 2020, $0.3 in 2019, and $(0.6) in 2018",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent": {
     "auth_ref": [
      "r473",
      "r474",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent",
        "terseLabel": "Change in pension plans, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r473",
      "r474",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax": {
     "auth_ref": [
      "r84",
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax",
        "terseLabel": "Changes in value of hedged interest rate caps, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r95",
      "r98",
      "r473",
      "r474",
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r95",
      "r98",
      "r473",
      "r474",
      "r479"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r87",
      "r91",
      "r92",
      "r203"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedLabel": "Loss (gain) reclassified from accumulated other comprehensive income (loss) to the statement of operations",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [
      "r87",
      "r91",
      "r92",
      "r493"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax",
        "negatedTerseLabel": "Loss reclassified from accumulated other comprehensive loss to the statement of operations, net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r84",
      "r87",
      "r516"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "(Loss) gain recognized, net of tax of $(8.3) million in 2020 and $1.2 million in 2019 for interest rate swaps",
        "verboseLabel": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r84",
      "r87",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax",
        "terseLabel": "Unrealized losses on derivatives, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other Income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "negatedTerseLabel": "Other long-term liabilities",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Other\u00a0Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of other liabilities.",
        "label": "Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments and non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r330",
      "r355",
      "r356",
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Nonqualified Deferred Compensation Plan [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r37",
      "r580",
      "r599"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "auth_ref": [
      "r147",
      "r418",
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other income tax expense (benefit).",
        "label": "Other Tax Expense (Benefit)",
        "terseLabel": "Other Tax Expense (Benefit)"
       }
      }
     },
     "localname": "OtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment for Contingent Consideration Liability, Financing Activities",
        "terseLabel": "Payment of contingent holdbacks"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of debt issuance costs",
        "terseLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Purchase of equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "terseLabel": "Payments to Acquire in Process Research and Development"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Payments to Noncontrolling Interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]",
        "terseLabel": "Pension and Other Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r37",
      "r331",
      "r332",
      "r340"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Pension liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r329",
      "r355",
      "r356",
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r374",
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value \u2013 1,623 shares authorized; 0 shares issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r21",
      "r53",
      "r54"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r20",
      "r22",
      "r223",
      "r224"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromAccountsReceivableSecuritization": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.",
        "label": "Proceeds from Accounts Receivable Securitization",
        "terseLabel": "Proceeds from accounts receivable securitization agreement"
       }
      }
     },
     "localname": "ProceedsFromAccountsReceivableSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Net proceeds from sale of business",
        "verboseLabel": "Proceeds from divestiture of businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds from issuance of senior long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r121",
      "r404"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Net proceeds from issuance of common stock under employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r122",
      "r145"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit line"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/OperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from other long-term debt.",
        "label": "Proceeds from (Repayments of) Other Long-term Debt",
        "terseLabel": "Proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepurchaseOfEquity": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow or outflow resulting from the entity's share transaction.",
        "label": "Proceeds from (Repurchase of) Equity",
        "terseLabel": "Common stock repurchases"
       }
      }
     },
     "localname": "ProceedsFromRepurchaseOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r294",
      "r295",
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Balance\u00a0at\u00a0End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning\u00a0of Period"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition": {
     "auth_ref": [
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from a business acquisition.",
        "label": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition",
        "terseLabel": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition"
       }
      }
     },
     "localname": "ProductWarrantyAccrualAdditionsFromBusinessAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Settlements/ Adjustments"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r94",
      "r97",
      "r128",
      "r188",
      "r193",
      "r473",
      "r476",
      "r477",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss) attributable to Hologic",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r58",
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r57",
      "r254"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, Plant and Equipment, Gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r32",
      "r33",
      "r256",
      "r604"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "negatedTerseLabel": "Property, plant and equipment, net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r56",
      "r142",
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r32",
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r32",
      "r254"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "verboseLabel": "Property, plant and equipment, estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r107",
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Charged\u00a0to Costs and Expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement maturing in the fifth fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.",
        "label": "Purchase Obligation, Due in Fifth Year",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "PurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFourthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement maturing in the fourth fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.",
        "label": "Purchase Obligation, Due in Fourth Year",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "PurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement maturing in the next fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.",
        "label": "Purchase Obligation, Due in Next Twelve Months",
        "terseLabel": "Fiscal 2021"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement maturing in the second fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.",
        "label": "Purchase Obligation, Due in Second Year",
        "terseLabel": "Fiscal 2022"
       }
      }
     },
     "localname": "PurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement maturing in the third fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.",
        "label": "Purchase Obligation, Due in Third Year",
        "terseLabel": "Fiscal 2023"
       }
      }
     },
     "localname": "PurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]",
        "terseLabel": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Quarterly Statement of Operations Information (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r90",
      "r93",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Changes in accumulated balances of other comprehensive income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfAccountsReceivableSecuritization": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.",
        "label": "Repayments of Accounts Receivable Securitization",
        "negatedTerseLabel": "Repayments under accounts receivable securitization agreement",
        "terseLabel": "Repayments under accounts receivable securitization agreement"
       }
      }
     },
     "localname": "RepaymentsOfAccountsReceivableSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/OperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "negatedTerseLabel": "Payments to extinguish convertible notes",
        "terseLabel": "Repayments of convertible debt"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r124",
      "r145"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayments under revolving credit line",
        "terseLabel": "Repayments under revolving credit line"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/OperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).",
        "label": "Repayments of Long-term Capital Lease Obligations",
        "negatedTerseLabel": "Payments under finance lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
        "label": "Repayments of Other Long-term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "terseLabel": "Repayments of secured debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r412",
      "r617"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r59",
      "r142",
      "r248",
      "r249",
      "r617"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "terseLabel": "Research and Software Development Costs"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
        "terseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)"
       }
      }
     },
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "terseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r133",
      "r262",
      "r268",
      "r272"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring and divestiture charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesMember": {
     "auth_ref": [
      "r264",
      "r268",
      "r273"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included.",
        "label": "Restructuring Charges [Member]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringChargesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r263",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r44",
      "r312",
      "r601"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]",
        "verboseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r329",
      "r330",
      "r355",
      "r356",
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail",
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r329",
      "r330",
      "r355",
      "r356",
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail",
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r318",
      "r319"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Revenue from product and services"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Estimated remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligation over time"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Remaining performance obligation over time (percent)"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r102",
      "r182",
      "r183",
      "r191"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r561",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use asset obtained in exchange for finance lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r561",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "ROU assets arising from entering into new operating lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Accounts Receivable Reserve Activity"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) Related to Derivatives"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Unrealized Loss Recognized in AOCI"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r452",
      "r453"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationSuperSonicImagineDetails",
      "http://www.hologic.com/role/BusinessCombinationsTables",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Statement Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Benefit Obligations, Plan Assets, Funded Status and Related Actuarial Assumptions"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Company's Borrowings and Interest Expense"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable": {
     "auth_ref": [
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule, table or text reflecting pension and other postretirement benefit arrangements with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]",
        "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Significant Components of the Company's Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments on the Consolidated Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r11",
      "r13",
      "r14",
      "r15",
      "r260",
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Disposed Business, Income from Operations and Assets held-for-sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Basic and Diluted Share Amounts"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about transactions recognized in the fourth quarter, including, but not limited to, disposals of components of an entity, unusual or infrequently occurring items, or both, effect from changes in accounting estimates and effect of year-end adjustments.",
        "label": "Effect of Fourth Quarter Events [Table]",
        "terseLabel": "Effect of Fourth Quarter Events [Table]"
       }
      }
     },
     "localname": "ScheduleOfEffectOfFourthQuarterEventsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Pension Benefit"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r518",
      "r519"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r526",
      "r527"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, Off-balance Sheet Risks [Table]",
        "terseLabel": "Schedule of Fair Value, Off-balance Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r236",
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r236",
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r231",
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Income (Loss) Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r30",
      "r50",
      "r51",
      "r52"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r62",
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Credit Agreements"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule Of Long Term Debt By Maturity Table"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Components of Net Periodic Benefit Cost and Related Actuarial Assumptions"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r502",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Gain (Loss) on Fair Value Hedges Recognized in Earnings"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Schedule of Product Warranty Activity"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r58",
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Purchase Price Allocation"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r266",
      "r267",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r266",
      "r267",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Charges Taken Related to Restructuring Actions"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r263",
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Charges Taken Related to Accrued Restructuring Actions"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r109",
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Revenues by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r109",
      "r197"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r181",
      "r188",
      "r189",
      "r190",
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r181",
      "r188",
      "r189",
      "r190",
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r374",
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r379",
      "r391",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Information Pertaining to Stock Options Granted and Related Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r430",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Activity of the Company's Unrecognized Income Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r585",
      "r606"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes principal amount"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r133",
      "r262",
      "r268",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "verboseLabel": "Severance charges"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Stock-based compensation, period of vest term granted to employees, years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Non-vested at September 26, 2020",
        "periodStartLabel": "Non-vested at September 28, 2019"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number\u00a0of Shares (in millions)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Non-vested at September 26, 2020",
        "periodStartLabel": "Non-vested at September 28, 2019"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant-Date\u00a0Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of RSUs vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Assumptions:"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "verboseLabel": "Risk-free interest rates"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- Average Remaining Contractual\u00a0Life (in Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable at September 26, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable at September 26, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Exercised",
        "verboseLabel": "Intrinsic value of option exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled/ forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled/ forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted",
        "verboseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Options outstanding at September 26, 2020",
        "periodStartLabel": "Options exercisable at September 28, 2019"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r381",
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding at September 26, 2020",
        "periodStartLabel": "Options exercisable at September 28, 2019"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of\u00a0Shares (in millions)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding at September 29, 2018",
        "periodStartLabel": "Options exercisable at September 28, 2019"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise\u00a0Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options vested and expected to vest at September 26, 2020 (1)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options vested and expected to vest at September 26, 2020 (1)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options vested and expected to vest at September 26, 2020 (1)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost",
        "terseLabel": "Incremental cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r372",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price",
        "verboseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r142",
      "r374",
      "r378"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r396",
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options exercisable at September 26, 2020"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable at September 26, 2020"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "terseLabel": "Weighted average grant date fair value (in usd per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options vested and expected to vest at September 26, 2020 (1)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, weighted average grant date fair value (in usd per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the standard product warranty accrual. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Period Increase (Decrease)",
        "terseLabel": "Standard Product Warranty Accrual, Period Increase (Decrease)"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r142",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r147",
      "r441",
      "r446"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "State, Total"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "State:"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r188",
      "r231",
      "r259",
      "r265",
      "r274",
      "r610"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/QuarterlyStatementofOperationsInformationUnauditedNarrativeDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r71",
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/RevenueNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Outstanding Stock Options and stock units [Member]"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r40",
      "r41",
      "r307",
      "r312"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under the employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r40",
      "r41",
      "r307",
      "r312",
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r40",
      "r41",
      "r307",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under the employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r71",
      "r307",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized value of common shares to be repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Period available for common stock to be repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r40",
      "r41",
      "r307",
      "r312"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r41",
      "r45",
      "r46",
      "r202"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Hologic's stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r471",
      "r472",
      "r481"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Credit carry forwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationAcessaDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFaxitronDetails",
      "http://www.hologic.com/role/BusinessCombinationsPurchasePriceAllocationFocalTherapeuticsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r70",
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r70",
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r41",
      "r307",
      "r312"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r70",
      "r314",
      "r315"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost \u2013 37,609 and 24,639 shares, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r307",
      "r312",
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.",
        "label": "Type of Adoption [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.",
        "label": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax",
        "terseLabel": "Unrealized gain (loss) on derivative"
       }
      }
     },
     "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.",
        "label": "Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss)",
        "terseLabel": "Unrealized gain on interest rate swap"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r415",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance as of the end of the fiscal year",
        "periodStartLabel": "Balance at beginning of fiscal year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions",
        "negatedLabel": "Reductions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Reductions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties Accrued",
        "terseLabel": "Income tax penalties accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Additions related to reserves acquired from acquisitions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions related to change in estimate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "terseLabel": "Interest accrued on unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Change in gross unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Lapses in statutes of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefit that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock": {
     "auth_ref": [
      "r275",
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of unconditional purchase obligations that are not recognized as a liability on the balance sheet, including the nature and significant terms of an unconditional purchase obligation; the amount of the fixed and determinable portion of the obligation as of the date of the latest balance sheet presented in the aggregate and, if determinable, for each of the five succeeding fiscal years; the nature of any variable components of the obligation; the amount purchased under the obligation (for example, the take-or-pay or throughput contract) for the reporting period; and may include the amount of imputed interest necessary to reduce the obligation to present value.",
        "label": "Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block]",
        "terseLabel": "Unrecorded Unconditional Purchase Obligations Disclosure"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r171",
      "r172",
      "r174",
      "r175",
      "r178",
      "r179",
      "r180"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Management's Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)",
        "negatedTerseLabel": "Decrease in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r159",
      "r163"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r158",
      "r163"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average anti-dilutive shares related to:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=118952077&loc=d3e1570-108306"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5865-108316"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(c))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=77896938&loc=d3e25287-109308"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=77896938&loc=d3e25336-109308"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409961&loc=d3e20487-108367"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116873391&loc=d3e408-128459"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5504-128473"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=13988685&loc=d3e8784-128493"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-02)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-03)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624186-113959"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41675-113959"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80845-113994"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13476-108611"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "Note 1",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "Note 3",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41499-112717"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=84164653&loc=d3e41551-112718"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=84164758&loc=d3e45023-112735"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918631-209977"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888252"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7,8)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r618": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r619": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r621": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r622": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r623": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r624": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r625": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r626": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>142
<FILENAME>0000859737-20-000039-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000859737-20-000039-xbrl.zip
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MW=3;.\__=(:"1^<'6C2@(%_R "O!0%$!GXU.1K$(2O@[0?EH>J;<OCL>#\^
M'1^WJ81[E\&N+-$EL[.*'("@6KU#%T/&X',5X]# MEK^&IR]:-4RA6EXB*/9
MO^_!I7D#08P$2=SC[?H.22[/CR;C3>:&Z0;7X9C+)DY?\?R,(-/A7.X;[WW7
M9I3D3 /3.>(7*E/&[H'8B<5\$;FMPUT9NUN"U"\C49[VY>.7KS9W1!&V\3N\
M4)F3D_;9[L[/!UL;?[R2<2W7W!2T29BQ>;JUT6S,R\/-C4?[F\\^4ID'3]SV
MAMS?XTVU)79)E.W^YJE<5UBW>;JI%D'KX>Z;S1</W_[G]/ZYG5BH3!$%4(42
M U(E-K+805)9@M;D7$B$.E5S[R=K_V7M!5TN^/&%?(%HVX1'JEF<B;,A6W:.
MD6NQ@:J+GS0.?\>7AX='H\D)3UO%TG28C]OU9^<D.J/._?'X&$>CD^5AQ_8&
M7;#CU4L9\UNGCQI+WHH-$'M0]G?EN,U30?ZTC+8.7BGQ&H>;#SZR!X=/1^)=
MK" IS'HH-N!WD2./]N5:IX*\O'YNMG=^%Z^Q^^8_I\_A3_8NFR!2!(WU W'B
M99!BU(,(I<H@);3!?0;?3YIZ4G+"%A:(G@&%&F.A3!*AN!"C\[FAV0H&3?ST
M1.%.*X9;>/MG/'T])-$^>U->6/@V=]@U5#N[%Z9;RT"2 7C?M.^*&E2;!WMM
MLF^T>7I?'/735S)(10ENOMGZB^E^?KH8@!N[<I^_R_=^/Y'(SHGC/MW<D',_
M;H-TJYU'_T?4Y%93CQM[T":&MS?V_JQ.630R*'-J<X=&RZM6 FM<)9T2EAA:
M@MAN?E%>$,DRI2K6&$%9EEC2JZA]K)8,Z?@N+1!74P^<;+Y/!$KX5 Y>OMC:
M7PR8TX<R"-O4_W/8?O&'F%DZ?2G?>WGX_.WF>Q-]^E+"-PD#Q2$_T2T<W!)V
M;&](>+;SRKQ\W ;TH^'NSM;A7TWTUJM-\W)_$0H>_"'_E\%ZN@>;XKBW=UZ^
MVI4!O?GBEWT)\=XN$H$/SDWTSJN3IA9U2QWY&@:)49QZ$P61R ^2D: NV*!S
M2C>N!ZZ=/?W3 ]](H*/1[H'X[YW1:',QS,6DO/AC7SX;OCQHIF!/M7O?/"C#
MW8\)="AQO_CO[9:);K4F![_KER\>[>\>_G(HFD/.)::H9:+-+_N+J:;W!%J8
MDV E+L^Q#M %'H#VX@C8\P"]2('*Q>D2OTH/?'^Y@'?*E>4X,>B?J#MNE>D_
MS!:%VL*H[Q:5ZC_,3XZ$*;.AN/16M;UX;W_:"'>IQ/A?;V>EY;LOG^/L^N\O
M>GX/L\GQ=/'3HL;_AW,6GS'G:VI<+D[$BSKBBY^&I?U<ASS];G%#_,E"^ =/
M_M_ELMB/O_S3Q5N7SWZT4#$7/\WF.)VW>JF?SBKVY>;2Q??>?_;N-LOYH:U0
M70[U[R]Q]LG%SQ<7^?[2@[HX3XOH%@_M>/'LS]X\E"%\/.6?SNO+?WC^;./B
MZQ<?7?S<OO])#+R.1?0((T4'!>09$QK- %2IH,WGF04KEJ3[1W^VI&!^_C3M
MP,1W)SK_Y N?YJPIV-E?'N@YF(L/O_B)DHE14?)LC04R+M?BDD6M3&&+%U5!
M(MG,LCU1K0?:?-T3O?0$5 %ME6)MD<%QC;ER17G75&\)J(-Q?8XH[S7/=O9C
MD8N]/1H-:3C?/*O0*\/#YM[:8JO9=/[#><W<]O0\,+[_=CA[;YC//SW[ZH_?
M?_*,[Y[6NPLOJWVYA)_$$)XH5W3 4%E%FQ#04XC@O84SNQQ5LFKP+LQ8X_=)
M_&(#Q:HKX'<.=;P&_ 0WB2A2T.@5*.W0N*ALUKZ5-\B+!7Y!J[.$4%S,/:[Q
M^R1^8:#; K.KX!<O#]5OP"\DX)02N.H -,C@*S6K0@!6%0FP5L)^GK^YBO8S
M^!Q=C:Q$%X(N/FJ=5?404 (#E6$E[.?MX->)_?0Q<LO<EZI%[2,AYE@DD'-:
M>Q\05\)^W@Y^G=A/9T.TN=02Q8@&8K25@]=M'9TSJJ0.QE\O>%^**!=M/%/T
M(+(PB^W*&;5KF:U(J@/>+RO?/M3CO_%T,1/Z[EF4X6OY'3X\=)&CP?GDW4C^
M0NG^E^^W-S=X/#D<CC]UVO/?_K,"]M(IOK]\]Y_-'*B@;!199TT$^7\$JA9]
M4)%\S*H/4<KE2KMA6Y ^FT\7:R(O&\LG\GO+HYP_%88\>X-'JQBUM.!$^U1T
M" J<+9B<QY0U5B*,MO0@:EE6/#NQYMEJ'5(*E<&"L2D;B4%EB*K([+V&'D0Q
MRXIG)U&-URDM,HJ8"K@8$7TIBF6H9N4#]\G>;LAO_1KGP]?\'M"GP]FKOP?U
MP6K:W% ,AN#$>8HLU*:BF-U*[#2W%<09>V1SEQ'33NRN)K+@-$*,!-;4F$ K
M<:"D57$%^F1WEQ'33FSO%]3?=B^(+L^2?6BIOF%.YPLJ#I;I"7P\KK]E5DL\
M+NI"&C@#*,SR*(I3CD-B"+Q8Y*U#L]7+.IS?E78\_.]QJQB:'!Y-QO+C[/)X
MEO</)^-G\PF]NOZQ_ $TX;)U_A9H5"I..P@J6 @>$!QK@<1X%W3EN#+0W"]E
M48B#H]]P6)Z,Q=P.YSCJ"4Q6IQQ33LZ))I$8)T;7Z@Q2=L9Q=FEE8'K*<VPU
MT@]QVI;JSGJ"3Q#KG5,(&"1RB35@LJZT90HJ6G:)5P:?^T3'A\>CUC5U45_5
MCIOR?CM;"W5H<G@#>?&;L7Q6BWSP)HHK!G(EIPA0/7L#H93@5P:RG>DB?7G2
M)[=$.55G@EBY7"5H,,W<R:!2IE(13&XQ9KIA<%I18JO_GXQ&8NXN],"-HG1]
M<5T$BA+#.U6"!F=5"DE4F\J4.4J@[VYO"'7%TVI]5.31:Q6A!AM9F6BJKMJ)
MO+&A1XIU&4+<[N6J+1YUBKXD4X72XA.*<SFA\MF3N(S5 _36 N/NP74*(['8
MK.JMV"?"Z#DF%<!$#!*TK1ZX-Q].=X]JK"TD2*DU&0)3"EKT$AJDUDT.$J^@
M#>XD".\>:)) @K(M3EL%A"5CK1F+9] !,-75 _J&0_?N(4V.T#H= E<"Y!1K
MRW)H;TQ,1=6S.'\5D+RMS.!'T'Q+:.NQ%F4LV(R@BH]57&0QQ<8<6W'3RD#3
M16;P^F RM3 'ZS5G A<A9[+HJ+('@*I69P3=:F;P^O!1ED%5MD$4(7@'6:7:
MUC0AN]2J$E8&GZXS@]<(F803Y*NH/PX0)(84XQ<E]&B-R:T*M#*0W5YF\/K
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M_?%Y0O5X.FT*:]%LN"<:%P-B5#ZIW&:P"D:=C03>W'(1IJ8>E'*LN7);LKN
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M>33<6]1Y/'Q[Q#3GLC,\E$.VZS-Y=U:1VF?/+I[R&?(_WLR)_U4F[3SO3:E
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ML&8*Y%6/1E,'7.EEFKD3GD4((8:V3C &(!^38=0A@;<% &KM$<]ZD0:\,^&
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MW;+&$IUP&%/"ZFTJH4:PX,4&!Y<Q<;4F85G'$CVWP[>GJSJA;\"B8]"L=59
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M+H,"4TD0AVKG$M O[[(IG)F W* D8<V@OR1;D-^1D@LJ RE21TX(40T5*=+
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MZ_ISY=K?7FG81')RK+>,HR4/VFF/+BN#WD6GDQ6N_@RZ9HN%:%.CK=/.&.E
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M[_>.R&TX>9+\Z/#L-%T*RPQ.GO>Q*3DFT1=C4GC%K0 52*R89:3+C,>0I&U
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M+=-E<@@8J*C(_82<?((D90I2!*=<D,VGT#0XUBS!22:J%""0BD%0-I!Z,4:
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MVRB1008A^1BM]P@Z&A2<Y$<C<G+% 7+]<U!N0IHOPF(-R<4 Y)GEH B[$H@
M/HLLM9="9!#>B_JGQ->..G-,?4=.EAGY2*6 %WRRF$":%(471F"V9C5@[6ZI
M,S]DDR8$3>ZM#9  F;(J^\"-LY:C ?#U1;;:N$"+*?,A[]2:Q G2-*!):"T+
M006I0&*(LKZ85D.ZS!'-O$\>%68I<P07DV5)8M0N<V8-BU!?-*LC7>9HH6F?
MZ#\AI6, G-Q.4C=*!"&C< Z;$F\]5S7/4O]H@*?'E5+YK&8VN]VJ/.YQ?]P;
M#3HU2J"98[35D[F0%$]91])*4:!C%GGP(FAG(Q<-B;;6C9;+F1;M7 #GD\N^
MV.;:>YELYN!,=DHH;$BLM6ZT7$[!N(C&9Y>=-@)$0H\N1M*"'+UA,L5ZVXK?
M(&&HJ';VX.5![>U"$SEG.AEF>8* WK.8&-GO)$Q>\TDDHI&0N&@:S-$&3&"M
M#P9TMAJ\(RH$$3.#;)T@)RK5VP9<)@WF9^\)#< 08BA34Y+(+@KP$:PP:,J\
MML9B4?EX:SSHGRX@CW8QE5 2I+8:=30!0#I/ZER5V0M&!,^];BPBW0TEYHA+
M3G*2@A1#!G*!!#FJV6)0B<QHZYBH\<9./2@QQZT<4"J4&;W6 )#'XC""#-P&
M+I%Y<(U%IYF&>+Q?>US"'(5@6F=&EI(A<C"0D+W1A@,&UGQ+:5$TF",B<5+'
M:,"8,GA'2-('PBJCI)? M9(UCY8MDP9SC/!'[Q5#EX-!T%9:):(.7&NKP)"R
M:"P6W97CO1@_SN3(71:(/@&0:K#&*:)0]#%JQ9N+3G=/E7E:4$H+X-8!*0H0
MFJ.5,FOCD&PH[YAJ+%XM@2ISM*9" ,="Z9E&E''2N1).C"[3PQ/9JOHBV$U;
MWKV8?*&Y70G)Q/6>D;>A.0>NK,?@"LVXTY;[F.H+9_4FT1RQ+3B3K2O)LJ5K
MB; 6F7:A3$54QN<\FS,K)9_LJNC%@]Q/[$9=')CTG1T,/:?:G"RM$$:G%$HK
M"^=C8%&&Y#//(EX9[E'O<NZ?2F2YL]Y2BR[K_F?GXX-!&O;'@Y"&DY?'"6.U
M^-AY__"_Z,<T^2*2MB]I%\@$Q-*&(0'I%V=8,IQ^O2FC!3Y_9S@ZZQ(M3SJ]
M]G'J'!V/'@AS.OKC0R>.CA]PQO[OO>JXA_\U/,7>[.C0[_8'#_Y1")WS'YD6
MV<YXTNF>/?C/0Z+<L+6;/K3V^R?8^\_[0\*<]I!N:WK@L/,IT8GI&M7+#Y.+
M&L;^Z!*I9HO@HKHRWNT5_R@/NQU3Z$_J;A_T^KUTKW4\2/F_[_WC^X_6W'MX
MB+Z;6OW<>EQ(1^SY7_]$>M[EZ<T>^Q</O[HJ=CM'O0<AE3*S>Y/'_?"__."?
M5[Y\D68X."*R^?YHU#]YH.C^IN^,^J?5R^O..ZK6-SV#[P^(A=KT<+MX.DP/
M9G_\$3O#TRZ>$617CZCZTA_OTV!4Q&MZ2KK*E$V<V1!"%'J-B!]'<7;Z*1-M
M5*3\YRA>\YG=<.SK'[,-_O6OKD\[M]/^LZ+;8'; 5"+DZ>A>]3UBB\*"_WV/
MJWM76&?*?/QTU*J2<UJ5B))H33\OK/CEAZ<82ZW[ ];BU34^+^*?%:M]G=FK
M\XFO\/97((HN^#. 86\$42]WMP^WGK0.#C</MPZ^*JJ+7ZV^T6H/MAZ_W-\^
MW-XZ:&WN/FEM_;_'_]K<?;;5>KRWL[-]<+"]M[O$6Q WNH6_<7A,O#/J]^ZW
MGFP\WF@)IL!]L>PY+^[JXX5KU_8?_^":_;'$1WA5R5V_S#<__<]W;O""D+H:
MR>C3O?V=UG^1R43J?'=\0B<)K:EEM5\T>X>\BYBTE8R3>^&\]47':Q4<)R4/
MT[EI5Q+P6CTL1G#I#OVD'\;%<"R.U[UIZI#\]YE_TG__7.R_?R5WQO'MUOO7
MS]S;O;?'[UX_VU:[;_>/=\76AYVW^^]VW^YV]IZ]9#M/-M7>8?CP^C!\W#M\
M)Y_+W>ZK3WUX_6R_LW?XBKTZC,<[3[;9ZR>O/KUZ>]S=?;+YH1RW\^REW#E\
MIW:Y_?A<O#Y[]7?0K]^^4Z_^IG.>_/EN]\DKOOOL)>S^O<UWQ:N/>\]>?=S]
M^\_NWI.G;U]]VGD?G_T;XK_^[+X6W??^[>G)WF'W^/7A7V>O3OYBNV]?LM>'
M1_S5VY?R]=LMH/_YJY.7L//W[ML=;C_M'+Y2;R0],YZB;0M,N@V9^[:3W+2-
M<!P4/3>6_+V'G+7_IS)</U/A8:L1<GN!K76EKQ8KM-<S\6]ERG-KKY=^_VF#
M<%'FG]NP2OZ,^2<VA#9S-WR<VE!2_HCA<]G*D>=&SLQ.$:<?BZ5R$="Z*8^N
M>20W9X[-00>[K9>]3NC'U-HYN*E6_(*#)S;>O-$M]P<G.*)OTQV3=__ ]_M=
MC]UN?^3['Z\#O\D4J?UTVA^,&@F"3SO^V4N]*W;.:!UG.V]??=A]4KZWV]D]
M?/=IYTE0Y?J[GP)==XNN^6KZG7_3M53O]6%?OOJT#:\/M\]VWV[2-?]B.V*;
M[QWN?-C]1.MZ^Y?<_;3;V3G<5+M=^^'YX>9HYX!]I-]O.-/:&V_:*3/7!INP
M[0+!:<!LO < RV(!*6= _W$50L_18,KK=\S&\[+M*B[>W-U]N?F\M;_U8F__
ML/7BY?[!R\W=P];A7HL,UT.R3EM<MO;V6US]%G]O[3UM'?YKJW7!ICVW9S<?
M'Y:/N9-PZ?E\V\>HGDNG5X)5#P1L&+4 L+^9D?NT/VB-CE,K=X9$E]99PD$K
MT<+B@_G;,1<D_4$L,38ZXW'$LW+1U+M.U%]40:JM2>BJD;+^TP8/K?/E&QEX
MC%$4>;78AJA\V_ODVE)BE"XIEI4B7RN=CJKXXL2Z$/I^JSST[YM UYL==V!-
MW\P0Z0]F*UZL9-S&5+O>!.+\+H-B:ZMH;16-#@>T_*K]8_,MH[=_L5=_[W9>
M_;W%=PX#WWWRDH[]\X2.4;N?ML3>DZ-/K__>?_OZR=95RTCL/MD_?B7^/'YU
M^/+C[J>7;/=P"UZ=O'Z[\XG6=_@*]I[L=E\_VWVW\^_+EI$@EHW&Y7;@&MK
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M1JJ<DP[6VU#EIOV_97'^W:CG%1*,JQ'\1 K_R^#]3)/,S('&)F?>M>Q<R&1
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M072=_UEW25'VWL._2G/9SJ@JL:Y@D=[HSEY?B%VW-GU_?-YEJ62-KJ%R)1A
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M;H ^F)N^6B"AR\-!V[3%NAS69&SDYW73P99VA;=KK: MQ3(V<BAUL ::@X7
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M2U+[X4GOBW,AY<SJ@=/2#$-NR#XB>Z\%NJ%-FR*/0R+2LQ# ,,8#1URB5JQ
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M)7DY8?C=2+NMN+4JAF#QVV _&FUDV#WD6()/4_M /-!%>6GPMP=$RP.BY8]
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MWM\J)#O/Z[X5@'G(MSE6<4ZY::^64<,+A'22EA-BUG'7[EG,)G(17JM5AV@
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M'";<T)!EW'5BL1SZ22>K(A(AO6J"4D*HW .K2U] FI-DO=F.L9$('B;80K"
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M:0$QE[WLI;D%]P.WK37U&DE.#>S]4P@?U@G8.EIBK2(Y9%V"D>SU^4X8--F
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MXUEP1]2..QY:<OUH#Y 'VAA77-SQ!?/3VBPR[IA-7UZZA*K7C)R+\-9Q[I0
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ME&I RQN(X5MM'8*%5PG)2#IF9"LL!]9Y&-P]=+O13_ZJCIAMX;!SRR,83 [
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MM,P>O3AZ_=BKEKCAN=1%@7:RO4E<ML*(HD@ENF*H P7F2(%H,82[(/[JNM]
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MT%5IQ*KG_+'.F3 "[.@.-@K$XF;6)3;#G>'=C2SOD ?P*1(4-R>G/>"W)J"
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M_-2.JJKN8?']J_?,M(JM2RE6$F>K7!4[T/VTRZ(LY8P%6"GGTIXSTZ5)_.N
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MTB>6*8W(EI8;*HB1CXD18X6$CR =Z2=+%S'[WI8[# :>@1;4'RZ]//"O' 7
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MFL4$?UG@7V=G:#>Z@6-NF7+ZFZE1E)%#5%IVGA:)=MRK(7F$CKWM)SD$87F
M!Q+#HE?+*E<RLN#EP64B['G;C-^+$IB%#-6T:(1US=@=D?\CLIRM,\'IN7RZ
MZ(?<OU6]TH;^?/;V]_>G7SY^YBS9^[.WI^_O?<77AWIG%<E8>$Z[>Y7(K'L6
MG"SGM,7MEXLT2DK!Z/'&#@DNTJ*>9Q>/$(ZH? #;%\2N;<;OPNL-?)?& ]+-
M*;:IIZ'CQQE4Y/;Y: 9OS-X_E#+:M7>;LD!Z(&''+WC4=@8% %=1J^XN-]2Y
M.=&(N^EO[J]%EQ9KZ#N;P3$ZW!A)_1?L+6VYJ8?N6 PW,.1F.!E,KG8P#QN?
MY3S"B2FXI69.%K0#[A>8"E30@04E5.[AUH2BT/!KP&P1F<[ M] 0WPT-814&
MFBEO7I]Z08LFA#RQS5R@(VX<)\G-GK*8/ ;;<*&<W)T36ICF;SMY<-YN[2UN
M[9)MI8-K-E$'"KQ)P#3[PN;8:<J"HL8#>7S'A#!8#)@F1!_;@Z$1.C;,9X)$
M#%S0-/VC/M"9F:3C!1J\Y!;;KRA0J+7+F:]85X,.9N0,F_'*DDM$&1.<&%=%
M?L#2-CPV/LV!+W#7W6*9W)WZ0LHNZB_9%-V@P(-"G)Y17:1MS</[L&BV#WSE
M+6::N'@<_FHGJSLJ(J,AL' +GE8^I0OSER1RT-%]/T,IJ6;7@P3+,A1@+$P=
M<!-@PK9"R?5\.,05[JSEXO"\4E63K@73<+/VB1@D-6^3N:VZK:BCP]OHPT=Y
M>)EB,*JPL6GP7:@*4-+] RT#N.[:5%KC[5@)?]#;??;UN7V?J,N=.A*P5!"#
MR.:.53>C6<C\<'HS?]"$@J$R2SML?")_N!552R8:.2"4W->CY]0V/9-JXI1N
M;YYE11$/<%/ -*/^'=5TUV*T..;&@H2\3Z @;6A;+>562_7;:JFV6NHA5TMI
M\=UQ!LHQY+".'IO(%#4):3_%A(VKPD E9*DRTY-6BRTS,*#A,HY8A37AR[(7
M/1SL?4OFUDYDB;EL5O&0[%,'M"(7T'",II'I2"\QSQ% KTME9I ;\>DCD#NE
M4U[6/8\Q,9CH"J%A?!&C*9_JS)0)Z6#%,\7Z35]NF75<A<Y1XBQWLQ^4XG;*
MR[RTLP._S[-;W$QO37'6!O-Q8QCI*BY/"K[MY A'9CH]MQ&QKF[^$,F<C3.<
MZ8=GT0IH\L$Q]L':6W<=UIK8) E"O4^< --_^B#4?\U,YJ:3\ JR_'=?XH6O
M/]-_]%X^-T4!8%C]$8-W%KPV#<@KGO#N#_L(G(K(.0C1^%2Q%[#+2..RG!2B
M[@>WAX6_.&GF'ULII8=Q86*=4JD:811(6_$:_5S+ORM.Z+B%?S.<$"&B 'S3
M"Q4G"5IJ8/=9MN9: XEDNT*@;A9252>E^?@\?PBI(ZQ'GJQ2I?24.U\O]A=O
M@8A Y\Z^=Z>0N0N: I-=2 23;&IX:J$\UVFQ>&>Q,(!GK,<EUX&Z&3)90U%[
M4SU [PRM,0%ZFZ>SS?*<%99(! @9&0VDXPCX,_?DBP$L#W#?O86BX4^4C6:R
M"GV['\9W,JG$2VZROQCF%?P' BK6VGE-(AU+;93VDZC(T\:#&L.W!IO"0[JH
MK82:*<.*FNE,:ZT!LM<#N"@!&Y.7(R6';MVQ4WYHF<!OPC<U8UYFQRT6>8TA
MQX)GZH#W,RL)G1VS&)9117^2^Z^GNZS*4>F(D _6X@8W*9D.;_30MRRC2H\H
ME7@3;%8C+EWN1#\1UJH,N?A@H1+'#729)D;QJ$>QK@?;OC27YZ;KK=&S@85O
M2)A-L?MKYN;,I5C+_"!0WG2YC6%CQ"\J9/;0-UU&1^A!PE?^!#D3TN:N7_]'
M0</0O%UK8)>\^M33$+79&C0^&;2#J\KCE)*4=/BLR^]+1:/V#<* Z&-"7;.K
M\M\FC_I;$?P?47+GI.1<A4U=ZUD6.9H-/_63B8UA.[?.VLHW8M$Y ;D(WEL!
MCRI&<U^[U*L:_ $]TH.6SMU3&L&C,L8RD.Q!)4<()WAKY)/K0DAL3 :?!BD+
MNSCSOFF8D6P::V#NA^-B-K> M"@)H IS^$"$23R(29Z(N?4U'GX=8,^?&%S2
MOI%PF> H#ZNH2@A$@"H_MD]8_*F:&)P@(0J=EPP-P8!,A&*1I:#Z/" &%+([
MFEI$U*H4ABRPV1R]0T%3L!3O6(0F(KS.3A8\1S[2: 4$>N+,&]#Y@D)'O,CC
MP]$?4JRI ?["(1MAJ(L8JD9/K3-M[8+.!-<5L58Y38E1+%V3O*CNOW2KC)$R
MNF*,J&/1"KU[Z?WRU9**U;-,0BY,LM1>1,'JN.S*-8A4:B@UF(G$&2\GBLBB
M'X18F&;ZF 8]T46/]*PA#Q$0<5(?"^K(3:Q@RW3-H3UOZ#_4K?BZR0[?1HZP
M!L?_&N.J<$B>J8SP\82L T(+LE!@[@B8"FTD4F>-LRG\P>7NAYBJ1 U:T+AJ
M73>[1&2,N9PPF5L>=@OH:#QBR20BF8MGALL9>30 =]-B&"%D&"H.U,J/&":7
MNE6J'M2Y>WP2.YPH]/G?XLA)_S4A\U&8.E=-TJO#!X0/1TP>F\NR,B%.P-$%
M+H:;G7%QR$KG?+:QB0VW]I/43'_RBS1/<6AB1$&X5_@Z++7737141^D4>>8*
MD]6,V.'[6^[<61>-<J#*2RSYE#A/S69(HX6))>@ZTW@%S3CP'5(?R_UXK"TP
MZF4$HG8C8?<[-LIN9"))(8E,B63\I-\*5.'].Z]PQ2E]ORD)]F):&4U -)WK
MK-89ED,(@Y>]^G#N8('.??!8KF0<"5>CHT[FP)4T:'R9?@L(?'@@4%NJ7YV)
M>XA>BE;U1/%,"U]<L\\93[GN$9D0=1D<-NQ')_!05WU8)2O<;TKLKB8HG9UA
M'F,JBT)S9)OJH)WMB'&Z^2@.]YR8/\U2QTIFQX[S8HXKL7U:WCF>7)7H%)&[
M96I7F@(F[_9&PF>ON(_2VK:V?^;HB$ H0@%=>O;DS:M/IT^>UY5^P0^TU<FR
MSS'5PK(@#'F .PD^FO%N\LY?*3ZE.Q_-*8#%ZP!?AG7YL79"Z9.J?*:]#),7
M)9M _X?VBRGG.0U3#?0H:!VJIIH-AEG!V 9C";H2G4.:CH'N5CBW :9( =<9
M@R-<6"T+?%ZHH3P2D'VHE3M8CX(:/#F2"_ZM9+<-\+CD4O/O]E#]_C]\,G^1
M"TYQ)(7N 7;F<)IR$SU,E"1GB1UKN!,&\!#?P%,O4D&O9 G*XM_@3M2C'!X&
MJ*P_<= ^N2Q5\!5-HH"ZQ"GC9ET?I\N5@-R^LLF4.V%]&8Q%[=RZD9?TX]C4
MD3?\';=(<XWTV]E-D06)-=H-_HBSQ);]E<8,8ST,LG]L?Z7MN# WZ$)=:9*E
M9=HW=;1U5YO]8?#RJ&HHM!KY-L :;<'90L_1GTIWT@C6MQN;EU<QPAS5+)*G
MH-R:>2NDW;R+2';G.OBN<9;S1\(J!8!4Q^2RO'&H@<LS'C/I/O:.-"&D*C'/
M<D,(I,U,2; [B@8?/VIN,HW 8Z4(OU/E+3:XW\:LCZTFU+(^9BD/$-#UP$EI
ML5 ;5468V&R(LN-E.I(G(]2E^"_;K:>+,KB\,$P7BK98%-MDPG*5^"BK"O;:
MJH*VJF"[JPJNWTG38#Q299@3P]?=YW-MV+O-]EXQFPV3.-J<M54$0I![.*2C
M>_OL\8]^THY4=G$%Q1SX:Z9=G&()7FJ([4<N7!MVQ*/1J'RC5O@;%PR22[T$
M!!4:4D0ERQ=!0_]5Y8(E$*FPG+"E98?]H..'RTV43%2VN1>&VF"#P'0 +GZB
MV5&7CR)%1<L##8&OOH'B*UCA?FDJ0N1B9_TD@XCMX@ 5%9G90CP-5:,#XWIA
MEN)UOA7\UK!<^1'N&Z4Y@R%K*D;KQ$P7MCCB7S%[TJ'A==0'AAXQ&]$[#,@;
M,0":_@]:QIKC#ORZ36&>)>U>G-^V2"@C^0OWFUC0>3=U)C J#C4P6-X[>EEX
MB.5:C>N<Q56&PZ:>W2\2('5K;WSP^'J*DTQ@#?FS5!3"WN-L&#RD>G 0N0)"
MVJ;#*[,ZJ#15(PK4\VL,P\//8-N2*VC!EAX.*ZHE96A;;<&SC^QFD!2=CA"-
M["RG_(D1SC%X>V$A?=\D.#A]KE1JPIKT/I$=7.3%T4$NP%U"CV"0(T0.8MJ&
M"$X+#Y=V<GRW%/TBGF[963"<J>'=@M*Z8[::CFE.%5>9[I)P&C:I&5[YF6.1
M)E[B#2%]BDP&4(:\+.U85JDS[7'9QQHAZI=<B[S397NT%R.51@+-VX#%&U.-
M.)]<Z_:9\X@X0BGC'E,HI2XT&N4!C?6F FA='(6K6C)<N%,#JMCPD3_?;>6H
M]"+.,ZGEZ'@#(IA83=W!KO?F]/(AH:I"C\89SH>)0()-PK_"/$)?4#OJ+ACJ
MU$C6K9\'\)'A2Q2AJA.@@#.\BZ%I&@L+3-A#4 70>T\L+'T#_1RLH.R;X-4.
MX;5QFHT5@@(,)VJ*YA136OOB>1C%63@47#&@/&;6+'R[MMY(,!-^C,$+ P$X
M-UYSH9R=M!T.*HG-J#0<%88KI,#5:DL+XY,6RU=L+5L,0(]Q)(Y^#$T21\'2
M#=[0NE#VH"V)_\3ZFCKRAV!I\)-C'H+KH9[8@JM)=JEG[]IGD#TT4!8V2)",
M-5X(F8<^Z K5%_*VI@KW&E':BU+-!*:^5M'BK=@9Y^.B@-1J]23VZ"'*^,5;
M<K-37.>&2#\[]7.=X,Q41':"4PDUVIJ0S[:7C_Q%8;'@G$UE[I+)@\]GIZ]^
MU8+4U&&S(69?QI$9(U>H4ENYXPH-!W=DH<[+I8.&;W@E-_QJCHE=$'[U&4%E
MT$KQA6<6.>,,UL:'\S6L<<BHA?@%V:_G]@/T^DH[MD2OT9[,PGME?>0B>X%.
M];,^<7^&P TW6.&?9V=GC226W!OM8*X:Q?$EO9/.\A7KU Q'^D#*']RA:J;'
MB+!J4$Z8DAZG>4NCZA@V_$<(LKD#_ /"PA-/!5>/NXF:Q5K4)?!3I,RHB+!^
MJFH(*PXJBHO"--#OT?E]V6H4$>*GSF>Z5$!DGSV0O")CALF][FQ&*S"Y)[I$
MN'G4NOZ@+;!6""[&F8UF;1.PY((QC<?.-9:U&.:DQ48..H;;+LMMN-K*JM<1
M8B<]>L[L*NIMEDI+CH$W)&7D:L=)=NK3W;#(E1;&%*VZW#,J,C#M9SK%LW!'
MQW^F ]C3:3J06J%*:)B8WTDI,/A5 48(XNI^\7T'-_"]H ]8$WEE6LU 2A9.
MQV0!C#Z3F((=&^(FTA?+K@T(F[NRTAQ2J5'U;#46$GR.K*F]+&5"L_!NGC39
M.I/XE0-Q$'Z3RB2+A%S4P-SI&HM!*3R@L5K]H_R*4L)SX[T(D<AH)LIMGX&[
MZ$#$*<T2 +HH?V@#_<66[:")R-?N#+ NG"8J#3(1SV9 GM8$.K.$?G<1Q3I#
MM4P8I3RN%7<G!!'"E:7Z6=XS1/72A7[A.@@!&F)<&U(KSDEAT&XQ+2PU+31;
MKL8>NDQ8CJ)IHJ5WRDQ<L6"K=!1>9(@$[<\(2BMPP8D*4EAK)6,HB;P@3CO6
MYW>A6*C2G=Y5Z9#C LJD\FD2F'E3EP9BJ..^B@3"6/$D'+!*P,'!/#?0+?[&
M25_G6H[E4D)]*KB8%%\RI45$HWN7$ZOGSOSVY>S]^[-77WX_?1]\^OSQT]GG
M+ULW/,>/TA?.P%,TW5PT>-AV>"283V*9\NQ.7<KM8MX5YDH2D_+OB_CRQ':X
M%@93-ZU\P-O#1*'#.HRQM%;RP5S;HB?"P$E48:$6RL-M<Z/N2!36=&)>>N"H
MBRFS?7)VY=:9#1!W/,XCIK"&'W5JRK^J>6TXJ]<02.9E6+(O^^7#J3LY$UY+
MDMKCEKG#*S);]1RL+*R+#'Y/.7PG1DV]?^E2,@K*#NTFY YZ&,DVIWI6;WV&
MR*SH-(/0S-FHML.]<>[!C+(<3H@4"_Y&61)G+*)Y%,$"?Y)A.F$KNSZ$L)&%
ML!?"@1\W>T"?)#6E: .2\I <#X[M,V> "I.URK+D9+1>VP2<4[X+UZ3/ED0&
M*.3(80IG'=Y':223G'C&#JYWHBR8L/$JC#"W(VD=;*AP_"D:P9#:4>Z<G'+Z
M;9VJ/'D@-I5Y21,SE;U8)E,TJ?#X<KUJF#KT$R*T]1E>?<9^6Y_1UF?\B/J,
MS=*(#6K>L;V=!&:I-%2M,24XZ():5$</'3QU7X?BX^."4F6NY6*-%4?.<KE=
MSED0?.Q4JN3XO;Y'-.%D'>;('<Q\_2[=K(>--.Q">-]+$2]?.K/!))I@R9?6
MS"-I>O4#TJ*D3$U<C1S<K?*U-H##678CM!+Y:0%5"2MG<)M9IA0J1N)=V9PL
MKOBWTR_N?H*CA66P8OS!B4JS*3<Y!!>41R"E*9T(56J&L"U1_N(W-=JGC;ML
M246:M)'G;+=42OT4*A_&TH-@JB10)1?7MV,;WK*=)JUG9BW+A7EH@V:2U()W
M8>.I;CN5VU=+=JW348)^,@7'*PX:@J-;&N;7?1\>[_,Q- :G<=P;1OO&#?SG
M'#:'9U8NPW(:Q_B$C;"5?ZO[7)OIB/GU);1SYV_QI"I5$EFL ;IU1^!/I6=Y
M)S&5(^'49NPCPH J[O; I%Q'V$Q @R6&N:+14\S-6"TRFS.S=/@:%%)&G'IX
M]+9 O(&BSM!UQZ;7S1&E#!M5PU /MO5&;/DJ8DIUVR/J?>OXT\64CX[)G0#*
MM/$L' 2933*;<_&WQ*93V$]%78^YZ2S 1[A+_\*M,445ER8ZE]L.%28@G[,:
MN! &Q%%*\QA[+T)A12_3:A!G]IVV74&P!*C6*->)<[I#U"'&,SO$XD-@>LR$
M,1T'<R^'8L$RV(>6"5C8=HFG1$.D.V@4_%62WJKEJ7DNM\F!C2KX.RCMF=(9
M-BG=*JA4R2G?HTW07;BH];4L)5$+BZ)'FQ?!)\$^PMY'7"MP >P7A69LA7<S
M1AAY'*KV;YTB,RO =?Y#'A4S<NQ0J8CBCIE-5&'N!IPV4S#@1%61S4H*3S<-
MNV'D+6E;=:H$?><<S0@[I%:OV7?KG3N,#84M.^#KDFK#/E:WV!,_U:WX;-8(
MG(J0$2QN2M349;HG>J56T>&'<"IE$SA_<M5K78C*,ZP*BT<+DMB;:U'HQ<A0
MF)KNQ;/?D6 UZ$%; # TN#W+!+[[&J,X')1/JAGCA(O"_EP1:K94S(QR]U)^
MM&>4<3<],C8KK]E&]R\YF#2Q;EPW1]5#V[?VL8=[XQ3 T.[3] [=Y3?.%MY"
M[<MEB=GJVB^Z=A /\UQ*3QP4#$,VWGDSCB8<%$I2RFXZ4<2'FT%=-J=2AW4P
M'W$Y\4X%BVLO4VW-N<R7TO[$4.%/TY--^ %:IF%#-[L/R(Z@B,$<NQ T:!D^
M/5<A9HYM%S&SG9M_UC+3ECA0$/+;+,Z5Q^?$-8,\PW3Z!$N<DX2:W1>]0]"(
M9)&9MN*:,KK&<+IM,M"TAN<<L<X\+14Z2!5"N=@^0XU%M2EL<36T<Q3MX##-
ML:;@?B5A3([,[7?H-/J2G+WSIGO$RLF#ZA9(6J9&Q@C,2:B#:;&=YN14:BZ3
M:3QDNX!'HM*>ZTS>R@_#3CX\]$V.U#N4WB!EAT:*.6^1U;HO,X*(D#LI7&_2
M!BP:M2C_R=@2]23"8H.%26(5<5FY$/=IYL3;V:JQ+0^Z62+TKUEHC2">\)U]
MFI:J:X"<2#D"DD<NWIE(>DV3W GZA#EWN&!)P<<_WKW>Z9WHB$C-_L4JD*%;
MG.*KRDMIO;TMA5F;,X.&HL<O\C%U9F!@;0,+@@=^FEH@5;C<SC:T=:%D634\
MOF,,5<(_8( /E6K(Z+Q2C-6]\;7<5R2D7Y_]\N7L]6]GY^?WOM+K5YU+G[8W
M67**D 0RLDT-0,(QS#@8O%B@1\ R'!"D(%GAMHHC.R!TFQX6P\[OT@%0+KX
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MC&UP2)A:A6P5EON2!9IB[]-PJ!("/XJXQ+UI=Y;17M*=7&V<9L&XPD'"I7+
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M1NSMG=+D"3#@@8=E(!E>' L*&7 6/<.0P0FE8^5#<!&2NQ]51KKSLWA9[SS
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M["&?M!7'>=^:?U><YL/NX5J'^:FC,_COJ )1.;_*8+?3^=^*8)9G4L8#)UD
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MG'Z"HQ<,YR56B<[E&>P8X2=_#F?P_6_H_+R)!WF6HD!)@R_ COR5IZ!,IV'
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MP)DM)\+,XI^H?$YGH5#.P[0M(P_4OHUQ\=E.UR< F:W_FG[=>PVR=(P:#9@
M-#E((N!KSRG"@  ^#'V)HM2G:1JG\!;4^'%Z 1KCPKQ\$&>S8AZ,JSBB2+/[
M+. =9)=.[5I21E3$)"Y)DL$!C?\*6?M@7!BV+G4)4R5@%A28?&3&1L<'@\>8
MM[)TP9\TD5$T K>BR\=D-*8@:YQIAH=;FW8U2LZ2L,2C $L_!V<&E"08E;"D
MPKQFS_XWK [\&^ E4B3#2<H[")^4T'F%-\U1QJ'ERJ<7U2CN!;Y.B7U53#(X
MI/"=,3@F?-['%1IC18+>GERJ:VYHN=I6O43=A[8W6L\%7? 6U@SWPCL^./NL
MOH533_/!:S"S@TG!!'ED5,'?64TU\0DO@NDWA#-"<C674!JR\IO7IRB&03[!
M#Z!],A1*7#E MD?M=4WO,,$GHQ#AF^$[?#IB# LSDW%&7[WD66$"HIR/7H8G
MMLF=("\!+R$_GZP)I,U8>>P4X5Z7,3G*9H&VQ AO6\R4:C>&O<-F7Y!T0@I;
MS]Z3#F8X_"X\V8'-R4E3:N:'[Y!6,XRPA0/@05PAK"O'%#!%WEAMP /AK4;\
MH-Q!.6SI@>Z!\:YJH8NM%-5>4*+1!_P->/0<->!9&L'.EZ@;@]-!PMKS7(RV
MS%[8,=''#_.,[OP5+P):#[,9[,$73+9A-')*W.\\0:[W3AX^YTU2H0*!?X#Y
M82/:QF+,]"5L#9D5.Z&2@B(98'_ $1/98"Y[]?[T_/P=&]SFCZ>O_SC][=79
M:RV;=7XW2RX46<+HT.T8HPE(!^*Q$DV%CS><04=ED&+D-P$)"'N5HB6@%*H/
M7K$F5%&AQ,=@@+Q4="9%F;(9"V_'L(%]BE&T[A *22X4I8,#2C:.0.3.LF0^
M$[N%?5FK.U&$R-'#=8&Y0:L1<A?&E@2+G$@_K9.>I96LI@B2^-]X&4;26'H%
M$6?-77\;U\&9!-"-$X\S#!&WU.ZI!?2TY?.WQ>@*2YU?LSS^"X-E__<4W9ZH
M@EM5JG+8FF\[>6B#'JR^%&QN!4JB "F=*A&U<]<BQ5^B.;&Z9'/% )<DA#;D
M88<SI#J0Z1T\!+X"-!+9+L&KG3 W;]0V/3")O %WL\'&@8,V0:\)-M$-%LMN
MH@L3(M_%3 W8,Q3?*(2M]87KFL "X=UP3$%G?TT5B()1EI4=L=B^)BN*:C:9
M,5;$2M'^PO,2<<FZ9Q7;N*X5)F(V7C\X:\N-&Z*SVT?6WU.2>5IYP[)8O%V"
MB =)2&Y4T6%[3Z7BBUT"0V%40IL#(*J16D,N_K+&H?S>P5JR+DO^DHQ F^4K
MJD$1@US+XU72ZE&69>RU91EM6<;MEF4T2*->_]YRQB:"B'E_L'RN4191+^F[
M\[*(*XL@=/B3 ]Z4'B1M,J.*![&5T^Q")9)RP+\!UX!O2HD&G<Z0+-\339PG
MST&=@]!$S87R$@Y]/ *E!#H,C.@0(P$E!BQ2";Z))8/YP R7 X_-*ZZ'$!N5
MV[D*"@ZB=^#EA>$!6<=-D,$-OW?/NYW@K,K!-.&*ER(.=SZ%0UP(11UM"A)#
MU''.41,TM\%\$T>T6/!$??H8;L#/3:EL$&OUJ+ATB)]N-"\^F[/CY%N&.C##
M@>ADWH4%NA?H$!%'L",=P 8;$CU4,JP5\$!$*R3C'/]FUJ.M/0X\X$^&N);J
M9(.-87OS5 I J'2=;KS,\B3BN&J,%J7"Y')8D$D'-BSL*,=9N5M)O![*<W$I
MC4,<71\+IR)&.Y>K-.7#Q+.F$ !511*'I? L]M[U0VC+J%^/TGB= ,QMJHQT
M;4VN!0Z!;+3P 7CN.A1&D6%\TP"MYR2<H]65<YP18U"TL[FBC>3[/+:ES]0,
M:<+<Z*-AX.D"0QQB8T^R@D9&R1J ="5\I_LV^'<9*Q7,JGPXP7R@Z_8F,=C'
M?(/"?T_Y$$E<N0-ON%2P9R8!S&GT29B,])%E=EX13"E*_(DVL% 8D\OA(1<8
M (2+5U)6NP<VV(ZGC_?/.SKL3QJZD2.!*20=6G(>3H2:A%%'"D=@ Y(8/C&@
MIB)W\_#*#M5Q\%&3@Z;S)+8V7 ?<:/?#8@)>;'8)EO.O3#O)YLK-(S$EIU.5
M4\D4F&@DUL2BMJ>*$\;3+*=$8:K;1DN*/=<6)7L:C-&M6Y"#.2P#/XJ"3-J$
MU['+0IG<=.ILZ-7RJ8LT-^M0(TSP%9Z@TH(!GI_!M^*R&L0N+ASC&2HI';DZ
M4"!D*!;6S'H?*"$"OTW1HA;BJ33:T=*;N"C,J2H)+D.1[,KM5Q/@=>NIRO;
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M?E%7=0]'>,#/P1B;?8^!];F;IS\<)X_X^=^_.=<Y[ RH^"E8!%$9V)K!%'8
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MAN-6.&1T4E,0V3.G/MA/?4Q^\J*ON,;% O;D>PWG-_="M8:6X?.BF2*M8RR
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M]XE#/6/J^9XXI&^N:0X%E>T;/&Y90A-)-7Y4;KQI3%1Z^!O?,' 2T;] /,H
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M(U;OQ7CW6&?'D&!8DUHP(45EOYK)(\.N%)$(-00J&29M(L;Y6<B\PCB: ;\
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MNM4:U>J)RJ%VX<,5>_+.&\Y%N)Q[SM7"FRE'@\2&GX3G(^\W/L3X"KC7-[Z
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M5'T2C2$NRP^5ZIU'2ODV/0,U)AZ]RUDVV .'5).U-<8>-LW (GZ5ZE-:Z._
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MK/_6:;K]UG#CSTVW=>!OO4[WH#>W;;8%*G"[;3=K-WMBF]UOV7\0\3(! R-
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M0,)[XUA&;X!7S84W88F.K(%N:**B3H!59#J3U]$YFP9)BJ=L./POH-<W2-4
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M;.RD\FB!,HP(6H'*\>4OL)-@[<I)#IK/4=A:%]64PB+<7L.H5*E##5D0RNE
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M%BJM"<ZI()T7$^G5UWCV!GPI#&6Z'S%KU;@$&RT$2:KJ, M:HOV9LD9NJ5)
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M\( -9\(RDUZD+\RP3G%)EEF@*&BD&2K3O&Y:TQS2U)AY9!4KM,Q6BO$J;@3
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MZL96,5%<L%__T5!B3D5MU9,Q:!X9HZ(AMWLP71ZK:PHW>L$6:A@Q/_RHQYM
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M%H:WLW3R(3L7UT598+HLQ@]#'>,ZC3->U34L@Z3AU:<I:'% &"&I1"/QGG_
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M5)STFU%4UV>G94%3&+P2@2"G,*F.>[NP>FK5<H77/L>(W?64$';]K8)(O=O
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MB]ZMHBA9@"2ZPWO)*&^%3-Y,UGXJ<V8:]?UW,25&Q@,O<W"]K3JX%O;**Q.
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M4USD&)89'VIHG?_]7YZAN^]SY?3L4AF-LWQ,>">@<ZP YFCZV^#HK:D?X2.
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M $**=\I;_4A(8(S)</+(\;5-VF,?%_/A'$>\>#9GA+>_-8Z "'^D_1^"RS-
M39BI  "MWZ?#6\86\G'P)S?LX$?1$-6G]\J?X^A64 =;]&I.@ICF[$*4PF"'
M*8RU#[\S2 '41BVS02FE_+&(ED&^TR'2. '&F?8I9Y!W7/R [W20+30&)UC
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M0;G0/=MV R!CU]HJ,GZIY^U9?L)%W_$83Q#O6#@68/\8AN_&$74 *G3=L/S
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M>]90 >R4 3MT#%CTPG$BP/B(,V M&!<P*(NYHT+0Y":LK-,"V)<,V*EO)Q3
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M#7W8RWE=B'L\XB:C7BS"+$3/ B"I)3!I)6ABDQ>+G.),)[,H6GFQT^I_\'A
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M??0-;?_QY7CG\[^/\GC\Y^+;Q<[FI_3:U_19^^?;>UL'7&1-&AUH(V5R9WP
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MAF!#M1=$(1?% 1I5B)BHH%W20%B4=F.%"^;M(Q4N> XN&/I#SHE O! 0(['
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M$>?)^_,$+)(8A%6,<BT3NZ-!O$?>$Y]^P?&>0HB%$.<;U2J$.!-"W!XE1'Q
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M&!D]J$1[@6 O&)<KZTR6].,%PW))HU@$*]4U_?A!MBTJ<VRR'<:P@_?(4"+
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M(QQ)PI55$CM';8<@^VRR+'^V?3OPL6?'O7?Q=!Q/7*Q[5&[V,G >.G'2#6O
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M_',L\8?[,G":QH8_9T&\7))#8>$;L?#1:B1"@CH$U@T-PB(NB(.-;A5B+/)
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M2$G97<D@ %DXPIQ%AGD,!H8WR#%GD!1*,F68-#ZWRKRLRJ,$(I\*:._..U!
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M#A&-./$)N>0L"E90;XV(E.5IM_Q.P[R%/[K"'P^9CU98H^.LL=0^3CH>0<M
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MAB5KWOY^Z]W69N_UI ;J:KYF9U19]-;Z?$M;<)[>@A47*S7?%_G!!_&H\<C
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M:LBIZ863GH$_$H?Y*AB3W9JQ=$Z'&9;_JZM#<$;F]'5,.=B13D=8=&,4CHK
MCV.ULU\2TG.&\L\9T?OCT?_^S:Y<R24IJD 9!YT\&$.&"@[OB88">C#%>%2&
M@$F[4]>FF<3P?)PUA73"$29RM(9;P71,3-@@? @AQY=W[CLS_Y_#W$AX?/'/
MGNV/G_?#R_],NN?Y($=[/.SPP^O+X[P.1F)0'8J"ZB#&(LLC08P9&6)R/G"V
MO*@T66 P(VB*D6L?'#9"JEQ7U$42J%B5R?\PQ\:FJ[_;*>M?CI+,..#Q'22;
M3^=\-ITXG4ZG.ZI/T51GR\K!F%XY0)./(=B^KX_5A'@.UW7KBE'PB.[9N>T.
M\S-&U:&<T7AH\VM1'D)]#*LZ4]2X$UXWR<>C\B-SA_'S>G"+H]KK?,]S.&NE
M_8>6\R//CJ5R..3#-QCGW3RK4^ZFG1 /AC&K3'*:W_($SF.2B;N<R=FZ<S!&
M[X$T?,TY&";W,%O_]5<? F%[[)[:/)N-#Y:H/6;NXWC-O0WV=JVN-Q^]?A3'
M1%[6YVU#YX]13)->YQ_=%-MC,^T9HO8,$0C'%9OV*S:BO[;G\GI2;%>XHQGE
M7&F ZB (8\Z!RRHY\\EQS$Q48)+"%\31E08HF+\ 2W WS&\4_;,P&5Y$.[RU
M95JA60:S1VJ:5G'/P9?#%R_I^P^_=0_/WI*#7P[PX0?_^<V+ &,]P >7?\![
M_9?W'UZ='2Q7'O_P$A\<P7-_>4W?O_CC\[O+M_3P\CF'.3+X_?+PZ+![> GW
M_?GNLIR6^;V.>QZ]XP<?_O@4?OD7#__OU]Y[VOOD/@S(^P]OR>&?KWKOSEZ=
MOGGQ$K_/-#IZSMX?O?IX\.)?O7<?3CZ_.SI@;UYI<7#YEKQY\9:_>7% #XY>
M7AY3(KD*Q" B940<*XR,8!9Q;I)U03 MW<X^6XXYEK(*Y*?KF N3",Q$I TX
M<'"J';AI7!+//#"JB[)EKB?.7.+8,A(\E1CA%',I'B^1P]Z@@)4V- $3Q-SU
M#B]S5R>O^=6Z-]>$8MMS5^VYJ^U-73@=]+X\.VC6&YH!%H#7[X,T_FR'\8EL
M"'Y'[+J8;0@Z8[EA4J @\H&(E!*H,>&0\CHF"SK&8Y(/1. ]]5@.8+5PUL+9
M=F8SM'!V+W!V^/L,SH1W3AJLD1#6Y59I'.GD#(HBYLU'3Y**8)4K\WC:!6^H
M=<DC"$ETRD9UQT]&,'WXI:J,9T^&L134^[K#+=]"C4<6E:":6^*IRQOO'(=H
M 902&%P*"["X8AN5V *T>KWH.%Z^7'8<\>$O[^B[#\\O#S\<P/M.\.%1^/#F
MSX/+P\N7%!Q)]N[L .8#].DM.XZO&3B.C@DC MAO%AQ'YQ2R7GBD*&$,!V$2
M%E\7E4C.,J%98EA1'@(W(B6PY'%D7("MV#+7$V>N@XMCZZ/50A-$.)>(1X&1
MD52@)(#/*$TLJ;2SK[]O4.*&MB:W.ANU0D<\O;-1&_'%YY*95?7/M:;^(ROJ
MYS,]W1JP=Y7:N3^NL4Z8$H=PTB!C,H*,>6&02_D,8U*@VSGXXT+NZ0VUR-RB
M'D2ML&[4TVR%]3Z$M>%M!LZD)J !C<Z-N9DUR I.$;?& +ZR2+$"8:5J8XVY
MVY((MY"SOT^ZO3S2T31G<3CX] T>Y+=,_Y%YD)+[J#0.U($'&3P'781)BAK;
M2$#YB-;(?W@$.E@R\D^6C?S/AR].+@\N?_L 1CX_?/$6C'P/AOROIX=_'EP<
MGKV#,0#]?GE]^?Y?5SS(+\>&),*QCT@RF7>S T?:>(^<T<1$J9(.;&>?7MEZ
MO(4+*:PCC"JL% E<!.:48(%SCRT6'E/6<M<3YRYVK(R16H,+F6A4B#N1ZW0P
MFO])/I@0I,]9$V*K-K;;^AJ;/HH^T] @J:\;^OF7X>#)E.+ZCA([=Q^]L\%J
M$9'E+"!N**"WX. ^ZIA4BHR!7L_U--56E=EHY73+W,=63N]#3AN>HR$^&APY
M$A3G7C=)(I=H0I1R3VP^R$1=5:]J4VD7[5;D+43L']&.XNF@MP&O\8GM._Y^
M.AB.J^YS^7#4&^"6;F[I=12'9_G#0KD[GP[_WK,8##O7GPYI-R<>MV$Y$^!6
M6WV;MGK;M"H5CH%$2I&27H*VD@2L2F*1X\%PYKT.*E=-WD#MMG9/8GME=%-&
M92NC&Y/1AD5)#!=>68><5;FR3Z+@ U*)+!7>L1B)#7)G7Y)O-RC;K8@[&)2V
M'^ZU)G/K+F^3]0&KW6+8G3#LCX7D!X>MB3$B)K')NZ@2Z2@YPCH?M%3&*)&3
M'S9W%J$-7FVA-&[,SFBE\>[2V+ HL/<)1VT054P@3I@'VT)$Y!DGL# :<X)+
MKY1M"B4_^1#5J\D01&<RC"6Y(76_Y-_;$-4-B0U6*!FPX2H$PI/3QD2)O=*2
M",Z53>W6\\.#S[N%K>?#H^4SU><?#N$-[RX/Q.'16W'PX0"_^>7@\LV?KSZ\
M^W!X>GCVQ^7!+R_9X8MW7PZOGJF^.,[G(8(Q@&2.YFI66"'C&4.14&^=<9$%
MO[-_9>?Y-JGQFFG&I(I*>XZM-YA9QYB.%E-/@VZ9ZXDS%SL&/X&2H"WR0@;$
M06,BX .*C)":".I,%&EG7[6I\5MI<6[*_YOI9A#45[5F;@-;7R6L<Z<PV*!D
M) H)(SSBG@6DE1(H DLFX>%OF5O[;*!#:!M\WEX1W913V(KHID2TX2DJS3#W
MDB$G\Z$513!R7(=<%8E@J6DB-F<S/*TT^'L-R7ZG0-*WU;!XU(#R]3J_8;D_
MZT_.PF!<?W]KV[T%G+L#CF_:!$P)PB0G2$7M<QJQ1E;8A#(,:1.4,UX X.P2
M+>[<R.*QUZUIY?^>#8I6_A]&_IL&ATI:8I!ZK U'/"8)\B\"2I*J0(@QG+,B
M_U0_'OE_\J'K?^06 ZACO9^<37HE!^]*AP%[-H#17I8/-A'4_BH+Z\?VRO[R
M )&3YW.>>-%@"?B]%_,O@)[/&YRQ%EE;4+T3J)XTC2K+N8U2"*1H+CK*&7AQ
M(DKD87V#ED(+DC.(#-_C5R#UKVV0Y2F(\Z:B+*TX/Y X-VPD+7".RP0$?A+8
M2,IJI'VT* 7N+ T2K!H#XBST'MX.<7ZJ 9E;&I9M_]3O0*#MANH',+S60N_3
M:;3ZO=#WX\*NE0P<>\60Q#P?Q.6 OC: 1>4CPXQJKE/<V>>&?'M,?.-2\C@*
M+[=XV>+E][=L6[S<(%XVK-4H&,$I4(2Y]8A; 7C)=$2:*,.ICI3:?,1,X4W'
M\QY7Q^JO[+B\NCVCV:KVC*O;"-_80?;VY:,[YT,0ZR&,?-KL<51:E7;M27\P
M@F7J=/NC\7"2+VZV/+5 KY-&I\C>P)?89>Z<.GW7J#L&2KC)N#/XW(?OW$4Y
M)OWSX PH>;'7^27VX]#V>A>[Y?/9?:=V5#XHW-(9#W*CU/+!_'6E:VH'0*=;
MM58= ]%S"]5/W=R^%:Z]Z)S%"&,!5K/=?C7AD)\%LPREQWC=K+4>3>G]"HQ9
MO;DT?X7'5D_,,UUZ_7!P5CX:V:H;=.Y,.1AEIAWM-DAJ1R-[ 9\ '<95X;53
M^.>\&WVL7[\0Z\VO'>6;!OD3&._G[OBT\=J;UM(.8>BGP,O3J<YF$29^#%/\
M%/L36)(\T6I&LW/?D^K<=Z^;XO0X>Z,)[5%-DU%^[!D0M!!UD2;U!ZD;>^&6
M(X&IPFU^,AS&L'>U\7SG-O)*^'<0SM7MD>^I&V\I4_F/0?_D']U/,3P?C>)X
M5+7;;IMN@^+\<IP\B1A4'Z*Y(R\/E"%'B$ 65!@)26/GW)6FVP+\09]<@%7@
M'$=8&2E)B$(RG"+UR\U[,_U168!.M0)7M=#-O+F^U>]J6+]QC(MSXB:8R#T0
M ,-](AHM(TU8)@8LE5A\()VUB*J?NO$S2#E 1R^3M%=(:@M)=SN?3[O^-$-
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M(&US_=E$L;?@;-" =_;9E?Z352F]12R;YAW4.997\A0RPH78P+%50<Z[),K
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M3C#Q57=>-UC"@%MI.]AVL$K<CF=O*&5QQXI=LU.#FT>?6QZT782?C8Y ?\4
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M1CJE=O;9KJ%J3[6PU,)2"TNM_?3=@.K-W'X*(3!B QA,G!/$*;'()F^1T(&
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M^ZYPUYJZFP+ MS, Q(I[3Q)'E.2"+]XQ!*N:D 1#EY)H8B"E:8&09F.UP%L
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M&" !!:?,85FK'[@GAN=99Y 8-??,DYS<"KK'2ND]%A)[9A/.#MQV1CE>3(8
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M;,'6:5[BKI<P[I?TF E.77 ,><LS2R6.K,,8,25]H%9;8L!3%FK5 9O.E)N
M,U8'Z^_"#8ISKZAF1 LP87DR-%D7<-+8X@A_M=QPS]SP%A^[#.C6:,2H8(C;
MW#8'O C$=,2$6\&Y"SO[=%4'X28SS/9H*H<>#,'3[OGH;NP0A=*$4LJ-PYPY
M#$P*O.&2,HJI:'3+#O?,#AX?4Q)4)C[RGE/$23+(F@0P83SC/$DG/( #URO2
MTYKLL+!%=R=;) 0EI=1,4 Y>L-(I8F!*+XP57AG1\L ]\\#'2X $RJ/28'-8
ME1!GW"#X*"+FI&="@J(VU>%I=;U^6+DK.[ISH%U2RESN:NVTYY)9RZ@VEEB!
M30S>^Y8E[I<ECEZS8QZPB(92)+GVB >1D.4D(&=D$#HP+[#?V5_55ZC)$=DW
M/L]TW>N\6>&8[M:N9\/'F^:PK(R<SQ);,D=5SO<T.^5JVD%Q[INI!]F&[0^*
M[^Q@) O1\KW.VKCM&7!$MU\RN<PT072;XFHW; L0O>A,6@?$&V3GWF87 8%[
M[C.YP/&,=NA/Z_!$L?2*GP 7?,@>;*-?9_7 B_Y@- %GNWQ1A7K*S?-%Z:_P
M-^[HJH(UX")/,?NIG%EN*76.)>F)\H[X4%Q512@CJ/BLC)$6"^[)._WP^I@F
MQ;5-#(4()B-72B$CHH8_+8O$*@D6 U@+\J;=U\6@UIPG2PAQRG"+D=Q)?S3Q
MF573I-?Q( XE$%Q]/]J[I?C>GZC>,>?Q38Y6=9[G;<?N^.)1@T\:3(;CT]OD
M+\XQY'E>2-OY?]'VQJ>[G==]O[>('7?!"!L)(U:2)(CC1"<=B'0D T:BX$7(
M#1Q$_'L=-86)N&Z_^#N_P5!/^KD(XNMZ \,VTKRK>3[OAW]TJU!Z-X[@N\G9
MU9SPP@I'I[8_C96UB%,ASN7!Y<MCDA1.3 FD:#GW30W*]=$1M> G^B0<S2D_
M!(S3&R G,^:J",;=S5-%<_:'I5HH3G$R3&N>PZF:40H?M^SV2-GM\(4_]H:#
M5>$(BISF ULTAU^E11H3P6@0!D=ZBZR2$N"?N\0=-]V\RIN8Y\/8ZY[!N@XO
M\H8>&$:C6+),)GF[]^21VZ+KL]F7-WYGVN#5(%\ %L'0GL=)WM7]5I4@:.*8
M.&\=4]R;8"EQE@LM#+.)6U5.^6B"\==;BZV,?B>'E!Q<'GPY3L:5\"2*FC%P
M2"E#QBN&<,3&,,Q9H'9G7[,5^;^=&S3 '0-6.>,O!DHLCMQ8\$)4XM(YP9BE
M6(>6M1X5:_TACDUB40D;D)<<,%^#L>&<IKG0N,_56HDQ&?/)=1'QDJ)WLS-]
M5UM#40,J1V#+&.>414>$!TN7 O]I0UF+8X^)V6 <Y%A)RG6*8,"RG+8*U@:R
MQ"7@/2>5XY)K5M*7KPFU+MH6)8WH!C]L6?,.W-B6E)]7+YY7F3V?X+J<9%42
M5NX2%:HT]#Q;MD3TJC#<FBW#O<ZZC+#QY\%=7CZZ$I-Z9;]TQ\,<AVK&I$Y.
M<L9)21&[T^X4CXY&ZX@3DA/N=7(.>R6D2U2D$&[(DKB5$)X.>E^>O>[7,YY.
M&.;;F&Z3O./!C*)S@O[80G7Y^O(X!)*BY@;AP/*9@*20CO"/C3P$"0H[.3 .
MQ(JNJ#.A*GE#'N2C%TN(^ I?KV'FQV>K-P^>E[S!_B@VC\ZM=))!J)LI\=6I
MOHPQ=:\'>,"GV)_$4<F2I#_9YDN*<EPJ'+G7N6D<ZW:8LY#FY5L^&+AF^ZE*
M[9SE9_:Z/K]H='5&MBS_H%_2Z%+GQAF4!%$ 'B#5L$*7>A++T<B%8]F+&&-4
M"E%JA@FAY9!A3CB6PALB6:Y?7)TI 6@QC:VN1?W]NS^-8=*+@W1-W8%7D_%D
M&)L4?UF-M:0P'\%X_MX;^(\_''Z\A;F\^W),%)?6 '2DE,^5"0S.!3,BYV!%
M:;B.A)J=3@28/<^IU<-)W'D<LG[42+ ,BRP]E;AF5F45PZ!RM\1NBT$0<\YO
MG:Z8<LYCB<+'T%#@.8%Z5"62S;/$[GP.8F.D,;>BS%+=AS7H71]&R8<H&FN\
M5*MW-HU2C6%^CJ54@(#I].SY*#Z;_O)33HWNV8MGW7X95;EIN=8#O*4^M<'8
MGJ0B']RHBPW7CZ_/=.R5,QU+92NJ[[C>,WC]UWB/K/UN0X^]H4;R'7L>G75#
MZ,4'JC#S:K:E0=;4"OFJ>D(/.J=U]83N5OCG0:?P7<I5WKZZSU7]>@CO/_H<
M>Y_B 0SF]/'O)M>5?LB[2WCW+[]FO7KYYI>W^.##1_[NSY?X'87Q7?:Z;U[
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M!(E%\N[F$M7JX=<)R%95YCJ7X\D/SXR;GS,5^*7'-4K"NXNY?,\<I!P&JFK
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MA+FPB%O0OXX+@Y1SS$HO(XUZZ^SG'S5'OSJNT?E[M+X4#_C&B-RJ9O-/#HK
M60^4)<,595RHX 1A7EA+X$_KUQP^OR>3H@6HVP#4'\V('!@.S&'BD9(!7 .%
M!7(8!Z2((&!L:))R)9,-F13?U'O^7C(-6CF>RG$N&V$L]AA+RBDV-E*C(V&!
M$:N!+5J3XD$E=N[,.\9Y"HZ@H$E 7!*.G 5/0"9J&?REF0.)E1O+=6RE=1NE
ME3*2$F5:.,F=\98ZIQ5Q/D6P-SUKM>[VR7 C(,>L%MII"9X[SS(LP(=G-B&C
M$[""5-$QUVK='T".?<+>*!6,]H)SZ0'!(_96A*R!5;R-UFWE^#O+<2,@1[3F
MR7J)E'4*\6 X KL)G'UC01W[@"7&K1S_ '(L@[#1"BN#CSPE9G&TRIJ$K8PJ
M8MY:SP]J/3<"<DER:56R*)D((BNE!?,Y83"?+=? JL(1N6WF<YO2^(BN7!,\
MY4\]I?%YZ4#4J6.H;3;C+;0&XP&\-1T#BYSK7$+8R&BE]8%)%[ULK;]MTR5^
M'CL]>@MC/SFF.$0&2(](]N>X"QIIZRWR3&'KK.*:M"F-/X(P<ZNCQHX%G(N!
M,ZFY*<ES1BLGI?2M,&^A,%_,A?GPZ. 82^>H  >.8D_!GZ,<:6$9(MIK;[PB
M))!6F'\ 8;;:2^.)@<4W/!+K'$F8<09,0(7 ;7[R@XKMX50'7WI^<'*<#&9,
M$(,(N',@M3@BS2U&3,M$A+0:6[^SS_4>;T7VZ8JLS)%3%6+@+(=@O+%)2"^,
ME 1'RFFK?[=0D)OZ]_+YL8E@.TM%D7>@>KDV'!F)-8J&2\.XE4Z85O_^ ,+,
MF+$"+&EM/.->"NN%LQI\Y) ;[=G;"',KMO<FMF\6?.!WQYP(%JCS*#%L$4^&
M(DLK!4P4^$4J:K%U"GC-T>.[Q>D>89+CJ\$0_NS7W:W]1=4F>GP:AQT;/DQ&
MX[.J=5:;\+C&SHA26S KK ;W,&!EM< D!D^)CBQ9\M705"_,S_6Z'.4^L+W2
MK.H7V^T_B8:@#Q:L>WX<>)02H DE&<&UMQHPBEN.\J$)#6LD0=_L[--OAZAV
MFW9[95>XH$70Q'-BN)/4>.=4BH1&9IUP7Y_DV,KN_<7FGA\+'3&+TJ*4LEO
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M7^^W#O>K PNJ8\8B>'3_JLT U/E_KF'P@*'C=>+!R>0YMM@%PHE,6(!VHFG
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M:<Z=B<X+%PUGW%--C+UN>/%)['6#[>\U#/Y@##YC+:4H0),D%D5N)>*<6>1
MQ43,"*^H+OZY%ZLE!XG^OJ N:0VG+R&G1Q#?6IL$FJ<'Z6TUBU9RD-XI4IX2
MG</ :#A]F3C]C+5AE8A""I#B),$/3I%-DB#!<Y1W-(9IN8R<_AS.R;:[ ]N^
MKDTWWUG_$W7SS#GYY8;GZUA7BRS5V4#R0T#RIS/6E1,I$&\="BHK7RH7[8P!
M$)H[(B6+T>EB79W-K[FV VCNP*!E=E\WB/?8$>]^*\PV./= .#=C9-((UB53
M! 5.-.(I,F2=9R@PE33--0,D6>B17(-V#=HMP:ROH]\MLB9R@WL/@WNS)K?3
M!%NO+;(DV]T."^1T !@$LH_!4\;LH@[X[A;QAC;X3-\G4F<@/VRH[4Q[\&6,
M!GXJ0WS4GICKAMT?CHN:U!'WP^C[A07>7Z$<-,^X#>$]SLB#187*SWM>L71K
M,+^6>-X4GXXNN(!8^0MTP?-*-5VL%8(.^'0J-=VO,OAUXNP[^20VCG:M"\[S
MD)#"C")N/4$F@$*(K25>Z*BU+%'SM_'U+=_Y:H-13Q6C%A QWV#4@V/4C*,N
M=S!)- 7$0N[$P!1#3CB!M)$\Q_Y(FT+N(M: 5 -2C^ (80%!\PTT/1 TS?K2
MO(*-TMPAI:U#W"N/;- &<0UR2'@+F^A>K,H+*Z\VH2N/*6)^WGRE1PU/"PB8
M;^#I0>#I^YE0#H.ML"372O6Y$:(5 1G+$O(R8>VYQX&P%ZO\*28=-@R]P&CY
MAJ$?BJ%G3"$)ZD:0D2#,8^Y)IC&R7BKDD]"Y-'7RM;_F;$^RAJ&?#$/?4U!\
MP^;WQN:S9H64*0:-*:*1F-P]*(!9$1TR+C 5G>-@."XL*KY)QKW#J/BYJW ]
M83?.DXB:NM^@^ :)'P2)WQX5%*[1F&]MOZ6[T46!I<D!HKEPBY(<&2X3TE0+
M:GFD.C<'9"MZ01Z>Y0@2O:5ONH&[QPYWUSET6T!,?'/H]O# MW$:^!C626 G
MD?).@*F9=5!E-3*&B4!= +JQ^=3MK*EY[5.W!O,:S%N"6=]O7'R#= ^&=)].
M(QV6'-1U+A%-8&-SQAFR(EJD* TD4H(ITXL\Q%NZJ/B;E7*_10#Y4WIA6>_?
M2@.3U=E>08^G>=K:!1WQ3C<GVK.AZAX.^@/;"<.V1E>$!]?]QTH#V]P>::I#
M<VZ)=*:UT:C]UF&_[D)=7Y#:AWYP.&QHUAIW*1NV%<L#SP/PME\Z/T^W_9II
M>C;3J^S-L"W9N$_9^(/9'F73_<FJH]9@K[)G&G-?LZOD#;M"S]-5LG2%OJ C
M^V.5$K?H&XESB>A=QY6CSB24:*YK:+%%CD>&",-8QZ05V/(O5HFBY^#\J''D
M2G5C/KFJI>"RL4EN]5?>,^KTMR"RO\-FJ@W9GR9[4(#(KF&>>ILLT+DCB'MI
M@.Q]+NX@@K,N*N/,BU6FSXOQ'I/]PGJ!7GCZL$ Y5UYUC7ZI0/<=WP*"7N^
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MH?YI6==JMP:M>,,8G$=B.BW%,YY7Z-?=UQI;,B!<ZF<L,OZ+X16Z[&=733F
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ME(#U:O0#\"OL?)AARAT#IPY-C;/WP+>90^OW92@ &\=^C57GL,1O 13 U?O
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M+."6VR_) B[UOO1?EE7Z<[FJU>9S5?-]<%_6[,8Z>XGK>+Y6Q*CYB[[Y]2=
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MQ3B3$9Z-X2QS;Q@8%9A3)K'B:CDL59S1\<F!E^+VYGDOA'<-D3X: \4I5#&
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M>P5.$:Y<R@95=+9DA3VNMHBK93Q8R4%8&0/3QI' *A:8M]$R';+2'E.12I#
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MFXT'(0\R3DYR&KP_RB<#'(UJ#:O96FJ\.!G.J%LXP$D>'.?9M\WG\V:/<#K
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M>;:"_GIKGQR\:E!.(/JN*@F$G?_\*UZZDA> TLIQ$WUT6=![. ( V4R.5'4
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M>S?< \DJ&:S.EH.%DI+WL>3" ;6EC8"QWP,;WP,?7OSYYJTI 5&IS!!%H8W
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M.0>$Q5<]YVK-FGV.RCPL1"(-U4)P:U6B!$V2C#N:BMRM?,[5"SHW;T*D,GA
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M%1:C/SB-55]?NL-!?VIM"\E'BX+$[T>AIFTL1E].@9^V9:SEK1:6R],R+K5
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M7"F<>\N(H1*])N6P"",AV@09 O+-4A\[!=V:*_WQ!*Q:0+XBZ-4"\A:0?P]
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M $/F!=,VRTA(= I62X#]HIP3FC-)J067)Q48&M6/R,UIE>\! 4.K>C=6O3G
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M)O[%BN\%*G(>0FIRHP1/O5(ZE0JC)KD3*NA5W[-!9P)>B5.A1)XYN-2&$!C
M()HE*EOU/0&?.Z=YT%0))$#GJ=(Z#2%A' :N7ES&E7)_FACO^ MNHEUW#=U$
MDMK!L+,%QOU+=WS>(27W0><KQA8Z_P,#.^JZ3G<4R5.*JQ=T>;7&7J95]VIS
MBFUJ\=^_PS9ANOV.&8W">+31.1L"%AG"\SN^:X[Z@Q%L(J-.MS\:#R<1;VQT
M#,Q#]#=]9SSHN,D([' 8CCI1.R(,PKUQ DZJ&0Y-_R@4!#+C8S/NC,_/<%."
MVW?[KC?QH0-3,:AY)F#F1X!D1@2N*Q^"U#)?0Z^'_X7K\L'P-)(V#"S8R"A^
M2#TS[("].RJ(:OJ^,X#%B4,934Y1^4:;G?WC #=;.3I\J='$G@0WQK<"LPD&
MLI#NL^'@2W<4'_3UN.N.X[4!F21-P4(-"*ZX'E\!Q:(8./XN#JU\#Q>Y5O&:
MBH%GL_-^[FV+@?0'L.G##M#-8;+ZX\UH.'#8\9ZCSA<S/._8\WKNXSN?FNFD
M#LZ*B6F\28@CJ]X?9[IQ$=BY +=H7K'9^1@EOK'T<6QQ-CR\=['<T[4KW[(Q
MJ1N 7$[A&X-AG$=X)#X /NE6$@2K]B7T)R$.W@9\L6XTEOA"C>6 'T?A_R;(
MX G8BQ3?14ZC01]_]U/8/-K<J$3@YT*&XI)W0-8&KEA',,#5XVP8?PVAWU@L
M?."26X]0TVV4]0'J+%P&FS-\U!F!3,:U''8=/NROF?<9AK."<12^:,Y@SKZ!
M6HT#R/U*)Z(_05ZE.3^"YYE7ABJ6FE0$%W2:2)_E)@CNC0[^<#LRH*5,D654
M:+4_<3SH??LE#O%=,<*W88CP B9L+X\1I?+WM2^!OL@3=2;^$?Y__NQ]8KTO
M]N3L&)R"WN[^%M_=?O/MT_:'9/?T;WFP[]C.Z0'?97]^/KCX? 'W%@?_*+ES
M\3?=V_Y;P)]ONR<?DD/O4^I2J8EW"24BEP9<A#PER$A'I9<T)!0<@P6OX%\H
M;0UZK?_Z#\5H]NLHVB2$\]%T5-*2EZH!0MG[ LH $G \ D5!-:L9MPI[S5*D
MW6+)9N<I[SIO^C@1_5"HP-?N^#B^/_)ZE6B^FK^=X''#Z&R%$?PU;D9V,H('
MC6;YRSH1*Q=- 0:XJ9BC88AFJ+0?I4T>='X_AUT-8Z==T.X/F^\W.\?!^/^;
MF.$8=['"E/8G.>X2PVC82@.RV=D:P9W<\>R#P0H"0@1C?0%/_\\U8@0ZRWU(
M%4\H94);91%%IM)I"C!2N QU.\8(]%+=EB\Z<3,<PZV^C7\!\^$'X_+C^3#"
M.UR3O?S#*&SA/K]G<<\/_DW_U3=WC/;Z]6!X.4EB^ORL0;)S\5GL;/_-=O=?
ML=WM(WIH):Q!&AP13N=$,)X0DUCP[5/)K$U3*C5_\9(F*Z.!H&(]E(I*X:.K
M3@8YF42@ TM3?Y27Y%11;C>JG3W"#=A.8-<=GP-:ZP$\B"(+NV/W#,5](_X5
M17*(EYMZHW6A^P7WUHT2Q7P%0+6.N-Z,C/,Z4MK<G*I1MH)7"=[^UM=#GJ0T
M]SPGQJ>!"(OE_"X'+Q_\,7 #K3)&7DJU60G>'(OCW)YR%74C>FMZCMB2B1@\
M>*!0RG[#$%=&'FSX%'/F\!<[Z?8P9 86OS/XVB]L?(2F\#'N L,"J(')+\G@
MXQ7'9E2J#>K1$>PG1PBC\6+8D$ ARSM\1YM/UC'Z<X=$[V#<K[Z=A?XHO"]G
MZEU\E1%]SLHF=D[^9CL7.QP#SSOPO$.NK134<Q(2[)@BP-1KFAFP\IQS:W.O
M>?[B)5O2OJ%3JMG&6C(A>::X];E76HO,!</SD*4T93R3+/$ZRH1*-.PV2P\-
M6IFX;YF G=_J/,NY),X83T20CBC++$FME0[I5JC"=F%+6OIU:M/;7P\>>J]4
M0AG #94*Y1-+/3S-4)GE::9<$L4BHPGX)85\,-V*Q?<4BX.+0P6^N93:$(XM
ME82QCF@.]@+45 <KP(++*!:+Z6FU6 ">RPNV633X):<RR@HN*L8T1F?H)GT)
MO?,*N>'&9#%\,45YHQA'RW-$D.#CS$=EW& T'FU6L8?=R2GLMNX.=J99*7KO
MCH.?],)>/G-268A.=5X)GL:<M,7P^#X,Y#?PM#X_/[%J1ATN]K8=/<Q@2^"I
M3@F-+21RGX*UX8(H:7+#,\NMEH6UZ/8GP6^ABGN14R-#PAQ/!$!%XVR6YYF4
M2E#+N'O1"2!E9WC"-)R$ CG-)1&9?A_CHK, IR8 +^)]XQA&K?WIVLL& 1RO
MPI4Q;CC#$#XCAW/!BJ6'"U>^W7T$.?0:,8YKLI[+6=9SN8PB^9YHT)78U(+>
MA 8]2S=!&.^<!AT>F8B[YRM7,%A^+X.]'KGZ=\I!A(5]H#28U_5V=3,2QELV
MS7H&O6#:;BZS.';]Y,=I(&F>*??IXM8B1VIG&ZX]_;.[]_$3/+-WNKO]S^GN
M*8SSXVYO]^3#!7SG8O?C&QCC0H[45P CYP>G;^0G^+/W\2#9_7C #O:WOAVP
M#VQW?Q= R0X]./FMM]-37__:?U7F2!W(W?U7AY[:-.1:$V\S"UXQ^$*6@N^1
M2I/F0G'M,H"Z?(E7_#@*.&]JD;Y3)=IC,.<WX\AKZ] >M?U;PN_9FL!KF<!O
M\R:0.VJ"51E)F5%$*!>(#H(1(Y3-,Z7PE/Y.3. ]%:/=5(N?$:*]&>57R^#Q
MV$W@(F%A:P2O903/YXU@IH7WTAB269L0$5A*C D)D99+KI.<\ERW./!)X\";
MT1BU./"1&\%%#K;6!E[+!E[,VT!I;%"8B0%_P!<.G!'%#2=,&RDXDTHG$H]]
M;ETMU +!A[*!L@6"/Z0-7*"5:FW@M6Q@,F\# >[A*3%XOSQE1%CMB$JT(C;+
M&3<2J>0!!])'2^C6XL"6ENH9FL E%#FM!;R6!:3S%I"E2F8!8)],?$I$ZA7!
MGH$D=SDRY7"9*[X\^:=%@8_$ E["L/,01]N7L@+<GE'CZ1^,W^$$M?O(K?:1
M=O=8;_>8XS;\3 ^%#T:[S!%-/0!H@YPC(>4D6*5S09FQ.=9TI)N+U87WP#GR
M76A'[@Q_?R_JDJNJ*@O1OY(#@DKZXCO68B[CLD""W_O.__VM+,S\?7!JR^+Y
M[>[(]6*YY6-)\ 7D]N53_\_C3Q>#\T]_O+KX=/+;Z<[^SL7.Z4YR\/&?DX,3
MQP\N_OD,^GN\>W% =T__/-EYKY-/_WN<N--_^N:CGNR=_/GY8'_W=.>/@V_P
MS?.#BW?'GS[N=G>1HPCLS@Y#F_.!'9SN?/O?BU?)SLD6/\QU2G.N.$GS!$^/
MLXQH32G)LSQDQOC =#*?U"L\5T*G+LN%%THP$Q)C++4J2:3W23:?U%NM0*>Q
M!*/+TVTO%?'E1!]7#FKV)1CS6>ZH2C*6""TSHV4BM5-*:6MT-D<,,E-;QC:_
M1VG9<GW9<C"1IO,_P?3&QY?3]2P;[BJ+49/T1-M&$)/]PM,'*Z#;ZW>V)D>3
M$1ATOE&6(#2KFY$)H1>P.@Y_:]S_3;K3 NV9*=KHO.F[S<Y/+XK?OO@YEK(:
M)+MPQY&=$ID2\&N/I#A]G6(<)[C.;9[ EJV$==:(Q%&>I\X$#JZ>+7D8%..D
M^N'&Q3A+S.COH,9='PH:HOTAO'0>AL/@'T\YSO<WJY\O=K<_B-WM([&WOR5V
M+SX<9IY3ZC$KAZJ, !;.B4X]<C?D3"3, TZVB*CH566R5:%-771M.L>#GB>(
M5-:M^$P3EXK A0X9$["KPKZI8"-(N,FY-7E6PO.[%QB$\F"59D3G\=7U/Z#<
M2/C#=K8_'U*D&3=.$<F2'';FG!,=$D92CSQ8"<VU"Y>E-%2E7&?F/-9M7 :S
MTI0I+ZP7B3#"<FT"S54FI7%4!RK3I8:D(0E@[-PO?C+\"EA]%/HS)?1+Y. M
MC&#@X?NE!S?(KY:,9RT/NR<'AUZZQ 7NB-=8U8<DV#I7E 1F*1K]7#/ \WFW
MIFJ91UB=?#@X+1A-L&(<B]"G&V=!T.#J98B4,/4Z5*9GAMID-([L0<4>G)ON
ML(/L4Y'-Q(:UK!&XECXW/&>9LR*G4J59FGC'\L# YTQ<:XT>UAJ=[!QJ993E
M+B/.8\\#!_^R@H%= D<,:0 U8.@7+Q5=V45^ENL!1>8T&'3!(AL.2N1FB=PV
M"FZ;@E5D"T!@%^0/'#4SVFAPX(2*%&?X.2 A%OQY.QS\,^F,SD?C<+J!'"/F
MS P'(S<X WLW-+X[ !6(A%WNO ,VL? >BNLC+$2^$WCF>!C,. X+1CH9@_+T
MD?G$#@==/ZI&^=](PS":],;Q?<K25B0NP[+"84"JA^(-&CH#W_GC8+?S?C(\
MBO1!Q65%55TXBD^\3$<7F3"N!>J;SL #8OK]DL:MM"]U!2?.5\UE9CJG,*7=
MLX*9LBS]!,!3B$F<LH*<ZF@X^#H^[@R^(,\<3-@P!'(>S!#9^&!O09HJ+#0N
M[A")_3K;P<4RT$C!ADQ+HTY_  +T+9:9PG?[@\EXL_-V,AQ-3,'0M/7^]XY*
MY*SS4=<WH\Q55K 2ZH8=+'^SRJ9V>I6A 1F#_UY4/'T[:!H[OYMA;] 9P=A*
M.:WGJ*R/K6;B;#@X*2BK1E/O9R.Z2&8892O^V$<"D;G9@X$$4*HN.%-=N/>7
M 3XJC@A5RYR=]<[C)':&W='GCO$GH(QPG>^.(FE@_/YFYY6!G:%DJIJ9J*^@
M\K@5H,YUAP4Q(RYD5/L5LS6=%*P>'XTFIR4?8,$(55+P(=UA'$TA0M,'52O3
MI&\,!6= I-Z#-6\\LVF!D'AH2JDWI3F$>YU-QJ/(?CBP(/LQT%PI=F%^XJC&
MQY/1+,->YR^8[EZ'SSP''N-#CCQ7T;RA@"%OVF5#@T\\S)\;HQS#U#J\NSV?
MLRQ-22Q%Y#+%*::[8BU#JX9S!_.%%?U=M#OCR>+78"C'H--(L3@$,_TUKK@I
MYJ(:P"A2IY43M/R59A7JZV#2J\BA.AB!P!6'9\.2#X_@=O H&_HP:4C>V*0>
M>-H&\5) +H)*'("?%+!^FCF=YTZ(1',6@W+)6KP'[VHFN#?XSB#8P4?&M=&6
M*S1SJ^\KV -F8@O5+OA'Q8#P !@(//@/X(G]S7>V/WS=W7:'FCF3Z\23- L>
M,%">$Z-91JBGTB1.Y"Q?B)5:GE",OM,L"R)+F4X437+CI61!2D67$2",8R^5
MN0@5VJ>2-K2PI#4, 8O3ZR*;ZA!, AC);D55VBU7NS18T\_BVL=+>M-5GUJ_
MIC+[A@:7R&TPFMZBV'+F0W7PZY(T#DR&#6 G-B\/]][@C.-Y,[73RXU;R]3>
M,K57!R-7'G3,6:PL3?,\6)L&I47&N?:9,)3G\#.Z>F8I8WJI3>D*YI#EE.Y7
MF<9[8ASAFR+3-V$<D9L97_WI3:E!4K7))+OSVS)02JH>$S?(@Z:N_&Y&QRTO
M2,L+<L\Q27J-N.,B'$>#=0U CC(,'[R"2P"/X490ARB3)PK/#S[^.<(^20?L
M%462L8./[W"<R2[[P/?B?U_W=D[>"'CF!8[_4_6=__WSV)[ZWM[)NY.#_0]B
M]^*?8QCOYX.3OSF\A\#_'GS\<+YS<@3OMPN_[_7^]V)KO-.-N4[CW>V=\YVC
M0YER87,I2"Z<(4(FEAC+%$E=8E6>^HSEV$[RSOJHW5LWR?3':D+]IO\%CX6&
MYRM-]K-/U'^$]JE>M=8LK6667M5F:2=^Y^!0<2X3+CP1W HB8%&),=82YV1F
MF5'!LO3%2_&H.#W6MDM/$$7NQ0X^1?#C1J;I6911/D+3%!=N=]!W!>]:\8W6
M3*UEIMXLF"F>9CE-,T,D]]A^@@=B=9H3ER=,Y"'3'HF&Q9WEBK?PZ9KPZ=+
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M)ISL'"8VY<PS@>V8P:+:%#3!.4IH!AM<IH3,<V1#VI2+CAVF8Q?R@5*.\E5
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M%&"%_<'RP%4K4;5$?3A4%LDG<T6"T)@XZ#&\JA.B<RZ8Q/,$CGU5LZLR!^O
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MT6'>'3_\F;=\1C%\RK7T[L4?+WHC\@U'59%JF# ZFVT^ZMR,"<-F]TY2X/J
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M^;O>>8L%,/(.%D"\D/9FZG7-*9^Y@PFO.!!TKA?]VF[SR\RGRSG1X:[S.KL
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M;?J[#/T]ETC5?:%4]N3+LY0EZ:\JEJ'AD1E,.FD9LI.ZZ>_CU]]EY"";_BY
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MGGWI>X'<61]9<3HQ2+5ZYH4D-S?&H(PQM+==MO61Y NNJ;S=!3JW=Z[2.YL
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MMOI:3_:&::65B]('B/Q'B9Z:DJZNDBXVX]V4=(%*>I;VEMPD$71FRBC#(,;
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M>'.\L;7>3UF$&%)DPFC-H-36I> 3\SFBY(XK*U+-N%PFENS-;UHZ=4AF?9]
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M[-4 N"8 [DW5/*X#IY@P)*UR8,K&@)SS&B42))BR-#F<<ALM.-=:TZLAL(;
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M[,DD6?+ASTT76' >]6(C#&/6WL<I/YN-=T"0(93XPURZT#C;H%\ECG<[U7?
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M6#C839X+KIP9#&YE&T?= - TPIOBO<F//6SU#RO8>#WR\HSOW+^H#+<16J&
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M4&6JLRM']YQ5E^\[VY^_-SU)>=XH0US(4L1.D'5*(V$4\<Q'Y6&G7S%QCL/
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M.-$6\CCL+,Y!,8CQ:+DQGRVR-&RW9X1]8R3G\49YH/+SH^-"[9,GLL>PG.]
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M? _/O%8PD]4!:WJ+B7?2(4M,MC6-S6Y?B1A.5@OI92 6R(JS378!68UR9[<
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MS^;S+O<H@WR\0?X$1VO9H?5)?+-,;)G8I_7-,K&/,[&7V3Q5_WM2LLK[GWG
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M?8N#^N?4[56??PCP1OE5ZE]7E=/[U2?_^%?\'D>_)K_<I&+,3>;T1:W-7S"
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M65MPKU.N2T'\6B!^)GTU63B:X4B73D;$.<OQ8!RC*"0SC$FKHES'<_WE>%T
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ME>_"&H'0S*P,,; \Q\>];J7Z,)C!EZPW/3 <,2]H6:2&&,'%=FZ'LFF*_YW
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M,L2IL<@YKQ +6 C,4Z Z;;P0JPJ&=@#.>GG]N_U.ZN9Y[.0U[*3AX&C^"V)
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M<'CVOG-4::<CHH:6G(N C)06"2(CX\!8(K4;+_J#LP(SMXFEG9F+V:Y5L_H
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MB3SSWV6/JP/S\AX%YG<&?50A28G.;]LQ,,8'&(M?RMQH)+(LY6U49N.+[4W
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MH,E)G. 7U'$'QC<"\ASG7+CA!-RW]PN[Z*_J7?1\8"Y_@,K:=)K+=^: XX)
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M>\,? U]TZS8E]/(07)A1+E]4N:#P$E5EO3(#67ZGJMN*[Q2?3[?VL2 ,[*-
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M>R*8=XHG[977ER@!T:+9#:#9SJ\S-#-6L!2I193BB+B#/ZQ)%HGH0TP :%H
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MR>4 B44F:HY2U$H;8K6A;.,%$W<1J&NUZ^*"N(HJ%L B)2FX)]1X(JP$QLR
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M6@>'(N:"PV<A$;G<_P:$5Q-)B#?:\,"]P\X0)@DG)*C$W'(UX#?]:KNCM$8
MA*KZ &?Y6Y#=JCYT#"N;K2_4R:T;(O1*J5T[7]'26J$_&,\;T,SK^Q;<>WX&
M\:ZUX.[*[D+?G:VV4.^3JGW[H :[5J'>Z1=F-JX8UB4G:CCX>E&"V9UY.\LE
M5U=S_=44[Y+O=V[<GXB'68#V8[3 (TJ/FE5U:)?D@>)5\K"(>I=BO_=[4L[V
M3;],UM1E7O\2^T:/<AIU9?[;:?RQ::R:U3^QBM&[2]SR;T ,ZUXEH[_?=3KC
MCT4"'U D;&6GH%O:J+Q$7Z!:2$I48?2F__OC:-@X#:+![^CN;]O?8 RG<'_\
MD;X^^O@)W,1/GT\__O&N]W'O@&Q_VB;;ORX'T?X-[N)'_O'T=6_G=!O>Y=VG
MCW_\V=W^%&#L.X=__O;OP]V7'TZV3S]\7:JX);3D+I]I9-&"5YE=2RLQ1]@1
MIV2*E))\IG'M&-I#KU_:@L-EP>&6]OU:<+@E<&CL%TJJK G&(4QI:2@ED7,L
M(H)IB,Q'JKUJP:$%A_/!X9:VT5IPN"UP:-07,H)3X3,:Y.TW$Q/2UN;4*.E=
M="QQ83(X/)@^#H^E4L(?Y1\Q( M#L@>Q$[_%H>^.8N=XV/4_4B[ALL=,'TSF
MPR/)70 P*Z!WO6X;71M[1VN![U1.MRHQ?55+Z>]92&? C%M@O@0P+Q1^PRKX
MP A85.L!F*U*R$;ND C*P2+':*G;>,'%IKF#4[@MX#QBP/E!5[ %G <$. L%
M[#!QG@7$+#.(4Q61"3H@+9DGP:<@D@; (9NL!9P6<*X3<'[0O6P!YR$!3B/S
M,X)14=0C2IA'7!&!C($_M*4*4Z"W7&7 P9NJK3-R"_YEV;'KY';JC<3$NVCX
M^GA@^W*O^/CPG'G :*:)!X^5$J[!;U41:QTDTU:3_3>7=U3=]X.$[AP4WQGT
MO\01B/@2@!=TS[G,.96Y9#*W*+X6BB\4.M2*:&DC1MY1H(W,<V2-B8A+P;D-
M,@:<"Y2S3?,("Q^W4/;(H4Q:SZ(WB5!F.6;1"B=S>K%.S%-/=(:RR[K +93=
M1RAK>, Z&,9H !3C.3??>H.TY@%AJT3 8+@8407*!&^AK(6R!P9E/"0K/0M>
M8\&CB@YSQ3565D>K@* 5*+ND<]U"V;V$LN:I2@EP912R(>=\8*J0#IR!@^VD
M("8&&?*V+MTT^AY!V6/9NVT<>GM^'77M']%7KRFN4AD@<Y^%X%UW]!FE88R=
M;DY2!\SK# '>1G>=!/V8LI6J0[;7NV'.KBU9:6;)&GB0I>(U",6;6B;>@4C,
M#!VBK:6[A*5;J.T4F$M"886<<A%QDAS2 FN4)(\X&*TM#]>9P/2#=NXNU.>O
M+>3<,.3\X)9Y"SGW'W*:<0(JHTHZ(>.(1]P%B31/ 6FJ//,)_N) KMFU)52W
MD--"SAG(^<%-\Q9R'@#D-.K@"\,X4%K$O+&(2^:1PY+G_99D6:!Y"V;C!=TD
M+>1<)93P -S)5]^.H\\G:GO=%,NQVI-<#> R9VJOX+,_),"\OGI'C2X!,";_
M/$R&>9*O+02Z"BJGZ[H7AT>D!<9+ *-?Z(^M&7-4"Q2Q%XAC)Y 53.<BOY$1
M[RE1?.,%W]3G5B)J]>:'/9E6;QZ&WC1\F.BC Y8HD1#!94+!$9 !@I@@+'$3
M!6.BU9O+Z\V5Z'BK-P]$;QKI3LP2*QQ'RG*@WUA@9#F0"*:HT#XQY7.XD<_#
MC2OUYNGL@LQHZY=!#\2VUQV?M*&!I[P!LK3M_^^96+0Q@O6AZ:!)A6/TQ@MI
M4&#,(IX84&&--1(.2Y\PBS+*C1>,K=NV\_$&"5KP>6);(2WX7"OX-/P)K US
M"1M$6  _W$F'#.$:!2*TDH8#)CD 'WY?^H>UX/,8P>=>;XJTX'.]X#-G/AR[
MZ(5C>3M$(2X]038*@I*1)#$;<:*J-"QOP>>Q;H^\['[IAM@/G9-N[(7K"%*M
MKI?]T&'S1OH77KV[\O5 Z33(,!6"MB#86ECZ>:%7(I72&<^1=!*(7.(<Z0CV
MTA@2&?PNBHRE5^K9?/N%()Z<,E]#&<]6F1^X,C>\LA0M)=(%9*ERP(Z,1%KH
M@(P'+0Y:>LIEJ\SW59FOH>QFJ\P/79D;%>&(=I$ICHRF'O%(++*>>Z1#TMY:
M[G4NU7EGRKS8[FZI-=/%7>)FGL6]Z1(W7'UXI],==<HN:R?W7>N,A]&.)L,3
M^-)H/)QDQ>A\/1R,8B>W><M?+AWA1N/R07=\6'IDQ85,KD$JOUSJ*O>FWSD>
M#C[!]W(OK=D5U;=* =#&AMJS<H>EQG9^<.2Z_:HO%CSC$$8Q&.;%.^<FI<=7
M]^BXUUW8K.NDX>"H,W PEU]*URQ8ML]Q7%T^RG<>=6$-[+ 3_SO)WY]/Q5)S
M/)A# *;\%BLG8;$UV6R2&^/.EPR[,;?"FXS*M,!H!R>Q41HUOT-UB_SM[K!Z
M_6#'=O,RW0H)OTFA*W>\?,_%TDX/%=#M-(&YDS&U#R^[-1X/NVZ2?_<(6C%6
M2C"T^3LH?[]CY^_7.8KCPT'(+>R&T0\.^O"D2F)0)2F^.4&QGB P?DMB5?6Q
M@\=T&^J4+?"H\[>-=^\_C#;^7@EM/J)<NMAE/3XCG:#8![$/!J[7.^DL3%].
MXT#=;^@0C'?L/W]PYNWJ[0VWR>[>AWU!O9)62$1" L(9@T,V@3.)?>#246)H
MK@:3!I-A+;(=6*.+\FJ(I]X(24(NP"$(-<9@IJ.-QDA.:+AL'N?7P3",8O_:
MN$_YX]^5E%1EXAYJ,LW5E_PS,)\/?.?E =_9>\MW7_I]Z;T7.#<D#U@C'JA%
MCG"#<)#2:9R%P\'R=[_$*GMY.4FF,I*V#ZRA-]-!4+_U=@&<""11Z3D)CC/P
MA#7(C4A G1S#,O#+5DP^'/2^/8?%S5VF@,ONIGJ]7P^&S5ZGOU6MCO8&KVI[
M-'KXP?P?P %XPO:^EWE#,!@4I96(*T60EABDP4B"DTQ1F;3Q@HHS-/6O!:/7
M6^\K842[WM>UWC".?1Z,#H8P!*Y)0!R<T0KWN18""VV%YQK6^^R)N+]6?@DP
MNX((S[)YSLP0(*('Q'90M94%1(!?#$<6N'9-F.?E"I\5D<G6NV&5,WAT!G#-
MA=:%24V"TM%PFKB.W!)MI0N>6AYP)*N1HK4N=V)=#O:%BYX9*9&1 L@%UA19
M)A)244NE8"ECQ!LOQH?9;;N\>;'C->$&&R>)D8X3Q3G%3C.J'#;$1"%2H/(:
MX.;=C*,6X/F0&6H+.PNPPW9.W^R'H%G* 4WA@T?<$XH<IA*)*"(F7%!!\DG<
ML]N^?^U,$>=2$+/9>9@>ECT:3. 5I@[,*F=IYD_-^H#;/#< .0O!CCP?LU;U
M^1_'@^$TME"F+R-6]N) G7)7\$FO\O8!BF>N/GAO6>DV.Q]@?H:=K?>_=A31
M"]&+_P4?S?L\Z#R2XP&XRB=Y''#I-'Z0\3?%[G@RS'&.<;D:/ID-(3]]VGVR
M\O>^=$=@)+JITX\^CO(*/\O]RD<3-XK_G>383/7"H_P=$)",#LV'A&Y*,-X2
M"1F7\,YT+*/-SB^S<%#^O^V=C+JCI8!+XUZ+H9I#"S>/V<>$U8/1=K+IZR:P
M4O-+JKA3=F5]U<I]'O;(J0G'E5.;[[0HHF<C< VAK06%TR*@/Q\/1MW\G>>E
MQSNH0=W3O(Y8-RZL^[/C^276C0:]R?C\2U8U;K\+?7B-!#U7B\\;Y(M_N.%/
M+Y9FMO'GX7 >0CV(R VC_0S,!V[PW/:^VI/1QD^+: %0L33YR_-V[NRD="VS
M<Z9O+<Q.!5M@HP95R.SY)&MH_A:,R=Z;L73 M(,%_I^N#@$\B9RH@"D/DCG@
M;F!HC<)1$?AK7P'^E7 E:.*OV7CWQ\ &[,J57%*4RI)RX@V/(= @)(_"6AX-
MLS90<",9I[SB!'!-#%N9"W*7K%4$B*, ,IG/:B>?<"*"B: IQQL7&(T[4@A[
M7 5[E[!FU,GT-,-O ;SUN!&5U@,ILDX3# M#K<#*,./ Z;-&&OL=;O1FY_4"
M.UI-H)N<Z?5L\(\CB^[JC.CM:>;(,*/)<&V0XQ8<,?!FD+8F=Q&R5"1A&&:@
M&RO\L&QBUUMK[8'T4N.MT9HS%VU(@2GNDW7 QIFY[#&3=J777^F]M^ -&6YD
MWM9W3B+.HD6.40MK[HAC@A%8E8T7<D45FK]V;*$HLU[EE0].96Y83C&L$2Q
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M]=_-R>ETMZ<2@)*EL1+O"YOL%+"BV MS\=!4?U#;2-, Z%:Z%8 %;'8=$QI
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M43!I@.SU_,TXIY[74J^7(CY%YLF;1I:7SFCD)_P?O_7U(%&M;H#+8D?]03S
M@=DZB:Y-G+GYM=3#N0U6,Q"BA*0=&/<M^,]70/[LNL]8&;!PA[[KXFKHUB=M
M3*>U.Q@/1[.G0\7:7D,J%N]WE>*YP#?6:(YGJSDV]ZWEN>)"@[X0"G%G/)+$
M.S!A.).>:"=R=B/-45'EA$):2PNE+AJK8+AVTPEFQ(.I1=(Z]GY4_C;& FJN
M?HH%#*,4PGT'\<:S=,2I(WS,OXZM9%*S^9+;S@XZ(QB0C@)_>MB)"JSBFYH
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M3,YX<G]0[W)FDL$.Z73A)O"H8MQAT#^>1(7[@TL_.NF.X_E8Z/R !Q1Y&G$
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M*U2K&[X%./<29V1Z@]]T-]FPGP]]LH _ &0/O!Z69Y0IT!^5_+ T=E<CWR0
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M!J ;@%X>H 7+)3,N.*D4SZW7+/@\(QEEN:#8J030$BM6D-$#0%](9FD ^ED
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MO 6F[0W\A ::[@&:ODR<@>VC/=P^V"<F-O@P%&%&$J^C1XK"*@0B).$ 7%*
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M!:CZP)U,5" VO0&1M (G0@#%DC:*&**DG5M DV*Z2@(5JD]+R:]"M0VH;ER
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M,$5G2*CHP%.E\#>K<49DXP)O@I97JQM4Z#X;Z+8@E5BA^[A[#HM;2F9GO%=
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M#AXLD#CU4]9/1J*I;8'$RE@M,Q:[((VX_GD+*2L&:R1P)BP(3R18211D'+/
MC&+!<F2MZPIW/F9(XW[::A6XTY)&K,!M'[AK%X"K=/96$PM.473L,W*J-49
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M?8;*T4QRD"2Q)%@0'GT^KHIIGP7SGE7K?L+ O&3=:^Z#3"&6@B4)X4@2V(C
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M1B.T>O'3(\_+A_)Y#IE3!LEJ#H)Z!YX8#3I&P0S+WF==+$_&6U"XF1GR;&(
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M\R2GHYE1^;+RY4SSI7*!IV S9=P)PI.37A%#E<D\,'01JT\X!;X<\PEU1%=
M"X;F963(ESZ!B3D"KG",%#EO[P3RI6XOMESYLO)EY<N;^%+$[%3@,1@B1=+)
M$S1:#-'.)*?1U*S>^33X<DS9EN9@B5- F;4@% M@0Z9@DK0DV*2TX(4OS<-#
MW3/#EQ=ET2YI+8T+I5U\_491)VH:'OV)BMKIM#0Q>JN*_!AA OTK;Q+BRUI-
MDJ;XSQ8C9NX1M=>NZ(@TVFM4SW<FI*?6R"HNAM _3/'M]X.T/TA%-&UUN)WZ
M13EM/?7W_MUUOKO;'7;38'94TKZ.8-T[6EZ*.YM?5A!F:]]73@I$/[.-G<]B
M]<M?>\M+X603O[>Y]_G[<O>22MK.XM$*PWNSMW)EZ2U>>XVOK&]V5]:_R@+Y
ME9.5;YOK<6]S_>WQ?T[>TN6CK<1I-(A#B)$;$*DDM/AL@<22?!28(\9=%DD3
MS.B8;-(F*T$B\9QEYJ5005$C1+HLDC8:C,[9:#2*:,UX=,J 0!F1SMB0_%SV
M[%K9LE\V:>'1U/M&3SL^Q69+C>_1YQDK=;2#BE9K"QQ'!@0E&KP*198S9*&0
MJPP1E^?--61XIF?7<'%W/^+:_)J)>2U_D.-CJTB>3>XT/KE[S>3>+9-[6";W
M[OED*#-OT!T4%:%>[N#G1FI_9;VYO[[?%=&H">GT*3W/)+V73I^=U\I.0$W.
MF/MIU/U434[/<VV>4&/-[1I4I>^J]%U[TG?/Z)3*]<]_V7"9Z%F56USC5D[+
M1*OP3*21SS[IL2@$XP0ZM5<;.>"]@]W><4H=G_93[@[O-[-^D;WQX(R-)QPL
MN^X1GTVXJZWMU#,G>309_S6:BV\.^WU<BF8HX'4_CV44\#K97%K9VUA_RS=.
M/E#\%[\3Q.K2'[N;Z]_8YOMWVRL[[[H;ZRM[RY\N![Q6OBVSS>WE];BSO//7
M=N/EG'P5RWM_[:ZN;W[;^(*>S9<_MI?9QO?_G'RX4,I)F>B+]'@.60-ZH0R<
M\@RXDY2Z9*,KATZ98O-ZAO)1*N]4WGF,;<G*.ZWRSOC&9)*)6<N*X)4!(9,'
MGZ4$F;@SDN  >HZ\P_A,:5+\POX[BU!@8]//J6KV/OF,7*3KZ>/#?NCMI;&@
MU]!]G["C].*/'S[4_AO?(3D=O[/]D?4R>)6 [T3 :Q>UH)E02+7 :>(@C'#@
MJ4C@9)+16"\DE7,+E,EY/D.G#BM"9\Q2J@AM%Z%C)E+26B=.,B@<&T1H5N!$
M$05R7HE@C)>*S2U(-4]G"*#50GJZP;\+-\6+!.A^A^UNC&G_=07N3X&[,5S^
MH;_Q[7AU:7F+"J*$RAIL<AX$B1)," HL*^4WN:;>VKF%U8/4=T.<'9W=Y,;C
M]O6X^:Q9I5>" S_&[M]EZ,ZR*(YK<."> #JS34\"+^?D6';>(WZT]HB?I- T
MS2Q UC(YQFD4O 0F>566?<Y0O9]YBE#-O?Z>*RE@WX>O3U*_%]U@NP)XH@#^
M8;HB@%>^;D5EC,XD0!1"@)!2@"L%V05WQGF#*"ZIM$TM4O;[#&'XV0?"SG(%
MNB6)(PV&-00VP\;&1?_Z=, J,]V)F<*XC*5<6?^VI8C-S$0&U@B*MCEZ.IXJ
M#_A?]-FB9UWR<!F;*<^Z(G-6;(N*S-:0.:9:B7WQ=BN;)*.B'LU\YD"@K0\^
M4@U26**L9=GZ4V2J&4+FLP\,-?'<&I.8/3/A:L9",U17#W94G^:!08G%+<%]
MII1$2"H6:G($7# <%&<^V)2T%W%N@5)1];6>,U#;2BVJ0)U,\&%Q*Z;(L]0>
MHBLIC40)0.0ZH)8:%9C3(9*RLUTEMB8J@7!S>OVSSJMLLVN>#6FVG =>^;*]
MD,CB5H@A,$X8T* "B.@\>*D9*$:SC3ZK+$J>@="M.5UM@.,IJ\-4:JS4.*%4
M]4J-[<6D%K>8,Q*Y44"@MA1.5 Q,T 9P;J,U*9.2''T^T6)IAFE2XT4AF!^R
M+^/Z%F,G_:\[R-\JUL2M5 TZ[4H13%9[XU3:I>IMG.MMK&TEQKE5+@)SHA07
M$ F\=MB'+"0>@A7!L2MZ&U4QHBI&5,6(JAA1%2/NJQC1+$6G-LH-TE950:(J
M2-RK;%;J_UVTHOJ=[NF1NZ'[CAY0P!:Z[OZ]YU8]R_TRSW*W%3O\D=_YKM?_
M?#8;U]WW/WN#;FG#8*6W'YZ5RWRPN['S#MW=W=WE]7"RNK1!5K[\M8WO=3=W
M5G:73[Z2TO;EG=C=N.PR[_W57?[R]OOJE\]XKV6QLK-&-[^\V][8^V-OF7W&
M:WW\MK'S[7B%_;%]25 BF2A2< X2E1+->67 :I8@9R.Y#H1(04NM,%X%)2H)
M/1D2:BM*5TEH<B0T7@I-.L>,\& 29U J88%5J1R=Y(EDKI1,)5>#J&>U!3SS
MMN&;1@WW*T[N4VW1V)R_Z.W7#/2G8$"=C]Z;\<%[L^L&@V[NIK@X*#+TR&VN
MV__+[1ZFI>X@[/8&A_U4R>Q.9+8\GK).EY>^;4E&O;="@$ZQG*:)"7P2!)@W
ME-'D<>#LW(*A#R>TFK(^NU"^OQERF_-P%>"/"/"QS'?\[.)6-#84Q0=@V1@T
M6;@'QU@ HJB26HMRC+RUXW(U^?U%JR(\UBQ?&U=%P/>^;FFN@O F@Y,Z@: J
M@FV.=BM&:4Y1TFBJ*L*3-A-O.%5='=M[@NC\$,+*^MK1RM&65-IP'!?@GN22
MKT? &$<A<"6=CMQDB\ZMD@]/UYN] %N%Z^.8@A7$;:^$%^R]];4MEISBA#,@
MS&BT]PP#XS4%177P,LN8*:GR"%/1"3T]R]M! *3.X,@=U/#44[ [EK"E?R-G
M_9W&LA@J8=V3L#Y?B$"MK!?3G9H8C8"BZ@*")P76L S$T20H93I+T@@R/?CX
M8XU S2Y:)VMV5 RWB^$QHZ/!L)*)II (:"(-"&T<&ATV@[>:&B(4#J6M0:8I
M(/#/M#\HR-M]8 )>=9\>V>H8#=R9Z/&?O<&PGX;=?BK%F)=2QC;&4=F(4JMY
M4'GMX;P6+NZ.K7_>XA+=*9$LQ!)1%$PX<+@<@?*>,4$3H204;8:'"SK5D,CL
M8KJM))V*Z6E@>MQ6*9AF3 KDY[(WD#0(0258:S(H+;7UFD2/X[A R<,KL=?H
MR-W%(YN-F4[/8W.:3>*1S?BCD'"-F<RF]7(;+VPTQA^1Q2J?M6*CK"R]W=(X
M7,QZ5NK7>Q!!2?"D",+CGUF$9%F<R0W^"MX9-5,J3-LV.PI,24XB:'0@,LL"
MA*$9C/,)6!!"QRQQM/+< F_A^$*-CU0%RAFBI585*#]A[_6/JV/4ZD;,XE;V
M7"J%ED/.I6JF$08,LQH2DY8(B=X2<^@3F2I!^9R1VJH$947J!+9;2OD::J*6
M$LKF*(CD WA&$W"1<\@J.2ME$Y&<I5.058/R>1S%K$)KD[9O*E^VF=A:1"B)
MXTJ0"#8H!R)8BVY7R0[W(3#+@B(QHMM%^,/#O3.@M#8+W%CIL:7>>38,V:I=
M61FR#88<LRA)Y-Y*:L%F0D#0$, $DR X)X3'(:*L6)2*S8O'8,C)D^1%.<I+
M0I3G\I2A.;5XV.Q"-?J/ISA;^*?O_[9P11SRIV^>SDD3H[>JB#L2)M X\"8A
MM*S5)&F*_VPQ2N=N?<E1)X\P*=B\+M*3!R.]A]?]M-ODNXTT"$>8'?OBJ/?)
M^5><QXX^'-[\E8DK<_Z:>AIISG>@Z(T=<E,CK^O'\9_;_7.YN:\)?#^Y;^ R
M7N"UVSURQX.YWRZJ@';WX5+G7^ZW&WLGY\D(L&'OG&(!6;1W>LCV-<(O]<NG
ML$UN9MK2V>Z7I>&_?@T*/;?0J)EV>KE3#A+CF [^^9N[=B1_UN>3$KUK9B0U
M\YT)2[S^-'EDE#4R.#\W/3/BK^MOSQ;$DY7W)0-C$5_;W5DYP<5M#Q>H+\M'
MR^MK<O7+VY.5I>7CC?5O=//-9?'79;P7+I1+'W"!6^:XN+&-LKB=+'Y?6?HF
M-]:7R?+)'[C0_O7M/R?XF:6UK1R)I(EQ7-"B!A$Y [0O\$>2AL;LF77ZU$Q!
MCD]QL6Q=BTR#=L(8DKRP-'M+0N),>J(43E-_62WV++G2[<=.,RB=MWL'N[WC
ME#IG W)U?1F?M9=6F=.1^G4K+K;:)1:X(R9*&06+UCO'H]""))(M%VKN.O'B
M"U+%783E_O U$PV-38G4U[<3XGL/[WS<V7:#SDC#" W")B^JXT][M',PZO2#
MDB&%78%+?3G0B]W?2:/>'Q2NP,[O_-_N,(7.ASWWM7SD?>KOE><Z](-N[+K^
M<><?Y5ME9YR1W\\&\VSDFI?I[_\S?VKC+#87_2'N>?KBF=QI,P,NOS=2_WS5
M-&WT9,TNO/Y]\.,ISO)RCSM'^,S_Y]%3-?8/]V)O.'K_:M;\A92TTR:7S+21
M CQRT;D)/F:7SXXU_OCD0]"BMM)FQ%\&EGD&(34%8Y,%+R3"DQC.=:,2=8VX
M>P>1M7O&*7>9#NV<GZC3H>WIL'*TA98-#KO(H"W'I2@)4R1V%%@5!!H% OE;
M-]/AZN;:V71XU>FGP4$*Q:+?/7[5.=KNANU.%WFDCR/51S;&#X3B-<4.\HC#
MN;%WT-LO@EC(6C^2Y\:/ 7206T^9:;_QK]P0O_LOA\,94N?3=DK#P7SG<S'8
MSHASUQTU9-9/'8?_[?<Z_<-=O-#7PL'[A6&[^W^GP7"ON6TQI]WP<-A#GAT<
M'J3^W]V&\; ]Y;;C-#[?078='(;ML\OC@^'5T<+N[AWN=3*:C>7J_?2_AR-[
MI]/%QQM@@_$*(];O8W//.'RT5@R:=@Y<3E\/7=,W_KBY^=GGWN/+;A_)]QW>
MXA5V6\%":6'IOL/=06E[/W7WT:!JNF6X[8:=KZ=?*LN,^W'WU#G"D2J#D'"(
M.J4;\'8'E]LSZO/T]VADNJ7O\8]P/-]9O]0K@\Y1Z8MBSYT^Z!)>O!&6YO15
MI]C&#4GT]G'P$_H[W6(DGR^!V-*FN65@\7D.=[$YKGC%W8/RRJ@EIS?"683C
M->PU-VM6TUYG'Y?U'U] FWO^BNDR06/W4]A.$2?7:GZS[?:_IL&'_3_[O1T$
MP _^6?V1(CICU0ZF8/"6"K<4S5KE<)4QL3GWG0TXYA6$$+TVR5OJY)5R!]<;
MAG;F#,,F6#- '.WV<%;V>W]W(Y)0PWG[ 0GMU'Q&0)U9B><)Q(-7S21'6AP@
MI;UJV"3%4W+"/PN$FEA)8<XP1&QWW6[Y\.'>0?/U,\*Z;,&-2/&RV3A_8V#B
M8MD0=;%L2.GR46P+2@3\M;#SIUT^B8H4VLZC@WV?BA36S%MR\]O7U$VX%*BB
MHZ>Z?4V :ZK'/+08RR3ZU)!Y0>Q]^A2'VI!)5/G0][SJ3PMGB'DN16WLA!I[
MNTHG-T"+70>M?N_H<GK3';,SIUE-XW3Y+];*B& [Y^O^S](V?_+4-R:34/DT
M*XYL)-<?=%)9UJXK-7)IEC#R$P*^5=V))]$I]ZI)TUIMD.?8C==5LZG=>.=N
MM$TWFN=:%.CZ9(%_73'+BW_J$QIJ3>  ;>QC9+%)'.Z[Y6;TKR?9\\Y6N<7S
MSW8^RC^FD)!R]<SVE>#$DP]^CC)3]C9WEK^O+'TX7OGR5FSLK.&]ON%[:V*#
M+<N5]96=S?7EHY63C]CBRYDIFWO+)V_)\DZIKKK=75GZ^&UU_>/VYM+VSL;)
M-[K,2F;+(E]YO\PNE7Q!?RK*3"TDGB2(D#EX3B+P[&D9*&XMN2%P^C\3@\'3
M2,VK=/:"Z$S$[%3@,1@B1=+)$Z&%(=J9Y+2PNJ$S4P*NE<X>F\[&$NTXS52;
MA#-6I@Q", 4N4 ="(<<Q[K6W>6[!7G-RH[)99;,7PV9&!&.<D21J*B0G5EO.
M,O'!)R,,DPV;:6(YJ6SVZ&QV;IP1QE)0,0)12:!QI@-891BP$*PQV:1,?6&S
MJSD.L\=FMRSQ//-N]J>RRQ[*=N]@V$8)YNM#QL_OX.N]=JSOHT)ZF9%& _8&
MQZMRT9VX:/F"HVB=3K@TX.@$#X(X"UY3#00=1QX-4U*K>TK@3,Y8JN@;H4]R
M;;B/.1IKA0[)\9RTHHIQ+1F)MD&?*0L^/$P#N**O/?2-'TFGTHHH*63/& BO
M,YCH-$@<-:1+*CF_KP!51=_DCR]'8PAE*@6CA(G$TZB\=U3JK+0)I$&?QLM2
MN"F*4-'WZ.@;DVX)%H<K:@BAZ$HYY\ :&X![RT+4G!LNIXB^9[^U]:.LQRV-
M[BIP=__00 MV^J]8Z6PX*RW=F9;6QDURIP/3!$TVDA(!$;,$YV-)>G>4:4<<
M*SHUY!KA[#N'!V8HGEFQVJ957[$Z0:R.;TPH(1/-#J3"'X)J"5XZ 29%%AVU
M.2*/+EPGB%VQ^BRPVH(/4+$Z2:R.A=T)+I[)95"*HK/-C %OG0')J//,26-"
MG"&L/I?(>IG"%XY#C<Z!-#CJ=_UA<U:DQMR?0,S]RB[@F_$A_-=Q^<R?YR-=
MR>I.9'5!5M9)Z7QP!+@5%@V+;, *+B$(YQ0EF@<5:F1P5A$ZM;A\1>AD$3IF
M^CMJ#)=10$3O',V)HHRH! =MDI$V1"T)K0B=581.+79?$3IAA)ZOH0I72<FB
M!.DC 6$R ^NEA*R)"P@_0Y2H\?U)%J8Z.Q3^M<@1_6.W-QA<<:5J/&+6XOP#
M?&#\[8S*MGN[WZ_AL1^#NY*&[W%X!__&T4T#_&LUK[OOBWO8]Y6][L9>%^27
M8Z34^,C 9U(*2W@+CIL$Q$H1? S&!5["%7(VPA45RC.X#5"A/#THC^L$NZ30
MULB UH<#D<MFGDZI#%ORS/(B/C.W0-LXC%6A/(M0;L';J%">(I3/5^7DT:60
MS ,-Z.L+:1@8JA#*DB;*I?&<\AG:G'\NFPCO>GW\<[^3OH=369/B4;SX/8/I
M.@8WQSA&HW4J;AF.WXX&[:,;II$H73U/]#!."N.>@C&6\Z@$,&44".<]X#*#
M/Q)2$\G)1)8+)]W^=&0-0#Z%+8(*P^G#<#P7*)B(8TE*(6F*,-02C$P(PY@M
M_I$=4Z[ 4-7-@!G#XB,D\50L/@(6QX)GB2I-T4+GVB$614S@2RDSA8:U3]XZ
M1]GUN3XU[-^28M6@<^"ZL8;[9SP3Z,[[E6?#^R>.;J6H.U'4UPOE%97D(I?#
M?N6\K<@Z@K760'0J!%K&4C7IB&V5#JN1P1D$\"-X 17 ;0)XS-Z/A@BKA0%.
MT;P0VF=PD3GPE&DIB0BV) "1>5X!_'P!_ BN0P5PJP >R['E+%JM)&@?.(@4
M"+B0%/ZFN3"*,GYZ>&>6 /Q< OK7R]JF4I7EUH*V=V&G!ZFAS1Y#W6GSL:4J
MZU45K&TV^G8QXU\9CZ, UI08(B,"'#,2@HHZ,YZXINF&TF<W;BU.1\NPXK)*
M*3]Q7(Z9^2IDHG%X(&M7<&D2>.T5$.,TS8I%H]1=I90K+F<8EU43>(9Q.1[B
M3TS&&,&&<OZ&^P"66@V!>6<4SY+;>$=-X"F+93[]T/^?Y^7B:N!_HF&'5DH8
MW_[4TCO7[?_E=@_3:F[2#)LAKNQU)_9Z>_3O]0_#Y4^%P1:W/.56DV1 HA$(
MP@@.UBH#WGL2&*XW*M]7^J]&$)\2E-LI/UVA_-A07OL!Y<!Q?#0"F$JET4-P
M#CPZ[,",BTH9+6BZKX9NA?)3@O+]/8<*Y6E">>,'E*.FVN=R-$=%"\(1 U9I
M"EKS1(3AGJLTBU!N=UM@JGB;Y,[ 14=O5/F88Y_'WF&I:WSV="^E>$I[_3#;
M'/XXVR6W/Q_1%%+_U-11/Z7N2MIW(^WOXZX4MX$I$S/05.JI:&;!D2!!&I$\
MBT$E8^^W<](",AXGA%N)K1+;Y!S-2FR/26QCCJ4PU#CG(3 20$3\S6NOBQB$
MYS:)D!F_W]93);9*;,^&V.[O=E=B>TQB&W.S/5,J*P<V"E8J;V@PB3(@P3)M
MO22VY+K<8^]NBKS6N."_#1W>%/^-W;\7SAJ_<KB'( AGD:31GRV<Y+@X:S^%
M[10/=]-J7DG#T=PMFM&#]=*F=;S5OW9[X=L3G:Z;_]DF8>^O???%'J[N+..]
M/G_'>WU?_;+,5W;6V,87_.[)(D[E;W)C?9DLG_RQO;K^U[?_G.!GEL*6MBDF
MZAQ0H7 MM9:#S\* *045K%(Q2C_720CJ ^S38?\0)^ _<13/)MB>ZW_M[C?S
MQYXM'ETDA?WA:R;FM6Q6K4=F2E:8<GT[=9I9-^CXM-L[ZO0.A^53G>%V*6>X
M=]#;QT8.2O2DO+*?AIT#O%,OXA3THUA+*<#2<?NQTT^[;IABQ_V0;G.#P>'>
M02-.>':)-WA1MW\\TG$>=-ZG/CY%Y\^T/RA,?9:>//\#J@T8KO;E"*S8=;^/
M]:Z\N#2'5.3/L6^;9[P$=^SC77<P2*_/?OD]=@<'N^[X=7>_Z:GF2]?LC_]^
MU(W#[=>&S MB2Y!W%#L;7?[T73K?Q'\O,<WI>\+.F]-O7OLVF:?W?$_?\ZH_
M:RP5\UR*VM@)-5;=ZK*C$.W9!WY@N"&.2T9QOW?TLQ/84[->S25&TM?:;F\N
MD XN1D@-(\(Y"^Z^^47%IY]TP(W;3U3>IK-.^626NFLCN?Z@!+C3Q=.RUT\8
M1JZ;,/?(8)KM3OF4#H9ISZ=^AZE7G6+RW":AZ#:/?^/\>>;=:$HW4EN[\6'=
M:)MN--<A]?GF]=VQ.O:=4PA^];V7$MUY^///=E3G*10Y>7[%57OH &_O;"Y]
MW%O9VQ K3<SFV_>-XCBS-;:,]UU=_WRT^>7#R948S\Y;L?I^Y=O*^PVVN?,5
MV[-VO+I>'.W L;U'*SLE1O2OW8V=$N/Y,'Z<R0?+#+<11(H"1*0>K"4$LA)>
M6A*MNG=A\8?#9,H94Y7N*MW-2L682G?WI[OQ4V)$)Z4$@:@$1<ZC"4P0$73F
MCFEND?1RI;M*=Y7NIEM^I]+= ^AN[/"=ESAX+ !7$DT\RC,XH2+X(+.,.*Q!
MZ"='=\]%6^.L8.QMW?6J ]JVG%ZCSG\>!N^5'=FS&/C8SNS90(7*1G=EH^4+
M4GJ.L$A5AE(7IRAQ47 \.-"4<<,$13(2UXOR5^7=)^_V5,0]%N+&*]JP0#ES
M!+3&55\8ZP!)4H$W3 HKM2/>34E?MR+N<03K*N(> 7'G:YS.P7D3$DAF#0@1
M)'A")+#@G6(A1V=R5;2>#+S>?C](H:1%]=/PL+_?080=5*6+)V.3WR]2<#;H
M'YLQ7]U_=B=L'XO&UBZHW"G!,BX[8&,J!QF8 *M"!L\R(TYI:5B5O7@)N)[:
MAD?%=6NX'G,()+6*$:-!4>- )!,!?7$.TA"D:L-R)E4#XR7@>FJ1_8KK]G ]
MYG9$Y2*C'IC,'(1'M\,F0<$6K3U.)/.EWN7LX?JYQ/(7]WK8DI-3'8Q>[AR@
M@]WO#.Z6CU>#']-V)L:'<37_609Q;"?R33_%;HV.W(VF/H^[%41)SH)AD(E,
M(&21\G?105+*R&)F&B?N25,U)OE\?8$*RPG <KPD9F32:V\@2!P[(3T!+TN2
ME/>6<XW^ K45EK,*RZF9\A66DX#E^6I),Q(MC1PHHQF$S;D4K9(0HHHD2V%9
MDE.$Y;/?3_B80N_K/GXA-L>QSP];W[*J?0U/3-,#N+5HR/DPKZ3A>QS:?_<&
M@Z7#M-[[E(;#W;17]DT7]^.;P_[0=7>;/VGEM3OQVL:X%Q!QN=(R,J#>V%)2
MDX(UM"1A$Z=$Q$D8Z3WV2&L \BDAO 5GHB)\IA ^YE"PK*(BT8-B1>K1I PV
M:D2XX91R)Y-*\1Z9?A7A3PGA+?@E%>&SA?#S-=Q2SHP-'+@5$826$A#;$BA'
M<XU8J9.[3RYOW6RX!097;M*&JI+;5<!QIGVR7]'X];FIE:?OQ--AW-=2E%G+
M2(;,,OI:DJ,E9C2.4(YHF\4H<SD!=O?BR5/7<:ST5NEMUAS22F^/0F_CCB;-
M-#&EP>)2!")E!R[G (FXK!,722I6Z:W26Z6WU@X457J;-+V-J3,EAB-ABO46
M) B*OQG*$VB6E) V>N7SDZ2W6ZAP-R^V"BI[*Z'F2SW7BBCR8RF*+YZK0'\>
MI%@5Q9?>;E%/59$R ^Q2"D)$ 2:SHH:1M*.>),?D%47QJF+]@H2AGU1C[Z1B
MW5*H<YJ:KE^:/U*$16R4^YIN%JKNC+%?&]G6M^JNV1/!O:4(\_-]_%N))S_C
MQW]AHL=+W4' ]@\[?3=,T\[*>IB#_80<S/W#HK/=[@Z!N$7*Z44#]XW;#8>[
M;HB]>KWS>38Y/N+<^.&( GNBIO#($Q4K2QML!;W*E9VO^#GT1-]OH#G\06XN
M;>XLKS=M_;:YM+VW><43_4I6=C;8\OI7MKJT^!WO<;2Y\U9N[.Q^6]E;_K[R
M'CU9]O';ZOO-O?^<O+V0LQ64DEQZT(%D$"X3,,PPD"JZE*FE,C:!-G.UQMWL
MR<A- TG_7:EIFM3TP.A^I:89HZ:Q/0!K'5<\<K!:&Q!><?!*2,A&9,-%#J)0
M$YVGE9HJ-<T@-3TP,E^I:=:HZ=QJ$I($230#YC4'824'1R@'%C4:Q)E&K4O)
M\WDK*S7=@IJ>2P+?@X7*7NC9QTDXG>S>IQ_O2*IG@_[OWO[7]=3?.Q- N21^
M4FGV5C3[X6*2&_)IU!F8<;P<-XA%YCR YRPK1H-&*IW.0<GI<V8ED F[AI5
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M*<08+2,J:FKXW<1=)F<BU#&^WQAGZ2D)S  +(H PGH!1@B(GIQ23]49D?[U
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MC&Z_WFK55&?8498$$" 1Q;&QSFLG),56PVV@O9C>*7!,#/M9WLX:RKT2P27
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M<]V.C'4=U3\.<BCKX.)1GTNU6GBH3OB7@[SWXO@D#*.$0\$O\MMLYH>C2'R
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M1YA4?_::M99<5Q/83C3V0^*ZZ121IMY0A-J Q1WA&KK%>#:?A[-M0[HTP\3
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M&"=H$-:CL!Z&@8CGZ(Y:)J* Z B03@YS)TGT2#&CU$4O33B^FN#3M/5L) T
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MXTTVP7N5/ZFK93]<?'HO0YH_DYNAO>=6+5<4]O4#98DHYYI$O/']C*_@[_C
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M>-%,^+KZ@ZOGH\/>6>^L<F.N"Z[..OS(G2>C<1[I+&(X@_Q(X1[[*G(;NVV
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M!=Z0N-]->DM5^];91SJQE.@R.;OR=ATEC6+*?OZZ,,:K/Z'>S[CG2KFMN.?
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M867VGK&<P;1Y+W<#&M)*_UQ85D6Y%:FV'GT;W JX!7*+-@M57I8T.4ZL4(8
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MAC/0B%(-.E20?VN/;XO)*6&"\H) *-?SX0)&K)% C.?&*8@4;)N+<1^%-=!
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M/V8E2C(?^1231PF1DOE'9&8,+4"F45J)9NVD5/%NL>,9Q',->$@&1T,F/F[
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MB6<LD<??W_L%+&;;MFF_Y@RQW)^%OU1^4B7!HAFLNKD9_4BO4EK'U5!7*,N
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MB#(3;65I=VL%"EL+HF/D"=\[[5*3Y/!]CBD&%I<_E!%/;EJ':Z =W7<DBR<
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M'"$9T9??:M>L3TA??H51GN^!D)SU+@(#:Y!I451M24(NF!;1UX%>JDTOF+M
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MQ'B54BV/57FS\H@U#SC\CK^'S(<="ZS%Q?+:F;E) U@W!49[E48;F3<&F91
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M_9H'')4^NQ!BUZ_E+%7U&056P\'B;M6F:(0IB1E16U9FXEBH ;RH5Q^)PJ'
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MN?CGEX*7Q+ YH6[=#J>#T\2'K/4L&K9RJ*@3. I5%^]DC5TRKP9)M_O8W_9
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MX"4$P]:V*:XU .:E*H/)6%>R-,MCW=9\L ^>>U0P;J&RJ6_7WV1>(M[2R-3
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MDG46D$^#:$G)^JA#S"XVS$>"OA)U>CP?<S4>#%=73O8\B29D*X6"7)T$@U%
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M'1NAK<Q61%-BE]WG"9F.GS53 =+!2']49YN$D9*RAQI;SR6J%C"%"E'I9$S
MG.N1EC?OFA5;J7YM+OJ4)<ZMA._RZV]T^6FVJ RYN&R;W!95S$\_</M"Y1$"
M+]4B*_;")9__5E(POB+6JGRRWAJK4-MZ\O2CI[I/7/V6B[O+,4LU:&,J5*LM
M&]/:0T1K($D;;2Q%J]2YW^US(FZ[(_V!7Q</_'-V$X%;\\(3)1RQP28!G>)3
MUH8$R+\!E0VUEK\;E.G2N6.H@+O?P3KQ:'GCZH)0%XN:-P;Z=79Q\0NK:IV0
M6-B\;V>OSRR:L5) 2FTVD91*6I=K+EW&,PR2[F@Y-#TV'0SI9W5Q'=/U)&LM
M);9TT RFQ?6#"AK8;Z3LD@RUSZRG8>+M*J=C1\3I@,F^\SHNYI?/+NOQ[]+"
M=KQN!&>]MB5%(.L+&&,\H$D(+DJOBW$ZE"')DBS'/?+QKY:)MZV@^[^EF8XS
MLSU@-^$6U^1>)]?MC>< R4;<Q0QBU],B[?:J9;?0SKKBLEOFV!Q0*%G!*L]?
M4Y4.@@T.HB[:*E.DB$-:H1PL8]9<D!PJ8<; ,77"R(<KWJ<_S,Y/\]O/^)$M
M@-NP5VSMF%4!4LVR2UZQDU KJ*I*05^%S,M'UNK,D34OV)WA/#4 LXFUM]:Q
MFC)2])Z7/+_*EU?ST_.//W["^4>Z/E0W"A,]\;3M8T1#15T*$ EE;;$%M4V:
MU9]#J**U#O>1?\<Y=S),Z*VU^NW)_Z;S13R9RN7LP5]\DQ<QYNO0U%3J'_O:
M/CAMM?@E0+%&3UYIY!],1I<*8K*8B\E.L*NY$M"Q FSG?SZ48'9Q^>:\M(NG
M^5]TSYDRJO6^S.!#5+RYM(0RS*V[?6&*2JF=ZW(C.$2XK8Z.]WR0+I3YKOYK
M-O]WG<TS_?SW%SZ$Z>*D6IG80&_MB90#(P6V-#H)L82$J(I"6C8Q5I\?3[UE
M]]&7R1%_<)Q,IM$)@W4+P7XZ;6?F*2^;;KZP$ZV<LM0NXE5E6R@YA.!B 1N"
MUY5B2>'9C6S-LX\-UBVU-WV.<&XE6U]_/)M=-)%XN1<GB6J4V7F0)-@$:E'@
M%'("/E6-2:&2?E2DMRY3^/'3CPW0K34XX47QS<;Q^"C\)Y^E\Y__/KU\-__I
M].++[ +/_CC#\Q/AA<Z.*N\CUK*<Q4!RBFW?&FIQ-LC\J-?KNIUY\$N/C0"]
M]-VA@]F=P_O0#&KJ6-A'"_9>!]B4<%9+EE*H18>IEN:04(.HK">4U>8^R4LC
M9-Q5M+P;?WKCLN]@^0 %+F(I44@C8VGY&+QG&E4<).1C4"9IG"/^5GR72YEG
MY-I_"'QB.LSZP=)CF@/_O245W,1HA@C6L_)@K63[J2^8%,?EQ*=)0=@I2UPI
M;'E%8O^H5##160@!)7@R,FM,V;LN.2<[9L<S%0#[(<<8W4_NTYQ>9#QKX%S'
M=VZ'DM1JLLJ2EV=$FW#4AF_Q+S&)J*N45N=A48C5S]^]63N1]F?3JF[J<,,W
MD<(#D6J5Z(WPH!>-)Y2ID+3)X(P+6BI$>F0R/(-F.%XT-U?=U-_FHK$SWI=&
MQAB*< Z<+QJ,H\6LSP)%"%\$):GML,_RT:./ L/M%#9U;.&644H\9%1.1J%Q
MP$=(89$R0G3!0Q+2YR))1[-<J/#TQ_CP^4<!Y 2JFS BL"32[?@VKWPR[*0D
MI1,8+10$2BR;1MXR?+'UD<7T'(Y'B> &ZNK0A/O!XEIX:6'/42I"YARA:LW;
M@\%V3(<(4L42:K7*F2XILBNE^:X\Z(T@Z% F]$BH&^(/$:NGU[Q&K@/PF3=#
M[CDN;*'V#G[R.O%J)B%E,.!5F]6HHH*8LF+_+Q6E2Q+)=_&2=\J&,3YR5S*,
MT?;4MO>?_YG]^6EV=8'GY4/KG7])=&N%J&2ED0$ARS99)4L^$PW;(X*/-_;]
MHI)Q^=!8??"O?\>>KWTVQ6 VO0*G]I!9K,L;L:C5R-])A3794'E]0E-KP)DJ
MA&@D<SEEF]B^I(&)>VM?<1RH3J"^?D&L?'VE>#NG.R<?99O.+1<V9[2 P4E(
MB01J+$Z%Y1Y/ST6Q'KS@" "=0G7]'.?;D!H)LLY48$>!O1!A$[#1J=D5R2JW
M*5?\BQ?B:G4#<"-E]7.2?WS ID6.%3OH8(WU[$;J +&RB:"%K8:H4AT8MUKS
M@J/"<7/5=?";K\L9/URR']@NMW^]F4J]L/E\<#9AK> $!C"8/:#S$KQ-,5I=
M!,DNK>R?D.G8?>BIX.B0+[-&M)OO8HAP??O?/2'=OCK=383E,(YL 427_G5/
M"9EU=:D4!T5F-B%K+!")S[!B^/.PY".93IWJ=LZ29WO2[8,D8_3?._SR\#BL
MN<02V::I)D0P3@J(@A1H3%J@U$*5+N,-UXNTCWX^DV'W9)+3QHK?6V76RBJ6
M-SG/K]H(Q+V4$CW_]AU6%(U4Q5)AD62[1<DDE2K!I&2CJ*(:$XQ'J7P*PPN+
MGI=C!_5%.=@8L?#G85N<HM3(/E*U0"5ZC6U6A^DR)[MG?='*=]P\_/WL[.R7
MV?P_."\GVA;-[B&!T[:VK]E#:IL$*R1J4XM'WV6BQC-R'6BZ^QBF/+FE;HE$
MAU9"J\0[J2(IFWT!J8EEDKI"J$& 0Y0R!B\K=G'L5@FS9TILB]@ -HQ2]]2A
MTS$%&6Q0Y,0F!/A$;:2\,)",J$#:%REMI6B.K0!F(OB[JGKJ\.L'%HU^P(L6
MM/C<:B@7UN5-.27;GF=7;!(L4JT>;9X7)R9(DJ5%,QQ+;V*N@#JV6YZ@2#HO
MT(M!'-E&BB,BS<[ F#H4_"->?&H7?W,\SW3;6.]$A*"TRP5R-AJ,YD,TJ&"
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M>]Y:;R/4VE;/#WX.;V=C1//%7R):).//T]E%C#,HF/_E+Z]@)(OR$@_$A80
MK8[E*DL9E)'1+I,TJBWOM%OK?9YV!EJO+M0& :K>!1HL!XM*I.A;R<).[HE'
MRYR$E"TWDIM^[3#/K%ZF[=E021T-;FIO&&5%%#_]$2^O$H*]NX812XDEXXL/
M429<15TN80A&P')("6BBN8GQU!?@>="FB3H:=&#OP#GB27H7\;#CY4Z5I&6.
MEN*94&D@1Z!4R28QSPXL9TN&O81<L>/N ;5<$2(WVNC2<-P3R;0A+@5'-),R
M:_!1N"/T97QZY76U6=)()8VZ--ZN?I4E3,RI#*C%I#@K'I)%2%D2X#*#MM1)
M:.*B=F Y9GE="Q(,$>V3+J\#Z7WT $1$S_&LLZ7N4#G"@X7D<S; FG#DJ977
M#5)PG_*Z?01]O&*J/JA>='G=7FKK5U5UB,R/QXC,:$X,2F,K'] (<IHXZQ)A
M")K*C(>;;&)://7RN@9$V$?4#0BPF1]XZ[^7K>\Z(X5K30R!$<,+0BT3\<%$
MDK167H#B0O7I\K\W#QY$]63*[O92W;25W(]R(_9G/YXMHW"_@I]?S5;YIN4A
M>=!EUX<^;GBVKC?8C?P;\TI:)8)AU$JT$YT.V>F4'/71!,='/6$/E^S--R_F
M<UB4;-\O8Q_&ERB+DBU>_F*:3MZ52>FS\>3C#WX^'I!JK8ZAD0ZKB65#\4)H
MX)::Z&*4VL:@%/<*DC0^<F9EM^*'H!DX GO]Y!_\I9]$>/\)8/'/V?3J"S[F
M9C;ES;"25W[9?W!^ZPE)K6F,/)1.S.@)B5(KG (EQDA//3JKDC>Y3S,4^. 8
M_E)3-RA*D!A]+]3314#_WL?%B M@G&E'S+(53G2<.*$YX8:Y)#7'A37IN?HH
MLN.?>D=EV59XOZJF&I2IO\;S>[ZXOQ'<HAQIH7S,EA.-)@&1RE%<.VI>LB@5
MSS;2W"0)]#"LXY.HLAZW KC5E-# MKX;*GSEYY]^OIQ^^]^0/JX.C(O%#>11
MCE1([X#XI"R1*;.2U?1$2:69=)Z9MKF?1Q&>'W%:J*9!UKE,BQI_G+Q"$P(F
M\3NZ#<O%+V%V41Y84)1:2C+#C5="9,1)9TGD,D;FM BT2?^J/7&>&Y]:JJE!
M4OJ.H?J01*BQTH!'OU,8A0<X0Y1&4J*A9$:-!-FF>7@_>"_,(FJ@LP9GW@VT
M#E_HS88O]"9<CC\NL^WSD4-7*RL=20@YXC:KRA5&3TE CRSZ$+6%)I&F _&>
M( ;50/V;F]@1=->2<C]\[WHO5ZD<RK+%?PI$"84;KK2&>*-MZ;KOJ/ >W\<F
M0WWZ@#M67O2DVU=U+3V5C.J-X#9NXC$M#)J.^$+H$,NPHM)J1W+"(O,R)".5
M:>(![L!SJKQJ?;UO$JN"_!OL2A]F?C+/,"O%B.]A]G5<JA-O"A7OHIV7E,*\
M^T?KFT8]UM(R0UMS,:?)ZU9AR?2)J?BITS9)1(Z&"*&T3'10.J.7P_"\$!;?
M\Q"4:M-#]^G3]9'D\Y-GZSZ:;1Y9^[*^#,N8\0DB4:&(*'E&@G&2@%5&)EYF
M:Z?V4;0OI\I2GT[!#P;7#M%.DWC]G;K-;S>H=%:0561H;\@R\L(Y8KT6A(%R
M''_(C&K22*H;SI^D&:*?%MVG%M/X[S=+/VA-8[!)A3(914ATL(/)Q(L"R.KD
M@K2<FB:;S!:2%\R585II%Z7_Z8_XJ=S&QK]^\[.TGJIC!*)*@B2!+I/,21/K
M!"?"VFRX4Y[;)E;00Z!>,'FJZ:IB7'YY";(D#5 F)?(R13,1/]'?8;C(S+LR
M]EC0*(B,P1 74.^<ARQ8Y$''S1KM[BNE#S[F!?*BLNP;W 6[&S?YI?QV44AQ
M![S@R$IO\%S,EDB? K&"9A*CT8X)9Z)N4L:S"]#9QIBJ:*#!N=.%Z_I5Z(.L
M9<AH-[33!(#JJ+ '+P;(OX$!^P#" ,)P5N((-GMTR( 2+RD0FIB@1L48VA1W
M'YL9C\1:CDV,?<3>@!"K.HBUN9-54 (8@5QF23C-B$O1H>TL3;"*)\\;5CN>
MRN2HI9S.DL4#)-L@VG'G1+SY\G^/T:J9Q4_??X&O<+EJ%^T4<CNCQP29$\G+
M"!HM)$EX1EIA.>>BR<6_?O#.UIQHH)T&14(/%[W?X%WWH.X!MJ6]L1?:$^6@
M&JA]%[.:Z:QE 4<OT"E$"\9:$EQ&9RPE27S6B20+ECKK;3)M*X5.1[#'LD9/
MC5_[J*HEKUY/OEPMYDL)L)M1UYF#89DD40K"G?;$4I_QD*;1 >#Q#$UNN#Z
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M?<#^>7>ONMH'W:TZ1&<GO[N'.S)/.2F"YE(I^T>C*4CNB#"<)B]D8FUJ@9\
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M1W>?^""9<IESM)MZJ?R!AYR1JFN)LEF:Y68L;(GS+86\]&N2!JU5)@ &_9K
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M7B*S\[G'STT^OOP-IC O?(Q4&@E4"L4<<T)3:EVT(1J1]DXW=B(X>0812<^
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M"&%Z4^!LNK>3.#H%9^.G&Q]'_>KJBH3VT^+J9K4+.R>GP'/.1#:%:9^1@<C
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M+4&:!+&>AC:]:3N2;NSZ*".S,'9"^EN\@,M7*2W)#I^!ULKD;!@62?:\L\#
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MB)%K9$[0_+5-KG8( 5;(MHLR1/(JFE3?>1+9=Z@TX[+1X"GN%H41AGY&JBJ
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M[DSW@+I1Z5UV.XHDFP9"3@H<LHT2#;;L" R:@XX)&M4V9-O6Q;Z221-SE^B
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MY5JX-#P&1;#%)M2[ZE#?JU&5<BW7?W%,SZP(5E7M^R\E%-X-/&%ZS:/!\ "
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M!HYBMEL66FK1&9CY3.266RX#&,IT-BU[UGZ\!K VY ?LYR$4 2C-LGH!0>V
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MO9 Z3&JN9GPQVTYT$Y^A ;DR#;3D]Y? O:'L0)Y7>Q;2T)WM<]C]UJ/;R(?
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MF]SG6D:^GR<\-GNIF>??)JP.$0(E%OH<^G];'+BUPP(N B@[TO% $2@=ZD!
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MX&JRS:2Z@FL@DG$T=FK-5";_[P.T_:XS#K[?'[ 'J8F-;K$D0RT!AZ#W^"D
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M[/7/-B='Z4Z5"(M2K\?5++\,6?[./TM=DN#H<5&UG="Z:BBC2T/0!:WP@M0
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MQXU73<7-<NI,>AJ?<!9/V",FUU4_Z:$58XJQF^%R75T%RTK_$Q8.\A$;4[K
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M,N&%>E*YY^J"F0LT/ZVPP?6<HS%G\>6,]U)L]7)T1ZD?+EQ@/D0DH[ F%M%
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M(?#=Y@MTD*+;1GA'5"(IXZ1)-0'E3ELYVR$J;QL;##L?ID<N%+L0YG*I8?8
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M/TYE+^XQ"<I(,L;>=R" #1MF+\V@)R\_GOE([]J9OL ?3C.@;\RP_CU$-PX
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MHA:'SGK6, KTJ5MS[G1*SUR)1Y0L.FX.<6=?F1R-8;IMI7..2=H(D G02_N
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MRJF&T.!@@Q916@X$Y8%UN^D.[<HT0R>):8'\'?ZT=1=NFJ.V'$;WGY](3]'
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MXQ>48THMQI:]VCY3?\J(O;.=6DX*UJ&O!2IWC5\X.%=RU+"K6]KERNC;4P
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M_.$/?_C#'_[PAS_\X0]_^,,?_O!_(\69*#?(E#UN;J,^:\WP\QI)-3,:5R7
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M&7T2QPGQ_7+7(_M-PT_'+JR'U7L#\,QR+C*,WH0J<Z$ET=D^O/GTTQ3>;Y4
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M90DA1;VY:.]]6J.WZ8RN!$/DN\ 9-@X=9"HYNPWC'$Q5_NS^:W3!'YGPP<K
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MM[5X,J#5V93XH:QT[D9H086AN@'*'[7ZUD+0.M;FQ>WIY4/H<\AS]&$P:!_
MYF0HIC0U'A[TK-@'6"]Y>C#?B"^0XH>_HB]LLJNL3)F>]+@V'<]9"G8!DZ7^
M>X_;T$:Y<"W"Y<@Y'O6(*C?5Y$IL5;D6!VL3!=3GB99C4+V?IAZ(RUKK*7;Q
M?_JA:ALCLUCA>WIV];(AE\^QRO%R=FQLVPER->EW_W%K. @K.0E/ZCPTU8E4
MBWOX<5@O70WBW?_=_CZE@YENJ7^I2?*C/ZWUGR"W]=^ Z9ABFDV P9=A69Q5
ME/"$& 9NE=VQ=O<E[>KIHMM:H%!TA=G&;6(V2:V6N+@5JCF:3Y4<?9A;V3 J
M/2-QI/DM7^0/\6VI=RR(IOK'7^\G9M>0&2E"5 ]:V0?R_<\(DX0*5 A==*A0
M9B=!O"/..^^SWHM-?/36,<G/GJDWO:XR57V.&R\&D9FOD;.Q,U8M&>=*Z<,#
M2N9&7Q;STB5L'SJ$Q!#+RGXPGPRYIRZ*$SW7I'E\D*J4A0D,N3XD<[JTK');
M#"(I.'+Z[/*9-%:@AP?R6 N4 2;<00?O R)(37A:BQ@?.0!;/P-M\I=)P2PD
M8M98LE_]G$QB$M/I3^'Y:!JK/KY;_!;)0Q6@U2.9R)XVC$U(L=&&*SD]7N,F
M5E.B,@U=YH#-FZX'7I^OJ -,2,S!E/#3FU"$X7V D A'TT\P4@PIRAOQ*,?
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MU@@V<HP?T??WO3QUUX\NB>2GV];#[[\DW7P3)6@83= __$G03O]P&!^1<^/
M;1_^-*1Y8A]P)H_C:5^JT/C**:7B\$=GRH:G/BID)'5K7-'14'XK1Q-8;<(:
M'_I/]N0,1/3FEX,A+A/0FU?='^.A'&DP-L2-&$T;;2>92FD.GI7S?5X 3Y Y
M^R%!@+EOCF"4;D8*)4L1,=!@I *AKPS!R>[+<PL36O^E,;$[>E7F2Q,3^Z,:
MMDKS3[(U=M_[UV)^_\RCL7V MT'8;_X358 YLL*U 7K8%E''ZSNHA#][J:9-
MV&L^X^TASFOG&3_]GZT0A^$S#1#IHM*V2(OTOD//NB1(O,"O1;HXU9B0V0)B
MLR;'=?C3XL*?6*'0/H%G!ZR$6*+VTOM4[C+%V;G/<V+JZ:Q=6-AS\$/"@01T
MJ"8_PT_LZ8Y'+E,D>SOW<DS??*5O.,,H=M%F'6!.E!,:(T5GU<&OJ+O.!]JN
MWR*45W_?W712>#78=NN&N67,N\ZZ31.];Y2Z(/_PS=]GJIY$6)N'&9UK'PBJ
M,UI*/O;M_:R&FR$,;/KE@1?_+""H*UQZZNV"W:GB0?"D&#1BF-Y/YTN:/P+&
MJ<+3BT).Y[1H+'<=9V*X7G_Y>]/Z^%*O/?UW W:]5LY)9Z-H,E1?8%;<A61-
M3C)ED]FH%;0KC+X>3GD!J#M[+WU9^W\/*Z7BR:'$D*9]X.@&<GQ>5L"E4?!Y
MT2)]I#'V2#RJI,#W"LG8R,^Y!3K5B:WNY(SH;$)R$*W<_-=U)*KHCB\'M'T6
M@X>DC4X7+=UEG^B4S(D.<F%<D93"@LGGJS?=B3W8E-@&->Q6*%(@P6,W@%-#
MB;S3,7(V UM_(9BW]:0#:X&VU/$E#D (+#%)_P:N6MXT?'QL.4J6JI.[^D/.
M:U9R- U2'5$^8O%N-GR5954+5&8+)I*>$>J;ZZHCJ::?=+)73EAK!LXL-"7'
M/ *PA\P3M?[E=&U\>:MMBRR#"MJ!7N8\! =9$!77?Q2.%2KZ!]:"9XT;[4M(
MISB'"P.S/U"Y0]J@Y8WI!#3>:!X^ ](-OSFZY2Q=Z'?Z])+QY+2@:MB]OHV/
M#Q[W^BVW'C@.\,9/0L?UU![<3&PY/ _L2F1L?/]X:N'EZPZ->&/FS -?K8'R
MA C1QS%Y,3(-1EB*J%B_OGENQ4C%R]=7MQ/9>82$RL_*-7T2 JC9T=1DBA[]
M&XH'_! \U8-7#MD!"[=^7OG%>M5/9BQ7<>[!8*+^L,?[CG?A:8G3%QD]'K5=
MQH(M=E<N-IS#:E@@0.\M^S].K&XWIN3HE,T*Y9E/M L(WF&GZ,(9KQ3WHR:=
MS6GO]P&G?8!MG6!#_W8B,UK=#&]D&^AL1129E2FO2B2Y"L:KHV5(GX/ATW[.
MZIY-P#K8:8XL8?9<DQT^WTJ_1%2.EJ5"BUQ2;J_QOZH:ZW%T2I$O@4^&+?M.
M-,G]?,ES1%>!TXCB:CZ-[$.?H(.0PY:*/**7NZ\3QF-PU2:(307?0U<F.#XH
MBT^7!#WA*ST0=584 ]1@EAN(;&V)(D8N(\41,/(N$=+D?V!*E;8FEHUK!W?S
M+SPL,J4?CU+?]!%_E%E.Z/9J(IT4&V$@S<3L-GZRAQT,U?=R"G?!0._Q(P;<
M09+=>L97#X/\,QK=#Z0F8B635UV<HKRJ*4 N?&?X;EWU6%LJ,J-:0-Y(8HR5
M[YW3C\G@S>E!P&^*)V-W)_>?8)_P7^>_>O(\'S:STFSS'8%"ND58K2'RS9$R
M(RZ*R^21/=M'9J8SGJ71_?0RRI3?802IE5L^/XN+4,UGE% 1^T#%<B0"1A3
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M<NW=,:C.$L?[0:\,;C3+?TO?BXI,4FIHS;E_#'IR\<L[Y/)#5$R$ AY%/=6
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M,F[;$B2JG/(VB1^;/7'Z&,<8K?)>UMR>-A"<YILGM:?0$A14JR:&Q3:V-G%
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M'N7S0[%FX!2C;D4MO81_[<%/!U%/DBUBO"%CW.XZ27CK['6ITQQQ*;*J=Z^
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MT&3]FO4(S?*),RJ&#?/.O!E;%U$!Z6?VDRL-NP>B4PH2*&" 'XN>O[=6\NR
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M13)5P%^2=)%=M]M9X2S<RN=M&LB2*^*ITI2WF%GKA_H'&3\H-K]>Z&8ZAE6
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M)6"KDMQJXA,:X4-\L^/UN-R,UUM.X*K4"4-FY8*JAR',8=DGZ+85+;$-O1!
MYD?O'H]]CCIF-2H Q?9V<3BF,BFK"*.9 .*XNG.G0Y 64,GG5M<E!\#Q$.9
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M@US@DYB_E]9(B Y9!8IX9-KY0=LJL" R)E>LXXQ>\H2.ZTU=8B]H=(TDPK8
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MMW>XWV[V)E:$;)TQ\MGH&29C^\M2T+,SHGNWR45,;B(93."]!,W$2\FXWL!
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M<\ *Q1<LB:RY,) %W\;Z!D%SD;K;/)D6#/KZ!<CG':;*0.4LSS0R(_CJ+.W
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ML2_\B9BCOY3X&8.?.<?0L\IP>;HE2X<G &>+34^F+!WZJ^K-^=O-E$/?[+K
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MY/Z$1@.BV<,Z,K6I$#&R\F3(+3UI2H[48W2LNIC<3HT$].:R <5%$AM^]C
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MX0[G_[)8^]NK_53CB+ZQLT^6.,:JH>[2P0"-Y?1B.=/#3R"]FQP7F"=L?7/
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M_%74-TW&6N9"H0H>C_5,Y?6%U!W;:<=1YF1<*SHQ2XPR&JNF;W@H+<*7BJT
M @=/%M:U)2T(*U BC'Y(E=G(2\^'S,Z@6PWV0:[V2ZB/4)&E3W4_G#0OS^X,
MUFHG_.U_WLO(T);)\FKG]1E_&R!913?P'G5IZ?\_V'OOJ":_;TW\151$P*CT
M&A4$E:8@O<2&@(B@2)$6!:4*B" U)(A2I H(?J0%1$1%B/0JH4=%I4D+)4!
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M8YX\F!P+T ?8CN3-;(?O89YD_M"7HN#BZ!"O*>CA<0='0\4?I/[6RU8ZT0G
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MBS]DV*3AKL=)C8IN2K<M'D%<23W'[+>+@QUZ@5IB 9IY\ IA1PW,:%>C_.;
MO\Q8R>QU0V63+B!\5<J@JI28[P/AIJ)B?$_=1CTRG=.DMD/),>S4["QD/0DV
MM;L>&UA-LQ4O:6!TJ97VE<"D/*D?V"OA84:NKC'-J;JE&&X,ED/B6, D)Q_7
MR'2__UQ[XXJ6F&+?1[:^O54.U;"'>*R<90'X$>H*.^OQY,4KQSGVYU^_/YBS
MRT#*-GQOKZ+U@PZMV<JP+78V=Y,%I$I0-AD!?:CUQO%&-!E-CZW38 3_2:<'
MPF'B272!5FHE>4TW QU5_,V 5BO$ EKZ+GT8QAV_,C$;[THNQ/VC2)7RVIBO
M\?VD\IYZS'<6X-:G?#3M5^K\0V"=R\=[@V9L]$WRRB?>-[>?L!--8GL278@X
M)>-!\ *#)^.>H%]^R9E2@"#*7>J*84R>M&"IE6J$> 0BN6($3,YO6GGN90<K
M0*()09PMVUD>+W/$>Y5ZKEFZECYKTL^7MZ_*HZDACO93J.RU&LG]N54(ZD8F
M967E%/ZUW<W54H=BIU<M#UU)!)Y'1<C+^EWO6Y4ENTY4]L^S5VI;PA._NX[@
M19Q0X0.@U=/U!.[]CV_)("?\B@?T4U<3GYE48 N,1Y8;-D?E@< WS]B_9<N.
MW3_8:DNQ,;"%=A=O#'7M]YE<7"SSS0 F_%= !>$E6ABS#L7/3A1.P]<3Y'1#
MZ(FCR,;^_GDL^>;*<+[Y)/-(I]-,1&1M]TJ''T&> P@S^NC)SA=DT$NSP>7?
MR-12YVHMFGZYUMC&N%UA=?%#-C&2+T,?!V;J9OO@A([[H:5O5.J4+S8.UX4Z
M%P.AB7^N\-K-R-Z(> V)W98(1=^F74\GH&EN<8^['-,&YV&5J&8'O]NE8/7$
ML[&U*F702%'H8B+VZ'.->;C( IQ\"1Z]BJ&;,(^!Z?U5R9F9GL%1R[B9F\21
MC1)#2S:UB'5<5,^D)+R(W'*J(T]H^03:Y3UF 1QG.;8M"^CF9._:BOE&Q>Y*
MX.MO2-F">6<:<_,;+M%0?Z,7=ZQ3K.ZT_YVT>UJ[0V+IC_NQ[,Q0ZRF6ZMJ&
M@3B$7^ZJ'#;;&^97C=399@K^^'/LY$.0-CF;O(X2 B\8!(PPGWUP/'_T>I;0
MWE%(JUPQ@.R]#H^#DYO8FA43.20IW9:1*DG;=&\\&_2@LZ?1G1]M5NAA\.<J
MO#T'R(G[&BGK-(Z7:,%F%(C"=<X6CC'8>B(CEGX+>A [D3<.P2,[B2-))TV2
MP.?GW]V52$3YR1))7R5"V?J&KYKV$+R$:EMLW:9MR=-:/X#B7Q>"%*MVXZXG
MON"@F1H@%:KI@N745'+Z9'&0=:O7S EC6.59^9H'UT[_J/)OAH7/%MR?__/>
M]#/?$\QN]CJ@E-@-&<[Y#<VLW7J#U,/: HR$UUBY=?:L*UW+$ZL>:3Q@9Y_%
MAW6EB%]\0M"J1+" G,I^&Q;0_*!!^:A/%5V^G]2A#Y>VBK5'(SIJ<B%]'O)K
MK7_J&(81,LDO24QN2L&GX51JD)=LJR].@QOGB+HROTX %5!-.BO*7564@.R:
MNXS"*S%+5'W['UU]9SDV#00IU%?LH7)B9&+H&%A[76)FPW."1X_2B&OM*M&G
M3\^SL \U40 O=WPGT$JY_$-#OYF:K4T]$$;_LI=+STR 8[U?<-(*5FW(9KYW
M\G\U*H(.ZAMK*^G03J0J:#6#(?F2M5<%4I3C'3DYMA5R9,HO+R;5]>Z"'3HG
M56[PH HMI2\&_WZT"GPV:?(J,UE">ZS\#.Y3"+X4C)STNFX_#+XTK.=N%5&>
M"JN=S](0X.B^?MUNM#5XO^GN][I**F67FU\P]KUW^Y=BF+,5YNF#=R)2G<D^
M41MVD'TF1"^[-K&-QL?.!8;(*KO?:3+W9&\D)3KC]XX7_[)^A6JU8O;"U]W$
MHIG"0FBZTP?VB%]A =."9![FMYPD%I#[ W[/G(M-;^1^;,5+AMA>=O1'MA>R
MQ=C;3MHM9 ^Y8Q6V%/GNU!$%'),_[AK  JI#:/L_>!!6]W]F 27*; L9P.K*
ML#4U/(Z: TJ_1ER(NX0ZP&;'K[[\\YB'2HBWL:[Q4Z;/:B1S&3V#DF5A#QM5
MV--JM1@2\(HF .KK=-+LC,56KM]._?[.B':W82(G;4.2T)ZTVT8TLBL> ;M_
MI^O5K,=SI>^/QEX2I=8Y^J\[^H31KM"/]CD='D?<))N^,:B*1K=9N7$OQK_2
M)J-.M34RRO1WSZ_&S(#-$^E.]>5[Z[U.T'N^=$F>X!R:PV1O0,$3\*7Y@D_\
M"*L>M$S2NG\&$KU\V?/Y+]3$!T*Y:>P32.)R)6^$KT\>/-ZYNFL_6T(7SV&B
M-F"@ KQ)?(_L/KKU^X.1I9X%1[XR5U:..Z*NA0P>_X!JOM\H<+&>IM'$5*G?
M>HCU2.SEK<X;T9D(9;[@V)8V0-Y>P)+M'?9#56D:D[)Y 9?5PXKL$WG7?P8T
M@2N+: _B1A*H)!?S5I&11D9?+1,EDC*^OQ01F5]MA6JQ +TYSHVZ6+ICPS]>
M=_8;+%#?5GZJ"^7T&HOQI]4_NPR18^J?242W@K\,J7.,Z@:OM&Y=O>++WZ\D
M+?GL%H_8MY6HT2IW!(G.!I!];([AFX* )P*34#,ODXH1H^N?GESIH#"G[5"F
MC;\@[*G<HC3S?5AT5*Z.NK!/+#KQNKEK!**B5B=H<36I(QSF7IYHMJN6+Y0H
M%XY0$%ETU"2//Q>XUT@H&FE^'#^][#N208^!@S(8TDGB54E4NY14DK2,QS:I
MOWEB I(BJM7\A9DVZ 8C7X((CPHP\6#>:W<B3&/H['#))]41/X,<+5(7>YJW
MN3#,,53Y9M1F&&:*$"4[,DC37W<,\5^].(OQ05U9RPYE[J^D:;A][/0ABI/N
MO8Q0.&O76"O],3E73_M)HF>+/^3/R_A/2524%_W&0"5D!>4Z_P _^Z0OM#/1
M=]$QX<\1*&),SOE3^L-A4PSW>@;&(I+K?+?!?M_FY9"-LQQ)&%2SAS[?4)'2
MRTD?T864Q\_O5E9&J.*NONI\U$3#9@?_Q+*YI:,LZ>$<>E^)W,^ SG>>G4+:
MMU^8!'2AIB3K!G_50>C\PE3/[BMU",W$;4NM->4-D^&UGY<MWXYLAWGV5$"'
M:!.!40&9D*<Y?(;V7NEA0N/!PJ)SJ_*G%Q?/05^%L-,IH?*IJO='HUO']Y#?
M9O5FQRBE_UX]G_6X^GYIQ&B)IIZV7X<A74.85$^!P<CQ;AF_SICT,0^Q@+W!
M"P+;NL^_G&L]X(?CTENDFIPC(Y],&M$_\U_J\_?O&*L+>_. U[?C(&0YZ4N(
M5?L_\L(6'G9_]H,%*9M2^N7&6K?Q;;8J$]N83.&9I/LWDL#C:)()Y7AU4%%;
MB+U!K0]HA##4Z]F8[30.XYJ'5YXUYYJ&1Z,FHL=/UN&HF^UZ4-,-YL_>@H8-
M)CT95;Z%OA9FUHK^LT627H^J;CP6E'D#VL[(W/,Y)V1]O(Q8/1T6Q#CZ.EQ?
MD]Q%/PRG^G7OS^PZX#%^]-ZL=DZY]BSF.N=E&,-RT5&8\:QQ%ZB;U]=X&+3,
MT15(H5TSP=TX$R%V>UJ*2^M'J)< 1VIND.$%<I;4M6>OY[=U-4=FYJFE337$
M^"-23U:+/?[N&I+_!_&??X[KO_50:2)NR9 <1TVA.!0^TPV<G-]0=!GX<5^Z
MMOJ77/7W4\L+!<X/#H@9SHK.SCNN&  (% LX@&9DHN;,?\'(@8$L '>"!42;
M,7]@UT]X0$&=>A9 3*/N$>!8W<5FCA,PE_[;9D]6ACB[%P/_@FT=;JROKD[L
M'3]Q]+S$F1.7#.8^[ 7H'Z[\KW_;_NAET9P#'=20-+G0]XCOQ^?&?E>)6A^+
M&BE/EUA@+=N,Z@T:%Q]^!(ULY,$>__YT+"BD]VKI N&L:XZ9_L:W!?@G%M D
M>?-TYJ3PTSZ_%9A+WXT#P?,SD4VSA5<V]Y_@_)U@PN2NIJDOM%R'M8SL7CM@
MMS0X^-QY?N9[#?V,?4<!.R/-8V3ZQ#<:/L&LDX@\5"]O\M*FU-V$[=^-C>QX
M%/N%G4A$ 9BX8!6PW.R;%]2EWWQB;0VB(CN[3BSP$R:0+[%)]K *(ZX#J5YM
MCV@)C=,RUA_Z'P(Y,Y3] !CY13*'.\70-L)TM )_5X4WY+;V6E_6P!^AVSM@
M?)XM@<\>\IIQ)7]Y,3MXC!0TWR&_H<+6@FGL(8^06'PV&_9R:ARMKA'L&! M
M$_I9PRE@)$<UGCC^"8.:B"$<S(\1-XO)$<TQ'?TXL'DH/F1:WJ\OWGI)3X #
MQ/[9"[5@*^R%^PW.$^[F0."/P%#^O5VW%>U&LGH@],-)U.S>%=$E^IT\PV.'
MBWQ]IL0K1K7O0F4DH AK$GNNP5(-.K\/M2'1VH!R[-N'-F[^]H>3GSL>/ AK
M*L2SW4"'!=P/4[FHAW[V-N+VF[W5%,0[W(A.)#N-/P>-)9#;4-7*#"[=\^R,
MZ@L[YXI]R,3!JM-C,7YW,$'OS!+J[],1I5^:DI-3_?,EM_2*J#GL7ENQ@"BV
ML(J(0G7#I[B8$D&H+>TDT 4-GG!E[&$>04WBHMEBMHCZ]G_SN_O!23*46D%>
MESJ4.E62/^6>CQTD58SQT)S;Y]]Y_;K'-W,VU/ONZE]>L 8=WYS*>12Y%5;%
MV-S6ZZ@MWCI,3YH-(CSTT@ODT/I"YPO[<Y6][B]%_R0^.F]C8VW4MX[!J8!4
MW4V-P_N(L6K&P]E#6:?"N67( ";LWRJ+@YW"3K*'K_+'X+(LA==)5-]P#6%Y
MTK3PR7/5Y"3GJS7L+EUD=N,+*HK>@^B6"+R@JM/:K?ID8\Y/0J2?JB,43'_2
MORH!\"AY3[-&'$XUK;<$VR?VND0V65+TGLF0=%'%N1 <=KB>R9U$7,'#)_6S
MB23^=GWQWHK.^<(H>:_S);J3,T;.3B/'CMQ[0=Q-22H(U4/3#W%U/#06J0,S
M<UM%::0#Z+.104O<]FO+\HM=H Q[97ZE_!2VN,E64KVUGDO[ 7INZ1\=23#&
MDK"BBJ2F#H)TJY=2F%]F <['=O3/-JZ$^Z%VMCULZ-DG*Q7:NRY#]![7W/==
M]OQ3KD4GLH7(,RB?DP_X%^(<Q?++*&3[;$ W_3/NA_C:RK:U'3M.FT79R0H-
MP3#I",F!^M*L"G=-^ZXRE\<T&<&+\,"><U I]I09=PUCS89G0;,;OZA9Z$K/
M0)/ZH2WOK+ S#MYI[% 88V3Z^RBSY0R/_Y9N Y%D71THZ3?X_57Y(/;*ME4L
M0 E3IBJ"?/E+-%@+9._7RH"D2K=N>R32J<JLMJ35$!0FC[328&5,*=#:=&@7
M9FC=SNT3USGUW'F'=@$.OH+L1C00-;"/E.=XZ4&NI>ABT_O_&U]+_K\!:Q \
MG&GT,H8%D$98P!4GC!GF-(/M9-//@I*88]CUMZ> ]>V_NY'_3FBA8Z"\=#F*
MW453\0Y'B3Y=LP*9S@?I(05E9F+?<L,G3FO>%HTRU'32&<Q&M0K0=[. UQ<G
MV!$LT,X4)/F;<\7^R[\*_%M?VROW1)>?S6#1CA*5W;K*^38@ZE+EV+3[MC\/
M[YEEI^\7W@&'OQMOR&2,_!?8)MK!OP__!6[AWL'_R]AQP!W\K=AQP!W\K=AQ
MP!W\K=AQP!W\K=AQP!W\'\,T4AYA0ZYNANU:T%>FI!=))>79G%#Y.5&NRA]Y
MR9P[T+G)7,5S+6>3R6/R)BE1J,P6]+P!XT[_@O/EQQLP2@9O^8P7KM"QRN+Z
M-_R:M4AV<+(=@90$6L%XZ4D:-"Z:XR(IU*^<)'5E2[S>U0=_)B>$^#D(W@3=
M2Q=AY+$ MZYH?=[N]<XSDYE=D7)7^V][/DAM+4K2_'%28>]BY,,R;B[XBT1-
M /J1!>Q%J@5=)&Z&+]'A$]F6CQS$IO_J]#JI<+A$P^"4U/5!Z2/4(_$1W)0N
MO#1SOR2YB'H/C- 5G_HUZ*V65-H>0A@.,#[KEB*TOR##0.=3;8?VH1\^S*^H
M4FP4S)D!=>RCJT[QA=K&V::?7+:P21=*U)(^P'FIM*/>1#Y\6#$[KD]PRXQV
M <0TP?EA$V]S9.O [)!/".U/ W9F_:(9]X/5K<8M+NDFC=^;>8KY^A->"80-
ML@!(RI\# _21IUE LSV<CFP<88Z6)IUG#M?4)G::VOE4?O7UGSH;JUC?6<\?
MR1$LD\4K1O\-ZI#13.X9RDC;]2!42\C-PXM]KE_[*OFL;<O346[TX;2[WMA3
M*:/\L>LH4!Z5Y*TO@?QR,L]=52V7<J#(\W5=!RYPV$I+]E&7/?3HP>WH(V13
MP&!J!50P;,+P@A\<CO4.MDL=JXAR%LAH?.D,&;ZF.9IS]\MR[4J%[Y<NP0VS
M9G@BDH>12^?WF<)P>E[WV+:/[DP[=U*MHN9KK%O7":(>Q/S\[@ANT)#)W4?C
MIRN">31)V7HBE'MHT187Y])X_8/]V\4X(^<T4O<YAM/1UR[?)E*"96Y;1Z&:
MH0CW]Z P]0T%%NY2XWRG:/[EH1_>(DL:5F6[$G4>Y 2Q@,?F7$L;_TDW(^U@
M!_\V)" =*[M!GBG75I))"_:0M5EJ:UV$DP&VQD;]M/3]Y-HC^>^/1'$]V6A'
M:B)\6$!$T#CH3"U[,FG8DA!B>GF9V(HEI\ZO>OHIJ"247=%-5O"LP"X_MCYZ
MV>CG>.6F,EU0F:K')@,W J>;_DFR*9J:%(=0GI6>?_;X^,:;S%MIW(O'5/9:
M+DLV?6V"Y4CQ,-XRM8)TB-51E;=T)8,_T*]V(V01QPOG-S-,<7C\P;NK;U-&
M^5:-'G^9X[R_I^RA$=<P@6P,PQ=UL(!#E3X"]).4\<+ XC&W &GS/N\-(>5
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MY:#G9^WA@[8C^$_*H6>S# 1<"[]?\QN^J*&)B<5.9&-%8:Z$&-ANI#A"E8)
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MP10O+GLP^[6=QR?LR[,'=49CT)JG5@Z7%7'^.KQOA1U85^3YFQO5R2R@S>P
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MN1."N7T*1""YD2Y=^%CLO8>M]>^ZS.]9;VC?SD^/]4KN'SG.?.37/R:"4C$
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MUR^6_@__\ __\ __\ __\ __\ __\ __\ __\ __\ __\ __\ __?P;,;T>
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M7#T6P=QN7%DU^,\>&X=_$CS54L#JYW_W$%? 34\$B7?HQB;^^T7&S0?(BJ=
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M+\'=TGA9UKR7E7B7O##!= <J18K<L78Y""7-'%]9=<B[N0U!19\"^YZM"J=
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MEV8@E7<V5NKYW@%DQYA"<CM\.<9CI2&VF:T !NY\:?4R,@#G XF2K2C^VOB
M4!.6VE/ #Q\("7[(GP60S"H'*^?"<0WX'#>"GH?@1;S7D3F"@<PT[ :*D]UQ
M[ IX,\VZ_34N<65_6GKXI-XP^&UE7B'%P(W"/9LM/1-?P]E63?GTV2QG%F4^
MB3")R&UET(1=:[^7FW9X"L0IY1CB&"@'O[Q5@[\)YL,7=J6Z=,=^W$L!:1_S
M[;#:O!'.O*![+:E3YOXOQQ&ZQ5P>K'C."HAE(P"7^#QC[G:)A\#OXA^(EQ:.
M=]8[9SZ=K=W"W$.I$CD8T6O;QYA>8XQX[ <\U&KTL%-B5GQ:5L[I:[3 P'%@
MX=<X=K->("[$)QN@VT@DLB%Q/5COG:!E""<45M.!4Q?KB?3U9C(_,;N9GI'[
MN-'Q07)V9.(CV8-<L=LY;=K?_K]+D#^3@+_ICB5ZQ[L-4N/2A;P >UKM$> 5
M[N?CH1"T;F'@*WETC9*20J97P$2V!A2R Y*(X*PKAZ#)S?:N.V-!JL:YE#9[
M?/XQ=#WT0]_C?I6<F/9W/FH=28@ 91.Y8>MQN<,=W3GI><8^NT7TW',0?]6W
M-$<G30ZAI&N;S,&&P:-+&(-ACHUOJP6E1,%)F;H65A>WQQCR)\CLGNR^T05#
MZ>!=?0%J#>$>JH7O0H*-!$JET"Y!I//!5!P]P(LMEP[*]Z0S\W46&7XRUE1_
MY=31]^IGWSS_)9ESC[3-SJV)M%"H9DL4P,]B0.UD.8Q?-P0T6.@JK:F:Q=I:
M[/:RZG]A[[VBFHK";M$@*"("TCM!0$%I(EU*1)0B8D I D)4E&($!$1Z0I'>
M! 04%%! E"J])_2H@/06E(2$HD @ 0D;$\*-_SD/YYS_CG%/N6/<^V#&F&_)
MWFNOK\WY[96UVO:BE@2,%;/8XO/864_%+[YFP%43( _1,^\]#$=]B3 VSQH=
M,V('CV]Q&S+ >+/)]?<RVAJ"SP<WW2]H*(W;<>;IG7J*#4Q[HI !3ZN)^@2;
MJ\'*7Y%[<6?&_G9Z]@T=KS*6:F;\71FEFU<B^@W5TWJ2E/(O9S==>&%UR'D]
MXX&G;^I S%-2@[CFWAZ3Q*Q-H]WT(+%(7FE@NMBC%H@=R?M9M3/3BPI/[86=
M'@G@KXA,Y5^Y*T,\Z01V0W9=0>(+GS.&'E='A)TIG84C="=(^G-%'TR7L9[4
ML2-6]Z\QMDR[NJ5 2[5'N?:$B9NS P1H3T$<0H)R $J@*P84![GWIG9W;]G:
M_NA?4DH:-)H^Q7KXN\#S<^H7P4[(+EE2 %.=S/'WYJ8]J]A4UN>5>A5*_;#L
M-R#8]O7]U!EQ'4_MPY@;3W4E.:IG*YT81O;HG3ZF;N*'O3X U1:0&L@\5,1^
MZA-EO^&+F9=12=9Q9M/UX9(W0O>JL=H^#37ID\4I8UIW^E NKN! 0>IP-R35
M4&C_G:% 4S)=4O/[GU.=^6SP ;?(W<*3_5-KT?U&LM+;?2 $'Z(+?3A,G6:$
M&)L'DZ%)[UKR+G4TMF??KW_=<]*#]&/Z^(6PKXJ_2PFJ=-XF/+5A(?1SV*D/
M:RC1Z6PMK:9 X:A5'$*'KW\@ [U1F_YZ>PQ]&NV.3LX_"[!3+"PI!5$DK^HP
M(W>!T1ZN'W7#H@ZR]\/>?9)?<IU'Y5%*Z0(YU$+@[<(<CLOQ%^67O%5"888/
MCX?_J=E+AG=2!Y>NG]=68+N/CQX"W4-V*2+DX6#N ] C2=8>ZK32DS3^DOZ<
M#W.RPJF6G[XH70<1_;Z(+;0IHMTT:3VP%V"R!70&VH\0 ;)\*($$[H2 A3QG
M%8Z;5\8U%9+M;PZ=%<&Z)Z#N7S%YS HROW.Q\\L^K/!8Z_L2GZ)?38&[?L%V
MC9_:M\V0,8(6:O3(ZI5=J@V@^HXQ"ZF73\)A#*7SNK&RCO- FM6D3*Y"HMFN
M6D3)TN$C+@AB3?7WS324*(4]!744V.Q!"6JM$21=K[2.5^2NWI2 _]TL,0GD
M&]'[>_4PPBKL)#.>SM.O44P^AJ!/:.[K=?[Q:K'FGXV9>-]F0"UK/:NPX_JZ
MH-6#]<=?"L_F#\@3!GA#WX59483JW'ZH:-#*SQ!U?VW+7;9O8\:Q!>H<+(QK
M__E.XVA5<=UDPY="\D[)A%<#D:]<HX+GWMU$JZ.+0FQ/J@=PB2XLP%^2W[%?
MI/%*@T<@;REW7F\-OA:$Y0RWFQZ4L0A]J7VN?U&Z:KG?-BNR"^S O/HME+0Q
MY2;5 % G<AD*15M2CA3YE"F=/Z?*F]UO:J.#S_K>24L$;8.!TZ7K['A5K-X"
M,D'?B\(M3IOA+OQS_17</6B*8) N:ZZK.*#URT9!WN?S[,W<;1XFB[2;0-]#
M @K%"+YHJUPO2?W+86HAMTG"=MI\SQ+-V:]5 0^(;Z]Q7V!$(;ND[33W4[V.
M2=3!<_KV&$J%C%O5W]+F'(K3&,>,"+%Q@:]1,N/'O$3UVLL?N5(*>=K0^%J8
MZ":=G2S?PS@VMG&_OJ!?>TQYKG]&U=V[;,QT+3;CEOHJ*VM7M>Q^ I*I";D9
M6H@!.Y0:I6@51LX 7GF#H2T-K6I5>6)71TT(:EMM_.)JN.>V$2QF0U9,VQ$T
MT.278:=OL&<H:1Y"M24_]]X_-/T#0H8VI"!=56,.R68Q/G]9@:AE#2!:"GD&
MT< I9.^0.WZ8%.Y+QOY9B,TCR 84S\\=V1]S<5)*DRB4VDLUP]2W_R92"6A6
M!D=]PM_^TR<U[Q\'($X^LF01Y$SK2^U?N?OD_^#R_WO84V<<$Z7!@IJH5\B0
MV  H!^ R?+MY2O544S;-QMSEV_ ]Q;.M_9\M4,2F90F3?3BS\(;#^ID47Q %
M/@#A6VD'H$P%5NK[1+K=_TW93/M?^3)JDSF'@8R9>>7]ZG:F;V\*!;E@+C>/
M;'@M)!Z KIK?&-L>M%=*K%5_3ED_C/+O_3C>S#X*%C%4 D+Q/CWA_OV,,RUP
M9W'SN*', ?'BK(1CZ=(;&TLV/':BTO>GA_)%R3XD01K4$4- "@*K:WCH,]6<
MH?'V4PNA3\)A7^Z^"&UK.>*:R:YW(E#4]F[BU'ZM$I&2PQS\;$$G-A_6$U*=
MZ-U@,2,N=7MK!ONJ, 5#.>,&.8-GV/8@NRZC?:"2C,\,>3(J:0',X1GRS+$A
MT\6\ EX#/=5R]Z0Q&UP@G;X*<AN0DKNNP/IID@%"C$#82:E-Y&&B6PGEF)/U
MLL4")/[Q%5^IPB/FE]N<J_FEDD;N)W\ZU!%']=E_JU&-5>S<7J5BPZ?C=D@J
MI-]#@3VM$7W?<D+!N)BM(Z:/9T0E(X\7;34QP/84-"/&ARG1 !74 6CQZW8!
MDQ!V6:+D 54B.!DE^\L%3 Y'E1/FX+<T+?4=?H3'FD9XI3Z.6CR7XRE=<^^H
M?/+K$?;-\/^UYMTV;EV-9K;&U(7:G;V4T@1]79XX3<$)]T]S#R6<?I2=/9=_
M8O'3[19H.T[#:_CN[U,@ ?L581+3C0^? =)IY^F/"SKGA<ENL=CPCM?"G!^!
M6,X$Q-RR]+V1^*5DMAM7P1W;LD^JVA@<.!HB:)/:Q+Q#F %AD\-3Z\2OW,=H
M2]BEQ""\W;8U&Y]2AOGV.;^!6(G+]!!0. X6#2%;@P5<@FC4[>EZI-BJ_R\7
MJ7'5]?J7B\=NW_)<DGF:Q=\B8YKSO6D,'5Q.&)ZK9G!@2AB3N<]<5,CSY3X+
M2+ QJ"D;_C*A?B(]R$C7RL'9]-!%$5)WEK3*R%&Z*C-I]NQGM;OBQ0-'GGQI
MF%$Y.2><4*%OJK_UV9?Q2>!YIQ/Z3WNH_9>".B:-4Z69((8*&M[G$%0Y@8<$
MY@1B73JHXBG. 7H*D'J-V!=*%2/M7?$>UTEMUR5-=*U=3A+ ,QCJ^_V7FIX[
MEOR7**<^Q2TS9L@&:]\D32F\WO-W8+LCOA/W.MJHNLS *0O:[4&?T"A@I]]#
MP7B#'OY94'*ZU1ISMV-<,N]A>W(AA^QQ1#@Q2/1DZH]B5JH*NL#-DJ<31[8R
ML&<(4_-42M^9$LK[IV5>J]D[.!H?7PSP, HJZ:2-)H/\HVE)3$I#S(E#ND-B
M'*=3Z=?')"%0VUNDPJ[<57<]U]ASR(27^R VI@3M58V_27=ECB:#6<;D4^LA
MAXQT1GZO6PJE'>M_[H3I(*84WQ,C/&6+T'7#?'UK CJ"HPNH,7A6<>!Z97DJ
M<FS=;D/$;OX/]-AII0T?1Z.E4[68K1Q0A*,AQP/6+$U:'O[SCED8^*UI92/)
M4TG::?F;OTY*6,_KU_39ZCY5X!1/&DH8D"=.4 TAH^OO*)*K;.3=^ "A/245
MX:= 8PTV35K'P9!\U@:<C[: N$,!!6CW,!;>OQ5DVCU0Y;@V(#%><2$E=F8Q
M47W;3,XDX)B?&MIS+Z(_J)#G&PQ0VJ6_03!3\+VL D:6\_04Y!@2_^( Q$+W
M).=T89??/JBN*BGW>!K8Q-=35ANIU/ASW?;J<T,W'8G$/3T&I\$!2![V#CE3
MXGX *K$/,.Z&D&U4L?+="*[1)UR*%T?FKH\_.EE3_ZI>]\>@=?^'9*>A+CT;
M"2+[6(1^#W5^/_<F5078*?V)$J-(_M@IGK):RW5>3)9MK]__'5^V_G)O\JW<
MA9AOIJ!H6 NNKJF7$YV(8V&  ;3U,4UEN'%=1]M,GO"PQXNO-D^=:36D1+K9
M"(.=,8)NVNR/F=;<5[1S1P41VRA"'^]16Q$%C[@O89Z778H]Y7JMC@_J-TG[
M^PJ^*P39@SP$A';G7JW]E2M5<.2-%SI[BY!B;;XCIV*^H\&"AD4PHVUS#Y(6
MC]RAE2)_<54B#D#VVW_?FB@YR.VW,DY5Z/(U#$58EK('SBC7#'M[L/XY7(WQ
M 90Q].RTN *JZA?FW*C>9F8;=2A=0)T1=0 Z 2$3F>GGR^0VC&3!' 4QK6>3
M_^<46E*EH:W2.U1=)1^[W-Y:'X4+9E.L&%L7K]M:]/^FP+HK2Q5DUAK(WX[_
MO7WT5@4Z#=<TW%4]BW'V8N^3DLG>[%7(6QI[ O</T)?>8GMV(KV&_:1#9!>[
MB/0T)QE#")_N2@-.4:.)3CRJ-%-3\M5A]Q6519J1Y:<-R7ZJB][OZL&T&?<K
M@!JQ.I%QB@(A<1%";6J;C (.OZ_VE>&ZL>5^;\OLR_:YVT*RLDIKKY.C6/Y@
MR/*,8Z?(4&H41<!0:J3=R+<X*':!ZO@K=Z=I]GZ+87JCHY;KK+:W061UR:NH
MCW)X;G--@.DUAT'DX?4#4.$:0X@"6=\G&$ &FX/Y;XS5AR8X*-^W3!&@;.A>
MHW?&X 79[F063*"C+Y0<@$B9- X/4^OI30U+B[X0_E^YJ36E97N,^WZ:#3T1
M/>!V-;.CO_VC=#18!L-,_^8.Q/ !B+O=R+\H)? &17.H[N7[G(LUZIT5'&P<
MSNDPD=68. /X.X"I5PZ+ 2<IV[U3\Q*C^D9,B1-%HK=9ZKDT: W[_<C6/ERD
M!+V,:Z8>09F3T]:':.*(+ZVQS89*=(M1A.S:$>?&J?/%&8;YD68>\]@I<VTS
MJ%XQ*T@%M%@0#?%4%0C3A$AM-FQ&-C9AP<\6,CCS1#8$G_?X10@'1=>=LR0^
M/NYWW@346<@SRP.<+:6_7$E#KS7F,3V&NK,M3.<S)1BFD).H7L 04?5$^^C/
M5L,B'_\G4Y17<D=/8KX6?5RT'P>3;5XQ)FD< .&.5@+8(ASU"MVDN8VD\[%W
M7A#N \^N$'EB]*&N^Z6%#UO?='0LE;Z1<WGD)D$,>U31'OE9>H0=DU-0GY]7
MA<!IH84:4EQM)]IE/8DL'YTL E .^/$;B^W6Q8_,K6KP;!+<67_:*/[$E6<'
M($^>&57"9A)=5'/BC]K(CJ+!=/:R\#8?.&])OG10M_K+&CAZ_D0>XY@$[GB!
MV7 4>UKQ**26,:Y-#TYJ3+ZRO+EMB&=]2IK?JYXZ *6B#^N+DCFIPD#;@@_+
M3]R,X]&1 /'JVO R>-I\N[R_SZL?+5B=;SJ%/$R# G)I?05'Z8(HH(-0( YO
M1(%'2/4#@O"D#// \P//4D#*LJ\ESD9=YY&PQ\Z+,MV@$3'L(C.=8YEW:ZK^
M<C";.?+CKT>-I,R(N?0W6:%++^Y(^0XA'B.[U)$/<%R,\0)Q33T?T=Y=E-"(
M!A'I^QZCWD?]XM#K:S+X[)Q1R_<LZ2703\N07;I@$M42\"&#3<G:">TL;^5C
M"VZVY'=3OV+M/4YA$W])V\O#>5Y*//;3^?P%M!];V]$T48%OJ\]7++>(G[KE
M'M.#D3GWM?83/NJH=&K+Q[4E-' :$J]*-Z7QTG4*K)OAKRJ)[;7F$HM[Y^8M
M)2Q^V]A:K[]#%3,G  <HHDFZ9?13@&M1F"%Y:#U;#)/,5HD,8!7,D#0T>)MN
MMBCJ$+6(/&8&26P7IX*8$W /\"%J]SA!$L ";A-@RTG1;UEO'3Y[T3_;4O>V
M/AL^TK7#EC<ML=0&'O=#DAT_>CM1\\D5?N[K PN<3^/]D_,&AC!KG710]43:
M#'4>.TVU!O2S2ZZ9=CLZO2F%Z#GV,XV2)E3($X7V\@'D&-$+U: OA.&H"X@:
MP\H'<N;^"W=EY_,^O.H6CI;^+&EQY([Y86/>Y#O[/']I!CFMOR 6=U03?)1^
MB[P_E5XR<STCZ*G%VH?[K^X\GK]_F'= I@CT58*5UB\)$J1Z"; 0P?7"I'!R
M'=4U=0PB"<0[K-HG+,]YVCUNZ/O^\;7/3-'2[>AM7:O'%^62[6,\T.1;X-E=
MNXFW#2W-%)6TXW%<P:'%&XF0I[QZZ,7WS6G8:"HO8(ZD$)!)8&&4IDI6\4/[
M=ZN;%Z?R%<16V:P^PMG*S^I<.5:^):LU$LRV 3[#^#Y_>O^Y)D_<TQ!8EZ2J
M>S+)1[;_;0GVQY5'7MWI,E?'TY?YMYYWW5I"4#D^LY,@S\+NO@NB]3@BX\-T
MRQS7'$^_%7X##W>7SCAC+W>?]Z<16P#;B6#!;0R3V>*+<&SMQA3Q&V3'-7LL
MHO3]?ALI4"PFTQA^#"N7IB?*\5-('B-!9G?<@@ R&PW^'Q #".G:?+L,94B?
MO9I3K+ZIN)-CBS6IXPVJ KXM:P&X'(#$#D!>>L.'*B>RK>'SYUOK\@DG<Q+Y
M TYF1>CSG5 #49XS98LQ?I@N$(K'8=(2G^:SD!NF6D[7A2[OI\+?*(]Q%BB+
MF6 [LV'I#K6K16FWCY'0'JISX 7H^N>I1H8.1:1ITCMS,,Z\)J'*>U9W;Q"^
M*_#\HOM9#G;1+@P/&4,% WHTF=4_.;W#QV8>6C^\<#TF0"+V#S L+FTM.Q +
M5HIQ5<PZ^7AH:QN6 68)2&-CC,(: G:3(!XP >-2#^U*P^J/YKZ*/9+?"S\D
MCCH@[D-?@H39Y)R,)$ZP_.D@ES*.)9!Y"$T)TB.$Z<UV=:0?0<^5H BM,U;/
M3SQE=_\F@Z82P@U?<Z3_/5 K H!0[?,Z0V#Q"'8X5KDI@53-A]TT'9//*FIM
M?. S_\@_YOZ=]FHKC&ZG["93Q [W<UD0V=<SWZ'J_':Q!7&J;B.G6K,2@OE.
MI9H%\D_$OT_PQWE#Y4;8IW: &F8)>4VI0G]$C+:"8U5/9:CR_ J1T+83FCTI
MN9QAI#2S89Y\.ESVSS3)(*R'YHWH,93:_]1N<%<-+25!>9^1G(NH_;272'F=
MZ7-A42@M4#KZA5SZZT_24J:TOXKD N0!)![&H1%N81F#DK;T=Q<?KCK=]CBC
MHB+BDYK1V>)KW,BG7Z\2N3*XPBJ9!!R0Y\$41!Z ZE]C<5U<1W8=1^KU?OK\
MMG3SNO$5ZUQB+'+;XJP/UJ(?IR(:DJRE.$3W_+M/SOY[M'O'W09GUBL3FM"Z
MQ;X*0&AO*2<587,IAY4!5-51PYES^)9^#P 3+;SX">%#N\GZVL<)..O:J;MS
M90Y5%]W,S;B_=3RU>.Z;7!4(XIDMD R[.(X2#S.8TG<E".0.6XRN@ZU09B\L
MY#P26CJ//>[U']EVN?O_O%[K%<UYS<Y%;C\)(?_PSX-N%\\F!F]K:V-S6E:V
M?)-2JD'B<Z08P,,XRAR?[&X?A';$ ?ES5H'U-Y2:O%]&/TQ3^A6BS"PQ&ZJ5
MI)W@XJB)&:SHE_M60\]Y),Y5)2WX8'@XZ7< 8W>*?$_M#_.%I&9O]T2+^.-^
MI"@'V4R%D+!10X.@ZB@TOAFR)4U7.@!]>K/)2$SM*&=P,'6BPB09LQ^MB=M7
MZ2CD9M8NN@ <G];W4?_RDZ&0;<L&,B/[3W]1</EL0[V:4T5ZO]F]Z\O*9T&%
M?.:=;)3;;EE,K_'=SP^ \"+=S,OAV4++4.4 B\I3?>7^$;@SGH=VE]@E?6$O
M<)\PG>(^6"=JS"B=OVS>V3'HJ=D#U&1,<9Y<]OP)\0'V_8_Z#<./,G0/H2\>
M@'S2 'G3;A@'XUO(;C)*"@AD\!J$=I.59X5V;UI(+C4'./!9RZ('!;*YS_DU
MRT5WLO_L3ZKT9,B-/=IQ/OT'=W-<5<:!5*U\RN%>KI:HO<D-XT-ZB7O$+@C9
M*BTZWP"H\2=O0R=]2 UK]AWF2^BZ<XY]5)OT%;>LU)&R&MTOQ,2]/,;1(@K<
MAL(>$19,IEFU;*^'&?CZ($N*%NL]_1YL/_?O9D^XQ;-Y=04-+O@#[A%E:""P
MTZC#450O7<U-X?G9V\X7$4&DH=[8>P;0;'!TUV8?"%']$$:VYYE=@5*46F^L
M8I=^U/M\6IW"6C2\W9&5,S-%?0MU0U63P6ET/8IQ=RXRH?U,A>-:J^"?X.S=
M*9\6B4#VUD_Z@M(GC-@.*1*A:3BR14%4-5G8.;IK7B*SAW%F]/=LU;KFLXY\
M!_=<A0'2:SW!@.=5W )>PP.I6=NF=-Z;A*F/I?0;E+B>X*I CPO9V=A!K<W,
MI1\]<M89K_$^J<9MTU^AUR_J)U&_'X!>Y,%QU',>Z#^6[K!*<.-O"/<&Q*U:
M $.Q(]HVD-4RADEC/PO%"W$/D[[./D<NO1^DC&ONJ=*\D5\M&S9I(AJP_=-U
MU6/5_P,9_,UBS.!H\B0;CG<9JH%9-\-,0TNTBC@FG'H?LB5I9VT]ZZX61SKN
MI&$YJ1C@)NV\9B4Z5=]$><>I>/ODV*-[\+S&ZPA_L?T^N1.B7Z.,^A_[4MSI
MO$VPN.X"$$-M+9!5ZX_7ZKQY9EJVGIW_\"B<@(YHQ40A/:JQK;2^@GK5Q)/C
M]>)3!?83Q<U9"ZD;5C97/"K0Y^4'09Q1?,J%J4=!^R[ 3:8[7P;8*4Z]SSU\
MX;OSHN@67\D:BF#I[-M7PU?XRL^?.0"%YQBP:^Y4(DXST]K%,#!-<0AOH-H+
M86T@"<WU4J<3O *+?O%_'?WA=+YI4TNWN_:<B_T'U]=XWAW<.I)BW ^31.-S
MI10;QKVK?,)\W_UR;(JMV"ART^8;D*RBW2GV7SZZG" 8IVL5LAQA($YHH@O0
M\/+=2%YGCT IF7:*5)%'OUX,>:<4^RZEJPNJ4=O?&XC%2%Z@V*..([O,&8?I
M/A3-@K@GZ!,_?N8NK<57*NVLJ7M1$S@Z+S\72O/5Z<YF6P1Q$-#2D/N0) @'
M@A,8N.V37, YAVD,//K<J(7/_,FRG8_ZOM2-#TNU14I&SJ\#-'?>I'6ISM11
MFX&B4AP (1Q>Z5',^S!V1E_6Q[O5WU+GGO&E[?++53VL]Q_$VIPX?_TBQ.EG
MF>/IW"?.0CU0^,";*Y7*Q(AYET^>*]BW85^.@H0?W7\.^J)_K.W_\]-9_J<1
M5LYT#*8>R^0'F*[\>'C_@J/]I.T _3K@NE"0G']D4E^2**D<4,"U>D^SK<:S
M.-Z\]DJZ8="L@]D3N\^R):   ?NO:/):VFP2(Z& 8;\#99@7,21]_R[-5S\
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M3T3=M:C4L<]E>C4)#T#<YM*!U5D0?,8!J $3B3I:FJS/3QRZ!^;"KNZ>6+V
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MZ)72S-37X=_::5;LQ*I/C6JKT^4E [Z&+^N:&[(W-%/=XWQGOI4-"B82I=5
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MW"V2T"]SFS[?L'X DC0\!H128P'7,H"G3S54*N&CAJJ>YU;\^\$;Q>4-B9_
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M*C;HKL3X\4$^&4,_'Z[_JT'>BUD)1KVN-(?3[/)9G:45NT@_CN,=I\.".N[
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MN#!#!F'7EOX]8RU X_CG0;XMX=Z \-1/GJ(NYB/RK*9F552OGV8"]+?U9NQ
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M\,L1J*VXW\,^0AQQGEZF$05+-1 JOY7KM'[OF.% NI=73R>1.OI(T!Q70BW
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M PMDFQ$8N $A4 U'8Q<6ODL;7VU[VRF1WV4OLT@HL]G\0RP2&Y.YMUDYA8D
M+X.Q99(.W(-'H#<367H1,I:BA12BYC)JYV<MQ\< Q5.W,Y]7)L=PF.@DJDT>
M@7S125 Q75/+8;2@F7YHYSKI$=#E- FW(4YHE#WEC/SZ)*GMYL@WYROY3,MM
MWPR2"6?6BL?43@$EDHQ\^S)@[C=8V('WV]1WZ^O$AF7=P.W; 7D8XLO?]1A
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M$Z&'ZZGM)Q^LW=^S;LWWU5PX)AD8(*5I::R%4/:=**%)TU]"@]$)$' ;AAV
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M$>MJ(%ZG )SQ,B>;F@3I4?[[!6M%OYA,C<V<B;H%[@S3@<A8TE.HM1-^8KL
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MO+LT$LI%<Q9B'6X-LXJ,A:E]A!9N3O0#O3XG6C1[+UPDYXC,742[KZC3T81
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M+L)(M39;+K?%/1XU\S>2Z>8L$M'CA?J= U,Y!=2]/@6L)Q1QM7=)PJQPR-X
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MT^J+W@&7R^<F5ON$!4(6BK+C;0/I])X8 -\@FUJ2=Q$/,A:SK)\O^+6? AY
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M.(=4,+I4_)^NZ1W3'F2#<I\02/;GQD[]2G_H:LGTJ\^ Z#85[A>!^Q;B.^6
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MMVKM'A&\6]Q><=ZNW4;(Y,<< :)8O5F$%NX&LB\OX+JAB>Y'6L 2BLXE9_4
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M"[]2Z(0SASWEV'^_3C6[-<QUGC/;3 T0=AHY !HQI(Q[-+T!(I8'A%W,ZCL
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M^LMENKWV<Z!GV]#%NB%QWN:\<;;5/:PSM@A'>+:TXX7C16\,KQP 5]:Q;^\
M6#D6P9X -XC0+I9N"M+UR0\[]"B7=,^8B6;Q/]\+/&Z0&+9#V!\='[5@_XCT
M7,F:KULI04T> ,<Z^$'VBY-TF^4C':+&$DE67AFG<\0^%4>N^MK.V]X*DO.N
M?9!1.1ZQNU)*LJ,9,8=0^I3DWO4O:O3;MZN<G7],FOH??NWO)\[M=>]8@(K5
M$5N'F\+(=543: A2=U8;+HPT(#?65?W\7+)1E)GO'XXNU;(1;&C.%8GT.'D
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M/J0\.>E5Z]+UENJ6C.*(*'V=D915E6\9Y=5G""_>Y%'AFP,T7="?Z@I>OTW
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M'(WR@HM9F ,_]%&,JL/(-H03H"FRI\!)2IYC_:RQ*IC_G[O#TP6.%]SS^7S
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M)<RC=&_*SH\]EXRL1Y7JVD80J]9,@QAVZX:V^!O3O.?/G=MJN2_<LF_QR0H
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MY_<^(SU9-G(ZM(%1A?-6?7&2Y9+P^4=ZM$_QS+$A3NF5>X59#[:=4%*@ G6
MD1GBC&0G;/-%(%8TX@)6T9O^\VF#FUMJ=E^SW[I'?%6G?K/?YLU+YITL SEI
M4+H=99O$[T_9I:9.:6V#EEI@]P^4R,1S2X[GYJ1G3RUM%18WRRI6ZQ"^@UW
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M46X&/3MBH55Q=, Y(E6H#PIX^S\+88!/KF=^;U1RL&6D8^2-/:<^RI*3;EA
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MB;9C/\$ /XB./$0>0KXG#PNW=@#_@$>9"+F0 T6<<$2.1!W45KI!?V&GWR)
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M(\W;VB-/S$8S8%0#N^KOII>#5]_ [G6;#'0- NA?E!T80(\#Z(  &R3 #A1
M8S'OU\<AWC7OUVBB*-E\7R>WT-C+&?-D0.T%Q)HN#/=RF.\%[UY0C*$A/UF4
M@K\2I?IA]5%]CWVW('T0:*$S>X,D)9 +2G3C509I@"(HHC23(I!Z;>Y6*_[T
M@%:L-&FY^%XZ4[O<-=QW$EO;6-_%>$U6\$<+"CI)@1;U:M.WS)PK\QGFLT'%
M;XSOY(@3!_ALM'\>W;.Z:V##B;IZ%/7JFW[LZKKDN@[K8TMXM^J))B(5IY'(
M,H9@QK,4(AQP2 7/H%3K+D4M(6>I6T>$\V/.;<G<BWQE/H^5:8*S$?L*:+$'
MA0%MX+?C&\^@CKW_?3F>[@T4[!'RVDC!8MAI&RK8X_"LL8+#K</XZ-=2'\!1
M-_!?=2O$S9'3+@?R9E-MHWE3-&Q9->M:W(JOJU=*P]\7.<NCF D,DR20$$5A
M"&F&U#\Y$13S(%#_=6&JBZ29&X=ME0%[VH!>';"C#]@JY,9HEQG0CNLF,\O(
M+#C4(N"W6Q.TU3H!HY1'FO0"KD\"O4R@2:G5"W9/2=?/0X?1<5]BXHUH__=]
M:;JI;4O)M.<+U'I3D6TF$XBS2!>;I?HGD4 9"1SD849E@OKUYJT]_UH./V#U
M>3O%/HOIM*A;RGUQ+C-H"[P=8?K$<1IJW-0V^;Z7^0=]^K:%="MW=P3*'_LY
M(N63YVR'GI31'/%XREVNMP]CJ5O]['7]S:38=><I"!$A$GD,)2)2+UIU'VK&
M8!ZF-$N#6(9VY:]/C#$W!Z\7L<LC=3XM= I..YZY$*21.66#CQ'/WXD2"^U]
M\L2A82;EA!-Z/OW^3UTZY*"A?MSJ/P59KNZ[+C(<H4S@-(8I"V.(U(<-,0D"
MJ):!413'%&=V52R./']NWW@K(6A%=#F0]APYBUWRR_ 8^7/>@^)\EQV[M\GA
M%-Y%V$QUS*[%Z-Y(Z>L(P7'-3Y^.>W[;A,??CLJ\?[[M^&6^]NG>-JOB02]!
MWJU7:J76_Z6K"W1-&[-+N,A81)G (61IIG@M9Q3B4$8PR1E)0HEI+'*WC/UA
M@LR-  ]O5^E#[>8(3:O+]J]=FL%OO3J.\?G!YANZ2>C?*"^R?>C!'A[V%MW
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MCQ4V))"22QHAXG0ZIW_PW#[,7BZW+W,#4YY2$8<L@5@B?78[(Y!D)(-13%"
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MQ5U1F@93W:6/:CC0>K6F0X%0_W_@3VH4+G1O=[U[JO]8FDG#9#29DH?Z"BI
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MJ7)>TE#]**WJ95J,-3>.V!&U#<?OE8___I=J)4 8FS^%Z ?'8U@G(+?C#4]
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M]E[?W'AEN WMZ&<2RXS,4ANC_*KW.HU1;G:,\G;7*)TN;9-"\.&L49Q9[6)
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MDN"WK9I Z^G(33ZM;\=I+V33D;EP>G,ZL^D(P/MD89_B3<K>(^#ZE/7'&&)
M//;UNEE5#Z+^)+I*Y_?%8Z-K$NEJYTWGV40!CP)* I@E5*=T94CYBR2%&><9
MBY($1ZG]Z3.;$>?&[+W,H-X5VB'69@6S1=C3-W@C4^@&MSUYP4;@(:D$5E Z
M1"9]0SI1\/'P*PE8+[BO@*(+/"=CAE8/FBXLZ*+77N3/Z<8!C/QJW12E:-0C
M'ZCB?3V$/@!^5^J>@^^Y>K,*69#-9EU7K9R3DO>32"$:T\Q"U^;<W]G;G$!?
M))P@Q&D(49:H_V"&(8E8!I,L13+. \ECJRS=Z42>VYR@!0-?M&17^KPFTRT@
M@9K277HE3&-K+E&4AD@MX=14#5',.:2"9)"%4J9AS+(4N_03F9VUIVE&LK7W
MOKG!]]V.CTOSD6D,;^%0S,Z8(WLDO;Y@1V&=Z-VK#'9U[E)E^NX<W"0N[>@-
M.L6O#J77F/?%J#^[]\+!.YK=^S&1>S6K]\3-8YO49"==OFDDF<YGG!39/:=S
MVI$'UC/H Q:]L)_%G2E:=_VU:!9!CH.,!C'D88 @2@,*:9BG$"<X5IYH&G.W
M8V$G1YN;K]C+!G[3TCG&<T_C:A>A]8;6R-.S+5#N)_)M /!ZQ/[D@-.>F;?1
M_=DA>*N;!JQOWY>/=<74 ]5[(]2M]XJD>)OAKY]?"Z8KFRDZ$WQ5\3[U?WN*
M8A&A-,TDR:$0,=%GWG.82YS!F,I<GWH/0YI9+UTOE69N3/.^!)U"H-?(>",[
M.H%=I712*#]P5L7!9[W8H!;+E"G--#+%_3U:R&'!,*6E)EH+C&XQ-__>%\(G
M7?>+!YG.*_>%QY[#[>VA0ZLQK)3_KD?2A<9NU4.,LQ>E@B=ID,$\#QE$E(9J
MZN,81C&)=#@7D12[U58X-,S<YK2ME*8,(=!R#O*DCZ!JYT)?CM7($\L0F ;4
M'SB%@M]J @='FK@VP"EMGY_T/WGU,"9H^P/=J8>JGYJ"=SV"7GW;O+XBDEB&
M,H5AKGM7$,(@CG1?29H+&DN$D\PIW?OLB'/CAZW 8$]B70)N,%><Q]V.-KRB
M.?9V_85 .K.)-3@^B>7\H)-RC#4&3^G&_D8/^>+MQD'.XTP$/(!)%N40H2B&
MA"(."<MP0C)*,<6+4MR1E6GL,RAKW'Y'(&\_BF?CC?>!;-*CS?FM*T!6IJLU
M^.<_X2@,_Q7$V54:Y&9Q$*&K-,Z[\U]7>N&@*[P4RE%T;%9[P QVS#,0U9=(
M-+_RM0%R7O?1LLPGW(PXK^7)'',?P?Y/XK%K27,C%?V8)MMT*=X(NEI0ED8H
MI@R&@BN'!"NJ(!E67@EF-(IC(E,QA"5.##E3NNB[]IC:P5\U6:^+YE[G:/7"
M@[):V5:NMX*>A"1,60)#@A%$H0@A#G,.4Y2C5(01S9%3O]M+,9]TE=B+VIYB
MWV+,E;3^(+9=+7H!;O0EXRYF.W*"-Z<P&[!J/(N&WZ7C\>$F7C^>U?OY(O+\
M+<,HNR_?\:E:+M]5M:Y5O$!A2A"F&<0)32&2>0ZI5&O'5$91DF4T3DGDPA<'
MQI@;3_0B@M^TD*"3TG%U> A+.V*X$*&1"<$5'&<F.*&^3P8X-,RD7_X)/9]^
M\:<N'=+GF=T+OEZ*&VGR/<SYX48]]VW7O*"M2+#6(>U&F$"5SANY5?[)*Z7
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MX<PSAY7VR1U/1IB4#PYK]_0;/W+5X,(!12EX1Q#ZT9HR=/V4=^O5NNZ9HR_
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M28HX2FGF5-S'HVQSFUYTGNE220_(:E47=+W:'"G=[R!?G.L@/[I1":.1E)3
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M!HW6 U2M(N"NU40[1:+7Q65O>HBQ;#;Y1S;!V)O_6_35ZJ)30%=X 48%T.D
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MHXDF7X4B4Q-$0HG3'",282J<W,\W1YP:N5[*R^ZF98.?>*W6Z57S)3#?@&.
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M3>^E-KN8]4YN3=5:<-._3(L.7BK9'5+XO";G.A&/ OG@IUEZE[B7'W30_Z3
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MPB)F4F_X4ZI$PC!)G<Z%0PHWM;7D6+===>I6.U"I!P[T:XIT[+J-@%K'NZJ
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M.=WKQTWOMNOE7&\^3'V_=_/OYJ>=ATG*!'-*3%=E I$T%26*&,%$Q$1@(9'
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M)G7X!K12^G/9+^'@TV4_.]:D+OLEC8]=]HO7#S )JV?49XQTV>PU<2093=,
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MG;!FUSK0U\Z6G6\ZX1R,O""UFM21J17J['@.;D"K4!7HT\:>_UXI-4[HHR>
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MJ=KC-L[^J<7X+[19:H_,^9U1AV<,8SSCS&I/MEKI;E?BB]SD1=6 9E_':-<
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M137Z?[2G&[0YW>!-H<>Z-.-ZK\94$V6WUHX&_LB+Z+/3I%IRL]U1RPXZPM^
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MG<TJWBK@X#2YS(>%<SD2RA.>31B OQP#?!PP,A+ #A[K2$!/Y,WZ ]S-3QV
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M/D&FC'21"#6SL=$";-'GU"9T(S5HQ08H"'_ZQ\^UV6FQ2S:$V^#XP#^( W/
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MDQRTHH-&=NW>U(@-]N36:=YKC?S9X([(^;3(;448U3YWQ.?86G=MQL%VWZ9
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MP[DL[+IZ1<>$$WW[W0].'W=P,KA;/C^2CT_D0;7:IG,),A$CRE(H,IQ#)+,
M4AFED(8B8H+32&T0C9T(3MN?&@_4$H)61(M+Z3/(&=SWWX;'T-<>^U"X9 DZ
M@XG%1?QMV(QTT6Z)D=VU^64$>J_%S[PVWK7W99D/KK5['G.@K7LUG(^* PNZ
M7#S4(ZYOR061:_W)Y31!.%9[')+JZ*H@@WF4QS"/N6!$T#3-S6NJ]_4T-2K[
MNI7,8L[V0FG :+X &IC;.C'!3DZP]HZ7!=OYPFTDWG/$SX[_3##I9<+>!L;C
M1!,]#MC1Z 7'J_0-K<1_;M07\OZ;^J-=EJ,<,1K("&9)1" 2^K0?8PH5;T8B
M%U$HN%6VA+.]3(T?=T*"6DK+^^FS0!I>(]\*S]"WO4?(#% :M!<"KY>E9SL:
M]TZS3]>3J\?>AQV,HRYJ_K<%JU,MMU^J]N;C.$!0J D.$9(<YD$D(,4T8&DJ
M:1 9U?3LZ6-J$WZ;!V/9BFFQSE] T< BNAV;@6?[%I9.0I>]W@5\+"R@VW$:
MR?8Y^8Q\N4GW(]!KZ5QX=3P;IU_V ^OFRJ-N=LW?25F[I^J[MG?%$UFLY@QE
M42@C#O4F3YDR(H XC$/(HC"2>4ADG%F=9)]V,36"ZR1L[KC_:H0TG,4]0)H9
M-;?!,S#'62)C;<Y<5MZG+7.FEU$-F<M:'ELQ/4\Z%PTZR9.PYX_U;XOUX\<5
M7WQ;\ U9WA?56B>'*>M_:TM^*+Y9B8]K\53-PSS"B;)Q(*8Q@HB3".*<!I!$
M@4R8I'F(K2* ?0HW-4XYG_IE3SOP7:D'=OK-P*&&H%,1_*65!+66EJ3D=?3-
MZ.RUQG1@(AQ[.%VJ('G'W7.5)'_RC5U%R3NR9ZHL^>_#=<4H%]](XXC5%0*M
M?E4KD:[B]5FP):FJA5RP6L8/"JT[IK8/FZ7.>/SI[<>O1>._];Y:+Y[T[_X0
MZ[NG8K-:?RW>B*]*I:I1=8X#(@1)4DBS7,> 8:(L3D%A0'@FLY"F5%"[U60<
MP:>WTG1Z[]7<K69 J][57CM6'^C/'.P! !0"8%VT#I\SL$6AK@[?X*#_G0JP
M!X7M:C32EV6Z4DWO>QE\%9O>I^*PTHT[;GY7P9%D'WF%''=$3E?/D?MWO$-B
MCX)OEN*3/$AY\ED?O2V[Q"<?BO(H/\I7O2'<Y61(>(HYEFK_%3!] ,U3F*,H
MABQ/N Q('@BS VBO4DUM3>R4TAZ)1^F$&L6V687J[*C'.8@LK[2\C*OA%=C8
MHS7TE=EM P7^JC4SRHAB?]?F$VNO=W->!!OW+L\GEB=W?UX;=R/WKZ5J<U.^
M?%FKMIK2-UTB[7FL-CA9)E.8I4A1=AH&D##&(*5Y&$HD1)X9%9<TZ&MJ1/Q9
M/&]=7N2V]):6V[W:5A_49BSJ"<"!N;&3$M1BSMK26;-MB0%_3&> AT_^ZNMN
M5%8RT/N8:TQ><3QX653/1466OY;%YEE9I,N-+IJE?JM34B]6&V6K-OQ5K-Z2
MZO%NQ?7_= +^;V2I&6Z.*$812Q'DB&80*;:!-,ESR!),XCRFF&96"3ANEFAJ
M;*3%LSRSN'E0# \CQH1ZZ%.&5A=0*U,7>VW4 ?OZ@*U",Z!UJ?.HU3_L:>7Q
MU, 7P%Z/ VX6:MQ]OB\,3S;PWAIV"=Z)@@COU>EJ77 03@6-<PYS&8<0\2B
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M[ *8)1AG,<))(JWN'*]W.356[R2>U;[_Z_HT=BOU#:$<!N";[:K]0CHPFWM
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MGOT$X@^EH0\WCK !-6(.B<4O(V612, +8B.E#G!$SBY5P%5 >I,#7'Y[O'0
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M,4$Y-G8ZN]S/U&:X/G+6H@+U/1]FQ*[%M?"JZL&V?\9[1&S@>3\*6!8^:'Y
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M,@&3C*8Z2VX&J=I#PR0,)$M#S!GF5F$(3F),C2QW)_&)912"VRB8';,-C^W
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M9Z8RG2?QC>J2OUT_Z1U?9=7>ZL1%#U4^M#<ONT<:06Y_D)Q_RE;B8RF>BH5
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M "5>*,,X".PJO)[V,3<&^,8>!=\LJTB"3^O5 U2=/H&CNF$]6>$<Q(8GU,.
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M<OX/0?)%&ODL#9,4HC".U?^D,234"V 88QDPYJ<BIE9&Y94.YT:;']2Z1)9
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M1<\277FC\MCX(G)=1HD\B#M9'2XUOU^0."9)D"+(N2Y^$?@"IE09:2$+TR!
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MBJRFXUV<!L<4I8BI';?O>6JSC7Q( M^#841BE$@FF;!RAG4JW=S85ZL$*IU
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MM!U2=.*@O>FJ3IQ3XZ#LQ-D'^BW$32G2CAW3NXW:*GW(OHOZ;"$*, M32J%
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M1A3!!$4BIC(B01+;N0R/+K,-+4[C>*REA%*)N3TM!KD2U'+G,?Y@C[RZC3&
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M><!A(N.$ID%,*+(ZV[$58&Y<N"<_J!0 !QJT"<%^T4K\"O[0>H!*$<M=EO5
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M69>TS'0:+.FF& <( "E! P+HH#!3PO0"9L=-^O5K*O9*R=P+F,OSJ>%+$&Z
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MJ+[!ED9^=3W-@["@D7;@R60OSH9>YHG0FR.6:!!P]IY= T0F=;CVC3>O']1
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M-(*$^@3BB&!/^+Z/ \M\D)/C+&W]T(*!1RV9WD5R)33(]E+;)H*<1M;,^IP
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MQ0L$7!U(' 9ZM>.'%[KV'3:\O'B X7-#?M1UY=Z2HGB2FT)O*5OC!R$:8)[
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M@U++";)*&;!3$UI424JB4:/Y_4.C"'BPKJ<U;,H,3X%=3X1CZJQD [4"H-8
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M(F_6[QAQ&3,L88RB%"*/I3#E(88)0@DF**8$&[FD+XRS- [[D)6,K(%Z_1+
ME E[*\K_LHA>Z0'4(/IG&I@<<X\2$K12@KV8E\TA*[ L(GRF 6VFP)ZAX-E%
M\UR&I#>(I^?V^6)W+NOP+&3'X/)A-N'1[K0M:EK[>K_LMN56#9GEMVJKF[&]
M 4(091)3'P9,'^CI<E7*,O0@1XC')%3_4&IC&0Z28FG<VBH!2>._(ODV@SQ;
M[ZH" F6E#"C$6A>. -N-(?&.FRDS4]$Y_HY)^X7K\%!YN=8!=)2X I4:3FS(
M44!.:4D.$V16>W(45L=6Y;B'#6X[NRTR[<RKSK<JQU\]H#XT$_RS4#;N#?FA
M"T,K%M?#ERO)O0A3)*&?^+KKK"\@1F$ &1>IET@JH\#**S=$B*4QY]^5#OH(
M6WVNQ5Z=?4Q#51\S%]5FL"%1743]3JQY5:IY'^^PM2_6/&@*S3C5]<0XIM2#
M^*"2_ZH^LKEJ";560B=QZGG1Y6ZZBDS:C78PC!,WH[678^Y>M(.1.M&*=OBS
MQI:U_UIL^(YM_R#ZP&7[U*9F/AT52_=3P2@E^GQ#2(A8$D'*(D6L:>AA7\K$
M)W;N24L!EL:BW8+JC0:@50%<Z_)#2H6AM>P-Y\30,^D0:=>NR3Z0]^+/5*7>
M#CTWI>D-97BE>O1V")TO0F_YG+$,^$WO\7="QU^]_Z&X(R?K?9N1ZZUB9KI3
MU'RS:6J&O=WL<O5#4;YY^E7H0H\/=\K(+03IE)5.0A\':BXEQ1%$U&,0DT3M
MW1.?^2+@0<*L0G =RKHT7FT4+'582ROR8!Z=?F9M*?=5YVM&=F[TK$.F6TT[
MC;(.NH+M9E^^<:]N=[8S!K3&,[&ZLPERLP!,+^XKK17.<#^_K+@;<L!IV;OL
M4>_#=0+*V_IH2*T:3/U_F,!$Q PB'@60Q"B$ B<L\"(?8VSDYSWS_*4Q?4?"
M]G3,XKSG!'X&AV+C4'',IY,#8G'P-0Z8F0Z\; "R.^0ZKW[OX=:)V^8[U#HO
M\[/#K)[+ACIB'^H@S/*+K*J/?-KDMS>BN'\GZ'85>H(%-*401S14!J^(=".#
M$"J3V$L"D>J^=W;%QGO',WI+9ZTBOA=7FT5K)2I49'H/N!+6UEO:A[.I6W0L
M=G/Y/ULY-6IU_:!/>^S>]6$WP,=I@,FTSLR^ 6?V6AKH_M(]:7*3'9EPD:W>
MYXJ6GOX0Z_7_DV_^RK\+4FYRP2N?9[$*XQ1CGB0P1E3MG(FN.NNG# 9AP#PJ
M$ N1T='-Q9&69A?5P@(M+?R'%A>T\M;' (49C5Q&N)]")L7-,7T,A\R8/8SA
M.#!'V5)'*=@OMYO'OZEG_$T;$?H/E371(8O+SY^%*(S5;$G"_(9AUD9%."<B
M%C]MRO*-D!M=6X>M25EF,F-U!G_]XQOR8R4]+A13",A#7;Z:1A)2'D@8)1B)
M.$P\YEO5IADCS-)HIEYD3\;[_J3U^?D*T$IV\$*G_6^46G8VS:C9-#-YYIHC
MQY3F>GJLS:8I<)W2JAHESZQ&UQ3('=MDDSQS&"._$S)3[-[TZ]2IYQ]T*0RN
M0\UWRD34/UEAA&F" @HYHQRBU(L@D;Z$C/B4"$PHE6BUW6S)VHQY30:U8MC]
MT.X^X498L*'K[+9IXKL%.BE;[7&>!#$TY*QP-^/(J=%T[1BKQ04MH%J\*U"+
M#'[Z/9?5GWX&M?C58;&Z8CKJLX%K2HHS&G=6*K-!XIBRK.Z=N5S%^W_NE 7[
M,2^WQ:[>Z6I^O;DC>5-'X_,FUVXT<5P6ZE=]0JWK..Z3D;]MUNL/FT(_=96@
MU$_B@$'B$Q\B3[O%B QU^[T@\K@,N&<5?K@P_99FTNYCPMO Y$IZJ,7_CW_S
M8^^_#\409JJ(X>B],CR%7I;4"UI0)JBK46,$.B U;LNM@NE0AW&/U(F*&Q5:
M=?W=3I4.)\F6RWP3%E&CPY&*_QIE/-S.[V25/AR+.<S8^)#ENE37)Z&DW8>H
M=?)MZ]]G9/UU4U:5,730@=JJT;6ZO-RNL A0A)F <:#V22CD*<2>'\" Q\IN
M($'LV:5UC91G:8MYHPZH]+DZ1'M>@6<)ZWNM0*L6^/.@&-":6=8'&#NO9HOS
MC+/E>#&=8Z*L5[R)X)URA1HKTJPKRD3X':\ 4SUV:$F6#?N'3J!0]%4O*2L9
M8.3%1$(6ZIJ#(5;FGL 8RCAD44#"!*>)C9_JY1!+\TK=Z#' _VS6F]N,_6=9
M)WXU$O_'O^' 3_X;B$IRV[(J+\ UW*:,@LSU3J$CW'^V1G\;+%C%IVXW:FN@
MNT9/61OE'"+3EC]Y,<K,%4[.:?FRB,G9*X<1P?7]IM@V33AT893MLP9U*Y](
M3YE@'(HPYCIK-(+4B_6Q(8D10P&-4\_&,NL?;FF&5U=:O7!G>WF;[K5VO' !
M:S..F Y!QWQQ#-Y!U$MM^*Q9P@R3*1GCPHBSLH>9]L=,8GC7D'AN(451Z%Z7
M/SK=+=^)AT(H>Z;:Y^:\._R*<QQ@X3,8QPIJ)&0(,4$"^M(/$C])>>!+LTC)
M80(L+W2R*VSML-65;4A'9IMX:.L)Z:<BAR#/=HI6R5ZECW>;"'?%KQH'7\^%
MN$V NDODYRK8="?TV[Q3&V)2'5-NU0\H65?;Y_).B"W@VAO<_$:';=]7Y6OD
MKHIYWZJ)$U(*ICO(']F@Y-*J?57U =)7@K50/RF T'NK[17@W?E7MSX4FP=1
M*#M7WZ"W @\:FU^F"K4?.I']D?C63YTQ4'^HQL_C^ <_94A;9?66%5E^6W6[
MV4CU'[4K?R#KZ^KM7<4IB5.?<IAX20019P%,U9(%$Z+,8\IP' MAWE2Y=ZRE
M6<>MM.HKR>KN(0^MP,VW;=,GN!]F@P5I.O <KSY[W+ZVN.UE!=<3XV;377DR
M_.;JK3P<1\ONRD;(]/=6[G_$C)V5C71YWE?9[!;[K(=/"O;UU[M-WI3-6E'*
MN P2!E$4Q1#)@$/L$0)QG$I$D)\P/S%-=#A^^-+8LY(/5 (V5>/,DQE> -=/
MCV/A<,R'%DA8Y2B<4WE$6L*+1\Z6B7!.F6[RP=EK!D>WMF96[13X++8K+Y41
M3B2"A&.U54<4PY0F'L0)\:(XB&/DV4:SOAAD:><$^^VBWG6T6XA<6"8QGH33
MS.<W%J0YM]/7#3Y-@38=:=!LI]?KS5]Z?S=I-.I97":./GTYSMS1IF<U/1%=
M>O[: 3N@3VI[==MNJZIPD]_4EELMD8=:,)$?1#[B(?0X5[N@E!%(O)! /XZX
M9&F4I 09[X(NC[>XM7PO<>4H^-:4VFW$MK#F#: VV E-"Z#KU?^ G7:XU9&#
MC;S@3Y.2-X-@M-@830OG3)NC\;#:[9',0>K=)QD\9KZ]DKE.S_9+%K?9L7%9
M;%?794:^$J9SF9J:_EX2D2BA$M+ 2R 200#3*-8ETGTITD0DD6?$O2>?OC2F
MU0+"1D(S0C@-6C^+CH;"]=&JD@TTPDW8Y*!7[1Y[2MW7L:74WX[MJ-,/GN5#
M[M6I_6S[+QJV>WJ[J7K5UJW4OV7E/]X\O1$YN[LGQ3^N?V3EBJ0Q\[FG*R-J
MCX=,(TACAJ#D<9KZ,>7(K*J#Z8!+^Y2?R0NTP& O+_A32VP9K7H1<;/-UI0X
M.N:!,1!:;[9,<9ERXW5QS%DW8:8('&_(C.\;S#2/HMCJ TY=AJ99X7PJ.8X)
M@CS!.G(+4TB]@,,T#GCD)[$(0EMZ>3G* CFE%;*_5)(%D,:L,0X>]U3Q#!D'
M?39[(9B8%4X,-#<5G-?UQ/??<_&PC_X3R?G*PT&,8Q%#SXN4Z1][(4RY(#!,
M(R)CI-MZ6!57U@]=VB>M9;+[C"MHS+Y:6X5=^T+Z=+7^'KO*3?GY5<^=]6OK
M:G+\<3W[W8C"2M]W.2^>.O$DNAWNKM#A[*LP#%"0!!'T0IQ"E*H_I:$G8))Z
M!)$TC859D(?I@$O[!BMY!Y0WZL/4[ .=$BG''V_M8JME[0855IG/C;@3UR R
M &;R.D-]8\Y?2\@ @9/U@DSN&T8F=?&A?2+7FSJF\;L.:=11:9Q7R5QD_2XK
MV7I3[@I=55O]Y6%3DO6OQ6;W4*I'K'>ZM8V^9I-OLWPG^)<'46\@RJH8_$I@
M%/B$2(@Q4FM_A$)(&**044*\,*"$,2M.FDGNI5%;JP&H5;@">R5 5PMP4*.I
MQF_IG)CKM3"CU05.MF-V=C#/UIP],^I34O]<HL^Z@LP\'\<+T=S##SCZOV9,
MQ_B5WP03V:-^VC=1BN)1U*74!5\1'@4,2P13Y@<0)4BWE:01C(5:C:(PB4)L
M?O)_<;BEK1ZMP*#82ZP[26J1 6]DMCBWO@QW/[U/#Z+K@ZRY\;,X]I\4QYE.
M_4?A:7?@;PQ/[WG_Y:?,=]QOK-&STW[SNP8F:#/UYNRJ@**;@N3ENHXLX/^[
M*[?ZC6J\U#CD//84^Z:2^1!AXD$:^@F4D6 ^3T)!O<@J4=MHV 7R<2OUH;-6
MM:UC3^ @_)FR!9=]XF-FR M3J?Z/0!GH#9O/$,2QFBO)6("1CXDO_=6C*.CF
M]>:H._S_/V?);/\T/?+N%UJGD-NG[%LA.&GJOMG(\Z;P6Z'Q(I7?[NZA?JVO
MQ8:)LM3+F[K[3NU1WHE'L=X\=#Z?F":<,"^&$6,,(D^G!WB1!T/)"0J)8 FQ
M.G4V&G5IJ]#''#[44E?&EQ:[B@OF!\%MG4<FV)NZ?B9&U#%S?<Q!(S#XU@6S
M([,#>K)":5I'B\G ,[M)++!XZ>2PN7G@67B6BR_R;2%XMOU 6%5)[6.NOG1E
M?W]3K'B]_2J*;,/?YVH#R!)&$REAA'P"4>IC2**0P#0)1(R9")/4RFUN,?;R
M:*H6$Q2ZTL*A'O]#);#EF;O%%$0>80K]!%(<"(@(#B'V1 R%\&E,0^'YG-L9
MPHXF81YK^+6FP3!"P@VTK@,IE-0:PUINT JNO?X-V-\:L&OIP?M) R_L,9LT
M/L-B^'G#..QQ>1'M,> 1PQ85M6SQ'=O^071-YNV3LK&+'5DW?\U$6;7TXJN
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M=TE1.D]XWN)\6B8]IG$G[;RG.\Y1?W$HY'[$ 6=)[P3S?3W73>%S1L,PXIA
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MOK/Y]5].?(!)]^HHP7C4??))6"SG/BY'UB?&(Z,D.I^)U-H3YY(D,<=L130
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M'T]',F&@CM024-03*4OIM].1<&DB%Y0::;><D!P$CX=4#(.1?A3[$"4'2GE
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M_WVD.'BM-26)\M+'B ;B*4:!B>LH.7<VJ5W<VGV!]!):A\7:8>#8CK1JFFH
MC*>SQ?)#7C-Z([049#FEIL2[TOU&!D=\X+C3,R%$\#2+4,4%VDI-(QM</\;K
M<'DW YK?9K-TUTO\/)NDD5)@LI69,)U3J2:3Q)9J(L]$5,D;"&E+*F1?R-E&
MTK#VJ =];T70P<)O&D8G%R5/^)^=ED824G*:)\),L:@Y2.)LX"3IE+-6T<BP
MI8JC)J3NDC>L=3HFO/96RH!0*U=&=UDJ?+R[N/3C>3'I'_([U-7T;(RA2]G#
MEXM1IIE3HV4Y:4?;'I YQX,@FH/RF=ML']QP/KB5>NE#A^GLWC^$J@J[ 7OU
MVWRV6'R<S_)X.0K4R^1$*MEA 4UM\L0CO6A#3%9"0U*F2F1WAX9A8=.S7[2O
M;/>'Q6SI)[W XL,EE%9PT[,WWR]ANK@3>S 0 4(.1!4>)'A!G#! 3' 6O,J&
MPI:\_\-!\BA%PXP*J 29?N3>@%WYA&I  LYQOWV-9G@RNRQ"6G,URL&SH)4G
M7.O2\=P""1K-L38^*#3#D?HM#3W["/V?H&I8I[HGS3^(]OM20P.8^@R323F9
MF*;?_?P?<$=8(XA@.)629.45D4DS8A5RD@3W4I7<)5HE1'N<I&%]Z#IHZDD!
M#4#I-YBB@";(R4FZ&$^[:0RE0.^:'8G;M I)8RC@BZMH2I/"D(D'A3YQ%LF[
M*GAZAJYAW:,ZH.I3%0T@ZVY$N24\\-1F&KPF(;DNY1%C3.?0[D83(?A@A3(U
M@/4T6</Z4'5PU:,B&H#54S%GF1J2<>4L88+K)KWYOC["+P'KM_%D,F*<"VE8
MPD@7& 8?RA*K)1"5$[X@F0.SI>B_AR3+ X@>9NI374@>38D- /::[EN>WV,T
M/'(:K*-9$NI+>SX9T9!'X<NL(Z],SC[[*@>?V\D99IQ4Y?WT<,'O#9^O, ^S
M_B+(Y?PJ+J_F**'3<S\_@\5(L*Q,\!2= 61%>IF(=26 X59'M.%.QRK;YS9B
MAID\53U>/$SH#5B>!Y(9R<RL+2,O N6(?14$L2E[(A*3T<?,!50Q.@\H&68F
M55W('";NELXZ5Y4*G;64 8-9;609S%@JW3#>"!$#6YH8X\EXFEU=Q-S2,JPC
M5.M\<T]9-P"7=].O:"2+2%8\=.U]\)41.F(FLE!Z@E%-I"T<R=+?)R@7/=?)
MVCI>]B,$#>O<] R<7J3>P.9T3??UZ4;R5+JH!!$B8!BJ1"!!:TZ4#QQ]_)!8
MVE*_W =H[M$QK"_3.U;VE_'+(>)6$)G"62FG["=V\N/IHMA&6'R8OOE>[.75
M>'&^"AQ?0UB.I$HIAFB(Q6V[M'X!XIP"D@P(#S[C6JAS/OD<9<-Z.'U?X/:J
MAP:LSX?E.<S_-IO.[F_#UPN%!NJ<L R-)_KX4@(G5LE,(K<R<J,2"K.*U_,D
M6<.,ZZSE /6G@0;P=.O%7><3CZ=7R-3:S9M-%Z\@S^:P>M\7_QT6OX^GL_EU
M5T0TTB?3=/]3WOR?*_SU[[ \GZ7;77\QXMH&X4I/38&V6R8 8K/B1 /GR6G&
MO:H"SB/R.-#LT6K;<)O@:"*&6+.\7O>O8 HE2PAC;HM[AL+EGS$4\JYD('I-
MN$K*:):Y"U6V]4?H&6@&:E4\'B;T!FSN*J&LBYR54$ I%R3&LELH34E(PA.6
M@H_<:\EBE32:6Q(&FGY:"2%[BK8!@X(>12S5/+,N0>/:?+Z;_@V6MP;TVO?8
M\L[%)T";>='5.WJKG E.E/.Z,BJ!&^(HQM99)B,=9*-$%53UR,- (U8KP7(H
MY39@[.ZQ.&)!"RYB-]N>EZ8/G(0R]\^*[!*54:E<Q06\1\5 HUEK86MO 3=@
M]=[X^11QOO@(\ZY9W6WK,G!<6990EU!\PHPH3]P19= 7M$HX%;<T#CT<*(\1
M--#(UDJ8Z47L#1B733Y>^<4XCB3W$KP6A/G@"A.Y%)PEPIS/.=B<P%;I@K"5
MFF%SDOM1]#/H>;G4&X3.Z_'D:@EI)#T7)H$G201&I$,V@C6:A.R4AN2H2T<!
MSYJ>89.0CP*??23? (#^#N.S<Z3[Y"O,_=EZ;N6'_*#GZHW,#(:B&( 8HJQ'
MF3D,2+P 1F*P+IBHY-9IP8<CZZ6$#C1YNM)65U5-/Q$,UT9:T92L%R33TK)1
M:$="F:^((3%&%49:%;=,^3@>!AO8,NL"9D]TOEQ[[4)S;>\?-J>V5'&=A"$Z
MJ$1DSIY8CUN!3\))",A[G9OT%](Y[);< CQ[T>!/U@ZZ#&&8PSE,%^.OT']O
MZ&T?7[-1]+/L]-0U^N:9']:]J4^F:<NS;]"J0*M$2Q6'$YY(4UJ+"V])9!D<
MY3PQLV7@4(\=[':CL^<NTSS8Z$H9I]*EC3IE&#N5X>=)>^6"U2B+NEPWT&6Z
M)E*>Z3[]$O$WL*^^AOGX:U=A]VY:DKT+(Y_&BW]T;753-DXQQDA@&:,H)B/!
M2$H0CM)R0E@;914/[RFB&@'6'LJ>59)\4RBZ[B+W!?_RNJEJE-%1T(1;55KE
M)D-L DHLAELF.6[HMFF ?:+H(5'#HJ@_U3^*J0/UT "FKN^K/N&*._67Z[ZZ
M+.:$IAKML\8O$@PE+O*(NF=,<>><I55VMZW4M(*B0Y7]2,;L_I)O #YOQU,_
MC6,_N5UBW?("Z:G'[9P87@2#WC2Q.MARVIA8BLDK4>76\!%Z&FG]>/AVUH>\
M&X#-E[F?+O#)MZWA2HY:WL+=HJRVQ?9?K1<AB'+*PC,QM)PU N<DY(SKQFJE
MC(DAVRW#I ['6I],#&OC>D'5K!$5-P#ONZ;]\[<;VTX--5()1Y*$,C_#:%+<
M#)*"MEDP:82LT@UW.SG#0FXX>#RQ#>^IJP80M^4*AD<&(:M$HBU%6IDI$C2Z
M*BY:36G&Q2SKSL%Z_Z+) O43PP[??0^4<@,XN9-MJ3F7H(4F$'R9 $91$& =
MB<Q8Q2 :F:LT%7QI(NL1;RU?I,S'\UA?(ME!VSYTC5:[),8MQW9=^O]L#N.S
MZ>G5O$R1_-$9[4FG(9_^^VI5"#"%Y=)_A^O>*?YB=H66>0YQXA>+<1Y#*K(_
M^7#Z;I2SLB XFNC22%^RY##,T8:(@-X$,,U /'L<?V2:&XD<#L-HRWINP"@^
M)9E/-_S%E=9OY/%VS2W*[K.?P(?\&>+5?+P<P^)OL/R0RQ ';L%EX3DN?=?=
MY+%RXIV(]<HG&5RI=*AA8ZMQU,A6WH_);D/O350_/R:*UZ4_%J1UV<['"=J%
M6TE<L_NQ-'U#$2V7\W&X6A8WZ\OL8Z?1D9!& \V.A.3+G8]@Z&Y13\ITD^#Q
M/U-G&FLMAIKK?%QC 1Q5ZX?B_TOU?>"/Z1S\9/Q/2*4XO2O\F-X>"R].YN,%
M;HBON_Y-'_'U65H5619+D"QE3&&DH11#2?C B0.?B68L">58=K)*=6$%7IIK
MBE,#^L?2=0MN3QRO:-_<ZV[VL:UKV\NLK7&<")U0ZH*7.S26"$L8[D#0/.DJ
M(\3V([>YACP'@;:^QEK Y4%NV;WE>N.0L:@=0W:0^S*]3>= 0BX!BC:&!YYI
MEG5 VS\OS;4-&LX%/US7[3L?11*[N%PYR,!*^J9,H7PIM]"LJZ"F(FB3A#5'
M=;1WI+NYWD6UT-RW#ALH!=W"Z<TBI"59P6=%7&F:+).GQ-%$20I*.1%XL*9*
MZ<P3-#77T^@0J/4E^P9@U&>I?40I\M**D$MG,/#$M11"2? RPED)RB=?99S6
MT?LH'+,AT2$X'4JY?X*-?;M 1B8@MXYZXIE#IR91U$;2G("#&&A"9]Y5R2+H
MF8_V^AP-LO/WH.3AQV(^8'N4;>21"D=,2+A L];$AJQ)C)EG7=H[L<T$TL?&
M7SY29=-2_Z.][^0.%=W/7Y&U\GS/88E!WJ1R>=;]9QVY5NL)1H<JW)*,4>&!
M9,M*#[82;2AF2 ;.G(_&,%7%5SIRX=9CIOGDJQ]/BA'.L_G"3^#V&N^9*$VZ
ME"3CFGCN4\DVPP7*O"4B.*D\Y1!"E7X3?3/22/I-!;3NNCL?!0(-GZANN>=[
M]H0B2XO;'<FFC)G(,J!?$B1125.E!9=:'!7[+^:@D7R> 4%?5^E#.Z/(RJ4?
MI]ETO':EYRCQQ3=_N1C19$+VN$I]R'0UM2!0;7'E1J^5QR6;-N\ MONDCS^C
MD?28BNCJ4\@-6\82M]VY6_A_KOQDG'^4)@V+_X1TUFT0(RIMS$9$DKDP1 :=
M<5TH0:1BBODR*U,=/;OK.:(;R5\9T/[UKMJ?( A[Y=',1_A\#F7PZ(%1UOT/
MZSN,>H+4_N.DFYJ2C[/%N%L$M[T*$@664.T.> GI!;$V +&. V5@P$*5H7>[
M$'?PN-QN^.4-JSD[&UU4A(<R:HX#6FM)-8F!NF29%H%6N3F\3T8ST4@_F'@P
M&7=_F3>P3:ZH7Z6'+V];"F;C2U83T<E@%.14(L%J1A@ MPYHJ:&J!YP-:H;%
MSR'JW8J40V3= &!._>*\[.WX3QD?\16#ZRG*9WGJY_.RU_Z7GUS!*.FHHU61
M"*%I29.6Q.DR*8J)T@<^"!NK1),[4=<"H Y"P>:-<>\J:0!G)S%V92B?( *R
MA%'KWV"YEMHH&J&X-9XP5UJ>1@LDR*P)-R8(G:*NU*/I*:*&/7_H'U6]*: !
M,)7A-E-\RP]D8<2$,(SA/L\Q!%C5B7K-),E,)E4Z\259;;+D-1'#'B?T#Y:]
M!=P .#[.H9QY=".31E1IQDVT)''N40@^E_:VC$"VLDPI<:[6$)A;(H:-Y/L'
MQ]X";@<<ZR%'N,MVAP_W9#2*/BBFLB>*2U4R_#1QW)2A(&67C3)E6J5!UPZT
M#5O940U*O:FC 83=)SZDY*VF!HVE1N%H&TOC]4309W/91TH]KX*EEZ.F6FE%
M!5=F;Q$WD$3Y<5ZF6RY_E/N<,L*ON/B7ZW*]46(V"2<H2;$[S12%%RY)E :T
MDU[D6*O5PZ-$M> (]Q*O]R;Y!JS,.U3!]&R,7OQ*0,C"F^N"_]]FL_1M/)F,
MK'0<'$>><",FTDM&;"QY3T8R=.E"#JE*WL@NQ+7@,?>"JMXUT0"Z;NAFD?O$
M01.:5"#2II(J)TN%C@5I%6[#NDIWP!>AI++KW M*]I)H TBXXX^5!-AKETPJ
M:CP-A(*D1((S)% 6RG1OZ35%<=3QD+=2TX)/W M&#I=U X!9T3^BCD+21A$A
M/3KMPAKBK'+E@E8);UEF=48]K1[?@L/;XQ7#BZ39@(O[?NS#>-*EYY6F@<M9
M_,?Y;()"7ZPF5-^(ABD>N(R<1# EM)."> >E6(1K1V.0SE9Q4'8EL)D<M#I7
MG57TU( -NL/79MC)0C \\3(VA9>*NY2(]\(1[H2S.3-*4Y6=ZW&2AKV]J@.!
MQW%VB#Y:0-9L>O8%YA>O(=S<G0B*2\^Y1')TZ-&YDG0IE4:.DA&*!HW;=Q5(
M/:2E&2P=I.9-]!PH\T$;-V[>OGWT/\K5VS4?SJA,R[$5]Q+EPDM;>FHST2EG
M$;7SD5?I=K&=G&&WNTKPZ4'R#1@>Y&)^A4]](*.1RCQ;JR-1FAD,(TLO(PKH
M *"C"9HFDWB=W)['*!KV9*<>BGJ0?P- >KU^["?X"M.KF^5@C(LR!D6LQ_A$
M&BK1@\0UX;2-QE&>8YU[TNWD#'OL4PE"/4B^ ?R<^LMQB1/!+^!#F(S/5FVM
MKKG1DB8/L:2 ,TTD,D9<F8A89A?+<F0!J4K-^]-D#7M$5 E//6JB 5QML:P.
M7;PLLR0";6SI4(PAAPU%0B8%&R0 JY+8L^>65NT\J99??9C$6SAGNA,9W#LQ
MS4$S&@@ 32@4H4EP7A AN0I6*Z%5E33Y[>0TXU17C.\/UT,#%N@1>WJ'H91D
M=ME8 L9G9$AEXDU,1!MIM ;I;:J2IOHL9<VXW/4PUJ]V&H#;M3NXJG7[XK_?
M$6-)2' ZH;5-E$@!R X/N'_3DN7"&7-6\9CK=&]]AJYF7/-Z4.M3,PT!;1UW
MW%DQTAGI-?H,1I<FG$$YXBFC^*-DRE#*DZMR2?<H1<WXZ?7!=9@V&H!5=UM]
M=V7<<L(B]:QT0K)@(I$ZEN"V="5PI:5A$*!EO7+KK20UX\#7 U9/^F@ 6:>S
MBXMQUSYXT56=3Y?CZ1E,(S(U,LXG$6(D2I3)Y$4X/N!V+Q0PHPT#G:OLBD_0
M-&R;Y^,X7SUII %P/24A#'AU"7R9Q"U=2I#$4@Q:1!;1R!B]<E62W0[,/ZC6
M<_DHT.I)'PT@Z^/U<SN65D6:#(..F'@@G$=+)-.:.)DRX:  I8,&V%4YPMI"
MR]!E^_VH^6']R$$R;P VQ;;.IG?HMSE;51+^C#$88T@JB<\TEC@V.Q9 6%_E
M0F^3D*&3GZH YB!I-X"6DY2Z_"\_^>C'&*&NCT5&N/>6TS9#/)1!?I)38E-I
M=L>3I<&ZJ'6="NKM] S=7JL*=OJ0?0,0^@1+7_K*O?'S*;IQBY,8KRZN)J6E
M3^DX%\?+48P.99$4\=YBP."8*J-W+?$J6Z<%6*95#30]3]K07;&J *MGC32
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M1K!14J(DFF(-CIM<I9IB"RW#WL'UCZ-#Q=T 8K:G1*]Y,2XYM+F") N*2).
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M76J9K; )US/;K=_9\\]J-B7U)5J_?]7;KWP;V$]7)Q\W,=HK/RDQV>=S@)*
M=KM2[^3:OOJ!/US.%G[RVWQV=5DZ)DRN$@JBO&=61'(%Z7;<Z<GW\6*4K*56
M2Q0#3;FT#2S3=5@@+&3!+/H:6E=Q$8_#WC! KX+(!]U'FX-' XOF10S^S5_
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MS+%@N'3BT6ZJ45Z\!F<Y#,7/-E4QM?2'7P"_O0#SC7I.'T9L5[HYR;U]$__
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M3&JW&9?F6!Q#=AV@<W.8UY^_X&Q9 QZO/N'R8Z8[QHW0 0MD6=>$R*+!&Q/
M8-0L6U%R>6BIC3.?92<YW69BQD'9"#+H $DWH9%7B\]A-M](I];&?9Q7(_5U
MHH/-R@SOW9^M9_QBGM[0;\\N9^LZZ&6UNOK\F,]OUY_R\L,GG/]CL4A_SBXO
M+X(WS&=.7$912S)+!+2>F..EB>A+#*')^+JSGK+;;-$XN.\7,5.[T*_G7[;I
M_>5U>A_G*=VE]Y<Y5D>2N)/3>I%N*E'6MY4H%UI$C"J2%YBL \5Y(!LI1BA)
M9D>VOE?B81YA7TCF-$JZS4Z=!N'S2VDT2$XQ@^]1!_#=:T<\V]S5%W$]^SI;
M?]O.HUM]?^PQI_(=0<OYYO2=RJCVD_NR$$Y&S% L&;G*"E*C/&O8C'G&F(LR
M33*4YYC<MV,8R^KEMWN_VD923!(I<)VAJH?:!Y> ;JL$5H(42NG"?1/C>"BA
MW4[Q&X*A_5/\&DBK S-Z?Y=Q,#5$)RQ1G@T0X;6BE-/CD4,I*I-_:9O [K0I
M V>8Y]<"" ?/&A@BE9[@-7:;DTHB>,\D6!.)#YGX@'5]N5'6,&Z8<[I)A=V_
MVZR!07@[UZR!(<*?VK>Z7T6&-X4^-V6N@57+N^[920*4P.HMTL_(K'>I<*:C
M/:SXX8DOZ018DT)@T4 >'2C7I_K5R9O3 6O"(KBZP#<&,G>D@8C>VD(\4ZS)
M+-Y_OXD#QR!Q; EV ,9'!=@8@T.L.Z.C(*N;K!T(FAX2I;$XBUYRU02!_R83
M!TZ!W4FRFOQ!W3LP1FA7BD,#S-0M$T*1K2*00RB23I.BQG18%/*TX3W/;V;
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MR_^%EU?Y(D3'LHH"(C=UD1!Z\,5P,*@"CUJGHIOT30PGM9=*B.8X6IQ5J!W
M]NY0]WREBQB2YTK[^CYA+8A,@"5+NOH^:$06@FM<TW6/FEXJ)\X-OM-%\ZS[
M#K>#!A>EKAE9YKB@O_J_<YK-'Z\CF6VZ0N>9_O(:_\KMFPY/)^U\'8<CL_'$
M=L/M;IF!)-TU="6AHN<2C/(9E":'RZ<B(&GCI%8E,G[@QI\C*1A[$._;J_7;
M<D#'\_7B019MS-Z 58&\!O(4P DI022N'5/"\M#$*3^)ZFE,A_/A[$?S=MN)
MN /KX>F5TX5;YST:2*G4+&(D+S<+!)W(3=7<EVR;Q %.7_W>S)0](SH&[8(?
M(JH.<+=[;["42>:("0*OY::<R3JQKA:>8J;_*9O=_]T%/UC:!^V"'\+Z#O!S
MX-IQ+(F[)!&2JZG(@ X"^6^0E"U.*G+G3)/9+<]W%_P@'!RW"WZ(4+K8(O+R
M:D7^X&KU(A++5K/;](&00KML-12GZ"#>".):YI")1R9+995NLKQU#SW3NMG3
M/8QCB*<#E;;K&/6GRWQ33>T0A0K9@#=1U<@4 DIOZ?8$%IR6DK7)Z?V0LHD+
M[<:0_P&8.EX84V_2^(7^^/(#W3_\DJ_6L[BBJ_<?-VUC9#!(+SB(NA9$Q:2)
M2U$ +UZZZ!4WXJ&-O]LE?^)+^L/'";)<-&!L!^KGE]E\MLYO2"^GUR2<^<<9
MZ>5M=/SEMU_QOQ?+5U6_;VY6TAEM21&DE[7 1TMP.06P4MM881%LD[S' !JG
M+;F;[C%L)<:^$7IWL-_P\\VMYI5= @4(-*KJ?P5.,P59TRN@Z6QTRC.C=!>=
MDP^3:8.7PW%YLO ZP";Y.RE7\F]K[UUVH=2J5\X-:?] ?I1D'E(0'@/Z0+_5
M GP/">D67:=+_?$(H^-%T &$]HYU(J9@G8>OI7'T&B@+CI'C7- 5#()GLE0:
MJ;&CY[@UJQ6=]&$]63P=H&S424Z"SB<9%W7$6%T<GCS]+"/8Q$HR1? 2FQ1R
M_1O,<AN"JI:SW(:(N -X[VD:SX4</&$]Y%B(G9HXZ7-B0-[=YM);'IN8@G_[
M66Z#X'%8@_\0676 N(<OTEVX^]"WZ;O]VV_NQJ);'S"X".CJG*E,9I#/HH!+
M4FLFI!*\2>=VJP--6T [G>'0!4 ZN"B/J^&^/5A)JR+3]4209%U)FU*U_@L#
M*9-QEAC-^)F*%K\=LR/X7-"=!D _K&T\19H=P'/4-=M9&<PJ.W">E(8*)H./
MW(*(LD@F+9>Q22'#V5>LGRV=V 7H)\-(!_=CW^%V;6"YQ_@7R]FJ=E!=+6M)
MZX8#=RM8HN;*IIR@)*=KL4$$IPC5F%G4GJ5B5)-1MPW.TE>^H8O;,C5B)JT=
MV=:OWO']<<GJEAFUM'73G')!WQ_H?<R0964UEP*<0P^2B<R#8T;(A];/GMKH
M =_:5S1O4MBVE=BS[N2X6WIT=W?KO7UWKR;[Q=M7K\^X+.HP0J;8"W4$BT9:
M ?743OML0K8"P>3:=)2EAY!EA(@R1?12EC;33_>3-)X[N771 WGH,G,!60MZ
M&:R*$ K=R"QU*-E'PUF3-,D#.B9?'CD& O8[>\-YW8'I^N0X]Z!83L*311%C
MJ:TB#.J &= ^2^&49J[->L>3URV<H5OW"&D/6:(PA/5=P6C'I%L151$H#!!M
MK*ZQIK,XG4$Q6UPN3I%+UQ9&SVJ)PB#1#UFB,$0.'6!J]RC_:$+A2AE@IAX"
MK8 @ H(TM@@?A-&J22#TN2U1&"3L@Y8H#.%\9_"YGT)#XYAUCLBN,](\2D"1
M%5C#,04>1+%-;*$3TIW3+$X8"T!'\KX#!-V/X]]XSU9++[%$\$&17ZML 5^L
MHU_Z&%1"AZ[)P,,=M/2"G3$MH>,8W0%6WL;9-A+W,&ZSN@EJOUBOE[-PM:[<
M^K#X?</D"^:1RV05, R!KI:A&Y&T@Y2\0*Z"LVUF'1Y';B_/W9$H>1B#;2^R
M9QW9NHE +^:W X VL;WOXC8_XW)._Z;]6)*CJ#E?C.MT9G6PZ]R2PC9<9# R
MD@XG:P_0E/I+S[-Q2B71I&FSMUWG-\)\^>V:@G=YVZ^[^C3[\O+;-M9]VX7^
MYGK"[\MO^]RZ[0M9'-<^) 4I.K)^M)) KEX!C)+G7/M^T_E&^S4Y8B_O0UOD
M'S0)<'H(=6 4/1GF8,JXP$L!%>L/UCA RUAM1D"=-3VF;0:H/(?@8E] &A*W
M'"+5KA"ZPP/V6828$B?[#@5YP+70G L$^I5FY.K0_QH_A\\J;CE(]$/BED/D
MT &FGMP:64I(3$4.UMD$BDX O@[4-$)'GNH@1=E$ZYV\O7.:*.8@T0_9WCE$
M#OUAZKN]D>B-,;8X8"K141(YPB'3>9)+)@@?T6*7VSNG"6N.B*BCI= !H)ZT
M->[B*UG7XF3%06.=Y6Z]!53)T*F4](@RB7RV#/!C\GJ!V;,SUTZ4= ?XO2N/
MW!MO>7T;;[E(FC-,3$.I@R^58'6LED+0(J%5GMO4I@!F$)6]/,/CP61Q+ID]
MZSCK]>]4+F020:A?L,K+K_DZ8O%M&RYL%UH]E( SSG4^AB7M*P5MV"PB":"Y
M5V0T2@7>TD.?O/*$UB+0-TG^M:L4?'%YN?BS[BHCT^:GQ558EZO+'<Q?7%Z6
MK?E\H5-0IG@#V15#]I/V$*27H.E.<5%2";[)H+7!E'9;;3@$18_&2#:55P?O
M^F$'O,@JQ<UJ\^0\6=M6D!5OR9$CBUO5>@4?=9-8^F'D30R]MA@Y"I&#!'8T
M#+]L.F+(NEZN1P'C[\O%U]FJ-K,]/MN%,(IN:V"UPJ&0PR<1$ DT'+V63G,N
MV\Q->(JH:1VB\P)O-.%,/8%RK['S4VW<6>=T811C-KD(3%IB4\D6? P)O%')
MJAB<*3\T!0_[JFE;]<X#H 9,[P]"MZQ\E]-5K *\""E:K;D EJRO07HZ$!:$
MX@33Z*RQZ:'".A1%C[]MVN:Y28%T(NN'8\EOL33/'VMOWCG-,+0AVX ):N$3
MJ! 9H"27W? B@G.Q1-^D&'M$,ZS95)4NS; A CO1#/MYGB8.K-2PTCS.+F>;
MKUN4E[BJ?S/]-+N\HHOR_A/)<3N08]4ZQ#*<E/,%6TYD4_NP"]?D(VCTH FA
MH)P-X'614+SWTA!N66Z2,QT_[+)Y,6XBG+_GY8:WUV.42G8^\P+"!4XW4SOP
MWABP07MCH]'.^X->YYT?WVTP9(ALOWMW3^=B#]$.8DJJUXR,SO<Y7BTW]6D_
M_Q4OK^A&U1$JM:__:BNIM^7AF5]^V_T!FW(,HRT+@HP,1>]&+8W6@"()R,A-
M($4?R0QI<FO:G6G"=6LCP.WAB]V)[+N]!O=F'P>IF':B3@&J62=AR V39".5
M)+7QRBH6VNPJ^@%A$ZO57A!T$+*/%&<'\'R_7L1_55;F^6K#R]\O\:;L0R/F
M2*8Y1+<I^V"&3&OO-].T+2]&J-!D$N43-/4(RF.%_VC/WSB2F#I>\VHQ_YJ7
MZSKQ_;?%^G8JNV/*)&%T?4DL*.,S(-,*;)+.LZP+*^H@&W#WYT\<'6X!C+&X
M.34@'NKF-[<%%Y[<=:.DA;09UT16!;AD.0@KR;J0RB;U,-]ZF%_P9MHJJI&M
MJA&YV,&+\\\\^_B)?.\7A&O\F'^[JH!^6S:'6KV]6J_6Y)_323>N^D4L'EEA
M$5BL0'<B @8LI/FX\KQPH1ZIC5'>H$%4=F2['PF+Q;ED-/UPO@=GHQ?W\V*^
M>7SK9LRO>%F+PS83/E>KJ\\Y_?Q77L;9*M/QZU_:%L;6WJMWF?S\6:QAI/H'
M?\QGZ]6%%$$Z9<G)CZ9.%K 67"&?7T8NC)6&.W_8,]>4S([4XFF [4RB_:K7
M^P'/^S?X(H>HK(@*BB4_2&DOZ/(Z1_:EBX3*Z(5JTJ4_D,YIDK?G5[&CR.EX
M&"[6>'G^5_XV8EK(RZ%3UEJ&:ML:PP&-V6SR)*]<1IW;Y-R.HG::-' OK_Y1
M,NM /YX86+H9<F\-9UX+B$S6T#YS]"@X#]F8;$6=]V.;#'H?A?II@RAG0-FX
MT>@C1/ZL:_9_7RYJ;<<_<;FD/V]>H;_[Z\Z7(C[@N.W3P!Z=2:@(WM*2D1GJ
MSL*"#)R2G-Y]%FV;,9+MJN]_77S=M(&])DN<+C0NTP-&TU<OK_"R%HE<MZ]>
MN)"ULR:#MMS1%=,(+M.-,P53*"$'%YIT>QY!:[=)YR%(>J@H6\NL@^=_]X$N
M9$%=DB!CR=9-X(X'(![6-X8A8F0,11/D[29G6G U1\'C8N=31=)35?V.LUS_
MDJ[IZ]7J*J<+R71RGFZE,+IVZ%M38PH()F8545AC31.G^S#RILVE] &_DT36
MK9Y[D=)L$^RJ1N_+JQ6YC:O5B_@_5[/5YO<O5)"L>#)MH\\&E/0*4-H, K-.
MDF&Q;2;('D?NM!7]?0!U5)%V -RG>;G="_1Z'I<95_FGO/WOA5<I1)E#M7($
M*!L\8,P1BD ;= DLL29QHV.(G;9[X-R@;2[.#B"[YVSX;3-GX$*X0KZCU6 E
MUN(-3B^'='2XDI$%+Y,(XGPZ]8:L:1L(^M"=1XFHBQZ6/3:S5J%H53=3,?I!
M94E'R-) 3-PKFP3'-HO93W!CS-\;8H-$TG%7RKO\-<^OMC5(Q\0"O_OW8P3W
M]A,T4K3N^@NVX>'MJ*U_SM:?7EVMUHO/>7D;<,DIU*9;#2R:6!V# $%;!5X[
MABHSCZ;)G3N0OM/WXS[Y-1^(VR_I[__K0A<I66:UQZ'&QPVQ(!A1H+"<G%0V
M,MO$ISV4P*F7.8^/IL=K:AN(JM-4QO59-T5UIRBDZP\842/M(NG,*HG>+:V5
M]V"38V0_RP2>9PV&).V=8S;R)BT%9U))/\U6^/'CLII3FX3=?<;?@9S,.4L>
M+KW@S)!-1Q<(T%JLD<3('>/*FR8IVH.H>Q[*: B.'HWF&UU(?6NBWZK=5S/,
M)VR+V/=18]I+3Y)Y9CW%/3,E&@G)U-$!!@N@( .9&:ZB%Y@D:U+<VX&>NL"H
M9":?$X(7Y!?HVM)1L@%MZ-#):X&N27/-4T0]#ZTT!#5#M-(@D700=KJ=M%JK
M7-??:@W+8K[9"U&;W%3P7N:($(*O-EY-GR7#P1"/,IW3ZC9UG4]2-?$8T-&$
M_SC(.9(D.H#5@S-<-S I.H*R0@#ZVLN.O( CGZ%6&4@M;!1%-2E0V4G-M# :
M4=J+L5G? 7[>5<-BGM--&=UUQQJ/DB>A,W A26O+(HA#.4-(S));RUWB35KV
M=Y,S+8)&D/,CU_]DID_:F7-;V)3^FY[[35#^E\7RM_SGO4JGY6)./XWY\^U=
M<P)CLI[>?TVNB2)-#2[J K4A*4IFI&XTKW4(E1,/<F_UYK635 <ZK.Y4>%M>
MI,7]+0C.<X[6*]">K$TE48''Y,$KE;D1/LG89&7.+F(F+C]L)_O%R(+H $QW
MS+E)1*W^^)+(AB!Y*^9O5#4ZEZ-VP*Q&4#ZFVM]CZ3$HUA7IG<Y-T'40==/"
M[700/-1=HTND YCMT?1O;EN#N"_!BI# %5WWR:*!H%&#C"@0LTN9-:EQ_1%A
MTU9Q-7L@1Y5'!_AZ=?7YZG(3.ORYE!S7;\L#Q3^;Q]F7R_QZOJWJN;NQ%YZI
MB-XB"-0"5*)+%.@= ,^9#";F(G.3W0+'D]QEH.)(Z"PFD>.I93(?1II&<_1I
M/^!?%])FR60A%[X.+%5)9G#,92B.E:08=\P^!.Z>H36GD-&E!W$:&,\LFP[4
MYS7;WN7JZ]?3Y659+#_7L;9OP^5LR]V+B$PSS2UDCC5Z9$H=],2 A21#H%M7
MXL-)F6-F1)ZFKLN'>ARE.+YT.H#<KBS*FQF&V>5L_>WVQ#?KJ2X\UE70D0Q<
M*S@HY^ATF7[&-6.%!Y>$:?-*#R)SVO+IMB]S.WGUG3N_:5NX_N7I&?0]'SAB
M'OT0DL^<30\J61N,@B3K4CF4MCZ-&H2MI:ODK[C0I."EAVRZCQ&S% Z"P'KM
ME =G?81")FNP7D5MF[R;SS^;/@0U@[+I0T32P6-YF]6[N=GO\\>[&*8,=36C
M]!"%8J!T=K6*VT/"6'(2BD?=)-/P)%5=.JE'"']?-OUD2?0 JRWMURD^YJ77
MD0?(K#[93")9!\&#(%<&K7&!3,HF,+I/12?9\].E^Q W1[-ZZ@FI/\WPXWRQ
M6L_BZG:%NW2H2QTV$P)1CT0]F94@E"PE96OQ4<_8[L##HX^>6/K'RV@Q&L.F
M%O?+VN6X_J^,E^M/U^0+8T+,DH./M6HDYEKV[^D:*)-T0N>3?IC]V2WOQY\]
M;?1H)(&?R+*I)?YK3K.(ER_R:OTIWT.MSQR#$0F,#1:4"!)\\0J"3X9)LKPD
M/BS2VRWV/5\P;<1F)-F/P;RI ?#^7_F27,3+[Q!L''GI+-1J=ROH (G,)<88
MB=>QA)@<3P]KZG9+?]>G3QLG&4GT)[-M0KFOENN;GM"WR_=Y^746\\;&24[P
MJ'R!G%D=9:<-..TR:)ZC<(P.%P\II:3/OV< TJ\>&G_[".@RG7"\VS *G_O
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MW^<W.==&8RY0:O!(<:7 9_H!JZ^H@[*DLR<O$)BFKGB0:']4(#"$SWW@9$=
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MW2'P@=*]0')GZV+2ND>LEO4E18<A52J5Q2B,B[K-,HPGJ3H,9\\JE#^^-#J
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M%_#!\UJ-Y.N ,:5RDS=R'T%3@V<DB2\:L+]3&%UOG#?:F,R4)J:X36B'D5E
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MO!OL4V,AEZ6%1+*-WD3F&'H/F>\L43%+8]/\Z1.OD=D#R Y$QHM9%9.*Z71
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MLXV_D;9 <'Q3"A6]4HI<&-B2?DXJ!R%[F0[D72#[(*E^ARC?T1CH+";2V;2
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M?#W*K&W*R-"=Q4%^O%@C69&K% )*0 3>X E0Y[R9VI=T-5JD6>)&IQ)K'(.
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M+@V*9T;B.%$TY9;JF9APPU82)(D!"*N**1M>XG8GM<G'"LT6P)M!93R<BST
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M]@*4L(8(55J6>E&"OXP27I(I!<.?^2I]T4XEO!\J+RJ$?U9=#H;=__%O3S2
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M@%A!<PW@\7!A3IR($4*IU7*E=*OL/4LI6D<Q)$%3Y! ;N:]'CIB.@]/*&FW
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M.E3P;1U4#YXL'DI(X=5-,VC")/5$)BJ(30'W \\"[W5CC*M][>VG;.0$Z'/
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M=M4ST]GG#XOYM^ERDP6]87AC6VT:GTVRUU(9"40#6FY2,4$LHY9$$-E29HR
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MV*!#6V/-IX_Q]N;VNF0D(,O3.%W]F%$1-(L^E'HPHY'1,N\Y!4MR9E1;P!N
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M()KR6-Y*@#AM-5$,6=).9]^W$\P/5FH#"\>H<%Y+GF.#XQ/<3*]FLUM__6R
M=LL5IYEYO)=#P(TC,\-3U7G\RD:7M PLJ]V<ZV=<W+Y+CGL?#067.A)NX+I9
MW[CXR]WA&H)&HYH&4J+T1(*GI;++$*VUDR9ZSGF5-)-'5(S[8MZ&!7.\6AK
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MW0])ZP?!U_J0.[#J&CCW/BSF$2 M2\+3/6/O\SIL.,E<)@BXFY0MHS>5HWB
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M:Y]5:*S'P6'\O9H7G2HP'V=7'H2YRWD#&K!I6+8 2A4SW)3<0&T\"1'_\,Y
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MCX)-2*\AI!*@5JS!DG!6]A(\'5O%\0D7\IR"X;(?X$9P%J^R([<Q5BRN5)D
MJ<@UEPM_Q6Y/1:M+KKF_[/@C28.79VOLB9:'LN+[B6X$P-NEMAF7WYCS[3]O
M_^MR^H,=^-E%2_^WD9%60U749AEG!T$5WVI'R6B7O)2#U[P_2/FP\#X$-@?4
MIQ\NP],"[:N<YY>\Q3_F%[3DG7^8XVSYF3+QWOD^^X,N)C&I(B,F\*38;/-"
M0VRSEW,-F4@5M+(79=OI+H8-FPP#YHYE>UK ?C_[P8*9+W[*29*6O1:KV-&P
MS&Y3 T22 H3&()(OVN2^YLGL3NVP9O(P0-U35J<%R$\+^A.GA<_A1W:/%U><
M?GVY:&*9D*\*6VY+-R@9H3,@FUE0D5S4T=JL^L\+[D__L"7QPX"V,WF>&HSG
M_.7%ST_L;C1'HYE)?S8'9,+W1C*^('CK^2XIU0 ZKZ"2P:Q,Q2S#X!A^A/AA
MR^V' G 7DCPM]+YGJ<[.IFS]7/%\4FM4LE7/ZB@*&$>F12<+!%NK5-K+7-S@
MML&O- ];C#^4A7" W$X+HG=NDXF,+LGV/,^@=6!BX6M$88:2T BDY++M91+<
M?N0.6\0_###WE=8(,'E%]<;,N:=W.]%LO<CJ)+B0*N_3LWDNHP!O;*Y.^*)4
M+W?\'K1NA<9P FCL6T[[0W%^@>>=0/'.FX<;EGGD Q38]/!6M*?)J !MUI"S
MMF2-2T+T$C=]@):77G/33:#_4"&.0"7N$5S[A#]7B;]*I%QH/3A5>^7G3.$3
MCGSV3"HVV<3NX-!A_@V2AXWO'XR6P^.B^XCNY$"ZX._O\'KB4J[%.@=>MF+5
MK!1$+ :J"H8(I7+8_]2N7:D>5@$/"]5#!'A::'VSIO S_2#^P40$)&%+@=8D
MJC5.;B.50P+MO%0AH4/=_[.>G4@>-G@_($X/$=T(0'J'<[O9V48GDIJM^1Q3
M<_F4AY#;,VP4VB!1"OW,0-R7X&$#]5T#]"ABZ\P].L*;^3M_^9G.V6$H&\Y#
MY]/1#UN[M]?T!S-B5$_KHXFA)';(*KM??$;XC^AM!F&0X>JC5/U<A*-X6K]+
M,.YZ6L*5L#_,ETLV[EU.3CK(-5%[.F@A>2? HRQ.^QRQ]C_A;F>R7\)#^%U0
M>T@$]D"AC[0GRG7M_!<Z6[$59^5O-#];X)_?IOF.]MI'?V_]V5WHY_TVTI'^
M72_ZF?Z<+QI&;L!90D7-_P/2T;;NYQY2\184EII]#<J:7E3J8P0=JB4W/_<V
M&/B56?D;_^H_)LZ*[%KM8BW9\*FP!0+9"N1"<MD4+WPOP?LM:!M6WW6"DDT5
MUK5$3EQ/K9Y'[&5M[KC",7760YOJ6W,9DV716;5A=HQ)(Q/$) Q40M(ZN13$
M9N/)<6NNM='^L6ZN<(?1O_U<__#V[ 1,6-OUCLDV/O IBBTB)F+TIABI@^HE
MX+XGO2/5<+N@Z9Z&.X+D1A <NMWF.KK56H._Y5.^F.'YZ\OE!5N=B^6KBXO%
M-%VRI_EU_FZ^H.D9F\Z7,_[+EHZ[U1ZO%H2WK+">.1')@5 &P437>D/Z#.B5
MH9@"%2?[!7'G>QHV5M\ST(=%P!@/P_)A7K37!K.S#],?5*[J%^YR ,\;#ZY>
M3-YR(BG2PF( &5H:SDH%*<4(2IE0;8B!4B^QU/ZV-&PZX#A'81CYG[@Q?%NT
M<2\.V:>%_-2RQS2;M]Y^W[9TCJ9FE6*+21$8S7\D*A%2+&ACSCJ'7I[==VU+
MK]HO/.%PKLH<C(D1,YM=4=<VM00UI!P%8,@4HS(IR\U(Z,-=+YY9:*26[BZR
M_J6M19=\'7B,XB_!W%7%UU5[/1N#C[5 -JZVEJ4.0DP:7(E1&.-(AFUZ_&PU
M3_%A$H;!3/?BG7?*Z]&A9=TAQF63K ZM]5 +BP6?(!A5P(J<@](RNJU>J^V)
MER$;/74EV"=QL@>71^ 9O)^M/FMUF-Z>3[]/9ZL=K7O_6'9CA"4!DMJ[SA@B
MH'&\HZ1$#+4$W4]W\">I&A.&]A'ZO?XQ74E@Z 9>C^OD#S>ERH;/F2!FDF1G
M!DPU!4)E=P&C3S+EDFO:?!NSJSGS8:?>19W'-'J[GGKA\0A4T!^7#>G--6U[
M:NRY]D0F2GJ!;<14DFHULH^!SXH92M*)J$94L9<R@,=)&J7)LZ?HY[W(802(
MN@YR3'+P3A430/C"MWL;*!5L5""33Y2%=M'TT@3EFH!1:J!NT+(7CT\\ +3^
M^5&C/X^N><S0SW8;[SON0RI11>/!AT)L"^G,MGKK?5.4%QJS-.(HE1 #Y5!7
MAH/RV+I9*4!7"AAR"$&' C[*:JS,UM=>&OON0>M((TJ[H.C W.G.$AO!W7G[
M8G%#-ZS<9>>#Q1P14+(G8J0@-@DD>R<V8- EH9;]E#$\1=7 0.L;$YL8[$Q
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ME'0?T\?!L/K0SOZ0:Q2$/&AV1IP^(U(LYU0L5JR4"XW*[#5]DU" ^GV6^DG
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M:V(:!J,BR*R_PE.H1.&ZGIP?!UMX$R(EN)KRPIVXQ WD1KQ7=!;BU(;;8AL
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MT_^_VZ#_/YJ5V17\S[)9Y3_\?U!+ P04    " "*0G%1:!AM[[\'  "@F@
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M4Y!S"@$1$<EH88SO4[J&7BR5Q+7M_<EY*>$=!<NH*,,JX(B\+F,C60)'T6:
MH3P)W*D=VU7HSTF.;L-)3<4:JGT+3K,*-QE3E2"06! *W/L)??UE#&59@H"T
MW;K>J]\<EOK?PN)7X2T1*:497)DPCI"R/%-!,SJ%<Y:1+&8DA?$4>8P@( )#
M]&S&XBKX66Q6@<" IF1%!(68BYP+S78X4G0Y/&BZKMWI\T5.LK4>.9W754@X
MS*F@T1IBO4765<C_%?O@J/CVV:VB$T0>'APW.Y^=Z)PD"9X41DJG*@/F\;/D
M&T[SAZ7^R'D@[/=?_BDR)V:MKG (,<N]+%LBXR84N80)SN"<BP4XMO$6IEQH
M(JPI$4 104P0Q?0MD+9E4MV3:GGX/N;?@X$M [>$VA 3ILLT12[B*&48X(K)
MN98+^L>2":I.[ )V^8,\ _3(.3Y*'DSBE*7 I@/->/?QG&0SNB6JTZK5D3VM
M#B O_Q\,<E\D@UB&1%F4=2A&*P0U$WRK$_2(380)3'LN:*$27%4S2)H":J(_
M2$$4Y)CQHJH5IP_%$&TFNJ]4B52SEFG)#Y[3LOP5SQAF[J3[:R/F?E;"2N9^
MBGL1EY(OVHIIC]A8GE&21%@A-_,C+A(J#/0^)7E!V]L_G805>4K6;99I'[12
MYT[5^IBDFVX ;6[ZTU;+;-@-U:)*[$MELC6_Z5Y-W;U:,MF5U9MFR]XOMDUG
MK^PKF;6TRZ7;&'Z!V7Y3J56V"AN.MMW\'IRGK:FB[7-,2N2__V[6P0[4EXT^
MWF#$[W11!:=1UM,'RFSP^+)0R\;O105[>%!O= K]+#?%[G.W+WJ"PF=FWE9@
M5/X1N<TVTB4_1R1XRA+80O!28=WILC6LWPVS_Q8L>]KI76PL72H_W1;\H ._
M!X%_,?(&,)[X%_ZH=PGC<PB'?@"W$S\,O1$$82_TKKQ1"!/OUQM_@G//WD/@
M]4-_/ +5S&L-#X+>Y*PW\@)C_.[2>P^]?J@DNID?]@(X\]#8]63\FS] $^$8
MAN/+\87?Q\^.4=^$WF@ M_[E)<[#A<*>/RH7VIUU?C,9^<&P-*(7]OHWZ*SO
M!5KNO>L/>Z,+#_KCJRL_")2;XPGX8:!B.3^'FVM\HX+Q@G#W'-]FX-G%2\[+
MFZ>VP(\CR>[HSE7,Q\VO#UO[HPJ)L (LY7Z5?9_4>^]U-L_REDG?=YW^!5!+
M 0(4 Q0    ( (I"<5$VSZ<]W1\& ",.1  1              "  0    !H
M;VQX+3(P,C P.3(V+FAT;5!+ 0(4 Q0    ( (I"<5&GAP7452P  %H' @ 1
M              "  0P@!@!H;VQX+3(P,C P.3(V+GAS9%!+ 0(4 Q0    (
M (I"<5&^5.P]FD<   03 P 5              "  9!,!@!H;VQX+3(P,C P
M.3(V7V-A;"YX;6Q02P$"% ,4    " "*0G%1<HF!M282 0#-%PP %0
M        @ %=E 8 :&]L>"TR,#(P,#DR-E]D968N>&UL4$L! A0#%     @
MBD)Q4<O,B&I8( , ,E,$ !0              ( !MJ8' &AO;'@M,C R,# Y
M,C9?9S$N:G!G4$L! A0#%     @ BD)Q4?%\IUKQ.@( OF@7 !4
M     ( !0,<* &AO;'@M,C R,# Y,C9?;&%B+GAM;%!+ 0(4 Q0    ( (I"
M<5$=]B=E:GH! #:+$0 5              "  60"#0!H;VQX+3(P,C P.3(V
M7W!R92YX;6Q02P$"% ,4    " "*0G%1A'F2FT4[   Z=P$ %0
M    @ $!?0X :&]L>'$T+3(P,C!E>#$P,SDN:'1M4$L! A0#%     @ BD)Q
M46@8;>^_!P  H)H  !0              ( !>;@. &AO;'AQ-"TR,#(P97@R
M,3$N:'1M4$L! A0#%     @ BD)Q4<!.S[#6!   \10  !0
M ( !:L . &AO;'AQ-"TR,#(P97@R,S$N:'1M4$L! A0#%     @ BD)Q4?*X
M:F8."   KB4  !0              ( !<L4. &AO;'AQ-"TR,#(P97@S,3$N
M:'1M4$L! A0#%     @ BD)Q4<PU9/7R!P  :24  !0              ( !
MLLT. &AO;'AQ-"TR,#(P97@S,3(N:'1M4$L! A0#%     @ BD)Q45^AJY1;
M!0  D!,  !0              ( !UM4. &AO;'AQ-"TR,#(P97@S,C$N:'1M
M4$L! A0#%     @ BD)Q45#<D$D]!0  2A,  !0              ( !8]L.
K &AO;'AQ-"TR,#(P97@S,C(N:'1M4$L%!@     .  X FP,  -+@#@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
